PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lam, TTY; Zhou, BP; Wang, J; Chai, YJ; Shen, YY; Chen, XC; Ma, C; Hong, WS; Chen, Y; Zhang, YJ; Duan, L; Chen, PW; Jiang, JF; Zhang, Y; Li, LF; Poon, LLM; Webby, RJ; Smith, DK; Leung, GM; Peiris, JSM; Holmes, EC; Guan, Y; Zhu, HC				Lam, Tommy Tsan-Yuk; Zhou, Boping; Wang, Jia; Chai, Yujuan; Shen, Yongyi; Chen, Xinchun; Ma, Chi; Hong, Wenshan; Chen, Yin; Zhang, Yanjun; Duan, Lian; Chen, Peiwen; Jiang, Junfei; Zhang, Yu; Li, Lifeng; Poon, Leo Lit Man; Webby, Richard J.; Smith, David K.; Leung, Gabriel M.; Peiris, Joseph S. M.; Holmes, Edward C.; Guan, Yi; Zhu, Huachen			Dissemination, divergence and establishment of H7N9 influenza viruses in China	NATURE			English	Article							MAXIMUM-LIKELIHOOD PHYLOGENIES; HUMAN INFECTIONS; A VIRUS; POULTRY; DIVERSITY; EVOLUTION; GENESIS; GENOME; PHYML; HOST	Since 2013 the occurrence of human infections by a novel avian H7N9 influenza virus in China has demonstrated the continuing threat posed by zoonotic pathogens(1,2). Although the first outbreak wave that was centred on eastern China was seemingly averted, human infections recurred in October 2013 (refs 3-7). It is unclear how the H7N9 virus re-emerged and how it will develop further; potentially it may become a long-term threat to public health. Here we show that H7N9 viruses have spread from eastern to southern China and become persistent in chickens, which has led to the establishment of multiple regionally distinct lineages with different reassortant genotypes. Repeated introductions of viruses from Zhejiang to other provinces and the presence of H7N9 viruses at live poultry markets have fuelled the recurrence of human infections. This rapid expansion of the geographical distribution and genetic diversity of the H7N9 viruses poses a direct challenge to current disease control systems. Our results also suggest that H7N9 viruses have become enzootic in China and may spread beyond the region, following the pattern previously observed with H5N1 and H9N2 influenza viruses(8,9).	[Lam, Tommy Tsan-Yuk; Zhou, Boping; Chen, Xinchun; Duan, Lian; Chen, Peiwen; Jiang, Junfei; Poon, Leo Lit Man; Peiris, Joseph S. M.; Guan, Yi; Zhu, Huachen] Shenzhen Third Peoples Hosp, HKU Shenzhen Branch, State Key Lab Emerging Infect Dis, Shenzhen 518112, Peoples R China; [Lam, Tommy Tsan-Yuk; Wang, Jia; Chai, Yujuan; Shen, Yongyi; Ma, Chi; Hong, Wenshan; Duan, Lian; Chen, Peiwen; Zhang, Yu; Li, Lifeng; Smith, David K.; Guan, Yi; Zhu, Huachen] SUMC, Joint Influenza Res Ctr SUMC HKU, Shantou 515041, Peoples R China; [Lam, Tommy Tsan-Yuk; Wang, Jia; Chai, Yujuan; Shen, Yongyi; Ma, Chi; Duan, Lian; Jiang, Junfei; Zhang, Yu; Li, Lifeng; Poon, Leo Lit Man; Smith, David K.; Leung, Gabriel M.; Peiris, Joseph S. M.; Guan, Yi; Zhu, Huachen] Univ Hong Kong, Sch Publ Hlth, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China; [Chen, Yin; Zhang, Yanjun] Zhejiang Prov Ctr Dis Control & Prevent, Key Lab Emergency Detect Publ Hlth Zhejiang Prov, Hangzhou 310051, Zhejiang, Peoples R China; [Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Hong Kong; Zhejiang Provincial Center for Disease Control & Prevention; St Jude Children's Research Hospital; University of Sydney; University of Sydney	Guan, Y (corresponding author), Shenzhen Third Peoples Hosp, HKU Shenzhen Branch, State Key Lab Emerging Infect Dis, Shenzhen 518112, Peoples R China.	yguan@hku.hk; zhuhch@hku.hk	Zhu, Huachen/A-8252-2017; Poon, Leo/AAP-6887-2020; Webby, Richard J/N-5657-2018; Poon, Leo Lit Man/C-4382-2009; Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; Peiris, Joseph Sriyal Malik/C-4380-2009; Lam, Tsan Yuk/D-4837-2012	Zhu, Huachen/0000-0003-2711-0501; Poon, Leo Lit Man/0000-0002-9101-7953; Holmes, Edward/0000-0001-9596-3552; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Shen, Yongyi/0000-0001-7660-5522; Smith, David/0000-0003-3608-0586; Lam, Tsan Yuk/0000-0002-9769-1527; Leung, Gabriel/0000-0002-2503-6283; Guan, Yi/0000-0001-6057-9243	Shenzhen Peacock Plan High-End Talents Program [KQTD201203]; Hong Kong Government [RRG-10, RRG-14]; University Grants Committee of Hong Kong [AoE/M-12/06]; National Institute of Allergy and Infectious Diseases [HHSN272201400006C]; Li Ka Shing Foundation; NHMRC [AF30]	Shenzhen Peacock Plan High-End Talents Program; Hong Kong Government; University Grants Committee of Hong Kong; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Li Ka Shing Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank C. L. Cheung, H. Y. Liang and G. C. Yu for their assistance in data processing; Z. H. Ou, Z. Y. Jin, T. Y. Leung, K. K. Chan, Y. R. Qiu, J. Z. Xie, N. Qi, J. Zhou, P. Y. Huang and all staff members at the Joint Influenza Research Centre (SUMC/HKU) for technical support, the four collaborative hospitals in Shenzhen for human sample collection, and P. Lemey for his advice on phylogeographic analysis. This study was supported by the Shenzhen Peacock Plan High-End Talents Program (KQTD201203), the Health and Medical Research Fund of the Hong Kong Government (RRG-10 and RRG-14), the University Grants Committee of Hong Kong (Area of Excellence Scheme grant AoE/M-12/06), the National Institute of Allergy and Infectious Diseases (contract HHSN272201400006C), and the Li Ka Shing Foundation. E.C.H. is supported by an NHMRC Australia Fellowship (AF30).	Chen E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.43.20616; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chen ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107266; Chen ZQ, 2014, EMERG INFECT DIS, V20, P1535, DOI 10.3201/eid2009.140424; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, VIRUS RES, V178, P35, DOI 10.1016/j.virusres.2013.05.012; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Lam TTY, 2013, INFECT GENET EVOL, V18, P367, DOI 10.1016/j.meegid.2013.03.015; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lu J, 2014, J VIROL, V88, P8297, DOI 10.1128/JVI.00630-14; Ma C., 2015, J VIROL; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Okamatsu M, 2013, VIRUS GENES, V47, P317, DOI 10.1007/s11262-013-0954-7; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Qi X, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00706-14; Rambaut A., 2007, TRACER V1 5; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Wang D, 2014, EUROSURVEILLANCE, V2013, P19, DOI DOI 10.2807/1560-7917.ES2014.19.25.20836; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, SIT UPD AV INFL; World Health Organization (WHO), 2014, WHO INF MOL DIAGN IN; Wu AP, 2013, CELL HOST MICROBE, V14, P446, DOI 10.1016/j.chom.2013.09.001; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhao KK, 2013, VET MICROBIOL, V163, P351, DOI 10.1016/j.vetmic.2012.12.025	38	168	175	3	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					102	U265		10.1038/nature14348	http://dx.doi.org/10.1038/nature14348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25762140				2022-12-28	WOS:000355543400038
J	Twyman-Saint Victor, C; Rech, AJ; Maity, A; Rengan, R; Pauken, KE; Stelekati, E; Benci, JL; Xu, BH; Dada, H; Odorizzi, PM; Herati, RS; Mansfield, KD; Patsch, D; Amaravadi, RK; Schuchter, LM; Ishwaran, H; Mick, R; Pryma, DA; Xu, XW; Feldman, MD; Gangadhar, TC; Hahn, SM; Wherry, EJ; Vonderheide, RH; Minn, AJ				Twyman-Saint Victor, Christina; Rech, Andrew J.; Maity, Amit; Rengan, Ramesh; Pauken, Kristen E.; Stelekati, Erietta; Benci, Joseph L.; Xu, Bihui; Dada, Hannah; Odorizzi, Pamela M.; Herati, Ramin S.; Mansfield, Kathleen D.; Patsch, Dana; Amaravadi, Ravi K.; Schuchter, Lynn M.; Ishwaran, Hemant; Mick, Rosemarie; Pryma, Daniel A.; Xu, Xiaowei; Feldman, Michael D.; Gangadhar, Tara C.; Hahn, Stephen M.; Wherry, E. John; Vonderheide, Robert H.; Minn, Andy J.			Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer	NATURE			English	Article							T-CELLS; EXPRESSION; SAFETY; REPERTOIRE; ANTI-PD-1; ANTIBODY; PD-1	Immune checkpoint inhibitors(1) result in impressive clinical responses(2-5), but optimal results will require combination with each other(6) and other therapies. This raises fundamental questions about mechanisms of non-redundancy and resistance. Here we report major tumour regressions in a subset of patients with metastatic melanoma treated with an anti-CTLA4 antibody (anti-CTLA4) and radiation, and reproduced this effect in mouse models. Although combined treatment improved responses in irradiated and unirradiated tumours, resistance was common. Unbiased analyses of mice revealed that resistance was due to upregulation of PD-L1 on melanoma cells and associated with T-cell exhaustion. Accordingly, optimal response in melanoma and other cancer types requires radiation, anti-CTLA4 and anti-PD-L1/PD-1. Anti-CTLA4 predominantly inhibits T-regulatory cells (T-reg cells), thereby increasing theCD8T-cell to T-reg (CD8/T-reg) ratio. Radiation enhances the diversity of the T-cell receptor (TCR) repertoire of intratumoral T cells. Together, anti-CTLA4 promotes expansion of T cells, while radiation shapes the TCR repertoire of the expanded peripheral clones. Addition of PD-L1 blockade reverses T-cell exhaustion to mitigate depression in the CD8/T-reg ratio and further encourages oligoclonal T-cell expansion. Similarly to results from mice, patients on our clinical trial with melanoma showing high PD-L1 did not respond to radiation plus anti-CTLA4, demonstrated persistent T-cell exhaustion, and rapidly progressed. Thus, PD-L1 on melanoma cells allows tumours to escape anti-CTLA4-based therapy, and the combination of radiation, anti-CTLA4 and anti-PD-L1 promotes response and immunity through distinct mechanisms.	[Twyman-Saint Victor, Christina; Herati, Ramin S.; Amaravadi, Ravi K.; Schuchter, Lynn M.; Gangadhar, Tara C.; Vonderheide, Robert H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Twyman-Saint Victor, Christina; Rech, Andrew J.; Benci, Joseph L.; Xu, Bihui; Dada, Hannah; Vonderheide, Robert H.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Maity, Amit; Rengan, Ramesh; Benci, Joseph L.; Xu, Bihui; Dada, Hannah; Patsch, Dana; Hahn, Stephen M.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Maity, Amit; Rengan, Ramesh; Amaravadi, Ravi K.; Schuchter, Lynn M.; Mick, Rosemarie; Pryma, Daniel A.; Xu, Xiaowei; Feldman, Michael D.; Gangadhar, Tara C.; Hahn, Stephen M.; Wherry, E. John; Vonderheide, Robert H.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Pauken, Kristen E.; Stelekati, Erietta; Odorizzi, Pamela M.; Mansfield, Kathleen D.; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Pauken, Kristen E.; Stelekati, Erietta; Odorizzi, Pamela M.; Herati, Ramin S.; Mansfield, Kathleen D.; Wherry, E. John; Vonderheide, Robert H.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Ishwaran, Hemant] Univ Miami, Dept Publ Hlth Sci, Div Biostat, Miami, FL 33136 USA; [Mick, Rosemarie] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Pryma, Daniel A.] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Xu, Xiaowei; Feldman, Michael D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Miami; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	andyminn@exchange.upenn.edu	Wherry, John/ABI-1280-2020; Rengan, Ramesh/L-4700-2019	Rengan, Ramesh/0000-0001-5379-536X; Minn, Andy/0000-0003-1418-0906; Twyman-Saint Victor, Christina/0000-0001-7253-6179; Ishwaran, Hemant/0000-0003-2758-9647; Herati, Ramin/0000-0003-2613-4050; Benci, Joseph/0000-0002-1759-4621; Sedaghat Herati, Ramin/0000-0001-7713-2587; Maity, Amit/0000-0001-7151-2845	NIH training grant and career development award [T32DK007066, KL2TR000139]; Robertson Foundation/Cancer Research Institute Irvington Fellowship; Melanoma Research Alliance; NIH [P50CA174523, R01CA163739, R01CA158186, P30CA016520, U19AI082630, R01AI105343, U01AI095608, P01AI112521]; Basser Research Center for BRCA; NIH/NCI [R01CA172651]; Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer; Institute for Translational Medicine and Therapeutics' Transdisciplinary Program in Translational Medicine and Therapeutics; National Center for Research Resources [UL1RR024134]; NATIONAL CANCER INSTITUTE [R01CA169134, R01CA172651, R01CA163739, P30CA016520, P50CA174523, R01CA158186, R01CA169123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000139] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, P01AI112521, R01AI105343, U01AI095608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066] Funding Source: NIH RePORTER	NIH training grant and career development award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Foundation/Cancer Research Institute Irvington Fellowship; Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basser Research Center for BRCA; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer; Institute for Translational Medicine and Therapeutics' Transdisciplinary Program in Translational Medicine and Therapeutics; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.T. was supported by an NIH training grant and career development award (T32DK007066, KL2TR000139). K.E.P. was supported by a Robertson Foundation/Cancer Research Institute Irvington Fellowship, T.C.G. and R.R. by the Melanoma Research Alliance, and X.X. and M.D.F by a grant from the NIH (P50CA174523). B.X. and A.J.M. were supported by the Basser Research Center for BRCA. A.J.M. is a Department of Defense Era of Hope Scholar (W81XWH-09-1-0339) and was supported by funding from the NIH/NCI (R01CA172651). H.I. and A.J.M. were supported by a grant from the NIH (R01CA163739). R.H.V. was supported by grants from the NIH (R01CA158186, P30CA016520) and by the Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer. E.J.W. was supported by funding from the NIH (U19AI082630, R01AI105343, U01AI095608 and P01AI112521). The project was supported in part by the Institute for Translational Medicine and Therapeutics' Transdisciplinary Program in Translational Medicine and Therapeutics, and the National Center for Research Resources (UL1RR024134).	Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holets LM, 2006, BIOL REPROD, V74, P352, DOI 10.1095/biolreprod.105.046581; Ishwaran Hemant, 2011, Statistical Analysis and Data Mining, V4, P115, DOI 10.1002/sam.10103; Ishwaran H., 2013, RANDOM FORESTS SURVI; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Rempala GA, 2013, J MATH BIOL, V67, P1339, DOI 10.1007/s00285-012-0589-7; Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thomas N, 2014, BIOINFORMATICS, V30, P3181, DOI 10.1093/bioinformatics/btu523; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	33	1536	1586	18	356	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					373	+		10.1038/nature14292	http://dx.doi.org/10.1038/nature14292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25754329	Green Accepted			2022-12-28	WOS:000352974200044
J	Wang, XC; Gong, W; Fang, LZ; Zhu, RY; Li, SH; Engle, KM; Yu, JQ				Wang, Xiao-Chen; Gong, Wei; Fang, Li-Zhen; Zhu, Ru-Yi; Li, Suhua; Engle, Keary M.; Yu, Jin-Quan			Ligand-enabled meta-C-H activation using a transient mediator	NATURE			English	Article							U-SHAPED TEMPLATE; ASYMMETRIC-SYNTHESIS; BOND ACTIVATION; PALLADIUM; ARYLATION; OLEFINATION; FUNCTIONALIZATION; 2-ALKYLATION; ALKYLATION; C(SP(3))-H	Achieving site selectivity in C-H functionalization reactions is a significant challenge, especially when the target C-H bond is distant from existing functional groups(1-5). Coordination of a functional group to a metal is often a key driving force and control element in many important reactions including asymmetric hydrogenation(6), epoxidation(7,8) and lithiation(9). Exploitation of this effect has led to the development of a broad range of directed C-H activation reactions(10-14). However, these C-H activation methods are limited to proximal C-H bonds, which are spatially and geometrically accessible from the directing functional group. The development of meta-selective C-H functionalizations remains a significant challenges(1-5,15-17). We recently developed a U-shaped template that can be used to overcome this constraint and have shown that it can be used to selectively activate remote meta-C-H bonds(1,2). Although this approach has proved to be applicable to various substrates and catalytic transformations(3-5), the need for a covalently attached, complex template is a substantial drawback for synthetic applications. Here we report an alternative approach employing norbornene as a transient mediator to achieve meta-selective C-H activation with a simple and common orthodirecting group. The use of a newly developed pyridine-based ligand is crucial for relaying the palladium catalyst to the meta position by norbornene after initial ortho-C-H activation. This catalytic reaction demonstrates the feasibility of switching ortho-selectivity to metaselectivity in C-H activation of the same substrate by catalyst control.	[Wang, Xiao-Chen; Gong, Wei; Fang, Li-Zhen; Zhu, Ru-Yi; Li, Suhua; Engle, Keary M.; Yu, Jin-Quan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Zhu, Ruyi/AAO-4630-2021; Engle, Keary/A-9223-2015	Engle, Keary/0000-0003-2767-6556	Scripps Research Institute; National Institutes of Health (NIGMS) [1R01 GM102265]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102265] Funding Source: NIH RePORTER	Scripps Research Institute; National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Spangler and A. Homs for constructive suggestions. We thank the Scripps Research Institute and the National Institutes of Health (NIGMS, 1R01 GM102265) for financial support. L.-Z.F. is a visiting scholar from School of Pharmacy, Xinxiang Medical University and is sponsored by the China Scholarship Council.	BROWN JM, 1993, CHEM SOC REV, V22, P25, DOI 10.1039/cs9932200025; Cardenas DJ, 2006, J AM CHEM SOC, V128, P5033, DOI 10.1021/ja056661j; Catellani M, 1996, SYNTHESIS-STUTTGART, P769; Catellani M, 1997, ANGEW CHEM INT EDIT, V36, P119, DOI 10.1002/anie.199701191; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Dong Z, 2013, J AM CHEM SOC, V135, P18350, DOI 10.1021/ja410823e; Duong HA, 2011, ANGEW CHEM INT EDIT, V50, P463, DOI 10.1002/anie.201004704; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Faccini F, 2004, J AM CHEM SOC, V126, P78, DOI 10.1021/ja039043g; Hartung C. G., 2004, MODERN ARENE CHEM, P330, DOI DOI 10.1002/3527601767.CH10; He J, 2014, SCIENCE, V343, P1216, DOI 10.1126/science.1249198; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Jiao L, 2012, J AM CHEM SOC, V134, P14563, DOI 10.1021/ja3058138; Jiao L, 2011, J AM CHEM SOC, V133, P12990, DOI 10.1021/ja2055066; Lee S, 2013, J AM CHEM SOC, V135, P18778, DOI 10.1021/ja4107034; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Li SH, 2014, J AM CHEM SOC, V136, P5267, DOI 10.1021/ja501689j; Li Z, 2013, ACCOUNTS CHEM RES, V46, P506, DOI 10.1021/ar300216r; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Martins A, 2010, ORG LETT, V12, P5186, DOI 10.1021/ol1019037; Martins A, 2010, TOP CURR CHEM, V292, P1, DOI 10.1007/128_2009_13; Ojima, 2005, CATALYTIC ASYMMETRIC, P231; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Tang RY, 2014, NATURE, V507, P215, DOI 10.1038/nature12963; Wan L, 2013, J AM CHEM SOC, V135, P18056, DOI 10.1021/ja410760f; Wang XC, 2013, J AM CHEM SOC, V135, P10326, DOI 10.1021/ja4055492; Wencel-Delord J, 2011, CHEM SOC REV, V40, P4740, DOI 10.1039/c1cs15083a; Yang GQ, 2014, J AM CHEM SOC, V136, P10807, DOI 10.1021/ja505737x; Zhu RY, 2014, J AM CHEM SOC, V136, P13194, DOI 10.1021/ja508165a	30	389	391	17	374	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					334	338		10.1038/nature14214	http://dx.doi.org/10.1038/nature14214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25754328	Green Accepted			2022-12-28	WOS:000351171900037
J	Najafzadeh, M; Andersson, K; Shrank, WH; Krumme, AA; Matlin, OS; Brennan, T; Avorn, J; Choudhry, NK				Najafzadeh, Mehdi; Andersson, Karin; Shrank, William H.; Krumme, Alexis A.; Matlin, Olga S.; Brennan, Troyen; Avorn, Jerry; Choudhry, Niteesh K.			Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus	ANNALS OF INTERNAL MEDICINE			English	Article							DISCRETE-EVENT SIMULATION; ACTING ANTIVIRAL THERAPY; TREATMENT-NAIVE PATIENTS; GENOTYPE 1 INFECTION; CHRONIC HCV; UNITED-STATES; FIBROSIS PROGRESSION; PLUS SOFOSBUVIR; ALCOHOL-USE; RIBAVIRIN	Background: New regimens for hepatitis C virus (HCV) have shorter treatment durations and increased rates of sustained virologic response compared with existing therapies but are extremely expensive. Objective: To evaluate the cost-effectiveness of these treatments under different assumptions about their price and efficacy. Design: Discrete-event simulation. Data Sources: Published literature. Target Population: Treatment-naive patents infected with chronic HCV genotype 1, 2, or 3. Time Horizon: Lifetime. Perspective: Societal. Intervention: Usual care (boceprevir-ribavirin-pegylated interferon [PEG]) was compared with sofosbuvir-ribavirin-PEG and 3 PEG-free regimens: sofosbuvir-simeprevir, sofosbuvir-daclatasvir, and sofosbuvir-ledipasvir. For genotypes 2 and 3, usual care (ribavirin-PEG) was compared with sofosbuvir-ribavirin, sofosbuvir-daclatasvir, and sofosbuvir-ledipasvir-ribavirin (genotype 3 only). Outcome Measures: Discounted costs (in 2014 U.S. dollars), quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Assuming sofosbuvir, simeprevir, daclatasvir, and ledipasvir cost $7000, $5500, $5500, and $875 per week, respectively, sofosbuvir-ledipasvir was cost-effective for genotype 1 and cost $12 825 more per OALY than usual care. For genotype 2, sofosbuvir-ribavirin and sofosbuvir-daclatasvir cost $110000 and $691 000 per QALY, respectively. For genotype 3, sofosbuvir-ledipasvir-ribavirin cost $73 000 per QALY, sofosbuvir-ribavirin was more costly and less effective than usual care, and sofosbuvir-daclatasvir cost more than $396 000 per QALY at assumed prices. Results of Sensitivity Analysis: Sofosbuvir-ledipasvir was the optimal strategy in most simulations for genotype 1 and would be cost-saving if sofosbuvir cost less than $5500. For genotype 2, sofosbuvir-ribavirin-PEG would be cost-saving if sofosbuvir cost less than $2250 per week. For genotype 3, sofosbuvir-ledipasvir-ribavirin would be cost-saving if sofosbuvir cost less than $1500 per week. Limitation: Data are lacking on real-world effectiveness of new treatments and some prices. Conclusion: From a societal perspective, novel treatments for HCV are cost-effective compared with usual care for genotype 1 and probably genotype 3 but not for genotype 2.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; CVS Hlth, Woonsocket, RI USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Choudhry, NK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	mnajafzadeh@partners.org; nchoudhry@partners.org		Andersson, Karin/0000-0002-8497-1335	CVS Health	CVS Health	CVS Health.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Anand BS, 2006, GASTROENTEROLOGY, V130, P1607, DOI 10.1053/j.gastro.2006.02.023; [Anonymous], 2014, FDA APPR VIEK PAK TR; [Anonymous], 2014, GIL ANN PHAS 2 RES 2; Arias E., 2012, NATL VITAL STAT REPO, V61; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BLS, 2014, CPI INFL CALC; Brennan T, 2014, JAMA-J AM MED ASSOC, V312, P593, DOI 10.1001/jama.2014.8897; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; Caro JJ, 2010, VALUE HEALTH, V13, P1056, DOI 10.1111/j.1524-4733.2010.00775.x; Chan K, 2013, CLIN GASTROENTEROL H, V11, P1503, DOI 10.1016/j.cgh.2013.05.014; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Ferrante SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-190; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gold MR, 1996, COST EFFECTIVENESS H; Gordon SC, 2012, HEPATOLOGY, V56, P1651, DOI 10.1002/hep.25842; Holmes JA, 2012, J VIRAL HEPATITIS, V19, P677, DOI 10.1111/jvh.12003; Jacobson I., 2013, 64 ANN M AM ASS STUD; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Karnon J, 2012, MED DECIS MAKING, V32, P701, DOI 10.1177/0272989X12455462; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; McCombs JS, 2011, CLIN THER, V33, P1268, DOI 10.1016/j.clinthera.2011.07.008; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Owens GM., 2014, AM J MANAG CARE; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Russell M, 2012, HEPATOLOGY, V56, P1223, DOI 10.1002/hep.25755; Ryan B., 2014, HEP MAGAZINE    1010; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Solomon M, 2011, DIGEST DIS SCI, V56, P3024, DOI 10.1007/s10620-011-1802-z; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Yee HS, 2012, AM J GASTROENTEROL, V107, P669, DOI 10.1038/ajg.2012.48; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	52	171	174	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					407	U136		10.7326/M14-1152	http://dx.doi.org/10.7326/M14-1152			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775313				2022-12-28	WOS:000351279600014
J	Maxwell, SL; Milner-Gulland, EJ; Jones, JPG; Knight, AT; Bunnefeld, N; Nuno, A; Bal, P; Earle, S; Watson, JEM; Rhodes, JR				Maxwell, S. L.; Milner-Gulland, E. J.; Jones, J. P. G.; Knight, A. T.; Bunnefeld, N.; Nuno, A.; Bal, P.; Earle, S.; Watson, J. E. M.; Rhodes, J. R.			Being smart about SMART environmental targets	SCIENCE			English	Editorial Material									[Maxwell, S. L.; Bal, P.; Watson, J. E. M.; Rhodes, J. R.] Univ Queensland, Sch Geog Planning & Environm Management, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia; [Milner-Gulland, E. J.; Knight, A. T.; Earle, S.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Jones, J. P. G.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor LL57 2DG, Gwynedd, Wales; [Bunnefeld, N.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Nuno, A.] Univ Exeter, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England; [Watson, J. E. M.] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY 10460 USA	University of Queensland; Imperial College London; Bangor University; University of Stirling; University of Exeter; Wildlife Conservation Society	Maxwell, SL (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia.	smaxwell@uq.edu.au	Knight, Andrew Thomas/C-8394-2009; Jones, Julia P G/A-3031-2011; Watson, James Edward Maxwell/D-8779-2013; Jones, Julia P G/ABD-5629-2021; Nuno, Ana/H-9497-2019; Rhodes, Jonathan/C-4841-2008	Knight, Andrew Thomas/0000-0002-6563-0500; Jones, Julia P G/0000-0002-5199-3335; Watson, James Edward Maxwell/0000-0003-4942-1984; Jones, Julia P G/0000-0002-5199-3335; Bunnefeld, Nils/0000-0002-1349-4463; Rhodes, Jonathan/0000-0001-6746-7412; Bal, Payal/0000-0002-8759-6964; Nuno, Ana/0000-0003-4680-2378				Bull JW, 2014, BIOL CONSERV, V178, P2, DOI 10.1016/j.biocon.2014.07.006; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Campbell LM, 2014, GLOBAL ENVIRON POLIT, V14, P41, DOI 10.1162/GLEP_a_00238; Daniels S.E., 2001, WORKING ENV CONFLICT; Dubash NK, 2014, SCIENCE, V345, P36, DOI 10.1126/science.1255734; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Pouwels R, 2011, ECOL SOC, V16, DOI 10.5751/ES-04191-160417; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; SKJAERSETH JB, 1992, GLOBAL ENVIRON CHANG, V2, P292, DOI 10.1016/0959-3780(92)90046-A; Smead R, 2014, NAT CLIM CHANGE, V4, P442, DOI [10.1038/NCLIMATE2229, 10.1038/nclimate2229]; Stafford-Smith M, 2014, NATURE, V513, P281, DOI 10.1038/513281a; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484	13	63	64	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1075	1076		10.1126/science.aaa1451	http://dx.doi.org/10.1126/science.aaa1451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4WB	25745152				2022-12-28	WOS:000350354200024
J	Bohaty, BR; Hebert, AA				Bohaty, Benjamin R.; Hebert, Adelaide A.			African Tick-Bite Fever after a Game-Hunting Expedition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bohaty, Benjamin R.; Hebert, Adelaide A.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Bohaty, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.	adelaide.a.hebert@uth.tmc.edu							0	9	9	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					E14	E14		10.1056/NEJMicm1312910	http://dx.doi.org/10.1056/NEJMicm1312910			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738687				2022-12-28	WOS:000350304500001
J	Wang, Q				Wang, Qiang			China's scientists must engage the public on GM	NATURE			English	Editorial Material									Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	qiangwang7@outlook.com	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093					0	22	22	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					7	7		10.1038/519007a	http://dx.doi.org/10.1038/519007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4EQ	25739594	Bronze			2022-12-28	WOS:000350304000004
J	Schaffer, JM; Singh, SK; Reitz, BA; Zamanian, RT; Mallidi, HR				Schaffer, Justin M.; Singh, Steve K.; Reitz, Bruce A.; Zamanian, Roham T.; Mallidi, Hari R.			Single- vs Double-Lung Transplantation in Patients With Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis Since the Implementation of Lung Allocation Based on Medical Need	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; PROPORTIONAL-HAZARDS; PROPENSITY SCORE; RECIPIENT AGE; SURVIVAL; OUTCOMES; MODELS; IMPACT; HEART; REGISTRY	IMPORTANCE Outcomes of single-and double-lung transplantation have not been rigorously assessed since the allocation of donor lungs according to medical need as quantified by the Lung Allocation Score, which began in 2005. OBJECTIVE To compare outcomes in single-and double-lung transplant recipients since the Lung Allocation Score was implemented. DESIGN, SETTING, AND PARTICIPANTS In this exploratory analysis, adults with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD) who underwent lung transplantation in the United States between May 4, 2005, and December 31, 2012, were identified in the United Network for Organ Sharing thoracic registry, with follow-up to December 31, 2012. Posttransplantation graft survival was assessed with Kaplan-Meier analysis. Propensity scores were used to control for treatment selection bias. A multivariable flexible parametric prognostic model was used to characterize the time-varying hazard associated with single-vs double-lung transplantation. EXPOSURE Single-or double-lung transplantation. MAIN OUTCOMES AND MEASURES Composite of posttransplant death and graft failure (retransplantation). RESULTS Patients with IPF (n = 4134, of whom 2010 underwent single-lung and 2124 underwent double-lung transplantation) or COPD (n = 3174, of whom 1299 underwent single-lung and 1875 underwent double-lung transplantation) were identified as having undergone lung transplantation since May 2005. Median follow-up was 23.5 months. Of the patients with IPF, 1380 (33.4%) died and 115 (2.8%) underwent retransplantation; of the patients with COPD, 1138 (34.0%) died and 59 (1.9%) underwent retransplantation. After confounders were controlled for with propensity score analysis, double-lung transplants were associated with better graft survival in patients with IPF (adjusted median survival, 65.2 months [interquartile range {IQR}, 21.4-91.3 months] vs 50.4 months [IQR, 17.0-87.5 months]; P < .001) but not in patients with COPD (adjusted median survival, 67.7 months [IQR, 25.2-89.6 months] vs 64.0 months [IQR, 25.2-88.7 months]; P = .23). The interaction between diagnosis type (COPD or IPF) and graft failure was significant (P = .049). Double-lung transplants had a time-varying association with graft survival; a decreased instantaneous late hazard for death or graft failure among patients with IPF was noted at 1 year and persisted at 5 years postoperatively (instantaneous hazard at 5 years, hazard ratio, 0.67 [95% CI, 0.52-0.84] in patients with IPF and 0.89 [95% CI, 0.71-1.13] in patients with COPD). CONCLUSIONS AND RELEVANCE In an exploratory analysis of registry data since implementation of a medical need-based lung allocation system, double-lung transplantation was associated with better graft survival than single-lung transplantation in patients with IPF. In patients with COPD, there was no survival difference between single-and double-lung transplant recipients at 5 years.	[Schaffer, Justin M.; Reitz, Bruce A.] Stanford Hosp & Clin, Dept Cardiothorac Surg, Stanford, CA USA; [Singh, Steve K.; Mallidi, Hari R.] Baylor Coll Med, Div Cardiothorac Surg, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Singh, Steve K.; Mallidi, Hari R.] Texas Heart Inst, Ctr Cardiac Support, Houston, TX 77030 USA; [Zamanian, Roham T.] Vera Moulton Wall Ctr Pulm Vasc Dis, Div Pulm & Crit Care Med, Dept Med, Stanford, CA USA	Stanford University; Baylor College of Medicine; Texas Heart Institute	Mallidi, HR (corresponding author), Texas Heart Inst, 6770 Bertner Ave,C355, Houston, TX 77030 USA.	mallidi@bcm.edu						AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen JG, 2009, J HEART LUNG TRANSPL, V28, P1063, DOI 10.1016/j.healun.2009.06.012; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Centers for Disease Control and Prevention, GUID PREV TRANSM HUM; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Colvin-Adams M, 2012, AM J TRANSPLANT, V12, P3213, DOI 10.1111/j.1600-6143.2012.04258.x; COX DR, 1972, J R STAT SOC B, V34, P187; Eberlein M, 2013, J HEART LUNG TRANSPL, V32, P1172, DOI 10.1016/j.healun.2013.06.011; Eberlein Michael, 2013, Ann Am Thorac Soc, V10, P418, DOI 10.1513/AnnalsATS.201301-008OC; Eberlein M, 2011, CLIN CHEST MED, V32, P213, DOI 10.1016/j.ccm.2011.02.004; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Iribarne A, 2009, CHEST, V135, P923, DOI 10.1378/chest.08-2052; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; King CS, 2009, J HEART LUNG TRANSPL, V28, P851, DOI 10.1016/j.healun.2009.04.023; Kotloff RM, 2011, AM J RESP CRIT CARE, V184, P159, DOI 10.1164/rccm.201101-0134CI; Lederer DJ, 2011, AM J RESP CRIT CARE, V184, P1055, DOI 10.1164/rccm.201104-0728OC; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; Meyer DM, 2005, ANN THORAC SURG, V79, P950, DOI 10.1016/j.athoracsur.2004.08.076; Meyer DM, 2001, J HEART LUNG TRANSPL, V20, P935, DOI 10.1016/S1053-2498(01)00295-9; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Schwaiblmair M, 1999, AM J RESP CRIT CARE, V159, P1277, DOI 10.1164/ajrccm.159.4.9805113; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tan ZQ, 2010, BIOMETRIKA, V97, P661, DOI 10.1093/biomet/asq035; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Thabut G, 2010, JAMA-J AM MED ASSOC, V304, P53, DOI 10.1001/jama.2010.885; Thabut G, 2009, ANN INTERN MED, V151, P767, DOI 10.7326/0003-4819-151-11-200912010-00004; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Tsuang WM, 2013, ANN INTERN MED, V158, P650, DOI 10.7326/0003-4819-158-9-201305070-00004; Valapour M, 2013, AM J TRANSPLANT, V13, P149, DOI 10.1111/ajt.12024; Whelan TPM, 2005, J HEART LUNG TRANSPL, V24, P1269, DOI 10.1016/j.healun.2004.10.014; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Williams TJ, 1997, CLIN CHEST MED, V18, P245, DOI 10.1016/S0272-5231(05)70376-2; Yusen RD, 2010, AM J TRANSPLANT, V10, P1047, DOI 10.1111/j.1600-6143.2010.03055.x	43	89	99	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					936	948		10.1001/jama.2015.1175	http://dx.doi.org/10.1001/jama.2015.1175			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734735	Bronze			2022-12-28	WOS:000350231800016
J	Narendra, V; Rocha, PP; An, DS; Raviram, R; Skok, JA; Mazzoni, EO; Reinberg, D				Narendra, Varun; Rocha, Pedro P.; An, Disi; Raviram, Ramya; Skok, Jane A.; Mazzoni, Esteban O.; Reinberg, Danny			CTCF establishes discrete functional chromatin domains at the Hox clusters during differentiation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; POOL IDENTITY; MOTOR-NEURONS; GENE; EXPRESSION; INSULATOR; NETWORK; SIGNALS	Polycomb and Trithorax group proteins encode the epigenetic memory of cellular positional identity by establishing inheritable domains of repressive and active chromatin within the Hox clusters. Here we demonstrate that the CCCTC-binding factor (CTCF) functions to insulate these adjacent yet antagonistic chromatin domains during embryonic stem cell differentiation into cervical motor neurons. Deletion of CTCF binding sites within the Hox clusters results in the expansion of active chromatin into the repressive domain. CTCF functions as an insulator by organizing Hox clusters into spatially disjoint domains. Ablation of CTCF binding disrupts topological boundaries such that caudal Hox genes leave the repressed domain and become subject to transcriptional activation. Hence, CTCF is required to insulate facultative heterochromatin from impinging euchromatin to produce discrete positional identities.	[Narendra, Varun; Reinberg, Danny] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Narendra, Varun; Reinberg, Danny] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA; [Rocha, Pedro P.; Raviram, Ramya; Skok, Jane A.] NYU, Dept Pathol, Sch Med, New York, NY 10016 USA; [An, Disi; Mazzoni, Esteban O.] NYU, Dept Biol, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	Reinberg, D (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	eom204@nyu.edu; danny.reinberg@nyumc.org	Skok, Jane/ABF-7249-2020	Skok, Jane/0000-0002-4145-1516; Reinberg, Danny/0000-0003-4288-2016; Rocha, Pedro/0000-0003-4691-7773; mazzoni, esteban/0000-0001-8994-681X; An, Disi/0000-0002-3821-7497	NIH [R37-37120, GM-64844, T32 GM007238, R01HD079682, GM086852, GM112192]; Project A. L. S. foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079682] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852, R01GM112192, R01GM064844, T32GM007238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project A. L. S. foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All sequencing data have been deposited to the Gene Expression Omnibus as series GSE60240 and will be made immediately available upon publication. We thank L. A. Rojas, C. Leek, A. Singhal, S. Tu, R. Bonasio, and L. Vales for thoughtful discussions and revision of the manuscript. We also thank the New York University Genome Technology Center for help with sequencing. This work was supported by grants from the NIH (R37-37120 and GM-64844 to D.R., T32 GM007238 to V.N., R01HD079682 to E.O.M., and GM086852 and GM112192 to J.A.S.). D.A. was supported by the Project A. L. S. foundation. P.P.R. is a National Cancer Center postdoctoral fellow. J.A.S. is a Leukemia and Lymphoma Society scholar. V.N., E.O.M., and D.R. conceived the project, designed the experiments, and wrote the paper; V.N. performed most of the experiments and the bioinformatic analysis; D.A. performed the immunocytochemistry; and P.P.R., R.R., and J.A.S. advised on the 4C-seq procedure and analysis.	Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bowman SK, 2014, ELIFE, V3, DOI 10.7554/eLife.02833; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; INGHAM PW, 1983, NATURE, V306, P591, DOI 10.1038/306591a0; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1191, DOI 10.1038/nn.3490; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467; Noordermeer D, 2014, ELIFE, V3, DOI 10.7554/eLife.02557; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Vella P, 2012, NUCLEIC ACIDS RES, V40, P3403, DOI 10.1093/nar/gkr1290; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	27	344	350	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					1017	1021		10.1126/science.1262088	http://dx.doi.org/10.1126/science.1262088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722416	Green Accepted			2022-12-28	WOS:000349958900045
J	Sedgwick, P				Sedgwick, Philip			Confidence intervals, P values, and statistical significance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Berlin Ivan, 2014, BMJ, V348, pg1622, DOI 10.1136/bmj.g1622; Sedgwick P, 2013, BMJ-BRIT MED J, V347, pf5067; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6051; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4550; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2130	6	10	10	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2015	350								h1113	10.1136/bmj.h1113	http://dx.doi.org/10.1136/bmj.h1113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AR	25724837				2022-12-28	WOS:000350293500001
J	Unizony, SH; Kim, ND; Hoang, MP				Unizony, Sebastian H.; Kim, Nancy D.; Hoang, Mai P.			Case 7-2015: A 25-Year-Old Man with Oral Ulcers, Rash, and Odynophagia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND TRIAL; BEHCETS-DISEASE; PAPULOPUSTULAR LESIONS; MANAGEMENT; COLCHICINE; DIAGNOSIS; SYPHILIS; FEATURES; TURKISH; ONSET		[Unizony, Sebastian H.; Kim, Nancy D.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hoang, Mai P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Unizony, Sebastian H.; Kim, Nancy D.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hoang, Mai P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Unizony, SH (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Unizony, Sebastian/H-3115-2019	Unizony, Sebastian/0000-0002-8935-7473				Alli N, 2009, AM J CLIN DERMATOL, V10, P411, DOI 10.2165/11310880-000000000-00000; Alpsoy E, 2007, BRIT J DERMATOL, V157, P901, DOI 10.1111/j.1365-2133.2007.08116.x; Bang Dongsik, 1995, Journal of Dermatology (Tokyo), V22, P926; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bystryn JC, 2005, LANCET, V366, P61, DOI 10.1016/S0140-6736(05)66829-8; Chiba M, 1997, J GASTROENTEROL, V32, P817, DOI 10.1007/BF02936961; Davatchi F, 2009, MOD RHEUMATOL, V19, P542, DOI 10.1007/s10165-009-0200-2; Davatchi F, 2010, CLIN RHEUMATOL, V29, P823, DOI 10.1007/s10067-010-1430-6; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; Demirkesen C, 2001, AM J CLIN PATHOL, V116, P341, DOI 10.1309/GCTH-0060-55K8-XCTT; FARTHING PM, 1995, J ORAL PATHOL MED, V24, P9, DOI 10.1111/j.1600-0714.1995.tb01122.x; Hamuryudan V, 2010, RHEUMATOLOGY, V49, P173, DOI 10.1093/rheumatology/kep350; Hatemi G, 2008, ANN RHEUM DIS, V67, P1656, DOI 10.1136/ard.2007.080432; HOOK EW, 1992, NEW ENGL J MED, V326, P1060, DOI 10.1056/NEJM199204163261606; Ideguchi H, 2011, MEDICINE, V90, P125, DOI 10.1097/MD.0b013e318211bf28; Ilknur T, 2006, EUR J DERMATOL, V16, P146; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kalkan G, 2009, J EUR ACAD DERMATOL, V23, P1056, DOI 10.1111/j.1468-3083.2009.03256.x; Kitaichi N, 2007, BRIT J OPHTHALMOL, V91, P1579, DOI 10.1136/bjo.2007.123554; Lamoreux MR, 2006, AM FAM PHYSICIAN, V74, P1883; Le Cleach L, 2012, NEW ENGL J MED, V366, P723, DOI 10.1056/NEJMcp1103641; Levine Jonathan S, 2011, Gastroenterol Hepatol (N Y), V7, P235; Mabey D, 2002, SEX TRANSM INFECT, V78, P90, DOI 10.1136/sti.78.2.90; MARCHAND C, 1987, ANN DERMATOL VENER, V114, P65; Mat C, 2006, RHEUMATOLOGY, V45, P348, DOI 10.1093/rheumatology/kei165; Mihai S, 2007, J CELL MOL MED, V11, P462, DOI 10.1111/j.1582-4934.2007.00033.x; Miloslavsky E, 2014, RHEUM DIS CLIN N AM, V40, P11, DOI 10.1016/j.rdc.2013.10.006; MINDEL A, 1989, GENITOURIN MED, V65, P1; Misago N, 2012, ACTA DERM-VENEREOL, V92, P681, DOI 10.2340/00015555-1349; OBRIEN JP, 1983, MEDICINE, V62, P395, DOI 10.1097/00005792-198311000-00005; Panackel Charles, 2008, Indian J Dermatol, V53, P146, DOI 10.4103/0019-5154.43207; Roett MA, 2012, AM FAM PHYSICIAN, V85, P254; Rzany B, 1996, BRIT J DERMATOL, V135, P6; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Schwartz RA, 2013, J AM ACAD DERMATOL, V69, DOI 10.1016/j.jaad.2013.05.003; SILMAN AJ, 1990, LANCET, V335, P1078; Siroy A, 2012, ARCH PATHOL LAB MED, V136, P329, DOI 10.5858/arpa.2010-0666-RS; TUZUN Y, 1980, HAEMATOLOGICA, V65, P395; van der Velden Jaap J A J, 2007, Int J Dermatol, V46 Suppl 3, P27, DOI 10.1111/j.1365-4632.2007.03507.x; WIESNER PJ, 1973, NEW ENGL J MED, V288, P181, DOI 10.1056/NEJM197301252880404; YAZICI H, 1984, ANN RHEUM DIS, V43, P783, DOI 10.1136/ard.43.6.783; YAZICI H, 1984, ANN RHEUM DIS, V43, P74, DOI 10.1136/ard.43.1.74; Yurdakul S, 2001, ARTHRITIS RHEUM-US, V44, P2686, DOI 10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H	44	2	3	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					864	872		10.1056/NEJMcpc1413303	http://dx.doi.org/10.1056/NEJMcpc1413303			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8SQ	25714165				2022-12-28	WOS:000349901700013
J	Smith, JM				Smith, Jeanette M.			By the River Edward W. Redfield	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					778	779		10.1001/jama.2014.11597	http://dx.doi.org/10.1001/jama.2014.11597			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710641				2022-12-28	WOS:000349826400001
J	Washam, JB; Stevens, SR; Lokhnygina, Y; Halperin, JL; Breithardt, G; Singer, DE; Mahaffey, KW; Hankey, GJ; Berkowitz, SD; Nessel, CC; Fox, KAA; Califf, RM; Piccini, JP; Patel, MR				Washam, Jeffrey B.; Stevens, Susanna R.; Lokhnygina, Yuliya; Halperin, Jonathan L.; Breithardt, Guenter; Singer, Daniel E.; Mahaffey, Kenneth W.; Hankey, Graeme J.; Berkowitz, Scott D.; Nessel, Christopher C.; Fox, Keith A. A.; Califf, Robert M.; Piccini, Jonathan P.; Patel, Manesh R.		ROCKET AF Steering Comm Investigat	Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)	LANCET			English	Article							INCREASED MORTALITY; MANAGEMENT; EPIDEMIOLOGY; ASSOCIATION; DEATH; RISK	Background Digoxin is a widely used drug for ventricular rate control in patients with atrial fibrillation (AF), despite a scarcity of randomised trial data. We studied the use and outcomes of digoxin in patients in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Methods For this retrospective analysis, we included and classified patients from ROCKET AF on the basis of digoxin use at baseline and during the study. Patients in ROCKET AF were recruited from 45 countries and had AF and risk factors putting them at moderate-to-high risk of stroke, with or without heart failure. We used Cox proportional hazards regression models adjusted for baseline characteristics and drugs to investigate the association of digoxin with all-cause mortality, vascular death, and sudden death. ROCKET AF was registered with ClinicalTrials.gov, number NCT00403767. Findings In 14 171 randomly assigned patients, digoxin was used at baseline in 5239 (37%). Patients given digoxin were more likely to be female (42% vs 38%) and have a history of heart failure (73% vs 56%), diabetes (43% vs 38%), and persistent AF (88% vs 77%; p<0.0001 for each comparison). After adjustment, digoxin was associated with increased all-cause mortality (5.41 vs 4.30 events per 100 patients-years; hazard ratio 1.17; 95% CI 1.04-1.32; p=0.0093), vascular death (3.55 vs 2.69 per 100 patient-years; 1.19; 1.03-1.39, p=0.0201), and sudden death (1.68 vs 1.12 events per 100 patient-years; 1.36; 1.08-1.70, p=0.0076). Interpretation Digoxin treatment was associated with a significant increase in all-cause mortality, vascular death, and sudden death in patients with AF. This association was independent of other measured prognostic factors, and although residual confounding could account for these results, these data show the possibility of digoxin having these effects. A randomised trial of digoxin in treatment of AF patients with and without heart failure is needed.	[Washam, Jeffrey B.] Duke Univ, Med Ctr, Duke Heart Ctr, Durham, NC 27705 USA; [Stevens, Susanna R.; Lokhnygina, Yuliya; Piccini, Jonathan P.; Patel, Manesh R.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA; [Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27705 USA; [Halperin, Jonathan L.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Breithardt, Guenter] Hops Univ Munster, Munster, Germany; [Singer, Daniel E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Singer, Daniel E.] Harvard Univ, Sch Med, Boston, MA USA; [Mahaffey, Kenneth W.] Stanford Sch Med, Stanford, CA USA; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Berkowitz, Scott D.] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Nessel, Christopher C.] Janssen Res & Dev, Raritan, NJ USA; [Fox, Keith A. A.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Fox, Keith A. A.] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland	Duke University; Duke University; Duke University; Icahn School of Medicine at Mount Sinai; University of Munster; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University; University of Western Australia; Bayer AG; Bayer Healthcare Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA.	manesh.patel@duke.edu	Fox, keith A A/I-3742-2013; Berkowitz, Scott Darrell/AAS-9397-2021; Hankey, Graeme J/H-4968-2014; Halperin, Jonathan/AAJ-4721-2020; Patel, Manesh/AAC-5385-2019	Berkowitz, Scott Darrell/0000-0002-9428-4408; Hankey, Graeme J/0000-0002-6044-7328; Halperin, Jonathan/0000-0002-8318-5471; Fox, Keith/0000-0002-0140-2752	Janssen Research Development; Bayer HealthCare AG	Janssen Research Development; Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals)	Janssen Research & Development and Bayer HealthCare AG.	Al-Khatib SM, 2013, TREATMENT ATRIAL FIB; Camm AJ, 2007, HEART, V93, P35, DOI 10.1136/hrt.2006.099903; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Friberg L, 2010, HEART, V96, P275, DOI 10.1136/hrt.2009.175786; Gheorghiade M, 2013, EUR HEART J, V34, P1489, DOI 10.1093/eurheartj/eht120; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hallberg P, 2007, EUR J CLIN PHARMACOL, V63, P959, DOI 10.1007/s00228-007-0346-9; Hersi AS, 2012, J SAUDI HEART ASSOC, V24, P243, DOI 10.1016/j.jsha.2012.08.001; January CT, 2014, CIRCULATION; Lane DA, 2011, CLIN EVID; Magnani JW, 2011, CIRCULATION, V124, P1982, DOI 10.1161/CIRCULATIONAHA.111.039677; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Mulder BA, 2014, HEART RHYTHM, V11, P1543, DOI 10.1016/j.hrthm.2014.06.007; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Patel MR, 2010, AM HEART J, V159, P340, DOI 10.1016/j.ahj.2009.11.025; Perry G, 1997, NEW ENGL J MED, V336, P525; Piccini JP, 2012, HEART RHYTHM, V9, P1403, DOI 10.1016/j.hrthm.2012.04.031; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Reinier K, 2014, JACC-HEART FAIL, V2, P221, DOI 10.1016/j.jchf.2013.12.006; Shah M, 2014, AM J CARDIOL, V114, P401, DOI 10.1016/j.amjcard.2014.05.013; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yusuf S, 2011, NEW ENGL J MED, V364, P928, DOI 10.1056/NEJMoa1008816	24	92	95	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2363	2370		10.1016/S0140-6736(14)61836-5	http://dx.doi.org/10.1016/S0140-6736(14)61836-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25749644				2022-12-28	WOS:000356003700029
J	Haak, W; Lazaridis, I; Patterson, N; Rohland, N; Mallick, S; Llamas, B; Brandt, G; Nordenfelt, S; Harney, E; Stewardson, K; Fu, QM; Mittnik, A; Banffy, E; Economou, C; Francken, M; Friederich, S; Pena, RG; Hallgren, F; Khartanovich, V; Khokhlov, A; Kunst, M; Kuznetsov, P; Meller, H; Mochalov, O; Moiseyev, V; Nicklisch, N; Pichler, SL; Risch, R; Guerra, MAR; Roth, C; Szecsenyi-Nagy, A; Wahl, J; Meyer, M; Krause, J; Brown, D; Anthony, D; Cooper, A; Alt, KW; Reich, D				Haak, Wolfgang; Lazaridis, Iosif; Patterson, Nick; Rohland, Nadin; Mallick, Swapan; Llamas, Bastien; Brandt, Guido; Nordenfelt, Susanne; Harney, Eadaoin; Stewardson, Kristin; Fu, Qiaomei; Mittnik, Alissa; Banffy, Eszter; Economou, Christos; Francken, Michael; Friederich, Susanne; Pena, Rafael Garrido; Hallgren, Fredrik; Khartanovich, Valery; Khokhlov, Aleksandr; Kunst, Michael; Kuznetsov, Pavel; Meller, Harald; Mochalov, Oleg; Moiseyev, Vayacheslav; Nicklisch, Nicole; Pichler, Sandra L.; Risch, Roberto; Rojo Guerra, Manuel A.; Roth, Christina; Szecsenyi-Nagy, Anna; Wahl, Joachim; Meyer, Matthias; Krause, Johannes; Brown, Dorcas; Anthony, David; Cooper, Alan; Alt, Kurt Werner; Reich, David			Massive migration from the steppe was a source for Indo-European languages in Europe	NATURE			English	Article							ANCIENT DNA; ADMIXTURE; HISTORY; DIVERSITY; FARMERS; GENOMES	We generated genome-wide data from 69 Europeans who lived between 8,000-3,000 years ago by enriching ancient DNA libraries for a target set of almost 400,000 polymorphisms. Enrichment of these positions decreases the sequencing required for genome-wide ancient DNA analysis by a median of around 250-fold, allowing us to study an order of magnitude more individuals than previous studies(1-8) and to obtain new insights about the past. We show that the populations of Western and Far Eastern Europe followed opposite trajectories between 8,000-5,000 years ago. At the beginning of the Neolithic period in Europe, similar to 8,000-7,000 years ago, closely related groups of early farmers appeared in Germany, Hungary and Spain, different from indigenous hunter-gatherers, whereas Russia was inhabited by a distinctive population of hunter-gatherers with high affinity to a similar to 24,000-year-old Siberian(6). By similar to 6,000-5,000 years ago, farmers throughout much of Europe had more hunter-gatherer ancestry than their predecessors, but in Russia, the Yamnaya steppe herders of this time were descended not only from the preceding eastern European hunter-gatherers, but also from a population of Near Eastern ancestry. Western and Eastern Europe came into contact similar to 4,500 years ago, as the Late Neolithic Corded Ware people from Germany traced similar to 75% of their ancestry to the Yamnaya, documenting a massive migration into the heartland of Europe from its eastern periphery. This steppe ancestry persisted in all sampled central Europeans until at least similar to 3,000 years ago, and is ubiquitous in present-day Europeans. These results provide support for a steppe origin(9) of at least some of the Indo-European languages of Europe.	[Haak, Wolfgang; Llamas, Bastien; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Haak, Wolfgang; Llamas, Bastien; Cooper, Alan] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Lazaridis, Iosif; Rohland, Nadin; Mallick, Swapan; Nordenfelt, Susanne; Harney, Eadaoin; Stewardson, Kristin; Fu, Qiaomei; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lazaridis, Iosif; Patterson, Nick; Rohland, Nadin; Mallick, Swapan; Nordenfelt, Susanne; Harney, Eadaoin; Stewardson, Kristin; Fu, Qiaomei; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Mallick, Swapan; Harney, Eadaoin; Stewardson, Kristin; Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Brandt, Guido; Nicklisch, Nicole; Roth, Christina; Szecsenyi-Nagy, Anna; Alt, Kurt Werner] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55128 Mainz, Germany; [Fu, Qiaomei; Meyer, Matthias] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Fu, Qiaomei] Chinese Acad Sci, IVPP, Key Lab Vertebrate Evolut & Human Origins, Beijing 100049, Peoples R China; [Mittnik, Alissa; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, D-72070 Tubingen, Germany; [Banffy, Eszter; Szecsenyi-Nagy, Anna] Hungarian Acad Sci, Inst Archaeol, Res Ctr Humanities, H-1014 Budapest, Hungary; [Banffy, Eszter] RGK, D-60325 Frankfurt, Germany; [Economou, Christos] Stockholm Univ, Archaeol Res Lab, S-11418 Stockholm, Sweden; [Francken, Michael; Krause, Johannes] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Dept Paleoanthropol, D-72070 Tubingen, Germany; [Francken, Michael; Krause, Johannes] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Dept Archaeogenet, D-72070 Tubingen, Germany; [Friederich, Susanne; Meller, Harald; Nicklisch, Nicole; Alt, Kurt Werner] Saxony Anhalt & State Museum Prehist, State Off Heritage Management & Archaeol, D-06114 Halle, Germany; [Pena, Rafael Garrido] Univ Autonoma Madrid, Fac Filosofia & Letras, Dept Prehist & Arqueol, E-28049 Madrid, Spain; [Hallgren, Fredrik] Cultural Heritage Fdn, S-72212 Vasteras, Sweden; [Khartanovich, Valery; Moiseyev, Vayacheslav] Peter Great Museum Anthropol & Ethnog Kunstkamera, St Petersburg 199034, Russia; [Khokhlov, Aleksandr; Kuznetsov, Pavel; Mochalov, Oleg] Volga State Acad Social Sci & Humanities, Samara 443099, Russia; [Kunst, Michael] Deutsch Archaeol Inst, Abt Madrid, E-28002 Madrid, Spain; [Nicklisch, Nicole; Alt, Kurt Werner] Danube Private Univ, A-3500 Krems, Austria; [Pichler, Sandra L.; Alt, Kurt Werner] Univ Basel, Inst Prehist & Archaeol Sci, CH-4003 Basel, Switzerland; [Risch, Roberto] Univ Autonoma Barcelona, Dept Prehist, E-08193 Barcelona, Spain; [Rojo Guerra, Manuel A.] Univ Valladolid, Dept Prehist & Arqueol, E-47002 Valladolid, Spain; [Wahl, Joachim] State Off Cultural Heritage Management Baden Wurt, D-78467 Constance, Germany; [Krause, Johannes] Max Planck Inst Sci Human Hist, D-07745 Jena, Germany; [Brown, Dorcas; Anthony, David] Hartwick Coll, Dept Anthropol, Oneonta, NY 13820 USA	University of Adelaide; University of Adelaide; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Johannes Gutenberg University of Mainz; Max Planck Society; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Eberhard Karls University of Tubingen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; Stockholm University; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Autonomous University of Madrid; Russian Academy of Sciences; The Kunstkamera; Samara State University of Social Sciences & Education; University of Basel; Autonomous University of Barcelona; Universidad de Valladolid	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu	Khartanovich, Valeri I/H-1872-2017; Llamas, Bastien/Y-2781-2018; Khokhlov, Aleksander/F-4737-2017; Rojo-Guerra, Manuel Ángel/AAB-6968-2019; Llamas, Bastien/AAK-1693-2021; Haak, Wolfgang/Z-4947-2019; Krause, Johannes/AFP-2642-2022; Garrido Pena, Rafael/E-8788-2013; Risch, Roberto/ABG-9562-2020; Risch, Roberto/L-4115-2014	Khartanovich, Valeri I/0000-0002-5533-0686; Llamas, Bastien/0000-0002-5550-9176; Khokhlov, Aleksander/0000-0003-0442-9616; Rojo-Guerra, Manuel Ángel/0000-0002-9317-8654; Llamas, Bastien/0000-0002-5550-9176; Haak, Wolfgang/0000-0003-2475-2007; Krause, Johannes/0000-0001-9144-3920; Garrido Pena, Rafael/0000-0001-8263-2949; Risch, Roberto/0000-0001-8534-5806; Risch, Roberto/0000-0001-8534-5806; Kuznetsov, Pavel/0000-0002-4898-5350; Cooper, Alan/0000-0002-7738-7851; Harney, Eadaoin/0000-0001-9385-7297; Szecsenyi-Nagy, Anna/0000-0003-2095-738X; Pichler, Sandra L./0000-0002-5557-1674	Australian Research Council [DP130102158]; German Research Foundation [Al 287/7-1, 7-3, Al 287/10-1, Al 287/14-1, Me 3245/1-1, 1-3]; US National Science Foundation HOMINID grant [BCS-1032255]; US National Institutes of Health [GM100233]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); German Research Foundation(German Research Foundation (DFG)); US National Science Foundation HOMINID grant(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Bellwood, J. Burger, P. Heggarty, M. Lipson, C. Renfrew, J. Diamond, S. Paabo, R. Pinhasi and P. Skoglund for critical comments, and the Initiative for the Science of the Human Past at Harvard for organizing a workshop around the issues touched on by this paper. We thank S. Paabo for support for establishing the ancient DNA facilities in Boston, and P. Skoglund for detecting the presence of two related individuals in our data set. We thank L. Orlando, T. S. Korneliussen, and C. Gamba for help in obtaining data. We thank Agilent Technologies and G. Frommer for help in developing the capture reagents. We thank C. Der Sarkissian, G. Valverde, L. Papac and B. Nickel for wet laboratory support. We thank archaeologists V. Dresely, R. Ganslmeier, O. Balanvosky, J. Ignacio Royo Guillen, A. Osztas, V. Majerik, T. Paluch, K. Somogyi and V. Voicsek for sharing samples and discussion about archaeological context. This research was supported by an Australian Research Council grant to W.H. and B.L. (DP130102158), and German Research Foundation grants to K.W.A. (Al 287/7-1 and 7-3, Al 287/10-1 and Al 287/14-1) and to H.M. (Me 3245/1-1 and 1-3). D.R. was supported by US National Science Foundation HOMINID grant BCS-1032255, US National Institutes of Health grant GM100233, and the Howard Hughes Medical Institute.	Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Bellwood P., 2004, 1 FARMERS ORIGINS AG; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Czebreszuk J., 2003, ANCIENT EUROPE 8000, P467; Der Sarkissian Clio, 2013, PLoS Genet, V9, pe1003296, DOI 10.1371/journal.pgen.1003296; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; GAMKRELIDZE TV, 1990, SCI AM, V262, P110, DOI 10.1038/scientificamerican0390-110; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lipson M, 2013, MOL BIOL EVOL, V30, P1788, DOI 10.1093/molbev/mst099; Mallory James P., 1991, SEARCH INDOEUROPEANS; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; RENFREW C, 1987, ARCHAEOLOGY LANGUAGE; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Szecsenyi-Nagy A., 2014, TRACING GENETIC ORIG; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50	30	868	883	7	286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					207	+		10.1038/nature14317	http://dx.doi.org/10.1038/nature14317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25731166	Green Submitted, Green Accepted			2022-12-28	WOS:000356016700037
J	Sabatine, MS; Giugliano, RP; Wiviott, SD; Raal, FJ; Blom, DJ; Robinson, J; Ballantyne, CM; Somaratne, R; Legg, J; Wasserman, SM; Scott, R; Koren, MJ; Stein, EA				Sabatine, Marc S.; Giugliano, Robert P.; Wiviott, Stephen D.; Raal, Frederick J.; Blom, Dirk J.; Robinson, Jennifer; Ballantyne, Christie M.; Somaratne, Ransi; Legg, Jason; Wasserman, Scott M.; Scott, Robert; Koren, Michael J.; Stein, Evan A.		Open-Label Study Long-Term	Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; SUBTILISIN/KEXIN TYPE 9; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; PLACEBO-CONTROLLED TRIAL; MONOCLONAL-ANTIBODY; AMG 145; RANDOMIZED-TRIAL; DOUBLE-BLIND; LDL-C; PCSK9 INHIBITION	BACKGROUND Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) cholesterol levels in short-term studies. We conducted two extension studies to obtain longer-term data. METHODS In two open-label, randomized trials, we enrolled 4465 patients who had completed 1 of 12 phase 2 or 3 studies ("parent trials") of evolocumab. Regardless of study-group assignments in the parent trials, eligible patients were randomly assigned in a 2: 1 ratio to receive either evolocumab (140 mg every 2 weeks or 420 mg monthly) plus standard therapy or standard therapy alone. Patients were followed for a median of 11.1 months with assessment of lipid levels, safety, and (as a prespecified exploratory analysis) adjudicated cardiovascular events including death, myocardial infarction, unstable angina, coronary revascularization, stroke, transient ischemic attack, and heart failure. Data from the two trials were combined. RESULTS As compared with standard therapy alone, evolocumab reduced the level of LDL cholesterol by 61%, from a median of 120 mg per deciliter to 48 mg per deciliter (P<0.001). Most adverse events occurred with similar frequency in the two groups, although neurocognitive events were reported more frequently in the evolocumab group. The risk of adverse events, including neurocognitive events, did not vary significantly according to the achieved level of LDL cholesterol. The rate of cardiovascular events at 1 year was reduced from 2.18% in the standard-therapy group to 0.95% in the evolocumab group (hazard ratio in the evolocumab group, 0.47; 95% confidence interval, 0.28 to 0.78; P=0.003). CONCLUSIONS During approximately 1 year of therapy, the use of evolocumab plus standard therapy, as compared with standard therapy alone, significantly reduced LDL cholesterol levels and reduced the incidence of cardiovascular events in a prespecified but exploratory analysis.	[Sabatine, Marc S.; Giugliano, Robert P.; Wiviott, Stephen D.] Brigham & Womens Hosp, TIMI Study Grp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA; [Sabatine, Marc S.; Giugliano, Robert P.; Wiviott, Stephen D.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Raal, Frederick J.] Univ Witwatersrand, Fac Hlth Sci, Carbohydrate & Lipid Metab Res Unit, Johannesburg, South Africa; [Blom, Dirk J.] Univ Cape Town, Dept Med, Div Lipidol, ZA-7925 Cape Town, South Africa; [Robinson, Jennifer] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Robinson, Jennifer] Univ Iowa, Dept Med, Coll Publ Hlth, Iowa City, IA 52242 USA; [Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA; [Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; [Ballantyne, Christie M.] Houston Methodist DeBakey Heart & Vasc Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX USA; [Somaratne, Ransi; Legg, Jason; Wasserman, Scott M.; Scott, Robert] Amgen Inc, Thousand Oaks, CA USA; [Koren, Michael J.] Jacksonville Ctr Clin Res, Jacksonville, FL USA; [Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Witwatersrand; University of Cape Town; University of Iowa; University of Iowa; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Amgen	Sabatine, MS (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.	msabatine@partners.org; esteinmrl@aol.com	Ballantyne, Christie/A-6599-2008; , Jennifer/AAD-8336-2019; Sabatine, Marc/AAJ-6751-2020; Raal, FJ/ABD-5111-2021; Wiviott, Stephen/HIK-2534-2022; Giugliano, Robert/N-7233-2017	Sabatine, Marc/0000-0002-0691-3359; Raal, FJ/0000-0002-9170-7938; Scott, Robert/0000-0001-8266-1061; Blom, Dirk/0000-0003-3965-5912; Giugliano, Robert/0000-0003-4110-7675; Ballantyne, Christie/0000-0002-6432-1730	Amgen	Amgen(Amgen)	Funded by Amgen; OSLER-1 and OSLER-2 ClinicalTrials.gov numbers, NCT01439880 and NCT01854918.	AIM- HIGH Investigators, 2012, NEW ENGL J MED, V367, P189; Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032; Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Cannon CP, 2014, AM HEART ASS SCI SES; ClinicalTrials.gov, NCT01975389 EVALUATI; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Food and Drug Administration, FDA EXP ADV STAT RIS; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Hirayama A, 2014, CIRC J, V78, P1073, DOI 10.1253/circj.CJ-14-0130; Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007; Koren MJ, 2014, J AM COLL CARDIOL, V63, P2531, DOI 10.1016/j.jacc.2014.03.018; Koren MJ, 2014, CIRCULATION, V129, P234, DOI 10.1161/CIRCULATIONAHA.113.007012; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Postmus I, 2013, J LIPID RES, V54, P561, DOI 10.1194/jlr.P033969; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Robinson JG, 2014, JAMA-J AM MED ASSOC, V311, P1870, DOI 10.1001/jama.2014.4030; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Stein EA, 2014, ENDOCRIN METAB CLIN, V43, P1007, DOI 10.1016/j.ecl.2014.08.008; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790	30	1120	1162	5	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1500	1509		10.1056/NEJMoa1500858	http://dx.doi.org/10.1056/NEJMoa1500858			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25773607	Green Published			2022-12-28	WOS:000352856500005
J	Roederer, M; Quaye, L; Mangino, M; Beddall, MH; Mahnke, Y; Chattopadhyay, P; Tosi, I; Napolitano, L; Barberio, MT; Menni, C; Villanova, F; Di Meglio, P; Spector, TD; Nestle, FO				Roederer, Mario; Quaye, Lydia; Mangino, Massimo; Beddall, Margaret H.; Mahnke, Yolanda; Chattopadhyay, Pratip; Tosi, Isabella; Napolitano, Luca; Barberio, Manuela Terranova; Menni, Cristina; Villanova, Federica; Di Meglio, Paola; Spector, Tim D.; Nestle, Frank O.			The Genetic Architecture of the Human Immune System: A Bioresource for Autoimmunity and Disease Pathogenesis	CELL			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC HEPATITIS-B; REGULATORY T-CELLS; SUSCEPTIBILITY LOCI; JAPANESE POPULATION; HIV-1 CONTROL; RISK LOCI; VARIANTS; INFECTION; DENSITY	Despite recent discoveries of genetic variants associated with autoimmunity and infection, genetic control of the human immune system during homeostasis is poorly understood. We undertook a comprehensive immunophenotyping approach, analyzing 78,000 immune traits in 669 female twins. From the top 151 heritable traits (up to 96% heritable), we used replicated GWAS to obtain 297 SNP associations at 11 genetic loci, explaining up to 36% of the variation of 19 traits. We found multiple associations with canonical traits of all major immune cell subsets and uncovered insights into genetic control for regulatory T cells. This data set also revealed traits associated with loci known to confer autoimmune susceptibility, providing mechanistic hypotheses linking immune traits with the etiology of disease. Our data establish a bioresource that links genetic control elements associated with normal immune traits to common autoimmune and infectious diseases, providing a shortcut to identifying potential mechanisms of immune-related diseases.	[Roederer, Mario; Beddall, Margaret H.; Mahnke, Yolanda; Chattopadhyay, Pratip] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Quaye, Lydia; Mangino, Massimo; Menni, Cristina; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Tosi, Isabella; Napolitano, Luca; Barberio, Manuela Terranova; Villanova, Federica; Di Meglio, Paola; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, Cutaneous Med Unit, London SE1 9RT, England; [Mangino, Massimo; Tosi, Isabella; Villanova, Federica; Nestle, Frank O.] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London SE1 9RT, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Roederer, M (corresponding author), NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	roederer@nih.gov; tim.spector@kcl.ac.uk	Roederer, Mario/G-1887-2011; Mangino, Massimo/F-5134-2011	Mangino, Massimo/0000-0002-2167-7470; Chattopadhyay, Pratip/0000-0002-5457-9666; Mahnke, Yolanda/0000-0002-2727-9887; Menni, Cristina/0000-0001-9790-0571; Di Meglio, Paola/0000-0002-2066-7780	Vaccine Research Center (NIAID, NIH); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Wellcome Trust; ERC; Medical Research Council [MR/J006742/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005020, ZIAAI005021] Funding Source: NIH RePORTER	Vaccine Research Center (NIAID, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Vaccine Research Center (NIAID, NIH) intramural research program and by the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, King's College Hospital NHS Foundation (guysbrc-2012-1) Trust, and Dunhill Medical Trust. TwinsUK is also supported by the Wellcome Trust, and TDS is an ERC Advanced Researcher. We wish to thank Kaimei Song, Steve Perfetto, Richard Nguyen, Lynda Myles, Gabriela Surdulescu, Dylan Hodgkiss, and Ayrun Nessa for technical help with the samples, as well as the TwinsUK volunteers for participation.	Ahmadi KR, 2001, GENES IMMUN, V2, P381, DOI 10.1038/sj.gene.6363796; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Bastid J, 2013, ONCOGENE, V32, P1743, DOI 10.1038/onc.2012.269; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Clementi M, 1999, HUM GENET, V105, P337, DOI 10.1007/s004390051111; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Cotsapas C, 2013, TRENDS IMMUNOL, V34, P22, DOI 10.1016/j.it.2012.09.001; Damoiseaux JGMC, 1999, J IMMUNOL, V163, P2983; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Hall MA, 2000, GENES IMMUN, V1, P423, DOI 10.1038/sj.gene.6363702; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kim YJ, 2013, HUM MOL GENET, V22, P4233, DOI 10.1093/hmg/ddt266; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; KRAAL G, 1983, IMMUNOGENETICS, V18, P585, DOI 10.1007/BF00345966; Kyvic K., 2000, ADV TWIN SIB PAIR AN, P67; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Mahnke YD, 2013, CYTOM PART A, V83A, P676, DOI [10.1002/cyto.a.22326, 10.1002/cyto.22326]; Mahnke YD, 2013, CYTOM PART A, V83A, P439, DOI 10.1002/cyto.a.22269; Mahnke YD, 2013, CYTOM PART A, V83A, P179, DOI 10.1002/cyto.a.22230; Mahnke YD, 2012, CYTOM PART A, V81A, P935, DOI 10.1002/cyto.a.22201; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Moayyeri A, 2012, J BONE MINER RES, V27, P2170, DOI 10.1002/jbmr.1659; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Neale MC, 1992, METHODOLOGY GENETIC; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sinha S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-13; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Starbeck-Miller GR, 2014, J IMMUNOL, V192, P35, DOI 10.4049/jimmunol.1302232; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Urabe Y, 2013, J HEPATOL, V58, P875, DOI 10.1016/j.jhep.2012.12.024; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	62	176	180	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					387	403		10.1016/j.cell.2015.02.046	http://dx.doi.org/10.1016/j.cell.2015.02.046			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25772697	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000352708300029
J	Florio, M; Albert, M; Taverna, E; Namba, T; Brandl, H; Lewitus, E; Haffner, C; Sykes, A; Wong, FK; Peters, J; Guhr, E; Klemroth, S; Prufer, K; Kelso, J; Naumann, R; Nusslein, I; Dahl, A; Lachmann, R; Paabo, S; Huttner, WB				Florio, Marta; Albert, Mareike; Taverna, Elena; Namba, Takashi; Brandl, Holger; Lewitus, Eric; Haffner, Christiane; Sykes, Alex; Wong, Fong Kuan; Peters, Jula; Guhr, Elaine; Klemroth, Sylvia; Pruefer, Kay; Kelso, Janet; Naumann, Ronald; Nuesslein, Ina; Dahl, Andreas; Lachmann, Robert; Paeaebo, Svante; Huttner, Wieland B.			Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion	SCIENCE			English	Article							MAMMALIAN CEREBRAL-CORTEX; GENOME SEQUENCE; NEURAL STEM; CELL; NEUROGENESIS; EVOLUTION; PHASE; ZONES; DIVERSITY; GROWTH	Evolutionary expansion of the human neocortex reflects increased amplification of basal progenitors in the subventricular zone, producing more neurons during fetal corticogenesis. In this work, we analyze the transcriptomes of distinct progenitor subpopulations isolated by a cell polarity-based approach from developing mouse and human neocortex. We identify 56 genes preferentially expressed in human apical and basal radial glia that lack mouse orthologs. Among these, ARHGAP11B has the highest degree of radial glia-specific expression. ARHGAP11B arose from partial duplication of ARHGAP11A (which encodes a Rho guanosine triphosphatase-activating protein) on the human lineage after separation from the chimpanzee lineage. Expression of ARHGAP11B in embryonic mouse neocortex promotes basal progenitor generation and self-renewal and can increase cortical plate area and induce gyrification. Hence, ARHGAP11B may have contributed to evolutionary expansion of human neocortex.	[Florio, Marta; Albert, Mareike; Taverna, Elena; Namba, Takashi; Brandl, Holger; Lewitus, Eric; Haffner, Christiane; Sykes, Alex; Wong, Fong Kuan; Peters, Jula; Guhr, Elaine; Naumann, Ronald; Nuesslein, Ina; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet MPI CBG, D-01307 Dresden, Germany; [Klemroth, Sylvia; Dahl, Andreas] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Pruefer, Kay; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol MPI EVA, D-04103 Leipzig, Germany; [Lachmann, Robert] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Frauenheilkunde & Geburtshilfe, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet MPI CBG, Pfotenhauerstr 108, D-01307 Dresden, Germany.	huttner@mpi-cbg.de	Namba, Takashi/ABF-4571-2020; Taverna, Elena/AFW-4935-2022; Wong, Fong Kuan/T-3257-2019; Kelso, Janet/N-1812-2019; Albert, Mareike/AAJ-5980-2020; Namba, Takashi/AAE-4439-2022; Dahl, Andreas/E-3783-2017; Huttner, Wieland B./P-4080-2018; taverna, elena/O-8180-2014	Namba, Takashi/0000-0003-4875-666X; Kelso, Janet/0000-0002-3618-322X; Albert, Mareike/0000-0001-9855-9344; Dahl, Andreas/0000-0002-2668-8371; taverna, elena/0000-0002-2430-4725; Brandl, Holger/0000-0003-1911-8570; Wong, Fong Kuan/0000-0003-3319-4625; Sykes, Alex/0000-0001-8981-6652; Florio, Marta/0000-0002-6168-005X	Deutsche Forschungsgemeinschaft (DFG) [SFB 655]; European Research Council [250197]; DFG; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We apologize to all researchers whose work could not be cited due to space limitation. We are grateful to the Services and Facilities of the MPI-CBG for the outstanding support provided, notably J. Helppi and his team of the Animal Facility, J. Peychl and his team of the Light Microscopy Facility, N. Lakshmanaperumal of the Bioinformatics Facility, and J. Jarrells and A. Eugster for support with single-cell analysis. We thank E. Perini for advice regarding RhoGAPs and all members of the Huttner lab for help and discussion, especially D. Stenzel for support in obtaining fetal human tissue, J. Paridaen and M. Wilsch-Brauninger for advice, and N. Kalebic and K. Long for critical reading of the manuscript. We thank B. Hober and A. Weihmann of MPI-EVA for expert DNA sequencing; B. Habermann of Max Planck Institute of Biochemistry (MPI-B) for bioinformatics advice; and K. Kaibuchi and M. Amano (Nagoya University) for pCAGGS-myc-KK1, pCAGGS-HA, and anti-MYPT1 antibody. M.F. was a member of the International Max Planck Research School for Cell, Developmental and Systems Biology and a doctoral student at the Technische Universitat Dresden. W.B.H. was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB 655, A2) and the European Research Council (250197), the DFG-funded Center for Regenerative Therapies Dresden, and the Fonds der Chemischen Industrie. The supplementary materials contain additional data. RNAseq raw data have been deposited with the Gene Expression Omnibus under accession codes GSE65000 and GSM1585634.	Antonacci F, 2014, NAT GENET, V46, P1293, DOI 10.1038/ng.3120; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Arcila ML, 2014, NEURON, V81, P1255, DOI 10.1016/j.neuron.2014.01.017; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007; Borrell V, 2012, DEV NEUROBIOL, V72, P955, DOI 10.1002/dneu.22013; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Houlihan SL, 2014, ELIFE, V3, DOI 10.7554/eLife.03297; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Kagawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083629; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Lewitus E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002000; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rash BG, 2013, J NEUROSCI, V33, P10802, DOI 10.1523/JNEUROSCI.3621-12.2013; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Stahl R, 2013, CELL, V153, P535, DOI 10.1016/j.cell.2013.03.027; Striedter G. F., 2005, PRINCIPLES BRAIN EVO; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Taverna E, 2012, NAT NEUROSCI, V15, P329, DOI 10.1038/nn.3008; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Zanin E, 2013, DEV CELL, V26, P496, DOI 10.1016/j.devcel.2013.08.005	35	331	338	5	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1465	1470		10.1126/science.aaa1975	http://dx.doi.org/10.1126/science.aaa1975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25721503				2022-12-28	WOS:000352136400038
J	Kelly, PL; Rodney, SA; Treu, T; Foley, RJ; Brammer, G; Schmidt, KB; Zitrin, A; Sonnenfeld, A; Strolger, LG; Graur, O; Filippenko, AV; Jha, SW; Riess, AG; Bradac, M; Weiner, BJ; Scolnic, D; Malkan, MA; von der Linden, A; Trenti, M; Hjorth, J; Gavazzi, R; Fontana, A; Merten, JC; McCully, C; Jones, T; Postman, M; Dressler, A; Patel, B; Cenko, SB; Graham, ML; Tucker, BE				Kelly, Patrick L.; Rodney, Steven A.; Treu, Tommaso; Foley, Ryan J.; Brammer, Gabriel; Schmidt, Kasper B.; Zitrin, Adi; Sonnenfeld, Alessandro; Strolger, Louis-Gregory; Graur, Or; Filippenko, Alexei V.; Jha, Saurabh W.; Riess, Adam G.; Bradac, Marusa; Weiner, Benjamin J.; Scolnic, Daniel; Malkan, Matthew A.; von der Linden, Anja; Trenti, Michele; Hjorth, Jens; Gavazzi, Raphael; Fontana, Adriano; Merten, Julian C.; McCully, Curtis; Jones, Tucker; Postman, Marc; Dressler, Alan; Patel, Brandon; Cenko, S. Bradley; Graham, Melissa L.; Tucker, Bradley E.			Multiple images of a highly magnified supernova formed by an early-type cluster galaxy lens	SCIENCE			English	Article							GRAVITATIONAL LENS; TIME DELAYS; IA SUPERNOVA; PS1-10AFX; COSMOLOGY; DISCOVERY; MASSES; MACS	In 1964, Refsdal hypothesized that a supernova whose light traversed multiple paths around a strong gravitational lens could be used to measure the rate of cosmic expansion. We report the discovery of such a system. In Hubble Space Telescope imaging, we have found four images of a single supernova forming an Einstein cross configuration around a redshift z = 0.54 elliptical galaxy in the MACS J1149.6+2223 cluster. The cluster's gravitational potential also creates multiple images of the z = 1.49 spiral supernova host galaxy, and a future appearance of the supernova elsewhere in the cluster field is expected. The magnifications and staggered arrivals of the supernova images probe the cosmic expansion rate, as well as the distribution of matter in the galaxy and cluster lenses.	[Kelly, Patrick L.; Filippenko, Alexei V.; Graham, Melissa L.; Tucker, Bradley E.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Rodney, Steven A.; Riess, Adam G.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Treu, Tommaso] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Foley, Ryan J.] Univ Illinois, Urbana, IL 61801 USA; [Foley, Ryan J.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Brammer, Gabriel; Strolger, Louis-Gregory; Riess, Adam G.; Postman, Marc] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Schmidt, Kasper B.; Sonnenfeld, Alessandro; McCully, Curtis; Jones, Tucker] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Zitrin, Adi; Merten, Julian C.] CALTECH, Pasadena, CA 91125 USA; [Strolger, Louis-Gregory] Western Kentucky Univ, Bowling Green, KY 42101 USA; [Graur, Or] NYU, Ctr Cosmol & Particle Phys, New York, NY 10003 USA; [Graur, Or] Amer Museum Nat Hist, Dept Astrophys, New York, NY 10024 USA; [Jha, Saurabh W.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Bradac, Marusa] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Weiner, Benjamin J.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Scolnic, Daniel] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Scolnic, Daniel] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [von der Linden, Anja] Univ Copenhagen, Dark Cosmol Ctr, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [von der Linden, Anja] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Trenti, Michele] Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia; [Gavazzi, Raphael] Inst Astrophys Paris, F-75014 Paris, France; [Fontana, Adriano] INAF OAR, I-00040 Rome, Italy; [McCully, Curtis] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Dressler, Alan] Carnegie Observ, Pasadena, CA 91101 USA; [Cenko, S. Bradley] NASA Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Cenko, S. Bradley] Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA; [Tucker, Bradley E.] Australian Natl Univ, Mt Stromlo Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia	University of California System; University of California Berkeley; Johns Hopkins University; University of California System; University of California Los Angeles; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Space Telescope Science Institute; University of California System; University of California Santa Barbara; California Institute of Technology; Western Kentucky University; New York University; American Museum of Natural History (AMNH); Rutgers State University New Brunswick; University of California System; University of California Davis; University of Arizona; University of Chicago; University of Chicago; University of Copenhagen; Niels Bohr Institute; Stanford University; University of Melbourne; UDICE-French Research Universities; Sorbonne Universite; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Australian National University	Kelly, PL (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	pkelly@astro.berkeley.edu	Sonnenfeld, Alessandro/AAW-3014-2021; Zitrin, Adi/M-3402-2018; Brammer, Gabriel/AAB-4859-2020; Riess, Adam/ABF-2480-2020	Zitrin, Adi/0000-0002-0350-4488; Brammer, Gabriel/0000-0003-2680-005X; Jones, Tucker/0000-0001-5860-3419; Graham, Melissa Lynn/0000-0002-9154-3136; Schmidt, Kasper/0000-0002-3418-7251; fontana, adriano/0000-0003-3820-2823; Bradac, Marusa/0000-0001-5984-0395; Tucker, Brad/0000-0002-4283-5159; Jha, Saurabh/0000-0001-8738-6011; Graur, Or/0000-0002-4391-6137; Trenti, Michele/0000-0001-9391-305X; Treu, Tommaso/0000-0002-8460-0390; Sonnenfeld, Alessandro/0000-0002-6061-5977; Rodney, Steven/0000-0003-1947-687X; Foley, Ryan/0000-0002-2445-5275; Weiner, Benjamin/0000-0001-6065-7483	NASA through HST [GO-13459, GO-13386]; NASA through Hubble Fellowship - STScI [HST-HF-51312.01, HF2-51334.001-A]; Christopher R. Redlich Fund; TABASGO Foundation; Gary and Cynthia Bengier; NSF [AST-1211916, AST-1313484]; Danish National Research Foundation; NSF CAREER [AST-0847157]; NASA HSI [GO-13386, GO-13343]; Centre National d'Etudes Spatiales; W. M. Keck Foundation;  [NAS 5-26555]; Direct For Mathematical & Physical Scien [1211916, 1313484] Funding Source: National Science Foundation; Division Of Astronomical Sciences [0847157] Funding Source: National Science Foundation	NASA through HST; NASA through Hubble Fellowship - STScI; Christopher R. Redlich Fund; TABASGO Foundation; Gary and Cynthia Bengier; NSF(National Science Foundation (NSF)); Danish National Research Foundation(Danmarks Grundforskningsfond); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NASA HSI; Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); W. M. Keck Foundation(W.M. Keck Foundation); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is based on data obtained with the NASA/ESA Hubble Space Telescope. We thank O. Fox, W. Zheng, J. Bloom, C. Keeton, J. Mauerhan, C. Steidel, and A. Strom for helpful discussions, as well as the Space Telescope Science Institute (STScI) and Director Matt Mountain for supporting our proposal for follow-up observations. GLASS is supported by NASA through HST grant GO-13459. Support for S.A.R. was provided by NASA through Hubble Fellowship grant HST-HF-51312.01 awarded by STScI, which is operated by the Association of Universities for Research in Astronomy for NASA, under contract NAS 5-26555. Follow-up imaging through the FrontierSN program is supported by NASA through HST grant GO-13386. A.V.F.'s group at the University of California Berkeley has received generous financial assistance from the Christopher R. Redlich Fund, the TABASGO Foundation, Gary and Cynthia Bengier, and NSF grant AST-1211916. The Dark Cosmotogy Centre is funded by the Danish National Research Foundation. Support for A.Z. was provided by NASA through Hubble Fellowship grant HF2-51334.001-A awarded by STScI. SN research at Rutgers University is supported in part by NSF CAREER award AST-0847157 to S.W.J. J.C.M. is supported by NSF grant AST-1313484 and by NASA HSI grants GO-13343 and GO-13386; this research was carried out in part at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. R.G. acknowledges the Centre National d'Etudes Spatiales for financial support on the GLASS project. Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA; the observatory was made possible by the generous financial support of the W. M. Keck Foundation. The HST imaging data used in this paper can be obtained from the Barbara A. Mikulski Archive for Space Telescopes at https://archives.stsci.edu, and the Keck-I LRIS spectra can be obtained at https://hercules.berkeley.edu/database.	Bentz MC, 2009, ASTROPHYS J, V705, P199, DOI 10.1088/0004-637X/705/1/199; Chornock R, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/162; Ebeling H, 2007, ASTROPHYS J, V661, pL33, DOI 10.1086/518603; Ebeling H, 2001, ASTROPHYS J, V553, P668, DOI 10.1086/320958; Ganeshalingam M, 2011, MON NOT R ASTRON SOC, V416, P2607, DOI 10.1111/j.1365-2966.2011.19213.x; Inada N, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/5/119; Jones T., 2014, ARXIVORGABS14100967; Kaspi S, 2007, ASTROPHYS J, V659, P997, DOI 10.1086/512094; Kochanek CS, 2006, ASTROPHYS J, V640, P47, DOI 10.1086/499766; Koopmans LVE, 2003, ASTROPHYS J, V599, P70, DOI 10.1086/379226; Linder EV, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.123529; Quimby RM, 2014, SCIENCE, V344, P396, DOI 10.1126/science.1250903; Quimby RM, 2013, ASTROPHYS J LETT, V768, DOI 10.1088/2041-8205/768/1/L20; REFSDAL S, 1964, MON NOT R ASTRON SOC, V128, P307, DOI 10.1093/mnras/128.4.307; Schmidt KB, 2014, ASTROPHYS J LETT, V782, DOI 10.1088/2041-8205/782/2/L36; SHAPIRO II, 1964, PHYS REV LETT, V13, P789, DOI 10.1103/PhysRevLett.13.789; Sharon K, 2005, ASTROPHYS J, V629, pL73, DOI 10.1086/452633; Smith GP, 2009, ASTROPHYS J LETT, V707, pL163, DOI 10.1088/0004-637X/707/2/L163; Suyu SH, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L35; Suyu SH, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/70; Tewes M, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201220352; Treu T, 2010, ANNU REV ASTRON ASTR, V48, P87, DOI 10.1146/annurev-astro-081309-130924; WALSH D, 1979, NATURE, V279, P381, DOI 10.1038/279381a0	23	156	158	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1123	1126		10.1126/science.aaa3350	http://dx.doi.org/10.1126/science.aaa3350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745167	Green Submitted, Green Accepted			2022-12-28	WOS:000350354200048
J	Li, JJ; Biggin, MD				Li, Jingyi Jessica; Biggin, Mark D.			Statistics requantitates the central dogma	SCIENCE			English	Editorial Material							PROTEIN; EXPRESSION; MICRORNAS; IMPACT; CELLS		[Li, Jingyi Jessica] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Li, Jingyi Jessica] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Biggin, Mark D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Li, JJ (corresponding author), Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA.	jli@stat.ucla.edu; mdbiggin@lbl.gov	Li, Jingyi Jessica/I-2779-2019	Li, Jingyi Jessica/0000-0002-9288-5648				Ahrne E, 2013, PROTEOMICS, V13, P2567, DOI 10.1002/pmic.201300135; Albert FW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004692; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Cheung MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr425; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Hebenstreit D, 2012, CURR OPIN CELL BIOL, V24, P350, DOI 10.1016/j.ceb.2012.03.007; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	14	110	111	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1066	1067		10.1126/science.aaa8332	http://dx.doi.org/10.1126/science.aaa8332			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745146				2022-12-28	WOS:000350354200018
J	McCarthy, M				McCarthy, Michael			US hospital rating systems rarely agree, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Austin JM, 2015, HEALTH AFFAIR, V34, P423, DOI 10.1377/hlthaff.2014.0201	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2015	350								h1255	10.1136/bmj.h1255	http://dx.doi.org/10.1136/bmj.h1255			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DP	25744247				2022-12-28	WOS:000351180000008
J	Stiffler, MA; Hekstra, DR; Ranganathan, R				Stiffler, Michael A.; Hekstra, Doeke R.; Ranganathan, Rama			Evolvability as a Function of Purifying Selection in TEM-1 beta-Lactamase	CELL			English	Article							EVOLUTION; ROBUSTNESS; ADAPTATION; TOLERANCE; LANDSCAPE; MUTATION	Evolvability-the capacity to generate beneficial heritable variation-is a central property of biological systems. However, its origins and modulation by environmental factors have not been examined systematically. Here, we analyze the fitness effects of all single mutations in TEM-1 beta-lactamase (4,997 variants) under selection for the wild-type function (ampicillin resistance) and for a new function (cefotaxime resistance). Tolerance to mutation in this enzyme is bimodal and dependent on the strength of purifying selection in vivo, a result that derives from a steep non-linear ampicillin-dependent relationship between biochemical activity and fitness. Interestingly, cefotaxime resistance emerges from mutations that are neutral at low levels of ampicillin but deleterious at high levels; thus the capacity to evolve new function also depends on the strength of selection. The key property controlling evolvability is an excess of enzymatic activity relative to the strength of selection, suggesting that fluctuating environments might select for high-activity enzymes.	[Stiffler, Michael A.; Hekstra, Doeke R.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu		Hekstra, Doeke/0000-0003-2332-9223	National Institutes of Health [RO1EY018720-05]; Robert A. Welch Foundation [I-1366]; Green Center for Systems Biology; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Green Center for Systems Biology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank F.J. Poelwijk, V. Salinas, V. Krishna, K.A. Reynolds, and S.J. Helms for assistance with the kinetic model, processing of Illumina data, and/or critical reading of the manuscript. We also thank C. Liang and the UT Southwestern Genomics Core for assistance with Illumina sequencing. R.R. acknowledges support from the National Institutes of Health (RO1EY018720-05), the Robert A. Welch Foundation (I-1366), and the Green Center for Systems Biology.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; [Anonymous], 2005, PLAUSIBILITY LIFE; Bershtein S, 2008, MOL BIOL EVOL, V25, P2311, DOI 10.1093/molbev/msn174; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Draghi JA, 2011, GENETICS, V187, P1139, DOI 10.1534/genetics.110.125997; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Firnberg E, 2014, MOL BIOL EVOL, V31, P1581, DOI 10.1093/molbev/msu081; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hall BG, 2002, ANTIMICROB AGENTS CH, V46, P3035, DOI 10.1128/AAC.46.9.3035-3038.2002; HARTL DL, 1985, GENETICS, V111, P655; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Jacquier H, 2013, P NATL ACAD SCI USA, V110, P13067, DOI 10.1073/pnas.1215206110; KACSER H, 1981, GENETICS, V97, P639; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Melnikov A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku511; Payne JL, 2014, SCIENCE, V343, P875, DOI 10.1126/science.1249046; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Schenk MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002783; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wylie CS, 2011, P NATL ACAD SCI USA, V108, P9916, DOI 10.1073/pnas.1017572108; ZIMMERMANN W, 1977, ANTIMICROB AGENTS CH, V12, P368, DOI 10.1128/AAC.12.3.368	45	144	144	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					882	892		10.1016/j.cell.2015.01.035	http://dx.doi.org/10.1016/j.cell.2015.01.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723163	Bronze			2022-12-28	WOS:000351116100011
J	Raal, FJ; Blom, DJ				Raal, Frederick J.; Blom, Dirk J.			Anacetrapib in familial hypercholesterolaemia: pros and cons	LANCET			English	Editorial Material							INHIBITION; REDUCTION; MORTALITY; DISEASE; EVENTS; PCSK9; RISK; CETP; LDL		[Raal, Frederick J.] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Div Endocrinol & Metab, ZA-2193 Johannesburg, South Africa; [Blom, Dirk J.] Univ Cape Town, Dept Med, Div Lipidol, ZA-7925 Cape Town, South Africa	University of Witwatersrand; University of Cape Town	Raal, FJ (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Med, Div Endocrinol & Metab, ZA-2193 Johannesburg, South Africa.	frederick.raal@wits.ac.za	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938; Blom, Dirk/0000-0003-3965-5912				Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Cannon C.P., 2014, IMPROVE IT TRIAL COM; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Johannsen TH, 2012, J AM COLL CARDIOL, V60, P2041, DOI 10.1016/j.jacc.2012.07.045; Kastelein JJ, 2015, LANCET; Keene D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4379; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Raal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Schmidt HHJ, 1996, AM J CARDIOL, V77, P575, DOI 10.1016/S0002-9149(97)89309-5; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2124	2126		10.1016/S0140-6736(14)62315-1	http://dx.doi.org/10.1016/S0140-6736(14)62315-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25743172				2022-12-28	WOS:000355583000005
J	Liu, WW; Mazor, O; Wilson, RI				Liu, Wendy W.; Mazor, Ofer; Wilson, Rachel I.			Thermosensory processing in the Drosophila brain	NATURE			English	Article							ANTENNAL LOBE; CENTRAL NEURONS; TEMPERATURE; MELANOGASTER; EXPRESSION; AVOIDANCE; LARVAL; TOOLS	In Drosophila, just as in vertebrates, changes in external temperature are encoded by bidirectional opponent thermoreceptor cells: some cells are excited by warming and inhibited by cooling, whereas others are excited by cooling and inhibited by warming(1,2). The central circuits that process these signals are not understood. In Drosophila, a specific brain region receives input from thermoreceptor cells(2,3). Here we show that distinct genetically identified projection neurons (PNs) in this brain region are excited by cooling, warming, or both. The PNs excited by cooling receive mainly feed-forward excitation from cool thermoreceptors. In contrast, the PNs excited by warming ('warm-PNs') receive both excitation from warm thermoreceptors and crossover inhibition from cool thermoreceptors through inhibitory interneurons. Notably, this crossover inhibition elicits warming-evoked excitation, because warming suppresses tonic activity in cool thermoreceptors. This in turn disinhibits warm-PNs and sums with feed-forward excitation evoked by warming. Crossover inhibition could cancel non-thermal activity (noise) that is positively correlated among warm and cool thermoreceptor cells, while reinforcing thermal activity which is anti-correlated. Our results show how central circuits can combine signals from bidirectional opponent neurons to construct sensitive and robust neural codes.	[Liu, Wendy W.; Mazor, Ofer; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mazor, Ofer] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Liu, Wendy/0000-0002-1648-4068; Mazor, Ofer/0000-0002-6860-7242; Wilson, Rachel/0000-0001-8573-9266	NIH [R01 DC008174]; HHMI International Research Fellowship; MD-PhD Program at Harvard Medical School; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI International Research Fellowship; MD-PhD Program at Harvard Medical School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to C. -H. Lee for the gift of LexAOp-HA-Ort flies, P. Garrity for Gr28b.d-Gal4, and A. Rajan for Gad1-Gal4 (line 2B). A. DiAntonio kindly supplied the anti-dVGluT antibody. We thank the Wilson laboratory, A. Samuel, P. Garrity, L. Griffith and D. Ginty for comments on the manuscript. D. Rogulja's laboratory and M. Y. Wong shared reagents and expertise. A portion of this work was supported by NIH grant R01 DC008174. W.W.L. is supported by an HHMI International Research Fellowship and a Presidential Scholarship from the MD-PhD Program at Harvard Medical School. R.I.W. is a Howard Hughes Investigator.	Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Enell L, 2007, J COMP NEUROL, V505, P18, DOI 10.1002/cne.21472; Fischer H, 2002, J COMP PHYSIOL A, V188, P643, DOI 10.1007/s00359-002-0339-1; Fisek M, 2014, NAT NEUROSCI, V17, P280, DOI 10.1038/nn.3613; FOELIX RF, 1989, CELL TISSUE RES, V258, P277, DOI 10.1007/BF00239448; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Green BG, 2004, J NEUROBIOL, V61, P13, DOI 10.1002/neu.20081; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Laissue PP, 1999, J COMP NEUROL, V405, P543; Liu WW, 2013, CURR BIOL, V23, P1202, DOI 10.1016/j.cub.2013.05.016; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; Mehren JE, 2006, LEARN MEMORY, V13, P686, DOI 10.1101/lm.317806; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Prescott SA, 2012, CURR OPIN NEUROBIOL, V22, P631, DOI 10.1016/j.conb.2012.02.010; Ruchty M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00174; Sachs F., 1998, REV PHYSL BIOCH PHAR, V132; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schepers RJ, 2010, NEUROSCI BIOBEHAV R, V34, P177, DOI 10.1016/j.neubiorev.2009.10.003; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Tang X, 2013, J NEUROSCI, V33, P894, DOI 10.1523/JNEUROSCI.1894-12.2013; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	36	51	52	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					353	+		10.1038/nature14170	http://dx.doi.org/10.1038/nature14170			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25739502	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000351171900041
J	Ma, Y; Dai, XY; Xu, YY; Luo, W; Zheng, XM; Zeng, DL; Pan, YJ; Lin, XL; Liu, HH; Zhang, DJ; Xiao, J; Guo, XY; Xu, SJ; Niu, YD; Jin, JB; Zhang, H; Xu, X; Li, LG; Wang, W; Qian, Q; Ge, S; Chong, K				Ma, Yun; Dai, Xiaoyan; Xu, Yunyuan; Luo, Wei; Zheng, Xiaoming; Zeng, Dali; Pan, Yajun; Lin, Xiaoli; Liu, Huanhuan; Zhang, Dajian; Xiao, Jun; Guo, Xiaoyu; Xu, Shujuan; Niu, Yuda; Jin, Jingbo; Zhang, Hui; Xu, Xun; Li, Legong; Wang, Wen; Qian, Qian; Ge, Song; Chong, Kang			COLD1 Confers Chilling Tolerance in Rice	CELL			English	Article							HETEROTRIMERIC G-PROTEIN; ALPHA-SUBUNIT; CALCIUM; ARABIDOPSIS; REVEALS; STRESS; IDENTIFICATION; DOMESTICATION; ASSOCIATION; ACTIVATION	Rice is sensitive to cold and can be grown only in certain climate zones. Human selection of japonica rice has extended its growth zone to regions with lower temperature, while the molecular basis of this adaptation remains unknown. Here, we identify the quantitative trait locus COLD1 that confers chilling tolerance in japonica rice. Overexpression of COLD1(jap) significantly enhances chilling tolerance, whereas rice lines with deficiency or downregulation of COLD1(jap) are sensitive to cold. COLD1 encodes a regulator of G-protein signaling that localizes on plasma membrane and endoplasmic reticulum (ER). It interacts with the G-protein alpha subunit to activate the Ca2+ channel for sensing low temperature and to accelerate G-protein GTPase activity. We further identify that a SNP in COLD1, SNP2, originated from Chinese Oryza rufipogon, is responsible for the ability of COLDjap/ind to confer chilling tolerance, supporting the importance of COLD1 in plant adaptation.	[Ma, Yun; Dai, Xiaoyan; Xu, Yunyuan; Luo, Wei; Lin, Xiaoli; Liu, Huanhuan; Zhang, Dajian; Xiao, Jun; Guo, Xiaoyu; Xu, Shujuan; Niu, Yuda; Jin, Jingbo; Zhang, Hui; Chong, Kang] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China; [Zheng, Xiaoming; Ge, Song] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Zeng, Dali; Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Pan, Yajun; Li, Legong] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Xu, Xun; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Chong, Kang] Natl Ctr Plant Gene Res, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Capital Normal University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences	Chong, K (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China.	chongk@ibcas.ac.cn	Wang, Wen/AAP-9873-2020; qian, qian/AAH-8708-2021; Xu, Xun/AAI-6763-2020	Xu, Xun/0000-0002-5338-5173; Wei, Luo/0000-0002-8149-6970; Ma, Yun/0000-0001-9838-1267	Major State Basic Research Program of China [2013CBA01403]; National Nature Science Foundation [30821007]; CAS [XDA08010205]	Major State Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	The authors appreciate Dr. Qiang Zhao and Dr. B. Wu for their friendly help with purification of the membrane proteins. We are grateful to Dr. Joerg Kudla for his helpful comments and the kind gifts of constructs. We thank Dr. Gynheung An for the mutant line, and Ms. Rongxi Jiang, and Ms. Yuan Zhao, as well as Mr. Bo Wang for assistance with either gene transformation or molecular assay. We thank Dr. Yongbiao Xue, Dr. Bin Han, and Dr. Zhiyong Wang for their useful comments and help on the project. This work was supported by the Major State Basic Research Program of China (2013CBA01403) and the National Nature Science Foundation (30821007), as well as CAS grants (XDA08010205) to K.C.	Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Finka A, 2012, PLANT CELL, V24, P3333, DOI 10.1105/tpc.112.095844; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Hu XM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003391; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jaffe FW, 2012, PLANT CELL, V24, P3649, DOI 10.1105/tpc.112.098681; Jeong DH, 2002, PLANT PHYSIOL, V130, P1636, DOI 10.1104/pp.014357; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Koseki M, 2010, MOL GENET GENOMICS, V284, P45, DOI 10.1007/s00438-010-0548-1; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Krebs M, 2012, PLANT J, V69, P181, DOI 10.1111/j.1365-313X.2011.04780.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HK, 2009, PLANT CELL, V21, P622, DOI 10.1105/tpc.108.061994; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Saidi Y, 2009, PLANT CELL, V21, P2829, DOI 10.1105/tpc.108.065318; Saito K, 2001, THEOR APPL GENET, V103, P862, DOI 10.1007/s001220100661; Saito K, 2010, PLANT SCI, V179, P97, DOI 10.1016/j.plantsci.2010.04.004; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; Shabala S, 2000, ANN BOT-LONDON, V85, P681, DOI 10.1006/anbo.2000.1131; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Steinhorst L, 2013, PLANT PHYSIOL, V163, P471, DOI 10.1104/pp.113.222950; Swarbreck SM, 2013, PLANT PHYSIOL, V163, P514, DOI 10.1104/pp.113.220855; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wang L, 2006, CELL RES, V16, P916, DOI 10.1038/sj.cr.7310111; Wang L, 2010, SIGNAL COMMUN PLANTS, P135, DOI 10.1007/978-3-642-03524-1_8; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Wu WX, 2013, P NATL ACAD SCI USA, V110, P2775, DOI 10.1073/pnas.1213962110; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yamauchi S, 2010, FEBS J, V277, P3596, DOI 10.1111/j.1742-4658.2010.07768.x; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	49	439	522	54	434	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1209	1221		10.1016/j.cell.2015.01.046	http://dx.doi.org/10.1016/j.cell.2015.01.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25728666	Bronze			2022-12-28	WOS:000351951800019
J	Trevatt, AEJ; Igwe, RO; Khan, U				Trevatt, Alexander E. J.; Igwe, Richard O.; Khan, Umraz			Management of soft tissue defects of the foot	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDIAL PLANTAR ARTERY; FLAP; ANKLE		[Trevatt, Alexander E. J.] Barnet Hosp, Royal Free London NHS Fdn Trust, Barnet EN5 3DJ, England; [Igwe, Richard O.] Homerton Univ Hosp NHS Fdn Trust, London, England; [Khan, Umraz] Frenchay Hosp, Bristol BS16 1LE, Avon, England	University of London; University College London; Royal Free London NHS Foundation Trust	Trevatt, AEJ (corresponding author), Barnet Hosp, Royal Free London NHS Fdn Trust, Barnet EN5 3DJ, England.	alextrevatt@gmail.com						BAKER GL, 1990, PLAST RECONSTR SURG, V85, P47, DOI 10.1097/00006534-199001000-00009; Knobloch K, 2010, PLAST RECONSTR SURG, V126, p220E, DOI 10.1097/PRS.0b013e3181ec1eef; Paget JTEH, 2015, FOOT ANKLE SURG, V21, P60, DOI 10.1016/j.fas.2014.09.009; Trevatt AEJ, 2014, FOOT ANKLE SURG, V20, P166, DOI 10.1016/j.fas.2014.03.001; Weinzweig N, 1998, PLAST RECONSTR SURG, V102, P1999, DOI 10.1097/00006534-199811000-00029	5	5	5	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2015	350								h1184	10.1136/bmj.h1184	http://dx.doi.org/10.1136/bmj.h1184			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EL	25761696				2022-12-28	WOS:000351182200002
J	Powell, JR				Powell, J. Robert			Are New Oral Anticoagulant Dosing Recommendations Optimal for All Patients?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ATRIAL-FIBRILLATION; DABIGATRAN		Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Powell, JR (corresponding author), Univ N Carolina, Eshelman Sch Pharm, 301 Pharm Ln, Chapel Hill, NC 27599 USA.	bob.powell49@gmail.com						Beasley BN, 2011, NEW ENGL J MED, V364, P1788, DOI 10.1056/NEJMp1103050; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; Girgis IG, 2014, J CLIN PHARMACOL, V54, P917, DOI 10.1002/jcph.288; Hellriegel ET, 1996, CLIN PHARMACOL THER, V60, P601, DOI 10.1016/S0009-9236(96)90208-8; Ingelheim Boehringer, ID MID LONG TERM STR; Kowalsk K, 2014, J PHARMACOKINET PHAR, V41, pS19; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee, ED NDA 206314 STAT C	9	23	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1013	1014		10.1001/jama.2015.59	http://dx.doi.org/10.1001/jama.2015.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756434				2022-12-28	WOS:000350643100013
J	Burg, JS; Ingram, JR; Venkatakrishnan, AJ; Jude, KM; Dukkipati, A; Feinberg, EN; Angelini, A; Waghray, D; Dror, RO; Ploegh, HL; Garcia, KC				Burg, John S.; Ingram, Jessica R.; Venkatakrishnan, A. J.; Jude, Kevin M.; Dukkipati, Abhiram; Feinberg, Evan N.; Angelini, Alessandro; Waghray, Deepa; Dror, Ron O.; Ploegh, Hidde L.; Garcia, K. Christopher			Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor	SCIENCE			English	Article							SULFOTYROSINE RECOGNITION; SIGNALING NETWORKS; CRYSTAL-STRUCTURE; IDENTIFICATION; COMPLEX; BINDING; DOMAIN	Chemokines are small proteins that function as immune modulators through activation of chemokine G protein-coupled receptors (GPCRs). Several viruses also encode chemokines and chemokine receptors to subvert the host immune response. How protein ligands activate GPCRs remains unknown. We report the crystal structure at 2.9 angstrom resolution of the human cytomegalovirus GPCR US28 in complex with the chemokine domain of human CX3CL1 (fractalkine). The globular body of CX3CL1 is perched on top of the US28 extracellular vestibule, whereas its amino terminus projects into the central core of US28. The transmembrane helices of US28 adopt an active-state-like conformation. Atomic-level simulations suggest that the agonist-independent activity of US28 may be due to an amino acid network evolved in the viral GPCR to destabilize the receptor's inactive state.	[Burg, John S.; Jude, Kevin M.; Dukkipati, Abhiram; Waghray, Deepa; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Burg, John S.; Jude, Kevin M.; Dukkipati, Abhiram; Waghray, Deepa; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Burg, John S.; Venkatakrishnan, A. J.; Jude, Kevin M.; Dukkipati, Abhiram; Feinberg, Evan N.; Waghray, Deepa; Dror, Ron O.; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Ingram, Jessica R.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Venkatakrishnan, A. J.; Feinberg, Evan N.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.; Feinberg, Evan N.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Angelini, Alessandro] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT)	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Angelini, Alessandro/AAB-3682-2019	/0000-0001-5923-3843; Jude, Kevin/0000-0002-3675-5136; Dror, Ron/0000-0002-6418-2793; Feinberg, Evan/0000-0002-7989-8751	Cancer Research Institute; Howard Hughes Medical Institute; Keck Foundation Medical Scholars Program; NIH [RO1 GM097015]; Terman Faculty Fellowship; Swiss National Science Foundation; NIH Pioneer award; Ludwig Foundation for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097015, DP1GM106409] Funding Source: NIH RePORTER	Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Keck Foundation Medical Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terman Faculty Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Foundation for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Kobilka and members of the Kobilka lab for advice and discussions; S. Kim, N. Lotorraca, and A. Sanborn for assistance with MD simulations and analysis; J. Spangler for helpful discussions; E. Ozkan for assistance with data collection; and H. Axelrod for advice on refinement strategies. We also acknowledge beamline resources and staff of Advanced Photon Source GM/CA beamlines 23-ID-B and 23-ID-D and Stanford. Synchrotron Radiation Lightsource beamline 12-2. The data in this paper are tabulated in the main manuscript and in the supplementary materials. Structure factors and coordinates have been deposited in the Protein Data Bank with identification (ID) numbers 4XT1 and 4XT3. We acknowledge support from the Cancer Research Institute (J.S.B.), Howard Hughes Medical Institute (K.C.G.) the Keck Foundation Medical Scholars Program (K.C.G.), NIH RO1 GM097015 (K.C.G.), a Terman Faculty Fellowship (R.O.D.), Swiss National Science Foundation (A.A.), NIH Pioneer award (H.L.P.), and Ludwig Foundation for Cancer Research (A.A.).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Casarosa P, 2003, J BIOL CHEM, V278, P5172, DOI 10.1074/jbc.M210033200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; Han Xinbing, 2014, Adv Pharmacol, V70, P265, DOI 10.1016/B978-0-12-417197-8.00009-2; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Millard CJ, 2014, STRUCTURE, V22, P1571, DOI 10.1016/j.str.2014.08.023; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2014, CURR MED CHEM, V21, P3594, DOI 10.2174/0929867321666140716093155; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Vischer HF, 2006, TRENDS PHARMACOL SCI, V27, P56, DOI 10.1016/j.tips.2005.11.006; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	30	212	216	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1113	1117		10.1126/science.aaa5026	http://dx.doi.org/10.1126/science.aaa5026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745166	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000350354200046
J	Van den Bruel, A; Jones, C; Yang, YL; Oke, J; Hewitson, P				Van den Bruel, Ann; Jones, Caroline; Yang, Yaling; Oke, Jason; Hewitson, Paul			People's willingness to accept overdetection in cancer screening: population survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; INFORMATION; BENEFITS; WOMEN; OVERDIAGNOSIS; RISKS	Objectives To describe the level of overdetection people would find acceptable in screening for breast, prostate, and bowel cancer and whether acceptability is influenced by the magnitude of the benefit from screening and the cancer specific harms from overdetection. Design Online survey. Women were presented with scenarios on breast and bowel cancer, men with scenarios on prostate and bowel cancer. For each particular cancer, we presented epidemiological information and described the treatment and its consequences. Secondly, we presented two different scenarios of benefit: one indicating a 10% reduction in cancer specific mortality and the second indicating a 50% reduction. Setting Online survey of the population in the United Kingdom. Participants Respondents were part of an existing panel of people who volunteer for online research and were invited by email or online marketing. We recruited 1000 respondents, representative for age and sex for the UK population. Main outcome measures Number of cases of overdetection people were willing to accept, ranging from 0-1000 (complete screened population) for each cancer modality and each scenario of benefit. Results There was large variability between respondents in the level of overdetection they would find acceptable, with medians ranging from 113 to 313 cases of overdetection per 1000 people screened. Across all scenarios, 4-7% of respondents indicated they would accept no overdetection at all compared with 7-14% who thought that it would be acceptable for the entire screened population to be overdetected. Acceptability in screening for bowel cancer was significantly lower than for breast and prostate cancer. People aged 50 or over accepted significantly less overdetection, whereas people with higher education levels accepted more; 29% of respondents had heard of overdetection before. Conclusions Acceptability of overdetection in cancer screening is variable. Invitations for screening should include clear information on the likelihood and consequences of overdetection to allow people to make an informed choice.	[Van den Bruel, Ann; Jones, Caroline; Yang, Yaling; Oke, Jason] Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Hewitson, Paul] Univ Oxford, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Van den Bruel, A (corresponding author), Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	ann.vandenbruel@phc.ox.ac.uk	Van den Bruel, Ann/AAC-2442-2020	Van den Bruel, Ann/0000-0001-9012-2009	National Institute for Health Research (NIHR) Diagnostic Evidence Co-operative Oxford	National Institute for Health Research (NIHR) Diagnostic Evidence Co-operative Oxford(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) Diagnostic Evidence Co-operative Oxford. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The study sponsors had no role in the design, analyses or reporting of the study. The researchers retained complete independence in the conduct of this study.	[Anonymous], 2008, 2 ALL BREAST CANC RE; Baum M, 2006, BMJ-BRIT MED J, V332, P728, DOI 10.1136/bmj.332.7543.728; Brodersen J, 2013, ANN FAM MED, V11, P106, DOI 10.1370/afm.1466; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Dreier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107575; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Giordano L, 2005, EUR J PUBLIC HEALTH, V15, P66, DOI 10.1093/eurpub/cki117; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Gummersbach E, 2010, EUR J PUBLIC HEALTH, V20, P409, DOI 10.1093/eurpub/ckp174; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; HSCIC, 2014, NAT BOW CANC AUD; Ilic Dragan, 2013, Cochrane Database Syst Rev, pCD004720, DOI 10.1002/14651858.CD004720.pub3; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McPherson K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d791; Moynihan R., 2013, BMJ-BRIT MED J, V347, pf5157; Perneger TV, 2010, EUR J CANCER, V46, P2267, DOI 10.1016/j.ejca.2010.04.011; Plumb AA, 2014, RADIOLOGY, V273, P144, DOI 10.1148/radiol.14131678; Rasky E, 2013, GESUNDHEITSWESEN, V75, pE18, DOI 10.1055/s-0032-1321751; Slaytor EK, 1998, BRIT MED J, V317, P263, DOI 10.1136/bmj.317.7153.263; Smith SK, 2009, PATIENT EDUC COUNS, V75, P358, DOI 10.1016/j.pec.2009.01.012; Trevena LJ, 2006, J EVAL CLIN PRACT, V12, P13, DOI 10.1111/j.1365-2753.2005.00596.x; Vaidya JS, 2014, LANCET, V383, P603, DOI 10.1016/S0140-6736(13)61950-9; Waller J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002703; Wegwarth O, 2013, JAMA INTERN MED, V173, P2086, DOI 10.1001/jamainternmed.2013.10363; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	27	30	30	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2015	350								h980	10.1136/bmj.h980	http://dx.doi.org/10.1136/bmj.h980			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC4DS	25736617	Green Published, hybrid			2022-12-28	WOS:000350301600007
J	Church, M				Church, Mary			We need drones, robots, and autonomous ambulances	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mvgchurch@gmail.com							0	1	1	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2015	350								h987	10.1136/bmj.h987	http://dx.doi.org/10.1136/bmj.h987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AQ	25721944				2022-12-28	WOS:000350293400012
J	Johansson, K; Cnattingius, S; Naslund, I; Roos, N; Lagerros, YT; Granath, F; Stephansson, O; Neovius, M				Johansson, Kari; Cnattingius, Sven; Naslund, Ingmar; Roos, Nathalie; Lagerros, Ylva Trolle; Granath, Fredrik; Stephansson, Olof; Neovius, Martin			Outcomes of Pregnancy after Bariatric Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL THERAPY; RISK; OBESITY; TRENDS	BACKGROUND Maternal obesity is associated with increased risks of gestational diabetes, large-for-gestational-age infants, preterm birth, congenital malformations, and stillbirth. The risks of these outcomes among women who have undergone bariatric surgery are unclear. METHODS We identified 627,693 singleton pregnancies in the Swedish Medical Birth Register from 2006 through 2011, of which 670 occurred in women who had previously undergone bariatric surgery and for whom presurgery weight was documented. For each pregnancy after bariatric surgery, up to five control pregnancies were matched for the mother's presurgery body-mass index (BMI; we used early-pregnancy BMI in the controls), age, parity, smoking history, educational level, and delivery year. We assessed the risks of gestational diabetes, large-for-gestational-age and small-for-gestational-age infants, preterm birth, stillbirth, neonatal death, and major congenital malformations. RESULTS Pregnancies after bariatric surgery, as compared with matched control pregnancies, were associated with lower risks of gestational diabetes (1.9% vs. 6.8%; odds ratio, 0.25; 95% confidence interval [CI], 0.13 to 0.47; P< 0.001) and large-for-gestational-age infants (8.6% vs. 22.4%; odds ratio, 0.33; 95% CI, 0.24 to 0.44; P< 0.001). In contrast, they were associated with a higher risk of small-for-gestational-age infants (15.6% vs. 7.6%; odds ratio, 2.20; 95% CI, 1.64 to 2.95; P< 0.001) and shorter gestation (273.0 vs. 277.5 days; mean difference -4.5 days; 95% CI, -2.9 to -6.0; P< 0.001), although the risk of preterm birth was not significantly different (10.0% vs. 7.5%; odds ratio, 1.28; 95% CI, 0.92 to 1.78; P = 0.15). The risk of stillbirth or neonatal death was 1.7% versus 0.7% (odds ratio, 2.39; 95% CI, 0.98 to 5.85; P = 0.06). There was no significant between-group difference in the frequency of congenital malformations. CONCLUSIONS Bariatric surgery was associated with reduced risks of gestational diabetes and excessive fetal growth, shorter gestation, an increased risk of small-for-gestational-age infants, and possibly increased mortality.	[Johansson, Kari; Cnattingius, Sven; Roos, Nathalie; Lagerros, Ylva Trolle; Granath, Fredrik; Stephansson, Olof; Neovius, Martin] Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Stephansson, Olof] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, SE-17176 Stockholm, Sweden; [Naslund, Ingmar] Univ Orebro, Dept Surg, Fac Med & Hlth, SE-70182 Orebro, Sweden	Karolinska Institutet; Karolinska Institutet; Orebro University	Johansson, K (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit T2, SE-17176 Stockholm, Sweden.	kari.johansson@ki.se	Lagerros, Ylva Trolle/AAH-7683-2020; Johanson, Kari/AAZ-4397-2020	Lagerros, Ylva Trolle/0000-0001-6816-7577; Neovius, Martin/0000-0003-2300-3055; Stephansson, Olof/0000-0003-1528-4563; Roos, Nathalie/0000-0001-9752-2355	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by the Swedish Research Council and others.	Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Center for Epidemiology, 2003, SWED MED BIRTH REG S; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Dalenius K, 2012, PREGNANCY NUTR SURVE; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Kjaer MM, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.046; Kjaer MM, 2013, ACTA OBSTET GYN SCAN, V92, P264, DOI 10.1111/aogs.12035; Lesko J, 2012, OBSTET GYNECOL, V119, P547, DOI 10.1097/AOG.0b013e318239060e; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Odlind V, 2003, ACTA OBSTET GYN SCAN, V82, P516, DOI 10.1034/j.1600-0412.2003.00112.x; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Rao A, 2004, BEST PRACT RES CL OB, V18, P557, DOI 10.1016/j.bpobgyn.2004.04.007; Roos N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6460; Saltzman E, 2013, ANNU REV NUTR, V33, P183, DOI 10.1146/annurev-nutr-071812-161225; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Singh J, 2012, J MATERN-FETAL NEO M, V25, P5, DOI 10.3109/14767058.2012.626920; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd	26	243	248	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					814	824		10.1056/NEJMoa1405789	http://dx.doi.org/10.1056/NEJMoa1405789			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8SQ	25714159	Bronze			2022-12-28	WOS:000349901700006
J	Millard, J; Ugarte-Gil, C; Moore, DAJ				Millard, James; Ugarte-Gil, Cesar; Moore, David A. J.			Multidrug resistant tuberculosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; ASSAY; MTB/RIF; RIFAMPIN; TRANSMISSION; DIAGNOSIS; SANATORIA; TIME		[Millard, James] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Ugarte-Gil, Cesar] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Moore, David A. J.] Univ London London Sch Hyg & Trop Med, TB Ctr, London WC1E 7HT, England	University of Brighton; University of Sussex; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Moore, DAJ (corresponding author), Univ London London Sch Hyg & Trop Med, TB Ctr, Keppel St, London WC1E 7HT, England.	David.moore@lshtm.ac.uk	Ugarte-Gil, Cesar/E-6074-2013; Millard, James Daniel/AAM-5347-2020	Ugarte-Gil, Cesar/0000-0002-2833-9087; Millard, James Daniel/0000-0001-6427-552X				Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; CHIANG CY, 2013, INT J TUBERC LUNG D, V17, P714, DOI [DOI 10.5588/IJT1D.12.0989, DOI 10.5588/IJTLD.12.0989]; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; FIND, PRIC XPERT MTB RIF F; Furin J, 2011, INT J TUBERC LUNG D, V15, P1294, DOI 10.5588/ijtld.10.0591; Health Protection Agency, 2013, TUB UK 2013 REP; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hughes J, 2012, LANCET, V379, P2148, DOI 10.1016/S0140-6736(12)60940-4; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Martin A, 2008, J ANTIMICROB CHEMOTH, V62, P56, DOI 10.1093/jac/dkn139; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233; Peter JG, 2013, LANCET RESP MED, V1, P471, DOI 10.1016/S2213-2600(13)70120-6; Raizada N, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088626, 10.1371/journal.pone.0105346]; Somoskovi A, 2013, J CLIN MICROBIOL, V51, P3127, DOI 10.1128/JCM.01377-13; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Sullivan T, 2013, LANCET INFECT DIS, V13, P373, DOI 10.1016/S1473-3099(12)70318-3; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; WHO, 2011, AUT REAL TIM NUCL AC; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2011, NONC CULT DRUG SUSC; World Health Organization, 2011, GUID PROGR MAN DRUG; Zetola NM, 2014, J CLIN MICROBIOL, V52, P2422, DOI 10.1128/JCM.02489-13	29	49	49	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2015	350								h882	10.1136/bmj.h882	http://dx.doi.org/10.1136/bmj.h882			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AQ	25721508	Green Published			2022-12-28	WOS:000350293400010
J	Chen, M; Kim, TY; Pessegueiro, AM				Chen, Meng; Kim, Tiffany Y.; Pessegueiro, Antonio M.			Elevated Lactate Levels in a Non-Critically Ill Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							B LACTIC-ACIDOSIS; METABOLIC COMPLICATION; PATHOGENESIS; MALIGNANCY		[Chen, Meng; Kim, Tiffany Y.; Pessegueiro, Antonio M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pessegueiro, AM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 757 Westwood Plaza,Ste 7501, Los Angeles, CA 90095 USA.	apessegueiro@mednet.ucla.edu		Pessegueiro, Antonio/0000-0002-0277-7919				BLOCK JB, 1974, ANN NY ACAD SCI, V230, P94, DOI 10.1111/j.1749-6632.1974.tb14439.x; Brenner BM, 2004, BRENNER RECTORS KIDN, V1; Centers for Medicare & Medicaid Services, 2014, FEE SCHED; Di Grande A, 2008, CLIN TER, V159, P87; Friedenberg AS, 2007, MEDICINE, V86, P225, DOI 10.1097/MD.0b013e318125759a; LANGE H, 1994, EUR J SURG, V160, P381; Ruiz JP, 2011, THESCIENTIFICWORLDJO, V11, P1316, DOI 10.1100/tsw.2011.125; Sia P, 2013, AM J KIDNEY DIS, V62, P633, DOI 10.1053/j.ajkd.2013.03.036; Sillos EM, 2001, CANCER-AM CANCER SOC, V92, P2237, DOI 10.1002/1097-0142(20011101)92:9<2237::AID-CNCR1569>3.0.CO;2-9	9	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					849	850		10.1001/jama.2014.14074	http://dx.doi.org/10.1001/jama.2014.14074			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710662				2022-12-28	WOS:000349826400019
J	Mohareb, MM; Qiu, F; Cantor, WJ; Kingsbury, KJ; Ko, DT; Wijeysundera, HC				Mohareb, Michael M.; Qiu, Feng; Cantor, Warren J.; Kingsbury, Kori J.; Ko, Dennis T.; Wijeysundera, Harindra C.			Validation of the Appropriate Use Criteria for Coronary Angiography A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; ACUTE MYOCARDIAL-INFARCTION; NEW-YORK-STATE; ARTERY-DISEASE; DIAGNOSTIC CATHETERIZATION; REVASCULARIZATION; UPDATE; RISK	Background: The use of invasive coronary angiography in stable ischemic heart disease (IHD) varies widely. Objective: To validate the 2012 appropriate use criteria for diagnostic catheterization by examining the relationship between the appropriateness of cardiac catheterization in patients with suspected stable IHD and the proportion of patients with obstructive coronary artery disease (CAD) and subsequent revascularization. Design: Population-based, observational, multicenter cohort study. Setting: The Cardiac Care Network, a registry of all patients having elective angiography at 18 hospitals in Ontario, Canada, between 1 October 2008 and 30 September 2011. Patients: Persons without prior coronary revascularization or myocardial infarction who had angiography for suspected stable CAD. Measurements: Appropriateness scores were ascertained by using data collected at the time of the index angiography and were categorized as appropriate, inappropriate, or uncertain. Results: Among the final cohort of 48 336 patients, 58.2% of angiographic studies were classified as appropriate, 10.8% were classified as inappropriate, and 31.0% were classified as uncertain. Overall, 45.5% of patients had obstructive CAD. In patients with appropriate indications for angiography, 52.9% had obstructive CAD, with 40.0% undergoing revascularization. In those with inappropriate indications, 30.9% had obstructive CAD and 18.9% underwent revascularization; in those with uncertain indications, 36.7% had obstructive CAD and 25.9% had revascularization. Although more patients with appropriate indications had obstructive CAD and underwent revascularization (P < 0.001), a substantial proportion of those with inappropriate or uncertain indications had important coronary disease. Limitation: Data were not available on whether symptoms were atypical. Conclusion: Despite the association between appropriateness category and obstructive CAD, this study raises concerns about the ability of the appropriate use criteria to guide clinical decision making.	[Wijeysundera, Harindra C.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Cardiol, Schulich Heart Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Wijeysundera, HC (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Cardiol, Schulich Heart Ctr, 2075 Bayview Ave,Suite A202, Toronto, ON M4N 3M5, Canada.	harindra.wijeysundera@sunnybrook.ca	Wijeysundera, Harindra/AAA-6058-2020	Ko, Dennis/0000-0001-6840-8051; Wijeysundera, Harindra/0000-0001-8464-1080	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research.	Douglas PS, 2011, J AM COLL CARDIOL, V58, P801, DOI 10.1016/j.jacc.2011.05.019; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Hannan EL, 2014, CIRC-CARDIOVASC INTE, V7, P19, DOI 10.1161/CIRCINTERVENTIONS.113.000741; Hemingway H, 2001, HEART, V85, P672, DOI 10.1136/heart.85.6.672; Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039; Ko DT, 2013, JAMA-J AM MED ASSOC, V310, P163, DOI 10.1001/jama.2013.7834; Ko DT, 2012, J AM COLL CARDIOL, V60, P1876, DOI 10.1016/j.jacc.2012.06.056; Levitt K, 2013, AM HEART J, V166, P694, DOI 10.1016/j.ahj.2013.07.030; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Patel MR, 2012, J AM COLL CARDIOL, V59, P1995, DOI [10.1016/j.jacc.2012.03.003, 10.1002/ccd.24467]; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schwalm JDR, 2014, CAN J CARDIOL, V30, P1155, DOI 10.1016/j.cjca.2014.04.006; Thomas MP, 2014, J AM COLL CARDIOL, V63, P427, DOI 10.1016/j.jacc.2013.10.010; Tu JV, 2012, CAN MED ASSOC J, V184, P179, DOI 10.1503/cmaj.111072; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	17	27	27	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					549	+		10.7326/M14-1889	http://dx.doi.org/10.7326/M14-1889			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25751586				2022-12-28	WOS:000353244300015
J	Ruschel, J; Hellal, F; Flynn, KC; Dupraz, S; Elliott, DA; Tedeschi, A; Bates, M; Sliwinski, C; Brook, G; Dobrindt, K; Peitz, M; Brustle, O; Norenberg, MD; Blesch, A; Weidner, N; Bunge, MB; Bixby, JL; Bradke, F				Ruschel, Joerg; Hellal, Farida; Flynn, Kevin C.; Dupraz, Sebastian; Elliott, David A.; Tedeschi, Andrea; Bates, Margaret; Sliwinski, Christopher; Brook, Gary; Dobrindt, Kristina; Peitz, Michael; Bruestle, Oliver; Norenberg, Michael D.; Blesch, Armin; Weidner, Norbert; Bunge, Mary Bartlett; Bixby, John L.; Bradke, Frank			Systemic administration of epothilone B promotes axon regeneration after spinal cord injury	SCIENCE			English	Article							FUNCTIONAL RECOVERY; IN-VIVO; RAT; GROWTH; ADULT; BRAIN; TAU; STABILIZATION; NEURONS; CANCER	After central nervous system (CNS) injury, inhibitory factors in the lesion scar and poor axon growth potential prevent axon regeneration. Microtubule stabilization reduces scarring and promotes axon growth. However, the cellular mechanisms of this dual effect remain unclear. Here, delayed systemic administration of a blood-brain barrier-permeable microtubule-stabilizing drug, epothilone B (epoB), decreased scarring after rodent spinal cord injury (SCI) by abrogating polarization and directed migration of scar-forming fibroblasts. Conversely, epothilone B reactivated neuronal polarization by inducing concerted microtubule polymerization into the axon tip, which propelled axon growth through an inhibitory environment. Together, these drug-elicited effects promoted axon regeneration and improved motor function after SCI. With recent clinical approval, epothilones hold promise for clinical use after CNS injury.	[Ruschel, Joerg; Hellal, Farida; Flynn, Kevin C.; Dupraz, Sebastian; Elliott, David A.; Tedeschi, Andrea; Bradke, Frank] German Ctr Neurodegenerat Dis, Axonal Growth & Regenerat, D-53175 Bonn, Germany; [Bates, Margaret; Bunge, Mary Bartlett; Bixby, John L.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Sliwinski, Christopher; Blesch, Armin; Weidner, Norbert] Univ Heidelberg Hosp, Spinal Cord Injury Ctr, D-69118 Heidelberg, Germany; [Brook, Gary] Rhein Westfal TH Aachen, Inst Neuropathol, D-52074 Aachen, Germany; [Brook, Gary] Univ Bonn, Julich Aachen Res Alliance Translat Brain Med, D-53127 Bonn, Germany; [Dobrindt, Kristina; Peitz, Michael; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life&Brain Ctr, D-53127 Bonn, Germany; [Dobrindt, Kristina; Peitz, Michael; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33101 USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Biochem, Miami, FL 33101 USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Mol Pathol, Miami, FL 33101 USA	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Miami; Ruprecht Karls University Heidelberg; RWTH Aachen University; University of Bonn; University of Bonn; University of Miami; University of Miami; University of Miami	Bradke, F (corresponding author), German Ctr Neurodegenerat Dis, Axonal Growth & Regenerat, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	frank.bradke@dzne.de	Hellal, Farida/D-1834-2015; Peitz, Michael/AHB-0741-2022; Hellal, Farida/AHC-2588-2022	Hellal, Farida/0000-0002-9344-1846; Hellal, Farida/0000-0002-9344-1846; Ruschel, Joerg/0000-0002-4782-9786; Bradke, Frank/0000-0002-0345-3772	NIH; International Foundation for Research in Paraplegia; Wings for Life; Deutsche Forschungsgemeinschaft; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Foundation for Research in Paraplegia; Wings for Life; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Materials and methods and other supporting materials are available on Science Online. We thank L. Meyn, K. Weisheit, D. Fleischer, and N. Thielen for technical assistance and animal care and C. Hill for teaching the spinal cord contusion injury model. We also thank C. Laskowski, C. H. Coles, A. Kania, M. Hubener, W. Jackson, and G. Tavosanis for critically reading and discussing the manuscript. We are grateful for support from the Human Spinal Cord Tissue Bank and the electron microscopy core at the Miami Project, as well as to B. Kakulas (University of Western Australia and Royal Perth) for providing anonymized postmortem sections after human spinal cord injury. This work was supported by NIH, International Foundation for Research in Paraplegia, Wings for Life, and Deutsche Forschungsgemeinschaft. H. Witte, A. Erturk, F. H., and F. B. filed a patent on the use of microtubule-stabilizing compounds for the treatment of lesions of CNS axons (European Patent no. 1858498; European patent application EP 11 00 9155.0; U.S. patent application 11/908,118). The authors declare no competing financial interests.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Ballatore C, 2012, J MED CHEM, V55, P8979, DOI 10.1021/jm301079z; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; CARBONELL AL, 1988, BRAIN RES, V439, P337, DOI 10.1016/0006-8993(88)91491-6; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fellner S, 2002, J CLIN INVEST, V110, P1309, DOI 10.1172/JCI200215451; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Laskowski CJ, 2013, EXP NEUROL, V242, P11, DOI 10.1016/j.expneurol.2012.07.007; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Slawinska U, 2013, EXP NEUROL, V247, P572, DOI 10.1016/j.expneurol.2013.02.008; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207	29	283	291	12	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					347	352		10.1126/science.aaa2958	http://dx.doi.org/10.1126/science.aaa2958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25765066	Green Accepted			2022-12-28	WOS:000352999000048
J	Han, YL; Guo, JC; Zheng, Y; Zang, HY; Su, X; Wang, Y; Chen, SL; Jiang, TM; Yang, P; Chen, JY; Jiang, DJ; Jing, QM; Liang, ZY; Liu, HW; Zhao, X; Li, J; Li, Y; Xu, B; Stone, GW				Han, Yaling; Guo, Jincheng; Zheng, Yang; Zang, Hongyun; Su, Xi; Wang, Yu; Chen, Shaoliang; Jiang, Tiemin; Yang, Ping; Chen, Jiyan; Jiang, Dongju; Jing, Quanmin; Liang, Zhenyang; Liu, Haiwei; Zhao, Xin; Li, Jing; Li, Yi; Xu, Bo; Stone, Gregg W.		BRIGHT Investigators	Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction The BRIGHT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORIZONS-AMI; IIB/IIIA INHIBITORS; STENT THROMBOSIS; ELUTING STENTS; OUTCOMES; RISK; ASSOCIATION; MULTICENTER; CLOPIDOGREL; MONOTHERAPY	IMPORTANCE The safety and efficacy of bivalirudin compared with heparin with or without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI) are uncertain. OBJECTIVE To determine if bivalirudin is superior to heparin alone and to heparin plus tirofiban during primary PCI. DESIGN, SETTING. AND PARTICIPANTS Multicenter, open-label trial involving 2194 patients with AMI undergoing primary PCI at 82 centers in China between August 2012 and June 2013. INTERVENTIONS Patients were randomly assigned to receive bivalirudin with a post-PCI infusion (n = 735), heparin alone (n = 729), or heparin plus tirofiban with a post-PCI infusion (n = 730). Among patients treated with bivalirudin, a postprocedure 1.75 mg/1<g/h infusion was administered for a median of 180 minutes (IQR, 148-240 minutes). MAIN OUTCOMES AND MEASURES The Primary end Point was 30-clay net adverse clinical events, a composite of major adverse cardiac or cerebral events (all-cause death, reinfarction, ischemia-driven target vessel revascularization, or stroke) or bleeding. Additional prespecified safety end points included the rates of acquired thrornbocytopenia at 30 days, and stent thrombosis at 30 days and 1 year. RESULTS Net adverse clinical events at 30 days occurred in 65 patients (8.8%) of 735 who were treated with bivalirudin compared with 96 patients (13.2%) of 729 treated with heparin (relative risk [RR], 0.67; 95% Cl, 0.50-0.90; difference, -4.3%, 95% Cl, -7.5% to -1.1%; P =.008); and 124 patients (17.0%) of 730 treated with heparin plus tirofiban (RR for bivalirudin vs heparin plus tirofiban, 0.52; 95% Cl, 0.39-0.69; difference, -8.1%, 95% Cl, -11.6% to -4.7%; P <.001). The 30-day bleeding rate was 4.1% for bivalirudin, 7.5% for heparin, and 12.3% for heparin plus tirofiban (P <.001). There were no statistically significant differences between treatments in the 30-day rates of major adverse cardiac or cerebral events (5.0% for bivalirudin, 5.8% for heparin, and 4.9% for heparin plus tirofiban, P =.74), stent thrombosis (0.6% vs 0.9% vs 0.7%, respectively, P =.77), acquired thrornbocytopenia (0.1% vs 0.7% vs 1.1%; P =.07), or in acute (<24-hour) stent thrombosis (0.3% in each group). At the 1-year follow-up, the results remained similar. CONCLUSIONS AND RELEVANCE Among patients with AIVII undergoing primary PCI, the use of bivalirudin with a median 3-hour postprocedure PCI-dose infusion resulted in a decrease in net adverse clinical events compared with both heparin alone and heparin plus tirofiban. This finding was primarily due to a reduction in bleeding events with bivalirudin, without significant differences in major adverse cardiac or cerebral events or stent thrombosis.	[Han, Yaling; Jing, Quanmin; Liang, Zhenyang; Liu, Haiwei; Zhao, Xin; Li, Jing; Li, Yi] Gen Hosp Shenyang Mil Reg, Shenyang, Liaoning Provin, Peoples R China; [Guo, Jincheng] Capital Med Univ, Luhe Hosp, Beijing, Peoples R China; [Zheng, Yang] Jilin Univ, Hosp 1, Changchun 130023, Jilin Province, Peoples R China; [Zang, Hongyun] PLA, Hosp 463, Shenyang, Liaoning Provin, Peoples R China; [Su, Xi] Wuhan Asia Heart Hosp, Wuhan, Hubei Province, Peoples R China; [Wang, Yu] Peoples Liberat Army, Gen Hosp, Beijing, Peoples R China; [Chen, Shaoliang] Nanjing First Hosp, Nanjing, Jiangsu, Peoples R China; [Jiang, Tiemin] CAPF, Logist Univ, Affiliated Hosp, Tianjin, Peoples R China; [Yang, Ping] Jilin Univ, Hosp 3, Changchun 130023, Jilin Province, Peoples R China; [Chen, Jiyan] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Jiang, Dongju] PLA, Hosp 210, Dalian, Liaoning Provin, Peoples R China; [Xu, Bo] Natl Ctr Cardiovasc Dis, Fu Wai Hosp, Beijing, Peoples R China; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA	Capital Medical University; Jilin University; Chinese People's Liberation Army General Hospital; Jilin University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Columbia University; Cardiovascular Research Foundation (CRF)	Han, YL (corresponding author), Gen Hosp Shenyang Mil Reg, 83 Wenhua Rd, Shenyang, Liaoning Provin, Peoples R China.	hanyaling@263.net	Xu, Bo/GQZ-1711-2022	Han, Yaling/0000-0003-4569-6737	General Hospital of Shenyang Military Region; Chinese Government National Key Research and Development project for the 12th five-year plan [2011BA111B07, 2012ZX093016-002]; Salubris Pharmaceutical Co (Shenzhen, China)	General Hospital of Shenyang Military Region; Chinese Government National Key Research and Development project for the 12th five-year plan; Salubris Pharmaceutical Co (Shenzhen, China)	The BRIGHT trial was sponsored by the General Hospital of Shenyang Military Region, supported by a general research fund from the General Hospital of Shenyang Military Region, as well as profit grants from the Chinese Government National Key Research and Development project for the 12th five-year plan (2011BA111B07, 2012ZX093016-002), and a research grant and study drug supply from Salubris Pharmaceutical Co (Shenzhen, China).	Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Bangalore S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6419; Bangalore S, 2014, CIRC-CARDIOVASC INTE, V7, P365, DOI 10.1161/CIRCINTERVENTIONS.113.001126; Bellomo R, 2009, CRIT CARE MED, V37, P3114, DOI 10.1097/CCM.0b013e3181bc7bd5; BITTL JA, 1995, NEW ENGL J MED, V333, P764, DOI 10.1056/NEJM199509213331204; Clemmensen P, 2015, JACC-CARDIOVASC INTE, V8, P214, DOI 10.1016/j.jcin.2014.11.002; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Heestermans AACM, 2008, THROMB RES, V122, P776, DOI 10.1016/j.thromres.2008.01.021; Kastrati A, 2011, NEW ENGL J MED, V365, P1980, DOI 10.1056/NEJMoa1109596; Kimmelstiel C, 2011, CIRC-CARDIOVASC INTE, V4, P171, DOI 10.1161/CIRCINTERVENTIONS.110.959098; Marso SP, 2010, JAMA-J AM MED ASSOC, V303, P2156, DOI 10.1001/jama.2010.708; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Ndrepepa G, 2012, CIRCULATION, V125, P1424, DOI 10.1161/CIRCULATIONAHA.111.060871; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Sorich MJ, 2014, CIRC-CARDIOVASC GENE, V7, P895, DOI 10.1161/CIRCGENETICS.114.000669; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2015, J AM COLL CARDIOL, V65, P27, DOI 10.1016/j.jacc.2014.10.029; Stone GW, 2014, J AM COLL CARDIOL, V63, P15, DOI 10.1016/j.jacc.2013.09.027; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541; Verheugt FWA, 2011, JACC-CARDIOVASC INTE, V4, P191, DOI 10.1016/j.jcin.2010.10.011; Wise GR, 2012, J INTERV CARDIOL, V25, P278, DOI 10.1111/j.1540-8183.2012.00720.x; Yoon YH, 2015, CATHETER CARDIO INTE, V85, P63, DOI 10.1002/ccd.25308; Zeymer U, 2014, EUR HEART J, V35, P2460, DOI 10.1093/eurheartj/ehu214	34	218	273	2	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1336	1346		10.1001/jama.2015.2323	http://dx.doi.org/10.1001/jama.2015.2323			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25775052	Bronze			2022-12-28	WOS:000352315900020
J	Rizvi, NA; Hellmann, MD; Snyder, A; Kvistborg, P; Makarov, V; Havel, JJ; Lee, W; Yuan, JD; Wong, P; Ho, TS; Miller, ML; Rekhtman, N; Moreira, AL; Ibrahim, F; Bruggeman, C; Gasmi, B; Zappasodi, R; Maeda, Y; Sander, C; Garon, EB; Merghoub, T; Wolchok, JD; Schumacher, TN; Chan, TA				Rizvi, Naiyer A.; Hellmann, Matthew D.; Snyder, Alexandra; Kvistborg, Pia; Makarov, Vladimir; Havel, Jonathan J.; Lee, William; Yuan, Jianda; Wong, Phillip; Ho, Teresa S.; Miller, Martin L.; Rekhtman, Natasha; Moreira, Andre L.; Ibrahim, Fawzia; Bruggeman, Cameron; Gasmi, Billel; Zappasodi, Roberta; Maeda, Yuka; Sander, Chris; Garon, Edward B.; Merghoub, Taha; Wolchok, Jedd D.; Schumacher, Ton N.; Chan, Timothy A.			Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer	SCIENCE			English	Article							EXOME ANALYSIS REVEALS; TUMOR; IPILIMUMAB; NIVOLUMAB; MPDL3280A; RESPONSES; ANTIGENS; ANTIBODY; EPITOPE	Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants of response to this therapy, we used whole-exome sequencing of non-small cell lung cancers treated with pembrolizumab, an antibody targeting programmed cell death-1 (PD-1). In two independent cohorts, higher nonsynonymous mutation burden in tumors was associated with improved objective response, durable clinical benefit, and progression-free survival. Efficacy also correlated with the molecular smoking signature, higher neoantigen burden, and DNA repair pathway mutations; each factor was also associated with mutation burden. In one responder, neoantigen-specific CD8+ T cell responses paralleled tumor regression, suggesting that anti-PD-1 therapy enhances neoantigen-specific T cell reactivity. Our results suggest that the genomic landscape of lung cancers shapes response to anti-PD-1 therapy.	[Rizvi, Naiyer A.; Hellmann, Matthew D.; Snyder, Alexandra; Ibrahim, Fawzia; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Rizvi, Naiyer A.; Hellmann, Matthew D.; Snyder, Alexandra; Wolchok, Jedd D.; Chan, Timothy A.] Weill Cornell Med Coll, New York, NY 10065 USA; [Snyder, Alexandra; Makarov, Vladimir; Havel, Jonathan J.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Kvistborg, Pia; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Lee, William; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Yuan, Jianda; Wong, Phillip; Ho, Teresa S.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, Immune Monitoring Core, New York, NY 10065 USA; [Miller, Martin L.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Rekhtman, Natasha; Moreira, Andre L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Bruggeman, Cameron] Columbia Univ, Dept Math, New York, NY 10027 USA; [Gasmi, Billel; Zappasodi, Roberta; Maeda, Yuka; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat Lab, New York, NY 10065 USA; [Garon, Edward B.] Univ Calif Los Angeles, David Geffen Sch Med, Santa Monica, CA 90404 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Netherlands Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chan, TA (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	chant@mskcc.org	Chan, Timothy A/ABD-5850-2021; Schumacher, Ton/Y-2432-2019; Merghoub, Taha/ABD-8362-2021	Schumacher, Ton/0000-0003-0517-8804; Wong, Phillip/0000-0002-6360-849X; Havel, Jonathan/0000-0003-0951-510X; Miller, Martin L/0000-0003-3161-8690; Zappasodi, Roberta/0000-0002-7031-6671; Snyder Charen, Alexandra/0000-0002-2606-3523	Geoffrey Beene Cancer Research Center; Society for Memorial Sloan Kettering Cancer Center; Lung Cancer Research Foundation; Frederick Adler Chair Fund; One Ball Matt Memorial Golf Tournament; Queen Wilhelmina Cancer Research Award; STARR Foundation; Ludwig Trust; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; Versus Arthritis [21141] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748, K23CA149079] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Center; Society for Memorial Sloan Kettering Cancer Center; Lung Cancer Research Foundation; Frederick Adler Chair Fund; One Ball Matt Memorial Golf Tournament; Queen Wilhelmina Cancer Research Award; STARR Foundation; Ludwig Trust; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Thoracic Oncology Service and the Chan and Wolchok laboratories at Memorial Sloan Kettering Cancer Center (MSKCC) for helpful discussions. We thank the Immune Monitoring Core at MSKCC, including L. Caro, R. Ramsawak, and Z. Mu, for exceptional support with processing and banking peripheral blood lymphocytes. We thank P. Worrell and E. Brzostowski for help in identifying tumor specimens for analysis. We thank A. Viale for superb technical assistance. We thank D. Philips, M. van Buuren, and M. Toebes for help performing the combinatorial coding screens. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Data are publicly available at the Cancer Genome Atlas (TCGA) cBio portal and database (www.cbioportal.org; study ID: Rizvi lung cancer). T.A.C. is the inventor on a patent (provisional application number 62/083,088). The application is directed toward methods for identifying patients who will benefit from treatment with immunotherapy. This work was supported by the Geoffrey Beene Cancer Research Center (M.D.H., N.A.R., T.A.C., J.D.W., and A.S.), the Society for Memorial Sloan Kettering Cancer Center (M.D.H.), Lung Cancer Research Foundation (W.L.), Frederick Adler Chair Fund (T.A.C.), The One Ball Matt Memorial Golf Tournament (E.B.G.), Queen Wilhelmina Cancer Research Award (T.N.S.), The STARR Foundation (T.A.C. and J.D.W.), the Ludwig Trust (J.D.W.), and a Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant (J.D.W., T.N.S., and T.A.C.). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Andersen RS, 2012, NAT PROTOC, V7, P891, DOI 10.1038/nprot.2012.037; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Garon EB, 2014, ANN ONCOL, V25; Goodwin JF, 2014, CANCER DISCOV, V4, P1126, DOI 10.1158/2159-8290.CD-14-0358; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hindges R, 1997, BIOL CHEM, V378, P345; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Matsutake T, 2001, P NATL ACAD SCI USA, V98, P3992, DOI 10.1073/pnas.071523398; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	45	5268	5492	44	990	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					124	128		10.1126/science.aaa1348	http://dx.doi.org/10.1126/science.aaa1348			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25765070	Green Accepted			2022-12-28	WOS:000352079500041
J	Bernstein, R				Bernstein, Rachel			Into the wilderness	SCIENCE			English	Editorial Material												SciCareerEditor@aaas.org							0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1282	1282		10.1126/science.347.6227.1282	http://dx.doi.org/10.1126/science.347.6227.1282			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766239				2022-12-28	WOS:000350824300043
J	Li, JQ; Ballmer, SG; Gillis, EP; Fujii, S; Schmidt, MJ; Palazzolo, AME; Lehmann, JW; Morehouse, GF; Burke, MD				Li, Junqi; Ballmer, Steven G.; Gillis, Eric P.; Fujii, Seiko; Schmidt, Michael J.; Palazzolo, Andrea M. E.; Lehmann, Jonathan W.; Morehouse, Greg F.; Burke, Martin D.			Synthesis of many different types of organic small molecules using one automated process	SCIENCE			English	Article							SOLID-PHASE SYNTHESIS; COUPLING REACTIONS; POLYKETIDE; CHEMISTRY; STRATEGY	Small-molecule synthesis usually relies on procedures that are highly customized for each target. A broadly applicable automated process could greatly increase the accessibility of this class of compounds to enable investigations of their practical potential. Here we report the synthesis of 14 distinct classes of small molecules using the same fully automated process. This was achieved by strategically expanding the scope of a building block-based synthesis platform to include even Csp3-rich polycyclic natural product frameworks and discovering a catch-and-release chromatographic purification protocol applicable to all of the corresponding intermediates. With thousands of compatible building blocks already commercially available, many small molecules are now accessible with this platform. More broadly, these findings illuminate an actionable roadmap to a more general and automated approach for small-molecule synthesis.	[Li, Junqi; Ballmer, Steven G.; Gillis, Eric P.; Fujii, Seiko; Schmidt, Michael J.; Palazzolo, Andrea M. E.; Lehmann, Jonathan W.; Morehouse, Greg F.; Burke, Martin D.] Univ Illinois, Howard Hughes Med Inst, Dept Chem, Urbana, IL 61801 USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Burke, MD (corresponding author), Univ Illinois, Howard Hughes Med Inst, Dept Chem, Urbana, IL 61801 USA.	mdburke@illinois.edu	Morehouse, Gregory/AGE-5989-2022	Morehouse, Gregory/0000-0001-9614-8808; Gillis, Eric/0000-0003-4294-6147; Li, Junqi/0000-0003-0336-2544; Palazzolo Ray, Andrea/0000-0002-2359-6690	NIH [GM080436, GM090153]; NSF [0747778]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090153, R01GM080436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the NIH (grants GM080436 and GM090153), the NSF (grant 0747778), HHMI, and Bristol-Myers Squibb for funding. M.D.B. is an HHMI Early Career Scientist, J.L. was an HHMI International Student Research Fellow, and J.L. and E.P.G. were Bristol-Myers Squibb Graduate Fellows. We thank D. Gray for performing the x-ray analysis on N-bromoacyl-14. The University of Illinois has filed patent applications on MIDA boronate chemistry and the automated synthesis platform reported herein. These inventions have been licensed to REVOLUTION Medicines, a company for which M.D.B. is a founder. Metrical parameters for the structure of N-bromoacyl-14 are available free of charge from the Cambridge Cyrstallographic Data Centre under reference CCDC-1045844.	Bracher F, 2003, NAT PROD RES, V17, P293, DOI 10.1080/1478641031000137004; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; Corey E. J., 2010, ENANTIOSELECTIVE CHE, P121; Dewick P.M., 2009, MED NATURAL PRODUCTS; Elliott EL, 2006, J ORG CHEM, V71, P5282, DOI 10.1021/jo0607212; Fujita K, 2012, ANGEW CHEM INT EDIT, V51, P7271, DOI 10.1002/anie.201203093; Fuse S., 2012, NEW STRATEGIES CHEM; Gillis EP, 2008, J AM CHEM SOC, V130, P14084, DOI 10.1021/ja8063759; Gillis EP, 2007, J AM CHEM SOC, V129, P6716, DOI 10.1021/ja0716204; Gillis EP, 2009, ALDRICHIM ACTA, V42, P17; Godfrey AG, 2013, DRUG DISCOV TODAY, V18, P795, DOI 10.1016/j.drudis.2013.03.001; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Grob JE, 2012, ORG LETT, V14, P5578, DOI 10.1021/ol302702q; Hall D, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, pXV; HEATHCOCK CH, 1992, J ORG CHEM, V57, P2554, DOI 10.1021/jo00035a009; Kinzel T, 2010, J AM CHEM SOC, V132, P14073, DOI 10.1021/ja1073799; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; Ley SV, 2015, ANGEW CHEM INT EDIT, V54, P3449, DOI 10.1002/anie.201410744; Maechling S, 2010, J COMB CHEM, V12, P818, DOI 10.1021/cc1001617; Mentel M, 2007, TOP CURR CHEM, V278, P209, DOI 10.1007/128_2006_107; MERRIFIELD RB, 1965, SCIENCE, V150, P178, DOI 10.1126/science.150.3693.178; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Newton S, 2014, ANGEW CHEM INT EDIT, V53, P4915, DOI 10.1002/anie.201402056; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; SHING TKM, 1995, J ORG CHEM, V60, P5785, DOI 10.1021/jo00123a011; Snyder SA, 2010, TETRAHEDRON, V66, P4796, DOI 10.1016/j.tet.2010.03.037; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Wilson RM, 2005, J AM CHEM SOC, V127, P11616, DOI 10.1021/ja054008q; Woerly EM, 2014, NAT CHEM, V6, P484, DOI 10.1038/NCHEM.1947; Woerly EM, 2010, J AM CHEM SOC, V132, P6941, DOI 10.1021/ja102721p; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l	32	316	318	20	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1221	1226		10.1126/science.aaa5414	http://dx.doi.org/10.1126/science.aaa5414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766227	Green Accepted			2022-12-28	WOS:000350824300030
J	Schmoger, L; Versolato, OO; Schwarz, M; Kohnen, M; Windberger, A; Piest, B; Feuchtenbeiner, S; Pedregosa-Gutierrez, J; Leopold, T; Micke, P; Hansen, AK; Baumann, TM; Drewsen, M; Ullrich, J; Schmidt, PO; Lopez-Urrutia, JRC				Schmoeger, L.; Versolato, O. O.; Schwarz, M.; Kohnen, M.; Windberger, A.; Piest, B.; Feuchtenbeiner, S.; Pedregosa-Gutierrez, J.; Leopold, T.; Micke, P.; Hansen, A. K.; Baumann, T. M.; Drewsen, M.; Ullrich, J.; Schmidt, P. O.; Lopez-Urrutia, J. R. Crespo			Coulomb crystallization of highly charged ions	SCIENCE			English	Article							OPTICAL CLOCKS; TRAPPED IONS; SPECTROSCOPY; CRYSTALS; PLASMA	Control over the motional degrees of freedom of atoms, ions, and molecules in a field-free environment enables unrivalled measurement accuracies but has yet to be applied to highly charged ions (HCIs), which are of particular interest to future atomic clock designs and searches for physics beyond the Standard Model. Here, we report on the Coulomb crystallization of HCIs (specifically Ar-40(13+)) produced in an electron beam ion trap and retrapped in a cryogenic linear radiofrequency trap by means of sympathetic motional cooling through Coulomb interaction with a directly laser-cooled ensemble of Be+ ions. We also demonstrate cooling of a single Ar13+ ion by a single Be+ ion-the prerequisite for quantum logic spectroscopy with a potential 10(-19) accuracy level. Achieving a seven-orders-of-magnitude decrease in HCI temperature starting at megakelvin down to the millikelvin range removes the major obstacle for HCI investigation with high-precision laser spectroscopy.	[Schmoeger, L.; Versolato, O. O.; Schwarz, M.; Windberger, A.; Piest, B.; Feuchtenbeiner, S.; Micke, P.; Lopez-Urrutia, J. R. Crespo] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Schmoeger, L.; Versolato, O. O.; Schwarz, M.; Kohnen, M.; Leopold, T.; Micke, P.; Ullrich, J.; Schmidt, P. O.] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany; [Pedregosa-Gutierrez, J.] Aix Marseille Univ, Phys Interact Ion & Mol, F-13397 Marseille, France; [Hansen, A. K.; Drewsen, M.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Baumann, T. M.] Michigan State Univ, NSCL, E Lansing, MI 48824 USA; [Schmidt, P. O.] Leibniz Univ Hannover, Inst Quantenopt, D-30167 Hannover, Germany	Max Planck Society; Physikalisch-Technische Bundesanstalt (PTB); UDICE-French Research Universities; Aix-Marseille Universite; Aarhus University; Michigan State University; Leibniz University Hannover	Lopez-Urrutia, JRC (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.	jose.crespo@mpi-hd.mpg.de	López-Urrutia, José R. Crespo/F-7069-2011; Gutierrez, Jofre Pedregosa/AFH-4290-2022; Hansen, Anders Kragh/AAF-4979-2020; Versolato, Oscar/Q-9640-2017; Schmidt, Piet/F-6384-2011; Pedregosa Gutierrez, Jofre/GSD-9922-2022	López-Urrutia, José R. Crespo/0000-0002-2937-8037; Gutierrez, Jofre Pedregosa/0000-0001-7527-4522; Hansen, Anders Kragh/0000-0002-4632-6538; Versolato, Oscar/0000-0003-3852-5227; Schmidt, Piet/0000-0003-0773-5889; Leopold, Tobias/0000-0002-0945-483X; Drewsen, Michael/0000-0002-0420-9923; Schmoger, Lisa/0000-0003-0231-6335; Micke, Peter/0000-0001-7430-8751	Max-Planck Society; Physikalisch-Technische Bundesanstalt; Deutsche Forschungsgemeinschaft through the Cluster of Excellence Quantum Engineering and Space-Time Research (QUEST); Danish National Research Foundation Center for Quantum Optics (QUANTOP); Danish Agency for Science, Technology and Innovation; Carlsberg Foundation; Lundbeck Foundation; European Commission [FP7 GA 607491 COMIQ]; Short-Term Scientific Missions travel grants from COST-Action IOTA	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Physikalisch-Technische Bundesanstalt; Deutsche Forschungsgemeinschaft through the Cluster of Excellence Quantum Engineering and Space-Time Research (QUEST)(German Research Foundation (DFG)); Danish National Research Foundation Center for Quantum Optics (QUANTOP); Danish Agency for Science, Technology and Innovation; Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); Short-Term Scientific Missions travel grants from COST-Action IOTA	The project was supported by the Max-Planck Society and the Physikalisch-Technische Bundesanstalt. P.O.S. acknowledges the support of Deutsche Forschungsgemeinschaft through the Cluster of Excellence Quantum Engineering and Space-Time Research (QUEST). M.D. appreciates generous support through the Danish National Research Foundation Center for Quantum Optics (QUANTOP); The Danish Agency for Science, Technology and Innovation; the Carlsberg Foundation; the Lundbeck Foundation; and the European Commission under the Seventh Framework Programme FP7 GA 607491 COMIQ. J.P.-G., O.O.V., and M.S. acknowledge funding from Short-Term Scientific Missions travel grants from COST-Action IOTA. Last, the Max-Planck-Institut fur Kernphysik mechanical workshops have been of crucial importance for the construction of the cryogenic traps.	Andelkovic Z, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.033423; Berengut JC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.210802; Berengut JC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.120801; Bernitt S, 2012, NATURE, V492, P225, DOI 10.1038/nature11627; Bloom BJ, 2014, NATURE, V506, P71, DOI 10.1038/nature12941; Blythe P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.183002; Brewer SM, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063403; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Derevianko A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.180801; Drewsen M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.243201; Drewsen M, 2003, INT J MASS SPECTROM, V229, P83, DOI 10.1016/S1387-3806(03)00259-8; DUBIN DHE, 1988, PHYS REV LETT, V60, P511, DOI 10.1103/PhysRevLett.60.511; Gruber L, 2001, PHYS REV LETT, V86, P636, DOI 10.1103/PhysRevLett.86.636; Hansen AK, 2014, NATURE, V508, P76, DOI 10.1038/nature12996; Hornekaer L, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.013412; Hornekaer L, 2001, PHYS REV LETT, V86, P1994, DOI 10.1103/PhysRevLett.86.1994; Huntemann N., 2014, ARXIV14074408; Knunz S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.023427; Lapierre A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.183001; LARSON DJ, 1986, PHYS REV LETT, V57, P70, DOI 10.1103/PhysRevLett.57.70; Lopez-Urrutia JRC, 2014, SPRINGER TRAC MOD PH, V256, P315, DOI 10.1007/978-3-642-45201-7_10; Mackel V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.143002; Meyrath TP, 1998, PHYS LETT A, V240, P37, DOI 10.1016/S0375-9601(98)00045-0; Nagerl HC, 1998, APPL PHYS B-LASERS O, V66, P603, DOI 10.1007/s003400050443; Orts RS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103002; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Safronova MS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.030801; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schmoger L., 2013, THESIS HEIDELBERG U; Schnorr K, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/121; Schwarz M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4742770; Sturm S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.023002; THOMAS H, 1994, PHYS REV LETT, V73, P652, DOI 10.1103/PhysRevLett.73.652; Wineland DJ, 2013, REV MOD PHYS, V85, P1103, DOI 10.1103/RevModPhys.85.1103; Zolotorev M, 1997, PHYS REV LETT, V78, P4717, DOI 10.1103/PhysRevLett.78.4717	36	89	89	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1233	1236		10.1126/science.aaa2960	http://dx.doi.org/10.1126/science.aaa2960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766230				2022-12-28	WOS:000350824300033
J	Ghosh, TS; Van Dyke, M; Maffey, A; Whitley, E; Erpelding, D; Wolk, L				Ghosh, Tista S.; Van Dyke, Michael; Maffey, Ali; Whitley, Elizabeth; Erpelding, Dana; Wolk, Larry			Medical Marijuana's Public Health Lessons - Implications for Retail Marijuana in Colorado	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXPOSURES		[Ghosh, Tista S.; Van Dyke, Michael; Maffey, Ali; Whitley, Elizabeth; Erpelding, Dana; Wolk, Larry] Colorado Dept Publ Hlth & Environm, Denver, CO 80246 USA	Colorado Department of Public Health & Environment	Ghosh, TS (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO 80246 USA.							Colorado Department of Public Health and Environment, 2013, HLTH KIDS COL SURV H; Colorado Department of Public Health and Environment, 2014, MON HLTH REL MAR COL; Salomonsen-Sautel S, 2014, DRUG ALCOHOL DEPEN, V140, P137, DOI 10.1016/j.drugalcdep.2014.04.008; Wang GS, 2014, ANN EMERG MED, V63, P684, DOI 10.1016/j.annemergmed.2014.01.017; Wang GS, 2013, JAMA PEDIATR, V167, P630, DOI 10.1001/jamapediatrics.2013.140	5	61	61	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					991	993		10.1056/NEJMp1500043	http://dx.doi.org/10.1056/NEJMp1500043			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD0XK	25760352				2022-12-28	WOS:000350797300002
J	Heler, R; Samai, P; Modell, JW; Weiner, C; Goldberg, GW; Bikard, D; Marraffini, LA				Heler, Robert; Samai, Poulami; Modell, Joshua W.; Weiner, Catherine; Goldberg, Gregory W.; Bikard, David; Marraffini, Luciano A.			Cas9 specifies functional viral targets during CRISPR-Cas adaptation	NATURE			English	Article							ADAPTIVE BACTERIAL IMMUNITY; STREPTOCOCCUS-THERMOPHILUS; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; SPACER ACQUISITION; STRUCTURAL BASIS; DUAL-RNA; DNA; SYSTEM; ENDONUCLEASE	Clustered regularly interspaced short palindromic repeat (CRISPR) loci and their associated (Cas) proteins provide adaptive immunity against viral infection in prokaryotes. Upon infection, short phage sequences known as spacers integrate between CRISPR repeats and are transcribed into small RNA molecules that guide the Cas9 nuclease to the viral targets (protospacers). Streptococcus pyogenes Cas9 cleavage of the viral genome requires the presence of a 5'-NGG-3' protospacer adjacent motif (PAM) sequence immediately downstream of the viral target. It is not known whether and how viral sequences flanked by the correct PAM are chosen as new spacers. Here we show that Cas9 selects functional spacers by recognizing their PAM during spacer acquisition. The replacement of cas9 with alleles that lack the PAM recognition motif or recognize an NGGNG PAM eliminated or changed PAM specificity during spacer acquisition, respectively. Cas9 associates with other proteins of the acquisition machinery (Cas1, Cas2 and Csn2), presumably to provide PAM-specificity to this process. These results establish a new function for Cas9 in the genesis of prokaryotic immunological memory.	[Heler, Robert; Samai, Poulami; Modell, Joshua W.; Weiner, Catherine; Goldberg, Gregory W.; Bikard, David; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA; [Bikard, David] Inst Pasteur, Synthet Biol Grp, F-75015 Paris, France	Rockefeller University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bikard, D (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA.	david.bikard@pasteur.fr; marraffini@rockefeller.edu	Ha, Dat Thinh/D-4995-2015; Bikard, David/L-2971-2015; Bikard, David/AAZ-3752-2021	Ha, Dat Thinh/0000-0003-4260-4876; Bikard, David/0000-0002-5729-1211; Bikard, David/0000-0002-5729-1211; Weiner Miller, Catherine/0000-0002-0183-968X; Goldberg, Gregory/0000-0002-5022-9976; Modell, Joshua/0000-0001-7733-1252	Howard Hughes International Student Research Fellowship; Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive Systemat The Rockefeller University; Harvey L. Karp Discovery Award; Bettencourt Schuller Foundation; Rita Allen Scholars Program; IrmaT. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award [1DP2AI104556-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER	Howard Hughes International Student Research Fellowship; Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive Systemat The Rockefeller University; Harvey L. Karp Discovery Award; Bettencourt Schuller Foundation; Rita Allen Scholars Program; IrmaT. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the laboratory for critical discussion of the experiments and their results, A. Zaytsev for help with the deep sequencing data analysis and A. Sherlock for help with plasmid construction. R.H. is the recipient of a Howard Hughes International Student Research Fellowship. P.S. is supported by a Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive Systemat The Rockefeller University. J.W.M. is a Fellow of The Jane Coffin Childs Memorial Fund for Medical Research. D.B. is supported by a Harvey L. Karp Discovery Award and the Bettencourt Schuller Foundation. L.A.M. is supported by the Rita Allen Scholars Program, an IrmaT. Hirschl Award, a Sinsheimer Foundation Award and a NIH Director's New Innovator Award (1DP2AI104556-01).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Arslan Z, 2013, NUCLEIC ACIDS RES, V41, P6347, DOI 10.1093/nar/gkt315; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; HORINOUCHI S, 1982, J BACTERIOL, V150, P804, DOI 10.1128/JB.150.2.804-814.1982; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Moore SD, 2002, J VIROL, V76, P10245, DOI 10.1128/JVI.76.20.10245-10255.2002; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	34	233	253	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					199	+		10.1038/nature14245	http://dx.doi.org/10.1038/nature14245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25707807	Green Accepted			2022-12-28	WOS:000350770500031
J	Sedgwick, P				Sedgwick, Philip			Bias in observational study designs: cross sectional studies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Bajos Nathalie, 2010, BMJ, V340, pc2573, DOI 10.1136/bmj.c2573; Sedgwick P., 2013, BMJ, V347, pf6304, DOI [DOI 10.1136/BMJ.F6304, 10.1136/bmj.f6304]; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2276	3	42	44	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2015	350								h1286	10.1136/bmj.h1286	http://dx.doi.org/10.1136/bmj.h1286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DX	25747413				2022-12-28	WOS:000351180800005
J	Chassaing, B; Koren, O; Goodrich, JK; Poole, AC; Srinivasan, S; Ley, RE; Gewirtz, AT				Chassaing, Benoit; Koren, Omry; Goodrich, Julia K.; Poole, Angela C.; Srinivasan, Shanthi; Ley, Ruth E.; Gewirtz, Andrew T.			Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome	NATURE			English	Article							CROHNS-DISEASE; INTESTINAL MICROBIOTA; ESCHERICHIA-COLI; RECEPTOR 5; MICE; BACTERIA; INFLAMMATION; OBESITY; CELLS; IMMUNOGLOBULINS	The intestinal tract is inhabited by a large and diverse community of microbes collectively referred to as the gut microbiota. While the gut microbiota provides important benefits to its host, especially in metabolism and immune development, disturbance of the microbiota-host relationship is associated with numerous chronic inflammatory diseases, including inflammatory bowel disease and the group of obesity-associated diseases collectively referred to as metabolic syndrome. A primary means by which the intestine is protected from its microbiota is via multi-layered mucus structures that cover the intestinal surface, thereby allowing the vast majority of gut bacteria to be kept at a safe distance from epithelial cells that line the intestine(1). Thus, agents that disrupt mucus-bacterial interactions might have the potential to promote diseases associated with gut inflammation. Consequently, it has been hypothesized that emulsifiers, detergent-like molecules that are a ubiquitous component of processed foods and that can increase bacterial translocation across epithelia in vitro(2), might be promoting the increase in inflammatory bowel disease observed since the mid-twentieth century(3). Here we report that, in mice, relatively low concentrations of two commonly used emulsifiers, namely carboxymethylcellulose and polysorbate-80, induced low-grade inflammation and obesity/metabolic syndrome in wild-type hosts and promoted robust colitis in mice predisposed to this disorder. Emulsifier-induced metabolic syndrome was associated with microbiota encroachment, altered species composition and increased pro-inflammatory potential. Use of germ-free mice and faecal transplants indicated that such changes in microbiota were necessary and sufficient for both low-grade inflammation and metabolic syndrome. These results support the emerging concept that perturbed host-microbiota interactions resulting in low-grade inflammation can promote adiposity and its associated metabolic effects. Moreover, they suggest that the broad use of emulsifying agents might be contributing to an increased societal incidence of obesity/metabolic syndrome and other chronic inflammatory diseases.	[Chassaing, Benoit; Gewirtz, Andrew T.] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Koren, Omry] Bar Ilan Univ, Fac Med, IL-13115 Safed, Israel; [Goodrich, Julia K.; Poole, Angela C.; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Srinivasan, Shanthi] Emory Univ, Sch Med, Dept Med, Digest Dis Div, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Bar Ilan University; Cornell University; Emory University	Gewirtz, AT (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	agewirtz@gsu.edu	Koren, Omry/A-5222-2016; Goodrich, Julia/ABD-8368-2021; Ley, Ruth E/M-8542-2014; Srinivasan, Shanthi/A-6133-2013; Chassaing, Benoit/R-3819-2017	Koren, Omry/0000-0002-7738-1337; Ley, Ruth E/0000-0002-9087-1672; Poole, Angela/0000-0003-0278-7655; Chassaing, Benoit/0000-0002-4285-769X	NIH [DK099071, DK083890]; Crohn's and Colitis Foundation of America (CCFA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153, R01DK099071, R01DK083890] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK099071 and DK083890. B.C. is a recipient of the Research Fellowship award from the Crohn's and Colitis Foundation of America (CCFA). We thank B. Zhang, L. Etienne-Mesmin, H. Q. Tran and E. Viennois for technical assistance.	Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Denizot J, 2012, INFLAMM BOWEL DIS, V18, P294, DOI 10.1002/ibd.21787; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FSCJ, 2007, EVALUATION REPORT FO; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI 10.4056/sigs.1433550; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; National Toxicology Program, 1992, Natl Toxicol Program Tech Rep Ser, V415, P1; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roberts CL, 2010, GUT, V59, P1331, DOI 10.1136/gut.2009.195370; Sitaraman SV, 2005, AM J PHYSIOL-GASTR L, V288, pG403, DOI 10.1152/ajpgi.00357.2004; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61; Swidsinski A, 2009, INFLAMM BOWEL DIS, V15, P359, DOI 10.1002/ibd.20763; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wong T, 2007, GASTROENTEROLOGY, V133, P1979, DOI 10.1053/j.gastro.2007.09.006; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007	45	1017	1060	29	566	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					92	U192		10.1038/nature14232	http://dx.doi.org/10.1038/nature14232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25731162	Green Accepted			2022-12-28	WOS:000350304000042
J	Kimberlin, DW; Jester, PM; Sanchez, PJ; Ahmed, A; Arav-Boger, R; Michaels, MG; Ashouri, N; Englund, JA; Estrada, B; Jacobs, RF; Romero, JR; Sood, SK; Whitworth, MS; Abzug, MJ; Caserta, MT; Fowler, S; Lujan-Zilbermann, J; Storch, GA; DeBiasi, RL; Han, JY; Palmer, A; Weiner, LB; Bocchini, JA; Dennehy, PH; Finn, A; Griffiths, PD; Luck, S; Gutierrez, K; Halasa, N; Homans, J; Shane, AL; Sharland, M; Simonsen, K; Vanchiere, JA; Woods, CR; Sabo, DL; Aban, I; Kuo, H; James, SH; Prichard, MN; Griffin, J; Giles, D; Acosta, EP; Whitley, RJ				Kimberlin, D. W.; Jester, P. M.; Sanchez, P. J.; Ahmed, A.; Arav-Boger, R.; Michaels, M. G.; Ashouri, N.; Englund, J. A.; Estrada, B.; Jacobs, R. F.; Romero, J. R.; Sood, S. K.; Whitworth, M. S.; Abzug, M. J.; Caserta, M. T.; Fowler, S.; Lujan-Zilbermann, J.; Storch, G. A.; DeBiasi, R. L.; Han, J. -Y.; Palmer, A.; Weiner, L. B.; Bocchini, J. A.; Dennehy, P. H.; Finn, A.; Griffiths, P. D.; Luck, S.; Gutierrez, K.; Halasa, N.; Homans, J.; Shane, A. L.; Sharland, M.; Simonsen, K.; Vanchiere, J. A.; Woods, C. R.; Sabo, D. L.; Aban, I.; Kuo, H.; James, S. H.; Prichard, M. N.; Griffin, J.; Giles, D.; Acosta, E. P.; Whitley, R. J.		Natl Inst Allergy Infect Dis	Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL VALGANCICLOVIR; GANCICLOVIR THERAPY; CMV INFECTION; HEARING-LOSS; CHILDREN; INFANTS	BACKGROUND The treatment of symptomatic congenital cytomegalovirus (CMV) disease with intravenous ganciclovir for 6 weeks has been shown to improve audiologic outcomes at 6 months, but the benefits wane over time. METHODS We conducted a randomized, placebo-controlled trial of valganciclovir therapy in neonates with symptomatic congenital CMV disease, comparing 6 months of therapy with 6 weeks of therapy. The primary end point was the change in hearing in the better ear ("best-ear" hearing) from baseline to 6 months. Secondary end points included the change in hearing from baseline to follow-up at 12 and 24 months and neurodevelopmental outcomes, with each end point adjusted for central nervous system involvement at baseline. RESULTS A total of 96 neonates underwent randomization, of whom 86 had follow-up data at 6 months that could be evaluated. Best-ear hearing at 6 months was similar in the 6-month group and the 6-week group (2 and 3 participants, respectively, had improvement; 36 and 37 had no change; and 5 and 3 had worsening; P = 0.41). Total-ear hearing (hearing in one or both ears that could be evaluated) was more likely to be improved or to remain normal at 12 months in the 6-month group than in the 6-week group (73% vs. 57%, P = 0.01). The benefit in total-ear hearing was maintained at 24 months (77% vs. 64%, P = 0.04). At 24 months, the 6-month group, as compared with the 6-week group, had better neurodevelopmental scores on the Bayley Scales of Infant and Toddler Development, third edition, on the language-composite component (P = 0.004) and on the receptive-communication scale (P = 0.003). Grade 3 or 4 neutropenia occurred in 19% of the participants during the first 6 weeks. During the next 4.5 months of the study, grade 3 or 4 neutropenia occurred in 21% of the participants in the 6-month group and in 27% of those in the 6-week group (P = 0.64). CONCLUSIONS Treating symptomatic congenital CMV disease with valganciclovir for 6 months, as compared with 6 weeks, did not improve hearing in the short term but appeared to improve hearing and developmental outcomes modestly in the longer term. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00466817.)	[Kimberlin, D. W.; Jester, P. M.; James, S. H.; Prichard, M. N.; Griffin, J.; Giles, D.; Whitley, R. J.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA; [Acosta, E. P.] Univ Alabama Birmingham, Dept Pharmacol, Birmingham, AL 35233 USA; [Aban, I.; Kuo, H.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35233 USA; [Estrada, B.] Univ S Alabama, Mobile, AL 36688 USA; [Sanchez, P. J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Whitworth, M. S.] Cook Childrens Med Ctr, Ft Worth, TX USA; [Ahmed, A.] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Arav-Boger, R.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Michaels, M. G.; Sabo, D. L.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Ashouri, N.] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Gutierrez, K.] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp, Stanford, CA 94305 USA; [Homans, J.] Univ So Calif, Los Angeles, CA USA; [Englund, J. A.] Univ Washington, Seattle, WA 98195 USA; [Jacobs, R. F.; Romero, J. R.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Sood, S. K.] Steven & Alexandra Cohen Childrens Med Ctr, New York, NY USA; [Caserta, M. T.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Weiner, L. B.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Abzug, M. J.] Univ Colorado, Sch Med, Aurora, CO USA; [Abzug, M. J.] Childrens Hosp Colorado, Aurora, CO USA; [Fowler, S.] Med Univ S Carolina, Charleston, SC 29425 USA; [Lujan-Zilbermann, J.] Univ S Florida, Coll Med, Tampa, FL USA; [Storch, G. A.] Washington Univ, Sch Med, St Louis, MO USA; [DeBiasi, R. L.] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Washington, DC USA; [Han, J. -Y.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Palmer, A.] Univ Mississippi, Jackson, MS USA; [Bocchini, J. A.; Vanchiere, J. A.] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA; [Dennehy, P. H.] Brown Univ, Hasbro Childrens Hosp, Alpert Med Sch, Providence, RI 02912 USA; [Finn, A.] Bristol Royal Hosp Children, Bristol, Avon, England; [Griffiths, P. D.; Luck, S.] UCL, Sch Med, London W1N 8AA, England; [Sharland, M.] St Georges NHS Trust, London, England; [Halasa, N.] Vanderbilt Univ, Nashville, TN 37235 USA; [Shane, A. L.] Emory Univ, Sch Med, Atlanta, GA USA; [Simonsen, K.] Univ Nebraska Med Ctr, Omaha, NE USA; [Woods, C. R.] Univ Louisville, Sch Med, Louisville, KY 40292 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cook Children's Medical Center; Carolinas Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Childrens Hospital of Orange County; Lucile Packard Children's Hospital (LPCH); Stanford University; University of Southern California; University of Washington; University of Washington Seattle; University of Arkansas System; University of Arkansas Medical Sciences; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Medical University of South Carolina; State University System of Florida; University of South Florida; Washington University (WUSTL); Children's National Health System; George Washington University; University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Brown University; Hasbro Children's Hospital; Bristol Royal Hospital For Children; University of London; University College London; UCL Medical School; Vanderbilt University; Emory University; University of Nebraska System; University of Nebraska Medical Center; University of Louisville	Kimberlin, DW (corresponding author), Univ Alabama Birmingham, Div Pediat Infect Dis, 1600 Seventh Ave S,Childrens Harbor Bldg,Rm 303, Birmingham, AL 35233 USA.	dkimberlin@peds.uab.edu	de Lima, Antonio Marcos Oliveira/AAT-2148-2021; Dennehy, Penelope/CAF-1123-2022; Vanchiere, John/AAD-8979-2019	Dennehy, Penelope/0000-0002-2259-5370; sharland, mike/0000-0001-8626-8291; Prichard, Mark/0000-0002-2720-6661; Han, Jin-Young/0000-0002-6500-3945; Simonsen, Kari/0000-0003-0233-1471; Finn, Adam/0000-0003-1756-5668	National Institute of Allergy and Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI108691, N01AI030025] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00466817.	Amir J, 2010, EUR J PEDIATR, V169, P1061, DOI 10.1007/s00431-010-1176-9; Bayley N., 2019, BAYLEY SCALES INFANT; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Boppana SB, 2010, JAMA-J AM MED ASSOC, V303, P1375, DOI 10.1001/jama.2010.423; Ciftdogan DY, 2011, J TROP PEDIATRICS, V57, P132, DOI 10.1093/tropej/fmq050; Dahle A J, 2000, J Am Acad Audiol, V11, P283; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; ELEK SD, 1974, LANCET, V1, P1; Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016; Fowler KB, 1999, J PEDIATR-US, V135, P60, DOI 10.1016/S0022-3476(99)70328-8; Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8; Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004; Jansen CFM, 2005, J PERINAT MED, V33, P364, DOI 10.1515/JPM.2005.065; Kashiwagi Y, 2011, J INFECT CHEMOTHER, V17, P538, DOI 10.1007/s10156-010-0204-z; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kimberlin DW, 2008, J INFECT DIS, V197, P836, DOI 10.1086/528376; Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6; Lombardi G, 2009, EUR J CLIN MICROBIOL, V28, P1465, DOI 10.1007/s10096-009-0806-5; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Muller A, 2008, J PERINATOL, V28, P74, DOI 10.1038/sj.jp.7211854; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS TABL GRAD S; Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012; PICKERING LK, 2012, RED BOOK 2012 REPORT, P300; Roche Pharmaceuticals, VALG PACK INS; Shoji K, 2010, J PEDIATR-US, V157, P331, DOI 10.1016/j.jpeds.2010.02.020; Tanaka-Kitajima N, 2005, PEDIATR INFECT DIS J, V24, P782, DOI 10.1097/01.inf.0000177280.28694.00; WILLIAMSON WD, 1982, AM J DIS CHILD, V136, P902, DOI 10.1001/archpedi.1982.03970460032007	28	370	388	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					933	943		10.1056/NEJMoa1404599	http://dx.doi.org/10.1056/NEJMoa1404599			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738669	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000350304500009
J	Ulbricht, M				Ulbricht, Mathias			MATERIALS SCIENCE Gating mechanism under pressure	NATURE			English	Editorial Material							MEMBRANES	Liquid-filled pores in membranes have been designed to reversibly open and close, allowing only particular fluids through at given pressures. This enables tunable and gated separations of mixtures of immiscible fluids. SEE LETTER P.70	[Ulbricht, Mathias] Univ Duisburg Essen, Dept Chem, Lehrstuhl Tech Chem 2, D-45117 Essen, Germany; [Ulbricht, Mathias] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CENIDE, D-45117 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Ulbricht, M (corresponding author), Univ Duisburg Essen, Dept Chem, Lehrstuhl Tech Chem 2, D-45117 Essen, Germany.	mathias.ulbricht@uni-due.de	Ulbricht, Mathias/L-5844-2015	Ulbricht, Mathias/0000-0002-2094-0708				Adrus N, 2012, J MATER CHEM, V22, P3088, DOI 10.1039/c2jm15022k; Germic L, 1997, J MEMBRANE SCI, V132, P131, DOI 10.1016/S0376-7388(97)00058-6; Hou X, 2015, NATURE, V519, P70, DOI 10.1038/nature14253; Mulder M., 1996, BASIC PRINCIPLES MEM, DOI DOI 10.1007/978-94-009-1766; Tyagi P, 2012, ANGEW CHEM INT EDIT, V51, P7166, DOI 10.1002/anie.201201686; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447	6	7	7	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					41	42		10.1038/519041a	http://dx.doi.org/10.1038/519041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739626				2022-12-28	WOS:000350304000030
J	Iacobucci, G				Iacobucci, Gareth			BMJ ROUND TABLE What hopes for the NHS: the election and beyond?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2015	350								h1172	10.1136/bmj.h1172	http://dx.doi.org/10.1136/bmj.h1172			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4CX	25736901				2022-12-28	WOS:000350299500012
J	Vijan, S				Vijan, Sandeep			Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; BLOOD-PRESSURE CONTROL; AMERICAN-COLLEGE; CARDIOVASCULAR OUTCOMES; CLINICAL-PRACTICE; INSULIN REGIMENS; GLYCEMIC CONTROL; LIFE-STYLE; MELLITUS; THERAPY											ABRAIRA C, 1995, DIABETES CARE, V18, P1113, DOI 10.2337/diacare.18.8.1113; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Buse JB, 2009, DIABETES CARE, V32, P1007, DOI 10.2337/dc08-2117; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hayward RA, 1997, JAMA-J AM MED ASSOC, V278, P1663, DOI 10.1001/jama.278.20.1663; Hofer TP, 2000, INT J TECHNOL ASSESS, V16, P822, DOI 10.1017/S0266462300102090; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Mahaffey KW, 2013, AM HEART J, V166, P240, DOI 10.1016/j.ahj.2013.05.004; Malanda UL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005060.pub3; Meneghini LF, 2009, DIABETES CARE, V32, pS266, DOI 10.2337/dc09-S320; Neal B, 2013, AM HEART J, V166, P217, DOI 10.1016/j.ahj.2013.05.007; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sheffield Catherine A, 2008, Endocr Pract, V14, P285; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Snow V, 2004, ANN INTERN MED, V140, P644, DOI 10.7326/0003-4819-140-8-200404200-00012; Snow V, 2003, ANN INTERN MED, V138, P587, DOI 10.7326/0003-4819-138-7-200304010-00017; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Upadhyay J, 2014, NEW ENGL J MED, V371, P285, DOI 10.1056/NEJMc1406009; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; Vijan S, 2003, ANN INTERN MED, V138, P593, DOI 10.7326/0003-4819-138-7-200304010-00018; Vijan S, 2004, ANN INTERN MED, V140, P650, DOI 10.7326/0003-4819-140-8-200404200-00013; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894; Yang XP, 2014, EUR J CLIN PHARMACOL, V70, P1149, DOI 10.1007/s00228-014-1730-x; Yki-Jarvinen H, 1999, ANN INTERN MED, V130, P389, DOI 10.7326/0003-4819-130-5-199903020-00002; Yoon NM, 2009, CLIN THER, V31, P1511, DOI 10.1016/j.clinthera.2009.07.021; Zinman B, 2013, CAN J DIABETES S4, V37, pS29	52	25	26	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2015	162	5								10.7326/AITC201503030	http://dx.doi.org/10.7326/AITC201503030			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0CE	25732301				2022-12-28	WOS:000364656100004
J	Xu, P; Burgess, JF; Cabral, H; Soria-Saucedo, R; Kazis, LE				Xu, Peng; Burgess, James F., Jr.; Cabral, Howard; Soria-Saucedo, Rene; Kazis, Lewis E.			Relationships Between Medicare Advantage Contract Characteristics and Quality-of-Care Ratings	ANNALS OF INTERNAL MEDICINE			English	Article							FOR-PROFIT; HEALTH-CARE; HOSPITALS; PLANS; BENEFICIARIES; MORTALITY; HMOS	Background: The Centers for Medicare & Medicaid Services (CMS) publishes star ratings on Medicare Advantage (MA) contracts to measure plan quality of care with implications for reimbursement and bonuses. Objective: To investigate whether MA contract characteristics are associated with quality of care through the Medicare plan star ratings. Design: Retrospective study of MA star ratings in 2010. Unadjusted and adjusted multivariable linear regression models assessed the relationship between 5-star rating summary scores and plan characteristics. Setting: CMS MA contracts nationally. Participants: 409 (71%) of a total of 575 MA contracts, covering 10.56 million Medicare beneficiaries (90% of the MA population) in the United States in 2010. Measurements: The MA quality ratings summary score (stars range from 1 to 5) is a quality measure based on 36 indicators related to processes of care, health outcomes, access to care, and beneficiary satisfaction. Results: Nonprofit, larger, and older MA contracts were more likely to receive higher star ratings. Star ratings ranged from 2 to 5. Nonprofit contracts received an average 0.55 (95% CI, 0.42 to 0.67) higher star ratings than for-profit contracts (P < 0.001) after controls were set for contract characteristics. Limitation: The study focused on persons aged 65 years or older covered by MA. Conclusion: In 2010, nonprofit MA contracts received significantly higher star ratings than for-profit contracts. When comparing health plans in the future, the CMS should give increasing attention to for-profit plans with lower quality ratings and consider developing programs to assist newer and smaller plans in improving their care for Medicare beneficiaries.	[Xu, Peng; Burgess, James F., Jr.; Soria-Saucedo, Rene] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02118 USA; [Cabral, Howard] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Kazis, Lewis E.] Boston Univ, Sch Publ Hlth, Ctr Assessment Pharmaceut Practices, Dept Hlth Policy & Management, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Kazis, LE (corresponding author), Boston Univ, Sch Publ Hlth, 715 Albany St,T3-W, Boston, MA 02118 USA.	lek@bu.edu						Ayanian JZ, 2013, HEALTH AFFAIR, V32, P1228, DOI 10.1377/hlthaff.2012.0773; Berenson RA, 2009, HEALTH AFFAIR, V28, pW29, DOI 10.1377/hlthaff.28.1.w29; Centers for Medicare & Medicaid Services, 2010, PROP CHANG MED ADV M; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; Grossman Joy M, 2002, Issue Brief Cent Stud Health Syst Change, P1; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Himmelstein DU, 1999, JAMA-J AM MED ASSOC, V282, P159, DOI 10.1001/jama.282.2.159; Ho V, 2000, CIRCULATION, V101, P1806, DOI 10.1161/01.CIR.101.15.1806; Kupersmith J, 2005, ACAD MED, V80, P458, DOI 10.1097/00001888-200505000-00012; Kutner M., 2004, APPL LINEAR STAT MOD; Landon BE, 2001, HEALTH AFFAIR, V20, P162, DOI 10.1377/hlthaff.20.3.162; Landon BE, 2001, HEALTH AFFAIR, V20, P274, DOI 10.1377/hlthaff.20.2.274; McWilliams JM, 2011, HEALTH AFFAIR, V30, P1786, DOI 10.1377/hlthaff.2011.0132; Needleman J, 2001, J HEALTH POLIT POLIC, V26, P1113, DOI 10.1215/03616878-26-5-1113; Schneider EC, 2005, AM J MED, V118, P1392, DOI 10.1016/j.amjmed.2005.05.032; Sjetne IS, 2007, MED CARE, V45, P252, DOI 10.1097/01.mlr.0000252162.78915.62; Sloan FA, 2001, J HEALTH ECON, V20, P1, DOI 10.1016/S0167-6296(00)00066-7; Tanne JH, 2002, BRIT MED J, V324, P1351, DOI 10.1136/bmj.324.7350.1351; The Henry J. Kaiser Family Foundation, 2009, WHATS STARS QUAL RAT; The Henry J. Kaiser Family Foundation, 2012, MED ADV FACT SHEET	20	11	11	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2015	162	5					353	U176		10.7326/M14-0332	http://dx.doi.org/10.7326/M14-0332			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC3HT	25732277				2022-12-28	WOS:000350238300004
J	Booth, BB				Booth, Ben B.			Why the Pacific is cool	SCIENCE			English	Editorial Material							WARMING HIATUS; ATLANTIC; VARIABILITY		Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England	Met Office - UK; Hadley Centre	Booth, BB (corresponding author), Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England.	ben.booth@metoffice.gov.uk						Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Hoerling M, 2006, J CLIMATE, V19, P3989, DOI 10.1175/JCLI3842.1; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Knudsen MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4323; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; McCabe GJ, 2004, P NATL ACAD SCI USA, V101, P4136, DOI 10.1073/pnas.0306738101; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856; Wang T, 2012, CLIM DYNAM, V39, P2917, DOI 10.1007/s00382-012-1373-5; Watanabe M, 2014, NAT CLIM CHANGE, V4, P893, DOI [10.1038/nclimate2355, 10.1038/NCLIMATE2355]	13	4	4	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					952	952		10.1126/science.aaa4840	http://dx.doi.org/10.1126/science.aaa4840			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722400				2022-12-28	WOS:000349958900021
J	Canfield, D				Canfield, Don			Robert A. Berner (1935-2015) OBITUARY	NATURE			English	Biographical-Item									Univ Southern Denmark, Nord Ctr Earth Evolut NordCEE, Odense, Denmark	University of Southern Denmark	Canfield, D (corresponding author), Univ Southern Denmark, Nord Ctr Earth Evolut NordCEE, Odense, Denmark.	dec@biology.sdu.dk	Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366				BERNER RS, PUBLICATION LIST	1	0	0	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					484	484		10.1038/518484a	http://dx.doi.org/10.1038/518484a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719659	Bronze			2022-12-28	WOS:000350097300023
J	Mnih, V; Kavukcuoglu, K; Silver, D; Rusu, AA; Veness, J; Bellemare, MG; Graves, A; Riedmiller, M; Fidjeland, AK; Ostrovski, G; Petersen, S; Beattie, C; Sadik, A; Antonoglou, I; King, H; Kumaran, D; Wierstra, D; Legg, S; Hassabis, D				Mnih, Volodymyr; Kavukcuoglu, Koray; Silver, David; Rusu, Andrei A.; Veness, Joel; Bellemare, Marc G.; Graves, Alex; Riedmiller, Martin; Fidjeland, Andreas K.; Ostrovski, Georg; Petersen, Stig; Beattie, Charles; Sadik, Amir; Antonoglou, Ioannis; King, Helen; Kumaran, Dharshan; Wierstra, Daan; Legg, Shane; Hassabis, Demis			Human-level control through deep reinforcement learning	NATURE			English	Article							RECOGNITION; CORTEX	The theory of reinforcement learning provides a normative account', deeply rooted in psychological' and neuroscientifie perspectives on animal behaviour, of how agents may optimize their control of an environment. To use reinforcement learning successfully in situations approaching real-world complexity, however, agents are confronted with a difficult task: they must derive efficient representations of the environment from high-dimensional sensory inputs, and use these to generalize past experience to new situations. Remarkably, humans and other animals seem to solve this problem through a harmonious combination of reinforcement learning and hierarchical sensory processing systems4'5, the former evidenced by a wealth of neural data revealing notable parallels between the phasic signals emitted by dopaminergic neurons and temporal difference reinforcement learning algorithms'. While reinforcement learning agents have achieved some successes in a variety of domains", their applicability has previously been limited to domains in which useful features can be handcrafted, or to domains with fully observed, low-dimensional state spaces. Here we use recent advances in training deep neural networks'" to develop a novel artificial agent, termed a deep Q-network, that can learn successful policies directly from high-dimensional sensory inputs using end-to-end reinforcement learning. We tested this agent on the challenging domain of classic Atari 2600 games". We demonstrate that the deep Q-network agent, receiving only the pixels and the game score as inputs, was able to surpass the performance of all previous algorithms and achieve a level comparable to that of a professional human games tester across a set of 49 games, using the same algorithm, network architecture and hyperparameters. This work bridges the divide between high-dimensional sensory inputs and actions, resulting in the first artificial agent that is capable of learning to excel at a diverse array of challenging tasks.	[Mnih, Volodymyr; Kavukcuoglu, Koray; Silver, David; Rusu, Andrei A.; Veness, Joel; Bellemare, Marc G.; Graves, Alex; Riedmiller, Martin; Fidjeland, Andreas K.; Ostrovski, Georg; Petersen, Stig; Beattie, Charles; Sadik, Amir; Antonoglou, Ioannis; King, Helen; Kumaran, Dharshan; Wierstra, Daan; Legg, Shane; Hassabis, Demis] Google DeepMind, London EC4A 3TW, England	Google Incorporated	Kavukcuoglu, K (corresponding author), Google DeepMind, 5 New St Sq, London EC4A 3TW, England.	demishassabis@google.com	Ma, Jialin/ABG-2965-2021; Bi, Fan/R-9511-2017; Jeong, Yongwook/N-7413-2016	Bi, Fan/0000-0003-1844-9685; Beattie, Charles/0000-0003-1840-054X				Bellemare M. G., 2012, P 26 AAAI C ART INT, P864; Bellemare MG, 2013, J ARTIF INTELL RES, V47, P253, DOI 10.1613/jair.3912; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Diuk C., 2008, ICML, DOI [10.1145/1390156.1390187, DOI 10.1145/1390156.1390187]; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Genesereth M, 2005, AI MAG, V26, P62; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Krizhevsky A., ADV NEURAL INFORM PR, P1106; LANGRIDGE S, 2010, ISA 55 AN DIV S NEW, P1; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Legg S, 2007, MIND MACH, V17, P391, DOI 10.1007/s11023-007-9079-x; Lin L.J, 1993, P TECHN REP DTIC DOC, DOI 10.5555/168871; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MOORE AW, 1993, MACH LEARN, V13, P103, DOI 10.1023/A:1022635613229; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Riedmiller M, 2005, LECT NOTES ARTIF INT, V3720, P317, DOI 10.1007/11564096_32; Riedmiller M, 2009, AUTON ROBOT, V27, P55, DOI 10.1007/s10514-009-9120-4; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Serre T, 2005, PROC CVPR IEEE, P994; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; Thorndike E. L., 1911, ANIMAL INTELLIGENCE; Tsitsiklis JN, 1997, IEEE T AUTOMAT CONTR, V42, P674, DOI 10.1109/9.580874; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698	30	10424	11007	350	3207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					529	533		10.1038/nature14236	http://dx.doi.org/10.1038/nature14236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719670				2022-12-28	WOS:000350097300045
J	Sonnenberg, JL				Sonnenberg, Justin L.			Microbiome Engineering	NATURE			English	Editorial Material									Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Sonnenberg, JL (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.								0	13	14	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					S10	S10		10.1038/518S10a	http://dx.doi.org/10.1038/518S10a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25715274	Bronze			2022-12-28	WOS:000350097300028
J	Fountas, A; Andrikoula, M; Tsatsoulis, A				Fountas, Athanasios; Andrikoula, Maria; Tsatsoulis, Agathocles			PICTURE QUIZ A 45 year old patient with headache, fever, and hyponatraemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SALT WASTING SYNDROME; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-TUMOR APOPLEXY; HYPOTHYROIDISM; MANAGEMENT; GUIDELINES; DIAGNOSIS; SECRETION		[Fountas, Athanasios; Andrikoula, Maria; Tsatsoulis, Agathocles] Univ Ioannina, Dept Endocrinol, GR-45110 Ioannina, Greece	University of Ioannina	Tsatsoulis, A (corresponding author), Univ Ioannina, Dept Endocrinol, GR-45110 Ioannina, Greece.	atsatsou@uoi.gr		Fountas, Athanasios/0000-0002-9467-3411				BARTTER FC, 1967, AM J MED, V42, P790, DOI 10.1016/0002-9343(67)90096-4; Brouns R, 2004, LANCET, V364, P502, DOI 10.1016/S0140-6736(04)16805-0; Bujawansa S, 2014, CLIN ENDOCRINOL, V80, P419, DOI 10.1111/cen.12307; Cagnin A, 2012, NEUROL SCI, V33, P147, DOI 10.1007/s10072-011-0638-9; Cerda-Esteve M, 2008, EUR J INTERN MED, V19, P249, DOI 10.1016/j.ejim.2007.06.019; Chang CV, 2009, ARQ NEURO-PSIQUIAT, V67, P328, DOI 10.1590/S0004-282X2009000200033; Dagash M, 2000, ISRAEL MED ASSOC J, V2, P865; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Gordon M B, 1999, Endocr Pract, V5, P233; Gross P, 2012, THER ADV ENDOCRINOL, V3, P61, DOI 10.1177/2042018812437561; Guerrero R, 2007, EUR J ENDOCRINOL, V156, P611, DOI 10.1530/EJE-06-0659; Hanna FWF, 1997, LANCET, V350, P755, DOI 10.1016/S0140-6736(05)62563-9; Huang WY, 2009, AM J EMERG MED, V27; IRANMANESH A, 1990, J CLIN ENDOCR METAB, V70, P155, DOI 10.1210/jcem-70-1-155; Kalogeras KT, 1996, J CLIN INVEST, V97, P2045, DOI 10.1172/JCI118640; Kanda M, 2004, ENDOCR J, V51, P435, DOI 10.1507/endocrj.51.435; Liu ZH, 2010, J CLIN NEUROSCI, V17, P694, DOI 10.1016/j.jocn.2009.11.012; Ma XM, 1999, ENDOCRINOLOGY, V140, P5642, DOI 10.1210/en.140.12.5642; Onitilo AA, 2007, CLIN MED RES, V5, P228, DOI 10.3121/cmr.2007.762; Rahman M, 2009, NEUROSURGERY, V65, P925, DOI 10.1227/01.NEU.0000358954.62182.B3; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Sibal Latika, 2004, Pituitary, V7, P157, DOI 10.1007/s11102-005-1050-3; Singh SK, 2003, NEUROL INDIA, V51, P110; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; Sun GEC, 2012, ENDOCR PRACT, V18, P894, DOI 10.4158/EP12130.OR; Turgut M, 2010, ACTA NEUROCHIR, V152, P749, DOI 10.1007/s00701-009-0595-8; Valente M, 2003, J ENDOCRINOL INVEST, V26, P754, DOI 10.1007/BF03347359; Wang WD, 2006, AM J PHYSIOL-RENAL, V290, pF1135, DOI 10.1152/ajprenal.00356.2005; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011; Zayour DH, 2004, J CLIN ENDOCR METAB, V89, P5649, DOI 10.1210/jc.2004-0884	31	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2015	350								h962	10.1136/bmj.h962	http://dx.doi.org/10.1136/bmj.h962			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AL	25711278				2022-12-28	WOS:000350292700022
J	Kopp, T; Riedl, E; Bangert, C; Bowman, EP; Greisenegger, E; Horowitz, A; Kittler, H; Blumenschein, WM; McClanahan, TK; Marbury, T; Zachariae, C; Xu, DL; Hou, XS; Mehta, A; Zandvliet, AS; Montgomery, D; van Aarle, F; Khalilieh, S				Kopp, Tamara; Riedl, Elisabeth; Bangert, Christine; Bowman, Edward P.; Greisenegger, Elli; Horowitz, Ann; Kittler, Harald; Blumenschein, Wendy M.; McClanahan, Terrill K.; Marbury, Thomas; Zachariae, Claus; Xu, Danlin; Hou, Xiaoli Shirley; Mehta, Anish; Zandvliet, Anthe S.; Montgomery, Diana; van Aarle, Frank; Khalilieh, Sauzanne			Clinical improvement in psoriasis with specific targeting of interleukin-23	NATURE			English	Article							DENDRITIC CELLS; MONOCLONAL-ANTIBODY; ATOPIC-DERMATITIS; DOUBLE-BLIND; EXPRESSION; PATHOGENESIS; USTEKINUMAB; VULGARIS; SAFETY; SKIN	Psoriasis is a chronic inflammatory skin disorder that affects approximately 2-3% of the population worldwide and has severe effects on patients' physical and psychological well-being(1-3). The discovery that psoriasis is an immune-mediated disease has led to more targeted, effective therapies; recent advances have focused on the interleukin (IL)-12/23p40 subunit shared by IL-12 and IL-23. Evidence suggests that specific inhibition of IL-23 would result in improvement in psoriasis. Here we evaluate tildrakizumab, a monoclonal antibody that targets the IL-23p19 subunit, in a three-part, randomized, placebo-controlled, sequential, rising multiple-dose phase I study in patients with moderate-to-severe psoriasis to provide clinical proof that specific targeting of IL-23p19 results in symptomatic improvement of disease severity in human subjects. A 75% reduction in the psoriasis area and severity index (PASI) score (PASI75) was achieved by all subjects in parts 1 and 3 (pooled) in the 3 and 10 mg kg(-1) groups by day 196. In part 2, 10 out of 15 subjects in the 3 mg kg(-1) group and 13 out of 14 subjects in the 10 mg kg(-1) group achieved a PASI75 by day 112. Tildrakizumab demonstrated important clinical improvement in moderate-to-severe psoriasis patients as demonstrated by improvements in PASI scores and histological samples.	[Kopp, Tamara; Bangert, Christine; Greisenegger, Elli] Univ Vienna, Sch Med, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria; [Kopp, Tamara] Juvenis Med Ctr, A-1010 Vienna, Austria; [Riedl, Elisabeth; Kittler, Harald] Univ Vienna, Sch Med, Dept Dermatol, Div Gen Dermatol, A-1090 Vienna, Austria; [Bowman, Edward P.; Horowitz, Ann; Blumenschein, Wendy M.; McClanahan, Terrill K.; Xu, Danlin; Hou, Xiaoli Shirley; Mehta, Anish; Zandvliet, Anthe S.; Montgomery, Diana; van Aarle, Frank; Khalilieh, Sauzanne] Merck & Co Inc, Whitehouse Stn, NJ 08889 USA; [Marbury, Thomas] Orlando Clin Res Ctr, Orlando, FL 32809 USA; [Zachariae, Claus] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, DK-2900 Hellerup, Denmark	University of Vienna; University of Vienna; Merck & Company; University of Copenhagen; Herlev & Gentofte Hospital	Khalilieh, S (corresponding author), Merck & Co Inc, Whitehouse Stn, NJ 08889 USA.	sauzanne.khalilieh@merck.com	Kittler, Harald/AAK-1502-2020; Kittler, Harald/K-7574-2013; Zachariae, Claus Otto Carl/G-6144-2018	Zachariae, Claus Otto Carl/0000-0001-5506-1319; Greisenegger, Elli/0000-0002-6734-054X; KITTLER, HARALD/0000-0002-0051-8016; Montgomery, Diana/0000-0002-1084-4720	Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	The authors thank E. Marcantonio (Merck & Co., Inc.) for his supervision of research and review of this manuscript and J. Pawlowski (Merck & Co., Inc) for editorial and administrative assistance with this manuscript. This study was funded by Merck & Co., Inc.	Ackerman A., 2005, HISTOLOGIC DIAGNOSIS; Bangert C, 2003, J INVEST DERMATOL, V121, P1409, DOI 10.1111/j.1523-1747.2003.12623.x; Bangert C, 2011, DERMATOLOGY, V222, P36, DOI 10.1159/000321711; Bustamante J, 2011, ANN NY ACAD SCI, V1246, P92, DOI 10.1111/j.1749-6632.2011.06273.x; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Keijsers RRMC, 2013, BRIT J DERMATOL, V168, P1294, DOI 10.1111/bjd.12236; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Langley RG, 2012, J EUR ACAD DERMATOL, V26, P21, DOI 10.1111/j.1468-3083.2011.04412.x; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lew W, 2004, BRIT J DERMATOL, V150, P668, DOI 10.1111/j.0007-0963.2004.05891.x; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Ngiow SF, 2013, TRENDS IMMUNOL, V34, P548, DOI 10.1016/j.it.2013.07.004; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Papp KA, 2013, BRIT J DERMATOL, V168, P844, DOI 10.1111/bjd.12214; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Stary G, 2005, INT ARCH ALLERGY IMM, V138, P278, DOI 10.1159/000088865; Toichi E, 2006, J IMMUNOL, V177, P4917, DOI 10.4049/jimmunol.177.7.4917; Torzicky M, 2012, J INVEST DERMATOL, V132, P1149, DOI 10.1038/jid.2011.420; TROZAK DJ, 1994, INT J DERMATOL, V33, P380, DOI 10.1111/j.1365-4362.1994.tb01073.x; US FDA, 2009, GUID IND ASS DEV IMM; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687	33	163	177	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					222	+		10.1038/nature14175	http://dx.doi.org/10.1038/nature14175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25754330				2022-12-28	WOS:000354377800059
J	Robinson, JG; Farnier, M; Krempf, M; Bergeron, J; Luc, G; Averna, M; Stroes, ES; Langslet, G; Raal, FJ; El Shahawy, M; Koren, MJ; Lepor, NE; Lorenzato, C; Pordy, R; Chaudhari, U; Kastelein, JJP				Robinson, Jennifer G.; Farnier, Michel; Krempf, Michel; Bergeron, Jean; Luc, Gerald; Averna, Maurizio; Stroes, Erik S.; Langslet, Gisle; Raal, Frederick J.; El Shahawy, Mahfouz; Koren, Michael J.; Lepor, Norman E.; Lorenzato, Christelle; Pordy, Robert; Chaudhari, Umesh; Kastelein, John J. P.		ODYSSEY LONG TERM Investigators	Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; MONOCLONAL-ANTIBODY; CONTROLLED-TRIAL; RISK PATIENTS; RATIONALE; DESIGN; PCSK9; THERAPY; ATORVASTATIN; EVOLOCUMAB	BACKGROUND Alirocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9), has been shown to reduce low-density lipoprotein (LDL) cholesterol levels in patients who are receiving statin therapy. Larger and longer-term studies are needed to establish safety and efficacy. METHODS We conducted a randomized trial involving 2341 patients at high risk for cardiovascular events who had LDL cholesterol levels of 70 mg per deciliter (1.8 mmol per liter) or more and were receiving treatment with statins at the maximum tolerated dose (the highest dose associated with an acceptable side-effect profile), with or without other lipid-lowering therapy. Patients were randomly assigned in a 2: 1 ratio to receive alirocumab (150 mg) or placebo as a 1-ml subcutaneous injection every 2 weeks for 78 weeks. The primary efficacy end point was the percentage change in calculated LDL cholesterol level from baseline to week 24. RESULTS At week 24, the difference between the alirocumab and placebo groups in the mean percentage change from baseline in calculated LDL cholesterol level was -62 percentage points (P<0.001); the treatment effect remained consistent over a period of 78 weeks. The alirocumab group, as compared with the placebo group, had higher rates of injection-site reactions (5.9% vs. 4.2%), myalgia (5.4% vs. 2.9%), neurocognitive events (1.2% vs. 0.5%), and ophthalmologic events (2.9% vs. 1.9%). In a post hoc analysis, the rate of major adverse cardiovascular events (death from coronary heart disease, nonfatal myocardial infarction, fatal or nonfatal ischemic stroke, or unstable angina requiring hospitalization) was lower with alirocumab than with placebo (1.7% vs. 3.3%; hazard ratio, 0.52; 95% confidence interval, 0.31 to 0.90; nominal P = 0.02). CONCLUSIONS Over a period of 78 weeks, alirocumab, when added to statin therapy at the maximum tolerated dose, significantly reduced LDL cholesterol levels. In a post hoc analysis, there was evidence of a reduction in the rate of cardiovascular events with alirocumab.	[Robinson, Jennifer G.] Univ Iowa, Iowa City, IA 52242 USA; [Farnier, Michel] Point Med, Dijon, France; [Krempf, Michel] CHU Nantes, Hop Nord Laennec, St Herblain, France; [Luc, Gerald] Univ Hosp Lille, Lille, France; [Lorenzato, Christelle] Sanofi, Chilly Mazarin, France; [Bergeron, Jean] Clin Malad Lipid Quebec, Quebec City, PQ, Canada; [Averna, Maurizio] Univ Palermo, Policlin P Giaccone, Palermo, Italy; [Stroes, Erik S.; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Langslet, Gisle] Oslo Univ Hosp, Lipid Clin, N-0450 Oslo, Norway; [Raal, Frederick J.] Univ Witwatersrand, Johannesburg, South Africa; [El Shahawy, Mahfouz] Cardiovasc Ctr Sarasota, Sarasota, FL USA; [Koren, Michael J.] Jacksonville Ctr Clin Res, Jacksonville, FL USA; [Lepor, Norman E.] Westside Med Associates Los Angeles, Beverly Hills, CA USA; [Pordy, Robert] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Chaudhari, Umesh] Sanofi, Bridgewater, NJ USA	University of Iowa; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; Sanofi-Aventis; Sanofi France; University of Palermo; University of Amsterdam; Academic Medical Center Amsterdam; University of Oslo; University of Witwatersrand; Regeneron; Sanofi-Aventis	Robinson, JG (corresponding author), Univ Iowa, Coll Publ Hlth, Prevent Intervent Ctr, Dept Epidemiol, 145 N Riverside Dr,S455 CPBH, Iowa City, IA 52242 USA.	jennifer-g-robinson@uiowa.edu	Weiss, Pierre/P-1372-2014; Kastelein, John/AAF-7950-2020; Averna, Maurizio/U-9527-2017; Lepor, Norman/AAP-2488-2021; Gislason, Gunnar/B-7561-2009; Podoleanu, Cristian/E-2850-2010; Carmen, Team2/Y-7383-2019; Raal, FJ/ABD-5111-2021; Nikolaev, Konstantin/P-4750-2017; , Jennifer/AAD-8336-2019; Ceska, Richard/A-1840-2017	Weiss, Pierre/0000-0002-6159-8590; Gislason, Gunnar/0000-0002-0548-402X; Podoleanu, Cristian/0000-0001-9987-2519; Carmen, Team2/0000-0001-9867-5724; Raal, FJ/0000-0002-9170-7938; Nikolaev, Konstantin/0000-0003-4601-6203; Ceska, Richard/0000-0002-2541-5179; Krempf, Michel/0000-0002-4353-9511; Lab, Carmen/0000-0002-5935-3236; Plana, Nuria/0000-0002-4231-7618; Caixas, Assumpta/0000-0001-8472-9189; HASSANIN, HANA/0000-0002-1492-3653; Bruckert, Eric/0000-0002-4527-9629; Averna, Maurizio/0000-0003-3558-9209	Sanofi; Regeneron Pharmaceuticals	Sanofi; Regeneron Pharmaceuticals(Regeneron)	Funded by Sanofi and Regeneron Pharmaceuticals; ODYSSEY LONG TERM ClinicalTrials.gov number, NCT01507831.	Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Colhoun HM, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-121; Gaudet D, 2014, AM J CARDIOL, V114, P711, DOI 10.1016/j.amjcard.2014.05.060; Kastelein JJP, 2014, CARDIOVASC DRUG THER, V28, P281, DOI 10.1007/s10557-014-6523-z; Koren MJ, 2014, CIRCULATION, V129, P234, DOI 10.1161/CIRCULATIONAHA.113.007012; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; Moriarty PM, 2014, J CLIN LIPIDOL, V8, P554, DOI 10.1016/j.jacl.2014.09.007; Robinson JG, 2014, CLIN CARDIOL, V37, P597, DOI 10.1002/clc.22327; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Schwartz GG, 2014, AM HEART J, V168, P682, DOI 10.1016/j.ahj.2014.07.028; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5	11	1378	1441	5	158	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1489	1499		10.1056/NEJMoa1501031	http://dx.doi.org/10.1056/NEJMoa1501031			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25773378				2022-12-28	WOS:000352856500004
J	Chen, R; Romero, G; Christiansen, MG; Mohr, A; Anikeeva, P				Chen, Ritchie; Romero, Gabriela; Christiansen, Michael G.; Mohr, Alan; Anikeeva, Polina			Wireless magnetothermal deep brain stimulation	SCIENCE			English	Article							IRON-OXIDE NANOPARTICLES; MAGNETIC NANOPARTICLES; MOLECULAR-MECHANISMS; HYPERTHERMIA; EXPRESSION; NEURONS; PROTEIN	Wireless deep brain stimulation of well-defined neuronal populations could facilitate the study of intact brain circuits and the treatment of neurological disorders. Here, we demonstrate minimally invasive and remote neural excitation through the activation of the heat-sensitive capsaicin receptor TRPV1 by magnetic nanoparticles. When exposed to alternating magnetic fields, the nanoparticles dissipate heat generated by hysteresis, triggering widespread and reversible firing of TRPV1(+) neurons. Wireless magnetothermal stimulation in the ventral tegmental area of mice evoked excitation in subpopulations of neurons in the targeted brain region and in structures receiving excitatory projections. The nanoparticles persisted in the brain for over a month, allowing for chronic stimulation without the need for implants and connectors.	[Chen, Ritchie; Christiansen, Michael G.; Anikeeva, Polina] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Chen, Ritchie; Romero, Gabriela; Christiansen, Michael G.; Anikeeva, Polina] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Mohr, Alan] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Anikeeva, P (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	anikeeva@mit.edu		Romero, Gabriela/0000-0001-8081-2946; Chen, Hong/0000-0003-1904-0857; Chen, Ritchie/0000-0001-5985-8843	Defense Advanced Research Projects Agency [D13AP00043]; McGovern Institute for Brain Research; NSF CAREER [CBET-1253890]; MIT Materials Research Science and Engineering Center Shared Experimental Facilities [DMR-0819762]; NSF; National Defense Science and Engineering Graduate fellowships	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); McGovern Institute for Brain Research; NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); MIT Materials Research Science and Engineering Center Shared Experimental Facilities; NSF(National Science Foundation (NSF)); National Defense Science and Engineering Graduate fellowships	We thank K. Deisseroth, D. Julius, and F. Zheng for generous gifts of plasmids and cell lines; C. Ramakrishnan for molecular biology advice; the GENIE project and Howard Hughes Medical Institute Janelia Farm for AAV9-hSyn::GCaMP6s supplied by the University of Pennsylvania vector core; and D. Irvine and A. Jasanoff for their thoughtful comments on our manuscript. This work was funded in part by a Defense Advanced Research Projects Agency Young Faculty Award (D13AP00043), the McGovern Institute for Brain Research, and the NSF CAREER award (CBET-1253890). This work made use of the MIT Materials Research Science and Engineering Center Shared Experimental Facilities under award DMR-0819762. R.C. and M.G.C. are supported by the NSF Graduate Research Fellowship Program and National Defense Science and Engineering Graduate fellowships, respectively. Methods of analysis and additional data are included in the supplementary materials. P.A., M.G.C., and R.C. have filed a U.S. and international patent (application PCT/US14/67866) describing magnetically multiplexed heating of volumes, which is peripherally related to this work.	Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Birmingham K, 2014, NAT REV DRUG DISCOV, V13, P399, DOI 10.1038/nrd4351; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Carrey J., 2011, J APPL PHYS, V109; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chen R, 2013, ACS NANO, V7, P8990, DOI 10.1021/nn4035266; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/NNANO.2010.125, 10.1038/nnano.2010.125]; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; Lepock JR, 2003, INT J HYPERTHER, V19, P252, DOI 10.1080/0265673031000065042; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Petters C, 2014, NEUROCHEM RES, V39, P1648, DOI 10.1007/s11064-014-1380-5; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; van Landeghem FKH, 2009, BIOMATERIALS, V30, P52, DOI 10.1016/j.biomaterials.2008.09.044; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Xie J, 2007, ADV MATER, V19, P3163, DOI 10.1002/adma.200701975; Yoo S, 2014, ACS NANO, V8, P8040, DOI 10.1021/nn5020775; YOUNG JH, 1980, ELECTRON LETT, V16, P358, DOI 10.1049/el:19800255	33	367	378	30	355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1477	1480		10.1126/science.1261821	http://dx.doi.org/10.1126/science.1261821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25765068	Green Submitted			2022-12-28	WOS:000352136400041
J	Andersson, C				Andersson, Charlotte			Review: Perioperative beta-blockers have variable effects on outcomes in cardiac and noncardiac surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Copenhagen, Gentofte Hosp, Hellerup, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Andersson, C (corresponding author), Univ Copenhagen, Gentofte Hosp, Hellerup, Denmark.							Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Husten L, 2012, ERASMUS MED CTR RELE; Sear JW, 2008, BRIT J ANAESTH, V101, P135, DOI 10.1093/bja/aen194	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC2	10.7326/ACPJC-2015-162-6-002	http://dx.doi.org/10.7326/ACPJC-2015-162-6-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775345				2022-12-28	WOS:000351279600001
J	Chhatwal, J; Kanwal, F; Roberts, MS; Dunn, MA				Chhatwal, Jagpreet; Kanwal, Fasiha; Roberts, Mark S.; Dunn, Michael A.			Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; QUALITY-OF-LIFE; PLUS RIBAVIRIN; CHRONIC HCV; HEPATOCELLULAR-CARCINOMA; INITIAL TREATMENT; NATIONAL-HEALTH; ALL-CAUSE; BOCEPREVIR	Background: Sofosbuvir and ledipasvir, which have recently been approved for treatment of chronic hepatitis C virus (HCV) infection, are more efficacious and safer than the old standard of care (oSOC) but are substantially more expensive. Whether and in which patients their improved efficacy justifies their increased cost is unclear. Objective: To evaluate the cost-effectiveness and budget impact of sofosbuvir and ledipasvir. Design: Microsimulat on model of the natural history of HCV infection. Data Sources: Published literature. Target Population: Treatment-naive and treatment-experienced HCV population defined on the basis of HCV genotype, age, and fibrosis distribution in the United States. Time Horizon: Lifetime. Perspective: Third-party payer. Intervention: Simulation of sofosbuvir-ledipasvir compared with the oSOC (interferon-based therapies). Outcome Measures: Quality-adjusted life-years (QALYs), incremental cost-effectiveness ratios (ICERs), and 5-year spending on antiviral drugs. Results of Base-Case Analysis: Sofosbuvir-based therapies added 0.56 (DALY relative to the oSOC at an ICER of $55 400 per additional OALY. The ICERs ranged from $9700 to $284 300 per QALY depending on the patient's status with respect to treatment history, HCV genotype, and presence of cirrhosis. At a willingness-to-pay threshold of $100 000 per (DALY, sofosbuvir-based therapies were cost-effective in 83% of treatment-naive and 81% of treatment-experienced patients. Compared with the oSOC, treating eligible HCV-infected persons in the United States with the new drugs would cost an additional $65 billion in the next 5 years, whereas the resulting cost offsets would be $16 billion. Results of Sensitivity Analysis: Results were sensitive to drug price, drug efficacy, and quality of life after successful treatment. Limitation: Data on real-world effectiveness of new antivirals are lacking. Conclusion: Treatment of HCV is cost-effective in most patients, but additional resources and value-based patient prioritization are needed to manage patients with HCV.	[Chhatwal, Jagpreet] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Unit 1444, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; [Kanwal, Fasiha] Houston Vet Affairs Hlth Serv Res & Dev Ctr Innov, Houston, TX 77021 USA; Michael E DeBakey VA Med Ctr, Houston, TX USA; [Roberts, Mark S.] Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Dunn, Michael A.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chhatwal, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Unit 1444, 1515 Holcombe Blvd, Houston, TX 77030 USA.	JChhatwal@mdanderson.org			National Institutes of Health; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000146]; Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety [CIN 13-413]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Institutes of Health.; This study was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number KL2TR000146. Dr. Kanwal was supported in part by the Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413).	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society, 2014, REC TEST MAN TREAT H; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Bronowicki JP, 2012, J HEPATOL, V56, pS6, DOI 10.1016/S0168-8278(12)60025-7; Bureau of Labor Statistics, 2015, CONS PRIC IND ALL UR; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chambers JD, 2010, MED DECIS MAKING, V30, pE14, DOI 10.1177/0272989X10371134; Chhatwal J, 2013, VALUE HEALTH, V16, P973, DOI 10.1016/j.jval.2013.07.006; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Drenth JPH, 2013, NEW ENGL J MED, V368, P1931, DOI 10.1056/NEJMe1303818; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Ferrante SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-190; First Databank, 2014, DRUG PRIC POL; Frakt AB, 2012, HEALTH ECON, V21, P485, DOI 10.1002/hec.1733; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hagan LM, 2013, J VIRAL HEPATITIS, V20, P847, DOI 10.1111/jvh.12111; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Japsen B., 2014, FORBES; Kabiri M, 2014, ANN INTERN MED, V161, P170, DOI 10.7326/M14-0095; Kantarjian HM, 2013, J CLIN ONCOL, V31, P3600, DOI 10.1200/JCO.2013.49.1845; Kanwal F, 2014, CLIN GASTROENTEROL H, V12, P1381, DOI 10.1016/j.cgh.2014.02.031; Kelly RJ, 2014, J CLIN ONCOL, V32, P983, DOI 10.1200/JCO.2013.54.6002; Khuroo MS, 2004, ALIMENT PHARM THER, V20, P931, DOI 10.1111/j.1365-2036.2004.02208.x; Knox Richard., 2013, NATL PUBLIC RADIO; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058975; Martin AB, 2014, HEALTH AFFAIR, V33, P67, DOI 10.1377/hlthaff.2013.1254; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Neumann PJ, 2005, USING COST EFFECTIVE; Ngo-Metzger Q, 2013, ANN INTERN MED, V159, P364, DOI 10.7326/0003-4819-159-5-201309030-00675; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Ruane PJ, 2013, HEPATOLOGY, V58, p736A; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Silverman Ed, 2014, WALL STREET J; Stepanova M, 2011, HEPATOLOGY, V53, P737, DOI 10.1002/hep.24131; Sussman NL, 2014, CLIN GASTROENTEROL H, V12, P533, DOI 10.1016/j.cgh.2014.01.025; Talal AH, 2013, ALIMENT PHARM THER, V37, P473, DOI 10.1111/apt.12200; Terhune Chad, 2014, LOS ANGELES TIMES; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Tice JA, 2014, COMP CLIN EFFECTIVEN; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Wilson J, 2007, HEALTH TECHNOL ASSES, V11, P1; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; Younossi ZM, 2014, J HEPATOL, V60, P530, DOI 10.1016/j.jhep.2013.11.009; Zeuzem S, 2013, HEPATOLOGY, V58, p733A; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	70	267	274	3	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					397	U114		10.7326/M14-1336	http://dx.doi.org/10.7326/M14-1336			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775312	Green Accepted			2022-12-28	WOS:000351279600013
J	Widera, A				Widera, Artur			A walk across a quantum lattice	SCIENCE			English	Editorial Material							TONKS-GIRARDEAU GAS; FERMI GAS; ATOMS		[Widera, Artur] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany; [Widera, Artur] Univ Kaiserslautern, State Res Ctr, D-67663 Kaiserslautern, Germany	University of Kaiserslautern; University of Kaiserslautern	Widera, A (corresponding author), Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany.	widera@physik.uni-kl.de	Widera, Artur/D-1032-2017	Widera, Artur/0000-0002-0338-9969				BenDahan M, 1996, PHYS REV LETT, V76, P4508, DOI 10.1103/PhysRevLett.76.4508; Greiner M, 2003, NATURE, V426, P537, DOI 10.1038/nature02199; Karski M, 2009, SCIENCE, V325, P174, DOI 10.1126/science.1174436; Kaufman AM, 2014, SCIENCE, V345, P306, DOI 10.1126/science.1250057; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Preiss PM, 2015, SCIENCE, V347, P1229, DOI 10.1126/science.1260364; Wenz AN, 2013, SCIENCE, V342, P457, DOI 10.1126/science.1240516; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	9	2	2	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1200	1201		10.1126/science.aaa6885	http://dx.doi.org/10.1126/science.aaa6885			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766218				2022-12-28	WOS:000350824300019
J	Ricci, MA; Manzo, C; Garcia-Parajo, MF; Lakadamyali, M; Cosma, MP				Aurelia Ricci, Maria; Manzo, Carlo; Filomena Garcia-Parajo, Maria; Lakadamyali, Melike; Pia Cosma, Maria			Chromatin Fibers Are Formed by Heterogeneous Groups of Nucleosomes In Vivo	CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; GENE-REGULATION; HISTONE; STATE; TCF3; TRANSCRIPTION; PLURIPOTENCY; DETERMINANTS; CHROMOSOMES	Nucleosomes help structure chromosomes by compacting DNA into fibers. To gain insight into how nucleosomes are arranged in vivo, we combined quantitative super-resolution nanoscopy with computer simulations to visualize and count nucleosomes along the chromatin fiber in single nuclei. Nucleosomes assembled in heterogeneous groups of varying sizes, here termed "clutches,'' and these were interspersed with nucleosome-depleted regions. The median number of nucleosomes inside clutches and their compaction defined as nucleosome density were cell-type-specific. Ground-state pluripotent stem cells had, on average, less dense clutches containing fewer nucleosomes and clutch size strongly correlated with the pluripotency potential of induced pluripotent stem cells. RNA polymerase II preferentially associated with the smallest clutches while linker histone H1 and heterochromatin were enriched in the largest ones. Our results reveal how the chromatin fiber is formed at nanoscale level and link chromatin fiber architecture to stem cell state.	[Aurelia Ricci, Maria; Pia Cosma, Maria] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Aurelia Ricci, Maria; Pia Cosma, Maria] UPF, Barcelona 08003, Spain; [Manzo, Carlo; Filomena Garcia-Parajo, Maria; Lakadamyali, Melike] ICFO, Inst Ciencies Foton, Barcelona 08860, Spain; [Filomena Garcia-Parajo, Maria; Pia Cosma, Maria] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA	Lakadamyali, M (corresponding author), ICFO, Inst Ciencies Foton, Mediterranean Technol Pk, Barcelona 08860, Spain.	melike.lakadamyali@icfo.es; pia.cosma@crg.es	Garcia-Parajo, Maria F./I-4610-2015; Manzo, Carlo/B-9745-2012; Cosma, Maria Pia/E-8731-2015	Garcia-Parajo, Maria F./0000-0001-6618-3944; Manzo, Carlo/0000-0002-8625-0996; Cosma, Maria Pia/0000-0003-4207-5097	Fundacio Cellex Barcelona; System's Microscopy Network of Excellence consortium [FP-7-HEALTH.2010.2.1.2.2]; European Union under the European Research Council [337191-MOTOS, 242630-RERE]; Human Frontier Science Program (HFSP);  [MAT2011-22887]; ICREA Funding Source: Custom	Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission); System's Microscopy Network of Excellence consortium; European Union under the European Research Council; Human Frontier Science Program (HFSP)(Human Frontier Science Program); ; ICREA(ICREA)	We thank A. Skoultchi (Albert Einstein College of Medicine), S. Grigoryev (Penn State Hershey Cancer Institute), T. Misgeld (TUM, Munich), X. Zhuang (Harvard University) and J. Ries (European Molecular Biology Laboratory [EMBL], Heidelberg) for providing reagents and cell lines, B. Huang (University of California, San Francisco [UCSF]) for Insight3 STORM analysis software, L. Batlle Morera (Center for Genomic Regulation [CRG], Barcelona) for helping in hiPSC generation, J. Font Mateu (CRG, Barcelona) for technical suggestions on in vitro polynucleosome, F. Sottile (CRG, Barcelona) for cloning the H2B-mEos2 plasmid. We thank M. Beato, C. di Vona, G. Filion, T. Graf, B. Lehner, M. Marti-Renom, M. Mendoza, J. Sharpe, J. Solon and J. Valcarcel (CRG, Barcelona), E. Meshorer (Hebrew University of Jerusalem), A. Oddone and J. Otterstrom (Institute of Photonic Sciences [ICFO], Barcelona), and X. Zhuang (Harvard University) for critical reading of the manuscript and helpful discussions. We acknowledge the ICFO Super-resolution Light Nanoscopy (SLN) facility, the ICFO Nikon Center of Excellence in STORM, the CRG microscopy facility and the EMBL electron microscopy core facility. We thank E. Sahagun Alonso (Scixel) and A. Hirschmann (ICFO) for help with the graphical abstract. The research leading to these results was supported in part by the Fundacio Cellex Barcelona (M. L.), the System's Microscopy Network of Excellence consortium (call identifier FP-7-HEALTH.2010.2.1.2.2 to M. L.), by the European Union Seventh Framework Programme under the European Research Council grants 337191-MOTOS to M. L. and 242630-RERE to M.P.C., a Human Frontier Science Program (HFSP) grant (M.P.C.), and MAT2011-22887 (M.F.G.-P). This article reflects only the author's views and the Union is not liable for any use that may be made of the information contained therein.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bohn M, 2010, BIOPHYS J, V99, P1358, DOI 10.1016/j.bpj.2010.05.043; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Durisic N, 2014, CURR OPIN CHEM BIOL, V20, P22, DOI 10.1016/j.cbpa.2014.04.005; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lluis F, 2013, CELL MOL LIFE SCI, V70, P1413, DOI 10.1007/s00018-012-1137-8; Lluis F, 2011, P NATL ACAD SCI USA, V108, P11912, DOI 10.1073/pnas.1017402108; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; Meister P, 2013, CURR OPIN GENET DEV, V23, P96, DOI 10.1016/j.gde.2012.12.001; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Wendt KS, 2014, CURR OPIN GENET DEV, V25, P62, DOI 10.1016/j.gde.2013.11.020; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	41	365	374	4	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1145	1158		10.1016/j.cell.2015.01.054	http://dx.doi.org/10.1016/j.cell.2015.01.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768910	Green Published, Bronze			2022-12-28	WOS:000351951800014
J	Blythe, SA; Wieschaus, EF				Blythe, Shelby A.; Wieschaus, Eric F.			Zygotic Genome Activation Triggers the DNA Replication Checkpoint at the Midblastula Transition	CELL			English	Article							RNA-POLYMERASE-II; EARLY DROSOPHILA EMBRYO; CELL-CYCLE PROGRAM; DEVELOPMENTAL CONTROL; GAGA FACTOR; BINDING; TRANSCRIPTION; NUCLEAR; GENES; ONSET	A conserved feature of the midblastula transition (MBT) is a requirement for a functional DNA replication checkpoint to coordinate cell-cycle remodeling and zygotic genome activation (ZGA). We have investigated what triggers this checkpoint during Drosophila embryogenesis. We find that the magnitude of the checkpoint scales with the quantity of transcriptionally engaged DNA. Measuring RNA polymerase II (Pol II) binding at 20 min intervals over the course of ZGA reveals that the checkpoint coincides with widespread de novo recruitment of Pol II that precedes and does not require a functional checkpoint. This recruitment drives slowing or stalling of DNA replication at transcriptionally engaged loci. Reducing Pol II recruitment in zelda mutants both reduces replication stalling and bypasses the requirement for a functional checkpoint. This suggests a model where the checkpoint functions as a feedback mechanism to remodel the cell cycle in response to nascent ZGA.	[Blythe, Shelby A.; Wieschaus, Eric F.] Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University	Wieschaus, EF (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.	efw@princeton.edu		Blythe, Shelby/0000-0003-4986-2579	National Institute of Child Health and Human Development (NICHD) [5R37HD15587]; Ruth Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship from NICHD [1F32HD072653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587, F32HD072653] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ruth Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship from NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the Bloomington Drosophila Stock Center for fly stocks. We thank C. Hannon, A. Roknabadi, and B. Pelham-Webb for help with experiments, all members of the E.F.W. and Schupbach laboratories, especially S. Little and B. He for lively discussion. We thank R. Kadzik, P. Klein, T. Schupbach, J. Lieb, M. Harrison, J. Zeitlinger, T. Orr-Weaver, W. Sullivan, and P. O'Farrell for helpful comments and C. Rushlow, P. Schedl, and J. Sekelsky for fly stocks. We are indebted to the staff of the Sequencing Core Facility of the Lewis Sigler Institute and to L. Parsons for support for the ChIP-seq studies. We thank S. Di Talia for comments on the manuscript. This work was supported in part by grant 5R37HD15587 from the National Institute of Child Health and Human Development (NICHD) to E.F.W. and Ruth Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship 1F32HD072653 from NICHD to S.A.B. E.F.W. is an investigator with the Howard Hughes Medical Institute.	Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Benoit B, 2009, DEVELOPMENT, V136, P923, DOI 10.1242/dev.031815; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bhat KM, 1996, DEVELOPMENT, V122, P1113; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Collart C, 2013, SCIENCE, V341, P893, DOI 10.1126/science.1241530; Conn CW, 2004, DEV CELL, V7, P275, DOI 10.1016/j.devcel.2004.07.003; Crest J, 2007, GENETICS, V175, P567, DOI 10.1534/genetics.106.065219; Di Talia S, 2013, CURR BIOL, V23, P127, DOI 10.1016/j.cub.2012.11.029; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Farrell JA, 2013, CURR BIOL, V23, P118, DOI 10.1016/j.cub.2012.11.036; Farrell JA, 2012, GENE DEV, V26, P714, DOI 10.1101/gad.186429.111; Fasulo B, 2012, MOL BIOL CELL, V23, P1047, DOI 10.1091/mbc.E11-10-0832; FOE VE, 1983, J CELL SCI, V61, P31; FOGARTY P, 1994, DEVELOPMENT, V120, P2131; Fujimoto M, 2012, MOL CELL, V48, P182, DOI 10.1016/j.molcel.2012.07.026; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Ji JY, 2004, DEVELOPMENT, V131, P401, DOI 10.1242/dev.00944; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaRocque JR, 2007, GENETICS, V176, P1441, DOI 10.1534/genetics.107.073635; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li BY, 1996, MOL CELL BIOL, V16, P5433; Li XY, 2014, ELIFE, V3, DOI 10.7554/eLife.03737; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perez-Montero S, 2013, DEV CELL, V26, P578, DOI 10.1016/j.devcel.2013.08.011; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sung HW, 2013, CURR BIOL, V23, P133, DOI 10.1016/j.cub.2012.12.013; Tadros W, 2003, GENETICS, V164, P989; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	104	104	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1169	1181		10.1016/j.cell.2015.01.050	http://dx.doi.org/10.1016/j.cell.2015.01.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25748651	Green Accepted, Bronze			2022-12-28	WOS:000351951800016
J	Luna, JM; Scheel, TKH; Danino, T; Shaw, KS; Mele, A; Fak, JJ; Nishiuchi, E; Takacs, CN; Catanese, MT; de Jong, YP; Jacobson, IM; Rice, CM; Darnell, RB				Luna, Joseph M.; Scheel, Troels K. H.; Danino, Tal; Shaw, Katharina S.; Mele, Aldo; Fak, John J.; Nishiuchi, Eiko; Takacs, Constantin N.; Catanese, Maria Teresa; de Jong, Ype P.; Jacobson, Ira M.; Rice, Charles M.; Darnell, Robert B.			Hepatitis C Virus RNA Functionally Sequesters miR-122	CELL			English	Article							SINGLE-NUCLEOTIDE RESOLUTION; HITS-CLIP; CERNA HYPOTHESIS; BINDING PROTEIN; MICRORNA; IDENTIFICATION; ARGONAUTE; INFECTION; GENES; SITES	Hepatitis C virus (HCV) uniquely requires the liver-specific microRNA-122 for replication, yet global effects on endogenous miRNA targets during infection are unexplored. Here, high-throughput sequencing and crosslinking immunoprecipitation (HITS-CLIP) experiments of human Argonaute (AGO) during HCV infection showed robust AGO binding on the HCV 5'UTR at known and predicted miR-122 sites. On the human transcriptome, we observed reduced AGO binding and functional mRNA de-repression of miR-122 targets during virus infection. This miR-122 "sponge'' effect was relieved and redirected to miR-15 targets by swapping the miRNA tropism of the virus. Single-cell expression data from reporters containing miR-122 sites showed significant derepression during HCV infection depending on expression level and site number. We describe a quantitative mathematical model of HCV-induced miR-122 sequestration and propose that such miR-122 inhibition by HCV RNA may result in global derepression of host miR-122 targets, providing an environment fertile for the long-term oncogenic potential of HCV.	[Luna, Joseph M.; Scheel, Troels K. H.; Danino, Tal; Shaw, Katharina S.; Nishiuchi, Eiko; Takacs, Constantin N.; Catanese, Maria Teresa; de Jong, Ype P.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA; [Luna, Joseph M.; Mele, Aldo; Fak, John J.; Darnell, Robert B.] Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10065 USA; [Luna, Joseph M.; Mele, Aldo; Fak, John J.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Scheel, Troels K. H.] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen Hepatitis C Program CO HEP, Hvidovre, Denmark; [Scheel, Troels K. H.] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Scheel, Troels K. H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen N, Denmark; [Danino, Tal] MIT, Hlth Sci & Technol, Cambridge, MA 02139 USA; [Takacs, Constantin N.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA; [de Jong, Ype P.; Jacobson, Ira M.] Weill Cornell Med Coll, Div Gastroenterol & Hepatol, Ctr Study Hepatitis C, New York, NY 10065 USA; [Darnell, Robert B.] New York Genome Ctr, New York, NY 10013 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Copenhagen; University of Copenhagen; University of Copenhagen; Massachusetts Institute of Technology (MIT); Rockefeller University; Cornell University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA.	ricec@rockefeller.edu; darnelr@rockefeller.edu	; Darnell, Robert/B-9022-2008	Luna, Joseph/0000-0003-2415-9203; Scheel, Troels/0000-0003-1545-4067; Darnell, Robert/0000-0002-5134-8088	Public Health Service; NIH, NIAID [AI099284, AI072613, AI075099, AI091707, AI090055]; NINDS [NS034389, NS081706]; Office of the Director through the NIH Roadmap for Medical Research [DK085713]; NCI [CA057973]; Rockefeller University Center for Clinical and Translational Science [UL1RR024143]; Center for Basic and Translational Research on Disorders of the Digestive System; Greenberg Medical Research Institute; Starr Foundation; David Rockefeller Graduate Student Fellowship; Danish Council for Independent Research; HHMI International Predoctoral Fellowship; Rockefeller University Women and Science Fellowship; Novo Nordisk Fonden [NNF12OC0002037, NNF14OC0012533] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091707, R01AI099284, R01AI072613, R01AI075099, R01AI090055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090576, R01DK085713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081706, R56NS034389, R01NS034389] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of the Director through the NIH Roadmap for Medical Research; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rockefeller University Center for Clinical and Translational Science; Center for Basic and Translational Research on Disorders of the Digestive System; Greenberg Medical Research Institute; Starr Foundation; David Rockefeller Graduate Student Fellowship; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); HHMI International Predoctoral Fellowship; Rockefeller University Women and Science Fellowship; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Zhang for bioinformatics support; M. Moore for flow cytometry assistance; the Rockefeller Genomics Resource Center; and M.E. Castillo, S.M. Pecoraro Di Vittorio, J. Palarca, J. Sable, B. Hough-Loomis, and J. Smith for excellent technical and administrative assistance. Lastly, we thank members of the Darnell and Rice labs for invaluable advice. This study was supported by grants from the Public Health Service, NIH, NIAID (AI099284, AI072613, AI075099, AI091707, AI090055), NINDS (NS034389, NS081706), Office of the Director through the NIH Roadmap for Medical Research (DK085713), NCI (CA057973), The Rockefeller University Center for Clinical and Translational Science (UL1RR024143), the Center for Basic and Translational Research on Disorders of the Digestive System through the generosity of the Leona M. and Harry B. Helmsley Charitable Trust, the Greenberg Medical Research Institute, and the Starr Foundation. J.M.L. was supported by a David Rockefeller Graduate Student Fellowship. T.K.H.S. was supported by a Postdoctoral Fellowship and a Sapere Aude Research Talent Award from The Danish Council for Independent Research. C.N.T. was supported by an HHMI International Predoctoral Fellowship. M.T.C. was supported by the Rockefeller University Women and Science Fellowship. R.B.D. is an investigator of the Howard Hughes Medical Institute.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Catanese MT, 2013, J VIROL, V87, P8282, DOI 10.1128/JVI.01102-13; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Horwitz JA, 2013, VIROLOGY, V439, P23, DOI [10.1016/j.virol.2013.01.019, 10.1016/j.virol.201]; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kandathil AJ, 2013, GASTROENTEROLOGY, V145, P1404, DOI 10.1053/j.gastro.2013.08.034; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lee S, 2013, CELL HOST MICROBE, V13, P678, DOI 10.1016/j.chom.2013.05.007; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Li YP, 2011, P NATL ACAD SCI USA, V108, P4991, DOI 10.1073/pnas.1016606108; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nasheri N, 2011, VIROLOGY, V410, P336, DOI 10.1016/j.virol.2010.11.015; Pal S, 2006, J VIROL, V80, P2280, DOI 10.1128/JVI.80.5.2280-2290.2006; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Saeed A, 2013, CLIN EXP IMMUNOL, V174, P265, DOI 10.1111/cei.12174; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007; Singaravelu R, 2014, CURR OPIN VIROL, V7, P1, DOI 10.1016/j.coviro.2014.03.004; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Yamane D, 2013, CURR TOP MICROBIOL, V369, P263, DOI 10.1007/978-3-642-27340-7_11; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263	44	240	243	3	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1099	1110		10.1016/j.cell.2015.02.025	http://dx.doi.org/10.1016/j.cell.2015.02.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768906	Bronze, Green Accepted			2022-12-28	WOS:000351951800010
J	Rose, AD				Rose, Aron Dana			Insight on the Irrawaddy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA	Yale University	Rose, AD (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA.	aron.rose@yale.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1015	1015		10.1001/jama.2014.13839	http://dx.doi.org/10.1001/jama.2014.13839			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756435				2022-12-28	WOS:000350643100014
J	McGuinness, LP; Jelezko, F				McGuinness, Liam P.; Jelezko, Fedor			Look but don't touch the metals	SCIENCE			English	Editorial Material							NITROGEN-VACANCY CENTERS; MAGNETIC-RESONANCE; DIAMOND; SPIN; MICROSCOPE		[McGuinness, Liam P.; Jelezko, Fedor] Univ Ulm, Inst Quantum Opt, D-89069 Ulm, Germany; [McGuinness, Liam P.] Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia; [Jelezko, Fedor] Univ Ulm, Ctr Integrated Quantum Sci & Technol IQST, D-89069 Ulm, Germany	Ulm University; University of Melbourne; Ulm University	McGuinness, LP (corresponding author), Univ Ulm, Inst Quantum Opt, D-89069 Ulm, Germany.	fedor.jelezko@uni-ulm.de		mcguinness, liam/0000-0003-0078-9307				Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Brenneis A, 2015, NAT NANOTECHNOL, V10, P135, DOI [10.1038/NNANO.2014.276, 10.1038/nnano.2014.276]; Chernobrod BM, 2005, J APPL PHYS, V97, DOI 10.1063/1.1829373; Cole JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495401; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Kolkowitz S, 2015, SCIENCE, V347, P1129, DOI 10.1126/science.aaa4298; Kubo Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140502; Maletinsky P, 2012, NAT NANOTECHNOL, V7, P320, DOI [10.1038/nnano.2012.50, 10.1038/NNANO.2012.50]; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Tetienne JP, 2014, SCIENCE, V344, P1366, DOI 10.1126/science.1250113; Zhu XB, 2011, NATURE, V478, P221, DOI 10.1038/nature10462	11	0	0	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1073	1074		10.1126/science.aaa6908	http://dx.doi.org/10.1126/science.aaa6908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745151				2022-12-28	WOS:000350354200023
J	Marshall, M				Marshall, Martin			A Precious Jewel - The Role of General Practice in the English NHS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									UCL, Dept Primary Care & Populat Hlth, London WC1E 6BT, England	University of London; University College London	Marshall, M (corresponding author), UCL, Dept Primary Care & Populat Hlth, London WC1E 6BT, England.							Commonwealth Fund, 2014, MIRR MIRR WALL 2014; Health and Social Care Information Centre, 2009, TRENDS GP CONS RAT 1; Health Education England, 2014, SEC FUT GP WORKF DEL; NHS, 2014, NHS 5 YEAR FORW VIEW; Royal College of General Practitioners, 2014, PUT PAT 1	5	21	21	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					893	897		10.1056/NEJMp1411429	http://dx.doi.org/10.1056/NEJMp1411429			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC4EU	25738663	Green Published			2022-12-28	WOS:000350304500002
J	Ansah, EK; Narh-Bana, S; Affran-Bonful, H; Bart-Plange, C; Cundill, B; Gyapong, M; Whitty, CJM				Ansah, Evelyn K.; Narh-Bana, Solomon; Affran-Bonful, Harriet; Bart-Plange, Constance; Cundill, Bonnie; Gyapong, Margaret; Whitty, Christopher J. M.			The impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a cluster randomized trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMBINATION THERAPY; FEBRILE ILLNESS; DRUG SHOPS; CARE; CHILDREN; TANZANIA; OVERDIAGNOSIS; PREVENTION; MICROSCOPY; MEDICINES	Objective To examine the impact of providing rapid diagnostic tests for malaria on fever management in private drug retail shops where most poor rural people with fever present, with the aim of reducing current massive overdiagnosis and overtreatment of malaria. Design Cluster randomized trial of 24 clusters of shops. Setting Dangme West, a poor rural district of Ghana. Participants Shops and their clients, both adults and children. Interventions Providing rapid diagnostic tests with realistic training. Main outcome measures The primary outcome was the proportion of clients testing negative for malaria by a double-read research blood slide who received an artemisinin combination therapy or other antimalarial. Secondary outcomes were use of antibiotics and antipyretics, and safety. Results Of 4603 clients, 3424 (74.4%) tested negative by double-read research slides. The proportion of slide-negative clients who received any antimalarial was 590/1854 (32%) in the intervention arm and 1378/1570 (88%) in the control arm (adjusted risk ratio 0.41 (95% CI 0.29 to 0.58), P<0.0001). Treatment was in high agreement with rapid diagnostic test result. Of those who were slide-positive, 690/787 (87.8%) in the intervention arm and 347/392 (88.5%) in the control arm received an artemisinin combination therapy (adjusted risk ratio 0.96 (0.84 to 1.09)). There was no evidence of antibiotics being substituted for antimalarials. Overall, 1954/2641 (74%) clients in the intervention arm and 539/1962 (27%) in the control arm received appropriate treatment (adjusted risk ratio 2.39 (1.69 to 3.39), P<0.0001). No safety concerns were identified. Conclusions Most patients with fever in Africa present to the private sector. In this trial, providing rapid diagnostic tests for malaria in the private drug retail sector significantly reduced dispensing of antimalarials to patients without malaria, did not reduce prescribing of antimalarials to true malaria cases, and appeared safe. Rapid diagnostic tests should be considered for the informal private drug retail sector.	[Ansah, Evelyn K.] Ghana Hlth Serv, Res & Dev Div, Accra, Ghana; [Narh-Bana, Solomon; Gyapong, Margaret] Ghana Hlth Serv, Dodowa Hlth Res Ctr, Accra, Ghana; [Affran-Bonful, Harriet] Ghana Hlth Serv, Dangme West Dist Hlth Directorate, Accra, Ghana; [Bart-Plange, Constance] Ghana Hlth Serv, Natl Malaria Control Programme, Accra, Ghana; [Cundill, Bonnie; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London WC1, England	Ghana Health Service; Ghana Health Service; Ghana Health Service; Ghana Health Service; University of London; London School of Hygiene & Tropical Medicine	Ansah, EK (corresponding author), Ghana Hlth Serv, Res & Dev Div, POB MB 190, Accra, Ghana.	Ansahekdr@yahoo.co.uk		Ansah, Evelyn/0000-0003-0401-8606; Affran Bonful, Harriet/0000-0003-0069-3241; Narh-Bana, Solomon A./0000-0001-8010-2637; Cundill, Bonnie/0000-0002-3648-820X; Gyapong, Margaret/0000-0002-4818-3497; Whitty, Christopher/0000-0002-6076-5027	Malaria Capacity Development Consortium of the London School of Hygiene & Tropical Medicine; Welcome Trust; Bill and Melinda Gates Foundation; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Malaria Capacity Development Consortium of the London School of Hygiene & Tropical Medicine; Welcome Trust(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was sponsored by the Malaria Capacity Development Consortium of the London School of Hygiene & Tropical Medicine with funding from the Welcome Trust and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Agyepong I, 2006, MED ED RESOURCES AFR, V21, P5; AGYEPONG IA, 1992, SOC SCI MED, V35, P131, DOI 10.1016/0277-9536(92)90160-R; AGYEPONG IA, 1994, ACTA TROP, V58, P317, DOI 10.1016/0001-706X(94)90025-6; Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; Albertini A, 2012, TROP MED INT HEALTH, V17, P147, DOI 10.1111/j.1365-3156.2011.02904.x; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; Ansah EK, 2010, BMJ-BRIT MED J, V5, P340; Ansah EK, 2013, AM J TROP MED HYG, V89, P724, DOI 10.4269/ajtmh.13-0033; Ansah EK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-258; Ansah EK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-853; Asenso-Okyere WK, 1998, HEALTH POLICY PLANN, V13, P181, DOI 10.1093/heapol/13.2.181; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045556; Bastiaens GJH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001590; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Chandler CIR, 2008, HEALTH POLICY PLANN, V23, P170, DOI 10.1093/heapol/czm046; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Cohen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048296; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Davis BL, 2013, EMERGENCE APPROACH TO SPEECH ACQUISITION: DOING AND KNOWING, P1; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Fritzsche C, 2013, T ROY SOC TROP MED H, V107, P158, DOI 10.1093/trstmh/trs087; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Hansen KS, 2013, HEALTH POLICY PLANN, V28, P185, DOI 10.1093/heapol/czs048; Hayes RJ, 2009, INTERD STAT, P3; Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Malm KL, 2013, J PUBLIC HEALTH POL, V34, P302, DOI 10.1057/jphp.2013.12; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; Mbonye AK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-131; Moulton Lawrence H, 2004, Clin Trials, V1, P297, DOI 10.1191/1740774504cn024oa; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; MWENESI H, 1995, SOC SCI MED, V40, P1271, DOI 10.1016/0277-9536(94)00250-W; Nkrumah Bernard, 2011, BMC Res Notes, V4, P529, DOI 10.1186/1756-0500-4-529; Nonvignon J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-188; Nsimba SE, 1999, DRUG INF J, V33, P1025, DOI 10.1177/009286159903300407; Raab GM, 2001, STAT MED, V20, P351, DOI 10.1002/1097-0258(20010215)20:3<351::AID-SIM797>3.0.CO;2-C; Rankin SL, 2001, ANZ J SURG, V71, P544, DOI 10.1046/j.1440-1622.2001.02188.x; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; SNOW RW, 1992, T ROY SOC TROP MED H, V86, P237, DOI 10.1016/0035-9203(92)90290-S; Van Dillen J, 2007, TROP DOCT, V37, P185, DOI 10.1258/004947507781524845; World Health Organization, 2009, MAL CAS MAN OP MAN, P26; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243; Yukich JO, 2012, AM J TROP MED HYG, V87, P437, DOI 10.4269/ajtmh.2012.12-0127	54	55	55	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2015	350								h1019	10.1136/bmj.h1019	http://dx.doi.org/10.1136/bmj.h1019			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4DS	25739769	Green Published, hybrid			2022-12-28	WOS:000350301600009
J	Pringsheim, T; Gardner, D; Patten, SB				Pringsheim, Tamara; Gardner, David; Patten, Scott B.			UNCERTAINTIES Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AUGMENTATION; ANTIDEPRESSANTS; COMBINATION; MONOTHERAPY; SYMPTOMS; LITHIUM		[Pringsheim, Tamara] Univ Calgary, Dept Clin Neurosci Psychiat & Community Hlth Sci, Calgary, AB, Canada; [Gardner, David] Dalhousie Univ, Dept Psychiat & Pharm, Halifax, NS, Canada; [Patten, Scott B.] Univ Calgary, Dept Community Hlth Sci & Psychiat, Calgary, AB, Canada	University of Calgary; Dalhousie University; University of Calgary	Pringsheim, T (corresponding author), Mathison Ctr Mental Hlth Res & Educ, TRW Bldg,4th Floor,4D72,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	tmprings@ucalgary.ca	Patten, Scott/B-4434-2011; Pringsheim, Tamara/L-5955-2019	Patten, Scott/0000-0001-9871-4041; Pringsheim, Tamara/0000-0002-8229-8431; Gardner, David/0000-0002-0980-6399				[Anonymous], 2014, GEN PRACTICE RES DAT; [Anonymous], 2013, EFFICACY EXTENDED RE; [Anonymous], 2014, EMR DATA ASSESS MONI; Aronson R, 1996, ARCH GEN PSYCHIAT, V53, P842, DOI 10.1001/archpsyc.1996.01830090090013; Bauer M, 2013, J AFFECT DISORDERS, V151, P209, DOI 10.1016/j.jad.2013.05.079; Bauer M, 2010, J AFFECT DISORDERS, V127, P19, DOI 10.1016/j.jad.2010.08.032; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Crossley NA, 2007, J CLIN PSYCHIAT, V68, P935, DOI 10.4088/JCP.v68n0617; Cuijpers P, 2009, J CLIN PSYCHIAT, V70, P1219, DOI 10.4088/JCP.09r05021; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fiedorowicz JG, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0492-6; Gardner D, 2009, EFFECT SIZE ILLUSTRA; Gardner D.M., 2010, ANTIPSYCHOTICS THEIR; Gerhard T, 2014, J CLIN PSYCHIAT, V75, P490, DOI 10.4088/JCP.13m08675; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008121.pub2; Liebowitz M, 2010, DEPRESS ANXIETY, V27, P964, DOI 10.1002/da.20740; McIntyre A, 2007, DEPRESS ANXIETY, V24, P487, DOI 10.1002/da.20275; National Institute for Health and Clinical Excellence, 2009, DEPR IN AD; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Papakostas GI, 2008, BIOL PSYCHIAT, V63, P699, DOI 10.1016/j.biopsych.2007.08.010; Pratt LA, 2014, DEPRESSION OBESITY U; Pringsheim Tamara, 2014, CMAJ Open, V2, pE225, DOI 10.9778/cmajo.20140009; Quante A, 2013, PSYCHIAT DANUB, V25, P214; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Spielmans GI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001403	25	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2015	350								h569	10.1136/bmj.h569	http://dx.doi.org/10.1136/bmj.h569			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4DS	25739588				2022-12-28	WOS:000350301600001
J	Qaseem, A; Mir, TP; Starkey, M; Denberg, TD				Qaseem, Amir; Mir, Tanveer P.; Starkey, Melissa; Denberg, Thomas D.		Clinical Guidelines Comm Amer Coll	Risk Assessment and Prevention of Pressure Ulcers: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; AUSTRALIAN MEDICAL SHEEPSKIN; RELIEVING SUPPORT SURFACES; ACUTE-CARE HOSPITALS; BRADEN-SCALE; PREDICTIVE-VALIDITY; SORE RISK; ELDERLY-PATIENTS; NURSING-HOME; NUTRITIONAL SUPPLEMENTATION	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations based on the comparative effectiveness of risk assessment scales and preventive interventions for pressure ulcers. Methods: This guideline is based on published literature on this topic that was identified by using MEDLINE (1946 through February 2014), CINAHL (1998 through February 2014), the Cochrane Library, clinical trials registries, and reference lists. Searches were limited to English-language publications. The outcomes evaluated for this guideline include pressure ulcer incidence and severity, resource use, diagnostic accuracy, measures of risk, and harms. This guideline grades the quality of evidence and strength of recommendations by using ACP's clinical practice guidelines grading system. The target audience for this guideline includes all clinicians, and the target patient population is patients at risk for pressure ulcers. Recommendation 1: ACP recommends that clinicians should perform a risk assessment to identify patients who are at risk of developing pressure ulcers. (Grade: weak recommendation, low-quality evidence) Recommendation 2: ACP recommends that clinicians should choose advanced static mattresses or advanced static overlays in patients who are at an increased risk of developing pressure ulcers. (Grade: strong recommendation, moderate-quality evidence) Recommendation 3: ACP recommends against using alternating-air mattresses or alternating-air overlays in patients who are at an increased risk of developing pressure ulcers. (Grade: weak recommendation, moderate-quality evidence)	[Qaseem, Amir; Starkey, Melissa] Amer Coll Physicians, Philadelphia, PA 19106 USA; [Mir, Tanveer P.] NYU, Ctr Clin Canc, New York, NY 10016 USA; [Denberg, Thomas D.] Carilion Clin, Roanoke, VA 24036 USA	American College of Physicians; New York University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265	ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	ANDERSEN KE, 1983, ACTA DERM-VENEREOL, V63, P227; [Anonymous], 2001, Adv Skin Wound Care, V14, P208; Baldwin K M, 1998, Adv Wound Care, V11, P168; Barnes D, 1993, Dermatol Nurs, V5, P386; Baumgarten M, 2006, J GERONTOL A-BIOL, V61, P749, DOI 10.1093/gerona/61.7.749; Beeckman D, 2013, INT J NURS STUD, V50, P475, DOI 10.1016/j.ijnurstu.2012.09.007; Bergstrom N, 1998, NURS RES, V47, P261, DOI 10.1097/00006199-199809000-00005; Bergstrom N, 2002, NURS RES, V51, P400; BERGSTROM N, 1987, NURS CLIN N AM, V22, P417; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; Bergstrom N, 2013, J AM GERIATR SOC, V61, P1705, DOI 10.1111/jgs.12440; Bourdel-Marchasson I, 2000, NUTRITION, V16, P1, DOI 10.1016/S0899-9007(99)00227-0; Boyle M, 2001, Aust Crit Care, V14, P24, DOI 10.1016/S1036-7314(01)80019-9; BRADEN BJ, 1994, RES NURS HEALTH, V17, P459, DOI 10.1002/nur.4770170609; Brienza D, 2010, J AM GERIATR SOC, V58, P2308, DOI 10.1111/j.1532-5415.2010.03168.x; Brindle CT, 2012, J WOUND OSTOMY CONT, V39, P133, DOI 10.1097/WON.0b013e318247cb82; Brown M M, 1981, J Gerontol Nurs, V7, P401; Capobianco M L, 1996, Adv Wound Care, V9, P32; Cavicchioli A, 2007, J Wound Care, V16, P285; Chan E Y, 2005, J Wound Care, V14, P383; Chan WH, 1997, INT J NURS STUD, V34, P165; Chou R, 2013, AHRQ PUBLICATION, V12(13)-EHC148-EF; Chou R, 2013, ANN INTERN MED, V159, P28, DOI 10.7326/0003-4819-159-1-201307020-00006; Collier M E, 1996, J Wound Care, V5, P207; Conine T A, 1994, Int J Rehabil Res, V17, P123, DOI 10.1097/00004356-199406000-00003; Conine T A, 1990, Int J Rehabil Res, V13, P57, DOI 10.1097/00004356-199003000-00006; CONINE TA, 1993, OCCUP THER J RES, V13, P101, DOI 10.1177/153944929301300203; Cooper P, 2001, Br J Nurs, V10, ppassim; Cooper P J, 1998, J Wound Care, V7, P374; Courtney Bobby A, 2006, Nurs Manage, V37, ppassim, DOI 10.1097/00006247-200604000-00010; DAECHSEL D, 1985, ARCH PHYS MED REHAB, V66, P246, DOI 10.1016/0003-9993(85)90161-3; Declair V, 1997, Ostomy Wound Manage, V43, P48; Defloor T, 2005, J CLIN NURS, V14, P373, DOI 10.1111/j.1365-2702.2004.01058.x; Defloor T, 2005, INT J NURS STUD, V42, P37, DOI 10.1016/j.ijnurstu.2004.05.013; DELMI M, 1990, LANCET, V335, P1013, DOI 10.1016/0140-6736(90)91073-J; Demarre L, 2012, INT J NURS STUD, V49, P416, DOI 10.1016/j.ijnurstu.2011.10.007; Donnelly J, 2011, J WOUND CARE, V20, P309, DOI 10.12968/jowc.2011.20.7.309; EK AC, 1991, CLIN NUTR, V10, P245, DOI 10.1016/0261-5614(91)90002-T; European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel, 2009, PREV TREATM PRESS UL; Fader M, 2003, J CLIN NURS, V12, P374, DOI 10.1046/j.1365-2702.2003.00731.x; Feuchtinger Johanna, 2007, Nurs Crit Care, V12, P42, DOI 10.1111/j.1478-5153.2006.00198.x; Fogerty MD, 2008, WOUND REPAIR REGEN, V16, P11, DOI 10.1111/j.1524-475X.2007.00327.x; Geyer M J, 2001, Adv Skin Wound Care, V14, P120, DOI 10.1097/00129334-200105000-00008; Goodridge D M, 1998, Can J Nurs Res, V30, P23; Gray D G, 2000, J Wound Care, V9, P29; Gray DG, 1994, J TISSUE VIABILITY, V4, P128, DOI DOI 10.1016/S0965-206X(14)80124-1; Hagisawa S, 1999, J ROY SOC MED, V92, P576, DOI 10.1177/014107689909201109; Halfens RJG, 2000, INT J NURS STUD, V37, P313, DOI 10.1016/S0020-7489(00)00010-9; Hampton S, 1999, Br J Nurs, V8, P990; Hartgrink HH, 1998, CLIN NUTR, V17, P287, DOI 10.1016/S0261-5614(98)80321-X; Houwing RH, 2003, CLIN NUTR, V22, P401, DOI 10.1016/S0261-5614(03)00039-6; INMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P1139; Jalali Rostam, 2005, Adv Skin Wound Care, V18, P92, DOI 10.1097/00129334-200503000-00013; Jesurum J, 1996, Crit Care Nurs Clin North Am, V8, P423; Jolley DJ, 2004, MED J AUSTRALIA, V180, P324, DOI 10.5694/j.1326-5377.2004.tb05966.x; KEMP MG, 1993, RES NURS HEALTH, V16, P89, DOI 10.1002/nur.4770160203; Kim EK, 2009, AUST J ADV NURS, V26, P87; Kuhn B A, 1992, Nurs Econ, V10, P353; Kwong E, 2005, APPL NURS RES, V18, P122, DOI 10.1016/j.apnr.2005.01.001; Langemo D K, 1991, Decubitus, V4, P25; Lazzara D J, 1991, Decubitus, V4, P42; Lewicki L J, 2000, J Wound Ostomy Continence Nurs, V27, P36; Lim R, 1988, J Rehabil Res Dev, V25, P19; Lincoln R, 1986, J Enterostomal Ther, V13, P132; Lyder C, 2008, AHRQ PUBLICATION, V8, P1; Lyder C H, 1998, Ostomy Wound Manage, V44, p42S; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Lyder CH, 1999, APPL NURS RES, V12, P60, DOI 10.1016/S0897-1897(99)80332-2; McGowan S, 2000, PRIMARY INTENTION, P127; McInerney Joan A, 2008, Adv Skin Wound Care, V21, P75, DOI 10.1097/01.ASW.0000305410.58350.34; Mistiaen P, 2010, WOUND REPAIR REGEN, V18, P572, DOI 10.1111/j.1524-475X.2010.00629.x; Moore Z, 2011, J CLIN NURS, V20, P2633, DOI 10.1111/j.1365-2702.2011.03736.x; Moore ZEH, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006471.pub3; Nakagami G, 2007, J ADV NURS, V59, P520, DOI 10.1111/j.1365-2648.2007.04334.x; Nixon J, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10220; Nixon J, 2006, BMJ-BRIT MED J, V332, P1413, DOI 10.1136/bmj.38849.478299.7C; Olson K, 1998, Clin Nurs Res, V7, P207, DOI 10.1177/105477389800700208; Padula WV, 2011, MED CARE, V49, P385, DOI 10.1097/MLR.0b013e31820292b3; Pang SM, 1998, NURS RES, V47, P147, DOI 10.1097/00006199-199805000-00005; Perneger TV, 2002, J CLIN EPIDEMIOL, V55, P498, DOI 10.1016/S0895-4356(01)00514-5; Pring J, 1998, J Wound Care, V7, P177; Qaseem A, 2015, ANN INTERN MED, V162, P370, DOI 10.7326/M14-1568; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Ramundo J M, 1995, J Wound Ostomy Continence Nurs, V22, P128; Redelings Matthew D, 2005, Adv Skin Wound Care, V18, P367, DOI 10.1097/00129334-200509000-00010; Rosen J, 2006, J AM MED DIR ASSOC, V7, P141, DOI 10.1016/j.jamda.2005.08.003; Russell L, 2000, J Wound Care, V9, P52; Russell Linda J, 2003, Adv Skin Wound Care, V16, P317, DOI 10.1097/00129334-200311000-00015; Salvadalena G D, 1992, J ET Nurs, V19, P160; Sanada Hiromi, 2003, J Tissue Viability, V13, P112; Schoonhoven L, 2002, BMJ-BRIT MED J, V325, P797, DOI 10.1136/bmj.325.7368.797; Scott E M, 2001, AORN J, V73, P921, DOI 10.1016/S0001-2092(06)61744-4; Seongsook RNJ, 2004, INT J NURS STUD, V41, P199, DOI 10.1016/S0020-7489(03)00135-4; Serpa LF, 2011, REV LAT-AM ENFERM, V19, P50, DOI 10.1590/S0104-11692011000100008; SIDERANKO S, 1992, RES NURS HEALTH, V15, P245, DOI 10.1002/nur.4770150403; Smith A M, 1990, Decubitus, V3, P20; Smith RG, 1986, J CLIN EXPT GERONTOL, V7, P337; Stapleton M, 1986, Geriatr Nurs (Lond), V6, P23; STOTTS NA, 1988, HEART LUNG, V17, P641; Sullivan N, 2013, ANN INTERN MED, V158, P410, DOI 10.7326/0003-4819-158-5-201303051-00008; Taylor L, 1999, Br J Nurs, V8, P771; Theaker C, 2005, ANAESTHESIA, V60, P395, DOI 10.1111/j.1365-2044.2004.04085.x; Theilla M, 2007, CLIN NUTR, V26, P752, DOI 10.1016/j.clnu.2007.06.015; Tippet AW, 2009, OSTOMY WOUND MANAG, V55, P52; Torra i Bou J E, 2005, J Wound Care, V14, P117; Tourtual D M, 1997, Ostomy Wound Manage, V43, P24; Tymec A C, 1997, Adv Wound Care, V10, P39; van Leen M, 2011, J TISSUE VIABILITY, V20, P30, DOI 10.1016/j.jtv.2010.04.001; VandenBosch T, 1996, APPL NURS RES, V9, P80, DOI 10.1016/S0897-1897(96)80457-5; VANDERCAMMEN TJM, 1987, BRIT J CLIN PRACT, V41, P1009; Vanderwee K, 2007, J ADV NURS, V57, P59, DOI 10.1111/j.1365-2648.2006.04060.x; Vanderwee K, 2005, AGE AGEING, V34, P261, DOI 10.1093/ageing/afi057; VanGilder C, 2009, OSTOMY WOUND MANAG, V55, P39; Vyhlidal SK, 1997, APPL NURS RES, V10, P111, DOI 10.1016/S0897-1897(97)80193-0; Webster J, 2011, BMJ QUAL SAF, V20, P297, DOI 10.1136/bmjqs.2010.043109; Xakellis G C, 1996, Adv Wound Care, V9, P18; Yap TL, 2013, J AM GERIATR SOC, V61, P1552, DOI 10.1111/jgs.12422; Young Trudie, 2004, J Tissue Viability, V14, P92	118	69	76	0	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2015	162	5					359	U160		10.7326/M14-1567	http://dx.doi.org/10.7326/M14-1567			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC3HT	25732278				2022-12-28	WOS:000350238300005
J	Hashiguchi, T; Fusco, ML; Bornholdt, ZA; Lee, JE; Flyak, AI; Matsuoka, R; Kohda, D; Yanagi, Y; Hammel, M; Crowe, JE; Saphire, EO				Hashiguchi, Takao; Fusco, Marnie L.; Bornholdt, Zachary A.; Lee, Jeffrey E.; Flyak, Andrew I.; Matsuoka, Rei; Kohda, Daisuke; Yanagi, Yusuke; Hammel, Michal; Crowe, James E., Jr.; Saphire, Erica Ollmann			Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody	CELL			English	Article							ENDOSOMAL CYSTEINE PROTEASES; VIRAL HEMORRHAGIC-FEVER; EBOLA-VIRUS; NONHUMAN-PRIMATES; ENTRY REQUIRES; HUMAN-DISEASE; BINDING SITE; GLYCOPROTEIN; HOST; RECOGNITION	The filoviruses, including Marburg and Ebola, express a single glycoprotein on their surface, termed GP, which is responsible for attachment and entry of target cells. Filovirus GPs differ by up to 70% in protein sequence, and no antibodies are yet described that cross-react among them. Here, we present the 3.6 angstrom crystal structure of Marburg virus GP in complex with a cross-reactive antibody from a human survivor, and a lower resolution structure of the antibody bound to Ebola virus GP. The antibody, MR78, recognizes a GP1 epitope conserved across the filovirus family, which likely represents the binding site of their NPC1 receptor. Indeed, MR78 blocks binding of the essential NPC1 domain C. These structures and additional small-angle X-ray scattering of mucin-containing MARV and EBOV GPs suggest why such antibodies were not previously elicited in studies of Ebola virus, and provide critical templates for development of immunotherapeutics and inhibitors of entry.	[Hashiguchi, Takao; Fusco, Marnie L.; Bornholdt, Zachary A.; Lee, Jeffrey E.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Hashiguchi, Takao; Yanagi, Yusuke] Kyushu Univ, Dept Virol, Fac Med, Fukuoka 8128582, Japan; [Flyak, Andrew I.; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Matsuoka, Rei; Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Fukuoka 8128582, Japan; [Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Kyushu University; Vanderbilt University; Kyushu University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Vanderbilt University; Scripps Research Institute	Saphire, EO (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	erica@scripps.edu	Crowe, James/B-5549-2009; Kohda, Daisuke/I-4990-2019	Crowe, James/0000-0002-0049-1079; Kohda, Daisuke/0000-0001-8234-3776; Flyak, Andrew/0000-0002-8722-479X; Saphire, Erica Ollmann/0000-0002-1206-7451; Yanagi, Yusuke/0000-0001-7815-1667; Hammel, Michal/0000-0002-5610-9289; Hashiguchi, Takao/0000-0001-7578-7571; Bornholdt, Zachary/0000-0002-7557-9219	NIAID CETR [U19 AI109762, R01 AI089498, R21AI069347]; Defense Threat Reduction Agency [HDTRA1-13-1-0034]; NIAID [U19 AI109711]; MEXT [26713018, 24115005]; MEXT Platform for Drug Discovery Informatics and Structural Life Science; JSPS; Uehara Memorial Foundation; Burroughs Wellcome Fund; NIH [MINOS GM105404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109711, R01AI089498, U19AI109762, T32AI007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	NIAID CETR; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT Platform for Drug Discovery Informatics and Structural Life Science; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Dr. Adrianna P.P. Zhang (TSRI) for help with data collection, Dr. Sebastien Igonet (TSRI and Calixar) for assistance with S2 cell expression, Dr. Kartik Chandran (Albert Einstein College of Medicine), C. Daniel Murin, and Dr. Andrew Ward (TSRI) for valuable discussions, and the beamline staff of Photon Factory (Tsukuba, Japan) for technical help during data collection. We thank NIAID CETR U19 AI109762 (E.O.S.), R01 AI089498, and R21AI069347 (E.O.S.); Defense Threat Reduction Agency grant HDTRA1-13-1-0034; NIAID grant U19 AI109711 (J.E.C.); MEXT KAKENHI grant numbers 26713018 (T.H.) and 24115005 (Y.Y.); MEXT Platform for Drug Discovery Informatics and Structural Life Science (T.H.), JSPS Postdoctoral Fellowships (DC2 [R.M.], Research Abroad [T.H.]); a Research Fellowship of The Uehara Memorial Foundation (TH.); an Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund (E.O.S.); and an NIH grant MINOS GM105404 (M.H.) for support. SIBYLS beamline efforts to combine SAXS and crystallography at the Advanced Light Source of Lawrence Berkeley National Laboratory are supported in part by US DOE program Integrated Diffraction Analysis Technologies (IDAT). This is manuscript # 28060 from The Scripps Research Institute.	Albarino CG, 2013, VIROLOGY, V442, P97, DOI 10.1016/j.virol.2013.04.014; Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Bale S, 2012, VIRUSES-BASEL, V4, P447, DOI 10.3390/v4040447; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; BOWEN ETW, 1977, LANCET, V1, P571; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Geisbert TW, 2007, J INFECT DIS, V196, pS372, DOI 10.1086/520608; Gnirss K, 2012, VIROLOGY, V424, P3, DOI 10.1016/j.virol.2011.11.031; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; MALHERBE H, 1968, LANCET, V1, P1434; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Manicassamy B, 2007, VIROLOGY, V358, P79, DOI 10.1016/j.virol.2006.06.041; Martinez O, 2013, J VIROL, V87, P3324, DOI 10.1128/JVI.01598-12; Martinez O, 2010, CELL MICROBIOL, V12, P148, DOI 10.1111/j.1462-5822.2009.01385.x; Marzi A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001923; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Misasi J, 2012, J VIROL, V86, P3284, DOI 10.1128/JVI.06346-11; Mpanju OM, 2006, VIRUS RES, V121, P205, DOI 10.1016/j.virusres.2006.06.002; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Ng M, 2014, VIROLOGY, V468, P637, DOI 10.1016/j.virol.2014.08.019; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pan YY, 2014, ARCH VIROL, V159, P1129, DOI 10.1007/s00705-012-1477-6; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Sanchez A, 2005, VIRUS RES, V113, P16, DOI 10.1016/j.virusres.2005.03.028; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Sayama Y, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-82; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Shoemaker T, 2012, EMERG INFECT DIS, V18, P1480, DOI 10.3201/eid1809.111536; SIEGERT R, 1968, DEUT MED WOCHENSCHR, V93, P604, DOI 10.1055/s-0028-1105103; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Tran EEH, 2014, J VIROL, V88, P10958, DOI 10.1128/JVI.00870-14; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wamala JF, 2010, EMERG INFECT DIS, V16, P1087, DOI 10.3201/eid1607.091525; Weissenhorn W, 1998, P NATL ACAD SCI USA, V95, P6032, DOI 10.1073/pnas.95.11.6032; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500	61	89	96	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					904	912		10.1016/j.cell.2015.01.041	http://dx.doi.org/10.1016/j.cell.2015.01.041			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723165	Bronze, Green Accepted			2022-12-28	WOS:000351116100013
J	Knight, R				Knight, Rob			Why Microbiome Treatments Could Pay Off Soon	NATURE			English	Editorial Material									[Knight, Rob] Univ Calif San Diego, New Microbiome Initiat, San Diego, CA 92103 USA	University of California System; University of California San Diego				Knight, Rob/0000-0002-0975-9019					0	9	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					S5	S5		10.1038/518S5a	http://dx.doi.org/10.1038/518S5a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC1JP	25715279	Bronze			2022-12-28	WOS:000350097300026
J	Aronson, L; Bautista, CA; Covinsky, K				Aronson, Louise; Bautista, Christopher A.; Covinsky, Kenneth			Medicare and Care Coordination Expanding the Clinician's Toolbox	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PAYMENT		[Aronson, Louise; Covinsky, Kenneth] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94118 USA; [Bautista, Christopher A.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California Davis	Aronson, L (corresponding author), Univ Calif San Francisco, Dept Med, Div Geriatr, 3333 Calif St,Ste 380, San Francisco, CA 94118 USA.	louise.aronson@ucsf.edu						Bindman AB, 2013, JAMA-J AM MED ASSOC, V310, P1125, DOI 10.1001/jama.2013.276525; Boult C, 2010, JAMA-J AM MED ASSOC, V304, P1936, DOI 10.1001/jama.2010.1623; Edwards ST, 2014, NEW ENGL J MED, V371, P2049, DOI 10.1056/NEJMp1410790; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Press MJ, 2014, NEW ENGL J MED, V371, P489, DOI 10.1056/NEJMp1406033; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871	6	12	12	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					797	798		10.1001/jama.2014.18174	http://dx.doi.org/10.1001/jama.2014.18174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710653				2022-12-28	WOS:000349826400010
J	Humikowski, CA				Humikowski, Catherine A.			For What It's Worth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Chicago, Dept Pediat, Sect Crit Care, Chicago, IL 60637 USA	University of Chicago	Humikowski, CA (corresponding author), Univ Chicago, Dept Pediat, Sect Crit Care, Chicago, IL 60637 USA.	cahumiko@uchicago.edu						Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Callaway E, 2014, NATURE, V508, P295, DOI 10.1038/508295a; Kuehn BM, 2014, JAMA-J AM MED ASSOC, V311, P2368, DOI 10.1001/jama.2014.5756	3	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					799	800		10.1001/jama.2014.15004	http://dx.doi.org/10.1001/jama.2014.15004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710654				2022-12-28	WOS:000349826400011
J	Kay, S; Wilks, D				Kay, Simon; Wilks, Daniel			Bionic hand transplantation: linking the cortex to the hand	LANCET			English	Editorial Material							REINNERVATION; INTERFACES; ELECTRODE		[Kay, Simon; Wilks, Daniel] Leeds Teaching Hosp NHS Trust, Dept Plast Reconstruct & Hand Surg, Leeds LS1 3EX, W Yorkshire, England	University of Leeds	Kay, S (corresponding author), Leeds Teaching Hosp NHS Trust, Dept Plast Reconstruct & Hand Surg, Leeds LS1 3EX, W Yorkshire, England.	spjkay@gmail.com		Wilks, Daniel/0000-0003-0617-6712				ASZMANN O., 2015, LANCET; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Broyles JM, 2014, PLAST RECONSTR SURG, V133, p543E, DOI 10.1097/PRS.0000000000000015; Bueno RA, 2011, J HAND SURG-AM, V36A, P890, DOI 10.1016/j.jhsa.2011.02.020; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kay SPJ, 2010, J PLAST RECONSTR AES, V63, P1939, DOI 10.1016/j.bjps.2010.05.014; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; Lawrence SM, 2003, J NEUROSCI METH, V131, P9, DOI 10.1016/S0165-0270(03)00231-0; Leventhal DK, 2004, IEEE T BIO-MED ENG, V51, P1649, DOI 10.1109/TBME.2004.827535; Navarro X, 2005, J PERIPHER NERV SYST, V10, P229, DOI 10.1111/j.1085-9489.2005.10303.x; Piselli P, 2014, BEST PRACT RES CL OB, V28, P1251, DOI 10.1016/j.bpobgyn.2014.08.007; Schultz AE, 2011, PM&R, V3, P55, DOI 10.1016/j.pmrj.2010.06.016; Weir REF, 2009, IEEE T BIO-MED ENG, V56, P159, DOI 10.1109/TBME.2008.2005942	13	1	1	2	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2130	2132		10.1016/S0140-6736(14)61989-9	http://dx.doi.org/10.1016/S0140-6736(14)61989-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25724530				2022-12-28	WOS:000355583000008
J	Soltwisch, J; Kettling, H; Vens-Cappell, S; Wiegelmann, M; Muthing, J; Dreisewerd, K				Soltwisch, Jens; Kettling, Hans; Vens-Cappell, Simeon; Wiegelmann, Marcel; Muething, Johannes; Dreisewerd, Klaus			Mass spectrometry imaging with laser-induced postionization	SCIENCE			English	Article							SINGLE CELLS; ION YIELDS; MALDI; IONIZATION; DESORPTION; MOLECULES; PRESSURE; TISSUE; RESOLUTION; SPECTRA	Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) can simultaneously record the lateral distribution of numerous biomolecules in tissue slices, but its sensitivity is restricted by limited ionization. We used a wavelength-tunable postionization laser to initiate secondary MALDI-like ionization processes in the gas phase. In this way, we could increase the ion yields for numerous lipid classes, liposoluble vitamins, and saccharides, imaged in animal and plant tissue with a 5-micrometer-wide laser spot, by up to two orders of magnitude. Critical parameters for initiation of the secondary ionization processes are pressure of the cooling gas in the ion source, laser wavelength, pulse energy, and delay between the two laser pulses. The technology could enable sensitive MALDI-MS imaging with a lateral resolution in the low micrometer range.	[Soltwisch, Jens; Kettling, Hans; Vens-Cappell, Simeon; Wiegelmann, Marcel; Muething, Johannes; Dreisewerd, Klaus] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Kettling, Hans; Vens-Cappell, Simeon; Dreisewerd, Klaus] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany	University of Munster; University of Munster	Dreisewerd, K (corresponding author), Univ Munster, Inst Hyg, Robert Koch Str 41, D-48149 Munster, Germany.	klaus.dreisewerd@uni-muenster.de	Soltwisch, Jens/N-8141-2015; Dreisewerd, Klaus/K-3884-2015	Soltwisch, Jens/0000-0002-0258-1561; Dreisewerd, Klaus/0000-0002-7619-808X; Niehaus, Marcel/0000-0002-4876-6190; Vens-Cappell, Simeon/0000-0003-4773-4653	German Science Foundation [DR416/8-2, DR416/9-1, SO976/2-1, GRK 1409, MU845/4-2]; Interdisciplinary Center for Clinical Research (IZKF) Munster [Z03]	German Science Foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Munster	We thank Waters Corp. and GWU Lasertechnik for technical support; F. Spieker and J. Haier for animal tissue; J. Klingauf for scanning electron microscopy images; W. Kramer for Fig. 1; and S. Albrecht, H. Karch, T. Kuhlmann, G. Pohlentz, and J. Y. Yew for helpful discussions. Financial support by the German Science Foundation (grants DR416/8-2 and DR416/9-1 to K.D., SO976/2-1 to J. S., GRK 1409 and MU845/4-2 to J.M.) and the Interdisciplinary Center for Clinical Research (IZKF) Munster (Z03 to K.D.) is gratefully acknowledged. We dedicate this work to the memory of Dr. Franz Hillenkamp in recognition of his lifetime achievements in the field of MALDI mass spectrometry.	BECKER CH, 1995, J AM SOC MASS SPECTR, V6, P883, DOI 10.1016/1044-0305(95)00472-P; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; DREISEWERD K, 1995, INT J MASS SPECTROM, V141, P127, DOI 10.1016/0168-1176(94)04108-J; Dreisewerd K, 2003, CHEM REV, V103, P395, DOI 10.1021/cr010375i; Dreisewerd K, 2014, ANAL BIOANAL CHEM, V406, P2261, DOI 10.1007/s00216-014-7646-6; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; Hanley L, 2009, ANAL CHEM, V81, P4174, DOI 10.1021/ac8013675; Hillenkamp F., 2013, MALDI MS PRACTICAL G; Jaskolla TW, 2011, J AM SOC MASS SPECTR, V22, P976, DOI 10.1007/s13361-011-0093-0; Kettling H, 2014, ANAL CHEM, V86, P7798, DOI 10.1021/ac5017248; Knochenmuss R, 2003, CHEM REV, V103, P441, DOI 10.1021/cr0103773; Knochenmuss R, 2012, ANAL BIOANAL CHEM, V402, P2511, DOI 10.1007/s00216-011-5194-x; Krutchinsky AN, 2002, J AM SOC MASS SPECTR, V13, P129, DOI 10.1016/S1044-0305(01)00336-1; Lanni EJ, 2012, J PROTEOMICS, V75, P5036, DOI 10.1016/j.jprot.2012.03.017; Lin Q, 2001, RAPID COMMUN MASS SP, V15, P1422, DOI 10.1002/rcm.380; Nemes P, 2007, ANAL CHEM, V79, P8098, DOI 10.1021/ac071181r; Norris JL, 2013, CHEM REV, V113, P2309, DOI 10.1021/cr3004295; Rompp A, 2010, ANGEW CHEM INT EDIT, V49, P3834, DOI 10.1002/anie.200905559; Rohlfing A, 2010, J PHYS CHEM C, V114, P5367, DOI 10.1021/jp905251r; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; Soltwisch J, 2012, ANAL CHEM, V84, P6567, DOI 10.1021/ac3008434; Soltwisch J, 2009, ANAL CHEM, V81, P2921, DOI 10.1021/ac802301s; Spengler B, 2015, ANAL CHEM, V87, P64, DOI 10.1021/ac504543v; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Zavalin A, 2012, J MASS SPECTROM, V47, P1473, DOI 10.1002/jms.3108; ZemskiBerry K. A., 2011, CHEM REV, V111, P6491; ZHANG JY, 1991, ANAL CHEM, V63, P2995, DOI 10.1021/ac00024a039	28	186	188	13	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					211	215		10.1126/science.aaa1051	http://dx.doi.org/10.1126/science.aaa1051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25745064				2022-12-28	WOS:000352613700039
J	Mitchell, DA; Batich, KA; Gunn, MD; Huang, MN; Sanchez-Perez, L; Nair, SK; Congdon, KL; Reap, EA; Archer, GE; Desjardins, A; Friedman, AH; Friedman, HS; Herndon, JE; Coan, A; McLendon, RE; Reardon, DA; Vredenburgh, JJ; Bigner, DD; Sampson, JH				Mitchell, Duane A.; Batich, Kristen A.; Gunn, Michael D.; Huang, Min-Nung; Sanchez-Perez, Luis; Nair, Smita K.; Congdon, Kendra L.; Reap, Elizabeth A.; Archer, Gary E.; Desjardins, Annick; Friedman, Allan H.; Friedman, Henry S.; Herndon, James E., II; Coan, April; McLendon, Roger E.; Reardon, David A.; Vredenburgh, James J.; Bigner, Darell D.; Sampson, John H.			Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients	NATURE			English	Article							HUMAN CYTOMEGALOVIRUS; MALIGNANT GLIOMA; PERIPHERAL-BLOOD; MELANOMA-CELLS; T-CELLS; RESPONSES; IMMUNITY; TUMORS; MIP-1-ALPHA; VACCINATION	After stimulation, dendritic cells(DCs) mature andmigrate to draining lymph nodes to induce immune responses(1). As such, autologous DCs generated ex vivo have been pulsed with tumour antigens and injected back into patients as immunotherapy. While DC vaccines have shown limited promise in the treatment of patients with advanced cancers(2-4) including glioblastoma(5-7), the factors dictating DC vaccine efficacy remain poorly understood. Here we show that pre-conditioning the vaccine site with a potent recall antigen such as tetanus/diphtheria (Td) toxoid can significantly improve the lymph node homing and efficacy of tumour-antigen-specific DCs. To assess the effect of vaccine site pre-conditioning in humans, we randomized patients with glioblastoma to pre-conditioning with either mature DCs8 or Td unilaterally before bilateral vaccination with DCs pulsed with Cytomegalovirus phosphoprotein 65(pp65) RNA. We and other laboratories have shown that pp65 is expressed in more than 90% of glioblastoma specimens but not in surrounding normal brain(9-12), providing an unparalleled opportunity to subvert this viral protein as a tumour-specific target. Patients given Td had enhanced DC migration bilaterally and significantly improved survival. In mice, Td pre-conditioning also enhanced bilateral DC migration and suppressed tumour growth in a manner dependent on the chemokine CCL3. Our clinical studies and corroborating investigations in mice suggest that pre-conditioning with a potent recall antigen may represent a viable strategy to improve anti-tumour immunotherapy.	[Mitchell, Duane A.; Archer, Gary E.; Desjardins, Annick; Friedman, Allan H.; Friedman, Henry S.; McLendon, Roger E.; Reardon, David A.; Vredenburgh, James J.; Bigner, Darell D.; Sampson, John H.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Mitchell, Duane A.; Batich, Kristen A.; Sanchez-Perez, Luis; Congdon, Kendra L.; Reap, Elizabeth A.; Archer, Gary E.; Desjardins, Annick; Friedman, Allan H.; Friedman, Henry S.; Reardon, David A.; Vredenburgh, James J.; Bigner, Darell D.; Sampson, John H.] Duke Univ, Med Ctr, Div Neurosurg, Dept Surg, Durham, NC 27710 USA; [Mitchell, Duane A.; Batich, Kristen A.; McLendon, Roger E.; Bigner, Darell D.; Sampson, John H.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gunn, Michael D.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Gunn, Michael D.; Huang, Min-Nung; Sampson, John H.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Nair, Smita K.] Duke Univ, Med Ctr, Dept Surg, Div Surg Sci, Durham, NC 27710 USA; [Herndon, James E., II; Coan, April] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Sampson, John H.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Sampson, JH (corresponding author), Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA.	duane.mitchell@neurosurgery.ufl.edu; john.sampson@duke.edu	Nair, Smita/GYR-2993-2022; Sykes, April/N-4407-2018; Nair Jain, Smita/M-2765-2018	Nair, Smita/0000-0001-5615-7056; Sykes, April/0000-0002-7667-8155; Nair Jain, Smita/0000-0002-1542-9913; Sampson, John/0000-0002-0104-7658	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [P50-CA108786]; SRC on Primary and Metastatic Tumors of the CNS [P50-NS20023]; NIH [R01-CA177476-01, R01-NS067037, R01-CA134844, P01-CA154291-01A1]; National Brain Tumor Society; American Brain Tumor Association; Accelerate Brain Cancer Cure Foundation; Kinetics Foundation; Ben and Catherine Ivy Foundation; Duke University from the National Institutes of Health National Center for Research Resources [1UL2 RR024128-01]; NATIONAL CANCER INSTITUTE [R01CA134844, R01CA177476, P01CA154291, P50CA108786] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067037, P50NS020023] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); SRC on Primary and Metastatic Tumors of the CNS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; American Brain Tumor Association; Accelerate Brain Cancer Cure Foundation; Kinetics Foundation; Ben and Catherine Ivy Foundation; Duke University from the National Institutes of Health National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the staff who supported this study, including R. Schmittling, P. Norberg, W. Xie, P. Healy, D. Lally-Goss, S. McGehee-Norman, B. Perry, S. Snipes and R. Edward Coleman. This work was supported by grants from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Specialized Program of Research Excellence in brain cancer (P50-CA108786, D.D.B. and J.H.S.) and SRC on Primary and Metastatic Tumors of the CNS (P50-NS20023, D. D. B. and J.H.S.) as well as NIH R01 (R01-CA177476-01, J.H.S.; R01-NS067037, R01-CA134844, D.A.M.) and P01 (P01-CA154291-01A1, D. D. B. and J.H.S.) funding sources. Additional support is from the National Brain Tumor Society (D.A.M. and J.H.S.), the American Brain Tumor Association (D.A.M. and J.H.S.), Accelerate Brain Cancer Cure Foundation Young Investigator's Award (D.A.M.), The Kinetics Foundation, (J.H.S.) Ben and Catherine Ivy Foundation (J.H.S.), and in part by Duke University's Clinical & Translational Science Awards grant 1UL2 RR024128-01 from the National Institutes of Health National Center for Research Resources.	Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cobbs CS, 2002, CANCER RES, V62, P3347; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Daniels GA, 2004, NAT BIOTECHNOL, V22, P1125, DOI 10.1038/nbt1007; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; FIDLER IJ, 1975, CANCER RES, V35, P218; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; He S, 2008, J LEUKOCYTE BIOL, V84, P1549, DOI 10.1189/jlb.0708420; Inaba K., 2001, CURR PROTOC IMMUNOL, V25; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; McLendon RE, 1998, LAB INVEST, V78, P643; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; MYERS MG, 1982, JAMA-J AM MED ASSOC, V248, P2478, DOI 10.1001/jama.248.19.2478; Nair S., 2012, CURR PROTOC IMMUNOL, V99, P7321; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Palucka AK, 2005, J CLIN IMMUNOL, V25, P288, DOI 10.1007/s10875-005-4089-z; Palucka AK, 2003, J IMMUNOTHER, V26, P432, DOI 10.1097/00002371-200309000-00006; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Sanchez-Perez L, 2005, CANCER RES, V65, P2009, DOI 10.1158/0008-5472.CAN-04-3216; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zhang YY, 2004, JNCI-J NATL CANCER I, V96, P201, DOI 10.1093/jnci/djh024	29	313	325	6	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					366	+		10.1038/nature14320	http://dx.doi.org/10.1038/nature14320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762141	Green Accepted			2022-12-28	WOS:000351171900044
J	Borzak, S				Borzak, Steven			Review: beta-blockers do not reduce mortality in myocardial infarction in the reperfusion era	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Borzak, Steven] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA; [Borzak, Steven] Florida Atlantic Univ, Charles E Schmidt Coll Med, Atlantis, FL USA	University of Miami; State University System of Florida; Florida Atlantic University	Borzak, S (corresponding author), Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA.							Chen ZM, 2005, LANCET, V366, P1622	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC3	10.7326/ACPJC-2015-162-6-003	http://dx.doi.org/10.7326/ACPJC-2015-162-6-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775346				2022-12-28	WOS:000351279600002
J	Finlay, K; Vogt, RJ; Bogard, MJ; Wissel, B; Tutolo, BM; Simpson, GL; Leavitt, PR				Finlay, Kerri; Vogt, Richard J.; Bogard, Matthew J.; Wissel, Bjoern; Tutolo, Benjamin M.; Simpson, Gavin L.; Leavitt, Peter R.			Decrease in CO2 efflux from northern hardwater lakes with increasing atmospheric warming	NATURE			English	Article							HARD-WATER LAKES; CARBON-DIOXIDE; TEMPORAL VARIABILITY; CASPIAN SEA; ICE COVER; EXCHANGE; FLUX; CLIMATE; REGULARIZATION; BACTERIA	Boreal lakes are biogeochemical hotspots that alter carbon fluxes by sequestering particulate organic carbon in sediments(1,2) and by oxidizing terrestrial dissolved organic matter to carbon dioxide (CO2) or methane through microbial processes(3,4). At present, such dilute lakes release similar to 1.4 petagrams of carbon annually to the atmosphere(3,4), and this carbon efflux may increase in the future in response to elevated temperatures(5) and increased hydrological delivery of mineralizable dissolved organic matter to lakes(6,7). Much less is known about the potential effects of climate changes on carbon fluxes from carbonate-rich hardwater and saline lakes that account for about 20 per cent of inland water surface area(4,8). Here we show that atmospheric warming may reduce CO2 emissions from hardwater lakes. We analyse decadal records of meteorological variability, CO2 fluxes and water chemistry to investigate the processes affecting variations in pH and carbon exchange(9,10) in hydrologically diverse lakes of central North America. We find that the lakes have shifted progressively from being substantial CO2 sources in the mid-1990s to sequestering CO2 by 2010, with a steady increase in annual mean pH. We attribute the observed changes in pH and CO2 uptake to an atmospheric-warming induced decline in ice cover in spring that decreases CO2 accumulation under ice, increases spring and summer pH, and enhances the chemical uptake of CO2 in hardwater lakes. Our study suggests that rising temperatures do not invariably increase CO2 emissions from aquatic ecosystems.	[Finlay, Kerri; Vogt, Richard J.; Bogard, Matthew J.; Leavitt, Peter R.] Univ Regina, Dept Biol, Limnol Lab, Regina, SK S4S 0A2, Canada; [Wissel, Bjoern; Simpson, Gavin L.; Leavitt, Peter R.] Univ Regina, Inst Environm Change & Soc, Regina, SK S4S 0A2, Canada; [Tutolo, Benjamin M.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA	University of Regina; University of Regina; University of Minnesota System; University of Minnesota Twin Cities	Leavitt, PR (corresponding author), Univ Regina, Dept Biol, Limnol Lab, Regina, SK S4S 0A2, Canada.	peter.leavitt@uregina.ca	Leavitt, Peter R/A-1048-2013	Leavitt, Peter R/0000-0001-9805-9307; Tutolo, Benjamin/0000-0002-3047-8828; Simpson, Gavin/0000-0002-9084-8413	NSERC Canada; Canada Foundation for Innovation; Province of Saskatchewan; Canada Research Chair programme	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Province of Saskatchewan; Canada Research Chair programme(Canada Research Chairs)	We thank I. Phillips for estimates of lake area in Saskatchewan; D. Conrad for water chemistry data from Buffalo Pound Lake, Katherine Miller for compilation and analysis of Buffalo Pound data; J. Piwowar for assistance with GIS data; S. Pham and the University of Regina Limnology Laboratory for field work in 1996-2010; and Y.T. Prairie, E.G. Stets, J. A. Downing and D. E. Schindler for reviewing the manuscript. NSERC Canada, the Canada Foundation for Innovation, the Province of Saskatchewan, and the Canada Research Chair programme provided funding for this work.	[Anonymous], 2014, R LANG ENV STAT COMP; Ask J, 2009, ECOLOGY, V90, P1923, DOI 10.1890/07-1855.1; Baehr MM, 2002, BIOGEOCHEMISTRY, V61, P95, DOI 10.1023/A:1020265315833; Bastviken D, 2011, SCIENCE, V331, P50, DOI 10.1126/science.1196808; Berggren M, 2012, ISME J, V6, P984, DOI 10.1038/ismej.2011.157; Bethke C., 2013, GEOCHEMISTS WORKBENC; Bonsal BR, 2006, J HYDROL, V330, P340, DOI 10.1016/j.jhydrol.2006.03.022; Buffalo Pound Water Administration Board, 2012, 2012 ANN REP; Burgermeister J., 2007, NAT REP, V3, P36, DOI DOI 10.1038/CLIMATE.2007.35; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1551, DOI 10.4319/lo.2010.55.4.1551; Finlay K, 2009, LIMNOL OCEANOGR, V54, P2553, DOI 10.4319/lo.2009.54.6_part_2.2553; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hammer U., 1986, SALINE LAKE ECOSYSTE; Hastie T., 2009, UNSUPERVISED LEARNIN; HOOVER TE, 1969, J GEOPHYS RES, V74, P456, DOI 10.1029/JB074i002p00456; KLING GW, 1992, HYDROBIOLOGIA, V240, P23, DOI 10.1007/BF00013449; Kouraev AV, 2004, J MARINE SYST, V47, P89, DOI 10.1016/j.jmarsys.2003.12.011; KRATZ TK, 1987, CAN J FISH AQUAT SCI, V44, P1082, DOI 10.1139/f87-129; Leavitt PR, 2009, LIMNOL OCEANOGR, V54, P2330, DOI 10.4319/lo.2009.54.6_part_2.2330; Luhmann AJ, 2014, CHEM GEOL, V380, P145, DOI 10.1016/j.chemgeo.2014.05.001; Lukashin VN, 2010, OCEANOLOGY+, V50, P439, DOI 10.1134/S0001437010030136; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Marotta H, 2014, NAT CLIM CHANGE, V4, P467, DOI [10.1038/NCLIMATE2222, 10.1038/nclimate2222]; Millero FJ, 2007, CHEM REV, V107, P308, DOI 10.1021/cr0503557; Patoine A, 2006, LIMNOL OCEANOGR, V51, P1665, DOI 10.4319/lo.2006.51.4.1665; Pham SV, 2008, LIMNOL OCEANOGR, V53, P728, DOI 10.4319/lo.2008.53.2.0728; Pham SV, 2009, LIMNOL OCEANOGR, V54, P101, DOI 10.4319/lo.2009.54.1.0101; Prairie YT, 2002, LIMNOL OCEANOGR, V47, P316, DOI 10.4319/lo.2002.47.1.0316; Province of Saskatchewan, 2008, SASK STAT ENV REP; Rantakari M, 2005, GLOBAL CHANGE BIOL, V11, P1368, DOI 10.1111/j.1365-2486.2005.00982.x; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Shapley MD, 2005, GEOCHIM COSMOCHIM AC, V69, P2517, DOI 10.1016/j.gca.2004.12.001; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208, DOI 10.4319/lo.2007.52.3.1208; Striegl RG, 2001, LIMNOL OCEANOGR, V46, P941, DOI 10.4319/lo.2001.46.4.0941; Striegl RG, 1998, LIMNOL OCEANOGR, V43, P1519, DOI 10.4319/lo.1998.43.7.1519; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tutolo BM, 2014, GEOCHIM COSMOCHIM AC, V133, P216, DOI 10.1016/j.gca.2014.02.036; Tuzhilkin VS, 2005, HANDB ENVIRON CHEM, V5, P83, DOI 10.1007/698_5_005; Vogt RJ, 2011, ECOLOGY, V92, P1104, DOI 10.1890/i0012-9658-92-5-1104; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wanninkhof R, 1996, LIMNOL OCEANOGR, V41, P689, DOI 10.4319/lo.1996.41.4.0689; Wissel B, 2011, GLOBAL CHANGE BIOL, V17, P172, DOI 10.1111/j.1365-2486.2010.02291.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	50	81	87	10	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					215	218		10.1038/nature14172	http://dx.doi.org/10.1038/nature14172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25731167				2022-12-28	WOS:000350770500035
J	Odde, DJ				Odde, David J.			Mitosis, Diffusible Crosslinkers, and the Ideal Gas Law	CELL			English	Editorial Material							METAPHASE SPINDLE LENGTH; MICROTUBULES; MOTORS		Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Odde, DJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/AAY-1720-2020	Odde, David/0000-0001-7731-2799				Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Hepperla AJ, 2014, DEV CELL, V31, P61, DOI 10.1016/j.devcel.2014.07.023; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Pringle J, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/37/374103; Subramanian R, 2012, DEV CELL, V23, P874, DOI 10.1016/j.devcel.2012.10.011; Syrovatkina V, 2013, CURR BIOL, V23, P2423, DOI 10.1016/j.cub.2013.10.023	8	7	8	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1041	1043		10.1016/j.cell.2015.02.048	http://dx.doi.org/10.1016/j.cell.2015.02.048			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768899	Bronze			2022-12-28	WOS:000351951800002
J	Dumbreck, S; Flynn, A; Nairn, M; Wilson, M; Treweek, S; Mercer, SW; Alderson, P; Thompson, A; Payne, K; Guthrie, B				Dumbreck, Siobhan; Flynn, Angela; Nairn, Moray; Wilson, Martin; Treweek, Shaun; Mercer, Stewart W.; Alderson, Phil; Thompson, Alex; Payne, Katherine; Guthrie, Bruce			Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE; EVENTS; PEOPLE	OBJECTIVE To identify the number of drug-disease and drug-drug interactions for exemplar index conditions within National Institute of Health and Care Excellence (NICE) clinical guidelines. DESIGN Systematic identification, quantification, and classification of potentially serious drug-disease and drug-drug interactions for drugs recommended by NICE clinical guidelines for type 2 diabetes, heart failure, and depression in relation to 11 other common conditions and drugs recommended by NICE guidelines for those conditions. SETTING NICE clinical guidelines for type 2 diabetes, heart failure, and depression. MAIN OUTCOME MEASURES Potentially serious drug-disease and drug-drug interactions. RESULTS Following recommendations for prescription in 12 national clinical guidelines would result in several potentially serious drug interactions. There were 32 potentially serious drug-disease interactions between drugs recommended in the guideline for type 2 diabetes and the 11 other conditions compared with six for drugs recommended in the guideline for depression and 10 for drugs recommended in the guideline for heart failure. Of these drug-disease interactions, 27 (84%) in the type 2 diabetes guideline and all of those in the two other guidelines were between the recommended drug and chronic kidney disease. More potentially serious drug-drug interactions were identified between drugs recommended by guidelines for each of the three index conditions and drugs recommended by the guidelines for the 11 other conditions: 133 drug-drug interactions for drugs recommended in the type 2 diabetes guideline, 89 for depression, and 111 for heart failure. Few of these drug-disease or drug-drug interactions were highlighted in the guidelines for the three index conditions. CONCLUSIONS Drug-disease interactions were relatively uncommon with the exception of interactions when a patient also has chronic kidney disease. Guideline developers could consider a more systematic approach regarding the potential for drug-disease interactions, based on epidemiological knowledge of the comorbidities of people with the disease the guideline is focused on, and should particularly consider whether chronic kidney disease is common in the target population. In contrast, potentially serious drug-drug interactions between recommended drugs for different conditions were common. The extensive number of potentially serious interactions requires innovative interactive approaches to the production and dissemination of guidelines to allow clinicians and patients with multimorbidity to make informed decisions about drug selection.	[Dumbreck, Siobhan; Flynn, Angela; Guthrie, Bruce] Univ Dundee, Dundee DD2 4BF, Scotland; [Nairn, Moray] Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland, Edinburgh EH12 9EB, Midlothian, Scotland; [Wilson, Martin] Raigmore Hosp, Inverness IV2 3UJ, Scotland; [Treweek, Shaun] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Mercer, Stewart W.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 9LX, Lanark, Scotland; [Alderson, Phil] Natl Inst Hlth & Care Excellence, Ctr Clin Practice, Manchester M1 4BD, Lancs, England; [Thompson, Alex; Payne, Katherine] Univ Manchester, Manchester Ctr Hlth Econ, Manchester M13 9PL, Lancs, England	University of Dundee; University of Aberdeen; University of Glasgow; National Institute for Health & Care Excellence; University of Manchester	Guthrie, B (corresponding author), Univ Dundee, Mackenzie Bldg, Dundee DD2 4BF, Scotland.	B.Guthrie@dundee.ac.uk	Treweek, Shaun/AAE-8006-2019; Guthrie, Bruce/HHM-9696-2022; Payne, Katherine/AAJ-3728-2020	Treweek, Shaun/0000-0002-7239-7241; Payne, Katherine/0000-0002-3938-4350; Guthrie, Bruce/0000-0003-4191-4880; Nairn, Moray/0000-0001-6474-4410; Dumbreck, Siobhan/0000-0001-8300-096X; Thompson, Alexander/0000-0003-4930-5107; Mercer, Stewart William/0000-0002-1703-3664	National Institutes for Health Services and Delivery Research Programme [NIHR HSDR 11/2003/27]; National Institute for Health Research [11/2003/27] Funding Source: researchfish; Chief Scientist Office [HSRU2] Funding Source: researchfish	National Institutes for Health Services and Delivery Research Programme; National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The study was funded by the National Institutes for Health Services and Delivery Research Programme (NIHR HS&DR 11/2003/27). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HS&DR Programme, NIHR, NHS or the Department of Health. The funder had no role in study design, study conduct, or the decision to publish.	Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2013, BRIT NATL FORMULARY; [Anonymous], 2010, CHRON HEART FAIL MAN; [Anonymous], 2011, CLIN MAN PRIM HYP AD; [Anonymous], 2009, MAN RHEUM ARTHR AD; [Anonymous], 2009, TREATM MAN DEPR AD; [Anonymous], 2008, CAR MAN OST AD; [Anonymous], 2006, SUPP PEOPL DEM THEIR; [Anonymous], 2006, MAN ATR FIBR; [Anonymous], 2008, EARL ID MAN CHRON KI; [Anonymous], 2006, BIP DIS MAN BIP DIS; [Anonymous], 2010, MAN TYP 2 DIAB; [Anonymous], 2010, MAN CHRON OBSTR PULM; [Anonymous], 2007, SEC PREV PRIM SEC CA; [Anonymous], 2010, PHARM MAN NEUR PAIN; [Anonymous], 2011, AM BP TABL 10MG SUMM; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2014, J GEN INTERN MED, V29, P552, DOI 10.1007/s11606-013-2658-z; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Guthrie Bruce, 2011, BMJ, V342, pd3514, DOI 10.1136/bmj.d3514; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; House of Commons Health Committee, 2014, MAN CAR PEOPL LONG T, P222; Hovstadius Bo, 2010, BMC Clin Pharmacol, V10, P16, DOI 10.1186/1472-6904-10-16; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Lorgunpai SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089447; Marengoni A, 2014, EUR J INTERN MED, V25, P843, DOI 10.1016/j.ejim.2014.10.001; National Institute for Health and Care Excellence, 2009, DEPR AD CHRON PHYS H; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Pronovost PJ, 2013, JAMA-J AM MED ASSOC, V310, P2501, DOI 10.1001/jama.2013.281334; Ruscitto A, 2015, EUR J PAIN, V19, P59, DOI 10.1002/ejp.520; Schedlbauer A, 2009, J AM MED INFORM ASSN, V16, P531, DOI 10.1197/jamia.M2910; Tan K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5019; Uhlig K, 2014, J GEN INTERN MED, V29, P670, DOI 10.1007/s11606-013-2659-y; Van Spall H, 2007, JAMA-J AM MED ASSOC, V297, P8; Vandvik PO, 2013, CHEST, V144, P381, DOI 10.1378/chest.13-0746; Zhang Min, 2009, BMJ, V338, pa2752, DOI 10.1136/bmj.a2752	41	173	176	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2015	350								h949	10.1136/bmj.h949	http://dx.doi.org/10.1136/bmj.h949			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EL	25762567	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000351182200016
J	Gauderman, WJ; Urman, R; Avol, E; Berhane, K; McConnell, R; Rappaport, E; Chang, R; Lurmann, F; Gilliland, F				Gauderman, W. James; Urman, Robert; Avol, Edward; Berhane, Kiros; McConnell, Rob; Rappaport, Edward; Chang, Roger; Lurmann, Fred; Gilliland, Frank			Association of Improved Air Quality with Lung Development in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTHERN CALIFORNIA COMMUNITIES; PULMONARY-FUNCTION; FUNCTION GROWTH; DIFFERING LEVELS; FOLLOW-UP; POLLUTION; MORTALITY; RISK; POPULATION; DECLINE	BACKGROUND Air-pollution levels have been trending downward progressively over the past several decades in southern California, as a result of the implementation of air quality-control policies. We assessed whether long-term reductions in pollution were associated with improvements in respiratory health among children. METHODS As part of the Children's Health Study, we measured lung function annually in 2120 children from three separate cohorts corresponding to three separate calendar periods: 1994-1998, 1997-2001, and 2007-2011. Mean ages of the children within each cohort were 11 years at the beginning of the period and 15 years at the end. Linear-regression models were used to examine the relationship between declining pollution levels over time and lung-function development from 11 to 15 years of age, measured as the increases in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) during that period (referred to as 4-year growth in FEV1 and FVC). RESULTS Over the 13 years spanned by the three cohorts, improvements in 4-year growth of both FEV1 and FVC were associated with declining levels of nitrogen dioxide (P<0.001 for FEV1 and FVC) and of particulate matter with an aerodynamic diameter of less than 2.5 mu m (P = 0.008 for FEV1 and P<0.001 for FVC) and less than 10 mu m (P<0.001 for FEV1 and FVC). These associations persisted after adjustment for several potential confounders. Significant improvements in lung-function development were observed in both boys and girls and in children with asthma and children without asthma. The proportions of children with clinically low FEV1 (defined as <80% of the predicted value) at 15 years of age declined significantly, from 7.9% to 6.3% to 3.6% across the three periods, as the air quality improved (P = 0.001). CONCLUSIONS We found that long-term improvements in air quality were associated with statistically and clinically significant positive effects on lung-function growth in children. (Funded by the Health Effects Institute and others.)	[Gauderman, W. James; Urman, Robert; Avol, Edward; Berhane, Kiros; McConnell, Rob; Rappaport, Edward; Chang, Roger; Gilliland, Frank] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90032 USA; [Lurmann, Fred] Sonoma Technol, Petaluma, CA USA	University of Southern California	Gauderman, WJ (corresponding author), Univ So Calif, Dept Prevent Med, 2001 Soto St,202-K, Los Angeles, CA 90032 USA.	jimg@usc.edu			Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011627, P30ES007048, R03ES022719, R21ES024844] Funding Source: NIH RePORTER	Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the Health Effects Institute and others.	ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; BURROWS B, 1983, CHEST, V83, P717, DOI 10.1378/chest.83.5.717; Department of Commerce Economics and Statistics Administration U.S. Census Bureau, 2012, CAL 2010 SUMM POP HO; FRIEDMAN GD, 1976, NEW ENGL J MED, V294, P1071, DOI 10.1056/NEJM197605132942001; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021; Gehring U, 2013, ENVIRON HEALTH PERSP, V121, P1357, DOI 10.1289/ehp.1306770; Georgiopoulou VV, 2011, AM J MED, V124, P334, DOI 10.1016/j.amjmed.2010.12.006; Gotschi T, 2008, INT J EPIDEMIOL, V37, P1349, DOI 10.1093/ije/dyn136; Hole DJ, 1996, BRIT MED J, V313, P711; Islam T, 2007, THORAX, V62, P957, DOI 10.1136/thx.2007.078964; KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X; Knuiman MW, 1999, ANN EPIDEMIOL, V9, P297, DOI 10.1016/S1047-2797(98)00066-0; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lepeule J, 2014, AM J RESP CRIT CARE, V190, P542, DOI 10.1164/rccm.201402-0350OC; Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; McDonald BC, 2012, J GEOPHYS RES-ATMOS, V117, DOI [10.1029/2012JD018304, 10.1029/2011JD016715]; Mckean MC, 2001, EUR RESPIR J, V18, P23, DOI 10.1183/09031936.01.00073101; Molter A, 2013, ENVIRON HEALTH PERSP, V121, P1232, DOI 10.1289/ehp.1205961; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Peters JM, 1999, AM J RESP CRIT CARE, V159, P768, DOI 10.1164/ajrccm.159.3.9804144; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Ryan G, 1999, J EPIDEMIOL COMMUN H, V53, P230, DOI 10.1136/jech.53.4.230; Sarder SB, 2005, J GEOPHYS RES-ATMOS, V110, P1; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Tager IB, 1999, AM J RESP CRIT CARE, V160, P387; U. S. Census Bureau, 2000, PROF GEN DEM CHAR; Urman R, 2014, THORAX, V69, P540, DOI 10.1136/thoraxjnl-2012-203159; WANG XB, 1993, AM REV RESPIR DIS, V148, P1502, DOI 10.1164/ajrccm/148.6_Pt_1.1502	34	396	411	2	137	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					905	913		10.1056/NEJMoa1414123	http://dx.doi.org/10.1056/NEJMoa1414123			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738666	Green Accepted			2022-12-28	WOS:000350304500006
J	Taylor, TB; Mulley, G; Dills, AH; Alsohim, AS; McGuffin, LJ; Studholme, DJ; Silby, MW; Brockhurst, MA; Johnson, LJ; Jackson, RW				Taylor, Tiffany B.; Mulley, Geraldine; Dills, Alexander H.; Alsohim, Abdullah S.; McGuffin, Liam J.; Studholme, David J.; Silby, Mark W.; Brockhurst, Michael A.; Johnson, Louise J.; Jackson, Robert W.			Evolutionary resurrection of flagellar motility via rewiring of the nitrogen regulation system	SCIENCE			English	Article							PSEUDOMONAS-AERUGINOSA; MORPHOLOGICAL EVOLUTION; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; KEY INNOVATION; EVO-DEVO; 2-COMPONENT; FLUORESCENS; CONTINGENCY; GROWTH	A central process in evolution is the recruitment of genes to regulatory networks. We engineered immotile strains of the bacterium Pseudomonas fluorescens that lack flagella due to deletion of the regulatory gene fleQ. Under strong selection for motility, these bacteria consistently regained flagella within 96 hours via a two-step evolutionary pathway. Step 1 mutations increase intracellular levels of phosphorylated NtrC, a distant homolog of FleQ, which begins to commandeer control of the fleQ regulon at the cost of disrupting nitrogen uptake and assimilation. Step 2 is a switch-of-function mutation that redirects NtrC away from nitrogen uptake and toward its novel function as a flagellar regulator. Our results demonstrate that natural selection can rapidly rewire regulatory networks in very few, repeatable mutational steps.	[Taylor, Tiffany B.; Mulley, Geraldine; Alsohim, Abdullah S.; McGuffin, Liam J.; Johnson, Louise J.; Jackson, Robert W.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England; [Dills, Alexander H.; Silby, Mark W.] Univ Massachusetts Dartmouth, Dept Biol, N Dartmouth, MA 02747 USA; [Alsohim, Abdullah S.] Qassim Univ, Dept Plant Prod & Protect, Qasim, Saudi Arabia; [Studholme, David J.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Brockhurst, Michael A.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Jackson, Robert W.] Univ Akureyri, IS-600 Akureyri, Iceland	University of Reading; University of Massachusetts System; University Massachusetts Dartmouth; Qassim University; University of Exeter; University of York - UK; University of Akureyri	Johnson, LJ (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England.	l.j.johnson@reading.ac.uk	Taylor, Tiffany/V-4814-2019; McGuffin, Liam/A-5598-2008; Jackson, Robert W/C-2973-2009; Studholme, David/H-6790-2019; Dills, Alexander H/L-5409-2018	Taylor, Tiffany/0000-0002-5274-7806; McGuffin, Liam/0000-0003-4501-4767; Jackson, Robert W/0000-0002-2042-4105; Studholme, David/0000-0002-3010-6637; Dills, Alexander H/0000-0002-8770-7935; Silby, Mark/0000-0002-3092-8008; Brockhurst, Michael/0000-0003-0362-820X; Johnson, Louise/0000-0002-0006-1511	Leverhulme grant; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J015350/1]; University of York; Qassim University; Agriculture and Food Research Initiative Competitive grant from the U.S. Department of Agriculture's National Institute of Food and Agriculture Microbial Functional Genomics Program [2010-65110-20392]; Wellcome Trust Institutional Strategic Support Fund [WT097835MF]; Wellcome Trust Multi User Equipment award [WT101650MA]; BBSRC LOLA award [BB/K003240/1]; BBSRC [BB/K003240/1, BB/J015350/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015350/1, BB/K003240/1] Funding Source: researchfish	Leverhulme grant; UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of York(European Commission); Qassim University; Agriculture and Food Research Initiative Competitive grant from the U.S. Department of Agriculture's National Institute of Food and Agriculture Microbial Functional Genomics Program; Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Wellcome Trust Multi User Equipment award; BBSRC LOLA award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	T.B.T., L.J.J., R.W.J., and M.A.B. conceived and designed the study; T.B.T., G.M., and A.S.A. performed experiments; M.W.S. and A.H.D. performed independent lines of inquiry on Pf0-2x; D.J.S. conducted bioinformatics analysis of genome resequencing data, identified mutated genes, and handled sequencing data; L.J.M. conducted the protein structure prediction and analysis; and T.B.T., G.M., L.J.J., R.W.J., M.W.S., D.J.S., and M.A.B. wrote the paper. This work was supported by a Leverhulme grant to L.J.J., M.A.B., and R.W.J.; UK Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/J015350/1 to R.W.J.; start-up funding from the University of York to M.A.B. and from Qassim University to A.S.A.; and Agriculture and Food Research Initiative Competitive grant 2010-65110-20392 from the U.S. Department of Agriculture's National Institute of Food and Agriculture Microbial Functional Genomics Program to M.W.S. We thank G. Bell, M. Pagel, A. Buckling, and J. Moir for useful discussions; P. Ashton for processing microarray data; and K. Paszkiewicz and the Exeter Sequencing Service facility for genome sequencing services. This work was also supported by the Wellcome Trust Institutional Strategic Support Fund (WT097835MF), Wellcome Trust Multi User Equipment award (WT101650MA), and BBSRC LOLA award (BB/K003240/1). Sequence data for genomic resequencing of AR2S and AR2F have been submitted to the Sequence Read Archive under accession numbers SRR1510202 and SRR1510203, respectively. The eArray design ID for the microarray is 045642. Microarray data have been submitted to the ArrayExpress database under accession number E-MTAB-2788 (www.ebi.ac.uk/arrayexpress).	Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Alsohim AS, 2014, ENVIRON MICROBIOL, V16, P2267, DOI 10.1111/1462-2920.12469; Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Blank D, 2014, P NATL ACAD SCI USA, V111, P3044, DOI 10.1073/pnas.1318797111; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Hall BG, 2003, GENETICA, V118, P143, DOI 10.1023/A:1024149508376; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Leon R, 2008, MICROBIOL-SGM, V154, P1719, DOI 10.1099/mic.0.2008/017665-0; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Robleto EA, 2003, J BACTERIOL, V185, P453, DOI 10.1128/JB.185.2.453-460.2003; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Wand ME, 2006, J BACTERIOL, V188, P7531, DOI 10.1128/JB.00263-06; Wassem R, 2000, MOL MICROBIOL, V35, P756, DOI 10.1046/j.1365-2958.2000.01746.x; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	21	41	41	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					1014	1017		10.1126/science.1259145	http://dx.doi.org/10.1126/science.1259145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722415	Green Accepted			2022-12-28	WOS:000349958900044
J	Ware, TH; McConney, ME; Wie, JJ; Tondiglia, VP; White, TJ				Ware, Taylor H.; McConney, Michael E.; Wie, Jeong Jae; Tondiglia, Vincent P.; White, Timothy J.			Voxelated liquid crystal elastomers	SCIENCE			English	Article							POLYMER NETWORKS; ARTIFICIAL MUSCLES; ACTUATORS; LITHOGRAPHY	Dynamic control of shape can bring multifunctionality to devices. Soft materials capable of programmable shape change require localized control of the magnitude and directionality of a mechanical response. We report the preparation of soft, ordered materials referred to as liquid crystal elastomers. The direction of molecular order, known as the director, is written within local volume elements (voxels) as small as 0.0005 cubic millimeters. Locally, the director controls the inherent mechanical response (55% strain) within the material. In monoliths with spatially patterned director, thermal or chemical stimuli transform flat sheets into three-dimensional objects through controlled bending and stretching. The programmable mechanical response of these materials could yield monolithic multifunctional devices or serve as reconfigurable substrates for flexible devices in aerospace, medicine, or consumer goods.	[Ware, Taylor H.; McConney, Michael E.; Wie, Jeong Jae; Tondiglia, Vincent P.; White, Timothy J.] Air Force Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA; [Ware, Taylor H.; Wie, Jeong Jae] Azimuth Corp, Dayton, OH USA; [Tondiglia, Vincent P.] Leidos, Dayton, OH USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory	White, TJ (corresponding author), Air Force Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.	timothy.white.24@us.af.mil	Wie, Jeong Jae (JJ)/I-9878-2019; White, Timothy/O-7797-2019; Ware, Taylor H/A-7130-2017; White, Timothy J/D-4392-2012; McConney, Michael E/A-1680-2011	Wie, Jeong Jae (JJ)/0000-0001-7381-947X; White, Timothy/0000-0001-8006-7173; Ware, Taylor H/0000-0001-7996-7393; White, Timothy J/0000-0001-8006-7173; 	Air Force Research Laboratory; Air Force Office of Scientific Research	Air Force Research Laboratory; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was completed at Wright-Patterson Air Force base with the support of the Air Force Research Laboratory and the Air Force Office of Scientific Research. The authors thank A. Harbach for experimental assistance and K. M. Lee for helpful discussions. Additional information is available in the supplementary materials and from the authors.	Agrawal A, 2014, SOFT MATTER, V10, P1411, DOI 10.1039/c3sm51654g; [Anonymous], 2001, E-POLYMERS, DOI DOI 10.1515/EPOLY.2001.1.1.111; Behl M, 2013, P NATL ACAD SCI USA, V110, P12555, DOI 10.1073/pnas.1301895110; Buguin A, 2006, J AM CHEM SOC, V128, P1088, DOI 10.1021/ja0575070; De Focatiis DSA, 2002, PHILOS T R SOC A, V360, P227, DOI 10.1098/rsta.2001.0928; de Haan LT, 2014, ADV FUNCT MATER, V24, P1251, DOI 10.1002/adfm.201302568; de Haan LT, 2012, ANGEW CHEM INT EDIT, V51, P12469, DOI 10.1002/anie.201205964; DISCH S, 1994, MACROMOL RAPID COMM, V15, P303, DOI 10.1002/marc.1994.030150402; Giurgiutiu V, 1996, J INTEL MAT SYST STR, V7, P656, DOI 10.1177/1045389X9600700605; Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; KUPFER J, 1991, MAKROMOL CHEM-RAPID, V12, P717; Lee KM, 2011, ADV FUNCT MATER, V21, P2913, DOI 10.1002/adfm.201100333; Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762; Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k; Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388; McConney ME, 2013, ADV MATER, V25, P5880, DOI 10.1002/adma.201301891; Modes CD, 2011, P ROY SOC A-MATH PHY, V467, P1121, DOI 10.1098/rspa.2010.0352; Modes CD, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.060701; Ohm C, 2010, ADV MATER, V22, P3366, DOI 10.1002/adma.200904059; Pei ZQ, 2014, NAT MATER, V13, P36, DOI [10.1038/NMAT3812, 10.1038/nmat3812]; Pritchard RH, 2013, SOFT MATTER, V9, P6037, DOI 10.1039/c3sm50901j; Safranski DL, 2010, POLYMER, V51, P3130, DOI 10.1016/j.polymer.2010.05.029; Sawa Y, 2011, P NATL ACAD SCI USA, V108, P6364, DOI 10.1073/pnas.1017658108; Schenk M, 2013, P NATL ACAD SCI USA, V110, P3276, DOI 10.1073/pnas.1217998110; Xie T, 2010, NATURE, V464, P267, DOI 10.1038/nature08863; Zotzmann J, 2010, ADV MATER, V22, P3424, DOI 10.1002/adma.200904202	27	658	664	45	592	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					982	984		10.1126/science.1261019	http://dx.doi.org/10.1126/science.1261019			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722408				2022-12-28	WOS:000349958900035
J	Kuramatsu, JB; Gerner, ST; Schellinger, PD; Glahn, J; Endres, M; Sobesky, J; Flechsenhar, J; Neugebauer, H; Juttler, E; Grau, A; Palm, F; Rother, J; Michels, P; Hamann, GF; Huwel, J; Hagemann, G; Barber, B; Terborg, C; Trostdorf, F; Bazner, H; Roth, A; Wohrle, J; Keller, M; Schwarz, M; Reimann, G; Volkmann, J; Mullges, W; Kraft, P; Classen, J; Hobohm, C; Horn, M; Milewski, A; Reichmann, H; Schneider, H; Schimmel, E; Fink, GR; Dohmen, C; Stetefeld, H; Witte, O; Gunther, A; Neumann-Haefelin, T; Racs, AE; Nueckel, M; Erbguth, F; Kloska, SP; Dorfler, A; Kohrmann, M; Schwab, S; Huttner, HB				Kuramatsu, Joji B.; Gerner, Stefan T.; Schellinger, Peter D.; Glahn, Joerg; Endres, Matthias; Sobesky, Jan; Flechsenhar, Julia; Neugebauer, Hermann; Juettler, Eric; Grau, Armin; Palm, Frederick; Roether, Joachim; Michels, Peter; Hamann, Gerhard F.; Huewel, Joachim; Hagemann, Georg; Barber, Beatrice; Terborg, Christoph; Trostdorf, Frank; Baezner, Hansjoerg; Roth, Aletta; Woehrle, Johannes; Keller, Moritz; Schwarz, Michael; Reimann, Gernot; Volkmann, Jens; Muellges, Wolfgang; Kraft, Peter; Classen, Joseph; Hobohm, Carsten; Horn, Markus; Milewski, Angelika; Reichmann, Heinz; Schneider, Hauke; Schimmel, Eik; Fink, Gereon R.; Dohmen, Christian; Stetefeld, Henning; Witte, Otto; Guenther, Albrecht; Neumann-Haefelin, Tobias; Racs, Andras E.; Nueckel, Martin; Erbguth, Frank; Kloska, Stephan P.; Doerfler, Arnd; Koehrmann, Martin; Schwab, Stefan; Huttner, Hagen B.			Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL-FIBRILLATION; HEMATOMA EXPANSION; VITAMIN-K; WARFARIN; STROKE; RISK; MANAGEMENT; VALIDATION; GUIDELINES; INTENSITY	IMPORTANCE Although use of oral anticoagulants (OACs) is increasing, there is a substantial lack of data on how to treat OAC-associated intracerebral hemorrhage (ICH). OBJECTIVE To assess the association of anticoagulation reversal and blood pressure (BP) with hematoma enlargement and the effects of OAC resumption. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study at 19 German tertiary care centers (2006-2012) including 1176 individuals for analysis of long-term functional outcome, 853 for analysis of hematoma enlargement, and 719 for analysis of OAC resumption. EXPOSURES Reversal of anticoagulation during acute phase, systolic BP at 4 hours, and reinitiation of OAC for long-term treatment. MAIN OUTCOMES AND MEASURES Frequency of hematoma enlargement in relation to international normalized ratio (INR) and BP. Incidence analysis of ischemic and hemorrhagic events with or without OAC resumption. Factors associated with favorable (modified Rankin Scale score, 0-3) vs unfavorable functional outcome. RESULTS Hemorrhage enlargement occurred in 307 of 853 patients (36.0%). Reduced rates of hematoma enlargement were associated with reversal of INR levels <1.3 within 4 hours after admission (43/217 [19.8%]) vs INR of >= 1.3 (264/636 [41.5%]; P < .001) and systolic BP <160 mm Hg at 4 hours (167/504 [33.1%]) vs >= 160 mm Hg (98/187 [52.4%]; P < .001). The combination of INR reversal < 1.3 within 4 hours and systolic BP of < 160 mm Hg at 4 hours was associated with lower rates of hematoma enlargement (35/193 [18.1%] vs 220/498 [44.2%] not achieving these values; OR, 0.28; 95% CI, 0.19-0.42; P < .001) and lower rates of in-hospital mortality (26/193 [13.5%] vs 103/498 [20.7%]; OR, 0.60; 95% CI, 0.37-0.95; P = .03). OAC was resumed in 172 of 719 survivors (23.9%). OAC resumption showed fewer ischemic complications (OAC: 9/172 [5.2%] vs no OAC: 82/547 [15.0%]; P < .001) and not significantly different hemorrhagic complications (OAC: 14/172 [8.1%] vs no OAC: 36/547 [6.6%]; P = .48). Propensity-matched survival analysis in patients with atrial fibrillation who restarted OAC showed a decreased HR of 0.258 (95% CI, 0.125-0.534; P < .001) for long-term mortality. Functional long-term outcome was unfavorable in 786 of 1083 patients (72.6%). CONCLUSIONS AND RELEVANCE Among patients with OAC-associated ICH, reversal of INR < 1.3 within 4 hours and systolic BP < 160 mm Hg at 4 hours were associated with lower rates of hematoma enlargement, and resumption of OAC therapy was associated with lower risk of ischemic events. These findings require replication and assessment in prospective studies.	[Kuramatsu, Joji B.; Gerner, Stefan T.; Koehrmann, Martin; Schwab, Stefan; Huttner, Hagen B.] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Schellinger, Peter D.; Glahn, Joerg] Johannes Wesling Klinikum Minden, Community Hosp, Dept Neurol & Neurogeriatry, Minden, Germany; [Endres, Matthias; Sobesky, Jan; Flechsenhar, Julia; Neugebauer, Hermann; Juettler, Eric] Charite, Dept Neurol, D-13353 Berlin, Germany; [Endres, Matthias] Ctr Stroke Res Berlin, Berlin, Germany; [Endres, Matthias] German Ctr Cardiovasc Res DZHK, Berlin, Germany; [Endres, Matthias] Charite, German Ctr Neurodegenerat Dis DZNE, Berlin, Germany; [Neugebauer, Hermann; Juettler, Eric] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Grau, Armin; Palm, Frederick] Community Hosp Klinikum Stadt Ludwigshafen Rhein, Dept Neurol, Ludwigshafen, Germany; [Roether, Joachim; Michels, Peter] Community Hosp Asklepios Klin Hamburg Altona, Dept Neurol, Hamburg, Germany; [Hamann, Gerhard F.; Huewel, Joachim] Community Hosp Dr Horst Schmidt Klinikum Wiesbade, Dept Neurol, Wiesbaden, Germany; [Hagemann, Georg; Barber, Beatrice] Community Hosp Helios Klinikum Berlin Buch, Dept Neurol, Berlin, Germany; [Terborg, Christoph; Trostdorf, Frank] Community Hosp Asklepios Klin St Georg, Dept Neurol, Hamburg, Germany; [Baezner, Hansjoerg; Roth, Aletta] Community Hosp Klinikum Stuttgart, Dept Neurol, Stuttgart, Germany; [Woehrle, Johannes; Keller, Moritz] Community Hosp Klinikum Koblenz, Dept Neurol, Koblenz, Germany; [Schwarz, Michael; Reimann, Gernot] Community Hosp Klinikum Dortmund, Dept Neurol, Dortmund, Germany; [Volkmann, Jens; Muellges, Wolfgang; Kraft, Peter] Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany; [Kraft, Peter] Univ Wurzburg, Comprehens Heart Failure Ctr, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany; [Classen, Joseph; Hobohm, Carsten] Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany; [Horn, Markus; Milewski, Angelika] Community Hosp Bad Hersfeld, Dept Neurol, Bad Hersfeld, Germany; [Reichmann, Heinz; Schneider, Hauke; Schimmel, Eik] Univ Dresden, Dept Neurol, Dresden, Germany; [Fink, Gereon R.; Dohmen, Christian; Stetefeld, Henning] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Witte, Otto; Guenther, Albrecht] Univ Jena, Dept Neurol, Jena, Germany; [Neumann-Haefelin, Tobias; Erbguth, Frank] Community Hosp Fulda, Dept Neurol, Fulda, Germany; [Kloska, Stephan P.; Doerfler, Arnd] Univ Erlangen Nurnberg, Dept Neuroradiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ulm University; Ludwigshafen Hospital; Asklepios Klinik Altona; Helios Kliniken; Asklepios Klinik St. Georg; Klinikum Stuttgart; University of Wurzburg; University of Wurzburg; Leipzig University; Technische Universitat Dresden; University of Cologne; Friedrich Schiller University of Jena; Klinikum Fulda; University of Erlangen Nuremberg	Huttner, HB (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Schwabachanlage 6, D-91054 Erlangen, Germany.	hagen.huttner@uk-erlangen.de	Fink, Gereon R./AFW-9377-2022; Volkmann, Jens/AAK-7570-2020; Witte, Otto/P-4127-2018; Neugebauer, Hermann/AAD-8309-2019; Fink, Gereon R./E-1616-2012; Neumann-Haefelin, Tobias/AAC-3915-2020; Gerner, Stefan T./ABH-8328-2020	Fink, Gereon R./0000-0002-8230-1856; Witte, Otto/0000-0003-2101-4105; Neugebauer, Hermann/0000-0003-3759-356X; Fink, Gereon R./0000-0002-8230-1856; Gerner, Stefan T./0000-0001-6020-8290; Sobesky, Jan/0000-0001-5459-3655; Schneider, Hauke/0000-0002-9641-0922; Volkmann, Jens/0000-0002-9570-593X; Kuramatsu, Joji B./0000-0002-7630-7880; Endres, Matthias/0000-0001-6520-3720; Classen, Joseph/0000-0001-7182-6967	Johannes and Frieda Marohn Foundation, University of Erlangen, Germany [FWN/Zo-Hutt/2011]	Johannes and Frieda Marohn Foundation, University of Erlangen, Germany	This work was supported by a research grant (FWN/Zo-Hutt/2011) from the Johannes and Frieda Marohn Foundation, University of Erlangen, Germany.	Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Bailey RD, 2001, NEUROLOGY, V56, P773, DOI 10.1212/WNL.56.6.773; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Burgess RE, 2008, STROKE, V39, P2017, DOI 10.1161/STROKEAHA.107.505719; Cervera A, 2012, J NEUROL, V259, P212, DOI 10.1007/s00415-011-6153-3; Chatterjee S, 2013, JAMA NEUROL, V70, P1486, DOI 10.1001/jamaneurol.2013.4021; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Flaherty ML, 2008, NEUROLOGY, V71, P1084, DOI 10.1212/01.wnl.0000326895.58992.27; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; Hacke W, 2004, LANCET, V363, P768; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Majeed A, 2010, STROKE, V41, P2860, DOI 10.1161/STROKEAHA.110.593087; Masotti L, 2011, INT J STROKE, V6, P228, DOI 10.1111/j.1747-4949.2011.00595.x; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Patel NJ, 2014, CIRCULATION, V129, P2371, DOI 10.1161/CIRCULATIONAHA.114.008201; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2014, NEUROLOGY, V82, P1020, DOI 10.1212/WNL.0000000000000245; Qureshi AI, 2010, ARCH NEUROL-CHICAGO, V67, P570, DOI 10.1001/archneurol.2010.61; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Steiner SH, 2010, STAT MED, V29, P444, DOI 10.1002/sim.3788; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Yung D, 2012, CAN J CARDIOL, V28, P33, DOI 10.1016/j.cjca.2011.10.002; Zubkov AY, 2008, ARCH NEUROL-CHICAGO, V65, P1320, DOI 10.1001/archneur.65.10.1320; ZWEIG MH, 1993, CLIN CHEM, V39, P561	40	347	362	2	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					824	836		10.1001/jama.2015.0846	http://dx.doi.org/10.1001/jama.2015.0846			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710659	Bronze			2022-12-28	WOS:000349826400016
J	Aronson, L				Aronson, Louise			The human lifecycle's neglected stepchild	LANCET			English	Editorial Material									Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Aronson, L (corresponding author), Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94118 USA.	aronsonl@medicine.ucsf.edu						Achenbaum WA, 2014, GERONTOLOGIST, V54, P6, DOI 10.1093/geront/gnt015; Allport G.W., 1954, NATURE PREJUDICE; Besterman Theodore, 1984, PHILOS DICT; Butler R. N., 1975, WHY SURVIVE BEING OL; Hazlitt W., 1903, SKETCHES AND ESSAYS	5	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					500	501		10.1016/S0140-6736(14)61819-5	http://dx.doi.org/10.1016/S0140-6736(14)61819-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25713844				2022-12-28	WOS:000349213600015
J	Zannad, F; Cannon, CP; Cushman, WC; Bakris, GL; Menon, V; Perez, AT; Fleck, PR; Mehta, CR; Kupfer, S; Wilson, C; Lam, H; White, WB; Aiub, J; Albisu, J; Alvarez, C; Astesiano, A; Barcudi, R; Bendersky, M; Bono, J; Bustos, B; Cartasegna, L; Caruso, O; Casabe, H; Castro, R; Colombo, H; Cuneo, C; Cura, F; De Loredo, L; Dran, R; Fernandez, H; Pinna, JG; Hrabar, A; de Saleme, MK; Luquez, H; Mackinnon, I; Maffei, L; Majul, C; Mallagray, M; Marino, J; Martinez, D; Martingano, R; Nul, D; Parody, ML; Petrucci, J; Pieroni, M; Piskorz, D; Prado, A; Ramos, H; Resk, J; Rodriguez, M; Rojas, C; Sarjanovich, R; Sarries, A; Sessa, H; Silveiro, S; Liprandi, MIS; Tartaglione, J; Tonin, H; Vallejos, J; Vigo, S; Visco, V; Vita, N; Vogel, D; Vogelmann, O; Zaidman, C; Zangroniz, P; Colquhoun, D; Coverdale, S; Flecknoe-Brown, S; Hii, CSL; Roberts-Thomson, P; Drexel, H; Luger, A; Pieber, T; Cools, F; Ruige, J; Schoors, D; Vercammen, C; Wollaert, B; da Costa, FA; Amodeo, C; Baggenstoss, R; Barbosa, E; de Souza, WKB; Bassan, R; Borges, JL; Botelho, R; Braile, MCV; Castello, H; Chrisman, C; dos Santos, F; Neto, JF; Farsky, P; Da Costa, AF; Fraige, F; Garbelini, B; Garcia, MF; Garzon, P; Guimaraes, AE; Herdy, A; Hernandes, M; Hilgemberg, S; Hissa, M; Jatene, JA; Kormann, A; Leaes, P; Lima, F; Lisboa, HR; Maia, L; da Silva, FM; Franco, DM; Martin, JF; Medeiros, A; Michalaros, Y; Leitao, AM; Montenegro, S; Moraes, J; Gomes, MM; Paiva, MS; Precoma, D; Rabelo, A; Reis, G; Reis, H; Rossi, P; Saporito, W; Leite, RS; Silva, RP; Silva, D; Sousa, L; Sousa, AC; Ueda, R; Vilas-Boas, F; Wainstein, M; Zago, A; Angelova, M; Apostolova, E; Daskalova, I; Delchev, A; Hristozov, K; Ilieva, M; Kovacheva, S; Lucheva, M; Temelkova, M; Toneva, A; Videva, V; Vuchkova, E; Bakbak, A; Carpentier, A; Chan, YK; Cheema, A; Chouinard, G; Conway, J; Dery, JP; Dowell, A; Frechette, A; Jakubowski, M; Kelly, A; Ma, P; Maung, TZ; Mehta, S; Parker, D; Pesant, Y; Polasek, P; Ransom, T; Syan, G; Vizel, S; Albornoz, F; Galvez, PC; Cobos, JL; Conejeros, C; Apablaza, MD; Fajardo, G; Brochet, GI; Lazcano, MO; Pincetti, C; Potthoff, S; Raffo, C; Saavedra, V; Schnettler, M; Sepulveda, P; Stockins, B; Vejar, M; Accini, JL; Aroca, CHC; Ruiz, RLF; Linares, LAO; Angarita, BEV; Aganovic, I; Bagatin, J; Canecki-Varzic, S; Erzen, DJ; Knezevic, A; Maric, A; Milicevic, G; Popovic, Z; Rubes, J; Weiss, SS; Dresslerova, I; Havelkova, J; Kucera, D; Machacek, J; Pumprla, J; May, O; Perrild, H; Aziz, MA; El Badry, M; Hasanein, M; Airaksinen, J; Laine, M; Nyman, K; Vikman, S; Bonnet, J; Elbaz, M; Henry, P; Paillard, F; Petit, C; Tropeano, AI; Behnke, T; Bornstein, S; Busch, K; Ebelt, H; Faghih, M; Fischer, H; Heuer, H; Paschke, R; Porner, TC; Tangerding, G; Vohringer, HF; Adamson, K; Beatt, K; Bellary, S; Chapman, J; Cooke, A; Fisher, M; Gnudi, L; Jones, H; Kumar, S; Nagi, D; Oldroyd, K; Richardson, T; Robertson, D; Robinson, A; Saravanan, P; Viljoen, A; Wilding, J; Wilkinson, P; Wong, YK; Zoupas, C; Arango, J; Castellanos, J; Flores, CC; Corona, V; Granados-Fuentes, A; Haase, F; Montenegro, P; Prado, JHP; Villalobos, R; Chow, F; Li, SK; Li, JN; Yan, PYB; Yeung, V; Abel, T; Benedek, A; Dezso, E; Dudas, M; Edes, I; Fulop, G; Kovacs, A; Lupkovics, G; Merkely, B; Nagy, A; Oroszlan, T; Palinkas, A; Papp, A; Patkay, J; Simon, E; Sitkei, E; Tabak, A; Tomcsanyi, J; Abdullakutty, J; Abhyankar, A; Akalkotkar, U; Alexander, T; Arneja, J; Aslam, N; Babu, PR; Babu, BR; Banker, D; Bantwal, G; Bhimashankar, PR; Calton, RK; Chopda, M; Dande, A; Dani, S; Deshpande, N; Deshpande, N; Dhanwal, D; Dharmadhikari, A; Gadkari, M; Garg, N; Ghaisas, N; Goyal, NK; Gupta, JB; Jawahirani, A; Joseph, S; Kumar, R; Kumble, M; Mathavan, A; Mathur, A; Mohanan, PP; Nair, A; Nair, T; Namjoshi, D; Pinto, R; Prakash, G; Purushotham, R; Raju, S; Ramachandran, P; Ramesh, SS; Rao, B; Ravikishore, A; Reddy, GR; Roy, S; Sadhu, N; Sastry, BKS; Singh, P; Srinivas, A; Thacker, H; Thanvi, S; Thomas, J; Adawi, F; Bashkin, A; Cohen, J; Harman-Boehm, I; Hasin, Y; Hayek, T; Iakobishvili, Z; Katz, A; Kracoff, O; Minuchin, O; Moriel, M; Mosseri, M; Omary, M; Wainstein, J; Weiss, A; Zeltser, D; Calabro, P; Derosa, G; Genovese, S; Novo, S; Olivieri, C; Piatti, P; Violini, R; Volpe, M; Ajioka, M; Amano, T; Arasaki, O; Daida, H; Fujimoto, K; Fujinaga, H; Higashiue, S; Hirohata, A; Hosokawa, S; Ikefuji, H; Inagaki, M; Iseki, H; Iwabuchi, M; Iwasaki, T; Kakishita, M; Katsuda, Y; Kawada, K; Kawajiri, K; Kawamitsu, K; Kobayashi, K; Komada, F; Komura, Y; Machida, M; Maemura, K; Matsubara, T; Matsubayashi, S; Matsumoto, T; Matsumoto, N; Mima, T; Miyamoto, N; Momiyama, Y; Morimoto, T; Murakami, M; Nakashima, E; Niijima, Y; Noda, T; Node, K; Nozaki, A; Nunohiro, T; Ogawa, T; Ono, Y; Saeki, T; Sakota, S; Sakuragi, S; Sasaki, T; Sato, Y; Sueyoshi, A; Suzuki, M; Takagi, G; Tanabe, J; Tanaka, S; Tei, I; Yamamoto, M; Yanagihara, K; Hong, TJ; Jeon, HK; Kang, DH; Kim, CH; Kim, DS; Kim, HS; Kim, JH; Kim, SK; Kim, WS; Kim, YK; Lee, S; Lee, KW; Park, HS; Pyun, WB; Rha, SW; Yoon, J; Yoon, KH; Bennakhi, A; Geldnere, K; Sokolova, J; Teterovska, D; Dautaraite, V; Kakariekiene, V; Kavaliauskiene, R; Kucinskiene, A; Lasiene, J; Mickuviene, N; Palinauskas, A; Urboniene, A; Zilaitiene, B; Manap, HA; Abidin, IZ; Isa, SHM; Khir, AM; Ng, KH; Tan, F; Yusof, Z; Yusoff, K; Zambahari, R; Aguila-Marin, J; Real, MA; Alvarado-Ruiz, R; Lopez, HA; Leon, JA; Llamas, EAB; Vargas, CC; Calvillo, JC; Ibarra, MD; Dominguez-Reyes, CA; Duarte, M; Elizondo, E; Campos, PF; Fanghanel-Salmon, G; Sauceda, SF; Martinez, JG; Garcia-Cantu, E; Ruiz, JAG; Gonzalez, JGG; Garza, MG; Herrera, CH; Munuzuri, JH; Hernandez-Garcia, H; Ramos, SJ; Molina, HL; Villezca, DL; Montano-Gonzalez, E; Ruiz, LN; Lopez, GR; Araiza, RR; Salazar-Gaytan, A; Vazquez, ES; Mijangos, HS; Morales, LS; Benatar, J; Dixon, P; Nirmalaraj, K; Rosen, I; Scott, R; Young, S; Tarco, OA; Caceres, LB; Lopez, CB; Cosavalente, LC; Huapalla, EC; Malaga, AC; Flores, AC; Aspilcueta, JF; Rojas, WG; Cazorla, AG; Caballero, DG; Matheus, JG; Carrasco, EG; Sanchez, JG; Zuniga, JH; Galarreta, LL; Luna, A; Hurtado, HM; Pastor, BO; Alvarez, RMP; Povis, JS; Eguiluz, PT; Portugal, AV; Gonzales, RV; Rincon, LZ; Aquitania, G; Fortinez, JT; Go, A; Gomez, MH; Habaluyas, R; Jasul, G; Magno, M; Manalo, CJ; Mirasol, R; Morales-Palomares, E; Salvador, DR; Sy, RA; Tirador, L; Yao, C; Arciszewska, M; Bartkowiak, R; Czajkowska-Kaczmarek, E; Gil, R; Gniot, J; Janik, K; Janion, M; Jaworska, K; Jozwa, R; Kawecka-Jaszcz, K; Kawka-Urbanek, T; Kondys, M; Korecki, J; Korzeniak, R; Kowalisko, A; Krzeminska-Pakula, M; Kwiecien, J; Nessler, J; Odrowaz-Pieniazek, P; Piepiorka, M; Rajzer, M; Skokowska, E; Spyra, J; Sroka, M; Stasinska, T; Szymczyk, I; Trznadel-Morawska, I; Wysokinski, A; Mateus, P; Matos, P; Mimoso, J; Monteiro, P; Caballero, B; Garcia-Rinaldi, R; Gonzalez, E; Ortiz-Carrasquillo, R; Roman, A; Sierra, Y; Unger, N; Vazquez-Tanus, J; Alexandru, T; Busegeanu, M; Cozman, DC; Fica, S; Minescu, B; Morosanu, M; Negrisanu, GD; Pintilei, E; Pop, L; Szilagyi, I; Teodorescu, I; Tomescu, M; Barbarash, O; Chumakova, G; Churina, S; Dogadin, S; Dvoryashina, I; Esip, V; Glezer, M; Gordeev, I; Gordienko, A; Gratsiansky, N; Grineva, E; Khasanov, N; Kostenko, V; Meleshkevich, T; Mikhin, V; Morugova, T; Motylev, I; Nikolaev, K; Ponomareva, A; Repin, M; Reshetko, O; Shustov, S; Shutemova, E; Shvarts, Y; Simanenkov, V; Sobolev, K; Sukmanova, I; Timofeev, A; Tsyba, L; Varvarina, G; Vertkin, A; Vishnevsky, A; Volkov, D; Vorobiev, S; Vorokhobina, N; Yakhontov, D; Zonova, E; Zrazhevskiy, K; Damjanovic, S; Djordjevic, D; Pavlovic, M; Perunicic, J; Ristic, A; Stojkovic, S; Tasic, N; Bolvanska, N; Buganova, I; Dulkova, K; Dzupina, A; Fulop, P; Gergel, V; Kokles, M; Micko, K; Svoren, P; Urban, M; Vadinova, S; Vargova, A; Burgess, L; Coetzee, K; Du Toit, J; Gani, M; Joshi, P; Naiker, P; Nortje, H; Sarvan, M; Seeber, M; Siebert, M; van Zyl, L; Wellmann, H; Calvo, C; De la Hera, J; De Teresa, L; Melero-Pita, A; Mesa, J; Barona, JP; Serrano, P; Soto, A; Tofe, S; Hornestam, B; Kempe, A; Rosenqvist, U; Rydberg, E; Tengmark, BO; Torstensson, I; Chang, CT; Hsia, TL; Hsieh, IC; Lai, WT; Wu, CJ; Hutayanon, P; Kosachunhanun, N; Marapracertsak, M; Piamsomboon, C; Seekaew, S; Srimahachota, S; Sukhum, P; Suraamornkul, S; Tantiwong, P; Wongvipaporn, C; Amosova, K; Barna, O; Bazylevych, A; Berenfus, V; Dyadyk, A; Fushtey, I; Gyrina, O; Iabluchanskyi, M; Karpenko, O; Kaydashev, I; Korzh, O; Kulynych, R; Legkonogov, O; Mankovsky, B; Mostovoy, Y; Parkhomenko, O; Popik, G; Rudenko, L; Rudyk, I; Shevchuk, S; Sirenko, Y; Suprun, Y; Tryshchuk, N; Tseluyko, V; Vakaliuk, I; Al Mahmeed, W; Acheatel, R; Ahmad, A; Akbar, S; Akhter, F; Albirini, A; Alexander, A; Al-Joundi, B; Al-Joundi, T; Allen, G; Aloi, J; Alvarado, O; Alzohaili, O; Anderson, C; Arastu, A; Arena, C; Argoud, G; Ariani, M; Arora, C; Awasty, V; Barker, B; Barnum, O; Bartkowiak, AJ; Barzilay, J; Behrens, P; Belledonne, M; Bergman, B; Bilnoski, W; Bisognano, J; Bissette, S; Blumberg, E; Bonabi, N; Bradley, A; Breton, C; Britos, M; Broadstone, V; Budoff, M; Burge, M; Butman, S; Carroll, M; Challappa, K; Chepuri, V; Cherlin, R; Cheung, D; Coats, P; Collins, J; Cruz, H; Daboul, N; Damberg, G; David, W; Dean, J; Dedeke, E; Deeb, W; DeHaven, J; Dobs, A; Donelan, T; Dy, J; Dykstra, G; Eisen, H; Farris, N; Fattal, P; Fishman, N; Foster, M; Fredrickson, S; Gabra, N; Gabriel, J; Gatien, L; Giddings, S; Ginsberg, B; Gips, S; Glandt, M; Goldfein, A; Gordon, M; Gould, R; Graf, R; Graham, B; Graves, M; Grena, P; Hahn, R; Hamilton, D; Hamroff, G; Hanke, F; Haque, I; Harper, J; Harris, A; Harris, S; Henson, B; Hermanns, D; Herndon, W; Hershberger, V; Hyman, D; Isserman, S; Iteld, B; Jacob, M; Jaffrani, N; Jamal, A; Johnson, D; Johnson, G; Kaluski, E; Keller, R; Kereiakes, D; Khan, M; Khan, S; Khan, M; Klein, M; Knutson, T; Korban, E; Kozinn, M; Kraft, P; Kroeze, J; Kukuy, E; Lader, E; Laliotis, A; Lambert, C; Landau, C; Latif, K; Lee, K; Lester, F; Levenson, D; Levinson, D; Lewis, D; Litt, M; Littlefield, R; Lo, E; Lovell, C; Mahal, S; Makam, S; Mandviwala, M; Marar, I; Masri, B; Mattson, S; Mays, M; McGrew, F; Meengs, M; Mikell, F; Miller, M; Miranda, F; Moll, D; Multani, P; Munuswamy, K; Nallasivan, M; Nayles, L; Ong, S; Pacheco, T; Paez, H; Patel, S; Phillips, R; Pierpont, B; Prasad, J; Quinlan, E; Quion, J; Qureshi, M; Rahman, A; Raikhel, M; Ramanathan, K; Randhawa, P; Ravi, R; Reddy, R; Rendell, M; Rickner, K; Rictor, K; Rivas, J; Rosenblit, P; Rosenstock, J; Ross, S; Salacata, A; Saririan, M; Schima, S; Schlau, A; Schmedtje, J; Scott, C; Scott, D; Serru-Paez, A; Shah, R; Shah, A; Shaoulian, E; Shomali, M; Shubrook, J; Silver, K; Singh, S; Speer, J; Stevens, J; Stringam, S; Taussig, A; Taylor, A; Tee, H; Teixeira, G; Tilley, A; Toggart, E; Twahirwa, M; Unks, D; Vakili, B; Vora, K; Wang, XB; Warner, A; Wefald, F; Weinberg, B; Weinstein, D; White, L; Wu, P; Yasuda, T; Yazdani, S; Yetman, C; Zarich, S; Zebrack, J; Fonseca, VA; McCullough, PA; Desouza, C; Goff, DC; Harrell, FE; Menon, V; Sila, C; Kalahasti, V; Ahmed, S; Al Solaiman, F; Bennett, M; Cavender, M; Heil, B; Katzan, I; Monteleone, P; O'Brien, B; Oommen, S; Senn, T; Sharma, J; Stegman, B; Uchino, K; Zishiri, E; Pasca, N; Brown, K; Scebbi, T; Atanasovski, I; Mccue, M; Streit, J; Oh, R; Bueno, O; Lee, D; Camisasca, R; Miyata, Y; Rubin, A; Williamson, N; Vara, S; Keeter, K; Ross, B; de los Reyes, A; Donnelly, J; Koshy-Hunt, S; Beers, B; Black, S; Buckley, M; Ephrem, M; Riley, B; West, N; Harre, M; Hsieh, R; Oshinyemi, K; Oka, Y; Matsui, N; Hoang, M; Doyle, C; Koziol, M; Lam, H; Edmonds, A; Azooz, W; Cao, C; Kim, D; Boeshaar, A; Dewindt, A; Nicholson, K; Smith, N; Hisada, M; Harding, S; Cannon, C; Yoshioka, N; Gujral-Sandhu, K; Gans, J; Gresk, C; Kujawski, MR; Villinski, A; Cosner, S; Johannsen, C; Barchha, N; Knapp, B				Zannad, Faiez; Cannon, Christopher P.; Cushman, William C.; Bakris, George L.; Menon, Venu; Perez, Alfonso T.; Fleck, Penny R.; Mehta, Cyrus R.; Kupfer, Stuart; Wilson, Craig; Lam, Hung; White, William B.; Aiub, Jorge; Albisu, Juan; Alvarez, Carlos; Astesiano, Alfredo; Barcudi, Raul; Bendersky, Mario; Bono, Julio; Bustos, Betina; Cartasegna, Luis; Caruso, Orlando; Casabe, Horacio; Castro, Remo; Colombo, Hugo; Cuneo, Carlos; Cura, Fernando; De Loredo, Luis; Dran, Ricardo; Fernandez, Horacio; Garcia Pinna, Jorge; Hrabar, Adrian; Klyver de Saleme, Maria; Luquez, Hugo; Mackinnon, Ignacio; Maffei, Laura; Majul, Claudio; Mallagray, Marcelo; Marino, Javier; Martinez, Diego; Martingano, Roberto; Nul, Daniel; Leonor Parody, Maria; Petrucci, Jacqueline; Pieroni, Mario; Piskorz, Daniel; Prado, Aldo; Ramos, Hugo; Resk, Jorge; Rodriguez, Marcelo; Rojas, Carlos; Sarjanovich, Rodolfo; Sarries, Alejandro; Sessa, Horacio; Silveiro, Sandra; Sosa Liprandi, Maria Ines; Tartaglione, Jorge; Tonin, Hugo; Vallejos, Julio; Vigo, Santiago; Visco, Virginia; Vita, Nestor; Vogel, Daniel; Vogelmann, Oscar; Zaidman, Cesar; Zangroniz, Pedro; Colquhoun, David; Coverdale, Steven; Flecknoe-Brown, Steve; Hii, Chris Sing Loi; Roberts-Thomson, Philip; Drexel, Heinz; Luger, Anton; Pieber, Thomas; Cools, Frank; Ruige, Johannes; Schoors, Danny; Vercammen, Chris; Wollaert, Bart; da Costa, Fernando Alves; Amodeo, Celso; Baggenstoss, Rejane; Barbosa, Eduardo; Barroso de Souza, Weimar Kunz; Bassan, Roberto; Borges, Joao Lindolfo; Botelho, Roberto; Valeria Braile, Maria Christiane; Castello, Helio, Jr.; Chrisman, Carolina; dos Santos, Fabio; Faria Neto, Jose; Farsky, Pedro; Da Costa, Alessandra Fernandes; Fraige Filho, Fadlo; Garbelini, Benito, Jr.; Garcia, Maria Fernanda; Garzon, Pedro; Guimaraes, Artur Eduardo; Herdy, Artur; Hernandes, Mauro; Hilgemberg, Sandra; Hissa, Miguel; Jatene, Jose Antonio; Kormann, Adrian; Leaes, Paulo; Lima, Felipe; Lisboa, Hugo Roberto; Maia, Lilia; da Silva, Francisco Maia; Franco, Daniela Maldonado; Martin, Jose Fernando; Medeiros, Ana; Michalaros, Yorghos; Leitao, Andressa Miguel; Montenegro, Sergio; Moraes Junior, Joao; Gomes, Marco Mota; Paiva, Maria Sanali; Precoma, Dalton; Rabelo, Alvaro; Reis, Gilmar; Reis, Helder; Rossi, Paulo; Saporito, Wladmir; Leite, Rogerio Sarmento; Silva, Ricardo Pereira; Silva Junior, Delcio; Sousa, Luciano; Sousa, Antonio Carlos; Ueda, Ricardo; Vilas-Boas, Fabio; Wainstein, Marco; Zago, Alexandre; Angelova, Mashka; Apostolova, Emilia; Daskalova, Ivona; Delchev, Alexy; Hristozov, Kiril; Ilieva, Mariana; Kovacheva, Sneghina; Lucheva, Maria; Temelkova, Margarita; Toneva, Antoaneta; Videva, Vyara; Vuchkova, Emilina; Bakbak, Asaad; Carpentier, Andre; Chan, Yun Kai; Cheema, Asim; Chouinard, Guy; Conway, James; Dery, Jean-Pierre; Dowell, Anthony; Frechette, Andre; Jakubowski, Marek; Kelly, Allan; Ma, Patrick; Maung, Tun Zan; Mehta, Shamir; Parker, David; Pesant, Yves; Polasek, Petr; Ransom, Thomas; Syan, Gurcharan; Vizel, Saul; Albornoz, Francisco; Castro Galvez, Pablo; Leonardo Cobos, Jorge; Conejeros, Carlos; D'Acuna Apablaza, Mauricio; Fajardo, Graciela; Illanes Brochet, Guillermo; Opazo Lazcano, Marcos; Pincetti, Christian; Potthoff, Sergio; Raffo, Carlos; Saavedra, Victor; Schnettler, Maria; Sepulveda, Pablo; Stockins, Benjamin; Vejar, Margarita; Accini, Jose Luis; Cotes Aroca, Carlos Hernan; Fernandez Ruiz, Ricardo Leon; Orozco Linares, Luis Alejandro; Vesga Angarita, Boris Eduardo; Aganovic, Izet; Bagatin, Jugoslav; Canecki-Varzic, Silvija; Erzen, Dubravka Jurisic; Knezevic, Aleksandar; Maric, Andreja; Milicevic, Goran; Popovic, Zeljko; Rubes, Josip; Weiss, Sonja Slosic; Dresslerova, Irma; Havelkova, Jana; Kucera, Dusan; Machacek, Josef; Pumprla, Jiri; May, Ole; Perrild, Hans; Aziz, Magdy Abdel; El Badry, Mahmoud; Hasanein, Mahmoud; Airaksinen, Juhani; Laine, Mika; Nyman, Kai; Vikman, Saila; Bonnet, Jacques; Elbaz, Meyer; Henry, Patrick; Paillard, Francois; Petit, Catherine; Tropeano, Anne-Isabelle; Behnke, Thomas; Bornstein, Stefan; Busch, Klaus; Ebelt, Henning; Faghih, Marcus; Fischer, Hermann; Heuer, Hubertus; Paschke, Ralf; Porner, Tudor-Constantin; Tangerding, Gerard; Voehringer, Hans-Friedrich; Adamson, Karen; Beatt, Kevin; Bellary, Srikanth; Chapman, John; Cooke, Alastair; Fisher, Miles; Gnudi, Luigi; Jones, Hugh; Kumar, Sudhesh; Nagi, Dinesh; Oldroyd, Keith; Richardson, Tristan; Robertson, Douglas; Robinson, Anthony; Saravanan, Ponnusamy; Viljoen, Adie; Wilding, John; Wilkinson, Peter; Wong, Yuk-ki; Zoupas, Christos; Arango, Juan; Castellanos, Jose; Ceren Flores, Carlos; Corona, Vinicio; Granados-Fuentes, Arnoldo; Haase, Franklin; Montenegro, Pablo; Palencia Prado, Julio Humberto; Villalobos, Renato; Chow, Francis; Li, Shu Kin; Li, June; Yan, Ping Yen Bryan; Yeung, Vincent; Abel, Tatjana; Benedek, Amalia; Dezso, Eniko; Dudas, Mihaly; Edes, Istvan; Fulop, Gabor; Kovacs, Aranka; Lupkovics, Geza; Merkely, Bela; Nagy, Andras; Oroszlan, Tamas; Palinkas, Attila; Papp, Andras; Patkay, Jozsef; Simon, Eva; Sitkei, Eva; Tabak, Adam; Tomcsanyi, Janos; Abdullakutty, Jabir; Abhyankar, Atul; Akalkotkar, Umesh; Alexander, Thomas; Arneja, Jaspal; Aslam, Naved; Babu, Pothineni Ramesh; Babu, Byrapaneni Ramesh; Banker, Darshan; Bantwal, Ganapati; Bhimashankar, P. R.; Calton, Rajneesh Kumar; Chopda, Manoj; Dande, Ajay; Dani, Sameer; Deshpande, Neeta; Deshpande, Niteen; Dhanwal, Dinesh; Dharmadhikari, Aniruddha; Gadkari, Milind; Garg, Nitish; Ghaisas, Nitin; Goyal, N. K.; Gupta, Jugal Bihari; Jawahirani, Anil; Joseph, Stigmon; Kumar, Ravi; Kumble, Mukund; Mathavan, A.; Mathur, Atul; Mohanan, Padnihare Purayil; Nair, Abhilash; Nair, Tiny; Namjoshi, Deepak; Pinto, Robin; Prakash, Guru; Purushotham, R.; Raju, Srinivas; Ramachandran, Padmakumar; Ramesh, S. S.; Rao, Bhaskara; Ravikishore, Amancherla; Reddy, G. Rajashekar; Roy, Sanjeeb; Sadhu, Nehal; Sastry, B. K. S.; Singh, Parvinder; Srinivas, Arun; Thacker, Hemant; Thanvi, Sunil; Thomas, Joy; Adawi, Faiad; Bashkin, Amir; Cohen, Josef; Harman-Boehm, Ilana; Hasin, Yonathan; Hayek, Tony; Iakobishvili, Zaza; Katz, Amos; Kracoff, Oscar; Minuchin, Oscar; Moriel, Mady; Mosseri, Morris; Omary, Muhamad; Wainstein, Julio; Weiss, Avraham; Zeltser, David; Calabro, Paolo; Derosa, Giuseppe; Genovese, Stefano; Novo, Salvatore; Olivieri, Carlo; Piatti, Piermarco; Violini, Roberto; Volpe, Massimo; Ajioka, Masayoshi; Amano, Tetsuya; Arasaki, Osamu; Daida, Hiroyuki; Fujimoto, Kazuteru; Fujinaga, Hiroyuki; Higashiue, Shinichi; Hirohata, Atsushi; Hosokawa, Shinobu; Ikefuji, Hiroyuki; Inagaki, Masayuki; Iseki, Harukazu; Iwabuchi, Masashi; Iwasaki, Toshiya; Kakishita, Mikio; Katsuda, Yousuke; Kawada, Kimiko; Kawajiri, Kenji; Kawamitsu, Katsunori; Kobayashi, Katsuyuki; Komada, Fumihiko; Komura, Yasuo; Machida, Masaharu; Maemura, Koji; Matsubara, Taku; Matsubayashi, Sunao; Matsumoto, Tomoaki; Matsumoto, Naoki; Mima, Tsutomu; Miyamoto, Nobuhide; Momiyama, Yukihiko; Morimoto, Takafumi; Murakami, Marohito; Nakashima, Eitaro; Niijima, Yawara; Noda, Toshiyuki; Node, Koichi; Nozaki, Akira; Nunohiro, Tatsuya; Ogawa, Tomohiro; Ono, Yasuhiro; Saeki, Takahiro; Sakota, Shinichiro; Sakuragi, Satoru; Sasaki, Toyoshi; Sato, Yasuhiro; Sueyoshi, Atsushi; Suzuki, Masahiro; Takagi, Gen; Tanabe, Jun; Tanaka, Seiichi; Tei, Imun; Yamamoto, Masato; Yanagihara, Kaoru; Hong, Taek Jong; Jeon, Hui-Kyung; Kang, Duk-Hyun; Kim, Cheol Ho; Kim, Dong-Soo; Kim, Hyun-Sook; Kim, June Hong; Kim, Soon Kil; Kim, Woo-Shik; Kim, Young-Kwon; Lee, SangRok; Lee, Kwan-Woo; Park, Hun-Sik; Pyun, Wook Bum; Rha, Seung-Woon; Yoon, Junghan; Yoon, Kun-Ho; Bennakhi, Abdullah; Geldnere, Kristine; Sokolova, Jelena; Teterovska, Dace; Dautaraite, Violeta; Kakariekiene, Vaida; Kavaliauskiene, Roma; Kucinskiene, Alina; Lasiene, Jurate; Mickuviene, Narseta; Palinauskas, Algirdas; Urboniene, Audrone; Zilaitiene, Birute; Manap, Hasmannizar Abdul; Abidin, Imran Zainal; Isa, Siti Harnida Md; Khir, Amir Md.; Ng, Kok Huan; Tan, Florence; Yusof, Zurkurnai; Yusoff, Khalid; Zambahari, Robaayah; Aguila-Marin, Javier; Aguilera Real, Manuel; Alvarado-Ruiz, Ricardo; Alvarez Lopez, Humberto; Arenas Leon, Jose; Bayram Llamas, Edmundo Alfredo; Calvo Vargas, Cesar; Carrillo Calvillo, Jorge; De los Rios Ibarra, Manuel; Alberto Dominguez-Reyes, Carlos; Duarte, Manuel; Elizondo, Eduardo; Fajardo Campos, Pedro; Fanghanel-Salmon, Guillermo; Figueroa Sauceda, Sergio; Gallegos Martinez, Jose; Garcia-Cantu, Elias; Garza Ruiz, Jose Angel; Gonzalez Gonzalez, Jose Gerardo; Guerrero Garza, Manuel; Hernandez Herrera, Carlos; Hernandez Munuzuri, Jesus; Hernandez-Garcia, Hugo; Jimenez Ramos, Silvia; Laviada Molina, Hugo; Lopez Villezca, David; Montano-Gonzalez, Efrain; Nevarez Ruiz, Luis; Ramos Lopez, Gabriel; Reyes Araiza, Raul; Salazar-Gaytan, Abel; Salcido Vazquez, Eduardo; Sanchez Mijangos, Hector; Solis Morales, Lucas; Benatar, Jocelyne; Dixon, Paul; Nirmalaraj, Kingsley; Rosen, Ian; Scott, Russell; Young, Simon; Araoz Tarco, Ofelia; Barreda Caceres, Luis; Benites Lopez, Carmen; Camacho Cosavalente, Luis; Chavez Huapalla, Edith; Chois Malaga, Augusto; Copaja Flores, Alex; Farfan Aspilcueta, Julio; Gallardo Rojas, Wilson; Gallegos Cazorla, Alex; Galvez Caballero, David; Garcia Matheus, Julio; Garrido Carrasco, Elizabeth; Gomez Sanchez, Jorge; Hernandez Zuniga, Jose; Lu Galarreta, Libia; Luna, Alejandro; Manrique Hurtado, Helard; Orihuela Pastor, Boris; Maria Pando Alvarez, Rosa; Sanchez Povis, Javier; Torres Eguiluz, Pedro; Valdivia Portugal, Angelica; Vargas Gonzales, Rolando; Zapata Rincon, Luis; Aquitania, Grace; Fortinez, Judy Theresa; Go, Angelita; Gomez, Maria Honolina; Habaluyas, Ramoncito; Jasul, Gabriel; Magno, Marie; Manalo, Carlo John; Mirasol, Roberto; Morales-Palomares, Ellen; Salvador, David Raymund; Sy, Rosa Allyn; Tirador, Louie; Yao, Christy; Arciszewska, Malgorzata; Bartkowiak, Radoslaw; Czajkowska-Kaczmarek, Eugenia; Gil, Robert; Gniot, Jacek; Janik, Krzysztof; Janion, Marianna; Jaworska, Krystyna; Jozwa, Robert; Kawecka-Jaszcz, Kalina; Kawka-Urbanek, Teresa; Kondys, Marek; Korecki, Janusz; Korzeniak, Romuald; Kowalisko, Alicja; Krzeminska-Pakula, Maria; Kwiecien, Jolanta; Nessler, Jadwiga; Odrowaz-Pieniazek, Piotr; Piepiorka, Marek; Rajzer, Marek; Skokowska, Ewa; Spyra, Janusz; Sroka, Michal; Stasinska, Teresa; Szymczyk, Ireneusz; Trznadel-Morawska, Iwona; Wysokinski, Andrzej; Mateus, Pedro; Matos, Pedro; Mimoso, Jorge; Monteiro, Pedro; Caballero, Baruch; Garcia-Rinaldi, Raul; Gonzalez, Elena; Ortiz-Carrasquillo, Ramon; Roman, Amaury; Sierra, Yolanda; Unger, Nestor; Vazquez-Tanus, Jose; Alexandru, Tom; Busegeanu, Mihaela; Cozman, Doina Constanta; Fica, Simona; Minescu, Bogdan; Morosanu, Magdalena; Negrisanu, Gabriela Doina; Pintilei, Ella; Pop, Lavinia; Szilagyi, Iosif; Teodorescu, Iulia; Tomescu, Mirela; Barbarash, Olga; Chumakova, Galina; Churina, Svetlana; Dogadin, Sergey; Dvoryashina, Irina; Esip, Valeria; Glezer, Maria; Gordeev, Ivan; Gordienko, Alexander; Gratsiansky, Nikolay; Grineva, Elena; Khasanov, Niaz; Kostenko, Victor; Meleshkevich, Tatiana; Mikhin, Vadim; Morugova, Tatyana; Motylev, Igor; Nikolaev, Konstantin; Ponomareva, Asya; Repin, Mikhail; Reshetko, Olga; Shustov, Sergey; Shutemova, Elena; Shvarts, Yury; Simanenkov, Vladimir; Sobolev, Konstantin; Sukmanova, Irina; Timofeev, Alexander; Tsyba, Larisa; Varvarina, Galina; Vertkin, Arkadiy; Vishnevsky, Alexander; Volkov, Dmitry; Vorobiev, Sergey; Vorokhobina, Natalya; Yakhontov, Davyd; Zonova, Elena; Zrazhevskiy, Konstantin; Damjanovic, Svetozar; Djordjevic, Dragan; Pavlovic, Milan; Perunicic, Jovan; Ristic, Arsen; Stojkovic, Sinisa; Tasic, Nebojsa; Bolvanska, Nora; Buganova, Ingrid; Dulkova, Katarina; Dzupina, Andrej; Fulop, Peter; Gergel, Vladimir; Kokles, Martin; Micko, Karol; Svoren, Peter; Urban, Miroslav; Vadinova, Silvia; Vargova, Anna; Burgess, Leslie; Coetzee, Kathleen; Du Toit, Jacques; Gani, Mashra; Joshi, Pankaj; Naiker, Puvanesveri; Nortje, Hendrik; Sarvan, Mahomed; Seeber, Mary; Siebert, Mirna; van Zyl, Louis; Wellmann, Holger; Calvo, Carlos; De la Hera, Jesus; De Teresa, Luis; Melero-Pita, Antonio; Mesa, Jordi; Parra Barona, Juan; Serrano, Pedro; Soto, Alfonso; Tofe, Santiago; Hornestam, Bjorn; Kempe, Anders; Rosenqvist, Ulf; Rydberg, Erik; Tengmark, Bengt-Olov; Torstensson, Ingemar; Chang, Chwen-Tzuei; Hsia, Te-Lin; Hsieh, I-Chang; Lai, Wen-Ter; Wu, Chiung-Jen; Hutayanon, Pisit; Kosachunhanun, Natapong; Marapracertsak, Mongkol; Piamsomboon, Chumpol; Seekaew, Samroeng; Srimahachota, Suphot; Sukhum, Pradub; Suraamornkul, Swangjit; Tantiwong, Puntip; Wongvipaporn, Chaiyasith; Amosova, Kateryna; Barna, Olga; Bazylevych, Andriy; Berenfus, Vadym; Dyadyk, Alexander; Fushtey, Ivan; Gyrina, Olga; Iabluchanskyi, Mykola; Karpenko, Oleksandr; Kaydashev, Igor; Korzh, Oleksii; Kulynych, Roman; Legkonogov, Olexandr; Mankovsky, Boris; Mostovoy, Yuriy; Parkhomenko, Oleksandr; Popik, Galyna; Rudenko, Leonid; Rudyk, Iurii; Shevchuk, Sergii; Sirenko, Yuriy; Suprun, Yevgen; Tryshchuk, Nadiya; Tseluyko, Vira; Vakaliuk, Igor; Al Mahmeed, Wael; Acheatel, Roger; Ahmad, Anwar; Akbar, Saleem; Akhter, Faiq; Albirini, Abdulhay; Alexander, Arnold; Al-Joundi, Bassam; Al-Joundi, Tammam; Allen, Gregory; Aloi, Joseph; Alvarado, Odilon; Alzohaili, Opada; Anderson, Corey; Arastu, Anwar; Arena, Charles; Argoud, Georges; Ariani, Mehrdad; Arora, Chander; Awasty, Vivek; Barker, Barbara; Barnum, Otis; Bartkowiak, Anthony J.; Barzilay, Joshua; Behrens, Phillip; Belledonne, Mario; Bergman, Bradford; Bilnoski, William; Bisognano, John; Bissette, Stephen; Blumberg, Edwin; Bonabi, Nagadeh; Bradley, Arden; Breton, Cristian; Britos, Martin; Broadstone, Vasti; Budoff, Matthew; Burge, Mark; Butman, Samuel; Carroll, Mary; Challappa, Krishnan; Chepuri, Vinaya; Cherlin, Richard; Cheung, Deanna; Coats, Peter; Collins, John; Cruz, Humberto; Daboul, Nizar; Damberg, Greg; David, William; Dean, Julius; Dedeke, Eric; Deeb, Wasim; DeHaven, Joseph; Dobs, Adrian; Donelan, Timothy; Dy, Johnny; Dykstra, Gary; Eisen, Howard; Farris, Neil; Fattal, Peter; Fishman, Norman; Foster, Malcom; Fredrickson, Sonja; Gabra, Nashwa; Gabriel, John; Gatien, Lionel; Giddings, Stephen; Ginsberg, Burton; Gips, Sanford; Glandt, Mariela; Goldfein, Aaron; Gordon, Murray; Gould, Randy; Graf, Ronald; Graham, Bruce; Graves, Mark; Grena, Paul; Hahn, Richard; Hamilton, Dale; Hamroff, Glenn; Hanke, Forrest; Haque, Ihsan; Harper, James, Jr.; Harris, Anthony; Harris, Sharon; Henson, Bruce; Hermanns, David; Herndon, William; Hershberger, Vernon; Hyman, Daniel; Isserman, Steven; Iteld, Bruce; Jacob, Moshir; Jaffrani, Naseem; Jamal, Aamir; Johnson, David; Johnson, Glover; Kaluski, Edo; Keller, Robert; Kereiakes, Dean; Khan, Muhammad; Khan, Salman; Khan, Misal; Klein, Michael; Knutson, Thomas; Korban, Elie; Kozinn, Marc; Kraft, Philip; Kroeze, James; Kukuy, Eugene; Lader, Ellis; Laliotis, Aristotelis; Lambert, Charles, Jr.; Landau, Charles; Latif, Kashif; Lee, Kwan; Lester, F.; Levenson, David; Levinson, Dennis; Lewis, Derek; Litt, Marc; Littlefield, Ronald; Lo, Eric; Lovell, Charles; Mahal, Sharan; Makam, Satyaprakash; Mandviwala, Mustafa; Marar, Isam; Masri, Bassem; Mattson, Steven; Mays, Maureen; McGrew, Frank; Meengs, Mark; Mikell, Frank; Miller, Michael; Miranda, Francisco; Moll, David; Multani, Pramod; Munuswamy, Karan; Nallasivan, Mani; Nayles, Lee; Ong, Stephen; Pacheco, Theodore; Paez, Henry; Patel, Shailendra; Phillips, Roland; Pierpont, Brien; Prasad, Jeereddi; Quinlan, Edward; Quion, Jun; Qureshi, Mansoor; Rahman, Aref; Raikhel, Marina; Ramanathan, Kodangudi; Randhawa, Preet; Ravi, Ram; Reddy, Rajneesh; Rendell, Marc; Rickner, Kyle; Rictor, Kenneth; Rivas, Jose; Rosenblit, Paul; Rosenstock, Julio; Ross, Steven; Salacata, Abraham; Saririan, Mehrdrad; Schima, Susan; Schlau, Aron; Schmedtje, John; Scott, Cranford; Scott, David; Serru-Paez, Antonio; Shah, Rakesh; Shah, Anil; Shaoulian, Emanuel; Shomali, Mansur; Shubrook, Jay; Silver, Kevin; Singh, Sanjay; Speer, John; Stevens, Jewel; Stringam, Stanley; Taussig, Andrew; Taylor, Angela; Tee, Howard; Teixeira, Gilbert; Tilley, Absalom; Toggart, Edward; Twahirwa, Marcel; Unks, Dennis; Vakili, Babak; Vora, Kishor; Wang, Xiangbing; Warner, Alberta; Wefald, Franklin; Weinberg, Bradley; Weinstein, Debra; White, Lindsey; Wu, Patricia; Yasuda, Tsunehiro; Yazdani, Shahram; Yetman, Cornelius; Zarich, Stuart; Zebrack, James; Fonseca, Vivian A.; McCullough, Peter A.; Desouza, Cyrus; Goff, David C.; Harrell, Frank E., Jr.; Menon, Venu; Sila, Cathy; Kalahasti, Vidyasagar; Ahmed, Salim; Al Solaiman, Firas; Bennett, Mosi; Cavender, Matthew; Heil, Barbara; Katzan, Irene; Monteleone, Peter; O'Brien, Bridget; Oommen, Santosh; Senn, Todd; Sharma, Jitendra; Stegman, Brian; Uchino, Ken; Zishiri, Edwin; Pasca, Narcis; Brown, Kimberly; Scebbi, Tambria; Atanasovski, Ilija; McCue, Maggie; Streit, Janet; Oh, Richard; Bueno, Orlando; Lee, Douglas; Camisasca, Riccardo; Miyata, Yuuko; Rubin, Anne; Williamson, Nyree; Vara, Sanjay; Keeter, Kraig; Ross, Ben; de los Reyes, Amy; Donnelly, Julie; Koshy-Hunt, Sini; Beers, Brian; Black, Stephen; Buckley, Maria; Ephrem, Maria; Riley, Bill; West, Nicola; Harre, Mark; Hsieh, Roger; Oshinyemi, Keji; Oka, Yumiko; Matsui, Nobuto; Hoang, Minhtri; Doyle, Cassandra; Koziol, Maria; Lam, Hung; Edmonds, Anthony; Azooz, Willow; Cao, Charlie; Kim, Denny; Boeshaar, Amy; Dewindt, Alex; Nicholson, Kim; Smith, Neila; Hisada, Michie; Harding, Sarah; Cannon, Clive; Yoshioka, Norihito; Gujral-Sandhu, Kiran; Gans, Jason; Gresk, Christopher; Kujawski, Michelle R.; Villinski, Allison; Cosner, Sandy; Johannsen, Clint; Barchha, Nina; Knapp, Beth		EXAMINE Investigators	Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial	LANCET			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITORS; LEFT-VENTRICULAR DYSFUNCTION; CARDIOVASCULAR OUTCOMES; PEPTIDE-1 INFUSION; TASK-FORCE; MELLITUS; ASSOCIATION; METAANALYSIS; RISK; HEMOGLOBIN	Background The EXAMINE trial showed non-inferiority of the DPP-4 inhibitor alogliptin to placebo on major adverse cardiac event (MACE) rates in patients with type 2 diabetes and recent acute coronary syndromes. Concerns about excessive rates of in-hospital heart failure in another DPP-4 inhibitor trial have been reported. We therefore assessed hospital admission for heart failure in the EXAMINE trial. Methods Patients with type 2 diabetes and an acute coronary syndrome event in the previous 15-90 days were randomly assigned alogliptin or placebo plus standard treatment for diabetes and cardiovascular disease prevention. The prespecified exploratory extended MACE endpoint was all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, urgent revascularisation due to unstable angina, and hospital admission for heart failure. The post-hoc analyses were of cardiovascular death and hospital admission for heart failure, assessed by history of heart failure and brain natriuretic peptide (BNP) concentration at baseline. We also assessed changes in N-terminal pro-BNP (NT-pro-BNP) from baseline to 6 months. This study is registered with ClinicalTrials.gov,number NCT00968708. Findings 5380 patients were assigned to alogliptin (n=2701) or placebo (n=2679) and followed up for a median of 533 days (IQR 280-751). The exploratory extended MACE endpoint was seen in 433 (16.0%) patients assigned to alogliptin and in 441 (16.5%) assigned to placebo (hazard ratio [HR] 0.98, 95% CI 0.86-1.12). Hospital admission for heart failure was the first event in 85 (3.1%) patients taking alogliptin compared with 79 (2.9%) taking placebo (HR 1.07, 95% CI 0.79-1.46). Alogliptin had no effect on composite events of cardiovascular death and hospital admission for heart failure in the post hoc analysis (HR 1.00, 95% CI 0.82-1.21) and results did not differ by baseline BNP concentration. NT-pro-BNP concentrations decreased significantly and similarly in the two groups. Interpretation In patients with type 2 diabetes and recent acute coronary syndromes, alogliptin did not increase the risk of heart failure outcomes.	[Zannad, Faiez] Univ Lorraine, Inst Lorrain Coeur & Vaisseaux, Ctr Invest Clin Inserm, Vandoeuvre Les Nancy, France; [Zannad, Faiez] CHU, Vandoeuvre Les Nancy, France; [Cannon, Christopher P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Cushman, William C.] Univ Tennessee, Memphis Vet Affairs Med Ctr, Coll Med, Memphis, TN USA; [Bakris, George L.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Menon, Venu] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Perez, Alfonso T.; Fleck, Penny R.; Kupfer, Stuart; Wilson, Craig; Lam, Hung] Takeda Dev Ctr Amer, Deerfield, IL USA; [Mehta, Cyrus R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [White, William B.] Univ Connecticut, Sch Med, Calhoun Cardiol Ctr, Farmington, CT USA	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Chicago; Cleveland Clinic Foundation; Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.; Harvard University; Harvard T.H. Chan School of Public Health; University of Connecticut	Zannad, F (corresponding author), Ctr Invest Clin Inserm, Inst Lorrain Coeur & Vaisseaux, F-54500 Vandoeuvre Les Nancy, France.	f.zannad@chu-nancy.fr	Zannad, Faiez/K-4649-2019; Menon, Venu/AAF-1871-2019; Wilding, John/ABB-6443-2020; Bazylevych, Andriy/G-2834-2019; Khan, Shahzeb/AAN-1515-2020; Cosman, Doina/L-9087-2013; Piskorz, Daniel/AAJ-8751-2020; Sepúlveda, Pablo/GXF-5175-2022; Reshetko, Olga/I-7011-2013; Rudyk, Iurii/AAG-4668-2021; Precoma, Dalton B/D-5674-2013; Miller, Michael/AGX-6773-2022; Chumakova, Galina A/L-5677-2015; Calabro, Paolo/AAC-2704-2022; Tryshchuk, Nadiya/AAB-6103-2020; Grineva, Ele N./V-8221-2018; Airaksinen, Juhani/AAC-7857-2021; Uchino, Ken/ABC-1611-2021; Volpe, Massimo/K-5240-2016; Maia, Lilia Nigro/AAV-6938-2021; Tomescu, Mirela Cleopatra/M-9101-2014; Piatti, Piermarco/AAN-3115-2020; Barbosa, Eduardo/AAJ-5790-2020; Reis, Gilmar/I-4500-2013; Sirenko, Yuriy M/C-8012-2019; Sepúlveda, Pablo Espicel/HCI-5123-2022; Yusof, Zurkurnai/AAA-5893-2021; Cannon, Christopher P/AAY-7644-2020; Shevchuk, Sergii/Y-8642-2018; Korzh, Oleksii/E-4291-2016; Stojkovic, Sinisa/AAD-4977-2022; VILELA-MARTIN, JOSE/I-8305-2014; Abhyankar, Atul/AAG-4551-2020; Dvoryashina, Irina/AAE-4533-2019; Cheema, Asim N./AAA-7676-2020; Budoff, Matthew/ABD-5175-2021; Mankovsky, Boris/W-3061-2018; Rha, Seung-Woon/AGE-5810-2022; Tasic, Nebojsa/AAE-1809-2020; Nikolaev, Konstantin/P-4750-2017; Barna, Olga/ABC-6535-2020	Wilding, John/0000-0003-2839-8404; Bazylevych, Andriy/0000-0001-5053-2548; Cosman, Doina/0000-0001-7102-2432; Piskorz, Daniel/0000-0002-8615-5446; Reshetko, Olga/0000-0003-3107-7636; Miller, Michael/0000-0002-1679-2095; Chumakova, Galina A/0000-0002-2810-6531; Tryshchuk, Nadiya/0000-0002-6680-2060; Airaksinen, Juhani/0000-0002-0193-568X; Uchino, Ken/0000-0001-9468-4172; Volpe, Massimo/0000-0002-9642-8380; Tomescu, Mirela Cleopatra/0000-0003-2117-0474; Barbosa, Eduardo/0000-0002-4361-936X; Reis, Gilmar/0000-0002-4847-1034; Sirenko, Yuriy M/0000-0002-4091-4910; Cannon, Christopher P/0000-0003-4596-2791; Shevchuk, Sergii/0000-0002-5649-2775; Korzh, Oleksii/0000-0001-6838-4360; VILELA-MARTIN, JOSE/0000-0001-6960-2825; Dvoryashina, Irina/0000-0001-9230-0710; Cheema, Asim N./0000-0002-3174-8957; Budoff, Matthew/0000-0002-9616-1946; Mankovsky, Boris/0000-0001-8289-3604; Rha, Seung-Woon/0000-0001-9456-9852; Nikolaev, Konstantin/0000-0003-4601-6203; 	Takeda Development Center Americas	Takeda Development Center Americas	Funding Takeda Development Center Americas.	Aguilar D, 2011, CIRC-HEART FAIL, V4, P53, DOI 10.1161/CIRCHEARTFAILURE.110.952556; Aguilar D, 2009, J AM COLL CARDIOL, V54, P422, DOI 10.1016/j.jacc.2009.04.049; Bach RG, 2013, CIRCULATION, V128, P785, DOI 10.1161/CIRCULATIONAHA.112.000678; Baetta R, 2011, DRUGS, V71, P1441, DOI 10.2165/11591400-000000000-00000; Boerrigter G, 2007, AM J PHYSIOL-REG I, V292, pR897, DOI 10.1152/ajpregu.00569.2006; Cubbon RM, 2013, DIABETES VASC DIS RE, V10, P330, DOI 10.1177/1479164112471064; de Simone G, 2013, NUTR METAB CARDIOVAS, V23, P285, DOI 10.1016/j.numecd.2011.06.007; dos Santos L, 2013, CIRC-HEART FAIL, V6, P1029, DOI 10.1161/CIRCHEARTFAILURE.112.000057; Erqou S, 2013, EUR J HEART FAIL, V15, P185, DOI 10.1093/eurjhf/hfs156; Eurich DT, 2007, BMJ-BRIT MED J, V335, P497, DOI 10.1136/bmj.39314.620174.80; Eurich DT, 2013, CIRC-HEART FAIL, V6, P395, DOI 10.1161/CIRCHEARTFAILURE.112.000162; Gitt AK, 2012, EUR J HEART FAIL, V14, P1389, DOI 10.1093/eurjhf/hfs136; Green JB, 2013, AM HEART J, V166, P983, DOI 10.1016/j.ahj.2013.09.003; [Guidance for Industry Center for Drug Evaluation and Research Food and Drug Administration U. S. Department of Health and Human Services], 2008, GUID IND DIAB MELL E; Halbirk M, 2010, AM J PHYSIOL-HEART C, V298, pH1096, DOI 10.1152/ajpheart.00930.2009; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hernandez AV, 2011, AM J CARDIOVASC DRUG, V11, P115, DOI 10.2165/11587580-000000000-00000; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Khan MA, 2013, HEART FAIL REV, V18, P141, DOI 10.1007/s10741-012-9318-y; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Leung AA, 2009, J CARD FAIL, V15, P152, DOI 10.1016/j.cardfail.2008.10.004; McMurray JJV, 2013, VILDAGLIPTIN SHOWS N; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Monami M, 2014, NUTR METAB CARDIOVAS, V24, P689, DOI 10.1016/j.numecd.2014.01.017; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Opie LH, 2011, LANCET, V378, P103, DOI 10.1016/S0140-6736(11)60787-3; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; Scirica BM, 2014, CIRCULATION, V130, P1579, DOI 10.1161/CIRCULATIONAHA.114.010389; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shindler DM, 1996, AM J CARDIOL, V77, P1017, DOI 10.1016/S0002-9149(97)89163-1; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Takahashi A, 2013, AM J PHYSIOL-HEART C, V304, pH1361, DOI 10.1152/ajpheart.00454.2012; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wu SY, 2014, CARDIOVASC THER, V32, P147, DOI 10.1111/1755-5922.12075; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	37	543	575	5	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2067	2076		10.1016/S0140-6736(14)62225-X	http://dx.doi.org/10.1016/S0140-6736(14)62225-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	25765696				2022-12-28	WOS:000354979100026
J	Villanueva, GL; Mumma, MJ; Novak, RE; Kaufl, HU; Hartogh, P; Encrenaz, T; Tokunaga, A; Khayat, A; Smith, MD				Villanueva, G. L.; Mumma, M. J.; Novak, R. E.; Kaeufl, H. U.; Hartogh, P.; Encrenaz, T.; Tokunaga, A.; Khayat, A.; Smith, M. D.			Strong water isotopic anomalies in the martian atmosphere: Probing current and ancient reservoirs	SCIENCE			English	Article							ANNUAL CYCLE; MARS; DEUTERIUM; EVOLUTION; HYDROGEN; VAPOR; SURFACE; H2O; HDO	We measured maps of atmospheric water (H2O) and its deuterated form (HDO) across the martian globe, showing strong isotopic anomalies and a significant high deuterium/hydrogen (D/H) enrichment indicative of great water loss. The maps sample the evolution of sublimation from the north polar cap, revealing that the released water has a representative D/H value enriched by a factor of about 7 relative to Earth's ocean [Vienna standard mean ocean water (VSMOW)]. Certain basins and orographic depressions show even higher enrichment, whereas high-altitude regions show much lower values (1 to 3 VSMOW). Our atmospheric maps indicate that water ice in the polar reservoirs is enriched in deuterium to at least 8 VSMOW, which would mean that early Mars (4.5 billion years ago) had a global equivalent water layer at least 137 meters deep.	[Villanueva, G. L.; Mumma, M. J.; Smith, M. D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Villanueva, G. L.] Catholic Univ Amer, Washington, DC 20064 USA; [Novak, R. E.] Iona Coll, New Rochelle, NY 10801 USA; [Kaeufl, H. U.] European So Observ, Munich, Germany; [Hartogh, P.] Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; [Encrenaz, T.] Observ Paris, F-92195 Meudon, France; [Tokunaga, A.; Khayat, A.] Univ Hawaii Manoa, Honolulu, HI 96822 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Catholic University of America; Iona College; European Southern Observatory; Max Planck Society; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Hawaii System; University of Hawaii Manoa	Villanueva, GL (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	geronimo.villanueva@nasa.gov	mumma, michael j/I-2764-2013	mumma, michael j/0000-0003-4627-750X; Tokunaga, Alan/0000-0001-8136-9704	NASA's Planetary Astronomy Program [08 PAST08 0034, RTOP 344 32 07]; NASA's Planetary Atmospheres Program [08 PATM08 0031]; NASA's Astrobiology Program [RTOP 344 53 51]; NSF Research in Undergraduate Institutions [AST 0805540]; NASA Keck PI Data Award	NASA's Planetary Astronomy Program(National Aeronautics & Space Administration (NASA)); NASA's Planetary Atmospheres Program(National Aeronautics & Space Administration (NASA)); NASA's Astrobiology Program(National Aeronautics & Space Administration (NASA)); NSF Research in Undergraduate Institutions(National Science Foundation (NSF)); NASA Keck PI Data Award	We thank the staff of the Very Large Telescope (runs 83.C-0538 and 92.C-0436), the NASA InfraRed Telescope Facility, and the W. M. Keck Observatory for their exceptional support throughout our long Mars observing Programs. G.L.V. acknowledges support from NASA's Planetary Astronomy Program (08 PAST08 0034) and NASA's Planetary Atmospheres Program (08 PATM08 0031). NASA's Planetary Astronomy Program (RTOP 344 32 07) and NASA's Astrobiology Program (RTOP 344 53 51) supported M.J.M. and G.L.V. NSF Research in Undergraduate Institutions supported R.E.N. through grant AST 0805540. This work was also supported by a NASA Keck PI Data Award. The authors recognize and acknowledge the very important cultural role and reverence that the summit of MaunaKea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain.	[Anonymous], [No title captured]; Aoki S., 2013, EUR PLAN SCI C 2013, P8; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bjoraker G. L., 1989, B AM ASTRON SOC, V21, P991; Boctor NZ, 2003, GEOCHIM COSMOCHIM AC, V67, P3971, DOI 10.1016/S0016-7037(03)00234-5; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Carr MH, 1999, J GEOPHYS RES-PLANET, V104, P21897, DOI 10.1029/1999JE001048; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; Fouchet T, 2007, ICARUS, V190, P32, DOI 10.1016/j.icarus.2007.03.003; Fouchet T, 2000, ICARUS, V144, P114, DOI 10.1006/icar.1999.6264; Fouchet T, 2011, PLANET SPACE SCI, V59, P683, DOI 10.1016/j.pss.2011.01.017; Greenwood JP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032721; Grotzinger JP, 2013, SCIENCE, V341, P1475, DOI 10.1126/science.1244258; JOUZEL J, 1984, J GEOPHYS RES-ATMOS, V89, P1749, DOI 10.1029/JD089iD07p11749; Krasnopolsky VA, 1998, SCIENCE, V280, P1576, DOI 10.1126/science.280.5369.1576; Kurokawa H, 2014, EARTH PLANET SC LETT, V394, P179, DOI 10.1016/j.epsl.2014.03.027; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Lasue J, 2013, SPACE SCI REV, V174, P155, DOI 10.1007/s11214-012-9946-5; Mahaffy PR, 2015, SCIENCE, V347, P412, DOI 10.1126/science.1260291; Montmessin F, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002357; Mouginot J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050286; Mumma M. J., 2003, 6 INT C MARS LUN PLA, P3186; Murray JB, 2005, NATURE, V434, P352, DOI 10.1038/nature03379; Novak RE, 2011, PLANET SPACE SCI, V59, P163, DOI 10.1016/j.pss.2010.06.017; Novak R. E., 2007, 7 INT C MARS PAS CA, P3283; Novak RE, 2002, ICARUS, V158, P14, DOI 10.1006/icar.2002.6863; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; Page DP, 2009, ICARUS, V203, P376, DOI 10.1016/j.icarus.2009.05.012; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001522; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; Tschimmel A, 2008, ICARUS, V195, P557, DOI 10.1016/j.icarus.2008.01.018; Usui T., 2012, 43 LUN PLAN SCI C WO, P1341; Villanueva GL, 2013, ICARUS, V223, P11, DOI 10.1016/j.icarus.2012.11.013; Villanueva GL, 2012, J QUANT SPECTROSC RA, V113, P202, DOI 10.1016/j.jqsrt.2011.11.001; Villanueva G. L., 2008, MARS ATMOSPHERE MODE, P9101; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Zuber MT, 1998, SCIENCE, V282, P2053, DOI 10.1126/science.282.5396.2053	42	174	177	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					218	221		10.1126/science.aaa3630	http://dx.doi.org/10.1126/science.aaa3630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25745065	Green Submitted			2022-12-28	WOS:000352613700041
J	Spencer, C				Spencer, Craig			Having and Fighting Ebola - Public Health Lessons from a Clinician Turned Patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Spencer, Craig] Columbia Univ Coll Phys & Surg, Dept Emergency Med, New York, NY 10032 USA; [Spencer, Craig] Med Frontieres, Operat Ctr Brussels, Gueckedou, Guinea	Columbia University	Spencer, C (corresponding author), Columbia Univ Coll Phys & Surg, Dept Emergency Med, 630 W 168th St, New York, NY 10032 USA.							[Anonymous], 2014, EB ISIS BIOAG; [Anonymous], 2014, FOX NEWS; Centers for Disease Control and Prevention, 2014, INT US GUID MON MOV; Cohen E., 2014, CNN             1006; WHO, 2015, EB SIT REP	5	22	22	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1089	1091		10.1056/NEJMp1501355	http://dx.doi.org/10.1056/NEJMp1501355			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD6EZ	25714039	Bronze			2022-12-28	WOS:000351183600003
J	Laver, JD; Lipshitz, HD				Laver, John D.; Lipshitz, Howard D.			Transcription Gets to the Checkpoint	CELL			English	Editorial Material							MIDBLASTULA TRANSITION; ZYGOTIC TRANSCRIPTION; DROSOPHILA; SMAUG		[Laver, John D.; Lipshitz, Howard D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto	Lipshitz, HD (corresponding author), Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	howard.lipshitz@utoronto.ca		Lipshitz, Howard/0000-0002-7372-4419				Benoit B, 2009, DEVELOPMENT, V136, P923, DOI 10.1242/dev.031815; Blythe SA, 2015, CELL, V160, P1169, DOI 10.1016/j.cell.2015.01.050; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Collart C, 2013, SCIENCE, V341, P893, DOI 10.1126/science.1241530; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sung HW, 2013, CURR BIOL, V23, P133, DOI 10.1016/j.cub.2012.12.013; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005	10	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1043	1044		10.1016/j.cell.2015.02.051	http://dx.doi.org/10.1016/j.cell.2015.02.051			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768900	Bronze			2022-12-28	WOS:000351951800003
J	Rangan, A; Handoll, H; Brealey, S; Jefferson, L; Keding, A; Martin, BC; Goodchild, L; Chuang, LH; Hewitt, C; Torgerson, D				Rangan, Amar; Handoll, Helen; Brealey, Stephen; Jefferson, Laura; Keding, Ada; Martin, Belen Corbacho; Goodchild, Lorna; Chuang, Ling-Hsiang; Hewitt, Catherine; Torgerson, David		PROFHER Trial Collaborators	Surgical vs Nonsurgical Treatment of Adults With Displaced Fractures of the Proximal Humerus The PROFHER Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONOPERATIVE TREATMENT; ELDERLY-PATIENTS; EPIDEMIOLOGY; SHOULDER; CLASSIFICATION; FIXATION; TRENDS	IMPORTANCE The need for surgery for the majority of patients with displaced proximal humeral fractures is unclear, but its use is increasing. OBJECTIVE To evaluate the clinical effectiveness of surgical vs nonsurgical treatment for adults with displaced fractures of the proximal humerus involving the surgical neck. DESIGN, SETTING, AND PARTICIPANTS A pragmatic, multicenter, parallel-group, randomized clinical trial, the Proximal Fracture of the Humerus Evaluation by Randomization (PROFHER) trial, recruited 250 patients aged 16 years or older (mean age, 66 years [range, 24-92 years]; 192 [77%] were female; and 249 [99.6%] were white) who presented at the orthopedic departments of 32 acute UK National Health Service hospitals between September 2008 and April 2011 within 3 weeks after sustaining a displaced fracture of the proximal humerus involving the surgical neck. Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data. The data for 231 patients (114 in surgical group and 117 in nonsurgical group) were included in the primary analysis. INTERVENTIONS Fracture fixation or humeral head replacement were performed by surgeons experienced in these techniques. Nonsurgical treatment was sling immobilization. Standardized outpatient and community-based rehabilitation was provided to both groups. MAIN OUTCOMES AND MEASURES Primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months. Sample size was based on a minimal clinically important difference of 5 points for the Oxford Shoulder Score. Secondary outcomes were the Short-Form 12 (SF-12), complications, subsequent therapy, and mortality. RESULTS There was no significant mean treatment group difference in the Oxford Shoulder Score averaged over 2 years (39.07 points for the surgical group vs 38.32 points for the nonsurgical group; difference of0.75 points [95% CI, -1.33 to 2.84 points]; P =.48) or at individual time points. Therewere also no significant between-group differences over 2 years in the mean SF-12 physical component score (surgical group: 1.77 points higher [95% CI, -0.84 to 4.39 points]; P =.18); the mean SF-12 mental component score (surgical group: 1.28 points lower [95% CI, -3.80to 1.23 points]; P =.32); complications related to surgery or shoulder fracture (30 patients in surgical group vs 23 patients in nonsurgical group; P =.28), requiring secondary surgery to the shoulder (11 patients in both groups), and increased or new shoulder-related therapy (7 patients vs 4 patients, respectively; P =.58); and mortality (9 patients vs 5 patients; P =.27). Ten medical complications (2 cardiovascular events, 2 respiratory events, 2 gastrointestinal events, and 4 others) occurred in the surgical group during the postoperative hospital stay. CONCLUSIONS AND RELEVANCE Among patients with displaced proximal humeral fractures involving the surgical neck, there was no significant difference between surgical treatment compared with nonsurgical treatment in patient-reported clinical outcomes over 2 years following fracture occurrence. These results do not support the trend of increased surgery for patients with displaced fractures of the proximal humerus.	[Rangan, Amar; Goodchild, Lorna] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; [Handoll, Helen] Univ Teesside, Hlth & Social Care Inst, Sch Hlth & Social Care, Middlesbrough, Cleveland, England; [Brealey, Stephen; Jefferson, Laura; Keding, Ada; Martin, Belen Corbacho; Hewitt, Catherine; Torgerson, David] Univ York, York Trials Unit, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Chuang, Ling-Hsiang] Pharmerit Europe, Rotterdam, Netherlands	James Cook University Hospital; University of Teesside; University of York - UK	Rangan, A (corresponding author), James Cook Univ Hosp, Marton Rd, Middlesbrough TS4 3BW, Cleveland, England.	amar.rangan@stees.nhs.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Handoll, Helen/0000-0002-8250-168X; Hewitt, Catherine Elizabeth/0000-0002-0415-3536; Jefferson, Laura/0000-0003-2139-3555; brealey, stephen/0000-0001-9749-7014	National Institute for Health Research [06/404/53]	National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was funded by the National Institute for Health Research, Health Technology Assessment Programme (project No. 06/404/53) and will be published in full in UK Health Technology Assessment.	Baker P, 2008, J SHOULDER ELB SURG, V17, P37, DOI 10.1016/j.jse.2007.04.019; Bell JE, 2011, J BONE JOINT SURG AM, V93A, P121, DOI 10.2106/JBJS.I.01505; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brorson S, 2008, J CLIN EPIDEMIOL, V61, P7, DOI 10.1016/j.jclinepi.2007.04.014; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Court-Brown CM, 2001, ACTA ORTHOP SCAND, V72, P365, DOI 10.1080/000164701753542023; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P593, DOI 10.1302/0301-620X.78B4.0780593; Dawson J, 2009, ARCH ORTHOP TRAUM SU, V129, P119, DOI 10.1007/s00402-007-0549-7; Fjalestad T, 2010, INJURY, V41, P599, DOI 10.1016/j.injury.2009.10.056; Handoll H, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-140; Handoll HHG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000434.pub3; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kim SH, 2012, ARTHRIT CARE RES, V64, P407, DOI 10.1002/acr.21563; KRISTIANSEN B, 1988, J BONE JOINT SURG BR, V70, P821, DOI 10.1302/0301-620X.70B5.3056948; Neer CS, 2002, J SHOULDER ELB SURG, V11, P389, DOI 10.1067/mse.2002.124346; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Olerud P, 2011, J SHOULDER ELB SURG, V20, P1025, DOI 10.1016/j.jse.2011.04.016; Olerud P, 2011, J SHOULDER ELB SURG, V20, P747, DOI 10.1016/j.jse.2010.12.018; Palvanen M, 2006, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000194672.79634.78; Polinder S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-531; STABLEFORTH PG, 1984, J BONE JOINT SURG BR, V66, P104, DOI 10.1302/0301-620X.66B1.6693466; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Thanasas C, 2009, J SHOULDER ELB SURG, V18, P837, DOI 10.1016/j.jse.2009.06.004; van de Water ATM, 2014, DISABIL REHABIL, V36, P1072, DOI 10.3109/09638288.2013.829529; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Zyto K, 1997, J BONE JOINT SURG BR, V79B, P412, DOI 10.1302/0301-620X.79B3.7419	26	255	266	2	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1037	1047		10.1001/jama.2015.1629	http://dx.doi.org/10.1001/jama.2015.1629			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756440	Bronze			2022-12-28	WOS:000350643100019
J	Hewitt, RJ; Francis, M; Singanayagam, A; Kon, OM				Hewitt, Richard J.; Francis, Marie; Singanayagam, Aran; Kon, Onn Min			RATIONAL TESTING Screening tests for tuberculosis before starting biological therapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GAMMA RELEASE ASSAYS; INFLAMMATORY-BOWEL-DISEASE; LATENT TUBERCULOSIS; SKIN-TEST; RHEUMATOID-ARTHRITIS; INFECTION; PERFORMANCE; RISK		[Hewitt, Richard J.; Francis, Marie; Singanayagam, Aran; Kon, Onn Min] Imperial Coll NHS Trust, St Marys Hosp, Chest & Allergy Dept, London W2 1NY, England; [Kon, Onn Min] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London; Imperial College London	Kon, OM (corresponding author), Imperial Coll NHS Trust, St Marys Hosp, Chest & Allergy Dept, London W2 1NY, England.	onn.kon@imperial.nhs.uk		Kon, Onn Min/0000-0003-2647-4688; Singanayagam, Aran/0000-0001-9849-0033				Bartalesi F, 2009, EUR RESPIR J, V33, P586, DOI 10.1183/09031936.00107608; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Costantino F, 2013, J RHEUMATOL, V40, P1986, DOI 10.3899/jrheum.130303; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; European Centre for Disease Prevention and Control, 2011, US INT GAMM REL ASS; Greveson K, 2013, J CROHNS COLITIS, V7, P412, DOI 10.1016/j.crohns.2012.08.010; Hsia EC, 2012, ARTHRITIS RHEUM-US, V64, P2068, DOI 10.1002/art.34382; Kleinert S, 2012, ANN RHEUM DIS, V71, P1791, DOI 10.1136/annrheumdis-2011-200941; Kourbeti IS, 2014, CLIN INFECT DIS, V58, P1649, DOI 10.1093/cid/ciu185; Mariette X, 2012, ANN RHEUM DIS, V71, P1783, DOI 10.1136/annrheumdis-2011-200408; Martyn-Simmons CL, 2013, BRIT J DERMATOL, V168, P1012, DOI 10.1111/bjd.12176; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Munoz L, 2015, CLIN INFECT DIS, V60, P349, DOI 10.1093/cid/ciu796; National Institute for Health and Care Excellence, 2011, TUB CLIN DIAGN MAN, V117; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Ruan Q, 2014, CLIN RHEUMATOL; Shahidi N, 2012, INFLAMM BOWEL DIS, V18, P2034, DOI 10.1002/ibd.22901; Singanayagam A, 2013, THORAX, V68, P955, DOI 10.1136/thoraxjnl-2013-203436; Soborg B, 2009, J RHEUMATOL, V36, P1876, DOI 10.3899/jrheum.081292; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	21	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2015	350								h1060	10.1136/bmj.h1060	http://dx.doi.org/10.1136/bmj.h1060			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DP	25742884				2022-12-28	WOS:000351180000001
J	Torjesen, I				Torjesen, Ingrid			Crowdfunding sought for study that will provide first images of human brain on LSD	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2015	350								h1215	10.1136/bmj.h1215	http://dx.doi.org/10.1136/bmj.h1215			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DP	25742689				2022-12-28	WOS:000351180000005
J	Ross, R; Hudson, R; Stotz, PJ; Lam, M				Ross, Robert; Hudson, Robert; Stotz, Paula J.; Lam, Miu			Effects of Exercise Amount and Intensity on Abdominal Obesity and Glucose Tolerance in Obese Adults	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; UNITED-STATES; ALL-CAUSE; MEN; MORTALITY; WOMEN; RISK	Background: Exercise reduces obesity and related glucose tolerance, but whether increasing exercise intensity offers additional benefit at fixed exercise amounts is unknown. Objective: To determine the separate effects of exercise amount and intensity on abdominal obesity and glucose tolerance. Design: 24-week, single-center, parallel-group trial from 2009 to 2013. (ClinicalTrials. gov: NCT00955071) Setting: Kingston, Ontario, Canada. Participants: 300 abdominally obese adults. Intervention: Control (no exercise) (n = 75) or 5 weekly sessions of low-amount, low-intensity exercise (LALI) (180 and 300 kcal/session for women and men, respectively, at 50% of maximum oxygen consumption [Vo(2)peak]) (n = 73); high-amount, low-intensity exercise (HALI) (360 and 600 kcal/session, respectively, at 50% of Vo(2)peak) (n = 76); or high-amount, high-intensity exercise (HAHI) (360 and 600 kcal/session, respectively, at 75% of Vo(2)peak) (n = 76). Daily unsupervised physical activity and sedentary time were measured by accelerometer. Measurements: Waist circumference and 2-hour glucose level (primary outcomes) and cardiorespiratory fitness and measures of insulin action (secondary measurements). Results: 217 participants (72.3%) completed the intervention. Mean exercise time in minutes per session was 31 (SD, 4.4) for LALI, 58 (SD, 7.6) for HALI, and 40 (SD, 6.2) for HAHI. Daily un- supervised physical activity and sedentary time did not change in any exercise group versus control (P > 0.33). After adjustment for age and sex in a linear mixed model, reductions in waist circumference were greater in the LALI (- 3.9 cm [95% CI, -5.6 to -2.3 cm]; P < 0.001), HALI (-4.6 cm [CI, - 6.2 to -3.0 cm]; P < 0.001), and HAHI (-4.6 cm [CI, -6.3 to -2.9 cm]; P < 0.001) groups than the control group but did not differ among the exercise groups (P > 0.43). After adjustment for covariates, reductions in 2-hour glucose level were greater in the HAHI group (-0.7 mmol/L [-12.5 mg/dL] [CI, -1.3 to -0.1 mmol/L {-23.5 to -1.5 mg/dL}]; P = 0.027) than the control group but did not differ for the LALI or HALI group versus the control group (P > 0.159). Weight loss was greater in all exercise groups than the control group (P < 0.001); however, reduction in body weight did not differ among the exercise groups (P > 0.182). Limitation: The clinical importance of reducing 2-hour glucose level in nondiabetic adults remains undetermined. Conclusion: Fixed amounts of exercise independent of exercise intensity resulted in similar reductions in abdominal obesity. Reduction in 2-hour glucose level was restricted to high-intensity exercise.	[Ross, Robert; Stotz, Paula J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON K7L 3N6, Canada; [Lam, Miu] Queens Univ, Dept Publ Hlth Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Ross, R (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, 28 Div St, Kingston, ON K7L 3N6, Canada.	rossr@queensu.ca		Stotz, Paula/0000-0003-3396-6963	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research.	Berentzen TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013097; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Duscha BD, 2005, CHEST, V128, P2788, DOI 10.1378/chest.128.4.2788; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64; Hedeker D., 2006, LONGITUDINAL DATA AN; Janiszewski PM, 2007, DIABETES CARE, V30, P3105, DOI 10.2337/dc07-0945; Janssen I, 2012, INT J EPIDEMIOL, V41, P1132, DOI 10.1093/ije/dys038; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Little R, 1996, BIOMETRICS, V52, P1324, DOI 10.2307/2532847; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; OVERALL JE, 1994, CONTROL CLIN TRIALS, V15, P100, DOI 10.1016/0197-2456(94)90015-9; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Ross R, 2013, CONTEMP CLIN TRIALS, V34, P155, DOI 10.1016/j.cct.2012.10.010; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; World Health Organization, 2010, GLOB REC PHYS ACT HL, P58	26	115	122	2	47	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2015	162	5					325	U117		10.7326/M14-1189	http://dx.doi.org/10.7326/M14-1189			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3HT	25732273				2022-12-28	WOS:000350238300001
J	Flyak, AI; Ilinykh, PA; Murin, CD; Garron, T; Shen, XL; Fusco, ML; Hashiguchi, T; Bornholdt, ZA; Slaughter, JC; Sapparapu, G; Klages, C; Ksiazek, TG; Ward, AB; Saphire, EO; Bukreyev, A; Crowe, JE				Flyak, Andrew I.; Ilinykh, Philipp A.; Murin, Charles D.; Garron, Tania; Shen, Xiaoli; Fusco, Marnie L.; Hashiguchi, Takao; Bornholdt, Zachary A.; Slaughter, James C.; Sapparapu, Gopal; Klages, Curtis; Ksiazek, Thomas G.; Ward, Andrew B.; Saphire, Erica Ollmann; Bukreyev, Alexander; Crowe, James E., Jr.			Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus	CELL			English	Article							VESICULAR STOMATITIS-VIRUS; EBOLA-VIRUS; NONHUMAN-PRIMATES; SYSTEM; GLYCOPROTEIN; LEGINON; ACQUISITION; GENERATION; MICROSCOPY; PROTECTION	The mechanisms by which neutralizing antibodies inhibit Marburg virus (MARV) are not known. We isolated a panel of neutralizing antibodies from a human MARV survivor that bind to MARV glycoprotein (GP) and compete for binding to a single major antigenic site. Remarkably, several of the antibodies also bind to Ebola virus (EBOV) GP. Single-particle EM structures of antibody-GP complexes reveal that all of the neutralizing antibodies bind to MARV GP at or near the predicted region of the receptor-binding site. The presence of the glycan cap or mucin-like domain blocks binding of neutralizing antibodies to EBOV GP, but not to MARV GP. The data suggest that MARV-neutralizing antibodies inhibit virus by binding to infectious virions at the exposed MARV receptor-binding site, revealing a mechanism of filovirus inhibition.	[Flyak, Andrew I.; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Slaughter, James C.; Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Slaughter, James C.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA; [Ilinykh, Philipp A.; Garron, Tania; Shen, Xiaoli; Klages, Curtis; Ksiazek, Thomas G.; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Ilinykh, Philipp A.; Garron, Tania; Shen, Xiaoli; Klages, Curtis; Ksiazek, Thomas G.; Bukreyev, Alexander] Galveston Natl Lab, Galveston, TX 77550 USA; [Murin, Charles D.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Murin, Charles D.; Fusco, Marnie L.; Hashiguchi, Takao; Bornholdt, Zachary A.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Medical Branch Galveston; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.	james.crowe@vanderbilt.edu	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014; Crowe, James/B-5549-2009; Murin, Charles Daniel/ABA-2861-2020	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Crowe, James/0000-0002-0049-1079; Flyak, Andrew/0000-0002-8722-479X; Saphire, Erica Ollmann/0000-0002-1206-7451; Sapparapu, Gopal/0000-0001-9670-1757; Hashiguchi, Takao/0000-0001-7578-7571; Slaughter, James/0000-0002-8770-980X; Bornholdt, Zachary/0000-0002-7557-9219	Defense Threat Reduction Agency [HDTRA1-13-1-0034]; U.S. NIH [1U19AI109711, U19AI109762, R01AI089498, U01AI082156]; NCRR [UL1 RR024975-01]; National Center for Advancing Translational Sciences [UL1 TR000445-06]; MEXT; JSPS; Uehara Memorial Foundation; NIH [P30 CA68485, DK058404]; Biomedical Technology Research Center program of the National Institute of General Medical Sciences [GM103310]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109711, R01AI089498, U01AI082156, T32AI007244, U19AI109762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Research Center program of the National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project received support from the Defense Threat Reduction Agency (HDTRA1-13-1-0034) (to J.E.C.) and the U.S. NIH (1U19AI109711 to J.E.C. and A.B.; U19AI109762 to E.O.S. and A.B.W.; R01AI089498 and U01AI082156 to E.O.S.). E.O.S. is an Investigator in the Pathogenesis of Infectious Disease of the Burroughs Wellcome Fund. The project was supported by the NCRR (UL1 RR024975-01) and is now at the National Center for Advancing Translational Sciences (UL1 TR000445-06). T.H. received support from MEXT and JSPS Postdoctoral Fellowships for Research Abroad and a Research Fellowship of The Uehara Memorial Foundation. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank Dr. Eugene Agapov (Washington University in St. Louis) for useful suggestions concerning the generation of VSV/GP-Uganda escape mutants. We thank the donor, Dr. Norman Fujit (Wheat Ridge, Colorado), and the Vanderbilt Clinical Trials Center for help in sample acquisition. We thank Frances Smith-House, Gloria Fritz, Vidisha Singh, and Leland Brown for excellent technical support and Dr. Scott A. Smith for thoughtful comments and discussions. Flow cytometry experiments were performed in the VMC Flow Cytometry Shared Resource and supported by NIH grants (P30 CA68485 and DK058404). The EM work was conducted at the National Resource for Automated Molecular Microscopy at The Scripps Research Institute, which is supported by the Biomedical Technology Research Center program (GM103310) of the National Institute of General Medical Sciences.	Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Brauburger K, 2012, VIRUSES-BASEL, V4, P1878, DOI 10.3390/v4101878; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cook JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003258; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Johnson ED, 1996, ARCH VIROL, P101; Kajihara M, 2012, J VIROL, V86, P13467, DOI 10.1128/JVI.01896-12; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lubaki NM, 2013, J VIROL, V87, P7471, DOI 10.1128/JVI.03316-12; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Saphire EO, 2013, IMMUNOTHERAPY-UK, V5, P1221, DOI [10.2217/IMT.13.124, 10.2217/imt.13.124]; SMITH DH, 1982, LANCET, V1, P816; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Warfield KL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-108; Warfield KL, 2009, J VIROL, V83, P6404, DOI 10.1128/JVI.00126-09; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027; WHO, 2015, EB SIT REP; World Health Organization, 2014, MARB VIR DIS UG; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008	47	106	116	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					893	903		10.1016/j.cell.2015.01.031	http://dx.doi.org/10.1016/j.cell.2015.01.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723164	Green Accepted, Bronze			2022-12-28	WOS:000351116100012
J	Marzec, P; Armenise, C; Perot, G; Roumelioti, FM; Basyuk, E; Gagos, S; Chibon, F; Dejardin, J				Marzec, Paulina; Armenise, Claudia; Perot, Gaelle; Roumelioti, Fani-Marlen; Basyuk, Eugenia; Gagos, Sarantis; Chibon, Frederic; Dejardin, Jerome			Nuclear-Receptor-Mediated Telomere Insertion Leads to Genome Instability in ALT Cancers	CELL			English	Article							GENE-EXPRESSION; DNA; SARCOMAS; LOCALIZATION; ORGANIZATION; DYSFUNCTION; PREDICTION; SEQUENCES; CONTAIN; BINDING	The breakage-fusion-bridge cycle is a classical mechanism of telomere-driven genome instability in which dysfunctional telomeres are fused to other chromosomal extremities, creating dicentric chromosomes that eventually break at mitosis. Here, we uncover a distinct pathway of telomere-driven genome instability, specifically occurring in cells that maintain telomeres with the alternative lengthening of telomeres mechanism. We show that, in these cells, telomeric DNA is added to multiple discrete sites throughout the genome, corresponding to regions regulated by NR2C/F transcription factors. These proteins drive local telomere DNA addition by recruiting telomeric chromatin. This mechanism, which we name targeted telomere insertion (TTI), generates potential common fragile sites that destabilize the genome. We propose that TTI driven by NR2C/F proteins contributes to the formation of complex karyotypes in ALT tumors.	[Marzec, Paulina; Armenise, Claudia; Dejardin, Jerome] CNRS UPR 1142, Inst Human Genet, INSERM AVENIR Team, F-34396 Montpellier, France; [Perot, Gaelle; Chibon, Frederic] Inst Bergonie, Dept Biopathol, Translat Res, F-33076 Bordeaux, France; [Perot, Gaelle; Chibon, Frederic] INSERM, U916, F-33076 Bordeaux, France; [Roumelioti, Fani-Marlen; Gagos, Sarantis] Acad Athens, Lab Genet & Gene Therapy, Ctr Basic Res 2, Biomed Res Fdn, Athens 11527, Greece; [Basyuk, Eugenia] CNRS UMR5535, Inst Genet Mol Montpellier, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Academy of Athens; Centre National de la Recherche Scientifique (CNRS)	Dejardin, J (corresponding author), CNRS UPR 1142, Inst Human Genet, INSERM AVENIR Team, 141 Rue Cardonille, F-34396 Montpellier, France.	jerome.dejardin@igh.cnrs.fr	Pérot, Gaëlle/W-8038-2019; chibon, frederic/A-2651-2013	DEJARDIN, Jerome/0000-0003-0151-1104; chibon, Frederic/0000-0002-6548-2181; Basyuk, Eugenia/0000-0001-9768-4557; GAGOS, SARANTIS/0000-0003-4907-7706	European Research Council [242934]; INSERM AVENIR; Association pour la Recherche contre le Cancer	European Research Council(European Research Council (ERC)European Commission); INSERM AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	We would like to thank Jan Karlseder and Cyril Ribeyre for critical reading of the manuscript and members of the Dejardin lab for stimulating discussions, Osamu Tanabe for the gift of the NR2C2 constructs, and Evi Soutoglou for the gift of the HeLa LacO transgenic line. Work in J.D.'s lab is funded by the European Research Council (StG#242934) and INSERM AVENIR. P.M. is funded by the Association pour la Recherche contre le Cancer.	ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bosco N, 2012, CHROMOSOMA, V121, P465, DOI 10.1007/s00412-012-0377-6; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; CHEN HW, 1995, P NATL ACAD SCI USA, V92, P422, DOI 10.1073/pnas.92.2.422; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Conomos D, 2012, J CELL BIOL, V199, P893, DOI 10.1083/jcb.201207189; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2012, BIOESSAYS, V34, P90, DOI 10.1002/bies.201100122; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Guillou L, 2010, VIRCHOWS ARCH, V456, P201, DOI 10.1007/s00428-009-0853-4; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henson JD, 2005, CLIN CANCER RES, V11, P217; Henson JD, 2010, FEBS LETT, V584, P3800, DOI 10.1016/j.febslet.2010.06.009; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Jain S, 2010, INT J CLIN EXP PATHO, V3, P416; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Kilburn AE, 2001, MOL CELL BIOL, V21, P126, DOI 10.1128/MCB.21.1.126-135.2001; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; McClintock B, 1941, GENETICS, V26, P234; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; O'Geen H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-689; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Scheel C, 2001, ONCOGENE, V20, P3835, DOI 10.1038/sj.onc.1204493; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Simonet T, 2011, CELL RES, V21, P1028, DOI 10.1038/cr.2011.40; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087	40	62	63	4	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					913	927		10.1016/j.cell.2015.01.044	http://dx.doi.org/10.1016/j.cell.2015.01.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723166	Bronze			2022-12-28	WOS:000351116100014
J	Tittel, W				Tittel, Wolfgang			QUANTUM PHYSICS Teleportation for two	NATURE			English	Editorial Material									[Tittel, Wolfgang] Univ Calgary, Inst Quantum Sci & Technol, Calgary, AB T2N 1N4, Canada; [Tittel, Wolfgang] Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Tittel, W (corresponding author), Univ Calgary, Inst Quantum Sci & Technol, Calgary, AB T2N 1N4, Canada.	wtittel@ucalgary.ca	Tittel, Wolfgang/AAW-7332-2020; Tittel, Wolfgang/A-1600-2011	Tittel, Wolfgang/0000-0003-3136-8919; 				BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Grice W. P., 2011, PHYS REV A, V84; Wang XL, 2015, NATURE, V518, P516, DOI 10.1038/nature14246; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0	5	3	3	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					491	492		10.1038/518491a	http://dx.doi.org/10.1038/518491a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719664				2022-12-28	WOS:000350097300036
J	Diouf, B; Crews, KR; Lew, G; Pei, DQ; Cheng, C; Bao, J; Zheng, JJ; Yang, WJ; Fan, YP; Wheeler, HE; Wing, C; Delaney, SM; Komatsu, M; Paugh, SW; McCorkle, JR; Lu, XM; Winick, NJ; Carroll, WL; Loh, ML; Hunger, SP; Devidas, M; Pui, CH; Dolan, ME; Relling, MV; Evans, WE				Diouf, Barthelemy; Crews, Kristine R.; Lew, Glen; Pei, Deqing; Cheng, Cheng; Bao, Ju; Zheng, Jie J.; Yang, Wenjian; Fan, Yiping; Wheeler, Heather E.; Wing, Claudia; Delaney, Shannon M.; Komatsu, Masaaki; Paugh, Steven W.; McCorkle, Joseph Robert; Lu, Xiaomin; Winick, Naomi J.; Carroll, William L.; Loh, Mignon L.; Hunger, Stephen P.; Devidas, Meenakshi; Pui, Ching-Hon; Dolan, M. Eileen; Relling, Mary V.; Evans, William E.			Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHARMACOKINETICS; CANCER; EXPRESSION; GENOTYPES; ANCESTRY; THERAPY; CELLS	IMPORTANCE With cure rates of childhood acute lymphoblastic leukemia (ALL) exceeding 85%, there is a need to mitigate treatment toxicities that can compromise quality of life, including peripheral neuropathy from vincristine treatment. OBJECTIVE To identify genetic germline variants associated with the occurrence or severity of vincristine-induced peripheral neuropathy in children with ALL. DESIGN, SETTING, AND PARTICIPANTS Genome-wide association study of patients in 1 of 2 prospective clinical trials for childhood ALL that included treatment with 36 to 39 doses of vincristine. Genome-wide single-nucleotide polymorphism (SNP) analysis and vincristine-induced peripheral neuropathy were assessed in 321 patients from whom DNA was available: 222 patients (median age, 6.0 years; range, 0.1-18.8 years) enrolled in 1994-1998 in the St Jude Children's Research Hospital protocol Total XIIIB with toxic effects follow-up through January 2001, and 99 patients (median age, 11.4 years; range, 3.0-23.8 years) enrolled in 2007-2010 in the Children's Oncology Group (COG) protocol AALL0433 with toxic effects follow-up through May 2011. Human leukemia cells and induced pluripotent stem cell neurons were used to assess the effects of lower CEP72 expression on vincristine sensitivity. EXPOSURE Treatment with vincristine at a dose of 1.5 or 2.0 mg/m(2). MAIN OUTCOMES AND MEASURES Vincristine-induced peripheral neuropathy was assessed at clinic visits using National Cancer Institute criteria and prospectively graded as mild (grade 1), moderate (grade 2), serious/disabling (grade 3), or life threatening (grade 4). RESULTS Grade 2 to 4 vincristine-induced neuropathy during continuation therapy occurred in 28.8% of patients (64/222) in the St Jude cohort and in 22.2%(22/99) in the COG cohort. A SNP in the promoter region of the CEP72 gene, which encodes a centrosomal protein involved in microtubule formation, had a significant association with vincristine neuropathy (meta-analysis P = 6.3x10(-9)). This SNP had a minor allele frequency of 37% (235/642), with 50 of 321 patients (16%; 95% CI, 11.6%-19.5%) homozygous for the risk allele (TT at rs924607). Among patients with the high-risk CEP72 genotype (TT at rs924607), 28 of 50 (56%; 95% CI, 41.2%-70.0%) developed at least 1 episode of grade 2 to 4 neuropathy, a higher rate than in patients with the CEP72 CC or CT genotypes (58/271 patients [21.4%; 95% CI, 16.9%-26.7%]; P = 2.4x10(-6)). The severity of neuropathy was greater in patients homozygous for the TT genotype compared with patients with the CC or CT genotype (2.4-fold by Poisson regression [P<.0001] and 2.7-fold based on mean grade of neuropathy: 1.23 [95% CI, 0.74-1.72] vs 0.45 [95% CI, 0.3-0.6]; P = .004 by t test). Reducing CEP72 expression in human neurons and leukemia cells increased their sensitivity to vincristine. CONCLUSIONS AND RELEVANCE In this preliminary study of children with ALL, an inherited polymorphism in the promoter region of CEP72 was associated with increased risk and severity of vincristine-related peripheral neuropathy. If replicated in additional populations, this finding may provide a basis for safer dosing of this widely prescribed anticancer agent.	[Diouf, Barthelemy; Crews, Kristine R.; Yang, Wenjian; Paugh, Steven W.; McCorkle, Joseph Robert; Relling, Mary V.; Evans, William E.] St Jude Childrens Res Hosp, Hematol Malignancies Program, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Lew, Glen] Emory Univ, Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Bao, Ju; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Wheeler, Heather E.; Wing, Claudia; Delaney, Shannon M.; Komatsu, Masaaki; Dolan, M. Eileen] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Lu, Xiaomin; Devidas, Meenakshi] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA; [Lu, Xiaomin; Devidas, Meenakshi] Univ Florida, Coll Publ Hlth, Dept Biostat, Gainesville, FL USA; [Lu, Xiaomin; Devidas, Meenakshi] Univ Florida, Coll Hlth Profess, Dept Biostat, Gainesville, FL USA; [Winick, Naomi J.] Univ Texas Southwestern Sch Med, Div Pediat Hematol Oncol, Dallas, TX USA; [Carroll, William L.] NYU, Inst Canc, New York, NY USA; [Loh, Mignon L.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Hunger, Stephen P.] Univ Colorado, Sch Med, Childrens Hosp Colorado,Ctr Canc & Blood Disorder, Sect Pediat Hematol Oncol Bone Marrow Transplanta, Aurora, CO USA; [Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Children's Healthcare of Atlanta (CHOA); Emory University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Chicago; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; New York University; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; St Jude Children's Research Hospital	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Hematol Malignancies Program, Dept Pharmaceut Sci, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	william.evans@stjude.org	McCorkle, Rob/AAH-3759-2019; Relling, Mary/N-5032-2018; Evans, William E./C-2069-2012; Pui, Ching-Hon/N-8076-2018; Wheeler, Heather/I-9279-2019; Devidas, Meenakshi/H-1170-2019; Paugh, Steven/A-7739-2008; Cheng, Cheng/N-8075-2018	McCorkle, Rob/0000-0002-5028-8853; Evans, William E./0000-0002-9333-5322; Pui, Ching-Hon/0000-0003-0303-5658; Wheeler, Heather/0000-0003-1365-9667; Devidas, Meenakshi/0000-0002-1099-3478; Paugh, Steven/0000-0001-5697-9228; Zheng, Jie/0000-0001-6524-6800; Loh, Mignon/0000-0003-4099-4700; Wing, Claudia/0000-0002-8243-5598; Crews, Kristine/0000-0002-7558-558X	National Institutes of Health [U01 GM92666, U01 GM61393, R01 CA136765, R37 CA36401, F32 CA165823]; Comprehensive Cancer Center grants [CA21765, U10 CA98543, U10 CA98413, U24 CA114766]; National Cancer Institute; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [U10CA098543, U24CA114766, R01CA036401, U10CA098413, U10CA180886, R37CA036401, F32CA165823, R01CA136765, P30CA021765] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM092666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center grants; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by National Institutes of Health grants U01 GM92666 (Drs Pei, Cheng, Yang, Paugh, Loh, Devidas, Relling, and Evans), U01 GM61393 (Dr Dolan), R01 CA136765 (Dr Dolan), and R37 CA36401 (Drs Relling and Evans), F32 CA165823 (Dr Wheeler); Comprehensive Cancer Center grants CA21765, U10 CA98543 (COG Chair's grant), U10 CA98413 (COG Statistical Center), and U24 CA114766 (COG Specimen Banking); and by the National Cancer Institute and the American Lebanese Syrian Associated Charities.	Aplenc R, 2003, BRIT J HAEMATOL, V122, P240, DOI 10.1046/j.1365-2141.2003.04430.x; Aytac S, 2006, TURKISH J PEDIATR, V48, P1; BRADLEY WG, 1970, J NEUROL SCI, V10, P107, DOI 10.1016/0022-510X(70)90013-4; CROM WR, 1994, J PEDIATR-US, V125, P642, DOI 10.1016/S0022-3476(94)70027-3; Egbelakin A, 2011, PEDIATR BLOOD CANCER, V56, P361, DOI 10.1002/pbc.22845; Gidding CEM, 1999, CANCER CHEMOTH PHARM, V44, P203, DOI 10.1007/s002800050968; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kalbfleisch JD, 2002, STAT ANAL FAILURE TI; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; National Cancer Institute, CANC THER EV PROGR; Pal P K, 1999, Electromyogr Clin Neurophysiol, V39, P323; Pizzo PA, 2011, PRINCIPLES PRACTICE; Plasschaert SLA, 2004, CLIN PHARMACOL THER, V76, P220, DOI 10.1016/j.clpt.2004.05.007; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Renbarger JL, 2008, PEDIATR BLOOD CANCER, V50, P769, DOI 10.1002/pbc.21435; Ross CJD, 2011, J POPUL THER CLIN PH, V18, pE134; ROWINSKY EK, 1991, PHARMACOL THERAPEUT, V52, P35, DOI 10.1016/0163-7258(91)90086-2; Toh HC, 1998, LEUKEMIA LYMPHOMA, V31, P195, DOI 10.3109/10428199809057599; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763	27	175	178	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					815	823		10.1001/jama.2015.0894	http://dx.doi.org/10.1001/jama.2015.0894			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710658	Green Accepted			2022-12-28	WOS:000349826400015
J	Vora, NL; Chescheir, N				Vora, Neeta L.; Chescheir, Nancy			Delivery of the growth restricted preterm fetus	LANCET			English	Editorial Material							MANAGEMENT		[Vora, Neeta L.; Chescheir, Nancy] Univ N Carolina, Sch Med, Chapel Hill, NC 27517 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Vora, NL (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27517 USA.	neeta_vora@med.unc.edu		Chescheir, Nancy/0000-0002-0205-5051; Vora, Neeta/0000-0002-2504-9455	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001441] Funding Source: NIH RePORTER; NICHD NIH HHS [K12 HD001441] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Berkley E, 2012, AM J OBSTET GYNECOL, V206, P300, DOI 10.1016/j.ajog.2012.01.022; Bilardo CM, 2004, ULTRASOUND OBST GYN, V23, P119, DOI 10.1002/uog.965; Lees CC, 2015, LANCET; Turan S, 2008, SEMIN PERINATOL, V32, P194, DOI 10.1053/j.semperi.2008.02.008; Unterscheider J, 2014, EUR J OBSTET GYN R B, V174, P41, DOI 10.1016/j.ejogrb.2013.11.022; Walker DM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.019; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]	7	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2126	2128		10.1016/S0140-6736(14)62455-7	http://dx.doi.org/10.1016/S0140-6736(14)62455-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25747580	Green Accepted			2022-12-28	WOS:000355583000006
J	Quick, JA; Barnes, SL				Quick, Jacob A.; Barnes, Stephen L.			Correct coagulopathy: quickly and effectively	LANCET			English	Editorial Material							PROTHROMBIN COMPLEX CONCENTRATE; FRESH-FROZEN PLASMA; REVERSAL; WARFARIN; TRAUMA; ANTICOAGULATION; SAFETY		[Quick, Jacob A.; Barnes, Stephen L.] Univ Missouri, Dept Surg, Div Acute Care Surg, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Quick, JA (corresponding author), Univ Missouri, Dept Surg, Div Acute Care Surg, Columbia, MO 65212 USA.	quickja@health.missouri.edu		Barnes, Stephen/0000-0001-6186-1435				Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Dzik W, 2012, TRANSFUSION, V52, p45S, DOI 10.1111/j.1537-2995.2012.03690.x; Goldstein JN, 2015, LANCET; Guest JF, 2010, CLIN THER, V32, P2478, DOI 10.1016/j.clinthera.2011.01.011; Joseph B, 2014, WORLD J SURG, V38, P1875, DOI 10.1007/s00268-014-2631-y; Li G, 2001, TRANSFUSION, V51, P338; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Pirmohamed M, 2006, BRIT J CLIN PHARMACO, V62, P509, DOI 10.1111/j.1365-2125.2006.02806.x; Quick JA, 2012, SURGERY, V152, P722, DOI 10.1016/j.surg.2012.07.024; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Sorensen B, 2011, CRIT CARE, V15, DOI 10.1186/cc9311; Xu Yan, 2013, CMAJ Open, V1, pE115, DOI 10.9778/cmajo.20130032	13	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2024	2026		10.1016/S0140-6736(14)61934-6	http://dx.doi.org/10.1016/S0140-6736(14)61934-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	25728934				2022-12-28	WOS:000354979100008
J	Fischer, N; Neumann, P; Konevega, AL; Bock, LV; Ficner, R; Rodnina, MV; Stark, H				Fischer, Niels; Neumann, Piotr; Konevega, Andrey L.; Bock, Lars V.; Ficner, Ralf; Rodnina, Marina V.; Stark, Holger			Structure of the E. coli ribosome-EF-Tu complex at < 3 angstrom resolution by C-s-corrected cryo-EM	NATURE			English	Article							PEPTIDYL TRANSFERASE CENTER; AMINOACYL-TRANSFER-RNA; ELONGATION-FACTOR TU; CRYSTAL-STRUCTURE; TRANSLATION; METHYLATIONS; REFINEMENT; RESISTANCE; INITIATION; MECHANISM	Single particle electron cryomicroscopy (cryo-EM) has recently made significant progress in high-resolution structure determination of macromolecular complexes due to improvements in electron microscopic instrumentation and computational image analysis. However, cryo-EM structures can be highly non-uniform in local resolution" and all structures available to date have been limited to resolutions above 3 angstrom(3,4). Here we present the cryo-EM structure of the 70S ribosome from Escherichia coli in complex with elongation factor Tu, aminoacyl-tRNA and the antibiotic kirromycin at 2.65-2.9 angstrom resolution using spherical aberration (c)-corrected cryo-EM. Overall, the cryo-EM reconstruction at 2.9 angstrom resolution is comparable to the best-resolved X-ray structure of the E. coil 70S ribosome(5) (2.8 angstrom), but provides more detailed information (2.65 angstrom) at the functionally important ribosomal core. The cryo-EM map elucidates for the first time the structure of all 35 rRNA modifications in the bacterial ribosome, explaining their roles in fine-tuning ribosome structure and function and modulating the action of antibiotics. We also obtained atomic models for flexible parts of the ribosome such as ribosomal proteins L9 and L31. The refined cryo-EM -based model presents the currently most complete high-resolution structure of the E. coil ribosome, which demonstrates the power of cryo-EM in structure determination of large and dynamic macromolecular complexes.	[Fischer, Niels; Stark, Holger] Max Planck Inst Biophys Chem, Electron Cryomicroscopy Grp 3D, D-37077 Gottingen, Germany; [Neumann, Piotr; Ficner, Ralf] Univ Gottingen, Abt Mol Strukturbiol, Inst Mikrobiol & Genet, GZMB, D-37077 Gottingen, Germany; [Konevega, Andrey L.] Kurchatov Inst, BP Konstantinov Petersburg Nucl Phys Inst, Natl Res Ctr, Mol & Radiat Biophys Dept, Gatchina 188300, Russia; [Konevega, Andrey L.] St Petersburg Polytech Univ, St Petersburg 195251, Russia; [Konevega, Andrey L.; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Bock, Lars V.] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Stark, Holger] Univ Gottingen, Inst Microbiol & Genet, Dept Electron Cryomicroscopy 3D, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Peter the Great St. Petersburg Polytechnic University; Max Planck Society; Max Planck Society; University of Gottingen	Fischer, N (corresponding author), Max Planck Inst Biophys Chem, Electron Cryomicroscopy Grp 3D, Fassberg 11, D-37077 Gottingen, Germany.	niels.fischer@mpibpc.mpg.de; hstark1@gwdg.de	Rodnina, Marina V./AAD-4667-2019; Fischer, Niels/ABA-5342-2021; Konevega, Andrey L./B-7887-2008	Rodnina, Marina V./0000-0003-0105-3879; Fischer, Niels/0000-0002-4609-4052; Konevega, Andrey L./0000-0003-0125-7150; Holger, Stark/0000-0002-6161-1118; Bock, Lars V./0000-0003-4554-7336	Deutsche Forschungsgemeinschaft [FOR 1805];  [Sonderforschungsbereich 860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	We thank F. Wurriehausen for expert technical assistance and M. Luttich and B. Busche for support in high-performance computation and programming. The work was supported by the Deutsche Forschungsgemeinschaft Grant FOR 1805 (to H.S. and M.V.R.) and by the Sonderforschungsbereich 860 (to H.S., R. F., and M.V.R.).	Akanuma G, 2006, J BACTERIOL, V188, P2715, DOI 10.1128/JB.188.7.2715-2720.2006; Bock LV, 2013, NAT STRUCT MOL BIOL, V20, P1390, DOI 10.1038/nsmb.2690; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Burakovsky DE, 2012, NUCLEIC ACIDS RES, V40, P7885, DOI 10.1093/nar/gks508; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Das G, 2008, EMBO J, V27, P840, DOI 10.1038/emboj.2008.20; David-Eden H, 2010, NUCLEIC ACIDS RES, V38, P5982, DOI 10.1093/nar/gkq411; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Green R, 1996, RNA, V2, P1011; Gutierrez B, 2012, ANTIMICROB AGENTS CH, V56, P2335, DOI 10.1128/AAC.06066-11; Ippolito JA, 2008, J MED CHEM, V51, P3353, DOI 10.1021/jm800379d; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LaMarre JM, 2011, ANTIMICROB AGENTS CH, V55, P2989, DOI 10.1128/AAC.00183-11; Leschziner AE, 2007, ANNU REV BIOPH BIOM, V36, P43, DOI 10.1146/annurev.biophys.36.040306.132742; Milon P, 2007, METHOD ENZYMOL, V430, P1, DOI 10.1016/S0076-6879(07)30001-3; Noeske J, 2014, ANTIMICROB AGENTS CH, V58, P5269, DOI 10.1128/AAC.03389-14; Osterman IA, 2011, BIOCHIMIE, V93, P725, DOI 10.1016/j.biochi.2010.12.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polikanov YS, 2014, MOL CELL, V56, P531, DOI 10.1016/j.molcel.2014.09.020; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schroder GF, 2014, ACTA CRYSTALLOGR D, V70, P2241, DOI 10.1107/S1399004714016496; Schuwirth BS, 2006, NAT STRUCT MOL BIOL, V13, P879, DOI 10.1038/nsmb1150; Sergiev PV, 2008, J MOL BIOL, V375, P291, DOI 10.1016/j.jmb.2007.10.051; Sergiev PV, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P97; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Toh SM, 2008, J MOL BIOL, V380, P593, DOI 10.1016/j.jmb.2008.05.027; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Yu XK, 2011, STRUCTURE, V19, P652, DOI 10.1016/j.str.2011.03.003	42	261	265	4	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					567	+		10.1038/nature14275	http://dx.doi.org/10.1038/nature14275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25707802	Green Published			2022-12-28	WOS:000353334500049
J	Feldman, DR; Collins, WD; Gero, PJ; Torn, MS; Mlawer, EJ; Shippert, TR				Feldman, D. R.; Collins, W. D.; Gero, P. J.; Torn, M. S.; Mlawer, E. J.; Shippert, T. R.			Observational determination of surface radiative forcing by CO2 from 2000 to 2010	NATURE			English	Article							EMITTED RADIANCE INTERFEROMETER; CARBON-DIOXIDE; WATER-VAPOR; LONGWAVE RADIATION; SPECTRA; TEMPERATURE; TRENDS; RECORD; CLOUD; MODEL	The climatic impact of CO2 and other greenhouse gases is usually quantified in terms of radiative forcing', calculated as the difference between estimates of the Earth's radiation field from pre-industrial and presentday concentrations of these gases. Radiative transfer models calculate that the increase in CO2 since 1750 corresponds to a global annualmean radiative forcing at the tropopause of 1.82 +/- 0.19W m(-2) (ref. 2). However, despite widespread scientific discussion and modelling of the climate impacts of well-mixed greenhouse gases, there is little direct observational evidence of the radiative impact of increasing atmospheric CO2. Here we present observationally based evidence of clear-sky CO2 surface radiative forcing that is directly attributable to the increase, between 2000 and 2010, of 22 parts per million atmospheric CO2. The time series of this forcing at the two locations the Southern Great Plains and the North Slope of Alaska are derived from Atmospheric Emitted Radiance Interferometer spectra' together with ancillary measurements and thoroughly corroborated radiative transfer calculations'. The time series both show statistically significant trends of 0.2 W m(-2) per decade (with respective uncertainties of +/- 0.06 W m(-2) per decade and 0.07 W m(-2) per decade) and have seasonal ranges of 0.1-0.2W m(-2). This is approximately ten per cent of the trend in downwelling longwave radiation'''. These results confirm theoretical predictions of the atmospheric greenhouse effect due to anthropogenic emissions, and provide empirical evidence of how rising CO2 levels, mediated by temporal variations due to photosynthesis and respiration, are affecting the surface energy balance.	[Feldman, D. R.; Collins, W. D.; Torn, M. S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Collins, W. D.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Gero, P. J.] Univ Wisconsin, Space Sci & Engn Ctr, Madison, WI 53706 USA; [Torn, M. S.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Mlawer, E. J.] Atmospher & Environm Res Inc, Lexington, MA 02141 USA; [Shippert, T. R.] Pacific NW Natl Lab, Fundamental & Computat Sci, Richland, WA 99354 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; Atmospheric & Environmental Research; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Feldman, DR (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, 1 Cyclotron Rd,MS 74R-316C, Berkeley, CA 94720 USA.	drfeldman@lbl.gov	Feldman, Daniel/AAL-2110-2021; Collins, William D/J-3147-2014; Torn, Margaret S/D-2305-2015; Feldman, Daniel/N-8703-2013; Torn, Margaret/CAF-8960-2022	Feldman, Daniel/0000-0003-3365-5233; Collins, William D/0000-0002-4463-9848; Torn, Margaret S/0000-0002-8174-0099; Feldman, Daniel/0000-0003-3365-5233; Torn, Margaret/0000-0002-8174-0099	US Department of Energy, Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division, of the US Department of Energy as part of the Atmospheric System Research Program [DE-AC02-05CH11231]; Atmospheric Radiation Measurement (ARM) Climate Research Facility Southern Great Plains; National Energy Research Scientific Computing Center (NERSC) [DE-AC02-05CH11231]	US Department of Energy, Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division, of the US Department of Energy as part of the Atmospheric System Research Program; Atmospheric Radiation Measurement (ARM) Climate Research Facility Southern Great Plains; National Energy Research Scientific Computing Center (NERSC)	This material is based upon work supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division, of the US Department of Energy under Award Number DE-AC02-05CH11231 as part of the Atmospheric System Research Program and the Atmospheric Radiation Measurement (ARM) Climate Research Facility Southern Great Plains. We used resources of the National Energy Research Scientific Computing Center (NERSC) under that same award. I. Williams, W. Riley, and S. Biraud of the Lawrence Berkeley National Laboratory, and D. Turner of the National Severe Storms Laboratory also provided feedback. The Broadband Heating Rate Profile (BBHRP) runs were performed using Pacific Northwest National Laboratory (PNNL) Institutional Computing at PNNL, with help from K. Cady-Pereira of Atmospheric Environmental Research, Inc., L. Riihimaki of PNNL, and D. Troyan of Brookhaven National Laboratory.	Alvarado MJ, 2013, ATMOS CHEM PHYS, V13, P6687, DOI 10.5194/acp-13-6687-2013; Anderson G, 1986, AFGLTR860110; Andrews T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043991; BAKWIN PS, 1995, TELLUS B, V47, P535, DOI 10.1034/j.1600-0889.47.issue5.2.x; Bakwin PS, 1998, TELLUS B, V50, P401, DOI 10.1034/j.1600-0889.1998.t01-4-00001.x; Best F. A., 2003, C CHAR RAD CAL REM S; Biraud SC, 2013, ATMOS MEAS TECH, V6, P751, DOI 10.5194/amt-6-751-2013; Bruhwiler L, 2014, ATMOS CHEM PHYS, V14, P8269, DOI 10.5194/acp-14-8269-2014; Cimini D, 2003, IEEE T GEOSCI REMOTE, V41, P2605, DOI 10.1109/TGRS.2003.815673; Clothiaux E. E., 2001, VAP0021 ARM; Clothiaux EE, 2000, J APPL METEOROL, V39, P645, DOI 10.1175/1520-0450(2000)039<0645:ODOCHA>2.0.CO;2; Clough SA, 2005, J QUANT SPECTROSC RA, V91, P233, DOI 10.1016/j.jqsrt.2004.05.058; Collins WD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006713; Dessler AE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035333; Gero PJ, 2011, J CLIMATE, V24, P4831, DOI [10.1175/2011JCLI4210.1, 10.1175/201UCLI4210.1]; Harries JE, 2001, NATURE, V410, P355, DOI 10.1038/35066553; Haskins RD, 1997, J GEOPHYS RES-ATMOS, V102, P16563, DOI 10.1029/97JD00897; Haywood JM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016000; Huang Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012766; Iacono MJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009944; Jiang YB, 2011, PROC SPIE, V8153, DOI 10.1117/12.892817; Knuteson RO, 2004, J ATMOS OCEAN TECH, V21, P1763, DOI 10.1175/JTECH-1662.1; Knuteson RO, 2004, J ATMOS OCEAN TECH, V21, P1777, DOI 10.1175/JTECH-1663.1; Kochel JM, 1997, J GEOPHYS RES-ATMOS, V102, P12891, DOI 10.1029/97JD00405; Li J, 2000, J ATMOS SCI, V57, P753, DOI 10.1175/1520-0469(2000)057<0753:GQAIAT>2.0.CO;2; Liljegren J. C., 1999, MICROWAVE RADIOMETRY, P433; MANABE S, 1967, J ATMOS SCI, V24, P241, DOI 10.1175/1520-0469(1967)024<0241:TEOTAW>2.0.CO;2; Masarie KA, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016270; McFarlane S., 2011, SCARMTR097 RIPBE; Mlawer E. J., 2002, P 12 ARM SCI TEAM M; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Niro F, 2005, J QUANT SPECTROSC RA, V95, P469, DOI 10.1016/j.jqsrt.2004.11.011; Oreopoulos L, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016821; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Philipona R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023624; Prata F, 2008, INT J REMOTE SENS, V29, P5247, DOI 10.1080/01431160802036508; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P349; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P4, DOI 10.1016/j.jqsrt.2013.07.002; Stephens GL, 2012, NAT GEOSCI, V5, P691, DOI [10.1038/NGEO1580, 10.1038/ngeo1580]; STOKES GM, 1994, B AM METEOROL SOC, V75, P1201, DOI 10.1175/1520-0477(1994)075<1201:TARMPP>2.0.CO;2; Turner DD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051542; Wang JH, 2002, J ATMOS OCEAN TECH, V19, P981, DOI 10.1175/1520-0426(2002)019<0981:COHMEF>2.0.CO;2; Wang KC, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011800; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; Wild M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034842	46	121	127	6	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					339	+		10.1038/nature14240	http://dx.doi.org/10.1038/nature14240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25731165	Green Published, Green Submitted			2022-12-28	WOS:000351171900038
J	Crowley, JW; Katz, RF; Huybers, P; Langmuir, CH; Park, SH				Crowley, John W.; Katz, Richard F.; Huybers, Peter; Langmuir, Charles H.; Park, Sung-Hyun			Glacial cycles drive variations in the production of oceanic crust	SCIENCE			English	Article							MELT EXTRACTION; PACIFIC; MANTLE	Glacial cycles redistribute water between oceans and continents, causing pressure changes in the upper mantle, with consequences for the melting of Earth's interior. Using Plio-Pleistocene sea-level variations as a forcing function, theoretical models of mid-ocean ridge dynamics that include melt transport predict temporal variations in crustal thickness of hundreds of meters. New bathymetry from the Australian-Antarctic ridge shows statistically significant spectral energy near the Milankovitch periods of 23, 41, and 100 thousand years, which is consistent with model predictions. These results suggest that abyssal hills, one of the most common bathymetric features on Earth, record the magmatic response to changes in sea level. The models and data support a link between glacial cycles at the surface and mantle melting at depth, recorded in the bathymetric fabric of the sea floor.	[Crowley, John W.; Katz, Richard F.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Crowley, John W.; Huybers, Peter; Langmuir, Charles H.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Park, Sung-Hyun] Korea Polar Res Inst, Div Polar Earth Syst Sci, Inchon, South Korea	University of Oxford; Harvard University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Katz, RF (corresponding author), Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England.	richard.katz@earth.ox.ac.uk; shpark314@kopri.re.kr	Katz, Richard/D-3364-2009	Katz, Richard/0000-0001-8746-5430; Huybers, Peter/0000-0002-3734-8145; Crowley, John/0000-0001-8655-7907	European Research Council (ERC) under the European Union [279925]; U.S. National Science Foundation [1338832]; Korea Polar Research Institute [PP13040, PE14050]; Leverhulme Trust; Div Atmospheric & Geospace Sciences [1338832] Funding Source: National Science Foundation	European Research Council (ERC) under the European Union(European Research Council (ERC)); U.S. National Science Foundation(National Science Foundation (NSF)); Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI)); Leverhulme Trust(Leverhulme Trust); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 279925 and from the U.S. National Science Foundation under grant 1338832. It is a part of project PP13040 and PE14050 funded by the Korea Polar Research Institute. J.W.C. thanks J. Mitrovica, and R.F.K. thanks the Leverhulme Trust for additional support. Numerical models were run at Oxford's Advanced Research Computing facility. Bathymetry data are included in the supplementary materials.	Buck WR, 2005, NATURE, V434, P719, DOI 10.1038/nature03358; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Goff JA, 1997, J GEOPHYS RES-SOL EA, V102, P15521, DOI 10.1029/97JB00781; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hewitt IJ, 2010, EARTH PLANET SC LETT, V300, P264, DOI 10.1016/j.epsl.2010.10.010; Huybers P, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2002PA000857; Huybers P, 2009, EARTH PLANET SC LETT, V286, P479, DOI 10.1016/j.epsl.2009.07.014; KAPPEL ES, 1986, J GEOPHYS RES-SOLID, V91, P13925, DOI 10.1029/JB091iB14p13925; Katz R., 2010, GEOCHEM GEOPHY GEOSY, V10; Katz RF, 2012, EARTH PLANET SC LETT, V335, P226, DOI 10.1016/j.epsl.2012.04.042; Katz RF, 2008, J PETROL, V49, P2099, DOI 10.1093/petrology/egn058; Lund DC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003693; Macdonald KC, 1996, NATURE, V380, P125, DOI 10.1038/380125a0; MCKENZIE D, 1984, J PETROL, V25, P713, DOI 10.1093/petrology/25.3.713; MENARD HW, 1967, EARTH PLANET SC LETT, V2, P465, DOI 10.1016/0012-821X(67)90191-4; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Scheirer DS, 1996, MAR GEOPHYS RES, V18, P1, DOI 10.1007/BF00286201; Siddall M, 2010, QUATERNARY SCI REV, V29, P170, DOI 10.1016/j.quascirev.2009.05.011; Stracke A, 2006, EARTH PLANET SC LETT, V244, P97, DOI 10.1016/j.epsl.2006.01.057	19	85	90	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1237	1240		10.1126/science.1261508	http://dx.doi.org/10.1126/science.1261508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766231	Green Submitted, Bronze			2022-12-28	WOS:000350824300034
J	Zimmerman, JB; Anastas, PT				Zimmerman, Julie B.; Anastas, Paul T.			Toward substitution with no regrets	SCIENCE			English	Editorial Material							BISPHENOL-A; FRAMEWORK; EXPOSURE; RISK		[Zimmerman, Julie B.; Anastas, Paul T.] Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06511 USA	Yale University	Zimmerman, JB (corresponding author), Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06511 USA.	julie.zimmerman@yale.edu	Anastas, Paul/L-3258-2013; Zimmerman, Julie B/K-9572-2013	Anastas, Paul/0000-0003-4777-5172; Zimmerman, Julie/0000-0002-5392-312X				Anastas P. T., 1998, GREEN CHEM THEORY PR; Anderson SE, 2013, FOOD CHEM TOXICOL, V62, P373, DOI 10.1016/j.fct.2013.08.053; Boethling RS, 2007, CHEM REV, V107, P2207, DOI 10.1021/cr050952t; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Eladak S, 2015, FERTIL STERIL, V103, P11, DOI 10.1016/j.fertnstert.2014.11.005; Hoque J, 2012, LANGMUIR, V28, P12225, DOI 10.1021/la302303d; Hubbs AF, 2012, AM J PATHOL, V181, P829, DOI 10.1016/j.ajpath.2012.05.021; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P257, DOI 10.1289/ehp.6115; National Research Council, 2014, FRAM GUID SEL CHEM A; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sudakin DL, 2003, J TOXICOL-CLIN TOXIC, V41, P831, DOI 10.1081/CLT-120025348; U.S. Environmental Protection Agency, 2012, EPAS DFE STAND SAF P; Velleux M, 2012, ENVIRON SCI TECHNOL, V46, P6723, DOI 10.1021/es204452w; Voutchkova AM, 2010, CHEM REV, V110, P5845, DOI 10.1021/cr9003105	15	77	78	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1198	1199		10.1126/science.aaa0812	http://dx.doi.org/10.1126/science.aaa0812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766217				2022-12-28	WOS:000350824300018
J	Adachi, M; Motohashi, M				Adachi, Makoto; Motohashi, Masayuki			Passage of a Sialolith	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adachi, Makoto; Motohashi, Masayuki] Asahi Univ Murakami Mem Hosp, Gifu, Japan		Adachi, M (corresponding author), Asahi Univ Murakami Mem Hosp, Gifu, Japan.	madachi_dds_phd@yahoo.co.jp	Adachi, Makoto/K-8113-2019	Adachi, Makoto/0000-0002-9382-7052					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11							e15	10.1056/NEJMicm1407548	http://dx.doi.org/10.1056/NEJMicm1407548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760374				2022-12-28	WOS:000350797300011
J	Sexton, T; Cavalli, G				Sexton, Tom; Cavalli, Giacomo			The Role of Chromosome Domains in Shaping the Functional Genome	CELL			English	Review							GENE-EXPRESSION; CHROMATIN INTERACTIONS; NUCLEAR-ORGANIZATION; SPATIAL-ORGANIZATION; TOPOLOGICAL DOMAINS; COHESIN; REVEALS; CTCF; TRANSCRIPTION; DYNAMICS	The genome must be highly compacted to fit within eukaryotic nuclei but must be accessible to the transcriptional machinery to allow appropriate expression of genes in different cell types and throughout developmental pathways. A growing body of work has shown that the genome, analogously to proteins, forms an ordered, hierarchical structure that closely correlates and may even be causally linked with regulation of functions such as transcription. This review describes our current understanding of how these functional genomic "secondary and tertiary structures'' form a blueprint for global nuclear architecture and the potential they hold for understanding and manipulating genomic regulation.	[Sexton, Tom] Inst Genet & Mol & Cellular Biol IGBMC, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France; [Cavalli, Giacomo] Inst Human Genet IGH, F-34396 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Sexton, T (corresponding author), Inst Genet & Mol & Cellular Biol IGBMC, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	sexton@igbmc.fr; giacomo.cavalli@igh.cnrs.fr	cavalli, giacomo/Z-2754-2019; Cavalli, Giacomo/A-7958-2008	cavalli, giacomo/0000-0003-3709-3469; Cavalli, Giacomo/0000-0003-3709-3469; Sexton, Thomas/0000-0002-7824-1846	European Research Council [232947]; CNRS; European Network of Excellence EpiGeneSys; Agence Nationale de la Recherche; Fondation ARC; INSERM; ATIP-Avenir program; Laboratoire d'Excellence INRT	European Research Council(European Research Council (ERC)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Network of Excellence EpiGeneSys; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation ARC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ATIP-Avenir program; Laboratoire d'Excellence INRT	We thank Cyril Sarrauste de Menthiere and Albert Weixlbaumer for help with the figures, and Csilla Varnai and Peter Fraser for contributing Figure 4C. Research at the G.C. lab is supported by grants from the European Research Council (ERC-2008-AdG No 232947), the CNRS, the European Network of Excellence EpiGeneSys, the Agence Nationale de la Recherche, and the Fondation ARC. Research at the T.S. lab is supported by INSERM, the ATIP-Avenir program, and the Laboratoire d'Excellence INRT.	Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Ay F, 2014, GENOME RES, V24, P974, DOI 10.1101/gr.169417.113; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheutin T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002465; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Feng SH, 2014, MOL CELL, V55, P694, DOI 10.1016/j.molcel.2014.07.008; Follmer NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003135; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Grob S, 2014, MOL CELL, V55, P678, DOI 10.1016/j.molcel.2014.07.009; Grzechnik P, 2014, TRENDS BIOCHEM SCI, V39, P319, DOI 10.1016/j.tibs.2014.05.001; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; He B, 2014, P NATL ACAD SCI USA, V111, pE2191, DOI 10.1073/pnas.1320308111; Heger P, 2012, P NATL ACAD SCI USA, V109, P17507, DOI 10.1073/pnas.1111941109; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jost D, 2014, NUCLEIC ACIDS RES, V42, P9553, DOI 10.1093/nar/gku698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kang J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002094; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lavelle C, 2014, CURR OPIN GENET DEV, V25, P74, DOI 10.1016/j.gde.2014.01.001; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Lemaitre C, 2014, GENE DEV, V28, P2450, DOI 10.1101/gad.248369.114; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Mizuguchi T, 2014, NATURE, V516, P432, DOI 10.1038/nature13833; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Rajapakse I, 2009, P NATL ACAD SCI USA, V106, P6679, DOI 10.1073/pnas.0900986106; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Saad H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004187; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schauer T, 2013, CELL REP, V5, P271, DOI 10.1016/j.celrep.2013.09.001; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schuettengruber B, 2014, CELL REP, V9, P219, DOI 10.1016/j.celrep.2014.08.072; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tark-Dame M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003877; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Tjong H, 2012, GENOME RES, V22, P1295, DOI 10.1101/gr.129437.111; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Veron AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-303; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zaret KS, 2014, DEV CELL, V29, P132, DOI 10.1016/j.devcel.2014.04.019; Zhang H, 2013, CELL STEM CELL, V13, P30, DOI 10.1016/j.stem.2013.05.012; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	97	257	266	2	124	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1049	1059		10.1016/j.cell.2015.02.040	http://dx.doi.org/10.1016/j.cell.2015.02.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768903	Bronze			2022-12-28	WOS:000351951800006
J	Cahill, KM				Cahill, Kevin M.			Irish Physician-Poets (Reprinted from JAMA, vol 183, pg 822, 1963)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1963, JAMA, V183, P822	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1064	1064		10.1001/jama.2015.1172	http://dx.doi.org/10.1001/jama.2015.1172			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756455				2022-12-28	WOS:000350643100033
J	Sedgwick, P				Sedgwick, Philip			Treatment allocation in trials: stratified randomisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2409; Sung Valerie, 2014, BMJ, V348, pg2107, DOI 10.1136/bmj.g2107	2	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2015	350								h978	10.1136/bmj.h978	http://dx.doi.org/10.1136/bmj.h978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AQ	25722098				2022-12-28	WOS:000350293400011
J	Venemans, B				Venemans, Bram			COSMOLOGY A giant in the young Universe	NATURE			English	Editorial Material							BLACK-HOLE; GALAXIES		Max Planck Inst Astron, D-69117 Heidelberg, Germany	Max Planck Society	Venemans, B (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	venemans@mpia-hd.mpg.de						Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; McConnell NJ, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/179; Meyer L, 2012, SCIENCE, V338, P84, DOI 10.1126/science.1225506; van den Bosch RCE, 2012, NATURE, V491, P729, DOI 10.1038/nature11592; Volonteri M, 2010, ASTRON ASTROPHYS REV, V18, P279, DOI 10.1007/s00159-010-0029-x; Willott CJ, 2010, ASTRON J, V139, P906, DOI 10.1088/0004-6256/139/3/906; Wu XB, 2015, NATURE, V518, P512, DOI 10.1038/nature14241	8	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					490	491		10.1038/518490b	http://dx.doi.org/10.1038/518490b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719662				2022-12-28	WOS:000350097300035
J	Mega, JL; Stitziel, NO; Smith, JG; Chasman, DI; Caulfield, MJ; Devlin, JJ; Nordio, F; Hyde, CL; Cannon, CP; Sacks, FM; Poulter, NR; Sever, PS; Ridker, PM; Braunwald, E; Melander, O; Kathiresan, S; Sabatine, MS				Mega, Jessica L.; Stitziel, Nathan O.; Smith, J. Gustav; Chasman, Daniel I.; Caulfield, Mark J.; Devlin, James J.; Nordio, Francesco; Hyde, Craig L.; Cannon, Christopher P.; Sacks, Frank M.; Poulter, Neil R.; Sever, Peter S.; Ridker, Paul M.; Braunwald, Eugene; Melander, Olle; Kathiresan, Sekar; Sabatine, Marc S.			Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials	LANCET			English	Article							RECURRENT MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY LOCI; LDL CHOLESTEROL; CHROMOSOME 9P21; ARTERY-DISEASE; CARDIAC DEATH; POLYMORPHISMS; VARIANTS; PRAVASTATIN	Background Genetic variants have been associated with the risk of coronary heart disease. In this study, we tested whether or not a composite of these variants could ascertain the risk of both incident and recurrent coronary heart disease events and identify those individuals who derive greater clinical benefit from statin therapy. Methods A community-based cohort study (the Malmo Diet and Cancer Study) and four randomised controlled trials of both primary prevention (JUPITER and ASCOT) and secondary prevention (CARE and PROVE IT-TIMI 22) with statin therapy, comprising a total of 48 421 individuals and 3477 events, were included in these analyses. We studied the association of a genetic risk score based on 27 genetic variants with incident or recurrent coronary heart disease, adjusting for traditional clinical risk factors. We then investigated the relative and absolute risk reductions in coronary heart disease events with statin therapy stratified by genetic risk. We combined data from the different studies using a meta-analysis. Findings When individuals were divided into low (quintile 1), intermediate (quintiles 2-4), and high (quintile 5) genetic risk categories, a significant gradient in risk for incident or recurrent coronary heart disease was shown. Compared with the low genetic risk category, the multivariable-adjusted hazard ratio for coronary heart disease for the intermediate genetic risk category was 1.34 (95% CI 1.22-1.47, p <0.0001) and that for the high genetic risk category was 1.72 (1.55-1.92, p<0.0001). In terms of the benefit of statin therapy in the four randomised trials, we noted a significant gradient (p=0.0277) of increasing relative risk reductions across the low (13%), intermediate (29%), and high (48%) genetic risk categories. Similarly, we noted greater absolute risk reductions in those individuals in higher genetic risk categories (p=0.0101), resulting in a roughly threefold decrease in the number needed to treat to prevent one coronary heart disease event in the primary prevention trials. Specifically, in the primary prevention trials, the number needed to treat to prevent one such event in 10 years was 66 in people at low genetic risk, 42 in those at intermediate genetic risk, and 25 in those at high genetic risk in JUPITER, and 57, 47, and 20, respectively, in ASCOT. Interpretation A genetic risk score identified individuals at increased risk for both incident and recurrent coronary heart disease events. People with the highest burden of genetic risk derived the largest relative and absolute clinical benefit from statin therapy.	[Mega, Jessica L.; Nordio, Francesco; Cannon, Christopher P.; Braunwald, Eugene; Sabatine, Marc S.] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA; [Mega, Jessica L.; Chasman, Daniel I.; Nordio, Francesco; Cannon, Christopher P.; Ridker, Paul M.; Braunwald, Eugene; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Med, Div Cardiovasc, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Smith, J. Gustav] Lund Univ, Dept Cardiol, Clin Sci, Lund, Sweden; [Smith, J. Gustav] Skane Univ Hosp, Lund, Sweden; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Genet, Boston, MA 02115 USA; [Caulfield, Mark J.] Queen Mary Univ London, William Harvey Res Inst, London, England; [Caulfield, Mark J.] Barts NIHR CV Biomed Res Inst, London, England; [Devlin, James J.] Quest Diagnost, Alameda, CA USA; [Hyde, Craig L.] Pfizer Res Lab, Groton, CT USA; [Sacks, Frank M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sacks, Frank M.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Poulter, Neil R.; Sever, Peter S.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London SW7 2AZ, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL); Lund University; Lund University; Skane University Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of London; Queen Mary University London; Pfizer; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Imperial College London	Mega, JL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	jmega@partners.org; nstitziel@wustl.edu	Sabatine, Marc/AAJ-6751-2020; Stitziel, Nathan/AAL-8413-2021	Sabatine, Marc/0000-0002-0691-3359; Stitziel, Nathan/0000-0002-4963-8211; Melander, Olle/0000-0002-2581-484X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Caulfield, Mark/0000-0001-9295-3594	National Institutes of Health; AstraZeneca; Pfizer; Bristol-Myers Squibb; Sankyo; Swedish Research Council; Swedish Heart and Lung Foundation; European Research Council; Novo Nordisk Foundation; National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) [RC1 HL099634]; NIH; NHLBI [K08 HL114642]; NIHR; MRC [G9521010] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099634, K08HL114642, R01HL098082, R01HL127564] Funding Source: NIH RePORTER; Medical Research Council [MR/K006584/1, G9521010] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10055, NF-SI-0512-10113, NF-SI-0513-10059] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005339, NNF14OC0009819] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Sankyo; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	National Institutes of Health.r JUPITER was supported by AstraZeneca; ASCOT was supported by Pfizer; CARE was supported by Bristol-Myers Squibb; and PROVE IT-TIMI 22 was supported by Bristol-Myers Squibb and Sankyo. The Malmo Diet and Cancer Study was funded by The Swedish Research Council, The Swedish Heart and Lung Foundation, the European Research Council, and the Novo Nordisk Foundation. Research reported in this publication was supported by National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) under award number RC1 HL099634. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. NOS was supported in part by a career development award from the NIH and the NHLBI (grant K08 HL114642). This work was facilitated by the National Institute for Health Research (NIHR) Biomedical Research Unit at Barts (London, UK) and the NIHR Biomedical Research Centre at Imperial College (London, UK). MC, NP, and PS are recipients of NIHR Senior Investigator Awards.	Akao H, 2012, ATHEROSCLEROSIS, V220, P456, DOI 10.1016/j.atherosclerosis.2011.11.037; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Basso F, 2002, ARTERIOSCL THROM VAS, V22, P599, DOI 10.1161/01.ATV.0000013283.84306.1A; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Brautbar A, 2012, ATHEROSCLEROSIS, V223, P421, DOI 10.1016/j.atherosclerosis.2012.05.035; Brautbar A, 2011, ATHEROSCLEROSIS, V219, P737, DOI 10.1016/j.atherosclerosis.2011.08.015; Buysschaert I, 2010, EUR HEART J, V31, P1132, DOI 10.1093/eurheartj/ehq053; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chiodini BD, 2007, EUR HEART J, V28, P1977, DOI 10.1093/eurheartj/ehm196; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Ganna A, 2013, ARTERIOSCL THROM VAS, V33, P2267, DOI 10.1161/ATVBAHA.113.301218; Hopewell JC, 2013, EUR HEART J, V34, P982, DOI 10.1093/eurheartj/ehs344; Hughes MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040922; Humphries SE, 2007, CLIN CHEM, V53, P8, DOI 10.1373/clinchem.2006.074591; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P449, DOI 10.1016/j.jacc.2007.10.017; Iakoubova OA, 2006, ARTERIOSCL THROM VAS, V26, P2763, DOI 10.1161/01.ATV.0000247248.76409.8b; Iakoubova OA, 2010, EUR J CARDIOV PREV R, V17, P455, DOI 10.1097/HJR.0b013e328336a0dd; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Laufs U, 2013, EUR HEART J, V34, P2660, DOI 10.1093/eurheartj/eht213; Li YH, 2011, HUM GENET, V129, P17, DOI 10.1007/s00439-010-0892-6; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Maitland-van der Zee AH, 2008, PHARMACOGENET GENOM, V18, P651, DOI 10.1097/FPC.0b013e3282fe1759; Maitland-van der Zee AH, 2009, PHARMACOGENET GENOM, V19, P338, DOI 10.1097/FPC.0b013e32832933b7; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Mega JL, 2009, ARTERIOSCL THROM VAS, V29, P1310, DOI 10.1161/ATVBAHA.109.188474; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Patel RS, 2014, J AM COLL CARDIOL, V63, P2234, DOI 10.1016/j.jacc.2014.01.065; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Sabatine MS, 2008, ARTERIOSCL THROM VAS, V28, P562, DOI 10.1161/ATVBAHA.107.156653; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shiffman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038240; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Tikkanen E, 2013, ARTERIOSCL THROM VAS, V33, P2261, DOI 10.1161/ATVBAHA.112.301120; Tragante V, 2013, EUR HEART J, V34, P2896, DOI 10.1093/eurheartj/eht222; Wang TJ, 2011, CIRCULATION, V123, P551, DOI 10.1161/CIRCULATIONAHA.109.912568; Wauters E, 2013, EUR HEART J, V34, P993, DOI 10.1093/eurheartj/ehs389	43	417	425	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2264	2271		10.1016/S0140-6736(14)61730-X	http://dx.doi.org/10.1016/S0140-6736(14)61730-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25748612	Green Accepted, Green Submitted			2022-12-28	WOS:000355943500028
J	Dalsgaard, S; Ostergaard, SD; Leckman, JF; Mortensen, PB; Pedersen, MG				Dalsgaard, Soren; Ostergaard, Soren Dinesen; Leckman, James F.; Mortensen, Preben Bo; Pedersen, Marianne Giortz			Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study	LANCET			English	Article							DEFICIT/HYPERACTIVITY DISORDER; MEDICATION USE; ADHD; CHILDHOOD; RISK; DEATH; SCHIZOPHRENIA; REGISTER; INCREASE; INJURY	Background Attention deficit hyperactivity disorder (ADHD) is a common mental disorder associated with factors that are likely to increase mortality, such as oppositional defiant disorder or conduct disorder, criminality, accidents, and substance misuse. However, whether ADHD itself is associated with increased mortality remains unknown. We aimed to assess ADHD-related mortality in a large cohort of Danish individuals. Methods By use of the Danish national registers, we followed up 1.92 million individuals, including 32 061 with ADHD, from their first birthday through to 2013. We estimated mortality rate ratios (MRRs), adjusted for calendar year, age, sex, family history of psychiatric disorders, maternal and paternal age, and parental educational and employment status, by Poisson regression, to compare individuals with and without ADHD. Findings During follow-up (24.9 million person-years), 5580 cohort members died. The mortality rate per 10 000 person-years was 5.85 among individuals with ADHD compared with 2.21 in those without (corresponding to a fully adjusted MRR of 2.07, 95% CI 1.70-2.50; p<0.0001). Accidents were the most common cause of death. Compared with individuals without ADHD, the fully adjusted MRR for individuals diagnosed with ADHD at ages younger than 6 years was 1.86 (95% CI 0.93-3.27), and it was 1.58 (1.21-2.03) for those aged 6-17 years, and 4.25 (3.05-5.78) for those aged 18 years or older. After exclusion of individuals with oppositional defiant disorder, conduct disorder, and substance use disorder, ADHD remained associated with increased mortality (fully adjusted MRR 1.50, 1.11-1.98), and was higher in girls and women (2.85, 1.56-471) than in boys and men (1.27, 0.89-1.76). Interpretation ADHD was associated with significantly increased mortality rates. People diagnosed with ADHD in adulthood had a higher MRR than did those diagnosed in childhood and adolescence. Comorbid oppositional defiant disorder, conduct disorder, and substance use disorder increased the MRR even further. However, when adjusted for these comorbidities, ADHD remained associated with excess mortality, with higher MRRs in girls and women with ADHD than in boys and men with ADHD. The excess mortality in ADHD was mainly driven by deaths from unnatural causes, especially accidents.	[Dalsgaard, Soren; Mortensen, Preben Bo; Pedersen, Marianne Giortz] Aarhus Univ, Natl Ctr Register Based Res, Dept Econ & Business, Sch Business & Social Sci, DK-8210 Aarhus V, Denmark; [Dalsgaard, Soren; Ostergaard, Soren Dinesen; Mortensen, Preben Bo; Pedersen, Marianne Giortz] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Dalsgaard, Soren; Ostergaard, Soren Dinesen; Mortensen, Preben Bo; Pedersen, Marianne Giortz] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Dalsgaard, Soren; Mortensen, Preben Bo] Aarhus Univ CIRRAU, Ctr Integrated Register Based Res, Aarhus, Denmark; [Dalsgaard, Soren] Hosp Telemark, Dept Child & Adolescent Psychiat, Kragero, Norway; [Ostergaard, Soren Dinesen] Aarhus Univ Hosp Risskov, Res Dept P, Risskov, Denmark; [Leckman, James F.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT USA	Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Telemark Hospital Trust; Aarhus University; Yale University	Dalsgaard, S (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, DK-8210 Aarhus V, Denmark.	sdalsgaard@econ.au.dk	Dalsgaard, Søren/AAA-4475-2020; Dalsgaard, Søren/I-4595-2013; Leckman, James/O-2426-2015; Mortensen, Preben B/D-2358-2015	Dalsgaard, Søren/0000-0003-4659-0969; Dalsgaard, Søren/0000-0003-4659-0969; Mortensen, Preben B/0000-0002-5230-9865; Ostergaard, Soren Dinesen/0000-0002-8032-6208	Lundbeck Foundation; Lundbeck Foundation [R155-2014-1724, R165-2013-15320] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This study was supported by a grant from the Lundbeck Foundation.	Barbaresi WJ, 2013, PEDIATRICS, V131, P637, DOI 10.1542/peds.2012-2354; Byrne JM, 2003, CHILD NEUROPSYCHOL, V9, P142, DOI 10.1076/chin.9.2.142.14501; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Dalsgaard S, 2014, EUR PSYCHIAT, V29, P259, DOI 10.1016/j.eurpsy.2013.06.004; Dalsgaard S, 2002, BRIT J PSYCHIAT, V181, P416, DOI 10.1192/bjp.181.5.416; Dalsgaard S, 2014, EUR CHILD ADOLES PSY, V23, P841, DOI 10.1007/s00787-013-0508-5; Dalsgaard S, 2014, J HEALTH ECON, V37, P137, DOI 10.1016/j.jhealeco.2014.05.005; Dalsgaard S, 2014, J CHILD ADOL PSYCHOP, V24, P302, DOI 10.1089/cap.2014.0020; Dalsgaard S, 2014, J CHILD ADOL PSYCHOP, V24, P253, DOI 10.1089/cap.2013.0101; Dalsgaard S, 2014, ADDICT BEHAV, V39, P325, DOI 10.1016/j.addbeh.2013.09.002; Dalsgaard S, 2013, J CHILD ADOL PSYCHOP, V23, P432, DOI 10.1089/cap.2012.0111; Dalsgaard Soren, 2013, Crim Behav Ment Health, V23, P86, DOI 10.1002/cbm.1860; Dalsgaard S, 2012, ECON LETT, V117, P663, DOI 10.1016/j.econlet.2012.08.008; Ginsberg Y, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-112; Hills, 1993, STAT MODELS EPIDEMIO; Juel K, 1999, DAN MED BULL, V46, P354; Khan A, 2013, JAMA PSYCHIAT, V70, P1091, DOI 10.1001/jamapsychiatry.2013.149; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Linnet KM, 2009, ACTA PAEDIATR, V98, P173, DOI 10.1111/j.1651-2227.2008.00980.x; Mahone EM, 2010, DEV MED CHILD NEUROL, V52, P790, DOI 10.1111/j.1469-8749.2010.03709.x; Maibing CF, 2015, SCHIZOPHRENIA BULL, V41, P963, DOI 10.1093/schbul/sbu119; Mazza M, 2013, INT J CARDIOL, V168, P4320, DOI 10.1016/j.ijcard.2013.04.169; McCarthy S, 2009, DRUG SAFETY, V32, P1089, DOI 10.2165/11317630-000000000-00000; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; National Collaborating Centre for Mental Health, 2009, ATT DEF HYP DIS THE; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Vincenten Joanne, 2005, Int J Inj Contr Saf Promot, V12, P123; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Young S, 2016, J ATTEN DISORD, V20, P206, DOI 10.1177/1087054712461934	32	348	351	1	85	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2190	2196		10.1016/S0140-6736(14)61684-6	http://dx.doi.org/10.1016/S0140-6736(14)61684-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ6DG	25726514				2022-12-28	WOS:000355583000029
J	Marini, B; Kertesz-Farkas, A; Ali, H; Lucic, B; Lisek, K; Manganaro, L; Pongor, S; Luzzati, R; Recchia, A; Mavilio, F; Giacca, M; Lusic, M				Marini, Bruna; Kertesz-Farkas, Attila; Ali, Hashim; Lucic, Bojana; Lisek, Kamil; Manganaro, Lara; Pongor, Sandor; Luzzati, Roberto; Recchia, Alessandra; Mavilio, Fulvio; Giacca, Mauro; Lusic, Marina			Nuclear architecture dictates HIV-1 integration site selection	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LENTIVIRUS VECTOR; HUMAN GENOME; CELLS; GENES; INFECTION; LATENCY; REPLICATION; EXPRESSION; DOMAIN	Long-standing evidence indicates that human immunodeficiency virus type 1 (HIV-1) preferentially integrates into a subset of transcriptionally active genes of the host cell genome(1-4). However, the reason why the virus selects only certain genes among all transcriptionally active regions in a target cell remains largely unknown. Here we show that HIV-1 integration occurs in the outer shell of the nucleus in close correspondence with the nuclear pore. This region contains a series of cellular genes, which are preferentially targeted by the virus, and characterized by the presence of active transcription chromatin marks before viral infection. In contrast, the virus strongly disfavours the heterochromatic regions in the nuclear lamin-associated domains(5) and other transcriptionally active regions located centrally in the nucleus. Functional viral integrase and the presence of the cellular Nup153 and LEDGF/p75 integration cofactors are indispensable for the peripheral integration of the virus. Once integrated at the nuclear pore, the HIV-1 DNA makes contact with various nucleoporins; this association takes part in the transcriptional regulation of the viral genome. These results indicate that nuclear topography is an essential determinant of the HIV-1 life cycle.	[Marini, Bruna; Ali, Hashim; Lucic, Bojana; Lisek, Kamil; Manganaro, Lara; Giacca, Mauro; Lusic, Marina] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34149 Trieste, Italy; [Kertesz-Farkas, Attila; Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, Prot Struct & Bioinformat Grp, I-34149 Trieste, Italy; [Luzzati, Roberto] Azienda Osped Univ, Struttura Complessa Malattie Infett, I-34134 Trieste, Italy; [Luzzati, Roberto; Giacca, Mauro] Univ Trieste, Dept Med Surg & Hlth Sci, I-34129 Trieste, Italy; [Recchia, Alessandra; Mavilio, Fulvio] Univ Modena & Reggio Emilia, Dept Life Sci, I-41121 Modena, Italy; [Mavilio, Fulvio] Genethon, F-91002 Evry, France	International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Trieste; Universita di Modena e Reggio Emilia	Giacca, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34149 Trieste, Italy.	giacca@icgeb.org; marina.lusic@med.uni-heidelberg.de	Ali, Hashim/GPC-4964-2022; Luzzati, Roberto/AAU-6939-2021; Lisek, Kamil/J-5785-2016; Manganaro, Lara/AAL-8632-2020; Giacca, Mauro/J-9287-2016; Lusic, Marina/AAS-9704-2020; Luzzati, Roberto/B-8380-2014	Ali, Hashim/0000-0002-5056-845X; Lisek, Kamil/0000-0002-2406-8830; Manganaro, Lara/0000-0003-2743-2658; Giacca, Mauro/0000-0003-2927-7225; Lusic, Marina/0000-0002-0120-3569; Luzzati, Roberto/0000-0001-5546-0715; Lucic, Bojana/0000-0001-5300-2489; Mavilio, Fulvio/0000-0003-0459-4320	Italian National Research Programme on AIDS of the Istituto Superiore di Sanita, Italy; Italian Ministry of Health [RF2007-16]	Italian National Research Programme on AIDS of the Istituto Superiore di Sanita, Italy; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from the Italian National Research Programme on AIDS of the Istituto Superiore di Sanita, Italy, to M.G. and M.L. and from the Young Investigator Grant RF2007-16 of the Italian Ministry of Health to M.L. The authors are grateful to S. Kerbavcic for editorial assistance.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Brady T, 2009, AIDS, V23, P1461, DOI 10.1097/QAD.0b013e32832caf28; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cattoglio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015688; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Light WH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001524; Liu HB, 2006, J VIROL, V80, P7765, DOI 10.1128/JVI.00542-06; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Lusic M, 2013, CELL HOST MICROBE, V13, P665, DOI 10.1016/j.chom.2013.05.006; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Manganaro L, 2010, NAT MED, V16, P329, DOI 10.1038/nm.2102; Matreyek KA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003693; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Negri DRM, 2007, MOL THER, V15, P1716, DOI 10.1038/sj.mt.6300241; Repnik U, 2003, J IMMUNOL METHODS, V278, P283, DOI 10.1016/S0022-1759(03)00231-X; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sherrill-Mix S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-90; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Solovei I, 2010, METHODS MOL BIOL, V659, P117, DOI 10.1007/978-1-60761-789-1_8; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	42	201	204	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					227	+		10.1038/nature14226	http://dx.doi.org/10.1038/nature14226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25731161	Green Submitted			2022-12-28	WOS:000354377800060
J	Coumou, D; Lehmann, J; Beckmann, J				Coumou, Dim; Lehmann, Jascha; Beckmann, Johanna			The weakening summer circulation in the Northern Hemisphere mid-latitudes	SCIENCE			English	Article							ARCTIC AMPLIFICATION; PLANETARY-WAVES; WEATHER; VARIABILITY; WARM	Rapid warming in the Arctic could influence mid-latitude circulation by reducing the poleward temperature gradient. The largest changes are generally expected in autumn or winter, but whether significant changes have occurred is debated. Here we report significant weakening of summer circulation detected in three key dynamical quantities: (i) the zonal-mean zonal wind, (ii) the eddy kinetic energy (EKE), and (iii) the amplitude of fast-moving Rossby waves. Weakening of the zonal wind is explained by a reduction in the poleward temperature gradient. Changes in Rossby waves and EKE are consistent with regression analyses of climate model projections and changes over the seasonal cycle. Monthly heat extremes are associated with low EKE, and thus the observed weakening might have contributed to more persistent heat waves in recent summers.	[Coumou, Dim; Lehmann, Jascha; Beckmann, Johanna] Potsdam Inst Climate Impact Res, Earth Syst Anal, D-14412 Potsdam, Germany; [Lehmann, Jascha; Beckmann, Johanna] Univ Potsdam, Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Coumou, D (corresponding author), Potsdam Inst Climate Impact Res, Earth Syst Anal, D-14412 Potsdam, Germany.	coumou@pik-potsdam.de	Coumou, Dim/ABE-6666-2020	Coumou, Dim/0000-0003-2155-8495; Lehmann, Jascha/0000-0003-3261-6750	German Research Foundation [CO994/2-1]; German Federal Ministry of Education and Research [01LN1304A]	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We thank the CMIP5 climate modeling groups and the European Centre for Medium-Range Weather Forecasts and NCEP-NCAR for making their model and reanalysis data available. Comments by three anonymous reviewers, S. Rahmstorf, and P. Eickemeier have considerably improved the manuscript. Data presented in this manuscript will be archived for at least 10 years by the Potsdam Institute for Climate Impact Research. The work was supported by the German Research Foundation (grant no. CO994/2-1) and the German Federal Ministry of Education and Research (grant no. 01LN1304A). D.C. designed the research; D.C., J.L., and J.B. performed the analysis; and D.C., J.L., and J.B. wrote the manuscript.	Barnes EA, 2013, GEOPHYS RES LETT, V40, P4734, DOI 10.1002/grl.50880; BLACKMON ML, 1976, J ATMOS SCI, V33, P1607, DOI 10.1175/1520-0469(1976)033<1607:ACSSOT>2.0.CO;2; BOER GJ, 1983, J ATMOS SCI, V40, P164, DOI 10.1175/1520-0469(1983)040<0164:LSTDTI>2.0.CO;2; Budikova D, 2009, GLOBAL PLANET CHANGE, V68, P149, DOI 10.1016/j.gloplacha.2009.04.001; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Cohen JL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014007; Coumou D, 2011, NONLINEAR PROC GEOPH, V18, P807, DOI 10.5194/npg-18-807-2011; Coumou D, 2014, P NATL ACAD SCI USA, V111, P12331, DOI 10.1073/pnas.1412797111; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dole R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046582; FRAEDRICH K, 1978, J ATMOS SCI, V35, P745, DOI 10.1175/1520-0469(1978)035<0745:AWFAOT>2.0.CO;2; Francis JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051000; Huntingford C, 2013, NATURE, V500, P327, DOI 10.1038/nature12310; Jaiser R, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.11595; Kintisch E, 2014, SCIENCE, V344, P250, DOI 10.1126/science.344.6181.250; Kysely J, 2006, THEOR APPL CLIMATOL, V85, P19, DOI 10.1007/s00704-005-0164-x; Kysely J, 2008, GLOBAL PLANET CHANGE, V62, P147, DOI 10.1016/j.gloplacha.2008.01.003; Lehmann J, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084002; Lu J, 2008, J CLIMATE, V21, P5835, DOI 10.1175/2008JCLI2200.1; MURAKAMI M, 1979, MON WEATHER REV, V107, P994, DOI 10.1175/1520-0493(1979)107<0994:LSAODC>2.0.CO;2; NEWSON RL, 1973, NATURE, V241, P39, DOI 10.1038/241039b0; Overland JE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053268; Pedlosky J., 1979, GEOPHYS FLUID DYN; Peixoto J.P., 1992, PHYS CLIMATE, P520; Petoukhov V, 2013, P NATL ACAD SCI USA, V110, P5336, DOI 10.1073/pnas.1222000110; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Schneider T, 2015, J CLIMATE, V28, P2312, DOI 10.1175/JCLI-D-14-00632.1; Schubert S, 2011, J CLIMATE, V24, P4773, DOI 10.1175/JCLI-D-10-05035.1; Screen JA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044015; Screen JA, 2014, NAT CLIM CHANGE, V4, P704, DOI 10.1038/nclimate2271; Screen JA, 2014, NAT CLIM CHANGE, V4, P577, DOI [10.1038/NCLIMATE2268, 10.1038/nclimate2268]; Screen JA, 2013, GEOPHYS RES LETT, V40, P959, DOI 10.1002/grl.50174; Screen JA, 2013, J CLIMATE, V26, P1230, DOI 10.1175/JCLI-D-12-00063.1; Teng HY, 2013, NAT GEOSCI, V6, P1056, DOI [10.1038/NGEO1988, 10.1038/ngeo1988]; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P911, DOI [10.1038/NCLIMATE2341, 10.1038/nclimate2341]; Walsh JE, 2014, GLOBAL PLANET CHANGE, V117, P52, DOI 10.1016/j.gloplacha.2014.03.003; Warshaw M., 1973, Journal of Applied Meteorology, V12, P43, DOI 10.1175/1520-0450(1973)012<0043:AEOTSO>2.0.CO;2; Woollings T, 2012, J CLIMATE, V25, P886, DOI 10.1175/JCLI-D-11-00087.1	38	206	214	15	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					324	327		10.1126/science.1261768	http://dx.doi.org/10.1126/science.1261768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25765067				2022-12-28	WOS:000352999000041
J	Hilfinger, A; Paulsson, J				Hilfinger, Andreas; Paulsson, Johan			SYSTEMS BIOLOGY Defiant daughters and coordinated cousins	NATURE			English	Editorial Material							GENERATION TIMES; CELLS		[Hilfinger, Andreas; Paulsson, Johan] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Hilfinger, A (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	johan_paulsson@hms.harvard.edu		Hilfinger, Andreas/0000-0002-2411-6775				FROESE G, 1964, EXP CELL RES, V35, P415, DOI 10.1016/0014-4827(64)90108-9; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Grassberger P., 2007, SCHOLARPEDIA, V2, P3043, DOI [10.4249/scholarpedia.3043, DOI 10.4249/SCHOLARPEDIA.3043]; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kantz H., 2003, NONLINEAR TIME SERIE; POWELL EO, 1958, J GEN MICROBIOL, V18, P382, DOI 10.1099/00221287-18-2-382; Sandler O, 2015, NATURE, V519, P468, DOI 10.1038/nature14318; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759	9	4	4	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					422	423		10.1038/nature14210	http://dx.doi.org/10.1038/nature14210			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25762142				2022-12-28	WOS:000351602800044
J	Dietrich, MO; Zimmer, MR; Bober, J; Horvath, TL				Dietrich, Marcelo O.; Zimmer, Marcelo R.; Bober, Jeremy; Horvath, Tamas L.			Hypothalamic Agrp Neurons Drive Stereotypic Behaviors beyond Feeding	CELL			English	Article							AGOUTI-RELATED PROTEIN; OBSESSIVE-COMPULSIVE DISORDER; NEUROPEPTIDE-Y; ANOREXIA-NERVOSA; FOOD-INTAKE; IN-VIVO; CAPSAICIN RECEPTOR; BRAIN CIRCUITRY; NEURAL CIRCUIT; MICE	The nervous system evolved to coordinate flexible goal-directed behaviors by integrating interoceptive and sensory information. Hypothalamic Agrp neurons are known to be crucial for feeding behavior. Here, however, we show that these neurons also orchestrate other complex behaviors in adult mice. Activation of Agrp neurons in the absence of food triggers foraging and repetitive behaviors, which are reverted by food consumption. These stereotypic behaviors that are triggered by Agrp neurons are coupled with decreased anxiety. NPY5 receptor signaling is necessary to mediate the repetitive behaviors after Agrp neuron activation while having minor effects on feeding. Thus, we have unmasked a functional role for Agrp neurons in controlling repetitive behaviors mediated, at least in part, by neuropeptidergic signaling. The findings reveal a new set of behaviors coupled to the energy homeostasis circuit and suggest potential therapeutic avenues for diseases with stereotypic behaviors.	[Dietrich, Marcelo O.; Zimmer, Marcelo R.; Bober, Jeremy; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Zimmer, Marcelo R.] Univ Fed Rio Grande do Sul, Grad Program Biochem, BR-90035 Porto Alegre, RS, Brazil; [Horvath, Tamas L.] Yale Univ, Kavli Inst Neurosci, New Haven, CT 06520 USA	Yale University; Yale University; Universidade Federal do Rio Grande do Sul; Yale University	Dietrich, MO (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.	marcelo.dietrich@yale.edu	Zimmer, Marcelo Rigon/ABB-7993-2020; Dietrich, Marcelo/A-9928-2009	Zimmer, Marcelo Rigon/0000-0001-9628-8915; Dietrich, Marcelo/0000-0001-9781-2221	NIH [DP1 DK006850, R01AG040236, P01NS062686]; American Diabetes Association; Helmholtz Society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [CNPq: 401476/2012-0]; Brain and Behavior Research Foundation; NCATS [UL1 TR000142]; CNPq, Brazil [487096/2013-4]; Science Without Borders fellowship from CNPq/Brazil; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040236] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Helmholtz Society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brain and Behavior Research Foundation; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science Without Borders fellowship from CNPq/Brazil; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Zhong-Wu Liu for electrophysiological recordings. We thank Marya Shanabrough for assistance. T.L.H. was supported by NIH (DP1 DK006850, R01AG040236, and P01NS062686), the American Diabetes Association, the Helmholtz Society (ICEMED), and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: 401476/2012-0, Brazil). M.O.D. received support from Brain and Behavior Research Foundation, NCATS (UL1 TR000142), and CNPq (487096/2013-4, Brazil). M.R.Z. was partially supported by a Science Without Borders fellowship from CNPq/Brazil.	Adamah-Biassi EB, 2013, BEHAV BRAIN RES, V243, P306, DOI 10.1016/j.bbr.2013.01.003; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Amodeo DA, 2012, BEHAV BRAIN RES, V227, P64, DOI 10.1016/j.bbr.2011.10.032; Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; BARNETT S.A, 1956, BEHAVIOUR, V9, P24, DOI 10.1163/156853956X00237; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; Dube MG, 2000, PEPTIDES, V21, P1557, DOI 10.1016/S0196-9781(00)00311-9; Erondu N, 2006, CELL METAB, V4, P275, DOI 10.1016/j.cmet.2006.08.002; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Grove KL, 2001, ENDOCRINOLOGY, V142, P4771, DOI 10.1210/en.142.11.4771; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Halmi KA, 2003, INT J EAT DISORDER, V33, P308, DOI 10.1002/eat.10138; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Horvath TL, 1999, J NEUROSCI, V19, P1072; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Kanatani A, 2000, ENDOCRINOLOGY, V141, P1011, DOI 10.1210/en.141.3.1011; Karvat G, 2012, BEHAV BRAIN RES, V233, P405, DOI 10.1016/j.bbr.2012.05.028; Kheifets A, 2012, P NATL ACAD SCI USA, V109, P8776, DOI 10.1073/pnas.1205131109; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kyzar EJ, 2012, BRAIN RES BULL, V89, P168, DOI 10.1016/j.brainresbull.2012.08.004; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Londei T, 1998, BEHAV BRAIN RES, V94, P249, DOI 10.1016/S0166-4328(97)00162-9; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Matsunaga H, 1999, PSYCHOL MED, V29, P407, DOI 10.1017/S003329179800796X; Merle JV, 2011, PSYCHOL MED, V41, P2183, DOI 10.1017/S0033291711000365; Moriya J, 2006, PSYCHONEUROENDOCRINO, V31, P1057, DOI 10.1016/j.psyneuen.2006.06.006; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Sarrar L, 2011, PSYCHONEUROENDOCRINO, V36, P1396, DOI 10.1016/j.psyneuen.2011.03.014; STANLEY BG, 1986, PEPTIDES, V7, P1189; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; THIEL A, 1995, AM J PSYCHIAT, V152, P72; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Witkin J. M., 2008, NEUROSCI; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	59	149	152	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1222	1232		10.1016/j.cell.2015.02.024	http://dx.doi.org/10.1016/j.cell.2015.02.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25748653	Green Accepted, Bronze			2022-12-28	WOS:000351951800020
J	Moraga, I; Wernig, G; Wilmes, S; Gryshkova, V; Richter, CP; Hong, WJ; Sinha, R; Guo, F; Fabionar, H; Wehrman, TS; Krutzik, P; Demharter, S; Plo, I; Weissman, IL; Minary, P; Majeti, R; Constantinescu, SN; Piehler, J; Garcia, KC				Moraga, Ignacio; Wernig, Gerlinde; Wilmes, Stephan; Gryshkova, Vitalina; Richter, Christian P.; Hong, Wan-Jen; Sinha, Rahul; Guo, Feng; Fabionar, Hyna; Wehrman, Tom S.; Krutzik, Peter; Demharter, Samuel; Plo, Isabelle; Weissman, Irving L.; Minary, Peter; Majeti, Ravindra; Constantinescu, Stefan N.; Piehler, Jacob; Garcia, K. Christopher			Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands	CELL			English	Article							COMBINATORIAL ANTIBODY LIBRARIES; TYROSINE KINASE JAK2; HUMAN GROWTH-HORMONE; ERYTHROPOIETIN RECEPTOR; THROMBOPOIETIN RECEPTOR; MONOCLONAL-ANTIBODIES; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; MYELOPROLIFERATIVE DISORDERS; ACTIVATING MUTATION	Most cell-surface receptors for cytokines and growth factors signal as dimers, but it is unclear whether remodeling receptor dimer topology is a viable strategy to "tune'' signaling output. We utilized diabodies (DA) as surrogate ligands in a prototypical dimeric receptor-ligand system, the cytokine Erythropoietin (EPO) and its receptor (EpoR), to dimerize EpoR ectodomains in non-native architectures. Diabody-induced signaling amplitudes varied from full to minimal agonism, and structures of these DA/EpoR complexes differed in EpoR dimer orientation and proximity. Diabodies also elicited biased or differential activation of signaling pathways and gene expression profiles compared to EPO. Non-signaling diabodies inhibited proliferation of erythroid precursors from patients with a myeloproliferative neoplasm due to a constitutively active JAK2V617F mutation. Thus, intracellular oncogenic mutations causing ligand-independent receptor activation can be counteracted by extracellular ligands that re-orient receptors into inactive dimer topologies. This approach has broad applications for tuning signaling output for many dimeric receptor systems.	[Moraga, Ignacio; Guo, Feng; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Moraga, Ignacio; Guo, Feng; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Wernig, Gerlinde; Hong, Wan-Jen; Sinha, Rahul; Weissman, Irving L.; Majeti, Ravindra] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Wernig, Gerlinde] Stanford Univ, Div Hematopathol, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Wilmes, Stephan; Richter, Christian P.; Piehler, Jacob] Univ Osnabruck, Dept Biol, Div Biophys, D-49076 Osnabruck, Germany; [Gryshkova, Vitalina; Constantinescu, Stefan N.] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Gryshkova, Vitalina; Constantinescu, Stefan N.] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Div Hematol, Sch Med, Dept Internal Med, Stanford, CA 94305 USA; [Fabionar, Hyna] DiscoveRx, Fremont, CA 94538 USA; [Wehrman, Tom S.; Krutzik, Peter] Prim Bio, Santa Clara, CA 95054 USA; [Demharter, Samuel; Minary, Peter] Univ Oxford, Dept Comp Sci, Dept Computat Biol, Oxford OX1 3QD, England; [Plo, Isabelle] Inst Gustave Roussy, INSERM U1009, F-94805 Villejuif, France	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; University Osnabruck; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Stanford University; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Plo, Isabelle/C-9056-2017; Plo, Isabelle/AAT-6742-2021	Plo, Isabelle/0000-0002-5915-6910; Constantinescu, Stefan N./0000-0002-8599-2699; Demharter, Samuel/0000-0001-7352-3994; Moraga, Ignacio/0000-0001-9909-0701; Wilmes, Stephan/0000-0002-4112-710X; Majeti, Ravindra/0000-0002-5814-0984	BELSPO fellowship; de Duve Institute Delori postdoctoral fellowship; Training Program un Investigative Oncology [T32CA009287-35]; Stanford CIRM Training Program [TG2-01159]; NIH [U01HL099999]; FRS-FNRS; Salus Sanguinis Foundation; Fondation contre le cancer (Belgium); Program IAP-BeMGI; Program ARC; Ludwig Institute; Howard Hughes Medical Institute;  [NIH-RO1-AI51321]; NATIONAL CANCER INSTITUTE [R01CA086065, T32CA009287] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321, R37AI051321] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [1231073] Funding Source: researchfish	BELSPO fellowship; de Duve Institute Delori postdoctoral fellowship; Training Program un Investigative Oncology; Stanford CIRM Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Salus Sanguinis Foundation; Fondation contre le cancer (Belgium); Program IAP-BeMGI; Program ARC(Australian Research Council); Ludwig Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Kevin Jude for technical assistance; the Division of Hematology Tissue Bank and the patients for donating their samples; Dr. William Vainchenker, Institut Gustave Roussy for providing patient JAK2V617F homozygous CD34+ cells; and Dr. Christian Pecquet for support with cell lines. This work was supported by the BELSPO and de Duve Institute Delori postdoctoral fellowships (V.G.), T32CA009287-35 (Training Program un Investigative Oncology) and TG2-01159 (Stanford CIRM Training Program) (to W.I.H.), NIH U01HL099999 (to G.W., R.S., and I.L.W.), FRS-FNRS, Salus Sanguinis Foundation, Fondation contre le cancer (Belgium), Programs IAP-BeMGI and ARC (S.N.C.), the Ludwig Institute (K.C.G.), NIH-RO1-AI51321 (K.C.G.), and the Howard Hughes Medical Institute (K.C.G.)	Ballinger MD, 1998, NAT STRUCT BIOL, V5, P938, DOI 10.1038/2911; Barclay JL, 2010, MOL ENDOCRINOL, V24, P204, DOI 10.1210/me.2009-0233; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Boersma YL, 2011, J BIOL CHEM, V286, P41273, DOI 10.1074/jbc.M111.293266; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Gabler Karoline, 2013, JAKSTAT, V2, pe25025, DOI 10.4161/jkst.25025; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; Heller NM, 2012, J BIOL CHEM, V287, P31948, DOI 10.1074/jbc.M112.348896; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; James C, 2005, TRENDS MOL MED, V11, P546, DOI 10.1016/j.molmed.2005.10.003; Jost C, 2013, STRUCTURE, V21, P1979, DOI 10.1016/j.str.2013.08.020; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kai M, 2008, NAT BIOTECHNOL, V26, P209, DOI 10.1038/nbt1376; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Li W, 2013, MOL CELL ENDOCRINOL, V376, P51, DOI 10.1016/j.mce.2013.06.008; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Lim AC, 2010, BIOCHEMISTRY-US, V49, P3797, DOI 10.1021/bi1001147; Liu WH, 2009, J BIOCHEM, V145, P575, DOI 10.1093/jb/mvp013; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Millot GA, 2004, CELL SIGNAL, V16, P355, DOI 10.1016/j.cellsig.2003.08.010; Muller-Newen G, 2000, J BIOL CHEM, V275, P4579, DOI 10.1074/jbc.275.7.4579; Nakano K, 2009, J IMMUNOL METHODS, V347, P31, DOI 10.1016/j.jim.2009.05.012; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; OHASHI H, 1994, P NATL ACAD SCI USA, V91, P158, DOI 10.1073/pnas.91.1.158; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pattyn E, 1999, J BIOL CHEM, V274, P34838, DOI 10.1074/jbc.274.49.34838; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Riese DJ, 2011, EXPERT OPIN DRUG DIS, V6, P185, DOI 10.1517/17460441.2011.547468; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Roder F, 2014, ACS CHEM BIOL, V9, P2479, DOI 10.1021/cb5005806; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rowlinson SW, 2008, NAT CELL BIOL, V10, P740, DOI 10.1038/ncb1737; Sander J, 1998, DATA MIN KNOWL DISC, V2, P169, DOI 10.1023/A:1009745219419; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Socolovsky M, 1998, BLOOD, V92, P1491, DOI 10.1182/blood.V92.5.1491.417k40_1491_1496; Spangler J. B., 2014, ANN REV IMMUNOL; Staerk J, 2011, EMBO J, V30, P4398, DOI 10.1038/emboj.2011.315; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553; You CJ, 2010, ANGEW CHEM INT EDIT, V49, P4108, DOI 10.1002/anie.200907032; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang HK, 2013, CHEM BIOL, V20, P734, DOI 10.1016/j.chembiol.2013.04.012; Zhang HK, 2012, P NATL ACAD SCI USA, V109, P15728, DOI 10.1073/pnas.1214275109	78	99	102	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1196	1208		10.1016/j.cell.2015.02.011	http://dx.doi.org/10.1016/j.cell.2015.02.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25728669	Green Accepted, Bronze			2022-12-28	WOS:000351951800018
J	Prescott, HC; Langa, KM; Iwashyna, TJ				Prescott, Hallie C.; Langa, Kenneth M.; Iwashyna, Theodore J.			Readmission Diagnoses After Hospitalization for Severe Sepsis and Other Acute Medical Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEALTH		[Prescott, Hallie C.; Langa, Kenneth M.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] Hlth Serv Res & Dev Serv Ctr Innovat, VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Prescott, HC (corresponding author), Univ Michigan, Dept Med, 2800 Plymouth Rd,North Campus Res Ctr, Ann Arbor, MI 48109 USA.	hprescot@med.umich.edu		Prescott, Hallie/0000-0002-8442-6724; Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030155, P30AG024824, U01AG009740, R21AG044752] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007749] Funding Source: Medline; NIA NIH HHS [U01 AG09740, P30 AG024824, R01 AG030155, U01 AG009740, R21 AG044752, R01 AG0030155] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agency for Healthcare Research and Quality, GUID PREV QUAL IND; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Prescott HC, 2014, AM J RESP CRIT CARE, V190, P62, DOI 10.1164/rccm.201403-0471OC; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067	6	141	147	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1055	1057		10.1001/jama.2015.1410	http://dx.doi.org/10.1001/jama.2015.1410			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756444	Green Accepted, Bronze			2022-12-28	WOS:000350643100023
J	Haussecker, D; Kay, MA				Haussecker, Dirk; Kay, Mark A.			Drugging RNAi	SCIENCE			English	Editorial Material							THERAPEUTICS; DELIVERY; MICE		[Haussecker, Dirk] RNAi Therapeut Consulting, Rastatt, Germany; [Kay, Mark A.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Haussecker, D (corresponding author), RNAi Therapeut Consulting, Rastatt, Germany.	dirk.haussecker@gmail.com; markay@stanford.edu		Kay, Mark/0000-0002-2799-2615	NIAID NIH HHS [R01 AI071068, R37 AI071068] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071068] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Haussecker D, 2014, J CONTROL RELEASE, V195, P49, DOI 10.1016/j.jconrel.2014.07.056; Haussecker D, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.9; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Maraganore J, 2014, NATURE, V510, P35, DOI 10.1038/510035b; Mueller C, 2012, MOL THER, V20, P590, DOI 10.1038/mt.2011.292; Prakash TP, 2014, NUCLEIC ACIDS RES, V42, P8796, DOI 10.1093/nar/gku531; Samakoglu S, 2006, NAT BIOTECHNOL, V24, P89, DOI 10.1038/nbt1176; Vaish N, 2011, NUCLEIC ACIDS RES, V39, P1823, DOI 10.1093/nar/gkq961; Wooddell CI, 2013, MOL THER, V21, P973, DOI 10.1038/mt.2013.31	12	68	72	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1069	1070		10.1126/science.1252967	http://dx.doi.org/10.1126/science.1252967			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745148	Green Accepted			2022-12-28	WOS:000350354200020
J	Hemmer, P; Gomes, C				Hemmer, Philip; Gomes, Carmen			Single proteins under a diamond spotlight	SCIENCE			English	Editorial Material							NUCLEAR-MAGNETIC-RESONANCE; SPIN; SPECTROSCOPY		[Hemmer, Philip] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Gomes, Carmen] Texas A&M Univ, Dept Biol & Agr Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Hemmer, P (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	prhemmer@ece.tamu.edu	Gomes, Carmen L/J-5091-2015	Gomes, Carmen L/0000-0003-0095-6478				Ajoy A, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011001; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Grotz B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/055004; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Muller C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5703; Shi FZ, 2015, SCIENCE, V347, P1135, DOI 10.1126/science.aaa2253; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474	10	6	6	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1072	1073		10.1126/science.aaa7440	http://dx.doi.org/10.1126/science.aaa7440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745150				2022-12-28	WOS:000350354200022
J	Johansson, M; Hansson, A; Brodersen, J				Johansson, Minna; Hansson, Anders; Brodersen, John			TOO MUCH MEDICINE Estimating overdiagnosis in screening for abdominal aortic aneurysm: could a change in smoking habits and lowered aortic diameter tip the balance of screening towards harm?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FOLLOW-UP; GROWTH-RATES; RUPTURE; EPIDEMIOLOGY; METAANALYSIS; EXPERIENCES; MORTALITY; REPAIR; IMPACT; TRIAL		[Johansson, Minna; Hansson, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Johansson, Minna; Hansson, Anders] FoUU Ctr Fyrbodal, Res Unit, Vanersborg, Sweden; [Johansson, Minna; Hansson, Anders] FoUU Ctr Fyrbodal, Sect Gen Practice, Vanersborg, Sweden; [Brodersen, John] Univ Copenhagen, Res Unit Gen Practice, Copenhagen, Denmark; [Brodersen, John] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark	University of Gothenburg; University of Copenhagen; University of Copenhagen	Johansson, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden.	minna.johansson@vgregion.se		Brodersen, John Brandt/0000-0001-9369-3376				Ashton HA, 2007, BRIT J SURG, V94, P696, DOI 10.1002/bjs.5780; Basnyat PS, 1999, BRIT J SURG, V86, P765, DOI 10.1046/j.1365-2168.1999.01170.x; Bertero C, 2010, J VASC NURS, V28, P97, DOI 10.1016/j.jvn.2010.04.001; Brown PM, 2003, J VASC SURG, V37, P280, DOI 10.1067/mva.2003.119; Calonge N., 2005, SCREENING ABDOMINAL; Choke E, 2012, CIRCULATION, V125, P1617, DOI 10.1161/CIRCULATIONAHA.111.077503; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Darwood R, 2012, J VASC SURG, V56, P8, DOI 10.1016/j.jvs.2011.12.069; Davis M, 2013, J VASC SURG, V57, P1440, DOI 10.1016/j.jvs.2012.10.114; DeFrank JT, 2015, J GEN INTERN MED, V30, P242, DOI 10.1007/s11606-014-2996-5; Duncan JL, 2012, BMJ-BRIT MED J, V344, P2958; Ehlers L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2243; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Hafez H, 2008, EUR J VASC ENDOVASC, V36, P553, DOI 10.1016/j.ejvs.2008.06.032; Hansson A, 2012, HEALTH RISK SOC, V14, P341, DOI 10.1080/13698575.2012.680953; Harris R, 2012, ARCH INTERN MED, V172, P1462, DOI 10.1001/archinternmed.2012.4280; Heleno B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5334; Lindholt JS, 2010, BRIT J SURG, V97, P826, DOI 10.1002/bjs.7001; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P369, DOI 10.1053/ejvs.2000.1191; Liss Per-Erik, 2005, Lakartidningen, V102, P2216; McCarthy RJ, 2003, BRIT J SURG, V90, P821, DOI 10.1002/bjs.4216; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Office for National Statistics, OP LIF SURV SMOK HAB; Pettersson M, 2013, J CARDIOVASC NURS, V28, P387, DOI 10.1097/JCN.0b013e31824bd965; Pettersson M, 2009, J VASC SURG, V50, P492, DOI 10.1016/j.jvs.2009.02.245; Ploug T, 2014, MED HEALTH CARE PHIL, V17, P641, DOI 10.1007/s11019-014-9566-9; Schanzer A, 2011, CIRCULATION, V123, P2848, DOI 10.1161/CIRCULATIONAHA.110.014902; Sogaard R, 2012, BMJ-BRIT MED J, V345, pe4276; Stather PW, 2013, BRIT J SURG, V100, P863, DOI 10.1002/bjs.9101; Svensjo S, 2011, CIRCULATION, V124, P1118, DOI 10.1161/CIRCULATIONAHA.111.030379; Sweeting MJ, 2012, BRIT J SURG, V99, P655, DOI 10.1002/bjs.8707; Thompson AR, 2010, BRIT J SURG, V97, P37, DOI 10.1002/bjs.6779; Thompson SG, 2013, HLTH TECHNOL ASSESS, V17; Thompson S G, 2012, Br J Surg, V99, P1649, DOI [10.1002/bjs.8941, 10.1002/bjs.8897]; Vardulaki KA, 1998, BRIT J SURG, V85, P1674; Wanhainen A, 2008, SCAND J SURG, V97, P105, DOI 10.1177/145749690809700204; Wanhainen A, 2011, J VASC SURG, V53, P1164, DOI 10.1016/j.jvs.2010.10.099; Welch GH, 2011, OVER DIAGNOSED MAKIN; Zahl PH, 2013, BRIT J CANCER, V109, P2014, DOI 10.1038/bjc.2013.427; Zarrouk M, 2013, J VASC SURG, V58, P50, DOI 10.1016/j.jvs.2012.12.080	40	35	35	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2015	350								h825	10.1136/bmj.h825	http://dx.doi.org/10.1136/bmj.h825			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4DS	25736421				2022-12-28	WOS:000350301600003
J	Chey, WD; Kurlander, J; Eswaran, S				Chey, William D.; Kurlander, Jacob; Eswaran, Shanti			Irritable Bowel Syndrome A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CELIAC-DISEASE; RISK-FACTORS; ABDOMINAL-PAIN; CHRONIC CONSTIPATION; COST-EFFECTIVENESS; COLORECTAL-CANCER; IMMUNE ACTIVATION; CONTROLLED-TRIAL; GUT MICROBIOTA; DOUBLE-BLIND	IMPORTANCE Irritable bowel syndrome (IBS) affects 7% to 21% of the general population. It is a chronic condition that can substantially reduce quality of life and work productivity. OBJECTIVES To summarize the existing evidence on epidemiology, pathophysiology, and diagnosis of IBS and to provide practical treatment recommendations for generalists and specialists according to the best available evidence. EVIDENCE REVIEW A search of Ovid (MEDLINE) and Cochrane Database of Systematic Reviews was performed for literature from 2000 to December 2014 for the terms pathophysiology, etiology, pathogenesis, diagnosis, irritable bowel syndrome, and IBS. The range was expanded from 1946 to December 2014 for IBS, irritable bowel syndrome, diet, treatment, and therapy. FINDINGS The database search yielded 1303 articles, of which 139 were selected for inclusion. IBS is not a single disease but rather a symptom cluster resulting from diverse pathologies. Factors important to the development of IBS include alterations in the gut microbiome, intestinal permeability, gut immune function, motility, visceral sensation, brain-gut interactions, and psychosocial status. The diagnosis of IBS relies on symptom-based criteria, exclusion of concerning features (symptom onset after age 50 years, unexplained weight loss, family history of selected organic gastrointestinal diseases, evidence of gastrointestinal blood loss, and unexplained iron-deficiency anemia), and the performance of selected tests (complete blood cell count, C-reactive protein or fecal calprotectin, serologic testing for celiac disease, and age-appropriate colorectal cancer screening) to exclude organic diseases that can mimic IBS. Determining the predominant symptom (IBS with diarrhea, IBS with constipation, or mixed IBS) plays an important role in selection of diagnostic tests and treatments. Various dietary, lifestyle, medical, and behavioral interventions have proven effective in randomized clinical trials. CONCLUSIONS AND RELEVANCE The diagnosis of IBS relies on the identification of characteristic symptoms and the exclusion of other organic diseases. Management of patients with IBS is optimized by an individualized, holistic approach that embraces dietary, lifestyle, medical, and behavioral interventions.	[Chey, William D.; Kurlander, Jacob; Eswaran, Shanti] Univ Michigan Hlth Syst, Div Gastroenterol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chey, WD (corresponding author), Univ Michigan Hlth Syst, GI Physiol Lab, Michigan Bowel Control Program, 3912 Taubman Ctr,SPC 5362, Ann Arbor, MI 48109 USA.	wchey@med.umich.edu	Chey, William/AAY-7766-2021		Department of Gastroenterology, University of Michigan Health System, Ann Arbor	Department of Gastroenterology, University of Michigan Health System, Ann Arbor	The Department of Gastroenterology, University of Michigan Health System, Ann Arbor, provided funding for all aspects of the preparation of this article, including administrative assistance and protected time to conduct all aspects of this project.	Agarwal N, 2011, GASTROENTEROL CLIN N, V40, P11, DOI 10.1016/j.gtc.2010.12.013; Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Boettcher E, 2013, AM J GASTROENTEROL, V108, P728, DOI 10.1038/ajg.2013.97; Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Brenner DM, 2009, AM J GASTROENTEROL, V104, P1033, DOI 10.1038/ajg.2009.25; Cash BD, 2011, GASTROENTEROLOGY, V141, P1187, DOI [10.1053/J.GASTRO.2011.06.084, 10.1053/j.gastro.2011.06.084]; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; Chang L, 2006, AM J GASTROENTEROL, V101, P1069, DOI 10.1111/j.1572-0241.2006.00459.x; Chapman RW, 2013, AM J GASTROENTEROL, V108, P1508, DOI 10.1038/ajg.2013.197; Chey W, 2012, AM J GASTROENTEROL, V107, pS718, DOI 10.14309/00000434-201210001-01764; Chey WD, 2012, AM J GASTROENTEROL, V107, P1702, DOI 10.1038/ajg.2012.254; Chey WD, 2010, AM J GASTROENTEROL, V105, P859, DOI 10.1038/ajg.2010.55; Chey WY, 2001, AM J GASTROENTEROL, V96, P1499; Chitkara DK, 2008, AM J GASTROENTEROL, V103, P765, DOI 10.1111/j.1572-0241.2007.01722.x; Collins SM, 2014, NAT REV GASTRO HEPAT, V11, P497, DOI 10.1038/nrgastro.2014.40; Dai C, 2012, HEPATO-GASTROENTEROL, V59, P67, DOI 10.5754/hge10796; Dekel R, 2013, EXPERT OPIN INV DRUG, V22, P329, DOI 10.1517/13543784.2013.761205; Drossman DA, 2009, ALIMENT PHARM THER, V29, P329, DOI 10.1111/j.1365-2036.2008.03881.x; Drossman DA, 2013, AM J GASTROENTEROL, V108, P521, DOI 10.1038/ajg.2013.56; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Drossman DA, 2009, AM J GASTROENTEROL, V104, P2897, DOI 10.1038/ajg.2009.341; DuPont HL, 2014, ALIMENT PHARM THER, V39, P1033, DOI 10.1111/apt.12728; El-Serag HB, 2004, ALIMENT PHARM THER, V19, P861, DOI 10.1111/j.1365-2036.2004.01929.x; Engsbro AL, 2012, ALIMENT PHARM THER, V35, P350, DOI 10.1111/j.1365-2036.2011.04948.x; Eswaran S, 2013, AM J GASTROENTEROL, V108, P718, DOI 10.1038/ajg.2013.63; Everhart JE, 2009, GASTROENTEROLOGY, V136, P741, DOI 10.1053/j.gastro.2009.01.015; Farre R, 2013, AM J GASTROENTEROL, V108, P698, DOI 10.1038/ajg.2013.24; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Ford AC, 2014, AM J GASTROENTEROL, V109, P1350, DOI 10.1038/ajg.2014.148; Ford AC, 2014, AM J GASTROENTEROL, V109, pS2, DOI 10.1038/ajg.2014.187; Ford AC, 2011, J GASTROENTEROL, V46, P421, DOI 10.1007/s00535-011-0379-9; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P401, DOI 10.1016/j.cgh.2009.07.020; Ford AC, 2009, ARCH INTERN MED, V169, P651, DOI 10.1001/archinternmed.2009.22; Garrigues V, 2007, ALIMENT PHARM THER, V25, P323, DOI 10.1111/j.1365-2036.2006.03197.x; Garsed K, 2014, GUT, V63, P1617, DOI 10.1136/gutjnl-2013-305989; Guerin A, 2014, ALIMENT PHARM THER, V40, P83, DOI 10.1111/apt.12789; Guilera M, 2005, AM J GASTROENTEROL, V100, P1174, DOI 10.1111/j.1572-0241.2005.40674.x; Halmos EP, 2014, GASTROENTEROLOGY, V146, P67, DOI [10.1053/j.gastro.2013.09.046, 10.1053/j.gastro.2014.04.034]; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; Hayes Paula A, 2014, Gastroenterol Hepatol (N Y), V10, P164; Hunt MG, 2009, BEHAV RES THER, V47, P797, DOI 10.1016/j.brat.2009.05.002; Hussain Z, 2006, ALIMENT PHARM THER, V23, P465, DOI 10.1111/j.1365-2036.2006.02776.x; Johannesson E, 2011, AM J GASTROENTEROL, V106, P915, DOI 10.1038/ajg.2010.480; Kamm MA, 2011, CLIN GASTROENTEROL H, V9, P577, DOI 10.1016/j.cgh.2011.03.026; Keefer L, 2015, NEUROGASTROENT MOTIL, V27, P313, DOI 10.1111/nmo.12474; Khanna R, 2014, J CLIN GASTROENTEROL, V48, P505, DOI 10.1097/MCG.0b013e3182a88357; Koloski NA, 2001, AM J GASTROENTEROL, V96, P1340, DOI 10.1016/S0002-9270(01)02352-8; Lacy BE, 2009, EXPERT OPIN PHARMACO, V10, P143, DOI [10.1517/14656560802631319, 10.1517/14656560802631319 ]; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Ljotsson B, 2011, AM J GASTROENTEROL, V106, P1481, DOI 10.1038/ajg.2011.139; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, AM J GASTROENTEROL, V107, P1793, DOI 10.1038/ajg.2012.336; Lovell RM, 2012, AM J GASTROENTEROL, V107, P991, DOI 10.1038/ajg.2012.131; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Macaigne G, 2014, AM J GASTROENTEROL, V109, P1461, DOI 10.1038/ajg.2014.182; Manheimer E, 2012, AM J GASTROENTEROL, V107, P835, DOI 10.1038/ajg.2012.66; Matricon J, 2012, ALIMENT PHARM THER, V36, P1009, DOI 10.1111/apt.12080; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Mayer EA, 2011, ANNU REV MED, V62, P381, DOI 10.1146/annurev-med-012309-103958; Menees SB, 2014, GASTROENTEROLOGY, V146, pS194; Menees SB, 2012, AM J GASTROENTEROL, V107, P28, DOI 10.1038/ajg.2011.355; Moayyedi P, 2014, AM J GASTROENTEROL, V109, P1367, DOI 10.1038/ajg.2014.195; Murray K, 2014, AM J GASTROENTEROL, V109, P110, DOI 10.1038/ajg.2013.386; Ohman L, 2010, NAT REV GASTRO HEPAT, V7, P163, DOI 10.1038/nrgastro.2010.4; Park MI, 2006, NEUROGASTROENT MOTIL, V18, P595, DOI 10.1111/j.1365-2982.2005.00745.x; Power AM, 2013, AM J GASTROENTEROL, V108, P894, DOI 10.1038/ajg.2013.52; Ratuapli SK, 2013, GASTROENTEROLOGY, V144, P314, DOI 10.1053/j.gastro.2012.10.049; Riedl A, 2008, J PSYCHOSOM RES, V64, P573, DOI 10.1016/j.jpsychores.2008.02.021; Ringel Y, 2009, CLIN GASTROENTEROL H, V7, P68, DOI 10.1016/j.cgh.2008.07.008; Ruepert L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003460.pub3, 10.1002/14651858.CD003460]; Saad RJ, 2010, AM J GASTROENTEROL, V105, P403, DOI 10.1038/ajg.2009.612; Sainsbury A, 2013, CLIN GASTROENTEROL H, V11, P359, DOI 10.1016/j.cgh.2012.11.033; Salix Pharmaceuticals Inc. Salix's TARGET, SAL TARGET 3 STUD EX; Shepherd SJ, 2013, AM J GASTROENTEROL, V108, P707, DOI 10.1038/ajg.2013.96; Shin A, 2013, CLIN GASTROENTEROL H, V11, P1270, DOI 10.1016/j.cgh.2013.04.020; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Song BK, 2012, J NEUROGASTROENTEROL, V18, P64, DOI 10.5056/jnm.2012.18.1.64; Spiegel BMR, 2004, GASTROENTEROLOGY, V126, P1721, DOI 10.1053/j.gastro.2004.03.012; Spiegel BMR, 2010, AM J GASTROENTEROL, V105, P848, DOI 10.1038/ajg.2010.47; Spiegel Brennan M R, 2009, Curr Gastroenterol Rep, V11, P265; Spiller R, 2012, J NEUROGASTROENTEROL, V18, P258, DOI 10.5056/jnm.2012.18.3.258; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Tuteja AK, 2008, AM J GASTROENTEROL, V103, P1241, DOI 10.1111/j.1572-0241.2007.01755.x; Vanner SJ, 1999, AM J GASTROENTEROL, V94, P2912; Vazquez-Roque MI, 2013, GASTROENTEROLOGY, V144, P903, DOI 10.1053/j.gastro.2013.01.049; Videlock EJ, 2013, CLIN GASTROENTEROL H, V11, P1084, DOI 10.1016/j.cgh.2013.04.032; Wald A, 2014, AM J GASTROENTEROL, V109, P1141, DOI 10.1038/ajg.2014.190; Wedlake L, 2009, ALIMENT PHARM THER, V30, P707, DOI 10.1111/j.1365-2036.2009.04081.x; Yang Z, 2014, CLIN GASTROENTEROL H, V12, P253, DOI 10.1016/j.cgh.2013.06.028; Zhou QQ, 2009, PAIN, V146, P41, DOI 10.1016/j.pain.2009.06.017	91	571	608	16	236	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					949	958		10.1001/jama.2015.0954	http://dx.doi.org/10.1001/jama.2015.0954			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734736				2022-12-28	WOS:000350231800017
J	Liira, J; Verbeek, J; Ruotsalainen, J				Liira, Juha; Verbeek, Jos; Ruotsalainen, Jani			Pharmacological Interventions for Sleepiness and Sleep Disturbances Caused by Shift Work	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Liira, Juha; Verbeek, Jos; Ruotsalainen, Jani] Finnish Inst Occupat Hlth, Helsinki, Finland	Finnish Institute of Occupational Health	Verbeek, J (corresponding author), Finnish Inst Occupat Hlth, Cochrane Occupat Safety & Hlth Review Grp, POB 310, Kuopio 70101, Finland.	jos.verbeek@ttl.fi			Finnish Institute of Occupational Health	Finnish Institute of Occupational Health	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Verbeek reports financial support from the Finnish Institute of Occupational Health. No other disclosures were reported.	Akerstedt T, 2008, CHRONOBIOL INT, V25, P333, DOI 10.1080/07420520802113922; Alterman T, 2013, AM J IND MED, V56, P647, DOI 10.1002/ajim.22108; Keuroghlian AS, 2012, AM J ADDICTION, V21, P576, DOI 10.1111/j.1521-0391.2012.00273.x; Liira J, 2014, COCHRANE DB SYST REV, V8; McBeth BD, 2009, ACAD EMERG MED, V16, P1311, DOI 10.1111/j.1553-2712.2009.00586.x; Morgenthaler TI, 2007, SLEEP, V30, P1445, DOI 10.1093/sleep/30.11.1445; Punja S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108416	7	19	20	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					961	962		10.1001/jama.2014.18422	http://dx.doi.org/10.1001/jama.2014.18422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734738	Green Published, Green Submitted			2022-12-28	WOS:000350231800019
J	Rappaport, BA; Suresh, S; Hertz, S; Evers, AS; Orser, BA				Rappaport, Bob A.; Suresh, Santhanam; Hertz, Sharon; Evers, Alex S.; Orser, Beverley A.			Anesthetic Neurotoxicity - Clinical Implications of Animal Models	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FETAL		[Rappaport, Bob A.; Hertz, Sharon] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Suresh, Santhanam] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Evers, Alex S.] Washington Univ, Sch Med, St Louis, MO USA; [Orser, Beverley A.] Univ Toronto, Dept Anesthesia & Physiol, Toronto, ON, Canada	US Food & Drug Administration (FDA); Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); University of Toronto	Rappaport, BA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.			Suresh, Santhanam/0000-0002-2568-5830; Evers, Alex/0000-0002-0342-0575				Brambrink AM, 2012, ANESTHESIOLOGY, V116, P372, DOI 10.1097/ALN.0b013e318242b2cd; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Rappaport B, 2011, NEW ENGL J MED, V364, P1387, DOI 10.1056/NEJMp1102155	5	221	227	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					796	797		10.1056/NEJMp1414786	http://dx.doi.org/10.1056/NEJMp1414786			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8SQ	25714157				2022-12-28	WOS:000349901700002
J	Eseonu, KC; Rafferty, M; Al-Nammari, S				Eseonu, K. C.; Rafferty, M.; Al-Nammari, S.			A 72 old woman with a painful leg after a fall	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REVERSE OBLIQUE; HIP FRACTURE; RISK-FACTORS; SCREW; NAIL		[Eseonu, K. C.] John Radcliffe Hosp, Dept Orthopaed, Oxford OX3 9DU, England; [Rafferty, M.; Al-Nammari, S.] Heatherwood & Wexham Pk NHS Trust, Wexham Pk Hosp, Slough, Berks, England	University of Oxford	Eseonu, KC (corresponding author), 724 Fulham Rd, London SW6 5SF, England.	eseonu@doctors.org.uk						Bergman GJD, 2010, CURR MED RES OPIN, V26, P1193, DOI 10.1185/03007991003659814; BOYD HB, 1949, ARCH SURG-CHICAGO, V58, P853, DOI 10.1001/archsurg.1949.01240030864012; British Editorial Society of Bone and Joint Surgery, 2010, FOC INTR FRACT FEM N; British Orthopaedic Association, 2012, STAND TRAUM BOAST BO; British Orthopedic Association and British Geriatrics Society, 2007, CAR PAT FRAG FRACT; Cannon J, 2009, J EMERG MED, V37, P144, DOI 10.1016/j.jemermed.2007.12.039; Chiang CY, 2013, BONE, V52, P360, DOI 10.1016/j.bone.2012.10.006; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; Duckworth AD, 2011, J BONE JOINT SURG BR, V93B, P811, DOI 10.1302/0301-620X.93B6.26432; Eisman JA, 2012, J BONE MINER RES, V27, P2039, DOI 10.1002/jbmr.1698; FIELDING JW, 1966, SURG GYNECOL OBSTETR, V122, P555; Franklin J, 2007, INJURY, V38, P655, DOI 10.1016/j.injury.2007.02.049; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Haidukewych GT, 2001, J BONE JOINT SURG AM, V83A, P643, DOI 10.2106/00004623-200105000-00001; Jorgensen EB, 2008, KAIS, V2021, P1, DOI [DOI 10.1002/14651858.CD001155.PUB2, 10.1002/mp.15257]; Matre K, 2013, INJURY, V44, P735, DOI 10.1016/j.injury.2012.12.010; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; Ozkan K, 2011, INT ORTHOP, V35, P595, DOI 10.1007/s00264-010-1002-z; Parker MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub4; Sadowski C, 2002, J BONE JOINT SURG AM, V84A, P372, DOI 10.2106/00004623-200203000-00007	21	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2015	350								h585	10.1136/bmj.h585	http://dx.doi.org/10.1136/bmj.h585			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AM	25716955				2022-12-28	WOS:000350292900007
J	Watts, G				Watts, Geoff			Ian George Jacobs Obituary	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					414	414		10.1016/S0140-6736(15)60145-3	http://dx.doi.org/10.1016/S0140-6736(15)60145-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25713853	Bronze			2022-12-28	WOS:000348509900015
J	Watts, G				Watts, Geoff			Robert Frederick Schilling	LANCET			English	Biographical-Item																			0	0	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					324	324		10.1016/S0140-6736(15)60109-X	http://dx.doi.org/10.1016/S0140-6736(15)60109-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	25713834				2022-12-28	WOS:000348509000014
J	Goldstein, JN; Refaai, MA; Milling, TJ; Lewis, B; Goldberg-Alberts, R; Hug, BA; Sarode, R				Goldstein, Joshua N.; Refaai, Majed A.; Milling, Truman J., Jr.; Lewis, Brandon; Goldberg-Alberts, Robert; Hug, Bruce A.; Sarode, Ravi			Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial	LANCET			English	Article							INTERNATIONAL NORMALIZED RATIO; FRESH-FROZEN PLASMA; WARFARIN REVERSAL; ANTICOAGULATION; SAFETY; 3-FACTOR; SURGERY	Background Rapid reversal of vitamin K antagonist (VKA)-induced anticoagulation is often necessary for patients needing urgent surgical or invasive procedures. The optimum means of VKA reversal has not been established in comparative clinical trials. We compared the efficacy and safety of four-factor prothrombin complex concentrate (4F-PCC) with that of plasma in VKA-treated patients needing urgent surgical or invasive procedures. Methods In a multicentre, open-label, phase 3b randomised trial we enrolled patients aged 18 years or older needing rapid VKA reversal before an urgent surgical or invasive procedure. We randomly assigned patients in a 1: 1 ratio to receive vitamin K concomitant with a single dose of either 4F-PCC (Beriplex/Kcentra/Confidex; CSL Behring, Marburg, Germany) or plasma, with dosing based on international normalised ratio (INR) and weight. The primary endpoint was effective haemostasis, and the co-primary endpoint was rapid INR reduction (<= 1.3 at 0.5 h after infusion end). The analyses were intended to evaluate, in a hierarchical fashion, first non-inferiority (lower limit 95% CI greater than -10% for group difference) for both endpoints, then superiority (lower limit 95% CI > 0%) if non-inferiority was achieved. Adverse events and serious adverse events were reported to days 10 and 45, respectively. This trial is registered at ClinicalTrials.gov, number NCT00803101. Findings 181 patients were randomised (4F-PCC n=90; plasma n=91). The intention-to-treat efficacy population comprised 168 patients (4F-PCC, n=87; plasma, n=81). Effective haemostasis was achieved in 78 (90%) patients in the 4F-PCC group compared with 61 (75%) patients in the plasma group, demonstrating both non-inferiority and superiority of 4F-PCC over plasma (difference 14.3%, 95% CI 2.8-25.8). Rapid INR reduction was achieved in 48 (55%) patients in the 4F-PCC group compared with eight (10%) patients in the plasma group, demonstrating both non-inferiority and superiority of 4F-PCC over plasma (difference 45.3%, 95% CI 31.9-56.4). The safety profile of 4F-PCC was generally similar to that of plasma; 49 (56%) patients receiving 4F-PCC had adverse events compared with 53 (60%) patients receiving plasma. Adverse events of interest were thromboembolic adverse events (six [7%] patients receiving 4F-PCC vs seven [8%] patients receiving plasma), fluid overload or similar cardiac events (three [3%] patients vs 11 [13%] patients), and late bleeding events (three [3%] patients vs four [5%] patients). Interpretation 4F-PCC is non-inferior and superior to plasma for rapid INR reversal and effective haemostasis in patients needing VKA reversal for urgent surgical or invasive procedures.	[Goldstein, Joshua N.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Refaai, Majed A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Milling, Truman J., Jr.] Univ Med Ctr Brackenridge, Seton UT Southwestern Clin Res Inst Austin, Dell Childrens Med Ctr, Austin, TX USA; [Lewis, Brandon] Texas A&M Hlth Sci Ctr, St Joseph Reg Hlth Ctr, Bryan, College Stn, TX USA; [Goldberg-Alberts, Robert; Hug, Bruce A.] CSL Behring LLC, King Of Prussia, PA USA; [Sarode, Ravi] UT Southwestern Med Ctr, Dallas, TX USA	Harvard University; Massachusetts General Hospital; University of Rochester; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; CSL; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JN (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Zero Emerson Pl,Suite 3B, Boston, MA 02114 USA.	jgoldstein@mgh.harvard.edu	Goldstein, Joshua N/H-8953-2016; Milling, Truman J/N-6601-2017	Milling, Truman J/0000-0002-5588-0426	CSL Behring	CSL Behring	Funding CSL Behring.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Bechtel BF, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-40; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Committee for Proprietary Medicinal Products (CPMP), 2000, POINTS TO CONSIDER O; Demeyere R, 2010, VOX SANG, V99, P251, DOI 10.1111/j.1423-0410.2010.01339.x; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P429, DOI 10.1160/TH11-01-0052; Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298; Food and Drug Administration (FDA), 2012, FATALITIES REPORTED; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Healey JS, 2012, CIRCULATION, V126, P343, DOI 10.1161/CIRCULATIONAHA.111.090464; Hickey M, 2013, CIRCULATION, V128, P360, DOI 10.1161/CIRCULATIONAHA.113.001875; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Holland L, 2009, TRANSFUSION, V49, P1171, DOI 10.1111/j.1537-2995.2008.02080.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jones CA, 2013, AM J EMERG MED, V31, P878, DOI 10.1016/j.ajem.2013.01.018; Lin DM, 2013, TRANSFUS MED REV, V27, P91, DOI 10.1016/j.tmrv.2013.01.002; Majeed A, 2014, THROMB HAEMOSTASIS, V111, P233, DOI 10.1160/TH13-07-0536; Menzin J, 2012, THROMB HAEMOSTASIS, V107, P662, DOI 10.1160/TH11-09-0646; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Quick JA, 2012, SURGERY, V152, P722, DOI 10.1016/j.surg.2012.07.024; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Sorensen B, 2011, CRIT CARE, V15, DOI 10.1186/cc9311; Voils SA, 2012, THROMB RES, V130, P833, DOI 10.1016/j.thromres.2012.10.001; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261; Yang L, 2012, TRANSFUSION, V52, P1673, DOI 10.1111/j.1537-2995.2011.03515.x	29	272	272	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2077	2087		10.1016/S0140-6736(14)61685-8	http://dx.doi.org/10.1016/S0140-6736(14)61685-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	25728933	Green Accepted			2022-12-28	WOS:000354979100027
J	von Minckwitz, G; Loibl, S				von Minckwitz, Gunter; Loibl, Sibylle			Evolution of adjuvant chemotherapy for breast cancer	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; DOSE-DENSE; EPIRUBICIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; DOCETAXEL; WOMEN		[von Minckwitz, Gunter; Loibl, Sibylle] GBG Forsch GmbH, German Breast Grp, D-63263 Neu Isenburg, Germany	German Breast Group	von Minckwitz, G (corresponding author), GBG Forsch GmbH, German Breast Grp, D-63263 Neu Isenburg, Germany.	gunter.vonminckwitz@germanbreastgroup.de						Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Bonilla L, 2010, JNCI-J NATL CANCER I, V102, P1845, DOI 10.1093/jnci/djq409; Budd GT, 2015, J CLIN ONCOL, V33, P58, DOI 10.1200/JCO.2014.56.3296; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Del Mastro L, 2015, LANCET; Levine MN, 2005, J CLIN ONCOL, V23, P5166, DOI 10.1200/JCO.2005.09.423; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; NORTON L, 1986, CANCER TREAT REP, V70, P163; Poole CJ, 2006, NEW ENGL J MED, V355, P1851, DOI 10.1056/NEJMoa052084; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; von Minckwitz G, 2008, ANN ONCOL, V19, P292, DOI 10.1093/annonc/mdm438	12	3	3	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1812	1814		10.1016/S0140-6736(14)62348-5	http://dx.doi.org/10.1016/S0140-6736(14)62348-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25740287				2022-12-28	WOS:000354184500008
J	Rodriguez, M; Morrow, J; Seifi, A				Rodriguez, Michelle; Morrow, Jason; Seifi, Ali			Ethical Implications of Patients and Families Secretly Recording Conversations With Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rodriguez, Michelle] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, San Antonio, TX 78229 USA; [Morrow, Jason] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Morrow, Jason] Univ Texas Hlth Sci Ctr San Antonio, Ctr Med Eth & Humanities, San Antonio, TX 78229 USA; [Seifi, Ali] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Seifi, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, Mail Code 7843,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	seifi@uthscsa.edu	Seifi, Ali/AAR-6163-2020	Seifi, Ali/0000-0002-5010-5041				American Medical Association, 2006, AMA COD ETH OP 5 05; [Anonymous], 2014, SECRETLY RECORDING D; Azoulay E, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0037-5; Kirby R., 2014, WELCOME WORLD DIGITA; PEW Research Center, MOB TECHN FACT SHEET; Ramachadran D., 2014, PAT SECR REC THEIR D; Weiss Barry D, 2014, Fam Pract Manag, V21, P14	7	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1615	1616		10.1001/jama.2015.2424	http://dx.doi.org/10.1001/jama.2015.2424			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25763514				2022-12-28	WOS:000353595200007
J	Basset, JM				Basset, Jean-Marie			Yves Chauvin (1930-2015) OBITUARY	NATURE			English	Biographical-Item									[Basset, Jean-Marie] King Abdullah Univ Sci & Technol, KAUST Catalysis Ctr, Thuwal, Saudi Arabia; [Basset, Jean-Marie] Univ Lyon, Lyon, France	King Abdullah University of Science & Technology	Basset, JM (corresponding author), King Abdullah Univ Sci & Technol, KAUST Catalysis Ctr, Thuwal, Saudi Arabia.	jeanmarie.basset@kaust.edu.sa		basset, jean marie/0000-0003-3166-8882					0	3	3	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					159	159		10.1038/519159a	http://dx.doi.org/10.1038/519159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25762275	Bronze			2022-12-28	WOS:000350770500020
J	Erisman, JW; Brasseur, G; Ciais, P; van Eekeren, N; Theis, TL				Erisman, Jan Willem; Brasseur, Guy; Ciais, Philippe; van Eekeren, Nick; Theis, Thomas L.			Put people at the centre of global risk management	NATURE			English	Editorial Material									[Erisman, Jan Willem; van Eekeren, Nick] Louis Bolk Inst, Driebergen, Netherlands; [Brasseur, Guy] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Ciais, Philippe] Univ Versailles, Lab Climate Sci & Environm, Versailles, France; [Theis, Thomas L.] Univ Illinois, Inst Environm Sci & Policy, Chicago, IL USA	Max Planck Society; UDICE-French Research Universities; Universite Paris Saclay; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Erisman, JW (corresponding author), Louis Bolk Inst, Driebergen, Netherlands.	j.erisman@louisbolk.nl	Erisman, Jan Willem/N-5093-2019; Ciais, Philippe/A-6840-2011	Erisman, Jan Willem/0000-0001-5058-7012; Ciais, Philippe/0000-0001-8560-4943; van Eekeren, Nick/0000-0002-4026-3839				Adger WN, 2009, FRONT ECOL ENVIRON, V7, P150, DOI 10.1890/070148; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Gilbert N., 2007, AGENT BASED MODELS; Guha-Sapir D., 2015, ANN DISASTER STAT RE; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Huber M, 2011, BMJ-BRIT MED J, V343, P235; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; United Nations, 2014, OP WORK GROUP PROP S; World Economic Forum, 2015, GLOB RISKS 2015, V10th	9	22	24	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					151	153		10.1038/519151a	http://dx.doi.org/10.1038/519151a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD0NH	25762266	Bronze			2022-12-28	WOS:000350770500012
J	LaDue, ND				LaDue, Nicole D.			Help to fight the battle for Earth in US schools	NATURE			English	Editorial Material									No Illinois Univ, Dept Geol & Environm Geosci, De Kalb, IL 60115 USA	Northern Illinois University	LaDue, ND (corresponding author), No Illinois Univ, Dept Geol & Environm Geosci, De Kalb, IL 60115 USA.	nladue@niu.edu							0	0	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					131	131		10.1038/519131a	http://dx.doi.org/10.1038/519131a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD0NH	25762247	Bronze			2022-12-28	WOS:000350770500004
J	Voit, GM; Donahue, M; Bryan, GL; McDonald, M				Voit, G. M.; Donahue, M.; Bryan, G. L.; McDonald, M.			Regulation of star formation in giant galaxies by precipitation, feedback and conduction	NATURE			English	Article							BRIGHTEST CLUSTER GALAXIES; GALACTIC NUCLEUS FEEDBACK; COOL-CORE CLUSTERS; THERMAL-INSTABILITY; PROFILE; SAMPLE; HALOES; FLOWS; GAS	The Universe's largest galaxies reside at the centres of galaxy clusters and are embedded in hot gas that, if left undisturbed, would cool quickly and create many more new stars than are actually observed(1-5). Cooling can be regulated by feedback from accretion of cooling gas onto the central black hole, but requires an accretion rate finely tuned to the thermodynamic state of the hot gas(6,7). Theoretical models in which cold clouds precipitate out of the hot gas via thermal instability and accrete onto the black hole exhibit the necessary tuning(8-10). Recent observational evidence shows that the abundance of cold gas in the centres of clusters increases rapidly near the predicted threshold for instability(11). Here we report observations showing that this precipitation threshold extends over a large range in cluster radius, cluster mass and cosmic time. We incorporate the precipitation threshold into a framework of theoretical models for the thermodynamic state of hot gas in galaxy clusters. According to that framework, precipitation regulates star formation in some giant galaxies, while thermal conduction prevents star formation in others if it can compensate for radiative cooling and shut off precipitation.	[Voit, G. M.; Donahue, M.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48864 USA; [Bryan, G. L.] Columbia Univ, Dept Astron, Pupin Phys Lab 1328, New York, NY 10027 USA; [McDonald, M.] MIT, MIT Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA	Michigan State University; Columbia University; Massachusetts Institute of Technology (MIT)	Voit, GM (corresponding author), Michigan State Univ, Dept Phys & Astron, 567 Wilson Rd, E Lansing, MI 48864 USA.	voit@pa.msu.edu	Bryan, Greg/AAT-4133-2021	Bryan, Greg/0000-0003-2630-9228; Donahue, Megan/0000-0002-2808-0853	NSF [AST-0908819, AST-1008134, AST-1210890]; NASA [NNX12AH41G, NAS 5-26555]; NASA through a Hubble Fellowship - Space Telescope Science Institute [HST-HF51308.01-A]; Direct For Mathematical & Physical Scien [1210890] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NASA through a Hubble Fellowship - Space Telescope Science Institute; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	G.M.V. and M.D. acknowledge NSF support through grant AST-0908819. G.L.B. acknowledges NSF AST-1008134, AST-1210890, NASA grant NNX12AH41G, and XSEDE Computational resources. M.McD. acknowledges support by NASA through a Hubble Fellowship grant HST-HF51308.01-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555.	Bernardi M, 2007, ASTRON J, V133, P1741, DOI 10.1086/511783; Borgani S, 2004, MON NOT R ASTRON SOC, V348, P1078, DOI 10.1111/j.1365-2966.2004.07431.x; BREGMAN JN, 1988, ASTROPHYS J, V326, P639, DOI 10.1086/166122; Cavagnolo KW, 2009, ASTROPHYS J SUPPL S, V182, P12, DOI 10.1088/0067-0049/182/1/12; FABIAN AC, 1994, ANNU REV ASTRON ASTR, V32, P277, DOI 10.1146/annurev.aa.32.090194.001425; Frenk CS, 1999, ASTROPHYS J, V525, P554, DOI 10.1086/307908; Gaspari M, 2013, MON NOT R ASTRON SOC, V432, P3401, DOI 10.1093/mnras/stt692; Gaspari M, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/94; Gaspari M., 2014, CHAOTIC COLD ACCRETI; Hoffer AS, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/1/23; Li Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/153; Li Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/54; McCourt M, 2012, MON NOT R ASTRON SOC, V419, P3319, DOI 10.1111/j.1365-2966.2011.19972.x; McDonald M, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/23; McDonald M., 2012, NATURE, V774, P23; McNamara BR, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055023; Nagai D, 2007, ASTROPHYS J, V668, P1, DOI 10.1086/521328; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; O'Dea CP, 2008, ASTROPHYS J, V681, P1035, DOI 10.1086/588212; Peterson JR, 2006, PHYS REP, V427, P1, DOI 10.1016/j.physrep.2005.12.007; Sharma P, 2012, MON NOT R ASTRON SOC, V427, P1219, DOI 10.1111/j.1365-2966.2012.22050.x; Sharma P, 2012, MON NOT R ASTRON SOC, V420, P3174, DOI 10.1111/j.1365-2966.2011.20246.x; Soker M, 2001, ASTROPHYS J, V549, P832, DOI 10.1086/319433; Vikhlinin A, 2009, ASTROPHYS J, V692, P1033, DOI 10.1088/0004-637X/692/2/1033; Voigt LM, 2004, MON NOT R ASTRON SOC, V347, P1130, DOI 10.1111/j.1365-2966.2004.07285.x; Voit GM, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/28; Voit GM, 2015, ASTROPHYS J LETT, V799, DOI 10.1088/2041-8205/799/1/L1; Voit GM, 2005, MON NOT R ASTRON SOC, V364, P909, DOI 10.1111/j.1365-2966.2005.09621.x; Voit GM, 2001, NATURE, V414, P425, DOI 10.1038/35106523; Zakamska NL, 2003, ASTROPHYS J, V582, P162, DOI 10.1086/344641	30	157	158	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					203	206		10.1038/nature14167	http://dx.doi.org/10.1038/nature14167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25739501	Green Submitted			2022-12-28	WOS:000350770500032
J	Anglada-Escude, G; Tuomi, M				Anglada-Escude, Guillem; Tuomi, Mikko			Comment on "Stellar activity masquerading as planets in the habitable zone of the M dwarf Gliese 581"	SCIENCE			English	Editorial Material							PERIODOGRAM; SEARCH; SYSTEM	Robertson et al. (Reports, 25 July 2014, p. 440) claimed that activity-induced variability is responsible for the Doppler signal of the proposed planet candidate GJ 581d. We point out that their analysis using periodograms of residual data is inappropriate and promotes inadequate tools. Because the claim challenges the viability of the method to detect exo-Earths, we encourage reanalysis and a deliberation on what the field-standard methods should be.	[Anglada-Escude, Guillem] Queen Mary Univ London, Sch Phys & Astron, London E1 4NS, England; [Anglada-Escude, Guillem; Tuomi, Mikko] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England	University of London; Queen Mary University London; University College London; University of Hertfordshire	Anglada-Escude, G (corresponding author), Queen Mary Univ London, Sch Phys & Astron, London E1 4NS, England.	guillem.anglada@gmail.com	Anglada-Escudé, Guillem/Y-3162-2018; Pinheiro, Marcelo Antonio Amaro/N-2040-2019	Anglada-Escudé, Guillem/0000-0002-3645-5977; Pinheiro, Marcelo Antonio Amaro/0000-0003-0758-5526	STFC [ST/J001333/1, ST/M001008/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Anglada-Escude G, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219910; Baluev RV, 2008, MON NOT R ASTRON SOC, V385, P1279, DOI 10.1111/j.1365-2966.2008.12689.x; Baluev RV, 2009, MON NOT R ASTRON SOC, V393, P969, DOI 10.1111/j.1365-2966.2008.14217.x; Cumming A, 2004, MON NOT R ASTRON SOC, V354, P1165, DOI 10.1111/j.1365-2966.2004.08275.x; Gregory PC, 2005, ASTROPHYS J, V631, P1198, DOI 10.1086/432594; Haywood RD, 2014, MON NOT R ASTRON SOC, V443, P2517, DOI 10.1093/mnras/stu1320; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Mayor M, 2009, ASTRON ASTROPHYS, V507, P487, DOI 10.1051/0004-6361/200912172; Pepe F, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117055; Robertson P, 2014, SCIENCE, V345, P440, DOI [10.1126/science.1253253, 10.1126/science.1255525]; Tuomi M, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015995; Zechmeister M, 2009, ASTRON ASTROPHYS, V496, P577, DOI 10.1051/0004-6361:200811296	13	21	21	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226								10.1126/science.1260796	http://dx.doi.org/10.1126/science.1260796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745156	Green Submitted, Green Accepted			2022-12-28	WOS:000350354200032
J	Vale, CL; Rydzewska, LHM; Rovers, MM; Emberson, JR; Gueyffier, F; Stewart, LA				Vale, Claire L.; Rydzewska, Larysa H. M.; Rovers, Maroeska M.; Emberson, Jonathan R.; Gueyffier, Francois; Stewart, Lesley A.		Cochrane IPD Meta-Anal Methods Grp	Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PATIENT DATA METAANALYSIS; BREAST-CANCER; BIAS; ANTIBIOTICS; INHIBITORS; THERAPY; STROKE; TRIALS	OBJECTIVE To establish the extent to which systematic reviews and meta-analyses of individual participant data (IPD) are being used to inform the recommendations included in published clinical guidelines. DESIGN Descriptive study. SETTING Database maintained by the Cochrane IPD Meta-analysis Methods Group, supplemented by records of published IPD meta-analyses held in a separate database. POPULATION A test sample of systematic reviews of randomised controlled trials that included a meta-analysis of IPD, and a separate sample of clinical guidelines, matched to the IPD meta-analyses according to medical condition, interventions, populations, and dates of publication. DATA EXTRACTION Descriptive information on each guideline was extracted along with evidence showing use or critical appraisal, or both, of the IPD meta-analysis within the guideline; recommendations based directly on its findings and the use of other systematic reviews in the guideline. RESULTS Based on 33 IPD meta-analyses and 177 eligible, matched clinical guidelines there was evidence that IPD meta-analyses were being under-utilised. Only 66 guidelines (37%) cited a matched IPD meta-analysis. Around a third of these (n=22, 34%) had critically appraised the IPD meta-analysis. Recommendations based directly on the matched IPD meta-analyses were identified for only 18 of the 66 guidelines (27%). For the guidelines that did not cite a matched IPD meta-analysis (n=111, 63%), search dates had preceded the publication of the IPD meta-analysis in 23 cases (21%); however, for the remainder, there was no obvious reasons why the IPD meta-analysis had not been cited. CONCLUSIONS Our results indicate that systematic reviews and meta-analyses based on IPD are being under-utilised. Guideline developers should routinely seek good quality and up to date IPD meta-analyses to inform guidelines. Increased use of IPD meta-analyses could lead to improved guidelines ensuring that routine patient care is based on the most reliable evidence available.	[Vale, Claire L.; Rydzewska, Larysa H. M.] UCL, MRC Clin Trials Unit, London WC2B 6NH, England; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands; [Emberson, Jonathan R.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Emberson, Jonathan R.] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Gueyffier, Francois] Univ Lyon 1, F-69365 Lyon, France; [Gueyffier, Francois] Hosp Civils Lyon, Serv Pharmacol Clin & Essais Therapeut, Bron, France; [Stewart, Lesley A.] Univ York, Ctr Reviews & Disseminat, AB Block Alcuin Coll, York YO10 5DD, N Yorkshire, England	Medical Research Council Clinical Trials Unit; University of London; University College London; Radboud University Nijmegen; University of Oxford; University of Oxford; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; University of York - UK	Rydzewska, LHM (corresponding author), UCL, MRC Clin Trials Unit, London WC2B 6NH, England.	larysa.rydzewska@ucl.ac.uk	Rydzewska, Larysa/AAA-4242-2020; Gueyffier, François/B-8545-2008; Rovers, Maroeska/F-2969-2014; Rydzewska, Larysa/AAG-7228-2019; Macleod, Malcolm Robert/B-2052-2010	Rydzewska, Larysa/0000-0001-6205-7457; Gueyffier, François/0000-0002-9921-0977; Rovers, Maroeska/0000-0002-3095-170X; Macleod, Malcolm Robert/0000-0001-9187-9839; Whiteley, William/0000-0002-4816-8991; Tierney, Jayne/0000-0002-4734-3014; PIGNON, Jean-Pierre/0000-0003-2047-1582; Emberson, Jonathan/0000-0001-7792-9422; Stewart, Lesley/0000-0003-0287-4724; Vale, Claire/0000-0001-5157-0634; Perera, Rafael/0000-0003-2418-2091	MRC Network of Hubs for Trials Methodology Research [R20]; Medical Research Council [MR/K025635/1, MC_UU_12023/24, MR/L004933/1, G0800792, G0902303, UD99999939] Funding Source: researchfish; MRC [MR/K025635/1, G0800792, G0902303, MR/L004933/1, MC_UU_12023/24] Funding Source: UKRI	MRC Network of Hubs for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the MRC Network of Hubs for Trials Methodology Research (R20). The funder had no role in the design, analysis, interpretation of the results, or the writing of the manuscript.	Abe O., 2010, Journal of the National Cancer Institute Monographs, P162, DOI 10.1093/jncimonographs/lgq039; Agency for Healthcare Research and Quality-National Guideline Clearinghouse (NGC), 2014, INCLUSION CRITERIA; Ahmed Ikhlaaq, 2012, BMJ, V344, pd7762, DOI 10.1136/bmj.d7762; [Anonymous], 2014, COCHRANE DATABASE OF; [Anonymous], 2014, AGENCY FOR HEALTHCAR; [Anonymous], 2014, COCHRANE INDIVIDUAL; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baujat B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002026.pub2; Bejan-Angoulvant T, 2010, J HYPERTENS, V28, P1366, DOI 10.1097/HJH.0b013e328339f9c5; Browning GG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001801.pub3; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Burdett S, 2003, INT J TECHNOL ASSESS, V19, P129, DOI 10.1017/S0266462303000126; Burns PB, 2011, PLAST RECONSTR SURG, V128, P305, DOI 10.1097/PRS.0b013e318219c171; Cates CJ, 2008, COCHRANE DB SYST REV, V3; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cools F, 2010, LANCET, V375, P2082, DOI 10.1016/S0140-6736(10)60278-4; Craig LE, 2010, STROKE, V41, P2632, DOI 10.1161/STROKEAHA.110.588244; Daniels JP, 2010, HUM REPROD UPDATE, V16, P568, DOI 10.1093/humupd/dmq031; De Luca G, 2008, HEART, V94, P1548, DOI 10.1136/hrt.2008.141648; DEBACKER TL, 2008, COCHRANE DB SYST REV, V2; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Ellis G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005066.pub2; Ford AC, 2008, ALIMENT PHARM THER, V28, P534, DOI 10.1111/j.1365-2036.2008.03784.x; Global Programme on Evidence for Health Policy-World Health Organization, 2003, GUIDELINES FOR WHO G; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Greb A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004024.pub2; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Halkes PHA, 2008, J NEUROL NEUROSUR PS, V79, P1218, DOI 10.1136/jnnp.2008.143875; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kassai B, 2008, EPILEPSIA, V49, P343, DOI 10.1111/j.1528-1167.2007.01423.x; KIRKHAM JJ, 2010, BMJ-BRIT MED J, V340, pc365, DOI DOI 10.1136/BMJ.C365; Kmietowicz Zosia, 2014, BMJ, V348, pg1428, DOI 10.1136/bmj.g1428; Koopman L, 2008, ARCH OTOLARYNGOL, V134, P128, DOI 10.1001/archoto.2007.3; Middleton LJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3929; O'Meara S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1344; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Piccart-Gebhart MJ, 2008, J CLIN ONCOL, V26, P1980, DOI 10.1200/JCO.2007.10.8399; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Rovers MM, 2006, LANCET, V368, P1429, DOI 10.1016/S0140-6736(06)69606-2; Smith CT, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-34; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Stewart L, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P261; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; UK Cochrane Centre, 2014, GUIDELINES PROJECT; Uronis HE, 2008, BRIT J CANCER, V98, P294, DOI 10.1038/sj.bjc.6604161; Vale C, 2008, J CLIN ONCOL, V26, P5802, DOI 10.1200/JCO.2008.16.4368; Vigna-Taglianti F, 2006, ANN ONCOL, V17, P691, DOI 10.1093/annonc/mdl003; Wallace J, 2012, INT J EVID-BASED HEA, V10, P338, DOI 10.1111/j.1744-1609.2012.00288.x; Wang D, 2008, HEALTH TECHNOL ASSES, V12, P1; Yetgin S, 2010, BRIT J HAEMATOL, V149, P722, DOI 10.1111/j.1365-2141.2010.08148.x; Yetgin S, 2009, BRIT J HAEMATOL, V145, P376, DOI 10.1111/j.1365-2141.2009.07624.x; Young J, 2008, LANCET, V371, P908, DOI 10.1016/S0140-6736(08)60416-X	61	40	40	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2015	350								h1088	10.1136/bmj.h1088	http://dx.doi.org/10.1136/bmj.h1088			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DX	25747860	Green Published, hybrid			2022-12-28	WOS:000351180800001
J	Mdodo, R; Frazier, EL; Dube, SR; Mattson, CL; Sutton, MY; Brooks, JT; Skarbinski, J				Mdodo, Rennatus; Frazier, Emma L.; Dube, Shanta R.; Mattson, Christine L.; Sutton, Madeline Y.; Brooks, John T.; Skarbinski, Jacek			Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; CESSATION; INFECTION; SURVEILLANCE; INDIVIDUALS; TOBACCO; IMPACT; CANCER; AIDS; TUBERCULOSIS	Background: The negative health effects of cigarette smoking and HIV infection are synergistic. Objective: To compare the prevalence of current cigarette smoking and smoking cessation between adults with HIV receiving medical care and adults in the general population. Design: Nationally representative cross-sectional surveys. Setting: United States. Patients: 4217 adults with HIV who participated in the Medical Monitoring Project and 27 731 U.S. adults who participated in the National Health Interview Survey in 2009. Measurements: The main exposure was cigarette smoking. The outcome measures were weighted prevalence of cigarette smoking and quit ratio (ratio of former smokers to the sum of former and current smokers). Results: Of the estimated 419 945 adults with HIV receiving medical care, 42.4% (95% CI, 39.7% to 45.1%) were current cigarette smokers, 20.3% (CI, 18.6% to 22.1%) were former smokers, and 37.3% (CI, 34.9% to 39.6%) had never smoked. Compared with the U.S. adult population, in which an estimated 20.6% of adults smoked cigarettes in 2009, adults with HIV were nearly twice as likely to smoke (adjusted prevalence difference, 17.0 percentage points [CI, 14.0 to 20.1 percentage points]) but were less likely to quit smoking (quit ratio, 32.4% vs. 51.7%). Among adults with HIV, factors independently associated with greater smoking prevalence were older age, non-Hispanic white or non-Hispanic black race, lower educational level, poverty, homelessness, incarceration, substance use, binge alcohol use, depression, and not achieving a suppressed HIV viral load. Limitation: Cross-sectional design with some generalizability limitations. Conclusion: Adults with HIV were more likely to smoke and less likely to quit smoking than the general adult population. Tobacco screening and cessation strategies are important considerations as part of routine HIV care.	Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Off Smoking & Hlth, Atlanta, GA 30329 USA; Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University	Sutton, MY (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Off Infect Dis, 1600 Clifton Rd NE,Mail Stop E-45, Atlanta, GA 30329 USA.	msutton@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Centers for Disease Control and Prevention.	Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; As I.F., 2009, FED REG, V74, P4199; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Blair JM, 2014, MMWR SURVEILL SUMM, V63, P1; Burns DN, 1996, J ACQ IMMUN DEF SYND, V13, P374, DOI 10.1097/00042560-199612010-00012; Centers for Disease Control and Prevention, 2004, QUICKSTATS CIG SMOK; Centers for Disease Control and Prevention, 2010, DIST PUBL HLTH RES P; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Crothers K, 2005, J GEN INTERN MED, V20, P1142, DOI 10.1111/j.1525-1497.2005.0255.x; Denning Paul H., 2011, Morbidity and Mortality Weekly Report, V60, P1045; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; Durkin SJ, 2009, AM J PUBLIC HEALTH, V99, P2217, DOI 10.2105/AJPH.2009.161638; Fiore MC, 2008, TREATING TOBACCO USE; Frankel Martin R, 2012, Open AIDS J, V6, P67, DOI 10.2174/1874613601206010067; Gfroerer J, 2013, MMWR-MORBID MORTAL W, V62, P81; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; Hajjeh RA, 1999, J INFECT DIS, V179, P449, DOI 10.1086/314606; Helleberg M, 2014, AIDS, V28, P1499, DOI 10.1097/QAD.0000000000000283; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; HUGHES JR, 1993, J SUBST ABUSE TREAT, V10, P181, DOI 10.1016/0740-5472(93)90043-2; Korn EL., 1999, ANAL HLTH SURVEYS; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Krueger PM, 2008, AM J PUBLIC HEALTH, V98, P889, DOI 10.2105/AJPH.2007.114454; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lyketsos CG, 1996, AM J PSYCHIAT, V153, P1430; Madeddu G, 2013, INFECTION, V41, P347, DOI 10.1007/s15010-012-0330-x; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Mani D, 2012, CLIN LUNG CANCER, V13, P6, DOI 10.1016/j.cllc.2011.05.005; Matthews AK, 2013, AIDS PATIENT CARE ST, V27, P22, DOI 10.1089/apc.2012.0253; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; McQuillan Geraldine M, 2008, NCHS Data Brief, P1; Moadel AB, 2012, JAIDS-J ACQ IMM DEF, V61, P208, DOI 10.1097/QAI.0b013e3182645679; National Center for Health Statistics, 2010, 2009 NAT HLTH INT SU; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3, P3, DOI DOI 10.1037/E306662005-004; Niaura R, 2000, CLIN INFECT DIS, V31, P808, DOI 10.1086/314048; Parsons Van L, 2014, Vital Health Stat 2, P1; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Rigotti NA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub2; Rigotti NA, 2012, ANN INTERN MED, V157, P907, DOI 10.7326/0003-4819-156-1-201201010-00541; ROYCE RA, 1990, AIDS, V4, P327, DOI 10.1097/00002030-199004000-00007; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub4; Stewart DW, 2011, BEHAV MED, V37, P77, DOI 10.1080/08964289.2011.583946; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; Tobacco Use and Dependence Guideline Panel, 2008, TREATING TOBACCO USE; United States Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE; Valery L, 2008, EUR J CANCER PREV, V17, P535, DOI 10.1097/CEJ.0b013e3282f75e48; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Veterans Affairs Health Care, 2012, HIV PROV SMOK CESS H; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9	62	300	309	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2015	162	5					335	U131		10.7326/M14-0954	http://dx.doi.org/10.7326/M14-0954			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC3HT	25732274				2022-12-28	WOS:000350238300002
J	Healey, JS; Hohnloser, SH; Glikson, M; Neuzner, J; Mabo, P; Vinolas, X; Kautzner, J; O'Hara, G; VanErven, L; Gadler, F; Pogue, J; Appl, U; Gilkerson, J; Pochet, T; Stein, KM; Merkely, B; Chrolavicius, S; Meeks, B; Foldesi, C; Thibault, B; Connolly, SJ				Healey, Jeff S.; Hohnloser, Stefan H.; Glikson, Michael; Neuzner, Jorg; Mabo, Phillipe; Vinolas, Xavier; Kautzner, Josef; O'Hara, Gilles; VanErven, Lieselot; Gadler, Fredrik; Pogue, Janice; Appl, Ursula; Gilkerson, Jim; Pochet, Thierry; Stein, Kenneth M.; Merkely, Bela; Chrolavicius, Susan; Meeks, Brandi; Foldesi, Csaba; Thibault, Bernard; Connolly, Stuart J.		Shockless IMPLant Evaluation SIMPL	Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)	LANCET			English	Article							HEART-FAILURE; THRESHOLD; TIME; AMIODARONE; THERAPY; DYSFUNCTION; PREVENTION; INSERTION; EFFICACY; REGISTRY	Background Defibrillation testing by induction and termination of ventricular fibrillation is widely done at the time of implantation of implantable cardioverter defibrillators (ICDs). We aimed to compare the efficacy and safety of ICD implantation without defibrillation testing versus the standard of ICD implantation with defibrillation testing. Methods In this single-blind, randomised, multicentre, non-inferiority trial (Shockless IMPLant Evaluation [SIMPLE]), we recruited patients aged older than 18 years receiving their first ICD for standard indications at 85 hospitals in 18 countries worldwide. Exclusion criteria included pregnancy, awaiting transplantation, particpation in another randomised trial, unavailability for follow-up, or if it was expected that the ICD would have to be implanted on the right-hand side of the chest. Patients undergoing initial implantation of a Boston Scientific ICD were randomly assigned (1: 1) using a computer-generated sequence to have either defibrillation testing (testing group) or not (no-testing group). We used random block sizes to conceal treatment allocation from the patients, and randomisation was stratified by clinical centre. Our primary efficacy analysis tested the intention-to-treat population for non-inferiority of no-testing versus testing by use of a composite outcome of arrhythmic death or failed appropriate shock (ie, a shock that did not terminate a spontaneous episode of ventricular tachycardia or fibrillation). The non-inferiority margin was a hazard ratio (HR) of 1.5 calculated from a proportional hazards model with no-testing versus testing as the only covariate; if the upper bound of the 95% CI was less than 1.5, we concluded that ICD insertion without testing was non-inferior to ICD with testing. We examined safety with two, 30 day, adverse event outcome clusters. The trial is registered with ClinicalTrials. gov, number NCT00800384. Findings Between Jan 13, 2009, and April 4, 2011, of 2500 eligible patients, 1253 were randomly assigned to defibrillation testing and 1247 to no-testing, and followed up for a mean of 3.1 years (SD 1.0). The primary outcome of arrhythmic death or failed appropriate shock occurred in fewer patients (90 [7% per year]) in the no-testing group than patients who did receive it (104 [8% per year]; HR 0.86, 95% CI 0.65-1.14; p(non-inferiority) <0.0001). The first safety composite outcome occurred in 69 (5.6%) of 1236 patients with no-testing and in 81 (6.5%) of 1242 patients with defibrillation testing, p=0.33. The second, pre-specified safety composite outcome, which included only events most likely to be directly caused by testing, occurred in 3.2% of patients with no-testing and in 4.5% with defibrillation testing, p=0.08. Heart failure needing intravenous treatment with inotropes or diuretics was the most common adverse event (in 20 [2%] of 1236 patients in the no-testing group vs 28 [2%] of 1242 patients in the testing group, p=0.25). Interpretation Routine defibrillation testing at the time of ICD implantation is generally well tolerated, but does not improve shock efficacy or reduce arrhythmic death.	[Healey, Jeff S.; Pogue, Janice; Chrolavicius, Susan; Meeks, Brandi; Connolly, Stuart J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Hohnloser, Stefan H.] Goethe Univ Frankfurt, Frankfurt, Germany; [Glikson, Michael] Sheba Med Ctr, Leviev Heart Ctr, Tel Hashomer, Israel; [Neuzner, Jorg] Klinikum Kassel, Kassel, Germany; [Mabo, Phillipe] Ctr Hosp Univ, Rennes, France; [Vinolas, Xavier] Hosp Santa Creu i Sant Pau, Barcelona, Spain; [Kautzner, Josef] Inst Clin & Expt Med, Prague, Czech Republic; [O'Hara, Gilles] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [VanErven, Lieselot] Leiden Univ, Med Ctr, Leiden, Netherlands; [Gadler, Fredrik] Karolinska Inst, Stockholm, Sweden; [Appl, Ursula; Gilkerson, Jim; Pochet, Thierry; Stein, Kenneth M.] Boston Sci, Minneapolis, MN USA; [Appl, Ursula; Gilkerson, Jim; Pochet, Thierry; Stein, Kenneth M.] Boston Sci, Brussels, Belgium; [Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Foldesi, Csaba] Gottsegen Natl Inst Cardiol, Budapest, Hungary; [Thibault, Bernard] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada	McMaster University; Population Health Research Institute; Goethe University Frankfurt; Chaim Sheba Medical Center; Klinikum Kassel; CHU Rennes; Institute for Clinical & Experimental Medicine (IKEM); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Boston Scientific; Semmelweis University; Universite de Montreal	Healey, JS (corresponding author), Hamilton Hlth Sci, DBCVSRI Bldg,Gen Site, Hamilton, ON L88L 2X2, Canada.	Jeff.Healey@phri.ca		Merkely, Bela/0000-0001-6514-0723	Boston Scientific; Heart and Stroke Foundation (Ontario Provincial office)	Boston Scientific(Boston Scientific); Heart and Stroke Foundation (Ontario Provincial office)(Heart & Stroke Foundation of Ontario)	Boston Scientific and the Heart and Stroke Foundation (Ontario Provincial office).	Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Birnie D, 2008, HEART RHYTHM, V5, P387, DOI 10.1016/j.hrthm.2007.11.018; Blatt JA, 2008, J AM COLL CARDIOL, V52, P551, DOI 10.1016/j.jacc.2008.04.051; Brignole M, 2007, EUROPACE, V9, P540, DOI 10.1093/europace/eum083; Brignole M, 2014, EUROPACE, V16, P1103, DOI 10.1093/europace/euu135; Brignole M, 2012, J AM COLL CARDIOL, V60, P981, DOI 10.1016/j.jacc.2012.05.014; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Gold MR, 2002, CIRCULATION, V105, P2043, DOI 10.1161/01.CIR.0000015508.59749.F5; Healey JS, 2010, J CARDIOVASC ELECTR, V21, P1344, DOI 10.1111/j.1540-8167.2010.01850.x; Healey JS, 2012, J CARDIOVASC ELECTR, V23, P1313, DOI 10.1111/j.1540-8167.2012.02393.x; Healey JS, 2012, AM HEART J, V164, P146, DOI 10.1016/j.ahj.2012.05.007; Healey JS, 2010, J CARDIOVASC ELECTR, V21, P177, DOI 10.1111/j.1540-8167.2009.01616.x; Healey JS, 2009, HEART RHYTHM, V6, pS374; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Hohnloser SH, 2006, CIRCULATION, V114, P104, DOI 10.1161/CIRCULATIONAHA.106.618421; Kremers MS, 2013, HEART RHYTHM, V10, pE59, DOI 10.1016/j.hrthm.2013.01.035; Matassini Maria Vittoria, 2013, Curr Treat Options Cardiovasc Med, V15, P497, DOI 10.1007/s11936-013-0244-7; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Nanthakumar K, 2004, J AM COLL CARDIOL, V44, P2166, DOI 10.1016/j.jacc.2004.08.054; Pires LA, 2006, J CARDIOVASC ELECTR, V17, P140, DOI 10.1111/j.1540-8167.2005.00294.x; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Russo AM, 2005, HEART RHYTHM, V2, P456, DOI 10.1016/j.hrthm.2005.01.015; Russo A, 2014, J AM COLL CARDIOL, V63, pA451, DOI 10.1016/S0735-1097(14)60451-4; Russo AM, 2014, CIRC-ARRHYTHMIA ELEC, V7, P337, DOI 10.1161/CIRCEP.113.000371; Russo AM, 2013, PACE, V36, P1522, DOI 10.1111/pace.12248; Stavrakis S, 2013, PACE, V36, P1402, DOI 10.1111/pace.12218; Strickberger SA, 2004, J AM COLL CARDIOL, V44, P88, DOI 10.1016/j.jacc.2003.11.068; Swerdlow CD, 2007, PACE, V30, P675, DOI 10.1111/j.1540-8159.2007.00730.x; Swerdlow CD, 2007, PACE, V30, P258, DOI 10.1111/j.1540-8159.2007.00659.x; WINKLE RA, 1984, CIRCULATION, V69, P766, DOI 10.1161/01.CIR.69.4.766	33	138	141	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					785	791		10.1016/S0140-6736(14)61903-6	http://dx.doi.org/10.1016/S0140-6736(14)61903-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25715991				2022-12-28	WOS:000350051700032
J	Matsumoto, Y; Amano, T; Kato, TN; Hoshino, M				Matsumoto, Y.; Amano, T.; Kato, T. N.; Hoshino, M.			Stochastic electron acceleration during spontaneous turbulent reconnection in a strong shock wave	SCIENCE			English	Article							HIGH MACH NUMBER; NONRELATIVISTIC COLLISIONLESS SHOCKS; IN-CELL SIMULATION; PARTICLE-ACCELERATION; MECHANISM	Explosive phenomena such as supernova remnant shocks and solar flares have demonstrated evidence for the production of relativistic particles. Interest has therefore been renewed in collisionless shock waves and magnetic reconnection as a means to achieve such energies. Although ions can be energized during such phenomena, the relativistic energy of the electrons remains a puzzle for theory. We present supercomputer simulations showing that efficient electron energization can occur during turbulent magnetic reconnection arising from a strong collisionless shock. Upstream electrons undergo first-order Fermi acceleration by colliding with reconnection jets and magnetic islands, giving rise to a nonthermal relativistic population downstream. These results shed new light on magnetic reconnection as an agent of energy dissipation and particle acceleration in strong shock	[Matsumoto, Y.] Chiba Univ, Dept Phys, Inage Ku, Chiba 2638522, Japan; [Amano, T.; Hoshino, M.] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kato, T. N.] Natl Astron Observ Japan, Ctr Computat Astrophys, Mitaka, Tokyo 1818588, Japan	Chiba University; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Matsumoto, Y (corresponding author), Chiba Univ, Dept Phys, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	ymatumot@chiba-u.jp	Amano, Takanobu/G-4983-2014; Hoshino, Masahiro/A-1837-2009	Amano, Takanobu/0000-0002-2140-6961; Hoshino, Masahiro/0000-0002-1818-9927; Matsumoto, Yosuke/0000-0002-1484-7056	RIKEN Advanced Institute for Computational Science through the High Performance Computing Infrastructure System Research project [hp120222, hp120287]; Japan Society for the Promotion of Science KAKENHI, Ministry of Education, Culture, Sports, Science and Technology Strategic Programs for Innovative Research [26400266]; Joint Institute for Computational Fundamental Science; Grants-in-Aid for Scientific Research [26400266, 25287151] Funding Source: KAKEN	RIKEN Advanced Institute for Computational Science through the High Performance Computing Infrastructure System Research project; Japan Society for the Promotion of Science KAKENHI, Ministry of Education, Culture, Sports, Science and Technology Strategic Programs for Innovative Research; Joint Institute for Computational Fundamental Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research used the computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the High Performance Computing Infrastructure System Research project (project identification nos. hp120222 and hp120287) and was supported in part by a Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research (C) 26400266, Ministry of Education, Culture, Sports, Science and Technology Strategic Programs for Innovative Research and the Joint Institute for Computational Fundamental Science.	Acero F, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200913916; Amano T, 2009, ASTROPHYS J, V690, P244, DOI 10.1088/0004-637X/690/1/244; Bamba A, 2003, ASTROPHYS J, V589, P827, DOI 10.1086/374687; CARGILL PJ, 1988, ASTROPHYS J, V329, pL29, DOI 10.1086/185170; Drake JF, 2006, NATURE, V443, P553, DOI 10.1038/nature05116; Drake JF, 2003, SCIENCE, V299, P873, DOI 10.1126/science.1080333; Egedal J, 2012, NAT PHYS, V8, P321, DOI [10.1038/nphys2249, 10.1038/NPHYS2249]; FERMI E, 1949, PHYS REV, V75, P578, DOI 10.1103/PhysRev.75.578; Frederiksen JT, 2004, ASTROPHYS J, V608, pL13, DOI 10.1086/421262; FRIED BD, 1959, PHYS FLUIDS, V2, P337, DOI 10.1063/1.1705933; Hoshino M, 2002, ASTROPHYS J, V572, P880, DOI 10.1086/340454; Hoshino M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.135003; Imada S, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011847; Kato TN, 2008, ASTROPHYS J LETT, V681, pL93, DOI 10.1086/590387; Kato TN, 2010, ASTROPHYS J, V721, P828, DOI 10.1088/0004-637X/721/1/828; Kowal G, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/102; LEROY MM, 1983, PHYS FLUIDS, V26, P2742, DOI 10.1063/1.864468; Lin RP, 2003, ASTROPHYS J, V595, pL69, DOI 10.1086/378932; Masters A, 2013, NAT PHYS, V9, P164, DOI 10.1038/nphys2541; Masters A, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016941; MASUDA S, 1994, NATURE, V371, P495, DOI 10.1038/371495a0; Matsumoto Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.215003; Matsumoto Y, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/109; McClements KG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.255002; Oieroset M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.195001; PAPADOPOULOS K, 1988, ASTROPHYS SPACE SCI, V144, P535; Riquelme MA, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/63; SKILLING J, 1975, MON NOT R ASTRON SOC, V172, P557, DOI 10.1093/mnras/172.3.557; WU CS, 1984, SPACE SCI REV, V37, P63, DOI 10.1007/BF00213958	29	100	102	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					974	978		10.1126/science.1260168	http://dx.doi.org/10.1126/science.1260168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722406				2022-12-28	WOS:000349958900033
J	Verduzco, R				Verduzco, Rafael			Shape-shifting liquid crystals	SCIENCE			English	Editorial Material							POLYMER NETWORKS; ELASTOMERS		Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA	Rice University	Verduzco, R (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA.	rafaelv@rice.edu						Agrawal A, 2014, SOFT MATTER, V10, P1411, DOI 10.1039/c3sm51654g; de Haan LT, 2012, ANGEW CHEM INT EDIT, V51, P12469, DOI 10.1002/anie.201205964; Evans JS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187802; Hong Y., 2009, J AM CHEM SOC, V41, P15000; KUPFER J, 1991, MAKROMOL CHEM-RAPID, V12, P717; McConney ME, 2013, ADV MATER, V25, P5880, DOI 10.1002/adma.201301891; Ohm C, 2010, ADV MATER, V22, P3366, DOI 10.1002/adma.200904059; Pei ZQ, 2014, NAT MATER, V13, P36, DOI [10.1038/NMAT3812, 10.1038/nmat3812]; Torras N, 2013, J MATER CHEM C, V1, P5183, DOI 10.1039/c3tc31109k; Ware TH, 2015, SCIENCE, V347, P982, DOI 10.1126/science.1261019; Warner M., 2003, LIQUID CRYSTAL ELAST	11	13	13	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					949	950		10.1126/science.aaa6579	http://dx.doi.org/10.1126/science.aaa6579			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722398				2022-12-28	WOS:000349958900019
J	Clemens, DL; Ge, P; Lee, BY; Horwitz, MA; Zhou, ZH				Clemens, Daniel L.; Ge, Peng; Lee, Bai-Yu; Horwitz, Marcus A.; Zhou, Z. Hong			Atomic Structure of T6SS Reveals Interlaced Array Essential to Function	CELL			English	Article							VI SECRETION SYSTEM; FRANCISELLA-TULARENSIS; PSEUDOMONAS-AERUGINOSA; RESOLUTION; PHAGE; BACTERIOPHAGE-T4; IDENTIFICATION; MACROPHAGES; TRAFFICKING; MECHANISM	Type VI secretion systems (T6SSs) are newly identified contractile nanomachines that translocate effector proteins across bacterial membranes. The Francisella pathogenicity island, required for bacterial phagosome escape, intracellular replication, and virulence, was presumed to encode a T6SS-like apparatus. Here, we experimentally confirm the identity of this T6SS and, by cryo electron microscopy (cryoEM), show the structure of its post-contraction sheath at 3.7 angstrom resolution. We demonstrate the assembly of this T6SS by IglA/IglB and secretion of its putative effector proteins in response to environmental stimuli. The sheath has a quaternary structure with handedness opposite that of contracted sheath of T4 phage tail and is organized in an interlaced two-dimensional array by means of beta sheet augmentation. By structure-based mutagenesis, we show that this interlacing is essential to secretion, phagosomal escape, and intracellular replication. Our atomic model of the T6SS will facilitate design of drugs targeting this highly prevalent secretion apparatus.	[Clemens, Daniel L.; Lee, Bai-Yu; Horwitz, Marcus A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Ge, Peng; Horwitz, Marcus A.; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ge, Peng; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Horwitz, MA (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	mhorwitz@mednet.ucla.edu; hong.zhou@ucla.edu	Pacific-Southwest, RCE/B-6155-2009; Zhou, Z Hong/HDN-0747-2022		National Institutes of Health [AI065359, AI094386, GM071940]; NIH/NCRR/NCATS UCLA CTSI grant [UL1TR000124]; American Heart Association Western States Affiliates Postdoc Fellowship [13POST17340020]; UCLA; NIH [1S10OD018111]; NSF [DBI-1338135, ACI-1053575]; Div Of Biological Infrastructure [1338135] Funding Source: National Science Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, R01AI094386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR/NCATS UCLA CTSI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Heart Association Western States Affiliates Postdoc Fellowship(American Heart Association); UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project received support from National Institutes of Health grants AI065359, AI094386, and GM071940 and the NIH/NCRR/NCATS UCLA CTSI grant number UL1TR000124. P.G. was supported in part by American Heart Association Western States Affiliates Postdoc Fellowship (13POST17340020). We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines supported by UCLA and by instrumentation grants from NIH (1S10OD018111) and NSF (DBI-1338135). This work used XSEDE (MCB130126), which is supported by NSF (ACI-1053575). The authors thank Denise M. Monack for the chicken anti-F. novicida antibody, Karl E. Klose for the F. novicida U112, and Francis E. Nano for the codon-optimized superfolder gfp.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aksyuk AA, 2011, STRUCTURE, V19, P1885, DOI 10.1016/j.str.2011.09.012; Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Clemens DL, 2012, INFECT IMMUN, V80, P952, DOI 10.1128/IAI.05221-11; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Egelman EH, 2010, METHOD ENZYMOL, V482, P167, DOI 10.1016/S0076-6879(10)82006-3; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Fokine A, 2013, J MOL BIOL, V425, P1731, DOI 10.1016/j.jmb.2013.02.012; Ge P, 2011, P NATL ACAD SCI USA, V108, P9637, DOI 10.1073/pnas.1018104108; Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766; Gillespie EJ, 2013, P NATL ACAD SCI USA, V110, pE4904, DOI 10.1073/pnas.1302334110; Golovliov I, 1997, INFECT IMMUN, V65, P2183, DOI 10.1128/IAI.65.6.2183-2189.1997; Ho BT, 2013, SCIENCE, V342, P250, DOI 10.1126/science.1243745; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Kube S, 2014, CELL REP, V8, P20, DOI 10.1016/j.celrep.2014.05.034; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; LoVullo ED, 2006, MICROBIOL-SGM, V152, P3425, DOI 10.1099/mic.0.29121-0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1126, DOI 10.1016/j.ultramic.2009.04.002; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	49	115	119	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					940	951		10.1016/j.cell.2015.02.005	http://dx.doi.org/10.1016/j.cell.2015.02.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723168	Bronze, Green Accepted			2022-12-28	WOS:000351116100016
J	Scholkopf, B				Schoelkopf, Bernhard			ARTIFICIAL INTELLIGENCE Learning to see and act	NATURE			English	Editorial Material									Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany	Max Planck Society	Scholkopf, B (corresponding author), Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany.	bs@tuebingen.mpg.de	Schölkopf, Bernhard/A-7570-2013	Schölkopf, Bernhard/0000-0002-8177-0925				Bareinboim E., 2011, P 25 AAAI C ART INT, P100; Guo X., 2014, ADV NEURAL INF PROCE, P27; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Scholkopf Bernhard, 2012, ICML; Watkins C. J. C. H., 1989, PHD DISSERTATION	6	23	23	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					486	487		10.1038/518486a	http://dx.doi.org/10.1038/518486a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719660				2022-12-28	WOS:000350097300032
J	Freeman, LM; Bloemenkamp, KW; Franssen, MT; Papatsonis, DN; Hajenius, PJ; Hollmann, MW; Woiski, MD; Porath, M; van den Berg, HJ; van Beek, E; Borchert, OWHM; Schuitemaker, N; Sikkema, JM; Kuipers, AHM; Logtenberg, SLM; van der Salm, PCM; Rengerink, KO; Lopriore, E; van den Akker-Van Marle, ME; le Cessie, S; van Lith, JM; Struys, MM; Mol, BJ; Dahan, A; Middeldorp, JM				Freeman, Liv M.; Bloemenkamp, Kitty W.; Franssen, Maureen T.; Papatsonis, Dimitri N.; Hajenius, Petra J.; Hollmann, Markus W.; Woiski, Mallory D.; Porath, Martina; van den Berg, Hans J.; van Beek, Erik; Borchert, Odette W. H. M.; Schuitemaker, Nico; Sikkema, J. Marko; Kuipers, A. H. M.; Logtenberg, Sabine L. M.; van der Salm, Paulien C. M.; Rengerink, Katrien Oude; Lopriore, Enrico; van den Akker-van Marle, M. Elske; le Cessie, Saskia; van Lith, Jan M.; Struys, Michel M.; Mol, Ben Willem J.; Dahan, Albert; Middeldorp, Johanna M.			Patient controlled analgesia with remifentanil versus epidural analgesia in labour: randomised multicentre equivalence trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTRAVENOUS REMIFENTANIL; METAANALYSIS; IMPUTATION; FENTANYL	Objective To determine women's satisfaction with pain relief using patient controlled analgesia with remifentanil compared with epidural analgesia during labour. Design Multicentre randomised controlled equivalence trial. Setting 15 hospitals in the Netherlands. Participants Women with an intermediate to high obstetric risk with an intention to deliver vaginally. To exclude a clinically relevant difference in satisfaction with pain relief of more than 10%, we needed to include 1136 women. Because of missing values for satisfaction this number was increased to 1400 before any analysis. We used multiple imputation to correct for missing data. Intervention Before the onset of active labour consenting women were randomised to a pain relief strategy with patient controlled remifentanil or epidural analgesia if they requested pain relief during labour. Main outcome measures Primary outcome was satisfaction with pain relief, measured hourly on a visual analogue scale and expressed as area under the curve (AUC), thus providing a time weighted measure of total satisfaction with pain relief. A higher AUC represents higher satisfaction with pain relief. Secondary outcomes were pain intensity scores, mode of delivery, and maternal and neonatal outcomes. Analysis was done by intention to treat. The study was defined as an equivalence study for the primary outcome. Results 1414 women were randomised, of whom 709 were allocated to patient controlled remifentanil and 705 to epidural analgesia. Baseline characteristics were comparable. Pain relief was ultimately used in 65% (447/687) in the remifentanil group and 52% (347/671) in the epidural analgesia group (relative risk 1.32, 95% confidence interval 1.18 to 1.48). Cross over occurred in 7% (45/687) and 8% (51/671) of women, respectively. Of women primarily treated with remifentanil, 13% (53/402) converted to epidural analgesia, while in women primarily treated with epidural analgesia 1% (3/296) converted to remifentanil. The area under the curve for total satisfaction with pain relief was 30.9 in the remifentanil group versus 33.7 in the epidural analgesia group (mean difference -2.8, 95% confidence interval -6.9 to 1.3). For who actually received pain relief the area under the curve for satisfaction with pain relief after the start of pain relief was 25.6 in the remifentanil group versus 36.1 in the epidural analgesia group (mean difference -10.4, -13.9 to -7.0). The rate of caesarean section was 15% in both groups. Oxygen saturation was significantly lower (SpO(2) <92%) in women who used remifentanil (relative risk 1.5, 1.4 to 1.7). Maternal and neonatal outcomes were comparable between both groups. Conclusion In women in labour, patient controlled analgesia with remifentanil is not equivalent to epidural analgesia with respect to scores on satisfaction with pain relief. Satisfaction with pain relief was significantly higher in women who were allocated to and received epidural analgesia.	[Freeman, Liv M.; Bloemenkamp, Kitty W.; Lopriore, Enrico; van den Akker-van Marle, M. Elske; van Lith, Jan M.; Dahan, Albert; Middeldorp, Johanna M.] Leiden Univ Med Ctr, Leiden, Netherlands; [Franssen, Maureen T.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, NL-9713 AV Groningen, Netherlands; [Papatsonis, Dimitri N.] Amphia Hosp, Breda, Netherlands; [Hajenius, Petra J.; Hollmann, Markus W.; Rengerink, Katrien Oude] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Woiski, Mallory D.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Porath, Martina; van den Berg, Hans J.] Maxima Med Ctr, Veldhoven, Netherlands; [van Beek, Erik; Borchert, Odette W. H. M.] St Antonius Hosp, Nieuwegein, Netherlands; [Schuitemaker, Nico] Diakonessen Hosp, Utrecht, Netherlands; [Sikkema, J. Marko; Kuipers, A. H. M.] Hosp Grp Twente, Almelo, Netherlands; [Logtenberg, Sabine L. M.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [van der Salm, Paulien C. M.] Meander Med Ctr, Amersfoort, Netherlands; [Struys, Michel M.] Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, NL-9713 AV Groningen, Netherlands; [Mol, Ben Willem J.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Inst, Adelaide, SA 5005, Australia	Leiden University; Leiden University Medical Center (LUMC); University of Groningen; Amphia Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Maxima Medical Center; St. Antonius Hospital Utrecht; Diakonessenhuis; Onze Lieve Vrouwe Gasthuis Hospital; Meander Medisch Centrum; University of Groningen; Robinson Research Institute; University of Adelaide	Freeman, LM (corresponding author), Leiden Univ Med Ctr, Leiden, Netherlands.	l.m.freeman@lumc.nl	Woiski, Mallory D/L-4763-2015; Woiski, Mallory D/AAN-6632-2021; Dahan, Albert/B-8845-2008; le+Cessie, Saskia/HGC-8966-2022; Lopriore, Enrico/ABE-3576-2021	Woiski, Mallory D/0000-0002-7553-5929; Woiski, Mallory D/0000-0002-7553-5929; Dahan, Albert/0000-0003-3161-3945; Lopriore, Enrico/0000-0002-3513-5066; Struys, Michel/0000-0003-0421-536X; le Cessie, Saskia/0000-0003-2154-4923; van den Akker-van Marle, M. Elske/0000-0002-5269-509X	ZonMW (Dutch Organization for Health Care Research and Development) [80-82310-97-11039]	ZonMW (Dutch Organization for Health Care Research and Development)	This study was funded by a grant from ZonMW (Dutch Organization for Health Care Research and Development) project No 80-82310-97-11039.	American Society of Anesthiologists, 2015, ASA PHYS STAT CLASS; Barden J, 2004, COCHRANE DB SYST REV, V2; Blair JM, 2005, ANAESTHESIA, V60, P22, DOI 10.1111/j.1365-2044.2004.03975.x; Cappelleri JC, 2009, PAIN PRACT, V9, P348, DOI 10.1111/j.1533-2500.2009.00293.x; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Douma MR, 2011, INT J OBSTET ANESTH, V20, P118, DOI 10.1016/j.ijoa.2010.11.009; Douma MR, 2010, BRIT J ANAESTH, V104, P209, DOI 10.1093/bja/aep359; Freeman LM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-63; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Kan RE, 1998, ANESTHESIOLOGY, V88, P1467, DOI 10.1097/00000542-199806000-00008; Kranke P, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-139; Liu ZQ, 2014, ANESTH ANALG, V118, P598, DOI 10.1213/ANE.0000000000000077; Marr R, 2013, ANAESTHESIA, V68, P283, DOI 10.1111/anae.12099; Michelsen LG, 1996, J CLIN ANESTH, V8, P679, DOI 10.1016/S0952-8180(96)00179-1; NVOG (Dutch Society of Obstetrics and Gynaecology), 2008, GUID PIJNST TIJD BEV; On Biostatistics and Clinical Trials, 2014, US AR CURV AUC CLIN; Schnabel A, 2012, EUR J ANAESTH, V29, P177, DOI 10.1097/EJA.0b013e32834fc260; Stocki D, 2014, ANESTH ANALG, V118, P589, DOI 10.1213/ANE.0b013e3182a7cd1b; Toms L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004602.pub2; Ullman R, 2011, COCHRANE DB SYST REV, V10; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Volmanen P, 2008, ACTA ANAESTH SCAND, V52, P249, DOI 10.1111/j.1399-6576.2007.01509.x	22	65	69	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2015	350								h846	10.1136/bmj.h846	http://dx.doi.org/10.1136/bmj.h846			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3YG	25713015	Green Published, hybrid			2022-12-28	WOS:000350286700014
J	Patel, MR; Washam, JB				Patel, Manesh R.; Washam, Jeffrey B.			Edoxaban and the need for outcomes-based NOAC dosing	LANCET			English	Editorial Material							WARFARIN; EXPOSURE		[Patel, Manesh R.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA; [Washam, Jeffrey B.] Duke Univ, Med Ctr, Duke Heart Ctr, Durham, NC 27705 USA	Duke University; Duke University	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA.	manesh.patel@duke.edu	Patel, Manesh/AAC-5385-2019					Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Ruff CT, 2015, LANCET; Salazar DE, 2012, THROMB HAEMOSTASIS, V107, P925, DOI 10.1160/TH11-08-0566; Yin OQP, 2014, EUR J CLIN PHARMACOL, V70, P1339, DOI 10.1007/s00228-014-1736-4	9	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2232	2233		10.1016/S0140-6736(14)62289-3	http://dx.doi.org/10.1016/S0140-6736(14)62289-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25769359				2022-12-28	WOS:000355943500008
J	Schunkert, H; Samani, NJ				Schunkert, Heribert; Samani, Nilesh J.			Statin treatment: can genetics sharpen the focus?	LANCET			English	Editorial Material							RECURRENT MYOCARDIAL-INFARCTION; ASSOCIATION ANALYSIS; RISK		[Schunkert, Heribert] Deutsch Herzzentrum Munich, D-80636 Munich, Germany; [Schunkert, Heribert] Tech Univ Munich, DZHK Munich Heart Alliance, D-80636 Munich, Germany; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] BHF Cardiovasc Res Ctr, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England	German Heart Centre Munich; Munich Heart Alliance; Technical University of Munich; University of Leicester	Schunkert, H (corresponding author), Deutsch Herzzentrum Munich, D-80636 Munich, Germany.	schunkert@dhm.mhn.de			National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erdmann J, 2013, NATURE, V504, P432, DOI 10.1038/nature12722; Hughes MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040922; Jansen H, 2014, EUR HEART J, V35, P1917, DOI 10.1093/eurheartj/ehu208; Mega JL, 2015, LANCET; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; The TG and HDL Working Group of the Exome Sequencing Project National Heart Lung and Blood Institute, 2014, NEW ENGL J MED, V371, P22, DOI [DOI 10.1056/NEJMOA1307095, 10.1056/NEJMoa1307095]; Virani SS, 2012, CIRC J, V76, P950, DOI 10.1253/circj.CJ-11-1166; Wauters E, 2013, EUR HEART J, V34, P993, DOI 10.1093/eurheartj/ehs389	15	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2227	2229		10.1016/S0140-6736(14)61931-0	http://dx.doi.org/10.1016/S0140-6736(14)61931-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25748613				2022-12-28	WOS:000355943500005
J	McDonald, TM; Mason, JA; Kong, XQ; Bloch, ED; Gygi, D; Dani, A; Crocella, V; Giordanino, F; Odoh, SO; Drisdell, WS; Vlaisavljevich, B; Dzubak, AL; Poloni, R; Schnell, SK; Planas, N; Lee, K; Pascal, T; Wan, LWF; Prendergast, D; Neaton, JB; Smit, B; Kortright, JB; Gagliardi, L; Bordiga, S; Reimer, JA; Long, JR				McDonald, Thomas M.; Mason, Jarad A.; Kong, Xueqian; Bloch, Eric D.; Gygi, David; Dani, Alessandro; Crocella, Valentina; Giordanino, Filippo; Odoh, Samuel O.; Drisdell, Walter S.; Vlaisavljevich, Bess; Dzubak, Allison L.; Poloni, Roberta; Schnell, Sondre K.; Planas, Nora; Lee, Kyuho; Pascal, Tod; Wan, Liwen F.; Prendergast, David; Neaton, Jeffrey B.; Smit, Berend; Kortright, Jeffrey B.; Gagliardi, Laura; Bordiga, Silvia; Reimer, Jeffrey A.; Long, Jeffrey R.			Cooperative insertion of CO2 in diamine-appended metal-organic frameworks	NATURE			English	Article							CARBON-DIOXIDE CAPTURE; TOTAL-ENERGY CALCULATIONS; COORDINATION POLYMER; CRYSTAL-STRUCTURE; ADSORPTION; PSEUDOPOTENTIALS; TRANSITIONS; ISOTHERMS; SOLVENTS; BINDING	The process of carbon capture and sequestration has been proposed as a method of mitigating the build-up of greenhouse gases in the atmosphere. If implemented, the cost of electricity generated by a fossil fuel-burning power plant would rise substantially, owing to the expense of removing CO2 from the effluent stream. There is therefore an urgent need for more efficient gas separation technologies, such as those potentially offered by advanced solid adsorbents. Here we show that diamine-appended metal-organic frameworks can behave as 'phase-change' adsorbents, with unusual step-shaped CO2 adsorption isotherms that shift markedly with temperature. Results from spectroscopic, diffraction and computational studies show that the origin of the sharp adsorption step is an unprecedented cooperative process in which, above a metal-dependent threshold pressure, CO2 molecules insert into metal-amine bonds, inducing a reorganization of the amines into well-ordered chains of ammonium carbamate. As a consequence, large CO2 separation capacities can be achieved with small temperature swings, and regeneration energies appreciably lower than achievable withstate-of-the-art aqueous amine solutions become feasible. The results provide a mechanistic framework for designing highly efficient adsorbents for removing CO2 from various gas mixtures, and yield insights into the conservation of Mg2+ within the ribulose-1,5-bisphosphate carboxylase/oxygenase family of enzymes.	[McDonald, Thomas M.; Mason, Jarad A.; Bloch, Eric D.; Gygi, David; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kong, Xueqian; Vlaisavljevich, Bess; Schnell, Sondre K.; Lee, Kyuho; Smit, Berend; Reimer, Jeffrey A.] Univ Calif Berkeley, Dept Chem & Biol Engn, Berkeley, CA 94720 USA; [Kong, Xueqian] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China; [Dani, Alessandro; Crocella, Valentina; Giordanino, Filippo; Bordiga, Silvia] Univ Turin, NIS & INSTM Ctr Reference, Dept Chem, I-10135 Turin, Italy; [Odoh, Samuel O.; Dzubak, Allison L.; Planas, Nora; Gagliardi, Laura] Univ Minnesota, Dept Chem, Chem Theory Ctr, Minneapolis, MN 55455 USA; [Odoh, Samuel O.; Dzubak, Allison L.; Planas, Nora; Gagliardi, Laura] Univ Minnesota, Supercomp Inst, Minneapolis, MN 55455 USA; [Drisdell, Walter S.; Smit, Berend; Kortright, Jeffrey B.; Reimer, Jeffrey A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Poloni, Roberta] Univ Grenoble Alpes, F-38000 Grenoble, France; [Poloni, Roberta] Sci & Ingn Mat & Proc SIMAP, F-38000 Grenoble, France; [Poloni, Roberta] CNRS, SIMAP, F-38000 Grenoble, France; [Schnell, Sondre K.] Norwegian Univ Sci & Technol, Dept Chem, N-7491 Trondheim, Norway; [Pascal, Tod; Wan, Liwen F.; Prendergast, David; Neaton, Jeffrey B.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Neaton, Jeffrey B.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Neaton, Jeffrey B.] Univ Calif Berkeley, Kavli Energy Nanosci Inst, Berkeley, CA 94720 USA; [Smit, Berend] EPFL, Inst Sci & Ingn Chim, Valais, CH-1950 Sion, Switzerland	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Zhejiang University; University of Turin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Norwegian University of Science & Technology (NTNU); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jrlong@berkeley.edu	Neaton, Jeffrey/F-8578-2015; Smit, Berend/B-7580-2009; Kong, Xueqian/P-3152-2018; Vlaisavljevich, Bess/AGH-3580-2022; LEE, KYUHO/O-5868-2019; Poloni, Roberta/AAC-8743-2020; Lee, Kyuho/B-9370-2008; Crocellà, Valentina/E-5203-2016; Schnell, Sondre K/H-4934-2016; Bordiga, Silvia/M-3875-2014; Prendergast, David/E-4437-2010; Gagliardi, Laura/S-3023-2017	Neaton, Jeffrey/0000-0001-7585-6135; Smit, Berend/0000-0003-4653-8562; Kong, Xueqian/0000-0002-1901-9073; Vlaisavljevich, Bess/0000-0001-6065-0732; LEE, KYUHO/0000-0001-9325-3717; Lee, Kyuho/0000-0001-9325-3717; Crocellà, Valentina/0000-0002-3606-8424; Schnell, Sondre K/0000-0002-0664-6756; Bordiga, Silvia/0000-0003-2371-4156; Prendergast, David/0000-0003-0598-1453; Drisdell, Walter/0000-0002-8693-4562; Gagliardi, Laura/0000-0001-5227-1396; Wan, Liwen/0000-0002-5391-0804; Dzubak, Allison/0000-0001-9967-0263	Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy (DOE) [DE-AR0000103, DE-AR0000402]; DOE, Office of Science, Office of Basic Energy Sciences [DE-SC0001015]; GENCI (CINES) [2014-c2015097211]; Nanoporous Materials Genome Center of the DOE, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG02-12ER16362]; DOE Office of Science [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences of the DOE [DE-AC02-05CH11231]; National Science Foundation; Research Council of Norway [230534];  [MIUR-PRIN 2010-2011]	Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy (DOE)(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); GENCI (CINES); Nanoporous Materials Genome Center of the DOE, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences; DOE Office of Science(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences of the DOE(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Research Council of Norway(Research Council of Norway); 	We thank A. S. Bhown and A. H. Berger of EPRI, H. Krutka, C. M. Brown and. K. S. Suslick for discussions, and L. Ribaud and the 11-BM staff at the Advanced Photon Source at Argonne National Laboratory for assisting with powder X-ray diffraction experiments. The work presented here pertaining to the synthesis and gas adsorption properties of metal-organic frameworks was funded by the Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy (DOE), under award numbers DE-AR0000103 and DE-AR0000402. Funding pertaining to the characterization of materials by spectroscopy and X-ray diffraction and the computational work performed by W.S.D., B.V., R.P., S.K.S., K.L., J.B.N., B.S. and J.B.K. was provided by the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center funded by the DOE, Office of Science, Office of Basic Energy Sciences under award DE-SC0001015. Experiments performed in Turin were supported by grant MIUR-PRIN 2010-2011. Work at SIMAP was performed using computer resources from GENCI (CINES grant 2014-c2015097211). The computational work performed by S.O.O., A.L.D., N.P. and L.G. was supported through the Nanoporous Materials Genome Center of the DOE, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, under award number DE-FG02-12ER16362. This research used resources of the Advanced Photon Source, a DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. Portions of this work (use of beamline 6.3.2 at the Advanced Light Source; a user project at The Molecular Foundry, facilitated by T.P., L.F.W. and D.P., and use of its computer cluster vulcan, managed by the High Performance Computing Services Group; use of the National Energy Research Scientific Computing Center) were performed at Lawrence Berkeley National Laboratory, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract no. DE-AC02-05CH11231. For fellowship support, we further thank the National Science Foundation (J.A.M.), Gerald K. Branch and Arkema (E.D.B.) and the Research Council of Norway (grant 230534 to S.K.S.).	Allen M.P., 1991, COMPUTER SIMULATION; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Boot-Handford ME, 2014, ENERG ENVIRON SCI, V7, P130, DOI 10.1039/c3ee42350f; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Choi S, 2012, J PHYS CHEM LETT, V3, P1136, DOI 10.1021/jz300328j; Choi S, 2009, CHEMSUSCHEM, V2, P796, DOI 10.1002/cssc.200900036; Coelho A., 2007, TOPAS ACAD VERSION 4; Coelho AA, 2000, J APPL CRYSTALLOGR, V33, P899, DOI 10.1107/S002188980000248X; Coelho AA, 2003, J APPL CRYSTALLOGR, V36, P86, DOI 10.1107/S0021889802019878; Demessence A, 2009, J AM CHEM SOC, V131, P8784, DOI 10.1021/ja903411w; Dietzel PDC, 2006, CHEM COMMUN, P959, DOI 10.1039/b515434k; Drisdell WS, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890816; Drisdell WS, 2013, J AM CHEM SOC, V135, P18183, DOI 10.1021/ja408972f; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Haszeldine RS, 2009, SCIENCE, V325, P1647, DOI 10.1126/science.1172246; Henke S, 2011, CRYSTENGCOMM, V13, P6399, DOI 10.1039/c1ce05446e; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/NCHEM.444, 10.1038/nchem.444]; International Energy Agency, 2013, CO2 EM FUEL COMB HIG; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Jessop PG, 2012, ENERG ENVIRON SCI, V5, P7240, DOI 10.1039/c2ee02912j; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081101; Lee WR, 2014, ENERG ENVIRON SCI, V7, P744, DOI 10.1039/c3ee42328j; Liebenthal U, 2013, ENRGY PROCED, V37, P1844, DOI 10.1016/j.egypro.2013.06.064; LIECHTENSTEIN AI, 1995, PHYS REV B, V52, pR5467, DOI 10.1103/PhysRevB.52.R5467; Lin LC, 2012, NAT MATER, V11, P633, DOI [10.1038/nmat3336, 10.1038/NMAT3336]; LORIMER GH, 1981, ANNU REV PLANT PHYS, V32, P349, DOI 10.1146/annurev.pp.32.060181.002025; Ma'mun S, 2013, ENRGY PROCED, V37, P331, DOI 10.1016/j.egypro.2013.05.119; Mason JA, 2011, ENERG ENVIRON SCI, V4, P3030, DOI 10.1039/c1ee01720a; McDonald TM, 2012, J AM CHEM SOC, V134, P7056, DOI 10.1021/ja300034j; McDonald TM, 2011, CHEM SCI, V2, P2022, DOI 10.1039/c1sc00354b; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Planas N, 2013, J AM CHEM SOC, V135, P7402, DOI 10.1021/ja4004766; Prendergast D, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235126; Rochelle G, 2011, CHEM ENG J, V171, P725, DOI 10.1016/j.cej.2011.02.011; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Sayari A, 2010, J AM CHEM SOC, V132, P6312, DOI 10.1021/ja1013773; Seo J, 2009, J AM CHEM SOC, V131, P12792, DOI 10.1021/ja904363b; Serre C, 2002, J AM CHEM SOC, V124, P13519, DOI 10.1021/ja0276974; Shirley EL, 1996, PHYS REV B, V54, P16464, DOI 10.1103/PhysRevB.54.16464; Stephens PW, 1999, J APPL CRYSTALLOGR, V32, P281, DOI 10.1107/S0021889898006001; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Taillefumier M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.195107; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; THOMY A, 1994, SURF SCI, V299, P415; Tiritiris I, 2011, Z NATURFORSCH B, V66, P164, DOI 10.5560/ZNB.2011.66b0164; van Lare C. E. J., 1991, THESIS TECH U EINDHO, P141; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Walton KS, 2008, J AM CHEM SOC, V130, P406, DOI 10.1021/ja076595g; Wang L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014431; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993; Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x	62	806	820	42	1149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					303	+		10.1038/nature14327	http://dx.doi.org/10.1038/nature14327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762144	Green Accepted, Green Published			2022-12-28	WOS:000351171900031
J	Sabado, RL; Bhardwaj, N				Sabado, Rachel Lubong; Bhardwaj, Nina			CANCER IMMUNOTHERAPY Dendritic-cell vaccines on the move	NATURE			English	Editorial Material							REGULATORY T-CELLS; MELANOMA PATIENTS; LYMPH-NODE; IMMUNITY; CHEMOKINES; MIGRATION; ANTIGEN		[Sabado, Rachel Lubong; Bhardwaj, Nina] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sabado, RL (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY 10029 USA.	nina.bhardwaj@mssm.edu		Bhardwaj, Nina/0000-0003-1865-4187				Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Bogunovic D, 2011, CANCER RES, V71, P5467, DOI 10.1158/0008-5472.CAN-10-3988; de Vries IJM, 2003, CANCER RES, V63, P12; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320; Morlacchi S, 2011, J IMMUNOL, V186, P6807, DOI 10.4049/jimmunol.1003265; Nair SK, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29289; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Ribas A, 2009, CLIN CANCER RES, V15, P6267, DOI 10.1158/1078-0432.CCR-09-1254; Ridolfi L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-135; Sabado RL, 2013, ANN NY ACAD SCI, V1284, P31, DOI 10.1111/nyas.12125; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Vera M, 2005, MOL THER, V12, P950, DOI 10.1016/j.ymthe.2005.03.030	17	61	64	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					300	301		10.1038/nature14211	http://dx.doi.org/10.1038/nature14211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762139				2022-12-28	WOS:000351171900030
J	Clack, JA				Clack, Jennifer A.			EVOLUTIONARY BIOLOGY The origin of terrestrial hearing	NATURE			English	Editorial Material							EARLY TETRAPOD		Univ Cambridge, Univ Museum Zool, Cambridge CB2 3EJ, England	University of Cambridge	Clack, JA (corresponding author), Univ Cambridge, Univ Museum Zool, Cambridge CB2 3EJ, England.	j.a.clack@zoo.cam.ac.uk						Christensen CB, 2015, J EXP BIOL, V218, P381, DOI 10.1242/jeb.116012; Christensen-Dalsgaard J, 2011, BIOL LETTERS, V7, P139, DOI 10.1098/rsbl.2010.0636; Clack J. A., 2012, GAINING GROUND ORIGI; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; Clark JA, 1997, BRAIN BEHAV EVOLUT, V50, P198, DOI 10.1159/000113334; Hawkins AD, 2014, SPRINGER HANDB AUDIT, V50, P247, DOI 10.1007/978-1-4614-9102-6_14; Long John A., 1993, Memoir of the Association of Australasian Palaeontologists, V15, P199; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Rogers P. H., EFFECTS NOISE AQUATI	11	9	9	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					168	169		10.1038/519168a	http://dx.doi.org/10.1038/519168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25762279				2022-12-28	WOS:000350770500026
J	Hsu, HW; Postberg, F; Sekine, Y; Shibuya, T; Kempf, S; Horanyi, M; Juhasz, A; Altobelli, N; Suzuki, K; Masaki, Y; Kuwatani, T; Tachibana, S; Sirono, S; Moragas-Klostermeyer, G; Srama, R				Hsu, Hsiang-Wen; Postberg, Frank; Sekine, Yasuhito; Shibuya, Takazo; Kempf, Sascha; Horanyi, Mihaly; Juhasz, Antal; Altobelli, Nicolas; Suzuki, Katsuhiko; Masaki, Yuka; Kuwatani, Tatsu; Tachibana, Shogo; Sirono, Sin-iti; Moragas-Klostermeyer, Georg; Srama, Ralf			Ongoing hydrothermal activities within Enceladus	NATURE			English	Article							SATURNS E-RING; NANOCOLLOID FORMATION; STREAM PARTICLES; DUST PARTICLES; IONIC-STRENGTH; SILICA; KINETICS; EVOLUTION; SYSTEMS; ICE	Detection of sodium-salt-rich ice grains emitted from the plume of the Saturnian moon Enceladus suggests that the grains formed as frozen droplets from a liquid water reservoir that is, or has been, in contact with rock(1,2). Gravitational field measurements suggest a regional south polar subsurface ocean of about 10 kilometres thickness located beneath an ice crust 30 to 40 kilometres thick(3). These findings imply rock-water interactions in regions surrounding the core of Enceladus. The resulting chemical 'footprints' are expected to be preserved in the liquid and subsequently transported upwards to the near-surface plume sources, where they eventually would be ejected and could be measured by a spacecraft(4). Here we report an analysis of silicon-rich, nanometre-sized dust particles(5-8) (so-called stream particles) that stand out from the water-ice-dominated objects characteristic of Saturn. We interpret these grains as nanometre-sized SiO2 (silica) particles, initially embedded in icy grains emitted from Enceladus' subsurface waters and released by sputter erosion in Saturn's E ring. The composition and the limited size range (2 to 8 nanometres in radius) of stream particles indicate ongoing high-temperature (>90 degrees C) hydrothermal reactions associated with global-scale geothermal activity that quickly transports hydrothermal products from the ocean floor at a depth of at least 40 kilometres up to the plume of Enceladus.	[Hsu, Hsiang-Wen; Kempf, Sascha; Horanyi, Mihaly; Juhasz, Antal] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Postberg, Frank] Heidelberg Univ, Inst Geowissensch, D-69120 Heidelberg, Germany; [Postberg, Frank; Moragas-Klostermeyer, Georg; Srama, Ralf] Univ Stuttgart, Inst Raumfahrtsyst, D-70569 Stuttgart, Germany; [Sekine, Yasuhito] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Shibuya, Takazo] JAMSTEC, Lab Ocean Earth Life Evolut Res, Yokosuka, Kanagawa 2370061, Japan; [Juhasz, Antal] Wigner RCP, Inst Particle & Nucl Phys, H-1121 Budapest, Hungary; [Altobelli, Nicolas] European Space Agcy, E-28691 Madrid, Spain; [Suzuki, Katsuhiko; Masaki, Yuka] JAMSTEC, Res & Dev Ctr Submarine Resources, Yokosuka, Kanagawa 2370061, Japan; [Kuwatani, Tatsu] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan; [Tachibana, Shogo] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Sirono, Sin-iti] Nagoya Univ, Grad Sch Environm Sci, Nagoya, Aichi 4648601, Japan	University of Colorado System; University of Colorado Boulder; Ruprecht Karls University Heidelberg; University of Stuttgart; University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; European Space Agency; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tohoku University; Hokkaido University; Nagoya University	Hsu, HW (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA.	sean.hsu@lasp.colorado.edu	Hsu, Hsiang-Wen/K-3018-2019; Suzuki, Katsuhiko/B-1143-2018; Postberg, Frank/AAE-6295-2019; Hsu, Hsiang-Wen/V-4791-2018; Tachibana, Shogo/R-7884-2018	Hsu, Hsiang-Wen/0000-0002-5478-4168; Suzuki, Katsuhiko/0000-0003-4266-5046; Postberg, Frank/0000-0002-5862-4276; Tachibana, Shogo/0000-0002-4603-9440; Sekine, Yasuhito/0000-0002-3544-3632; Shibuya, Takazo/0000-0002-1289-1328; Kuwatani, Tatsu/0000-0001-7161-9458; KEMPF, SASCHA/0000-0001-5236-3004	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Astrobiology Program of the National Institutes of Natural Sciences, Japan; DLR [50 OH1103]; Grants-in-Aid for Scientific Research [25108001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astrobiology Program of the National Institutes of Natural Sciences, Japan; DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge support from the CDA team, the Cassini project, and NASA. This research was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by the Japan Society for the Promotion of Science, and by the Astrobiology Program of the National Institutes of Natural Sciences, Japan. This work was partly supported by the DLR grant 50 OH1103. We thank J. Schmidt, M. Y. Zolotov and D. J. Tobler for discussions, and E.S. Guralnick, J. K. Hillier, A. Rasca and T. Munsat for advice on writing this Letter. Y.S. thanks A. Okubo for her technical help in taking FE-SEM images.	ALLEN LH, 1969, J COLLOID INTERF SCI, V31, P287, DOI 10.1016/0021-9797(69)90172-6; Brearley A.J., 2006, METEORITES EARLY SOL, P587; Burton ME, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045148; Channing A, 2007, EARTH PLANET SC LETT, V257, P121, DOI 10.1016/j.epsl.2007.02.026; Christon SP, 2013, J GEOPHYS RES-SPACE, V118, P3446, DOI 10.1002/jgra.50383; Conrad CF, 2007, GEOCHIM COSMOCHIM AC, V71, P531, DOI 10.1016/j.gca.2006.10.001; Fiege K., 2013, 76 ANN MET SOC M; HERZIG PM, 1988, EARTH PLANET SC LETT, V89, P261, DOI 10.1016/0012-821X(88)90115-X; Hillier JK, 2007, MON NOT R ASTRON SOC, V377, P1588, DOI 10.1111/j.1365-2966.2007.11710.x; Horanyi M, 2000, PHYS PLASMAS, V7, P3847, DOI 10.1063/1.1288909; HORANYI M, 1992, ICARUS, V97, P248, DOI 10.1016/0019-1035(92)90131-P; Horanyi M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032726; HORNUNG K, 1994, ASTRON ASTROPHYS, V291, P324; Hornung K, 2000, ASTROPHYS SPACE SCI, V274, P355, DOI 10.1023/A:1026553502542; Hsu HW, 2013, GEOPHYS RES LETT, V40, P2902, DOI 10.1002/grl.50604; Hsu H.-W., 2012, SPRINGER ASTROPHYSIC, V385, P77; Hsu HW, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016488; Icenhower JP, 2000, GEOCHIM COSMOCHIM AC, V64, P4193, DOI 10.1016/S0016-7037(00)00487-7; Icopini GA, 2005, GEOCHIM COSMOCHIM AC, V69, P293, DOI 10.1016/j.gca.2004.06.038; Iess L, 2014, SCIENCE, V344, P78, DOI 10.1126/science.1250551; Iler R. K, 1979, CHEM SILICA; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; Johnson RE, 2008, PLANET SPACE SCI, V56, P1238, DOI 10.1016/j.pss.2008.04.003; Jurac S, 2001, ICARUS, V149, P384, DOI 10.1006/icar.2000.6528; Kempf S, 2008, ICARUS, V193, P420, DOI 10.1016/j.icarus.2007.06.027; Kempf S, 2006, PLANET SPACE SCI, V54, P999, DOI 10.1016/j.pss.2006.05.012; Kempf S, 2005, SCIENCE, V307, P1274, DOI 10.1126/science.1106218; Kempf S, 2005, NATURE, V433, P289, DOI 10.1038/nature03218; Malamud U, 2013, ICARUS, V225, P763, DOI 10.1016/j.icarus.2013.04.024; Martens HR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035433; Matson DL, 2012, ICARUS, V221, P53, DOI 10.1016/j.icarus.2012.05.031; McCollom TM, 2003, GEOCHIM COSMOCHIM AC, V67, P3625, DOI 10.1016/S0016-7037(03)00136-4; MING T, 1989, NATURE, V339, P351, DOI 10.1038/339351a0; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995; Ozima M., 1982, J JPN ASS MINERAL, V3, P97; Postberg F, 2011, NATURE, V474, P620, DOI 10.1038/nature10175; Postberg F, 2009, PLANET SPACE SCI, V57, P1359, DOI 10.1016/j.pss.2009.06.027; Postberg F, 2009, NATURE, V459, P1098, DOI 10.1038/nature08046; Postberg F, 2006, ICARUS, V183, P122, DOI 10.1016/j.icarus.2006.02.001; Schmidt J, 2008, NATURE, V451, P685, DOI 10.1038/nature06491; Seyfried WE, 2007, GEOCHIM COSMOCHIM AC, V71, P3872, DOI 10.1016/j.gca.2007.05.015; Shi M, 1995, J GEOPHYS RES-PLANET, V100, P26387, DOI 10.1029/95JE03099; Shibuya T, 2013, CHEM GEOL, V359, P1, DOI 10.1016/j.chemgeo.2013.08.044; Sirono S, 2013, EARTH PLANETS SPACE, V65, P1563, DOI 10.5047/eps.2013.07.002; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; Stephan T, 2001, PLANET SPACE SCI, V49, P859, DOI 10.1016/S0032-0633(01)00037-X; Tachibana S, 2002, GEOCHIM COSMOCHIM AC, V66, P713, DOI 10.1016/S0016-7037(01)00797-9; TIELENS AGGM, 1994, ASTROPHYS J, V431, P321, DOI 10.1086/174488; Tobler DJ, 2013, GEOCHIM COSMOCHIM AC, V114, P156, DOI 10.1016/j.gca.2013.03.045; Tobler DJ, 2009, GEOCHIM COSMOCHIM AC, V73, P5377, DOI 10.1016/j.gca.2009.06.002; Vance S, 2007, ASTROBIOLOGY, V7, P987, DOI 10.1089/ast.2007.0075; Zolotov MY, 2012, ICARUS, V220, P713, DOI 10.1016/j.icarus.2012.05.036	53	259	262	3	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					207	+		10.1038/nature14262	http://dx.doi.org/10.1038/nature14262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25762281				2022-12-28	WOS:000350770500033
J	Nusse, R				Nusse, Roel			CELL SIGNALLING Disarming Wnt	NATURE			English	Editorial Material							SECRETION; ACYLATION; WINGLESS		Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol,Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol,Sch Med, Stanford, CA 94305 USA.	rnusse@stanford.edu						Alegado RA, 2012, ELIFE, V1, DOI 10.7554/eLife.00013; Bazan JF, 2012, DEV CELL, V23, P227, DOI 10.1016/j.devcel.2012.07.011; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Nusse R., 2014, SCIENCE; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	12	28	30	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					163	164		10.1038/nature14208	http://dx.doi.org/10.1038/nature14208			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25731170				2022-12-28	WOS:000350770500022
J	Rosemond, AD; Benstead, JP; Bumpers, PM; Gulis, V; Kominoski, JS; Manning, DWP; Suberkropp, K; Wallace, JB				Rosemond, Amy D.; Benstead, Jonathan P.; Bumpers, Phillip M.; Gulis, Vladislav; Kominoski, John S.; Manning, David W. P.; Suberkropp, Keller; Wallace, J. Bruce			Experimental nutrient additions accelerate terrestrial carbon loss from stream ecosystems	SCIENCE			English	Article							LITTER DECOMPOSITION; DETRITUS; ENRICHMENT; NITROGEN; EUTROPHICATION; RESPONSES; BREAKDOWN; ECOLOGY; FLUXES	Nutrient pollution of freshwater ecosystems results in predictable increases in carbon (C) sequestration by algae. Tests of nutrient enrichment on the fates of terrestrial organic C, which supports riverine food webs and is a source of CO2, are lacking. Using whole-stream nitrogen (N) and phosphorus (P) additions spanning the equivalent of 27 years, we found that average terrestrial organic C residence time was reduced by similar to 50% as compared to reference conditions as a result of nutrient pollution. Annual inputs of terrestrial organic C were rapidly depleted via release of detrital food webs from N and P co-limitation. This magnitude of terrestrial C loss can potentially exceed predicted algal C gains with nutrient enrichment across large parts of river networks, diminishing associated ecosystem services.	[Rosemond, Amy D.; Bumpers, Phillip M.; Kominoski, John S.; Manning, David W. P.; Wallace, J. Bruce] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Benstead, Jonathan P.; Suberkropp, Keller] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Gulis, Vladislav] Coastal Carolina Univ, Dept Biol, Conway, SC 29528 USA	University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Tuscaloosa; Coastal Carolina University	Rosemond, AD (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	rosemond@uga.edu	Kominoski, John Stephen/A-5907-2008; Rosemond, Amy D./I-2688-2018	Kominoski, John Stephen/0000-0002-0978-3326; Rosemond, Amy D./0000-0003-4299-9353; Bumpers, Phillip M/0000-0003-1298-0571	National Science Foundation Division Environmental Biology (NSF DEB) [0823293]; NSF from the Ecosystem Studies Program [DEB-9806610, 0318063, 0918894, 0918904, 0919054]; Direct For Biological Sciences [0823293] Funding Source: National Science Foundation; Division Of Environmental Biology [1440485] Funding Source: National Science Foundation	National Science Foundation Division Environmental Biology (NSF DEB); NSF from the Ecosystem Studies Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank H. Weyers, N. Taylor, R. Hilten, S. Dye, J. Coombs, and K. Norris or their assistance in maintaining the enrichments and associated data collection and analyses; C. Tant and J. Greenwood for conducting the N+P litterbag studies; and S. Eggert for assisting in data collection and analysis and helping develop sampling protocols. T. Mccallister illustrated Fig. 1 (photo credit: PMB). The manuscript was improved by comments from R. Hall, E. Rosi-Marshall, F. Ballantyne, S. Altizer, A. Helton, A. Huryn, M. Paul, J. Davis, R. Sponseller, C. Song; and anonymous reviewers. J. Maerz contributed ideas and logistical help associated with the NxP experiment; S. Wenger, R. Hall, C. Song, and D. Hall provided statistical advice; D. Leigh and J. Hepinstall-Cymerman provided spatial data; and J. Webster provided site information. We are grateful to A. Helton for conducting the network-scale extrapolation. Data are available in the supplementary materials in Science Online. This research leveraged logistical support from the Coweeta Long Term Ecological Research Program at the University of Georgia, which is supported by the National Science Foundation Division Environmental Biology (NSF DEB grant 0823293). The order of authors after the first author is alphabetical; funding for these experiments was provided in NSF grants DEB-9806610, 0318063, 0918894, 0918904, and 0919054 from the Ecosystem Studies Program to A.D.R., J.P.B., V.G., K.S., J.B.W., and others (J. Maerz, above; M. Black, University of Georgia; and P. Mulholland, Oak Ridge National Laboratory).	Alexander RB, 2006, LIMNOL OCEANOGR, V51, P639, DOI 10.4319/lo.2006.51.1_part_2.0639; Allgeier JE, 2011, J APPL ECOL, V48, P96, DOI 10.1111/j.1365-2664.2010.01894.x; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benstead JP, 2009, ECOLOGY, V90, P2556, DOI 10.1890/08-0862.1; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dodds WK, 2007, TRENDS ECOL EVOL, V22, P669, DOI 10.1016/j.tree.2007.07.010; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Ferreira V, 2015, BIOL REV, V90, P669, DOI 10.1111/brv.12125; Finlay JC, 2013, SCIENCE, V342, P247, DOI 10.1126/science.1242575; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Gessner MO, 2002, ECOL APPL, V12, P498, DOI 10.1890/1051-0761(2002)012[0498:ACFULB]2.0.CO;2; Greenwood JL, 2007, OECOLOGIA, V151, P637, DOI 10.1007/s00442-006-0609-7; Griffiths NA, 2009, ECOL APPL, V19, P133, DOI 10.1890/07-1876.1; Gulis V, 2003, FRESHWATER BIOL, V48, P123, DOI 10.1046/j.1365-2427.2003.00985.x; Pacheco FS, 2014, INLAND WATERS, V4, P41, DOI 10.5268/IW-4.1.614; Suberkropp K, 2010, LIMNOL OCEANOGR, V55, P149, DOI 10.4319/lo.2010.55.1.0149; Tant CJ, 2013, FRESHW SCI, V32, P1111, DOI 10.1899/12-049.1; Thomas SA, 2001, LIMNOL OCEANOGR, V46, P1415, DOI 10.4319/lo.2001.46.6.1415; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; WALLACE JB, 1982, OECOLOGIA, V53, P197, DOI 10.1007/BF00545663; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; WALLACE JB, 1991, INT VER THEOR ANGEW, V24, P1676; Walther DA, 2011, J N AM BENTHOL SOC, V30, P357, DOI 10.1899/10-006.1; Webster J.R., 2000, VERHANDLUNGEN INT VE, V27, P1337, DOI DOI 10.1080/03680770.1998.11901453; Webster JR, 2007, J N AM BENTHOL SOC, V26, P375, DOI 10.1899/06-095.1; Webster JR, 1999, FRESHWATER BIOL, V41, P687, DOI 10.1046/j.1365-2427.1999.00409.x; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534	29	159	165	15	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1142	1145		10.1126/science.aaa1958	http://dx.doi.org/10.1126/science.aaa1958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745171				2022-12-28	WOS:000350354200054
J	Ball, P				Ball, Philip			Carl Djerassi (1923-2015) OBITUARY	NATURE			English	Biographical-Item												p.ball@btinternet.com							0	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					34	34		10.1038/519034a	http://dx.doi.org/10.1038/519034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739624	Bronze			2022-12-28	WOS:000350304000025
J	Moore, HCF; Unger, JM; Phillips, KA; Boyle, F; Hitre, E; Porter, D; Francis, PA; Goldstein, LJ; Gomez, HL; Vallejos, CS; Partridge, AH; Dakhil, SR; Garcia, AA; Gralow, J; Lombard, JM; Forbes, JF; Martino, S; Barlow, WE; Fabian, CJ; Minasian, L; Meyskens, FL; Gelber, RD; Hortobagyi, GN; Albain, KS				Moore, Halle C. F.; Unger, Joseph M.; Phillips, Kelly-Anne; Boyle, Frances; Hitre, Erika; Porter, David; Francis, Prudence A.; Goldstein, Lori J.; Gomez, Henry L.; Vallejos, Carlos S.; Partridge, Ann H.; Dakhil, Shaker R.; Garcia, Agustin A.; Gralow, Julie; Lombard, Janine M.; Forbes, John F.; Martino, Silvana; Barlow, William E.; Fabian, Carol J.; Minasian, Lori; Meyskens, Frank L., Jr.; Gelber, Richard D.; Hortobagyi, Gabriel N.; Albain, Kathy S.		POEMS S0230 Investigators	Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FERTILITY PRESERVATION; HORMONE AGONISTS; SUPPRESSION; AMENORRHEA; WOMEN; TRIPTORELIN; PREVENTION	BACKGROUND Ovarian failure is a common toxic effect of chemotherapy. Studies of the use of gonadotropin-releasing hormone (GnRH) agonists to protect ovarian function have shown mixed results and lack data on pregnancy outcomes. METHODS We randomly assigned 257 premenopausal women with operable hormone-receptor-negative breast cancer to receive standard chemotherapy with the GnRH agonist goserelin (goserelin group) or standard chemotherapy without goserelin (chemotherapy-alone group). The primary study end point was the rate of ovarian failure at 2 years, with ovarian failure defined as the absence of menses in the preceding 6 months and levels of follicle-stimulating hormone (FSH) in the postmenopausal range. Rates were compared with the use of conditional logistic regression. Secondary end points included pregnancy outcomes and disease-free and overall survival. RESULTS At baseline, 218 patients were eligible and could be evaluated. Among 135 with complete primary end-point data, the ovarian failure rate was 8% in the goserelin group and 22% in the chemotherapy-alone group (odds ratio, 0.30; 95% confidence interval, 0.09 to 0.97; two-sided P = 0.04). Owing to missing primary end-point data, sensitivity analyses were performed, and the results were consistent with the main findings. Missing data did not differ according to treatment group or according to the stratification factors of age and planned chemotherapy regimen. Among the 218 patients who could be evaluated, pregnancy occurred in more women in the goserelin group than in the chemotherapy-alone group (21% vs. 11%, P = 0.03); women in the goserelin group also had improved disease-free survival (P = 0.04) and overall survival (P = 0.05). CONCLUSIONS Although missing data weaken interpretation of the findings, administration of goserelin with chemotherapy appeared to protect against ovarian failure, reducing the risk of early menopause and improving prospects for fertility. (Funded by the National Cancer Institute and others; POEMS/S0230 ClinicalTrials.gov number, NCT00068601.)	[Moore, Halle C. F.] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Unger, Joseph M.; Barlow, William E.] Fred Hutchinson Canc Res Ctr, SWOG Canc Res Grp Stat Ctr, Seattle, WA 98104 USA; [Gralow, Julie] Seattle Canc Care Alliance, Seattle, WA USA; [Gralow, Julie] Univ Washington, Seattle, WA 98195 USA; [Phillips, Kelly-Anne; Francis, Prudence A.] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Phillips, Kelly-Anne; Francis, Prudence A.; Forbes, John F.] New Zealand Breast Canc Trials Grp ANZBCTG, Newcastle, NSW, Australia; [Boyle, Frances; Lombard, Janine M.; Forbes, John F.] Calvary Mater Hosp, Newcastle, NSW, Australia; [Boyle, Frances] Univ Sydney, Sydney, NSW 2006, Australia; [Phillips, Kelly-Anne; Francis, Prudence A.] IBCSG, Bern, Switzerland; [Hitre, Erika] Natl Inst Oncol, Budapest, Hungary; [Porter, David] Auckland Reg Canc & Blood Serv, Auckland, New Zealand; [Goldstein, Lori J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Gomez, Henry L.] Inst Enfermedades Neoplas, Lima, Peru; [Vallejos, Carlos S.] Oncosalud SAC, Lima, Peru; [Partridge, Ann H.; Gelber, Richard D.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Gelber, Richard D.] IBCSG Stat Ctr, Boston, MA USA; [Dakhil, Shaker R.] Wichita Community Clin Oncol Program, Wichita, KS USA; [Fabian, Carol J.] Univ Kansas, Westwood, KS USA; [Garcia, Agustin A.] Univ So Calif, Norris Canc Ctr, Los Angeles, CA USA; [Martino, Silvana] Angeles Clin, Santa Monica, CA USA; [Martino, Silvana] Res Inst, Santa Monica, CA USA; [Meyskens, Frank L., Jr.] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA; [Minasian, Lori] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Albain, Kathy S.] Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Cleveland Clinic Foundation; Fred Hutchinson Cancer Center; Southwest Oncology Group; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Peter Maccallum Cancer Center; University of Melbourne; Calvary Mater Newcastle Hospital; University of Sydney; National Institute of Oncology Hungary; Fox Chase Cancer Center; Instituto Nacional de Enfermedades Neoplasicas; Harvard University; Dana-Farber Cancer Institute; University of Kansas; University of Southern California; Angeles Clinic & Research Institute; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; Loyola University Chicago	Moore, HCF (corresponding author), Cleveland Clin Fdn, Taussig Canc Inst, R35,9500 Euclid Ave, Cleveland, OH 44195 USA.	mooreh1@ccf.org	Francis, Prudence A/J-4003-2012; Unger, Joseph/O-7457-2019	Francis, Prudence A/0000-0002-7207-9286; Gomez, Henry/0000-0003-2660-1843; Vallejos, Carlos/0000-0002-7872-3693; Phillips, Kelly-Anne/0000-0002-0475-1771	National Cancer Institute; NATIONAL CANCER INSTITUTE [U10CA180821, UG1CA189858, UG1CA189953, U10CA031946, U10CA180888, U24CA075362, UG1CA189957, U10CA180801, U10CA027525, UG1CA189972, UG1CA189974, UG1CA189808, U10CA180819, UG1CA189822, U10CA180858, U10CA180820, U10CA180830, UG1CA189954, UG1CA189872] Funding Source: NIH RePORTER; National Breast Cancer Foundation [PRAC-13-04] Funding Source: researchfish	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Breast Cancer Foundation	Funded by the National Cancer Institute and others; POEMS/S0230 ClinicalTrials.gov number, NCT00068601.	Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Albain KS, 2002, ASCO ANN M ORL FL MA; Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044; Buchholz S, 2009, INT J ONCOL, V35, P789, DOI 10.3892/ijo_00000391; Del Mastro L, 2014, CANCER TREAT REV, V40, P675, DOI 10.1016/j.ctrv.2013.12.001; Del Mastro L, 2011, JAMA-J AM MED ASSOC, V306, P269, DOI 10.1001/jama.2011.991; Elgindy EA, 2013, OBSTET GYNECOL, V121, P78, DOI [10.1097/AOG.0b013e31827374e2, http://10.1097/AOG.0b013e31827374e2]; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Gerber B, 2011, J CLIN ONCOL, V29, P2334, DOI 10.1200/JCO.2010.32.5704; Grundker C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2606; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Munster PN, 2012, J CLIN ONCOL, V30, P533, DOI 10.1200/JCO.2011.34.6890; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Oktay K, 2007, ONCOLOGIST, V12, P1055, DOI 10.1634/theoncologist.12-9-1055; Pagani O, 1998, EUR J CANCER, V34, P632, DOI 10.1016/S0959-8049(97)10036-3; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Poikonen P, 2000, EUR J CANCER, V36, P43, DOI 10.1016/S0959-8049(99)00225-7; Ruddy KJ, 2014, J CLIN ONCOL, V32, P1151, DOI 10.1200/JCO.2013.52.8877; Schubert A, 2011, BREAST CANCER RES TR, V130, P783, DOI 10.1007/s10549-011-1358-9; Senkus E, 2014, PSYCHO-ONCOLOGY, V23, P173, DOI 10.1002/pon.3384; Sverrisdottir A, 2009, BREAST CANCER RES TR, V117, P561, DOI 10.1007/s10549-009-0313-5; Swain SM, 2010, NEW ENGL J MED, V362, P2053, DOI 10.1056/NEJMoa0909638; Turner NH, 2013, ANN ONCOL, V24, P2224, DOI 10.1093/annonc/mdt196	23	330	363	4	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					923	932		10.1056/NEJMoa1413204	http://dx.doi.org/10.1056/NEJMoa1413204			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738668	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000350304500008
J	Ozanne, SE				Ozanne, Susan E.			Epigenetic Signatures of Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIET		[Ozanne, Susan E.] Univ Cambridge, Inst Metab Sci, Cambridge, England; [Ozanne, Susan E.] Univ Cambridge, MRC, Metab Dis Unit, Cambridge, England	University of Cambridge; University of Cambridge	Ozanne, SE (corresponding author), Univ Cambridge, Inst Metab Sci, Cambridge, England.			Ozanne, Susan/0000-0001-8753-5144	British Heart Foundation [FS/09/029/27902] Funding Source: Medline; Medical Research Council [MC_UU_12012/4] Funding Source: Medline; MRC [MC_UU_12012/4] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010	3	19	19	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					973	974		10.1056/NEJMcibr1414707	http://dx.doi.org/10.1056/NEJMcibr1414707			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738675				2022-12-28	WOS:000350304500015
J	Smith, JM				Smith, Jeanette M.			The Sea at Le Havre	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					878	879		10.1001/jama.2014.11611	http://dx.doi.org/10.1001/jama.2014.11611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734720				2022-12-28	WOS:000350231800001
J	Whyard, S				Whyard, Steve			Insecticidal RNA, the long and short of it	SCIENCE			English	Editorial Material							INTERFERENCE		Univ Manitoba, Dept Biol Sci, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Whyard, S (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB R3T 2N2, Canada.	steve.whyard@umanitoba.ca		Whyard, Steve/0000-0002-9874-7780				Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wynant N, 2014, INT REV CEL MOL BIO, V312, P139, DOI 10.1016/B978-0-12-800178-3.00005-1; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang J, 2015, SCIENCE, V347, P991, DOI 10.1126/science.1261680	12	11	17	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					950	951		10.1126/science.aaa7722	http://dx.doi.org/10.1126/science.aaa7722			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722399				2022-12-28	WOS:000349958900020
J	Newton, PN; Schellenberg, D; Ashley, EA; Ravinetto, R; Green, MD; ter Kuile, FO; Tabernero, P; White, NJ; Guerin, PJ				Newton, Paul N.; Schellenberg, David; Ashley, Elizabeth A.; Ravinetto, Raffaella; Green, Michael D.; ter Kuile, Feiko O.; Tabernero, Patricia; White, Nicholas J.; Guerin, Philippe J.			Quality assurance of drugs used in clinical trials: proposal for adapting guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Newton, Paul N.] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit, Viangchan, Laos; [Schellenberg, David] London Sch Hyg & Trop Med, London WC1, England; [Ashley, Elizabeth A.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand; [Ravinetto, Raffaella] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Green, Michael D.] Ctr Dis Control & Prevent, Atlanta, GA USA; [ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Tabernero, Patricia; Guerin, Philippe J.] Univ Oxford, Ctr Trop Med & Global Hlth, Worldwide Antimalarial Resistance Network, Oxford OX1 2JD, England; [White, Nicholas J.] Univ Oxford, Churchill Hosp, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX1 2JD, England	University of London; London School of Hygiene & Tropical Medicine; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford; Worldwide Antimalarial Resistance Network (WWARN); University of Oxford	Newton, PN (corresponding author), Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit, Viangchan, Laos.	paul@tropmedres.ac	White, Nick/AAC-6527-2019; Tabernero, Patricia M/O-8340-2017; Kuile, Feiko ter/ABD-6681-2020; Guerin, Philippe/AAH-8873-2021	White, Nick/0000-0002-1897-1978; Tabernero, Patricia M/0000-0002-1015-6207; Kuile, Feiko ter/0000-0003-3663-5617; Schellenberg, David/0000-0001-8222-0186; Newton, Paul/0000-0002-4608-6431; Guerin, Philippe/0000-0002-6008-2963				ALTMAN DG, 1988, STAT MED, V7, P629, DOI 10.1002/sim.4780070602; [Anonymous], STAND REP DIAGN ACC; [Anonymous], 1996, ICH HARM TRIP GUID; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; CONSORT, TRANSP REG TRIALS; Csillag C, 1998, LANCET, V352, P553, DOI 10.1016/S0140-6736(05)79267-9; Equator Network, BETT REP INT TEMPL I; Golomb BA, 2010, ANN INTERN MED, V153, P532, DOI 10.7326/0003-4819-153-8-201010190-00010; Gutman J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-58; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Idindili B, 2007, AM J CLIN NUTR, V85, P1312, DOI 10.1093/ajcn/85.5.1312; Lang T, 2011, LANCET, V377, P1553, DOI 10.1016/S0140-6736(10)62052-1; Mori M, 2011, TROP MED INT HEALTH, V16, P1439, DOI 10.1111/j.1365-3156.2011.02852.x; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; SHAW TRD, 1974, POSTGRAD MED J, V50, P98, DOI 10.1136/pgmj.50.580.98; Sowunmi A, 1994, Afr J Med Med Sci, V23, P275; Strauch S, 2011, J PHARM SCI-US, V100, P11, DOI 10.1002/jps.22249; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2009, LIST COUNTR CONS STR; Weidekamm E, 1998, EUR J CLIN PHARMACOL, V54, P615, DOI 10.1007/s002280050523; WHO, 2010, ASS MED REG SYST SUB; World Health Organization, 1995, WHO TECH REP SER, V854, P1; World Health Organization, 2013, WHO PROJ SURV MON SS	26	14	14	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2015	350								h602	10.1136/bmj.h602	http://dx.doi.org/10.1136/bmj.h602			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AM	25716700	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000350292900008
J	Nandraj, S				Nandraj, Sunil			PERSONAL VIEW Private healthcare providers in India are above the law, leaving patients without protection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sunil.nandraj@gmail.com						[Anonymous], 2013, DECCAN CHRONICL 0104; [Anonymous], 2014, TIMES INDIA; Balakrishnan S, 2014, DNA; Correspondent, 2012, HINDUSTAN TIMES 1011; Express News Service, 2012, FINANCIAL EXPRE 1128; HT correspondent, 2013, HINDUSTAN TIMES 0130; Jain A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4184; Mathew M, 2012, ASIAN AGE       1007; Nandraj S, 2012, EC POLITICAL WEEKLY; Times of India, 2013, TIMES INDIA 0916; Trivedi D, 2014, FRONTLINE	11	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2015	350								h675	10.1136/bmj.h675	http://dx.doi.org/10.1136/bmj.h675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AL	25712177				2022-12-28	WOS:000350292700017
J	Ngandu, T; Lehtisalo, J; Solomon, A; Levalahti, E; Ahtiluoto, S; Antikainen, R; Backman, L; Hanninen, T; Jula, A; Laatikainen, T; Lindstrom, J; Mangialasche, F; Paajanen, T; Pajala, S; Peltonen, M; Rauramaa, R; Stigsdotter-Neely, A; Strandberg, T; Tuomilehto, J; Soininen, H; Kivipelto, M				Ngandu, Tiia; Lehtisalo, Jenni; Solomon, Alina; Levalahti, Esko; Ahtiluoto, Satu; Antikainen, Riitta; Backman, Lars; Hanninen, Tuomo; Jula, Antti; Laatikainen, Tiina; Lindstrom, Jaana; Mangialasche, Francesca; Paajanen, Teemu; Pajala, Satu; Peltonen, Markku; Rauramaa, Rainer; Stigsdotter-Neely, Anna; Strandberg, Timo; Tuomilehto, Jaakko; Soininen, Hilkka; Kivipelto, Miia			A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial	LANCET			English	Article							FINNISH GERIATRIC INTERVENTION; ALZHEIMERS-DISEASE; IMPAIRMENT; FITNESS	Background Modifiable vascular and lifestyle-related risk factors have been associated with dementia risk in observational studies. In the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), a proof-of-concept randomised controlled trial, we aimed to assess a multidomain approach to prevent cognitive decline in at-risk elderly people from the general population. Methods In a double-blind randomised controlled trial we enrolled individuals aged 60-77 years recruited from previous national surveys. Inclusion criteria were CAIDE (Cardiovascular Risk Factors, Aging and Dementia) Dementia Risk Score of at least 6 points and cognition at mean level or slightly lower than expected for age. We randomly assigned participants in a 1: 1 ratio to a 2 year multidomain intervention (diet, exercise, cognitive training, vascular risk monitoring), or a control group (general health advice). Computer-generated allocation was done in blocks of four (two individuals randomly allocated to each group) at each site. Group allocation was not actively disclosed to participants and outcome assessors were masked to group allocation. The primary outcome was change in cognition as measured through comprehensive neuropsychological test battery (NTB) Z score. Analysis was by modified intention to treat (all participants with at least one post-baseline observation). This trial is registered at ClinicalTrials.gov, number NCT01041989. Findings Between Sept 7, 2009, and Nov 24, 2011, we screened 2654 individuals and randomly assigned 1260 to the intervention group (n=631) or control group (n=629). 591 (94%) participants in the intervention group and 599 (95%) in the control group had at least one post-baseline assessment and were included in the modified intention-to-treat analysis. Estimated mean change in NTB total Z score at 2 years was 0.20 (SE 0.02, SD 0.51) in the intervention group and 0.16 (0.01, 0.51) in the control group. Between-group difference in the change of NTB total score per year was 0.022 (95% CI 0.002-0.042, p=0.030). 153 (12%) individuals dropped out overall. Adverse events occurred in 46 (7%) participants in the intervention group compared with six (1%) participants in the control group; the most common adverse event was musculoskeletal pain (32 [5%] individuals for intervention vs no individuals for control). Interpretation Findings from this large, long-term, randomised controlled trial suggest that a multidomain intervention could improve or maintain cognitive functioning in at-risk elderly people from the general population.	[Ngandu, Tiia; Lehtisalo, Jenni; Levalahti, Esko; Ahtiluoto, Satu; Jula, Antti; Laatikainen, Tiina; Lindstrom, Jaana; Peltonen, Markku; Tuomilehto, Jaakko; Kivipelto, Miia] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland; [Pajala, Satu] Natl Inst Hlth & Welf, Welf & Hlth Promot Unit, Helsinki, Finland; [Ngandu, Tiia; Solomon, Alina; Kivipelto, Miia] Karolinska Inst, Ctr Alzheimer Res, S-11330 Stockholm, Sweden; [Solomon, Alina; Soininen, Hilkka; Kivipelto, Miia] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Solomon, Alina; Backman, Lars; Mangialasche, Francesca; Kivipelto, Miia] Stockholm Univ, Karolinska Inst, Aging Res Ctr, S-10691 Stockholm, Sweden; [Antikainen, Riitta; Strandberg, Timo] Univ Oulu, Inst Hlth Sci Geriatr, Oulu, Finland; [Antikainen, Riitta; Strandberg, Timo] Oulu Univ Hosp, Oulu, Finland; [Antikainen, Riitta] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Antikainen, Riitta] Oulu City Hosp, Oulu, Finland; [Hanninen, Tuomo; Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Paajanen, Teemu] Finnish Inst Occupat Hlth, Helsinki, Finland; [Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Stigsdotter-Neely, Anna] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Strandberg, Timo] Univ Helsinki, Cent Hosp, Dept Med, Geriatr Clin, Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Cent Hosp, HJELT Inst, Dept Publ Hlth, Helsinki, Finland; [Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Karolinska Institutet; University of Eastern Finland; University of Eastern Finland; Karolinska Institutet; Stockholm University; University of Oulu; University of Oulu; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finnish Institute of Occupational Health; Umea University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Danube University Krems; King Abdulaziz University	Kivipelto, M (corresponding author), Karolinska Inst, Ctr Alzheimer Res, S-11330 Stockholm, Sweden.	miia.kivipelto@ki.se	Kivipelto, Miia/AAS-3557-2021; Peltonen, Markku/F-3037-2015; Laatikainen, Tiina/ABD-6622-2021	Peltonen, Markku/0000-0002-3767-4223; Laatikainen, Tiina/0000-0002-6614-4782; Lehtisalo, Jenni/0000-0002-8818-0848; Mangialasche, Francesca/0000-0002-2686-3926; Solomon, Alina/0000-0002-7166-9903; Ngandu, Tiia/0000-0002-3698-2021; Lindstrom, Jaana/0000-0001-9255-020X	Academy of Finland [120676, 11745, 251645]; La Carita Foundation; Alzheimer Association [HAT-10 173121]; Alzheimer's Research and Prevention Foundation; Juho Vainio Foundation; Novo Nordisk Foundation; Finnish Social Insurance Institution; Ministry of Education and Culture; Salama bint Hamdan Al Nahyan Foundation; Axa Research Fund; EVO; Swedish Research Council; Swedish Research Council for Health, Working Life and Welfare; af Jochnick Foundation; Academy of Finland's Responding to Public Health Challenges Research Programme (SALVE) [129395, 129397, 129459, 129421, 129416, 129511, 129401, 259615]; Axa Research Grant; EVO of University Hospital of Kuopio; EVO of University Hospital of Oulu; EVO of University Hospital of Turku; EVO of Seinajoki Central Hospital; EVO of Oulu City Hospital; Swedish Society for Medical Research; Saastamoinen Foundation; Loo och Hans Osterman Foundation; Stiftelsen Dementia; Gustaf o Victoria Frimurarestiftelse; Alexander von Humboldt Research award; Novo Nordisk Fonden [NNF12OC1016402, NNF11OC1014884] Funding Source: researchfish	Academy of Finland(Academy of Finland); La Carita Foundation; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Alzheimer's Research and Prevention Foundation; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finnish Social Insurance Institution; Ministry of Education and Culture; Salama bint Hamdan Al Nahyan Foundation; Axa Research Fund(AXA Research Fund); EVO; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); af Jochnick Foundation; Academy of Finland's Responding to Public Health Challenges Research Programme (SALVE)(Academy of Finland); Axa Research Grant(AXA Research Fund); EVO of University Hospital of Kuopio; EVO of University Hospital of Oulu; EVO of University Hospital of Turku; EVO of Seinajoki Central Hospital; EVO of Oulu City Hospital; Swedish Society for Medical Research; Saastamoinen Foundation; Loo och Hans Osterman Foundation; Stiftelsen Dementia; Gustaf o Victoria Frimurarestiftelse; Alexander von Humboldt Research award(Alexander von Humboldt Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	Academy of Finland, La Carita Foundation, Alzheimer Association, Alzheimer's Research and Prevention Foundation, Juho Vainio Foundation, Novo Nordisk Foundation, Finnish Social Insurance Institution, Ministry of Education and Culture, Salama bint Hamdan Al Nahyan Foundation, Axa Research Fund, EVO funding for University Hospitals of Kuopio, Oulu, and Turku and for Seinajoki Central Hospital and Oulu City Hospital, Swedish Research Council, Swedish Research Council for Health, Working Life and Welfare, and af Jochnick Foundation.; We sincerely thank all participants of the FINGER study. This study was supported by Academy of Finland's Responding to Public Health Challenges Research Programme (SALVE) grants 129395, 129397, 129459, 129421, 129416, 129511, 129401, and 259615, La Carita Foundation, Alzheimer Association grant (HAT-10 173121), Alzheimer's Research and Prevention Foundation, Juho Vainio Foundation, Novo Nordisk Foundation, Finnish Social Insurance Institution, Ministry of Education and Culture Research Grant, Salama bint Hamdan Al Nahyan Foundation, Axa Research Grant, and EVO grants of University Hospitals of Kuopio, Oulu, and Turku, Seinajoki Central Hospital and Oulu City Hospital, as well as personal grants from Academy of Finland 120676 and 11745 (MK), 251645 (AS), Swedish Society for Medical Research (TN), Saastamoinen Foundation (AS), Loo och Hans Osterman Foundation (AS), Stiftelsen Dementia (AS), and Gustaf o Victoria Frimurarestiftelse (TS). LB was supported by grants from the Swedish Research Council, the Swedish Research Council for Health, Working Life, and Welfare, an Alexander von Humboldt Research award, and a donation from the af Jochnick Foundation. The blood pressure monitoring devices were provided by Microlife (Vilnius, Lithuania). We thank Aulikki Nissinen, Erkki Vartiainen, Pekka Puska, Juhani Eskola, Bengt Winblad, and Laura Fratiglioni for their support and valuable feedback. We thank our study nurses, psychologists, physicians, nutritionists, and physiotherapists for their efforts in the conduct of the field work. We thank Liisa Saarikoski, Marko Gronholm, Pirjo Saastamoinen, Laura Lund, Pauliina Pippola, Tony Qwillbard, and all other members of the FINGER study group for their cooperation in data collection and management.	Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Duff K, 2011, AM J GERIAT PSYCHIAT, V19, P932, DOI 10.1097/JGP.0b013e318209dd3a; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Hanninen Tuomo, 2010, Duodecim, V126, P2013; Harrison J, 2007, ARCH NEUROL-CHICAGO, V64, P1323, DOI 10.1001/archneur.64.9.1323; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kivipelto M, 2013, ALZHEIMERS DEMENT, V9, P657, DOI 10.1016/j.jalz.2012.09.012; Komulainen P, 2010, EUR GERIATR MED, V1, P266, DOI 10.1016/j.eurger.2010.08.001; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Lindenberger U, 2014, SCIENCE, V346, P572, DOI 10.1126/science.1254403; Mormino EC, 2014, JAMA NEUROL, V71, P1379, DOI 10.1001/jamaneurol.2014.2031; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; National Nutrition Council, 2005, FINN NUTR REC DIET P; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Ngandu T, 2014, INT J ENV RES PUB HE, V11, P9345, DOI 10.3390/ijerph110909345; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; Saaristo T, 2007, INT J CIRCUMPOL HEAL, V66, P101, DOI 10.3402/ijch.v66i2.18239; Salthouse TA, 2014, J GERONTOL B, DOI 10.1093/geronb/gbu063; Singh MAF, 2014, J AM MED DIR ASSOC, V15, P873, DOI 10.1016/j.jamda.2014.09.010; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Vellas B, 2011, LANCET NEUROL, V10, P297, DOI 10.1016/S1474-4422(08)70087-5; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Working group appointed by the Finnish Medical Society Duodecim and the Finnish Hypertension Society, 2009, HYP CURR CAR SUMM; Working group appointed by the Finnish Medical Society Duodecim and the Medical Advisory Board of the Finnish Diabetes Society, 2007, DIAB CURR CAR SUMM; Working group set up by the Finnish Medical Society Duodecim and Finnish Society of Internal Medicine, 2009, DYSL CURR CAR SUMM; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	32	1549	1615	31	466	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2255	2263		10.1016/S0140-6736(15)60461-5	http://dx.doi.org/10.1016/S0140-6736(15)60461-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25771249				2022-12-28	WOS:000355943500027
J	Saunders, A; Oldenburg, IA; Berezovskii, VK; Johnson, CA; Kingery, ND; Elliott, HL; Xie, T; Gerfen, CR; Sabatini, BL				Saunders, Arpiar; Oldenburg, Ian A.; Berezovskii, Vladimir K.; Johnson, Caroline A.; Kingery, Nathan D.; Elliott, Hunter L.; Xie, Tiao; Gerfen, Charles R.; Sabatini, Bernardo L.			A direct GABAergic output from the basal ganglia to frontal cortex	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; GLOBUS-PALLIDUS; CHOLINERGIC NEURONS; INDIRECT PATHWAYS; CRE-RECOMBINASE; NUCLEUS BASALIS; DRIVER LINES; SCHIZOPHRENIA; FOREBRAIN; RAT	The basal ganglia are phylogenetically conserved subcortical nuclei necessary for coordinated motor action and reward learning(1). Current models postulate that the basal ganglia modulate cerebral cortex indirectly via an inhibitory output to thalamus, bidirectionally controlled by direct-and indirect-pathway striatal projection neurons (dSPNs and iSPNs, respectively)(2-4). The basal ganglia thalamic output sculpts cortical activity by interacting with signals from sensory and motor systems(5). Here we describe a direct projection from the globus pallidus externus (GP), a central nucleus of the basal ganglia, to frontal regions of the cerebral cortex (FC). Two cell types make up the GP-FC projection, distinguished by their electrophysiological properties, cortical projections and expression of choline acetyltransferase (ChAT), a synthetic enzyme for the neurotransmitter acetylcholine (ACh). Despite these differences, ChAT(+) cells, which have been historically identified as an extension of the nucleus basalis, as well asChAT(-) cells, release the inhibitory neurotransmitter GABA (c-aminobutyric acid) and are inhibited by iSPNs and dSPNs of dorsal striatum. Thus, GP-FC cells comprise a direct GABAergic/cholinergic projection under the control of striatum that activates frontal cortex in vivo. Furthermore, iSPN inhibition of GP-FC cells is sensitive to dopamine 2 receptor signalling, revealing a pathway by which drugs that target dopamine receptors for the treatment of neuropsychiatric disorders can act in the basal ganglia to modulate frontal cortices.	[Saunders, Arpiar; Oldenburg, Ian A.; Berezovskii, Vladimir K.; Johnson, Caroline A.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Kingery, Nathan D.] Harvard Univ, Sch Med, Dept Neurobiol, Neurobiol Imaging Facil, Boston, MA 02115 USA; [Elliott, Hunter L.; Xie, Tiao] Harvard Univ, Sch Med, Image & Data Anal Core, Boston, MA 02115 USA; [Gerfen, Charles R.] NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Berezovskii, Vladimir/B-9866-2013; soler, martha maricel m gomez/L-6025-2014; Berezovskii, Vladimir/AAB-5253-2022	Berezovskii, Vladimir/0000-0003-4077-3940; soler, martha maricel m gomez/0000-0002-4412-8108; Johnson, Caroline/0000-0001-5770-6176	National Institutes of Health [F31 NS074842, F31-MH093026-01A1, P30 EY12196]; NINDS P30 Core Center grant [NS072030]; NIH [R01 NS046579]; NATIONAL EYE INSTITUTE [P30EY012196, P30EY002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH093026, ZIAMH002497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072030, R01NS046579, F31NS074842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS P30 Core Center grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Lowell laboratory at Beth Israel Deaconess Medical Center for the gift of the DIO-synaptophysin-mCherry and DIO-synaptophysin-GFP rAAVs, R. Pemberton for technical support and F. Krienen, N. Duggan, P. Kaeser and members of the Sabatini laboratory for helpful discussions. This work was supported by grants from the National Institutes of Health (F31 NS074842) to A.S., (F31-MH093026-01A1) to I.A.O., (P30 EY12196) to the Vision Core and NINDS P30 Core Center grant (#NS072030) to the Neural Imaging Center and Neurobiology Imaging Center in the Department of Neurobiology at Harvard Medical School and a NIH grant (R01 NS046579) to B.L.S.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Beurrier C, 2006, NEUROSCIENCE, V140, P77, DOI 10.1016/j.neuroscience.2006.02.029; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; Blum BP, 2002, INT J NEUROPSYCHOPH, V5, P159, DOI 10.1017/S1461145702002894; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CHANG HT, 1987, BRAIN RES, V426, P197, DOI 10.1016/0006-8993(87)90443-4; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Eberly D., 1994, Journal of Mathematical Imaging and Vision, V4, P353, DOI 10.1007/BF01262402; Freeze BS, 2013, J NEUROSCI, V33, P18531, DOI 10.1523/JNEUROSCI.1278-13.2013; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Goldberg JH, 2013, TRENDS NEUROSCI, V36, P695, DOI 10.1016/j.tins.2013.09.001; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GROVE EA, 1986, BRAIN RES, V367, P379, DOI 10.1016/0006-8993(86)91623-9; Henderson Z, 1997, NEUROSCIENCE, V78, P943, DOI 10.1016/S0306-4522(96)00636-7; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Kita H, 2007, PROG BRAIN RES, V160, P111, DOI 10.1016/S0079-6123(06)60007-1; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; LAPLANE D, 1989, BRAIN, V112, P699, DOI 10.1093/brain/112.3.699; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Madisen L., 2012, NAT NEUROSCI, V15, P1; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Marx M, 2012, NAT PROTOC, V7, P394, DOI 10.1038/nprot.2011.449; MCKINNEY M, 1983, J COMP NEUROL, V217, P103, DOI 10.1002/cne.902170109; MESULAM MM, 1984, NEUROSCIENCE, V12, P669, DOI 10.1016/0306-4522(84)90163-5; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sarter M, 2002, EUR J NEUROSCI, V15, P1867, DOI 10.1046/j.1460-9568.2002.02004.x; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Scarr E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00055; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Smith Y, 1998, NEUROSCIENCE, V86, P353; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Tohen M, 2009, BIPOLAR DISORD, V11, P45, DOI 10.1111/j.1399-5618.2009.00710.x; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	44	169	171	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					85	U193		10.1038/nature14179	http://dx.doi.org/10.1038/nature14179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25739505	Green Accepted, Green Submitted			2022-12-28	WOS:000354040900038
J	Selmecki, AM; Maruvka, YE; Richmond, PA; Guillet, M; Shoresh, N; Sorenson, AL; De, S; Kishony, R; Michor, F; Dowell, R; Pellman, D				Selmecki, Anna M.; Maruvka, Yosef E.; Richmond, Phillip A.; Guillet, Marie; Shoresh, Noam; Sorenson, Amber L.; De, Subhajyoti; Kishony, Roy; Michor, Franziska; Dowell, Robin; Pellman, David			Polyploidy can drive rapid adaptation in yeast	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; DNA-SEQUENCING DATA; SACCHAROMYCES-CEREVISIAE; ASEXUAL POPULATIONS; CLONAL INTERFERENCE; CANDIDA-ALBICANS; BUDDING YEAST; BENEFICIAL MUTATIONS; ADAPTIVE EVOLUTION; DRUG-RESISTANCE	Polyploidy is observed across the tree of life, yet its influence on evolution remains incompletely understood(1-4). Polyploidy, usually whole-genome duplication, is proposed to alter the rate of evolutionary adaptation. This could occur through complex effects on the frequency or fitness of beneficial mutations(2,5-7). For example, in diverse cell types and organisms, immediately after a whole-genome duplication, newly formed polyploids missegregate chromosomes and undergo genetic instability(8-13). The instability following wholegenome duplications is thought to provide adaptive mutations in microorganisms(13,14) and can promote tumorigenesis in mammalian cells(11,15). Polyploidy may also affect adaptation independently of beneficial mutations through ploidy-specific changes in cell physiology(16). Here we perform in vitro evolution experiments to test directly whether polyploidy can accelerate evolutionary adaptation. Compared with haploids and diploids, tetraploids undergo significantly faster adaptation. Mathematical modelling suggests that rapid adaptation of tetraploids is driven by higher rates of beneficial mutations with stronger fitness effects, which is supported by whole-genome sequencing and phenotypic analyses of evolved clones. Chromosome aneuploidy, concerted chromosome loss, and point mutations all provide large fitness gains. We identify several mutations whose beneficial effects are manifest specifically in the tetraploid strains. Together, these results provide direct quantitative evidence that in some environments polyploidy can accelerate evolutionary adaptation.	[Selmecki, Anna M.; Guillet, Marie; Pellman, David] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Selmecki, Anna M.; Guillet, Marie; Pellman, David] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02215 USA; [Selmecki, Anna M.; Guillet, Marie; Pellman, David] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Maruvka, Yosef E.; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Maruvka, Yosef E.; Michor, Franziska] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Richmond, Phillip A.; Sorenson, Amber L.; Dowell, Robin] Univ Colorado, BioFrontiers Inst, Boulder, CO 80303 USA; [Richmond, Phillip A.; Sorenson, Amber L.; Dowell, Robin] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Shoresh, Noam] Broad Inst, Cambridge, MA 02142 USA; [De, Subhajyoti] Univ Colorado Sch Med, Dept Med, Aurora, CO 80045 USA; [De, Subhajyoti] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [De, Subhajyoti] Univ Colorado Canc Ctr, Mol Oncol Program, Aurora, CO 80045 USA; [Kishony, Roy] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Kishony, Roy] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Pellman, David] Childrens Hosp, Dept Pediat Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Boston University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Technion Israel Institute of Technology; Harvard University; Boston Children's Hospital	Selmecki, AM (corresponding author), Creighton Univ Sch Med, Dept Med Microbiol & Immunol, 2500 Calif Plaza, Omaha, NE 68178 USA.	AnnaSelmecki@creighton.edu; david_pellman@dfci.harvard.edu		Maruvka, Yosef/0000-0002-8918-9887; DOWELL, ROBIN/0000-0001-7665-9985; RICHMOND, PHILLIP/0000-0003-1882-6014; Selmecki, Anna/0000-0003-3298-2400	Howard Hughes Medical Institute; National Institutes of Health [R37 GM61345, R01 GM081617]; G. Harold & Leila Y. Mathers Charitable Foundation; Dana-Farber Cancer Institute Physical Sciences-Oncology Center [U54CA143798]; Boettcher Foundation's Webb-Waring Biomedical Research Program; National Science Foundation [NSF 1350915]; American Cancer Society Postdoctoral Fellowship; Direct For Biological Sciences [1350915] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM061345, R01GM081617] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold & Leila Y. Mathers Charitable Foundation; Dana-Farber Cancer Institute Physical Sciences-Oncology Center; Boettcher Foundation's Webb-Waring Biomedical Research Program; National Science Foundation(National Science Foundation (NSF)); American Cancer Society Postdoctoral Fellowship(American Cancer Society); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute, the National Institutes of Health (R37 GM61345), the G. Harold & Leila Y. Mathers Charitable Foundation, the Dana-Farber Cancer Institute Physical Sciences-Oncology Center (U54CA143798), the Boettcher Foundation's Webb-Waring Biomedical Research Program, the National Science Foundation (NSF 1350915), the National Institutes of Health (R01 GM081617), and an American Cancer Society Postdoctoral Fellowship.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson JB, 2004, GENETICS, V168, P1915, DOI 10.1534/genetics.104.033266; Barbera MA, 2006, P NATL ACAD SCI USA, V103, P12819, DOI 10.1073/pnas.0605778103; Barrett RDH, 2006, GENETICS, V174, P2071, DOI 10.1534/genetics.106.062406; Barrick JE, 2010, MOL BIOL EVOL, V27, P1338, DOI 10.1093/molbev/msq024; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; Chao DY, 2013, SCIENCE, V341, P658, DOI 10.1126/science.1240561; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Dalca AV, 2010, BIOINFORMATICS, V26, pi343, DOI 10.1093/bioinformatics/btq184; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Durrett R, 2011, GENETICS, V188, P461, DOI 10.1534/genetics.110.125724; Efron B., 1994, MONOGRAPHS STAT APPL; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; Frenkel EM, 2014, GENETICS, V196, P1217, DOI 10.1534/genetics.113.160069; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goyal S, 2012, GENETICS, V191, P1309, DOI 10.1534/genetics.112.141291; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Haccou P., 2005, BRANCHING PROCESSES, P82; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Hittinger CT, 2010, NATURE, V464, P54, DOI 10.1038/nature08791; Homer N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r99; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hufton AL, 2009, CURR OPIN GENET DEV, V19, P600, DOI 10.1016/j.gde.2009.10.005; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Kryazhimskiy S, 2014, SCIENCE, V344, P1519, DOI 10.1126/science.1250939; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; de Sousa JAM, 2013, GENOME BIOL EVOL, V5, P794, DOI 10.1093/gbe/evt045; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Novocraft, 2009, NOV SHORT READ AL PA; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P587, DOI 10.1073/pnas.242719299; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vetterling W. T, 1992, NUMERICAL RECIPES EX; Wakeley J., 2009, COALESCENT THEORY; Wenger JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002202; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhu YO, 2014, P NATL ACAD SCI USA, V111, pE2310, DOI 10.1073/pnas.1323011111; Zorgo E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003388	68	255	260	2	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					349	+		10.1038/nature14187	http://dx.doi.org/10.1038/nature14187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25731168	Green Accepted, Green Published			2022-12-28	WOS:000351171900040
J	Chou, R; Qaseem, A				Chou, Roger; Qaseem, Amir		High Value Care Task Force Amer	Cardiac Screening With Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging: Advice for High-Value Care From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; BYPASS GRAFT-SURGERY; C-REACTIVE PROTEIN; ARTERY-DISEASE; APPROPRIATENESS CRITERIA; ASYMPTOMATIC ADULTS; COMPUTED-TOMOGRAPHY; TASK-FORCE; CARDIOVASCULAR-DISEASE; DIAGNOSTIC-ACCURACY	Background: Cardiac screening in adults with resting or stress electrocardiography, stress echocardiography, or myocardial perfusion imaging can reveal findings associated with increased risk for coronary heart disease events, but inappropriate cardiac testing of low-risk adults has been identified as an important area of overuse by several professional societies. Methods: Narrative review based on published systematic reviews; guidelines; and articles on the yield, benefits, and harms of cardiac screening in low-risk adults. Results: Cardiac screening has not been shown to improve patient outcomes. It is also associated with potential harms due to false-positive results because they can lead to subsequent, potentially unnecessary tests and procedures. Cardiac screening is likely to be particularly inefficient in adults at low risk for coronary heart disease given the low prevalence and predictive values of testing in this population and the low likelihood that positive findings will affect treatment decisions. In this patient population, clinicians should focus on strategies for mitigating cardiovascular risk by treating modifiable risk factors (such as smoking, diabetes, hypertension, hyperlipidemia, and overweight) and encouraging healthy levels of exercise. High-Value Care Advice: Clinicians should not screen for cardiac disease in asymptomatic, low-risk adults with resting or stress electrocardiography, stress echocardiography, or stress myocardial perfusion imaging.	[Chou, Roger; Qaseem, Amir; High Value Care Task Force Amer] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Chou, Roger/0000-0001-9889-8610	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	ABIM Foundation, 2014, CHOOS WIS 5 THINGS P; Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; American Academy of Family Physicians, 2010, REC CLIN PREV SERV; Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Balady GJ, 2000, ACSMS GUIDELINES EXE; Banerjee A, 2012, INT J CLIN PRACT, V66, P477, DOI 10.1111/j.1742-1241.2012.02900.x; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brubaker PH, 2011, CIRCULATION, V123, P1010, DOI 10.1161/CIRCULATIONAHA.110.940577; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Calonge N, 2009, ANN INTERN MED, V150, P396; Carrier ER, 2013, HEALTH AFFAIR, V32, P1383, DOI 10.1377/hlthaff.2013.0233; Carroll Margaret D, 2012, NCHS Data Brief, P1; Centers for Disease Control and Prevention, 2010, NAT AMB MED CAR SURV; Cerqueira MD, 2010, J NUCL CARDIOL, V17, P709, DOI 10.1007/s12350-010-9244-0; CHAITMAN BR, 1981, CIRCULATION, V64, P360, DOI 10.1161/01.CIR.64.2.360; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Chou R, 2011, ANN INTERN MED, V155, P375, DOI 10.7326/0003-4819-155-6-201109200-00006; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cournot M, 2006, EUR J CARDIOV PREV R, V13, P37, DOI 10.1097/00149831-200602000-00006; Davies RF, 1997, CIRCULATION, V95, P2037, DOI 10.1161/01.CIR.95.8.2037; de Gonzalez AB, 2010, CIRCULATION, V122, P2403, DOI 10.1161/CIRCULATIONAHA.110.941625; DEBONO D, 1993, BRIT HEART J, V70, P297; Douglas PS, 2008, J AM COLL CARDIOL, V51, P1127, DOI 10.1016/j.jacc.2007.12.005; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Ferket BS, 2011, J AM COLL CARDIOL, V57, P1591, DOI 10.1016/j.jacc.2010.10.055; Fitch K., 2001, RAND UCLA APPROPRIAT; Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913; Frame P S, 1975, J Fam Pract, V2, P29; Galper BZ, 2012, CIRCULATION, V125, P260, DOI 10.1161/CIRCULATIONAHA.111.041293; Gibbons RJ, 2008, J AM COLL CARDIOL, V51, P1283, DOI 10.1016/j.jacc.2007.10.064; Gibbons RJ, 2011, CIRCULATION, V123, P499, DOI 10.1161/CIRCULATIONAHA.110.975995; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grimshaw JM, 2001, MED CARE, V39, pII2; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hendel RC, 2011, J NUCL CARDIOL, V18, P3, DOI 10.1007/s12350-010-9320-5; Hendel RC, 2010, J AM COLL CARDIOL, V55, P156, DOI 10.1016/j.jacc.2009.11.004; Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013; Hillis LD, 2012, J THORAC CARDIOV SUR, V143, P4, DOI 10.1016/j.jtcvs.2011.10.015; HOFFMAN JR, 1985, AM J MED, V79, P699, DOI 10.1016/0002-9343(85)90520-0; HOLLENBERG M, 1985, NEW ENGL J MED, V313, P600, DOI 10.1056/NEJM198509053131003; Hudson B, 2012, ANN FAM MED, V10, P495, DOI 10.1370/afm.1407; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kale MS, 2013, JAMA INTERN MED, V173, P142, DOI 10.1001/2013.jamainternmed.1022; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Kravitz RL, 2000, J GEN INTERN MED, V15, P38, DOI 10.1046/j.1525-1497.2000.12058.x; Lattanzi F, 2000, DRUG SAFETY, V22, P251, DOI 10.2165/00002018-200022040-00001; Lauer M, 2005, CIRCULATION, V112, P771, DOI 10.1161/CIRCULATIONAHA.105.166543; Lauer MS, 2011, ANN INTERN MED, V155, P395, DOI 10.7326/0003-4819-155-6-201109200-00011; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Levin David C, 2005, J Am Coll Radiol, V2, P736, DOI 10.1016/j.jacr.2005.01.015; Levin David C, 2009, J Am Coll Radiol, V6, P437, DOI 10.1016/j.jacr.2008.12.015; Lim LS, 2011, AM J PREV MED, V40, DOI 10.1016/j.amepre.2010.11.021; Lockwood CM, 2012, CLIN CHEM, V58, P1068, DOI 10.1373/clinchem.2012.182998; Lovett KM, 2011, JAMA-J AM MED ASSOC, V305, P2567, DOI 10.1001/jama.2011.865; Mahajan N, 2010, HEART, V96, P956, DOI 10.1136/hrt.2009.182295; Marwick TH, 2003, HEART, V89, P113, DOI 10.1136/heart.89.1.113; Matheny M, 2011, SYSTEMATIC REV CARDI; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Moyer VA, 2012, ANN INTERN MED, V157, P512, DOI 10.7326/0003-4819-157-7-201210020-00514; Myers J, 2009, CIRCULATION, V119, P3144, DOI 10.1161/CIRCULATIONAHA.109.192520; Neilson EG, 2004, ANN INTERN MED, V141, P196, DOI 10.7326/0003-4819-141-3-200408030-00008; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005; Patel MR, 2005, J AM COLL CARDIOL, V46, P1606, DOI 10.1016/j.jacc.2005.08.030; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PEPINE CJ, 1994, CIRCULATION, V90, P762, DOI 10.1161/01.CIR.90.2.762; Picano E, 2003, AM J MED, V114, P126, DOI 10.1016/S0002-9343(02)01427-4; RANHOSKY A, 1990, CIRCULATION, V81, P1205, DOI 10.1161/01.CIR.81.4.1205; RUBENSTEIN LZ, 1980, JAMA-J AM MED ASSOC, V244, P2536, DOI 10.1001/jama.244.22.2536; Schwartz A, 2010, HEART DIS PREVENTION; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Shah BR, 2011, JAMA-J AM MED ASSOC, V306, P1993, DOI 10.1001/jama.2011.1604; Sheifer SE, 2000, J AM COLL CARDIOL, V35, P119, DOI 10.1016/S0735-1097(99)00524-0; SIGURDSSON E, 1995, ANN INTERN MED, V122, P96, DOI 10.7326/0003-4819-122-2-199501150-00003; SOX HC, 1989, ANN INTERN MED, V110, P456, DOI 10.7326/0003-4819-110-6-456; SOX HC, 1989, ANN INTERN MED, V111, P489, DOI 10.7326/0003-4819-111-6-489; Stafford RS, 2003, AM HEART J, V145, P979, DOI 10.1016/S0002-8703(03)00107-8; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; UHL GS, 1983, J AM COLL CARDIOL, V1, P946, DOI 10.1016/S0735-1097(83)80215-0; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wilson IB, 2001, ARCH INTERN MED, V161, P256, DOI 10.1001/archinte.161.2.256; Winchester DE, 2013, JAMA INTERN MED, V173, P1381, DOI 10.1001/jamainternmed.2013.953; WOOLF SH, 1990, J CLIN EPIDEMIOL, V43, P891, DOI 10.1016/0895-4356(90)90073-X; Woolf SH, 2012, ANN FAM MED, V10, P491, DOI 10.1370/afm.1452; Young LH, 2009, JAMA-J AM MED ASSOC, V301, P1547, DOI 10.1001/jama.2009.476; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	93	34	35	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					438	U92		10.7326/M14-1225	http://dx.doi.org/10.7326/M14-1225			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775317				2022-12-28	WOS:000351279600017
J	Henry, P				Henry, Patrick			In rotator cuff tears, primary tendon repair was better than physiotherapy for some measures of function at 5 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Henry, P (corresponding author), Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.							Kuhn JE, 2013, J SHOULDER ELB SURG, V22, P1371, DOI 10.1016/j.jse.2013.01.026	1	0	0	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC11	10.7326/ACPJC-2015-162-6-011	http://dx.doi.org/10.7326/ACPJC-2015-162-6-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775342				2022-12-28	WOS:000351279600010
J	Hartman, RJ				Hartman, Robert J., Jr.			Penile Fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Hartman, RJ (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	rjhartmanjr@gmail.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					1055	1055		10.1056/NEJMicm1404224	http://dx.doi.org/10.1056/NEJMicm1404224			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760358				2022-12-28	WOS:000350797300010
J	Hakala, A; Kimmelman, J; Carlisle, B; Freeman, G; Fergusson, D				Hakala, Amanda; Kimmelman, Jonathan; Carlisle, Benjamin; Freeman, Georgina; Fergusson, Dean			Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PUBLICATION	Objective To quantify the proportion of trials for unsuccessfully licensed drugs that are not published. Design A systematic assessment of the availability of published research reports for publicly registered trials testing drugs stalling in clinical development ("stalled drugs") and drugs receiving regulatory licensure in the same time period ("licensed drugs"). Data sources Searches of clinicaltrials.gov, Google Scholar, PubMed, Embase, and electronic query of contacts in registries to identify trials and assess publication status. Eligibility criteria The cohort of licensed drugs consisted of all disease modifying drugs in cancer, cardiovascular disease, or neurological disorders that received Food and Drug Administration licensure during 2005 to 2009 inclusive. The cohort of stalled drugs included unlicensed drugs in the same disease areas that had at least one completed phase III trial before 2009 and no evidence of any clinical trial activity after 31 December 2009. Inclusion criteria for registered trials advanced into publication searching were an intervention tested in a disease modifying, phase II, III, or IV trial registered on clinicaltrials. gov, with enrolment of at least one patient, that reported primary outcome collection end date between 1 January 2006 and 31 December 2008. Results The unadjusted publication proportion for registered trials of licensed drugs was 75% (72/96) versus 37% (30/81) for stalled drugs. The adjusted hazard ratio for publication was 2.7 (95% confidence interval 1.7 to 4.3) in favour of licensed drug trials. Higher publication rates for licensed drug trials were observed regardless of disease type, sponsorship, trial phase, and geography. The rate of non-publication of stalled drug trials was significantly higher for studies that did not complete enrolment compared with licensed drug trials. A total of 20 135 patients participated in trials of stalled drugs that were never published. Conclusions Much of the information collected in unsuccessful drug trials is inaccessible to the broader research and practice communities. These findings provide an evidence base and rationale for policy reforms aimed at promoting transparency, ethics, and accountability in clinical research.	[Hakala, Amanda; Kimmelman, Jonathan; Carlisle, Benjamin; Freeman, Georgina] McGill Univ, Dept Social Studies Med, Biomed Eth Unit, Studies Translat Eth & Med STREAM, Montreal, PQ H3A 1X1, Canada; [Fergusson, Dean] Univ Ottawa, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON K1H 8L6, Canada	McGill University; University of Ottawa; Ottawa Hospital Research Institute	Kimmelman, J (corresponding author), McGill Univ, Dept Social Studies Med, Biomed Eth Unit, Studies Translat Eth & Med STREAM, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmelman@mcgill.ca	Carlisle, Benjamin/AAD-6332-2020	Carlisle, Benjamin/0000-0001-8975-0649; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research [EOG111391]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes of Health Research (EOG111391). The study sponsor played no role in study design; collection, analysis, or interpretation of data; writing of the article; or the decision to submit the manuscript for publication. All researchers are independent from the funder.	Allarakhia M, 2013, DRUG DES DEV THER, V7, P753, DOI 10.2147/DDDT.S46289; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; [Anonymous], FED REG; Burton TM, 2012, WALL STREET J; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2010, TRI COUNC POL STAT E; Deftereos SN, 2011, WIRES SYST BIOL MED, V3, P323, DOI 10.1002/wsbm.147; Doshi P, 2013, JAMA INTERN MED, V173, P380, DOI 10.1001/jamainternmed.2013.3838; Goodyear M, 2006, BRIT MED J, V332, P677, DOI 10.1136/bmj.38797.635012.47; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hudson KL, 2015, JAMA-J AM MED ASSOC, V313, P355, DOI 10.1001/jama.2014.10716; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Karve S, 2012, P NATL ACAD SCI USA, V109, P8230, DOI 10.1073/pnas.1120508109; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; NIH Office of Science Policy, 2011, NIH IND ROUNDT EXPL; Peart KN, 2014, YALE NEWS       0130; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Rogawski MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002939; US National Institutes of Health, FDAAA 801 REQ AR THE; Wadman M, 2013, NAT NEWS BLOG   0618	20	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2015	350								h1116	10.1136/bmj.h1116	http://dx.doi.org/10.1136/bmj.h1116			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EA	25752879	hybrid			2022-12-28	WOS:000351181100001
J	Jovanovic, M; Rooney, MS; Mertins, P; Przybylski, D; Chevrier, N; Satija, R; Rodriguez, EH; Fields, AP; Schwartz, S; Raychowdhury, R; Mumbach, MR; Eisenhaure, T; Rabani, M; Gennert, D; Lu, DN; Delorey, T; Weissman, JS; Carr, SA; Hacohen, N; Regev, A				Jovanovic, Marko; Rooney, Michael S.; Mertins, Philipp; Przybylski, Dariusz; Chevrier, Nicolas; Satija, Rahul; Rodriguez, Edwin H.; Fields, Alexander P.; Schwartz, Schraga; Raychowdhury, Raktima; Mumbach, Maxwell R.; Eisenhaure, Thomas; Rabani, Michal; Gennert, Dave; Lu, Diana; Delorey, Toni; Weissman, Jonathan S.; Carr, Steven A.; Hacohen, Nir; Regev, Aviv			Dynamic profiling of the protein life cycle in response to pathogens	SCIENCE			English	Article							MESSENGER-RNA; TEMPORAL DYNAMICS; DENDRITIC CELLS; REVEALS; EXPRESSION; TRANSLATION; PRINCIPLES; ABUNDANCE; TLR; QUANTIFICATION	Protein expression is regulated by the production and degradation of messenger RNAs (mRNAs) and proteins, but their specific relationships remain unknown. We combine measurements of protein production and degradation and mRNA dynamics so as to build a quantitative genomic model of the differential regulation of gene expression in lipopolysaccharide-stimulated mouse dendritic cells. Changes in mRNA abundance play a dominant role in determining most dynamic fold changes in protein levels. Conversely, the preexisting proteome of proteins performing basic cellular functions is remodeled primarily through changes in protein production or degradation, accounting for more than half of the absolute change in protein molecules in the cell. Thus, the proteome is regulated by transcriptional induction for newly activated cellular functions and by protein life-cycle changes for remodeling of preexisting functions.	[Jovanovic, Marko; Rooney, Michael S.; Mertins, Philipp; Przybylski, Dariusz; Chevrier, Nicolas; Satija, Rahul; Schwartz, Schraga; Raychowdhury, Raktima; Mumbach, Maxwell R.; Eisenhaure, Thomas; Rabani, Michal; Gennert, Dave; Lu, Diana; Delorey, Toni; Carr, Steven A.; Hacohen, Nir; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rooney, Michael S.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Chevrier, Nicolas] Harvard Univ, Harvard Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Rodriguez, Edwin H.; Fields, Alexander P.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Eisenhaure, Thomas; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [Regev, Aviv] MIT, Dept Biol, HHMI, Cambridge, MA 02140 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	nhacohen@mgh.harvard.edu; aregev@broad.mit.edu	Carr, Steven A./AAH-8366-2019; Satija, Rahul/AAF-9564-2019	Weissman, Jonathan/0000-0003-2445-670X; Mumbach, Maxwell/0000-0002-5570-6663; Schwartz, Schraga/0000-0002-3671-9709; Delorey, Toni/0000-0001-6614-3803	National Human Genome Research Institute Centers of Excellence in Genomics Science [P50 HG006193]; Broad Institute Funds; NIH Pioneer Award; Klarman Cell Observatory; HHMI; Swiss National Science Foundation (SNF); Marie Sklodowska-Curie International Outgoing Fellowships; NIH Training Program in Bioinformatics and Integrative Genomics training grant; Rothschild Fellowship; European Molecular Biology Organization fellowship; Human Frontier Science Program fellowships; Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER	National Human Genome Research Institute Centers of Excellence in Genomics Science; Broad Institute Funds; NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; HHMI(Howard Hughes Medical Institute); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Marie Sklodowska-Curie International Outgoing Fellowships; NIH Training Program in Bioinformatics and Integrative Genomics training grant; Rothschild Fellowship; European Molecular Biology Organization fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program fellowships; Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Regev, Hacohen, and Carr groups, as well as G. Brar, N. Slavov, and E. Airoldi for constant input and discussions. We thank L. Gaffney for help with the figures and K. Lage and A. Kashani for help with some of the analyses. This work was supported by National Human Genome Research Institute Centers of Excellence in Genomics Science P50 HG006193 (A.R, N.H., S.A.C.) and Broad Institute Funds. A.R. was supported by an NIH Pioneer Award, the Klarman Cell Observatory, and HHMI. M.J. was supported by fellowships of the Swiss National Science Foundation for advanced researchers (SNF) and the Marie Sklodowska-Curie International Outgoing Fellowships. M.S.R. was supported by the NIH Training Program in Bioinformatics and Integrative Genomics training grant. S.S. was supported by a Rothschild Fellowship, a European Molecular Biology Organization fellowship, and Human Frontier Science Program fellowships. E.H.R. was supported by the Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study. Data have been deposited in the Gene Expression Omnibus under accession number GSE59793. The original mass spectra, may be downloaded from MassIVE (http://massive.ucsd.edu) using the identifier MSV000078994. The data are accessible at ftp://MSV000078994:a@massive.ucsd.edu. DogmaQuant is distributed under open source (BSD) license.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Albert FW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004692; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aviner R, 2013, GENE DEV, V27, P1834, DOI 10.1101/gad.219105.113; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bell C, 2013, MOL CELL PROTEOMICS, V12, P2394, DOI 10.1074/mcp.M112.025775; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Eichelbaum K, 2014, MOL CELL PROTEOMICS, V13, P792, DOI 10.1074/mcp.M113.030916; Eichelbaum K, 2012, NAT BIOTECHNOL, V30, P984, DOI 10.1038/nbt.2356; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Geiger T, 2013, MOL CELL PROTEOMICS, V12, P1709, DOI 10.1074/mcp.M112.024919; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kuan AP, 1999, IMMUNOGENETICS, V49, P79, DOI 10.1007/s002510050466; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Lelouard H, 2007, J CELL BIOL, V179, P1427, DOI 10.1083/jcb.200707166; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Sanada T, 2008, J BIOL CHEM, V283, P33858, DOI 10.1074/jbc.M806923200; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Weiss M, 2010, PROTEOMICS, V10, P1297, DOI 10.1002/pmic.200900414; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015	56	281	281	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226							1259038	10.1126/science.1259038	http://dx.doi.org/10.1126/science.1259038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745177	Green Submitted, Green Accepted			2022-12-28	WOS:000350354200045
J	Ahalt, C; Bolano, M; Wang, EA; Williams, B				Ahalt, Cyrus; Bolano, Marielle; Wang, Emily A.; Williams, Brie			The State of Research Funding From the National Institutes of Health for Criminal Justice Health Research	ANNALS OF INTERNAL MEDICINE			English	Article							PUBLIC-HEALTH; COMMUNITY-HEALTH; RACIAL DISPARITIES; OLDER JAIL; CARE; INCARCERATION; SYSTEM; INDIVIDUALS; INMATES; PRISONERS	Background: Over 20 million Americans are currently or have been incarcerated. Most are from medically underserved populations; 1 in 3 African American men and 1 in 6 Latino men born in 2001 are projected to go to prison during their lifetime. The amount of funding from the National Institutes of Health (NIH) to understand and improve the health of persons involved with the criminal justice system is unknown. Objective: To describe NIH funding for research on the health and health care needs of criminal justice-involved persons. Design: Review of NIH grants (2008-2012) in the RePORT (Research Portfolio Online Reporting Tools) database. Setting: U.S. criminal justice system. Patients: Criminal justice-involved persons participating in NIH-funded clinical research. Measurements: NIH research and training grants awarded, by number, type, research area, institute or center, and dollar amount. Results: Of more than 250 000 NIH-funded grants, 180 (<0.1%) focused on criminal justice health research. The 3 most common foci were substance use or HIV (64%), mental health (11%), and juvenile health (8%). The National Institute on Drug Abuse and the National Institute of Mental Health funded 78% of all grants. In 2012, the NIH invested $40.9 million in criminal justice health research, or 1.5% of the $2.7 billion health disparities budget for that year. Limitation: NIH-supported research that did not explicitly include current or former prisoners but may have relevance to criminal justice health was not included. Conclusion: Federal funding for research focused on understanding and improving the health of criminal justice-involved persons is small, even compared with the NIH's overall investment in health disparities research. The NIH is well-positioned to transform the care of current and former prisoners by investing in this critical yet overlooked research area.	[Ahalt, Cyrus; Williams, Brie] Univ Calif San Francisco, San Francisco, CA 94118 USA; [Wang, Emily A.] Yale Sch Med, New Haven, CT 06520 USA	University of California System; University of California San Francisco; Yale University	Ahalt, C (corresponding author), Univ Calif San Francisco, 3333 Calif St,Suite 380, San Francisco, CA 94118 USA.	cyrusahalt@gmail.com			Tideswell at UCSF; National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [K23AG033102, T35AG026736, P30AG044281] Funding Source: NIH RePORTER	Tideswell at UCSF; National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging, National Institutes of Health; Tideswell at UCSF.	Agency for Healthcare Research and Quality, 2011, SERV DEL INN PROF CO; Ahalt C, 2013, J AM GERIATR SOC, V61, P2013, DOI 10.1111/jgs.12510; Ahalt C, 2012, J GEN INTERN MED, V27, P160, DOI 10.1007/s11606-011-1858-7; American Civil Liberties Union, 2012, AM EXP MASS INC ELD; [Anonymous], 2014, FAST FACTS US HOSP; [Anonymous], 2012, OLD BARS AG PRIS POP; Asch Steven M, 2011, J Correct Health Care, V17, P138, DOI 10.1177/1078345810397712; Baillargeon J, 2004, PREV MED, V38, P607, DOI 10.1016/j.ypmed.2003.11.020; Belluck Pam, 2012, NY TIMES, pA1; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2012, J URBAN HEALTH, V89, P98, DOI 10.1007/s11524-011-9614-1; Bonczar Thomas P., 2003, 197976 NCJ US DEP JU; Brandt ALS, 2012, J OFFENDER REHABIL, V51, P541, DOI 10.1080/10509674.2012.693902; Bureau of Justice Statistics, PRIS SER 1990 2010; Carson EA, 2013, 242567 NCJ US DEP JU; Centers for Disease Control and Prevention, 2011, TRAUM BRAIN INJ PRIS; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Chodos AH, 2014, AM J PUBLIC HEALTH, V104, P1728, DOI 10.2105/AJPH.2014.301952; Damberg Cheryl L, 2011, J Correct Health Care, V17, P122, DOI 10.1177/1078345810397605; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Dumont DM, 2013, J HEALTH CARE POOR U, V24, P78, DOI 10.1353/hpu.2013.0000; Fields G, 2013, WALL STREET J   0926, pA1; Frank JW, 2014, J GEN INTERN MED, V29, P1226, DOI 10.1007/s11606-014-2877-y; Freeman RB, 2003, URBAN I REENTRY ROUN; Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214; Gelfman LP, 2008, J PALLIAT MED, V11, P36, DOI 10.1089/jpm.2006.0231; Glaze L, 2006, MENTAL HLTH PROBLEMS, P12; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P737, DOI 10.1001/jama.297.7.737; Greifinger R.B., 2007, PUBLIC HLTH BARS PRI, P1; Hockenberry S., 2010, JUVENILES RESIDENTIA; Iguchi MY, 2005, J HEALTH CARE POOR U, V16, P48, DOI 10.1353/hpu.2005.0114; Institute of Medicine, 2006, REP ETH CONS RES INV; Kalmbach KC, 2003, BEHAV SCI LAW, V21, P671, DOI 10.1002/bsl.533; Kulkarni SP, 2010, J COMMUN HEALTH, V35, P268, DOI 10.1007/s10900-010-9234-9; Mallik-Kane K, 2008, HLTH PRISONER REENTR; Minton T. D., 2013, 241264 NCJ US DEP JU, V241264; National Commission for Correctional Health Care, 2004, HLTH STAT SOON BE RE; National Institute on Minority Health and Health Disparities, 2013, NIH HLTH DISP STRAT; National Institutes of Health, 2014, NIH DAT BOOK; National Research Council, 2014, GROWTH INC US EXPL C; National Research Council and Institute of Medicine, 2013, HLTH INC WORKSH SUMM; *PEW CHAR TRUSTS, 2008, ON 100 BARS AM 2008; Regenstein M, 2012, MED COVERAGE INDIVID; Rich JD, 2014, HEALTH AFFAIR, V33, P462, DOI 10.1377/hlthaff.2013.1133; Rich JD, 2011, NEW ENGL J MED, V364, P2081, DOI 10.1056/NEJMp1102385; Sartorius PJ, 2009, MICHIGAN PATHWAYS PR; Stephan J, 2011, 230188 NCJ US DEP JU; Stephan J., 2008, 222482 NCJ US DEP JU; Teplin LA, 2003, AM J PUBLIC HEALTH, V93, P906, DOI 10.2105/AJPH.93.6.906; Thomas JC, 2008, AM J PUBLIC HEALTH, V98, pS181, DOI 10.2105/AJPH.98.Supplement_1.S181; Underwood RL, 2011, AM J PUBLIC HEALTH, V101, P1540, DOI 10.2105/AJPH.2011.300276; Wang EA, 2011, JAMA-J AM MED ASSOC, V305, P1708, DOI 10.1001/jama.2011.532; Wang EA, 2009, ARCH INTERN MED, V169, P687, DOI 10.1001/archinternmed.2009.26; Williams BA, 2014, J PALLIAT MED, V17, P1336, DOI 10.1089/jpm.2014.0160; Williams BA, 2012, AM J PUBLIC HEALTH, V102, P1475, DOI 10.2105/AJPH.2012.300704; Williams BA, 2012, J AM GERIATR SOC, V60, P1150, DOI 10.1111/j.1532-5415.2012.03962.x; Wool J., 2007, PUBLIC HLTH BARS, P25	57	31	31	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2015	162	5					345	U175		10.7326/M14-2161	http://dx.doi.org/10.7326/M14-2161			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC3HT	25732276	Green Submitted, Green Accepted			2022-12-28	WOS:000350238300003
J	Markwalter, DW				Markwalter, Daniel Webb			In the Hands of Another	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Vanderbilt University	Markwalter, DW (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	daniel.w.markwalter@vanderbilt.edu		Markwalter, Daniel/0000-0002-5369-7724					0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					899	900		10.1001/jama.2014.15002	http://dx.doi.org/10.1001/jama.2014.15002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734729				2022-12-28	WOS:000350231800006
J	Chatterjee, P				Chatterjee, Patralekha			CORRUPTION IN INDIA Whistleblowing in India: what protections can doctors who raise concerns expect?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com						Chatterjee P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e453; Choudhuri N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6551; Freshfields Bruckhaus Deringer, 2013, WHAT MAK GOOD WHISTL; Liu C., 2014, GLOBAL ANTICORR 0602; Majumdar B, 2003, TELEGRAPH; Medical Council of India, 2002, COD ETH REG 2002; Mehrotra S., 2015, NDTV            0215; Ministry of Law and Justice, 2011, WHISTL BLOW PROT ACT; Mudur G, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6695; Nagarajan R., 2014, TIMES INDIA; Nayak V., 2011, PUBLIC INTEREST DISC; Organisation for Economic Co-operation and Development, 2012, WHISTL PROT ENC REP; PRS Legislative Research, 2011, WHISTL BLOW PROT BIL; Sampath G., 2014, MINT            0304; Sethi N., 2014, BUSINESS STANDA 0924	15	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2015	350								h763	10.1136/bmj.h763	http://dx.doi.org/10.1136/bmj.h763			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AL	25712178				2022-12-28	WOS:000350292700018
J	Allegretti, M; Klusch, N; Mills, DJ; Vonck, J; Kuhlbrandt, W; Davies, KM				Allegretti, Matteo; Klusch, Niklas; Mills, Deryck J.; Vonck, Janet; Kuehlbrandt, Werner; Davies, Karen M.			Horizontal membrane-intrinsic alpha-helices in the stator a-subunit of an F-type ATP synthase	NATURE			English	Article							ESSENTIAL ARGININE RESIDUE; C-RING; F0F1-ATP SYNTHASE; POLYTOMELLA SP; RESOLUTION; SUBSTITUTION; TRANSPORT; COMPLEX; MODEL; POLAR	ATP, the universal energy currency of cells, is produced by F-type ATP synthases, which are ancient, membrane-bound nanomachines. F-type ATP synthases use the energy of a transmembrane electrochemical gradient to generate ATP by rotary catalysis. Protons moving across the membrane drive a rotor ring composed of 8-15 c-subunits(1). A central stalk transmits the rotation of the c-ring to the catalytic F-1 head, where a series of conformational changes results in ATP synthesis(2). A key unresolved question in this fundamental process is how protons pass through the membrane to drive ATP production. Mitochondrial ATP synthases form V-shaped homodimers in cristae membranes(3). Here we report the structure of a native and active mitochondrial ATP synthase dimer, determined by single-particle electron cryomicroscopy at 6.2 angstrom resolution. Our structure shows four long, horizontal membrane-intrinsic alpha-helices in the a-subunit, arranged in two hairpins at an angle of approximately 70 degrees relative to the c-ring helices. It has been proposed that a strictly conserved membrane-embedded arginine in the a-subunit couples proton translocation to c-ring rotation(4). A fit of the conserved carboxy-terminal a-subunit sequence places the conserved arginine next to a proton-binding c-subunit glutamate. The map shows a slanting solvent-accessible channel that extends from the mitochondrial matrix to the conserved arginine. Another hydrophilic cavity on the lumenal membrane surface defines a direct route for the protons to an essential histidine-glutamate pair(5). Our results provide unique new insights into the structure and function of rotary ATP synthases and explain how ATP production is coupled to proton translocation.	[Allegretti, Matteo; Klusch, Niklas; Mills, Deryck J.; Vonck, Janet; Kuehlbrandt, Werner; Davies, Karen M.] Max Planck Inst Biophys, Dept Struct Biol, D-60438 Frankfurt, Germany	Max Planck Society	Kuhlbrandt, W (corresponding author), Max Planck Inst Biophys, Dept Struct Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	werner.kuehlbrandt@biophys.mpg.de; karen.davies@biophys.mpg.de	Allegretti, Matteo/B-7030-2016	Allegretti, Matteo/0000-0002-9542-7482; Kuhlbrandt, Werner/0000-0002-2013-4810; Davies, Karen/0000-0002-3207-9337	Max Planck Society; Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt 'Macromolecular Complexes'	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt 'Macromolecular Complexes'	We thank T. Meier and J. D. Faraldo-Gomez for discussions and reading the manuscript. O. Yildiz and J. F. Castillo-Hernandez provided computer support. This work was funded by the Max Planck Society (M.A., N.K., D.J.M., J.V., K.M.D., W.K.) and the Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt 'Macromolecular Complexes' (K.M.D., W.K.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Atteia A, 2000, EUR J BIOCHEM, V267, P2850, DOI 10.1046/j.1432-1327.2000.01288.x; CAIN BD, 1988, J BIOL CHEM, V263, P6606; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Hakulinen JK, 2012, P NATL ACAD SCI USA, V109, pE2050, DOI 10.1073/pnas.1203971109; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HOPPE J, 1982, FEBS LETT, V145, P21, DOI 10.1016/0014-5793(82)81198-8; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matthies D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6286; Mills DJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00218; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pogoryelov D, 2012, P NATL ACAD SCI USA, V109, pE1599, DOI 10.1073/pnas.1120027109; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Steed PR, 2014, J BIOL CHEM, V289, P2127, DOI 10.1074/jbc.M113.527879; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Lis R, 2005, BBA-BIOENERGETICS, V1708, P23, DOI 10.1016/j.bbabio.2004.12.010; van Lis R, 2007, PLANT PHYSIOL, V144, P1190, DOI 10.1104/pp.106.094060; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Villavicencio-Queijeiro A, 2009, J BIOENERG BIOMEMBR, V41, P1, DOI 10.1007/s10863-009-9203-0; Vincent OD, 2007, J BIOL CHEM, V282, P33788, DOI 10.1074/jbc.M706904200; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080	45	191	194	0	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					237	+		10.1038/nature14185	http://dx.doi.org/10.1038/nature14185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25707805				2022-12-28	WOS:000354377800062
J	Wang, DT; Gruen, DS; Lollar, BS; Hinrichs, KU; Stewart, LC; Holden, JF; Hristov, AN; Pohlman, JW; Morrill, PL; Konneke, M; Delwiche, KB; Reeves, EP; Sutcliffe, CN; Ritter, DJ; Seewald, JS; McIntosh, JC; Hemond, HF; Kubo, MD; Cardace, D; Hoehler, TM; Ono, S				Wang, David T.; Gruen, Danielle S.; Lollar, Barbara Sherwood; Hinrichs, Kai-Uwe; Stewart, Lucy C.; Holden, James F.; Hristov, Alexander N.; Pohlman, John W.; Morrill, Penny L.; Koenneke, Martin; Delwiche, Kyle B.; Reeves, Eoghan P.; Sutcliffe, Chelsea N.; Ritter, Daniel J.; Seewald, Jeffrey S.; McIntosh, Jennifer C.; Hemond, Harold F.; Kubo, Michael D.; Cardace, Dawn; Hoehler, Tori M.; Ono, Shuhei			Nonequilibrium clumped isotope signals in microbial methane	SCIENCE			English	Article							HYDROGEN; FRACTIONATION; CARBON; BASIN; GAS; REDUCTION; OXIDATION; FLUIDS; WATER; D/H	Methane is a key component in the global carbon cycle, with a wide range of anthropogenic and natural sources. Although isotopic compositions of methane have traditionally aided source identification, the abundance of its multiply substituted "clumped" isotopologues (for example, (CH3D)-C-13) has recently emerged as a proxy for determining methane-formation temperatures. However, the effect of biological processes on methane's clumped isotopologue signature is poorly constrained. We show that methanogenesis proceeding at relatively high rates in cattle, surface environments, and laboratory cultures exerts kinetic control on (CH3D)-C-13 abundances and results in anomalously elevated formation-temperature estimates. We demonstrate quantitatively that H-2 availability accounts for this effect. Clumped methane thermometry can therefore provide constraints on the generation of methane in diverse settings, including continental serpentinization sites and ancient, deep groundwaters.	[Wang, David T.; Gruen, Danielle S.; Reeves, Eoghan P.; Ono, Shuhei] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Wang, David T.; Gruen, Danielle S.; Seewald, Jeffrey S.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; [Lollar, Barbara Sherwood; Sutcliffe, Chelsea N.] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada; [Hinrichs, Kai-Uwe; Koenneke, Martin] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Hinrichs, Kai-Uwe; Koenneke, Martin] Univ Bremen, Dept Geosci, D-28359 Bremen, Germany; [Stewart, Lucy C.; Holden, James F.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Hristov, Alexander N.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Pohlman, John W.] US Geol Survey, Woods Hole Coastal & Marine Sci Ctr, Woods Hole, MA 02543 USA; [Morrill, Penny L.] Mem Univ Newfoundland, Dept Earth Sci, St John, NF A1B 3X5, Canada; [Delwiche, Kyle B.; Hemond, Harold F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Ritter, Daniel J.; McIntosh, Jennifer C.] Univ Arizona, Det Hydrol & Water Resources, Tucson, AZ 85721 USA; [Kubo, Michael D.; Hoehler, Tori M.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Cardace, Dawn] Univ Rhode Isl, Dept Geosci, Kingston, RI 02881 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; University of Toronto; University of Bremen; University of Bremen; University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; Memorial University Newfoundland; Massachusetts Institute of Technology (MIT); University of Arizona; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Rhode Island	Ono, S (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	sono@mit.edu	Holden, James F/E-6815-2013; Reeves, Eoghan P./M-3542-2013; Hinrichs, Kai-Uwe/C-7675-2009; Koenneke, Martin/E-6893-2013	Reeves, Eoghan P./0000-0003-0146-0714; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Koenneke, Martin/0000-0001-6770-414X; Gruen, Danielle/0000-0003-1019-4390; Stewart, Lucy/0000-0001-7352-3329; Holden, James/0000-0002-4343-2378; Wang, David/0000-0002-2656-8951	NSF [EAR-1250394, EAR-1322805]; N. R. Braunsdorf and D. J. H. Smit of Shell PTI/EG; Deep Carbon Observatory; Natural Sciences and Engineering Research Council of Canada; Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft [HI 616-14-1]; National Defense Science and Engineering Graduate Fellowship; Neil a nd Anna Rasmussen Foundation Fund; Grayce B. Kerr Fellowship; Shell-MITEI Graduate Fellowship; Directorate For Geosciences [1322805] Funding Source: National Science Foundation; Division Of Earth Sciences [1250394] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); N. R. Braunsdorf and D. J. H. Smit of Shell PTI/EG; Deep Carbon Observatory; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Defense Science and Engineering Graduate Fellowship; Neil a nd Anna Rasmussen Foundation Fund; Grayce B. Kerr Fellowship; Shell-MITEI Graduate Fellowship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank J. Hayes, R. Summons, A. Whitehill, S. Zaarur, C. Ruppel, L. T. Bryndzia, N. Blair, D. Vinson, K. Nealson, and M. Schrenk for discussions; W. Olszewski, D. Nelson, G. Lacrampe-Couloume, and B. Topcuoglu for technical assistance; A. Whitehill, G. Luo, A. Apprill, K. Twing, W. Brazelton, A. Wray, J. Oh, A. Rowe, G. Chadwick, and A. Rietze for assistance in the field; R. Michener for the delta D<INF>water</INF> analyses; L. T. Bryndzia (Shell) for providing the shale gas samples; R. Dias (USGS) for sharing the NGS samples; and R. Raiche, D. McCrory, S. Moore (HomestakeMining Co.), the staff of the McLaughlin Natural Reserve, and the well operators for access to samples. Grants from the NSF (EAR-1250394 to S.O. and EAR-1322805 to J.C.M.), N. R. Braunsdorf and D. J. H. Smit of Shell PTI/EG (to S.O.), the Deep Carbon Observatory (to S.O., B. S. L., M.K., and K.-U.H.), the Natural Sciences and Engineering Research Council of Canada (to B. S. L.), and the Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft (HI 616-14-1 to K.-U.H. and M.K.) supported this study. D. T. W. was supported by a National Defense Science and Engineering Graduate Fellowship. D. S. G. was supported by the Neil a nd Anna Rasmussen Foundation Fund, the Grayce B. Kerr Fellowship, and a Shell-MITEI Graduate Fellowship. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. government. All data used to support the conclusions in this manuscript are provided in the supplementary materials. Author contributions: D. T. W. and S.O. developed the methods, analyzed data, and performed modeling. D. T. W. and D. S. G. performed isotopic analyses. D. S. G., L.C.S., J.F.H., M.K., K.-U.H., and S.O. designed and/or conducted microbiological experiments. D. T. W., D. S. G., B. S. L., P.L.M., K. B. D., A. N. H., C.N.S., M.D.K., D. J. R., J.C.M., D.C., and S.O. designed and/or executed the field-sampling campaigns. D.T.W. and S.O. wrote the manuscript with input from all authors.	BALABANE M, 1987, ORG GEOCHEM, V11, P115, DOI 10.1016/0146-6380(87)90033-7; Baldassare FJ, 2014, AAPG BULL, V98, P341, DOI 10.1306/06111312178; Bates BL, 2011, CHEM GEOL, V284, P45, DOI 10.1016/j.chemgeo.2011.02.004; BURKE RA, 1993, CHEMOSPHERE, V26, P55, DOI 10.1016/0045-6535(93)90412-X; BURKE RA, 1988, NATURE, V332, P829, DOI 10.1038/332829a0; Burruss RC, 2010, ORG GEOCHEM, V41, P1285, DOI 10.1016/j.orggeochem.2010.09.008; Cardace D, 2013, SCI DRILL, V16, P45, DOI 10.5194/sd-16-45-2013; Etiope G, 2013, REV GEOPHYS, V51, P276, DOI 10.1002/rog.20011; Flores RM, 2008, INT J COAL GEOL, V76, P52, DOI 10.1016/j.coal.2008.02.005; Holland G, 2013, NATURE, V497, P357, DOI 10.1038/nature12127; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Horibe Y, 1995, GEOCHIM COSMOCHIM AC, V59, P5209, DOI 10.1016/0016-7037(95)00391-6; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Lollar BS, 2008, GEOCHIM COSMOCHIM AC, V72, P4778, DOI 10.1016/j.gca.2008.07.004; Lollar BS, 2014, NATURE, V516, P379, DOI 10.1038/nature14017; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; McCalley CK, 2014, NATURE, V514, P478, DOI 10.1038/nature13798; Morrill PL, 2013, GEOCHIM COSMOCHIM AC, V109, P222, DOI 10.1016/j.gca.2013.01.043; Ono S, 2014, ANAL CHEM, V86, P6487, DOI 10.1021/ac5010579; Pohlman JW, 2009, EARTH PLANET SC LETT, V287, P504, DOI 10.1016/j.epsl.2009.08.037; REES CE, 1973, GEOCHIM COSMOCHIM AC, V37, P1141, DOI 10.1016/0016-7037(73)90052-5; Reeves EP, 2014, P NATL ACAD SCI USA, V111, P5474, DOI 10.1073/pnas.1400643111; Reeves EP, 2012, GEOCHIM COSMOCHIM AC, V77, P582, DOI 10.1016/j.gca.2011.10.008; SCHOELL M, 1988, CHEM GEOL, V71, P1, DOI 10.1016/0009-2541(88)90101-5; Stolper DA, 2014, SCIENCE, V344, P1500, DOI 10.1126/science.1254509; Stolper DA, 2014, GEOCHIM COSMOCHIM AC, V126, P169, DOI 10.1016/j.gca.2013.10.045; Takai K, 2008, P NATL ACAD SCI USA, V105, P10949, DOI 10.1073/pnas.0712334105; Valentine DL, 2004, GEOCHIM COSMOCHIM AC, V68, P1571, DOI 10.1016/j.gca.2003.10.012; Varadharajan C, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001866; WELHAN JA, 1987, AAPG BULL, V71, P215; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; WHITICAR MJ, 1990, ORG GEOCHEM, V16, P531, DOI 10.1016/0146-6380(90)90068-B; Wing BA, 2014, P NATL ACAD SCI USA, V111, P18116, DOI 10.1073/pnas.1407502111	34	146	155	4	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					428	431		10.1126/science.aaa4326	http://dx.doi.org/10.1126/science.aaa4326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25745067	Green Submitted			2022-12-28	WOS:000353338000032
J	Adashi, EY; Gao, H; Cohen, IG				Adashi, Eli Y.; Gao, Hans; Cohen, I. Glenn			Hospital-Based Active Shooter Incidents Sanctuary Under Fire	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.; Gao, Hans] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA; [Cohen, I. Glenn] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Harvard Law Sch, Cambridge, MA 02138 USA	Brown University; Harvard University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						[Anonymous], STUD ACT SHOOT INC U; Hodge JG, 2014, J LAW MED ETHICS, V42, P268, DOI 10.1111/jlme.12141; Joint Commission, 2014, PREPARING FOR ACTIVE; Kelen GD, 2012, ANN EMERG MED, V60, P790, DOI 10.1016/j.annemergmed.2012.08.012; Obama BH, NOW IS THE TIME THE; Rankins RG, 1999, ANN EMERG MED, V33, P676, DOI 10.1016/S0196-0644(99)70197-6; US Department of Health and Human Services, 2013, MESSAGE TO OUR NATIO; US Department of Health and Human Services, 2014, PREPAREDNESS AND RES; US Department of Homeland Security, 2008, ACTIVE SHOOTER HOW T	9	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1209	1210		10.1001/jama.2015.1733	http://dx.doi.org/10.1001/jama.2015.1733			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25719264				2022-12-28	WOS:000351435500014
J	Heesterbeek, H; Anderson, RM; Andreasen, V; Bansal, S; De Angelis, D; Dye, C; Eames, KTD; Edmunds, WJ; Frost, SDW; Funk, S; Hollingsworth, TD; House, T; Isham, V; Klepac, P; Lessler, J; Lloyd-Smith, JO; Metcalf, CJE; Mollison, D; Pellis, L; Pulliam, JRC; Roberts, MG; Viboud, C				Heesterbeek, Hans; Anderson, Roy M.; Andreasen, Viggo; Bansal, Shweta; De Angelis, Daniela; Dye, Chris; Eames, Ken T. D.; Edmunds, W. John; Frost, Simon D. W.; Funk, Sebastian; Hollingsworth, T. Deirdre; House, Thomas; Isham, Valerie; Klepac, Petra; Lessler, Justin; Lloyd-Smith, James O.; Metcalf, C. Jessica E.; Mollison, Denis; Pellis, Lorenzo; Pulliam, Juliet R. C.; Roberts, Mick G.; Viboud, Cecile		Isaac Newton Inst IDD Collaboratio	Modeling infectious disease dynamics in the complex landscape of global health	SCIENCE			English	Review							HIV TRANSMISSION; EPIDEMIC; SPREAD; IMPACT; COMMUNITY; MEASLES; NETWORK; EBOLA; RESISTANCE; WILDLIFE	Despite some notable successes in the control of infectious diseases, transmissible pathogens still pose an enormous threat to human and animal health. The ecological and evolutionary dynamics of infections play out on a wide range of interconnected temporal, organizational, and spatial scales, which span hours to months, cells to ecosystems, and local to global spread. Moreover, some pathogens are directly transmitted between individuals of a single species, whereas others circulate among multiple hosts, need arthropod vectors, or can survive in environmental reservoirs. Many factors, including increasing antimicrobial resistance, increased human connectivity and changeable human behavior, elevate prevention and control from matters of national policy to international challenge. In the face of this complexity, mathematical models offer valuable tools for synthesizing information to understand epidemiological patterns, and for developing quantitative evidence for decision-making in global health.	[Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Anderson, Roy M.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Andreasen, Viggo] Roskilde Univ, Roskilde, Denmark; [Bansal, Shweta; Funk, Sebastian] Georgetown Univ, Washington, DC USA; [De Angelis, Daniela] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Dye, Chris] WHO, CH-1211 Geneva, Switzerland; [Eames, Ken T. D.; Edmunds, W. John] London Sch Hyg Trop Med, Ctr Math Modelling Infect Dis, London, England; [Frost, Simon D. W.; Klepac, Petra] Univ Cambridge, Cambridge, England; [Hollingsworth, T. Deirdre] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Hollingsworth, T. Deirdre] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [House, Thomas; Pellis, Lorenzo] Univ Warwick, Warwick Math Inst, Coventry CV4 7AL, W Midlands, England; [Isham, Valerie] UCL, Dept Stat Sci, London, England; [Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Metcalf, C. Jessica E.] Univ Oxford, Dept Zool, Oxford, England; [Metcalf, C. Jessica E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Mollison, Denis] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Pulliam, Juliet R. C.] Univ Florida, Dept Biol, Emerging Pathogens Inst, Gainesville, FL USA; [Pulliam, Juliet R. C.; Viboud, Cecile] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Roberts, Mick G.] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand	Utrecht University; Imperial College London; Roskilde University; Georgetown University; MRC Biostatistics Unit; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Warwick; Liverpool School of Tropical Medicine; University of Liverpool; University of Warwick; University of London; University College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of Oxford; Princeton University; Heriot Watt University; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Massey University	Heesterbeek, H (corresponding author), Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.	j.a.p.heesterbeek@uu.nl	Hollingsworth, Deirdre/D-2421-2009; Pulliam, Juliet RC/A-6516-2008; Lloyd-Smith, James/AAG-4463-2021; Lloyd, Alun/AAN-6639-2020; Bansal, Shweta/AFV-6623-2022; Roberts, Mick/Q-7277-2019; Bansal, Shweta/GPW-8977-2022; /K-4080-2012; Frost, Simon/F-3648-2010	Hollingsworth, Deirdre/0000-0001-5962-4238; Pulliam, Juliet RC/0000-0003-3314-8223; Lloyd, Alun/0000-0002-6389-6321; Bansal, Shweta/0000-0002-1740-5421; Roberts, Mick/0000-0003-2693-5093; /0000-0001-7941-502X; De Angelis, Daniela/0000-0001-6619-6112; Andreasen, Viggo/0000-0001-8152-3898; Riley, Steven/0000-0001-7904-4804; House, Thomas/0000-0001-5835-8062; Wood, James/0000-0002-0258-3188; Gog, Julia/0000-0003-1240-7214; O'Neill, Philip/0000-0001-9084-8184; Lessler, Justin/0000-0002-9741-8109; Anderson, Roy/0000-0002-9528-3175; Bogich, Tiffany/0000-0002-8143-5289; Pellis, Lorenzo/0000-0002-3436-6487; Frost, Simon/0000-0002-5207-9879; Heesterbeek, Hans/0000-0001-8537-6418; Funk, Sebastian/0000-0002-2842-3406; Isham, Valerie/0000-0001-5189-2844	Isaac Newton Institute for Mathematical Sciences; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, NIH; Engineering and Physical Sciences Research Council [EP/K026550/2, EP/L001950/1, EP/J002437/2] Funding Source: researchfish; Medical Research Council [MR/K010174/1B, MC_U105260556, MR/K021680/1] Funding Source: researchfish; EPSRC [EP/K026550/2, EP/L001950/1, EP/J002437/2] Funding Source: UKRI; MRC [MC_U105260556, MR/K021680/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER	Isaac Newton Institute for Mathematical Sciences; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H.H. conceived and wrote the paper; R.M.A., V.A., S.B., D.D.A., C.D., K.T.D.E., W.J.E., S.D.W.F., S.F., T.D.H., T.H., V.I., P.K., J.L., J.O.L.-S., C.J.E.M., D.M., J.R.C.P., L.P., M.G.R., and C.V. provided text and edited the manuscript; J.L., C.J.E.M. and T.D.H. produced figures; the Isaac Newton Institute IDD Collaboration jointly produced and discussed ideas for the outline and content (all of the above plus N.A., F.B., T.B., J.G., B.G., A.L.L., A.M., P.O.N., C.P., S.R., G.S.T., P.T., and J.W.). We gratefully acknowledge help by K. Koelle and D. Fisman in producing adapted versions of their figures for Fig. 2 (panels C, D, and E). This paper was conceived and developed at a program on Infectious Disease Dynamics at the Isaac Newton Institute for Mathematical Sciences, Cambridge, UK, 19 August to 13 September 2013 and 19 May to 6 June 2014 (www.newton.ac.uk). We gratefully acknowledge financial and infrastructural support from the Isaac Newton Institute for Mathematical Sciences which is fundamental to the success of this program. We are also grateful for the financial support the program received from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center, NIH. R.M.A. is a non-executive director of GlaxoSmithKline. C.D. acts as an advisor for the Wellcome Trust, for which he receives financial remuneration.	ANDERSON R M, 1991; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Anderson R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0435; Anderson R, 2012, LANCET, V379, P289, DOI 10.1016/S0140-6736(12)60120-2; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P20154, DOI 10.1073/pnas.1209683109; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bansal Shweta, 2010, Journal of Biological Dynamics, V4, P478, DOI 10.1080/17513758.2010.503376; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bellan SE, 2013, LANCET, V381, P1561, DOI 10.1016/S0140-6736(12)61960-6; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bharti N, 2011, SCIENCE, V334, P1424, DOI 10.1126/science.1210554; Blower S, 2004, REV MED VIROL, V14, P275, DOI 10.1002/rmv.443; Blumberg S, 2013, EPIDEMICS-NETH, V5, P131, DOI 10.1016/j.epidem.2013.05.002; Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993; Camacho A, 2014, EPIDEMICS-NETH, V9, P70, DOI 10.1016/j.epidem.2014.09.003; Cattadori IM, 2014, ECOLOGY, V95, P1684, DOI 10.1890/13-1538.1; Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chan CH, 2012, SEX TRANSM INFECT, V88, P200, DOI 10.1136/sextrans-2011-050049; Cobey S, 2013, AM NAT, V181, P12, DOI 10.1086/668598; Cobey S, 2012, SCIENCE, V335, P1376, DOI 10.1126/science.1215947; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; De Angelis D, 2014, STAT SCI, V29, P9, DOI 10.1214/13-STS428; Diekmann O., 2013, PRINCETON SERIES THE; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Donnelly C. A., 2000, STAT ASPECTS BSE VCJ; Dureau J, 2013, BIOSTATISTICS, V14, P541, DOI 10.1093/biostatistics/kxs052; Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426; Dye C, 2013, LANCET, V381, P413, DOI 10.1016/S0140-6736(12)61812-1; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Farah M, 2014, J AM STAT ASSOC, V109, P1398, DOI 10.1080/01621459.2014.934453; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Funk S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002855; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; Halloran ME., 2010, DESIGN ANAL VACCINE; HIV Modelling Consortium Treatment, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001259; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; House T, 2011, P ROY SOC B-BIOL SCI, V278, P2753, DOI 10.1098/rspb.2010.2688; Jewell CP, 2012, BIOSTATISTICS, V13, P567, DOI 10.1093/biostatistics/kxs012; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Klepac P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0137; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Knock ES, 2014, BIOSTATISTICS, V15, P46, DOI 10.1093/biostatistics/kxt023; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kucharski A., 2014, PLOS CURR; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lee BY, 2011, HUM VACCINES, V7, P115, DOI 10.4161/hv.7.1.13740; Lessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067639; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Lloyd-Smith J. O., 2015, EPIDEMICS, V10; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Mbah MLN, 2013, P NATL ACAD SCI USA, V110, P7952, DOI 10.1073/pnas.1221396110; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Metcalf CJE, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0756; Metcalf CJE, 2012, THEOR POPUL BIOL, V82, P275, DOI 10.1016/j.tpb.2011.12.001; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Oraby T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3172; Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Perelson AS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-96; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Ratmann O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002835; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Restif O, 2012, ECOL LETT, V15, P1083, DOI 10.1111/j.1461-0248.2012.01836.x; Rohani P, 2010, TRENDS ECOL EVOL, V25, P611, DOI 10.1016/j.tree.2010.07.010; Rose MA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-40; Ross R., 1911, PREVENTION MALARIA; Saint-Victor DS, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0148; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Selakovic S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2709; Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Stuckey EM, 2013, TRENDS PARASITOL, V29, P477, DOI 10.1016/j.pt.2013.08.001; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Terry RF, 2014, SCIENCE, V345, P1302, DOI 10.1126/science.1258737; Van Kerkhove MD, 2012, B WORLD HEALTH ORGAN, V90, P306, DOI 10.2471/BLT.11.097949; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS221, DOI 10.1097/QAI.0b013e318299c3f4; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Vrancken B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003505; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Whitty CJM, 2014, NATURE, V515, P192, DOI 10.1038/515192a; WOOLHOUSE M, 2011, GUIDE GOOD PRACTICE; Woolhouse M, 2014, NATURE, V509, P555, DOI 10.1038/509555a; World Health Organization, 2013, MORT GLOB HLTH EST 2; World Health Organization (WHO), 1981, GLOB STRAT HLTH ALL; Wu JT, 2011, EXP BIOL MED, V236, P955, DOI 10.1258/ebm.2010.010271	132	333	343	13	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1216	U29	aaa4339	10.1126/science.aaa4339	http://dx.doi.org/10.1126/science.aaa4339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE9NH	25766240	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000370964100002
J	Weber, GF; Chousterman, BG; He, S; Fenn, AM; Nairz, M; Anzai, A; Brenner, T; Uhle, F; Iwamoto, Y; Robbins, CS; Noiret, L; Maier, SL; Zonnchen, T; Rahbari, NN; Scholch, S; Ameln, AKV; Chavakis, T; Weitz, J; Hofer, S; Weigand, MA; Nahrendorf, M; Weissleder, R; Swirski, FK				Weber, Georg F.; Chousterman, Benjamin G.; He, Shun; Fenn, Ashley M.; Nairz, Manfred; Anzai, Atsushi; Brenner, Thorsten; Uhle, Florian; Iwamoto, Yoshiko; Robbins, Clinton S.; Noiret, Lorette; Maier, Sarah L.; Zoennchen, Tina; Rahbari, Nuh N.; Schoelch, Sebastian; Ameln, Anne Klotzsche-von; Chavakis, Triantafyllos; Weitz, Juergen; Hofer, Stefan; Weigand, Markus A.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.			Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis	SCIENCE			English	Article							B-CELLS PROTECT; IN-VITRO; IMMUNOSUPPRESSION; BIOLOGY; TRIAL; CSF	Sepsis is a frequently fatal condition characterized by an uncontrolled and harmful host reaction to microbial infection. Despite the prevalence and severity of sepsis, we lack a fundamental grasp of its pathophysiology. Here we report that the cytokine interleukin-3 (IL-3) potentiates inflammation in sepsis. Using a mouse model of abdominal sepsis, we showed that innate response activator B cells produce IL-3, which induces myelopoiesis of Ly-6C(high) monocytes and neutrophils and fuels a cytokine storm. IL-3 deficiency protects mice against sepsis. In humans with sepsis, high plasma IL-3 levels are associated with high mortality even after adjusting for prognostic indicators. This study deepens our understanding of immune activation, identifies IL-3 as an orchestrator of emergency myelopoiesis, and reveals a new therapeutic target for treating sepsis.	[Weber, Georg F.; Chousterman, Benjamin G.; He, Shun; Fenn, Ashley M.; Nairz, Manfred; Anzai, Atsushi; Iwamoto, Yoshiko; Robbins, Clinton S.; Noiret, Lorette; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02163 USA; [Weber, Georg F.; Maier, Sarah L.; Zoennchen, Tina; Rahbari, Nuh N.; Schoelch, Sebastian; Weitz, Juergen] Tech Univ Dresden, Dept Visceral Thorac & Vasc Surg, D-01062 Dresden, Germany; [Brenner, Thorsten; Uhle, Florian; Hofer, Stefan; Weigand, Markus A.] Heidelberg Univ, Dept Anesthesiol, Heidelberg, Germany; [Ameln, Anne Klotzsche-von; Chavakis, Triantafyllos] Tech Univ Dresden, Dept Clin Pathobiochem, D-01062 Dresden, Germany; [Ameln, Anne Klotzsche-von; Chavakis, Triantafyllos] Tech Univ Dresden, Inst Clin Chem & Lab Med, D-01062 Dresden, Germany; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Technische Universitat Dresden; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Technische Universitat Dresden; Harvard University; Harvard Medical School	Weber, GF (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02163 USA.	georg.weber@uniklinikum-dresden.de; fswirski@mgh.harvard.edu	Schoelch, Sebastian/W-4314-2019; Uhle, Florian/Q-6191-2019; Weitz, Juergen/L-7136-2018; Chavakis, Triantafyllos/ABE-8845-2020; Swirski, Filip/AAF-1340-2019	Schoelch, Sebastian/0000-0003-0012-3177; Nairz, Manfred/0000-0001-9103-7041; Robbins, Clinton/0000-0001-9848-1495; Swirski, Filip/0000-0002-3163-9152; Chousterman, Benjamin Glenn/0000-0002-9592-7014; /0000-0003-0828-4143	NIH [5R01HL095612, R56-AI104695]; Massachusetts General Hospital Howard M. Goodman Fellowship; German Research Foundation [WE4892/1-2, WE4892/3-1]; Societe Francaise d'Anesthesie-Reanimation (SFAR); Institut Servier; Fondation Groupe Pasteur Mutualite; Fulbright Scholarships (Monahan Foundation); Fulbright Scholarships (Harvard French Scholarship Fund); Erwin Schrodinger Fellowship of the Austrian Science Fund FWF [J3486-B13]; Austrian Science Fund (FWF) [J 3486] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI104695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Howard M. Goodman Fellowship; German Research Foundation(German Research Foundation (DFG)); Societe Francaise d'Anesthesie-Reanimation (SFAR); Institut Servier; Fondation Groupe Pasteur Mutualite; Fulbright Scholarships (Monahan Foundation); Fulbright Scholarships (Harvard French Scholarship Fund); Erwin Schrodinger Fellowship of the Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Greene for secretarial assistance, M. Waring and A. Chicoine for sorting cells, and K. Joyes for editing the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The General Hospital Corporation has filed a patent application (61/973,458) with the U.S. Patent and Trademark Office entitled "Agents and Methods for Diagnosing and Treating Sepsis," which names F.K.S. and G.F.W. as inventors. Il3<SUP>-/-</SUP> mice are available from Riken, Japan, under a materials transfer agreement. This work was supported by NIH grants 5R01HL095612 and R56-AI104695 and the Massachusetts General Hospital Howard M. Goodman Fellowship (F.K.S.). G.F.W. was supported by the German Research Foundation (WE4892/1-2 and 3-1). B.G.C. was supported by the Societe Francaise d'Anesthesie-Reanimation (SFAR), Institut Servier, Fondation Groupe Pasteur Mutualite, and Fulbright Scholarships (Monahan Foundation and Harvard French Scholarship Fund). M.N. was supported by an Erwin Schrodinger Fellowship of the Austrian Science Fund FWF (J3486-B13). The authors declare no conflicts of interest.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Brenner T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0683-x; Coopersmith CM, 2012, CRIT CARE MED, V40, P1072, DOI 10.1097/CCM.0b013e31823c8d03; DALLOUL AH, 1991, BLOOD, V77, P69; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Dolgin E, 2012, NAT MED, V18, P1000, DOI 10.1038/nm0712-1000; GROOPMAN JE, 1989, NEW ENGL J MED, V321, P1449, DOI 10.1056/NEJM198911233212106; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; HAPEL AJ, 1981, CELL, V25, P179, DOI 10.1016/0092-8674(81)90242-7; Hilgendorf I, 2014, CIRCULATION, V129, P1677, DOI 10.1161/CIRCULATIONAHA.113.006381; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; IHLE JN, 1981, J IMMUNOL, V126, P2184; Jamur Maria Celia, 2011, Front Biosci (Schol Ed), V3, P1390; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Ronnberg E, 2014, IMMUNOLOGY, V143, P155, DOI 10.1111/imm.12297; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Voehringer D, 2012, EUR J IMMUNOL, V42, P2544, DOI 10.1002/eji.201142318; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Ward PA, 2011, JAMA-J AM MED ASSOC, V306, P2618, DOI 10.1001/jama.2011.1831; Weber GF, 2014, J EXP MED, V211, P1243, DOI 10.1084/jem.20131471; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0	32	186	199	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1260	1265		10.1126/science.aaa4268	http://dx.doi.org/10.1126/science.aaa4268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766237	Green Accepted			2022-12-28	WOS:000350824300041
J	Anderson, ML; Chiswell, K; Peterson, ED; Tasneem, A; Topping, J; Califf, RM				Anderson, Monique L.; Chiswell, Karen; Peterson, Eric D.; Tasneem, Asba; Topping, James; Califf, Robert M.			Compliance with Results Reporting at ClinicalTrials.gov	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; DRUGS	BACKGROUND The Food and Drug Administration Amendments Act (FDAAA) mandates timely reporting of results of applicable clinical trials to ClinicalTrials.gov. We characterized the proportion of applicable clinical trials with publicly available results and determined independent factors associated with the reporting of results. METHODS Using an algorithm based on input from the National Library of Medicine, we identified trials that were likely to be subject to FDAAA provisions (highly likely applicable clinical trials, or HLACTs) from 2008 through 2013. We determined the proportion of HLACTs that reported results within the 12-month interval mandated by the FDAAA or at any time during the 5-year study period. We used regression models to examine characteristics associated with reporting at 12 months and throughout the 5-year study period. RESULTS From all the trials at ClinicalTrials.gov, we identified 13,327 HLACTs that were terminated or completed from January 1, 2008, through August 31, 2012. Of these trials, 77.4% were classified as drug trials. A total of 36.9% of the trials were phase 2 studies, and 23.4% were phase 3 studies; 65.6% were funded by industry. Only 13.4% of trials reported summary results within 12 months after trial completion, whereas 38.3% reported results at any time up to September 27, 2013. Timely reporting was independently associated with factors such as FDA oversight, a later trial phase, and industry funding. A sample review suggested that 45% of industry-funded trials were not required to report results, as compared with 6% of trials funded by the National Institutes of Health (NIH) and 9% of trials that were funded by other government or academic institutions. CONCLUSIONS Despite ethical and legal obligations to disclose findings promptly, most HLACTs did not report results to ClinicalTrials.gov in a timely fashion during the study period. Industry-funded trials adhered to legal obligations more often than did trials funded by the NIH or other government or academic institutions.	[Anderson, Monique L.; Peterson, Eric D.; Califf, Robert M.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27715 USA; [Anderson, Monique L.; Chiswell, Karen; Peterson, Eric D.; Tasneem, Asba; Topping, James] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; [Califf, Robert M.] Duke Univ, Sch Med, Duke Translat Med Inst, Durham, NC USA	Duke University; Duke University; Duke University	Anderson, ML (corresponding author), Duke Univ, Med Ctr 17969, Duke Clin Res Inst, 7022 North Pavilion,2400 Pratt St, Durham, NC 27715 USA.	monique.anderson@duke.edu	Peterson, Eric David/ABF-5033-2021		Clinical Trials Transformation Initiative; NIH; National Center for Complementary & Integrative Health [U54AT007748] Funding Source: NIH RePORTER	Clinical Trials Transformation Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the Clinical Trials Transformation Initiative and the NIH.	Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Clinical Trials Transformation Initiative, AACT DAT; ClinicalTrials. gov, FDAAA 801 REQ; Drazen JM, 2007, NEW ENGL J MED, V357, P1756, DOI 10.1056/NEJMe0706501; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Feczko J, 2006, NEW ENGL J MED, V354, P1426; Gill CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001186; GSK.com, 2014, GLOB PUBL POL ISS PU; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Kuehn BM, 2012, JAMA-J AM MED ASSOC, V307, P651, DOI 10.1001/jama.2012.127; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; Law MR, 2011, HEALTH AFFAIR, V30, P2338, DOI 10.1377/hlthaff.2011.0172; Merck.com, 2014, PUBL POL STAT CLIN T; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pfizer.com, 2009, CLIN CAS STUD SER DI; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Saito H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101826; Shalowitz DI, 2005, JAMA-J AM MED ASSOC, V294, P737, DOI 10.1001/jama.294.6.737; Tasneem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033677; Nguyen TAH, 2013, J CLIN ONCOL, V31, P2998, DOI 10.1200/JCO.2012.46.9577; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	22	232	234	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					1031	1039		10.1056/NEJMsa1409364	http://dx.doi.org/10.1056/NEJMsa1409364			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760355	Green Accepted			2022-12-28	WOS:000350797300007
J	MacCoun, RJ; Mello, MM				MacCoun, Robert J.; Mello, Michelle M.			Half-Baked - The Retail Promotion of Marijuana Edibles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[MacCoun, Robert J.; Mello, Michelle M.] Stanford Law Sch, Stanford, CA 94305 USA; [MacCoun, Robert J.] Freeman Spogli Inst, Stanford, CA USA; [Mello, Michelle M.] Stanford Univ Sch Med, Stanford, CA USA	Stanford University; Stanford University	MacCoun, RJ (corresponding author), Stanford Law Sch, Stanford, CA 94305 USA.		MacCoun, Robert/N-1765-2019	MacCoun, Robert/0000-0003-0929-4423; Mello, Michelle/0000-0003-2877-4270				Appelboam A, 2006, EUR J EMERG MED, V13, P177, DOI 10.1097/01.mej.0000194405.38206.f2; Grotenhermen F, 2003, CLIN PHARMACOKINET, V42, P327, DOI 10.2165/00003088-200342040-00003; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; Richter KP, 2014, NEW ENGL J MED, V371, P399, DOI 10.1056/NEJMp1406074; Wang GS, 2013, JAMA PEDIATR, V167, P630, DOI 10.1001/jamapediatrics.2013.140	5	83	83	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					989	991		10.1056/NEJMp1416014	http://dx.doi.org/10.1056/NEJMp1416014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD0XK	25760351				2022-12-28	WOS:000350797300001
J	Wise, GJ; Schlegel, PN				Wise, Gilbert J.; Schlegel, Peter N.			Sterile Pyuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							URINARY-TRACT-INFECTION; HUMAN-PAPILLOMAVIRUS INFECTION; HEMORRHAGIC CYSTITIS; GENITAL HERPES; COLONY COUNTS; TUBERCULOSIS; DIAGNOSIS; MEN; EPIDEMIOLOGY; BACTERIURIA	Pyuria is defined as the presence of 10 or more white cells per cubic millimeter in a urine specimen, 3 or more white cells per high-power field of unspun urine, a positive result on Gram's staining of an unspun urine specimen, or a urinary dipstick test that is positive for leukocyte esterase.(1) Sterile pyuria is the persistent finding of white cells in the urine in the absence of bacteria, as determined by means of aerobic laboratory techniques (on a 5% sheep-blood agar plate and MacConkey agar plate). Sterile pyuria is a highly prevalent condition, and population-based studies show that 13.9% of women and 2.6% of men are affected.(2) Specific populations have a higher risk of this condition; for example, the frequency of detection of sterile pyuria was 23% among inpatients in one study (excluding those with urinary tract infection), and sterile pyuria is more common among women than among men because of pelvic infection.(3) Subsequent to initial detection, the costs of laboratory, radiographic, and invasive evaluation in such large populations can have a considerable effect on health care expenditures.(4) Although colony counts greater than 100,000 colony-forming units (CFU) per milliliter in voided urine have historically been used to distinguish bacterial urinary tract infection from colonization,(5) many U. S. laboratories currently report bacterial colony counts of more than 1000 CFU per milliliter in urine as being diagnostic of bacteriuria.(6) It is important to consider that lower bacterial counts can be associated with urinary tract infection. Contemporary studies indicate that a colony count of 100,000 CFU per milliliter would differentiate clinically significant from clinically nonsignificant infections and thus reduce the number of positive cultures by 38% relative to the number of cultures that would be considered positive with the 1000 CFU per milliliter cutoff point. Use of the higher cutoff point as the "level to treat" could also decrease the use of antibiotics.(6) In this article, we review causes of sterile pyuria and describe a clinical approach to its evaluation.	[Wise, Gilbert J.; Schlegel, Peter N.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA	Cornell University; NewYork-Presbyterian Hospital	Wise, GJ (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Urol, 525 E 68th St, New York, NY 10065 USA.	giw2002@med.cornell.edu						ALWALL N, 1973, ACTA MED SCAND, V194, P529; American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; [Anonymous], 2002, MMWR Recomm Rep, V51, P1; [Anonymous], 2014, INT J STD AIDS, V25, P294; [Anonymous], 2010, MMWR, V59, P1; [Anonymous], 2013, MMWR MORB MORTAL WKL, V63, P229; [Anonymous], 2014, MMWR RECOMM REP, V63, P1; Aubron C, 2015, EPIDEMIOL INFECT, V143, P653, DOI 10.1017/S0950268814000934; Baldwin SB, 2003, J INFECT DIS, V187, P1064, DOI 10.1086/368220; CHATTOPADHYAY B, 1980, BRIT MED J, V281, P841, DOI 10.1136/bmj.281.6244.841; Chen PH, 2002, ARCH PHYS MED REHAB, V83, P1624, DOI 10.1053/apmr.2002.34602; Choi Ja Yun, 2013, Korean J Pediatr, V56, P13, DOI 10.3345/kjp.2013.56.1.13; De Broe ME, 1998, NEW ENGL J MED, V338, P446, DOI 10.1056/NEJM199802123380707; Dieter Robert S., 2000, Comprehensive Therapy, V26, P150, DOI 10.1007/s12019-000-0001-1; Eastwood JB, 2001, J AM SOC NEPHROL, V12, P1307, DOI 10.1681/ASN.V1261307; FolefackKaze Francois, 2013, Saudi J Kidney Dis Transpl, V24, P1291, DOI 10.4103/1319-2442.121280; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; FRALICK RA, 1994, UROLOGY, V43, P361, DOI 10.1016/0090-4295(94)90080-9; Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087; Hemal AK, 2000, UROLOGY, V56, P570, DOI 10.1016/S0090-4295(00)00668-3; Hobbs MM, 2006, J CLIN MICROBIOL, V44, P3994, DOI 10.1128/JCM.00952-06; Hooker JB, 2014, J AM BOARD FAM MED, V27, P97, DOI 10.3122/jabfm.2014.01.130084; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Johnson AM, 2012, SEX TRANSM INFECT, V88, P212, DOI 10.1136/sextrans-2011-050306; Kauffman CA, 2014, INFECT DIS CLIN N AM, V28, P61, DOI 10.1016/j.idc.2013.09.004; Kimberlin DW, 2004, NEW ENGL J MED, V350, P1970, DOI 10.1056/NEJMcp023065; Koskenvuo M, 2013, J CLIN VIROL, V56, P77, DOI 10.1016/j.jcv.2012.09.003; Kwon JH, 2012, AM J CLIN PATHOL, V137, P778, DOI 10.1309/AJCP4KVGQZEG1YDM; LeGoff J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-83; Melchers NVSV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002807; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Montaruli E, 2014, UROLOGY, V83, P217, DOI 10.1016/j.urology.2013.09.018; Nicolls DJ, 2008, AM J TROP MED HYG, V79, P729, DOI 10.4269/ajtmh.2008.79.729; Rahman MS, 2014, INT J STD AIDS, V25, P138, DOI 10.1177/0956462413495670; Rahman P, 2001, LUPUS, V10, P418, DOI 10.1191/096120301678646164; Rane VS, 2014, J CLIN MICROBIOL, V52, P2971, DOI 10.1128/JCM.00899-14; ROBERTS AP, 1967, BMJ-BRIT MED J, V1, P400, DOI 10.1136/bmj.1.5537.400; Ross AGP, 2013, NEW ENGL J MED, V368, P1817, DOI 10.1056/NEJMra1207777; Shipitsyna E, 2010, ACTA DERM-VENEREOL, V90, P461, DOI 10.2340/00015555-0929; Taktak A, 2014, RENAL FAILURE, V36, P1148, DOI 10.3109/0886022X.2014.926757; Warren JW, 2008, UROLOGY, V71, P1085, DOI 10.1016/j.urology.2007.12.091; Wise G J, 2001, Expert Opin Pharmacother, V2, P1211, DOI 10.1517/14656566.2.8.1211; Wise GJ, 2003, UROL CLIN N AM, V30, P111, DOI 10.1016/S0094-0143(02)00123-4; Wisplinghoff H, 2014, INT J ANTIMICROB AG, V43, P78, DOI 10.1016/j.ijantimicag.2013.09.005	44	48	49	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					1048	1054		10.1056/NEJMra1410052	http://dx.doi.org/10.1056/NEJMra1410052			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760357	Bronze			2022-12-28	WOS:000350797300009
J	Ganda, OP				Ganda, Om P.			Deciphering Cholesterol Treatment Guidelines A Clinician's Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Med Sch, Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Ganda, OP (corresponding author), Harvard Univ, Med Sch, Joslin Diabet Ctr, 1 Joslin Pl,Ste 242, Boston, MA 02215 USA.	om.ganda@joslin.harvard.edu			NIDDK NIH HHS [DK036836, P30 DK036836] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2015, DIABETES CARE, V38, pS49, DOI 10.2337/dc15-S011; Ginsberg HN, 2014, CIRC RES, V114, P761, DOI 10.1161/CIRCRESAHA.114.303398; Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007; National Institute for Health and Care Excellence, 2014, LIPID MODIFICATION C; Nissen SE, 2014, JAMA INTERN MED, V174, P1972, DOI 10.1001/jamainternmed.2014.3278; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	6	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1009	1010		10.1001/jama.2015.216	http://dx.doi.org/10.1001/jama.2015.216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756432	Green Accepted			2022-12-28	WOS:000350643100011
J	Fuchs-Schundeln, N; Schundeln, M				Fuchs-Schuendeln, Nicola; Schuendeln, Matthias			On the endogeneity of political preferences: Evidence from individual experience with democracy	SCIENCE			English	Article							REDISTRIBUTIVE POLITICS; CULTURE; FAIRNESS; AFRICA; WORLD	Democracies depend on the support of the general population, but little is known about the determinants of this support. We investigated whether support for democracy increases with the length of time spent under the system and whether preferences are thus affected by the political system. Relying on 380,000 individual-level observations from 104 countries over the years 1994 to 2013, and exploiting individual-level variation within a country and a given year in the length of time spent under democracy, we find evidence that political preferences are endogenous. For new democracies, our findings imply that popular support needs time to develop. For example, the effect of around 8.5 more years of democratic experience corresponds to the difference in support for democracy between primary and secondary education.	[Fuchs-Schuendeln, Nicola; Schuendeln, Matthias] Goethe Univ Frankfurt, D-60320 Frankfurt, Germany	Goethe University Frankfurt	Fuchs-Schundeln, N (corresponding author), Goethe Univ Frankfurt, D-60320 Frankfurt, Germany.	fuchs@wiwi.uni-frankfurt.de; schuendeln@wiwi.uni-frankfurt.de			European Research Council [262116]; research cluster "Formation of Normative Orders" at Goethe University Frankfurt	European Research Council(European Research Council (ERC)European Commission); research cluster "Formation of Normative Orders" at Goethe University Frankfurt	Supported by the European Research Council under starting grant 262116 (N.F.-S.) and by the research cluster "Formation of Normative Orders" at Goethe University Frankfurt. Data used in the analysis are described in the supplementary materials. All data used for this study can be downloaded from publicly available websites. World Values Survey data are available from www.worldvaluessurvey.org, Afrobarometer survey data from www.atrobarometer.org, Polity IV data from www.systemicpeace.org/polity/polity4.htm, and Freedom House data from www.freedomhouse.org. Statistical programs to replicate the analysis are archived in Dataverse (doi: 10.7910/DVN/29151).	Alesina A, 2005, AM ECON REV, V95, P960, DOI 10.1257/0002828054825655; Alesina A., 2004, FIGHTING POVERTY US; Alesina A, 2007, AM ECON REV, V97, P1507, DOI 10.1257/aer.97.4.1507; Benabou R, 2006, Q J ECON, V121, P699, DOI 10.1162/qjec.2006.121.2.699; Bratton M, 2004, J DEMOCR, V15, P147, DOI 10.1353/jod.2004.0059; Diamond L., 1999, DEV DEMOCRACY CONSOL, P1; Fehr E, 2011, ECON J, V121, pF396, DOI 10.1111/j.1468-0297.2011.02478.x; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Inglehart R, 2003, COMP POLIT, V36, P61, DOI 10.2307/4150160; Inglehart R, 2003, PS-POLIT SCI POLIT, V36, P51; Karatnycky A, 2003, J DEMOCR, V14, P100, DOI 10.1353/jod.2003.0014; Linz JJ., 1996, PROBLEMS DEMOCRATIC; Luttmer EFP, 2011, AM ECON J-ECON POLIC, V3, P157, DOI 10.1257/pol.3.1.157; Malmendier U, 2011, Q J ECON, V126, P373, DOI 10.1093/qje/qjq004; Marshall M.G., 2005, POLITY 4 PROJECT DAT; Mattes R, 2007, AM J POLIT SCI, V51, P192, DOI 10.1111/j.1540-5907.2007.00245.x; Persson T, 2009, AM ECON J-MACROECON, V1, P88, DOI 10.1257/mac.1.2.88; PIKETTY T, 1995, Q J ECON, V110, P551, DOI 10.2307/2946692	18	37	37	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1145	1148		10.1126/science.aaa0880	http://dx.doi.org/10.1126/science.aaa0880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4WB	25745172				2022-12-28	WOS:000350354200055
J	Rahman, F				Rahman, Farzana			IF I RULED THE NHS Harness technology to produce real change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rahman, Farzana] Univ Coll London Hosp, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Rahman, F (corresponding author), Univ Coll London Hosp, London, England.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2015	350								h1142	10.1136/bmj.h1142	http://dx.doi.org/10.1136/bmj.h1142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DP	25743854				2022-12-28	WOS:000351180000002
J	Durante, C; Costante, G; Lucisano, G; Bruno, R; Meringolo, D; Paciaroni, A; Puxeddu, E; Torlontano, M; Tumino, S; Attard, M; Lamartina, L; Nicolucci, A; Filetti, S				Durante, Cosimo; Costante, Giuseppe; Lucisano, Giuseppe; Bruno, Rocco; Meringolo, Domenico; Paciaroni, Alessandra; Puxeddu, Efisio; Torlontano, Massimo; Tumino, Salvatore; Attard, Marco; Lamartina, Livia; Nicolucci, Antonio; Filetti, Sebastiano			The Natural History of Benign Thyroid Nodules	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IODINE-DEFICIENT AREA; RISK; MANAGEMENT; POPULATION; ULTRASOUND; CANCER; ASPIRATION; GLUCOSE; SYSTEM	IMPORTANCE Detection of asymptomatic thyroid nodules has increased. Consensus is lacking regarding the optimal follow-up of cytologically proven benign lesions and sonographically nonsuspicious nodules. Current guidelines recommend serial ultrasound examinations and reassessment of cytology if significant growth is observed. OBJECTIVE To determine the frequency, magnitude, and factors associated with changes in thyroid nodule size. DESIGN, SETTING, AND PARTICIPANTS Prospective, multicenter, observational study involving 992 consecutive patients with 1 to 4 asymptomatic, sonographically or cytologically benign thyroid nodules. Patients were recruited from 8 hospital-based thyroid-disease referral centers in Italy between 2006 and 2008. Data collected during the first 5 years of follow-up, through January 2013, were analyzed. MAIN OUTCOMES AND MEASURES Baseline nodule growth (primary end point) was assessed with yearly thyroid ultrasound examinations. Size changes were considered significant for growth if an increase of 20% or more was recorded in at least 2 nodule diameters, with a minimum increase of 2 mm. Baseline factors associated with growth were identified. Secondary end points were the sonographic detection of new nodules and the diagnosis of thyroid cancer during follow-up. RESULTS Nodule growth occurred in 153 patients (15.4% [95% CI, 14.3%-16.5%]). One hundred seventy-four of the 1567 original nodules (11.1% [95% CI, 10.3%-11.9%]) increased in size, with a mean 5-year largest diameter increase of 4.9mm(95% CI, 4.2-5.5 mm), from 13.2 mm(95% CI, 12.1-14.2 mm) to 18.1mm(95% CI, 16.7-19.4 mm). Nodule growth was associated with presence of multiple nodules (OR, 2.2 [95% CI 1.4-3.4] for 2 nodules; OR, 3.2 [95% CI, 1.8-5.6 for 3 nodules; and OR, 8.9 [95% CI, 4.4-18.0] for 4 nodules), main nodule volumes larger than 0.2mL (OR, 2.9 [95% CI, 1.7-4.9] for volumes >0.2 to <1 mL and OR, 3.0 [95% CI, 1.8-5.1] for volumes >= 1 mL), and male sex (OR, 1.7 [95% CI, 1.1-2.6]), whereas an age of 60 years or older was associated with a lower risk of growth than age younger than 45 years (OR, 0.5 [95% CI 0.3-0.9]). In 184 individuals (18.5% [95% CI, 16.4%-20.9%]), nodules shrank spontaneously. Thyroid cancer was diagnosed in 5 original nodules (0.3% [95% CI, 0.0%-0.6%]). Only 2 had grown. An incidental cancer was found at thyroidectomy in a nonvisualized nodule. New nodules developed in 93 patients (9.3% [95% CI, 7.5%-11.1%]), with detection of one cancer. CONCLUSIONS AND RELEVANCE Among patients with asymptomatic, sonographically or cytologically benign thyroid nodules, the majority of nodules exhibited no significant size increase during 5 years of follow-up and thyroid cancer was rare. These findings support consideration of revision of current guideline recommendations for follow-up of asymptomatic thyroid nodules.	[Durante, Cosimo; Paciaroni, Alessandra; Lamartina, Livia; Filetti, Sebastiano] Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, I-00161 Rome, Italy; [Costante, Giuseppe] Univ Catanzaro Magna Graecia, Dipartimento Sci Salute, Catanzaro, Italy; [Lucisano, Giuseppe; Nicolucci, Antonio] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy; [Bruno, Rocco] Osped Tinchi Pisticci, Unita Endocrinol, Matera, Italy; [Meringolo, Domenico] Osped Bentivoglio, Unita Operat Semplice, Dipartimentale Endocrinol, Bologna, Italy; [Puxeddu, Efisio] Univ Perugia, Dipartimento Med, I-06100 Perugia, Italy; [Torlontano, Massimo] Ist Ricovero & Cura Carattere Sci, Unita Operat Endocrinol, San Giovanni Rotondo, Italy; [Tumino, Salvatore] Univ Catania, Dipartimento Med Clin & Sperimentale, Catania, Italy; [Attard, Marco] Azienda Osped Osped Riuniti Villa Sofia Cervello, Unita Operat Endocrinol, Palermo, Italy; [Lucisano, Giuseppe] Univ Bari Aldo Moro, Dipartimento Sci Med Base Neurosci & Organi Senso, Bari, Italy	Sapienza University Rome; Magna Graecia University of Catanzaro; University of Perugia; IRCCS Casa Sollievo Della Sofferenza; University of Catania; Universita degli Studi di Bari Aldo Moro	Filetti, S (corresponding author), Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, Viale Policlin 155, I-00161 Rome, Italy.	sebastiano.filetti@uniroma1.it	Durante, Cosimo/E-4926-2014; paciaroni, alessandro/J-2447-2012	Durante, Cosimo/0000-0002-1791-5915; paciaroni, alessandro/0000-0002-3952-1634	Umberto Di Mario Foundation; Banca d'Italia; Italian Thyroid Cancer Observatory (ITCO) Foundation	Umberto Di Mario Foundation; Banca d'Italia; Italian Thyroid Cancer Observatory (ITCO) Foundation	The study was funded by research grants from the Umberto Di Mario Foundation, Banca d'Italia, and the Italian Thyroid Cancer Observatory (ITCO) Foundation.	Aghini-Lombardi F, 2013, J ENDOCRINOL INVEST, V36, P282, DOI 10.1007/BF03347103; Alexander EK, 2003, ANN INTERN MED, V138, P315, DOI 10.7326/0003-4819-138-4-200302180-00010; Anil C, 2013, METABOLISM, V62, P970, DOI 10.1016/j.metabol.2013.01.009; Brauer VFH, 2005, THYROID, V15, P1169, DOI 10.1089/thy.2005.15.1169; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Ciampi A., 1992, CONSTRUCTING PREDICT, P165; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; Erdogan MF, 2006, CLIN ENDOCRINOL, V65, P767, DOI 10.1111/j.1365-2265.2006.02664.x; Fernando SW, 2013, EUR J CLIN NUTR, V67, P366, DOI 10.1038/ejcn.2013.44; Filetti S, 2006, NAT CLIN PRACT ENDOC, V2, P384, DOI 10.1038/ncpendmet0215; Franciosi M, 2005, DIABETIC MED, V22, P900, DOI 10.1111/j.1464-5491.2005.01546.x; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Gharib H, 2013, J CLIN ENDOCR METAB, V98, P3949, DOI 10.1210/jc.2013-1806; Horvath E, 2009, J CLIN ENDOCR METAB, V94, P1748, DOI 10.1210/jc.2008-1724; Ito Y, 2010, WORLD J SURG, V34, P28, DOI 10.1007/s00268-009-0303-0; Knudsen N, 1999, THYROID, V9, P1069, DOI 10.1089/thy.1999.9.1069; Layfield LJ, 2009, CA-CANCER J CLIN, V59, P99, DOI 10.3322/caac.20014; Mandel Susan J, 2004, Endocr Pract, V10, P246; de Sousa PAM, 2013, ARQ BRAS ENDOCRINOL, V57, P120, DOI 10.1590/S0004-27302013000200004; Nou E, 2014, J CLIN ENDOCR METAB, V99, P510, DOI 10.1210/jc.2013-3160; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Quadbeck B, 2002, EXP CLIN ENDOCR DIAB, V110, P348, DOI 10.1055/s-2002-34992; Rendina D, 2012, J ENDOCRINOL INVEST, V35, P407, DOI 10.3275/7842; Smith-Bindman R, 2013, JAMA INTERN MED, V173, P1788, DOI 10.1001/jamainternmed.2013.9245; Sosa JA, 2013, SURGERY, V154, P1420, DOI 10.1016/j.surg.2013.07.006	29	235	250	3	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					926	935		10.1001/jama.2015.0956	http://dx.doi.org/10.1001/jama.2015.0956			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734734	Bronze			2022-12-28	WOS:000350231800015
J	Wolfe, SD				Wolfe, Sven Daniel			2018 FIFA World Cup: isolating Russia could harm global health	LANCET			English	Editorial Material							MASS GATHERINGS HEALTH		Univ Zurich, Dept Geog, CH-8057 Zurich, Switzerland	University of Zurich	Wolfe, SD (corresponding author), Univ Zurich, Dept Geog, CH-8057 Zurich, Switzerland.	daniel.wolfe@geo.uzh.ch		Wolfe, Sven Daniel/0000-0002-4517-6056				Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9; Levada, 2015, LEV CENT POLL COND R; Levada, 2015, RUSS FOR POL OR CRIT; Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1; Memish ZA, 2012, LANCET INFECT DIS, V12, P10, DOI 10.1016/S1473-3099(11)70319-X; Memish ZA, 2011, LANCET INFECT DIS, V11, P342, DOI 10.1016/S1473-3099(11)70075-5; Muller M, 2015, LEISURE STUD, V34, P627, DOI 10.1080/02614367.2014.993333; Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3; Steffen R, 2012, LANCET INFECT DIS, V12, P142, DOI 10.1016/S1473-3099(11)70293-6; WHO, 2014, RUSS FED AIMS SMOK F; WHO Regional Office for Europe, 2014, STRAT NAT COOP	13	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					749	750		10.1016/S0140-6736(15)60316-6	http://dx.doi.org/10.1016/S0140-6736(15)60316-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25752158	Green Accepted			2022-12-28	WOS:000350051700008
J	Zaldivar-Jolissaint, JF; Bervini, D; Harari, MM; Baud, D				Zaldivar-Jolissaint, Julien Francisco; Bervini, David; Harari, Mathilde Morisod; Baud, David			Seizures and metrorrhagia: a case of denied pregnancy	LANCET			English	Editorial Material							WOMEN		[Zaldivar-Jolissaint, Julien Francisco; Bervini, David] CHU Vaudois, Serv Neurochirurg, CH-1011 Lausanne, Switzerland; [Harari, Mathilde Morisod] CHU Vaudois, Serv Univ Psychiat Enfant & Adolescent, CH-1011 Lausanne, Switzerland; [Baud, David] CHU Vaudois, Serv Obstet, CH-1011 Lausanne, Switzerland; [Baud, David] Univ Lausanne, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Zaldivar-Jolissaint, JF (corresponding author), CHU Vaudois, Serv Neurochirurg, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	julienzaldivar@gmail.com		Baud, David/0000-0001-9914-6496; Bervini, David/0000-0003-4873-4452				Bartynski WS, 2008, AM J NEURORADIOL, V29, P1036, DOI 10.3174/ajnr.A0928; Friedman SH, 2007, PSYCHOSOMATICS, V48, P117, DOI 10.1176/appi.psy.48.2.117; Spinelli Margaret G, 2010, J Am Acad Psychoanal Dyn Psychiatry, V38, P117, DOI 10.1521/jaap.2010.38.1.117; Wessel J, 2002, ACTA OBSTET GYN SCAN, V81, P1021, DOI 10.1034/j.1600-0412.2002.811105.x; Wessel J, 2007, ACTA OBSTET GYN SCAN, V86, P542, DOI 10.1080/00016340601159199	5	4	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					828	828		10.1016/S0140-6736(15)60032-0	http://dx.doi.org/10.1016/S0140-6736(15)60032-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25752182				2022-12-28	WOS:000350051700038
J	Grady, C				Grady, Christine			Enduring and Emerging Challenges of Informed Consent	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DECISION-MAKING; HEALTH-CARE; PATIENT; PERSPECTIVE; QUALITY; FORMS; INTERVENTIONS; PARTICIPANTS; CHOICE; ETHICS		NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Grady, C (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10-1C118, Bethesda, MD 20892 USA.	cgrady@nih.gov						ALBERGOTTI R, 2014, WALL STREET J; [Anonymous], 2009, DEM ETH ISS; [Anonymous], 1979, NATL COMMISSION PROT; [Anonymous], 2012, PRES COMM STUD BIOET; Appelbaum PS, 2008, HASTINGS CENT REP, V38, P5; Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; Appelbaum PS, 2014, HASTINGS CENT REP, V44, P22, DOI 10.1002/hast.328; Berg JW, 2001, INFORM CONSENT LEGAL; Bottrell MM, 2000, ARCH SURG-CHICAGO, V135, P26, DOI 10.1001/archsurg.135.1.26; Candilis P.J., 2010, ETHICS CONSENT THEOR, P329; Census Bureau, US CENS BUR PROJ SHO; Chrystoja CC, 2014, CLIN CHEM, V60, P724, DOI 10.1373/clinchem.2013.209213; Clarke AJ, 2014, BRIT MED BULL, V111, P17, DOI 10.1093/bmb/ldu017; Drazen JM, 2013, NEW ENGL J MED, V368, P1929, DOI 10.1056/NEJMe1304996; Dunn LB, 2006, AM J PSYCHIAT, V163, P1323, DOI 10.1176/appi.ajp.163.8.1323; Faden R., 1986, HIST THEORY INFORM C; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Feero WG, 2014, JAMA-J AM MED ASSOC, V311, P1017, DOI 10.1001/jama.2014.1718; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; GOSTIN LO, 1995, JAMA-J AM MED ASSOC, V274, P844; Hall DE, 2012, CAN MED ASSOC J, V184, P533, DOI 10.1503/cmaj.112120; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Henderson GE, 2011, AM J MED SCI, V342, P267, DOI 10.1097/MAJ.0b013e31822a6c47; Hudson KL, 2013, NATURE, V500, P141, DOI 10.1038/500141a; Hudson KL, 2013, NEW ENGL J MED, V368, P2349, DOI 10.1056/NEJMp1306986; Institute of Medicine, 2007, LEARN HEALTHC SYST W; Institute of Medicine, 2012, BEST CAR LOW COST PA; Jefford MH, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.3341; Joffe S, 2010, ETHICS CONSENT THEOR, P357; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Kaye J, 2014, EUR J HUM GENET, V22, P1100, DOI 10.1038/ejhg.2013.290; Kim SYH, 2014, NEW ENGL J MED, V370, P769, DOI 10.1056/NEJMhle1312508; Kim SYH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054790, 10.1371/journal.pone.0053908, 10.1371/journal.pone.0063749, 10.1371/journal.pone.0068092]; Kinnersley P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009445.pub2; Koenig BA, 2014, HASTINGS CENT REP, V44, P33, DOI 10.1002/hast.329; Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P8788, DOI 10.1073/pnas.1320040111; Krogstad DJ, 2010, AM J TROP MED HYG, V83, P743, DOI 10.4269/ajtmh.2010.10-0014; Krumholz HM, 2010, JAMA-J AM MED ASSOC, V303, P1190, DOI 10.1001/jama.2010.309; Kutner M, 2006, 2006483 NCES DEP ED; Leclercq WKG, 2010, WORLD J SURG, V34, P1406, DOI 10.1007/s00268-010-0542-0; Magnus D, 2013, NEW ENGL J MED, V368, P1864, DOI 10.1056/NEJMp1305086; Mandava A, 2012, J MED ETHICS, V38, P356, DOI 10.1136/medethics-2011-100178; McKneally ME, 2000, J THORAC CARDIOV SUR, V120, P264, DOI 10.1067/mtc.2000.106525; McKneally MF, 2004, J AM COLL SURGEONS, V199, P51, DOI 10.1016/j.jamcollsurg.2004.02.021; McManus PL, 2003, ANN ROY COLL SURG, V85, P79, DOI 10.1308/003588403321219812; Miller F., 2010, ETHICS CONSENT; Miller FG, 2003, NEW ENGL J MED, V348, P1383, DOI 10.1056/NEJMsb030228; Miller FG, 2008, NEW ENGL J MED, V358, P765, DOI 10.1056/NEJMp0800136; Miller VA, 2009, J EMPIR RES HUM RES, V4, P21, DOI 10.1525/jer.2009.4.3.21; Morgenstern J, 2014, PUBLIC UNDERST SCI; National Human Genome Research Institute, INF CONS GEN RES; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Platt R, 2014, JAMA-J AM MED ASSOC, V311, P1497, DOI 10.1001/jama.2014.2144; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAKING HLTH CARE DEC; Ruhnke GW, 2000, CHEST, V118, P1172, DOI 10.1378/chest.118.4.1172; Sanderson SC, 2013, GENOME MED, V5, DOI 10.1186/gm518; Schenker Y, 2007, J GEN INTERN MED, V22, P294, DOI 10.1007/s11606-007-0359-1; Schenker Y, 2011, JAMA-J AM MED ASSOC, V305, P1130, DOI 10.1001/jama.2011.333; Schenker Y, 2011, MED DECIS MAKING, V31, P151, DOI 10.1177/0272989X10364247; Schreiner MS, 2014, NEW ENGL J MED, V370, P1958, DOI 10.1056/NEJMc1403310; Sessums LL, 2011, JAMA-J AM MED ASSOC, V306, P420, DOI 10.1001/jama.2011.1023; Shepherd L, 2013, SUPPORT STUD STAND C; Simon CM, 2011, GENET MED, V13, P821, DOI 10.1097/GIM.0b013e31821d2f88; Skloot R, 2011, IMMORTAL LIFE HENRIE; Stacey D, 2014, COCHRANE DATABASE SY, V1; Turner L, 2005, J MED PHILOS, V30, P305, DOI 10.1080/03605310590960193; Wade CH, 2013, ANNU REV GENOM HUM G, V14, P535, DOI 10.1146/annurev-genom-091212-153425; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228; Wendler D, 2008, BIOETHICS, V22, P203, DOI 10.1111/j.1467-8519.2008.00632.x; Whitney SN, 2004, ANN INTERN MED, V140, P54, DOI 10.7326/0003-4819-140-1-200401060-00012; Woolf SH, 2005, ANN INTERN MED, V143, P293, DOI 10.7326/0003-4819-143-4-200508160-00010; World Medical Association, 2013, WMA DECL HELS ETH PR; World Medical Association, 2005, WMA DECL LISB RIGHTS	74	189	192	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					855	862		10.1056/NEJMra1411250	http://dx.doi.org/10.1056/NEJMra1411250			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8SQ	25714163				2022-12-28	WOS:000349901700010
J	Rajasingham, R; Boulware, DR				Rajasingham, Radha; Boulware, David R.			HIV care: ART adherence support and cryptococcal screening	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; DIAGNOSIS; PROGRAM; AFRICA		[Rajasingham, Radha; Boulware, David R.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Boulware, DR (corresponding author), Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA.	boulw001@umn.edu	Boulware, David R/AAF-7124-2021; Boulware, David R/GRS-0999-2022	Boulware, David R/0000-0002-4715-0060				Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Haddow LJ, 2010, LANCET INFECT DIS, V10, P791, DOI 10.1016/S1473-3099(10)70170-5; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mfinanga S, 2015, LANCET; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; UNAIDS, 2013, ACC ANT THER AFR STA; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	12	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2128	2129		10.1016/S0140-6736(15)60455-X	http://dx.doi.org/10.1016/S0140-6736(15)60455-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ6DG	25765697				2022-12-28	WOS:000355583000007
J	Frank, DD; Jouandet, GC; Kearney, PJ; Macpherson, LJ; Gallio, M				Frank, Dominic D.; Jouandet, Genevieve C.; Kearney, Patrick J.; Macpherson, Lindsey J.; Gallio, Marco			Temperature representation in the Drosophila brain	NATURE			English	Article							FLUORESCENT PROTEINS; ANTENNAL LOBE; CIRCUIT; NEURONS; MELANOGASTER; NEUROBIOLOGY; MARKER; GFP	In Drosophila, rapid temperature changes are detected at the periphery by dedicated receptors forming a simple sensory map for hot and cold in the brain(1). However, flies show a host of complex innate and learned responses to temperature, indicating that they are able to extract a range of information from this simple input. Here we define the anatomical and physiological repertoire for temperature representation in the Drosophila brain. First, we use a photolabelling strategy(2) to trace the connections that relay peripheral thermosensory information to higher brain centres, and show that they largely converge onto three target regions: the mushroom body, the lateral horn (both of which are well known centres for sensory processing) and the posterior lateral protocerebrum, a region we now define as a major site of thermosensory representation. Next, using in vivo calcium imaging(3), we describe the thermosensory projection neurons selectively activated by hot or cold stimuli. Fast-adapting neurons display transient ON and OFF responses and track rapid temperature shifts remarkably well, while slow-adapting cell responses better reflect the magnitude of simple thermal changes. Unexpectedly, we also find a population of broadly tuned cells that respond to both heating and cooling, and show that they are required for normal behavioural avoidance of both hot and cold in a simple two-choice temperature preference assay. Taken together, our results uncover a coordinated ensemble of neural responses to temperature in the Drosophila brain, demonstrate that a broadly tuned thermal line contributes to rapid avoidance behaviour, and illustrate how stimulus quality, temporal structure, and intensity can be extracted from a simple glomerular map at a single synaptic station.	[Frank, Dominic D.; Jouandet, Genevieve C.; Kearney, Patrick J.; Gallio, Marco] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Macpherson, Lindsey J.] Columbia Univ, Dept Biochem, New York, NY 10032 USA; [Macpherson, Lindsey J.] Columbia Univ, Dept Mol Biophys, New York, NY 10032 USA	Northwestern University; Columbia University; Columbia University	Gallio, M (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	marco.gallio@northwestern.edu		Gallio, Marco/0000-0003-2132-0639; Kearney, Patrick/0000-0002-7145-5964; Macpherson, Lindsey/0000-0002-1089-3733	NIH [1R01NS086859-01];  [2T32MH067564]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076774, R01NS086859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Ruta and B. Noro for providing PA-GFP flies and reagents, and especially G. Rubin for providing access to the FlyLight collection before publication. We are grateful to N. Ryba, D. Yarmolinsky, C. Zuker and members of the Gallio laboratory for critical comments on the manuscript. Z. Turan and A. Kuang provided technical assistance and we thank C. Ulmer and a number of undergraduate students for fly husbandry. This work was supported by NIH grant 1R01NS086859-01 (to M.G.) and by training grant 2T32MH067564 (to D.D.F.).	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bruckner S, 2009, IEEE T VIS COMPUT GR, V15, P1497, DOI 10.1109/TVCG.2009.121; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Karuppudurai T, 2014, NEURON, V81, P603, DOI 10.1016/j.neuron.2013.12.010; Lai JSY, 2012, P NATL ACAD SCI USA, V109, P2607, DOI 10.1073/pnas.1117307109; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	22	90	91	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					358	+		10.1038/nature14284	http://dx.doi.org/10.1038/nature14284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25739506	Green Accepted			2022-12-28	WOS:000351171900042
J	Kimsey, IJ; Petzold, K; Sathyamoorthy, B; Stein, ZW; Al-Hashimi, HM				Kimsey, Isaac J.; Petzold, Katja; Sathyamoorthy, Bharathwaj; Stein, Zachary W.; Al-Hashimi, Hashim M.			Visualizing transient Watson-Crick-like mispairs in DNA and RNA duplexes	NATURE			English	Article							RARE TAUTOMER HYPOTHESIS; STRUCTURAL BASIS; ROTATING-FRAME; NUCLEIC-ACIDS; BASE-PAIR; N-15 NMR; RELAXATION DISPERSION; CHEMICAL-EXCHANGE; POLYMERASE-I; REPLICATION	Rare tautomeric and anionic nucleobases are believed to have fundamental biological roles, but their prevalence and functional importance has remained elusive because they exist transiently, in low abundance, and involve subtle movements of protons that are difficult to visualize. Using NMR relaxation dispersion, we show here that wobble dG.dT and rG.rU mispairs in DNA and RNA duplexes exist in dynamic equilibrium with short-lived, low-populated Watson-Crick-like mispairs that are stabilized by rare enolic or anionic bases. These mispairs can evade Watson-Crick fidelity checkpoints and form with probabilities (10(-3) to 10(-5)) that strongly imply a universal role in replication and translation errors. Our results indicate that rare tautomeric and anionic bases are widespread in nucleic acids, expanding their structural and functional complexity beyond that attainable with canonical bases.	[Kimsey, Isaac J.; Sathyamoorthy, Bharathwaj; Al-Hashimi, Hashim M.] Duke Univ Med Ctr, Dept Biochem & Chem, Durham, NC 27710 USA; [Petzold, Katja] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Stein, Zachary W.] Univ Michigan, Ann Arbor, MI 48109 USA	Duke University; Karolinska Institutet; University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Duke Univ Med Ctr, Dept Biochem & Chem, Durham, NC 27710 USA.	hashim.al.hashimi@duke.edu	Petzold, Katja/M-7298-2015; Petzold, Katja/E-9816-2011; Sathyamoorthy, Bharathwaj/ABG-2715-2020	Petzold, Katja/0000-0001-9470-0347; Petzold, Katja/0000-0001-9470-0347; Sathyamoorthy, Bharathwaj/0000-0002-1568-2599	NIH [R01GM089846]; Agilent Thought Leader Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agilent Thought Leader Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Horowitz, H. Zhou, J. Lee, A. M. Mustoe, and E. N. Nikolova for assistance and critical comments. We are grateful for technical support and resources from the Duke Magnetic Resonance Spectroscopy Center and University of Michigan Flux HPC Cluster. This work was supported by an NIH grant (R01GM089846) and an Agilent Thought Leader Award given to H.M.A.	[Anonymous], 2009, GAUSSIAN 09; Bebenek K, 2011, P NATL ACAD SCI USA, V108, P1862, DOI 10.1073/pnas.1012825108; Bevilacqua PC, 2006, CURR OPIN CHEM BIOL, V10, P455, DOI 10.1016/j.cbpa.2006.08.014; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Bothe JR, 2014, J MAGN RESON, V244, P18, DOI 10.1016/j.jmr.2014.04.010; Brovarets O. O., 2010, Biopolymers and Cell, V26, P398; Brovarets O. O., 2013, REP NATL ACAD SCI UK, V4, P154; Brovarets O.O., 2009, UKRAIN BIOORG ACTA 2, V8, P12; Brovarets' OO, 2014, J BIOMOL STRUCT DYN, V32, P993, DOI 10.1080/07391102.2013.799439; Cantara WA, 2013, P NATL ACAD SCI USA, V110, P10964, DOI 10.1073/pnas.1222641110; Cavanagh J., 1995, PROTEIN NMR SPECTROS; CHO BP, 1990, CHEM RES TOXICOL, V3, P445, DOI 10.1021/tx00017a010; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Czernek J, 2000, J MAGN RESON, V145, P142, DOI 10.1006/jmre.2000.2091; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dethoff EA, 2012, NATURE, V491, P724, DOI 10.1038/nature11498; DOSANJH MK, 1991, BIOCHEMISTRY-US, V30, P11595, DOI 10.1021/bi00113a015; DOSANJH MK, 1990, BIOCHEMISTRY-US, V29, P4698, DOI 10.1021/bi00471a026; DRIGGERS PH, 1988, BIOCHEMISTRY-US, V27, P1729, DOI 10.1021/bi00405a052; DUTHALER RO, 1978, J AM CHEM SOC, V100, P4969, DOI 10.1021/ja00484a008; ECKERT KA, 1993, J BIOL CHEM, V268, P13462; Farjon J, 2009, J AM CHEM SOC, V131, P8571, DOI 10.1021/ja901633y; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Gilbert SD, 2009, STRUCTURE, V17, P857, DOI 10.1016/j.str.2009.04.009; GOSWAMI B, 1993, J AM CHEM SOC, V115, P3832, DOI 10.1021/ja00062a082; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Hansen AL, 2014, P NATL ACAD SCI USA, V111, pE1705, DOI 10.1073/pnas.1400577111; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Harris VH, 2003, J MOL BIOL, V326, P1389, DOI 10.1016/S0022-2836(03)00051-2; Hoogstraten CG, 2000, BIOCHEMISTRY-US, V39, P9951, DOI 10.1021/bi0007627; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P11233, DOI 10.1093/nar/gku789; Kochina O. S., 2008, REP NATL ACAD SCI UK, V1, P181; Korzhnev DM, 2005, J AM CHEM SOC, V127, P713, DOI 10.1021/ja0446855; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; Li DY, 2014, P NATL ACAD SCI USA, V111, pE3252, DOI 10.1073/pnas.1405635111; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Miloushev VZ, 2005, J MAGN RESON, V177, P221, DOI 10.1016/j.jmr.2005.07.023; Nikolova EN, 2012, J AM CHEM SOC, V134, P3667, DOI 10.1021/ja2117816; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; Nomura K., 2013, J MOD PHYS, V4, P422, DOI DOI 10.4236/JMP.2013.43A059; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Orozco M, 1998, J PHYS CHEM B, V102, P5228, DOI 10.1021/jp981005+; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Palmer AG, 2014, J MAGN RESON, V241, P3, DOI 10.1016/j.jmr.2014.01.008; Sathyamoorthy B, 2014, J BIOMOL NMR, V60, P77, DOI 10.1007/s10858-014-9856-9; Satpati P, 2014, NUCLEIC ACIDS RES, V42, P12876, DOI 10.1093/nar/gku1044; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; SINGER B, 1989, P NATL ACAD SCI USA, V86, P8271, DOI 10.1073/pnas.86.21.8271; SINGER B, 1990, MUTAT RES, V233, P45, DOI 10.1016/0027-5107(90)90150-3; Singh V, 2014, ACS CHEM BIOL, V9, P227, DOI 10.1021/cb400581f; SOWERS LC, 1989, J MOL BIOL, V205, P437, DOI 10.1016/0022-2836(89)90353-7; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0; TOPAL MD, 1976, NATURE, V263, P285, DOI 10.1038/263285a0; Trott O, 2004, J MAGN RESON, V170, P104, DOI 10.1016/j.jmr.2004.06.005; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P498, DOI 10.1038/nsmb1242; Wijmenga SS, 1998, PROG NUCL MAG RES SP, V32, P287, DOI 10.1016/S0079-6565(97)00023-X; Xia SL, 2014, BIOCHEMISTRY-US, V53, P2752, DOI 10.1021/bi4014215; Xia SL, 2014, PROTEIN SCI, V23, P508, DOI 10.1002/pro.2434; Xu XP, 2000, J PHYS CHEM B, V104, P5641, DOI 10.1021/jp0007538; YU H, 1993, J BIOL CHEM, V268, P15935; Zhang ZQ, 2013, BIOCHEMISTRY-US, V52, P8165, DOI 10.1021/bi401002c; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; ZIMMER DP, 1995, P NATL ACAD SCI USA, V92, P3091, DOI 10.1073/pnas.92.8.3091	77	157	157	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					315	+		10.1038/nature14227	http://dx.doi.org/10.1038/nature14227			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762137	Green Accepted			2022-12-28	WOS:000351171900033
J	Haroush, K; Williams, ZM				Haroush, Keren; Williams, Ziv M.			Neuronal Prediction of Opponent's Behavior during Cooperative Social Interchange in Primates	CELL			English	Article							ANTERIOR CINGULATE CORTEX; MIXED-STRATEGY GAME; DECISION-MAKING; NEURAL BASIS; PREFRONTAL CORTEX; PRISONERS-DILEMMA; SIGNALS; RESPONSES; MIND; OUTCOMES	A cornerstone of successful social interchange is the ability to anticipate each other's intentions or actions. While generating these internal predictions is essential for constructive social behavior, their single neuronal basis and causal underpinnings are unknown. Here, we discover specific neurons in the primate dorsal anterior cingulate that selectively predict an opponent's yet unknown decision to invest in their common good or defect and distinct neurons that encode the monkey's own current decision based on prior outcomes. Mixed population predictions of the other was remarkably near optimal compared to behavioral decoders. Moreover, disrupting cingulate activity selectively biased mutually beneficial interactions between the monkeys but, surprisingly, had no influence on their decisions when no net-positive outcome was possible. These findings identify a group of other-predictive neurons in the primate anterior cingulate essential for enacting cooperative interactions and may pave a way toward the targeted treatment of social behavioral disorders.	[Haroush, Keren; Williams, Ziv M.] Harvard Univ, Sch Med, Harvard MIT Hlth Sci & Technol, Boston, MA 02114 USA; [Haroush, Keren; Williams, Ziv M.] Harvard Univ, Sch Med, MGH HMS Ctr Nervous Syst Repair, Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Haroush, K (corresponding author), Harvard Univ, Sch Med, Harvard MIT Hlth Sci & Technol, Boston, MA 02114 USA.	haroush.keren@mgh.harvard.edu; zwilliams@mgh.harvard.edu			NIH [5R01-HD059852]; Presidential Early Career Award for Scientists and Engineers; Whitehall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059852] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Presidential Early Career Award for Scientists and Engineers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was funded by NIH 5R01-HD059852, the Presidential Early Career Award for Scientists and Engineers, and the Whitehall Foundation. Data are available as Supplemental Information. We thank John Assad, Wael Asaad, Shaul Druckmann, Shaul Hochstein, Daeyeol Lee, Israel Nelken, and Sameer Sheth for insightful discussions, Caitlin Commins, Christine Emmanuel, Rebecca Gwaltney, Morgan Jamiel, and Kaitlin Sodon for technical assistance, and Katie Ris-Vicari for the graphical abstract.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Apps MAJ, 2012, SOC NEUROSCI-UK, V7, P424, DOI 10.1080/17470919.2011.638799; Apps MAJ, 2014, J NEUROSCI, V34, P6190, DOI 10.1523/JNEUROSCI.2701-13.2014; Azzi JCB, 2012, P NATL ACAD SCI USA, V109, P2126, DOI 10.1073/pnas.1111715109; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Bshary R, 2008, NATURE, V455, P964, DOI 10.1038/nature07184; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Carter RM, 2012, SCIENCE, V337, P109, DOI 10.1126/science.1219681; Chang SWC, 2013, NAT NEUROSCI, V16, P243, DOI 10.1038/nn.3287; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Donahue CH, 2013, NEURON, V80, P223, DOI 10.1016/j.neuron.2013.07.040; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Hosokawa T, 2012, J NEUROSCI, V32, P7662, DOI 10.1523/JNEUROSCI.6479-11.2012; Karlsson MP, 2012, SCIENCE, V338, P135, DOI 10.1126/science.1226518; KUHLMAN DM, 1975, J PERS SOC PSYCHOL, V32, P922, DOI 10.1037/0022-3514.32.5.922; Lee D, 2005, COGNITIVE BRAIN RES, V25, P416, DOI 10.1016/j.cogbrainres.2005.07.003; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Lombardo MV, 2011, CONSCIOUS COGN, V20, P130, DOI 10.1016/j.concog.2010.09.006; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Parush N, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00022; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rapoport A., 1965, PRISONERS DILEMMA ST; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2014, SCIENCE, V346, P340, DOI 10.1126/science.1256254; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Stephens DW, 2002, SCIENCE, V298, P2216, DOI 10.1126/science.1078498; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Yoshida K, 2012, NAT NEUROSCI, V15, P1307, DOI 10.1038/nn.3180	49	126	127	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1233	1245		10.1016/j.cell.2015.01.045	http://dx.doi.org/10.1016/j.cell.2015.01.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25728667	Bronze, Green Accepted			2022-12-28	WOS:000351951800021
J	Kandala, NB; Connock, M; Pulikottil-Jacob, R; Sutcliffe, P; Crowther, MJ; Grove, A; Mistry, H; Clarke, A				Kandala, Ngianga-Bakwin; Connock, Martin; Pulikottil-Jacob, Ruth; Sutcliffe, Paul; Crowther, Michael J.; Grove, Amy; Mistry, Hema; Clarke, Aileen			Setting benchmark revision rates for total hip replacement: analysis of registry evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL DEVICES; FAILURE; JOINT; PROSTHESES; MODELS	Objective To compare 10 year revision rates for frequently used types of primary total hip replacement to inform setting of a new benchmark rate in England and Wales that will be of international relevance. Design Retrospective cohort study. Setting National Joint Registry. Participants 239 000 patient records. Main outcome measures Revision rates for five frequently used types of total hip replacement that differed according to bearing surface and fixation mode, encompassing 62% of all primary total hip replacements in the National Joint Registry for England and Wales. Revision rates were compared using Kaplan-Meier and competing risks analyses, and five and 10 year rates were estimated using well fitting parametric models. Results Estimated revision rates at 10 years were 4% or below for four of the five types of total hip replacement investigated. Rates differed little according to Kaplan-Meier or competing risks analysis, but differences between prosthesis types were more substantial. Cemented prostheses with ceramic-on-polyethylene bearing surfaces had the lowest revision rates (1.88-2.11% at 10 years depending on the method used), and cementless prostheses with ceramic-on-ceramic bearing surfaces had the highest revision rates (3.93-4.33%). Men were more likely to receive revision of total hip replacement than were women, and this difference was statistically significant for four of the five prosthesis types. Conclusions Ten year revision rate estimates were all less than 5%, and in some instances considerably less. The results suggest that the current revision rate benchmark should be at least halved from 10% to less than 5% at 10 years. This has implications for benchmarks internationally.	[Kandala, Ngianga-Bakwin; Connock, Martin; Pulikottil-Jacob, Ruth; Sutcliffe, Paul; Grove, Amy; Mistry, Hema; Clarke, Aileen] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick Evidence, Coventry CV4 7AL, W Midlands, England; [Crowther, Michael J.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England	University of Warwick; University of Leicester	Clarke, A (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick Evidence, Coventry CV4 7AL, W Midlands, England.	Aileen.Clarke@warwick.ac.uk	Clarke, Aileen/I-5679-2012; Crowther, Michael/AAL-9932-2021; Sutcliffe, Paul/AAB-7325-2020	Clarke, Aileen/0000-0001-8299-3146; Grove, Prof Amy/0000-0002-8027-7274; Mistry, Hema/0000-0002-5023-1160; Crowther, Michael/0000-0001-8378-8259; Pulikottil-Jacob, Ruth/0000-0003-0630-960X	Health Technology Assessment programme [11/118]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust; NIHR [DRF-2013-06-064, DRF-2012-05-409]; National Institute for Health Research [DRF-2012-05-409] Funding Source: researchfish	Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the Health Technology Assessment programme (project number 11/118). Further information is available at www.nets.nihr.ac.uk/programmes/hta. N-BK and AC are also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust. AG is supported by the NIHR Doctoral Fellowship Programme (project number DRF-2013-06-064), and MJC is funded by an NIHR doctoral research fellowship (DRF-2012-05-409). This report presents independent research commissioned by the NIHR) to support the work of the National Institute for Health and Care Excellence (NICE). The views and opinions expressed in this publication are those of the authors and do not necessarily reflect those of the NHS, NICE, NIHR, MRC, CCF, NETSCC, Health Technology Assessment programme, or Department of Health.	American Joint Replacement Registry, 2013, AB US; [Anonymous], 2013, DEPUY ASR HIP REC GU; [Anonymous], 2011, INTRO NEW PROSTH WEB; Australian Orthopaedic Association National Joint Replacement Registry, 2012, ANN REP 2012; Briggs Andrew, 2004, Appl Health Econ Health Policy, V3, P79, DOI 10.2165/00148365-200403020-00004; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Centers for Disease Control and Prevention, 2010, NUMB ALL LIST PROC D; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; Coviello E, STCOMPADJ STATA MODU; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Crowther MJ, 2013, J STAT SOFTW, V53, P1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garellick G, 2011, SWEDISH HIP ARTHROPL; Gillam MH, 2011, ACTA ORTHOP, V82, P513, DOI 10.3109/17453674.2011.618918; Higashi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025403; Hinchliffe SR, 2013, STATA J, V13, P344, DOI 10.1177/1536867X1301300209; Konan S, 2013, BONE JOINT J, V95B, P1585, DOI 10.1302/0301-620X.95B12.33353; Kynaston-Pearson F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6956; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Makela KT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7592; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; National Audit Office, 2000, HIP REPL GETT IT RIG; National Institute for Health and Care Excellence, 2014, REV TECHN APPR GUID; National Institute for Health and Clinical Excellence, 2002, GUID US MET MET HIP; National Institute for Health and Clinical Excellence, 2003, GUID SEL PROSTH PRIM; National Joint Registry, 2012, NAT JOINT REG ENGL W; National Joint Registry, 2013, NAT JOINT REG ENGL W; NHS Supply Chain, 2013, ORTH DEV EV PAN; Norton MR, 2002, J BONE JOINT SURG BR, V84B, P631, DOI 10.1302/0301-620X.84B5.12679; Norwegian Arthroplasty Register, NORW ARTHR REG REP 2; Pennington M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1026; Royal College of Surgeons 3M Capital Hip System Steering Group, 2001, 3M CAP HIP SYST LESS; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Smith AJ, 2012, LANCET, V380, P1759, DOI 10.1016/S0140-6736(12)60989-1; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Tucker K, 2012, DESIGN METHODOLOGY P	37	46	47	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2015	350								h756	10.1136/bmj.h756	http://dx.doi.org/10.1136/bmj.h756			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EA	25752749	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000351181100007
J	Beaglehole, R; Bonita, R				Beaglehole, Robert; Bonita, Ruth			The art of medicine Development with values: lessons from Bhutan	LANCET			English	Editorial Material									[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1010, New Zealand	University of Auckland	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1010, New Zealand.	r.beaglehole@auckland.ac.nz						Hall J, 2013, GLOB CHOICES, V1, P7; Helliwell J., 2013, WORLD HAPPINESS REPO; Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8; OECD, 2013, GUID MEAS SUBJ WELL; United Nations (UN), 2014, ROAD DIGN 2030 END P; Ura Karma, 2012, EXTENSIVE ANAL GNH I	6	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					848	849		10.1016/S0140-6736(15)60475-5	http://dx.doi.org/10.1016/S0140-6736(15)60475-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC6CB	25773082	Bronze			2022-12-28	WOS:000350451100018
J	Holmes, D				Holmes, David			Dainius Puras: UN Special Rapporteur on the right to health	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					847	847		10.1016/S0140-6736(15)60474-3	http://dx.doi.org/10.1016/S0140-6736(15)60474-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25773081				2022-12-28	WOS:000350451100017
J	Doughty, CE; Metcalfe, DB; Girardin, CAJ; Amezquita, FF; Cabrera, DG; Huasco, WH; Silva-Espejo, JE; Araujo-Murakami, A; da Costa, MC; Rocha, W; Feldpausch, TR; Mendoza, ALM; da Costa, ACL; Meir, P; Phillips, OL; Malhi, Y				Doughty, Christopher E.; Metcalfe, D. B.; Girardin, C. A. J.; Farfan Amezquita, F.; Galiano Cabrera, D.; Huaraca Huasco, W.; Silva-Espejo, J. E.; Araujo-Murakami, A.; da Costa, M. C.; Rocha, W.; Feldpausch, T. R.; Mendoza, A. L. M.; da Costa, A. C. L.; Meir, P.; Phillips, O. L.; Malhi, Y.			Drought impact on forest carbon dynamics and fluxes in Amazonia	NATURE			English	Article							NET PRIMARY PRODUCTIVITY; TROPICAL FOREST; THROUGHFALL EXCLUSION; RAIN-FOREST; ALLOCATION; ECOSYSTEM; RESPIRATION; BALANCE; SENSITIVITY; BIOMASS	In 2005 and 2010 the Amazon basin experienced two strong droughts', driven by shifts in the tropical hydrological regime(2) possibly associated with global climate change(3), as predicted by some global models'. Tree mortality increased after the 2005 drought(4), and regional atmospheric inversion modelling showed basin-wide decreases in CO2 uptake in 2010 compared with 2011 (ref. 5). But the response of tropical forest carbon cycling to these droughts is not fully understood and there has been no detailed multi-site investigation in situ. Here we use several years of data from a network of thirteen 1-ha forest plots spread throughout South America, where each component of net primary production (NPP), autotrophic respiration and heterotrophic respiration is measured separately, to develop a better mechanistic understanding of the impact of the 2010 drought on the Amazon forest. We find that total NPP remained constant throughout the drought. However, towards the end of the drought, autotrophic respiration, especially in roots and stems, declined significantly compared with measurements in 2009 made in the absence of drought, with extended decreases in autotrophic respiration in the three driest plots. In the year after the drought, total NPP remained constant but the allocation of carbon shifted towards canopy NPP and away from fine-root NPP. Both leaf-level and plot-level measurements indicate that severe drought suppresses photosynthesis. Scaling these measurements to the entire Amazon basin with rainfall data, we estimate that drought suppressed Amazon-wide photosynthesis in 2010 by 0.38 petagrams of carbon (0.23-0.53 petagrams of carbon). Overall, we find that during this drought, instead of reducing total NPP, trees prioritized growth by reducing autotrophic respiration that was unrelated to growth. This suggests that trees decrease investment in tissue maintenance and defence, in line with eco-evolutionary theories that trees are competitively disadvantaged in the absence of growth(6). We propose that weakened maintenance and defence investment may, in turn, cause the increase in post-drought tree mortality observed at our plots.	[Doughty, Christopher E.; Girardin, C. A. J.; Malhi, Y.] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford OX1 3QY, England; [Metcalfe, D. B.] Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22362 Lund, Sweden; [Farfan Amezquita, F.; Galiano Cabrera, D.; Huaraca Huasco, W.; Silva-Espejo, J. E.; Mendoza, A. L. M.] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Araujo-Murakami, A.] Univ Autonoma Gabriel Rene Moreno, Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [da Costa, M. C.; da Costa, A. C. L.] Fed Univ Para, Inst Geociencias, Fac Meteorol, BR-66075110 Belem, Para, Brazil; [Rocha, W.] IPAM Inst Pesquisa Ambiental Amazonia, BR-78640000 Canarana, Mato Grosso, Brazil; [Feldpausch, T. R.] Univ Exeter, Coll Life & Environm Sci, Dept Geog, Exeter EX4 4RJ, Devon, England; [Meir, P.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3FF, Midlothian, Scotland; [Meir, P.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Phillips, O. L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of Oxford; Lund University; Universidad Nacional de San Antonio Abad del Cusco; Universidade Federal do Para; University of Exeter; University of Edinburgh; Australian National University; University of Leeds	Doughty, CE (corresponding author), Univ Oxford, Sch Geog & Environm, Environm Change Inst, S Parks Rd, Oxford OX1 3QY, England.	chris.doughty@ouce.ox.ac.uk	Phillips, Oliver/A-1523-2011; Feldpausch, Ted/ABH-3123-2020; Meir, Patrick/J-8344-2012; Feldpausch, Ted/D-3436-2009; Silva Espejo, Javier Eduardo/U-2962-2017	Phillips, Oliver/0000-0002-8993-6168; Feldpausch, Ted/0000-0002-6631-7962; Feldpausch, Ted/0000-0002-6631-7962; Huaraca Huasco, Walter/0000-0001-5300-4986; Silva Espejo, Javier Eduardo/0000-0003-1954-3817; Doughty, Christopher/0000-0003-3985-7960	Gordon and Betty Moore Foundation; Andes Biodiversity and Ecosystems Research Group (ABERG); UK Natural Environment Research Council [NE/D01025X/1, NE/D014174/1, NE/F002149/1, NE/J011002/1]; NERC AMAZONICA consortium grant [NE/F005776/1]; EU [282664, 283080]; National Council for Scientific and Technological Development (CNPq, Brazil); ARC [FT110100457]; ERC Advanced Investigator Award; Royal Society Wolfson Research Merit Award; Jackson Foundation; John Fell Fund; Natural Environment Research Council [NE/D014174/1, NE/D01185X/1, NE/F005776/1, NE/B504630/1, NE/D010306/1, NE/D011191/1, NE/J023418/1, NE/D01025X/1, NER/A/S/2003/00608/2, NE/I02982X/1, NE/J011002/1] Funding Source: researchfish; NERC [NE/D01025X/1, NE/I02982X/1, NE/D014174/1, NE/F005776/1, NE/D011191/1, NE/D010306/1, NE/J011002/1, NE/D01185X/1, NE/J023418/1] Funding Source: UKRI	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Andes Biodiversity and Ecosystems Research Group (ABERG); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC AMAZONICA consortium grant; EU(European Commission); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ARC(Australian Research Council); ERC Advanced Investigator Award; Royal Society Wolfson Research Merit Award(Royal Society of London); Jackson Foundation; John Fell Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank P. Brando and Tanguro partners for logistical support and advice. This work is a product of the Global Ecosystems Monitoring (GEM) network (http://gem.tropicalforests.ox.ac.uk) and the RAIN FOR and ABERG research consortia, and was funded by grants to Y.M. and O.L.P. from the Gordon and Betty Moore Foundation to the Amazon Forest Inventory Network (RAINFOR) and the Andes Biodiversity and Ecosystems Research Group (ABERG), and grants from the UK Natural Environment Research Council (NE/D01025X/1, NE/D014174/1, NE/F002149/1 and NE/J011002/1), the NERC AMAZONICA consortium grant (NE/F005776/1) and the EU FP7 Amazalert (282664) GEOCARBON (283080) projects. Some data in this publication were provided by the Tropical Ecology Assessment and Monitoring (TEAM) Network, a collaboration between Conservation International, the Missouri Botanical Garden, the Smithsonian Institution and the Wildlife Conservation Society, and partly funded by these institutions, the Gordon and Betty Moore Foundation, and other donors. T.R.F. is supported by a National Council for Scientific and Technological Development (CNPq, Brazil) award. P.M. is supported by an ARC fellowship award FT110100457; O.L.P. is supported by an ERC Advanced Investigator Award and a Royal Society Wolfson Research Merit Award; Y.M. is supported by an ERC Advanced Investigator Award and by the Jackson Foundation. C.E.D. acknowledges funding from the John Fell Fund.	Araujo-Murakami A, 2014, PLANT ECOL DIVERS, V7, P55, DOI 10.1080/17550874.2013.798364; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Chambers JQ, 2004, ECOL APPL, V14, pS72; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; da Costa ACL, 2014, PLANT ECOL DIVERS, V7, P7, DOI 10.1080/17550874.2013.798366; da Rocha HR, 2004, ECOL APPL, V14, pS22; Dietze MC, 2014, ANNU REV PLANT BIOL, V65, P667, DOI 10.1146/annurev-arplant-050213-040054; Doughty CE, 2014, ECOLOGY, V95, P2192, DOI 10.1890/13-1507.1; Doughty CE, 2014, PLANT ECOL DIVERS, V7, P41, DOI 10.1080/17550874.2013.798367; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Doughty CE, 2011, BIOTROPICA, V43, P658, DOI 10.1111/j.1744-7429.2010.00746.x; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fenn K., 2014, ECOSYSTEMS; Fisher RA, 2007, GLOBAL CHANGE BIOL, V13, P2361, DOI 10.1111/j.1365-2486.2007.01417.x; Franklin O, 2012, TREE PHYSIOL, V32, P648, DOI 10.1093/treephys/tpr138; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P107, DOI 10.1080/17550874.2013.820222; Gloor M, 2013, GEOPHYS RES LETT, V40, P1729, DOI 10.1002/grl.50377; Hikosaka K, 2012, FUNCT ECOL, V26, P1024, DOI 10.1111/j.1365-2435.2012.02042.x; Huasco WH, 2014, PLANT ECOL DIVERS, V7, P125, DOI 10.1080/17550874.2013.819042; KING DA, 1993, TREE PHYSIOL, V12, P119, DOI 10.1093/treephys/12.2.119; LEHMANN J, 2003, AMAZONIAN DARK EARTH; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Malhi Y, 2015, GLOBAL CHANGE BIOL, V21, P2283, DOI 10.1111/gcb.12859; Malhi Y, 2014, PLANT ECOL DIVERS, V7, P85, DOI 10.1080/17550874.2013.820805; Malhi Y, 2011, PHILOS T R SOC B, V366, P3225, DOI 10.1098/rstb.2011.0062; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Meir P, 2008, PHILOS T R SOC B, V363, P1849, DOI 10.1098/rstb.2007.0021; Metcalfe DB, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000443; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; Rocha W, 2014, PLANT ECOL DIVERS, V7, P25, DOI 10.1080/17550874.2013.798368; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Sala A, 2012, TREE PHYSIOL, V32, P764, DOI 10.1093/treephys/tpr143; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Townsend AR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013454; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; Xu LA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046824	48	360	379	40	538	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					78	U140		10.1038/nature14213	http://dx.doi.org/10.1038/nature14213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739631	Green Submitted			2022-12-28	WOS:000350304000039
J	Ma, DL; Hu, J				Ma, Dong-Lai; Hu, Jin			Segmental Neurofibromatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ma, Dong-Lai] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Hu, Jin] Affiliated Childrens Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Ma, DL (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	mdonglai@sohu.com							0	3	3	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					963	963		10.1056/NEJMicm1403193	http://dx.doi.org/10.1056/NEJMicm1403193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738672				2022-12-28	WOS:000350304500012
J	Zastrow, M				Zastrow, Mark			SCIENCE ON THE MAP	NATURE			English	Editorial Material																			0	18	18	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					119	120		10.1038/519119a	http://dx.doi.org/10.1038/519119a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739633	Bronze			2022-12-28	WOS:000350304000049
J	Smith, G; Wessely, S				Smith, Greg; Wessely, Simon			The future of mental health in the UK: an election manifesto	LANCET			English	Editorial Material									[Wessely, Simon] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London SE5 9RJ, England; [Smith, Greg; Wessely, Simon] Royal Coll Psychiatrists, London SW1X 8PG, England	University of London; King's College London	Wessely, S (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London SE5 9RJ, England.	simon.wessely@kcl.ac.uk	Wessely, Simon C/A-8713-2008	Smith, Gregory/0000-0001-7647-4702; Wessely, Simon Charles/0000-0002-6743-9929				[Anonymous], 2012, NHS PROF WHIT PAP AU; [Anonymous], NHS STAFF SURV 2013; [Anonymous], 2014, CHIEF MED OFFICERS A; [Anonymous], 2014, SICKN ABS RAT NHS JA; Department of Health, 2014, MENTAL HLTH SERVICES; Millard C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6821; NHS England Care Quality Commission Public Health England Health Education England Monitor Trust Development Authority, 2014, NHS 5 YEAR FORW VIEW; ROSE S, 2001, COCHRANE DB SYST REV, V3; Royal College of Psychiatrists, 2014, MAK PAR REAL 6 ASKS; Shipman T, 2015, SUNDAY TIMES; The Commission on Acute Adult Psychiatric Care, 2015, COMM REV PROV AC INP; Travis A., 2014, GUARDIAN	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					747	749		10.1016/S0140-6736(15)60315-4	http://dx.doi.org/10.1016/S0140-6736(15)60315-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25752157				2022-12-28	WOS:000350051700007
J	Alonzo, SH				Alonzo, Suzanne H.			An unexpected cost of sex	SCIENCE			English	Editorial Material							EJACULATE		[Alonzo, Suzanne H.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Alonzo, Suzanne H.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Alonzo, SH (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	shalonzo@ucsc.edu						Alonzo SH, 2010, TRENDS ECOL EVOL, V25, P99, DOI 10.1016/j.tree.2009.07.012; Hoi A. G., 2014, PUBLIC HLTH, V2014, P162; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; McGraw LA, 2015, BIOESSAYS, V37, P142, DOI 10.1002/bies.201400117; Mitchell SN, 2015, SCIENCE, V347, P985, DOI 10.1126/science.1259435; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; Reinhardt K, 2009, P NATL ACAD SCI USA, V106, P21743, DOI 10.1073/pnas.0905347106; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Ward JL, 2012, EVOL APPL, V5, P901, DOI 10.1111/j.1752-4571.2012.00283.x	11	0	0	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					948	949		10.1126/science.aaa6495	http://dx.doi.org/10.1126/science.aaa6495			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB9NQ	25722397				2022-12-28	WOS:000349958900018
J	Ji, HT; Zweibel, E				Ji, Hantao; Zweibel, Ellen			Understanding particle acceleration in astrophysical plasmas	SCIENCE			English	Editorial Material							GAMMA-RAY FLARES; CRAB-NEBULA; MAGNETIC RECONNECTION; ELECTRON ACCELERATION		[Ji, Hantao] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Ji, Hantao] Princeton Univ, Princeton Plasma Phys Lab, Princeton, NJ 08544 USA; [Ji, Hantao] Harbin Inst Technol, Lab Space Environm & Phys Sci, Harbin 150001, Heilongjiang, Peoples R China; [Zweibel, Ellen] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Zweibel, Ellen] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA	Princeton University; Princeton University; United States Department of Energy (DOE); Princeton Plasma Physics Laboratory; Harbin Institute of Technology; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ji, HT (corresponding author), Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA.	hji@princeton.edu		Zweibel, Ellen/0000-0003-4821-713X				Abdo AA, 2011, SCIENCE, V331, P739, DOI 10.1126/science.1199705; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Drake JF, 2006, NATURE, V443, P553, DOI 10.1038/nature05116; Fox W, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.225002; Hester JJ, 2008, ANNU REV ASTRON ASTR, V46, P127, DOI 10.1146/annurev.astro.45.051806.110608; Hoshino M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.135003; Huntington CM, 2015, NAT PHYS, V11, P173, DOI [10.1038/NPHYS3178, 10.1038/nphys3178]; Ji HT, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3647505; Matsumoto Y, 2015, SCIENCE, V347, P974, DOI 10.1126/science.1260168; Tavani M, 2011, SCIENCE, V331, P736, DOI 10.1126/science.1200083; Treumann RA, 2009, ASTRON ASTROPHYS REV, V17, P409, DOI 10.1007/s00159-009-0024-2; Uzdensky DA, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/2/L40; WEIBEL ES, 1959, PHYS REV LETT, V2, P83, DOI 10.1103/PhysRevLett.2.83; Yamada M, 2010, REV MOD PHYS, V82, P603, DOI 10.1103/RevModPhys.82.603; Zweibel EG, 2009, ANNU REV ASTRON ASTR, V47, P291, DOI 10.1146/annurev-astro-082708-101726	15	6	6	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					944	945		10.1126/science.aaa3036	http://dx.doi.org/10.1126/science.aaa3036			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722394				2022-12-28	WOS:000349958900015
J	Pardo-De-Santayana, M; Macia, MJ				Pardo-de-Santayana, Manuel; Macia, Manuel J.			BIODIVERSITY The benefits of traditional knowledge	NATURE			English	Editorial Material									[Pardo-de-Santayana, Manuel; Macia, Manuel J.] Univ Autonoma Madrid, Dept Biol Bot, E-28049 Madrid, Spain	Autonomous University of Madrid	Pardo-De-Santayana, M (corresponding author), Univ Autonoma Madrid, Dept Biol Bot, E-28049 Madrid, Spain.	manuel.pardo@uam.es	Macia, Manuel J/H-4631-2012; Pardo-de-Santayana, Manuel/A-1123-2012	Macia, Manuel J/0000-0002-4676-612X; Pardo-de-Santayana, Manuel/0000-0001-9406-4758				Hunn E, 2014, ETHNOBIOL LETT, V5, P146, DOI 10.14237/ebl.5.2014.297; Johns T., 2000, EATING ON THE WILD S, P46; Macia M. J., 2014, J ETHNOPHARMACOL, V158, P58; Menendez-Baceta G, 2015, J ETHNOPHARMACOL, V161, P116, DOI 10.1016/j.jep.2014.12.007; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Pardo-de-Santayana M., 2010, ETHNOBOTANY IN THE N; Quave CL, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.21, 10.1038/nplants.2014.21]; Reyes-Garcia V, 2013, EVOL HUM BEHAV, V34, P249, DOI 10.1016/j.evolhumbehav.2013.03.002; Schultes R.E., 1995, ETHNOBOTANY EVOLUTIO; Verschuuren B., 2010, SACRED NATURAL SITES	10	38	41	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					487	488		10.1038/518487a	http://dx.doi.org/10.1038/518487a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC1JP	25719661				2022-12-28	WOS:000350097300033
J	Xie, ZW; Jay, KA; Smith, DL; Zhang, Y; Liu, ZR; Zheng, JS; Tian, RL; Li, H; Blackburn, EH				Xie, Zhengwei; Jay, Kyle A.; Smith, Dana L.; Zhang, Yi; Liu, Zairan; Zheng, Jiashun; Tian, Ruilin; Li, Hao; Blackburn, Elizabeth H.			Early Telomerase Inactivation Accelerates Aging Independently of Telomere Length	CELL			English	Article							DAMAGE CHECKPOINT RESPONSE; DNA-REPLICATION STRESS; SACCHAROMYCES-CEREVISIAE; YEAST-CELLS; LIFE-SPAN; MRC1; IDENTIFICATION; RECOMBINATION; ASSOCIATION; EXPRESSION	Telomerase is required for long-term telomere maintenance and protection. Using single budding yeast mother cell analyses we found that, even early after telomerase inactivation (ETI), yeast mother cells show transient DNA damage response (DDR) episodes, stochastically altered cell-cycle dynamics, and accelerated mother cell aging. The acceleration of ETI mother cell aging was not explained by increased reactive oxygen species (ROS), Sir protein perturbation, or deprotected telomeres. ETI phenotypes occurred well before the population senescence caused late after telomerase inactivation (LTI). They were morphologically distinct from LTI senescence, were genetically uncoupled from telomere length, and were rescued by elevating dNTP pools. Our combined genetic and single-cell analyses show that, well before critical telomere shortening, telomerase is continuously required to respond to transient DNA replication stress in mother cells and that a lack of telomerase accelerates otherwise normal aging.	[Xie, Zhengwei; Zhang, Yi; Liu, Zairan; Tian, Ruilin] Peking Univ, Ctr Quantitat Biol, Sch Phys, Beijing 100871, Peoples R China; [Xie, Zhengwei; Zhang, Yi; Liu, Zairan; Tian, Ruilin] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Xie, Zhengwei; Jay, Kyle A.; Smith, Dana L.; Zhang, Yi; Liu, Zairan; Zheng, Jiashun; Li, Hao; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Xie, Zhengwei; Zhang, Yi; Liu, Zairan; Zheng, Jiashun; Li, Hao] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Peking University; Peking University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Li, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	haoli@genome.ucsf.edu; elizabeth.blackburn@ucsf.edu		Tian, Ruilin/0000-0001-7680-6682; Zhang, Yi/0000-0001-6609-8635	NIH [GM26259, GM070808, AG043080]; Packard Fellowship in Science and Engineering; NIH Center for Systems and Synthetic Biology [P50 GM081879]; PKU-THU Center for Life Science and Special Financial Grant from the China Postdoctoral Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026259, R01GM070808, R01GM026259, T32GM008284, P50GM081879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship in Science and Engineering; NIH Center for Systems and Synthetic Biology; PKU-THU Center for Life Science and Special Financial Grant from the China Postdoctoral Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant GM26259 to E.H.B. and NIH grants (GM070808 and AG043080) and a Packard Fellowship in Science and Engineering to H.L. and by the NIH Center for Systems and Synthetic Biology (P50 GM081879). Z.X. thanks the Postdoctoral Fellowship from PKU-THU Center for Life Science and Special Financial Grant from the China Postdoctoral Science Foundation.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Basenko E, 2011, EUKARYOT CELL, V10, P1131, DOI 10.1128/EC.05079-11; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chang M, 2009, GENETICS, V183, P779, DOI 10.1534/genetics.109.107631; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Drosopoulos WC, 2012, J CELL BIOL, V197, P253, DOI 10.1083/jcb.201112083; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Grandin N, 2005, BIOL CELL, V97, P799, DOI 10.1042/BC20040526; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Jossen Rachel, 2013, Frontiers in Genetics, V4, DOI 10.3389/fgene.2013.00026; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; LINGNER J, 1997, SCIENCE, V276, P561, DOI DOI 10.1126/SCIENCE.276.5312.561; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Nautiyal S, 2002, P NATL ACAD SCI USA, V99, P9316, DOI 10.1073/pnas.142162499; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Park PU, 1999, MOL CELL BIOL, V19, P3848; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Sabourin M, 2008, TRENDS CELL BIOL, V18, P337, DOI 10.1016/j.tcb.2008.04.004; Salmon' TB, 2004, NUCLEIC ACIDS RES, V32, P3712, DOI 10.1093/nar/gkh696; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Takata H, 2004, MOL CELL, V14, P515, DOI 10.1016/S1097-2765(04)00262-X; Tsolou A, 2007, DNA REPAIR, V6, P1607, DOI 10.1016/j.dnarep.2007.05.010; Xie ZW, 2012, AGING CELL, V11, P599, DOI 10.1111/j.1474-9726.2012.00821.x; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048275; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	40	86	89	3	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					928	939		10.1016/j.cell.2015.02.002	http://dx.doi.org/10.1016/j.cell.2015.02.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723167	Green Accepted, Bronze			2022-12-28	WOS:000351116100015
J	Zarzar, LD; Sresht, V; Sletten, EM; Kalow, JA; Blankschtein, D; Swager, TM				Zarzar, Lauren D.; Sresht, Vishnu; Sletten, Ellen M.; Kalow, Julia A.; Blankschtein, Daniel; Swager, Timothy M.			Dynamically reconfigurable complex emulsions via tunable interfacial tensions	NATURE			English	Article							MULTIPLE EMULSIONS; PHASE-SEPARATION; AIR-WATER; SURFACTANTS; MICROFLUIDICS; FABRICATION; ADSORPTION; PARTICLES; RELEASE; HEXANE	Emulsification is a powerful, well-known technique for mixing and dispersing immiscible components within a continuous liquid phase. Consequently, emulsions are central components of medicine, food and performance materials. Complex emulsions, including Janus droplets (that is, droplets with faces of differing chemistries) and multiple emulsions, are of increasing importance' in pharmaceuticals and medical diagnostics', in the fabrication of microparticles and capsules' for food', in chemical separations', in cosmetics', and in dynamic optics'. Because complex emulsion properties and functions are related to the droplet geometry and composition, the development of rapid, simple fabrication approaches allowing precise control over the droplets' physical and chemical characteristics is critical. Significant advances in the fabrication of complex emulsions have been made using a number of procedures, ranging from largescale, less precise techniques that give compositional heterogeneity using high-shear mixers and membranes'', to small-volume but more precise microfluidic methodsn'''. However, such approaches have yet to create droplet morphologies that can be controllably altered after emulsification. Reconfigurable complex liquids potentially have great utility as dynamically tunable materials. Here we describe an approach to the one-step fabrication of three- and four-phase complex emulsions with highly controllable and reconfigurable morphologies. The fabrication makes use of the temperature-sensitive miscibility of hydrocarbon, silicone and fluorocarbon liquids, and is applied to both the microfluidic and the scalable batch production of complex droplets. We demonstrate that droplet geometries can be alternated between encapsulated and Janus configurations by varying the interfacial tensions using hydrocarbon and fluorinated surfactants including stimuli-responsive and cleavable surfactants. This yields a generalizable strategy for the fabrication of multiphase emulsions with controllably reconfigurable morphologies and the potential to create a wide range of responsive materials.	[Zarzar, Lauren D.; Sletten, Ellen M.; Kalow, Julia A.; Swager, Timothy M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Zarzar, Lauren D.; Sletten, Ellen M.; Kalow, Julia A.; Swager, Timothy M.] MIT, Inst Soldier Nanotechnol, Cambridge, MA 02139 USA; [Sresht, Vishnu; Blankschtein, Daniel] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Blankschtein, D (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	dblank@mit.edu; tswager@mit.edu	Kalow, Julia A/C-7353-2016; Zarzar, Lauren D./C-4239-2019	Kalow, Julia A/0000-0001-9215-520X; /0000-0002-5764-9383; Zarzar, Lauren/0000-0002-3287-3602; /0000-0002-4449-9566	Eni S.p.A. under Eni-MIT Alliance Solar Frontiers Program; US Army Research Laboratory; US Army Research Office through Institute for Soldier Nanotechnologies [W911NF-13-D-0001]; F32 Ruth L. Kirschtein NRSA Fellowships [EB014682, GM106550]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB014682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106550] Funding Source: NIH RePORTER	Eni S.p.A. under Eni-MIT Alliance Solar Frontiers Program; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office through Institute for Soldier Nanotechnologies; F32 Ruth L. Kirschtein NRSA Fellowships; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support from Eni S.p.A. under the Eni-MIT Alliance Solar Frontiers Program and by the US Army Research Laboratory and the US Army Research Office through the Institute for Soldier Nanotechnologies under contract number W911NF-13-D-0001 is acknowledged. EMS. and J.A.K. were supported by F32 Ruth L. Kirschtein NRSA Fellowships under award numbers EB014682 (E.M.S.) and GM106550 (J.A.K.). We thank L Arriaga for introducing us to the fabrication of capillary microfluidic devices.	Aserin A., 2008, MULTIPLE EMULSIONS T; Augustin MA, 2009, CHEM SOC REV, V38, P902, DOI 10.1039/b801739p; BEDFORD RG, 1958, J AM CHEM SOC, V80, P282, DOI 10.1021/ja01535a007; Brown P, 2013, SOFT MATTER, V9, P2365, DOI 10.1039/c3sm27716j; CHAKRAVARTI AK, 1995, COLLOID SURFACE A, V103, P59, DOI 10.1016/0927-7757(95)03201-N; Chen LJ, 2014, ADV OPT MATER, V2, P845, DOI 10.1002/adom.201400166; Chevallier E, 2011, SOFT MATTER, V7, P7866, DOI 10.1039/c1sm05378g; Choi CH, 2014, CHEMPHYSCHEM, V15, P21, DOI 10.1002/cphc.201300821; Choi CH, 2013, ADV MATER, V25, P2536, DOI 10.1002/adma.201204657; Duncanson WJ, 2014, LANGMUIR, V30, P13765, DOI 10.1021/la502473w; Gladysz J. A., 2004, HDB FLUOROUS CHEM, V18-20, P521; GRESHAM PA, 1971, NATURE, V234, P149, DOI 10.1038/234149a0; Guzowski J., 2012, SOFT MATTER, V8, P7269; Haase MF, 2014, ANGEW CHEM INT EDIT, V53, P11793, DOI 10.1002/anie.201406040; Kim J.W., 2007, ANGEW CHEM INT EDIT, V119, P1851, DOI DOI 10.1002/ANGE.200604206; Li MS, 2010, J ORG CHEM, V75, P6149, DOI 10.1021/jo100954q; Li XF, 2010, CHEMPHYSCHEM, V11, P3074, DOI 10.1002/cphc.201000500; Lone S, 2014, RSC ADV, V4, P13322, DOI 10.1039/c4ra00158c; McClain BR, 1999, EUR PHYS J B, V10, P45, DOI 10.1007/s100510050828; MUKERJEE P, 1981, J PHYS CHEM-US, V85, P2298, DOI 10.1021/j150615a032; Patravale V. B., 2008, International Journal of Cosmetic Science, V30, P19, DOI 10.1111/j.1468-2494.2008.00416.x; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P235; Rowlinson J. S., 1982, MOL THEORY CAPILLARI, P209; Shah RK, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70053-1; Shum HC, 2010, MACROMOL RAPID COMM, V31, P108, DOI 10.1002/marc.200900590; Sletten EM, 2014, J AM CHEM SOC, V136, P13574, DOI 10.1021/ja507848f; Song Y, 2012, LANGMUIR, V28, P12054, DOI 10.1021/la3026599; van der Graaf S, 2005, J MEMBRANE SCI, V251, P7, DOI 10.1016/j.memsci.2004.12.013; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Yang Y, 2013, SOFT MATTER, V9, P1458, DOI 10.1039/c2sm27288a; Zhao CX, 2009, ANGEW CHEM INT EDIT, V48, P7208, DOI 10.1002/anie.200902485	31	260	265	48	826	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					520	524		10.1038/nature14168	http://dx.doi.org/10.1038/nature14168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719669	Green Accepted, Green Submitted			2022-12-28	WOS:000350097300043
J	Darzi, A; Keown, OP; Chapman, S				Darzi, Ara; Keown, Oliver P.; Chapman, Simon			Is a smoking ban in UK parks and outdoor spaces a good idea?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLIC SPACES; IMPACT		[Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London W2 1NY, England; [Darzi, Ara] London Hlth Commiss, London, England; [Keown, Oliver P.] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, St Marys Hosp, London W2 1NY, England; [Chapman, Simon] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	Imperial College London; Imperial College London; University of Sydney	Darzi, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, 10th Floor,QEQM Bldg, London W2 1NY, England.		Chapman, Simon/D-4114-2009		National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Australian Institute of Health and Welfare, 2014, NAT DRUGS STRAT HOUS; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Callum C, 2011, HEALTH ECON POLICY L, V6, P489, DOI 10.1017/S1744133110000241; Chapman S, 2008, TOB CONTROL, V17, P25, DOI 10.1136/tc.2007.021386; Chapman S, 1999, AM J PUBLIC HEALTH, V89, P1018, DOI 10.2105/AJPH.89.7.1018; Chapman S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2804; COLLEY JRT, 1974, LANCET, V2, P1031; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Fong Geoffrey T, 2004, Nicotine Tob Res, V6 Suppl 3, pS341; Health and Social Care Information Centre, 2014, STAT SMOK ENGL 2014; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lee W, 2014, INT J PUBLIC HEALTH, V59, P87, DOI 10.1007/s00038-013-0477-y; Licht AS, 2013, TOB CONTROL, V22, P172, DOI 10.1136/tobaccocontrol-2012-050493; London Health Commission, 2014, BETT HLTH LOND; London Health Commission, 2014, NEW YORK INT CIT COM; Mill JS, 1975, 3 ESSAYS, P1; Thomson G, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2806; World Health Organization, 2011, SYST REV LINK TOB PO	18	1	1	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2015	350								h958	10.1136/bmj.h958	http://dx.doi.org/10.1136/bmj.h958			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AM	25715970				2022-12-28	WOS:000350292900012
J	Doudna, JA				Doudna, Jennifer A.			Genomic Engineering and the Future of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CRISPR/CAS9		[Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Innovat Genom Initiat, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Innovat Genom Initiat, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, 731 Stanley Hall,MS 3220, Berkeley, CA 94720 USA.	doudna@berkeley.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2014, NATURE, DOI [10.1038/nature14136, DOI 10.1038/NATURE14136]; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	9	18	18	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					791	792		10.1001/jama.2015.287	http://dx.doi.org/10.1001/jama.2015.287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710652				2022-12-28	WOS:000349826400007
J	Lee, N				Lee, Naomi			The Lancet Technology: January, 2015	LANCET			English	Editorial Material												naomi.lee@lancet.com							0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					408	408		10.1016/S0140-6736(15)60140-4	http://dx.doi.org/10.1016/S0140-6736(15)60140-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25713851				2022-12-28	WOS:000348509900012
J	Kastelein, JJP; Besseling, J; Shah, S; Bergeron, J; Langslet, G; Hovingh, GK; Al-Saady, N; Koeijvoets, M; Hunter, J; Johnson-Levonas, AO; Fable, J; Sapre, A; Mitchel, Y				Kastelein, John J. P.; Besseling, Joost; Shah, Sukrut; Bergeron, Jean; Langslet, Gisle; Hovingh, G. Kees; Al-Saady, Naab; Koeijvoets, Michiel; Hunter, John; Johnson-Levonas, Amy O.; Fable, Jennifer; Sapre, Aditi; Mitchel, Yale			Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ESTER TRANSFER PROTEIN; HIGH-RISK; CAROTID ATHEROSCLEROSIS; MONOCLONAL-ANTIBODY; CARDIOVASCULAR RISK; TRIAL; INHIBITOR; STATIN; TORCETRAPIB	Background Present guidelines emphasise the importance of low concentrations of LDL cholesterol (LDL-C) in patients with familial hypercholesterolaemia. In most patients with the disease, however, these concentrations are not achieved with present treatments, so additional treatment is therefore warranted. Inhibition of cholesteryl ester transfer protein has been shown to reduce LDL-C concentrations in addition to regular statin treatment in patients with hypercholesterolaemia or at high risk of cardiovascular disease. We aimed to investigate the safety and efficacy of anacetrapib, a cholesteryl ester transfer protein inhibitor, in patients with heterozygous familial hypercholesterolaemia. Methods In this multicentre, randomised, double-blind, placebo-controlled, phase 3 study, patients aged 18-80 years with a genotype-confirmed or clinical diagnosis of heterozygous familial hypercholesterolaemia, on optimum lipid-lowering treatment for at least 6 weeks, and with an LDL-C concentration of 2.59 mmol/L or higher without cardiovascular disease or 1.81 mmol/L or higher with cardiovascular disease from 26 lipid clinics across nine countries were eligible. We randomly allocated participants with a computer-generated allocation schedule (2: 1; block size of six; no stratification) to oral anacetrapib 100 mg or placebo for 52 weeks, with a 12 week post-treatment follow-up afterwards. We masked patients, care providers, and those assessing outcomes to treatment groups throughout the study. The primary outcome was percentage change from baseline in LDL-C concentration. We did analysis using a constrained longitudinal repeated measures model. This trial is registered with ClinicalTrials.gov, number NCT01524289. Findings Between Feb 10, 2012, and Feb 12, 2014, we randomly allocated 204 patients to anacetrapib and 102 to placebo. One patient in the anacetrapib group did not receive the drug. At week 52, anacetrapib reduced mean LDL-C concentration from 3.3 mmol/L (SD 0.8) to 2.1 mmol/L (0.8; percentage change 36.0% [95% CI -39.5 to -32.5] compared with an increase with placebo from 3.4 mmol/L (1.2) to 3.5 mmol/L (1.6; percentage change 3.7% [-1.2 to 8.6], with a difference in percentage change between anacetrapib and placebo of -39.7% (95% CI -45.7 to -33.7; p<0.0001). The number of cardiovascular events was increased in patients given anacetrapib compared with those given placebo (4 [2%] of 203 vs none [0%] of 102; p=0.1544), but the proportion with adverse events leading to discontinuation was similar (12 [6%] of 203 vs five [5%] of 102). Interpretation In patients with heterozygous familial hypercholesterolaemia, treatment with anacetrapib for 1 year was well tolerated and resulted in substantial reductions in LDL-C concentration. Whether this change leads to a reduction of cardiovascular events will be answered in an outcome study.	[Kastelein, John J. P.; Besseling, Joost; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Shah, Sukrut; Fable, Jennifer; Mitchel, Yale] Merck & Co Inc, Clin Res, Kenilworth, NJ USA; [Johnson-Levonas, Amy O.] Merck & Co Inc, Sci Affairs, Kenilworth, NJ USA; [Sapre, Aditi] Merck & Co Inc, Biostat, Kenilworth, NJ USA; [Bergeron, Jean] Univ Laval, Ctr Hosp Univ, Quebec Res Ctr, Endocrinol & Nephrol Unit, Quebec City, PQ, Canada; [Langslet, Gisle] Oslo Univ Hosp, Dept Med, Lipid Clin, Oslo, Norway; [Al-Saady, Naab] Covance, Cardiovasc Metab, Sydney, NSW, Australia; [Koeijvoets, Michiel] Covance, Project Management, Rotterdam, Netherlands; [Hunter, John] Covance, Biostat, Madison, WI USA	University of Amsterdam; Academic Medical Center Amsterdam; Merck & Company; Merck & Company; Merck & Company; Laval University; University of Oslo; Covance	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands.	j.j.kastelein@amc.uva.nl	Kastelein, John/AAF-7950-2020		Merck Co, Inc.	Merck Co, Inc.(Merck & Company)	Merck & Co, Inc.	[Anonymous], 2014, ESC C 2014 AUG 31; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2001, CURR OPIN LIPIDOL, V12, P377, DOI 10.1097/00041433-200108000-00002; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gutstein DE, 2012, CLIN PHARMACOL THER, V91, P109, DOI 10.1038/clpt.2011.271; Hovingh GK, 2013, EUR HEART J, V34, P962, DOI 10.1093/eurheartj/eht015; Hovingh K, 2013, EXPERT OPIN DRUG SAF, V12, P569, DOI 10.1517/14740338.2013.793670; Huijgen R, 2012, EUR HEART J, V33, P2325, DOI 10.1093/eurheartj/ehs038; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Liang K-Y, 2000, SANKHYA INDIAN J S B, P134, DOI [DOI 10.2307/25053123, DOI 10.2337/DB12-0868]; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; MOL MJTM, 1986, LANCET, V2, P936; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Nolting PRWD, 2002, AM J CARDIOL, V90, P181, DOI 10.1016/S0002-9149(02)02449-9; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Pijlman AH, 2010, ATHEROSCLEROSIS, V209, P189, DOI 10.1016/j.atherosclerosis.2009.09.014; Raal FJ, 2014, LANCET; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sirtori CR, 2014, ANN MED, V46, P464, DOI 10.3109/07853890.2014.931100; Sjouke B, 2014, LANCET DIABETES ENDO, V2, P455, DOI 10.1016/S2213-8587(14)70006-3; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2011, CIRCULATION, V123, P1974, DOI 10.1161/CIRCULATIONAHA.110.975284; Vergeer M, 2008, CIRCULATION, V118, P2515, DOI 10.1161/CIRCULATIONAHA.108.772665; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423	31	76	79	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2153	2161		10.1016/S0140-6736(14)62115-2	http://dx.doi.org/10.1016/S0140-6736(14)62115-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25743173				2022-12-28	WOS:000355583000025
J	Drage, M				Drage, Michelle			IF I RULED THE NHS Stop trying to integrate organisations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Londonwide Local Med Comm, London, England		Drage, M (corresponding author), Londonwide Local Med Comm, London, England.	Michelle.Drage@lmc.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2015	350								h1271	10.1136/bmj.h1271	http://dx.doi.org/10.1136/bmj.h1271			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EQ	25767096				2022-12-28	WOS:000351182700005
J	Gresham, D				Gresham, David			EVOLUTION Fitness tracking for adapting populations	NATURE			English	Editorial Material							MUTATIONS		NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA	New York University	Gresham, D (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	dgresham@nyu.edu		Gresham, David/0000-0002-4028-0364	NIGMS NIH HHS [R01 GM107466] Funding Source: Medline; Div Of Molecular and Cellular Bioscience [1244219] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107466] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; Gresham D., 2014, FEMS MICROBIOL; Hong JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004041; Kvitek DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003972; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Orr HA, 2003, GENETICS, V163, P1519	9	2	2	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					164	165		10.1038/nature14207	http://dx.doi.org/10.1038/nature14207			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25731163				2022-12-28	WOS:000350770500023
J	de Iongh, A; Giles, C				de Iongh, Anya; Giles, Ceinwen			PATIENT PARTNERSHIP Patients and healthcare conferences: what does true involvement look like?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												anya.deiongh@cantab.net; ceinwen.giles@gmail.com							0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2015	350								h1325	10.1136/bmj.h1325	http://dx.doi.org/10.1136/bmj.h1325			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EH	25758592				2022-12-28	WOS:000351181800014
J	Watts, G				Watts, Geoff			Jean Lindenmann Obituary	LANCET			English	Biographical-Item																		LINDENMANN J, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					850	850		10.1016/S0140-6736(15)60476-7	http://dx.doi.org/10.1016/S0140-6736(15)60476-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25773083	Bronze			2022-12-28	WOS:000350451100019
J	Reilly, SK; Yin, J; Ayoub, AE; Emera, D; Leng, J; Cotney, J; Sarro, R; Rakic, P; Noonan, JP				Reilly, Steven K.; Yin, Jun; Ayoub, Albert E.; Emera, Deena; Leng, Jing; Cotney, Justin; Sarro, Richard; Rakic, Pasko; Noonan, James P.			Evolutionary changes in promoter and enhancer activity during human corticogenesis	SCIENCE			English	Article							EMBRYONIC LIMB; CELL-CYCLE; EXPRESSION; NEURONS; ORIGIN; CORTEX; MURINE; BRAIN	Human higher cognition is attributed to the evolutionary expansion and elaboration of the human cerebral cortex. However, the genetic mechanisms contributing to these developmental changes are poorly understood. We used comparative epigenetic profiling of human, rhesus macaque, and mouse corticogenesis to identify promoters and enhancers that have gained activity in humans. These gains are significantly enriched in modules of coexpressed genes in the cortex that function in neuronal proliferation, migration, and cortical-map organization. Gain-enriched modules also showed correlated gene expression patterns and similar transcription factor binding site enrichments in promoters and enhancers, suggesting that they are connected by common regulatory mechanisms. Our results reveal coordinated patterns of potential regulatory changes associated with conserved developmental processes during corticogenesis, providing insight into human cortical evolution.	[Reilly, Steven K.; Yin, Jun; Emera, Deena; Leng, Jing; Cotney, Justin; Sarro, Richard; Noonan, James P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Ayoub, Albert E.; Rakic, Pasko; Noonan, James P.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Ayoub, Albert E.; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Leng, Jing; Noonan, James P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University	Noonan, JP (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	james.noonan@yale.edu	Noonan, James/ABF-1320-2021; Cotney, Justin L/ABE-8500-2021; Yin, Jun/A-7502-2010	Cotney, Justin L/0000-0001-8230-2157; Reilly, Steven/0000-0003-3140-1483; Yin, Jun/0000-0003-4543-1229	NIH [GM094780, DA023999, NS014841, F32 GM106628]; Brown Cone Fellowship in the Medical Sciences; NSF Graduate Research Fellowship; Joint Medical Research Council (UK)/Wellcome Trust [099175/Z/12/Z]; Medical Research Council [MC_PC_15004, G0700089] Funding Source: researchfish; MRC [MC_PC_15004, G0700089] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094780, T32GM007223, F32GM106628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown Cone Fellowship in the Medical Sciences; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Joint Medical Research Council (UK)/Wellcome Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants GM094780 (to J.P.N.), DA023999 (to P.R.), NS014841 (to P.R), and F32 GM106628 (to D.E.); a Brown Cone Fellowship in the Medical Sciences (to IN.); and an NSF Graduate Research Fellowship (to S.K.R.). Human tissue was provided by the Joint Medical Research Council (UK)/Wellcome Trust (grant 099175/Z/12/Z) Human Developmental Biology Resource (HDBR) (http://hdbr.org). The human tissues used in this study are covered by a material transfer agreement regarding their transfer, but tissues may be requested directly from the HDBR. We thank S. Mae, K. Bilguvar, S. Umlaut, and A. Lopez at the Yale Center for Genome Analysis for sequencing data; the members of the BrainSpan consortium tor providing human brain transcriptome data to the research community; N. Carriero and R. Bjornson at the Yale University Biomedical Peformance Computing Center for computing support: T. Nottoli and C. Pease at the Yale Animal Genomics Service for generating transgenic mice; and S. Wilson and M. Horn for veterinary care of nonhuman, primates. All ChIP-seq data are available through the Gene Expression Omnibus under accession number GSE63649.	Capra JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0025; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Pearlman AL, 1996, PROG BRAIN RES, V108, P119, DOI 10.1016/S0079-6123(08)62536-4; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1968, J NEUROPATH EXP NEUR, V27, P246; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rakic P, 2009, TRENDS NEUROSCI, V32, P291, DOI 10.1016/j.tins.2009.01.007; SCHWARTZ ML, 1991, P NATL ACAD SCI USA, V88, P1354, DOI 10.1073/pnas.88.4.1354; Takahashi T, 1999, J NEUROSCI, V19, P10357; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041	24	139	141	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1155	1159		10.1126/science.1260943	http://dx.doi.org/10.1126/science.1260943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745175	Green Accepted			2022-12-28	WOS:000350354200058
J	Robertson, P; Mahadevan, S; Endl, M; Roy, A				Robertson, Paul; Mahadevan, Suvrath; Endl, Michael; Roy, Arpita			Response to Comment on "Stellar activity masquerading as planets in the habitable zone of the M dwarf Gliese 581"	SCIENCE			English	Editorial Material							M-CIRCLE-PLUS; SYSTEM		[Robertson, Paul; Mahadevan, Suvrath; Roy, Arpita] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Robertson, Paul; Mahadevan, Suvrath; Roy, Arpita] Penn State Univ, Ctr Exoplanets & Habitable Worlds, University Pk, PA 16802 USA; [Mahadevan, Suvrath; Roy, Arpita] Penn State Univ, Penn State Astrobiol Res Ctr, University Pk, PA 16802 USA; [Endl, Michael] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Austin	Robertson, P (corresponding author), Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA.	pmr19@psu.edu	Robertson, Paul/AEV-0522-2022	Robertson, Paul/0000-0003-0149-9678; Mahadevan, Suvrath/0000-0001-9596-7983; Roy, Arpita/0000-0001-8127-5775				Anglada-Escude G, 2015, SCIENCE, V347, DOI 10.1126/science.1260796; Astudillo-Defru N., 2014, ASTRON ASTROPHYS; Boisse I, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201014354; Haywood RD, 2014, MON NOT R ASTRON SOC, V443, P2517, DOI 10.1093/mnras/stu1320; Marchwinski RC, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/63; Mayor M, 2009, ASTRON ASTROPHYS, V507, P487, DOI 10.1051/0004-6361/200912172; Robertson P, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/2/L24; Robertson P, 2014, SCIENCE, V345, P440, DOI [10.1126/science.1253253, 10.1126/science.1255525]; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; Vogt SS, 2010, ASTROPHYS J, V723, P954, DOI 10.1088/0004-637X/723/1/954	10	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226								10.1126/science.1260974	http://dx.doi.org/10.1126/science.1260974			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745157	Green Submitted			2022-12-28	WOS:000350354200031
J	Micieli, JA; Margolin, E				Micieli, Jonathan A.; Margolin, Edward			A 55-Year-Old Man With Severe Papilledema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THROMBOSIS		[Micieli, Jonathan A.; Margolin, Edward] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada	University of Toronto	Micieli, JA (corresponding author), 340 Coll St,Ste 400, Toronto, ON M5T 3A9, Canada.	jonathan.micieli@utoronto.ca						Biousse V, 2003, AM J OPHTHALMOL, V135, P437, DOI 10.1016/S0002-9394(02)02062-7; Biousse V, 1999, NEUROLOGY, V53, P1537, DOI 10.1212/WNL.53.7.1537; Bushnell Cheryl, 2014, Continuum (Minneap Minn), V20, P335, DOI 10.1212/01.CON.0000446105.67173.a8; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Trobe JD, 2011, J NEURO-OPHTHALMOL, V31, P175, DOI 10.1097/WNO.0b013e31821a8b0b	6	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					963	964		10.1001/jama.2015.0800	http://dx.doi.org/10.1001/jama.2015.0800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734739				2022-12-28	WOS:000350231800020
J	Jain, S; Williams, DJ; Arnold, SR; Ampofo, K; Bramley, AM; Reed, C; Stockmann, C; Anderson, EJ; Grijalva, CG; Self, WH; Zhu, YW; Patel, A; Hymas, W; Chappell, JD; Kaufman, RA; Kan, JH; Dansie, D; Lenny, N; Hillyard, DR; Haynes, LM; Levine, M; Lindstrom, S; Winchell, JM; Katz, JM; Erdman, D; Schneider, E; Hicks, LA; Wunderink, RG; Edwards, KM; Pavia, AT; McCullers, JA; Finelli, L				Jain, Seema; Williams, Derek J.; Arnold, Sandra R.; Ampofo, Krow; Bramley, Anna M.; Reed, Carrie; Stockmann, Chris; Anderson, Evan J.; Grijalva, Carlos G.; Self, Wesley H.; Zhu, Yuwei; Patel, Anami; Hymas, Weston; Chappell, James D.; Kaufman, Robert A.; Kan, J. Herman; Dansie, David; Lenny, Noel; Hillyard, David R.; Haynes, Lia M.; Levine, Min; Lindstrom, Stephen; Winchell, Jonas M.; Katz, Jacqueline M.; Erdman, Dean; Schneider, Eileen; Hicks, Lauri A.; Wunderink, Richard G.; Edwards, Kathryn M.; Pavia, Andrew T.; McCullers, Jonathan A.; Finelli, Lyn		CDC EPIC Study Team	Community-Acquired Pneumonia Requiring Hospitalization among US Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; PNEUMOCOCCAL CONJUGATE VACCINE; MYCOPLASMA-PNEUMONIAE; VIRAL-INFECTIONS; PCR; DIAGNOSIS; ASSAYS; TESTS; IDENTIFICATION; EPIDEMIOLOGY	BACKGROUND Incidence estimates of hospitalizations for community-acquired pneumonia among children in the United States that are based on prospective data collection are limited. Updated estimates of pneumonia that has been confirmed radiographically and with the use of current laboratory diagnostic tests are needed. METHODS We conducted active population-based surveillance for community-acquired pneumonia requiring hospitalization among children younger than 18 years of age in three hospitals in Memphis, Nashville, and Salt Lake City. We excluded children with recent hospitalization or severe immunosuppression. Blood and respiratory specimens were systematically collected for pathogen detection with the use of multiple methods. Chest radiographs were reviewed independently by study radiologists. RESULTS From January 2010 through June 2012, we enrolled 2638 of 3803 eligible children (69%), 2358 of whom (89%) had radiographic evidence of pneumonia. The median age of the children was 2 years (interquartile range, 1 to 6); 497 of 2358 children (21%) required intensive care, and 3 (<1%) died. Among 2222 children with radiographic evidence of pneumonia and with specimens available for bacterial and viral testing, a viral or bacterial pathogen was detected in 1802 (81%), one or more viruses in 1472 (66%), bacteria in 175 (8%), and both bacterial and viral pathogens in 155 (7%). The annual incidence of pneumonia was 15.7 cases per 10,000 children (95% confidence interval [CI], 14.9 to 16.5), with the highest rate among children younger than 2 years of age (62.2 cases per 10,000 children; 95% CI, 57.6 to 67.1). Respiratory syncytial virus was more common among children younger than 5 years of age than among older children (37% vs. 8%), as were adenovirus (15% vs. 3%) and human metapneumovirus (15% vs. 8%). Mycoplasma pneumoniae was more common among children 5 years of age or older than among younger children (19% vs. 3%). CONCLUSIONS The burden of hospitalization for children with community-acquired pneumonia was highest among the very young, with respiratory viruses the most commonly detected causes of pneumonia.	[Jain, Seema; Bramley, Anna M.; Reed, Carrie; Haynes, Lia M.; Levine, Min; Lindstrom, Stephen; Winchell, Jonas M.; Katz, Jacqueline M.; Erdman, Dean; Schneider, Eileen; Hicks, Lauri A.; Finelli, Lyn] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A-32, Atlanta, GA 30333 USA; [Williams, Derek J.; Grijalva, Carlos G.; Self, Wesley H.; Zhu, Yuwei; Chappell, James D.; Kan, J. Herman; Edwards, Kathryn M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Williams, Derek J.; Edwards, Kathryn M.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Williams, Derek J.; Edwards, Kathryn M.] Vanderbilt Vaccine Res Program, Nashville, TN USA; [Arnold, Sandra R.; Patel, Anami; Lenny, Noel; McCullers, Jonathan A.] Le Bonheur Childrens Hosp, Memphis, TN USA; [Arnold, Sandra R.; Patel, Anami; Kaufman, Robert A.; Lenny, Noel; McCullers, Jonathan A.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Kaufman, Robert A.; McCullers, Jonathan A.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Ampofo, Krow; Stockmann, Chris; Hymas, Weston; Dansie, David; Hillyard, David R.; Pavia, Andrew T.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Anderson, Evan J.; Wunderink, Richard G.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Centers for Disease Control & Prevention - USA; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Utah System of Higher Education; University of Utah; Northwestern University; Feinberg School of Medicine	Jain, S (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A-32, Atlanta, GA 30333 USA.	bwc8@cdc.gov	Sherwin, Catherine Mary Turner/B-2888-2012; Finelli, Lyn/AAK-2360-2020; Arnold, Sandra R/O-4712-2014; Levine, Min/ABB-4350-2021	Sherwin, Catherine Mary Turner/0000-0002-0844-3207; Arnold, Sandra R/0000-0001-6130-8154; Wunderink, Richard/0000-0002-8527-4195; Grijalva, Carlos/0000-0002-2329-7797; Kaufman, Robert/0000-0001-7066-5516; Self, Wesley/0000-0002-9300-3045	Influenza Division of the National Center for Immunization and Respiratory Diseases; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U18IP000303, U18IP000299, U18IP000301, U18IP000302] Funding Source: NIH RePORTER; National Center for Immunization and Respiratory Diseases (NCIRD) [U18IP000488, U18IP000490, U18IP000489, U18IP000491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI104779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM110469] Funding Source: NIH RePORTER	Influenza Division of the National Center for Immunization and Respiratory Diseases; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the Influenza Division of the National Center for Immunization and Respiratory Diseases.	[Anonymous], 2012, VINT 2012 BRIDG RAC; [Anonymous], 2012, VACCINES; Bartlett RC, 1974, MED MICROBIOLOGY QUA, P24; Blaschke AJ, 2012, DIAGN MICR INFEC DIS, V74, P349, DOI 10.1016/j.diagmicrobio.2012.08.013; Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Blaschke AJ, 2011, PEDIATR INFECT DIS J, V30, P289, DOI 10.1097/INF.0b013e3182002d14; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Caliendo AM, 2014, CLIN INFECT DIS, V58, P1346, DOI 10.1093/cid/ciu092; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Caliendo AM, 2011, CLIN INFECT DIS, V52, pS326, DOI 10.1093/cid/cir047; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; Feikin DR, 2013, CLIN VACCINE IMMUNOL, V20, P113, DOI 10.1128/CVI.00325-12; Fry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017780; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Iwane MK, 2011, J INFECT DIS, V204, P1702, DOI 10.1093/infdis/jir634; Jartti T, 2008, EUR RESPIR J, V32, P314, DOI 10.1183/09031936.00161907; KENDAL AP, 1983, J CLIN MICROBIOL, V18, P930, DOI 10.1128/JCM.18.4.930-934.1983; Lee GE, 2010, PEDIATRICS, V126, P204, DOI 10.1542/peds.2009-3109; Loens K, 2012, J CLIN MICROBIOL, V50, P977, DOI 10.1128/JCM.00200-11; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Garcia-Garcia ML, 2012, PEDIATR INFECT DIS J, V31, P808, DOI 10.1097/INF.0b013e3182568c67; MacNeil JR, 2011, CLIN INFECT DIS, V53, P1230, DOI 10.1093/cid/cir735; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2013, PEDIATR INFECT DIS J, V32, pE119, DOI 10.1097/INF.0b013e3182784b26; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; MONTO AS, 1981, J CLIN MICROBIOL, V13, P54, DOI 10.1128/JCM.13.1.54-57.1981; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Pavia Andrew T, 2011, Clin Infect Dis, V52 Suppl 4, pS284, DOI 10.1093/cid/cir043; POLLOCK HM, 1983, J CLIN MICROBIOL, V17, P255, DOI 10.1128/JCM.17.2.255-259.1983; Sawatwong P, 2012, CLIN INFECT DIS, V54, P445, DOI 10.1093/cid/cir710; Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065; Thurman KA, 2011, DIAGN MICR INFEC DIS, V70, P1, DOI 10.1016/j.diagmicrobio.2010.11.014; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wallace Paul S, 2013, Methods Mol Biol, V943, P49, DOI 10.1007/978-1-60327-353-4_3; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; World Health Organization, 2011, MAN LAB DIAGN VIR SU	42	974	1089	7	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					835	845		10.1056/NEJMoa1405870	http://dx.doi.org/10.1056/NEJMoa1405870			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8SQ	25714161	Green Accepted			2022-12-28	WOS:000349901700008
J	Kohler, M; Haag, S; Biester, K; Brockhaus, AC; McGauran, N; Grouven, U; Kolsch, H; Seay, U; Horn, H; Moritz, G; Staeck, K; Wieseler, B				Koehler, Michael; Haag, Susanne; Biester, Katharina; Brockhaus, Anne Catharina; McGauran, Natalie; Grouven, Ulrich; Koelsch, Heike; Seay, Ulrike; Hoern, Helmut; Moritz, Gregor; Staeck, Kerstin; Wieseler, Beate			Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRIALS	Background When a new drug becomes available, patients and doctors require information on its benefits and harms. In 2011, Germany introduced the early benefit assessment of new drugs through the act on the reform of the market for medicinal products (AMNOG). At market entry, the pharmaceutical company responsible must submit a standardised dossier containing all available evidence of the drug's added benefit over an appropriate comparator treatment. The added benefit is mainly determined using patient relevant outcomes. The "dossier assessment" is generally performed by the Institute for Quality and Efficiency in Health Care (IQWiG) and then published online. It contains all relevant study information, including data from unpublished clinical study reports contained in the dossiers. The dossier assessment refers to the patient population for which the new drug is approved according to the summary of product characteristics. This patient population may comprise either the total populations investigated in the studies submitted to regulatory authorities in the drug approval process, or the specific subpopulations defined in the summary of product characteristics ("approved subpopulations"). Objective To determine the information gain from AMNOG documents compared with non-AMNOG documents for methods and results of studies available at market entry of new drugs. AMNOG documents comprise dossier assessments done by IQWiG and publicly available modules of company dossiers; non-AMNOG documents comprise conventional, publicly available sources-that is, European public assessment reports, journal publications, and registry reports. The analysis focused on the approved patient populations. Design Retrospective analysis. Data sources All dossier assessments conducted by IQWiG between 1 January 2011 and 28 February 2013 in which the dossiers contained suitable studies allowing for a full early benefit assessment. We also considered all European public assessment reports, journal publications, and registry reports referring to these studies and included in the dossiers. Data analysis We assessed reporting quality for each study and each available document for eight methods and 11 results items (three baseline characteristics and eight patient relevant outcomes), and dichotomised them as "completely reported" or "incompletely reported (including items not reported at all)." For each document type we calculated the proportion of items with complete reporting for methods and results, for each item and overall, and compared the findings. Results 15 out of 27 dossiers were eligible for inclusion and contained 22 studies. The 15 dossier assessments contained 28 individual assessments of 15 total study populations and 13 approved subpopulations. European public assessment reports were available for all drugs. Journal publications were available for 14 out of 15 drugs and 21 out of 22 studies. A registry report in ClinicalTrials.gov was available for all drugs and studies; however, only 11 contained results. In the analysis of total study populations, the AMNOG documents reached the highest grade of completeness, with about 90% of methods and results items completely reported. In non-AMNOG documents, the rate was 75% for methods and 52% for results items; journal publications achieved the best rates, followed by European public assessment reports and registry reports. The analysis of approved subpopulations showed poorer complete reporting of results items, particularly in non-AMNOG documents (non-AMNOG versus AMNOG: 11% v 71% for overall results items and 5% v 70% for patient relevant outcomes). The main limitation of our analysis is the small sample size. Conclusion Conventional, publicly available sources provide insufficient information on new drugs, especially on patient relevant outcomes in approved subpopulations. This type of information is largely available in AMNOG documents, albeit only partly in English. The AMNOG approach could be used internationally to develop a comprehensive publication model for clinical studies and thus represents a key open access measure.	[Koehler, Michael; Haag, Susanne; Biester, Katharina; Brockhaus, Anne Catharina; McGauran, Natalie; Grouven, Ulrich; Koelsch, Heike; Seay, Ulrike; Hoern, Helmut; Moritz, Gregor; Staeck, Kerstin] Inst Qual & Efficiency Hlth Care, D-50670 Cologne, Germany; [Wieseler, Beate] Inst Qual & Efficiency Hlth Care, Dept Drug Assessment, D-50670 Cologne, Germany		Wieseler, B (corresponding author), Inst Qual & Efficiency Hlth Care, Dept Drug Assessment, Mediapk 8, D-50670 Cologne, Germany.	beate.wieseler@iqwig.de		Wieseler, Beate/0000-0002-3519-754X	Institute for Quality and Efficiency in Health Care (Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, IQWiG)	Institute for Quality and Efficiency in Health Care (Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, IQWiG)	This work was supported by the Institute for Quality and Efficiency in Health Care (Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, IQWiG). No external financial support was received.	All Trials, 2014, EMA REM SOM RESTR IT; Barbui C, 2011, BMJ-BRIT MED J, V342, pd2291; Basch E, 2013, NEW ENGL J MED, V369, P397, DOI 10.1056/NEJMp1114649; Berntgen M, 2014, VALUE HEALTH, V17, P634, DOI 10.1016/j.jval.2014.04.006; Bundesministerium fur Gesundheit, 2010, GES NEUORDN ARZN G 1, V1, P2262; Doshi Peter, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002496; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; European Medicines Agency, 2014, EUR PUBL ASS REP; European Medicines Agency, 2014, EUR PUBL ASS REP BAC; European Medicines Agency, 2014, PUBL CLIN REP EMA AD; European Medicines Agency, 2014, GUID DOC CONT CO RAP; European Medicines Agency, 2011, BRIL EUR PUBL ASS RE; European Medicines Agency, 2011, ED EUR PUBL ASS REP; European Medicines Agency, 2013, MONTHL STAT REP DEC; Food and Drug Administration, 2013, NEW MOL ENT APPR 201; Food and Drug Administration, 2014, NEW MOL ENT APPR 201; Gemeinsamer Bundesausschuss, 2014, VERF GEM BUND; Gemeinsamer Bundesausschuss, 2014, FORM GLIED DOSS EINZ; Gill CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001186; Goldacre B, 2014, BMJ-BRIT MED J, V348, pg2940; Habibi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092038; Haidich AB, 2011, J CLIN EPIDEMIOL, V64, P124, DOI 10.1016/j.jclinepi.2010.03.005; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Horn H, 2014, HEALTH POLICY, V116, P147, DOI 10.1016/j.healthpol.2013.12.008; Institute for Quality and Efficiency in Health Care, 2013, GEN METH VERS 4 1; Janssen, 2013, INCIVO 375 MG FILMTA; Kanavos P., 2011, DIFFERENCES COSTS AC; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Prayle AP, 2012, BMJ-BRIT MED J, V344, pd7373; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schwartz LM, 2009, NEW ENGL J MED, V361, P1717, DOI 10.1056/NEJMp0907708; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Nguyen TAH, 2013, J CLIN ONCOL, V31, P2998, DOI 10.1200/JCO.2012.46.9577; To MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084779; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Vale CL, 2013, BMJ-BRIT MED J, V346, pf1798; Waffenschmidt S, 2013, J CLIN EPIDEMIOL, V66, P660, DOI 10.1016/j.jclinepi.2012.11.011; Wieseler B, 2012, BMJ-BRIT MED J, V344, pd8141; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2151; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	44	26	26	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2015	350								h796	10.1136/bmj.h796	http://dx.doi.org/10.1136/bmj.h796			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AQ	25722024	hybrid, Green Published			2022-12-28	WOS:000350293400009
J	Oboho, IK; Tomczyk, SM; Al-Asmari, AM; Banjar, AA; Al-Mugti, H; Aloraini, MS; Alkhaldi, KZ; Almohammadi, EL; Alraddadi, BM; Gerber, SI; Swerdlow, DL; Watson, JT; Madani, TA				Oboho, Ikwo K.; Tomczyk, Sara M.; Al-Asmari, Ahmad M.; Banjar, Ayman A.; Al-Mugti, Hani; Aloraini, Muhannad S.; Alkhaldi, Khulud Z.; Almohammadi, Emad L.; Alraddadi, Basem M.; Gerber, Susan I.; Swerdlow, David L.; Watson, John T.; Madani, Tariq A.			2014 MERS-CoV Outbreak in Jeddah - A Link to Health Care Facilities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SAUDI-ARABIA	BACKGROUND A marked increase in the number of cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection occurred in Jeddah, Saudi Arabia, in early 2014. We evaluated patients with MERS-CoV infection in Jeddah to explore reasons for this increase and to assess the epidemiologic and clinical features of this disease. METHODS We identified all cases of laboratory-confirmed MERS-CoV infection in Jeddah that were reported to the Saudi Arabian Ministry of Health from January 1 through May 16, 2014. We conducted telephone interviews with symptomatic patients who were not health care personnel, and we reviewed hospital records. We identified patients who were reported as being asymptomatic and interviewed them regarding a history of symptoms in the month before testing. Descriptive analyses were performed. RESULTS Of 255 patients with laboratory-confirmed MERS-CoV infection, 93 died (case fatality rate, 36.5%). The median age of all patients was 45 years (interquartile range, 30 to 59), and 174 patients (68.2%) were male. A total of 64 patients (25.1%) were reported to be asymptomatic. Of the 191 symptomatic patients, 40 (20.9%) were health care personnel. Among the 151 symptomatic patients who were not health care personnel, 112 (74.2%) had data that could be assessed, and 109 (97.3%) of these patients had had contact with a health care facility, a person with a confirmed case of MERS-CoV infection, or someone with severe respiratory illness in the 14 days before the onset of illness. The remaining 3 patients (2.7%) reported no such contacts. Of the 64 patients who had been reported as asymptomatic, 33 (52%) were interviewed, and 26 of these 33 (79%) reported at least one symptom that was consistent with a viral respiratory illness. CONCLUSIONS The majority of patients in the Jeddah MERS-CoV outbreak had contact with a health care facility, other patients, or both. This highlights the role of health care-associated transmission.	[Oboho, Ikwo K.; Tomczyk, Sara M.; Gerber, Susan I.; Swerdlow, David L.; Watson, John T.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Oboho, Ikwo K.; Tomczyk, Sara M.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Al-Asmari, Ahmad M.; Banjar, Ayman A.; Alkhaldi, Khulud Z.; Almohammadi, Emad L.; Alraddadi, Basem M.; Madani, Tariq A.] Minist Hlth, Jeddah, Saudi Arabia; [Al-Mugti, Hani] Minist Natl Guard, Natl Guard Hlth Affairs, Community & Prevent Med Ctr, Jeddah, Saudi Arabia; [Alraddadi, Basem M.] King Faisal Specialist Hosp & Res Ctr, Jeddah, Saudi Arabia; [Madani, Tariq A.] King Abdulaziz Univ, Fac Med, Dept Med, Jeddah 21413, Saudi Arabia; [Aloraini, Muhannad S.] Al Qassim Univ, Fac Med, Dept Family & Community Med, Al Qassim, Saudi Arabia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ministry of Health - Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; Ministry of National Guard - Health Affairs; King Faisal Specialist Hospital & Research Center; King Abdulaziz University; Qassim University	Madani, TA (corresponding author), King Abdulaziz Univ, Dept Med, POB 80215, Jeddah 21589, Saudi Arabia.	tmadani@kau.edu.sa	Madani, Tariq/AAY-8909-2020; Alraddadi, Basem/AAB-1085-2019	Madani, Tariq/0000-0003-2453-0623; Almohammadi, Emad/0000-0003-0920-2736; Tomczyk, Sara/0000-0001-6975-2663	Ministry of Health, Saudi Arabia; U.S. Centers for Disease Control and Prevention	Ministry of Health, Saudi Arabia; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Ministry of Health, Saudi Arabia, and by the U.S. Centers for Disease Control and Prevention.	Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359; [Anonymous], 2014, SCI INSIDER; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Drosten C, 2015, CLIN INFECT DIS, V60, P369, DOI 10.1093/cid/ciu812; Gulland A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2968; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Madani TA, 2014, LANCET INFECT DIS, V14, P911, DOI 10.1016/S1473-3099(14)70918-1; Madani TA, 2014, SAUDI MED J, V35, P897; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Poissy J, 2014, J CLIN VIROL, V61, P275, DOI 10.1016/j.jcv.2014.07.002; The WHO MERS-CoV Research Group, 2013, PLOS CURR OUTBR; WHO, 2014, UPD MERS COV TRANSM; World Health Organization, 2014, MIDDL E RESP SYNDR C; World Health Organization, 2014, WHO RISK ASS MIDDL E; World Health Organization, 2014, CAS CONTR STUD ASS P	16	331	342	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					846	854		10.1056/NEJMoa1408636	http://dx.doi.org/10.1056/NEJMoa1408636			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8SQ	25714162	Bronze, Green Accepted			2022-12-28	WOS:000349901700009
J	Razooky, BS; Pai, A; Aull, K; Rouzine, IM; Weinberger, LS				Razooky, Brandon S.; Pai, Anand; Aull, Katherine; Rouzine, Igor M.; Weinberger, Leor S.			A Hardwired HIV Latency Program	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-EXPRESSION; FATE SELECTION; TAT; CELLS; NOISE; INFECTION; ESTABLISHMENT; TRANSCRIPTION; REPLICATION	Biological circuits can be controlled by two general schemes: environmental sensing or autonomous programs. For viruses such as HIV, the prevailing hypothesis is that latent infection is controlled by cellular state (i.e., environment), with latency simply an epiphenomenon of infected cells transitioning from an activated to resting state. However, we find that HIV expression persists despite the activated-to-resting cellular transition. Mathematical modeling indicates that HIV's Tat positive-feedback circuitry enables this persistence and strongly controls latency. To overcome the inherent crosstalk between viral circuitry and cellular activation and to directly test this hypothesis, we synthetically decouple viral dependence on cellular environment from viral transcription. These circuits enable control of viral transcription without cellular activation and show that Tat feedback is sufficient to regulate latency independent of cellular activation. Overall, synthetic reconstruction demonstrates that a largely autonomous, viral-encoded program underlies HIV latency potentially explaining why cell-targeted latency-reversing agents exhibit incomplete penetrance.	[Razooky, Brandon S.; Pai, Anand; Rouzine, Igor M.; Weinberger, Leor S.] Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; [Razooky, Brandon S.; Aull, Katherine] Univ Calif San Francisco, Biophys Grad Grp, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Pai, Anand; Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, QB3, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberger, LS (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	leor.weinberger@gladstone.ucsf.edu	Rouzine, Igor M/AFO-3706-2022	Rouzine, Igor M/0000-0002-0744-6705; Aull, Katherine/0000-0003-4289-1342	NSF [1144247]; NIH [R01-AI109593, DP2-OD006677]; Center for Synthetic and Systems Biology at UCSF [P50GM081879]; NIH Delaney CARE Collaboratory of AIDS Researchers for a Cure [U19A1096113]; UCSF-GIVI CFAR [P30AI027763, S10RR028962-01]; Alfred P. Sloan Foundation; Pew Scholar's in the Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109593, P30AI027763, U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, P50GM081879, T32GM067547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006677] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Synthetic and Systems Biology at UCSF; NIH Delaney CARE Collaboratory of AIDS Researchers for a Cure(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF-GIVI CFAR; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Pew Scholar's in the Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to M. Thompson, O. Weiner, J. Toettcher, J. Miranda, A. Weinberger, M. Ott, E. Verdin, A. Frankel, M. Simpson, and G. Suel for comments, helpful discussions, and providing reagents. B.S.R. was supported by an NSF graduate research fellowship (GRFP, grant 1144247). This work was supported by NIH award R01-AI109593 and, in part, by the Center for Synthetic and Systems Biology at UCSF (P50GM081879), the NIH Delaney CARE Collaboratory of AIDS Researchers for a Cure (U19A1096113), and UCSF-GIVI CFAR (P30AI027763 and S10RR028962-01). L.S.W. acknowledges support from NIH Director's New Innovator Award Program (DP2-OD006677), the Alfred P. Sloan Foundation, and the Pew Scholar's in the Biomedical Sciences.	[Anonymous], 2011, CSH PERSPECT MED, DOI DOI 10.1101/cshperspect.a007096; Arkin A, 1998, GENETICS, V149, P1633; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; BULL JJ, 1979, SCIENCE, V206, P1186, DOI 10.1126/science.505003; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Calvanese V, 2013, VIROLOGY, V446, P283, DOI 10.1016/j.virol.2013.07.037; Coffin J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012526; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Dahabieh MS, 2013, J VIROL, V87, P4716, DOI 10.1128/JVI.03478-12; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Donahue DA, 2012, J VIROL, V86, P3253, DOI 10.1128/JVI.06648-11; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; HUANG LM, 1994, EMBO J, V13, P2886, DOI 10.1002/j.1460-2075.1994.tb06583.x; Jeeninga RE, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-37; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002271; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Knedler J.W., 1947, MASTERWORKS SCI DIGE; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; Molle D, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-36; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Razooky BS, 2011, METHODS, V53, P68, DOI 10.1016/j.ymeth.2010.12.006; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rouzine IM, 2015, CELL, V160, P1002, DOI 10.1016/j.cell.2015.02.017; Singh A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.38; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Terry VH, 2009, VIROLOGY, V388, P294, DOI 10.1016/j.virol.2009.03.022; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; Weinberger AD, 2013, CELL, V155, P497, DOI 10.1016/j.cell.2013.09.039; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Xing SF, 2012, J ANTIMICROB CHEMOTH, V67, P398, DOI 10.1093/jac/dkr496; Youngblood B, 2013, IMMUNOLOGY, V139, P277, DOI 10.1111/imm.12074; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453	51	160	163	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					990	1001		10.1016/j.cell.2015.02.009	http://dx.doi.org/10.1016/j.cell.2015.02.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723172	Bronze, Green Accepted			2022-12-28	WOS:000351116100020
J	Waddell, N; Pajic, M; Patch, AM; Chang, DK; Kassahn, KS; Bailey, P; Johns, AL; Miller, D; Nones, K; Quek, K; Quinn, MCJ; Robertson, AJ; Fadlullah, MZH; Bruxner, TJC; Christ, AN; Harliwong, I; Idrisoglu, S; Manning, S; Nourse, C; Nourbakhsh, E; Wani, S; Wilson, PJ; Markham, E; Cloonan, N; Anderson, MJ; Fink, JL; Holmes, O; Kazakoff, SH; Leonard, C; Newell, F; Poudel, B; Song, S; Taylor, D; Waddell, N; Wood, S; Xu, QY; Wu, JM; Pinese, M; Cowley, MJ; Lee, HC; Jones, MD; Nagrial, AM; Humphris, J; Chantrill, LA; Chin, V; Steinmann, AM; Mawson, A; Humphrey, ES; Colvin, EK; Chou, A; Scarlett, CJ; Pinho, AV; Giry-Laterriere, M; Rooman, I; Samra, JS; Kench, JG; Pettitt, JA; Merrett, ND; Toon, C; Epari, K; Nguyen, NQ; Barbour, A; Zeps, N; Jamieson, NB; Graham, JS; Niclou, SP; Bjerkvig, R; Grutzmann, R; Aust, D; Hruban, RH; Maitra, A; Iacobuzio-Donahue, CA; Wolfgang, CL; Morgan, RA; Lawlor, RT; Corbo, V; Bassi, C; Falconi, M; Zamboni, G; Tortora, G; Tempero, MA; Gill, AJ; Eshleman, JR; Pilarsky, C; Scarpa, A; Musgrove, EA; Pearson, JV; Biankin, AV; Grimmond, SM				Waddell, Nicola; Pajic, Marina; Patch, Ann-Marie; Chang, David K.; Kassahn, Karin S.; Bailey, Peter; Johns, Amber L.; Miller, David; Nones, Katia; Quek, Kelly; Quinn, Michael C. J.; Robertson, Alan J.; Fadlullah, Muhammad Z. H.; Bruxner, Tim J. C.; Christ, Angelika N.; Harliwong, Ivon; Idrisoglu, Senel; Manning, Suzanne; Nourse, Craig; Nourbakhsh, Ehsan; Wani, Shivangi; Wilson, Peter J.; Markham, Emma; Cloonan, Nicole; Anderson, Matthew J.; Fink, J. Lynn; Holmes, Oliver; Kazakoff, Stephen H.; Leonard, Conrad; Newell, Felicity; Poudel, Barsha; Song, Sarah; Taylor, Darrin; Waddell, Nick; Wood, Scott; Xu, Qinying; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Lee, Hong C.; Jones, Marc D.; Nagrial, Adnan M.; Humphris, Jeremy; Chantrill, Lorraine A.; Chin, Venessa; Steinmann, Angela M.; Mawson, Amanda; Humphrey, Emily S.; Colvin, Emily K.; Chou, Angela; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Samra, Jaswinder S.; Kench, James G.; Pettitt, Jessica A.; Merrett, Neil D.; Toon, Christopher; Epari, Krishna; Nguyen, Nam Q.; Barbour, Andrew; Zeps, Nikolajs; Jamieson, Nigel B.; Graham, Janet S.; Niclou, Simone P.; Bjerkvig, Rolf; Gruetzmann, Robert; Aust, Daniela; Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Corbo, Vincenzo; Bassi, Claudio; Falconi, Massimo; Zamboni, Giuseppe; Tortora, Giampaolo; Tempero, Margaret A.; Gill, Anthony J.; Eshleman, James R.; Pilarsky, Christian; Scarpa, Aldo; Musgrove, Elizabeth A.; Pearson, John V.; Biankin, Andrew V.; Grimmond, Sean M.		Australian Pancreatic Canc Genome	Whole genomes redefine the mutational landscape of pancreatic cancer	NATURE			English	Article							RANDOMIZED-TRIALS; GEMCITABINE; ADENOCARCINOMA; CHEMOTHERAPY; INSTABILITY; PATTERNS; GENES; CHROMOTHRIPSIS; REARRANGEMENT; METAANALYSIS	Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We performed whole-genome sequencing and copy number variation (CNV) analysis of 100 pancreatic ductal adenocarcinomas (PDACs). Chromosomal rearrangements leading to gene disruption were prevalent, affecting genes known to be important in pancreatic cancer (TP53, SMAD4, CDKN2A, ARID1A and ROBO2) and new candidate drivers of pancreatic carcinogenesis (KDM6A and PREX2). Patterns of structural variation (variation in chromosomal structure) classified PDACs into 4 subtypes with potential clinical utility: the subtypes were termed stable, locally rearranged, scattered and unstable. A significant proportion harboured focal amplifications, many of which contained druggable oncogenes (ERBB2, MET, FGFR1, CDK6, PIK3R3 and PIK3CA), but at low individual patient prevalence. Genomic instability co-segregated with inactivation of DNA maintenance genes (BRCA1, BRCA2 or PALB2) and a mutational signature of DNA damage repair deficiency. Of 8 patients who received platinum therapy, 4 of 5 individuals with these measures of defective DNA maintenance responded.	[Waddell, Nicola; Patch, Ann-Marie; Kassahn, Karin S.; Bailey, Peter; Miller, David; Nones, Katia; Quek, Kelly; Quinn, Michael C. J.; Robertson, Alan J.; Fadlullah, Muhammad Z. H.; Bruxner, Tim J. C.; Christ, Angelika N.; Harliwong, Ivon; Idrisoglu, Senel; Manning, Suzanne; Nourse, Craig; Nourbakhsh, Ehsan; Wani, Shivangi; Wilson, Peter J.; Markham, Emma; Cloonan, Nicole; Anderson, Matthew J.; Fink, J. Lynn; Holmes, Oliver; Kazakoff, Stephen H.; Leonard, Conrad; Newell, Felicity; Poudel, Barsha; Song, Sarah; Taylor, Darrin; Waddell, Nick; Wood, Scott; Xu, Qinying; Pearson, John V.; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia; [Waddell, Nicola; Cloonan, Nicole; Pearson, John V.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Pajic, Marina; Chang, David K.; Johns, Amber L.; Wu, Jianmin; Pinese, Mark; Cowley, Mark J.; Lee, Hong C.; Jones, Marc D.; Nagrial, Adnan M.; Humphris, Jeremy; Chantrill, Lorraine A.; Chin, Venessa; Steinmann, Angela M.; Mawson, Amanda; Humphrey, Emily S.; Colvin, Emily K.; Chou, Angela; Scarlett, Christopher J.; Pinho, Andreia V.; Giry-Laterriere, Marc; Rooman, Ilse; Kench, James G.; Pettitt, Jessica A.; Toon, Christopher; Gill, Anthony J.; Biankin, Andrew V.] Univ New S Wales, Kinghorn Canc Ctr, Canc Div, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Pajic, Marina] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Chang, David K.; Merrett, Neil D.; Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Chang, David K.; Biankin, Andrew V.] Univ New S Wales, Fac Med, South Western Sydney Clin Sch, Liverpool, NSW 2170, Australia; [Chang, David K.; Bailey, Peter; Nourse, Craig; Jones, Marc D.; Jamieson, Nigel B.; Graham, Janet S.; Musgrove, Elizabeth A.; Biankin, Andrew V.; Grimmond, Sean M.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow G61 1BD, Lanark, Scotland; [Chou, Angela] St Vincents Hosp, Dept Anat Pathol, Sydney, NSW 2010, Australia; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia; [Samra, Jaswinder S.] Royal N Shore Hosp, Dept Surg, Sydney, NSW 2065, Australia; [Samra, Jaswinder S.; Kench, James G.; Gill, Anthony J.] Univ Sydney, Sydney, NSW 2006, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Merrett, Neil D.] Univ Western Sydney, Sch Med, Penrith, NSW 2175, Australia; [Epari, Krishna] Fremantle Hosp, Dept Surg, Fremantle, WA 6160, Australia; [Nguyen, Nam Q.] Royal Adelaide Hosp, Dept Gastroenterol, Adelaide, SA 5000, Australia; [Barbour, Andrew] Princess Alexandra Hosp, Dept Surg, Woollongabba, Qld 4102, Australia; [Zeps, Nikolajs] Univ Western Australia, Sch Surg M507, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] St John God Pathol, Subiaco, WA 6008, Australia; [Zeps, Nikolajs] St John God Subiaco Hosp, Bendat Family Comprehens Canc Ctr, Subiaco, WA 6008, Australia; [Jamieson, Nigel B.] Univ Glasgow, Glasgow Royal Infirm, Coll Med Vet & Life Sci, Acad Unit Surg,Sch Med, Glasgow G4 0SF, Lanark, Scotland; [Jamieson, Nigel B.] Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow G31 2ER, Lanark, Scotland; [Graham, Janet S.] Beatson West Scotland Canc Ctr, Dept Med Oncol, Glasgow G12 0YN, Lanark, Scotland; [Niclou, Simone P.] CRP Sante Luxembourg, Norlux Neurooncol Lab, L-1526 Luxembourg, Luxembourg; [Bjerkvig, Rolf] Univ Bergen, Dept Biomed, N-5019 Bergen, Norway; [Gruetzmann, Robert; Aust, Daniela; Pilarsky, Christian] Tech Univ Dresden, Dept Surg, D-01307 Dresden, Germany; [Gruetzmann, Robert; Aust, Daniela; Pilarsky, Christian] Tech Univ Dresden, Dept Pathol, D-01307 Dresden, Germany; [Hruban, Ralph H.; Morgan, Richard A.; Eshleman, James R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, David M Rubenstein Pancreat Canc Res Ctr, New York, NY 10065 USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Wolfgang, Christopher L.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Lawlor, Rita T.; Corbo, Vincenzo; Scarpa, Aldo] Univ Verona, ARC NET Ctr Appl Res Canc, I-37134 Verona, Italy; [Lawlor, Rita T.; Corbo, Vincenzo; Bassi, Claudio; Falconi, Massimo; Tortora, Giampaolo; Scarpa, Aldo] Hosp Trust Verona, I-37134 Verona, Italy; [Lawlor, Rita T.; Zamboni, Giuseppe; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy; [Bassi, Claudio; Falconi, Massimo] Univ Verona, Dept Surg & Oncol, Pancreas Inst, I-37134 Verona, Italy; [Falconi, Massimo; Zamboni, Giuseppe] Osped Sacro Cuore Don Calabria Negrar, Dept Surg, I-37024 Verona, Italy; [Falconi, Massimo; Zamboni, Giuseppe] Osped Sacro Cuore Don Calabria Negrar, Dept Pathol, I-37024 Verona, Italy; [Tortora, Giampaolo] Univ Verona, Dept Oncol, I-37134 Verona, Italy; [Tempero, Margaret A.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94122 USA	University of Queensland; QIMR Berghofer Medical Research Institute; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Glasgow; St Vincents Hospital Sydney; University of Newcastle; Royal North Shore Hospital; University of Sydney; University of Sydney; University of Sydney; Western Sydney University; University of Western Australia; Royal Adelaide Hospital; University of Western Australia; St John of God Health Care; St John of God Health Care; University of Glasgow; University of Glasgow; Beatson Oncology Centre; Luxembourg Institute of Health; University of Bergen; Technische Universitat Dresden; Technische Universitat Dresden; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; University of Verona; University of California System; University of California San Francisco	Grimmond, SM (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia.		Merrett, Neil/H-8033-2019; Nones, Katia/AAX-6453-2021; Zeps, Nikolajs/AAF-3186-2021; scarpa, aldo/K-6832-2016; Cowley, Mark/K-8731-2019; Jamieson, Nigel/X-1071-2019; Niclou, Simone/P-2304-2018; Patch, Ann-Marie/C-4201-2018; Falconi, Massimo/K-2194-2016; Grimmond, Sean M/J-5304-2016; Newell, Felicity/AAN-1253-2020; Wolfgang, Christopher/HGD-0863-2022; Iacobuzio-Donahue, Christine/ABF-1295-2020; Gill, Anthony J./M-5015-2019; Waddell, Nicola/H-4929-2015; Chantrill, Lorraine/GXF-5117-2022; Fink, Lynn/C-2031-2008; Corbo, Vincenzo/J-7754-2016; Giuseppe, Zamboni/L-6029-2019; Gill, Anthony/D-4215-2015; Pearson, John/AAT-4211-2020; Leonard, Conrad/AAD-2587-2020; Tortora, Giampaolo/AAA-1252-2019; Pearson, John V/F-2249-2011; Grimmond, Sean/K-3246-2019; Merrett, Neil/ABB-4342-2021; Cloonan, Nicole/B-5272-2008; Wu, Jianmin/G-3629-2010	Merrett, Neil/0000-0002-8370-0293; Nones, Katia/0000-0003-1925-5196; Zeps, Nikolajs/0000-0002-6404-6839; scarpa, aldo/0000-0003-1678-739X; Cowley, Mark/0000-0002-9519-5714; Jamieson, Nigel/0000-0002-9552-4725; Niclou, Simone/0000-0002-3417-9534; Patch, Ann-Marie/0000-0001-6121-4019; Falconi, Massimo/0000-0001-9654-7243; Grimmond, Sean M/0000-0002-8102-7998; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Waddell, Nicola/0000-0002-3950-2476; Fink, Lynn/0000-0003-2912-6048; Corbo, Vincenzo/0000-0002-6340-8009; Giuseppe, Zamboni/0000-0001-7428-4673; Gill, Anthony/0000-0002-9447-1967; Leonard, Conrad/0000-0002-4131-2065; Pearson, John V/0000-0003-0904-4598; Grimmond, Sean/0000-0002-8102-7998; Merrett, Neil/0000-0002-8370-0293; Cloonan, Nicole/0000-0001-7802-6647; Chou, Angela/0000-0001-9212-6927; Chantrill, Lorraine/0000-0002-5790-0208; Pinese, Mark/0000-0001-5078-6687; Rooman, Ilse/0000-0001-7264-2246; Brancato, Mary-Anne/0000-0002-5439-4549; lawlor, Rita/0000-0003-3160-0634; Bailey, Peter/0000-0002-0857-2041; Robertson, Alan/0000-0002-3631-5894; Wu, Jianmin/0000-0002-8876-128X; Chang, David/0000-0002-4821-3078; Barbour, Andrew/0000-0002-0991-7662; Daly, Roger/0000-0002-5739-8027; Kassahn, Karin/0000-0002-1662-3355; Scarlett, Christopher/0000-0002-4140-7785; SALVIA, Roberto/0000-0002-3514-8473; Pilarsky, Christian/0000-0002-7968-3283; Nikfarjam, Mehrdad/0000-0003-4866-276X; Biankin, Andrew/0000-0002-0362-5597; Bruxner, Timothy/0000-0002-8088-316X; Chin, Venessa/0000-0002-4630-4451; Kench, James Geoffrey/0000-0001-8687-4988; Pajic, Marina/0000-0002-3871-3829; Colvin, Emily/0000-0002-5435-5902; Spry, Nigel/0000-0001-8659-5065; Christophi, Christopher/0000-0002-1349-0884; Jones, Marc/0000-0002-3078-8359; Tortora, Giampaolo/0000-0002-1378-4962; Pinho, Andreia V./0000-0003-0647-4015; Murphy, Angela/0000-0002-8910-7626	National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, 427601]; Queensland Government (NIRAP); University of Queensland; Institute for Molecular Bioscience; Cancer Research UK [C596/A18076, C29717/A17263]; Australian Government: Department of Innovation, Industry, Science and Research (DIISR); Australian Cancer Research Foundation (ACRF); Cancer Council NSW [SRP06-01, SRP11-01. ICGC]; Cancer Institute NSW [10/ECF/2-26, 06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; University of Glasgow; Howat Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation - INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); Italian Ministry of Research (Cancer Genome) [FIRB RBAP10AHJB]; Associazione Italiana Ricerca Cancro [12182]; Fondazione Italiana Malattie Pancreas - Ministero Salute [CUP_J33G13000210001]; Wilhelm Sander Stiftung [2009.039.2]; National Institutes of Health [P50 CA62924]; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA062924] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS) [AMS-SGCL9-Jamieson] Funding Source: researchfish; Cancer Research UK [17263] Funding Source: researchfish; Wellcome Trust [103721/Z/14/Z] Funding Source: researchfish	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government (NIRAP); University of Queensland(University of Queensland); Institute for Molecular Bioscience; Cancer Research UK(Cancer Research UK); Australian Government: Department of Innovation, Industry, Science and Research (DIISR)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Cancer Research Foundation (ACRF); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; University of Glasgow; Howat Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation - INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); Italian Ministry of Research (Cancer Genome); Associazione Italiana Ricerca Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Malattie Pancreas - Ministero Salute; Wilhelm Sander Stiftung; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank C. Axford, M.-A. Brancato, S. Rowe, M. Thomas, S. Simpson and G. Hammond for central coordination of the Australian Pancreatic Cancer Genome Initiative, data management and quality control; M. Martyn-Smith, L. Braatvedt, H. Tang, V. Papangelis and M. Beilin for biospecimen acquisition; and D. Gwynne for support at the Queensland Centre for Medical Genomics. We also thank M. Hodgins, M. Debeljak and D. Trusty for technical assistance at Johns Hopkins University. N. Sperandio and D. Filippini for technical assistance at Verona University. We acknowledge the following funding support: National Health and Medical Research Council of Australia (NHMRC; 631701, 535903,427601); Queensland Government (NIRAP); University of Queensland; Institute for Molecular Bioscience; Cancer Research UK (C596/A18076, C29717/A17263); Australian Government: Department of Innovation, Industry, Science and Research (DIISR); Australian Cancer Research Foundation (ACRF); Cancer Council NSW: (SRP06-01, SRP11-01. ICGC); Cancer Institute NSW: (10/ECF/2-26; 06/ECF/1-24; 09/CDF/2-40; 07/CDF/1-03; 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26,10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26); Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; University of Glasgow; Cancer Research UK; Howat Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation - INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); Italian Ministry of Research (Cancer Genome Project FIRB RBAP10AHJB); Associazione Italiana Ricerca Cancro (12182); Fondazione Italiana Malattie Pancreas - Ministero Salute (CUP_J33G13000210001); Wilhelm Sander Stiftung 2009.039.2; National Institutes of Health grant P50 CA62924.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chang DK, 2014, NAT REV CANCER, V14, P291, DOI 10.1038/nrc3723; Ciliberto D, 2013, EUR J CANCER, V49, P593, DOI 10.1016/j.ejca.2012.08.019; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Golan T, 2014, BRIT J CANCER, V111, P1132, DOI 10.1038/bjc.2014.418; GRIFFIN CA, 1995, CANCER RES, V55, P2394; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Hellebrand H, 2011, HUM MUTAT, V32, pE2176, DOI 10.1002/humu.21478; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jiang X., 2013, P NATL ACAD SCI USA, V110, P12649; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kassahn KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074380; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nikkila J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3578; Nones K, 2014, INT J CANCER, V135, P1110, DOI 10.1002/ijc.28765; Oettle H, 2014, J CLIN ONCOL, V32, P2423, DOI 10.1200/JCO.2013.53.6995; Peddi PF, 2012, J PANCREAS, V13, P497, DOI 10.6092/1590-8577/913; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Showalter SL, 2010, EXPERT OPIN DRUG DEL, V7, P273, DOI 10.1517/17425240903544462; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Villarroel MC, 2011, MOL CANCER THER, V10, P3, DOI 10.1158/1535-7163.MCT-10-0893; Vogelzang NJ, 2012, J CLIN ONCOL, V30, P88, DOI 10.1200/JCO.2011.40.1919; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587	41	1585	1638	6	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					495	501		10.1038/nature14169	http://dx.doi.org/10.1038/nature14169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719666	Green Accepted			2022-12-28	WOS:000350097300038
J	Wang, XL; Cai, XD; Su, ZE; Chen, MC; Wu, D; Li, L; Liu, NL; Lu, CY; Pan, JW				Wang, Xi-Lin; Cai, Xin-Dong; Su, Zu-En; Chen, Ming-Cheng; Wu, Dian; Li, Li; Liu, Nai-Le; Lu, Chao-Yang; Pan, Jian-Wei			Quantum teleportation of multiple degrees of freedom of a single photon	NATURE			English	Article							ENTANGLEMENT; STATE; COMPUTATION; QUBITS	Quantum teleportation' provides a 'disembodied' way to transfer quantum states from one object to another at a distant location, assisted by previously shared entangled states and a classical communication channel. As well as being of fundamental interest, teleportation has been recognized as an important element in long-distance quantum communication', distributed quantum networks' and measurementbased quantum computation. There have been numerous demonstrations of teleportation in different physical systems such as photons's, atoms', ionsio,H, electrons' and superconducting circuits'3. All the previous experiments were limited to the teleportation of one degree of freedom only. However, a single quantum particle can naturally possess various degrees of freedom internal and external and with coherent coupling among them. A fundamental open challenge is to teleport multiple degrees of freedom simultaneously, which is necessary to describe a quantum particle fully and, therefore, to teleport it intact. Here we demonstrate quantum teleportation of the composite quantum states of a single photon encoded in both spin and orbital angular momentum. We use photon pairs entangled in both degrees of freedom (that is, hyper-entangled) as the quantum channel for teleportation, and develop a method to project and discriminate hyper-entangled Bell states by exploiting probabilistic quantum non-demolition measurement, which can be extended to more degrees of freedom. We verify the teleportation for both spin-orbit product states and hybrid entangled states, and achieve a teleportation fidelity ranging from 0.57 to 0.68, above the classical limit. Our work is a step towards the teleportation of more complex quantum systems, and demonstrates an increase in our technical control of scalable quantum technologies.	[Wang, Xi-Lin; Cai, Xin-Dong; Su, Zu-En; Chen, Ming-Cheng; Wu, Dian; Li, Li; Liu, Nai-Le; Lu, Chao-Yang; Pan, Jian-Wei] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Wang, Xi-Lin; Cai, Xin-Dong; Su, Zu-En; Chen, Ming-Cheng; Wu, Dian; Li, Li; Liu, Nai-Le; Lu, Chao-Yang; Pan, Jian-Wei] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Wang, Xi-Lin; Cai, Xin-Dong; Su, Zu-En; Chen, Ming-Cheng; Wu, Dian; Li, Li; Liu, Nai-Le; Lu, Chao-Yang; Pan, Jian-Wei] Univ Sci & Technol China, CAS Ctr Excellence, Hefei 230026, Anhui, Peoples R China; [Wang, Xi-Lin; Cai, Xin-Dong; Su, Zu-En; Chen, Ming-Cheng; Wu, Dian; Li, Li; Liu, Nai-Le; Lu, Chao-Yang; Pan, Jian-Wei] Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Lu, CY (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	cylu@ustc.edu.cn; pan@ustc.edu.cn	Wu, Dian/AGX-9828-2022; Wang, Xi-Lin/E-2562-2011; Chen, Ming-Cheng/AAN-9647-2020; Pan, Jian-Wei/A-2332-2010; Lu, Chao-Yang/D-8481-2011	Wu, Dian/0000-0002-2220-2071; Wang, Xi-Lin/0000-0002-3990-6454; Pan, Jian-Wei/0000-0002-6100-5142; Lu, Chao-Yang/0000-0002-8227-9177	National Natural Science Foundation of China; Chinese Academy of Sciences; National Fundamental Research Program [2011CB921300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Fundamental Research Program	This work was supported by the National Natural Science Foundation of China, the Chinese Academy of Sciences and the National Fundamental Research Program (grant no. 2011CB921300).	Barreiro JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260501; Barreiro JT, 2008, NAT PHYS, V4, P282, DOI 10.1038/nphys919; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; D'Ambrosio V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1951; Fickler R, 2012, SCIENCE, V338, P640, DOI 10.1126/science.1227193; Guhne O, 2009, PHYS REP, V474, P1, DOI 10.1016/j.physrep.2009.02.004; Hayashi A, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.032325; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Jacobs BC, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052307; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Krauter H, 2013, NAT PHYS, V9, P400, DOI 10.1038/nphys2631; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; Leach J, 2010, SCIENCE, V329, P662, DOI 10.1126/science.1190523; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Nagali E, 2009, NAT PHOTONICS, V3, P720, DOI 10.1038/nphoton.2009.214; Nagali E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.013601; Pan JW, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.777; Takeda S, 2013, NATURE, V500, P315, DOI 10.1038/nature12366; Wei TC, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.060305; WEINFURTER H, 1994, EUROPHYS LETT, V25, P559, DOI 10.1209/0295-5075/25/8/001; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	30	443	466	15	374	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					516	519		10.1038/nature14246	http://dx.doi.org/10.1038/nature14246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719668				2022-12-28	WOS:000350097300042
J	Yozwiak, NL; Schaffner, SF; Sabeti, PC				Yozwiak, Nathan L.; Schaffner, Stephen F.; Sabeti, Pardis C.			Make outbreak research open access	NATURE			English	Editorial Material									[Yozwiak, Nathan L.; Schaffner, Stephen F.; Sabeti, Pardis C.] Broad Inst, Cambridge, MA 02142 USA; [Yozwiak, Nathan L.; Schaffner, Stephen F.; Sabeti, Pardis C.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Yozwiak, NL (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	nyozwiak@broadinstitute.org	Schaffner, Stephen F/D-1189-2011; Sabeti, Pardis/GQH-8610-2022	Schaffner, Stephen/0000-0001-6699-3568				Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; H3 Africa, 2013, H3 AFR GUID INF CONS; Jackson M., 2011, LIFE LIMITS WELL BEI; Marshall E, 2001, SCIENCE, V291, P1192, DOI 10.1126/science.291.5507.1192; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; US National Institutes of Health, 2014, NIH GEN DAT SHAR POL; Vogel G, 2014, SCIENCE, V346, P684, DOI 10.1126/science.346.6210.684	9	82	87	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					477	479		10.1038/518477a	http://dx.doi.org/10.1038/518477a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC1JP	25719649	hybrid			2022-12-28	WOS:000350097300012
J	Hultman, J; Waldrop, MP; Mackelprang, R; David, MM; McFarland, J; Blazewicz, SJ; Harden, J; Turetsky, MR; McGuire, AD; Shah, MB; VerBerkmoes, NC; Lee, LH; Mavrommatis, K; Jansson, JK				Hultman, Jenni; Waldrop, Mark P.; Mackelprang, Rachel; David, Maude M.; McFarland, Jack; Blazewicz, Steven J.; Harden, Jennifer; Turetsky, Merritt R.; McGuire, A. David; Shah, Manesh B.; VerBerkmoes, Nathan C.; Lee, Lang Ho; Mavrommatis, Kostas; Jansson, Janet K.			Multi-omics of permafrost, active layer and thermokarst bog soil microbiomes	NATURE			English	Article							THAW; BACTERIAL; CLIMATE; CARBON	Over 20% of Earth's terrestrial surface is underlain by permafrost with vast stores of carbon that, once thawed, may represent the largest future transfer of carbon from the biosphere to the atmosphere(1). This process is largely dependent on microbial responses, but we know little about microbial activity in intact, let alone in thawing, permafrost. Molecular approaches have recently revealed the identities and functional gene composition of microorganismsin some permafrost soils(2-4) and a rapid shift in functional gene composition during short-term thaw experiments(3). However, the fate of permafrost carbon depends on climatic, hydrological and microbial responses to thaw at decadal scales(5,6). Here we use the combination of several molecular 'omics' approaches to determine the phylogenetic composition of the microbial communities, including several draft genomes of novel species, their functional potential and activity in soils representing different states of thaw: intact permafrost, seasonally thawed active layer and thermokarst bog. The multi-omics strategy reveals a good correlation of process rates to omics data for dominant processes, such as methanogenesis in the bog, as well as novel survival strategies for potentially active microbes in permafrost.	[Hultman, Jenni; David, Maude M.; Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Waldrop, Mark P.; McFarland, Jack; Blazewicz, Steven J.; Harden, Jennifer] US Geol Survey, Menlo Pk, CA 94025 USA; [Mackelprang, Rachel] Calif State Univ Northridge, Biol Dept, Northridge, CA 91330 USA; [Mackelprang, Rachel; Mavrommatis, Kostas; Jansson, Janet K.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Turetsky, Merritt R.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [McGuire, A. David] Univ Alaska Fairbanks, Alaska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Fairbanks, AK 99775 USA; [Shah, Manesh B.; VerBerkmoes, Nathan C.] Oak Ridge Natl Lab, Chem Sci Div, Oak Ridge, TN 37831 USA; [Lee, Lang Ho] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Lee, Lang Ho] Oak Ridge Natl Lab, Knoxville, TN 37996 USA; [Jansson, Janet K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Jansson, Janet K.] Univ Copenhagen, Dept Biol, Ctr Permafrost Res CENPERM, DK-2100 Copenhagen, Denmark	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey; California State University System; California State University Northridge; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Guelph; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Berkeley; University of Copenhagen	Jansson, JK (corresponding author), Pacific NW Natl Lab, Div Biol Sci, 902 Battelle Blvd, Richland, WA 99352 USA.	janet.jansson@pnnl.gov	Hultman, Jenni/K-1990-2015; Jansson, Janet/H-5478-2018	Hultman, Jenni/0000-0002-3431-1785; Jansson, Janet/0000-0002-5487-4315; David, Maude/0000-0003-1561-418X; Blazewicz, Steven/0000-0001-7517-1750; Mavrommatis, Konstantinos/0000-0003-4549-385X; Waldrop, Mark/0000-0003-1829-7140; Harden, Jennifer W/0000-0002-6570-8259	Office of Science, Office of Biological and Environmental Research, Climate and Environmental [JGI CSP - 152]; Lawrence Berkeley National Laboratory Laboratory Directed Research & Development (LDRD) grant [DE-AC02-05CH11231]; Pacific Northwest National Laboratory [DE-AC05-76RL01830]; Danish National Research Foundation [CENPERM DNRF100]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Bonanza Creek Long-Term Ecological Research Program - National Science Foundation [DEB 1026415]; US Department of Agriculture Forest Service, Pacific Northwest Research Station [PNW01-JV112619320-16]; US Geological Survey Climate RD Program; Alaska Climate Science Center; Academy of Finland [135669]; Division Of Environmental Biology [1026415] Funding Source: National Science Foundation	Office of Science, Office of Biological and Environmental Research, Climate and Environmental; Lawrence Berkeley National Laboratory Laboratory Directed Research & Development (LDRD) grant; Pacific Northwest National Laboratory(United States Department of Energy (DOE)); Danish National Research Foundation(Danmarks Grundforskningsfond); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Bonanza Creek Long-Term Ecological Research Program - National Science Foundation; US Department of Agriculture Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); US Geological Survey Climate RD Program; Alaska Climate Science Center; Academy of Finland(Academy of Finland); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Hettich and the Organic and Biological Mass Spectrometry group at Oak Ridge National Laboratory for access to mass spectrometry instrumentation. M. Haw, K. Li, K. Chavarria and R. Lamendella are acknowledged for help with pre-processing frozen samples. We thank K. Billis for help with RNA sequence preprocessing. This work was partly supported by the Director, Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division, of the US Department of Energy, Terrestrial Ecosystem Science-Scientific Focus Area (TES-SFA), through a Community Sequencing Project at the DOE Joint Genome Institute (JGI CSP - 152) and by a Lawrence Berkeley National Laboratory Laboratory Directed Research & Development (LDRD) grant, all under contract number DE-AC02-05CH11231; by the Pacific Northwest National Laboratory under contract number DE-AC05-76RL01830; and by the Danish National Research Foundation (CENPERM DNRF100). The work conducted by the US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, is supported by the Office of Science of the US Department of Energy under contract number DE-AC02-05CH11231. Additional funding and considerable logistic support were provided by the Bonanza Creek Long-Term Ecological Research Program, which is jointly funded by National Science Foundation (DEB 1026415) and the US Department of Agriculture Forest Service, Pacific Northwest Research Station (PNW01-JV112619320-16). Support was also received from the US Geological Survey Climate R&D Program and Alaska Climate Science Center. J.Hu. was supported by Academy of Finland grant number 135669.	Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; BALDERSTON WL, 1976, APPL ENVIRON MICROB, V31, P504, DOI 10.1128/AEM.31.4.504-508.1976; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chourey K, 2010, J PROTEOME RES, V9, P6615, DOI 10.1021/pr100787q; Florens Laurence, 2006, V328, P159; Giannone RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022942; Jansson J. K., 2012, MICROBE, V6, P309; Jorgenson MT, 2001, CLIMATIC CHANGE, V48, P551, DOI 10.1023/A:1005667424292; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Kunin V, 2010, OPEN J, V1, P1; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; MACY JM, 1972, AM J CLIN NUTR, V25, P1318; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McCalley CK, 2014, NATURE, V514, P478, DOI 10.1038/nature13798; Meyer D., 2012, VCD VISUALIZING CATE; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mondav R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4212; Nicora CD, 2013, PROTEOMICS, V13, P2776, DOI 10.1002/pmic.201300003; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Parks DH, 2014, PEERJ PREPRINTS, V2, DOI DOI 10.7287/PEERJ.PREPRINTS.554V1; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Schuur EAG, 2011, NATURE, V480, P32, DOI 10.1038/480032a; Waldrop MP, 2010, GLOBAL CHANGE BIOL, V16, P2543, DOI 10.1111/j.1365-2486.2009.02141.x; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; ZEHNDER AJB, 1980, APPL ENVIRON MICROB, V39, P194, DOI 10.1128/AEM.39.1.194-204.1980	30	283	294	32	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					208	+		10.1038/nature14238	http://dx.doi.org/10.1038/nature14238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25739499				2022-12-28	WOS:000354377800056
J	Bonaca, MP; Bhatt, DL; Cohen, M; Steg, PG; Storey, RF; Jensen, EC; Magnani, G; Bansilal, S; Fish, MP; Im, K; Bengtsson, O; Ophuis, TO; Budaj, A; Theroux, P; Ruda, M; Hamm, C; Goto, S; Spinar, J; Nicolau, JC; Kiss, RG; Murphy, SA; Wiviott, SD; Held, P; Braunwald, E; Sabatine, MS; Morin, S; Dantzer, E; Acquilano, D; McGuire, RL; Gannon, JB; Gershman, E; Ahlbom, AM; Boberg, B; Abola, MT; Ardissino, D; Aylward, P; Corbalan, R; Dalby, A; Diaz, R; Hu, DY; Isaza, D; Kamensky, G; Kiss, R; Kontny, F; Lopez-Sendon, J; Medina, F; Montalescot, G; Nicolau, J; Paolasso, E; Parkhomenko, A; Van De Werf, F; Anderson, JL; White, HD; Verheugt, FWA; Pedersen, TR; DeMets, DL; Lowe, C; Arevalo, C; Awtry, E; Berger, C; Croce, K; Desai, A; Gelfand, E; Ho, C; Leeman, D; Link, M; Norden, A; Pande, A; Rost, N; Ruberg, F; Silverman, S; Singhal, A; Vita, J; Alvarisqueta, A; De Gennaro, N; Berli, M; Roude, AE; Di Gennaro, JA; Albisu, JF; Caccavo, A; Torres, M; Cuadrado, J; Bordoni, P; Cuello, J; Aviles, A; Glenny, A; Recoaro, R; Fernandez, R; Strada, BN; Fuentealba, V; Gallo, C; Duran, RG; Garcia, C; Hominal, M; Castoldi, M; Jure, H; Pacora, FF; Lorenzatti, A; Martinez, JM; Macin, S; Cocco, N; MacKinnon, I; Bagnato, MB; Marino, J; Cusimano, S; Arias, V; Focaccia, M; Muntaner, J; Mansilla, V; Poy, C; Prado, A; Paterlini, G; Montana, O; Camino, A; Sala, J; Luciani, C; Vico, M; Morell, Y; Dumont, C; Vottero, E; Zangroniz, P; Lescano, A; Morara, P; Marquez, LL; Patron, FR; Labarta, GB; Sivila, CD; Quiroga, AR; Maffei, L; Sassone, S; Rolandi, F; Vesentini, N; Carnero, G; Del Verme, S; Hershson, A; Figal, JC; Viso, ME; Hii, C; Smith, K; Singh, B; Acampo, M; Rogers, J; ODonoghue, M; Amerena, J; Long, A; Dart, A; Kay, S; Worthley, M; Nimmo, J; Lehman, R; Morrison, H; Dick, R; Savage, C; van Gaal, W; Park, M; Blombery, P; McCarthy, C; Oqueli, E; Hill, D; Sader, M; Vrachas, D; Purnell, P; Vibert, J; Collins, N; Gordon, A; Arstall, M; Rose, J; Aroney, C; Cleave, P; Fitzpatrick, M; Mackenzie, M; Garrahy, P; Hall, C; Nelson, G; Reid, E; Lee, A; Gibbs, J; Thompson, P; Crittenden, J; Hammett, C; Hindom, L; Antonis, P; Manzoney, A; Cross, D; Pollard, C; Brieger, D; Wu, J; Whelan, A; Tulloch, G; Taylor, A; Smith, B; Horowitz, J; Black, M; Boland, J; Malmendier, D; Celen, H; Wendelen, E; Claeys, M; Pieter, M; Cools, F; Simons, N; De Maeseneire, S; De Wolf, L; Brike, C; Dubois, P; Bolado, ACY; Foading-Deffo, B; Tahon, S; Friart, A; Arend, C; Gevaert, S; Verdegem, P; Marechal, P; Gits, F; Pierard, L; Celentano, C; Pirenne, B; Bouvy, C; Renkin, J; Huyberechts, D; Sinnaeve, P; De Velder, L; Stammen, F; Casier, T; Striekwold, H; Van den Broeck, D; Thoeng, J; Goris, R; Timmermans, P; Collard, SJ; Van De Borne, P; De Clippel, M; Wollaert, B; Jacobs, C; Vankelecom, B; Daelemans, Y; Vervoort, G; Drieghe, S; Vranckx, P; Janssen, A; Vrolix, M; Simenon, I; Wijns, W; Delacroix, H; Denie, D; Schoors, D; Lemoine, I; Cornelis, K; Willems, AM; Schroder, E; Domange, J; Greque, G; Machado, H; Armaganijan, D; Del Monaco, MI; da Silva, D; Nakazone, R; Dutra, O; Vaz, R; Daher, R; Rodrigues, D; Guimaraes, A; Teixeira, A; Saraiva, J; Costa, M; Leaes, P; Blacher, M; Maia, L; Nakazone, MA; Manenti, E; Ruschel, K; Marin-Neto, J; Pavao, R; Preto, R; Junior, AA; Oliveira, G; Rassi, S; Sampaio, D; Rossi, PR; dos Santos, L; de Souza, J; Lino, E; Filho, PP; Zucchetti, C; Gomes, M; de Paiva, A; Sousa, AC; Almeida, A; Botelho, R; da Silva, R; Giraldez, R; Franken, M; Faludi, A; Bertolami, M; Hernandes, M; Lucas, N; Carvalho, A; Bertolami, A; Precoma, D; Geralde, L; Pereira, A; Cesar, L; Mioto, B; Marino, R; Rabelo, W; dos Santos, F; Vidotti, M; Mangione, J; Mauro, M; Kormann, A; Ultramari, F; Zimmermann, S; Michalaros, Y; Fonseca, M; Sampaio, C; Eliaschewitz, F; Barbosa, E; Drews, C; de Lorenzo, A; Barros, C; Cancado, G; Neuesnchwander, F; Zimmermann, E; Chompalova, B; Denchev, S; Gocheva, N; Mihov, A; Mincheva, V; Pencheva, G; Gelev, V; Tisheva, S; Todorov, G; Goudev, A; Parvanova, Z; Peneva, Y; Todorova, M; Mitkova, M; Smilov, L; Yakovova, S; Milanova, K; Aleksov, N; Mollov, M; Gergova, V; Shishmanova, D; Stoykov, A; Hristova, K; Uzunangelov, Y; Postadzhian, A; Peltegov, V; Karamitev, G; Benov, H; Vasileva, D; Parishev, G; Milcheva, N; Avramov, D; Miteva, B; Stoyanovski, V; Pencheva, G; Nikolova, L; Stancheva, N; Nyagina, M; Markov, D; Spirova, D; Peneva, Y; Peshkov, O; Mitkova, L; Mandzhukova, S; Rangelova, V; Ivanov, K; Krusheva, B; Raycheva, V; Gergova, V; Goranov, K; Stoykov, A; Staleva, M; Rashkova, V; Postadzhian, A; Krancheva, V; Lulova, E; Delchev, G; Cantor, W; Constance, C; Gosselin, G; Gosselin, G; Marr, D; Pandey, A; Pesant, Y; Pouliot, J; Gladstone, P; McPherson, T; Rupka, D; Saw, J; St-Amour, E; Syan, G; Syan, R; Rosenbloom, A; Vizel, S; Della Siega, A; Halperin, F; Nigro, F; Chehayeb, R; Fell, D; Labonte, R; Nawaz, S; Gupta, M; Ma, P; Glanz, A; Kouz, S; Bhargava, R; Dion, D; Dupuis, R; Grondin, F; Wong, B; Sabbah, E; Hui, W; Belisle, P; Tymchak, W; Montigny, M; Lonn, E; Bose, S; Kincade, D; Gallo, R; Lamy, A; Bell, A; Lemay, M; Bata, I; Kostuk, W; Cheung, S; Petrella, R; Lubelsky, B; Berlingieri, J; Fortin, C; DeYoung, J; Babapulle, M; Landry, D; Gupta, A; Bertrand, O; Jadin, M; Robbins, K; Gauthier, MF; Masson, C; Reyes, V; O'Blenis, G; Clarus, S; Sardin, V; Marquette, S; Bozek, B; Spurrell, D; Thiessen, S; Fox, R; Tremblay, I; Singh, J; Samms, S; Ross, B; Solomon, P; Nelson, S; Roberts, P; Forsyth, C; Lepage, C; McPherson, C; Dewar, C; Dela Cruz, C; Louch, D; Vilag, C; Roy, M; Stata, C; Morissette, A; Ouimet, F; Bilodeau, N; Chausse, I; Kvill, L; Chartrand, MJ; Harris, L; Bolduc, H; Magi, A; Jule, P; Valley, S; Morrissette, J; Power, P; Kailey, P; Thomas, A; Wright, D; Carr, S; Cleveland, T; Dihel, C; Coldwell, J; Schellenberg, S; Viau, C; Watt, M; Corke, R; Shea-Landry, G; Gandhi, A; Tishler, S; Prieto, JC; Noriega, V; Cobos, L; Obreque, C; Potthof, S; Zapata, J; Lucero, F; Luque, M; Pincetti, C; Torres, G; Yanez, M; Vasquez, C; Manriquez, L; Espinoza, MJ; Yovaniniz, P; Grandon, M; Castro, P; Llevaneras, S; Lanas, F; Hidalgo, J; Arriagada, G; Villan, C; Florenzano, F; Chacon, MV; Rodriguez, M; Barreda, B; Raffo, C; Reyes, T; Hu, D; Liu, W; Tan, N; Feng, Y; Dong, Y; Yang, D; Liao, Y; Wei, F; Wei, M; Yan, M; Yan, X; Wang, S; Chen, Y; Li, Y; Yuan, Z; Xiong, Y; Zhu, J; Li, S; Ma, G; Chen, L; Li, Z; Liu, Y; Yang, X; Xiong, W; Pang, W; Chen, Y; Lu, G; Chen, Z; Zhao, S; Zhou, H; Huang, J; Gang, Y; Chai, Y; Yang, X; Zhang, Z; Mu, Z; Hernandez, E; Mora, C; Maria, E; Catalan, Y; Reynales, H; Huertas, D; Molina, D; Rendon, N; Sanchez, G; Tellez, R; Botero, R; Salazar, P; Vesga, B; Delgado, P; Herrera, M; Perez, D; Jaramillo, N; Toloza, R; Orozco, A; Bustamante, Y; Jaramillo, C; Garces, G; Saaibi, J; Castillo, J; Arana, C; Gonzalez, M; Urina, M; Ramirez, N; Manzur, F; Rosales, D; Quintero, A; Gonzalez, E; Accini, J; Reyes, M; Elbl, L; Malecha, J; Stanek, L; Jerabek, O; Lubanda, H; Kos, P; Zidkova, E; Vlckova, D; Naplava, R; Ludka, O; Ludkova, A; Soucek, M; Kuchar, J; Poloczek, M; Wasserburger, B; Panovsky, R; Linhart, A; Rihacek, I; Macha, J; Spinar, J; Grunfeldova, H; Spinarova, L; Zanova, M; Bren, J; Zarembova, J; Cermak, O; Sembera, Z; Svobodova, I; Monhart, Z; Pleva, L; Sipula, J; Polasek, R; Kolmas, P; Dedek, V; Janota, T; Stipal, R; Turkova, N; Kucera, D; Bednarova, J; Broulova, P; Lukac, M; Hanak, P; Reichert, P; Bouchal, P; Turkova, N; Krocova, E; Petrova, I; Matyasek, I; Brychta, T; Machova, V; Marusincova, I; Sperlingova, B; Steg, PG; Montalescot, G; Macquin-Mavier, T; Khalife, K; Galley, D; Elhadad, S; Decoulx, E; Cottin, Y; Coisne, D; Bonnet, JL; Ferrari, E; Range, G; Cayla, G; Goralski, M; Furber, A; Elbaz, M; Aboyans, V; Poulard, JE; Zemour, G; Labeque, JN; Hirsch, JL; Vaquette, B; Livarek, B; Igigabel, P; Lafitte, S; Oudghiri, M; Bertin, B; Beitar, T; Merkling, D; Beltra, C; Maubert, A; El Jarroudi, M; Bichat, F; Berger, N; Fiacchetti, C; Douillet, M; Laure, C; Leperchois-Jacquey, C; Miran, S; Cornet, C; Rosolin, N; Pradel, V; Leparree, S; Doux, N; Mais, C; Sevilla, J; Laurencon, V; Georges, J; Gilard, V; Duprat, C; Hamm, C; Giannitsis, E; Schenkenberger, I; Appel, KF; Toursarkissian, N; Bott, J; Nischik, R; Schmidt, E; Jung, T; Steiner, S; Fischer, S; Khariouzov, A; Heuer, H; Kadel, C; Hanefeld, M; Weil, J; Koenig, W; Horacek, T; Muenzel, T; Brachmann, J; Weber, D; Wittlich, N; Stellbrink, C; Dungen, HD; Leschke, M; Zeymer, U; Dorsel, T; Voehringer, HF; Dissmann, M; Vom Dahl, J; Derwahl, KM; Trenk, D; Frey, N; Schroeder, T; Foerster, A; Bartels, R; Kisselbach, C; Deigentasch, H; Dreykluft, K; Becker, P; Scheuren, A; Erdas, M; Wipper, J; Schmidt, A; Henzler, A; Winter, K; Fischer, S; Kopf, S; Laschewski, B; Rahn, G; Schrapel, C; Miodek, M; Hildenbrand, S; Fink, P; Gebel, G; Goebel, U; Siepmann, C; Drexler, A; Iselt, M; Maiwald, A; Blaich, B; Baumann, S; Iselt, M; Gebhardt, S; Kazcmarek, N; Krug-Hoeren, B; Traubler, B; Nicula, D; Reichenbach, D; Langer, C; Kiroglu, K; Riedel, S; Schulte, M; Borst, M; Katona, A; Vertes, A; Kiss, R; Turi, T; Merkely, B; Ungi, I; Kiraly, C; Zolyomi, S; Horvath, I; Lupkovics, G; Edes, I; Simon, E; Czuriga, I; Laszlo, Z; Kancz, S; Takacs, J; Papp, A; Czigany, A; Muller, G; Tas, AS; Polgar, P; Jilling, MJ; Bartal, G; Kerkovits, A; Bodi, M; Benczur, B; Valco, J; Erdei, F; Sebo, J; Korda, A; Turi, T; Becker, D; Kalapos, A; Bosko, M; Pap, G; Magyari, B; Basa, A; Jenei, C; Bakai, J; Unterberger, K; Vas, K; Fulop, G; Nagy, M; Takacs, A; Mate, Z; Szilagyi, A; Nagy, K; Svab, M; Kis, E; Horthy, R; Kantor, F; Sperr, E; Bajcsi, E; Bujdoso, A; Ardissino, D; Martina, P; Fiscella, A; Marenzi, G; Tamburino, C; Terrosu, P; Presbitero, P; Cuccia, C; Bovenzi, F; Berti, S; Colivicchi, F; Paloscia, L; Scherillo, M; Tartaglione, S; Della Rovere, F; De Cesare, N; Manari, A; Astarita, C; Oltrona, L; Marzilli, M; Caldarola, P; Merlini, P; Celentano, A; Di Sciascio, G; Pajes, G; Silvestri, O; Delfino, R; Bassani, F; Puccetti, L; Cavallini, C; Patrizi, G; Fattore, L; Di Lorenzo, L; Notarangelo, F; Stefanin, C; Giacoppo, M; Rubino, M; Dammino, L; Chessa, P; Di Pizzo, A; Musmeci, G; Mazzoni, A; Tyack, K; Aiello, A; Mascellanti, M; Formigli, D; Guglielmino, G; Bernabo, P; Bocciarelli, M; De Iaco, G; Russo, G; Rizzotti, D; Orsini, E; Saponetti, LS; Babbolin, M; De Divitiis, M; Patti, G; Monti, F; Silvestri, N; Valbusa, A; Lazzarotti, M; Puccetti, L; Grikstaite, E; Patrizi, G; Bosco, B; Marchegiano, R; Takenaka, T; Ono, M; Suzuki, M; Hasegawa, K; Domae, H; Fukui, K; Iseki, H; Aoyama, T; Suzuki, C; Sakai, R; Hashimoto, T; Inoko, M; Sasaki, T; Kataoka, T; Okutsu, M; Yasaka, Y; Miyamoto, T; Tomobuchi, Y; Tamura, R; Hosokawa, S; Komura, Y; Takahashi, N; Mima, T; Sadamatsu, K; Fujimoto, K; Matsumura, T; Koide, S; Himi, T; Hashimoto, Y; Yamasaki, M; Okubo, M; Takase, H; Morii, I; Utsu, N; Higashino, Y; Shigematsu, S; Nakagawa, T; Goto, S; Ota, T; Takahashi, W; Kakishita, M; Hayashi, Y; Momiyama, Y; Baden, M; Saeki, T; Hiroi, S; Wada, A; Nakata, A; Nishi, Y; Hirasawa, S; Shibata, Y; Fukuzawa, S; Machida, M; Takama, N; Teranishi, J; Sakuma, K; Abe, Y; Suzuki, A; Yamazaki, A; Nakachi, T; Nagayama, H; Fujino, S; Tsurukai, A; Nojima, S; Ishiguchi, Y; Hada, K; Nakatani, K; Yamamoto, K; Matsuo, A; Yamaguchi, E; Ito, S; Matsuda, M; Onishi, M; Kawanishi, Y; Ohashi, Y; Ochi, K; Miyamoto, S; Ichishita, Y; Iwamoto, H; Sagara, Y; Komori, M; Matsumura, A; Nakashima, R; Kondo, M; Suzuki, K; Kodama, S; Kotajima, H; Fujimoto, N; Honda, K; Iwamoto, M; Okada, S; Ichinose, K; Takinami, N; Takagi, E; Nakano, A; Tomari, H; Yokoyama, T; Matsui, Y; Nishimura, N; Asano, T; Mochiduki, A; Yamashita, S; Okino, S; Hirabayashi, K; Funada, R; Wardeh, AJ; Dille, C; De Melker, EC; van der Spoel, A; Willems, FF; Maassen, E; Westendorp, ICD; Zweers, D; Dunselman, PHJM; Blom, L; Ronner, E; Wissenburg, A; van der Sluis, A; Badings, EA; den Hartog, FR; Singerling, M; Aksoy, I; Heil, A; Tjeerdsma, G; van Daalen, C; Lenderink, T; Lardenois, R; Prins, FJ; Rutten, R; Plomp, J; Veldmeijer, S; De Vries, RJM; Krikken, J; Ophuis, TAJMO; Buvelot, S; Bos, RJ; Tan-Urgert, B; Werner, HA; Wittekoek, M; van Daele, MERM; Bouwens, M; Oomen, A; Meijlis, P; Verheul, JA; Uiterwaal, H; Knufman, N; de Lange, H; Bartels, GL; Hendriks-Van Woerden, M; van Bemmel, B; Beyering, M; Zwart, PAG; Teng, Y; van der Zwaan, C; Havenaar, J; Hermans, WRM; de Graauw, J; Hamraoui, K; Dabrowska, K; de Nooijer, C; Groenenberg, I; Kietselae, BLJH; Muis, L; Hamer, BJB; Hobe, C; van Eck, JWM; Elzebroek, N; Tans, JGM; Stapel, AGT; Nierop, PR; Dirks, M; Kuijper, AFM; Schiks, M; de Groot, MR; Post, G; ten Berg, JM; Bras, R; Koolen, JJ; van Leur, L; Herrman, JPR; Roelse, A; Ebink, C; Jones, B; Lipsic, E; Couperus, M; Bogaard, K; Dijk, A; Pettersen, KI; Kontny, F; Fortun, M; Gullestad, L; Stueflotten, W; Popovic, I; Sobye, ET; Hogalmen, G; German, M; Hysing, J; Flagstad, E; Slettom, G; Nordrehaug, JE; Isaksen, A; Graven, T; Haug, H; Sandvik, J; Thunhaug, H; Ronning, PB; Gravrok, B; Lappegard, KT; Enebakk, T; Ronnevik, P; Ronnevik, T; Hurtig, U; Skanke, E; Omland, T; Tobiassen, GM; Berrospi, P; Ragas, Y; Bustamante, G; Marruffo, Y; Chavez, E; Chaname, A; Heredia, J; Gamero, K; Lema, J; Carrion, AM; Rodriguez, V; Cabanillas, N; Rodriguez, A; Zena, N; Segura, L; Rojas, C; Toce, L; Carrera, J; Orihuela, B; Del Portal, M; Roldan, Y; Roldan, G; Medina, F; Rodriguez, J; Chavez, C; Luna, G; Parra, J; Ramos, J; Mogrovejo, W; Godoy, J; Talledo, MZ; Diestra, J; Godoy, A; Matta, M; Pino, C; Vergara, R; Chois, A; Guillen, AM; Medina, J; Chirinos, J; Paredes, A; Quiroz, M; Camacho, L; Gil, M; Abola, MT; Cerbito, S; Beltran, J; Tanglao, M; Uy, N; Busa, J; Rogelio, G; Arbis, MG; Prado, JP; Miranda, M; Sulit, DJ; Dioquino, R; Sevilla, R; Soriano, RA; Rosita, RR; Amazona, A; Atilano, A; Lim, E; Ebo, G; Maglasang, P; Palmes, P; Loreno, CA; Tirador, L; Alagban, C; Roxas, DJ; Roxas, JF; Cheng, F; De Guzman, S; Morales, D; Mararac, T; Barbas, B; Barbas, K; Ferrolino, A; Baysac, C; Llarena, AC; Julianes, C; Budaj, A; Torun, A; Dalkowski, M; Widejko, K; Derlaga, B; Laskowska, E; Dudek, D; Dziewierz, A; Jozwa, R; Busz-Papiez, B; Pawlowicz, L; Kaczmarczyk, M; Jaworska, K; Skonieczny, G; Kopaczewski, J; Wujkowski, M; Krasowski, W; Krzyzanek, P; Kubica, J; Kozinski, M; Miekus, P; Glaza, M; Podolec, P; Wilkolek, P; Piepiorka, M; Piepiorka-Broniecka, M; Pluta, W; Ploch, M; Rynkiewicz, A; Mosakowska, K; Szpajer, M; Lesinski, D; Szwed, H; Jasek, S; Sciborski, R; Piotrowicz, R; Musial, W; Lisowska, A; Rekosz, J; Kasznicka, M; Korzeniak, R; Staneta, P; Konczakowski, P; Waluszek-Konczakowska, I; Cymerman, K; Lubinski, A; Grycewicz, T; Hiczkiewicz, J; Plucinski, M; Korol, M; Szczech, J; Hawro, M; Skorski, M; Cichon, K; Jankowski, M; Cygler, J; Ottomanska-Cygler, M; Korecki, J; Gulaj, E; Zechowicz, T; Zechowicz, M; Goch, A; Topolinski, B; Ogorek, M; Szczepanska, A; Wojewoda, P; Jagoda, E; Krzyzanowski, W; Muzyk-Osikowicz, M; Jaszczurowski, W; Stasiewski, A; Wietrzynska, J; Miklaszewicz, B; Beme, A; Sudnik, W; Matys, U; Ponikowski, P; Powierza, S; Kim, YH; Choi, DJ; Seung, KB; Lim, DS; Lee, SH; Kim, HS; Bae, JH; Hong, TJ; Hong, MK; Tahk, SJ; Kim, YJ; Yoon, J; Jeong, MH; Chae, JK; Cho, MC; Hong, SK; Hur, SH; Jeong, JO; Her, SH; Lee, JM; Chang, KC; Yoon, CH; Chang, K; Park, J; Choi, S; Park, K; Bae, Y; Lee, H; Kim, BK; Yoon, MH; Park, JS; Jang, H; Kim, C; Cho, EJ; Bae, J; Lee, H; Lee, D; Lee, J; Park, M; Choi, YY; Dimulescu, D; Vintila, M; Fruntelata, A; Pirvu, O; Stanciulescu, G; Giuca, A; Militaru, C; Radoi, M; Bobescu, E; Crisu, D; Creteanu, M; Minescu, B; Bolohan, F; Manitiu, I; Bengus, C; Iosipescu, L; Ciobotaru, V; Basarab, G; Benedek, I; Constantinescu, M; Cristea, M; Capalneanu, R; Tatu-Chitoiu, G; Huidu, S; Protopopescu, L; Greavu, M; Diaconu, M; Blajan, D; Istratoaie, O; Lican, G; Bisoc, A; Doka, B; Jemna, D; Parasteac, M; Serban, L; Mihai, M; Cioca, G; Ochean, V; Costache, L; Andor, M; Stoica, D; Benedek, T; Sava, N; Anciu, M; Mot, S; Cornaciu, S; Boldueva, S; Golitsyn, S; Karpov, Y; Kobalava, Z; Konstantinov, V; Kuimov, A; Ezhov, M; Panov, A; Ruda, M; Novikova, T; Simanenkov, V; Smolenskaya, O; Tsyba, L; Vishnevsky, A; Yakhontova, P; Kislyak, O; Demchenko, E; Yakovlev, A; Ermoshkina, L; Arkhipov, M; Galyavich, A; Strongin, L; Kosmacheva, E; Goloshchekin, B; Sidorenko, B; Izmozherova, N; Shustov, S; Orlikova, O; Paltsman, Z; Lukyanov, Y; Koziolova, N; Nedogoda, S; Statsenko, M; Kotelnikov, M; Osipenko, M; Oshchepkova, E; Bolieva, L; Ryamzina, I; Pavlysh, E; Samokhvalova, M; Mironova, N; Buza, V; Shavarov, A; Serebrenitskaya, M; Khomyakova, L; Safarova, M; Lohovinina, N; Staroverov, I; Bitakova, F; Zakharova, N; Khurs, E; Belenky, D; Kositsyn, D; Rovnykh, Y; Kasatova, T; Lubinskaya, E; Omelchenko, M; Slukhaenko, I; Kozulin, A; Baleeva, L; Pochinka, I; Kizhvatova, N; Laptev, I; Bugrimova, M; Popov, A; Kovalevskaya, E; Orlikov, E; Paltsman, Z; Lamden, D; Surovtseva, M; Tsoma, V; Derevjanchenko, M; Streltsov, S; Bikbulatova, E; Dmitriev, V; Byazrova, S; Khovaeva, Y; Komandenko, O; Kamensky, G; Dlesk, A; Urban, M; Vinanska, D; Dzupina, A; Hranai, M; Cisar, P; Toth, P; Paulov, S; Sivak, V; Bolvanska, N; Pella, D; Palka, J; Nedelova, I; Benacka, J; Gergel, V; Hatalova, K; Kohut, P; Kovar, F; Knazeje, M; Macek, V; Sinska, R; Bugan, V; Badenhorst, JCW; Erasmus, L; Burgess, LJ; de Necker, I; Corbett, CH; Fouche, L; Dawood, SY; Conradie, C; Delport, EF; Kruger, M; Ebrahim, I; Bobak, C; Nethononda, MR; Nunkoo, T; van Rensburg, FPJ; Middle, R; Horak, AR; Henley, L; Mabin, TA; King, A; Ranjith, N; Ramdas, S; Roodt, A; Coetsee, E; Theron, H; Karsten, M; Van Zyl, LJ; Roscher, M; Venter, TP; de Kock, L; Becker, AC; Swanepoel, J; Ismail, SM; Christie, H; Dalby, AJ; Allman, J; Roux, JP; Christie, H; Naidoo, DP; Vawda, GHM; Manga, P; Olckers, W; Mpe, MT; Farrell, BM; Lopez-Sendon, J; Areses, ELD; Lopez, SV; Fernandez, JMC; Roldan, JG; Pavia, PG; Segovia, AG; Puig, JG; Garcia, VC; Aguilera, RM; Munoa, MD; Cortada, JB; Cereto, PC; Perez, IP; Cid, LP; Basilio, EG; Guerra, PC; Ortiz, AF; Balcones, LDV; Vera, TR; Martinez, JMG; Galvan, ED; Caballero, AH; Blanco, VMR; Lopez, JMR; Franco, MRP; Soriano, FR; Porcar, LC; Fillat, ARC; Moreno, SG; Montejano, MG; Guerrero, JMD; Coronado, JLB; Eizagaechevarria, NM; Araucua, GN; Rubio, AM; Roca, MC; Marimon, XGM; Perales, MV; Gonzalez, AB; Sastre, MP; Juanatey, JRG; Acuna, JMG; Al-Khalili, F; Lof, P; Bandh, S; Myllyla, L; Christensen, K; Johansson, K; Dellborg, M; Hultsberg-Olsson, G; Alstrom, P; Damm, TL; Erlinge, D; Brolin, G; Ravn-Fischer, PA; Johansson, P; Andreen, S; Linderfalk, C; Ram, B; Lindholm, CJ; Assarsson, E; Mooe, T; Lindberg, A; Paren, P; Moodh, J; Svensson, P; Andersson, I; Wodlin, P; Raschperger, A; Skogvard, P; Koch, A; Lind, N; Osberg, L; Nilsson, C; Svensson, K; Bengtsson, M; Samad, B; Nilsson, M; Berglund, E; Lundgren, C; Lindmark, K; Sundholm, C; Aladellie, L; Welin-Berger, B; Guneri, S; Dogan, NB; Ersanli, M; Coskun, U; Cayli, M; Seker, T; Camsari, A; Ozcan, T; Ongen, Z; Karadag, B; Boyaci, B; Sezenoz, B; Pekdemir, H; Hidayet, S; Erol, M; Yalcin, A; Sezer, M; Emet, S; Bozkurt, E; Ozen, MB; Parkhomenko, A; Lutay, Y; Dyadyk, O; Kholopov, L; Rudyk, I; Shaposhnikova, Y; Chopey, I; Ternuschak, T; Reshotko, D; Popova, G; Batushkin, V; Gema, A; Vizir, V; Berezyn, O; Lutai, M; Tovstukha, V; Shumakov, V; Pogurelska, O; Sirenko, Y; Rekovets, O; Kraiz, I; Kamenska, E; Tseluyko, V; Yakovleva, L; Yena, L; Artemenko, V; Koval, O; Kaplan, P; Karpenko, O; Nevolina, I; Bazilevych, A; Harbar, M; Rudenko, L; Beregova, O; Mostovyi, Y; Rasputina, L; Vatutin, M; Shevelok, A; Kovalenko, V; Polenova, N; Amosova, K; Tkachenko, L; Volkov, V; Zaprovalna, O; Storey, R; Thomas, M; Pell, A; Anderson, J; Moriarty, A; Kinnin, M; Ahsan, A; Burton, J; ORourke, B; Young, J; Lang, C; Forbes, J; Rowlands, D; Hamill, S; Sprigings, D; Cadd, A; de Belder, M; Atkinson, B; Ramsey, M; Fagan, JC; Pye, M; Wright, L; Keeling, P; Hughes, D; Fraser, D; Phillips, H; Muthusamy, R; Lawan, M; Levy, T; Kennard, S; Bodalia, B; Mottram, J; Calvert, J; Brodie, K; Gunstone, A; Douglas, C; Trouton, T; Hunter, B; Gerber, R; Pepper, H; Mathur, A; Andiapen, M; Baumbach, A; Bowles, R; Hildick-Smith, D; McGregor, A; Loh, I; Plocky, J; Adams, K; Clemmer, K; Aggarwal, K; Burkhardt, V; Costa, M; Lemmertz, K; Anderson, J; York, T; Angiolillo, D; Green, E; Sperling, M; Vasquez, E; Aycock, G; Tatum, D; Amin, J; Davidson, A; Hendrix, E; Shepard, L; Strain, J; Michel, K; Talano, J; Szalanski, N; Berk, M; Ibarra, M; Bhagwat, R; Winterrowd, D; Bilazarian, S; Marsters, M; Blonder, R; Graf, L; Brilakis, E; Roesle, M; Byrd, L; Sullivan, A; Longo, J; Pennella, A; Westerhausen, D; Weil, R; Carr, K; Piazza, J; Carr, KW; Castello, R; Hawks, M; Chandna, H; Holly, D; Chandrashekhar, YS; Molinaro, N; Carter, M; Antonino, M; Kosmicki, D; Kelley, M; Richwine, R; Pazier, P; Cohen, M; Glasgow, B; Bresee, S; Alexander, J; Concha, M; Martinez, E; Connelly, T; Schenks, R; Cooper, M; Garman, V; Condit, J; White, A; Fialkow, J; Mckercher, M; Luna, M; Soto, G; Prodafikas, J; Rambaud, B; Donovan, J; Mudd, D; Doty, W; Parsons, T; D'Urso, M; Bies, J; Han, J; Treadwell, M; Erickson, B; Dahl, P; Fattal, P; Braem, J; Felten, W; Prior, J; French, W; Barillas, O; Berger, R; Genova, E; Gelernt, M; Cockrell, D; Miller, G; Dumka, K; Gill, S; Elliot, S; Goldberg, R; Barrett, M; Gordon, P; Stern, L; Ayres, T; Rhule, V; Gupta, D; Holton, T; Haddad, T; Jain, J; Hakas, J; McSorley, J; Hamroff, G; Hollenweger, L; Wainwright, W; Jones, S; Casagrande, M; Tang, N; Casagrande, MG; Effat, M; Mardis, R; Henderson, D; Millard, D; Hermany, P; Meissner-Dengler, S; Hinchman, D; Luck, K; Hodson, R; Severson, L; Horwitz, P; Miller, K; Isserman, S; Moore, C; Jan, M; Bilyk, O; Kersh, R; DaCosta, A; Kim, E; Gonzales, C; Kmetzo, J; Taylor, D; Knutson, T; Belanger, B; Hage-Korban, E; Harrington, A; Murdock, D; Johnson, M; Heiman, M; Dandekar, U; Khan, M; Khan, G; Lui, H; Holman, L; MacDonald, L; Derbyshire, S; Mehta, R; Watkins, K; Mayer, N; Mitchell, B; McCullum, K; Delio-Cox, B; Mckay, R; Cloutier, J; McKenzie, M; Rodkey, K; McLaurin, B; Lack, A; Minisi, A; Jeter, D; Mitchell, R; Keane-Richmond, P; Stine, R; Bullivant, M; Morford, R; White, J; Oberoi, M; Geraldo-Abache, A; O'Dea, D; Landi, T; Mehta, R; Tang, N; Ong, S; Edwards, M; Osborne, J; Alonzo, C; Lev, V; Monroe, J; Popeil, L; Sorrentino, N; Portelli, J; Landi, T; Potu, R; Smith, N; Prashad, R; McDonough, C; Qureshi, M; Howe, A; Raikhel, M; Arsate, M; Rogers, W; Saag, L; Sangrigoli, R; Schwarz, L; Abu-Fadel, M; Hagee, A; Kinnaman, S; McDaniel, V; Wilson, V; Purcell, T; Roberts, J; Riofrio, K; Shah, U; Narang, S; Gredler, F; Knap, P; Shanes, J; Hansen, C; Sharma, M; Gibson, T; Sheldon, W; Bohn, A; Siegel, C; Tibbits, L; Singh, V; Nelson, M; Singh, N; Logwood, D; Randhawa, P; Vargas, B; Stegemoller, R; Cole, B; Aggarwal, R; Johnson, M; Steinhoff, J; Dunaway, B; Patel, K; Boomer, L; Taheri, H; Morgan, K; Tahirkheli, N; Santos, A; Thadani, U; Alexander, D; Bennett, W; Kelley, E; Thomas, J; Macnicholas, D; Varma, S; Evans, S; Vlastaris, A; Bittel, B; Voyce, S; Mack, B; Weiss, R; Fournier, T; Whitney, R; Orosco, C; Willis, J; VonGerichten, S; Wiseman, A; Sharrow, A; Wohns, D; Schuitema, J; Amin, M; Ramus, A; Wilson, W; Moeller, C; Newell, M; Tindell, L; Rivera, W; Kwierant, J; Bretton, E; Corbin, B; Labroo, A; Lopez, C; Brown, C; Craig, M; Lucca, M; Keinanen, T; Eisenberg, S; Fielding, M; Doorey, A; Squire, A; Suresh, D; Frost, J; Teklinski, A; Stone, B; Waksman, R; Griffin, S; Wharton, W; Blakely, J; Fishbein, G; Weller, C; Camp, A; Fisher, S; Meholick, A; Hejna, E; Anderson, R; Long, S; Parikh, S; Norton, N; Vijay, N; Washam, M; Smith, S; Stepanov, N				Bonaca, Marc P.; Bhatt, Deepak L.; Cohen, Marc; Steg, Philippe Gabriel; Storey, Robert F.; Jensen, Eva C.; Magnani, Giulia; Bansilal, Sameer; Fish, M. Polly; Im, Kyungah; Bengtsson, Olof; Ophuis, Ton Oude; Budaj, Andrzej; Theroux, Pierre; Ruda, Mikhail; Hamm, Christian; Goto, Shinya; Spinar, Jindrich; Nicolau, Jose Carlos; Kiss, Robert G.; Murphy, Sabina A.; Wiviott, Stephen D.; Held, Peter; Braunwald, Eugene; Sabatine, Marc S.; Morin, Suzanne; Dantzer, Emily; Acquilano, Dayle; McGuire, Rachael L.; Gannon, Joseph B.; Gershman, Elaine; Ahlbom, Ann Maxe; Boberg, Barbro; Abola, Maria Teresa; Ardissino, Diego; Aylward, Philip; Corbalan, Ramon; Dalby, Anthony; Diaz, Rafael; Hu, Dayi; Isaza, Daniel; Kamensky, Gabriel; Kiss, Robert; Kontny, Frederic; Lopez-Sendon, Jose; Medina, Felix; Montalescot, Gilles; Nicolau, Jose; Paolasso, Ernesto; Parkhomenko, Alexander; Van de Werf, Frans; Anderson, Jeffrey L.; White, Harvey D.; Verheugt, Freek W. A.; Pedersen, Terje R.; DeMets, David L.; Lowe, Cheryl; Arevalo, Christina; Awtry, Eric; Berger, Clifford; Croce, Kevin; Desai, Akshay; Gelfand, Eli; Ho, Carolyn; Leeman, David; Link, Mark; Norden, Andrew; Pande, Ashvin; Rost, Natalia; Ruberg, Frederick; Silverman, Scott; Singhal, Aneesh; Vita, Joseph; Alvarisqueta, A.; De Gennaro, N.; Berli, M.; Roude, A. E.; Di Gennaro, J. Albisu; Albisu, J. F.; Caccavo, A.; Torres, M.; Cuadrado, J.; Bordoni, P.; Cuello, J.; Aviles, A.; Glenny, A.; Recoaro, R.; Fernandez, R.; Strada, B. N.; Fuentealba, V.; Gallo, C.; Duran, R. Garc-a; Garcia, C.; Hominal, M.; Castoldi, M.; Jure, H.; Pacora, F. Ferre; Lorenzatti, A.; Martinez, J. M.; Macin, S.; Cocco, N.; MacKinnon, I.; Bagnato, M. B.; Marino, J.; Cusimano, S.; Arias, V.; Focaccia, M.; Muntaner, J.; Mansilla, V.; Poy, C.; Prado, A.; Paterlini, G.; Montana, O.; Camino, A.; Sala, J.; Luciani, C.; Vico, M.; Morell, Y.; Dumont, C.; Vottero, E.; Zangroniz, P.; Lescano, A.; Morara, P.; Marquez, L. Lobo; Patron, F. Risso; Labarta, G. Bustamante; Sivila, C. D.; Quiroga, A. R.; Maffei, L.; Sassone, S.; Rolandi, F.; Vesentini, N.; Carnero, G.; Del Verme, S.; Hershson, A.; Figal, J. C.; Viso, M. E.; Hii, C.; Smith, K.; Singh, B.; Acampo, M.; Rogers, J.; ODonoghue, M.; Amerena, J.; Long, A.; Dart, A.; Kay, S.; Worthley, M.; Nimmo, J.; Lehman, R.; Morrison, H.; Dick, R.; Savage, C.; van Gaal, W.; Park, M.; Blombery, P.; McCarthy, C.; Oqueli, E.; Hill, D.; Sader, M.; Vrachas, D.; Purnell, P.; Vibert, J.; Collins, N.; Gordon, A.; Arstall, M.; Rose, J.; Aroney, C.; Cleave, P.; Fitzpatrick, M.; Mackenzie, M.; Garrahy, P.; Hall, C.; Nelson, G.; Reid, E.; Lee, A.; Gibbs, J.; Thompson, P.; Crittenden, J.; Hammett, C.; Hindom, L.; Antonis, P.; Manzoney, A.; Cross, D.; Pollard, C.; Brieger, D.; Wu, J.; Whelan, A.; Tulloch, G.; Taylor, A.; Smith, B.; Horowitz, J.; Black, M.; Boland, J.; Malmendier, D.; Celen, H.; Wendelen, E.; Claeys, M.; Pieter, M.; Cools, F.; Simons, N.; De Maeseneire, S.; De Wolf, L.; Brike, C.; Dubois, P.; Bolado, A. Conde Y.; Foading-Deffo, B.; Tahon, S.; Friart, A.; Arend, C.; Gevaert, S.; Verdegem, P.; Marechal, P.; Gits, F.; Pierard, L.; Celentano, C.; Pirenne, B.; Bouvy, C.; Renkin, J.; Huyberechts, D.; Sinnaeve, P.; De Velder, L.; Stammen, F.; Casier, T.; Striekwold, H.; Van den Broeck, D.; Thoeng, J.; Goris, R.; Timmermans, P.; Collard, S. -J.; van de Borne, P.; De Clippel, M.; Wollaert, B.; Jacobs, C.; Vankelecom, B.; Daelemans, Y.; Vervoort, G.; Drieghe, S.; Vranckx, P.; Janssen, A.; Vrolix, M.; I., Simenon; Wijns, W.; Delacroix, H.; Denie, D.; Schoors, D.; Lemoine, I.; Cornelis, K.; Willems, A. -M.; Schroder, E.; Domange, J.; Greque, G.; Machado, H.; Armaganijan, D.; Del Monaco, M. I.; da Silva, D.; Nakazone, R.; Dutra, O.; R., Vaz; Daher, R.; Rodrigues, D.; Guimaraes, A.; Teixeira, A.; Saraiva, J.; Costa, M.; Leaes, P.; Blacher, M.; Maia, L.; Nakazone, MA.; Manenti, E.; Ruschel, K.; Marin-Neto, J.; Pavao, R.; Preto, Riberao; Junior, A. Alves; Oliveira, G.; Rassi, S.; Sampaio, D.; Rossi, P. R.; dos Santos, L.; de Souza, J.; Lino, E.; Pimentel Filho, P.; Zucchetti, C.; Gomes, M.; de Paiva, A.; Sousa, A. C.; Almeida, A.; Botelho, R.; da Silva, R.; Giraldez, R.; Franken, M.; Faludi, A.; Bertolami, M.; Hernandes, M.; Lucas, N.; Carvalho, A.; Bertolami, A.; Precoma, D.; Geralde, L.; Pereira, A.; Cesar, L.; Mioto, B.; Marino, R.; Rabelo, W.; dos Santos, F.; Vidotti, M. H.; Mangione, J.; Mauro, M.; Kormann, A.; Ultramari, F.; Zimmermann, S.; Michalaros, Y.; Fonseca, M.; Sampaio, C.; Eliaschewitz, F.; Barbosa, E.; Drews, C.; de Lorenzo, A.; Barros, C.; Cancado, G.; Neuesnchwander, F.; Zimmermann, E.; Chompalova, B.; Denchev, S.; Gocheva, N.; Mihov, A.; Mincheva, V.; Pencheva, G.; Gelev, V.; Tisheva, S.; Todorov, G.; Goudev, A.; Parvanova, Z.; Peneva, Y.; Todorova, M.; Mitkova, M.; Smilov, L.; Yakovova, S.; Milanova, K.; Aleksov, N.; Mollov, M.; Gergova, V.; Shishmanova, D.; Stoykov, A.; Hristova, K.; Uzunangelov, Y.; Postadzhian, A.; Peltegov, V.; Karamitev, G.; Benov, H.; Vasileva, D.; Parishev, G.; Milcheva, N.; Avramov, D.; Miteva, B.; Stoyanovski, V.; Pencheva, G.; Nikolova, L.; Stancheva, N.; Nyagina, M.; Markov, D.; Spirova, D.; Peneva, Y.; Peshkov, O.; Mitkova, L.; Mandzhukova, S.; Rangelova, V.; Ivanov, K.; Krusheva, B.; Raycheva, V.; Gergova, V.; Goranov, K.; Stoykov, A.; Staleva, M.; Rashkova, V.; Postadzhian, A.; Krancheva, V.; Lulova, E.; Delchev, Gotse; Cantor, W.; Constance, C.; Gosselin, G.; Gosselin, G.; Marr, D.; Pandey, A. S.; Pesant, Y.; Pouliot, J.; Gladstone, P.; McPherson, T.; Rupka, D.; Saw, J.; St-Amour, E.; Syan, G.; Syan, R.; Rosenbloom, A.; Vizel, S.; Della Siega, A.; Halperin, F.; Nigro, F.; Chehayeb, R.; Fell, D.; Labonte, R.; Nawaz, S.; Gupta, M.; Ma, P.; Glanz, A.; Kouz, S.; Bhargava, R.; Dion, D.; Dupuis, R.; Grondin, F.; Wong, B.; Sabbah, E.; Hui, W.; Belisle, P.; Tymchak, W.; Montigny, M.; Lonn, E.; Bose, S.; Kincade, D.; Gallo, R.; Lamy, A.; Bell, A.; LeMay, M.; Bata, I.; Kostuk, W.; Cheung, S.; Petrella, R.; Lubelsky, B.; Berlingieri, J.; Fortin, C.; DeYoung, J. P.; Babapulle, M.; Landry, D.; Gupta, A.; Bertrand, O.; Jadin, M.; Robbins, K.; Gauthier, M. -F.; Masson, C.; Reyes, V.; O'Blenis, G.; Clarus, S.; Sardin, V.; Marquette, S.; Bozek, B.; Spurrell, D.; Thiessen, S.; Fox, R.; Tremblay, I.; Singh, J.; Samms, S.; Ross, B.; Solomon, P.; Nelson, S.; Roberts, P.; Forsyth, C.; Lepage, C.; McPherson, C.; Dewar, C.; Dela Cruz, C.; Louch, D.; Vilag, C.; Roy, M.; Stata, C.; Morissette, A.; Ouimet, F.; Bilodeau, N.; Chausse, I.; Kvill, L.; Chartrand, M. -J.; Harris, L.; Bolduc, H.; Magi, A.; Jule, P.; Valley, S.; Morrissette, J.; Power, P.; Kailey, P.; Thomas, A.; Wright, D.; Carr, S.; Cleveland, T.; Dihel, C.; Coldwell, J.; Schellenberg, S.; Viau, C.; Watt, M.; Corke, R.; Shea-Landry, G.; Gandhi, A.; Tishler, S.; Prieto, J. C.; Noriega, V.; Cobos, L.; Obreque, C.; Potthof, S.; Zapata, J.; Lucero, F.; Luque, M.; Pincetti, C.; Torres, G.; Yanez, M.; Vasquez, C.; Manriquez, L.; Espinoza, M. J.; Yovaniniz, P.; Grandon, M.; Castro, P.; Llevaneras, S.; Lanas, F.; Hidalgo, J.; Arriagada, G.; Villan, C.; Florenzano, F.; Chacon, M. V.; Rodriguez, M.; Barreda, B.; Raffo, C.; Reyes, T.; Hu, D.; Liu, W.; Tan, N.; Feng, Y.; Dong, Y.; Yang, D.; Liao, Y.; Wei, F.; Wei, M.; Yan, M.; Yan, X.; Wang, S.; Chen, Y.; Li, Y.; Yuan, Z.; Xiong, Y.; Zhu, J.; Li, S.; Ma, G.; Chen, L.; Li, Z.; Liu, Y.; Yang, X.; Xiong, W.; Pang, W.; Chen, Y.; Lu, G.; Chen, Z.; Zhao, S.; Zhou, H.; Huang, J.; Gang, Y.; Chai, Y.; Yang, X.; Zhang, Z.; Mu, Z.; Hernandez, E.; Mora, C.; Maria, E.; Catalan, Y.; Reynales, H.; Huertas, D.; Molina, D.; Rendon, N.; Sanchez, G.; Tellez, R.; Botero, R.; Salazar, P.; Vesga, B.; Delgado, P.; Herrera, M.; Perez, D.; Jaramillo, N.; Toloza, R.; Orozco, A.; Bustamante, Y.; Jaramillo, C.; Garces, G.; Saaibi, J.; Castillo, J.; Arana, C.; Gonzalez, M.; Urina, M.; Ramirez, N.; Manzur, F.; Rosales, D.; Quintero, A.; Gonzalez, E.; Accini, J.; Reyes, M.; Elbl, L.; Malecha, J.; Stanek, L.; Jerabek, O.; Lubanda, H.; Kos, P.; Zidkova, E.; Vlckova, D.; Naplava, R.; Ludka, O.; Ludkova, A.; Soucek, M.; Kuchar, J.; Poloczek, M.; Wasserburger, B.; Panovsky, R.; Linhart, A.; Rihacek, I.; Macha, J.; Spinar, J.; Grunfeldova, H.; Spinarova, L.; Zanova, M.; Bren, J.; Zarembova, J.; Cermak, O.; Sembera, Z.; Svobodova, I.; Monhart, Z.; Pleva, L.; Sipula, J.; Polasek, R.; Kolmas, P.; Dedek, V.; Janota, T.; Stipal, R.; Turkova, N.; Kucera, D.; Bednarova, J.; Broulova, P.; Lukac, M.; Hanak, P.; Reichert, P.; Bouchal, P.; Turkova, N.; Krocova, E.; Petrova, I.; Matyasek, I.; Brychta, T.; Machova, V.; Marusincova, I.; Sperlingova, B.; Steg, P. -G.; Montalescot, G.; Macquin-Mavier, T.; Khalife, K.; Galley, D.; Elhadad, S.; Decoulx, E.; Cottin, Y.; Coisne, D.; Bonnet, J. -L.; Ferrari, E.; Range, G.; Cayla, G.; Goralski, M.; Furber, A.; Elbaz, M.; Aboyans, V.; Poulard, J. -E.; Zemour, G.; Labeque, J. -N.; Hirsch, J. -L.; Vaquette, B.; Livarek, B.; Igigabel, P.; Lafitte, S.; Oudghiri, M.; Bertin, B.; Beitar, T.; Merkling, D.; Beltra, C.; Maubert, A.; El Jarroudi, M.; Bichat, F.; Berger, N.; Fiacchetti, C.; Douillet, M.; Laure, C.; Leperchois-Jacquey, C.; Miran, S.; Cornet, C.; Rosolin, N.; Pradel, V.; Leparree, S.; Doux, N.; Mais, C.; Sevilla, J.; Laurencon, V.; Georges, J. L.; Gilard, V.; Duprat, C.; Hamm, C.; Giannitsis, E.; Schenkenberger, I.; Appel, K. -F.; Toursarkissian, N.; Bott, J.; Nischik, R.; Schmidt, E.; Jung, T.; Steiner, S.; Fischer, S.; Khariouzov, A.; Heuer, H.; Kadel, C.; Hanefeld, M.; Weil, J.; Koenig, W.; Horacek, T.; Muenzel, T.; Brachmann, J.; Weber, D.; Wittlich, N.; Stellbrink, C.; Duengen, H. -D.; Leschke, M.; Zeymer, U.; Dorsel, T.; Voehringer, H. -F.; Dissmann, M.; vom Dahl, J.; Derwahl, K. -M.; Trenk, D.; Frey, N.; Schroeder, T.; Foerster, A.; Bartels, R.; Kisselbach, C.; Deigentasch, H.; Dreykluft, K.; Becker, P.; Scheuren, A.; Erdas, M.; Wipper, J.; Schmidt, A.; Henzler, A.; Winter, K.; Fischer, S.; Kopf, S.; Laschewski, B.; Rahn, G.; Schrapel, C.; Miodek, M.; Hildenbrand, S.; Fink, P.; Gebel, G.; Goebel, U.; Siepmann, C.; Drexler, A.; Iselt, M.; Maiwald, A.; Blaich, B.; Baumann, S.; Iselt, M.; Gebhardt, S.; Kazcmarek, N.; Krug-Hoeren, B.; Traeubler, B.; Nicula, D.; Reichenbach, D.; Langer, C.; Kiroglu, K.; Riedel, S.; Schulte, M.; Borst, M.; Katona, A.; Vertes, A.; Kiss, R.; Turi, T.; Merkely, B.; Ungi, I.; Kiraly, C.; Zolyomi, S.; Horvath, I.; Lupkovics, G.; Edes, I.; Simon, E.; Czuriga, I.; Laszlo, Z.; Kancz, S.; Takacs, J.; Papp, A.; Czigany, A.; Muller, G.; Tas, A. Sipos; Polgar, P.; Jilling, M. Jozan; Bartal, G.; Kerkovits, A.; Bodi, M.; Benczur, B.; Valco, J.; Erdei, F.; Sebo, J.; Korda, A.; Turi, T.; Becker, D.; Kalapos, A.; Bosko, M.; Pap, G.; Magyari, B.; Basa, A.; Jenei, C.; Bakai, J.; Unterberger, K.; Vas, K.; Fulop, G.; Nagy, M. A.; Takacs, A.; Mate, Z.; Szilagyi, A.; Nagy, K.; Svab, M.; Kis, E.; Horthy, R.; Kantor, F.; Sperr, E.; Bajcsi, E.; Bujdoso, A.; Ardissino, D.; Martina, P.; Fiscella, A.; Marenzi, G.; Tamburino, C.; Terrosu, P.; Presbitero, P.; Cuccia, C.; Bovenzi, F.; Berti, S.; Colivicchi, F.; Paloscia, L.; Scherillo, M.; Tartaglione, S.; Della Rovere, F.; De Cesare, N.; Manari, A.; Astarita, C.; Oltrona, L.; Marzilli, M.; Caldarola, P.; Merlini, P.; Celentano, A.; Di Sciascio, G.; Pajes, G.; Silvestri, O.; Delfino, R.; Bassani, F.; Puccetti, L.; Cavallini, C.; Patrizi, G.; Fattore, L.; Di Lorenzo, L.; Notarangelo, F.; Stefanin, C.; Giacoppo, M.; Rubino, M.; Dammino, L.; Chessa, P.; Di Pizzo, A.; Musmeci, G.; Mazzoni, A.; Tyack, K.; Aiello, A.; Mascellanti, M.; Formigli, D.; Guglielmino, G.; Bernabo, P.; Bocciarelli, M.; De Iaco, G.; Russo, G.; Rizzotti, D.; Orsini, E.; Saponetti, L. Sublimi; Babbolin, M.; De Divitiis, M.; Patti, G.; Monti, F.; Silvestri, N.; Valbusa, A.; Lazzarotti, M.; Puccetti, L.; Grikstaite, E.; Patrizi, G.; Bosco, B.; Marchegiano, R.; Takenaka, T.; Ono, M.; Suzuki, M.; Hasegawa, K.; Domae, H.; Fukui, K.; Iseki, H.; Aoyama, T.; Suzuki, C.; Sakai, R.; Hashimoto, T.; Inoko, M.; Sasaki, T.; Kataoka, T.; Okutsu, M.; Yasaka, Y.; Miyamoto, T.; Tomobuchi, Y.; Tamura, R.; Hosokawa, S.; Komura, Y.; Takahashi, N.; Mima, T.; Sadamatsu, K.; Fujimoto, K.; Matsumura, T.; Koide, S.; Himi, T.; Hashimoto, Y.; Yamasaki, M.; Okubo, M.; Takase, H.; Morii, I.; Utsu, N.; Higashino, Y.; Shigematsu, S.; Nakagawa, T.; Goto, S.; Ota, T.; Takahashi, W.; Kakishita, M.; Hayashi, Y.; Momiyama, Y.; Baden, M.; Saeki, T.; Hiroi, S.; Wada, A.; Nakata, A.; Nishi, Y.; Hirasawa, S.; Shibata, Y.; Fukuzawa, S.; Machida, M.; Takama, N.; Teranishi, J.; Sakuma, K.; Abe, Y.; Suzuki, A.; Yamazaki, A.; Nakachi, T.; Nagayama, H.; Fujino, S.; Tsurukai, A.; Nojima, S.; Ishiguchi, Y.; Hada, K.; Nakatani, K.; Yamamoto, K.; Matsuo, A.; Yamaguchi, E.; Ito, S.; Matsuda, M.; Onishi, M.; Kawanishi, Y.; Ohashi, Y.; Ochi, K.; Miyamoto, S.; Ichishita, Y.; Iwamoto, H.; Sagara, Y.; Komori, M.; Matsumura, A.; Nakashima, R.; Kondo, M.; Suzuki, K.; Kodama, S.; Kotajima, H.; Fujimoto, N.; Honda, K.; Iwamoto, M.; Okada, S.; Ichinose, K.; Takinami, N.; Takagi, E.; Nakano, A.; Tomari, H.; Yokoyama, T.; Matsui, Y.; Nishimura, N.; Asano, T.; Mochiduki, A.; Yamashita, S.; Okino, S.; Hirabayashi, K.; Funada, R.; Wardeh, A. J.; Dille, C.; de Melker, E. C.; van der Spoel, A.; Willems, F. F.; Maassen, E.; Westendorp, I. C. D.; Zweers, D.; Dunselman, P. H. J. M.; Blom, L.; Ronner, E.; Wissenburg, A.; van der Sluis, A.; Badings, E. A.; den Hartog, F. R.; Singerling, M.; Aksoy, I.; Heil, A.; Tjeerdsma, G.; van Daalen, C.; Lenderink, T.; Lardenois, R.; Prins, F. J.; Rutten, R.; Plomp, J.; Veldmeijer, S.; de Vries, R. J. M.; Krikken, J.; Ophuis, T. A. J. M. Oude; Buvelot, S.; Bos, R. J.; Tan-Urgert, B.; Werner, H. A.; Wittekoek, M.; van Daele, M. E. R. M.; Bouwens, M.; Oomen, A.; Meijlis, P.; Verheul, J. A.; Uiterwaal, H.; Knufman, N.; de Lange, H.; Bartels, G. L.; Hendriks-van Woerden, M.; van Bemmel, B.; Beyering, M.; Zwart, P. A. G.; Teng, Y.; van der Zwaan, C.; Havenaar, J.; Hermans, W. R. M.; de Graauw, J.; Hamraoui, K.; Dabrowska, K.; de Nooijer, C.; Groenenberg, I.; Kietselae, B. L. J. H.; Muis, L.; Hamer, B. J. B.; Hobe, C.; van Eck, J. W. M.; Elzebroek, N.; Tans, J. G. M.; Stapel, A. G. Th.; Nierop, P. R.; Dirks, M.; Kuijper, A. F. M.; Schiks, M.; de Groot, M. R.; Post, G.; ten Berg, J. M.; Bras, R.; Koolen, J. J.; van Leur, L.; Herrman, J. P. R.; Roelse, A.; Ebink, C.; Jones, B.; Lipsic, E.; Couperus, M.; Bogaard, K.; Dijk, A.; Pettersen, K. I.; Kontny, F.; Fortun, M.; Gullestad, L.; Stueflotten, W.; Popovic, I.; Sobye, E. Turkerud; Hogalmen, G.; German, M.; Hysing, J.; Flagstad, E.; Slettom, G.; Nordrehaug, J. E.; Isaksen, A.; Graven, T.; Haug, H.; Sandvik, J.; Thunhaug, H.; Ronning, P. Bjornerud; Gravrok, B.; Lappegard, K. T.; Enebakk, T.; Ronnevik, P.; Ronnevik, T.; Hurtig, U.; Skanke, E.; Omland, T.; Tobiassen, G. M.; Berrospi, P.; Ragas, Y.; Bustamante, G.; Marruffo, Y.; Chavez, E.; Chaname, A.; Heredia, J.; Gamero, K.; Lema, J.; Carrion, A. M.; Rodriguez, V.; Cabanillas, N.; Rodriguez, A.; Zena, N.; Segura, L.; Rojas, C.; Toce, L.; Carrera, J.; Orihuela, B.; Del Portal, M.; Roldan, Y.; Roldan, G.; Medina, F.; Rodriguez, J.; Chavez, C.; Luna, G.; Parra, J.; Ramos, J.; Mogrovejo, W.; Godoy, J.; Talledo, M. Zubiate; Diestra, J.; Godoy, A.; Matta, M.; Pino, C.; Vergara, R.; Chois, A.; Guillen, A. M.; Medina, J.; Chirinos, J.; Paredes, A.; Quiroz, M.; Camacho, L.; Gil, M.; Abola, M. T.; Cerbito, S.; Beltran, J.; Tanglao, M.; Uy, N.; Busa, J.; Rogelio, G.; Arbis, M. G.; Prado, J. P.; Miranda, M.; Sulit, D. J.; Dioquino, R.; Sevilla, R.; Soriano, R. A.; Rosita, R. R.; Amazona, A.; Atilano, A.; Lim, E.; Ebo, G.; Maglasang, P.; Palmes, P.; Loreno, C. A.; Tirador, L.; Alagban, C.; Roxas, D. J.; Roxas, J. F.; Cheng, F.; De Guzman, S.; Morales, D.; Mararac, T.; Barbas, B.; Barbas, K.; Ferrolino, A.; Baysac, C.; Llarena, A. C.; Julianes, C.; Budaj, A.; Torun, A.; Dalkowski, M.; Widejko, K.; Derlaga, B.; Laskowska, E.; Dudek, D.; Dziewierz, A.; Jozwa, R.; Busz-Papiez, B.; Pawlowicz, L.; Kaczmarczyk, M.; Jaworska, K.; Skonieczny, G.; Kopaczewski, J.; Wujkowski, M.; Krasowski, W.; Krzyzanek, P.; Kubica, J.; Kozinski, M.; Miekus, P.; Glaza, M.; Podolec, P.; Wilkolek, P.; Piepiorka, M.; Piepiorka-Broniecka, M.; Pluta, W.; Ploch, M.; Rynkiewicz, A.; Mosakowska, K.; Szpajer, M.; Lesinski, D.; Szwed, H.; Jasek, S.; Sciborski, R.; Piotrowicz, R.; Musial, W.; Lisowska, A.; Rekosz, J.; Kasznicka, M.; Korzeniak, R.; Staneta, P.; Konczakowski, P.; Waluszek-Konczakowska, I.; Cymerman, K.; Lubinski, A.; Grycewicz, T.; Hiczkiewicz, J.; Plucinski, M.; Korol, M.; Szczech, J.; Hawro, M.; Skorski, M.; Cichon, K.; Jankowski, M.; Cygler, J.; Ottomanska-Cygler, M.; Korecki, J.; Gulaj, E.; Zechowicz, T.; Zechowicz, M.; Goch, A.; Topolinski, B.; Ogorek, M.; Szczepanska, A.; Wojewoda, P.; Jagoda, E.; Krzyzanowski, W.; Muzyk-Osikowicz, M.; Jaszczurowski, W.; Stasiewski, A.; Wietrzynska, J.; Miklaszewicz, B.; Beme, A.; Sudnik, W.; Matys, U.; Ponikowski, P.; Powierza, S.; Kim, Y. -H.; Choi, D. -J.; Seung, K. -B.; Lim, D. -S.; Lee, S. -H.; Kim, H. -S.; Bae, J. -H.; Hong, T. -J.; Hong, M. -K.; Tahk, S. -J.; Kim, Y. -J.; Yoon, J.; Jeong, M. -H.; Chae, J. -K.; Cho, M. -C.; Hong, S. -K.; Hur, S. -H.; Jeong, J. -O.; Her, S. -H.; Lee, J. -M.; Chang, K. -C.; Yoon, C. -H.; Chang, K.; Park, J. H.; Choi, S. H.; Park, K. W.; Bae, Y. H.; Lee, H. W.; Kim, B. -K.; Yoon, M. -H.; Park, J. -S.; Jang, H.; Kim, C.; Cho, E. -J.; Bae, J. H.; Lee, H. J.; Lee, D. J.; Lee, J. W.; Park, M. W.; Choi, Y. -Y.; Dimulescu, D.; Vintila, M. M.; Fruntelata, A.; Pirvu, O.; Stanciulescu, G.; Giuca, A.; Militaru, C.; Radoi, M.; Bobescu, E.; Crisu, D.; Creteanu, M.; Minescu, B.; Bolohan, F.; Manitiu, I.; Bengus, C. M.; Iosipescu, L. C.; Ciobotaru, V.; Basarab, G.; Benedek, I. S.; Constantinescu, M.; Cristea, M. I.; Capalneanu, R.; Tatu-Chitoiu, G. P.; Huidu, S.; Protopopescu, L.; Greavu, M. C.; Diaconu, M. C.; Blajan, D.; Istratoaie, O.; Lican, G.; Bisoc, A.; Doka, B.; Jemna, D.; Parasteac, M. M.; Serban, L. D.; Mihai, M.; Cioca, G.; Ochean, V.; Costache, L.; Andor, M.; Stoica, D.; Benedek, T.; Sava, N.; Anciu, M. R.; Mot, S.; Cornaciu, S.; Boldueva, S.; Golitsyn, S.; Karpov, Y.; Kobalava, Z.; Konstantinov, V.; Kuimov, A.; Ezhov, M.; Panov, A.; Ruda, M.; Novikova, T.; Simanenkov, V.; Smolenskaya, O.; Tsyba, L.; Vishnevsky, A.; Yakhontova, P.; Kislyak, O.; Demchenko, E.; Yakovlev, A.; Ermoshkina, L.; Arkhipov, M.; Galyavich, A.; Strongin, L.; Kosmacheva, E.; Goloshchekin, B.; Sidorenko, B.; Izmozherova, N.; Shustov, S.; Orlikova, O.; Paltsman, Z.; Lukyanov, Y.; Koziolova, N.; Nedogoda, S.; Statsenko, M.; Kotelnikov, M.; Osipenko, M.; Oshchepkova, E.; Bolieva, L.; Ryamzina, I.; Pavlysh, E.; Samokhvalova, M.; Mironova, N.; Buza, V.; Shavarov, A.; Serebrenitskaya, M.; Khomyakova, L.; Safarova, M.; Lohovinina, N.; Staroverov, I.; Bitakova, F.; Zakharova, N.; Khurs, E.; Belenky, D.; Kositsyn, D.; Rovnykh, Y.; Kasatova, T.; Lubinskaya, E.; Omelchenko, M.; Slukhaenko, I.; Kozulin, A.; Baleeva, L.; Pochinka, I.; Kizhvatova, N.; Laptev, I.; Bugrimova, M.; Popov, A.; Kovalevskaya, E.; Orlikov, E.; Paltsman, Z.; Lamden, D.; Surovtseva, M.; Tsoma, V.; Derevjanchenko, M.; Streltsov, S.; Bikbulatova, E.; Dmitriev, V.; Byazrova, S.; Khovaeva, Y.; Komandenko, O.; Kamensky, G.; Dlesk, A.; Urban, M.; Vinanska, D.; Dzupina, A.; Hranai, M.; Cisar, P.; Toth, P.; Paulov, S.; Sivak, V.; Bolvanska, N.; Pella, D.; Palka, J.; Nedelova, I.; Benacka, J.; Gergel, V.; Hatalova, K.; Kohut, P.; Kovar, F.; Knazeje, M.; Macek, V.; Sinska, R.; Bugan, V.; Badenhorst, J. C. W.; Erasmus, L.; Burgess, L. J.; de Necker, I.; Corbett, C. H.; Fouche, L.; Dawood, S. Y.; Conradie, C.; Delport, E. F.; Kruger, M.; Ebrahim, I.; Bobak, C.; Nethononda, M. R.; Nunkoo, T.; van Rensburg, F. P. Janse; Middle, R.; Horak, A. R.; Henley, L.; Mabin, T. A.; King, A.; Ranjith, N.; Ramdas, S.; Roodt, A.; Coetsee, E.; Theron, H.; Karsten, M.; Van Zyl, L. J.; Roscher, M.; Venter, T. P.; de Kock, L.; Becker, A. C.; Swanepoel, J.; Ismail, S. M.; Christie, H.; Dalby, A. J.; Allman, J.; Roux, J. P.; Christie, H.; Naidoo, D. P.; Vawda, G. H. M.; Manga, P.; Olckers, W.; Mpe, M. T.; Farrell, B. M.; Lopez-Sendon, J.; de Sa Areses, E. Lopez; Valbuena Lopez, S.; Cruz Fernandez, J. M.; Gonzalez Roldan, J.; Garcia Pavia, P.; Gonzalez Segovia, A.; Garcia Puig, J.; Velasco Garcia, C.; Munoz Aguilera, R.; Dominguez Munoa, M.; Bruguera Cortada, J.; Cabero Cereto, P.; Plaza Perez, I.; Perez Cid, L.; Galve Basilio, E.; Cibeira Guerra, P.; Fernandez Ortiz, A.; Vivas Balcones, L. D.; Ripoll Vera, T.; Gamez Martinez, J. M.; De Teresa Galvan, E.; Hernandez Caballero, A.; Rodriguez Blanco, V. M.; Rubin Lopez, J. M.; Pastor Franco, M. R.; Ridocci Soriano, F.; Caracena Porcar, L.; Cequier Fillat, A. R.; Guerrero Moreno, S.; Galan Montejano, M.; Duran Guerrero, J. M.; Blanco Coronado, J. L.; Murga Eizagaechevarria, N.; Nunez Araucua, G.; Martinez Rubio, A.; Cazorla Roca, M.; Garcia-Moll Marimon, X.; Vila Perales, M.; Bethencourt Gonzalez, A.; Pascual Sastre, M.; Gonzalez Juanatey, J. R.; Garcia Acuna, J. M.; Al-Khalili, F.; Lof, P.; Bandh, S.; Myllyla, L.; Christensen, K.; Johansson, K.; Dellborg, M.; Hultsberg-Olsson, G.; Alstrom, P.; Damm, T. Larsdotter; Erlinge, D.; Brolin, G.; Ravn-Fischer, P. A.; Johansson, P.; Andreen, S.; Linderfalk, C.; Ram, B.; Lindholm, C. -J.; Assarsson, E.; Mooe, T.; Lindberg, A.; Paren, P.; Moodh, J.; Svensson, P.; Andersson, I.; Wodlin, P.; Raschperger, A.; Skogvard, P.; Koch, A.; Lind, N.; Osberg, L.; Nilsson, C.; Svensson, K.; Bengtsson, M.; Samad, B.; Nilsson, M.; Berglund, E.; Lundgren, C.; Lindmark, K.; Sundholm, C.; Aladellie, L.; Welin-Berger, B.; Guneri, S.; Dogan, N. B.; Ersanli, M.; Coskun, U.; Cayli, M.; Seker, T.; Camsari, A.; Ozcan, T.; Ongen, Z.; Karadag, B.; Boyaci, B.; Sezenoz, B.; Pekdemir, H.; Hidayet, S.; Erol, M. K.; Yalcin, A.; Sezer, M.; Emet, S.; Bozkurt, E.; Ozen, M. B.; Parkhomenko, A.; Lutay, Y.; Dyadyk, O.; Kholopov, L.; Rudyk, I.; Shaposhnikova, Y.; Chopey, I.; Ternuschak, T.; Reshotko, D.; Popova, G.; Batushkin, V.; Gema, A.; Vizir, V.; Berezyn, O.; Lutai, M.; Tovstukha, V.; Shumakov, V.; Pogurelska, O.; Sirenko, Y.; Rekovets, O.; Kraiz, I.; Kamenska, E.; Tseluyko, V.; Yakovleva, L.; Yena, L.; Artemenko, V.; Koval, O.; Kaplan, P.; Karpenko, O.; Nevolina, I.; Bazilevych, A.; Harbar, M.; Rudenko, L.; Beregova, O.; Mostovyi, Y.; Rasputina, L.; Vatutin, M.; Shevelok, A.; Kovalenko, V.; Polenova, N.; Amosova, K.; Tkachenko, L.; Volkov, V.; Zaprovalna, O.; Storey, R.; Thomas, M.; Pell, A.; Anderson, J.; Moriarty, A.; Kinnin, M.; Ahsan, A.; Burton, J.; ORourke, B.; Young, J.; Lang, C.; Forbes, J.; Rowlands, D.; Hamill, S.; Sprigings, D.; Cadd, A.; de Belder, M.; Atkinson, B.; Ramsey, M.; Fagan, J. C.; Pye, M.; Wright, L.; Keeling, P.; Hughes, D.; Fraser, D.; Phillips, H.; Muthusamy, R.; Lawan, M.; Levy, T.; Kennard, S.; Bodalia, B.; Mottram, J.; Calvert, J.; Brodie, K.; Gunstone, A.; Douglas, C.; Trouton, T.; Hunter, B.; Gerber, R.; Pepper, H.; Mathur, A.; Andiapen, M.; Baumbach, A.; Bowles, R.; Hildick-Smith, D.; McGregor, A.; Loh, I.; Plocky, J.; Adams, K.; Clemmer, K.; Aggarwal, K.; Burkhardt, V.; Costa, M.; Lemmertz, K.; Anderson, J.; York, T.; Angiolillo, D.; Green, E.; Sperling, M.; Vasquez, E.; Aycock, G.; Tatum, D.; Amin, J.; Davidson, A.; Hendrix, E.; Shepard, L.; Strain, J.; Michel, K.; Talano, J.; Szalanski, N.; Berk, M.; Ibarra, M.; Bhagwat, R.; Winterrowd, D.; Bilazarian, S.; Marsters, M. J.; Blonder, R.; Graf, L.; Brilakis, E.; Roesle, M.; Byrd, L.; Sullivan, A.; Longo, J.; Pennella, A.; Westerhausen, D.; Weil, R.; Carr, K.; Piazza, J.; Carr, Kenneth W.; Castello, R.; Hawks, M.; Chandna, H.; Holly, D.; Chandrashekhar, Y. S.; Molinaro, N.; Carter, M. E.; Antonino, M.; Kosmicki, D.; Kelley, M.; Richwine, R.; Pazier, P.; Cohen, M.; Glasgow, B.; Bresee, S.; Alexander, J.; Concha, M.; Martinez, E.; Connelly, T.; Schenks, R.; Cooper, M.; Garman, V.; Condit, J.; White, A.; Fialkow, J.; Mckercher, M.; Luna, M.; Soto, G.; Prodafikas, J.; Rambaud, B.; Donovan, J.; Mudd, D.; Doty, W. D.; Parsons, T.; D'Urso, M.; Bies, J.; Han, J.; Treadwell, M.; Erickson, B.; Dahl, P.; Fattal, P.; Braem, J.; Felten, W.; Prior, J.; French, W.; Barillas, O.; Berger, R.; Genova, E.; Gelernt, M.; Cockrell, D.; Miller, G.; Dumka, K.; Gill, S.; Elliot, S.; Goldberg, R.; Barrett, M.; Gordon, P.; Stern, L.; Ayres, T.; Rhule, V.; Gupta, D.; Holton, T.; Haddad, T.; Jain, J.; Hakas, J.; McSorley, J.; Hamroff, G.; Hollenweger, L.; Wainwright, W.; Jones, S.; Casagrande, M.; Tang, N.; Casagrande, Michael G.; Effat, M.; Mardis, R.; Henderson, D.; Millard, D.; Hermany, P.; Meissner-Dengler, S.; Hinchman, D.; Luck, K.; Hodson, R.; Severson, L.; Horwitz, P.; Miller, K.; Isserman, S.; Moore, C.; Jan, M.; Bilyk, O.; Kersh, R.; DaCosta, A.; Kim, E.; Gonzales, C.; Kmetzo, J.; Taylor, D.; Knutson, T.; Belanger, B.; Hage-Korban, E.; Harrington, A.; Murdock, D.; Johnson, M.; Heiman, M.; Dandekar, U.; Khan, M.; Khan, G.; Lui, H.; Holman, L.; MacDonald, L.; Derbyshire, S.; Mehta, R.; Watkins, K.; Mayer, N.; Mitchell, B.; McCullum, K.; Delio-Cox, B.; McKay, R.; Cloutier, J.; McKenzie, M.; Rodkey, K.; McLaurin, B.; Lack, A.; Minisi, A.; Jeter, D.; Mitchell, R.; Keane-Richmond, P.; Stine, R.; Bullivant, M.; Morford, R.; White, J.; Oberoi, M.; Geraldo-Abache, A.; O'Dea, D.; Landi, T.; Mehta, R.; Tang, N.; Ong, S.; Edwards, M.; Osborne, J.; Alonzo, C.; Lev, V.; Monroe, J.; Popeil, L.; Sorrentino, N.; Portelli, J.; Landi, T.; Potu, R.; Smith, N.; Prashad, R.; McDonough, C.; Qureshi, M.; Howe, A.; Raikhel, M.; Arsate, M.; Rogers, W.; Saag, L.; Sangrigoli, R.; Schwarz, L.; Abu-Fadel, M.; Hagee, A.; Kinnaman, S.; McDaniel, V.; Wilson, V.; Purcell, T.; Roberts, J.; Riofrio, K.; Shah, U.; Narang, S.; Gredler, F.; Knap, P.; Shanes, J.; Hansen, C.; Sharma, M.; Gibson, T.; Sheldon, W.; Bohn, A.; Siegel, C.; Tibbits, L.; Singh, V.; Nelson, M.; Singh, N.; Logwood, D.; Randhawa, P.; Vargas, B.; Stegemoller, R.; Cole, B.; Aggarwal, R.; Johnson, M.; Steinhoff, J.; Dunaway, B.; Patel, K.; Boomer, L.; Taheri, H.; Morgan, K.; Tahirkheli, N.; Santos, A.; Thadani, U.; Alexander, D.; Bennett, W.; Kelley, E.; Thomas, J.; Macnicholas, D.; Varma, S.; Evans, S.; Vlastaris, A.; Bittel, B.; Voyce, S.; Mack, B.; Weiss, R.; Fournier, T.; Whitney, R.; Orosco, C.; Willis, J.; VonGerichten, S.; Wiseman, A.; Sharrow, A.; Wohns, D.; Schuitema, J.; Amin, M.; Ramus, A. M.; Wilson, W.; Moeller, C.; Newell, M.; Tindell, L.; Rivera, W.; Kwierant, J.; Bretton, E.; Corbin, B.; Labroo, A.; Lopez, C.; Brown, C.; Craig, M. A.; Lucca, M.; Keinanen, T.; Eisenberg, S.; Fielding, M.; Doorey, A.; Squire, A.; Suresh, D.; Frost, J.; Teklinski, A.; Stone, B.; Waksman, R.; Griffin, S.; Wharton, W.; Blakely, J.; Fishbein, G.; Weller, C.; Camp, A.; Fisher, S.; Meholick, A.; Hejna, E.; Anderson, R. D.; Long, S.; Parikh, S.; Norton, N.; Vijay, N.; Washam, M.; Smith, S.; Stepanov, N.		PEGASUS-TIMI 54 Steering Comm	Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; ESC GUIDELINES; CLOPIDOGREL; MANAGEMENT; ASPIRIN; PREVENTION; PRASUGREL; ANGIOGRAPHY; SECONDARY	BACKGROUND The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y(12) receptor antagonist with established efficacy after an acute coronary syndrome, in this context. METHODS We randomly assigned, in a double-blind 1: 1: 1 fashion, 21,162 patients who had had a myocardial infarction 1 to 3 years earlier to ticagrelor at a dose of 90 mg twice daily, ticagrelor at a dose of 60 mg twice daily, or placebo. All the patients were to receive low-dose aspirin and were followed for a median of 33 months. The primary efficacy end point was the composite of cardiovascular death, myocardial infarction, or stroke. The primary safety end point was Thrombolysis in Myocardial Infarction (TIMI) major bleeding. RESULTS The two ticagrelor doses each reduced, as compared with placebo, the rate of the primary efficacy end point, with Kaplan-Meier rates at 3 years of 7.85% in the group that received 90 mg of ticagrelor twice daily, 7.77% in the group that received 60 mg of ticagrelor twice daily, and 9.04% in the placebo group (hazard ratio for 90 mg of ticagrelor vs. placebo, 0.85; 95% confidence interval [CI], 0.75 to 0.96; P = 0.008; hazard ratio for 60 mg of ticagrelor vs. placebo, 0.84; 95% CI, 0.74 to 0.95; P = 0.004). Rates of TIMI major bleeding were higher with ticagrelor (2.60% with 90 mg and 2.30% with 60 mg) than with placebo (1.06%) (P < 0.001 for each dose vs. placebo); the rates of intracranial hemorrhage or fatal bleeding in the three groups were 0.63%, 0.71%, and 0.60%, respectively. CONCLUSIONS In patients with a myocardial infarction more than 1 year previously, treatment with ticagrelor significantly reduced the risk of cardiovascular death, myocardial infarction, or stroke and increased the risk of major bleeding. (Funded by AstraZeneca; PEGASUS-TIMI 54 ClinicalTrials.gov number, NCT01225562.)	[Bonaca, Marc P.; Bhatt, Deepak L.; Magnani, Giulia; Fish, M. Polly; Im, Kyungah; Murphy, Sabina A.; Wiviott, Stephen D.; Braunwald, Eugene; Sabatine, Marc S.] Brigham & Womens Hosp, Thrombolysis Myocardial Infarct TIMI Study Grp, Cardiovasc Div, Dept Med, Boston, MA 02115 USA; [Bonaca, Marc P.; Bhatt, Deepak L.; Magnani, Giulia; Fish, M. Polly; Im, Kyungah; Murphy, Sabina A.; Wiviott, Stephen D.; Braunwald, Eugene; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA USA; [Cohen, Marc] Rutgers New Jersey Med Sch, Newark Beth Israel Med Ctr, Dept Med, Cardiovasc Div, Newark, NJ USA; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ Fibrosis,INSERM,U1148, French Alliance Cardiovasc Trials,Inflammat,Remod, F-75877 Paris, France; [Steg, Philippe Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England; [Storey, Robert F.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Jensen, Eva C.; Bengtsson, Olof; Held, Peter] AstraZeneca, Molndal, Sweden; [Bansilal, Sameer] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ophuis, Ton Oude] Canisius Wilhelmina Hosp, Nijmegen, Netherlands; [Budaj, Andrzej] Grochowski Hosp, Postgrad Med Sch, Warsaw, Poland; [Theroux, Pierre] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Ruda, Mikhail] Cardiol Res Ctr, Moscow, Russia; [Hamm, Christian] Kerckhoff Heart Ctr, Bad Nauheim, Germany; [Hamm, Christian] Univ Giessen, D-35390 Giessen, Germany; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 25911, Japan; [Spinar, Jindrich] Univ Hosp, Brno, Czech Republic; [Nicolau, Jose Carlos] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Kiss, Robert G.] Mil Hosp, Dept Cardiol, Budapest, Hungary; [Alvarisqueta, A.; De Gennaro, N.] Ctr Investigac Med, Mar Del Plata, Argentina; [Alvarisqueta, A.; De Gennaro, N.] Ctr Invest Med, Mar Del Plata, Argentina; [Berli, M.; Roude, A. E.] CEDIR, Santa Fe, NM USA; [Di Gennaro, J. Albisu; Albisu, J. F.] Inst Cardiovasc San Luis, San Luis Obispo, CA USA; [Caccavo, A.; Torres, M.] Clin Coronel Suarez, Coronel Suarez, Argentina; [Cuadrado, J.; Bordoni, P.] Framingham Ctr Med, La Plata, Argentina; [Cuello, J.; Aviles, A.] Inst Invest Clin Bahia Blanca, Bahia Blanca, Buenos Aires, Argentina; [Glenny, A.; Recoaro, R.] AXISMED SRL, Buenos Aires, Argentina; [Fernandez, R.; Strada, B. N.] Sanatorio San Geronimo, Santa Fe, NM USA; [Fuentealba, V.; Gallo, C.] Hosp Cordoba, Cordoba, Argentina; [Duran, R. Garc-a; Garcia, C.] Inst Invest Clin San Nicolas, San Nicolas, Argentina; [Hominal, M.; Castoldi, M.] Ctr Invest Clin Litoral, Santa Fe, NM USA; [Jure, H.; Pacora, F. Ferre] Clin Chutro, Cordoba, Argentina; [Lorenzatti, A.; Martinez, J. M.] Fdn Rusculleda, Cordoba, Argentina; [Macin, S.; Cocco, N.] Inst Cardiol JF Cabral, Corrientes, Argentina; [MacKinnon, I.; Bagnato, M. B.] Inst Invest Clin Mar del Plata, Mar Del Plata, Buenos Aires, Argentina; [Marino, J.; Cusimano, S.] Ctr Med Consultan Salud, Haedo, Argentina; [Arias, V.; Focaccia, M.] Sanatorio Allende, Cordoba, Argentina; [Muntaner, J.; Mansilla, V.] Ctr Modelo Cardiol, San Miguel De Tucuman, Argentina; [Poy, C.] Sanatorio Parque SA, Rosario, Santa Fe, Argentina; [Prado, A.; Paterlini, G.] Invest Clin Tucuman, San Miguel De Tucuman, Argentina; [Montana, O.; Camino, A.] DIM Clin Privada, Ramos Mejia, Argentina; [Sala, J.; Luciani, C.] IIC Rosario, Rosario, Santa Fe, Argentina; [Vico, M.; Morell, Y.] Inst Invest Clin Zarate, Zarate, Argentina; [Dumont, C.; Vottero, E.] Hosp Italiano Garibaldi, Rosario, Argentina; [Zangroniz, P.; Viso, M. E.] Inst CAICI, Rosario, Argentina; [Lescano, A.; Morara, P.] Sanatorio San Jose, Buenos Aires, Argentina; [Marquez, L. Lobo; Patron, F. Risso] Inst Cardiol, San Miguel De Tucuman, Tucuman, Argentina; [Labarta, G. Bustamante; Sivila, C. D.] Sanatorio Nuestra Senora del Rosario, San Salvador de Jujuy, Argentina; [Quiroga, A. R.] Hosp Espanol Rosario, Rosario, Argentina; [Maffei, L.; Sassone, S.] Consultorios Asociados Endocrinol, Buenos Aires, DF, Argentina; [Rolandi, F.; Vesentini, N.] CENPEC Invest, Buenos Aires, DF, Argentina; [Carnero, G.; Del Verme, S.] IMEP Inst Med Elsa Perez, Ciudadela, Argentina; [Hershson, A.; Figal, J. C.] Fdn Favaloro Docencia & Invest Med, Buenos Aires, DF, Argentina; [Hii, C.; Smith, K.] Calvary Hosp ACT, Bruce, Australia; [Singh, B.; Acampo, M.] Launceston Gen Hosp, Launceston, Tas, Australia; [Rogers, J.; ODonoghue, M.] Gosford Hosp, Gosford, Australia; [Amerena, J.; Long, A.] Geelong Hosp, Geelong, Vic, Australia; [Amerena, J.; Long, A.] Geelong Hosp, Geelong, Vic, Australia; [Dart, A.; Kay, S.] Alfred Hosp, Melbourne, Vic, Australia; [Worthley, M.; Nimmo, J.] Cardiovasc Clin Trials, North Terrace, Adelaide, SA, Australia; [Lehman, R.; Morrison, H.] Adelaide Med Res, Ashford, Australia; [Dick, R.; Savage, C.] Victorian Heart Ctr, Richmond, Australia; [van Gaal, W.; Park, M.] Northern Hosp, Epping, NSW, Australia; [Blombery, P.; McCarthy, C.] Ave Cardiovascular Ctr, East St Kilda, Australia; [Oqueli, E.; Hill, D.] Ballarat Hlth Serv, Ballarat, Vic, Australia; [Sader, M.; Vrachas, D.] St George Hosp, Kogarah, NSW, Australia; [Purnell, P.; Vibert, J.] Joondalup Clinical Trial Fdn Inc, Joondalup, Australia; [Collins, N.; Gordon, A.] John Hunter Hosp, New Lambton Heights, Australia; [Arstall, M.; Rose, J.] Lyell McEwin Hosp, Elizabeth Vale, Australia; [Aroney, C.; Cleave, P.] Holy Spirit Private Hosp, Chermside, Australia; [Fitzpatrick, M.; Mackenzie, M.] Nepean Hosp, Kingswood, NSW, Australia; [Garrahy, P.; Hall, C.] Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [Nelson, G.; Reid, E.] Royal North Shore Hosp, St Leonards, NSW, Australia; [Lee, A.; Gibbs, J.] Wollongong Hosp, Wollongong, NSW, Australia; [Thompson, P.; Crittenden, J.] Sir Charles Gairdner Hosp, Nedlands, WA, Australia; [Hammett, C.; Hindom, L.] Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Antonis, P.; Manzoney, A.] Monash Med Ctr, Clayton, Vic, Australia; [Cross, D.; Pollard, C.] Wesley Hosp, Auchenflower, Australia; [Brieger, D.; Wu, J.] Concord Repatriat Gen Hosp, Concord, Australia; [Whelan, A.; Tulloch, G.] Fremantle Hosp, Fremantle, WA, Australia; [Taylor, A.; Smith, B.] Greenslopes Private Hosp, Greenslopes, Australia; [Horowitz, J.; Black, M.] Queen Elizabeth Hosp, Woodville, SA, Australia; [Boland, J.; Malmendier, D.] CHR Citadelle, Liege, Belgium; [Celen, H.; Wendelen, E.] Regionaal Ziekenhuis Heilig Hart, Leuven, Belgium; [Claeys, M.; Pieter, M.] UZ Antwerpen, Edegem, Belgium; [Cools, F.; Simons, N.] AZ Klina, Brasschaat, Belgium; [De Maeseneire, S.] AZ Sint Elisabeth, Zottegem, Belgium; [De Wolf, L.; Brike, C.] Dr De Wolf, Tienen, Belgium; [Dubois, P.; Bolado, A. Conde Y.] CHU Charleroi, Charleroi, Belgium; [Foading-Deffo, B.; Tahon, S.] BHC Site Clin St Jean Brussels, Brussels, Belgium; [Friart, A.; Arend, C.] CHU Tivoli, La Louviere, Belgium; [Gevaert, S.; Verdegem, P.] UZ Gent, Ghent, Belgium; [Marechal, P.; Gits, F.] Ctr Hosp Reg Huy, Huy, Belgium; [Pierard, L.; Celentano, C.] CHU Sart Tilman, Liege, Belgium; [Pirenne, B.; Bouvy, C.] Brussels Heart Ctr Site Clin St Pierre Ottignies, Ottignies, Belgium; [Renkin, J.; Huyberechts, D.] Clin Univ St Luc UCL, Brussels, Belgium; [Sinnaeve, P.; De Velder, L.] UZ Leuven Gasthuisberg, Leuven, Belgium; [Stammen, F.; Casier, T.] H Hartziekenhuis Roeselare Menen vzw, Roeselare, Belgium; [Striekwold, H.; Van den Broeck, D.] Heilig Hartziekenhuis Mol, Mol, Belgium; [Thoeng, J.; Goris, R.] AZ Turnhout Campus St Elisabeth, Turnhout, Belgium; [Timmermans, P.; Collard, S. -J.] Clin St Luc Bouge, Bouge, Belgium; [van de Borne, P.; De Clippel, M.] Clin Univ Bruxelles Hop Erasme, Brussels, Belgium; [Jacobs, C.] ZNA Middelheim, Antwerp, Belgium; [Vankelecom, B.; Daelemans, Y.] Imelda Ziekenhuis, Bonheiden, Belgium; [Vervoort, G.; Drieghe, S.] AZ St Maarten Mechelen, Mechelen, Belgium; [Vranckx, P.; Janssen, A.] Virga Jesse Ziekenhuis, Hasselt, Belgium; [Vrolix, M.; I., Simenon] Ziekenhuis Oost Limburg Campus St Jan, Genk, Belgium; [Wijns, W.; Delacroix, H.] Onze Lieve Vrouw Hosp, Aalst, Belgium; [Wollaert, B.; Denie, D.] ZNA Stuivenberg, Antwerp, Belgium; [Schoors, D.; Lemoine, I.] UZ Brussel, Brussels, Belgium; [Cornelis, K.; Willems, A. -M.] AZ Maria Middelares Campus Maria Middelares, Ghent, AZ, Belgium; [Schroder, E.; Domange, J.] CHU Mont Godinne, Yvoir, Belgium; [Greque, G.; Machado, H.] Assoc Portuguesa Beneficencia Sao J R Preto, Sao Jose Do Rio Preto, Brazil; [Armaganijan, D.; Del Monaco, M. I.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [da Silva, D.; Nakazone, R.] Univ Hosp UFMS, Campo Grande, Brazil; [Dutra, O.; R., Vaz] Inst Cardiol Rio Grande Do Sul, Porto Alegre, RS, Brazil; [Daher, R.; Rodrigues, D.] ICM Inst Coracao Marilia, Marilia, Brazil; [Guimaraes, A.; Teixeira, A.] Hosp Fed Bonsucesso, Rio De Janeiro, Brazil; [Saraiva, J.; Costa, M.] Hosp Maternidade Celso Pierro PUCCAMP, Campinas, Brazil; [Leaes, P.; Blacher, M.] Irmandade Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil; [Maia, L.; Nakazone, MA.] Hosp Base FAMERP SJRP UCOR, Sao Jose Do Rio Preto, Brazil; [Manenti, E.; Ruschel, K.] Hosp Mae Deus, Porto Alegre, RS, Brazil; [Marin-Neto, J.; Pavao, R.] Hosp Clin Fac Med Ribei, Ribeirao Preto, Brazil; [Junior, A. Alves; Oliveira, G.] Fdn Baiana Cardiol, Salvador, BA, Brazil; [Rassi, S.; Sampaio, D.] Hosp Clin Univ Fed Goias, Goiania, Go, Brazil; [Rossi, P. R.; dos Santos, L.] Nucl Pesquisa Clin S S, Curitiba, Parana, Brazil; [de Souza, J.; Lino, E.] Inst Cardiol Distrito Fed, Brasilia, DF, Brazil; [Pimentel Filho, P.; Zucchetti, C.] Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil; [Gomes, M.; de Paiva, A.] Clinicor, Maceio, Brazil; [Sousa, A. C.; Almeida, A.] Hosp Sao Lucas, Aracaju, Brazil; [Botelho, R.; da Silva, R.] Inst Coracao Triangulo Mineiro, Uberlandia, MG, Brazil; [Giraldez, R.; Franken, M.] Inst Coracao INCOR, Sao Paulo, Brazil; [Faludi, A.; Bertolami, M.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Hernandes, M.; Lucas, N.] Santa Casa Votuporanga, Votuporanga, Brazil; [Carvalho, A.; Bertolami, A.] UNIFESP Univ Fed Sao Paulo, Sao Paulo, Brazil; [Precoma, D.; Geralde, L.] Soc Hop Angelina Caron, Campina Grande do Sul, Brazil; [Pereira, A.] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Cesar, L.; Mioto, B.] INCOR Inst Coracao, Sao Paulo, Brazil; [Marino, R.; Rabelo, W.] Cardiol Clin & Intervencionista S C Ltd, Belo Horizonte, MG, Brazil; [dos Santos, F.; Vidotti, M. H.] Loema Inst Pesquisa Clin, Campinas, Brazil; [Mangione, J.; Mauro, M.] Real Benemerita Ass Portuguesa Beneficencia, Sao Paulo, Brazil; [Kormann, A.; Ultramari, F.] Soc Div Providencia Hosp Santa Isabel, Blumenau, Brazil; [Zimmermann, S.; Zimmermann, E.] Clin Procardio Ltd, Blumenau, Brazil; [Michalaros, Y.; Fonseca, M.] Liga Mineira Ressuscitacao Cardiopulmonar, Belo Horizonte, MG, Brazil; [Sampaio, C.; Eliaschewitz, F.] CPCLIN Ctr Pesquisa Clin, Sao Paulo, Brazil; [Barbosa, E.; Drews, C.] Hosp Moinhos Vento, Porto Alegre, RS, Brazil; [de Lorenzo, A.; Barros, C.] Inst Nacl Cardiol, Rio De Janeiro, Brazil; [Cancado, G.; Neuesnchwander, F.] Hosp Vera Cruz, Belo Horizonte, MG, Brazil; [Benov, H.; Vasileva, D.] MHAT Dr St Cherkezov, Veliko Tarnovo, Bulgaria; [Chompalova, B.; Parishev, G.] MHAT Plovdiv, Plovdiv, Bulgaria; [Denchev, S.; Milcheva, N.] UMHAT Aleksandrovska, Sofia, Bulgaria; [Gocheva, N.; Avramov, D.] Natl Heart Hosp Clin Cardiol, Sofia, Bulgaria; [Mihov, A.; Miteva, B.] MHAT Sveta Ekaterina, Ist Dpt Internal Dis, Dimitrovgrad, Bulgaria; [Mincheva, V.; Stoyanovski, V.] NMH Tsar Boris III, Sofia, Bulgaria; [Pencheva, G.] IV MHAT Sofia, Sofia, Bulgaria; [Gelev, V.; Nikolova, L.] MHAT Tokuda Hosp Sofia Cardiol Clin, Sofia, Bulgaria; [Tisheva, S.; Stancheva, N.] UMHAT Dr Georgi Stranski Cardiol & Rheumatol, Pleven, Bulgaria; [Todorov, G.; Nyagina, M.] II MHAT Sofia ICU Internal Dis, Sofia, Bulgaria; [Goudev, A.; Markov, D.] UMHAT Tsaritsa Yoanna, Sofia, Bulgaria; [Parvanova, Z.; Spirova, D.] II MHAT Sofia, Sofia, Bulgaria; [Peneva, Y.] DCC Russe, Ruse, Bulgaria; [Todorova, M.; Peshkov, O.] DCC Akta Medika, Sevlievo, Bulgaria; [Mitkova, M.; Mitkova, L.] DCC IV Varna, Varna, Bulgaria; [Smilov, L.; Mandzhukova, S.] DCC Akta Medika Smilov, Sevlievo, Bulgaria; [Yakovova, S.; Rangelova, V.] DCC II Sofia, Sofia, Bulgaria; [Milanova, K.; Ivanov, K.] DCC VII Sofia, Sofia, Bulgaria; [Aleksov, N.; Krusheva, B.] MHAT Rahila Angelova, Pernik, Bulgaria; [Mollov, M.; Raycheva, V.] I MHAT Sofia, Sofia, Bulgaria; [Gergova, V.] DCC Ascendent, Sofia, Bulgaria; [Shishmanova, D.; Goranov, K.] DCC Greenberg, Sofia, Bulgaria; [Stoykov, A.] MHAT Vita, Sofia, Bulgaria; [Hristova, K.; Staleva, M.] Med Ctr Syrce zdrave, Sofia, Bulgaria; [Uzunangelov, Y.; Rashkova, V.] UMHAT Dr Georgi Stranski, Pleven, Bulgaria; [Postadzhian, A.] MHAT Sveta Anna, Sofia, Bulgaria; [Peltegov, V.; Krancheva, V.] MHAT Razlog, Razlog, Bulgaria; [Karamitev, G.; Lulova, E.] MHAT Ivan Skenderov, Gotse Delchev, Bulgaria; [Bertrand, O.; Jadin, M.] Inst Univ Cardiol & Pneumol, Quebec City, PQ, Canada; [Cantor, W.; Robbins, K.] York PCI Res, Newmarket, ON, Canada; [Constance, C.; Gauthier, M. -F.] Clin Sante Cardio MC, Montreal, PQ, Canada; [Gosselin, G.; Masson, C.] CCRC Pierre Gardeur, Terrebonne, PQ, Canada; [Reyes, V.; Tishler, S.] Mississauga Clin Res Ctr Inc, Mississauga, ON, Canada; [Marr, D.; O'Blenis, G.] St John Med Clin, Saint John, NB, Canada; [Pandey, A. S.; Clarus, S.] Cambridge Cardiac Care Inc, Cambridge, ON, Canada; [Pesant, Y.; Sardin, V.] St Jerome Med Res Inc, St Jerome, PQ, Canada; [Pouliot, J.; Marquette, S.] CSSS Vallee LOr, Val dOr, PQ, Canada; [Gladstone, P.; Bozek, B.] Scarborough Cardiol Res, Scarborough, ON, Canada; [McPherson, T.; Spurrell, D.] Hlth Sci Ctr, St John, NF, Canada; [Rupka, D.; Thiessen, S.] Fraser Clin Trials, New Westminster, BC, Canada; [Saw, J.; Fox, R.] Vancouver Hosp, Vancouver, BC, Canada; [St-Amour, E.; Tremblay, I.] Q & T Res Outaouais Inc, Gatineau, PQ, Canada; [Syan, R.; Samms, S.] G S Cardiac Lab Med Professional Corp, Sudbury, ON, Canada; [Syan, R.; Samms, S.] Off Dr Rajinder Syan, Sarnia, ON, Canada; [Rosenbloom, A.; Ross, B.] SGH Cardiol Res Ass, Scarborough, ON, Canada; [Vizel, S.; Solomon, P.] Vizel Cardiac Res, Cambridge, ON, Canada; [Della Siega, A.; Nelson, S.] Victoria Heart Inst Fdn, Victoria, BC, Canada; [Halperin, F.; Roberts, P.] Cardiol Associates, Kelowna, BC, Canada; [Nigro, F.; Forsyth, C.] Intermountain Res Consultants, Thunder Bay, ON, Canada; [Chehayeb, R.; Lepage, C.] Viacar Rech Clinique Inc, Greenfield Park, PQ, Canada; [Fell, D.; McPherson, C.] Newmarket Cardiol Res Grp, Newmarket, ON, Canada; [Labonte, R.; Dewar, C.] Dr R Labonte Professional Med Corp, Sudbury, ON, Canada; [Nawaz, S.; Dewar, C.] Sudbury Cardiac Res, Sudbury, ON, Canada; [Gupta, M.; Dela Cruz, C.] Brampton Res Associates, Brampton, ON, Canada; [Ma, P.; Glanz, A.] Heart Hlth Res 611916 Alberta Ltd, Calgary, AB, Canada; [Glanz, A.; Vilag, C.] Glanz Med Professional Corp, Windsor, ON, Canada; [Kouz, S.; Roy, M.] Ctr Hospitalier Reg Lanaudiere, St Charles Borromee, PQ, Canada; [Bhargava, R.; Stata, C.] Heart Care, Oshawa, ON, Canada; [Dion, D.; Morissette, A.] CSSS Beauce, St Georges Beauce, PQ, Canada; [Dupuis, R.; Ouimet, F.] CSSSRT, Thetford Mines, PQ, Canada; [Grondin, F.; Bilodeau, N.] Clin Cardiol Levis, Levis, PQ, Canada; [Wong, B.; Dewar, C.] Brian L Wong Med Professional Corp, Sudbury, ON, Canada; [Sabbah, E.; Chausse, I.] CDRC Rive Sud, Longueuil, PQ, Canada; [Hui, W.; Kvill, L.] Royal Alexandra Hosp, Edmonton, AB, Canada; [Belisle, P.; Chartrand, M. -J.] CSSS Chicoutimi, Chicoutimi, PQ, Canada; [Tymchak, W.; Harris, L.] Univ Alberta Hosp, Edmonton, AB, Canada; [Montigny, M.; Bolduc, H.] Ctr Sante & Serv Sociaux Laval, Laval, PQ, Canada; [Lonn, E.; Magi, A.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Bose, S.; Jule, P.] Downtown Med Specialists, Saskatoon, SK, Canada; [Kincade, D.; Valley, S.] Penticton Regional Hosp, Penticton, BC, Canada; [Gallo, R.; Morrissette, J.] Montreal Heart Inst, Montreal, PQ, Canada; [Lamy, A.; Power, P.] Hamilton Hlth Sci Gen Hosp, Hamilton, ON, Canada; [Bell, A.; Kailey, P.] Keele Med Pl, Toronto, ON, Canada; [LeMay, M.; Thomas, A.] Univ Ottawa Heart Inst, Ottawa, ON, Canada; [Bata, I.; Wright, D.] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Kostuk, W.; Carr, S.] London Hlth Sci Ctr, London, ON, Canada; [Cheung, S.; Cleveland, T.] Dr Stephen S Cheung Inc, Surrey, BC, Canada; [Petrella, R.; Dihel, C.] Lawson Hlth Res Inst, London, ON, Canada; [Lubelsky, B.; Coldwell, J.] Dr Bruce Lubelsky MD, Toronto, ON, Canada; [Berlingieri, J.; Schellenberg, S.] JBN Med Diagnostic Serv Inc, Burlington, ON, Canada; [Fortin, C.; Viau, C.] Neufort Inc, St Lambert, PQ, Canada; [DeYoung, J. P.; Watt, M.] Cornwall Clin Trials, Cornwall, ON, Canada; [Babapulle, M.; Corke, R.] Mohan Babapulle Med Professional Corp, Kitchener, ON, Canada; [Landry, D.; Shea-Landry, G.] G A Res Associates Ltd, Moncton, NB, Canada; [Gupta, A.; Gandhi, A.] Dr Anil K Gupta Med Professional Corp, Toronto, ON, Canada; [Prieto, J. C.; Noriega, V.] Hosp Clin Univ Chile, Santiago, Chile; [Cobos, L.; Obreque, C.] CARDIOCOB, Santiago, Chile; [Potthof, S.; Zapata, J.] Corp Beneficencia Osorno, Osorno, Chile; [Lucero, F.; Luque, M.] Hosp San Borja Arriran, Santiago, Chile; [Pincetti, C.; Torres, G.] Ctr Investigac Med Sur, Temuco, Chile; [Yanez, M.; Vasquez, C.] Hosp Naval Almirante Nef, Vina del Mar, Chile; [Manriquez, L.; Espinoza, M. J.] Hosp Reg Rancagua, Rancagua, Chile; [Yovaniniz, P.; Grandon, M.] Hosp Barros Luco, Santiago, Chile; [Castro, P.; Llevaneras, S.] Ctr investigac Clin Univ Catol, Santiago Centro, Chile; [Lanas, F.; Hidalgo, J.] Ctr Etudios Cardiol, Temuco, Chile; [Arriagada, G.; Villan, C.] Hosp Reg Concepcion, Concepcion, Chile; [Florenzano, F.; Chacon, M. V.] Psicomedica, Santiago, Chile; [Rodriguez, M.; Barreda, B.] Hosp Dr Sotero del Rio, Santiago, Chile; [Raffo, C.; Reyes, T.] Estudios Clin V Region CINVEC, Vina del Mar, Chile; [Hu, D.; Liu, W.] Peoples Hosp Peking Univ, Beijing, Peoples R China; [Tan, N.; Feng, Y.] Guangdong Gen Hosp, Guangzhou, Peoples R China; [Dong, Y.; Yang, D.] Affiliated Hosp Sun Yat Sen Univ Heart 1, Guangzhou, Peoples R China; [Liao, Y.; Wei, F.] Wuhan Union Hosp, Wuhan, Peoples R China; [Wei, M.; Yan, M.] Peoples Hosp Affiliated Shanghai Jiaoto 6, Shanghai, Peoples R China; [Yan, X.; Wang, S.] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Chen, Y.; Li, Y.] Beijing 301 PLA Hosp, Beijing, Peoples R China; [Yuan, Z.; Xiong, Y.] Affiliated Hosp Xian Jiaotong Univ Cardio 1, Shanxi, Peoples R China; [Zhu, J.; Li, S.] Affiliated Hosp Zhejiang Univ 1, Hangzhou, Peoples R China; [Ma, G.; Chen, L.] Zhongda Hosp Southeast Univ, Nanjing, Peoples R China; [Li, Z.; Liu, Y.] Peoples Hosp Liaoning Prov, Shenyang, Peoples R China; [Yang, X.; Xiong, W.] Beijing Chao Yang Hosp, Beijing, Peoples R China; [Chen, Y.; Pang, W.] Shengjing Hosp China Med Univ, Shenyang, Peoples R China; [Lu, G.; Chen, Z.] Shanghai Ruijin Hosp, Shanghai, Peoples R China; [Zhao, S.; Zhou, H.] Second Xiangya Hosp, Changsha, Peoples R China; [Huang, J.; Gang, Y.] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Yang, X.; Chai, Y.] Hosp Shanxi Med Univ 2, Taiyuan, Peoples R China; [Zhang, Z.; Mu, Z.] First Affiliated Hosp Lanzhou Univ, Lanzhou, Peoples R China; [Hernandez, E.; Mora, C.] Fdn CardioInfantil, Bogota, Colombia; [Maria, E.; Catalan, Y.] CARDIOLAB, Barranquilla, Colombia; [Reynales, H.; Huertas, D.] CAIMED, Bogota, Colombia; [Molina, D.; Rendon, N.] IPS Med Internistas Caldas, Manizalez, Colombia; [Sanchez, G.; Tellez, R.] Ctr Estudios Clin Quindio, Armenia, Colombia; [Botero, R.; Salazar, P.] IPS Rodrigo Botero SAS, Medellin, Colombia; [Vesga, B.; Delgado, P.] Inst Corazon Bucaramanga, Bucaramanga, Colombia; [Herrera, M.; Perez, D.] Unidad Cardiolog Cartagena, Cartagena, Colombia; [Jaramillo, N.; Toloza, R.] CEMDE Fdn Ciencia Vital, Medellin, Colombia; [Orozco, A.; Bustamante, Y.] FOQUS, Bogota, Colombia; [Jaramillo, C.; Garces, G.] Incare, Medellin, Colombia; [Saaibi, J.; Castillo, J.] Fdn Cardiovascular Colombia, Bucaramanga, Colombia; [Arana, C.; Gonzalez, M.] Ctr Investigac Clin SAS, Cali, Colombia; [Urina, M.; Ramirez, N.] Fdn Caribe Investigac Biomed, Barranquilla, Colombia; [Manzur, F.; Rosales, D.] Ctr Diagnost Cardiol LTDA, Cartagena, Colombia; [Quintero, A.; Gonzalez, E.] Ctr Cardiovasc Colombiano Clin Santa Maria, Medellin, Colombia; [Accini, J.; Reyes, M.] IPS Jose Luis Accini Ctr Cient Asisitencial SAS, Barranquilla, Colombia; [Elbl, L.] Kardiol ambulance, Brno, Czech Republic; [Malecha, J.; Stanek, L.] Ordinace pro choroby srdce, Chomutov, Czech Republic; [Jerabek, O.] Kardiol ambulance, Pribram, Czech Republic; [Kos, P.] Kardiol ambulance, Pelhrimov, Czech Republic; [Lubanda, H.; Zidkova, E.] Poliklin Lipa, Prague 5, Czech Republic; [Vlckova, D.; Naplava, R.] Lunacor s r o, Kromeriz, Czech Republic; [Ludka, O.; Ludkova, A.] Privatni int ambulance, Brno, Czech Republic; [Kuchar, J.] Kardiol MUDr Jiri Kuchar, Cesky Krumlov, Czech Republic; [Wasserburger, B.; Sperlingova, B.] DIKa centrum s r o, Havirov, Czech Republic; [Linhart, A.] VFN Praze II int klin, Prague 2, Czech Republic; [Soucek, M.; Rihacek, I.] Centrum pro zdravi s r o Lekarsky dum Hlinky, Brno, Czech Republic; [Poloczek, M.; Spinar, J.] FN Brno, Brno, Czech Republic; [Panovsky, R.; Spinarova, L.] Fak nemocnice sv Anny, Brno, Czech Republic; [Bren, J.] Nemocnice Kyjov, Kyjov, Czech Republic; [Macha, J.; Cermak, O.] Nemocnice Slany, Slany, Czech Republic; [Grunfeldova, H.; Svobodova, I.] Mestska nemocnice Caslav, Caslav, Czech Republic; [Zanova, M.; Monhart, Z.] Nemocnice Znojmo, Znojmo, Czech Republic; [Zarembova, J.; Pleva, L.] Fak nemocn poliklin Ostrava, Ostrava, Czech Republic; [Sembera, Z.; Polasek, R.] Krajska nemocn Liberec, Liberec, Czech Republic; [Dedek, V.] Orlickoustecka nemocnice, Usti Nad Orlici, Czech Republic; [Janota, T.] VFN Praze 3 interni klin, Prague 2, Czech Republic; [Sipula, J.; Stipal, R.; Hanak, P.; Matyasek, I.] Kardiol Ambulance Ostrava, Ostrava, Czech Republic; [Kolmas, P.; Kucera, D.] Kardiol Angiol Ambulance, Ostrava Vitkovice, Czech Republic; [Bednarova, J.; Broulova, P.; Petrova, I.] Kardiol Ambulance Usti Nad Labem, Usti Nad Labem, Czech Republic; [Lukac, M.] Nefromed s r o, Prague 6, Czech Republic; [Turkova, N.; Reichert, P.] Reg Hlth Care, Teplice Hospital, Teplice, Czech Republic; [Bouchal, P.; Brychta, T.] Privatni Kardiol Ambulance, Brno, Czech Republic; [Krocova, E.; Machova, V.] InterKardioML, Marianske Lazne, Czech Republic; [Marusincova, I.] Kardio Sever, Ceska Lipa, Czech Republic; [Steg, P. -G.; Oudghiri, M.] Ho Bichat, Paris, France; [Montalescot, G.; Bertin, B.] CHU Pitie Salpetriere, Paris, France; [Macquin-Mavier, T.; Beitar, T.] Hop Henri Mondor, Creteil, France; [Khalife, K.; Merkling, D.] CHR Metz Thionville, Hop Mercy, Metz, France; [Galley, D.; Beltra, C.] Ctr Hosp Albi, Albi, France; [Elhadad, S.; Maubert, A.] CH Marne Vallee, Jossigny, France; [Decoulx, E.; El Jarroudi, M.] Ctr Hosp Gustave Dron, Tourcoing, France; [Cottin, Y.; Bichat, F.] CHU Dijon, Hop Bocage, Dijon, France; [Coisne, D.; Berger, N.] CHU Miletrie, Poitiers, France; [Bonnet, J. -L.; Fiacchetti, C.] CHU Timone, Marseille, France; [Ferrari, E.; Douillet, M.] Hop Louis Pasteur, Nice, France; [Range, G.; Laure, C.] Ctr Hosp Louis Pasteur, Le Coudray, France; [Cayla, G.; Leperchois-Jacquey, C.] CHU Caremeau, Nimes, France; [Goralski, M.; Miran, S.] CHR Orleans, Hop Source, Orleans, France; [Furber, A.; Cornet, C.] CHU Angers, Angers, France; [Elbaz, M.; Rosolin, N.] CHU Rangueil, Toulouse, France; [Aboyans, V.; Pradel, V.] CHU Dupuytren, Limoges, France; [Poulard, J. -E.; Leparree, S.] Ctr Hosp Gen Abbeville, Abbeville, France; [Zemour, G.; Doux, N.] CH Cannes, Cannes, France; [Labeque, J. -N.] Clin Lafourcade, Bayonne, France; [Hirsch, J. -L.; Sevilla, J.] Hop Henri Duffaut, Avignon, France; [Vaquette, B.; Laurencon, V.] Ctr Hosp St Louis, La Rochelle, France; [Livarek, B.; Georges, J. L.] Ctr Hosp Versailles, Le Chesnay, France; [Igigabel, P.; Gilard, V.] Cabinet Med, Tierce, France; [Lafitte, S.; Duprat, C.] Hop Haut Leveque, Pessac, France; [Hamm, C.; Kisselbach, C.] Kerckhoff Klin GmbH, Bad Nauheim, Germany; [Giannitsis, E.] Univ Klin, Heidelberg, Germany; [Schenkenberger, I.; Dreykluft, K.] KFB Klin Forsch Berlin, Berlin, Germany; [Appel, K. -F.; Becker, P.] Ambulantes Herzzentrum Kassel, Kassel, Germany; [Toursarkissian, N.; Scheuren, A.] Praxis Dr Med Nicole Toursarkissian, Berlin, Germany; [Bott, J.; Erdas, M.] Praxis Dr Med Jochen Bott, Berlin, Germany; [Nischik, R.; Wipper, J.] Studienambulanz medamed GmbH, Leipzig, Germany; [Schmidt, E.; Schmidt, A.] Cardiol Hamburg, Hamburg, Germany; [Jung, T.; Henzler, A.] Praxis Dr Med Thomas Jung, Deggingen, Germany; [Steiner, S.; Winter, K.] St Vincenz Hosp, Limburg, Germany; [Fischer, S.] Praxisgemeinschaft Dres Fischer, Leipzig, Germany; [Khariouzov, A.; Kopf, S.] Klin Forsch Berlin Buch, Berlin, Germany; [Heuer, H.; Laschewski, B.] St Johannes Hosp, Dortmund, Germany; [Kadel, C.; Rahn, G.] Staedt Klin Frankfurt Main Hoechst, Frankfurt, Germany; [Hanefeld, M.; Schrapel, C.] Zentrum Klin Studien GWT TU Dresden, Dresden, Germany; [Weil, J.; Miodek, M.] SANA Klin Lubeck, Lubeck, Germany; [Koenig, W.; Hildenbrand, S.] Univ Ulm, Ulm, Germany; [Horacek, T.; Fink, P.] Forschungszentrum Ruhr, Witten, Germany; [Muenzel, T.; Gebel, G.] Univ Mainz Klin, Mainz, Germany; [Brachmann, J.; Goebel, U.] Klin Coburg, Coburg, Germany; [Weber, D.; Siepmann, C.] Praxis Dr Med Weber, Essen, Germany; [Wittlich, N.; Drexler, A.] Cardio Praxis Mainz Ingelheim, Mainz, Germany; [Stellbrink, C.; Iselt, M.] Staedt Klin Bielefeld, Bielefeld, Germany; [Duengen, H. -D.; Maiwald, A.] Campus Virchow Klin Charite Berlin, Campus Virchow Klinikum Charite Berlin, Berlin, Germany; [Leschke, M.; Blaich, B.] Staedt Klin Esslingen, Esslingen, Germany; [Zeymer, U.; Baumann, S.] Herzzentrum Ludwigshafen, Ludwigshafen, Germany; [Dorsel, T.; Iselt, M.] Josephs Hosp Warendorf, Warendorf, Germany; [Voehringer, H. -F.; Gebhardt, S.] DRK Klin Berlin Koepenick, Berlin, Germany; [Dissmann, M.; Kazcmarek, N.] Vivantes Humboldt Klin, Berlin, Germany; [vom Dahl, J.; Krug-Hoeren, B.] Kliniken Maria Hilf GmbH, Monchengladbach, Germany; [Traeubler, B.; Borst, M.] Caritas Krankenhaus, Bad Mergentheim, Germany; [Derwahl, K. -M.; Nicula, D.] IKFE GmbH St Hedwig Krankenhaus, Berlin, Germany; [Trenk, D.; Reichenbach, D.] Univ Herzzentrum Bad Krozingen, Bad Krozingen, Germany; [Frey, N.; Langer, C.] Univ Klin Schleswig Holstein Campus Kiel, Kiel, Germany; [Schroeder, T.; Kiroglu, K.] Drs Schroeder Brockhoff, Hamburg, Germany; [Foerster, A.; Riedel, S.] Praxis Dr Med Andreas Foerster, Berlin, Germany; [Bartels, R.; Schulte, M.] Praxis Westend Berlin, Berlin, Germany; [Katona, A.; Erdei, F.] Bekes Megyei Pandy Kalman Korhaz, Gyula, Hungary; [Vertes, A.; Sebo, J.] Egyesitett Szent Istvan & Szent Laszlo Korhaz, Budapest, Hungary; [Kiss, R.; Korda, A.] Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary; [Turi, T.] Fejer Megyei Szent Gyorgy Korhaz, Szekesfehervar, Hungary; [Merkely, B.; Becker, D.] Semmelweis Egyet, Budapest, Hungary; [Ungi, I.; Kalapos, A.] Szegedi Tudomanyegyetem, Szeged, Hungary; [Kiraly, C.; Bosko, M.] Bacs Kiskun Megyei Korhaz, Kecskemet, Hungary; [Zolyomi, S.; Pap, G.] Szent Kereszt Korhaz Kalocsa, Kalocsa, Hungary; [Horvath, I.; Magyari, B.] Pecsi Tudomanyegyetem Klin Kozpont, Pecs, Hungary; [Lupkovics, G.; Basa, A.] Zala Megyei Korhaz, Zalaegerszeg, Hungary; [Edes, I.; Jenei, C.] Debreceni Egyet Orvos Egeszsegtudomanyi Centrum, Debrecen, Hungary; [Simon, E.; Bakai, J.] Soproni Erzsebet Oktato Korhaz & Rehabil, Sopron, Hungary; [Czuriga, I.; Unterberger, K.] Kenezy Gyula Korhaz Rendeloint, Debrecen, Hungary; [Laszlo, Z.; Vas, K.] Szent Janos Korhaz & Eszak Budai Egyesitett Korha, Budapest, Hungary; [Kancz, S.; Fulop, G.] Gottsegen Gyorgy Orszagos Kardiologiai Int, Budapest, Hungary; [Takacs, J.; Nagy, M. A.] TaNa Med Kft, Mosonmagyarovar, Hungary; [Papp, A.; Takacs, A.] Szt Rokus Korhaz, Budapest, Hungary; [Czigany, A.; Mate, Z.] Nyiro Gyula Korhaz, Budapest, Hungary; [Muller, G.; Szilagyi, A.] Markhot Ferenc Oktatokorhaz & Rendel, Eger, Hungary; [Tas, A. Sipos; Nagy, K.] Rethy Pal Korhaz Rendel, Bekescsaba, Hungary; [Polgar, P.; Svab, M.] Szabolcs Szatmar Bereg megyei Korhazak, Nyiregyhaza, Hungary; [Jilling, M. Jozan; Kis, E.] Tolna Megyei Balassa Janos Korhaz, Szekszard, Hungary; [Bartal, G.; Horthy, R.] Dr Kenessey Albert Korhaz Rendel, Balassagyarmat, Hungary; [Kerkovits, A.; Kantor, F.] Szent Imre Korhaz, Budapest, Hungary; [Bodi, M.; Sperr, E.] Peterfy Sandor Korhaz, Budapest, Hungary; [Benczur, B.; Bajcsi, E.] Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz, Szolnok, Hungary; [Valco, J.; Bujdoso, A.] Toldy Ferenc Korhaz & Rendelointezet, Cegled, Hungary; [Ardissino, D.; Notarangelo, F.] Azienda Ospedaliera Univ Parma, Parma, Italy; [Martina, P.; Stefanin, C.] Osped Civile Legnano, Legnano, Italy; [Fiscella, A.; Giacoppo, M.] Azienda Ospedaliera Cannizzaro, Catania, Italy; [Marenzi, G.; Rubino, M.] Ctr Cardiol Monzino IRCCS, Milan, Italy; [Tamburino, C.; Dammino, L.] Osped Ferrarotto, Catania, Italy; [Terrosu, P.; Chessa, P.] Osped SS Annunziata, Sassari, Italy; [Presbitero, P.; Di Pizzo, A.] Ist Clinico Humanitas, Rozzano, Italy; [Cuccia, C.; Musmeci, G.] Fondaz Poliambulanza Ist Ospedaliero, Brescia, Italy; [Bovenzi, F.; Mazzoni, A.] Presidio Osped Campo Marte Lucca, Lucca, Italy; [Berti, S.; Tyack, K.] Ist Fisiol Clin CNR Pisa, Pisa, Italy; [Colivicchi, F.; Aiello, A.] Osped San Filippo Neri, Rome, Italy; [Paloscia, L.; Mascellanti, M.] Osped Civile Spirito Santo, Pescara, Italy; [Scherillo, M.; Formigli, D.] Azienda Ospedaliera G Rummo, Benevento, Italy; [Tartaglione, S.; Guglielmino, G.] Osped Civile Sanremo, San Remo, Italy; [Della Rovere, F.; Bernabo, P.] Osped Galliera, Genoa, Italy; [De Cesare, N.; Bocciarelli, M.] Policlin San Marco, Zingonia, Italy; [Manari, A.; De Iaco, G.] Cardiol Interventist, Reggio Emilia, Italy; [Astarita, C.; Russo, G.] Osped Sorrento, Sorrento, Italy; [Oltrona, L.; Rizzotti, D.] Osped Policlinico San Matteo, Pavia, Italy; [Marzilli, M.; Orsini, E.] A O U Pisana Osped Cisanello, Pisa, Italy; [Merlini, P.; Babbolin, M.] Osped Niguarda Ca Granda, Milan, Italy; [Celentano, A.; De Divitiis, M.] Osped Pellegrini, Naples, Italy; [Di Sciascio, G.; Patti, G.] Univ Campus Biomed, Rome, Italy; [Pajes, G.; Monti, F.] Osped San Giuseppe, Rome, Italy; [Silvestri, O.; Silvestri, N.] Osped Cardarelli, Naples, Italy; [Delfino, R.; Valbusa, A.] Osped San Martino Genova, Genoa, Italy; [Bassani, F.; Lazzarotti, M.] Osped Vimercate, Vimercate, Italy; [Puccetti, L.] Osped Santa Maria Scotte, Siena, Italy; [Cavallini, C.; Grikstaite, E.] A O Silvestrini, Perugia, Italy; [Patrizi, G.] Osped B Ramazzini, Carpi, Italy; [Fattore, L.; Bosco, B.] Presidio Ospedaliero San Giuseppe Melorio, Santa Maria Capua Vetere, Italy; [Di Lorenzo, L.; Marchegiano, R.] Osped San Rocco, Sessa Aurunca, Italy; [Takenaka, T.; Teranishi, J.] NHO Hokkaido, Med Ctr, Sapporo, Hokkaido, Japan; [Ono, M.; Sakuma, K.] So TOHOKU, Med Clin, Koriyama, Fukushima, Japan; [Suzuki, M.; Abe, Y.] NHO Saitama Natl Hosp, Wako, Saitama, Japan; [Hasegawa, K.; Suzuki, A.] Sayama Sogo Clin, Sayama, Osaka, Japan; [Domae, H.; Yamazaki, A.] Med Corp Tokushukai Tokyo Nishi Tokushukai Hosp, Akishima, Tokyo, Japan; [Fukui, K.; Nakachi, T.] Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan; [Iseki, H.; Nagayama, H.] Sagamihara Kyodo Hosp, Sagamihara, Kanagawa, Japan; [Aoyama, T.; Fujino, S.] Fukui Prefectural Hosp, Fukui, Japan; [Suzuki, C.; Tsurukai, A.] Aizawa Hosp, Matsumoto, Nagano, Japan; [Sakai, R.; Nojima, S.] Suwa Red Cross Hosp, Suwa, Japan; [Hashimoto, T.] Ijinkai Takeda Gen Hosp, Kyoto, Japan; [Inoko, M.; Ishiguchi, Y.] Tazuke Kofukai Med Res Ins, Kitano Hosp, Osaka, Japan; [Sasaki, T.; Hada, K.] NHO Osaka Minami, Med Ctr, Kawachi Nagano, Japan; [Kataoka, T.; Nakatani, K.] Bell Land Gen Hosp, Sakai, Osaka, Japan; [Okutsu, M.; Yamamoto, K.] Med Corp Tokushukai Nozaki Tokushukai hosp, Daito, Japan; [Yasaka, Y.; Matsuo, A.] Hyogo Brain & Heart Ctr, Himeji, Hyogo, Japan; [Miyamoto, T.; Yamaguchi, E.] Hyogo Kenritsu Amagasaki Hosp, Amagasaki, Hyogo, Japan; [Tomobuchi, Y.] Seiyu Mem Hosp, Wakayama, Japan; [Tamura, R.; Matsuda, M.] NHO Kure Med Ctr, Kure, Japan; [Hosokawa, S.; Onishi, M.] Tokushima Red Cross Hosp, Tokushima, Japan; [Komura, Y.; Kawanishi, Y.] TAIJYU KAI Fdn Social Med Corp, Kaisei Gen Hosp, Sakaide, Japan; [Takahashi, N.; Ohashi, Y.] Matsuyama Shimin Hosp, Matsuyama, Ehime, Japan; [Mima, T.; Ochi, K.] Saiseikai Imabari Hosp, Imabari, Japan; [Sadamatsu, K.; Miyamoto, S.] Saga Ken Med Ctr Koseikan, Saga, Japan; [Fujimoto, K.; Ichishita, Y.] NHO Kumamoto, Med Ctr, Kumamoto, Japan; [Matsumura, T.; Iwamoto, H.] Kumamoto Rosai Hosp, Kumamoto, Japan; [Koide, S.; Sagara, Y.] Kumamoto Social Insurance Gen Hosp, Kumamoto, Japan; [Himi, T.; Komori, M.] Kimitsu Chuo Hosp, Kisarazu, Japan; [Hashimoto, Y.] Kameda Clin, Kamogawa, Japan; [Yamasaki, M.; Nakashima, R.] NTT Med Ctr Tokyo, Shinagawa, Japan; [Okubo, M.; Kondo, M.] Gifu Heart Ctr, Gifu, Japan; [Takase, H.; Suzuki, K.] JA Shizuoka Kohseiren Enshu Hosp, Hamamatsu, Shizuoka, Japan; [Morii, I.] Hokusetsu Gen Hosp, Takatsuki, Osaka, Japan; [Utsu, N.; Kodama, S.] Minami Osaka Hosp, Keigakukai Social Med Corpo, Osaka, Japan; [Higashino, Y.; Kotajima, H.] Higashi Takarazuka Satoh Hosp, Takarazuka, Hyogo, Japan; [Shigematsu, S.; Fujimoto, N.] NHO Beppu, Med Ctr, Beppu, Oita, Japan; [Nakagawa, T.; Honda, K.] Toyonaka City Hosp, Toyonaka, Osaka, Japan; [Goto, S.; Iwamoto, M.] Tokai Univ Hosp, Isehara, Kanagawa, Japan; [Ota, T.; Okada, S.] Matsue city Hosp, Matsue, Shimane, Japan; [Takahashi, W.; Ichinose, K.] NHO Shinshu Ueda, Med Ctr, Ueda, Nagano, Japan; [Kakishita, M.] Showa Hosp Saibikai, Amagasaki, Hyogo, Japan; [Hayashi, Y.; Takinami, N.] Wakayama Rosai Hosp, Wakayama, Japan; [Momiyama, Y.; Takagi, E.] NHO Tokyo, Med Ctr, Meguro, Japan; [Baden, M.; Suzuki, K.] Takarazuka Hosp, Takarazuka, Hyogo, Japan; [Saeki, T.; Nakano, A.] NHO Kanazawa, Med Ctr, Kanazawa, Ishikawa, Japan; [Hiroi, S.; Tomari, H.] NHO Takasaki Gen, Med Ctr, Takasaki, Gumma, Japan; [Aoyama, T.; Yokoyama, T.] Shimada Municipal Hosp, Shimada, Japan; [Wada, A.; Matsui, Y.] Kusatsu Gen Hosp, Kusatsu, Japan; [Nakata, A.; Nishimura, N.] Sanai Hosp, Saitama, Japan; [Nishi, Y.; Asano, T.] St Lukes Int Hosp, Chuoku, Japan; [Hirasawa, S.; Mochiduki, A.] Shizuoka City Shimizu Hosp, Shizuoka, Japan; [Shibata, Y.; Yamashita, S.] Miyazaki Med Assoc Hosp, Miyazaki, Japan; [Fukuzawa, S.; Okino, S.] Funabashi Municipal, Med Ctr, Funabashi, Chiba, Japan; [Machida, M.; Hirabayashi, K.] Tomakomai City Hosp, Tomakomai, Japan; [Takama, N.; Funada, R.] Gunma Univ Hosp, Maebashi, Gumma, Japan; [Wardeh, A. J.; Dille, C.] MCH Locatie Westeinde, The Hague, Netherlands; [de Melker, E. C.; van der Spoel, A.] St Lucas Andreas Ziekenhuis, Amsterdam, Netherlands; [Westendorp, I. C. D.; Zweers, D.] Rode Kruis Ziekenhuis, Beverwijk, Netherlands; [Dunselman, P. H. J. M.; Blom, L.] Mphia Ziekenhuis Locatie Molengracht, Breda, Netherlands; [Ronner, E.; Wissenburg, A.] Reinier Graaf Gasthuis, Delft, Netherlands; [van der Sluis, A.; Badings, E. A.] Deventer Ziekenhuis, Deventer, Netherlands; [den Hartog, F. R.; Singerling, M.] Ziekenhuis Gelderse Vallei, Ede, Netherlands; [Aksoy, I.; Heil, A.] Admiraal Ruyter Ziekenhuis, Goes, Netherlands; [Tjeerdsma, G.; van Daalen, C.] Ziekenhuis Tjongerschans, Heerenveen, Netherlands; [Lenderink, T.; Lardenois, R.] Atrium Med Ctr, Heerlen, Netherlands; [Prins, F. J.; Rutten, R.] Elkerliek Ziekenhuis, Helmond, Netherlands; [Plomp, J.; Veldmeijer, S.] Tergooiziekenhuizen Loc Hilversum, Hilversum, Netherlands; [de Vries, R. J. M.; Krikken, J.] Ziekenhuis Bethesda, Hoogeveen, Netherlands; [Ophuis, T. A. J. M. Oude; Buvelot, S.] Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; [Bos, R. J.; Tan-Urgert, B.] Franciscus Ziekenhuis, Roosendaal, Netherlands; [Werner, H. A.; Wittekoek, M.] Vlietland Ziekenhuis, Schiedam, Netherlands; [van Daele, M. E. R. M.; Bouwens, M.] Orbis Med Ctr, Sittard Geleen, Netherlands; [Oomen, A.; Meijlis, P.] Antonius Ziekenhuis, Sneek, Netherlands; [Verheul, J. A.; Uiterwaal, H.] Flevoziekenhuis, Almere, Netherlands; [Knufman, N.; de Lange, H.] Ziekenhuis Bronovo, The Hague, Netherlands; [Bartels, G. L.; Hendriks-van Woerden, M.] Martini Ziekenhuis Cardio Res Noord BV, Groningen, Netherlands; [van Bemmel, B.; Beyering, M.] Ropcke Zweers Ziekenhuis, Hardenberg, Netherlands; [Zwart, P. A. G.; Teng, Y.] Ziekenhuis Bernhoven, Uden, Netherlands; [van der Zwaan, C.; Havenaar, J.] Ziekenhuis Rivierenland, Tiel, Netherlands; [Hermans, W. R. M.; de Graauw, J.] St Elizabeth Hosp, Tilburg, Netherlands; [Hamraoui, K.; Dabrowska, K.] TweeSteden Ziekenhuis, Tilburg, Netherlands; [de Nooijer, C.; Groenenberg, I.] Maxima Med Ctr Locatie Veldhoven, Veldhoven, Netherlands; [Kietselae, B. L. J. H.; Muis, L.] Maastricht Med Ctr, Maastricht, Netherlands; [Hamer, B. J. B.; Hobe, C.] Meander Med Ctr, Amersfoort, Netherlands; [van Eck, J. W. M.; Elzebroek, N.] Jeroen Bosch Ziekenhuis, sHertogenbosch, Netherlands; [Tans, J. G. M.; Stapel, A. G. Th.] Gemini Ziekenhuis, Den Helder, Netherlands; [Nierop, P. R.; Dirks, M.] St Franciscus Gasthuis, Rotterdam, Netherlands; [Kuijper, A. F. M.; Schiks, M.] Spaarne Ziekenhuis, Hoofddorp, Netherlands; [de Groot, M. R.; Post, G.] Nij Smellinghe Ziekenhuis, Drachten, Netherlands; [ten Berg, J. M.; Bras, R.] St Antonius Ziekenhuis BV, Nieuwegein, Netherlands; [Koolen, J. J.; van Leur, L.] Catharina Hosp, Eindhoven, Netherlands; [Herrman, J. P. R.; Roelse, A.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Ebink, C.; Jones, B.] Maasstad Ziekenhuis, Rotterdam, Netherlands; [Lipsic, E.; Couperus, M.] Univ Med Ctr Groningen, Groningen, Netherlands; [Bogaard, K.; Dijk, A.] Rijnland Ziekenhuis, Leiderdorp, Netherlands; [Pettersen, K. I.; Kontny, F.; Fortun, M.] Volvat Med senter AS, Oslo, Norway; [Gullestad, L.; Stueflotten, W.] Rikshospitalet Oslo Univ HF, Oslo, Norway; [Popovic, I.; Sobye, E. Turkerud] Sykehuset Innlandet HF Hamar, Hamar, Norway; [Hogalmen, G.; German, M.] Sykehuset Innlandet HF Hamar, Lillehammer, Norway; [Hysing, J.; Flagstad, E.] Sykehuset Telemark HF Skien, Skien, Norway; [Nordrehaug, J. E.; Isaksen, A.] Helse Bergen HF Haukeland Univ, Bergen, Norway; [Graven, T.; Haug, H.] Sykehuset Levanger, Levanger, Norway; [Sandvik, J.; Thunhaug, H.] Nordland Hjertesenter AS Bodo, Bodo, Norway; [Ronning, P. Bjornerud; Gravrok, B.] Univ Nord Norge HF Tromso, Tromso, Norway; [Lappegard, K. T.; Enebakk, T.] Nordlandssykehuset HF Bodo, Bodo, Norway; [Ronnevik, P.; Ronnevik, T.] Fana Hjertesenter AS Nesttun, Nesttun, Norway; [Hurtig, U.; Skanke, E.] Sykehuset Innlandet HF Tynset, Tynset, Norway; [Omland, T.; Tobiassen, G. M.] Sykehuset Sorlandet HF Flekkefjord, Flekkefjord, Norway; [Berrospi, P.; Ragas, Y.] Clin El Golf, Lima, Peru; [Bustamante, G.; Marruffo, Y.] Clin San Borja, Lima, Peru; [Chavez, E.; Chaname, A.] Clin San Pablo, Lima, Peru; [Heredia, J.; Gamero, K.] Clin Anglo Amer, Lima, Peru; [Lema, J.; Carrion, A. M.] Hosp Nacl Arzobispo Loayza, Lima, Peru; [Rodriguez, V.; Cabanillas, N.] Hosp Cent Fuerza Aerea Peru, Lima, Peru; [Rodriguez, A.; Zena, N.] Hosp Nacl Alberto Sabogal Sologuren, Lima, Peru; [Segura, L.; Rojas, C.] Inst Med Miraflores, Lima, Peru; [Toce, L.; Carrera, J.] Clin Int, Lima, Peru; [Orihuela, B.; Del Portal, M.] Clin San Gabriel, Lima, Peru; [Roldan, Y.; Roldan, G.] Ctr Invest Heart Help, Lima, Peru; [Medina, F.; Rodriguez, J.] Clin Med Cayetano Heredia, Lima, Peru; [Chavez, C.; Luna, G.] Hosp Nacl Daniel Alcides Carr, Lima, Peru; [Parra, J.; Ramos, J.] Hosp Maria Auxiliadora, Lima, Peru; [Mogrovejo, W.; Godoy, J.] Inst Neuro Cardiovascular Amer, Lima, Peru; [Talledo, M. Zubiate; Diestra, J.] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru; [Godoy, A.; Matta, M.] Inst Nacl Corazon EsSalud, Lima, Peru; [Pino, C.; Vergara, R.] Hosp Mayo, Lima, Peru; [Chois, A.; Guillen, A. M.] Clin Maison Sante, Lima, Peru; [Medina, J.; Chirinos, J.] Ctr Cardiol Prevenc, Arequipa, Peru; [Paredes, A.; Quiroz, M.] Inst Cardiol Paredes Horna, Arequipa, Peru; [Camacho, L.; Gil, M.] Clin Peruano Amer Trujillo, La Libertad Trujillo, Peru; [Abola, M. T.; Cerbito, S.] Philippine Heart Ctr, Quezon City, Philippines; [Beltran, J.; Tanglao, M.] Metropolitan Med Ctr, Manila, Philippines; [Uy, N.; Busa, J.] UERM Mem Med Ctr, Quezon City, Philippines; [Rogelio, G.; Arbis, M. G.] St Lukes Med Ctr, Quezon City, Philippines; [Prado, J. P.; Miranda, M.] Med City, Pasig, Philippines; [Sulit, D. J.; Dioquino, R.] Quirino Mem Med Ctr, Quezon City, Philippines; [Sevilla, R.; Soriano, R. A.] Perpetual Help Med Ctr, Las Pinas, Philippines; [Rosita, R. R.; Amazona, A.] Mary Mediatrix Med Ctr, Lipa Batangas, Philippines; [Atilano, A.; Lim, E.] Perpetual Succor Hosp Manila, Manila, Philippines; [Ebo, G.; Maglasang, P.] Perpetual Succour Hosp Cebu, Cebu, Philippines; [Palmes, P.; Loreno, C. A.] Hlth Partners Condo Clin, Iloilo, Philippines; [Tirador, L.; Alagban, C.] St Pauls Hosp, Iloilo, Philippines; [Roxas, D. J.; Roxas, J. F.] Victor R Potenciano Med Ctr, Mandaluyong, Philippines; [Cheng, F.; De Guzman, S.] Cardinal Santos Med Ctr, San Juan, Philippines; [Morales, D.; Mararac, T.] Manila Doctors Hosp, Manila, Philippines; [Barbas, B.; Barbas, K.] Chong Hua Hosp, Fuente Osmena Cebu City, Philippines; [Ferrolino, A.; Baysac, C.] Vet Mem Med Ctr, Quezon City, Philippines; [Llarena, A. C.; Julianes, C.] Jose R Reyes Mem Med Ctr, Manila, Philippines; [Budaj, A.; Torun, A.] Oddzial Klin Kardiol Szpital Grochowski, Warsaw, Poland; [Dalkowski, M.; Widejko, K.] NZOZ Miedziowe Ctr Zdrowia SA Lubinie, Lubin, Poland; [Derlaga, B.; Laskowska, E.] Specjalisty Gabinet Lekarski, Tarnow, Poland; [Dudek, D.; Dziewierz, A.] Szpital Uniwersytecki Klin Kardiol, Krakow, Poland; [Jozwa, R.; Busz-Papiez, B.] Indywidualna Specjalistyczna Praktyka Lekarska, Szczecin, Poland; [Pawlowicz, L.; Kaczmarczyk, M.] Prywatne Ctr Kardiol, Torun, Poland; [Jaworska, K.; Skonieczny, G.] Wojewodzki Szpital Zespolony L Rydygiera, Torun, Poland; [Kopaczewski, J.; Wujkowski, M.] Specjalistyczne Gabinety Lekarskie Medicor Plus, Wloclawek, Poland; [Krasowski, W.; Krzyzanek, P.] Szpital Specjalistyczny Sw Wojciecha SPZOZ, Gdansk, Poland; [Kubica, J.; Kozinski, M.] NZOZ SALUS Dorota Borowska, Bydgoszcz, Poland; [Miekus, P.; Glaza, M.] Gabinet Kardiol MEDIPULS, Gdynia, Poland; [Podolec, P.; Wilkolek, P.] Krakowski Szpital Specjalisty Jana Pawla II, Krakow, Poland; [Piepiorka, M.; Piepiorka-Broniecka, M.] Gabinet Kardiol Internisty, Gdynia, Poland; [Pluta, W.; Ploch, M.] NZOZ Poradnia Kardiol, Opole, Poland; [Rynkiewicz, A.; Mosakowska, K.] Pomorskie Centra Kardiol SA, Gdansk, Poland; [Szpajer, M.; Lesinski, D.] Szpital Morski PCK Oddzial Kardiol, Gdynia, Poland; [Szwed, H.; Jasek, S.] Inst Kardiol, Warsaw, Poland; [Sciborski, R.; Piotrowicz, R.] Zespol Opieki Zdrowotnej Olawie SPZOZ, Olawa, Poland; [Musial, W.; Lisowska, A.] Uniwersytecki Szpital Klin Bialymstoku SPZOZ, Bialystok, Poland; [Rekosz, J.; Kasznicka, M.] WSPRiTS MEDITRANS SPZOZ Warszawie, Warsaw, Poland; [Korzeniak, R.; Staneta, P.] Specjalisty Przychodnia Lekarska MEDIKARD Sp zoo, Plock, Poland; [Konczakowski, P.; Waluszek-Konczakowska, I.] NZOZ MADA MED, Chorzow, Poland; [Cymerman, K.] Ind Spec Praktyka Lekarska Dziedzinie Kardiol, Gdynia, Poland; [Lubinski, A.; Grycewicz, T.] Indywidualna Praktyka Lekarska Andrzej Lubinski, Lodz, Poland; [Hiczkiewicz, J.; Plucinski, M.] NZOZ Kardiol Nowa Sol, Nowa Sol, Poland; [Korol, M.] Osrodek Med Rodzinnej Sp zoo, Sobotka, Poland; [Szczech, J.; Hawro, M.] Ctr Med Lancucie Sp Zoo, Lancut, Poland; [Skorski, M.; Cichon, K.] SPZOZ Lecznej, Ul Krasnystawska 52, PL-21010 Leczna, Poland; [Jankowski, M.] Zaklad Opieki Zdrowotnej Trojmiejskie Ctr Med, Gdansk, Poland; [Cygler, J.; Ottomanska-Cygler, M.] NZOZ MEDICA Jerzy Cygler, Gizycko, Poland; [Korecki, J.; Gulaj, E.] Podlaski Osrodek Kardiol, Bialystok, Poland; [Zechowicz, T.; Zechowicz, M.] Medeusz Plus Lekarska Spoka Partnerska, Olsztyn, Poland; [Goch, A.; Topolinski, B.] 10 Wojskowy Szpital Klin Poliklin SPZOZ, Bydgoszcz, Poland; [Ogorek, M.; Szczepanska, A.] Prywatny Gabinet Lekarski Dr N Med Michal Ogorek, Piotrkow Trybunalski, Poland; [Wojewoda, P.; Jagoda, E.] NZOZ Przychodnia Zdrowia Zadebie, Skierniewice, Poland; [Krzyzanowski, W.; Muzyk-Osikowicz, M.] Szpital Powiatowy Marii Skodowskiej Curie SP ZOZ, Ostrow Mazowiecka, Poland; [Jaszczurowski, W.] Szpital Wojewodzki Bielsku Bialej SPZOZ, Bielsko Biala, Poland; [Stasiewski, A.; Wietrzynska, J.] NZOZ NEUROKARD Ilkowski Partnerzy, Ul Wierzbowa 2-2, Poznan, Poland; [Miklaszewicz, B.; Beme, A.] CARDIAMED Spolka Jawna, Legnica, Poland; [Sudnik, W.; Matys, U.] SPZOZ Przychodnia Specjalisty Sokolce, Sokolka, Poland; [Ponikowski, P.; Powierza, S.] 4 Wojskowy Szpital Klin Poliklin SPZOZ, Wroclaw, Poland; [Kim, Y. -H.; Chang, K. -C.] Asan Med Ctr, Seoul, South Korea; [Choi, D. -J.; Yoon, C. -H.] Seoul Natl Univ Bundang Hosp, Seongnam, South Korea; [Seung, K. -B.; Chang, K.] Cathol Univ, Korea Seoul St Marys Hosp, Seoul, South Korea; [Lim, D. -S.; Park, J. H.] Korea Univ Anam Hosp, Seoul, South Korea; [Lee, S. -H.; Choi, S. H.] Samsung Med Ctr, Seoul, South Korea; [Kim, H. -S.; Park, K. W.] Seoul Natl Univ Hosp, Seoul, South Korea; [Bae, J. -H.; Bae, Y. H.] Konyang Univ Hosp, Daejon, South Korea; [Hong, T. -J.; Lee, H. W.] Pusan Natl Univ Hosp, Busan, South Korea; [Hong, M. -K.; Kim, B. -K.] Yonsei Univ Hlth Syst, Seoul, South Korea; [Tahk, S. -J.; Yoon, M. -H.] Ajou Univ Hosp, Suwon, South Korea; [Kim, Y. -J.; Park, J. -S.] Yeungnam Univ Hosp, Daegu, South Korea; [Yoon, J.; Jang, H.] Yonsei Univ Wonju Coll Med Wonju, Wonju, South Korea; [Jeong, M. -H.; Kim, C.] Chonnam Natl Univ, GwangJu, South Korea; [Chae, J. -K.; Cho, E. -J.] Chonbuk Natl Univ Hosp, Jeonju, South Korea; [Bae, J. -H.; Cho, M. -C.] Chungbuk Natl Univ Hosp, Cheongju, South Korea; [Hong, S. -K.; Lee, H. J.] Sejong Gen Hosp, Bucheon, South Korea; [Hur, S. -H.; Lee, D. J.] Keimyung Univ Dongsan Med Ctr, Daegu, South Korea; [Jeong, J. -O.; Lee, J. W.] Chungnam Natl Univ Hosp, Daejeon si, South Korea; [Her, S. -H.; Park, M. W.] Daejeon St Marys Hosp, Daejeon, South Korea; [Lee, J. -M.; Choi, Y. -Y.] Uijeongbu St Marys Hosp, Uijongbu, South Korea; [Dimulescu, D.; Huidu, S.] Elias Univ Emergency Hosp, Bucharest, Romania; [Vintila, M. M.; Protopopescu, L.] Sf Pantelimon Emergency Hosp, Bucharest, Romania; [Fruntelata, A.; Greavu, M. C.] Ilro Med SRL, Bucharest, Romania; [Pirvu, O.; Diaconu, M. C.] Med Plus SRL, Bucharest, Romania; [Stanciulescu, G.; Blajan, D.] Arges Cty Hosp, Pitesti, Romania; [Giuca, A.; Istratoaie, O.] Craiova Cardiol Ctr, Craiova, Romania; [Militaru, C.; Lican, G.] Cardiomed SRL, Craiova, Romania; [Radoi, M.; Bisoc, A.] Radoi Cty Hosp Brasov, Brasov, Romania; [Bobescu, E.; Doka, B.] Emergency Cty Hosp Brasov, Brasov, Romania; [Crisu, D.; Jemna, D.] Consultmed SRL, Iasi, Romania; [Creteanu, M.; Parasteac, M. M.] Suceava Sf Ioan cel Nou Emergency Cty Hosp, Suceava, Romania; [Minescu, B.; Serban, L. D.] Braila Emergency Cty Hosp, Braila, Romania; [Bolohan, F.; Mihai, M.] C tin Zamfir Emergency Cardiovascular Ctr, Bucharest, Romania; [Manitiu, I.; Cioca, G.] Sibiu Cty Hosp, Sibiu, Romania; [Bengus, C. M.; Ochean, V.] Focsani Cty Hosp Sf Pantelimon, Focsani, Romania; [Iosipescu, L. C.; Costache, L.] Bacau Cty Hosp, Bacau, Romania; [Ciobotaru, V.; Andor, M.] Medicalis Clin Timisoara, Timisoara, Romania; [Basarab, G.; Stoica, D.] Deva Cty Hosp, Deva, Romania; [Benedek, I. S.; Benedek, T.] Cardio Med SRL, Targu Mures, Romania; [Constantinescu, M.; Sava, N.] Medcon SRL, Buzau, Romania; [Cristea, M. I.; Anciu, M. R.] CMDTAMP, Bucharest, Romania; [Capalneanu, R.; Mot, S.] N Stancioiu Heart Inst Cluj Napoca, Cluj Napoca, Romania; [Tatu-Chitoiu, G. P.; Cornaciu, S.] Cardiomed SRL, Bucharest, Romania; [Boldueva, S.; Samokhvalova, M.] St Petersburg State Med Acad Mechnikova, St Petersburg, Russia; [Golitsyn, S.; Mironova, N.] Russian Cardiol Res & Mfg Complex, Moscow, Russia; [Karpov, Y.; Buza, V.] Russian Cardiol Res Complex Inst, Moscow, Russia; [Kobalava, Z.; Shavarov, A.] City clin Hosp 64, Moscow, Russia; [Konstantinov, V.; Serebrenitskaya, M.] St Petersburg State Med Acad Mechnikov, St Petersburg, Russia; [Kuimov, A.; Khomyakova, L.] MUZ City Clin Hosp 1, Novosibirsk, Russia; [Ezhov, M.; Safarova, M.] Russian Cardiol Res Complex, Moscow, Russia; [Panov, A.; Lohovinina, N.] Fed Ctr heart blood & endocrinol, St Petersburg, Russia; [Ruda, M.; Staroverov, I.] Russian Cardiol Res Complex, Moscow, Russia; [Novikova, T.; Bitakova, F.] SPb GUZ Pokrovskaya Hosp, St Petersburg, Russia; [Simanenkov, V.; Zakharova, N.] SPb GUZ City Hosp 26, St Petersburg, Russia; [Smolenskaya, O.; Khurs, E.] Hosp 14, Ekaterinburg, Russia; [Tsyba, L.; Belenky, D.] MUZ Municipal Clin Hosp Emergency 2, Novosibirsk, Russia; [Vishnevsky, A.; Kositsyn, D.] SPb GUZ Pokrovskaya Hosp, St Petersburg, Russia; [Yakhontova, P.; Rovnykh, Y.] Novosibirsk Reg Cardiol Ctr, Novosibirsk, Russia; [Kislyak, O.; Kasatova, T.] City Clin Hosp 79, Moscow, Russia; [Demchenko, E.; Yakovlev, A.; Lubinskaya, E.; Omelchenko, M.] Fed Ctr heart blood & endocrinol, St Petersburg, Russia; [Ermoshkina, L.; Slukhaenko, I.] Gatchina Cent Dist Clin Hosp, Gatchina, Russia; [Arkhipov, M.; Kozulin, A.] Ural State Med Acad based Med Assoc, Ekaterinburg, Russia; [Galyavich, A.; Baleeva, L.] Interreg clin diagnost Ctr, Kazan, Russia; [Strongin, L.; Pochinka, I.] City Hosp 13, Nizhnii Novgorod, Russia; [Kosmacheva, E.; Kizhvatova, N.] Krasnodar Reg Hosp 1, Krasnodar, Russia; [Goloshchekin, B.; Laptev, I.] SPb GUZ City Hosp 15, St Petersburg, Russia; [Sidorenko, B.; Bugrimova, M.] Cent Clin Hosp, Moscow, Russia; [Izmozherova, N.; Popov, A.] Ural State Med Acad, Dept Internal Dis 2, Ekaterinburg, Russia; [Shustov, S.; Kovalevskaya, E.] Mil Med Acad, Dept Postgrad Ed Ther 1, St Petersburg, Russia; [Orlikova, O.; Orlikov, E.] Saratov Res Inst Cardiol, Saratov, Russia; [Paltsman, Z.] OOO Inst Clin Res, St Petersburg, Russia; [Lukyanov, Y.; Lamden, D.] St Petersburg State Med Univ n a Pavlov, St Petersburg, Russia; [Koziolova, N.; Surovtseva, M.] Perm Reg Hosp Vet War, Perm, Russia; [Nedogoda, S.; Statsenko, M.; Tsoma, V.; Derevjanchenko, M.] Volgograd State Med Univ, Volgograd, Russia; [Kotelnikov, M.; Streltsov, S.] Hosp GUVD, Moscow, Russia; [Osipenko, M.; Bikbulatova, E.] Novosibirsk Med Univ, City Hosp 12, Novosibirsk, Russia; [Oshchepkova, E.; Dmitriev, V.] Russian Cardiol Res complex Lab oh Hype, Moscow, Russia; [Bolieva, L.; Byazrova, S.] Chair Pharmacol SOGMA, Vladikavkaz, Russia; [Ryamzina, I.; Khovaeva, Y.] MHI City Clin Hosp 2 n a Dr Gral, Perm, Russia; [Pavlysh, E.; Komandenko, O.] Our patient Dept 25 St Petersburg, St Petersburg, Russia; [Kamensky, G.; Dlesk, A.] V Interna Klin, Bratislava, Slovakia; [Urban, M.] UV NSP Ruzomberok FN, Ruzomberok, Slovakia; [Vinanska, D.] Interna Kardiol Ambulancia MEDISPOL S R O, Presov, Slovakia; [Dzupina, A.] KArdiol Ambulancia ALIAN S R O, Bardejov, Slovakia; [Hranai, M.; Cisar, P.] Kardiocentrum Nitra S R O, Nitra, Slovakia; [Toth, P.] Ambulancia Kardiol COMCOR S R O, Komarno, Slovakia; [Paulov, S.] KARDIONITRA S R O, Nitra, Slovakia; [Sivak, V.] Sukromna Kardiol Ambulancia, Liptovsky Mikulas, Slovakia; [Bolvanska, N.] Privatna Interna Ambulancia, Liptovsky Hradok, Slovakia; [Palka, J.] Kardiol Interna Ambulancia CORP S R O, Kosice, Slovakia; [Nedelova, I.] Kardiol Ambulancia NOVAMED Spol S R O, Banska Bystrica, Slovakia; [Benacka, J.] Kardiol Ambulancia BENIMED S R O, Piestany, Slovakia; [Gergel, V.] MUDr Vladimir Gergel S R O, Nestatna Interna Ambulancia, Bratislava, Slovakia; [Cisar, P.; Hatalova, K.] Cardioconsult S R O, Bratislava, Slovakia; [Kohut, P.] Kardiol Ambulancia, Povazska Bystrica, Slovakia; [Kovar, F.; Knazeje, M.] Univ Nemocn Martin, I Interna Klin, Martin, Slovakia; [Macek, V.] MUDr Macek Vladimir, Kardiol Ambulancia, Trnava, Slovakia; [Sinska, R.] Kardiol Ambulancia NsP Partizanske N O, Partizanske, Slovakia; [Bugan, V.] MEDIVASA S R O, Zilina, Slovakia; [Badenhorst, J. C. W.; Erasmus, L.] Unitas Hosp, Pretoria, South Africa; [Burgess, L. J.; de Necker, I.] Tread Res Cc, Cape Town, South Africa; Corbad Res Cc, Cape Town, South Africa; [Dawood, S. Y.; Conradie, C.] Vincent Pallotti Hosp, 1st Floor, Cape Town, South Africa; [Delport, E. F.; Kruger, M.] Univ Pretoria, Clin Res Unit, Pretoria, South Africa; [Ebrahim, I.; Bobak, C.] Unitas Hosp, Suite 309, Centurion, South Africa; [Nethononda, M. R.; Nunkoo, T.] Bara Cardiac Res Unit, Soweto, South Africa; [van Rensburg, F. P. Janse; Middle, R.] Excellentis Clin Trial Consultants, George, South Africa; [Horak, A. R.; Henley, L.] Vincent Pallotti Hosp, 2nd Floor, Cape Town, South Africa; [Mabin, T. A.; King, A.] Helderberg Res Inst, Somerset West, South Africa; [Ranjith, N.; Ramdas, S.] Dr N Ranjith Res Ctr, Durban, South Africa; [Roodt, A.; Coetsee, E.] Clinresco Ctr, Kempton Pk, South Africa; [Theron, H.; Karsten, M.] Netcare Univ Hosp Cardiol Res, Bloemfontein, South Africa; [Van Zyl, L. J.; Roscher, M.] Clin Projects Res Trial Ctr, Worcester, South Africa; [Venter, T. P.; de Kock, L.] Cardiol Clin Res, Alberton, South Africa; [Becker, A. C.; Swanepoel, J.] Flora Clin, Johannesburg, South Africa; [Ismail, S. M.; Christie, H.] Gatesville Med Ctr, Room 310, Cape Town, South Africa; [Dalby, A. J.; Allman, J.] Milpark Hosp, Parktown, W Johannesburg, South Africa; [Christie, H.; Roux, J. P.] Panorama Medi Clin, Room 121, Panorama, South Africa; [Naidoo, D. P.; Vawda, G. H. M.] Cardiol Res Clin, Durban, South Africa; [Manga, P.; Olckers, W.] Wits Donald Gordon Clin Trial Site, Gauteng, South Africa; [Mpe, M. T.; Farrell, B. M.] 1 Mil Hosp, Pretoria, South Africa; [de Sa Areses, E. Lopez; Valbuena Lopez, S.; Garcia Puig, J.; Velasco Garcia, C.] Hosp Univ La Paz, Madrid, Spain; [Cruz Fernandez, J. M.; Gonzalez Roldan, J.] Hosp Virgen Macarena, Seville, Spain; [Garcia Pavia, P.; Gonzalez Segovia, A.] Hosp Puerta Hierro, Majadahonda, Madrid, Spain; [Munoz Aguilera, R.; Dominguez Munoa, M.] Hosp Infanta Leonor, Madrid, Spain; [Bruguera Cortada, J.; Cabero Cereto, P.] Hosp del Mar, Barcelona, Spain; [Plaza Perez, I.; Perez Cid, L.] Hosp Infanta Sofia, San Sebastian, Madrid, Spain; [Galve Basilio, E.; Cibeira Guerra, P.] Hosp Valle De Hebron, Barcelona, Spain; [Fernandez Ortiz, A.; Vivas Balcones, L. D.] Hosp Clin San Carlos, Madrid, Spain; [Ripoll Vera, T.; Gamez Martinez, J. M.] Hosp Son Llatzer, Palma de Mallorca, Spain; [De Teresa Galvan, E.; Hernandez Caballero, A.] Hosp Clin Virgen Victoria, Malaga, Spain; [Rodriguez Blanco, V. M.] Hosp Comarcal San Agustin, Aviles, Asturias, Spain; [Rubin Lopez, J. M.; Pastor Franco, M. R.] Hosp Cent Asturias, Oviedo, Asturias, Spain; [Ridocci Soriano, F.; Caracena Porcar, L.] Hosp Gen Univ Valencia, Valencia, Spain; [Cequier Fillat, A. R.; Guerrero Moreno, S.] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Barcelona, Spain; [Galan Montejano, M.; Duran Guerrero, J. M.] Hosp Comarcal Don Benito, Don Benito, Badajoz, Spain; [Blanco Coronado, J. L.] Hosp Virgen Mar, Almeria, Spain; [Murga Eizagaechevarria, N.; Nunez Araucua, G.] Hosp Basurto, Bilbao, Spain; [Martinez Rubio, A.; Cazorla Roca, M.] Hosp Sabadell, Corp Parc Tauli, Sabadell, Barcelona, Spain; [Garcia-Moll Marimon, X.; Vila Perales, M.] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Bethencourt Gonzalez, A.; Pascual Sastre, M.] Hosp Son Espases, Palma de Mallorca, Spain; [Gonzalez Juanatey, J. R.; Garcia Acuna, J. M.] Hosp Clin Santiago de Compostela, Santiago De Compostela, Spain; [Al-Khalili, F.; Lof, P.] Stockholm Heart Ctr, Stockholm, Sweden; [Bandh, S.; Myllyla, L.] Cent Lasarettet, Vasteras, Sweden; [Christensen, K.; Johansson, K.] Univ Sjukhuset Orebro, Orebro, Sweden; [Dellborg, M.; Hultsberg-Olsson, G.] Sahlgrenska Sjukhuset Ostra, Gothenburg, Sweden; [Alstrom, P.; Damm, T. Larsdotter] Soder Sjukhuset, Stockholm, Sweden; [Erlinge, D.; Brolin, G.] Skanes Univ Sjukhus Lund, Lund, Sweden; [Ravn-Fischer, P. A.; Johansson, P.; Andreen, S.] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Linderfalk, C.; Ram, B.] Redeby Lakarserv AB, Eksjo, Sweden; [Lindholm, C. -J.; Assarsson, E.] Capio Citykliniken Lund, Lund, Sweden; [Mooe, T.; Lindberg, A.] Ostersunds Sjukhus, Ostersund, Sweden; [Paren, P.; Moodh, J.] Sahlgrenska Univ Sjukhus Molndal, Molndal, Sweden; [Svensson, P.; Andersson, I.] Karolinska Univ Sjukhuset Solna, Stockholm, Sweden; [Wodlin, P.; Raschperger, A.] Univ Sjukhuset Linkoping, Linkoping, Sweden; [Skogvard, P.; Koch, A.] Lanssjukhuset Ryhov, Jonkoping, Sweden; [Lind, N.; Osberg, L.] Hjartmottagningen Malmo, Malmo, Sweden; [Nilsson, C.; Svensson, K.] Ljungby Lasarett, Ljungby, Sweden; [Bengtsson, M.; Samad, B.; Nilsson, M.] Danderyds Sjukhus Stockholm, Stockholm, Sweden; [Berglund, E.; Lundgren, C.] Lanssjukhuset Sundsvall Harnosand, Sundsvall, Sweden; [Lindmark, K.; Sundholm, C.] Norrlands Univ Sjukhus, Umea, Sweden; [Aladellie, L.; Welin-Berger, B.] Karolinska Univ Sjukhuset, Stockholm, Sweden; [Guneri, S.; Dogan, N. B.] Dokuz Eylul Univ, Med Fac, Izmir, Turkey; [Ersanli, M.; Coskun, U.] Istanbul Univ, Haseki Kardiyol Enstitu, Istanbul, Turkey; [Cayli, M.; Seker, T.] Adana Numune Hastanesi Seyhan Uygulama Merkezi, Adana, Turkey; [Camsari, A.; Ozcan, T.] Mersin Univ, Tip Fak, Mersin, Turkey; [Ongen, Z.; Karadag, B.] Istanbul Univ, Cerrahpasa Tip Fak, Istanbul, Turkey; [Boyaci, B.; Sezenoz, B.] Gazi Univ, Typ Fak, Ankara, Turkey; [Pekdemir, H.; Hidayet, S.] Inonu Univ, Med Fac, Malatya, Turkey; [Erol, M. K.; Yalcin, A.] Mehmet Akif Ersoy Res & Training Hosp, Istanbul, Turkey; [Sezer, M.; Emet, S.] Istanbul Univ, Istanbul Sch Med, Istanbul, Turkey; [Bozkurt, E.; Ozen, M. B.] Yildirim Beyazit Univ, Sch Med, Ankara, Turkey; [Parkhomenko, A.; Lutay, Y.] Nat Sci Ctr, Inst Cardiol, Kiev, Ukraine; [Dyadyk, O.; Kholopov, L.] Donetsk Natl Med Univ, Donetsk, Ukraine; [Rudyk, I.; Shaposhnikova, Y.] Inst Therapy AMS Ukraine, Kharkov, Ukraine; [Chopey, I.; Ternuschak, T.] STEA, Uzhhorod Railway Stn Clin Hosp, Uzhgorod, Ukraine; [Reshotko, D.; Popova, G.] Kyiv OleksandrivskaClin Hosp, Kiev, Ukraine; [Batushkin, V.; Gema, A.] 5th Kyiv City Clin Hosp, Kiev, Ukraine; [Vizir, V.; Berezyn, O.] Zaporizhzhya Municipal Inst City Hosp 7, Zaporizhzhya, Ukraine; [Lutai, M.; Tovstukha, V.] NSC MD Strazhesko Inst Cardiol, Kiev, Ukraine; [Shumakov, V.; Pogurelska, O.] NSC Dept Myocardial Infarct & Rehabil, Kiev, Ukraine; [Sirenko, Y.; Rekovets, O.] NSC Symptomat Arterial Hypertens Dept, Kiev, Ukraine; [Kraiz, I.; Kamenska, E.] Kharkiv Cent Clin Hosp Ukrzaliznitsia, Kharkov, Ukraine; [Tseluyko, V.; Yakovleva, L.] Kharkiv City Clin Hosp 8, Kharkov, Ukraine; [Yena, L.; Artemenko, V.] State Inst DF Chebotarev Inst Gerontol, Kiev, Ukraine; [Koval, O.; Kaplan, P.] City Joint Emergency Hosp, Dnepropetrovsk, Ukraine; [Karpenko, O.; Nevolina, I.] Municipal Clin Hosp 1, Kiev, Ukraine; [Bazilevych, A.; Harbar, M.] Lviv Natl Med Univ, Lvov, Ukraine; [Rudenko, L.; Beregova, O.] City Municipal Joint Emergency Hosp, Kiev, Ukraine; [Mostovyi, Y.; Rasputina, L.] Vinnitsa Natl Med Univ, Vinnitsa, Ukraine; [Vatutin, M.; Shevelok, A.] Donetsk Urgent & Recovery Surg, Donetsk, Ukraine; [Kovalenko, V.; Polenova, N.] NSN Dept Noncoronary Heart Dis, Kiev, Ukraine; [Amosova, K.; Tkachenko, L.] Kyiv Oleksandrivska Clin Hosp, Kiev, Ukraine; [Volkov, V.; Zaprovalna, O.] State Inst Inst Therapy, Kharkov, Ukraine; [Storey, R.; Thomas, M.] No Gen Hosp, Sheffield, S Yorkshire, England; [Pell, A.; Anderson, J.] Monklands Hosp, Airdrie, Scotland; [Moriarty, A.; Kinnin, M.] Craigavon Area Hosp, Portadown, North Ireland; [Ahsan, A.; Burton, J.] Nottingham City Hosp, Nottingham, England; [ORourke, B.; Young, J.] Hairmyres Hosp, E Kilbride, Lanark, Scotland; [Lang, C.; Forbes, J.] Ninewells Hosp, Dundee, Scotland; [Rowlands, D.; Hamill, S.] Peterborough City Hosp, Peterborough, Cambs, England; [Sprigings, D.; Cadd, A.] Northampton Gen Hosp, Northampton, England; [de Belder, M.; Atkinson, B.] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Ramsey, M.; Fagan, J. C.] Morriston Hosp, Swansea, W Glam, Wales; [Pye, M.; Wright, L.] York Hosp, York, N Yorkshire, England; [Keeling, P.; Hughes, D.] Torbay Hosp, Torquay, England; [Fraser, D.; Phillips, H.] Manchester Royal Infirm, Manchester, Lancs, England; [Muthusamy, R.; Lawan, M.] Rotherham Gen Hosp, Rotherham, S Yorkshire, England; [Levy, T.; Kennard, S.] Royal Bournemouth Hosp, Bournemouth, Dorset, England; [Bodalia, B.; Mottram, J.] Gables Medictr, Coventry, W Midlands, England; [Calvert, J.; Brodie, K.] Waterloo Med Ctr, Blackpool, England; [Gunstone, A.; Douglas, C.] Staploe Med Ctr, Soham, England; [Trouton, T.; Hunter, B.] Antrim Area Hosp, Antrim, North Ireland; [Gerber, R.; Pepper, H.] Conquest Hosp, St Leonards On Sea, E Sussex, England; [Mathur, A.; Andiapen, M.] Barts & London NHS Trust, London, England; [Baumbach, A.; Bowles, R.] Bristol Heart Inst, Bristol, Avon, England; [Hildick-Smith, D.; McGregor, A.] Royal Sussex Cty Hosp, Brighton, E Sussex, England; [Loh, I.; Plocky, J.] Westlake Med Res, Westlake Vlg, CA USA; [Adams, K.; Clemmer, K.] Baptist Cardiology Inc, DBA Jacksonville Heart Ctr, Jacksonville, FL USA; [Aggarwal, K.; Burkhardt, V.] Univ Missouri, Hlth Care Syst, Columbia, MO USA; [Costa, M.; Lemmertz, K.] Hawthorn Med Associates, N Dartmouth, MA USA; [Anderson, J.; York, T.] Integris Cardiovasc Phys LLC, Oklahoma City, OK USA; [Angiolillo, D.; Green, E.] Univ Florida HSC, Jacksonville, FL USA; [Sperling, M.; Vasquez, E.] Edinger Med Grp & Res Ctr, Fountain Valley, CA USA; [Aycock, G.; Tatum, D.] Cardiol Consultants, Pensacola, FL USA; [Amin, J.; Davidson, A.] Clearwater Cardiovasc & Intervent Consultants, Clearwater, FL USA; [Hendrix, E.; Shepard, L.] N Alabama Res Ctr LLC, Athens, AL USA; [Strain, J.; Michel, K.] Cardiac & Endovasc Associates, Ridgewood, NJ USA; [Talano, J.; Szalanski, N.] SWICFT Inst, Naples, FL USA; [Berk, M.; Ibarra, M.] Cardiovasc Res Inst Dallas, Dallas, TX USA; [Bhagwat, R.; Winterrowd, D.] Cardiol Associates NW Indiana P C, Hammond, IN USA; [Bilazarian, S.; Marsters, M. J.] Pentucket Med Associates, Haverhill, MA USA; [Blonder, R.; Graf, L.] Colorado Hlth Med Grp, Colorado Springs, CO USA; [Brilakis, E.; Roesle, M.] Dallas VA Med Ctr, VA N Texas Hlth Care Ce, Dallas, TX USA; [Byrd, L.; Sullivan, A.] Rowan Res Inc, Spokane, WA USA; [Longo, J.; Pennella, A.] Cardiol P C, Syracuse, NY USA; [Westerhausen, D.; Weil, R.] Midwest Cardiovasc Res Educ Fdn, Elkhart, IN USA; [Carr, K.; Piazza, J.; Carr, Kenneth W.] Cardiol, Oceanside, CA USA; [Castello, R.; Hawks, M.] Jacksonville Ctr Clin Res, Jacksonville, FL USA; [Chandna, H.; Holly, D.] Victoria Heart & Vasc Ctr, Victoria, TX USA; [Chandrashekhar, Y. S.; Molinaro, N.] VA Med Ctr, Minneapolis, MN USA; [Carter, M. E.; Antonino, M.] Cent Utah Clin, Amer Fork, UT USA; [Kosmicki, D.; Kelley, M.] Nebraska Heart Inst, Hastings, NE USA; [Richwine, R.; Pazier, P.] Leading Edge Res, Ft Worth, TX USA; [Cohen, M.; Glasgow, B.] Maine Cardiol Associates, Portland, ME USA; [Bresee, S.; Alexander, J.] Volunteer Res Grp, Knoxville, TN USA; [Concha, M.; Martinez, E.] Intercoastal Med Grp, Sarasota, FL USA; [Connelly, T.; Schenks, R.] Charlotte Heart Grp Res Ctr, Port Charlotte, FL USA; [Cooper, M.; Garman, V.] LeBauer Cardiovasc Res Fdn, Greensboro, NC USA; [Condit, J.; White, A.] Amer Hlth Network, Muncie, IN USA; [Fialkow, J.; Mckercher, M.] Cardiovasc Res Ctr S Florida, Miami, FL USA; [Luna, M.; Soto, G.] Univ Texas, SW Med Ctr, Dallas, TX USA; [Prodafikas, J.; Rambaud, B.] Aultman Hosp, Canton, OH USA; [Donovan, J.; Mudd, D.] Norton Cardiovasc Associates, Louisville, KY USA; [Doty, W. D.; Parsons, T.] Cardiol Consultants, Pensacola, FL USA; [D'Urso, M.; Bies, J.] Rapid City Reg Hosp Inc, Rapid City, SD USA; [Han, J.; Treadwell, M.] VA Greater Angeles Hlth Care Syst, Los Angeles, CA USA; [Erickson, B.; Dahl, P.] CentraCare Heart & Vasc Ctr, St Cloud Hosp, St Cloud, MN USA; [Fattal, P.; Braem, J.] Michigan Cardiovasc Inst, Saginaw, MI USA; [Felten, W.; Prior, J.] Michigan Cardiovasc Inst, Midland, MI USA; [French, W.; Barillas, O.] Harbor UCLA, Med Ctr, Torrance, CA USA; [Berger, R.; Genova, E.] Northshore Univ Hlth Syst, Bannockburn, IL USA; [Gelernt, M.; Cockrell, D.] Cardiovasc Associates, Delaware, OH USA; [Gelernt, M.; Cockrell, D.] Cardiovasc Associates, Elmer, NJ USA; [Miller, G.; Dumka, K.] Clin Res Works LLC, Bristol, RI USA; [Gill, S.; Elliot, S.] Fox Valley Clin Res Ctr LLC, Aurora, IL USA; [Goldberg, R.; Barrett, M.] Mesa Cardiac Ctr, La Mesa, CA USA; [Gordon, P.; Stern, L.] Miriam Hosp, Providence, RI USA; [Ayres, T.; Rhule, V.] Knoxville Heart Grp, Knoxville, TN USA; [Gupta, D.; Holton, T.] Tennessee Ctr Clin Trials, Tullahoma, TN USA; [Haddad, T.; Jain, J.] Virginia Heart, Falls Church, VA USA; [Hakas, J.; McSorley, J.] Pinehurst Med Clin Inc, Pinehurst, NC USA; [Hamroff, G.; Hollenweger, L.] NYU Hudson Valley Cardiol PC, Cortlandt Manor, NY USA; [Wainwright, W.; Jones, S.] Baptist Cardiology Inc, DBA Jacksonville Heart Ctr, Jacksonville, FL USA; [Effat, M.; Mardis, R.] Univ Cincinnati, Cincinnati, OH USA; [Henderson, D.; Millard, D.] Cardiol Res Associates, Daytona Beach, FL USA; [Hermany, P.; Meissner-Dengler, S.] Grand View Lehigh Valley Hlth Serv, Sellersville, PA USA; [Hinchman, D.; Luck, K.] St Lukes Idaho Cardiol Associates, Boise, ID USA; [Hodson, R.; Severson, L.] Providence Heart Clin, Oregon Clin Gateway, Portland, OR USA; [Horwitz, P.; Miller, K.] Univ Iowa Hosp & Clin, Iowa City, IA USA; [Isserman, S.; Moore, C.] Clin Trials Am Inc, Hickory, NC USA; [Jan, M.; Bilyk, O.] W Chester Cardiol PC, W Chester, PA USA; [Kersh, R.; DaCosta, A.] Goodman Cardio Pulm Associates, Plantation, FL USA; [Kim, E.; Gonzales, C.] Eastside Cardiol Associates P C, Kirkland, WA USA; [Kmetzo, J.; Taylor, D.] Cent Bucks Cardiol, Doylestown, PA USA; [Knutson, T.; Belanger, B.] Prevea Hlth, Green Bay, WI USA; [Hage-Korban, E.; Harrington, A.] Heart & Vasc Ctr W TN, Jackson, TN USA; [Murdock, D.; Johnson, M.] Aspirus Res Inst, Wausau, WI USA; [Heiman, M.; Dandekar, U.] Cardiol Associates Fairfield Cty PC, Stamford, CT USA; [Khan, M.; Khan, G.] Springfiel Med Ctr, Panama City, FL USA; [Lui, H.; Holman, L.] Res Associates Jackson, Jackson, TN USA; [MacDonald, L.; Derbyshire, S.] S Denver Cardiol Associates, Littleton, CO USA; [Mehta, R.; Watkins, K.] Jackson Cardiol Associates PC, Jackson, MS USA; [Mayer, N.; Mitchell, B.] Ventura Cardiol Consultants, Med Grp, Ventura, CA USA; [McCullum, K.; Delio-Cox, B.] York Hosp Cardiol, Yorktown Hts, NY USA; [McKay, R.; Cloutier, J.] Hartford Hosp, Cardiac Lab, Hartford, CT USA; [McKenzie, M.; Rodkey, K.] Legacy Heart Ctr, Plano, TX USA; [McLaurin, B.; Lack, A.] AnMed Hlth, Anderson, SC USA; [Minisi, A.; Jeter, D.] McGuire Vet Affairs, Med Ctr, Richmond, VA USA; [Mitchell, R.; Keane-Richmond, P.] Glacier View Cardiol, Kalispell, MT USA; [Stine, R.; Bullivant, M.] Sentara Norfolk Gen Hosp, Norfolk, VA USA; [Morford, R.; White, J.] Stroobants Cardiovascular Ctr, Lynchburg, VA USA; [Oberoi, M.; Geraldo-Abache, A.] Cent Jersey Med Res Ctr, Elizabeth, NJ USA; [O'Dea, D.; Landi, T.] Poughkeepsie, Hudson Valley Cardiovasc Practice, New York, NY USA; [Tang, N.; Mehta, R.] Katy Cardiol, Houston, TX USA; [Ong, S.; Edwards, M.] Med Res, Oxon Hill, MD USA; [Osborne, J.; Alonzo, C.] State Heart, PLLC, Grapewine, TX USA; [Lev, V.; Monroe, J.] Cardiac Study Ctr, Tacoma, WA USA; [Popeil, L.; Sorrentino, N.] Magnolia Res Grp Inc, Ocala, FL USA; [Landi, T.; Portelli, J.] Hudson Valley Cardiovasc Practice PC, New Windsor, NY USA; [Potu, R.; Smith, N.] Nat Coast Clin Res, Crystal River, FL USA; [Prashad, R.; McDonough, C.] Ocala Res Inst Inc, Ocala, FL USA; [Qureshi, M.; Howe, A.] Michigan Heart, Ypsilanti, MI USA; [Raikhel, M.; Arsate, M.] Torrance Clin Res, Lomita, CA USA; [Rogers, W.; Saag, L.] UAB Med Ctr, Birmingham, AL USA; [Sangrigoli, R.; Schwarz, L.] Doylestown Cardiol Specialists VIAA, Doylestown, PA USA; [Abu-Fadel, M.; Hagee, A.] Univ Oklahoma Hlth, Sci Ctr, Oklahoma City, OK USA; [Kinnaman, S.; McDaniel, V.] Amer Hlth Network Indiana LLC, Greenfield, IN USA; [Wilson, V.; Purcell, T.] Daytona Heart Grp, Daytona Beach, FL USA; [Roberts, J.; Riofrio, K.] S Florida Res Grp LLC, Miami, FL USA; [Shah, U.; Narang, S.] MidAtlant Med Res Centers, Hollywood, MD USA; [Gredler, F.; Knap, P.] Tallahassee Res Inst Inc, Tallahassee, FL USA; [Shanes, J.; Hansen, C.] Consultants Cardiovasc Med, Melrose Pk, IL USA; [Sharma, M.; Gibson, T.] Pkwy Cardiol Associates, Oak Ridge, TN USA; [Sheldon, W.; Bohn, A.] N Ohio Res Ltd, Sandusky, OH USA; [Siegel, C.; Tibbits, L.] Austin Heart PLLC, Austin, TX USA; [Singh, V.; Nelson, M.] Suncoast Cardiovasc Res, St Petersburg, FL USA; [Singh, N.; Logwood, D.] Atlanta Heart Specialists LLC, Atlanta, GA USA; [Randhawa, P.; Vargas, B.] NJ Heart, Linden, NJ USA; [Stegemoller, R.; Cole, B.] Amer Hlth Network, Avon, IN USA; [Johnson, M.; Aggarwal, R.] CVMS Res Inst LLC, Jupiter, FL USA; [Steinhoff, J.; Dunaway, B.] Heart & Vasc Inst Florida, Clearwater, FL USA; [Patel, K.; Boomer, L.] St Joseph Mercy Oakland, Pontiac, MI USA; [Taheri, H.; Morgan, K.] Carient Heart & Vasc, Manassas, VA USA; [Tahirkheli, N.; Santos, A.] S Oklahoma Heart Res, Oklahoma City, OK USA; [Thadani, U.; Alexander, D.] VA Med Ctr, Oklahoma City, OK USA; [Bennett, W.; Kelley, E.] Kootenai Heart Clin LLC, Spokane, WA USA; [Thomas, J.; Macnicholas, D.] Med Univ S Carolina, Charleston, SC USA; [Varma, S.; Evans, S.] Boice Willis Clin, Rocky Mount, NC USA; [Vlastaris, A.; Bittel, B.] Cleveland Cardiovasc Res Fdn, Fairview Pk, OH USA; [Voyce, S.; Mack, B.] Adv Cardiol Specialists, Scranton, PA USA; [Weiss, R.; Fournier, T.] Maine Res Associates, Auburn, NY USA; [Whitney, R.; Orosco, C.] BryanLGH Heart Inst, Lincoln, NE USA; [Willis, J.; VonGerichten, S.] San Gabriel Clin Res, Georgetown, TX USA; [Wiseman, A.; Sharrow, A.] Eastern Maine Med Ctr, Bangor, ME USA; [Wohns, D.; Schuitema, J.] Spectrum Hlth, Grand Rapids, MI USA; [Amin, M.; Ramus, A. M.] Westcoast Cardiol, Clearwater, FL USA; [Wilson, W.; Moeller, C.] Parkview Res Ctr, Ft Wayne, IN USA; [Newell, M.; Tindell, L.] Minneapolis Heart Inst Fdn, Minneapolis, MN USA; [Rivera, W.; Kwierant, J.] McLaren Reg Med Ctr, Flint, MI USA; [Bretton, E.; Corbin, B.] Albuquerque Clinical Trials Inc, Albuquerque, NM USA; [Labroo, A.; Lopez, C.] Adv Cardiovasc Consultants, Rock Isl, IL USA; [Brown, C.; Craig, M. A.] Mobile Heart Specialists PC, Mobile, AL USA; [Lucca, M.; Keinanen, T.] Essentia Inst Rural Hlth, Duluth, MN USA; [Eisenberg, S.; Fielding, M.] Complete Cardiol, Atlanta, GA USA; [Doorey, A.; Squire, A.] Christiana Care Hlth Syst, Newark, DE USA; [Suresh, D.; Frost, J.] Comprehens Cardiol Consultants Inc, Crestview Hills, KY USA; [Teklinski, A.; Stone, B.] Nisus Res No Michigan Hosp, Petoskey, MI USA; [Waksman, R.; Griffin, S.] Washington Hosp Ctr, Washington, DC USA; [Wharton, W.; Blakely, J.] Asheville Cardiol Associates, Asheville, NC USA; [Fishbein, G.; Weller, C.] Dayton Heart Ctr, Dayton, OH USA; [Camp, A.; Fisher, S.] Heart & Vasc Inst Florida, Safety Harbor, FL USA; [Meholick, A.; Hejna, E.] Buffalo Heart Grp LLP, Buffalo, NY USA; [Anderson, R. D.; Long, S.] Univ Florida, Coll Med Div, Gainesville, FL USA; [Parikh, S.; Norton, N.] Univ Hosp Case, Med Ctr, Cleveland, OH USA; [Vijay, N.; Washam, M.] Aurora Denver Cardiol Associates, Denver, CO USA; [Smith, S.; Stepanov, N.] Mt States Hlth Alliance, Johnson City, TN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Newark Beth Israel Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; University of Sheffield; AstraZeneca; Icahn School of Medicine at Mount Sinai; Canisius-Wilhelmina Hospital; Centre of Postgraduate Medical Education - Poland; Universite de Montreal; National Medical Research Center of Cardiology; Kerckhoff Clinic; Justus Liebig University Giessen; Tokai University; University Hospital Brno; Universidade de Sao Paulo; Geelong Hospital; Geelong Hospital; Florey Institute of Neuroscience & Mental Health; St George Hospital; John Hunter Hospital; Lyell McEwin Hospital; Nepean Hospital; Royal North Shore Hospital; Wollongong Hospital; University of Western Australia; Royal Brisbane & Women's Hospital; Monash University; Wesley Hospital; Concord Repatriation General Hospital; University of Western Australia; University of Antwerp; Ghent University; Ghent University Hospital; University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; ZNA Middelheim Hospital; Imeldaziekenhuis; East Limburg Hospital; ZNA Stuivenberg; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Instituto Dante Pazzanese de Cardiologia; Fundacao Universitaria de Cardiologia; Instituto Dante Pazzanese de Cardiologia; Universidade Federal de Sao Paulo (UNIFESP); Medical University Sofia; Medical University Pleven; Scarborough Hospital; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of British Columbia; Royal Alexandra Hospital; University of Alberta; Centre Integre de Sante et de Services Sociaux de Laval; McMaster University; Universite de Montreal; University of Ottawa; University of Ottawa Heart Institute; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; Western University (University of Western Ontario); Universidad de Chile; Universidad de Chile; Universidad de Chile; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Southeast University - China; Capital Medical University; Shanghai Jiao Tong University; Chongqing Medical University; Shanxi Medical University; Fundacion Cardioinfantil - Instituto de Cardiologia; St Anne's University Hospital Brno (FNUSA-ICRC); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHR Metz-Thionville; CHU Dijon Bourgogne; CHU Poitiers; Universite de Poitiers; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Nice; Universite de Montpellier; CHU de Nimes; Centre Hospitalier Regional d'Orleans; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Toulouse; CHU Limoges; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; CHU Bordeaux; Kerckhoff Clinic; Ruprecht Karls University Heidelberg; St. Johannes Hospital; Ulm University; Klinikum Coburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Caritas Hospital Bad Mergentheim; Semmelweis University; Szeged University; University of Pecs; University of Parma; University Hospital of Parma; IRCCS Centro Cardiologico Monzino; IRCCS Humanitas Research Hospital; Fondazione Poliambulanza di Brescia; San Filippo Neri Hospital; Ente Ospedaliero Ospedali Galliera; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University Campus Bio-Medico - Rome Italy; Antonio Cardarelli Hospital; University of Genoa; IRCCS AOU San Martino IST; Ospedale di Vimercate; Kanagawa Cardiovascular & Respiratory Center; Kitano Hospital; Kanto Medical Center NTT EC; Tokai University; St. Luke's International Hospital; Gunma University; Sint Lucas Andreas Hospital; Reinier de Graaf Hospital; Deventer Hospital; Gelderse Vallei Hospital; Atrium Medical Center; Canisius-Wilhelmina Hospital; Orbis Medical Center; Haaglanden Medical Center; Bronovo Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ); Maastricht University; Meander Medisch Centrum; Jeroen Bosch Ziekenhuis; Franciscus Gasthuis; Spaarne Hospital; Catharina Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Maasstad Hospital; University of Groningen; Rijnland Hospital; University of Oslo; National Hospital Norway; Innlandet Hospital Trust; Innlandet Hospital Trust; University of Bergen; Haukeland University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway; Innlandet Hospital Trust; Seguro Social de Salud del Peru; Philippine Heart Center; UERM Memorial Medical Center; Saint Lukes Medical Center - Philippines; Institute of Cardiology - Poland; Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Konyang University; Konyang University Hospital; Pusan National University; Pusan National University Hospital; Yonsei University; Yonsei University Health System; Ajou University; Ajou University Hospital; Yeungnam University; Yeungnam University Hospital; Chonnam National University; Jeonbuk National University; Jeonbuk National University Hospital; Chungbuk National University; Chungbuk National University Hospital; Sejong General Hospital; Keimyung University; Chungnam National University; Chungnam National University Hospital; North-Western State Medical University named after I.I. Mechnikov; National Medical Research Center of Cardiology; National Medical Research Center of Cardiology; Ural State Medical University; Volgograd State Medical University; University of Pretoria; Hospital Universitario La Paz; Hospital Universitario Virgen Macarena; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario Infanta Leonor; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Vall d'Hebron; Hospital Clinico San Carlos; Hospital Universitari Son Llatzer; Central University Hospital Asturias; Hospital Clinic Universitari de Valencia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Basurto Hospital; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital of Santa Creu i Sant Pau; Hospital Universitari Son Espases; Complexo Hospitalario Universitario de Santiago de Compostela; Vasteras Central Hospital; Sodersjukhuset Hospital; Sahlgrenska University Hospital; Linkoping University; Umea University; Dokuz Eylul University; Istanbul University; Adana Numune Training & Research Hospital; Mersin University; Istanbul University; Istanbul University - Cerrahpasa; Gazi University; Inonu University; Mehmet Akif Ersoy Thoracic Cardiovascular Surgery Education Research Hospital; Istanbul University; Ankara Yildirim Beyazit University; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Donetsk National Medical University; National Academy of Medical Sciences of Ukraine; L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; Danylo Halytsky Lviv National Medical University; National Pirogov Memorial Medical University Vinnytsya; National Academy of Medical Sciences of Ukraine; L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine; Northern General Hospital; Monklands Hospital; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University Hospital Hairmyres; University of Dundee; James Cook University Hospital; Morriston Hospital; University of Manchester; Barts Health NHS Trust; University of Bristol; University of Brighton; University of Missouri System; University of Missouri Columbia; State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; LeBauer-Brodie Center for Cardiovascular Research & Education; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; NorthShore University Health System; Lifespan Health Rhode Island; Miriam Hospital; University System of Ohio; University of Cincinnati; University of Iowa; Hartford Hospital; Sentara Healthcare; University of Alabama System; University of Alabama Birmingham; University of Oklahoma System; University of Oklahoma Health Sciences Center; Saint Joseph Mercy Health System (SJMHS); University of Oklahoma System; University of Oklahoma Health Sciences Center; Medical University of South Carolina; Eastern Maine Medical Center; Michigan State University; Michigan State University College of Human Medicine; Minneapolis Heart Institute Foundation; Michigan State University; Michigan State University College of Human Medicine; Christiana Care Health System; MedStar Washington Hospital Center; State University System of Florida; University of Florida; Case Western Reserve University; Case Western Reserve University Hospital	Bonaca, MP (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.	mbonaca@partners.org	Kozinski, Marek/G-4203-2014; Lanas, Fernando/AAE-8842-2022; Berti, Sergio/AAV-6619-2021; Emet, Samim/AAE-6238-2020; Elbl, Lubomir/AAM-1074-2020; Fernandez-Ortiz, Antonio/B-2227-2017; Ardissino, Diego/AAC-4041-2022; Ponikowski, Piotr/O-6454-2015; Bertolami, Adriana/AAO-4250-2020; Rubino, Mara/K-1537-2016; Rasputina, Lesia/AAE-5764-2019; Frey, Norbert/A-9695-2010; Labonte, Ronald/G-4229-2011; Nicolau, Jose C/E-1487-2012; Marwick, Thomas/AAK-3869-2021; Kosmacheva, Elena/AAY-4841-2020; Lutay, Yaroslav/GLT-9262-2022; Benedek, Imre/E-7052-2017; Bonaca, Marc/AAJ-2397-2021; Timmermans, Philippe/AHA-6596-2022; Statsenko, Mikhail E./N-7573-2015; Frey, Norbert/M-7749-2019; Bobescu, Elena/AAC-6840-2021; Petrella, Robert J/G-6557-2018; Jenei, Csaba/GQI-1478-2022; Derevyanchenko, Maria M.V./A-1859-2016; Rekovets, Oksana/AAL-7698-2021; Hiczkiewicz, Jarosław/ABC-5678-2021; Rizzotti, Diego/H-5610-2015; Precoma, Dalton B/D-5674-2013; Prunier, Fabrice/A-5210-2011; Benedek, Theodora/F-6353-2016; Řiháček, Ivan/F-7871-2017; Wiviott, Stephen/HIK-2534-2022; Nethononda, Richard/AAQ-7036-2021; Omel'chenko, MA/K-6508-2016; Lopez de Sa, Esteban/AAY-2627-2021; Zaprovalna, Olga/AAT-1774-2021; Boldueva, Svetlana/AAH-3862-2019; Stellbrink, Christoph/AAX-7701-2021; Maia, Lilia Nigro/AAV-6938-2021; Kislyak, Oxana Andreevna/K-8235-2018; Urina-Triana, Miguel A/H-2605-2016; Izmozherova, Nadezhda/AAI-1947-2020; Magnani, Giulia/AGM-1833-2022; Ripoll-Vera, Tomas/AAT-3535-2021; Nedogoda, Sergey V/O-4656-2014; Shumakov, Valentyn/AAL-8593-2020; Hamm, Christian W./I-3155-2017; Shavarov, Andrey A./A-5498-2017; Abdel-Latif, Ahmed/V-8097-2019; Bobescu, Elena/ABD-6951-2020; Arkhipov, Mikhail V/Q-2316-2015; Korda, Andrew/P-2854-2019; Marin-Neto, Jose Antonio/F-6099-2012; Hidayet, Şıho/ABI-2256-2020; Janota, Tomas/S-7725-2017; Giraldez, Roberto RCV/E-2498-2012; coskun, ugur/A-6371-2013; Kubica, Jacek/D-6906-2014; MacKenzie, M.A./L-4499-2015; Sezer, Murat/AAE-5807-2020; Bolieva, Laura/AAH-3726-2019; Bazylevych, Andriy/G-2834-2019; Galyavich, Albert/L-6327-2015; Linhart, Ales/O-2375-2017; Costa, Francesco/O-1304-2019; Toth, Peter/GMW-6552-2022; Cioca, Gabriela/B-5504-2012; Ferrari, Emile/R-2917-2016; Ersanli, Murat Kazim/D-8315-2019; van Dijk, Arie/L-4272-2015; Derevyanchenko, Mariya/C-1673-2016	Kozinski, Marek/0000-0002-6460-4802; Fernandez-Ortiz, Antonio/0000-0002-3239-1910; Ponikowski, Piotr/0000-0002-3391-7064; Rubino, Mara/0000-0001-7820-9814; Rasputina, Lesia/0000-0003-1230-4039; Nicolau, Jose C/0000-0002-9680-3689; Marwick, Thomas/0000-0001-9065-0899; Benedek, Imre/0000-0003-0051-4047; Bonaca, Marc/0000-0002-9860-3584; Statsenko, Mikhail E./0000-0002-3306-0312; Frey, Norbert/0000-0001-7611-378X; Derevyanchenko, Maria M.V./0000-0002-6232-4583; Rekovets, Oksana/0000-0002-3925-2948; Rizzotti, Diego/0000-0003-0641-8857; Benedek, Theodora/0000-0001-8326-1537; Řiháček, Ivan/0000-0003-2434-5807; Omel'chenko, MA/0000-0001-8343-168X; Lopez de Sa, Esteban/0000-0002-3504-6901; Zaprovalna, Olga/0000-0002-5066-0483; Boldueva, Svetlana/0000-0002-1898-084X; Kislyak, Oxana Andreevna/0000-0002-2028-8748; Urina-Triana, Miguel A/0000-0001-6003-4622; Magnani, Giulia/0000-0003-1090-0101; Nedogoda, Sergey V/0000-0001-5981-1754; Hamm, Christian W./0000-0001-6763-4161; Shavarov, Andrey A./0000-0003-3929-431X; Abdel-Latif, Ahmed/0000-0002-8178-7102; Bobescu, Elena/0000-0002-0945-9067; Arkhipov, Mikhail V/0000-0002-7924-7668; Hidayet, Şıho/0000-0002-4103-9345; Janota, Tomas/0000-0001-5659-3747; coskun, ugur/0000-0002-1958-7978; Kubica, Jacek/0000-0001-8250-754X; Bazylevych, Andriy/0000-0001-5053-2548; Linhart, Ales/0000-0002-3372-7850; Costa, Francesco/0000-0002-3097-2834; Cioca, Gabriela/0000-0003-1165-1389; Budaj, Andrzej/0000-0002-6395-2098; Kietselaer, Bas/0000-0002-0096-8594; Ersanli, Murat Kazim/0000-0003-1847-3087; Lubinski, Andrzej/0000-0003-2779-0041; ELBAZ, Meyer/0000-0002-3520-7883; Valbuena-Lopez, Silvia/0000-0002-6252-4390; A. Samad, Bassem/0000-0001-9440-5073; STEG, Philippe Gabriel/0000-0001-6896-2941; van Dijk, Arie/0000-0002-7843-8251; Costa Duarte Barbosa, Eduardo/0000-0002-4361-936X; Aboyans, Victor/0000-0002-0322-9818; Yena, Larisa/0000-0001-9633-1848; Lanas, Fernando/0000-0003-3595-9759; Sinnaeve, Peter/0000-0003-4716-5892; Derevyanchenko, Mariya/0000-0001-7742-3085; Safarova, Maya/0000-0003-3069-3752; Manzur, Fernando/0000-0001-6679-5609; Anderson, R. David/0000-0003-3490-3286; Patti, Giuseppe/0000-0002-5404-3968; Golitsyn, Sergey/0000-0001-9913-9974; Storey, Robert/0000-0002-6677-6229; Wijns, William/0000-0002-7267-4376	AstraZeneca; PEGASUS-TIMI [54]	AstraZeneca(AstraZeneca); PEGASUS-TIMI	Funded by AstraZeneca; PEGASUS-TIMI 54 ClinicalTrials.gov number, NCT01225562.	Amsterdam EA, 2014, CIRCULATION, V130, P2354, DOI 10.1161/CIR.0000000000000133; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonaca MP, 2014, AM HEART J, V167, P437, DOI 10.1016/j.ahj.2013.12.020; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Husted S, 2006, EUR HEART J, V27, P1038, DOI 10.1093/eurheartj/ehi754; Jernberg T, 2015, EUR HEART J, V36, P1163, DOI 10.1093/eurheartj/ehu505; Kapoor JR, 2008, NEW ENGL J MED, V358, P1638, DOI 10.1056/NEJMc080056; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2013, LANCET, V382, P605, DOI 10.1016/S0140-6736(13)61451-8; World Health Organization, 2004, ATLAS HEART DIS STRO; Yusuf S, 2003, CIRCULATION, V107, P966, DOI 10.1161/01.CIR.0000051362.96946.15; Yusuf S, 2001, NEW ENGL J MED, V345, P1716	25	1282	1345	15	318	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1791	1800		10.1056/NEJMoa1500857	http://dx.doi.org/10.1056/NEJMoa1500857			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH4BB	25773268	Green Published			2022-12-28	WOS:000353974700004
J	Huo, Y; Li, JP; Qin, XH; Huang, YN; Wang, XB; Gottesman, RF; Tang, GF; Wang, BY; Chen, DF; He, ML; Fu, J; Cai, YF; Shi, XL; Zhang, Y; Cui, YM; Sun, NL; Li, XY; Cheng, XS; Wang, JA; Yang, XC; Yang, TL; Xiao, CS; Zhao, G; Dong, Q; Zhu, DL; Wang, X; Ge, JB; Zhao, LY; Hu, DY; Liu, LS; Hou, FF				Huo, Yong; Li, Jianping; Qin, Xianhui; Huang, Yining; Wang, Xiaobin; Gottesman, Rebecca F.; Tang, Genfu; Wang, Binyan; Chen, Dafang; He, Mingli; Fu, Jia; Cai, Yefeng; Shi, Xiuli; Zhang, Yan; Cui, Yimin; Sun, Ningling; Li, Xiaoying; Cheng, Xiaoshu; Wang, Jian'an; Yang, Xinchun; Yang, Tianlun; Xiao, Chuanshi; Zhao, Gang; Dong, Qiang; Zhu, Dingliang; Wang, Xian; Ge, Junbo; Zhao, Lianyou; Hu, Dayi; Liu, Lisheng; Hou, Fan Fan		CSPPT Investigators	Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China The CSPPT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							B-VITAMINS; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; LOWERING HOMOCYSTEINE; MORTALITY; DISEASE; RISK; PLACEBO; SUPPLEMENTATION; ASSOCIATION	IMPORTANCE Uncertainty remains about the efficacy of folic acid therapy for the primary prevention of stroke because of limited and inconsistent data. OBJECTIVE To test the primary hypothesis that therapy with enalapril and folic acid is more effective in reducing first stroke than enalapril alone among Chinese adults with hypertension. DESIGN, SETTING, AND PARTICIPANTS The China Stroke Primary Prevention Trial, a randomized, double-blind clinical trial conducted from May 19, 2008, to August 24, 2013, in 32 communities in Jiangsu and Anhui provinces in China. A total of 20 702 adults with hypertension without history of stroke or myocardial infarction (MI) participated in the study. INTERVENTIONS Eligible participants, stratified by MTHFR C677T genotypes (CC, CT, and TT), were randomly assigned to receive double-blind daily treatment with a single-pill combination containing enalapril, 10 mg, and folic acid, 0.8 mg (n = 10 348) or a tablet containing enalapril,10 mg, alone (n = 10 354). MAIN OUTCOMES AND MEASURES The primary outcome was first stroke. Secondary outcomes included first ischemic stroke; first hemorrhagic stroke; MI; a composite of cardiovascular events consisting of cardiovascular death, MI, and stroke; and all-cause death. RESULTS During a median treatment duration of 4.5 years, compared with the enalapril alone group, the enalapril-folic acid group had a significant risk reduction in first stroke (2.7% of participants in the enalapril-folic acid group vs 3.4% in the enalapril alone group; hazard ratio [HR], 0.79; 95% Cl, 0.68-0.93), first ischemic stroke (2.2% with enalapril-folic acid vs 2.8% with enalapril alone; HR, 0.76; 95% Cl, 0.64-0.91), and composite cardiovascular events consisting of cardiovascular death, MI, and stroke (3.1% with enalapril-folic acid vs 3.9% with enalapril alone; HR, 0.80; 95% Cl, 0.69-0.92). The risks of hemorrhagic stroke (HR, 0.93; 95% Cl, 0.65-1.34), MI (HR, 1.04; 95% Cl, 0.60-1.82), and all-cause deaths (HR, 0.94; 95% Cl, 0.81-1.10) did not differ significantly between the 2 treatment groups. There were no significant differences between the 2 treatment groups in the frequencies of adverse events. CONCLUSIONS AND RELEVANCE Among adults with hypertension in China without a history of stroke or MI, the combined use of enalapril and folic acid, compared with enalapril alone, significantly reduced the risk of first stroke. These findings are consistent with benefits from folate use among adults with hypertension and low baseline folate levels.	[Huo, Yong; Li, Jianping; Zhang, Yan] Peking Univ, Hosp 1, Dept Cardiol, Beijing 100034, Peoples R China; [Qin, Xianhui; Wang, Binyan; Hou, Fan Fan] Southern Med Univ, Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Renal Div,Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Qin, Xianhui; Tang, Genfu; Wang, Binyan] Anhui Med Univ, Inst Biomed, Hefei, Peoples R China; [Huang, Yining] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China; [Wang, Xiaobin] Johns Hopkins Univ, Dept Populat Family & Reprod Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gottesman, Rebecca F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gottesman, Rebecca F.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tang, Genfu] Anhui Med Univ, Sch Hlth Adm, Hefei, Peoples R China; [Chen, Dafang] Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing 100871, Peoples R China; [He, Mingli] First Peoples Hosp, Dept Neurol, Lianyungang, Peoples R China; [Fu, Jia; Shi, Xiuli] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Peoples R China; [Cai, Yefeng] Guangdong Prov Hosp Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Cui, Yimin] Peking Univ, Hosp 1, Dept Pharm, Beijing 100034, Peoples R China; [Sun, Ningling; Hu, Dayi] Peking Univ, Hosp 1, Dept Cardiol, Beijing 100034, Peoples R China; [Li, Xiaoying] Peoples Liberat Army, Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [Cheng, Xiaoshu] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Peoples R China; [Wang, Jian'an] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Xinchun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China; [Yang, Tianlun] Cent South Univ, Dept Cardiol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Xiao, Chuanshi] Shanxi Med Univ, Hosp 1, Dept Cardiol, Taiyuan, Peoples R China; [Zhao, Gang] Fourth Mil Med Univ, Dept Neurol, Xijing Hosp, Xian 710032, Peoples R China; [Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Zhu, Dingliang] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai Key Lab Hypertens, Ruijin Hosp, Shanghai 200030, Peoples R China; [Wang, Xian] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100034, Peoples R China; [Ge, Junbo] Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China; [Zhao, Lianyou] Fourth Mil Med Univ, Dept Cardiol, Tangdu Hosp, Xian 710032, Peoples R China; [Liu, Lisheng] Fu Wai Hosp, Div Hypertens, Beijing, Peoples R China; [Liu, Lisheng] Beijing Hypertens League Inst, Beijing, Peoples R China	Peking University; Southern Medical University - China; Anhui Medical University; Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Anhui Medical University; Peking University; Anhui Medical University; Guangzhou University of Chinese Medicine; Peking University; Peking University; Chinese People's Liberation Army General Hospital; Nanchang University; Zhejiang University; Capital Medical University; Central South University; Shanxi Medical University; Air Force Military Medical University; Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Peking University; Fudan University; Air Force Military Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Hypertension League	Huo, Y (corresponding author), Peking Univ, Hosp 1, Dept Cardiol, 8 Xishiku St, Beijing 100034, Peoples R China.	ffhouguangzhou@163.com; ffhouguangzhou@163.com	Gottesman, Rebecca/ABA-8468-2020	He, Mingli/0000-0002-1772-8183; Qin, Xianhui/0000-0001-7812-7982	Shenzhen AUSA Pharmed Co Ltd; National Science and Technology Major Projects Specialized for "Major New Drugs Innovation and Development" during the 12th Five-Year Plan Period: China Stroke Primary Prevention Trial [zx09101105]; Major State Basic Research Development Program of China (973 program) [2012 CB517703]; Clinical Center [zx09401013]; National Natural Science Foundation of China [81473052, 81441091, 81402735]; National Clinical Research Center for Kidney Disease, Nanfang Hospital, Nanfang Medical University, Guangzhou, China; State Key Laboratory for Organ Failure Research, Nanfang Hospital, Nanfang Medical University, Guangzhou, China; Department of Development and Reform, Shenzhen Municipal Government [SFG 20201744]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086013] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079872, U01AI090727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES011666] Funding Source: NIH RePORTER	Shenzhen AUSA Pharmed Co Ltd; National Science and Technology Major Projects Specialized for "Major New Drugs Innovation and Development" during the 12th Five-Year Plan Period: China Stroke Primary Prevention Trial; Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); Clinical Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Research Center for Kidney Disease, Nanfang Hospital, Nanfang Medical University, Guangzhou, China; State Key Laboratory for Organ Failure Research, Nanfang Hospital, Nanfang Medical University, Guangzhou, China; Department of Development and Reform, Shenzhen Municipal Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The trial was jointly supported by Shenzhen AUSA Pharmed Co Ltd and national, municipal, and private funding, including from the National Science and Technology Major Projects Specialized for "Major New Drugs Innovation and Development" during the 12th Five-Year Plan Period: China Stroke Primary Prevention Trial (grant zx09101105); the Major State Basic Research Development Program of China (973 program) (2012 CB517703); Clinical Center (grant zx09401013); Projects of National Natural Science Foundation of China (grants 81473052, 81441091, and 81402735); National Clinical Research Center for Kidney Disease, Nanfang Hospital, Nanfang Medical University, Guangzhou, China; State Key Laboratory for Organ Failure Research, Nanfang Hospital, Nanfang Medical University, Guangzhou, China; and research grants from the Department of Development and Reform, Shenzhen Municipal Government (grant SFG 20201744).	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Fang XH, 2006, STROKE, V37, P38, DOI 10.1161/01.STR.0000195005.65998.38; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Hankey GJ, 2012, LANCET NEUROL, V11, P512, DOI 10.1016/S1474-4422(12)70091-1; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Huo Y, 2012, INT J CLIN PRACT, V66, P544, DOI 10.1111/j.1742-1241.2012.02929.x; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marchetta CM, 2016, MATERN CHILD NUTR, V12, P39, DOI 10.1111/mcn.12134; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Saposnik G, 2009, STROKE, V40, P1365, DOI 10.1161/STROKEAHA.108.529503; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Wald DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016473; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Yang Q, 2010, AM J CLIN NUTR, V92, P1001, DOI 10.3945/ajcn.2010.30166; Yang QH, 2010, AM J CLIN NUTR, V91, P64, DOI 10.3945/ajcn.2009.28401	26	461	540	19	458	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1325	1335		10.1001/jama.2015.2274	http://dx.doi.org/10.1001/jama.2015.2274			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25771069				2022-12-28	WOS:000352315900019
J	Leek, JT; Peng, RD				Leek, Jeffery T.; Peng, Roger D.			What is the question?	SCIENCE			English	Editorial Material									[Leek, Jeffery T.; Peng, Roger D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Leek, JT (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	jleek@jhsph.edu	Noojipady, Praveen/B-2511-2010	Leek, Jeffrey/0000-0002-2873-2671				[Anonymous], 2012, WIRED UK; [Anonymous], 2015, DUK LEG STANC WE DID; [Anonymous], 2013, ECONOMIST; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237; Gelman A, 2014, BIOSTATISTICS, V15, P18, DOI 10.1093/biostatistics/kxt034; Jager LR, 2014, BIOSTATISTICS, V15, P1, DOI 10.1093/biostatistics/kxt007; Lazer D., 2014, PARABLE GOOGLE FLU T; Oster E., 2015, CELLPHONES DO NOT GI; Panagiotou OA, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-2157; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825	12	48	49	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1314	1315		10.1126/science.aaa6146	http://dx.doi.org/10.1126/science.aaa6146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25721505				2022-12-28	WOS:000351219600021
J	Camasso, NM; Sanford, MS				Camasso, Nicole M.; Sanford, Melanie S.			Design, synthesis, and carbon-heteroatom coupling reactions of organometallic nickel(IV) complexes	SCIENCE			English	Article							FORMING REDUCTIVE ELIMINATION; BOND FORMATION; ALKYL-HALIDES; HIGH-VALENT; PD-IV; CATALYSIS; OXIDATION; PLATINUM(IV); REACTIVITY; TRIFLUOROMETHYLATION	Homogeneous nickel catalysis is used for the synthesis of pharmaceuticals, natural products, and polymers. These reactions generally proceed via nickel intermediates in the Ni-O, Ni-I, Ni-II, and/or Ni-III oxidation states. In contrast, Ni-IV intermediates are rarely accessible. We report herein the design, synthesis, and characterization of a series of organometallic Ni-IV complexes, accessed by the reaction of Ni-II precursors with the widely used oxidant S-(trifluoromethyl) dibenzothiophenium triflate. These Ni-IV complexes undergo highly selective carbon(sp(3))-oxygen, carbon(sp(3))-nitrogen, and carbon(sp(3))-sulfur coupling reactions with exogenous nucleophiles. The observed reactivity has the potential for direct applications in the development of nickel-catalyzed carbon-hetero-atom coupling reactions.	[Camasso, Nicole M.; Sanford, Melanie S.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sanford, MS (corresponding author), Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA.	mssanfor@umich.edu	Sanford, Melanie/G-8619-2016	Sanford, Melanie/0000-0001-9342-9436	NSF [CHE-1361542, CHE-0840456]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant CHE-1361542. We acknowledge J. W. Kampf for x-ray crystallographic analyses of 6 and S2, as well as funding from NSF grant CHE-0840456 for x-ray instrumentation. Metrical parameters for the structures are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-1038703 and 1038702, respectively. R. E. M. Brooner is acknowledged for assistance with electrochemical studies of 1. The supplementary materials contain complete experimental and spectral details for all new compounds and all reactions reported herein. This paper is dedicated to the memory of Prof. Gregory Hillhouse for his seminal contributions to the organometallic chemistry of nickel.	Aihara Y, 2014, J AM CHEM SOC, V136, P898, DOI 10.1021/ja411715v; Camasso NM, 2014, J AM CHEM SOC, V136, P12771, DOI [10.1021/Ja507056u, 10.1021/ja507056u]; CAMPORA J, 1994, ORGANOMETALLICS, V13, P1728, DOI 10.1021/om00017a033; Canty AJ, 2009, DALTON T, P10409, DOI 10.1039/b914080h; Carnes M, 2009, ANGEW CHEM INT EDIT, V48, P290, DOI 10.1002/anie.200804435; Cloutier JP, 2015, ORGANOMETALLICS, V34, P133, DOI 10.1021/om5010176; Dimitrov V, 2003, ANGEW CHEM INT EDIT, V42, P2631, DOI 10.1002/anie.200219383; Feller M, 2013, J AM CHEM SOC, V135, P11040, DOI 10.1021/ja401852c; GRUBBS RH, 1978, J AM CHEM SOC, V100, P2418, DOI 10.1021/ja00476a026; Hickman AJ, 2012, NATURE, V484, P177, DOI 10.1038/nature11008; Higgs AT, 2009, ORGANOMETALLICS, V28, P6142, DOI 10.1021/om900849m; Hu XL, 2011, CHEM SCI, V2, P1867, DOI 10.1039/c1sc00368b; Klein HF, 1997, ORGANOMETALLICS, V16, P668, DOI 10.1021/om960436g; KLEIN HF, 1994, ORGANOMETALLICS, V13, P2557, DOI 10.1021/om00019a007; KOO K, 1995, ORGANOMETALLICS, V14, P4421, DOI 10.1021/om00009a054; Koo K, 1998, ORGANOMETALLICS, V17, P2924, DOI 10.1021/om980182u; Lipshutz B. H., 2013, ORGANOMETALLICS SYNT, P319; LUINSTRA GA, 1993, J AM CHEM SOC, V115, P3004, DOI 10.1021/ja00060a070; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Maleckis A, 2013, J AM CHEM SOC, V135, P6618, DOI 10.1021/ja401557m; Marquard SL, 2011, ANGEW CHEM INT EDIT, V50, P7119, DOI 10.1002/anie.201101088; Martinez-Garcia H., 2014, CHEMISTRY, V20, P5821; Muniz K, 2009, ANGEW CHEM INT EDIT, V48, P9412, DOI 10.1002/anie.200903671; Pawlikowski AV, 2007, J AM CHEM SOC, V129, P10382, DOI 10.1021/ja069191h; PEARSON RG, 1968, J AM CHEM SOC, V90, P319, DOI 10.1021/ja01004a021; Perez-Temprano MH, 2014, J AM CHEM SOC, V136, P4097, DOI 10.1021/ja411433f; Reinartz S, 2001, J AM CHEM SOC, V123, P6425, DOI 10.1021/ja0104047; Rosen BM, 2011, CHEM REV, V111, P1346, DOI 10.1021/cr100259t; Sehnal P, 2010, CHEM REV, V110, P824, DOI 10.1021/cr9003242; Shimada S, 1999, ORGANOMETALLICS, V18, P291, DOI 10.1021/om980904h; SWAIN CG, 1953, J AM CHEM SOC, V75, P141, DOI 10.1021/ja01097a041; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Terao J, 2008, ACCOUNTS CHEM RES, V41, P1545, DOI 10.1021/ar800138a; Vedernikov AN, 2010, TOP ORGANOMETAL CHEM, V31, P101, DOI 10.1007/978-3-642-12073-2_5; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Ye YD, 2010, J AM CHEM SOC, V132, P14682, DOI 10.1021/ja107780w; Zhang C, 2014, ORG BIOMOL CHEM, V12, P6580, DOI 10.1039/c4ob00671b; Zheng B, 2014, J AM CHEM SOC, V136, P6499, DOI 10.1021/ja5024749; Zultanski SL, 2013, J AM CHEM SOC, V135, P624, DOI 10.1021/ja311669p	39	189	188	2	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1218	1220		10.1126/science.aaa4526	http://dx.doi.org/10.1126/science.aaa4526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766226				2022-12-28	WOS:000350824300029
J	Garoon, R; Carvounis, PE				Garoon, Robert; Carvounis, Petros E.			Central retinal vein occlusion with bilateral stenosis of the internal carotid arteries	LANCET			English	Editorial Material							MOYAMOYA-DISEASE		[Garoon, Robert; Carvounis, Petros E.] Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA	Baylor College of Medicine	Carvounis, PE (corresponding author), Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA.	carvounis@yahoo.com		Carvounis, Petros/0000-0002-3879-3486				Arias EJ, 2014, NEUROSURGERY, V74, pS116, DOI 10.1227/NEU.0000000000000229; DUKER JS, 1989, OPHTHALMOLOGY, V96, P475; Matsushima C, 2007, RETINA-J RET VIT DIS, V27, P1038, DOI 10.1097/IAE.0b013e31806196bc; SLAMOVITS TL, 1981, J CLIN NEURO-OPHTHAL, V1, P123; Yannuzzi LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P545	5	8	10	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					914	914		10.1016/S0140-6736(15)60124-6	http://dx.doi.org/10.1016/S0140-6736(15)60124-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25773096				2022-12-28	WOS:000350451100040
J	Lu, Y; Sathasivam, S; Song, JL; Crick, CR; Carmalt, CJ; Parkin, IP				Lu, Yao; Sathasivam, Sanjayan; Song, Jinlong; Crick, Colin R.; Carmalt, Claire J.; Parkin, Ivan P.			Robust self-cleaning surfaces that function when exposed to either air or oil	SCIENCE			English	Article							ARTIFICIAL SUPERHYDROPHOBIC SURFACES; BOUNCING DROP; CONTACT TIME; SLIPPERY	Superhydrophobic self-cleaning surfaces are based on the surface micro/nanomorphologies; however, such surfaces are mechanically weak and stop functioning when exposed to oil. We have created an ethanolic suspension of perfluorosilane-coated titanium dioxide nanoparticles that forms a paint that can be sprayed, dipped, or extruded onto both hard and softmaterials to create a self-cleaning surface that functions even upon emersion in oil. Commercial adhesives were used to bond the paint to various substrates and promote robustness. These surfaces maintained their water repellency after finger-wipe, knife-scratch, and even 40 abrasion cycles with sandpaper. The formulations developed can be used on clothes, paper, glass, and steel for a myriad of self-cleaning applications.	[Lu, Yao; Sathasivam, Sanjayan; Carmalt, Claire J.; Parkin, Ivan P.] UCL, Dept Chem, London WC1H 0AJ, England; [Song, Jinlong] Dalian Univ Technol, Key Lab Precis & Nontradit Machining Technol, Minist Educ, Dalian 116024, Peoples R China; [Crick, Colin R.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England	University of London; University College London; Dalian University of Technology; Imperial College London	Parkin, IP (corresponding author), UCL, Dept Chem, 20 Gordon St, London WC1H 0AJ, England.	i.p.parkin@ucl.ac.uk	Song, Jin/HHS-8731-2022; Lu, Yao/AAN-5141-2021; Crick, Colin/GMW-8293-2022; Crick, Colin R/E-6519-2011; Carmalt, Claire J/E-3984-2016; Lu, Yao/N-5190-2014	Lu, Yao/0000-0001-9566-4122; Crick, Colin/0000-0001-9674-3973; Crick, Colin R/0000-0001-9674-3973; Carmalt, Claire J/0000-0003-1788-6971; Lu, Yao/0000-0001-9566-4122; Parkin, Ivan/0000-0002-4072-6610	EPSRC [EP/F035330/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F035330/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bhushan B, 2009, LANGMUIR, V25, P3240, DOI 10.1021/la803860d; Bird JC, 2013, NATURE, V503, P385, DOI 10.1038/nature12740; Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856; Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115; Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020; Furstner R, 2005, LANGMUIR, V21, P956, DOI 10.1021/la0401011; Grinthal A, 2014, CHEM MATER, V26, P698, DOI 10.1021/cm402364d; Im M, 2010, SOFT MATTER, V6, P1401, DOI 10.1039/b925970h; Leslie DC, 2014, NAT BIOTECHNOL, V32, P1134, DOI 10.1038/nbt.3020; Lu Y, 2014, J MATER CHEM A, V2, P12177, DOI 10.1039/c4ta02391a; Lu Y, 2013, ACS SUSTAIN CHEM ENG, V1, P102, DOI 10.1021/sc3000527; Nakajima A, 2000, LANGMUIR, V16, P7044, DOI 10.1021/la000155k; Nosonovsky M, 2011, NATURE, V477, P412, DOI 10.1038/477412a; Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o; Parkin IP, 2005, J MATER CHEM, V15, P1689, DOI 10.1039/b412803f; Richard D, 2002, NATURE, V417, P811, DOI 10.1038/417811a; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Vella D, 2005, AM J PHYS, V73, P817, DOI 10.1119/1.1898523; Wang B, 2013, ACS APPL MATER INTER, V5, P1827, DOI 10.1021/am303176a; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Zhu Q, 2013, J MATER CHEM A, V1, P5386, DOI 10.1039/c3ta00125c; Zhu XT, 2011, J MATER CHEM, V21, P15793, DOI 10.1039/c1jm12513c; Zimmermann J, 2008, ADV FUNCT MATER, V18, P3662, DOI 10.1002/adfm.200800755	25	1268	1319	142	2048	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1132	1135		10.1126/science.aaa0946	http://dx.doi.org/10.1126/science.aaa0946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745169				2022-12-28	WOS:000350354200051
J	Taniguchi, K; Wu, LW; Grivennikov, SI; de Jong, PR; Lian, I; Yu, FX; Wang, KP; Ho, SB; Boland, BS; Chang, JT; Sandborn, WJ; Hardiman, G; Raz, E; Maehara, Y; Yoshimura, A; Zucman-Rossi, J; Guan, KL; Karin, M				Taniguchi, Koji; Wu, Li-Wha; Grivennikov, Sergei I.; de Jong, Petrus R.; Lian, Ian; Yu, Fa-Xing; Wang, Kepeng; Ho, Samuel B.; Boland, Brigid S.; Chang, John T.; Sandborn, William J.; Hardiman, Gary; Raz, Eyal; Maehara, Yoshihiko; Yoshimura, Akihiko; Zucman-Rossi, Jessica; Guan, Kun-Liang; Karin, Michael			A gp130-Src-YAP module links inflammation to epithelial regeneration	NATURE			English	Article							IN-VITRO; INTESTINAL REGENERATION; STEM-CELLS; PATHWAY; YAP; STAT3; IL-6; SRC; TUMORIGENESIS; ACTIVATION	Inflammation promotes regeneration of injured tissues through poorly understood mechanisms, some of which involve interleukin (IL)-6 family members, the expression of which is elevated in many diseases including inflammatory bowel diseases and colorectal cancer. Here we show in mice and human cells that 0130, a co-receptor for IL-6 cytokines, triggers activation of YAP and Notch, transcriptional regulators that control tissue growth and regeneration, independently of the gp130 effector STAT3. Through YAP and Notch, intestinal gp130 signalling stimulates epithelial cell proliferation, causes aberrant differentiation and confers resistance to mucosal erosion. gp130 associates with the related tyrosine kinases Src and Yes, which are activated on receptor engagement to phosphorylate YAP and induce its stabilization and nuclear translocation. This signalling module is strongly activated upon mucosal injury to promote healing and maintain barrier function.	[Taniguchi, Koji; Wu, Li-Wha; Grivennikov, Sergei I.; Wang, Kepeng; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Taniguchi, Koji; Lian, Ian; Yu, Fa-Xing; Guan, Kun-Liang; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taniguchi, Koji; Lian, Ian; Yu, Fa-Xing; Guan, Kun-Liang; Karin, Michael] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Taniguchi, Koji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Taniguchi, Koji; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Wu, Li-Wha] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Grivennikov, Sergei I.] Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA; [de Jong, Petrus R.; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lian, Ian; Yu, Fa-Xing; Guan, Kun-Liang; Karin, Michael] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Lian, Ian] Lamar Univ, Dept Biol, Beaumont, TX 77710 USA; [Yu, Fa-Xing] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Yu, Fa-Xing] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Ho, Samuel B.] VA San Diego Healthcare Syst, Dept Med, San Diego, CA 92161 USA; [Boland, Brigid S.; Chang, John T.; Sandborn, William J.] Univ Calif San Diego, Sch Med, Dept Med, Inflammatory Bowel Dis Ctr,Div Gastroenterol, La Jolla, CA 92093 USA; [Hardiman, Gary] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Hardiman, Gary] San Diego State Univ, CSRC, San Diego, CA 92182 USA; [Hardiman, Gary] San Diego State Univ, BIMRC, San Diego, CA 92182 USA; [Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan; [Zucman-Rossi, Jessica] IUH, INSERM, UMR 1162, F-75010 Paris, France; [Zucman-Rossi, Jessica] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Labex Immunooncol, F-75006 Paris, France	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Kyushu University; Keio University; National Cheng Kung University; Fox Chase Cancer Center; University of California System; University of California San Diego; University of California System; University of California San Diego; Texas State University System; Lamar University; Fudan University; Fudan University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Medical University of South Carolina; California State University System; San Diego State University; California State University System; San Diego State University; Japan Science & Technology Agency (JST); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Wu, Li-Wha/AAH-7768-2021; Grivennikov, Sergei/AAE-7365-2019; Guan, Kun-Liang/ADK-7088-2022; j, zucman-rossi/AAV-3594-2021; Sandborn, William/ABE-8342-2020; Yoshimura, Akihiko/K-5515-2013; zucman-rossi, Jessica/B-5098-2009; Wang, Kepeng/F-8363-2014	Wu, Li-Wha/0000-0001-7010-6220; Grivennikov, Sergei/0000-0003-2987-0555; j, zucman-rossi/0000-0002-5687-0334; zucman-rossi, Jessica/0000-0002-5687-0334; Chang, John/0000-0003-0873-6218; Wang, Kepeng/0000-0001-6428-4709; Yu, Fa-Xing/0000-0003-4834-9335; de Jong, Petrus/0000-0003-2321-1153; Hardiman, Gary/0000-0003-4558-0400	Japan Society for the Promotion of Science; Uehara Memorial Foundation Fellowship; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; National Science Council of Taiwan [NSC-101-2918-I-006-005, NSC-103-2320-B-006-032]; NIH [R00DK088589, EY022611, CA132809, CA118165-09]; FCCC-Temple University Nodal grant; AACR-Landon Innovator Award in Tumor Microenvironment; Pew Scholar in Biomedical Sciences Program; CCFA [RFA2927]; Croucher Foundation; China Postdoctoral Science Foundation; Research Service of the Department of Veterans Affairs; UCSD Digestive Disease Research Center; Grants-in-Aid for Scientific Research [24390321] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA132809, R01CA118165] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK088589, T32DK007202] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008469] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation Fellowship; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCCC-Temple University Nodal grant; AACR-Landon Innovator Award in Tumor Microenvironment; Pew Scholar in Biomedical Sciences Program; CCFA; Croucher Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); UCSD Digestive Disease Research Center; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Pan and S. Akira for Yap<SUP>fl/fl</SUP> and Stat3<SUP>fl/fl</SUP> mice, respectively. We also thank D. L. Gumucio for a plasmid containing the 12.4-kb villin promoter, T. Sato, H. Clevers and Y. Hippo for protocols describing intestinal organoid culture, C. Kuo for R-spondin1-producing cells, D. Huszar for AZD1480, F. Schaper for plasmids, L. Eckmann for advice, A. Umemura, H. Nakagawa, H. Ogata, E.J. Park, G.Y. Yu, J. Font-Burgada, D. Dhar, J. Kim and E. Seki for providing liver samples, J. Zhao, T. Meerloo, Y. Jones, L. Gapuz, R. Ly, N. Varki, D. Aki, N. Hiramatsu, T. Moroishi, Y. Endo, H. Nishinakamura, A. Chang and T. Lee for technical advice and assistance, and Cell Signaling, Santa Cruz Biotechnology and GeneTex for antibodies. This work was supported by Postdoctoral Fellowship for Research Abroad and Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science, a Uehara Memorial Foundation Fellowship, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Kanae Foundation for the Promotion of Medical Science to K.T.; a traveling grant NSC-101-2918-I-006-005 and a research grant NSC-103-2320-B-006-032 by National Science Council of Taiwan to L.-W.W.; NIH R00DK088589, FCCC-Temple University Nodal grant, AACR-Landon Innovator Award in Tumor Microenvironment, and the Pew Scholar in Biomedical Sciences Program for S.I.G.; a CCFA fellowship (RFA2927) to P.R.d.J.; Croucher Foundation and China Postdoctoral Science Foundation to K.W.; by the Research Service of the Department of Veterans Affairs to S.B.H.; by the NIH and the UCSD Digestive Disease Research Center Grant to J.T.C. and W.J.S.; by the NIH EY022611 and CA132809 to K.-L.G.; and by the NIH CA118165-09 and AACR to M.K., who is an American Cancer Society Research Professor and holds the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Baddour JA, 2012, BIRTH DEFECTS RES C, V96, P1, DOI 10.1002/bdrc.21006; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen JZ, 2014, CLIN COLORECTAL CANC, V13, P5, DOI 10.1016/j.clcc.2013.10.003; Cordero JB, 2014, EMBO J, V33, P1474, DOI 10.1002/embj.201387454; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Gordon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075483; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Hu HT, 2008, J INVEST DERMATOL, V128, P2325, DOI 10.1038/jid.2008.89; Hu LM, 2000, CLIN CANCER RES, V6, P880; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kozak I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074712; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Li YC, 2012, STEM CELLS, V30, P741, DOI 10.1002/stem.1030; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rose-John S, 2009, CURR PHARM DESIGN, V15, P2095, DOI 10.2174/138161209788489140; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SUDOL M, 1994, ONCOGENE, V9, P2145; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Tsutsumi R, 2013, DEV CELL, V26, P658, DOI 10.1016/j.devcel.2013.08.013; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	60	417	424	7	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					57	U107		10.1038/nature14228	http://dx.doi.org/10.1038/nature14228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25731159	Green Accepted			2022-12-28	WOS:000350304000034
J	Lakhina, V; Murphy, CT				Lakhina, Vanisha; Murphy, Coleen T.			For Longevity, Perception is Everything	CELL			English	Editorial Material							LIFE-SPAN; METABOLISM; ELEGANS; DAF-16; TISSUE; CRTC-1; AMPK	Aging is a risk factor for chronic diseases, and identifying targets for intervention is a goal of the aging field. Burkewitz et al. now describe a mechanism that mediates the specific role for AMPK in longevity, whereby its activity in neurons modulates metabolism and mitochondrial integrity in peripheral tissues.	[Lakhina, Vanisha; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Lakhina, Vanisha; Murphy, Coleen T.] Princeton Univ, LSI Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Murphy, CT (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ctmurphy@princeton.edu		Lakhina, Vanisha/0000-0002-5872-6838; Murphy, Coleen/0000-0002-8257-984X	NIA NIH HHS [R01 AG034446] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004; Lakhina V, 2015, NEURON, V85, P330, DOI 10.1016/j.neuron.2014.12.029; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Tatum MC, 2015, CURR BIOL, V25, P163, DOI 10.1016/j.cub.2014.11.040; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006	10	2	2	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					807	809		10.1016/j.cell.2015.02.027	http://dx.doi.org/10.1016/j.cell.2015.02.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723157	Bronze, Green Accepted			2022-12-28	WOS:000351116100002
J	Seeley, RJ; Berridge, KC				Seeley, Randy J.; Berridge, Kent C.			The Hunger Games	CELL			English	Editorial Material							LEPTIN; SYSTEM	Although AgRP and POMC neurons in the hypothalamus have long been associated with regulation of food intake, in this issue of Cell, Chen et al. use direct imaging in vivo to demonstrate rapid changes in their activity upon food presentation. The rapidity of their altered responses challenges classic notions of their functions and raises new hypotheses.	[Seeley, Randy J.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Berridge, Kent C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Seeley, RJ (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	seeleyrj@med.umich.edu	Berridge, Kent C/C-1525-2009	Berridge, Kent C/0000-0002-6031-2626; Seeley, Randy/0000-0002-3721-5625				Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Berthoud HR, 2012, P NUTR SOC, V71, P478, DOI 10.1017/S0029665112000602; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; DiLeone RJ, 2009, INT J OBESITY, V33, pS25, DOI 10.1038/ijo.2009.68; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Figlewicz DP, 2010, PHARMACOL BIOCHEM BE, V97, P15, DOI 10.1016/j.pbb.2010.03.002; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Matarese G, 2013, P NATL ACAD SCI USA, V110, P6193, DOI 10.1073/pnas.1210644110; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534	10	21	21	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					805	806		10.1016/j.cell.2015.02.028	http://dx.doi.org/10.1016/j.cell.2015.02.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723156	Bronze			2022-12-28	WOS:000351116100001
J	Weston, G				Weston, Gabriel			Developing judgment, not being judgmental	LANCET			English	Editorial Material									Frimley Pk Hosp NHS Fdn Trust, Frimley GU16 7UJ, Surrey, England		Weston, G (corresponding author), Frimley Pk Hosp NHS Fdn Trust, Frimley GU16 7UJ, Surrey, England.								0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					108	109		10.1016/S0140-6736(15)60010-1	http://dx.doi.org/10.1016/S0140-6736(15)60010-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25713835				2022-12-28	WOS:000347715900012
J	Xiao, L; Zhu, PM; Fang, GY; Xiao, ZY; Zou, YL; Zhao, JN; Zhao, N; Yuan, YF; Le Qiao, L; Zhang, XP; Zhang, H; Wang, J; Huang, J; Huang, Q; He, Q; Zhou, B; Ji, YC; Zhang, QY; Shen, SX; Li, YX; Gao, YZ				Xiao, Long; Zhu, Peimin; Fang, Guangyou; Xiao, Zhiyong; Zou, Yongliao; Zhao, Jiannan; Zhao, Na; Yuan, Yuefeng; Qiao, Le; Zhang, Xiaoping; Zhang, Han; Wang, Jiang; Huang, Jun; Huang, Qian; He, Qi; Zhou, Bin; Ji, Yicai; Zhang, Qunying; Shen, Shaoxiang; Li, Yuxi; Gao, Yunze			A young multilayered terrane of the northern Mare Imbrium revealed by Chang'E-3 mission	SCIENCE			English	Article								China's Chang'E-3 (CE-3) spacecraft touched down on the northern Mare Imbrium of the lunar nearside (340.49 degrees E, 44.12 degrees N), a region not directly sampled before. We report preliminary results with data from the CE-3 lander descent camera and from the Yutu rover's camera and penetrating radar. After the landing at a young 450-meter crater rim, the Yutu rover drove 114 meters on the ejecta blanket and photographed the rough surface and the excavated boulders. The boulder contains a substantial amount of crystals, which are most likely plagioclase and/or other mafic silicate mineral aggregates similar to terrestrial dolerite. The Lunar Penetrating Radar detection and integrated geological interpretation have identified more than nine subsurface layers, suggesting that this region has experienced complex geological processes since the Imbrian and is compositionally distinct from the Apollo and Luna landing sites.	[Xiao, Long; Zhu, Peimin; Xiao, Zhiyong; Zhao, Jiannan; Zhao, Na; Yuan, Yuefeng; Qiao, Le; Zhang, Han; Wang, Jiang; Huang, Jun; Huang, Qian; He, Qi] China Univ Geosci, Wuhan 430074, Peoples R China; [Xiao, Long; Zhang, Xiaoping] Macau Univ Sci & Technol, Macau, Peoples R China; [Fang, Guangyou; Zhou, Bin; Ji, Yicai; Zhang, Qunying; Shen, Shaoxiang; Li, Yuxi; Gao, Yunze] Chinese Acad Sci, Inst Elect, Beijing 100190, Peoples R China; [Xiao, Zhiyong] Univ Oslo, Ctr Earth Evolut & Dynam, N-0371 Oslo, Norway; [Zou, Yongliao] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China	China University of Geosciences; Macau University of Science & Technology; Chinese Academy of Sciences; Institute of Electronics, CAS; University of Oslo; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Xiao, L (corresponding author), China Univ Geosci, Wuhan 430074, Peoples R China.	longxiao@cug.edu.cn; zhupm@cug.edu.cn; gyfang@mail.ie.ac.cn	Qiao, Le/R-6719-2019; Zhao, Jiannan/P-2092-2015; Zhang, Hao/C-1704-2009; Xiao, Long/R-1343-2017	Zhao, Jiannan/0000-0001-6658-2363; Zhang, Hao/0000-0003-2902-1887; Xiao, Long/0000-0002-5271-8554; Zhu, Peimin/0000-0003-1613-9261; WANG, Jiang/0000-0001-6961-9504	Chinese Academy of Sciences [KGZD-EW-603]; Natural Science Foundation of China [41373066]; Science and Technology Development Fund (FDCT) of Macau [068/2011/A, 048/2012/A2, 091/2013/A3]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Fund (FDCT) of Macau	All the authors acknowledge support from the Key Research Program of the Chinese Academy of Sciences (grant KGZD-EW-603). L.X., Z.Y.X., J.N.Z., L.Q., and J.H. acknowledge support of the Natural Science Foundation of China (grant 41373066). X.P.Z. acknowledges support from the Science and Technology Development Fund (FDCT) of Macau (grants 068/2011/A, 048/2012/A2, and 091/2013/A3). We thank C.L. Li and the Ground Application System of Lunar Exploration, National Astronomical Observatories, Chinese Academy of Sciences, for their valuable and efficient help on data calibration and supplying. Author contributions: L.X., Z.Y.X., J.N.Z., L.Q., Y.L.Z., J.H., H.Z., X.P.Z., J.W., Q. Huang, and Q. He processed the imagery data and conducted image and radar data interpretation and geological analysis. P.M.Z., G.Y.F., N.Z., and Y.F.Y processed LPR data and did interpretation. B.Z, Y.C.J., Q.Y.Z., S.X.S., Y.X.L., and Y.Z.G. are team members of the LPR instrument. All authors contributed to the writing of the paper. The imagery data obtained by the Panoramic Camera onboard Yutu are the level 2C data. The imagery data obtained by the Descent Camera onboard the Chang'E-3 lander are the level 2A data. The IDs for the images used in the figures are listed in table S2 in the supplementary materials. Data presented in this paper are hosted at http://moon.bao.ac.cn.	Fang GY, 2014, RES ASTRON ASTROPHYS, V14, P1607, DOI 10.1088/1674-4527/14/12/009; Hiesinger H, 2011, GEOL SOC AM SPEC PAP, V477, P1, DOI 10.1130/2011.2477(01); MCGETCHIN TR, 1973, EARTH PLANET SC LETT, V20, P226, DOI [10.1016/0012-821X(73)90162-3, 10.1016/0012-821X(74)90115-0]; Neal, 2006, NEW VIEWS MOON; Prettyman TH, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002656; Qiao L, 2014, PLANET SPACE SCI, V101, P37, DOI 10.1016/j.pss.2014.06.007; Schaber G. G., 1971, P LUNAR PLANET SCI C, V1, P27; SHOEMAKE.EM, 1969, J GEOPHYS RES, V74, P6081, DOI 10.1029/JB074i025p06081; Thiessen F, 2014, PLANET SPACE SCI, V104, P244, DOI 10.1016/j.pss.2014.10.003; Thomson BJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037600; Wang ZZ, 2010, SCI CHINA EARTH SCI, V53, P1365, DOI 10.1007/s11430-010-4022-z; Wilcox BB, 2005, METEORIT PLANET SCI, V40, P695, DOI 10.1111/j.1945-5100.2005.tb00974.x; Wolfe E. W., 1972, P LUNAR PLANET SCI C, V1, P15; Xiao L, 2014, NAT GEOSCI, V7, P391, DOI 10.1038/ngeo2175; Zhao JN, 2014, SCI CHINA PHYS MECH, V57, P569, DOI 10.1007/s11433-014-5399-z; Zhao N, 2014, SCI CHINA PHYS MECH, V57, P2346, DOI 10.1007/s11433-014-5590-2	16	149	166	17	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1226	1229		10.1126/science.1259866	http://dx.doi.org/10.1126/science.1259866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766228				2022-12-28	WOS:000350824300031
J	Hart, RA; Duarte, PM; Yang, TL; Liu, XX; Paiva, T; Khatami, E; Scalettar, RT; Trivedi, N; Huse, DA; Hulet, RG				Hart, Russell A.; Duarte, Pedro M.; Yang, Tsung-Lin; Liu, Xinxing; Paiva, Thereza; Khatami, Ehsan; Scalettar, Richard T.; Trivedi, Nandini; Huse, David A.; Hulet, Randall G.			Observation of antiferromagnetic correlations in the Hubbard model with ultracold atoms	NATURE			English	Article							OPTICAL LATTICE; QUANTUM SIMULATION; FERMIONS; INSULATOR; GASES; SPINS	Ultracold atoms in optical lattices have great potential to contribute to a better understanding of some of the most important issues in many-body physics, such as high-temperature superconductivity(1). The Hubbard model-a simplified representation of fermions moving on a periodic lattice-is thought to describe the essential details of copper oxide superconductivity(2). This model describes many of the features shared by the copper oxides, including an interaction-driven Mott insulating state and an antiferromagnetic (AFM) state. Optical lattices filled with a two-spin-component Fermi gas of ultracold atoms can faithfully realize the Hubbard model with readily tunable parameters, and thus provide a platform for the systematic exploration of its phase diagram(3,4). Realization of strongly correlated phases, however, has been hindered by the need to cool the atoms to temperatures as low as the magnetic exchange energy, and also by the lack of reliable thermometry(5). Here we demonstrate spin-sensitive Bragg scattering of light to measure AFM spin correlations in a realization of the three-dimensional Hubbard model at temperatures down to 1.4 times that of the AFM phase transition. This temperature regime is beyond the range of validity of a simple high-temperature series expansion, which brings our experiment close to the limit of the capabilities of current numerical techniques, particularly at metallic densities. We reach these low temperatures using a compensated optical lattice technique(6), in which the confinement of each lattice beam is compensated by a blue-detuned laser beam. The temperature of the atoms in the lattice is deduced by comparing the light scattering to determinant quantum Monte Carlo simulations(7) and numerical linked-cluster expansion(8) calculations. Further refinement of the compensated lattice may produce even lower temperatures which, along with light scattering thermometry, would open avenues for producing and characterizing other novel quantum states of matter, such as the pseudogap regime and correlated metallic states of the two-dimensional Hubbard model.	[Hart, Russell A.; Duarte, Pedro M.; Yang, Tsung-Lin; Liu, Xinxing; Hulet, Randall G.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Hart, Russell A.; Duarte, Pedro M.; Yang, Tsung-Lin; Liu, Xinxing; Hulet, Randall G.] Rice Univ, Rice Quantum Inst, Houston, TX 77005 USA; [Paiva, Thereza] Univ Fed Rio de Janeiro, Inst Fis, BR-21941972 Rio De Janeiro, RJ, Brazil; [Khatami, Ehsan] San Jose State Univ, Dept Phys & Astron, San Jose, CA 95192 USA; [Scalettar, Richard T.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Trivedi, Nandini] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Huse, David A.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Rice University; Rice University; Universidade Federal do Rio de Janeiro; California State University System; San Jose State University; University of California System; University of California Davis; University System of Ohio; Ohio State University; Princeton University	Hulet, RG (corresponding author), Rice Univ, Dept Phys & Astron, 6100 Main St, Houston, TX 77005 USA.	randy@rice.edu	Paiva, Thereza/B-9778-2013; Khatami, Ehsan/G-9565-2012	Paiva, Thereza/0000-0002-4199-3809; Hulet, Randall/0000-0001-7045-8947; Khatami, Ehsan/0000-0003-4256-6232	ARO [W911NF-13-1-0018]; DARPA OLE; NSF; ONR; Welch Foundation [C-1133]; ARO-MURI [W911NF-14-1-003]; CNPq; FAPERJ; INCT on Quantum Information; Office of the President of the University of California; Direct For Mathematical & Physical Scien [1408309] Funding Source: National Science Foundation; Division Of Physics [1102515] Funding Source: National Science Foundation	ARO; DARPA OLE(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); ONR(Office of Naval Research); Welch Foundation(The Welch Foundation); ARO-MURI(MURI); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCT on Quantum Information; Office of the President of the University of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported under ARO grant no. W911NF-13-1-0018 with funds from the DARPA OLE programme, NSF, ONR, the Welch Foundation (grant no. C-1133), and an ARO-MURI grant no. W911NF-14-1-003. T.P. acknowledges support from CNPq, FAPERJ, and the INCT on Quantum Information. R.T.S. acknowledges support from the Office of the President of the University of California.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; BLANKENBECLER R, 1981, PHYS REV D, V24, P2278, DOI 10.1103/PhysRevD.24.2278; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Butts DA, 1997, PHYS REV A, V55, P4346, DOI 10.1103/PhysRevA.55.4346; Chiesa S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.035301; Corcovilos TA, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.013415; Duarte PM, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.061406; Fuchs S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.030401; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; Houbiers M, 1998, PHYS REV A, V57, pR1497, DOI 10.1103/PhysRevA.57.R1497; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Imriska J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.115301; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Khatami E, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053611; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Kohl M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.031601; Kozik E, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205102; Ma PN, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023605; Mathy CJM, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063412; Mathy CJM, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.023606; McKay DC, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/5/054401; Miyake H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.175302; Paiva T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.086401; Paiva T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066406; Rigol M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187202; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Staudt R, 2000, EUR PHYS J B, V17, P411, DOI 10.1007/s100510070120; Weidemuller M, 1998, PHYS REV A, V58, P4647, DOI 10.1103/PhysRevA.58.4647; Werner F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.056401	35	280	281	4	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					211	+		10.1038/nature14223	http://dx.doi.org/10.1038/nature14223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25707803	Green Submitted			2022-12-28	WOS:000350770500034
J	Lansky, Z; Braun, M; Ludecke, A; Schlierf, M; ten Wolde, PR; Janson, ME; Diez, S				Lansky, Zdenek; Braun, Marcus; Luedecke, Annemarie; Schlierf, Michael; ten Wolde, Pieter Rein; Janson, Marcel E.; Diez, Stefan			Diffusible Crosslinkers Generate Directed Forces in Microtubule Networks	CELL			English	Article							FISSION YEAST; OVERLAPPING MICROTUBULES; KINESIN MOTORS; CELL-DIVISION; PROTEIN; ASE1P; FRICTION; COMPLEX; CYTOKINESIS; TRANSPORT	Cytoskeletal remodeling is essential to eukaryotic cell division and morphogenesis. The mechanical forces driving the restructuring are attributed to the action of molecular motors and the dynamics of cytoskeletal filaments, which both consume chemical energy. By contrast, non-enzymatic filament cross-linkers are regarded as mere friction-generating entities. Here, we experimentally demonstrate that diffusible microtubule crosslinkers of the Ase1/PRC1/Map65 family generate directed microtubule sliding when confined between partially overlapping microtubules. The Ase1-generated forces, directly measured by optical tweezers to be in the piconewton-range, were sufficient to antagonize motor-protein driven microtubule sliding. Force generation is quantitatively explained by the entropic expansion of confined Ase1 molecules diffusing within the microtubule overlaps. The thermal motion of crosslinkers is thus harnessed to generate mechanical work analogous to compressed gas propelling a piston in a cylinder. As confinement of diffusible proteins is ubiquitous in cells, the associated entropic forces are likely of importance for cellular mechanics beyond cytoskeletal networks.	[Lansky, Zdenek; Braun, Marcus; Luedecke, Annemarie; Schlierf, Michael; Diez, Stefan] Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01307 Dresden, Germany; [Lansky, Zdenek; Braun, Marcus; Diez, Stefan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [ten Wolde, Pieter Rein] AMOLF, NL-1098 XG Amsterdam, Netherlands; [Janson, Marcel E.] Wageningen Univ, Lab Cell Biol, NL-6708 PB Wageningen, Netherlands	Technische Universitat Dresden; Max Planck Society; AMOLF; Wageningen University & Research	ten Wolde, PR (corresponding author), AMOLF, NL-1098 XG Amsterdam, Netherlands.	tenwolde@amolf.nl; marcel.janson@wur.nl; diez@bcube-dresden.de	Braun, Marcus/L-8931-2018; Schlierf, Michael/F-5343-2012; Lansky, Zdenek/M-4548-2014; Wolde, Pieter Rein Ten/U-4433-2019; Diez, Stefan/E-8172-2010	Braun, Marcus/0000-0003-2026-2238; Schlierf, Michael/0000-0002-6209-2364; Lansky, Zdenek/0000-0001-8474-053X; Wolde, Pieter Rein Ten/0000-0001-9933-4016; Diez, Stefan/0000-0002-0750-8515	European Research Council (ERC) [242933]; Deutsche Forschungsgemeinschaft [DI 1226/4]; Deutsche Forschungsgemeinschaft (research unit SFG 877) [DI 1226/4]; Dresden International Graduate School for Biomedicine and Bioengineering; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [03Z2EN11]; Foundation for Fundamental Research on Matter (FOM) part of the Netherlands Organisation for Scientific Research (NWO); Division for Earth and Life Sciences (ALW) part of the Netherlands Organisation for Scientific Research (NWO) [834.09.005]	European Research Council (ERC)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (research unit SFG 877); Dresden International Graduate School for Biomedicine and Bioengineering; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Foundation for Fundamental Research on Matter (FOM) part of the Netherlands Organisation for Scientific Research (NWO); Division for Earth and Life Sciences (ALW) part of the Netherlands Organisation for Scientific Research (NWO)	We thank Stephan Grill, Joe Howard, Tim Mitchison, Francois Nedelec, Friedrich Schwarz, Antoine van Oijen, and Klaus Kroy for discussions, as well as Gijsje Koenderink and Marileen Dogterom for comments on an earlier version of the manuscript. M.B., Z.L., A.L., and S.D. acknowledge support from the European Research Council (ERC starting grant 242933 to S.D.), the Deutsche Forschungsgemeinschaft (Heisenberg programme grant DI 1226/4 and research unit SFG 877 grant DI 1226/4), and the Dresden International Graduate School for Biomedicine and Bioengineering (stipend to A.L.); M.S. from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung grant 03Z2EN11); and M.E.J., and P.R.t.W. from the Foundation for Fundamental Research on Matter (FOM) and the Division for Earth and Life Sciences (ALW grant 834.09.005), which are part of the Netherlands Organisation for Scientific Research (NWO).	Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Civelekoglu-Scholey G, 2010, CELL MOL LIFE SCI, V67, P2231, DOI 10.1007/s00018-010-0326-6; Compton DA, 1998, J CELL SCI, V111, P1477; Einstein A, 1906, ANN PHYS-BERLIN, V19, P371; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Forth S, 2014, CELL, V157, P420, DOI 10.1016/j.cell.2014.02.018; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Ma XF, 2012, P NATL ACAD SCI USA, V109, P4509, DOI 10.1073/pnas.1116268109; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE3986, DOI 10.1073/pnas.1406535111; Neujahr R, 1997, J CELL SCI, V110, P123; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Sun SX, 2010, CURR BIOL, V20, pR649, DOI 10.1016/j.cub.2010.07.004; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Volkov VA, 2013, P NATL ACAD SCI USA, V110, P7708, DOI 10.1073/pnas.1305821110; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zandi R, 2003, P NATL ACAD SCI USA, V100, P8649, DOI 10.1073/pnas.1533334100	41	95	96	2	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1159	1168		10.1016/j.cell.2015.01.051	http://dx.doi.org/10.1016/j.cell.2015.01.051			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25748652	Green Submitted, Bronze			2022-12-28	WOS:000351951800015
J	Lewis, SL; Maslin, MA				Lewis, Simon L.; Maslin, Mark A.			Defining the Anthropocene	NATURE			English	Article							TROPICAL SECONDARY FORESTS; GLOBAL CARBON-CYCLE; ATMOSPHERIC CO2; ICE-CORE; HUMAN IMPACT; CLIMATE; METHANE; FIRE; EVOLUTION; VARIABILITY	Time is divided by geologists according to marked shifts in Earth's state. Recent global environmental changes suggest that Earth may have entered a new human-dominated geological epoch, the Anthropocene. Here we review the historical genesis of the idea and assess anthropogenic signatures in the geological record against the formal requirements for the recognition of a new epoch. The evidence suggests that of the various proposed dates two do appear to conform to the criteria to mark the beginning of the Anthropocene: 1610 and 1964. The formal establishment of an Anthropocene Epoch would mark a fundamental change in the relationship between humans and the Earth system.	[Lewis, Simon L.; Maslin, Mark A.] UCL, Dept Geog, London WC1E 6BT, England; [Lewis, Simon L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of Leeds	Lewis, SL (corresponding author), UCL, Dept Geog, Gower St, London WC1E 6BT, England.	s.l.lewis@ucl.ac.uk		Maslin, Mark/0000-0001-9957-3463; Lewis, Simon/0000-0002-8066-6851	European Research Council (T-FORCES); Philip Leverhulme Prize award; Royal Society Wolfson Research Merit Award	European Research Council (T-FORCES)(European Research Council (ERC)); Philip Leverhulme Prize award; Royal Society Wolfson Research Merit Award(Royal Society of London)	We acknowledge C. Hamilton, whose idea that humans are a reflexive power rather than force of nature was presented at the 'Thinking the Anthropocene' conference in Paris on 15 November 2013, and used with permission. We thank J. Kaplan and K. Krumhardt for the estimates of the population of the Americas, M. Irving for assistance with the figures, and C. Brierley, M.-E. Carr, W. Laurance, A. Mackay, O. Morton, R. Newman and C. Tzedakis for constructive discussion and remarks, and reviewer P. Gibbard for important comments. This work was funded by the European Research Council (T-FORCES, S.L.L.), a Philip Leverhulme Prize award (S.L.L.), and a Royal Society Wolfson Research Merit Award (M.A.M.).	Ahn J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004247; Ahn J, 2008, J GLACIOL, V54, P685, DOI 10.3189/002214308786570764; Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; [Anonymous], 2011, ECONOMIST; Autin W. J., 2012, GSA TODAY, V22, P60, DOI DOI 10.1130/G153GW.1; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Balter M, 2013, SCIENCE, V340, P261, DOI 10.1126/science.340.6130.261; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2014, GEOL SOC SPEC PUBL, V395, P149, DOI 10.1144/SP395.6; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; BLUNIER T, 1995, NATURE, V374, P46, DOI 10.1038/374046a0; Bohm F, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000264; Bonner MTL, 2013, FOREST ECOL MANAG, V291, P73, DOI 10.1016/j.foreco.2012.11.024; BROECKER W. S., 2006, EOS T, V87, P27, DOI DOI 10.1029/2006EO030002; BUSH MB, 1994, ECOLOGY, V75, P1761, DOI 10.2307/1939635; Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Certini G, 2011, HOLOCENE, V21, P1269, DOI 10.1177/0959683611408454; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Cooke CA, 2009, P NATL ACAD SCI USA, V106, P8830, DOI 10.1073/pnas.0900517106; Crosby A. W., 2003, COLUMBIAN EXCHANGE B, V30th; Crutzen P, 2000, GLOBAL CHANGE NEWSLE, V41, P17; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Dalby S, 2013, GEOFORUM, V49, P184, DOI 10.1016/j.geoforum.2013.06.013; Dana J. D., 1863, MANUAL OF GEOLOGY; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Davis RV, 2011, EARTH SCI HIST, V30, P63; de Silva SL, 1998, NATURE, V393, P455, DOI 10.1038/30948; Denevan W, 1992, NATIVE POPULATION AM; Diamond J., 1997, GUNS GERMS STEEL SHO; Dull RA, 2010, ANN ASSOC AM GEOGR, V100, P755, DOI 10.1080/00045608.2010.502432; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Fairchild IJ, 2014, GEOL SOC SPEC PUBL, V395, P239, DOI 10.1144/SP395.7; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FEHN U, 1986, GEOPHYS RES LETT, V13, P137, DOI 10.1029/GL013i002p00137; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Finney SC, 2014, GEOL SOC SPEC PUBL, V395, P23, DOI 10.1144/SP395.9; Fischer-Kowalski M, 2014, ANTHROPOCENE REV, V1, P8, DOI 10.1177/2053019613518033; Foley SF, 2013, ANTHROPOCENE, V3, P83, DOI 10.1016/j.ancene.2013.11.002; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Gale SJ, 2012, HOLOCENE, V22, P1491, DOI 10.1177/0959683612449764; Galuszka A, 2014, GEOL SOC SPEC PUBL, V395, P221, DOI 10.1144/SP395.5; Gibbard PL, 2014, GEOL SOC SPEC PUBL, V395, P29, DOI 10.1144/SP395.1; Glikson A, 2013, ANTHROPOCENE, V3, P89, DOI 10.1016/j.ancene.2014.02.002; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1, DOI 10.1016/B978-0-444-59425-9.00001-9; Hansen Peter, 2013, SUMMITS MODERN MAN M; Hansen V, 2011, J ENVIRON RADIOACTIV, V102, P1096, DOI 10.1016/j.jenvrad.2011.07.005; Harnisch J, 1998, GEOPHYS RES LETT, V25, P2401, DOI 10.1029/98GL01779; Haughton S., 1865, MANUAL OF GEOLOGY; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Hong SM, 1996, SCIENCE, V272, P246, DOI 10.1126/science.272.5259.246; Hua Q, 2009, QUAT GEOCHRONOL, V4, P378, DOI 10.1016/j.quageo.2009.03.006; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; International Geosphere-Biosphere Programme Intergovernmental Oceanographic Commission Scientific Committee on Oceanic Research., 2013, OC AC SUMM POL 3 S O; Jenkyn T., 1854, POPULAR EDUCATOR, V4, P139; Jenkyn T.W., 1854, POPULAR ED, V4, P312; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Ketterer ME, 2004, J ANAL ATOM SPECTROM, V19, P241, DOI 10.1039/b302903d; Killick D, 2012, ANNU REV ANTHROPOL, V41, P559, DOI 10.1146/annurev-anthro-092611-145719; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Krausmann F, 2013, P NATL ACAD SCI USA, V110, P10324, DOI 10.1073/pnas.1211349110; Le Conte J., 1877, AM J SCI, V14, P99; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Lyell C., 1990, PRINCIPLES GEOLOGY, VII; Lyell C., 1990, PRINCIPLES GEOLOGY, VIII; Lyell C., 1990, PRINCIPLES GEOLOGY, V1; Macfarlane DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025005; Mann C., 2005, 1491 NEW REVELATIONS; Mann CC, 2011, 1493 ECOLOGICAL COLL; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; Mercuri AM, 2012, VEG HIST ARCHAEOBOT, V21, P353, DOI 10.1007/s00334-012-0352-4; Mischler JA, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003460; Mitchell LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001441; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Neukom R, 2014, NAT CLIM CHANGE, V4, P362, DOI [10.1038/nclimate2174, 10.1038/NCLIMATE2174]; Nevle RJ, 2011, HOLOCENE, V21, P853, DOI 10.1177/0959683611404578; Nevle RJ, 2008, PALAEOGEOGR PALAEOCL, V264, P25, DOI 10.1016/j.palaeo.2008.03.008; Orihuela-Belmonte DE, 2013, AGR ECOSYST ENVIRON, V171, P72, DOI 10.1016/j.agee.2013.03.012; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Piperno DR, 2009, QUATERN INT, V193, P146, DOI 10.1016/j.quaint.2007.11.011; Pomeranz K., 2000, GREAT DIVERGENCE CHI; Pongratz J, 2011, HOLOCENE, V21, P843, DOI 10.1177/0959683610386981; Power MJ, 2013, HOLOCENE, V23, P3, DOI 10.1177/0959683612450196; Rakowski AZ, 2013, NUCL INSTRUM METH B, V294, P503, DOI 10.1016/j.nimb.2012.07.017; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Rose NL, 2005, J PALEOLIMNOL, V34, P349, DOI 10.1007/s10933-005-4925-4; Rubino M, 2013, J GEOPHYS RES-ATMOS, V118, P8482, DOI 10.1002/jgrd.50668; Ruddiman WF, 2013, ANNU REV EARTH PL SC, V41, P45, DOI 10.1146/annurev-earth-050212-123944; Rudwick M. J. S., 2005, BURSTING LIMITS TIME; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; Sapart CJ, 2012, NATURE, V490, P85, DOI 10.1038/nature11461; Schurer AP, 2013, J CLIMATE, V26, P6954, DOI 10.1175/JCLI-D-12-00826.1; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Shantser E. V., 1979, GREAT SOVIET ENCY, V2, P139; Siegenthaler U, 2005, TELLUS B, V57, P51, DOI 10.1111/j.1600-0889.2005.00131.x; Singarayer JS, 2011, NATURE, V470, P82, DOI 10.1038/nature09739; Smith VC, 2014, GEOL SOC SPEC PUBL, V395, P283, DOI 10.1144/SP395.11; Snowball I, 2014, GEOL SOC SPEC PUBL, V395, P119, DOI 10.1144/SP395.13; Steffen W., ANTHROPOCEN IN PRESS; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; Stocker BD, 2011, BIOGEOSCIENCES, V8, P69, DOI 10.5194/bg-8-69-2011; Stoppani A, 1873, CORSO DI GEOLOGIA, VII; Stuart YE, 2014, SCIENCE, V346, P463, DOI 10.1126/science.1257008; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Thomas CD, 2013, NATURE, V502, P7, DOI 10.1038/502007a; Thompson LG, 2013, SCIENCE, V340, P945, DOI 10.1126/science.1234210; Trudinger C. M., 2002, J GEOPHYS RES D, V107, pD20; Trudinger CM, 1999, TELLUS B, V51, P233, DOI 10.1034/j.1600-0889.1999.t01-1-00009.x; Tzedakis PC, 2012, NAT GEOSCI, V5, P138, DOI [10.1038/ngeo1358, 10.1038/NGEO1358]; van der Pluijm B, 2014, EARTHS FUTURE, V2, P566, DOI 10.1002/2014EF000268; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Vernadsky V. I., 1945, AM SCI, V33, P1, DOI DOI 10.2307/27826043; Walker M, 2009, J QUATERNARY SCI, V24, P3, DOI 10.1002/jqs.1227; Wallerstein I, 2011, MOD WORLD SYST, V1, P1; Wang Z, 2010, SCIENCE, V330, P1663, DOI 10.1126/science.1197257; Waters CN, 2014, GEOL SOC SPEC PUBL, V395, P1, DOI 10.1144/SP395.18; Wolfe AP, 2013, EARTH-SCI REV, V116, P17, DOI 10.1016/j.earscirev.2012.11.001; Wolff EW, 2014, GEOL SOC SPEC PUBL, V395, P255, DOI 10.1144/SP395.10; Wright R., 2004, SHORT HIST PROGR; Zalasiewicz J., QUAT INT IN PRESS; Zalasiewicz JA., 2008, EARTH US WHAT LEGACY; Zalasiewicz J, 2011, PHILOS T R SOC A, V369, P835, DOI 10.1098/rsta.2010.0339; Zalasiewicz J, 2014, GEOL SOC SPEC PUBL, V395, P39, DOI 10.1144/SP395.16; Zalasiewicz J, 2014, REND LINCEI-SCI FIS, V25, P5, DOI 10.1007/s12210-013-0265-x; Zalasiewicz J, 2011, PHILOS T R SOC A, V369, P1036, DOI 10.1098/rsta.2010.0315	129	1286	1338	58	1064	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					171	180		10.1038/nature14258	http://dx.doi.org/10.1038/nature14258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CD0NH	25762280				2022-12-28	WOS:000350770500027
J	Wigley, F; Friday, RP; Shepard, JAO; Nazarian, RM				Wigley, Fredrick; Friday, Robert P.; Shepard, Jo-Anne O.; Nazarian, Rosalynn M.			Case 8-2015: A 68-Year-Old Man with Multiple Myeloma, Skin Tightness, Arthralgias, and Edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-SCLEROSIS; RENAL-FAILURE; SCLERODERMA; SCLEROMYXEDEMA; PATIENT; DISEASE; CANCER; CRISIS		[Wigley, Fredrick] Johns Hopkins Univ, Sch Med, Dept Med, Johns Hopkins Hosp, Baltimore, MD 21205 USA; [Wigley, Fredrick] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Friday, Robert P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Nazarian, Rosalynn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Friday, Robert P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shepard, Jo-Anne O.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Nazarian, Rosalynn M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wigley, F (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Johns Hopkins Hosp, Baltimore, MD 21205 USA.		Nazarian, Rosalynn/AFL-3176-2022	Nazarian, Rosalynn/0000-0003-4003-7193	Eiger Biopharmaceuticals; Actelion Pharmaceuticals; MedImmune; Novartis; United Therapeutics; CSL Behring; Sanofi Aventis; Hoffmann-La Roche	Eiger Biopharmaceuticals; Actelion Pharmaceuticals; MedImmune(AstraZenecaMedimmune); Novartis(Novartis); United Therapeutics; CSL Behring; Sanofi Aventis(Sanofi-Aventis); Hoffmann-La Roche(Hoffmann-La Roche)	Dr. Wigley reports receiving consulting fees from Eiger Bio-pharmaceuticals and grant support from Actelion Pharmaceuticals, MedImmune, Novartis, United Therapeutics, CSL Behring, Sanofi Aventis, and Hoffmann-La Roche; and Dr. Shepard, receiving consulting fees for providing expert testimony in a legal case regarding thoracic imaging. No other potential conflict of interest relevant to this article was reported.	AIBA S, 1994, ARCH DERMATOL, V130, P593, DOI 10.1001/archderm.130.5.593; [Anonymous], 2009, NEW ENGL J MED, V361, P2166; Blum M, 2008, MEDICINE, V87, P10, DOI 10.1097/MD.0b013e3181630835; Boin F, 2013, KELLEYS TXB RHEUMATO, P1366; Boin F, 2008, RHEUM DIS CLIN N AM, V34, P199, DOI 10.1016/j.rdc.2007.11.001; Bonifazi M, 2013, RHEUMATOLOGY, V52, P143, DOI 10.1093/rheumatology/kes303; Chung Lorinda, 2004, Curr Rheumatol Rep, V6, P156, DOI 10.1007/s11926-004-0061-9; Cowper SE, 2001, AM J DERMATOPATH, V23, P383, DOI 10.1097/00000372-200110000-00001; Gwinner W, 2007, NEPHROL DIAL TRANSPL, V22, P2063, DOI 10.1093/ndt/gfm103; HELFRICH DJ, 1989, ARTHRITIS RHEUM, V32, P1128, DOI 10.1002/anr.1780320911; KANTOR GR, 1986, J AM ACAD DERMATOL, V14, P879, DOI 10.1016/S0190-9622(86)70104-7; Khandpur S, 2009, INDIAN J DERMATOL VE, V75, P388, DOI 10.4103/0378-6323.53136; Kucher C, 2005, J CUTAN PATHOL, V32, P484, DOI 10.1111/j.0303-6987.2005.00365.x; Lee YH, 2011, JCR-J CLIN RHEUMATOL, V17, P318, DOI 10.1097/RHU.0b013e31822be61e; MULDROW ML, 1983, CLEVELAND CLIN Q, V50, P189, DOI 10.3949/ccjm.50.2.189; Nashel J, 2012, CURR RHEUMATOL REP, V14, P39, DOI 10.1007/s11926-011-0220-8; Nazarian RM, 2011, J AM ACAD DERMATOL, V64, P741, DOI 10.1016/j.jaad.2010.05.034; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3544; Piera-Velazquez Sonsoles, 2007, Skinmed, V6, P24, DOI 10.1111/j.1540-9740.2007.05829.x; Rongioletti F, 2001, J AM ACAD DERMATOL, V44, P273, DOI 10.1067/mjd.2001.111630; Rongioletti F, 2008, J CUTAN PATHOL, V35, P705, DOI 10.1111/j.1600-0560.2007.00884.x; Rongioletti F, 2013, J AM ACAD DERMATOL, V69, P66, DOI 10.1016/j.jaad.2013.01.007; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Stone JH, 2010, CLIN PEARLS MYTHS RH; Walters R, 2009, J CUTAN PATHOL, V36, P952, DOI 10.1111/j.1600-0560.2009.01201.x; Yaqub A, 2013, RHEUM DIS CLIN N AM, V39, P347, DOI 10.1016/j.rdc.2013.02.013	27	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					1056	1067		10.1056/NEJMcpc1409840	http://dx.doi.org/10.1056/NEJMcpc1409840			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760359				2022-12-28	WOS:000350797300012
J	Holmes, DR; Brennan, JM; Rumsfeld, JS; Dai, D; O'Brien, SM; Vemulapalli, S; Edwards, FH; Carroll, J; Shahian, D; Grover, F; Tuzcu, EM; Peterson, ED; Brindis, RG; Mack, MJ				Holmes, David R., Jr.; Brennan, J. Matthew; Rumsfeld, John S.; Dai, David; O'Brien, Sean M.; Vemulapalli, Sreekanth; Edwards, Fred H.; Carroll, John; Shahian, David; Grover, Fred; Tuzcu, E. Murat; Peterson, Eric D.; Brindis, Ralph G.; Mack, Michael J.		STS ACC TVT Registry	Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							END-POINT DEFINITIONS; HIGH-RISK PATIENTS; EDWARDS SAPIEN; PREDICT OUTCOMES; EUROSCORE II; IMPLANTATION; REGISTRY; MORTALITY; STENOSIS; DEVICES	IMPORTANCE Introducing new medical devices into routine practice raises concerns because patients and outcomesmay differ from those in randomized trials. OBJECTIVE To update the previous report of 30-day outcomes and present 1-year outcomes following transcatheter aortic valve replacement (TAVR) in the United States. DESIGN, SETTING, AND PARTICIPANTS Data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) Transcatheter Valve Therapies Registry were linked with patient-specific Centers for Medicare & Medicaid Services (CMS) administrative claims data. At 299 US hospitals, 12 182 patients linked with CMS data underwent TAVR procedures performed from November 2011 through June 30, 2013, and the end of the follow-up period was June 30, 2014. EXPOSURE Transcatheter aortic valve replacement. MAIN OUTCOMES AND MEASURES One-year outcomes including mortality, stroke, and rehospitalization were evaluated using multivariate modeling. RESULTS The median age of patients was 84 years and 52% were women, with a median STS Predicted Risk of Operative Mortality (STS PROM) score of 7.1%. Following the TAVR procedure, 59.8% were discharged to home and the 30-day mortality was 7.0% (95% CI, 6.5%-7.4%) (n = 847 deaths). In the first year after TAVR, patients were alive and out of the hospital for a median of 353 days (interquartile range, 312-359 days); 24.4%(n = 2074) of survivors were rehospitalized once and 12.5%(n = 1525) were rehospitalized twice. By 1 year, the overall mortality rate was 23.7%(95% CI, 22.8%-24.5%) (n = 2450 deaths), the stroke rate was 4.1%(95% CI, 3.7%-4.5%) (n = 455 stroke events), and the rate of the composite outcome of mortality and stroke was 26.0%(25.1%-26.8%) (n = 2719 events). Characteristics significantly associated with 1-year mortality included advanced age (hazard ratio [HR] for >= 95 vs <75 years, 1.61 [95% CI, 1.24-2.09]; HR for 85-94 years vs <75 years, 1.35 [95% CI, 1.18-1.55]; and HR for 75-84 years vs < 75 years, 1.23 [95% CI, 1.08-1.41]), male sex (HR, 1.21; 95% CI, 1.12-1.31), end-stage renal disease (HR, 1.66; 95% CI, 1.41-1.95), severe chronic obstructive pulmonary disease (HR, 1.39; 95% CI, 1.25-1.55), nontransfemoral access (HR, 1.37; 95% CI, 1.27-1.48), STS PROM score greater than 15% vs less than 8%(HR, 1.82; 95% CI, 1.60-2.06), and preoperative atrial fibrillation/flutter (HR, 1.37; 95% CI, 1.27-1.48). Compared with men, women had a higher risk of stroke (HR, 1.40; 95% CI, 1.15-1.71). CONCLUSIONS AND RELEVANCE Among patients undergoing TAVR in US clinical practice, at 1-year follow-up, overall mortality was 23.7%, the stroke rate was 4.1%, and the rate of the composite outcome of death and stroke was 26.0%. These findings should be helpful in discussions with patients undergoing TAVR.	[Holmes, David R., Jr.] Mayo Clin, Rochester, MN 55905 USA; [Brennan, J. Matthew; Dai, David; O'Brien, Sean M.; Vemulapalli, Sreekanth] Duke Clin Res Inst, Durham, NC USA; [Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO USA; [Edwards, Fred H.] Univ Florida, Jacksonville, FL USA; [Carroll, John; Grover, Fred] Univ Colorado, Denver, CO 80202 USA; [Shahian, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tuzcu, E. Murat] Cleveland Clin, Cleveland, OH 44106 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Durham, NC USA; [Brindis, Ralph G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mack, Michael J.] Baylor Scott & White Hlth, Plano, TX USA	Mayo Clinic; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Denver; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation; Duke University; University of California System; University of California San Francisco; Baylor Health Care System	Holmes, DR (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	holmes.david@mayo.edu	Peterson, Eric David/ABF-5033-2021; Doğan, Ali/AAN-5331-2020		American College of Cardiology Foundation's National Cardiovascular Data Registry; Society of Thoracic Surgeons	American College of Cardiology Foundation's National Cardiovascular Data Registry; Society of Thoracic Surgeons	The STS/ACC TVT Registry is an initiative of the Society of Thoracic Surgeons and the American College of Cardiology Foundation. This research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry and the Society of Thoracic Surgeons.	Adams DH, 2014, NEW ENGL J MED, V371, P967, DOI 10.1056/NEJMc1408396; Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Centers for Medicare and Medicaid Services, NAT COV DET NCD TRAN; Chieffo A, 2013, J AM COLL CARDIOL, V61, P830, DOI 10.1016/j.jacc.2012.11.050; cmprsk Gray B, SUBDISTRIBUTION ANAL; D'Ascenzo F, 2013, J CARDIOVASC MED, V14, P894, DOI 10.2459/JCM.0b013e3283638e26; Dewey TM, 2008, J THORAC CARDIOV SUR, V135, P180, DOI 10.1016/j.jtcvs.2007.09.011; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hamm CW, 2014, EUR HEART J, V35, P1588, DOI 10.1093/eurheartj/eht381; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Iturra SA, 2014, J THORAC CARDIOV SUR, V147, P127, DOI 10.1016/j.jtcvs.2013.08.036; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1093/ejcts/ezs533, 10.1016/j.jacc.2012.09.001]; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Kohl M, 2013, PSHREG SAS MACRO PRO; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mylotte D, 2013, J AM COLL CARDIOL, V62, P210, DOI 10.1016/j.jacc.2013.03.074; Nombela-Franco L, 2013, AM J CARDIOL, V111, P1026, DOI 10.1016/j.amjcard.2012.11.063; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stahli BE, 2013, CARDIOLOGY, V126, P15, DOI 10.1159/000351438; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Unbehaun A, 2012, J AM COLL CARDIOL, V59, P211, DOI 10.1016/j.jacc.2011.10.857; Van Mieghem NM, 2014, EUROINTERVENTION, V9, P1317, DOI 10.4244/EIJV9I11A222; Vanhuyse F, 2013, J HEART VALVE DIS, V22, P517; Watanabe Y, 2013, CATHETER CARDIO INTE, V81, P1053, DOI 10.1002/ccd.24702	33	344	346	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1019	1028		10.1001/jama.2015.1474	http://dx.doi.org/10.1001/jama.2015.1474			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756438	Bronze			2022-12-28	WOS:000350643100017
J	Boehnke, K				Boehnke, Kevin			Oh the humanities!	SCIENCE			English	Editorial Material									Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Boehnke, K (corresponding author), Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA.								0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1166	1166		10.1126/science.347.6226.1166	http://dx.doi.org/10.1126/science.347.6226.1166			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CC4WB	25745176				2022-12-28	WOS:000350354200059
J	Devery, JJ; Stephenson, CRJ				Devery, James J., III; Stephenson, Corey R. J.			CATALYSIS Dual catalysis at the flick of a switch	NATURE			English	Editorial Material							C-H BONDS; PHOTOREDOX CATALYSIS; DIRECT ARYLATION; ACTIVATION; ORGANOCATALYSIS; MERGER	A combination of two catalysts - one of which is light-activated - has been used to promote new chemical reactivity, opening up fresh opportunities for the synthesis of structurally complex organic molecules. SEE LETTER P.74	[Devery, James J., III; Stephenson, Corey R. J.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Devery, JJ (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	crjsteph@umich.edu	Stephenson, Corey/G-1457-2016; Stephenson, Corey/Y-3069-2019	Stephenson, Corey/0000-0002-2443-5514; Stephenson, Corey/0000-0002-2443-5514				Baguley PA, 1998, ANGEW CHEM INT EDIT, V37, P3073, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3072::AID-ANIE3072>3.0.CO;2-9; Bergonzini G, 2014, CHEM SCI, V5, P112, DOI [10.1039/C3SC52265B, 10.1039/c3sc52265b]; Cuthbertson JD, 2015, NATURE, V519, P74, DOI 10.1038/nature14255; DiRocco DA, 2012, J AM CHEM SOC, V134, P8094, DOI 10.1021/ja3030164; Du JN, 2014, SCIENCE, V344, P392, DOI 10.1126/science.1251511; Hager D, 2014, J AM CHEM SOC, V136, P16986, DOI 10.1021/ja5102695; Hamilton DS, 2012, J AM CHEM SOC, V134, P18577, DOI 10.1021/ja309635w; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; Karkas MD, 2014, CHEM REV, V114, P11863, DOI 10.1021/cr400572f; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Newcomb M., 2012, CHEM BIOL MAT, V1st; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qvortrup K, 2014, J AM CHEM SOC, V136, P626, DOI 10.1021/ja411596q	14	20	20	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					42	43		10.1038/519042a	http://dx.doi.org/10.1038/519042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739627				2022-12-28	WOS:000350304000031
J	Barratt, A				Barratt, Alexandra			TOO MUCH MEDICINE Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER INCIDENCE; DIGITAL MAMMOGRAPHY; RANDOMIZED-TRIAL; FOLLOW-UP; PROGRAM; TOMOSYNTHESIS; MORTALITY; WOMEN; FILM; RADIOTHERAPY		Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Barratt, A (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	alexandra.barratt@sydney.edu.au	Barratt, Alexandra/A-7349-2011	Barratt, Alexandra/0000-0002-2561-3319				Abe O, 2005, LANCET, V366, P2087; Aschwanden C, 2015, JAMA INTERN MED, V175, P164, DOI 10.1001/jamainternmed.2014.6394; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; BBC, 2013, BBC; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Cancer Research UK, TNM BREAST CANC STAG; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; De Glas NA, 2014, BMJ-BRIT MED J, V349, pg5410; Duffy SW, 2008, BRIT J CANCER, V99, P1176, DOI 10.1038/sj.bjc.6604638; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Entwistle VA, 2008, BMJ-BRIT MED J, V337, pa1591; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Fallowfield L, 2004, J CLIN ONCOL, V22, P4261, DOI 10.1200/JCO.2004.08.029; FEINLEIB M, 1969, ARCH ENVIRON HEALTH, V19, P412, DOI 10.1080/00039896.1969.10666863; Forrest P, 1986, BREAST CANC SCREEING; Ganz PA, 2008, ONCOLOGY-NY, V22, P642; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Gotzsche PC, 2011, CAN MED ASSOC J, V183, P1957, DOI 10.1503/cmaj.111721; Hawley ST, 2014, JAMA SURG, V149, P582, DOI 10.1001/jamasurg.2013.5689; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Hery C, 2008, ANN ONCOL, V19, P1009, DOI 10.1093/annonc/mdm593; Hofvind S, 2014, RADIOLOGY, V272, P52, DOI 10.1148/radiol.14131502; Hofvind S, 2012, BREAST CANCER RES TR, V135, P291, DOI 10.1007/s10549-012-2162-x; Houssami N, 2014, EUR J CANCER, V50, P1799, DOI 10.1016/j.ejca.2014.03.017; Irwig L, 2006, BMJ-BRIT MED J, V332, P678, DOI 10.1136/bmj.332.7543.678; ISRCTN registry, ISRCTN27544579; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kerlikowske Karla, 2010, Journal of the National Cancer Institute Monographs, P139, DOI 10.1093/jncimonographs/lgq027; Kummerow KL, 2015, JAMA SURG, V150, P9, DOI 10.1001/jamasurg.2014.2895; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McCartney M, 2014, GUARDIAN; McPherson K, 2010, BMJ-BRIT MED J, V340, pc3106; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Nederend J, 2014, EUR J CANCER, V50, P31, DOI 10.1016/j.ejca.2013.09.018; Orenstein P, 2013, NY TIMES; SHAPIRO S, 1977, CANCER, V39, P2772, DOI 10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K; Skaane P, 2007, RADIOLOGY, V244, P708, DOI 10.1148/radiol.2443061478; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; Waller J, 2014, BRIT J CANCER, V111, P1831, DOI 10.1038/bjc.2014.482; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132; Zahl PH, 2013, BRIT J CANCER, V109, P2014, DOI 10.1038/bjc.2013.427; Zahl PH, 2011, LANCET ONCOL, V12, P1118, DOI 10.1016/S1470-2045(11)70250-9	53	49	49	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2015	350								h867	10.1136/bmj.h867	http://dx.doi.org/10.1136/bmj.h867			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4DS	25736426				2022-12-28	WOS:000350301600004
J	Farris, G				Farris, Grace			The library card	LANCET			English	Editorial Material									Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Farris, G (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	gfarris@bidmc.harvard.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					766	767		10.1016/S0140-6736(15)60426-3	http://dx.doi.org/10.1016/S0140-6736(15)60426-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25752166				2022-12-28	WOS:000350051700017
J	Schnorr, SL				Schnorr, Stephanie L.			The Diverse Microbiome of the Hunter-Gatherer	NATURE			English	Editorial Material									Max Planck Inst Evolutionary Anthropol, Res Grp Plant Foods Hominin Dietary Ecol, Leipzig, Germany	Max Planck Society	Schnorr, SL (corresponding author), Max Planck Inst Evolutionary Anthropol, Res Grp Plant Foods Hominin Dietary Ecol, Leipzig, Germany.								0	19	19	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					S14	S15		10.1038/518S14a	http://dx.doi.org/10.1038/518S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25715276	Bronze			2022-12-28	WOS:000350097300030
J	Levey, AS; Becker, C; Inker, LA				Levey, Andrew S.; Becker, Cassandra; Inker, Lesley A.			Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLINICAL-PRACTICE GUIDELINE; ACUTE-RENAL-FAILURE; COLLABORATIVE METAANALYSIS; RIFLE CRITERIA; CYSTATIN C; CANADIAN SOCIETY; SERUM CREATININE; END-POINT; ALL-CAUSE; MORTALITY	IMPORTANCE Because early-stage kidney disease is asymptomatic and is associated with both morbidity and mortality, laboratory measurements are required for its detection. OBJECTIVE To summarize evidence supporting the use of laboratory tests for glomerular filtration rate (GFR) and albuminuria to detect and stage acute kidney injury, acute kidney diseases and disorders, and chronic kidney disease in adults. EVIDENCE REVIEW We reviewed recent guidelines from various professional groups identified via the National Guideline Clearing House and author knowledge, and systematically searched MEDLINE for other sources of evidence for selected topics. FINDINGS The KDIGO (Kidney Disease Improving Global Outcomes) guidelines define and stage acute and chronic kidney diseases by GFR and albuminuria. For initial assessment of GFR, measuring serum creatinine and reporting estimated GFR based on serum creatinine (eGFRcr) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009 equation is recommended. If confirmation of GFR is required because of conditions that affect serum creatinine independent of GFR (eg, extremes of muscle mass or diet), or interference with the assay, cystatin C should be measured and estimated GFR should be calculated and reported using cystatin C (eGFRcys) and serum creatinine (eGFRcr-cys) or GFR should be measured directly using a clearance procedure. Initial assessment of albuminuria includes measuring urine albumin and creatinine in an untimed spot urine collection and reporting albumin-to-creatinine ratio. If confirmation of albuminuria is required because of diurnal variation or conditions affecting creatinine excretion, such as extremes of muscle mass or diet, the albumin excretion rate should be measured from a timed urine collection. CONCLUSIONS AND RELEVANCE Detection and staging of acute and chronic kidney diseases can be relatively simple. Because of the morbidity and mortality associated with kidney disease, early diagnosis is important and should be pursued in at-risk populations.	[Levey, Andrew S.; Becker, Cassandra; Inker, Lesley A.] Tufts Med Ctr, Div Nephrol, Boston, MA 02111 USA	Tufts Medical Center	Levey, AS (corresponding author), Tufts Med Ctr, Div Nephrol, 800 Washington St,Box 391, Boston, MA 02111 USA.	alevey@tuftsmedicalcenter.org			National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK 053869P]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK053869] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The CKD-EPI research group reports receipt of grant support from the National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK 053869P).	Akbari A, 2015, AM J KIDNEY DIS, V65, P177, DOI 10.1053/j.ajkd.2014.10.013; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; de Boer IH, 2012, JAMA-J AM MED ASSOC, V308, P2401, DOI 10.1001/jama.2012.30761; Deo A, 2011, HDB CHRONIC KIDNEY D, P566; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Inker LA, 2014, AM J KIDNEY DIS, V64, P74, DOI 10.1053/j.ajkd.2014.02.020; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Inker LA, 2014, AM J KIDNEY DIS, V63, P378, DOI 10.1053/j.ajkd.2014.01.002; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; James M, 2013, AM J KIDNEY DIS, V61, P673, DOI 10.1053/j.ajkd.2013.02.350; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; KDIGO, KDIGO CLIN PRACT GUI; Kellum JA, 2007, CRIT CARE MED, V35, P1983, DOI 10.1097/01.CCM.0000277518.67114.F8; Kidney Disease; Improving Global Outcomes (KDIGO) Acute Kidney InjuryWork Group, KDIGO CLIN PRACT GUI; Kidney Health Australia, 2014, KHA CARI AD KDIGO CL; Kropelin TF, 2014, J AM SOC NEPHROL; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2014, CLIN CHEM, V60, P916, DOI 10.1373/clinchem.2014.225383; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2010, AM J KIDNEY DIS, V56, P255, DOI 10.1053/j.ajkd.2010.06.005; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, UPTODATE WOLTERS KLU; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matzke GR, 2011, KIDNEY INT, V80, P1122, DOI 10.1038/ki.2011.322; McTaggart MP, 2014, ANN INTERN MED, V160, P550, DOI 10.7326/M13-2331; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Moyer VA, 2012, ANN INTERN MED, V157, P567, DOI 10.7326/0003-4819-157-8-201210160-00533; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; National Institute for Health and Care Excellence, 2014, CHRON KIDN DIS PART; National Institute for Health and Care Excellence, AC KIDN INJ PREV DET; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Soveri I, 2014, AM J KIDNEY DIS, V64, P411, DOI 10.1053/j.ajkd.2014.04.010; Stevens LA, 2009, CLIN PHARMACOL THER, V86, P465, DOI 10.1038/clpt.2009.124; Stevens LA, 2008, AM J KIDNEY DIS, V51, P353, DOI 10.1053/j.ajkd.2008.01.009; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Thurlow JS, 2014, AM J KIDNEY DIS, V63, P167, DOI 10.1053/j.ajkd.2013.07.014; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wen CP, 2014, KIDNEY INT, V86, P819, DOI 10.1038/ki.2013.553; Wu HY, 2014, JAMA INTERN MED, V174, P1108, DOI 10.1001/jamainternmed.2014.1363	63	313	324	9	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					837	846		10.1001/jama.2015.0602	http://dx.doi.org/10.1001/jama.2015.0602			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710660	Green Accepted			2022-12-28	WOS:000349826400017
J	Ouyang, YD				Ouyang, Yadan			Haiyan Wang	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					502	502						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25713845				2022-12-28	WOS:000349213600016
J	Richardson, R				Richardson, Ruth			Robert Louis Stevenson's The Body Snatcher	LANCET			English	Editorial Material									Lancet, London EC2Y 5AS, England		Richardson, R (corresponding author), Lancet, London EC2Y 5AS, England.								0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					412	413		10.1016/S0140-6736(15)60144-1	http://dx.doi.org/10.1016/S0140-6736(15)60144-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25713852				2022-12-28	WOS:000348509900014
J	Khan, SS; Gheorghiade, M				Khan, Sadiya S.; Gheorghiade, Mihai			Digoxin use in atrial fibrillation: a critical reappraisal	LANCET			English	Editorial Material							INCREASED MORTALITY; HEART-FAILURE; DIGITALIS; MANAGEMENT; AFFIRM		[Khan, Sadiya S.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Khan, Sadiya S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Khan, SS (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu		Khan, Sadiya/0000-0003-0643-1859				Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Gheorghiade M, 2013, EUR HEART J, V34, P1489, DOI 10.1093/eurheartj/eht120; Goldberger ZD, 2014, JAMA INTERN MED, V174, P151, DOI 10.1001/jamainternmed.2013.10432; Goldberger ZD, 2012, AM J CARDIOL, V109, P1818, DOI 10.1016/j.amjcard.2012.02.028; Hauptman PJ, 2013, JAMA INTERN MED, V173, P1552, DOI 10.1001/jamainternmed.2013.7756; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Khand AU, 2003, J AM COLL CARDIOL, V42, P1944, DOI 10.1016/j.jacc.2003.07.020; Mulder BA, 2014, HEART RHYTHM, V11, P1543, DOI 10.1016/j.hrthm.2014.06.007; Olshansky B, 2004, J AM COLL CARDIOL, V43, P1201, DOI 10.1016/j.jacc.2003.11.032; Perry G, 1997, NEW ENGL J MED, V336, P525; Turakhia MP, 2014, J AM COLL CARDIOL, V64, P660, DOI 10.1016/j.jacc.2014.03.060; Washam JB, 2015, LANCET; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; YUSUF S, 1986, CIRCULATION, V73, P14, DOI 10.1161/01.CIR.73.1.14	17	7	7	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2330	2332		10.1016/S0140-6736(14)62301-1	http://dx.doi.org/10.1016/S0140-6736(14)62301-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25749645				2022-12-28	WOS:000356003700008
J	Lees, CC; Marlow, N; van Wassenaer-Leemhuis, A; Arabin, B; Bilardo, CM; Brezinka, C; Calvert, S; Derks, JB; Diemert, A; Duvekot, JJ; Ferrazzi, E; Frusca, T; Ganzevoort, W; Hecher, K; Martinelli, P; Ostermayer, E; Papageorghiou, AT; Schlembach, D; Schneider, KTM; Thilaganathan, B; Todros, T; Valcamonico, A; Visser, GHA; Wolf, H				Lees, Christoph C.; Marlow, Neil; van Wassenaer-Leemhuis, Aleid; Arabin, Birgit; Bilardo, Caterina M.; Brezinka, Christoph; Calvert, Sandra; Derks, Jan B.; Diemert, Anke; Duvekot, Johannes J.; Ferrazzi, Enrico; Frusca, Tiziana; Ganzevoort, Wessel; Hecher, Kurt; Martinelli, Pasquale; Ostermayer, Eva; Papageorghiou, Aris T.; Schlembach, Dietmar; Schneider, K. T. M.; Thilaganathan, Baskaran; Todros, Tullia; Valcamonico, Adriana; Visser, Gerard H. A.; Wolf, Hans		TRUFFLE Study Grp	2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial	LANCET			English	Article							HEART-RATE VARIATION; RETARDED FETUSES; DOPPLER; AGE; INTERVENTION; PREECLAMPSIA; PREDICTORS; FLOW	Background No consensus exists for the best way to monitor and when to trigger delivery in mothers of babies with fetal growth restriction. We aimed to assess whether changes in the fetal ductus venosus Doppler waveform (DV) could be used as indications for delivery instead of cardiotocography short-term variation (STV). Methods In this prospective, European multicentre, unblinded, randomised study, we included women with singleton fetuses at 26-32 weeks of gestation who had very preterm fetal growth restriction (ie, low abdominal circumference [<10th percentile] and a high umbilical artery Doppler pulsatility index [>95th percentile]). We randomly allocated women 1: 1: 1, with randomly sized blocks and stratified by participating centre and gestational age (<29 weeks vs >= 29 weeks), to three timing of delivery plans, which differed according to antenatal monitoring strategies: reduced cardiotocograph fetal heart rate STV (CTG STV), early DV changes (pulsatility index >95th percentile; DV p95), or late DV changes (A wave [the deflection within the venous waveform signifying atrial contraction] at or below baseline; DV no A). The primary outcome was survival without cerebral palsy or neurosensory impairment, or a Bayley III developmental score of less than 85, at 2 years of age. We assessed outcomes in surviving infants with known outcomes at 2 years. We did an intention to treat study for all participants for whom we had data. Safety outcomes were deaths in utero and neonatal deaths and were assessed in all randomly allocated women. This study is registered with ISRCTN, number 56204499. Findings Between Jan 1, 2005 and Oct 1, 2010, 503 of 542 eligible women were randomly allocated to monitoring groups (166 to CTG STV, 167 to DV p95, and 170 to DV no A). The median gestational age at delivery was 30.7 weeks (IQR 29.1-32.1) and mean birthweight was 1019 g (SD 322). The proportion of infants surviving without neuroimpairment did not differ between the CTG STV (111 [77%] of 144 infants with known outcome), DV p95 (119 [84%] of 142), and DV no A (133 [85%] of 157) groups (p(trend) = 0.09). 12 fetuses (2%) died in utero and 27 (6%) neonatal deaths occurred. Of survivors, more infants where women were randomly assigned to delivery according to late ductus changes (133 [95%] of 140, 95%, 95% CI 90-98) were free of neuroimpairment when compared with those randomly assigned to CTG (111 [85%] of 131, 95% CI 78-90; p=0.005), but this was accompanied by a non-significant increase in perinatal and infant mortality. Interpretation Although the difference in the proportion of infants surviving without neuroimpairment was non-significant at the primary endpoint, timing of delivery based on the study protocol using late changes in the DV waveform might produce an improvement in developmental outcomes at 2 years of age.	[Lees, Christoph C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England; [Lees, Christoph C.] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Marlow, Neil] UCL, Inst Womens Hlth, Dept Acad Neonatol, London, England; [van Wassenaer-Leemhuis, Aleid] Emma Childrens Hosp, Acad Med Ctr, Dept Neonatol, Amsterdam, Netherlands; [Arabin, Birgit] Isala Clin, Dept Perinatol, Overijssel, Netherlands; [Arabin, Birgit] Philipps Univ Marburg, Ctr Mother & Child, Marburg, Germany; [Bilardo, Caterina M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, NL-9700 AB Groningen, Netherlands; [Brezinka, Christoph] Med Univ Innsbruck, Dept Gynecol Endocrinol & Reprod Med, A-6020 Innsbruck, Austria; [Calvert, Sandra] St Georges Univ London, London, England; [Derks, Jan B.] Univ Med Ctr, Dept Perinatal Med, Utrecht, Netherlands; [Diemert, Anke; Hecher, Kurt] Univ Med Ctr, Dept Obstet & Fetal Med, Hamburg, Germany; [Duvekot, Johannes J.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Ferrazzi, Enrico] Univ Milan, Childrens Hosp, Milan, Italy; [Frusca, Tiziana] Univ Parma, I-43100 Parma, Italy; [Ganzevoort, Wessel; Wolf, Hans] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands; [Martinelli, Pasquale] Univ Naples Federico II, Dept Neurosci Reprod Sci & Dent, Naples, Italy; [Ostermayer, Eva; Schneider, K. T. M.] Tech Univ, Dept Obstet & Gynecol, Div Perinatal Med, Munich, Germany; [Schlembach, Dietmar] Univ Jena, Dept Obstet, Jena, Germany; [Papageorghiou, Aris T.; Thilaganathan, Baskaran] St Georges Univ London, London, England; [Todros, Tullia] Univ Turin, St Anna Hosp, Dept Surg Sci, Turin, Italy; [Frusca, Tiziana; Valcamonico, Adriana] Univ Brescia, Maternal Fetal Med Unit, Brescia, Italy; [Visser, Gerard H. A.] Univ Med Ctr, Dept Perinatal Med, Utrecht, Netherlands; [Wolf, Hans] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands	Imperial College London; KU Leuven; University of London; University College London; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Isala Clinics; Philipps University Marburg; University of Groningen; Medical University of Innsbruck; St Georges University London; Utrecht University; Utrecht University Medical Center; University of Hamburg; University Medical Center Hamburg-Eppendorf; Erasmus University Rotterdam; Erasmus MC; University of Milan; University of Parma; University of Amsterdam; Academic Medical Center Amsterdam; University of Naples Federico II; Technical University of Munich; Friedrich Schiller University of Jena; St Georges University London; A.O.U. Citta della Salute e della Scienza di Torino; University of Ferrara; Arcispedale Sant'Anna; University of Turin; University of Brescia; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Lees, CC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England.	christoph.lees@imperial.nhs.uk	Schlembach, Dietmar/AAJ-4433-2020; Marlow, Neil/D-2918-2009; Fratelli, Nicola/H-6685-2018; Ganzevoort, Wessel/AAH-4468-2020; Prefumo, Federico/F-3837-2015; Lobmaier, Silvia M/AAY-7515-2020; Ferrazzi, Enrico Mario/AAB-9416-2019	Schlembach, Dietmar/0000-0003-3641-5278; Marlow, Neil/0000-0001-5890-2953; Fratelli, Nicola/0000-0002-0417-1793; Ganzevoort, Wessel/0000-0002-7243-2115; Prefumo, Federico/0000-0001-7793-714X; Lobmaier, Silvia M/0000-0002-5696-6686; Ferrazzi, Enrico Mario/0000-0001-5243-0537; Thilaganathan, Basky/0000-0002-5531-4301; Maso, Gianpaolo/0000-0003-4954-4968; Skabar, Aldo/0000-0003-3034-8203; Todros, Tullia/0000-0003-3016-1510; Johnson, Samantha/0000-0001-8963-7881; Papageorghiou, Aris T./0000-0001-8143-2232; van der Post, Joris/0000-0003-3311-2116; Napolitano, Raffaele/0000-0001-9434-7678; Wolf, Hans/0000-0003-3924-2149; Raimondi, Francesco/0000-0003-3250-1582	ZonMw, The Netherlands; Dr Hans Ludwig Geisenhofer Foundation, Germany; ZonMw, AE Den Haag, Netherlands in the Netherlands [94506556]; Dr Hans Ludwig Geisenhofer Foundation, Munich, Germany; MRC [G9533539] Funding Source: UKRI; Medical Research Council [G9533539] Funding Source: researchfish	ZonMw, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Dr Hans Ludwig Geisenhofer Foundation, Germany; ZonMw, AE Den Haag, Netherlands in the Netherlands; Dr Hans Ludwig Geisenhofer Foundation, Munich, Germany; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ZonMw, The Netherlands and Dr Hans Ludwig Geisenhofer Foundation, Germany.; We thank Patrizia Accorsi (Spedali Civili Brescia, Italy), Amar Bhide (St George's, London, UK), and Karen Melchiorre (St George's, London, UK) for assisting in recruitment and follow up in their centre and Patrick M Bossuyt (University of Amsterdam, Netherlands) for independent statistical advice. TRUFFLE was supported by ZonMw, 2509 AE Den Haag, Netherlands (Grant Number 94506556) in the Netherlands. In other countries, the study was not funded. A contribution was made to study funding from the Dr Hans Ludwig Geisenhofer Foundation, Munich, Germany.	[Anonymous], 1996, Eur J Obstet Gynecol Reprod Biol, V67, P121; Baschat AA, 2009, ULTRASOUND OBST GYN, V33, P44, DOI 10.1002/uog.6286; Baschat AA, 2007, OBSTET GYNECOL, V109, P253, DOI 10.1097/01.AOG.0000253215.79121.75; Bayley N., 2019, BAYLEY SCALES INFANT; BEKEDAM DJ, 1987, AM J OBSTET GYNECOL, V157, P126, DOI 10.1016/S0002-9378(87)80362-9; Bilardo CM, 2004, ULTRASOUND OBST GYN, V23, P119, DOI 10.1002/uog.965; Brodszki J, 2009, ULTRASOUND OBST GYN, V34, P288, DOI 10.1002/uog.7321; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Ferrazzi E, 2002, ULTRASOUND OBST GYN, V19, P140, DOI 10.1046/j.0960-7692.2002.00627.x; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HARRINGTON K, 1995, ULTRASOUND OBST GYN, V6, P19, DOI 10.1046/j.1469-0705.1995.06010019.x; HECHER K, 1994, ULTRASOUND OBST GYN, V4, P381, DOI 10.1046/j.1469-0705.1994.04050381.x; Hecher K, 2001, ULTRASOUND OBST GYN, V18, P564, DOI 10.1046/j.0960-7692.2001.00590.x; Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10; Lees C, 2013, ULTRASOUND OBST GYN, V42, P400, DOI 10.1002/uog.13190; Manuck TA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.046; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Morsing E, 2011, PEDIATRICS, V127, pE874, DOI 10.1542/peds.2010-1821; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Rep A, 2008, BJOG-INT J OBSTET GY, V115, P290, DOI 10.1111/j.1471-0528.2007.01544.x; SNIJDERS RJM, 1992, AM J OBSTET GYNECOL, V166, P22, DOI 10.1016/0002-9378(92)91821-Q; SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x; Talmor A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0376; Thornton JG, 2004, LANCET, V364, P513, DOI 10.1016/S0140-6736(04)16809-8; Torrance HL, 2010, ULTRASOUND OBST GYN, V36, P171, DOI 10.1002/uog.7627; Unterscheider J, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.007; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27; VOLPE JJ, 1989, CLIN PERINATOL, V16, P387, DOI 10.1016/S0095-5108(18)30638-9; Walker DM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.019; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6	31	222	236	3	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2162	2172		10.1016/S0140-6736(14)62049-3	http://dx.doi.org/10.1016/S0140-6736(14)62049-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25747582				2022-12-28	WOS:000355583000026
J	Standl, E; Schnell, O				Standl, Eberhard; Schnell, Oliver			DPP-4 inhibitors and risk of heart failure EXAMINEd	LANCET			English	Editorial Material							SAXAGLIPTIN		[Standl, Eberhard; Schnell, Oliver] Helmholtz Ctr, Munich Diabet Res Grp, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Standl, E (corresponding author), Helmholtz Ctr, Munich Diabet Res Grp, D-85764 Neuherberg, Germany.	eberhard.standl@lrz.uni-muenchen.de						Berger M, 1996, DIABETOLOGIA, V39, P749, DOI 10.1007/s001250050507; McMurray J, 2013, HEART FAIL C 2013 LI, V2013, P25; McMurray JJV, 2014, LANCET DIABETES ENDO, V2, P843, DOI 10.1016/S2213-8587(14)70031-2; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Scirica BM, 2014, CIRCULATION, V130, P1579, DOI 10.1161/CIRCULATIONAHA.114.010389; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Standl Eberhard, 2014, Curr Treat Options Cardiovasc Med, V16, P353, DOI 10.1007/s11936-014-0353-y; Standl E, 2014, NEW ENGL J MED, V370, P483, DOI 10.1056/NEJMc1313880; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zannad F., 2015, LANCET, V85, P2067	10	15	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2022	2024		10.1016/S0140-6736(15)60037-X	http://dx.doi.org/10.1016/S0140-6736(15)60037-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	25765695				2022-12-28	WOS:000354979100007
J	Xiong, QJ; Znamenskiy, P; Zador, AM				Xiong, Qiaojie; Znamenskiy, Petr; Zador, Anthony M.			Selective corticostriatal plasticity during acquisition of an auditory discrimination task	NATURE			English	Article							RECEPTIVE-FIELD PLASTICITY; DECISION-MAKING; NEURONS; CORTEX; RAT; NETWORKS; CIRCUITS; HUMANS; TRACE	Perceptual decisions are based on the activity of sensory cortical neurons, but how organisms learn to transform this activity into appropriate actions remains unknown. Projections from the auditory cortex to the auditory striatum carry information that drives decisions in an auditory frequency discrimination task(1). To assess the role of these projections in learning, we developed a channelrhodopsin-2-based assay to probe selectively for synaptic plasticity associated with corticostriatal neurons representing different frequencies. Here we report that learning this auditory discrimination preferentially potentiates corticostriatal synapses from neurons representing either high or low frequencies, depending on reward contingencies. We observe frequency-dependent corticostriatal potentiation in vivo over the course of training, and in vitro in striatal brain slices. Our findings suggest a model in which the corticostriatal synapses made by neurons tuned to different features of the sound are selectively potentiated to enable the learned transformation of sound into action.	[Xiong, Qiaojie; Znamenskiy, Petr; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Znamenskiy, Petr] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Znamenskiy, Petr/0000-0002-4658-6807; Xiong, Qiaojie/0000-0002-9221-860X	National Institutes of Health [R01DC012565, R01NS088649]; Swartz Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Burbach for technical help, R. Eifert for mechanical material support, and J. Cohen for training the rats. AAV-CAGGS-ChR2-Venus was provided by K. Svoboda. We thank U. Livneh and A. Reid for discussions. This work was supported by grants (R01DC012565 and R01NS088649) from the National Institutes of Health and the Swartz Foundation (A.M.Z.).	Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; CAREW TJ, 1981, SCIENCE, V211, P501, DOI 10.1126/science.7455692; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; MALENKA RC, 1988, J NEUROSCI, V8, P3750; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Thompson JA, 2013, J NEUROPHYSIOL, V110, P2817, DOI 10.1152/jn.00464.2013; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	30	133	135	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					348	+		10.1038/nature14225	http://dx.doi.org/10.1038/nature14225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25731173	Green Accepted, Green Submitted			2022-12-28	WOS:000354816500055
J	Cira, NJ; Benusiglio, A; Prakash, M				Cira, N. J.; Benusiglio, A.; Prakash, M.			Vapour-mediated sensing and motility in two-component droplets	NATURE			English	Article							SOLID-SURFACES; BEHAVIOR; LIQUIDS; MOTIONS; DROPS	Controlling the wetting behaviour of liquids on surfaces is important for a variety of industrial applications such as water-repellent coatings(1) and lubrication(2). Liquid behaviour on a surface can range from complete spreading, as in the 'tears of wine' effect(3,4), tominimal wetting as observed on a superhydrophobic lotus leaf(5). Controlling droplet movement is important in microfluidic liquid handling(6), on self-cleaning surfaces(7) and in heat transfer(8). Droplet motion can be achieved by gradients of surface energy(9-13). However, existing techniques require either a large gradient or a carefully prepared surface(9) to overcome the effects of contact line pinning, which usually limit dropletmotion(14). Here we show that two-component droplets of well-chosen miscible liquids such as propylene glycol and water depositedon clean glass are not subject to pinning and cause the motion of neighbouring droplets over a distance. Unlike the canonical predictions for these liquids on a high-energy surface, these droplets do not spread completely but exhibit an apparent contact angle. We demonstrate experimentally and analytically that these droplets are stabilized by evaporation-induced surface tension gradients and that they move in response to the vapour emitted by neighbouring droplets. Our fundamental understanding of this robust system enabled us to construct a wide variety of autonomous fluidic machines out of everyday materials.	[Cira, N. J.; Benusiglio, A.; Prakash, M.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Prakash, M (corresponding author), Stanford Univ, Dept Bioengn, 450 Serra Mall, Stanford, CA 94305 USA.	manup@stanford.edu		Prakash, Manu/0000-0002-8046-8388	National Science Foundation; Pew Foundation; Pew Program in Biomedical Sciences; Terman Fellowship; Keck Foundation; Gordon and Betty Moore Foundation	National Science Foundation(National Science Foundation (NSF)); Pew Foundation; Pew Program in Biomedical Sciences; Terman Fellowship; Keck Foundation(W.M. Keck Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank all members of the Prakash Laboratory for discussions. We thank J. C. Williams for early support of this work, B. Buisson for discussions, and G. R. Dick for discussions and reagents. N.J.C. is supported by a National Science Foundation Graduate Research Fellowship Program fellowship. A.B. is supported by the Pew Foundation. M.P. is supported by the Pew Program in Biomedical Sciences, the Terman Fellowship, Keck Foundation, the Gordon and Betty Moore Foundation and a National Science Foundation Career Grant.	Bangham DH, 1938, T FARADAY SOC, V34, P0554, DOI 10.1039/tf9383400554; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bascom W. D., 1963, NRL5963 DTIC; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Bernett M.K., 1964, CONTACT ANGLE WETTAB, P332; BROCHARD F, 1989, LANGMUIR, V5, P432, DOI 10.1021/la00086a025; BRZOSKA JB, 1993, LANGMUIR, V9, P2220, DOI 10.1021/la00032a052; CARLES P, 1989, COLLOID SURFACE, V41, P97, DOI 10.1016/0166-6622(89)80045-9; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Daniel S, 2001, SCIENCE, V291, P633, DOI 10.1126/science.291.5504.633; De Gennes P-G., 2004, CAPILLARITY WETTING, V336; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012; Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57; HOKE BC, 1992, J CHEM ENG DATA, V37, P331, DOI 10.1021/je00007a016; Hu H, 2005, LANGMUIR, V21, P3972, DOI 10.1021/la0475270; Hu H, 2002, J PHYS CHEM B, V106, P1334, DOI 10.1021/jp0118322; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Karpitschka S, 2010, LANGMUIR, V26, P11823, DOI 10.1021/la1007457; MARANGONI CGM, 1871, ANN PHYS, V143, P337, DOI DOI 10.1002/ANDP.18712190702; PESACH D, 1987, LANGMUIR, V3, P519, DOI 10.1021/la00076a013; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; Riegler H, 2008, LANGMUIR, V24, P6395, DOI 10.1021/la800630w; Ristenpart WD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.234502; Saha S, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062316; Style RW, 2013, P NATL ACAD SCI USA, V110, P12541, DOI 10.1073/pnas.1307122110; TANNER LH, 1979, J PHYS D APPL PHYS, V12, P1473, DOI 10.1088/0022-3727/12/9/009; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Thomson J, 1855, PHILOS MAG, V10, P330, DOI DOI 10.1080/14786445508641982; Truskett V, 2003, LANGMUIR, V19, P8271, DOI 10.1021/la030049t; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Zhang X, 2008, J MATER CHEM, V18, P621, DOI 10.1039/b711226b	32	265	267	24	460	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					446	+		10.1038/nature14272	http://dx.doi.org/10.1038/nature14272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25762146	Green Submitted			2022-12-28	WOS:000351602800051
J	Yeeles, JTP; Deegan, TD; Janska, A; Early, A; Diffley, JFX				Yeeles, Joseph T. P.; Deegan, Tom D.; Janska, Agnieszka; Early, Anne; Diffley, John F. X.			Regulated eukaryotic DNA replication origin firing with purified proteins	NATURE			English	Article							CDK-DEPENDENT PHOSPHORYLATION; BUDDING YEAST; IN-VITRO; CRYSTAL-STRUCTURE; POLYMERASE ALPHA; MCM2-7 HELICASE; S-PHASE; KINASES; REPLISOME; COMPLEX	Eukaryotic cells initiate DNA replication from multiple origins, which must be tightly regulated to promote precise genome duplication in every cell cycle. To accomplish this, initiation is partitioned into two temporally discrete steps: a double hexameric minichromosome maintenance (MCM) complex is first loaded at replication origins during G1 phase, and then converted to the active CMG (Cdc45-MCM-GINS) helicase during S phase. Here we describe the reconstitution of budding yeast DNA replication initiation with 16 purified replication factors, made from 42 polypeptides. Origin-dependent initiation recapitulates regulation seen in vivo. Cyclin-dependent kinase (CDK) inhibits MCM loading by phosphorylating the origin recognition complex (ORC) and promotes CMG formation by phosphorylating Sld2 and Sld3. Dbf4-dependent kinase (DDK) promotes replication by phosphorylating MCM, and can act either before or after CDK. These experiments define the minimum complement of proteins, protein kinase substrates and co-factors required for regulated eukaryotic DNA replication.	[Yeeles, Joseph T. P.; Deegan, Tom D.; Janska, Agnieszka; Early, Anne; Diffley, John F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk		Yeeles, Joseph/0000-0002-2255-2119; Diffley, John/0000-0001-5184-7680	Cancer Research UK; FEBS; Boehringer Ingelheim; ERC [249883 - EUKDNAREP]; Cancer Research UK [15669] Funding Source: researchfish; Wellcome Trust [106252/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10273, 10066] Funding Source: researchfish; Worldwide Cancer Research [10-0270] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); FEBS; Boehringer Ingelheim(Boehringer Ingelheim); ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; Worldwide Cancer Research	We are grateful to B. Pfander and M. Douglas for the Mcm10 expression plasmid and advice on purification, C. Kurat for construction of plasmids used to generate ARS1 linear templates, K. On and D. Boos for Sic1 and A-Cdk2 and K. Labib for Psf1 antibodies and the E. coli GINS expression strain. We thank A. Alidoust and N. Patel for growing yeast cultures. This work was supported by Cancer Research UK, a FEBS Return-to-Europe fellowship to J.T.P.Y., a Boehringer Ingelheim Fonds PhD fellowship to A.J. and an ERC grant (249883 - EUKDNAREP) to J.F.X.D.	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Clausen A. R., 2015, NATURE STRUCT MOL BI; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Georgescu RE, 2014, NAT STRUCT MOL BIOL, V21, P664, DOI 10.1038/nsmb.2851; Gros J, 2014, EMBO J, V33, P621, DOI 10.1002/embj.201387278; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Itou H, 2014, STRUCTURE, V22, P1341, DOI 10.1016/j.str.2014.07.001; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rowles A, 1999, J CELL SCI, V112, P2011; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Yu CH, 2014, MOL CELL, V56, P551, DOI 10.1016/j.molcel.2014.09.017; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	34	303	308	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					431	+		10.1038/nature14285	http://dx.doi.org/10.1038/nature14285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25739503	Bronze, Green Accepted			2022-12-28	WOS:000351602800047
J	Hotchkiss, RS; Sherwood, ER				Hotchkiss, Richard S.; Sherwood, Edward R.			Getting sepsis therapy right	SCIENCE			English	Editorial Material							IMMUNOSUPPRESSION		[Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol Med & Surg, St Louis, MO 63130 USA; [Sherwood, Edward R.] Vanderbilt Univ, Sch Med, Dept Anesthesiol & Pathol Microbiol & Immunol, Nashville, TN 37212 USA	Washington University (WUSTL); Vanderbilt University	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol Med & Surg, St Louis, MO 63130 USA.	hotch@wustl.edu; edward.r.sherwood@vanderbilt.edu			BMS; GSK; Merck; MedImmune; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044118, R01GM104306, R01GM066885] Funding Source: NIH RePORTER	BMS(Bristol-Myers Squibb); GSK(GlaxoSmithKline); Merck(Merck & Company); MedImmune(AstraZenecaMedimmune); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.S.H. has been on the advisory boards of Bristol-Myers Squibb (BMS), GlaxoSmithKline (GSK), and Merck, on immunotherapy for sepsis (he speaks on the topics of IL-7, anti-PD-1, anti-PD-L1, IL-15, IFN-gamma, and GM-CSF). He is a paid consultant to BMS, GSK, Merck, and MedImmune on immunotherapy for sepsis. He collaborates with Revimmune on a trial of IL-7 in sepsis and with BMS on a trial of anti-PD-L1 in sepsis. He receives funding from BMS and MedImmune for studies with anti-PD-1 and anti-PD-L1 and from GSK to test immunomodulators in sepsis.	Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2012, J IMMUNOL, V189, P1099, DOI 10.4049/jimmunol.1290038; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Vincent JL, 2014, AM J RESP CRIT CARE, V190, P1081, DOI 10.1164/rccm.201410-1895ED; Walton AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098819; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268	15	67	72	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1201	1202		10.1126/science.aaa8334	http://dx.doi.org/10.1126/science.aaa8334			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766219	Green Accepted			2022-12-28	WOS:000350824300020
J	Park, SE; Kim, JM; Seok, OH; Cho, H; Wadas, B; Kim, SY; Varshavsky, A; Hwang, CS				Park, Sang-Eun; Kim, Jeong-Mok; Seok, Ok-Hee; Cho, Hanna; Wadas, Brandon; Kim, Seon-Young; Varshavsky, Alexander; Hwang, Cheol-Sang			Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathway	SCIENCE			English	Article							UBIQUITIN LIGASE; CELLULAR-PROTEINS; DEGRADATION; RGS2; REGULATORS; TEB4	Rgs2, a regulator of G proteins, lowers blood pressure by decreasing signaling through G alpha(q). Human patients expressing Met-Leu-Rgs2 (ML-Rgs2) or Met-Arg-Rgs2 (MR-Rgs2) are hypertensive relative to people expressing wild-type Met-Gln-Rgs2 (MQ-Rgs2). We found that wild-type MQ-Rgs2 and its mutant, MR-Rgs2, were destroyed by the Ac/N-end rule pathway, which recognizes N-alpha-terminally acetylated (Nt-acetylated) proteins. The shortest-lived mutant, ML-Rgs2, was targeted by both the Ac/N-end rule and Arg/N-end rule pathways. The latter pathway recognizes unacetylated N-terminal residues. Thus, the Nt-acetylated Ac-MX-Rgs2 (X = Arg, Gln, Leu) proteins are specific substrates of the mammalian Ac/N-end rule pathway. Furthermore, the Ac/N-degron of Ac-MQ-Rgs2 was conditional, and Teb4, an endoplasmic reticulum (ER) membrane-embedded ubiquitin ligase, was able to regulate G protein signaling by targeting Ac-MX-Rgs2 proteins for degradation through their N-alpha-terminal acetyl group.	[Park, Sang-Eun; Kim, Jeong-Mok; Seok, Ok-Hee; Cho, Hanna; Hwang, Cheol-Sang] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Gyeongbuk, South Korea; [Wadas, Brandon; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Kim, Seon-Young] KRIBB, Med Genom Res Ctr, Taejon, South Korea; [Kim, Seon-Young] Univ Sci & Technol, Dept Funct Genom, Taejon, South Korea	Pohang University of Science & Technology (POSTECH); California Institute of Technology; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu; cshwang@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; Kim, Jeong-Mok/0000-0002-7223-248X; cho, Hanna/0000-0002-5339-2541; Wadas, Brandon/0000-0003-2796-2384	National Research Foundation of the Korea government (MSIP) [NRF-2011-0021975, NRF-2012R1A4A1028200, NRF-2013R1A1A2012529]; BK21 Plus Program; NIH [DK039520, GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520, R56DK039520, R37DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Research Foundation of the Korea government (MSIP); BK21 Plus Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Neubig, M. Mulvihill, and E. Wiertz for gifts of plasmids, and K. Piatkov for helpful suggestions. Supported by grants from the National Research Foundation of the Korea government (MSIP) (NRF-2011-0021975, NRF-2012R1A4A1028200, NRF-2013R1A1A2012529) and BK21 Plus Program (C.-S.H.), and by NIH grants DK039520 and GM031530 (A.V.).	Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Chidiac P, 2014, CELL SIGNAL, V26, P1226, DOI 10.1016/j.cellsig.2014.02.006; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim JM, 2014, CELL CYCLE, V13, P1366, DOI 10.4161/cc.28751; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Matsuo M, 2013, FEBS LETT, V587, P1392, DOI 10.1016/j.febslet.2013.03.016; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13	26	97	98	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1249	1252		10.1126/science.aaa3844	http://dx.doi.org/10.1126/science.aaa3844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766235	Green Accepted			2022-12-28	WOS:000350824300038
J	Tian, J; Uchida, N				Tian, Ju; Uchida, Naoshige			Monkeys in a Prisoner's Dilemma	CELL			English	Editorial Material							COOPERATION; BEHAVIOR		[Tian, Ju; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University	Tian, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	jutian@fas.harvard.edu; uchida@mcb.harvard.edu		Uchida, Naoshige/0000-0002-5755-9409				Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Camerer C, 2003, BEHAV GAME THEORY; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Haroush K, 2015, CELL, V160, P1233, DOI 10.1016/j.cell.2015.01.045; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Von Neumann, 1953, THEORY GAMES EC BEHA	9	1	1	2	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1046	1048		10.1016/j.cell.2015.02.049	http://dx.doi.org/10.1016/j.cell.2015.02.049			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768902	Bronze			2022-12-28	WOS:000351951800005
J	Newman, CB; Tobert, JA				Newman, Connie B.; Tobert, Jonathan A.			Statin Intolerance Reconciling Clinical Trials and Clinical Experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Newman, Connie B.] NYU, Sch Med, New York, NY 10016 USA	New York University	Newman, CB (corresponding author), NYU, Dept Med, Sch Med, 550 First Ave, New York, NY 10016 USA.	connie.newman@nyumc.org	Tobert, Jonathan/AAD-2155-2020; Tobert, Jonathan/J-4294-2019	Tobert, Jonathan/0000-0001-7105-299X; Newman, Connie/0000-0001-9144-056X				Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Maningat P, 2011, NEW ENGL J MED, V365, P2250, DOI 10.1056/NEJMp1112023; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	7	48	48	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1011	1012		10.1001/jama.2015.1335	http://dx.doi.org/10.1001/jama.2015.1335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756433				2022-12-28	WOS:000350643100012
J	Stuwe, T; Correia, AR; Lin, DH; Paduch, M; Lu, VT; Kossiakoff, AA; Hoelz, A				Stuwe, Tobias; Correia, Ana R.; Lin, Daniel H.; Paduch, Marcin; Lu, Vincent T.; Kossiakoff, Anthony A.; Hoelz, Andre			Architecture of the nuclear pore complex coat	SCIENCE			English	Article							NUP84 COMPLEX; VESICLE COATS; MEMBRANE; PROTEINS; REVEALS; STATES; MODULE	The nuclear pore complex (NPC) constitutes the sole gateway for bidirectional nucleocytoplasmic transport. Despite half a century of structural characterization, the architecture of the NPC remains unknown. Here we present the crystal structure of a reconstituted similar to 400-kilodalton coat nucleoporin complex (CNC) from Saccharomyces cerevisiae at a 7.4 angstrom resolution. The crystal structure revealed a curved Y-shaped architecture and the molecular details of the coat nucleoporin interactions forming the central "triskelion" of the Y. A structural comparison of the yeast CNC with an electron microscopy reconstruction of its human counterpart suggested the evolutionary conservation of the elucidated architecture. Moreover, 32 copies of the CNC crystal structure docked readily into a cryoelectron tomographic reconstruction of the fully assembled human NPC, thereby accounting for similar to 16 megadalton of its mass.	[Stuwe, Tobias; Correia, Ana R.; Lin, Daniel H.; Hoelz, Andre] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Paduch, Marcin; Lu, Vincent T.; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	California Institute of Technology; University of Chicago	Hoelz, A (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	hoelz@caltech.edu	Hoelz, Andre/AAB-6978-2021		Gordon and Betty Moore Foundation; Beckman Institute; Sanofi-Aventis Bioengineering Research Program; U.S. Department of Energy; National Institues of Health (NIH); National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; Postdoctoral Fellowship of the Deutsche Forschungsgemeinschaft; NIH Research Service Award [5 T32 GM07616]; NIH [U01 GM094588, U54 GM087519]; Searle Funds at The Chicago Community Trust; Caltech startup funds; Albert Wyrick V Scholar Award of the V Foundation for Cancer Research; 54th Mallinckrodt Scholar Award of the Edward Mallinckrodt Jr. Foundation; Kimmel Scholar Award of the Sidney Kimmel Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117360, U54GM087519, T32GM007616, U01GM094588] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Sanofi-Aventis Bioengineering Research Program; U.S. Department of Energy(United States Department of Energy (DOE)); National Institues of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Postdoctoral Fellowship of the Deutsche Forschungsgemeinschaft; NIH Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Funds at The Chicago Community Trust; Caltech startup funds; Albert Wyrick V Scholar Award of the V Foundation for Cancer Research; 54th Mallinckrodt Scholar Award of the Edward Mallinckrodt Jr. Foundation; Kimmel Scholar Award of the Sidney Kimmel Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. J. Bley, W. M. Clemons, A. M. Davenport, O. Dreesen, A. Patke, D. C. Rees, S. O. Shan, P. Stravropoulos, and K. Thierbach for critical reading of the manuscript: K. Kato and K. Kato for their contributions at the initial stages of this project; L. N. Collins for technical support; D. King for mass spectrometry analysis; E. Hurt and P. Loppnau for material; S. Koide for providing the phage display library; S. Graskind for the pSFV4 vector; P. Afoninc for advice regarding structure refinement in PHENIX; and J. Kaiser and the scientific staff of Stanford Synchrotron Radiation Laboratory (SSRL) Beamline 12-2 and the National Institue of General Medical Sciences and National Cancer Institue Structural Biology Facility (GM/CA) at the Advanced Photon Source (APS) for their support with x-ray diffraction measurements. We acknowledge the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program for their support of the Molecular Observatory at the California Institute of Technology (Caltech). The operations at the SSRL and APS are supported by the U.S. Department of Energy and the National Institues of Health (NIH). GM/CA has been funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). T.S. was supported by a Postdoctoral Fellowship of the Deutsche Forschungsgemeinschaft. D.H.L. was supported by a NIH Research Service Award (5 T32 GM07616). A.A.K was supported by NIH awards U01 GM094588 and U54 GM087519 and by Searle Funds at The Chicago Community Trust. A.H. was supported by Caltech startup funds, the Albert Wyrick V Scholar Award of the V Foundation for Cancer Research, the 54th Mallinckrodt Scholar Award of the Edward Mallinckrodt Jr. Foundation and a Kimmel Scholar Award of the Sidney Kimmel Foundation for Cancer Research. The coordinates and structure factors have Seen deposited with the Protein Data Bank with accession codes 4XMM and 4XMN. The authors declare no financial conflicts of interest.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Debler EW, 2010, NUCLEUS-PHILA, V1, P150, DOI 10.4161/nucl.1.2.11120; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Harrison SC, 2010, NATURE, V466, P1048, DOI 10.1038/4661048a; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Seo HS, 2009, P NATL ACAD SCI USA, V106, P14281, DOI 10.1073/pnas.0907453106; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Thierbach K, 2013, STRUCTURE, V21, P1672, DOI 10.1016/j.str.2013.07.004	17	73	75	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1148	1152		10.1126/science.aaa4136	http://dx.doi.org/10.1126/science.aaa4136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745173	Green Accepted, Green Submitted			2022-12-28	WOS:000350354200056
J	Schaefer, L; Paik, JM; Rennke, H; Levy, BD; Loscalzo, J				Schaefer, Libby; Paik, Julie M.; Rennke, Helmut; Levy, Bruce D.; Loscalzo, Joseph			Itching for a Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; COLLAPSING GLOMERULOPATHY; NEPHROTIC SYNDROME		[Schaefer, Libby; Paik, Julie M.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rennke, Helmut] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, 77 Ave Louis Pasteur HIM855, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021		NIDDK NIH HHS [K23 DK100447] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK100447] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albaqumi M, 2008, J AM SOC NEPHROL, V19, P1276, DOI 10.1681/ASN.2007080926; Albaqumi M, 2006, J AM SOC NEPHROL, V17, P2854, DOI 10.1681/ASN.2006030225; DETWILER RK, 1994, KIDNEY INT, V45, P1416, DOI 10.1038/ki.1994.185; Diaz MFP, 2011, AM J KIDNEY DIS, V58, P855, DOI 10.1053/j.ajkd.2011.07.011; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Golgert WA, 2008, CLIN J AM SOC NEPHRO, V3, P800, DOI 10.2215/CJN.04050907; Schwimmer JA, 2003, SEMIN NEPHROL, V23, P209, DOI 10.1053/snep.2003.50019; Sperati CJ, 2013, CLIN NEPHROL, V80, P231, DOI 10.5414/CN107337; Thaunat O, 2006, KIDNEY INT, V69, P1892, DOI 10.1038/sj.ki.5000352; WEISS MA, 1986, AM J KIDNEY DIS, V7, P20, DOI 10.1016/S0272-6386(86)80052-X	10	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					964	968		10.1056/NEJMcps1409348	http://dx.doi.org/10.1056/NEJMcps1409348			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738673				2022-12-28	WOS:000350304500013
J	Teshale, E; Ward, JW				Teshale, Eyasu; Ward, John W.			Making Hepatitis E a Vaccine-Preventable Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION; BURDEN		[Teshale, Eyasu; Ward, John W.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Teshale, E (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA.							Drobeniuc J, 2013, EMERG INFECT DIS, V19, P218, DOI 10.3201/eid1902.120961; Gurley ES, 2012, AM J PUBLIC HEALTH, V102, P2248, DOI 10.2105/AJPH.2012.300749; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	5	9	11	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					899	901		10.1056/NEJMp1415240	http://dx.doi.org/10.1056/NEJMp1415240			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC4EU	25738664				2022-12-28	WOS:000350304500004
J	Qaseem, A; Humphrey, LL; Forciea, MA; Starkey, M; Denberg, TD				Qaseem, Amir; Humphrey, Linda L.; Forciea, Mary Ann; Starkey, Melissa; Denberg, Thomas D.		Amer Coll Phys	Treatment of Pressure Ulcers: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							SPINAL-CORD-INJURY; RANDOMIZED CONTROLLED-TRIAL; III DECUBITUS ULCERS; GROWTH FACTOR-BB; AIR-FLUIDIZED THERAPY; LEVEL LASER THERAPY; ELDERLY-PATIENTS; DOUBLE-BLIND; MONOCHROMATIC PHOTOTHERAPY; HYDROCOLLOID DRESSINGS	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations based on the comparative effectiveness of treatments of pressure ulcers. Methods: This guideline is based on published literature on this topic that was identified by using MEDLINE, EMBASE, CINAHL, EBM Reviews, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects, and the Health Technology Assessment database through February 2014. Searches were limited to English-language publications. The outcomes evaluated for this guideline include complete wound healing, wound size (surface area, volume, and depth) reduction, pain, prevention of sepsis, prevention of osteomyelitis, recurrence rate, and harms of treatment (including but not limited to pain, dermatologic complications, bleeding, and infection). This guideline grades the quality of evidence and strength of recommendations by using ACP's clinical practice guidelines grading system. The target audience for this guideline includes all clinicians, and the target patient population is patients with pressure ulcers. Recommendation 1: ACP recommends that clinicians use protein or amino acid supplementation in patients with pressure ulcers to reduce wound size. (Grade: weak recommendation, low-quality evidence) Recommendation 2: ACP recommends that clinicians use hydrocolloid or foam dressings in patients with pressure ulcers to reduce wound size. (Grade: weak recommendation, low-quality evidence) Recommendation 3: ACP recommends that clinicians use electrical stimulation as adjunctive therapy in patients with pressure ulcers to accelerate wound healing. (Grade: weak recommendation, moderate-quality evidence)	[Qaseem, Amir; Starkey, Melissa] Amer Coll Physicians, Philadelphia, PA 19106 USA; [Forciea, Mary Ann] Univ Penn Hlth Syst, Philadelphia, PA 19104 USA; [Humphrey, Linda L.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Denberg, Thomas D.] Carilion Clin, Roanoke, VA 24036 USA	American College of Physicians; University of Pennsylvania; Oregon Health & Science University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265	ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Adegoke B O, 2001, Afr J Med Med Sci, V30, P195; Adunsky A, 2005, ARCH GERONTOL GERIAT, V41, P261, DOI 10.1016/j.archger.2005.04.004; Ahmad E T, 2008, Ann Burns Fire Disasters, V21, P124; Ahmad ET., 2008, INDIAN J PHYSIOTHER, V2, P1; ALLMAN RM, 1987, ANN INTERN MED, V107, P641, DOI 10.7326/0003-4819-107-5-641; ALM A, 1989, ACTA DERM-VENEREOL, P1; Baker Lucinda L., 1996, Wound Repair and Regeneration, V4, P21, DOI 10.1046/j.1524-475X.1996.40106.x; Bale S, 1998, J Wound Care, V7, P327; Bale S, 1997, J WOUND CARE, V6, P463, DOI DOI 10.12968/JOWC.1997.6.10.463; Banks V, 1994, J Wound Care, V3, P132; Banks V, 1994, J Wound Care, V3, P175; Barnes Peyton Jr, 2007, Tex Med, V103, P65; Bauman WA, 2013, ANN INTERN MED, V158, P718, DOI 10.7326/0003-4819-158-10-201305210-00006; Benati G, 2001, ARCH GERONTOL GERIAT, P43, DOI 10.1016/S0167-4943(01)00120-0; Biglari B, 2014, SPINAL CORD, V52, P80, DOI 10.1038/sc.2013.130; BRESLOW RA, 1993, J AM GERIATR SOC, V41, P357, DOI 10.1111/j.1532-5415.1993.tb06940.x; Brewer S, 2010, J WOUND CARE, V19, P311, DOI 10.12968/jowc.2010.19.7.48905; BROD M, 1990, ARCH DERMATOL, V126, P969, DOI 10.1001/archderm.126.7.969; Caley~ L, 1994, P 9 ANN CLIN S PRESS, P1; Cereda E, 2009, J AM GERIATR SOC, V57, P1395, DOI 10.1111/j.1532-5415.2009.02351.x; Chang K W, 1998, Med J Malaysia, V53, P428; Chernoff RS, 1990, J AM DIET ASSOC, V90, pA; Clark M, 1999, P 7 EUR C ADV WOUND, P122; Colin D, 1996, J Wound Care, V5, P444; Colwell J C, 1993, Decubitus, V6, P28; Comorosan S, 1993, Rom J Physiol, V30, P41; Day A, 1993, Decubitus, V6, P32; Dehlin O, 2003, AGING CLIN EXP RES, V15, P259; Dehlin O, 2007, AGING CLIN EXP RES, V19, P478; Desneves KJ, 2005, CLIN NUTR, V24, P979, DOI 10.1016/j.clnu.2005.06.011; Devine B, 1995, J TISSUE VIABILITY, V5, P94; Durovic A, 2008, VOJNOSANIT PREGL, V65, P906; Evans D, 2000, J Wound Care, V9, P181; FERRELL BA, 1993, JAMA-J AM MED ASSOC, V269, P494, DOI 10.1001/jama.269.4.494; Ford CN, 2002, ANN PLAS SURG, V49, P55, DOI 10.1097/00000637-200207000-00009; Foster RD, 1997, BRIT J PLAST SURG, V50, P374, DOI 10.1016/S0007-1226(97)90548-8; Foster RD, 1997, ARCH SURG-CHICAGO, V132, P868; Gentzkow GD, 1991, WOUNDS, V3, P158; GORSE GJ, 1987, ARCH DERMATOL, V123, P766, DOI 10.1001/archderm.123.6.766; Graumlich JF, 2003, J AM GERIATR SOC, V51, P147, DOI 10.1046/j.1532-5415.2003.51051.x; GRIFFIN JW, 1991, PHYS THER, V71, P433, DOI 10.1093/ptj/71.6.433; Gupta A, 2009, NEUROL INDIA, V57, P622, DOI 10.4103/0028-3886.57820; Ho CH, 2010, ADV SKIN WOUND CARE, V23, P508, DOI 10.1097/01.ASW.0000390493.43835.ec; Hollisaz Mohammad Taghi, 2004, BMC Dermatol, V4, P18; HONDE C, 1994, J AM GERIATR SOC, V42, P1180, DOI 10.1111/j.1532-5415.1994.tb06985.x; Houghton PE, 2010, ARCH PHYS MED REHAB, V91, P669, DOI 10.1016/j.apmr.2009.12.026; Iordanou Pangiota, 2002, Int J Nurs Pract, V8, P49, DOI 10.1046/j.1440-172x.2002.00338.x; Jackson B S, 1988, J Enterostomal Ther, V15, P220; Kierney PC, 1998, PLAST RECONSTR SURG, V102, P765, DOI 10.1097/00006534-199809030-00022; KIM YC, 1996, YONSEI MED J, V37, P181; KLOTH LC, 1988, PHYS THER, V68, P503, DOI 10.1093/ptj/68.4.503; Kloth Luther C, 2002, Adv Skin Wound Care, V15, P270, DOI 10.1097/00129334-200211000-00008; Land L, 2000, J Tissue Viability, V10, P6; Lee S Kwon, 2006, Adv Skin Wound Care, V19, P92, DOI 10.1097/00129334-200603000-00011; Leigh B, 2012, J WOUND CARE, V21, P150, DOI 10.12968/jowc.2012.21.3.150; Lucas C, 2003, LASER MED SCI, V18, P72, DOI 10.1007/s10103-003-0259-5; Lucas C, 2000, LASER MED SCI, V15, P94, DOI 10.1007/s101030050054; Malbrain M, 2010, J TISSUE VIABILITY, V19, P7, DOI 10.1016/j.jtv.2009.12.001; McDiarmid T, 1985, PHYSIOTHERAPY, V71, P66; McGaughey H, 2009, PHYS THER REV, V14, P132, DOI 10.1179/174328809X435231; Meaume S, 2009, J NUTR HEALTH AGING, V13, P623, DOI 10.1007/s12603-009-0173-z; Zeron HM, 2007, INT J DERMATOL, V46, P314, DOI 10.1111/j.1365-4632.2007.03181.x; Mulder GD, 1994, J GERIATRIC DERMATOL, V2, P87; Mulder Gerit D., 1993, Wound Repair and Regeneration, V1, P213, DOI 10.1046/j.1524-475X.1993.10406.x; Munro B H, 1989, Geriatr Nurs, V10, P190; MUSTOE TA, 1994, ARCH SURG-CHICAGO, V129, P213; Myers S A, 1990, Decubitus, V3, P16; National Pressure Ulcer Advisory Panel, 2014, NPUAP PRESS ULC STAG; Neill KM, 1989, WOUNDS, V1, P173; Nixon J, 2006, BMJ-BRIT MED J, V332, P1413, DOI 10.1136/bmj.38849.478299.7C; NUSSBAUM EL, 1994, PHYS THER, V74, P812, DOI 10.1093/ptj/74.9.812; Nussbaum EL, 2013, ARCH PHYS MED REHAB, V94, P650, DOI 10.1016/j.apmr.2012.12.003; Ochs RF, 2005, OSTOMY WOUND MANAG, V51, P38; Ohura T, 2011, WOUND REPAIR REGEN, V19, P330, DOI 10.1111/j.1524-475X.2011.00691.x; Ozdemir F, 2011, BALK MED J, V28, P274, DOI 10.5174/tutfd.2010.03601.2; Piatkowski A, 2012, J WOUND CARE, V21, P505, DOI 10.12968/jowc.2012.21.10.505; Price P, 2000, J Wound Care, V9, P201; Qaseem A, 2015, ANN INTERN MED, V162, P359, DOI 10.7326/M14-1567; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Rees RS, 1999, WOUND REPAIR REGEN, V7, P141, DOI 10.1046/j.1524-475X.1999.00141.x; ROBSON MC, 1992, ANN PLAS SURG, V29, P193, DOI 10.1097/00000637-199209000-00001; ROBSON MC, 1992, LANCET, V339, P23, DOI 10.1016/0140-6736(92)90143-Q; Russell L, 2003, Br J Nurs, V12, P256; Russell L, 2000, J Wound Care, V9, P52; Russell L, 2000, Br J Nurs, V9, P2270; Saha S, 2013, AHRQ PUBLICATION; SALZBERG CA, 1995, WOUNDS, V7, P11; Sayag J., 1996, J WOUND CARE, V5, P357, DOI 10.12968/jowc.1996.5.8.357; Scevola S, 2010, INT WOUND J, V7, P184, DOI 10.1111/j.1742-481X.2010.00671.x; Schryvers OI, 2000, ARCH PHYS MED REHAB, V81, P1556, DOI 10.1053/apmr.2000.17828; Schubert V, 2001, PHOTODERMATOL PHOTO, V17, P32, DOI 10.1034/j.1600-0781.2001.017001032.x; Seeley J, 1999, Ostomy Wound Manage, V45, P39; Smith MEB, 2013, ANN INTERN MED, V159, P39, DOI 10.7326/0003-4819-159-1-201307020-00007; STRAUSS MJ, 1991, J FAM PRACTICE, V33, P52; Taly AB, 2004, ARCH PHYS MED REHAB, V85, P1657, DOI 10.1016/j.apmr.2004.03.028; terRiet G, 1996, PHYS THER, V76, P1301, DOI 10.1093/ptj/76.12.1301; terRiet G, 1995, J CLIN EPIDEMIOL, V48, P1453, DOI 10.1016/0895-4356(95)00053-4; TERRIET G, 1995, BMJ-BRIT MED J, V310, P1040, DOI 10.1136/bmj.310.6986.1040; Thomas DR, 2006, J AM MED DIR ASSOC, V7, P46, DOI 10.1016/j.jamda.2005.10.004; Thomas S, 1997, J Wound Care, V6, P383; Valente SA, 2012, KUWAIT MED J, V44, P40; Van Anholt RD, 2010, EUROPEAN WOUND MANAG, V10, P45; Wanner MB, 2003, SCAND J PLAST RECONS, V37, P28; Warner D J, 1992, Decubitus, V5, P52; Whitney J D, 2001, J Wound Ostomy Continence Nurs, V28, P244, DOI 10.1067/mjw.2001.117564; Winter A, 1990, Nurs Times, V86, P59; WOOD JM, 1993, ARCH DERMATOL, V129, P999, DOI 10.1001/archderm.129.8.999; XAKELLIS GC, 1992, ARCH PHYS MED REHAB, V73, P463; Yamamoto T, 2009, WOUNDS, V21, P153; Yamamoto Y, 1997, PLAST RECONSTR SURG, V100, P1212, DOI 10.1097/00006534-199710000-00021	110	56	60	2	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2015	162	5					370	U177		10.7326/M14-1568	http://dx.doi.org/10.7326/M14-1568			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3HT	25732279				2022-12-28	WOS:000350238300006
J	Angell, SY; De Cock, KM; Frieden, TR				Angell, Sonia Y.; De Cock, Kevin M.; Frieden, Thomas R.			A public health approach to global management of hypertension	LANCET			English	Editorial Material							COUNTRIES; DISEASE		[Angell, Sonia Y.; De Cock, Kevin M.; Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], GLOB ACT PLAN PREV C; [Anonymous], 2014, LANCET, V383, P1861; [Anonymous], 2013, JAMA-J AM MED ASSOC; [Anonymous], 2015, BLOOD PRESSURE MED 5; [Anonymous], 2015, GLOB STAND HYP TREAT; [Anonymous], 2015, COUNT PROBL FALS SUB; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Bloom DE, 2011, GLOBAL EC BURDEN NON; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Ford N, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-33; Frieden TR, 2014, JAMA-J AM MED ASSOC, V311, P21, DOI 10.1001/jama.2013.282615; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Ikeda N, 2014, B WORLD HEALTH ORGAN, V92, P10, DOI 10.2471/BLT.13.121954; Khader A, 2012, TROP MED INT HEALTH, V17, P1163, DOI 10.1111/j.1365-3156.2012.03048.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Organization WH, 2009, GLOB HLTH RISKS MORT; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Warstrom, 2014, MENTIMETER; World Health Organisation, 2014, TUBERCULOSIS; World Health Organization, 2015, GLOB STAT REP NONC D	21	51	54	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					825	827		10.1016/S0140-6736(14)62256-X	http://dx.doi.org/10.1016/S0140-6736(14)62256-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25752181	Green Accepted			2022-12-28	WOS:000350051700037
J	Liu, JG; Mooney, H; Hull, V; Davis, SJ; Gaskell, J; Hertel, T; Lubchenco, J; Seto, KC; Gleick, P; Kremen, C; Li, SX				Liu, Jianguo; Mooney, Harold; Hull, Vanessa; Davis, Steven J.; Gaskell, Joanne; Hertel, Thomas; Lubchenco, Jane; Seto, Karen C.; Gleick, Peter; Kremen, Claire; Li, Shuxin			Systems integration for global sustainability	SCIENCE			English	Review							CLIMATE-CHANGE; ECOSYSTEM SERVICES; LAND-USE; INTERNATIONAL-TRADE; ENERGY; MANAGEMENT; EMISSIONS; SECURITY; FUTURE; BIODIVERSITY	Global sustainability challenges, from maintaining biodiversity to providing clean air and water, are closely interconnected yet often separately studied and managed. Systems integration-holistic approaches to integrating various components of coupled human and natural systems-is critical to understand socioeconomic and environmental interconnections and to create sustainability solutions. Recent advances include the development and quantification of integrated frameworks that incorporate ecosystem services, environmental footprints, planetary boundaries, human-nature nexuses, and telecoupling. Although systems integration has led to fundamental discoveries and practical applications, further efforts are needed to incorporate more human and natural components simultaneously, quantify spillover systems and feedbacks, integrate multiple spatial and temporal scales, develop new tools, and translate findings into policy and practice. Such efforts can help address important knowledge gaps, link seemingly unconnected challenges, and inform policy and management decisions.	[Liu, Jianguo; Hull, Vanessa; Li, Shuxin] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; [Mooney, Harold] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Davis, Steven J.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Gaskell, Joanne] World Bank, Washington, DC 20433 USA; [Hertel, Thomas] Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA; [Lubchenco, Jane] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Seto, Karen C.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Gleick, Peter] Pacific Inst, Oakland, CA USA; [Kremen, Claire] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Michigan State University; Stanford University; University of California System; University of California Irvine; The World Bank; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University; Yale University; University of California System; University of California Berkeley	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	liuji@msu.edu	Li, Shuxin/ADF-9222-2022; Seto, Karen C./C-2722-2008; Davis, Steven/Y-2838-2019; Davis, Steven J/F-9968-2010; Gleick, Peter H/E-5528-2015; Liu, Jianguo/G-5211-2015	Seto, Karen C./0000-0002-4928-2446; Davis, Steven/0000-0002-9338-0844; Davis, Steven J/0000-0002-9338-0844; Gleick, Peter H/0000-0001-7232-9284; Liu, Jianguo/0000-0001-6344-0087	Direct For Social, Behav & Economic Scie [0823003] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1229429] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Agboola JI, 2009, WATER RESOUR MANAG, V23, P2761, DOI 10.1007/s11269-009-9407-4; Agrawal D, 2011, P 14 INT C EXTENDING, P530, DOI [10.1145/1951365.1951432, DOI 10.1145/1951365.1951432]; Allan T., 1997, SCH ORIENTAL AFRICAN, V5145; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Anderson B.D.O., 2006, NETWORK ANAL SYNTHES; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Biggs R, 2010, ECOL SOC, V15, DOI 10.5751/ES-03411-150209; Bingham F., 2012, TRADE COMPETITIVENES; Boelens R, 2012, AGR WATER MANAGE, V108, P16, DOI 10.1016/j.agwat.2011.06.013; Bollen J, 2010, ENERG POLICY, V38, P4021, DOI 10.1016/j.enpol.2010.03.026; Brundtland Commission, 1987, OUR COMMON FUTURE, DOI DOI 10.1080/07488008808408783; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carr JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055825; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Coers R, 2013, ENERG ECON, V36, P708, DOI 10.1016/j.eneco.2012.11.015; Cools J, 2011, ENVIRON MODELL SOFTW, V26, P44, DOI 10.1016/j.envsoft.2010.04.017; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Criqui P, 2012, ENERG POLICY, V41, P827, DOI 10.1016/j.enpol.2011.11.061; Dalin C, 2012, P NATL ACAD SCI USA, V109, P5989, DOI 10.1073/pnas.1203176109; Davis SJ, 2014, CARBON MANAG, V5, P233, DOI 10.1080/17583004.2014.913867; Davis SJ, 2011, P NATL ACAD SCI USA, V108, P18554, DOI 10.1073/pnas.1107409108; Diffenbaugh NS, 2012, NAT CLIM CHANGE, V2, P514, DOI 10.1038/NCLIMATE1491; Digest B., 2014, BIOFUELS MANDATES WO; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Eakin H, 2014, STRUNGMANN FORUM REP, P141; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Galaz V, 2012, CURR OPIN ENV SUST, V4, P80, DOI 10.1016/j.cosust.2012.01.006; Galloway JN, 2007, AMBIO, V36, P622, DOI 10.1579/0044-7447(2007)36[622:ITIMTT]2.0.CO;2; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Granit J., 2013, UNPACKING WATER ENER, P45; Griffin DW, 2002, AM SCI, V90, P228, DOI 10.1511/2002.3.228; Hahn T, 2011, ECOL SOC, V16; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Hammond GP, 2013, APPL ENERG, V112, P547, DOI 10.1016/j.apenergy.2013.01.009; Hanjra MA, 2010, FOOD POLICY, V35, P365, DOI 10.1016/j.foodpol.2010.05.006; Hejazi M, 2014, TECHNOL FORECAST SOC, V81, P205, DOI 10.1016/j.techfore.2013.05.006; Hertel TW, 2010, BIOSCIENCE, V60, P223, DOI 10.1525/bio.2010.60.3.8; Hoekstra A.Y., 2002, VALUE WATER RES REPO, V11; Hoekstra AY, 2014, SCIENCE, V344, P1114, DOI 10.1126/science.1248365; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Hubert B, 2010, CROP SCI, V50, pS33, DOI 10.2135/cropsci2009.09.0530; Ivanic M, 2008, AGR ECON-BLACKWELL, V39, P405, DOI 10.1111/j.1574-0862.2008.00347.x; Janssen MA, 2006, ECOL SOC, V11; Khan FI, 2013, NAT CLIM CHANGE, V3, P692; Konar M, 2013, HYDROL EARTH SYST SC, V17, P3219, DOI 10.5194/hess-17-3219-2013; Kremen C, 2012, ECOL SOC, V17, DOI 10.5751/ES-05103-170444; Lambin EF, 2005, GLOBAL ENVIRON CHANG, V15, P177, DOI 10.1016/j.gloenvcha.2005.06.002; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Levin SA, 2008, BIOSCIENCE, V58, P27, DOI 10.1641/B580107; Liu C, 2012, ECOL INDIC, V18, P42, DOI 10.1016/j.ecolind.2011.10.005; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu JG, 2014, STRUNGMANN FORUM REP, P119; Liu JG, 2014, ASIA PAC POLICY STUD, V1, P230, DOI 10.1002/app5.17; Liu JG, 2013, P NATL ACAD SCI USA, V110, P16297, DOI 10.1073/pnas.1316036110; Liu JG, 2013, ECOL SOC, V18, DOI 10.5751/ES-05873-180226; Margolis M, 2012, ENVIRON RESOUR ECON, V51, P105, DOI 10.1007/s10640-011-9490-x; Melillo JM, 2009, SCIENCE, V326, P1397, DOI 10.1126/science.1180251; Millennium, 2005, EC HUM WELL BEING SY; Mooney HA, 2013, P NATL ACAD SCI USA, V110, P3665, DOI 10.1073/pnas.1107484110; Munang RT, 2011, SUSTAINABILITY-BASEL, V3, P937, DOI 10.3390/su3070937; Nair S, 2014, RESOUR CONSERV RECY, V89, P1, DOI 10.1016/j.resconrec.2014.05.007; Naylor Rosamond, 2014, EVOLVING SPHERE FOOD; Norberg J., 2013, COMPLEXITY THEORY SU; Oladosu G, 2013, AGRICULTURE-BASEL, V3, P53, DOI 10.3390/agriculture3010053; Ostrom E., CHOICE RULES COLLECT, P213; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Phelps J, 2013, P NATL ACAD SCI USA, V110, P7601, DOI 10.1073/pnas.1220070110; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Portman ME, 2012, SCI TOTAL ENVIRON, V439, P194, DOI 10.1016/j.scitotenv.2012.09.016; Prospero JM, 2013, B AM METEOROL SOC, V94, P1329, DOI 10.1175/BAMS-D-12-00142.1; Raupach MR, 2014, NAT CLIM CHANGE, V4, P873, DOI 10.1038/NCLIMATE2384; Reis J, 2014, MAR POLICY, V43, P3, DOI 10.1016/j.marpol.2013.03.013; Reis S, 2012, SCIENCE, V338, P1153, DOI 10.1126/science.1226514; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; Saboori B., 2012, INT J EC FINANC, V4, P243, DOI [10.5539/ijef.v4n2p243, DOI 10.5539/IJEF.V4N2P243]; Santhosh A, 2014, ENERGY, V66, P363, DOI 10.1016/j.energy.2014.01.031; Schellnhuber H.J., 2004, GLOBAL CHANGE EARTH; Schindler DW, 2010, BIOL CONSERV, V143, P1571, DOI 10.1016/j.biocon.2010.04.003; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Seto KC, 2012, P NATL ACAD SCI USA, V109, P7687, DOI 10.1073/pnas.1117622109; Shackleton SE, 2012, INT J SUST DEV WORLD, V19, P275, DOI 10.1080/13504509.2011.641039; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Spies TA, 2014, ECOL SOC, V19, DOI 10.5751/ES-06584-190309; Stillwell Ashlynn S., 2010, Sustainability, V2, P945, DOI 10.3390/su2040945; Suweis S, 2013, P NATL ACAD SCI USA, V110, P4230, DOI 10.1073/pnas.1222452110; Szaro RC, 1998, LANDSCAPE URBAN PLAN, V40, P1, DOI 10.1016/S0169-2046(97)00093-5; Taheripour F, 2013, ENERGY SUSTAIN SOC, V3, DOI 10.1186/2192-0567-3-4; Thompson MC, 2011, ENVIRON SCI POLICY, V14, P100, DOI 10.1016/j.envsci.2010.11.006; Unruh GC, 2000, ENERG POLICY, V28, P817, DOI 10.1016/S0301-4215(00)00070-7; Vergragt PJ, 2011, GLOBAL ENVIRON CHANG, V21, P282, DOI 10.1016/j.gloenvcha.2011.01.020; Villoria NB, 2011, AM J AGR ECON, V93, P919, DOI 10.1093/ajae/aar025; Vina A, 2011, AMBIO, V40, P274, DOI 10.1007/s13280-010-0098-0; Wang JX, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014035; Westhoff P., 2010, EC FOOD; White C, 2012, P NATL ACAD SCI USA, V109, P4696, DOI 10.1073/pnas.1114215109; Wicke B, 2014, STRUNGMANN FORUM REP, P163; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110; Worldwatch Institute, 2011, BIOF MAK COM DESP TO; Yang W, 2013, P NATL ACAD SCI USA, V110, P10916, DOI 10.1073/pnas.1301733110; Zheng H, 2013, P NATL ACAD SCI USA, V110, P16681, DOI 10.1073/pnas.1312324110	105	578	611	97	1125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225							1258832	10.1126/science.1258832	http://dx.doi.org/10.1126/science.1258832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB9NQ	25722418	Green Published			2022-12-28	WOS:000349958900029
J	Ley, RE				Ley, Ruth E.			The Gene-Microbe Link	NATURE			English	Editorial Material									Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Ley, RE (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.		Ley, Ruth E/M-8542-2014	Ley, Ruth E/0000-0002-9087-1672					0	11	13	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					S7	S7		10.1038/518S7a	http://dx.doi.org/10.1038/518S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25715280	Bronze			2022-12-28	WOS:000350097300027
J	Sacks, CA				Sacks, Chana A.			In Memory of Daniel - Reviving Research to Prevent Gun Violence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Sacks, CA (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							[Anonymous], SCH SHOOT AM SAND HO; Hemenway D., 2004, PRIVATE GUNS PUBLIC; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Leventhal JM, 2014, PEDIATRICS, V133, P219, DOI 10.1542/peds.2013-1809; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf	5	13	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					800	801		10.1056/NEJMp1415128	http://dx.doi.org/10.1056/NEJMp1415128			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8SQ	25714158	Bronze			2022-12-28	WOS:000349901700004
J	Chapman, TP; Chen, LY; Leaver, L				Chapman, Thomas P.; Chen, Lucia Y.; Leaver, Laurence			Investigating young adults with chronic diarrhoea in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; CELIAC-DISEASE; SYMPTOMS; CALPROTECTIN; CRITERIA; MARKERS		[Chapman, Thomas P.] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Chen, Lucia Y.] Maidstone & Tunbridge Wells NHS Trust, Maidstone Hosp, Maidstone, Kent, England; [Leaver, Laurence] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX3 9DU, England; [Leaver, Laurence] Univ Oxford, Green Templeton Coll, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford	Chapman, TP (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England.	tomchap@doctors.org.uk		Chen, Lucia Y/0000-0002-0380-7112				BERTOMEU A, 1991, J CLIN GASTROENTEROL, V13, P531, DOI 10.1097/00004836-199110000-00011; Canavan C, 2014, CLIN EPIDEMIOL, V6, P71, DOI 10.2147/CLEP.S40245; Choung RS, 2009, AM J GASTROENTEROL, V104, P1772, DOI 10.1038/ajg.2009.239; Gaafar MR, 2011, INT J INFECT DIS, V15, pE541, DOI 10.1016/j.ijid.2011.04.004; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; National Institute for Health and Care Excellence, 2015, IRR BOW SYNDR DIAGN; National Institute for Health and Care Excellence, 2011, OV CANC REC IN MAN O; National Institute for Health and Care Excellence, 2013, FAEC CALPR DIAGN TES; National Institute for Health and Care Excellence, 2009, COEL DIS REC ASS COE; Pavlidis P, 2013, SCAND J GASTROENTERO, V48, P1048, DOI 10.3109/00365521.2013.816771; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Thomas P. D., 2003, Gut, V52, pv1, DOI 10.1136/gut.52.suppl_5.v1; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Walters Julian R F, 2010, Therap Adv Gastroenterol, V3, P349, DOI 10.1177/1756283X10377126; Waugh N, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17550; Wedlake L, 2009, ALIMENT PHARM THER, V30, P707, DOI 10.1111/j.1365-2036.2009.04081.x; Whitehead WE, 2010, AM J GASTROENTEROL, V105, P814, DOI 10.1038/ajg.2010.56	21	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2015	350								h573	10.1136/bmj.h573	http://dx.doi.org/10.1136/bmj.h573			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AM	25716699				2022-12-28	WOS:000350292900006
J	Wang, Y; Midthun, DE; Wampfler, JA; Deng, B; Stoddard, SM; Zhang, S; Yang, P				Wang, Yi; Midthun, David E.; Wampfler, Jason A.; Deng, Bo; Stoddard, Shawn M.; Zhang, Shuo; Yang, Ping			Trends in the Proportion of Patients With Lung Cancer Meeting Screening Criteria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wang, Yi; Deng, Bo; Stoddard, Shawn M.; Zhang, Shuo; Yang, Ping] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA; [Midthun, David E.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Wampfler, Jason A.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Wang, Yi] Wenzhou Med Univ, Div Prevent Med, Wenzhou, Zhejiang, Peoples R China	Mayo Clinic; Mayo Clinic; Mayo Clinic; Wenzhou Medical University	Yang, P (corresponding author), Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, 200 First St SW, Rochester, MN 55905 USA.	yang.ping@mayo.edu			NATIONAL CANCER INSTITUTE [R01CA080127, R03CA077118, R01CA115857, R01CA084354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA80127, R01 CA84354, R01 CA080127, R03 CA77118, R03 CA077118, R01 CA115857, R01 CA084354] Funding Source: Medline; NIA NIH HHS [R01 AG034676] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bergstralh EJ, CALCULATING INCIDENC; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3244-0, DOI 10.1007/978-1-4899-3244-0]; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009	6	40	41	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					853	855		10.1001/jama.2015.413	http://dx.doi.org/10.1001/jama.2015.413			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710663	Green Accepted, Bronze			2022-12-28	WOS:000349826400020
J	Gabel, HW; Kinde, B; Stroud, H; Gilbert, CS; Harmin, DA; Kastan, NR; Hemberg, M; Ebert, DH; Greenberg, ME				Gabel, Harrison W.; Kinde, Benyam; Stroud, Hume; Gilbert, Caitlin S.; Harmin, David A.; Kastan, Nathaniel R.; Hemberg, Martin; Ebert, Daniel H.; Greenberg, Michael E.			Disruption of DNA-methylation-dependent long gene repression in Rett syndrome	NATURE			English	Article							BDNF TRANSCRIPTION; EXPRESSION CHANGES; BINDING DOMAIN; MESSENGER-RNAS; MOUSE MODELS; MECP2; PHOSPHORYLATION; PURIFICATION; DUPLICATION; CHROMATIN	Disruption of the MECP2 gene leads to Rett syndrome (RTT), a severe neurological disorder with features of autism(1). MECP2 encodes a methyl-DNA-binding protein(2) that has been proposed to function as a transcriptional repressor, but despite numerous mouse studies examining neuronal gene expression in Mecp2 mutants, no clear model has emerged for how MeCP2 protein regulates transcription(3-9). Here we identify a genome-wide length-dependent increase in gene expression in MeCP2 mutant mouse models and human RTT brains. We present evidence that MeCP2 represses gene expression by binding to methylated CA sites within long genes, and that in neurons lacking MeCP2, decreasing the expression of long genes attenuates RTT-associated cellular deficits. In addition, we find that long genes as a population are enriched for neuronal functions and selectively expressed in the brain. These findings suggest that mutations in MeCP2 may cause neurological dysfunction by specifically disrupting long gene expression in the brain.	[Gabel, Harrison W.; Kinde, Benyam; Stroud, Hume; Gilbert, Caitlin S.; Harmin, David A.; Kastan, Nathaniel R.; Ebert, Daniel H.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Hemberg, Martin] Harvard Univ, Ctr Brain Sci, Childrens Hosp Boston, Dept Ophthalmol, Boston, MA 02115 USA; [Hemberg, Martin] Harvard Univ, Swartz Ctr Theoret Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	Stroud, Hume/ABF-1325-2021		Rett Syndrome Research Trust; National Institutes of Health (NIH) [1RO1NS048276]; Damon Runyon Cancer Research Foundation [DRG-2048-10]; William Randolf Hearst fund; NIH [T32GM007753]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	Rett Syndrome Research Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; William Randolf Hearst fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Griffith and members of the Greenberg laboratory, A. Bird, G. Mandel and members of their laboratories, and M. Coenraads for discussions, M. Goodell for providing the Dnmt3a mice, N. Sharma and F. DiBiase for experimental support, and M. Mistry of the HSPH Bioinformatics Core, Harvard School of Public Health for assistance with gene expression analysis. This work was supported by grants from the Rett Syndrome Research Trust and the National Institutes of Health (NIH) (1RO1NS048276) to M.E.G., fellowships from the Damon Runyon Cancer Research Foundation (DRG-2048-10) and the William Randolf Hearst fund to H.W.G., as well as NIH grant T32GM007753, and the HHMI Gilliam fellowship to B.K., H.S. is a HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2194-14).	Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Khrapunov S, 2014, BIOCHEMISTRY-US, V53, P3379, DOI 10.1021/bi500424z; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagy G, 2013, IMMUNOBIOLOGY, V218, P1416, DOI 10.1016/j.imbio.2013.07.006; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Samaco RC, 2012, NAT GENET, V44, P206, DOI 10.1038/ng.1066; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wu YJ, 2006, BIOMETRICS, V62, P877, DOI 10.1111/j.1541-0420.2006.00533.x; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Zhao YT, 2013, NEUROBIOL DIS, V59, P257, DOI 10.1016/j.nbd.2013.08.001; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	53	339	341	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					89	U221		10.1038/nature14319	http://dx.doi.org/10.1038/nature14319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25762136	Green Submitted, Green Accepted			2022-12-28	WOS:000355543400035
J	Cheng, ZY; Li, JF; Niu, YJ; Zhang, XC; Woody, OZ; Xiong, Y; Djonovic, S; Millet, Y; Bush, J; McConkey, BJ; Sheen, J; Ausubel, FM				Cheng, Zhenyu; Li, Jian-Feng; Niu, Yajie; Zhang, Xue-Cheng; Woody, Owen Z.; Xiong, Yan; Djonovic, Slavica; Millet, Yves; Bush, Jenifer; McConkey, Brendan J.; Sheen, Jen; Ausubel, Frederick M.			Pathogen-secreted proteases activate a novel plant immune pathway	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; PROTEIN-KINASE; XANTHOMONAS-CAMPESTRIS; ARABIDOPSIS-THALIANA; RACK1; TRANSFORMATION; INTERACTS; IDENTIFICATION; IV	Mitogen-activated protein kinase (MAPK) cascades play central roles in innate immune signalling networks in plants and animals(1,2). In plants, however, the molecular mechanisms of how signal perception is transduced to MAPK activation remain elusive(1). Here we report that pathogen-secreted proteases activate a previously unknown signalling pathway in Arabidopsis thaliana involving the G alpha, G beta, and G gamma subunits of heterotrimeric G-protein complexes, which function upstream of an MAPK cascade. In this pathway, receptor for activated C kinase 1 (RACK1) functions as a novel scaffold that binds to the G beta subunit as well as to all three tiers of the MAPK cascade, thereby linking upstream G-protein signalling to downstream activation of an MAPK cascade. The protease-G-protein-RACK1-MAPK cascade modules identified in these studies are distinct from previously described plant immune signalling pathways such as that elicited by bacterial flagellin, in which G proteins function downstream of or in parallel to an MAPK cascade without the involvement of the RACK1 scaffolding protein. The discovery of the new protease-mediated immune signalling pathway described here was facilitated by the use of the broad host range, opportunistic bacterial pathogen Pseudomonas aeruginosa. The ability of P. aeruginosa to infect both plants and animals makes it an excellent model to identify novel immunoregulatory strategies that account for its niche adaptation to diverse host tissues and immune systems.	[Cheng, Zhenyu; Li, Jian-Feng; Niu, Yajie; Zhang, Xue-Cheng; Xiong, Yan; Djonovic, Slavica; Millet, Yves; Bush, Jenifer; Sheen, Jen; Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Cheng, Zhenyu; Li, Jian-Feng; Niu, Yajie; Zhang, Xue-Cheng; Xiong, Yan; Djonovic, Slavica; Millet, Yves; Bush, Jenifer; Sheen, Jen; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Woody, Owen Z.; McConkey, Brendan J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Waterloo	Ausubel, FM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ausubel@molbio.mgh.harvard.edu	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022	Cheng, Zhenyu/0000-0002-7240-9126; Xiong, Yan/0000-0003-0676-8267	Natural Sciences and Engineering Research Council of Canada; Banting Postdoctoral Fellowships; National Science Foundation [MCB-0519898, IOS-0929226, IOS-0618292]; National Institutes of Health [R37-GM48707, P30 DK040561, R01-GM70567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707, R01GM070567, R01GM060493] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Banting Postdoctoral Fellowships; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Tena for generating the mekk1/pMEKK1::MEKK1(K361M) transgenic line, Y. Zhang for the summ1-1 mutant, M. C. Suarez-Rodriguez and P. J. Krysan for discussion, the Arabidopsis Biological Resource Center for tDNA insertion lines, and M. Curtis and U. Grossniklaus for the oestradiol-inducible binary vector. We thank S. Lory for P. aeruginosa PAO ADD1976, and M. B. Mudgett for pVSP61. We thank N. Clay, X. Dong, S. Somerville, and Ausubel laboratory members for reading the manuscript. This work was supported by Natural Sciences and Engineering Research Council of Canada and Banting Postdoctoral Fellowships awarded to Z.C., National Science Foundation grants MCB-0519898 and IOS-0929226 and National Institutes of Health grants R37-GM48707 and P30 DK040561 to F.M.A., and National Science Foundation grant IOS-0618292 and National Institutes of Health grant R01-GM70567 to J.S.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Cheng ZY, 2009, MOL PLANT MICROBE IN, V22, P686, DOI 10.1094/MPMI-22-6-0686; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Djonovic S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003217; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo JJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-108; HIRSCH AM, 1984, J BACTERIOL, V158, P1133, DOI 10.1128/JB.158.3.1133-1143.1984; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li JF, 2013, PLANT CELL, V25, P1507, DOI 10.1105/tpc.113.112235; Li JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027364; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Meyer D, 2005, MOL PLANT PATHOL, V6, P327, DOI 10.1111/j.1364-3703.2005.00287.x; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Motley ST, 1999, INFECT IMMUN, V67, P5386, DOI 10.1128/IAI.67.10.5386-5394.1999; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; PARKER JE, 1993, MOL PLANT MICROBE IN, V6, P216, DOI 10.1094/MPMI-6-216; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; SMITH AW, 1989, NUCLEIC ACIDS RES, V17, P10509, DOI 10.1093/nar/17.24.10509; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Traidej M, 2003, J BIOL CHEM, V278, P2549, DOI 10.1074/jbc.M208973200; Ullah H, 2008, PROTEIN SCI, V17, P1771, DOI 10.1110/ps.035121.108; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Witzel F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00475; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	39	140	151	7	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					213	+		10.1038/nature14243	http://dx.doi.org/10.1038/nature14243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25731164	Green Submitted, Green Accepted			2022-12-28	WOS:000354377800057
J	Park, SJ; Ahn, JM; Kim, YH; Park, DW; Yun, SC; Lee, JY; Kang, SJ; Lee, SW; Lee, CW; Park, SW; Choo, SJ; Chung, CH; Lee, JW; Cohen, DJ; Yeung, AC; Hur, SH; Seung, KB; Ahn, TH; Kwon, HM; Lim, DS; Rha, SW; Jeong, MH; Lee, BK; Tresukosol, D; Fu, GS; Ong, TK				Park, Seung-Jung; Ahn, Jung-Min; Kim, Young-Hak; Park, Duk-Woo; Yun, Sung-Cheol; Lee, Jong-Young; Kang, Soo-Jin; Lee, Seung-Whan; Lee, Cheol Whan; Park, Seong-Wook; Choo, Suk Jung; Chung, Cheol Hyun; Lee, Jae Won; Cohen, David J.; Yeung, Alan C.; Hur, Seung Ho; Seung, Ki Bae; Ahn, Tae Hoon; Kwon, Hyuck Moon; Lim, Do-Sun; Rha, Seung-Woon; Jeong, Myung-Ho; Lee, Bong-Ki; Tresukosol, Damras; Fu, Guo Sheng; Ong, Tiong Kiam		BEST Trial Investigators	Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM OUTCOMES; 5-YEAR FOLLOW-UP; GRAFT-SURGERY; 3-VESSEL DISEASE; INTERVENTION; REVASCULARIZATION; METAANALYSIS; THROMBOSIS; SYSTEM; TAXUS	BACKGROUND Most trials comparing percutaneous coronary intervention (PCI) with coronary-artery bypass grafting (CABG) have not made use of second-generation drug-eluting stents. METHODS We conducted a randomized noninferiority trial at 27 centers in East Asia. We planned to randomly assign 1776 patients with multivessel coronary artery disease to PCI with everolimus-eluting stents or to CABG. The primary end point was a composite of death, myocardial infarction, or target-vessel revascularization at 2 years after randomization. Event rates during longer-term follow-up were also compared between groups. RESULTS After the enrollment of 880 patients (438 patients randomly assigned to the PCI group and 442 randomly assigned to the CABG group), the study was terminated early owing to slow enrollment. At 2 years, the primary end point had occurred in 11.0% of the patients in the PCI group and in 7.9% of those in the CABG group (absolute risk difference, 3.1 percentage points; 95% confidence interval [CI], -0.8 to 6.9; P = 0.32 for noninferiority). At longer-term follow-up (median, 4.6 years), the primary end point had occurred in 15.3% of the patients in the PCI group and in 10.6% of those in the CABG group (hazard ratio, 1.47; 95% CI, 1.01 to 2.13; P = 0.04). No significant differences were seen between the two groups in the occurrence of a composite safety end point of death, myocardial infarction, or stroke. However, the rates of any repeat revascularization and spontaneous myocardial infarction were significantly higher after PCI than after CABG. CONCLUSIONS Among patients with multivessel coronary artery disease, the rate of major adverse cardiovascular events was higher among those who had undergone PCI with the use of everolimus-eluting stents than among those who had undergone CABG.	[Park, Seung-Jung; Ahn, Jung-Min; Kim, Young-Hak; Park, Duk-Woo; Lee, Jong-Young; Kang, Soo-Jin; Lee, Seung-Whan; Lee, Cheol Whan; Park, Seong-Wook; Choo, Suk Jung; Chung, Cheol Hyun; Lee, Jae Won] Univ Ulsan, Coll Med, Asan Med Ctr, Heart Inst,Ctr Med Res & Informat, Seoul 138736, South Korea; [Yun, Sung-Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Div Biostat,Ctr Med Res & Informat, Seoul 138736, South Korea; [Seung, Ki Bae] Catholic Univ Korea, St Marys Hosp, Seoul, South Korea; [Kwon, Hyuck Moon] Gangnam Severance Hosp, Seoul, South Korea; [Lim, Do-Sun] Korea Univ Anam, Seoul, South Korea; [Rha, Seung-Woon] Guro Hosp, Seoul, South Korea; [Hur, Seung Ho] Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea; [Ahn, Tae Hoon] Gachon Univ, Gil Hosp, Inchon, South Korea; [Jeong, Myung-Ho] Chonnam Natl Univ Hosp, Kwangju, South Korea; [Lee, Bong-Ki] Kangwon Natl Univ Hosp, Chunchon, South Korea; [Cohen, David J.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Yeung, Alan C.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Tresukosol, Damras] Siriraj Hosp, Bangkok, Thailand; [Fu, Guo Sheng] Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China; [Ong, Tiong Kiam] Sarawak Gen Hosp, Kuching, Malaysia	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Keimyung University; Gachon University; Chonnam National University; Chonnam National University Hospital; Kangwon National University; Kangwon National University Hospital; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Stanford University; Mahidol University; Zhejiang University	Park, SJ (corresponding author), Univ Ulsan, Inst Heart, Asan Med Ctr, 388-1 Pungnap Dong, Seoul 138736, South Korea.	sjpark@amc.seoul.kr	Cohen, David/AAF-1648-2019; Rha, Seung-Woon/AGE-5810-2022; 안, 태훈/GON-9067-2022	Rha, Seung-Woon/0000-0001-9456-9852; 안, 태훈/0000-0003-1544-1784; Lee, Bong-Ki/0000-0002-4289-2284; Kwon, Hyuck Moon/0000-0001-9901-5015	CardioVascular Research Foundation	CardioVascular Research Foundation	Funded by CardioVascular Research Foundation and others; BEST ClinicalTrials.gov number, NCT00997828.	Alfonso F, 2014, EUR HEART J, V35, P2541, DOI [DOI 10.1093/EURHEARTJ/EHU278, 10.1093/eurheartj/ ehu278, 10.1093/eurheartj/ehu278]; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; CAIN KC, 1984, BIOMETRICS, V40, P493, DOI 10.2307/2531402; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Deb S, 2013, JAMA-J AM MED ASSOC, V310, P2086, DOI 10.1001/jama.2013.281718; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Farooq V, 2013, J AM COLL CARDIOL, V62, P2360, DOI 10.1016/j.jacc.2013.07.106; Gada H, 2013, JACC-CARDIOVASC INTE, V6, P1263, DOI 10.1016/j.jcin.2013.07.009; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Head SJ, 2014, EUR HEART J, V35, P2821, DOI 10.1093/eurheartj/ehu213; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148; Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416; Mercado N, 2005, J THORAC CARDIOV SUR, V130, P512, DOI 10.1016/j.jtcvs.2004.12.049; Misfeld M, 2011, J THORAC CARDIOV SUR, V142, pE11, DOI 10.1016/j.jtcvs.2010.11.034; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Nasir K, 2008, ATHEROSCLEROSIS, V198, P104, DOI 10.1016/j.atherosclerosis.2007.09.008; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Serruys PW, 2013, NEW ENGL J MED, V368, P584; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Sipahi I, 2014, JAMA INTERN MED, V174, P223, DOI 10.1001/jamainternmed.2013.12844; Smit Y, 2014, J THORAC CARDIOVASC; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012	25	299	312	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1204	1212		10.1056/NEJMoa1415447	http://dx.doi.org/10.1056/NEJMoa1415447			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25774645	Green Published			2022-12-28	WOS:000351585900006
J	Pastores, SM; DeSancho, MT				Pastores, Stephen M.; DeSancho, Maria T.			Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients, with similar costs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THROMBOSIS		[Pastores, Stephen M.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [DeSancho, Maria T.] Weill Cornell Med Ctr, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Pastores, SM (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.			DeSancho, Maria T/0000-0001-9239-5131; Pastores, Stephen/0000-0002-8850-7062				Alhazzani W, 2013, CRIT CARE MED, V41, P2088, DOI 10.1097/CCM.0b013e31828cf104; Cook D, 2005, CRIT CARE MED, V33, P1565, DOI 10.1097/01.CCM.0000171207.95319.B2; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; National Institute for Health and Care Excellence, 2010, VEN THROMB RED RISK; Schadlich PK, 2006, PHARMACOECONOMICS, V24, P571, DOI 10.2165/00019053-200624060-00005	5	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC13	10.7326/ACPJC-2015-162-6-013	http://dx.doi.org/10.7326/ACPJC-2015-162-6-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775344				2022-12-28	WOS:000351279600012
J	Takahashi, S; Metcalf, CJE; Ferrari, MJ; Moss, WJ; Truelove, SA; Tatem, AJ; Grenfell, BT; Lessler, J				Takahashi, Saki; Metcalf, C. Jessica E.; Ferrari, Matthew J.; Moss, William J.; Truelove, Shaun A.; Tatem, Andrew J.; Grenfell, Bryan T.; Lessler, Justin			Reduced vaccination and the risk of measles and other childhood infections post-Ebola	SCIENCE			English	Article							MORTALITY	The Ebola epidemic in West Africa has caused substantial morbidity and mortality. The outbreak has also disrupted health care services, including childhood vaccinations, creating a second public health crisis. We project that after 6 to 18 months of disruptions, a large connected cluster of children unvaccinated for measles will accumulate across Guinea, Liberia, and Sierra Leone. This pool of susceptibility increases the expected size of a regional measles outbreak from 127,000 to 227,000 cases after 18 months, resulting in 2000 to 16,000 additional deaths (comparable to the numbers of Ebola deaths reported thus far). There is a clear path to avoiding outbreaks of childhood vaccine-preventable diseases once the threat of Ebola begins to recede: an aggressive regional vaccination campaign aimed at age groups left unprotected because of health care disruptions.	[Takahashi, Saki; Metcalf, C. Jessica E.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Metcalf, C. Jessica E.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Ferrari, Matthew J.] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16801 USA; [Moss, William J.; Truelove, Shaun A.; Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton SO17 1BJ, Hants, England; [Tatem, Andrew J.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Tatem, Andrew J.] Flowminder Fdn, S-17177 Stockholm, Sweden	Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Southampton; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	justin@jhu.edu	Truelove, Shaun/D-4187-2018	Truelove, Shaun/0000-0003-0538-0607; Lessler, Justin/0000-0002-9741-8109; Takahashi, Saki/0000-0001-5413-5507; Tatem, Andrew/0000-0002-7270-941X	Bill & Melinda Gates Foundation [OPP1094793, OPP1106427, 1032350]; U.S. Department of Homeland Security Science & Technology Directorate [HSHQDC-12-C-00058]; RAPIDD program of the Department of Homeland Security Science & Technology Directorate; NIH Fogarty International Center; National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI102939, U19AI089674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102939, U19AI089674] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); U.S. Department of Homeland Security Science & Technology Directorate(United States Department of Homeland Security (DHS)); RAPIDD program of the Department of Homeland Security Science & Technology Directorate; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Bill & Melinda Gates Foundation grant OPP1094793 and U.S. Department of Homeland Security Science & Technology Directorate contract HSHQDC-12-C-00058 (B.T.G., C.J.E.M.); the RAPIDD program of the Department of Homeland Security Science & Technology Directorate and the NIH Fogarty International Center (C.J.E.M., B.T.G., A.J.T.); National Institute of Allergy and Infectious Diseases (NIAID) grant R01 AI102939 (J.L.); and NIAID grant U19AI089674 and Bill & Melinda Gates Foundation grants OPP1106427 and 1032350 (A.J.T.). We thank M. Hanson for helping to organize the assessment of the impact of Ebola on measles vaccination and for motivating this work, and W. Hao for helpful discussion in preparation of the manuscript. Demographic and Health Surveys data are made freely available to those filing a request (22). WorldPop project demographic data may be obtained from www.worldpop.org.uk. Data on measles incidence, routine vaccination coverage, and SIAs are available at www.who.int/immunization/monitoring_surveillance/data/en/. Ebola incidence data were extracted from publicly available situation reports (23-25).	Ambassade de France a Conakry, EBOLA POINT DE SITUA; Bolkan Hakon Angell, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0307d588df619f9c9447f8ead5b72b2d; Epicentre, 2014, MEDECINS SANS FRONTI; Garcia AJ, 2015, MIGR STUD, V3, P89, DOI 10.1093/migration/mnu036; ICF International, DEMOGRAPHIC AND HEAL; Liberian Ministry of Health, LIBERIA EBOLA DAILY; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mancini S, 2014, CONFL HEALTH, V8, P9, DOI [DOI 10.1186/1752-1505-8-9, 10.1186/1752-1505-8-9]; McFerron W., 2014, BLOOMBERG NEWS; Medecins Sans Frontieres, 2015, MSF BEGINS MALARIA P; Nyenswah TG, 2014, MMWR-MORBID MORTAL W, V63, P1; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; Sharara SL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004438; Sierra Leone National Ebola Response Centre (NERC), EBOLA OUTBREAK UPDAT; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; SURMIEDA M R S, 1992, Morbidity and Mortality Weekly Report, V41, P9; Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2; UNICEF, SANCTIONS CHILDREN H; Wesolowski A, 2014, PLOS CURR, V6; who, WHO RECOMMENDATIONS; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224; World Health Organization, 2015, IMMUNIZATION VACCINE; World Health Organization, 2013, GLOB VACC ACT PLAN M; World Health Organization, 2015, EBOLA SITUATION REPO	25	127	132	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1240	1242		10.1126/science.aaa3438	http://dx.doi.org/10.1126/science.aaa3438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766232	Green Accepted			2022-12-28	WOS:000350824300035
J	Moevus, CJ; Greene, EC				Moevus, Corentin J.; Greene, Eric C.			A Molecular Take on Aesop's The Oak and the Reeds	CELL			English	Editorial Material							RNA-POLYMERASE-II; DNA; NUCLEOSOMES; FLUCTUATIONS; BINDING		[Moevus, Corentin J.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Greene, Eric C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	ecg2108@columbia.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Killian JL, 2012, CURR OPIN STRUC BIOL, V22, P80, DOI 10.1016/j.sbi.2011.11.003; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; Perales R, 2011, MOL CELL BIOL, V31, P3485, DOI 10.1128/MCB.05599-11; Tomschik M, 2005, P NATL ACAD SCI USA, V102, P3278, DOI 10.1073/pnas.0500189102	10	1	1	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1039	1040		10.1016/j.cell.2015.02.036	http://dx.doi.org/10.1016/j.cell.2015.02.036			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768898	Bronze			2022-12-28	WOS:000351951800001
J	Theodoris, CV; Li, ML; White, MP; Liu, L; He, D; Pollard, KS; Bruneau, BG; Srivastava, D				Theodoris, Christina V.; Li, Molong; White, Mark P.; Liu, Lei; He, Daniel; Pollard, Katherine S.; Bruneau, Benoit G.; Srivastava, Deepak			Human Disease Modeling Reveals Integrated Transcriptional and Epigenetic Mechanisms of NOTCH1 Haploinsufficiency	CELL			English	Article							REGULATORY NETWORKS; GENE-EXPRESSION; CALCIFICATION; BINDING; CELLS; DIFFERENTIATION; MUTATIONS; ALIGNMENT; LEUKEMIA; RECEPTOR	The mechanisms by which transcription factor haploinsufficiency alters the epigenetic and transcriptional landscape in human cells to cause disease are unknown. Here, we utilized human induced pluripotent stem cell (iPSC)-derived endothelial cells (ECs) to show that heterozygous nonsense mutations in NOTCH1 that cause aortic valve calcification disrupt the epigenetic architecture, resulting in derepression of latent pro-osteogenic and -inflammatory gene networks. Hemodynamic shear stress, which protects valves from calcification in vivo, activated anti-osteogenic and anti-inflammatory networks in NOTCH1(+/+), but not NOTCH1(+/-), iPSC-derived ECs. NOTCH1 haploinsufficiency altered H3K27ac at NOTCH1-bound enhancers, dysregulating downstream transcription of more than 1,000 genes involved in osteogenesis, inflammation, and oxidative stress. Computational predictions of the disrupted NOTCH1-dependent gene network revealed regulatory nodes that, when modulated, restored the network toward the NOTCH1(+/+) state. Our results highlight how alterations in transcription factor dosage affect gene networks leading to human disease and reveal nodes for potential therapeutic intervention.	[Theodoris, Christina V.; Li, Molong; White, Mark P.; Liu, Lei; He, Daniel; Pollard, Katherine S.; Bruneau, Benoit G.; Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Theodoris, Christina V.; Li, Molong; White, Mark P.; Liu, Lei; He, Daniel; Bruneau, Benoit G.; Srivastava, Deepak] Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA; [Theodoris, Christina V.; Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Program Dev & Stem Cell Biol, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Srivastava, D (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	Theodoris, Christina/N-4403-2016	Theodoris, Christina/0000-0003-1658-1447; Srivastava, Deepak/0000-0002-3480-5953	NIH/NHLBI [U01 HL098179, U01 HL100406, HL089707]; L.K. Whittier Foundation; William H. Younger Family Foundation; Eugene Roddenberry Foundation; California Institute for Regenerative Medicine; Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association (AHA) Established Investigator Award; California Institute for Regenerative Medicine [RB4-05901]; AHA; UCSF; Roddenberry Fellowship; Winslow Fellowship; UCSF Core Exploratory Award; Developmental and Stem Cell Biology Graduate Program [NIH T32HD007470]; Medical Scientist Training Program [NIH T32GM007618]; Sarnoff Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, U01HL098179, U01HL100406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); L.K. Whittier Foundation; William H. Younger Family Foundation; Eugene Roddenberry Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association (AHA) Established Investigator Award; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); AHA(American Heart Association); UCSF; Roddenberry Fellowship; Winslow Fellowship; UCSF Core Exploratory Award; Developmental and Stem Cell Biology Graduate Program; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sarnoff Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Srivastava Lab and Gladstone/UCSF community for helpful scientific discussions. We thank the Gladstone Genomics, Histology, and Stem Cell Cores and UCSF ESC Targeting Core for their technical expertise. We thank G. Howard and B. Taylor for their editorial help and K. Ivey and C. Gifford for critical comments. This work was supported by NIH/NHLBI grants U01 HL098179 (B. G. B., K.S.P., and D.S.) and U01 HL100406 (B. G. B. and D.S.). D.S. was supported by the L.K. Whittier, William H. Younger Family, and Eugene Roddenberry Foundations and the California Institute for Regenerative Medicine. B. G. B. was supported by the Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association (AHA) Established Investigator Award, William H. Younger Family Foundation, and a grant from the California Institute for Regenerative Medicine (RB4-05901). K.S.P. was supported by a grant from NIH/NHLBI (HL089707). C.V.T. was supported by the AHA Predoctoral, UCSF Discovery, Roddenberry, and Winslow Fellowships and the UCSF Core Exploratory Award, Developmental and Stem Cell Biology Graduate Program (NIH T32HD007470), and Medical Scientist Training Program (NIH T32GM007618). M.P.W. was supported by the AHA Predoctoral and Winslow Fellowship, and M.L. was supported by a Sarnoff Fellowship.	Alatalo SL, 2000, CLIN CHEM, V46, P1751; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Conway DE, 2009, CARDIOVASC RES, V81, P669, DOI 10.1093/cvr/cvn360; Del Bianco C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015034; Deleuze V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040484; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; Engelholm LH, 2001, LAB INVEST, V81, P1403, DOI 10.1038/labinvest.3780354; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Foffa I, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-44; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goettsch C, 2013, CIRC RES, V112, P1073, DOI 10.1161/CIRCRESAHA.113.300937; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hofmann JJ, 2012, DEVELOPMENT, V139, P4449, DOI 10.1242/dev.084871; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOSTKA D, 2014, ARXIV14020042; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kwa MQ, 2014, J BIOL CHEM, V289, P19758, DOI 10.1074/jbc.M114.584540; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li HL, 2013, STEM CELL RES, V10, P313, DOI 10.1016/j.scr.2012.11.007; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007780; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; VANDERLAAN MJ, 2001, J STAT PLAN INFEREN, V117, P275; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Weinberg EJ, 2010, CARDIOVASC ENG, V10, P5, DOI 10.1007/s10558-009-9089-9; White MP, 2013, STEM CELLS, V31, P92, DOI 10.1002/stem.1267; Wu J, 2014, J BIOL CHEM, V289, P12168, DOI 10.1074/jbc.M114.553859; Yamashiro T, 2004, J BONE MINER RES, V19, P1671, DOI 10.1359/JBMR.040801; Yashiro-Ohtani Y, 2014, P NATL ACAD SCI USA, V111, pE4946, DOI 10.1073/pnas.1407079111; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	66	131	132	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1072	1086		10.1016/j.cell.2015.02.035	http://dx.doi.org/10.1016/j.cell.2015.02.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768904	Bronze, Green Accepted			2022-12-28	WOS:000351951800008
J	Spergel, DN				Spergel, David N.			The dark side of cosmology: Dark matter and dark energy	SCIENCE			English	Review							PROBE WMAP OBSERVATIONS; SPECTROSCOPIC SURVEY; GALAXIES; COEVOLUTION; CONSTRAINTS; SUPERNOVAE; EVOLUTION; CONSTANT; ROTATION; SPECTRUM	A simple model with only six parameters (the age of the universe, the density of atoms, the density of matter, the amplitude of the initial fluctuations, the scale dependence of this amplitude, and the epoch of first star formation) fits all of our cosmological data. Although simple, this standard model is strange. The model implies that most of the matter in our Galaxy is in the form of "dark matter," a new type of particle not yet detected in the laboratory, and most of the energy in the universe is in the form of "dark energy," energy associated with empty space. Both dark matter and dark energy require extensions to our current understanding of particle physics or point toward a breakdown of general relativity on cosmological scales.	Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Spergel, DN (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	dns@astro.princeton.edu	Spergel, David N/A-4410-2011	Spergel, David N/0000-0002-5151-0006	National Science Foundation; NASA	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	D.N.S. is supported by grants from the National Science Foundation and NASA.	Ackermann M, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.042001; Ackermann M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.082002; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321529; Aguilar M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.141102; Akerib DS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.091303; Aprile E, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.021301; Babcock H.W., 1939, LICOB, V19, P41, DOI DOI 10.5479/ADS/BIB/1939LICOB.19.41B; Bennett CL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/20; Bernabei R, 2014, NUCL INSTRUM METH A, V742, P177, DOI 10.1016/j.nima.2013.10.079; Betoule M, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201423413; Bosma A., 1978, THESIS U GRONINGEN N; Brooks AM, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/87; Bulbul E, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/13; Capela F, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.123524; Clifton T, 2012, PHYS REP, V513, P1, DOI 10.1016/j.physrep.2012.01.001; Clowe D, 2006, ASTROPHYS J, V648, pL109, DOI 10.1086/508162; Deffayet C, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.044023; DRUKIER AK, 1986, PHYS REV D, V33, P3495, DOI 10.1103/PhysRevD.33.3495; EINASTO J, 1974, NATURE, V250, P309, DOI 10.1038/250309a0; Feng JL, 2010, ANNU REV ASTRON ASTR, V48, P495, DOI 10.1146/annurev-astro-082708-101659; Freedman WL, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/24; Garrison-Kimmel S, 2014, MON NOT R ASTRON SOC, V444, P222, DOI 10.1093/mnras/stu1477; GUNN JE, 1975, NATURE, V257, P454, DOI 10.1038/257454a0; Hou Z, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/74; KAHN FD, 1959, ASTROPHYS J, V130, P705, DOI 10.1086/146762; Kawasaki M, 2013, ANNU REV NUCL PART S, V63, P69, DOI 10.1146/annurev-nucl-102212-170536; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; MILGROM M, 1983, ASTROPHYS J, V270, P365, DOI 10.1086/161130; Naess S, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/10/007; OSTRIKER JP, 1974, ASTROPHYS J, V193, pL1, DOI 10.1086/181617; OSTRIKER JP, 1973, ASTROPHYS J, V186, P467, DOI 10.1086/152513; PEEBLES PJE, 1984, ASTROPHYS J, V284, P439, DOI 10.1086/162425; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Price-Whelan AM, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/4; RATRA B, 1988, PHYS REV D, V37, P3406, DOI 10.1103/PhysRevD.37.3406; Riess AG, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/119; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; ROBERTS MS, 1973, ASTRON ASTROPHYS, V26, P483; RUBIN VC, 1970, ASTROPHYS J, V159, P379, DOI 10.1086/150317; RUBIN VC, 1980, ASTROPHYS J, V238, P471, DOI 10.1086/158003; Schaye J, 2015, MON NOT R ASTRON SOC, V446, P521, DOI 10.1093/mnras/stu2058; Shen Y, 2007, ASTRON J, V133, P2222, DOI 10.1086/513517; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; TURNER MS, 1984, PHYS REV LETT, V52, P2090, DOI 10.1103/PhysRevLett.52.2090; Vogelsberger M, 2014, MON NOT R ASTRON SOC, V444, P1518, DOI 10.1093/mnras/stu1536; Weinberg DH, 2013, PHYS REP, V530, P87, DOI 10.1016/j.physrep.2013.05.001; WEINBERG S, 1989, REV MOD PHYS, V61, P1, DOI 10.1103/RevModPhys.61.1; Wheeler J. A., 2000, GEONS BLACK HOLES QU, P153; Zurek KM, 2014, PHYS REP, V537, P91, DOI 10.1016/j.physrep.2013.12.001; Zwicky F, 1937, PHYS REV, V51, P290, DOI 10.1103/PhysRev.51.290; Zwicky F., 1933, HELV PHYS ACTA, V6, P110, DOI [DOI 10.1007/S10714-008-0707-4, 10.1007/s10714-008-0707-4]	56	35	35	4	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1100	1102		10.1126/science.aaa0980	http://dx.doi.org/10.1126/science.aaa0980			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745164	Green Submitted			2022-12-28	WOS:000350354200043
J	Maurice-Szamburski, A; Auquier, P; Viarre-Oreal, V; Cuvillon, P; Carles, M; Ripart, J; Honore, S; Triglia, T; Loundou, A; Leone, M; Bruder, N				Maurice-Szamburski, Axel; Auquier, Pascal; Viarre-Oreal, Veronique; Cuvillon, Philippe; Carles, Michel; Ripart, Jacques; Honore, Stephane; Triglia, Thibaut; Loundou, Anderson; Leone, Marc; Bruder, Nicolas		PremedX Study Investigators	Effect of Sedative Premedication on Patient Experience After General Anesthesia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMSTERDAM PREOPERATIVE ANXIETY; PERIOPERATIVE SATISFACTION QUESTIONNAIRE; INFORMATION SCALE APAIS; POSTOPERATIVE PAIN; REGIONAL ANESTHESIA; RECOVERY-SCALE; MIDAZOLAM; VALIDATION; QUALITY; CARE	IMPORTANCE Sedative premedication is widely administered before surgery, but little clinical evidence supports its use. OBJECTIVE To assess the efficacy of sedative premedication on perioperative patient experience. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial, the PremedX study, enrolled 1062 adult patients who were younger than 70 years and had been scheduled for various elective surgeries under general anesthesia at 5 French teaching hospitals (in Marseille, Montpellier, Nimes, and Nice) between January 2013 and June 2014. Neurosurgery, obstetrical, cardiac, and outpatient surgery were excluded. INTERVENTIONS Patients were randomized to 3 groups of 354 participants each to receive 2.5 mg of lorazepam, no premedication, or placebo. MAIN OUTCOMES AND MEASURES The primary outcome was perioperative patient experience assessed 24 hours after surgery with a validated questionnaire (Evaluation du Vecu de l'Anesthesie Generale; EVAN-G) describing 6 domains of satisfaction and a global index (score range, 0-100; high scores represent high satisfaction); secondary outcomes included time to extubation and early cognitive recovery. A subgroup analysis was planned a priori in patients with a high level of preoperative anxiety. RESULTS Premedication with lorazepam did not improve the EVAN-G mean global index for overall level of patient satisfaction (72 [95% CI, 70-73]; n = 330) compared with no premedication (73 [95% CI, 71-74]; n = 319) or placebo (71 [95% CI, 70-73]; n = 322) (P = .38). Among patients with heightened preoperative anxiety, there were no significant differences found in the EVAN-G mean global index between the lorazepam group (68 [95% CI, 65-72]; n = 87) and the no premedication group (73 [95% CI, 69-77]; n = 57) or the placebo group (70 [95% CI, 67-72]; n = 87) (P = .18). Time to extubation was 17 minutes (95% CI, 14-20 minutes) in the lorazepam group, 12 minutes (95% CI, 11-13 minutes) for the no premedication group, and 13 minutes (95% CI, 12-14 minutes) for the placebo group (P < .001) and the rate of early cognitive recovery was 51% (95% CI, 45%-56%), 71%(95% CI, 66%-76%), and 64% (95% CI, 59%-69%), respectively (P < .001). CONCLUSIONS AND RELEVANCE Among patients undergoing elective surgery under general anesthesia, sedative premedication with lorazepam compared with placebo or no premedication did not improve the self-reported patient experience the day after surgery, but was associated with modestly prolonged time to extubation and a lower rate of early cognitive recovery. The findings suggest a lack of benefit with routine use of lorazepam as sedative premedication in patients undergoing general anesthesia.	[Maurice-Szamburski, Axel; Viarre-Oreal, Veronique; Triglia, Thibaut; Bruder, Nicolas] Hop Timone Adulte, Serv Anesthesie Reanimat, F-13385 Marseille 05, France; [Auquier, Pascal] Univ Aix Marseille, Lab Univ EA 3279, Marseille, France; [Cuvillon, Philippe] Univ Montpellier I, Inst Canc, Serv Anesthesie, Montpellier, France; [Carles, Michel] Univ Nice Sophia Antipolis, Hop Archet, Serv Anesthesie Reanimat, F-06189 Nice, France; [Ripart, Jacques] Hop Univ Caremeau, Pole ARDU, Serv Anesthesie, Nimes, France; [Ripart, Jacques] Univ Montpellier I, Montpellier, France; [Honore, Stephane] Univ Aix, Hop Timone Adulte, Marseille, France; [Loundou, Anderson] AP HM, Direct Rech Clin, Unite Aide Methodol, Marseille, France; [Leone, Marc] Univ Aix Marseille, Hop Nord, Serv Anesthesie Reanimat, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Maurice-Szamburski, A (corresponding author), Hop Timone Adulte, Serv Anesthesie Reanimat, 264 Rue St Pierre, F-13385 Marseille 05, France.	amszamburski@gmail.com	Leone, Marc/P-4835-2016; Carles, Michel/CAH-0065-2022	Leone, Marc/0000-0002-3097-758X; Walrave, Yannick/0000-0001-8707-0156; CARLES, MICHEL/0000-0001-5485-1511	French Institutional Clinical Hospital Research Program, Ministry of Health [2011-32A-1337]	French Institutional Clinical Hospital Research Program, Ministry of Health	This work was supported by grant 2011-32A-1337 from the French Institutional Clinical Hospital Research Program, Ministry of Health (awarded to Dr Maurice-Szamburski).	Agelink MW, 2002, CRIT CARE MED, V30, P997, DOI 10.1097/00003246-200205000-00008; Auquier P, 2005, ANESTHESIOLOGY, V102, P1116, DOI 10.1097/00000542-200506000-00010; Barnett SF, 2013, ANESTHESIOLOGY, V119, P452, DOI 10.1097/ALN.0b013e3182976014; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 1997, PAIN, V71, P135, DOI 10.1016/S0304-3959(97)03346-0; Boker A, 2002, CAN J ANAESTH, V49, P792, DOI 10.1007/BF03017410; CALNAN M, 1988, SOC SCI MED, V27, P927, DOI 10.1016/0277-9536(88)90283-3; Campbell J, 2001, BUILDING PARTNERSHIP; Fung D, 1998, ANESTH ANALG, V87, P1089, DOI 10.1097/00000539-199811000-00020; Ho KY, 2006, PAIN, V126, P91, DOI 10.1016/j.pain.2006.06.018; Hsu J., 1996, MULTIPLE COMP THEORY; Hurley RW, 2006, REGION ANESTH PAIN M, V31, P237, DOI 10.1016/j.rapm.2006.01.005; Jeantieu M, 2014, J THORAC ONCOL, V9, P362, DOI 10.1097/JTO.0000000000000084; Jlala HA, 2010, BRIT J ANAESTH, V104, P369, DOI 10.1093/bja/aeq002; Kain ZN, 2000, ANESTHESIOLOGY, V93, P141, DOI 10.1097/00000542-200007000-00024; Kain ZN, 1997, ANESTH ANALG, V84, P427, DOI 10.1097/00000539-199702000-00035; KALES A, 1986, PHARMACOLOGY, V32, P121, DOI 10.1159/000138160; Kehlet H, 1997, BRIT J ANAESTH, V78, P606, DOI 10.1093/bja/78.5.606; Kiecolt-Glaser JK, 1998, AM PSYCHOL, V53, P1209, DOI 10.1037/0003-066X.53.11.1209; Kon AA, 2010, JAMA-J AM MED ASSOC, V304, P903, DOI 10.1001/jama.2010.1208; Laufenberg-Feldmann R, 2013, EUR J ANAESTH, V30, P758, DOI 10.1097/EJA.0b013e3283631751; Mashour GA, 2013, ANESTH ANALG, V116, P889, DOI 10.1213/ANE.0b013e318281e9ad; Maurice-Szamburski A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-166; Maurice-Szamburski A, 2013, ANESTHESIOLOGY, V118, P78, DOI 10.1097/ALN.0b013e31827469f2; MIRAKHUR RK, 1991, J ROY SOC MED, V84, P481, DOI 10.1177/014107689108400811; Moerman N, 1996, ANESTH ANALG, V82, P445, DOI 10.1097/00000539-199603000-00002; Rogers JF, 2002, CLIN PHARMACOL THER, V72, P711, DOI 10.1067/mcp.2002.128866; Royse CF, 2013, ANESTHESIOLOGY, V119, P576, DOI 10.1097/ALN.0b013e318299f72b; Royse CF, 2010, ANESTHESIOLOGY, V113, P892, DOI 10.1097/ALN.0b013e3181d960a9; Schou I, 2004, PSYCHO-ONCOLOGY, V13, P309, DOI 10.1002/pon.747; Sjoling M, 2003, PATIENT EDUC COUNS, V51, P169, DOI 10.1016/S0738-3991(02)00191-X; SMITH AF, 2003, COCHRANE DB SYST REV; Svedman Paul, 2005, BMC Anesthesiol, V5, P9, DOI 10.1186/1471-2253-5-9; Vetter TR, 2013, ANESTHESIOLOGY, V119, P1261, DOI 10.1097/ALN.0b013e3182a8e9e6; Vetter TR, 2013, ANESTHESIOLOGY, V119, P245, DOI 10.1097/ALN.0b013e318297605d; Wilder-Smith OHG, 2001, CAN J ANAESTH, V48, P439, DOI 10.1007/BF03028305	36	88	91	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					916	925		10.1001/jama.2015.1108	http://dx.doi.org/10.1001/jama.2015.1108			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734733	Bronze			2022-12-28	WOS:000350231800014
J	Larson, G				Larson, Greger			How wheat came to Britain	SCIENCE			English	Editorial Material							DNA		Univ Oxford, Res Lab Archaeol & Hist Art, Palaeogen & Bioarchaeol Res Network, Oxford OX1 3QY, England	University of Oxford	Larson, G (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Palaeogen & Bioarchaeol Res Network, S Parks Rd, Oxford OX1 3QY, England.	greger.larson@arch.ox.ac.uk			NERC [NE/F003382/1, NE/F003382/2] Funding Source: UKRI; Natural Environment Research Council [NE/F003382/1, NE/F003382/2] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Jeunesse C., 2003, REV ALSACE, V129, P97; Momber G., 2011, MESOLITHIC OCCUPATIO, P66; Rawlence NJ, 2014, J QUATERNARY SCI, V29, P610, DOI 10.1002/jqs.2740; Smith O, 2015, SCIENCE, V347, P998, DOI 10.1126/science.1261278; Tresset A, 2011, CR BIOL, V334, P182, DOI 10.1016/j.crvi.2010.12.010; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758	9	6	8	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					945	946		10.1126/science.aaa6113	http://dx.doi.org/10.1126/science.aaa6113			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB9NQ	25722395				2022-12-28	WOS:000349958900016
J	Zhang, J; Khan, SA; Hasse, C; Ruf, S; Heckel, DG; Bock, R				Zhang, Jiang; Khan, Sher Afzal; Hasse, Claudia; Ruf, Stephanie; Heckel, David G.; Bock, Ralph			Full crop protection from an insect pest by expression of long double-stranded RNAs in plastids	SCIENCE			English	Article							GENE-EXPRESSION; RESISTANCE; POTATO; IDENTIFICATION	Double-stranded RNAs (dsRNAs) targeted against essential genes can trigger a lethal RNA interference (RNAi) response in insect pests. The application of this concept in plant protection is hampered by the presence of an endogenous plant RNAi pathway that processes dsRNAs into short interfering RNAs. We found that long dsRNAs can be stably produced in chloroplasts, a cellular compartment that appears to lack an RNAi machinery. When expressed from the chloroplast genome, dsRNAs accumulated to as much as 0.4% of the total cellular RNA. Transplastomic potato plants producing dsRNAs targeted against the beta-actin gene of the Colorado potato beetle, a notorious agricultural pest, were protected from herbivory and were lethal to its larvae. Thus, chloroplast expression of long dsRNAs can provide crop protection without chemical pesticides.	[Zhang, Jiang; Hasse, Claudia; Ruf, Stephanie; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany; [Khan, Sher Afzal; Heckel, David G.] Max Planck Inst Chem Okol, D-07745 Jena, Germany	Max Planck Society; Max Planck Society	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany.	rbock@mpimp-golm.mpg.de	Bock, Ralph/B-4352-2009; Heckel, David G/K-2138-2013; Ruf, Stephanie/AAW-8311-2020	Bock, Ralph/0000-0001-7502-6940; Heckel, David G/0000-0001-8991-2150; Ruf, Stephanie/0000-0002-9469-5944	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank P. Endries for help with plant transformation, E. Maximova for help with microscopy, Y. Zhang for providing phalloidin-FITC, the MPI-MP Greenteam for plant cultivation, M. Kaltenpoth and B. Weiss for help in insect tissue preparation, and T. Krugel and the MPI-CE greenhouse team. This research was financed by the Max Planck Society. Plastid transformation vectors and transplastomic plants are available under a material transfer agreement. J.Z., S.A.K., D.G.H., R.B., and the Max Planck Society (MPG) have filed a patent application (EP14199415) that relates to the transplastomic production of dsRNAs for plant protection. Supplement contains additional data.	Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Kahlau S, 2008, PLANT CELL, V20, P856, DOI 10.1105/tpc.107.055202; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; STERN DB, 1987, CELL, V51, P1145, DOI 10.1016/0092-8674(87)90600-3; Valkov VT, 2011, TRANSGENIC RES, V20, P137, DOI 10.1007/s11248-010-9402-9; Valkov VT, 2009, PLANT PHYSIOL, V150, P2030, DOI 10.1104/pp.109.140483; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhou F, 2007, PLANT J, V52, P961, DOI 10.1111/j.1365-313X.2007.03261.x; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048; Zhu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038572	23	252	275	16	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					991	994		10.1126/science.1261680	http://dx.doi.org/10.1126/science.1261680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722411				2022-12-28	WOS:000349958900038
J	Kudryashev, M; Wang, RYR; Brackmann, M; Scherer, S; Maier, T; Baker, D; DiMaio, F; Stahlberg, H; Egelman, EH; Basler, M				Kudryashev, Mikhail; Wang, Ray Yu-Ruei; Brackmann, Maximilian; Scherer, Sebastian; Maier, Timm; Baker, David; DiMaio, Frank; Stahlberg, Henning; Egelman, Edward H.; Basler, Marek			Structure of the Type VI Secretion System Contractile Sheath	CELL			English	Article							NEAR-ATOMIC-RESOLUTION; HELICAL FILAMENTS; PROTEIN; BACTERIOPHAGE-T4; RECONSTRUCTION; COMPLEX; VISUALIZATION; MICROSCOPY; PREDICTION; MECHANISM	Bacteria use rapid contraction of a long sheath of the type VI secretion system (T6SS) to deliver effectors into a target cell. Here, we present an atomic-resolution structure of a native contracted Vibrio cholerae sheath determined by cryo-electron microscopy. The sheath subunits, composed of tightly interacting proteins VipA and VipB, assemble into a six-start helix. The helix is stabilized by a core domain assembled from four b strands donated by one VipA and two VipB molecules. The fold of inner and middle layers is conserved between T6SS and phage sheaths. However, the structure of the outer layer is distinct and suggests a mechanism of interaction of the bacterial sheath with an accessory ATPase, ClpV, that facilitates multiple rounds of effector delivery. Our results provide a mechanistic insight into assembly of contractile nanomachines that bacteria and phages use to translocate macromolecules across membranes.	[Kudryashev, Mikhail; Brackmann, Maximilian; Basler, Marek] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland; [Kudryashev, Mikhail; Scherer, Sebastian; Stahlberg, Henning] Univ Virginia, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland; [Wang, Ray Yu-Ruei; Baker, David; DiMaio, Frank] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wang, Ray Yu-Ruei] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Maier, Timm] Univ Basel, Biozentrum, Focal Area Struct Biol, CH-4056 Basel, Switzerland; [Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Basel; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Basel; University of Virginia	Egelman, EH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	egelman@virginia.edu; marek.basler@unibas.ch	Stahlberg, Henning/H-1868-2011; Maier, Timm/A-8835-2016; Basler, Marek/A-3559-2012; Baker, David/K-8941-2012	Stahlberg, Henning/0000-0002-1185-4592; Maier, Timm/0000-0002-7459-1363; Basler, Marek/0000-0001-5414-2088; Baker, David/0000-0001-7896-6217; Brackmann, Maximilian/0000-0003-0079-1693; Kudryashev, Misha/0000-0003-3550-6274; Egelman, Edward/0000-0003-4844-5212	NIH [EB001567, R01GM092802]; Swiss systems biology initiative SystemsX.ch grant CINA; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss systems biology initiative SystemsX.ch grant CINA; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mihai Ionescu for excellent technical assistance in preparation of the sheath sample. We thank Kenneth Goldie and Bill Anderson for expert assistance with cryo-EM and Venkat Dandey for support with software. Grant support was from NIH EB001567 (to E.H.E.), Swiss systems biology initiative SystemsX.ch grant CINA, and NIH R01GM092802 (to R.Y.-R.W. and D.B.).	Aksyuk AA, 2011, STRUCTURE, V19, P1885, DOI 10.1016/j.str.2011.09.012; Aksyuk AA, 2009, STRUCTURE, V17, P800, DOI 10.1016/j.str.2009.04.005; Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; Castelain M, 2011, EUR BIOPHYS J BIOPHY, V40, P305, DOI 10.1007/s00249-010-0648-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Egelman EH, 2010, METHOD ENZYMOL, V482, P167, DOI 10.1016/S0076-6879(10)82006-3; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faruqi AR, 2003, ULTRAMICROSCOPY, V94, P263, DOI 10.1016/S0304-3991(02)00336-4; Fokine A, 2013, J MOL BIOL, V425, P1731, DOI 10.1016/j.jmb.2013.02.012; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Kajan L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-85; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kube S, 2014, CELL REP, V8, P20, DOI 10.1016/j.celrep.2014.05.034; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Scherer S, 2014, J STRUCT BIOL, V186, P302, DOI 10.1016/j.jsb.2014.03.016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Song Y, 2015, NAT METHODS; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; von der Ecken J., 2014, NATURE; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Wang RY, 2015, NAT METHODS; Wang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01448; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	60	163	165	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					952	962		10.1016/j.cell.2015.01.037	http://dx.doi.org/10.1016/j.cell.2015.01.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723169	Green Accepted, Bronze			2022-12-28	WOS:000351116100017
J	Schicho, A; Riepl, C				Schicho, Andreas; Riepl, Christoph			Femoral-Head Dislocation to the Scrotum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schicho, Andreas; Riepl, Christoph] Univ Ulm, D-89069 Ulm, Germany	Ulm University	Schicho, A (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	andreas.schicho@uniklinik-ulm.de							0	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					863	863		10.1056/NEJMicm1313857	http://dx.doi.org/10.1056/NEJMicm1313857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8SQ	25714164				2022-12-28	WOS:000349901700011
J	Schmidt, C				Schmidt, Charles			The microbiome may yield a new class of psychobiotics for the treatment of anxiety, depression and other mood disorders	NATURE			English	Editorial Material																			0	98	106	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					S12	+		10.1038/518S13a	http://dx.doi.org/10.1038/518S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25715275	Bronze			2022-12-28	WOS:000350097300029
J	Theler, D; Allain, FHT				Theler, Dominik; Allain, Frederic H. -T.			MOLECULAR BIOLOGY RNA modification does a regulatory two-step	NATURE			English	Editorial Material							MESSENGER-RNA; N-6-METHYLADENOSINE; M(6)A		[Theler, Dominik; Allain, Frederic H. -T.] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Theler, D (corresponding author), ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland.	dtheler@mol.biol.ethz.ch; allain@mol.biol.ethz.ch						Cienikova Z, 2014, J AM CHEM SOC, V136, P14536, DOI 10.1021/ja507690d; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Theler D, 2014, NUCLEIC ACIDS RES, V42, P13911, DOI 10.1093/nar/gku1116	11	5	6	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					492	493		10.1038/518492a	http://dx.doi.org/10.1038/518492a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719665				2022-12-28	WOS:000350097300037
J	Vize, R				Vize, Richard			NHS LEADERSHIP Why would a consultant think of going into management?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com						American College of Healthcare Executives, 2006, IMP HOSP CEO TURN US; [Anonymous], 2014, SUPP ROL MED DIR; Goodall AH, 2011, SOC SCI MED, V73, P535, DOI 10.1016/j.socscimed.2011.06.025; Griffiths ER, 1983, NHS MANAGEMENT INQUI; Health Research and Educational Trust, 2014, BUILD LEAD TEAM HLTH; Joynt KE, 2014, JAMA INTERN MED, V174, P61, DOI 10.1001/jamainternmed.2013.11537; McKinsey and Company, 2011, WHY HOSP MAN MATT; McKinsey and Company London School of Economics and Political Science, 2009, MAN HEALTHC WHY GOOD; Vize R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6883	9	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2015	350								h922	10.1136/bmj.h922	http://dx.doi.org/10.1136/bmj.h922			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AL	25712001				2022-12-28	WOS:000350292700021
J	Faraone, SV				Faraone, Stephen V.			Attention deficit hyperactivity disorder and premature death	LANCET			English	Editorial Material							DEFICIT/HYPERACTIVITY DISORDER; ADHD; METAANALYSIS; ADULTS		[Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Faraone, SV (corresponding author), SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA.	sfaraone@childpsychresearch.org	Faraone, Stephen V/O-7239-2018; Faraone, Stephen/AAE-7334-2019	Faraone, Stephen V/0000-0002-9217-3982; Faraone, Stephen/0000-0002-9217-3982				Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Biederman J, 2008, PSYCHOL MED, V38, P1027, DOI 10.1017/S0033291707002668; Biederman J, 2012, J PSYCHIATR RES, V46, P484, DOI 10.1016/j.jpsychires.2012.01.007; Cortese S, 2013, BRIT J PSYCHIAT, V203, P24, DOI 10.1192/bjp.bp.112.123299; Dalsgaard S, 2015, LANCET; Faraone SV, 2014, CHILD ADOL PSYCH CL, V23, P965, DOI 10.1016/j.chc.2014.06.003; Faraone SV, 2005, EUR CHILD ADOLES PSY, V14, P1, DOI 10.1007/s00787-005-0429-z; Graziano PA, 2015, J ATTEN DISORD, V19, P179, DOI 10.1177/1087054714527792; Groen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074909; Joseph N, 2013, J ATTEN DISORD, V2013; Spencer TJ, 2014, J NERV MENT DIS, V202, P725, DOI 10.1097/NMD.0000000000000191; Vaa T, 2014, ACCIDENT ANAL PREV, V62, P415, DOI 10.1016/j.aap.2013.10.003; van de Glind G, 2014, DRUG ALCOHOL DEPEN, V134, P158, DOI 10.1016/j.drugalcdep.2013.09.026	13	24	24	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2132	2133		10.1016/S0140-6736(14)61822-5	http://dx.doi.org/10.1016/S0140-6736(14)61822-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25726517				2022-12-28	WOS:000355583000009
J	Wilson, FP; Shashaty, M; Testani, J; Aqeel, I; Borovskiy, Y; Ellenberg, SS; Feldman, HI; Fernandez, H; Gitelman, Y; Lin, J; Negoianu, D; Parikh, CR; Reese, PP; Urbani, R; Fuchs, B				Wilson, F. Perry; Shashaty, Michael; Testani, Jeffrey; Aqeel, Iram; Borovskiy, Yuliya; Ellenberg, Susan S.; Feldman, Harold I.; Fernandez, Hilda; Gitelman, Yevgeniy; Lin, Jennie; Negoianu, Dan; Parikh, Chirag R.; Reese, Peter P.; Urbani, Richard; Fuchs, Barry			Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial	LANCET			English	Article							DECISION-SUPPORT-SYSTEMS; CRITICALLY-ILL PATIENTS; LONG-TERM RISK; SERUM CREATININE; CARDIAC-SURGERY; RIFLE CRITERIA; CLINICAL-TRIAL; MORTALITY; TIME; DIALYSIS	Background Acute kidney injury often goes unrecognised in its early stages when effective treatment options might be available. We aimed to determine whether an automated electronic alert for acute kidney injury would reduce the severity of such injury and improve clinical outcomes in patients in hospital. Methods In this investigator-masked, parallel-group, randomised controlled trial, patients were recruited from the hospital of the University of Pennsylvania in Philadelphia, PA, USA. Eligible participants were adults aged 18 years or older who were in hospital with stage 1 or greater acute kidney injury as defined by Kidney Disease Improving Global Outcomes creatinine-based criteria. Exclusion criteria were initial hospital creatinine 4.0 mg/dL (to convert to mu mol/L, multiply by 88.4) or greater, fewer than two creatinine values measured, inability to determine the covering provider, admission to hospice or the observation unit, previous randomisation, or end-stage renal disease. Patients were randomly assigned (1: 1) via a computer-generated sequence to receive an acute kidney injury alert (a text-based alert sent to the covering provider and unit pharmacist indicating new acute kidney injury) or usual care, stratified by medical versus surgical admission and intensive care unit versus non-intensive care unit location in blocks of 4-8 participants. The primary outcome was a composite of relative maximum change in creatinine, dialysis, and death at 7 days after randomisation. All analyses were by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01862419. Findings Between Sept 17, 2013, and April 14, 2014, 23 664 patients were screened. 1201 eligible participants were assigned to the acute kidney injury alert group and 1192 were assigned to the usual care group. Composite relative maximum change in creatinine, dialysis, and death at 7 days did not differ between the alert group and the usual care group (p=0.88), or within any of the four randomisation strata (all p>0.05). At 7 days after randomisation, median maximum relative change in creatinine concentrations was 0.0% (IQR 0.0-18.4) in the alert group and 0.6% (0.0-17.5) in the usual care group (p=0.81); 87 (7.2%) patients in the alert group and 70 (5.9%) patients in usual care group had received dialysis (odds ratio 1.25 [95% CI 0.90-1.74]; p=0.18); and 71 (5.9%) patients in the alert group and 61 (5.1%) patients in the usual care group had died (1.16 [0.81-1.68]; p=0.40). Interpretation An electronic alert system for acute kidney injury did not improve clinical outcomes among patients in hospital.	[Wilson, F. Perry; Testani, Jeffrey; Parikh, Chirag R.] Yale Univ, Sch Med, Program Appl Translat Res, New Haven, CT USA; [Shashaty, Michael; Borovskiy, Yuliya; Feldman, Harold I.; Gitelman, Yevgeniy; Lin, Jennie; Negoianu, Dan; Reese, Peter P.; Fuchs, Barry] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Aqeel, Iram] Nephrol Associates, Teaneck, NJ USA; [Ellenberg, Susan S.; Feldman, Harold I.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Fernandez, Hilda] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Shashaty, Michael; Ellenberg, Susan S.; Feldman, Harold I.; Reese, Peter P.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Urbani, Richard] Univ Penn, Dept Informat Serv, Perelman Sch Med, Philadelphia, PA 19104 USA	Yale University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wilson, FP (corresponding author), Yale Univ, Sch Med, Program Appl Translat Res, Dept Med, 60 Temple St,Suite 6C, New Haven, CT 06410 USA.	francis.p.wilson@yale.edu	Shashaty, Michael/X-3690-2019	Shashaty, Michael/0000-0002-8766-3418; Lin, Jennie/0000-0002-9328-6700; Wilson, Francis Perry/0000-0002-2633-2412; Parikh, Chirag/0000-0001-9051-7385; Fernandez, Hilda/0000-0003-3740-1062	A K23 Mentored Career Development Award from NIH [K23DK097201]; Penn Center for Healthcare Improvement and Patient Safety Pilot Grant; Mentored Career Development Grant from NIH [K23HL114868]; Loan-repayment grant from NIH [L30HL115790]; Fellowship Training Grant from NIH [T32DK007006]; midcareer investigator award from NIH [K24DK090203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL114868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097307, T32DK007785, K24DK090203, K23DK097201, T32DK007006] Funding Source: NIH RePORTER	A K23 Mentored Career Development Award from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for Healthcare Improvement and Patient Safety Pilot Grant; Mentored Career Development Grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loan-repayment grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fellowship Training Grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); midcareer investigator award from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Penn Center for Healthcare Improvement and Patient Safety.; This work was funded in part by A K23 Mentored Career Development Award from the NIH (K23DK097201) and a Penn Center for Healthcare Improvement and Patient Safety Pilot Grant to FPW, a Mentored Career Development Grant from the NIH (K23HL114868), a Loan-repayment grant from the NIH (L30HL115790) to JT, a Fellowship Training Grant from the NIH (T32DK007006) to JL, and a midcareer investigator award from the NIH (K24DK090203) to CRP. We thank the Penn Data Store for their assistance in assembling some of the information used in this study.	Aitken E, 2013, QJM-INT J MED, V106, P323, DOI 10.1093/qjmed/hcs237; Anderson Howard J, 2009, Health Data Manag, V17, P42; Andrikos Emilios, 2009, Blood Purif, V28, P239, DOI 10.1159/000231986; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Bagshaw SM, 2008, CRIT CARE, V12, DOI [10.1186/cc6863, 10.1186/cc6268]; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948; Balasubramanian G, 2011, AM J KIDNEY DIS, V57, P228, DOI 10.1053/j.ajkd.2010.08.026; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Berger MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6981; Bihorac A, 2010, ANN SURG, V252, P158, DOI 10.1097/SLA.0b013e3181deb6bc; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Colpaert K, 2012, CRIT CARE MED, V40, P1164, DOI 10.1097/CCM.0b013e3182387a6b; Dexter PR, 2001, NEW ENGL J MED, V345, P965, DOI 10.1056/NEJMsa010181; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ejaz AA, 2009, J THORAC CARDIOV SUR, V138, P959, DOI 10.1016/j.jtcvs.2009.05.014; Embi PJ, 2012, J AM MED INFORM ASSN, V19, pE145, DOI 10.1136/amiajnl-2011-000743; Garzotto F, 2011, BLOOD PURIFICAT, V31, P159, DOI 10.1159/000322161; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; Hoste EAJ, 2006, CURR OPIN CRIT CARE, V12, P531, DOI 10.1097/MCC.0b013e3280102af7; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Kesselheim AS, 2011, HEALTH AFFAIR, V30, P2310, DOI 10.1377/hlthaff.2010.1111; Kolli H, 2010, RENAL FAILURE, V32, P1066, DOI 10.3109/0886022X.2010.510616; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Lee Eva K, 2010, AMIA Annu Symp Proc, V2010, P417; Linder A, 2014, AM J RESP CRIT CARE, V189, P1075, DOI 10.1164/rccm.201311-2097OC; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; National Confidential Enquiry into Patient Outcome and Death, 2009, ADD INS INJ REV CAR; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Nigwekar SU, 2009, COCHRANE DB SYST REV, V4; Porter CJ, 2014, NEPHROL DIAL TRANSPL, V29, P1888, DOI 10.1093/ndt/gfu082; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Strom BL, 2010, ARCH INTERN MED, V170, P1578, DOI 10.1001/archinternmed.2010.324; Strom BL, 2010, J AM MED INFORM ASSN, V17, P411, DOI 10.1136/jamia.2009.000695; Tumlin JA, 2005, AM J KIDNEY DIS, V46, P26, DOI 10.1053/j.ajkd.2005.04.002; Wilson FP, 2014, CLIN TRIALS, V11, P521, DOI 10.1177/1740774514542619; Wilson FP, 2013, CLIN NEPHROL, V80, P417, DOI 10.5414/CN108072; Wilson FP, 2013, CLIN J AM SOC NEPHRO, V8, P527, DOI 10.2215/CJN.06450612; Zhao XQ, 2008, BIOMETRICAL J, V50, P375, DOI 10.1002/bimj.200710419	46	209	214	2	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1966	1974		10.1016/S0140-6736(15)60266-5	http://dx.doi.org/10.1016/S0140-6736(15)60266-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	25726515	Green Accepted			2022-12-28	WOS:000354541700030
J	Herzlinger, RE; Richman, BD; Schulman, KA				Herzlinger, Regina E.; Richman, Barak D.; Schulman, Kevin A.			Market-Based Solutions to Antitrust Threats - The Rejection of the Partners Settlement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Herzlinger, Regina E.; Schulman, Kevin A.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Durham, NC USA; [Richman, Barak D.] Duke Univ, Sch Law, Durham, NC 27706 USA	Harvard University; Duke University; Duke University	Herzlinger, RE (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							[Anonymous], 2008, BOSTON GLOBE; [Anonymous], 2014, NUMB HOSP T GREW 201; Dafny L, 2009, J LAW ECON, V52, P523, DOI 10.1086/600079; Office of Attorney General Martha Coakley, 2010, EX HLTH CAR COST TRE	4	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1287	1289		10.1056/NEJMp1501782	http://dx.doi.org/10.1056/NEJMp1501782			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE7NL	25738542				2022-12-28	WOS:000352028500003
J	Carrington-Ford, A; Prochazka, AV				Carrington-Ford, Alexis; Prochazka, Allan V.			Review: In benign paroxysmal positional vertigo, the Epley maneuver increases symptom resolution	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Carrington-Ford, Alexis; Prochazka, Allan V.] Denver VA Med Ctr, Denver, CO 80220 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Carrington-Ford, A (corresponding author), Denver VA Med Ctr, Denver, CO 80220 USA.							Kim JS, 2014, NEW ENGL J MED, V370, P1138, DOI 10.1056/NEJMcp1309481; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC10	10.7326/ACPJC-2015-162-6-010	http://dx.doi.org/10.7326/ACPJC-2015-162-6-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775341				2022-12-28	WOS:000351279600009
J	Manishankar, P; Kudla, J				Manishankar, Prabha; Kudla, Joerg			Cold Tolerance Encoded in One SNP	CELL			English	Editorial Material									[Manishankar, Prabha; Kudla, Joerg] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany	University of Munster	Kudla, J (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, Schlosspl 7, D-48149 Munster, Germany.	jkudla@uni-muenster.de	Kudla, Jörg/C-2174-2012	Kudla, Jörg/0000-0002-8238-767X				da Cruz RP, 2013, FOOD ENERGY SECUR, V2, P96, DOI 10.1002/fes3.25; Juliano B. O., 2003, RICE CHEM QUALITY, P1; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773	3	15	17	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1045	1046		10.1016/j.cell.2015.02.037	http://dx.doi.org/10.1016/j.cell.2015.02.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768901	Bronze			2022-12-28	WOS:000351951800004
J	Thomas, KH; Martin, RM; Knipe, DW; Higgins, JPT; Gunnell, D				Thomas, Kyla H.; Martin, Richard M.; Knipe, Duleeka W.; Higgins, Julian P. T.; Gunnell, David			Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECEPTOR PARTIAL AGONIST; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND PLACEBO; SUSTAINED-RELEASE BUPROPION; SMOKING-CESSATION; SMOKELESS TOBACCO; BIPOLAR DISORDER; CLINICAL-TRIAL; EFFICACY; SAFETY	Objective To determine the risk of neuropsychiatric adverse events associated with use of varenicline compared with placebo in randomised controlled trials. Design Systematic review and meta-analysis comparing study effects using two summary estimates in fixed effects models, risk differences, and Peto odds ratios. Data sources Medline, Embase, PsycINFO, the Cochrane Central Register of Controlled Trials (CENTRAL), and clinicaltrials.gov. Eligibility criteria for selecting studies Randomised controlled trials with a placebo comparison group that reported on neuropsychiatric adverse events (depression, suicidal ideation, suicide attempt, suicide, insomnia, sleep disorders, abnormal dreams, somnolence, fatigue, anxiety) and death. Studies that did not involve human participants, did not use the maximum recommended dose of varenicline (1 mg twice daily), and were cross over trials were excluded. Results In the 39 randomised controlled trials (10 761 participants), there was no evidence of an increased risk of suicide or attempted suicide (odds ratio 1.67, 95% confidence interval 0.33 to 8.57), suicidal ideation (0.58, 0.28 to 1.20), depression (0.96, 0.75 to 1.22), irritability (0.98, 0.81 to 1.17), aggression (0.91, 0.52 to 1.59), or death (1.05, 0.47 to 2.38) in the varenicline users compared with placebo users. Varenicline was associated with an increased risk of sleep disorders (1.63, 1.29 to 2.07), insomnia (1.56, 1.36 to 1.78), abnormal dreams (2.38, 2.05 to 2.77), and fatigue (1.28, 1.06 to 1.55) but a reduced risk of anxiety (0.75, 0.61 to 0.93). Similar findings were observed when risk differences were reported. There was no evidence for a variation in depression and suicidal ideation by age group, sex, ethnicity, smoking status, presence or absence of psychiatric illness, and type of study sponsor (that is, pharmaceutical industry or other). Conclusions This meta-analysis found no evidence of an increased risk of suicide or attempted suicide, suicidal ideation, depression, or death with varenicline. These findings provide some reassurance for users and prescribers regarding the neuropsychiatric safety of varenicline. There was evidence that varenicline was associated with a higher risk of sleep problems such as insomnia and abnormal dreams. These side effects, however, are already well recognised. Systematic review registration PROSPERO 2014: CRD42014009224.	[Thomas, Kyla H.; Martin, Richard M.; Knipe, Duleeka W.; Higgins, Julian P. T.; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England	University of Bristol	Thomas, KH (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England.	Thomaskyla.thomas@bristol.ac.uk	Gunnell, David/ABE-6653-2020; Higgins, Julian PT/H-4008-2011	Gunnell, David/0000-0002-0829-6470; Higgins, Julian PT/0000-0002-8323-2514; Knipe, Duleeka/0000-0002-1040-7635; Thomas, Kyla/0000-0001-5418-4034; Martin, Richard/0000-0002-7992-7719	National Institute for Health Research; National Institute for Health Research [DRF-2010-03-138]; Wellcome Trust [WT099874MA]; Academy of Medical Sciences (AMS) [AMS-SGCL12-Thomas] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068, CL-2013-25-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	KHT is currently funded by a clinical lectureship from the National Institute for Health Research. Part of this work was undertaken while KHT was on a National Institute for Health Research doctoral research fellowship (DRF-2010-03-138). DWK is funded by a Wellcome Trust four year studentship (WT099874MA). DG is an NIHR senior investigator. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Allender S, 2009, TOB CONTROL, V18, P262, DOI 10.1136/tc.2008.026294; [Anonymous], 2008, SMOK CESS SERV PRIM; Anthenelli RM, 2013, ANN INTERN MED, V159, P390, DOI 10.7326/0003-4819-159-6-201309170-00005; Bolliger CT, 2011, CLIN THER, V33, P465, DOI 10.1016/j.clinthera.2011.04.013; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brandon TH, 2011, PSYCHOPHARMACOLOGY, V218, P391, DOI 10.1007/s00213-011-2327-z; Burstein AH, 2006, J CLIN PHARMACOL, V46, P1234, DOI 10.1177/0091270006291837; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Chengappa KNR, 2014, J CLIN PSYCHIAT, V75, P765, DOI 10.4088/JCP.13m08756; Cinciripini PM, 2013, JAMA PSYCHIAT, V70, P522, DOI 10.1001/jamapsychiatry.2013.678; Ebbert JO, 2011, NICOTINE TOB RES, V13, P820, DOI 10.1093/ntr/ntr078; Etter JF, 2007, ADDICTION, V102, P815, DOI 10.1111/j.1360-0443.2007.01822.x; Evins AE, 2014, JAMA-J AM MED ASSOC, V311, P145, DOI 10.1001/jama.2013.285113; Faessel H, 2009, CLIN THER, V31, P177, DOI 10.1016/j.clinthera.2009.01.003; Fagerstrom K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6549; Fatemi SH, 2013, SCHIZOPHR RES, V146, P376, DOI 10.1016/j.schres.2013.02.015; Garza D, 2011, BIOL PSYCHIAT, V69, P1075, DOI 10.1016/j.biopsych.2010.12.005; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Gonzales D, 2014, CLIN PHARMACOL THER, V96, P390, DOI 10.1038/clpt.2014.124; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong LE, 2011, ARCH GEN PSYCHIAT, V68, P1195, DOI 10.1001/archgenpsychiatry.2011.83; Huang YB, 2012, J PUBLIC HEALTH-HEID, V20, P355, DOI 10.1007/s10389-011-0476-5; Hughes JR, 2011, NICOTINE TOB RES, V13, P955, DOI 10.1093/ntr/ntr103; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kishi T, 2014, EUR ARCH PSYCHIAT CL; Litten RZ, 2013, J ADDICT MED, V7, P277, DOI 10.1097/ADM.0b013e31829623f4; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McClure EA, 2013, NICOTINE TOB RES, V15, P139, DOI 10.1093/ntr/nts101; McKee SA, 2009, BIOL PSYCHIAT, V66, P185, DOI 10.1016/j.biopsych.2009.01.029; Medicines and Healthcare Products Regulatory Agency, 2008, DRUG SAFETY UPDATE, V2, P2; Meszaros ZS, 2013, J CLIN PSYCHOPHARM, V33, P243, DOI 10.1097/JCP.0b013e3182870551; Meyer TE, 2013, ADDICTION, V108, P203, DOI 10.1111/j.1360-0443.2012.04024.x; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; Miller M, 2000, AM J EPIDEMIOL, V151, P1060, DOI 10.1093/oxfordjournals.aje.a010148; Mitchell JM, 2012, PSYCHOPHARMACOLOGY, V223, P299, DOI 10.1007/s00213-012-2717-x; Mocking RJT, 2013, NEUROPSYCHOPHARMACOL, V38, P476, DOI 10.1038/npp.2012.205; Nakamura M, 2007, CLIN THER, V29, P1040, DOI 10.1016/j.clinthera.2007.06.012; Niaura R, 2008, CURR MED RES OPIN, V24, P1931, DOI [10.1185/03007990802177523, 10.1185/03007990802177523 ]; Nides M, 2006, ARCH INTERN MED, V166, P1561, DOI 10.1001/archinte.166.15.1561; Oncken C, 2006, ARCH INTERN MED, V166, P1571, DOI 10.1001/archinte.166.15.1571; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Plebani JG, 2013, DRUG ALCOHOL DEPEN, V133, P754, DOI 10.1016/j.drugalcdep.2013.06.019; Plebani JG, 2012, DRUG ALCOHOL DEPEN, V121, P163, DOI 10.1016/j.drugalcdep.2011.08.025; Poling J, 2010, AM J ADDICTION, V19, P401, DOI 10.1111/j.1521-0391.2010.00066.x; Prescribing and Primary Care team Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Rennard S, 2012, NICOTINE TOB RES, V14, P343, DOI 10.1093/ntr/ntr220; Rigotti NA, 2010, CIRCULATION, V121, P221, DOI 10.1161/CIRCULATIONAHA.109.869008; Shim JC, 2012, NEUROPSYCHOPHARMACOL, V37, P660, DOI 10.1038/npp.2011.238; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Stein MD, 2013, DRUG ALCOHOL DEPEN, V133, P486, DOI 10.1016/j.drugalcdep.2013.07.005; Steinberg MB, 2011, ADDICT BEHAV, V36, P1127, DOI 10.1016/j.addbeh.2011.07.002; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Tashkin DP, 2011, CHEST, V139, P591, DOI 10.1378/chest.10-0865; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Thomas KH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5704; Tonnesen P, 2013, NICOTINE TOB RES, V15, P419, DOI 10.1093/ntr/nts146; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Tsai ST, 2007, CLIN THER, V29, P1027, DOI 10.1016/j.clinthera.2007.06.011; US Food and Drug Administration, 2009, FDA DRUG SAF NEWSL; Walker AM, 1996, EPIDEMIOLOGY, V7, P335; Wang C, 2009, RESPIROLOGY, V14, P384, DOI 10.1111/j.1440-1843.2008.01476.x; Weiner E, 2011, SCHIZOPHR RES, V129, P94, DOI 10.1016/j.schres.2011.02.003; Williams JM, 2012, J CLIN PSYCHIAT, V73, P654, DOI 10.4088/JCP.11m07522; Williams KE, 2007, CURR MED RES OPIN, V23, P793, DOI 10.1185/030079907X182185; Wong J, 2012, ANESTHESIOLOGY, V117, P755, DOI 10.1097/ALN.0b013e3182698b42; Zesiewicz TA, 2012, NEUROLOGY, V78, P545, DOI 10.1212/WNL.0b013e318247cc7a; Zhao QY, 2011, J CLIN PHARMACOL, V51, P492, DOI 10.1177/0091270010370461	74	93	96	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2015	350								h1109	10.1136/bmj.h1109	http://dx.doi.org/10.1136/bmj.h1109			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EQ	25767129	hybrid, Green Published			2022-12-28	WOS:000351182700001
J	Mateja, A; Paduch, M; Chang, HY; Szydlowska, A; Kossiakoff, AA; Hegde, RS; Keenan, RJ				Mateja, Agnieszka; Paduch, Marcin; Chang, Hsin-Yang; Szydlowska, Anna; Kossiakoff, Anthony A.; Hegde, Ramanujan S.; Keenan, Robert J.			Structure of the Get3 targeting factor in complex with its membrane protein cargo	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; TAIL-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; ER MEMBRANE; INSERTION; MECHANISM; BINDING; CHAPERONE	Tail-anchored (TA) proteins are a physiologically important class of membrane proteins targeted to the endoplasmic reticulum by the conserved guided-entry of TA proteins (GET) pathway. During transit, their hydrophobic transmembrane domains (TMDs) are chaperoned by the cytosolic targeting factor Get3, but the molecular nature of the functional Get3-TA protein targeting complex remains unknown. We reconstituted the physiologic assembly pathway for a functional targeting complex and showed that it comprises a TA protein bound to a Get3 homodimer. Crystal structures of Get3 bound to different TA proteins showed an alpha-helical TMD occupying a hydrophobic groove that spans the Get3 homodimer. Our data elucidate the mechanism of TA protein recognition and shielding by Get3 and suggest general principles of hydrophobic domain chaperoning by cellular targeting factors.	[Mateja, Agnieszka; Paduch, Marcin; Chang, Hsin-Yang; Szydlowska, Anna; Kossiakoff, Anthony A.; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Hegde, Ramanujan S.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	University of Chicago; MRC Laboratory Molecular Biology	Hegde, RS (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk; bkeenan@uchicago.edu		Keenan, Robert/0000-0003-1466-0889; Hegde, Ramanujan/0000-0001-8338-852X	NIH [P41 GM103403, U01 GM094588, U54 GM087519, R01 GM086487]; U.S. Department of Energy [DE-AC02-06CH11357]; UK Medical Research Council [MC_UP_A022_1007]; Searle Funds at The Chicago Community trust for the Chicago Biomedical Consortium; MRC [MC_UP_A022_1007] Funding Source: UKRI; Medical Research Council [MC_UP_A022_1007] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, P41GM103403, R01GM086487, U01GM094588] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Searle Funds at The Chicago Community trust for the Chicago Biomedical Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Shao tor help with assay development; S. Koide for the phage library; S. Sidhu for the sAB expression vector; M. Kivlen for plasmids; F. Bezanilla, E. Perozo and J. Piccirilli for instrumentation; members of the Keenan, Hegde, and Kossiakoff labs tor support; and the NE CAT (24-ID-C) beamline staff at Advanced Photon Source for technical assistance. NE-CAT is supported by NIH grant P41 GM103403 and U.S. Department of Energy contract DE-AC02-06CH11357. Additional support was from the UK Medical Research Council (MC_UP_A022_1007 to R.S.H.), the NIH (U01 GM094588 and U54 GM087519 to A.A.K.: R01 GM086487 to R.J.K.), and the Searle Funds at The Chicago Community trust for the Chicago Biomedical Consortium (to A.A.K. and R.J.K.). The Protein Data Bank (PDB) accession codes are 4XTR (Pep12), 4XVU (Nyv1), and 4XWO (Sec22).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Denic V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013334; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Gristick HB, 2014, NAT STRUCT MOL BIOL, V21, P437, DOI 10.1038/nsmb.2813; Hainzl T, 2011, NAT STRUCT MOL BIOL, V18, P389, DOI 10.1038/nsmb.1994; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Rome ME, 2014, P NATL ACAD SCI USA, V111, pE4929, DOI 10.1073/pnas.1411284111; Rome ME, 2013, P NATL ACAD SCI USA, V110, P7666, DOI 10.1073/pnas.1222054110; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Voth W, 2014, MOL CELL, V56, P116, DOI 10.1016/j.molcel.2014.08.017; Wang F, 2014, NATURE, V512, P441, DOI 10.1038/nature13471; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	29	76	76	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1152	1155		10.1126/science.1261671	http://dx.doi.org/10.1126/science.1261671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745174	Green Accepted			2022-12-28	WOS:000350354200057
J	Barnard, AS				Barnard, Amanda S.			MATERIALS SCIENCE Nanoscale locomotion without fuel	NATURE			English	Editorial Material							CARBON NANOTUBES; DRIVEN	Computer simulations have revealed a mechanism by which nanostructures of the material graphene can be driven in one direction by controlling the stiffness of the underlying substrate.	Commonwealth Sci & Ind Res Org, Virtual Nanosci Lab, Parkville, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Barnard, AS (corresponding author), Commonwealth Sci & Ind Res Org, Virtual Nanosci Lab, Parkville, Vic 3052, Australia.	amanda.barnard@csiro.au	Barnard, Amanda/A-7340-2011	Barnard, Amanda/0000-0002-4784-2382				Barreiro A, 2008, SCIENCE, V320, P775, DOI 10.1126/science.1155559; Chang TC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.015504; Dundas D, 2009, NAT NANOTECHNOL, V4, P99, DOI [10.1038/nnano.2008.411, 10.1038/NNANO.2008.411]; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Kim JH, 2013, NAT MATER, V12, P856, DOI [10.1038/NMAT3689, 10.1038/nmat3689]; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Shklyaev OE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.156803; Son K, 2013, NAT PHYS, V9, P494, DOI 10.1038/NPHYS2676; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; Zheng QS, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.045503	10	13	13	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					37	38		10.1038/519037a	http://dx.doi.org/10.1038/519037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739625				2022-12-28	WOS:000350304000027
J	Zhang, J; Zhang, XF; Huang, SJ; Wu, T; Hu, YM; Wang, ZZ; Wang, H; Jiang, HM; Wang, YJ; Yan, Q; Guo, M; Liu, XH; Li, JX; Yang, CL; Tang, Q; Jiang, RJ; Pan, HR; Li, YM; Shih, JWK; Ng, MH; Zhu, FC; Xia, NS				Zhang, Jun; Zhang, Xue-Feng; Huang, Shou-Jie; Wu, Ting; Hu, Yue-Mei; Wang, Zhong-Ze; Wang, Hua; Jiang, Han-Min; Wang, Yi-Jun; Yan, Qiang; Guo, Meng; Liu, Xiao-Hui; Li, Jing-Xin; Yang, Chang-Lin; Tang, Quan; Jiang, Ren-Jie; Pan, Hui-Rong; Li, Yi-Min; Shih, J. Wai-Kuo; Ng, Mun-Hon; Zhu, Feng-Cai; Xia, Ning-Shao			Long-Term Efficacy of a Hepatitis E Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							E VIRUS-INFECTION; DEVELOPED-COUNTRIES; VIRAL-HEPATITIS; PREGNANCY	BACKGROUND Hepatitis E virus (HEV) is a leading cause of acute hepatitis. The long-term efficacy of a hepatitis E vaccine needs to be determined. METHODS In an initial efficacy study, we randomly assigned healthy adults 16 to 65 years of age to receive three doses of either a hepatitis E vaccine (vaccine group; 56,302 participants) or a hepatitis B vaccine (control group; 56,302 participants). The vaccines were administered at 0, 1, and 6 months, and the participants were followed for 19 months. In this extended follow-up study, the treatment assignments of all participants remained double-blinded, and follow-up assessments of efficacy, immunogenicity, and safety were continued for up to 4.5 years. RESULTS During the 4.5-year study period, 60 cases of hepatitis E were identified; 7 cases were confirmed in the vaccine group (0.3 cases per 10,000 person-years), and 53 cases in the control group (2.1 cases per 10,000 person-years), representing a vaccine efficacy of 86.8% (95% confidence interval, 71 to 94) in the modified intention-to-treat analysis. Of the participants who were assessed for immunogenicity and were seronegative at baseline, 87% of those who received three doses of the hepatitis E vaccine maintained antibodies against HEV for at least 4.5 years; HEV antibody titers developed in 9% in the control group. The rate of adverse events was similar in the two groups. CONCLUSIONS Immunization with this hepatitis E vaccine induced antibodies against HEV and provided protection against hepatitis E for up to 4.5 years. (Funded by the Chinese Ministry of Science and Technology and others; ClinicalTrials.gov number, NCT01014845.)	[Zhang, Jun; Huang, Shou-Jie; Wu, Ting; Shih, J. Wai-Kuo; Ng, Mun-Hon; Xia, Ning-Shao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, State Key Lab Mol Vaccinol & Mol Diagnost, Collaborat Innovat Ctr Biol Prod,Sch Publ Hlth, Xiamen 361102, Peoples R China; [Yan, Qiang; Guo, Meng; Liu, Xiao-Hui; Pan, Hui-Rong; Li, Yi-Min] Xiamen Innovax Biotech Co, Xiamen, Peoples R China; [Zhang, Xue-Feng; Hu, Yue-Mei; Wang, Hua; Li, Jing-Xin; Zhu, Feng-Cai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Zhong-Ze; Jiang, Han-Min; Wang, Yi-Jun; Yang, Chang-Lin] Dongtai Ctr Dis Control & Prevent, Dongtai, Peoples R China; [Tang, Quan; Jiang, Ren-Jie] Yancheng Ctr Dis Control & Prevent, Yancheng, Peoples R China	Xiamen University; Jiangsu Provincial Center for Disease Control & Prevention	Zhang, J (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiangan South Rd, Xiamen 361102, Peoples R China.	zhangj@xmu.edu.cn; jszfc@vip.sina.com; nsxia@xmu.edu.cn	Wang, Yixuan/GZK-6559-2022; Hu, Yue/HGE-1673-2022; Wang, Yijun/GXW-1763-2022; wang, yixuan/GXW-2866-2022; wang, yi/GVT-8516-2022; Zhang, Jun/G-4598-2010	Zhang, Jun/0000-0002-6601-9180; Wu, Ting/0000-0002-1806-3056; Xia, Ningshao/0000-0003-0179-5266	Chinese Ministry of Science and Technology	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	Funded by the Chinese Ministry of Science and Technology and others; ClinicalTrials.gov number, NCT01014845.	Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P581; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Dalton HR, 2013, SEMIN LIVER DIS, V33, P50, DOI 10.1055/s-0033-1338114; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Kmush B, 2013, SEMIN LIVER DIS, V33, P15, DOI 10.1055/s-0033-1338111; Krain LJ, 2014, CLIN MICROBIOL REV, V27, P139, DOI 10.1128/CMR.00062-13; Labrique AB, 2012, EMERG INFECT DIS, V18, P1401, DOI 10.3201/eid1809.120241; Pischke S, 2013, J HEPATOL, V58, P1045, DOI 10.1016/j.jhep.2012.12.013; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Teshale EH, 2010, EMERG INFECT DIS, V16, P126, DOI 10.3201/eid1601.090764; VELAZQUEZ O, 1990, JAMA-J AM MED ASSOC, V263, P3281, DOI 10.1001/jama.263.24.3281; Zhang J, 2014, CLIN MICROBIOL INFEC, V20, pO397, DOI 10.1111/1469-0691.12419; Zhang J, 2013, SEMIN LIVER DIS, V33, P79, DOI 10.1055/s-0033-1338116; Zhang J, 2009, VACCINE, V27, P1869, DOI 10.1016/j.vaccine.2008.12.061; Zhu FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087154; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	25	201	226	1	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					914	922		10.1056/NEJMoa1406011	http://dx.doi.org/10.1056/NEJMoa1406011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738667				2022-12-28	WOS:000350304500007
J	Kotas, ME; Medzhitov, R				Kotas, Maya E.; Medzhitov, Ruslan			Homeostasis, Inflammation, and Disease Susceptibility	CELL			English	Review							NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; SETTLING POINTS; SET POINTS; PPAR-ALPHA; OBESITY; METABOLISM; GLUCOKINASE; EXPRESSION; PLASTICITY	While modernization has dramatically increased lifespan, it has also witnessed the increasing prevalence of diseases such as obesity, hypertension, and type 2 diabetes. Such chronic, acquired diseases result when normal physiologic control goes awry and may thus be viewed as failures of homeostasis. However, while nearly every process in human physiology relies on homeostatic mechanisms for stability, only some have demonstrated vulnerability to dysregulation. Additionally, chronic inflammation is a common accomplice of the diseases of homeostasis, yet the basis for this connection is not fully understood. Here we review the design of homeostatic systems and discuss universal features of control circuits that operate at the cellular, tissue, and organismal levels. We suggest a framework for classification of homeostatic signals that is based on different classes of homeostatic variables they report on. Finally, we discuss how adaptability of homeostatic systems with adjustable set points creates vulnerability to dysregulation and disease. This framework highlights the fundamental parallels between homeostatic and inflammatory control mechanisms and provides a new perspective on the physiological origin of inflammation.	[Kotas, Maya E.; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute; Blavatnik Family Foundation; Else Kroner-Fresenius-Stiftung award; NIH [AI046688, AI089771, CA157461, DK071754]; NIH MSTP training grant [2T32GM07205]; NATIONAL CANCER INSTITUTE [R01CA157461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089771, R37AI046688, R01AI046688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Blavatnik Family Foundation; Else Kroner-Fresenius-Stiftung award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MSTP training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Medzhitov lab and Dr. Stephen Stearns for discussions and critical reading of the manuscript. The work in the Medzhitov lab is supported by the Howard Hughes Medical Institute, Blavatnik Family Foundation, Else Kroner-Fresenius-Stiftung award, and grants from the NIH (AI046688 AI089771, CA157461, DK071754). M.E.K. was supported by the NIH MSTP training grant (2T32GM07205).	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bernard C., 1879, LECONS PHENOMENES VI, DOI 10.5962/bhl.title.1817; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; Cabanac M, 2006, J APPL PHYSIOL, V100, P1338, DOI 10.1152/japplphysiol.01021.2005; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Gluckman PD, 2009, PRINCIPLES EVOLUTION; HAMMEL HT, 1968, ANNU REV PHYSIOL, V30, P641, DOI 10.1146/annurev.ph.30.030168.003233; HARDY JD, 1954, HARVEY LECT, V49, P242; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; King JC, 2000, AM J CLIN NUTR, V71, p1218S, DOI 10.1093/ajcn/71.5.1218s; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moran TH, 2000, AM J PHYSIOL-REG I, V279, pR357, DOI 10.1152/ajpregu.2000.279.2.R357; Mrosovsky N., 1990, RHEOSTASIS PHYSL CHA; Murray R.M, 2008, FEEDBACK SYSTEMS INT; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Park C, 1999, ARCH BIOCHEM BIOPHYS, V362, P217, DOI 10.1006/abbi.1998.1004; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Power ML, 2012, PHYSIOL BEHAV, V106, P22, DOI 10.1016/j.physbeh.2011.09.011; Prabhakar NR, 2000, J APPL PHYSIOL, V88, P2287, DOI 10.1152/jappl.2000.88.6.2287; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Richter CP., 1943, HARVEY LECTURES SERI, V38, P63; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shulman G.I., 2011, MED PHYSL CELLULAR M; Speakman JR, 2011, DIS MODEL MECH, V4, P733, DOI 10.1242/dmm.008698; Stearns SC, 2008, EVOLUTION HLTH DIS; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Watve MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-61; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WIRTSHAFTER D, 1977, PHYSIOL BEHAV, V19, P75, DOI 10.1016/0031-9384(77)90162-7; Woods SC, 2007, APPETITE, V49, P388, DOI 10.1016/j.appet.2006.09.015; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	65	584	610	13	137	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					816	827		10.1016/j.cell.2015.02.010	http://dx.doi.org/10.1016/j.cell.2015.02.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723161	Bronze, Green Accepted			2022-12-28	WOS:000351116100006
J	Nandakumar, D; Patel, SS				Nandakumar, Divya; Patel, Smita S.			Finding the Right Match Fast	CELL			English	Editorial Material							HOMOLOGOUS RECOMBINATION; TIME	DNA recombinases face the daunting task of locating and pairing up specific sequences among millions of base pairs in a genome, all within about an hour. Qi et al. show that recombinases solve this problem by searching in 8-nt microhomology units, reducing the search space and accelerating the homology search.	[Nandakumar, Divya; Patel, Smita S.] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes Lane West, Princeton, NJ 08544 USA.	patelss@rutgers.edu	Nandakumar, Divya/K-6250-2014	Nandakumar, Divya/0000-0001-7672-0213	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310, R37GM051966] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055310, R37 GM051966] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Jiang LL, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022704; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; Ragunathan K, 2011, STRUCTURE, V19, P1064, DOI 10.1016/j.str.2011.06.009; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Sanchez H, 2014, DNA REPAIR, V20, P110, DOI 10.1016/j.dnarep.2014.02.012	10	3	3	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					809	811		10.1016/j.cell.2015.02.007	http://dx.doi.org/10.1016/j.cell.2015.02.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723158	Bronze			2022-12-28	WOS:000351116100003
J	Wang, AM; Promislow, DEL; Kaeberlein, M				Wang, Adrienne M.; Promislow, Daniel E. L.; Kaeberlein, Matt			Fertile Waters for Aging Research	CELL			English	Editorial Material							AGE; MORTALITY	The quest to slow aging has come far, and what used to be the domain of science fiction writers and snake oil salesmen may soon become science fact. Innovative new approaches, such as the use of the very short-lived African killifish (Harel et al.), are bridging the translational gap and bring the promise of healthy longevity to fruition.	[Wang, Adrienne M.; Promislow, Daniel E. L.; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Promislow, Daniel E. L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@uw.edu		Promislow, Daniel/0000-0001-7088-4495	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007103] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anchelin M, 2013, DIS MODEL MECH, V6, P1101, DOI 10.1242/dmm.011635; Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Tardif SD, 2011, ILAR J, V52, P54, DOI 10.1093/ilar.52.1.54; Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x; Waters DJ, 2011, ILAR J, V52, P97, DOI 10.1093/ilar.52.1.97	9	7	7	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					814	815		10.1016/j.cell.2015.02.026	http://dx.doi.org/10.1016/j.cell.2015.02.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723160	Bronze			2022-12-28	WOS:000351116100005
J	Hughes, LS; Peltz, A; Conway, PH				Hughes, Lauren S.; Peltz, Alon; Conway, Patrick H.			State Innovation Model Initiative A State-Led Approach to Accelerating Health Care System Transformation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COSTS; QUALITY		[Hughes, Lauren S.] Univ Michigan, Dept Family Med, Robert Wood Johnson Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA; [Hughes, Lauren S.; Peltz, Alon; Conway, Patrick H.] Ctr Medicare Serv, Baltimore, MD USA; [Hughes, Lauren S.; Peltz, Alon; Conway, Patrick H.] Ctr Medicaid Serv, Baltimore, MD USA; [Peltz, Alon] Boston Childrens Hosp, Boston, MA USA; [Peltz, Alon] Boston Med Ctr, Boston, MA USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Harvard University; Boston Children's Hospital; Boston Medical Center; Cincinnati Children's Hospital Medical Center	Hughes, LS (corresponding author), Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, North Campus Res Ctr, 2800 Plymouth Rd,Bldg 10,Room G016-4A, Ann Arbor, MI 48109 USA.	lshughes@umich.edu						Auerbach J, 2013, OPPORTUNITY KNOCKS P; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Pham HH, 2014, JAMA-J AM MED ASSOC, V312, P1635, DOI 10.1001/jama.2014.13109; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703; Silow-Carroll S., 2013, STATE INNOVATION MOD; Stecker EC, 2013, NEW ENGL J MED, V368, P982, DOI 10.1056/NEJMp1214141; Steinbrook R, 2012, JAMA-J AM MED ASSOC, V308, P1215, DOI 10.1001/2012.jama.11322	7	16	16	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1317	1318		10.1001/jama.2015.2017	http://dx.doi.org/10.1001/jama.2015.2017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25730488				2022-12-28	WOS:000352315900015
J	Goulson, D; Nicholls, E; Botias, C; Rotheray, EL				Goulson, Dave; Nicholls, Elizabeth; Botias, Cristina; Rotheray, Ellen L.			Bee declines driven by combined stress from parasites, pesticides, and lack of flowers	SCIENCE			English	Review							NOSEMA-CERANAE MICROSPORIDIA; PROVIDING FORAGING RESOURCES; BUMBLEBEE NEST DENSITY; WESTERN HONEY-BEE; APIS-MELLIFERA L; POLLINATION SERVICES; BOMBUS-TERRESTRIS; HYMENOPTERA APIDAE; PATHOGEN SPILLOVER; NATIVE BUMBLEBEES	Bees are subject to numerous pressures in the modern world. The abundance and diversity of flowers has declined; bees are chronically exposed to cocktails of agrochemicals, and they are simultaneously exposed to novel parasites accidentally spread by humans. Climate change is likely to exacerbate these problems in the future. Stressors do not act in isolation; for example, pesticide exposure can impair both detoxification mechanisms and immune responses, rendering bees more susceptible to parasites. It seems certain that chronic exposure to multiple interacting stressors is driving honey bee colony losses and declines of wild pollinators, but such interactions are not addressed by current regulatory procedures, and studying these interactions experimentally poses a major challenge. In the meantime, taking steps to reduce stress on bees would seem prudent; incorporating flower-rich habitat into farmland, reducing pesticide use through adopting more sustainable farming methods, and enforcing effective quarantine measures on bee movements are all practical measures that should be adopted. Effective monitoring of wild pollinator populations is urgently needed to inform management strategies into the future.	[Goulson, Dave; Nicholls, Elizabeth; Botias, Cristina; Rotheray, Ellen L.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Goulson, D (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	d.goulson@sussex.ac.uk	Botías, Cristina/L-4918-2017; Goulson, David/A-2462-2010	Botías, Cristina/0000-0002-3891-9931; Goulson, David/0000-0003-4421-2876; Nicholls, Elizabeth/0000-0002-3697-0223	BBSRC [BB/J014753/1, BB/K014579/1, BB/J014753/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014753/2, BB/K014579/1, BB/J014753/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alghamdi A, 2008, BIOL LETTERS, V4, P479, DOI 10.1098/rsbl.2008.0331; Arbetman MP, 2013, BIOL INVASIONS, V15, P489, DOI 10.1007/s10530-012-0311-0; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Aurori C. M., 2011, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies, V68, P63; Bakonyi T, 2002, APIDOLOGIE, V33, P63, DOI 10.1051/apido:2001004; Baron GL, 2014, J APPL ECOL, V51, P460, DOI 10.1111/1365-2664.12205; Bartomeus I, 2013, ECOL LETT, V16, P1331, DOI 10.1111/ele.12170; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blaauw BR, 2014, J APPL ECOL, V51, P890, DOI 10.1111/1365-2664.12257; Blackmore LM, 2014, INSECT CONSERV DIVER, V7, P480, DOI 10.1111/icad.12071; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Botias C, 2012, J INVERTEBR PATHOL, V110, P108, DOI 10.1016/j.jip.2012.02.014; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Brunner FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068181; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Chaimanee V, 2010, J INVERTEBR PATHOL, V105, P207, DOI 10.1016/j.jip.2010.06.005; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Coors A, 2008, J APPL ECOL, V45, P1820, DOI 10.1111/j.1365-2664.2008.01566.x; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3067; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3068; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3066; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Forup ML, 2005, ECOL ENTOMOL, V30, P47, DOI 10.1111/j.0307-6946.2005.00660.x; Freier Bernd, 2009, P435, DOI 10.1007/978-1-4020-8990-9_14; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garbuzov M, 2014, FUNCT ECOL, V28, P364, DOI 10.1111/1365-2435.12178; Garibaldi LA, 2014, FRONT ECOL ENVIRON, V12, P439, DOI 10.1890/130330; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Goulson Dave, 2010, P415; Goulson D, 2009, J INSECT CONSERV, V13, P177, DOI 10.1007/s10841-008-9140-y; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Gross M, 2008, CURR BIOL, V18, pR1073, DOI 10.1016/j.cub.2008.11.013; Han P, 2010, ECOTOXICOLOGY, V19, P1452, DOI 10.1007/s10646-010-0530-z; Hanley ME, 2008, FUNCT ECOL, V22, P592, DOI 10.1111/j.1365-2435.2008.01415.x; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Herrmann F, 2007, MOL ECOL, V16, P1167, DOI 10.1111/j.1365-294X.2007.03226.x; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hoffmann D, 2008, INSECT SOC, V55, P153, DOI 10.1007/s00040-008-0982-9; Holden C, 2006, SCIENCE, V314, P397, DOI 10.1126/science.314.5798.397; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Howard DC, 2003, J ENVIRON MANAGE, V67, P219, DOI 10.1016/S0301-4797(02)00175-5; Inoue MN, 2008, J INSECT CONSERV, V12, P135, DOI 10.1007/s10841-007-9071-z; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; James RR, 2012, J INVERTEBR PATHOL, V109, P175, DOI 10.1016/j.jip.2011.12.005; Jauker F, 2012, BASIC APPL ECOL, V13, P268, DOI 10.1016/j.baae.2012.03.010; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Kosior A, 2007, ORYX, V41, P79, DOI 10.1017/S0030605307001597; Kovacs-Hostyanszki A, 2013, ECOL APPL, V23, P1938, DOI 10.1890/12-2012.1; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kumar Rajesh, 2013, Journal of Entomological Research, V37, P41; Lebuhn G, 2013, CONSERV BIOL, V27, P113, DOI 10.1111/j.1523-1739.2012.01962.x; Li JL, 2012, INT J PARASITOL, V42, P49, DOI 10.1016/j.ijpara.2011.10.005; London-Shafir I, 2003, PLANT SYST EVOL, V238, P87, DOI 10.1007/s00606-003-0272-y; Mallinger RE, 2015, J APPL ECOL, V52, P323, DOI 10.1111/1365-2664.12377; Mallon EB, 2003, P ROY SOC B-BIOL SCI, V270, P2471, DOI 10.1098/rspb.2003.2456; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Martinez J, 2012, PARASITOL RES, V111, P601, DOI 10.1007/s00436-012-2875-0; Matsumura Chizuru, 2004, Global Environmental Research, V8, P51; Maurizio A., 1950, BEE WORLD, V31, P9, DOI 10.1080/0005772X.1950.11094617; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morais MM, 2013, J APICULT RES, V52, P119, DOI 10.3896/IBRA.1.52.3.01; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; Morandin LA, 2007, BASIC APPL ECOL, V8, P117, DOI 10.1016/j.baae.2006.06.003; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; National Research Council, 2007, STAT POLL N AM; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Osteen CD, 2013, PEST MANAG SCI, V69, P1001, DOI 10.1002/ps.3529; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Paradis D, 2014, ANAL BIOANAL CHEM, V406, P621, DOI 10.1007/s00216-013-7483-z; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Ploquin EF, 2013, OECOLOGIA, V173, P1649, DOI 10.1007/s00442-013-2731-7; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Pywell RF, 2005, BIOL CONSERV, V121, P479, DOI 10.1016/j.biocon.2004.05.020; Pywell RF, 2006, BIOL CONSERV, V129, P192, DOI 10.1016/j.biocon.2005.10.034; Rader R, 2012, J APPL ECOL, V49, P126, DOI 10.1111/j.1365-2664.2011.02066.x; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Riddell CE, 2006, BRAIN BEHAV IMMUN, V20, P135, DOI 10.1016/j.bbi.2005.06.008; Roberts J., 2013, RIRDC PUBL; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Roulston TH, 2000, EVOL ECOL RES, V2, P627; Rundlof M, 2008, BIOL CONSERV, V141, P417, DOI 10.1016/j.biocon.2007.10.011; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Schmid-Hempel R, 2014, J ANIM ECOL, V83, P823, DOI 10.1111/1365-2656.12185; SCHMIDT LS, 1995, J ECON ENTOMOL, V88, P1591, DOI 10.1093/jee/88.6.1591; Schmuck R, 2003, PEST MANAG SCI, V59, P279, DOI 10.1002/ps.626; Sih A, 2004, TRENDS ECOL EVOL, V19, P274, DOI 10.1016/j.tree.2004.02.010; Skorka P, 2013, BIOL CONSERV, V159, P148, DOI 10.1016/j.biocon.2012.12.028; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Spiewok S, 2006, ECOL ENTOMOL, V31, P623, DOI 10.1111/j.1365-2311.2006.00827.x; STANDIFER LN, 1967, INSECT SOC, V14, P415, DOI 10.1007/BF02223687; Stanley RG., 1974, POLLEN, DOI [10.1007/978-3-642-65905-8, DOI 10.1007/978-3-642-65905-8]; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2008, ECOLOGY, V89, P1375, DOI 10.1890/06-1323.1; Stevens S., 2014, HEAVY COSTS WEIGHING; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Thomson DM, 2006, OIKOS, V114, P407, DOI 10.1111/j.2006.0030-1299.14604.x; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tuell JK, 2010, J ECON ENTOMOL, V103, P668, DOI 10.1603/EC09314; Tyler Elizabeth R, 2006, BMC Physiol, V6, P6, DOI 10.1186/1472-6793-6-6; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; VANENGELSDORP D, 2009, J INVERTEBR IN PRESS, DOI DOI 10.1016/J.JIP.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Walther-Hellwig K, 2006, APIDOLOGIE, V37, P517, DOI 10.1051/apido:2006035; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams P, 2009, SYST BIODIVERS, V7, P101, DOI 10.1017/S1477200008002843; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Williams PH, 2014, BUMBLE BEES N AM IDE; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Willmer P, 2012, CURR BIOL, V22, pR131, DOI 10.1016/j.cub.2012.01.009; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Xie ZH, 2008, J INSECT CONSERV, V12, P695, DOI 10.1007/s10841-008-9180-3; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; YATES WDG, 1982, CAN J COMP MED, V46, P225; Yoneda M, 2008, APPL ENTOMOL ZOOL, V43, P73, DOI 10.1303/aez.2008.73	170	1911	1967	94	1785	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229							1255957	10.1126/science.1255957	http://dx.doi.org/10.1126/science.1255957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25721506				2022-12-28	WOS:000352136400030
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Drugs for Chronic Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint													Pflomm, Jean-Marie/HDO-0765-2022					Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776	2	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1052	1053		10.1001/jama.2015.1302	http://dx.doi.org/10.1001/jama.2015.1302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756443				2022-12-28	WOS:000350643100022
J	Appleby, J				Appleby, John			UK NHS: Less money (but more bangs per buck)?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J, 2009, COLD WILL IT BE PROS; Appleby J, 2010, IMPROVING NHS PRODUC; McKinsey & Company, 2009, ACH WORLD CLASS PROD; NHS England, 2014, 5 YEAR FORW VIEW; Office for National Statistics, 2012, EXP HEALTHC UK 2012; Office for National Statistics, 2015, PUBL SERV PROD EST H	6	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2015	350								h1037	10.1136/bmj.h1037	http://dx.doi.org/10.1136/bmj.h1037			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EH	25757982				2022-12-28	WOS:000351181800001
J	Standfuss, J				Standfuss, Joerg			Viral chemokine mimicry	SCIENCE			English	Editorial Material							PROTEIN-COUPLED RECEPTORS; HERPESVIRUS; BINDING; COMPLEX; ENTRY		Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland	Paul Scherrer Institute	Standfuss, J (corresponding author), Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland.	joerg.standfuss@psi.ch	Standfuss, Joerg/G-5126-2011					Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Singhal A, 2013, EMBO REP, V14, P520, DOI 10.1038/embor.2013.44; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2014, CURR MED CHEM, V21, P3594, DOI 10.2174/0929867321666140716093155; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Vischer HF, 2006, TRENDS PHARMACOL SCI, V27, P56, DOI 10.1016/j.tips.2005.11.006; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	13	7	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1071	1072		10.1126/science.aaa7998	http://dx.doi.org/10.1126/science.aaa7998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745149				2022-12-28	WOS:000350354200021
J	Sakurai, Y; Kolokoltsov, AA; Chen, CC; Tidwell, MW; Bauta, WE; Klugbauer, N; Grimm, C; Wahl-Schott, C; Biel, M; Davey, RA				Sakurai, Yasuteru; Kolokoltsov, Andrey A.; Chen, Cheng-Chang; Tidwell, Michael W.; Bauta, William E.; Klugbauer, Norbert; Grimm, Christian; Wahl-Schott, Christian; Biel, Martin; Davey, Robert A.			Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment	SCIENCE			English	Article							NIEMANN-PICK C1; NAADP; CALCIUM; INFECTION; IDENTIFICATION; TETRANDRINE; MICE	Ebola virus causes sporadic outbreaks of lethal hemorrhagic fever in humans, but there is no currently approved therapy. Cells take up Ebola virus by macropinocytosis, followed by trafficking through endosomal vesicles. However, few factors controlling endosomal virus movement are known. Here we find that Ebola virus entry into host cells requires the endosomal calcium channels called two-pore channels (TPCs). Disrupting TPC function by gene knockout, small interfering RNAs, or small-molecule inhibitors halted virus trafficking and prevented infection. Tetrandrine, the most potent small molecule that we tested, inhibited infection of human macrophages, the primary target of Ebola virus in vivo, and also showed therapeutic efficacy in mice. Therefore, TPC proteins play a key role in Ebola virus infection and may be effective targets for antiviral therapy.	[Sakurai, Yasuteru; Davey, Robert A.] Texas Biomed Res Inst, San Antonio, TX 78227 USA; [Kolokoltsov, Andrey A.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Chen, Cheng-Chang; Grimm, Christian; Wahl-Schott, Christian; Biel, Martin] Univ Munich, Ctr Drug Res, Dept Pharm, CIPSM, Munich, Germany; [Tidwell, Michael W.; Bauta, William E.] SW Res Inst, San Antonio, TX USA; [Klugbauer, Norbert] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79106 Freiburg, Germany	Texas Biomedical Research Institute; University of Texas System; University of Texas Medical Branch Galveston; University of Munich; Southwest Research Institute; University of Freiburg	Davey, RA (corresponding author), Texas Biomed Res Inst, San Antonio, TX 78227 USA.	rdavey@txbiomed.org	Wahl-Schott, Christian A/J-2623-2015; Biel, Martin/G-1175-2014; Grimm, Christian/ABF-9121-2020	Biel, Martin/0000-0002-9974-3052; Grimm, Christian/0000-0002-0177-5559; Tidwell, Michael/0000-0002-3760-8752; Davey, Robert/0000-0001-9168-2892	NIH [R01AI063513]; DOD/DTRA [HDTRA1-12-1-0002, FRBAA09-6H-2-0043]; Ewing Halsell Foundation;  [SFB TRR 152 TP04];  [SFB TRR 152 TP05];  [SFB TRR 152 TP06];  [SFB TRR 152 TP12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063513] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD/DTRA(United States Department of DefenseDefense Threat Reduction Agency); Ewing Halsell Foundation; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All BSL4 work was performed at Texas Biomedical Research Institute by Y.S. and veterinary staff. For advice about preparation of NAADP-AM, we thank G. Churchill. For guidance and use of their high-performance liquid chromatography system, we thank A. Hayhurst and L. Sherwood. We thank D. Ren (University of Pennsylvania) for guidance in using the modified patch clamp. A. Reyes and J. Bentz provided technical support. O. Shtanko and M. Anantpadma gave helpful discussions and advice. We also thank all those cited in Materials and Methods for reagents. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. R.A.D and A.A.K. are inventors on U.S. patent 8,889,743, issued 28 November 2014, entitled "Inhibition of filovirus entry into cells and uses thereof." This work was supported by NIH R01AI063513, DOD/DTRA HDTRA1-12-1-0002, Project FRBAA09-6H-2-0043, the Ewing Halsell Foundation, and SFB TRR 152 TP04, TP05, TP06, and TP12.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Arndt L, 2014, MOL BIOL CELL, V25, P948, DOI 10.1091/mbc.E13-09-0523; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Boguski MS, 2009, SCIENCE, V324, P1394, DOI 10.1126/science.1169920; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Dai CL, 2007, CANCER CHEMOTH PHARM, V60, P741, DOI 10.1007/s00280-007-0420-0; Dolnik O, 2008, CELL MOL LIFE SCI, V65, P756, DOI 10.1007/s00018-007-7406-2; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Friedrich BM, 2012, VIRUSES-BASEL, V4, P1619, DOI 10.3390/v4091619; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Gehring G, 2014, J ANTIMICROB CHEMOTH, V69, P2123, DOI 10.1093/jac/dku091; Genazzani AA, 1997, BRIT J PHARMACOL, V121, P1489, DOI 10.1038/sj.bjp.0701295; Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699; Kolokoltsov AA, 2009, DRUG DEVELOP RES, V70, P255, DOI 10.1002/ddr.20303; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Kwan CY, 2002, ACTA PHARMACOL SIN, V23, P1057; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579; Martinez O, 2010, CELL MICROBIOL, V12, P148, DOI 10.1111/j.1462-5822.2009.01385.x; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009	35	353	365	4	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					995	998		10.1126/science.1258758	http://dx.doi.org/10.1126/science.1258758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722412	Green Accepted			2022-12-28	WOS:000349958900039
J	Aeby, E; Lingner, J				Aeby, Eric; Lingner, Joachim			ALT Telomeres Get Together with Nuclear Receptors	CELL			English	Editorial Material								Nuclear receptors bind chromosome ends in "alternative lengthening of telomeres'' (ALT) cancer cells that maintain their ends by homologous recombination instead of telomerase. Marzec et al. now demonstrate that, in ALT cells, nuclear receptors not only trigger distal chromatin associations to mediate telomere-telomere recombination events, but also drive chromosome-internal targeted telomere insertions (TTI).	[Aeby, Eric; Lingner, Joachim] Ecole Polytech Fed Lausanne, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Lingner, J (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland.	joachim.lingner@epfl.ch	Aeby, Eric/A-4819-2017	Aeby, Eric/0000-0002-0463-4444; Lingner, Joachim/0000-0002-2853-5803				Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Conomos D, 2014, NAT STRUCT MOL BIOL, V21, P760, DOI 10.1038/nsmb.2877; Conomos D, 2012, J CELL BIOL, V199, P893, DOI 10.1083/jcb.201207189; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Flynn RL, 2015, SCIENCE, V347, P273, DOI 10.1126/science.1257216; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Marzec P, 2015, CELL, V160, P913, DOI 10.1016/j.cell.2015.01.044; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Pfeiffer V, 2013, EMBO J, V32, P2861, DOI 10.1038/emboj.2013.217; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498	10	2	4	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					811	813		10.1016/j.cell.2015.02.006	http://dx.doi.org/10.1016/j.cell.2015.02.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723159	Bronze			2022-12-28	WOS:000351116100004
J	Marmor, MF; Melles, RB				Marmor, Michael F.; Melles, Ronald B.			Hydroxychloroquine and the Retina	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RETINOPATHY	IMPORTANCE According to evidence-based, expert recommendations, long-term users of chloroquine or hydroxychloroquine sulfate should undergo regular visits to eye care providers and diagnostic testing to check for maculopathy. OBJECTIVE To determine whether patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) taking chloroquine or hydroxychloroquine are regularly visiting eye care providers and being screened for maculopathy. DESIGN, SETTING, AND PARTICIPANTS Patients with RA or SLE who were continuously enrolled in a particular managed care network for at least 5 years between January 1, 2001, and December 31, 2011, were studied. Patients' amount of chloroquine or hydroxychloroquine use in the 5 years since the initial RA or SLE diagnosis was calculated, along with their number of eye care visits and diagnostic tests for maculopathy. Those at high risk for maculopathy were identified. Logistic regression was performed to assess potential factors associated with regular eye care visits (annual visits in >= 3 of 5 years) among chloroquine or hydroxychloroquine users, including those at highest risk for maculopathy. MAIN OUTCOMES AND MEASURES Among chloroquine or hydroxychloroquine users and those at high risk for toxic maculopathy, the proportions with regular eye care visits and diagnostic testing, as well as the likelihood of regular eye care visits. RESULTS Among 18 051 beneficiaries with RA or SLE, 6339 (35.1%) had at least 1 record of chloroquine or hydroxychloroquine use, and 1409 (7.8%) had used chloroquine or hydroxychloroquine for at least 4 years. Among those at high risk for maculopathy, 27.9% lacked regular eye care visits, 6.1% had no visits to eye care providers, and 34.5% had no diagnostic testing for maculopathy during the 5-year period. Among high-risk patients, each additional month of chloroquine or hydroxychloroquine use was associated with a 2.0% increased likelihood of regular eye care (adjusted odds ratio, 1.02; 95% CI, 1.01-1.03). High-risk patients whose SLE or RA was managed by rheumatologists had a 77.4% increased likelihood of regular eye care (adjusted odds ratio, 1.77; 95% CI, 1.27-2.47) relative to other patients. CONCLUSIONS AND RELEVANCE In this insured population, many patients at high risk for maculopathy associated with the use of chloroquine or hydroxychloroquine are not undergoing routine monitoring for this serious adverse effect. Future studies should explore factors contributing to suboptimal adherence to expert guidelines and the potential effect on patients' vision-related outcomes.	[Marmor, Michael F.] Stanford Univ, Sch Med, Dept Ophthalmol, Byers Eye Inst, 2452 Watson Ct, Palo Alto, CA 94303 USA; [Melles, Ronald B.] Kaiser Permanente No Calif, Dept Ophthalmol, Redwood City, CA USA	Stanford University; Kaiser Permanente	Marmor, MF (corresponding author), Stanford Univ, Sch Med, Dept Ophthalmol, Byers Eye Inst, 2452 Watson Ct, Palo Alto, CA 94303 USA.	marmor@stanford.edu		Marmor, Michael/0000-0001-6057-440X; Melles, Ronald/0000-0003-1027-4083				Blyth C, 1998, BRIT MED J, V316, P716, DOI 10.1136/bmj.316.7133.716; Marmor MF, 2014, JAMA OPHTHALMOL, V132, P1105, DOI 10.1001/jamaophthalmol.2014.1099; Marmor MF, 2011, OPHTHALMOLOGY, V118, P415, DOI 10.1016/j.ophtha.2010.11.017; Melles RB, 2015, OPHTHALMOLOGY, V122, P110, DOI 10.1016/j.ophtha.2014.07.018; Melles RB, 2014, JAMA OPHTHALMOL, V132, P1453, DOI 10.1001/jamaophthalmol.2014.3459	5	11	13	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					847	+		10.1001/jama.2014.14558	http://dx.doi.org/10.1001/jama.2014.14558			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710661				2022-12-28	WOS:000349826400018
J	Van Roy, P; Daley, AC; Briggs, DEG				Van Roy, Peter; Daley, Allison C.; Briggs, Derek E. G.			Anomalocaridid trunk limb homology revealed by a giant filter-feeder with paired flaps	NATURE			English	Article							BURGESS SHALE; APPENDAGES; MORPHOLOGY; EVOLUTION; OPABINIA; AFFINITY; BRAIN	Exceptionally preserved fossils from the Palaeozoic era provide crucial insights into arthropod evolution, with recent discoveries bringing phylogeny and character homology into sharp focus(1-4). Integral to such studies are anomalocaridids, a clade of stem arthropods whose remarkable morphology illuminates early arthropod relationships(5,6) and Cambrian ecology(7-9). Although recent work has focused on the anomalocaridid head(6-10), the nature of their trunk has been debated widely(5,11-18). Here we describe new anomalocaridid(17) specimens from the Early Ordovician Fezouata Biota of Morocco(19), which not only show well-preserved head appendages providing key ecological data, but also elucidate the nature of anomalocaridid trunk flaps, resolving their homology with arthropod trunk limbs. The new material shows that each trunk segment bears a separate dorsal and ventral pair of flaps, with a series of setal blades attached at the base of the dorsal flaps. Comparisons with other stem lineage arthropods(16,20-22) indicate that anomalocaridid ventral flaps are homologous with lobopodous walking limbs and the endopod of the euarthropod biramous limb, whereas the dorsal flaps and associated setal blades are homologous with the flaps of gilled lobopodians (for example, Kerygmachela kierkegaardi, Pambdelurion whittingtoni) and exites of the 'Cambrian biramous limb'(23). This evidence shows that anomalocaridids represent a stage before the fusion of exite and endopod into the 'Cambrian biramous limb'(5,16,23), confirming their basal placement in the euarthropod stem(4-6), rather than in the arthropod crown(24) or with cycloneuralian worms(14). Unlike other anomalocaridids, the Fezouata taxon combines head appendages convergently(9) adapted for filter-feeding with an unprecedented body length exceeding 2 m, indicating a new direction in the feeding ecology of the clade. The evolution of giant filter-feeding anomalocaridids may reflect the establishment of highly developed planktic ecosystems during the Great Ordovician Biodiversification Event(25).	[Van Roy, Peter; Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Van Roy, Peter] Univ Ghent, Dept Geol & Soil Sci, Res Unit Palaeontol, B-9000 Ghent, Belgium; [Daley, Allison C.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Daley, Allison C.] Oxford Univ Museum Nat Hist, Oxford OX1 3PW, England; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA	Yale University; Ghent University; University of Oxford; University of Oxford; Yale University	Van Roy, P (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.	peter.vanroy@yale.edu	Daley, Allison/A-3117-2015	Daley, Allison/0000-0001-5369-5879; Van Roy, Peter/0000-0001-5330-8402	Biology Commission of the Research Foundation - Flanders (FWO); Swedish Research Council (Vetenskapsradet); Oxford University Museum of Natural History; National Science Foundation [EAR-1053247]; Division of Invertebrate Paleontology, YPM; Division Of Earth Sciences [1053247] Funding Source: National Science Foundation	Biology Commission of the Research Foundation - Flanders (FWO)(FWO); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Oxford University Museum of Natural History; National Science Foundation(National Science Foundation (NSF)); Division of Invertebrate Paleontology, YPM; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	M. and B. 'Ou Said' Ben Moula discovered the specimens and provided support in the field. S. Beardmore, D. Field, A. Little, R. Racicot and O. E. Tetlie assisted with fieldwork in 2011. L. Ben Moula and B. Tahiri provided practical assistance. J.-B. Caron loaned specimens of Hurdia from ROM collections. S. Butts and J. Utrup, K. Hollis and D. Erwin curated specimens and facilitated access to the collections at the YPM and USNM respectively. N. Utrup built custom cradles to support the articulated specimens. J. Vinther and P. Hull discussed filter-feeding and gigantism, and J. Lamsdell eurypterid book gills and phylogenetic methodology. E. Martin made available precise biostratigraphical data for the localities. G. Edgecombe provided unpublished observations on Cucumericrus. M. Collins discussed appendage function and prepared the digital reconstruction (Fig. 3). M. Fox advised on preparation and consolidation techniques and provided equipment. C. Graham and J. Slawski provided support and access to digital imaging facilities. The initial part of the research was done while P.V.R. was at Ghent University and in receipt of a mobility grant from the Biology Commission of the Research Foundation - Flanders (FWO). A.C.D. was financially supported by the Swedish Research Council (Vetenskapsradet) and the Oxford University Museum of Natural History. The research was supported by National Science Foundation Grant EAR-1053247 and by the Division of Invertebrate Paleontology, YPM.	BERGSTROM J, 1986, LETHAIA, V19, P241, DOI 10.1111/j.1502-3931.1986.tb00738.x; Braddy SJ, 2008, BIOL LETTERS, V4, P106, DOI 10.1098/rsbl.2007.0491; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Budd GE, 2012, LETHAIA, V45, P83, DOI 10.1111/j.1502-3931.2011.00264.x; CHEN JY, 1994, SCIENCE, V264, P1304, DOI 10.1126/science.264.5163.1304; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Cong PY, 2014, NATURE, V513, P538, DOI 10.1038/nature13486; Daley AC, 2014, J PALEONTOL, V88, P68, DOI 10.1666/13-067; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2010, PALAEONTOLOGY, V53, P721, DOI 10.1111/j.1475-4983.2010.00955.x; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Schneider Jorg W., 1998, Veroeffentlichungen Naturhistorisches Museum Schloss Bertholdsburg Schleusingen, V13, P19; Servais T, 2010, PALAEOGEOGR PALAEOCL, V294, P99, DOI 10.1016/j.palaeo.2010.05.031; Tanaka G, 2013, NATURE, V502, P364, DOI 10.1038/nature12520; Van Roy P, 2011, NATURE, V473, P510, DOI 10.1038/nature09920; Van Roy P, 2010, NATURE, V465, P215, DOI 10.1038/nature09038; Vinther J, 2014, NATURE, V507, P496, DOI 10.1038/nature13010; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096; Wolff C, 2008, P ROY SOC B-BIOL SCI, V275, P1023, DOI 10.1098/rspb.2007.1327; Yang J, 2013, NATURE, V494, P468, DOI 10.1038/nature11874; Zhang XL, 2007, LETHAIA, V40, P161, DOI 10.1111/j.1502-3931.2007.00013.x	30	106	106	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					77	U178		10.1038/nature14256	http://dx.doi.org/10.1038/nature14256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25762145				2022-12-28	WOS:000355543400032
J	Del Mastro, L; De Placido, S; Bruzzi, P; De Laurentiis, M; Boni, C; Cavazzini, G; Durando, A; Turletti, A; Nistico, C; Valle, E; Garrone, O; Puglisi, F; Montemurro, F; Barni, S; Ardizzoni, A; Gamucci, T; Colantuoni, G; Giuliano, M; Gravina, A; Papaldo, P; Bighin, C; Bisagni, G; Forestieri, V; Cognetti, F				Del Mastro, Lucia y; De Placido, Sabino; Bruzzi, Paolo; De Laurentiis, Michele; Boni, Corrado; Cavazzini, Giovanna; Durando, Antonio; Turletti, Anna; Nistico, Cecilia; Valle, Enrichetta; Garrone, Ornella; Puglisi, Fabio; Montemurro, Filippo; Barni, Sandro; Ardizzoni, Andrea; Gamucci, Teresa; Colantuoni, Giuseppe; Giuliano, Mario; Gravina, Adriano; Papaldo, Paola; Bighin, Claudia; Bisagni, Giancarlo; Forestieri, Valeria; Cognetti, Francesco		Grp Italiano Mammella GIM Investig	Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 x 2 factorial, randomised phase 3 trial	LANCET			English	Article							CLINICAL-TRIALS; METAANALYSIS; PACLITAXEL; REGIMENS; LEUKEMIA; OUTCOMES; WOMEN	Background Whether addition of fluorouracil to epirubicin, cyclophosphamide, and paclitaxel (EC-P) is favourable in adjuvant treatment of patients with node-positive breast cancer is controversial, as is the benefit of increased density of dosing. We aimed to address these questions in terms of improvements in disease-free survival. Methods In this 2 x 2 factorial, open-label, phase 3 trial, we enrolled patients aged 18-70 years with operable, node positive, early-stage breast cancer from 81 Italian centres. Eligible patients were randomly allocated in a 1: 1: 1: 1 ratio with a centralised, interactive online system to receive either dose-dense chemotherapy (administered intravenously every 2 weeks with pegfilgrastim support) with fluorouracil plus EC-P (FEC-P) or EC-P or to receive standard-interval chemotherapy (administered intravenously every 3 weeks) with FEC-P or EC-P. The primary study endpoint was disease-free survival, assessed with the Kaplan-Meier method in the intention-to-treat population. Our primary comparisons were between dose schedule (every 2 weeks vs every 3 weeks) and dose type (FEC-P vs EC-P). This study is registered with ClinicalTrials.gov, number NCT00433420. Findings Between April 24, 2003, and July 3, 2006, we recruited 2091 patients. 88 patients were enrolled in centres that only provided standard-intensity dosing. After a median follow-up of 7.0 years (interquartile range [IQR] 4.5-6.3), 140 (26%) of 545 patients given EC-P every 3 weeks, 157 (29%) of 544 patients given FEC-P every 3 weeks, 111 (22%) of 502 patients given EC-P every 2 weeks, and 113 (23%) of 500 patients given FEC-P every 2 weeks had a disease-free survival event. For the dose-density comparison, disease-free survival at 5 years was 81% (95% CI 79-84) in patients treated every 2 weeks and 76% (74-79) in patients treated every 3 weeks (HR 0.77, 95% CI 0.65-0.92; p=0.004); overall survival rates at 5 years were 94% (93-96) and 89% (87-91; HR 0.65, 0.51-0.84; p=0.001) and for the chemotherapy-type comparison, disease-free survival at 5 years was 78% (75-81) in the FEC-P groups and 79% (76-82) in the EC-P groups (HR 1.06, 0.89-1.25; p=0.561); overall survival rates at 5 years were 91% (89-93) and 92% (90-94; 1.16, 0.91-1.46; p=0.234). Compared with 3 week dosing, chemotherapy every 2 weeks was associated with increased rate of grade 3-4 of anaemia (14 [1.4%] of 988 patients vs two [0.2%] of 984 patients; p=0.002); transaminitis (19 [1.9%] vs four [0.4%]; p=0.001), and myalgias (31 [3.1%] vs 16 [1.6%]; p=0.019), and decreased rates of grade 3-4 neutropenia (147 [14.9%] vs 433 [44.0%]; p<0.0001). Addition of fluorouracil led to increased rates of grade 3-4 neutropenia (354 [34.5%] of 1025 patients on FEC-P vs 250 [24.2%] of 1032 patients on EC-P; p<0.0001), fever (nine [0.9%] vs two [0.2%]), nausea (47 [4.6%] vs 28 [2.7%]), and vomiting (32 [3.1%] vs 15 [1.4%]). Interpretation In patients with node-positive early breast cancer, dose-dense adjuvant chemotherapy improved disease-free survival compared with standard interval chemotherapy. Addition of fluorouracil to a sequential EC-P regimen was not associated with an improved disease-free survival outcome.	[Del Mastro, Lucia y; Bighin, Claudia] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Dept Med Oncol, I-16132 Genoa, Italy; [Bruzzi, Paolo] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Epidemiol Unit, I-16132 Genoa, Italy; [De Placido, Sabino; Giuliano, Mario; Forestieri, Valeria] Azienda Osped Univ Federico II, Med Oncol, Naples, Italy; [De Laurentiis, Michele; Gravina, Adriano] Ist Nazl Tumori IRCCS Fdn Pascale, Med Oncol, Naples, Italy; [Boni, Corrado; Bisagni, Giancarlo] IRCCS Arcispedale S Maria Nuova, Med Oncol, Reggio Emilia, Italy; [Cavazzini, Giovanna] Azienda Osped Carlo Poma, Med Oncol, Mantua, Italy; [Durando, Antonio] Azienda Osped Univ Citta Saute & Sci, Breast Unit, Turin, Italy; [Turletti, Anna] ASLTO1, Med Oncol, Turin, Italy; [Nistico, Cecilia; Papaldo, Paola; Cognetti, Francesco] Ist Regina Elena Studio & Cura Tumori, Dept Med Oncol, Rome, Italy; [Valle, Enrichetta] ASL8 Osped Oncol, Med Oncol, Cagliari, Italy; [Garrone, Ornella] Osped Insegnamento S Croce & Carle, Dept Med Oncol, Cuneo, Italy; [Puglisi, Fabio] Azienda Osped Udine, Dept Oncol, Udine, Italy; [Montemurro, Filippo] Fdn Piemonte Oncol Candiolo Canc Ctr IRCCS, Investigat Clin Oncol, Turin, Italy; [Barni, Sandro] Azienda Osped, Med Oncol, Bergamo, Italy; [Ardizzoni, Andrea] Azienda Osped Univ, Med Oncol, Parma, Italy; [Gamucci, Teresa] Osped SS, ASL Frosinone, Med Oncol, Sora, Frosinone, Italy; [Colantuoni, Giuseppe] Azienda Osped S Giuseppe Moscati, Med Oncol, Avellino, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; IRCCS Fondazione Pascale; IRCCS Arcispedale S. Maria Nuova; Hospital Carlo Poma; A.O.U. Citta della Salute e della Scienza di Torino; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Fondazione del Piemonte per l'Oncologia; University of Parma; University Hospital of Parma; San Giuseppe Moscati Hospital	Del Mastro, L (corresponding author), Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Dept Oncol, I-16132 Genoa, Italy.	lucia.delmastro@hsanmartino.it	Puglisi, Fabio/N-3863-2017; Garrone, Ornella/AAC-5978-2022; ardizzoni, andrea/AAC-4337-2021; Bruzzi, Paolo/AAU-3363-2021; Ferro, Antonella/AAA-8241-2020; Bisagni, Giancarlo/AAC-2735-2020; De Laurentiis, Michelino/AAC-6321-2022; Morano, Federica/B-7910-2018; Garrone, Ornella/HHS-9402-2022; Montemurro, Filippo/AAC-1957-2019; Cognetti, Francesco/AAC-2637-2019; Del Mastro, Lucia/J-6163-2016	Puglisi, Fabio/0000-0003-0573-4938; Garrone, Ornella/0000-0001-7359-5410; ardizzoni, andrea/0000-0003-2678-0714; Ferro, Antonella/0000-0003-4109-6769; Bisagni, Giancarlo/0000-0003-1042-3771; De Laurentiis, Michelino/0000-0001-9009-1572; Morano, Federica/0000-0002-5306-3596; Del Mastro, Lucia/0000-0002-9546-5841; Nistico, Cecilia/0000-0002-2379-5550; Montemurro, Filippo/0000-0003-4231-2291; DE PLACIDO, Sabino/0000-0001-5077-6286; Bruzzi, Paolo/0000-0002-7874-2077; COGNETTI, FRANCESCO/0000-0003-2022-9446; BIGHIN, Claudia/0000-0001-9956-0216; Nuzzo, Annamaria/0000-0001-7328-5877	Bristol-Myers Squibb; Pharmacia; Dompe Biotec	Bristol-Myers Squibb(Bristol-Myers Squibb); Pharmacia; Dompe Biotec	Bristol-Myers Squibb, Pharmacia, and Dompe Biotec.; We thank Marco Venturini, leader of the Gruppo Italiano Mammella (GIM) group, who left all of us too early. We thank patients, physicians, nurses, and trial coordinators who participated in the GIM2 trial. We acknowledge Giovanni Cucchiara and Carlo Panzano of Clinical Research Technology, Salerno, Italy, for clinical record online management. Simona Pastorino provided all the technical assistance and computer work for statistical analyses. The GIM group received financial support for trial conduct from Bristol-Myers Squibb and Pharmacia. Bristol-Myers Squibb provided paclitaxel and Dompe Biotech, Italy provided filgrastim.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bonilla L, 2010, JNCI-J NATL CANCER I, V102, P1845, DOI 10.1093/jnci/djq409; Budd GT, 2015, J CLIN ONCOL, V33, P58, DOI 10.1200/JCO.2014.56.3296; Cameron D, 2012, CANC RES S, V72; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hillner BE, 2012, J CLIN ONCOL, V30, P772, DOI 10.1200/JCO.2011.40.2537; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Kummel S, 2006, BRIT J CANCER, V94, P1237, DOI 10.1038/sj.bjc.6603085; Lambertini M, 2014, J CLIN ONCOL S, V32, p15s; Linden HM, 2007, J CLIN ONCOL, V25, P656, DOI 10.1200/JCO.2006.07.0847; Loibl S, 2011, SUPPORT CARE CANCER, V19, P1789, DOI 10.1007/s00520-010-1020-9; Lyman GH, 2010, J CLIN ONCOL, V28, P2914, DOI 10.1200/JCO.2009.25.8723; Moebus V, 2010, J CLIN ONCOL, V28, P2874, DOI 10.1200/JCO.2009.24.7643; *NAT CANC I, COMM TOX CRIT VERS 2; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Swain SM, 2013, J CLIN ONCOL, V31, P3197, DOI 10.1200/JCO.2012.48.1275; Venturini M, 2005, JNCI-J NATL CANCER I, V97, P1724, DOI 10.1093/jnci/dji398	22	117	117	1	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1863	1872		10.1016/S0140-6736(14)62048-1	http://dx.doi.org/10.1016/S0140-6736(14)62048-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25740286				2022-12-28	WOS:000354184500030
J	Deng, WW; Gowen, BG; Zhang, L; Wang, L; Lau, S; Iannello, A; Xu, JF; Rovis, TL; Xiong, N; Raulet, DH				Deng, Weiwen; Gowen, Benjamin G.; Zhang, Li; Wang, Lin; Lau, Stephanie; Iannello, Alexandre; Xu, Jianfeng; Rovis, Tihana L.; Xiong, Na; Raulet, David H.			A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection	SCIENCE			English	Article							IN-VIVO; EXPRESSION; NK; CYTOTOXICITY; RESPONSES; RECEPTOR; MOLECULES; EXOSOMES; RELEASE; NKP46	Immune cells, including natural killer (NK) cells, recognize transformed cells and eliminate them in a process termed immunosurveillance. It is thought that tumor cells evade immunosurveillance by shedding membrane ligands that bind to the NKG2D-activating receptor on NK cells and/or T cells, and desensitize these cells. In contrast, we show that in mice, a shed form of MULT1, a high-affinity NKG2D ligand, causes NK cell activation and tumor rejection. Recombinant soluble MULT1 stimulated tumor rejection in mice. Soluble MULT1 functions, at least in part, by competitively reversing a global desensitization of NK cells imposed by engagement of membrane NKG2D ligands on tumor-associated cells, such as myeloid cells. The results overturn conventional wisdom that soluble ligands are always inhibitory and suggest a new approach for cancer immunotherapy.	[Deng, Weiwen; Gowen, Benjamin G.; Zhang, Li; Wang, Lin; Lau, Stephanie; Iannello, Alexandre; Xu, Jianfeng; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Deng, Weiwen; Gowen, Benjamin G.; Zhang, Li; Wang, Lin; Lau, Stephanie; Iannello, Alexandre; Xu, Jianfeng; Raulet, David H.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Rovis, Tihana L.] Univ Rijeka, Fac Med, Ctr Prote, Rijeka 51000, Croatia; [Xiong, Na] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Rijeka; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@berkeley.edu	wang, lin/GSE-3040-2022; lenac rovis, tihana/C-5857-2018; wang, lili/HDL-7210-2022; wang, lin/HHM-2225-2022; Lenac Rovis, Tihana/ABB-7451-2021; Gowen, Benjamin/E-2977-2015	lenac rovis, tihana/0000-0002-3299-1334; Lenac Rovis, Tihana/0000-0002-3299-1334; Raulet, David/0000-0002-1257-8649; Gowen, Benjamin/0000-0002-1111-3284; Lau, Stephanie/0000-0003-1352-8923	Cancer Research Institute postdoctoral fellowship; National Science Foundation Graduate Research Fellowship; Hirth Chair Graduate Fellowship of University of California, Berkeley; Leukemia and Lymphoma Society Fellowships; NIH-Initiative for Maximizing Student Development grant; NIH [R01 CA093678]; NATIONAL CANCER INSTITUTE [R01CA093678] Funding Source: NIH RePORTER	Cancer Research Institute postdoctoral fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Hirth Chair Graduate Fellowship of University of California, Berkeley; Leukemia and Lymphoma Society Fellowships; NIH-Initiative for Maximizing Student Development grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Nolla and A. Valeros for help with cell sorting; C. Kang for targeting eggs for creating the Raet1 knockout mice; Q. Yan for assistance with Biacore assays; and T. Trevino, L. Bai, S. Li for technical assistance. We thank Raulet Lab members and R. Vance for useful discussion and comments on the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. D.H.R. is an inventor on a patent (U.S. 6821522) filed by University of California, Berkeley describing the use of soluble ligands for immunotherapy of cancer. W.D. was supported by a Cancer Research Institute postdoctoral fellowship. B.G.G. was supported by a National Science Foundation Graduate Research Fellowship and the Hirth Chair Graduate Fellowship of University of California, Berkeley. L.W. and A.I. were supported by Leukemia and Lymphoma Society Fellowships, and S. L. was supported by a NIH-Initiative for Maximizing Student Development grant. This work was supported by NIH grant R01 CA093678 to D.H.R.	Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Chitadze G, 2013, SCAND J IMMUNOL, V78, P120, DOI 10.1111/sji.12072; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Crane CA, 2014, P NATL ACAD SCI USA, V111, P12823, DOI 10.1073/pnas.1413933111; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Eagle RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004503; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Marten A, 2006, INT J CANCER, V119, P2359, DOI 10.1002/ijc.22186; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Nausch N, 2008, BLOOD, V112, P4080, DOI 10.1182/blood-2008-03-143776; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Sheppard S, 2013, BLOOD, V121, P5025, DOI 10.1182/blood-2012-12-471607; Song H, 2006, CELL IMMUNOL, V239, P22, DOI 10.1016/j.cellimm.2006.03.002; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; von Lilienfeld-Toal M, 2010, CANCER IMMUNOL IMMUN, V59, P829, DOI 10.1007/s00262-009-0807-3; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Xia MC, 2011, CIRCULATION, V124, P2933, DOI 10.1161/CIRCULATIONAHA.111.034850; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017	28	172	184	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					136	139		10.1126/science.1258867	http://dx.doi.org/10.1126/science.1258867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25745066	Green Accepted			2022-12-28	WOS:000352079500044
J	Hunter, DJ				Hunter, David J.			Viscosupplementation for Osteoarthritis of the Knee	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAARTICULAR HYALURONIC-ACID; RANDOMIZED CONTROLLED-TRIALS; CLINICAL-PRACTICE GUIDELINES; MOLECULAR-WEIGHT; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; UNITED-STATES; METAANALYSIS; MANAGEMENT; INJECTION	A 67-year-old woman with right-knee osteoarthritis is referred by her primary care physician for treatment of her knee pain. The patient weighs 83 kg and is 161 cm tall, and her body-mass index (the weight in kilograms divided by the square of the height in meters) is 32. She has had pain intermittently for 9 years, which has been relieved with infrequent use of naproxen. She has recently become more sedentary and is finding it increasingly difficult to play golf. A recent radiograph of her right knee reveals moderate joint-space narrowing and osteophytes, affecting primarily the medial tibiofemoral compartment and lateral patellofemoral compartment. A friend at her golf club received a hyaluronate injection and had sustained relief of her knee pain for 6 months. The patient inquires about whether this form of therapy may be appropriate for her. The specialist recommends weight loss and exercise and counsels the patient about the appropriate use of viscosupplements.	[Hunter, David J.] Royal N Shore Hosp, Dept Rheumatol, St Leonards, NSW 2065, Australia; [Hunter, David J.] Univ Sydney, Kolling Inst, Sydney, NSW 2006, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Hunter, DJ (corresponding author), Royal N Shore Hosp, Dept Rheumatol, St Leonards, NSW 2065, Australia.	david.hunter@sydney.edu.au			Abbott; Flexion; Merck Serono	Abbott(Abbott Laboratories); Flexion; Merck Serono(Merck & Company)	Dr. Hunter reports receiving fees for serving on advisory boards from Abbott, Flexion, and Merck Serono and receiving royalties from DJO Global from a license agreement related to a patellofemoral sleeve. No other potential conflict of interest relevant to this article was reported.	Access Economics, 2007, ACC EC PAINF REAL EC; Albert C, 2006, JOINT BONE SPINE, V73, P205, DOI 10.1016/j.jbspin.2005.03.005; Arrich J, 2005, CAN MED ASSOC J, V172, DOI 10.1503/cmaj.1041203; BALAZS EA, 1993, J RHEUMATOL, V20, P3; BALAZS EA, 1967, ARTHRITIS RHEUM, V10, P357, DOI 10.1002/art.1780100407; Bannuru RR, 2011, OSTEOARTHR CARTILAGE, V19, P611, DOI 10.1016/j.joca.2010.09.014; Bannuru RR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1704, DOI 10.1002/art.24925; BELLAMY N, 2005, COCHRANE DB SYST REV, V2; Bennell KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4934; Berenbaum F, 2012, ANN RHEUM DIS, V71, P1454, DOI 10.1136/annrheumdis-2011-200972; Calmbach WL, 2003, AM FAM PHYSICIAN, V68, P917; Campbell J, 2007, OSTEOARTHR CARTILAGE, V15, P1424, DOI 10.1016/j.joca.2007.01.022; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P345; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P120; Chevalier X, 2010, ANN RHEUM DIS, V69, P113, DOI 10.1136/ard.2008.094623; Conrozier T, 2008, EXPERT OPIN PHARMACO, V9, P1797, DOI [10.1517/14656566.9.10.1797, 10.1517/14656566.9.10.1797 ]; Dehaan MN, 2007, J RHEUMATOL, V34, P2099; Dunlop DD, 2001, ARTHRITIS RHEUM-US, V44, P212, DOI 10.1002/1529-0131(200101)44:1<212::AID-ANR28>3.0.CO;2-Q; Eisenberg Center at Oregon Health and Science University, 2009, 3 TREATM OST KNEE EV; Ghosh P, 2002, SEMIN ARTHRITIS RHEU, V32, P10, DOI 10.1053/sarh.2002.33720; Glazier RH, 1998, CAN MED ASSOC J, V158, P1037; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Henley B, 2008, J BONE JOINT SURG AM, V90A, P2781, DOI 10.2106/JBJS.H.00374; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hunter David J, 2007, Ann Intern Med, V147, pITC8; Hunter DJ, 2011, BEST PRACT RES CL RH, V25, P801, DOI 10.1016/j.berh.2011.11.008; Hunter DJ, 2011, BRIT J SPORT MED, V45, P283, DOI 10.1136/bjsm.2010.081117; Hunter DJ, 2011, ARTHRIT CARE RES, V63, P31, DOI 10.1002/acr.20278; Jackson DW, 2002, J BONE JOINT SURG AM, V84A, P1522, DOI 10.2106/00004623-200209000-00003; Jawad Ali S M, 2005, Am J Ther, V12, P98, DOI 10.1097/00045391-200501000-00013; Jevsevar DS, 2013, J AM ACAD ORTHOP SUR, V21, P571, DOI 10.5435/JAAOS-21-09-571; Jubb RW, 2003, INT J CLIN PRACT, V57, P467; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115; Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898; Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001; Maheu E, 2011, CLIN EXP RHEUMATOL, V29, P527; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McAlindon TE, 2012, NAT REV RHEUMATOL, V8, P635, DOI 10.1038/nrrheum.2012.152; Medina JM, 2006, J FAM PRACTICE, V55, P669; Miller LE, 2013, CLIN MED INSIGHTS-AR, V6, P57, DOI 10.4137/CMAMD.S12743; Modawal A, 2005, J FAM PRACTICE, V54, P758; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Navarro-Sarabia F, 2011, ANN RHEUM DIS, V70, P1957, DOI 10.1136/ard.2011.152017; Neogi T, 2013, RHEUM DIS CLIN N AM, V39, P1, DOI 10.1016/j.rdc.2012.10.004; Pencharz JN, 2002, ARTHRITIS RES, V4, P36, DOI 10.1186/ar381; Reichenbach S, 2007, ARTHRIT RHEUM-ARTHR, V57, P1410, DOI 10.1002/art.23103; Richmond J, 2009, J AM ACAD ORTHOP SUR, V17, P591, DOI 10.5435/00124635-200909000-00006; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Strand V, 2012, OSTEOARTHR CARTILAGE, V20, P350, DOI 10.1016/j.joca.2012.01.013; Strauss EJ, 2009, AM J SPORT MED, V37, P1636, DOI 10.1177/0363546508326984; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang CT, 2004, J BONE JOINT SURG AM, V86A, P538, DOI 10.2106/00004623-200403000-00012; Wang YY, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-195; Wind WM, 2004, J ARTHROPLASTY, V19, P858, DOI 10.1016/j.arth.2004.02.042; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	58	81	86	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					1040	1047		10.1056/NEJMct1215534	http://dx.doi.org/10.1056/NEJMct1215534			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760356				2022-12-28	WOS:000350797300008
J	Kakugawa, S; Langton, PF; Zebisch, M; Howell, SA; Chang, TH; Liu, Y; Ten, FZ; Bineva, G; O'Reilly, N; Snijders, AP; Jones, EY; Vincent, JP				Kakugawa, Satoshi; Langton, Paul F.; Zebisch, Matthias; Howell, Steven A.; Chang, Tao -Hsin; Liu, Yon; Ten Feizi; Bineva, Ganka; O'Reilly, Nicola; Snijders, Ambrosius P.; Jones, E. Yvonne; Vincent, Jean-Paul			Notum deacylates Wnt proteins to suppress signalling activity	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MORPHOGEN GRADIENT; CELL-SURFACE; DROSOPHILA; WINGLESS; HEDGEHOG; ACTIVATION; DPP; IDENTIFICATION; RECOGNITION	Signalling by Wnt proteins is finely balanced to ensure normal development and tissue homeostasis while avoiding diseases such as cancer. This is achieved in part by Notum, a highly conserved secreted feedback antagonist. Notum has been thought to act as a phospholipase, shedding glypicans and associated Wnt proteins from the cell surface. However, this view fails to explain specificity, as glypicans bind many extracellular ligands. Here we provide genetic evidence in Drosophila that Notum requires glypicans to suppress Wnt signalling, but does not cleave their glycophosphatidylinositol anchor. Structural analyses reveal glycosaminoglycan binding sites on Notum, which probably help Notum to co-localize with Wnt proteins. They also identify, at the active site of human and Drosophila Notum, a large hydrophobic pocket that accommodates palmitoleate. Kinetic and mass spectrometric analyses of human proteins show that Notum is a carboxylesterase that removes an essential palmitoleate moiety from Wnt proteins and thus constitutes the first known extracellular protein deacylase.	[Kakugawa, Satoshi; Langton, Paul F.; Howell, Steven A.; Vincent, Jean-Paul] MRCs Natl Inst Med Res, London NW7 1AA, England; [Zebisch, Matthias; Chang, Tao -Hsin; Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Liu, Yon; Ten Feizi] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England; [Bineva, Ganka; O'Reilly, Nicola] Canc Res UK, London Res Inst, London WC2A 3LY, England; [Snijders, Ambrosius P.] Canc Res UK, Clare Hall Labs, Potters Bar EN6 3LD, Herts, England	University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Cancer Research UK; Cancer Research UK	Zebisch, M (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	matthias.zebisch@evotec.com; yvonne@strubi.ox.ac.uk; jvincen@nimr.mrc.ac.uk	Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; O'Reilly, Nicola/0000-0002-4204-6491; Snijders, Bram/0000-0002-5416-8592; Bineva-Todd, Ganka/0000-0001-8926-9417; Langton, Paul/0000-0002-8895-3513; Liu, Yan/0000-0002-2566-6867; Chang, Tao-Hsin/0000-0001-7242-2585	MRC [U117584268, G0900084]; UK Research Council Basic Technology Initiative (Glycoarrays Grant) [GRS/79268]; UK Research Council Basic Technology Initiative (EPSRC Translational Grant) [EP/G037604/1]; Wellcome Trust (Biomedical Resource Grants) [WT093378MA, WT099197MA]; European Union (ERC grant WNTEXPORT) [294523]; European Union (Marie Curie IEF grant); Cancer Research UK [C375/A10976]; Japan Society for the Promotion of Science; Nuffield Department of Medicine Prize Studentship; Clarendon and Somerville College Scholarships; Wellcome Trust Centre grant [090532/Z/09/Z]; EPSRC [EP/G037604/1] Funding Source: UKRI; MRC [MC_U117584268] Funding Source: UKRI; Cancer Research UK [17721] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G037604/1] Funding Source: researchfish; Medical Research Council [MC_U117584268] Funding Source: researchfish; The Francis Crick Institute [10013, 10204, 10011, 10205] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Research Council Basic Technology Initiative (Glycoarrays Grant); UK Research Council Basic Technology Initiative (EPSRC Translational Grant); Wellcome Trust (Biomedical Resource Grants); European Union (ERC grant WNTEXPORT); European Union (Marie Curie IEF grant); Cancer Research UK(Cancer Research UK); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nuffield Department of Medicine Prize Studentship; Clarendon and Somerville College Scholarships; Wellcome Trust Centre grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We thank K. Dingwell for supplying purified mWnt3A, H. Bellen for anti-Senseless, C. Alexandre for plasmids and advice, W. Chai for glycosaminoglycan probes, T. Holder for suggestions, T. Malinauskas and C. Lorenz for advice and technical support, T. Walter for technical support with crystallization, W. Lu and Y. Zhao for help with tissue culture, and the organisers of the EMBO Wnt meeting 2012 where our collaboration began. We thank staff at Diamond Light Source beamlines (i02, i03, i04, i04-1, i24) for assistance with data collection (proposal mx8423). This work was supported by the MRC (U117584268 to J.-P.V.; G0900084 to E.Y.J.), the UK Research Council Basic Technology Initiative (Glycoarrays Grant GRS/79268 and EPSRC Translational Grant EP/G037604/1), the Wellcome Trust (Biomedical Resource Grants WT093378MA and WT099197MA) to T.F., the European Union (ERC grant WNTEXPORT; 294523 to J.-P.V., a Marie Curie IEF grant to M.Z.), Cancer Research UK (C375/A10976 to E.Y.J.), and the Japan Society for the Promotion of Science (to S.K.). T.-H. C. was funded by a Nuffield Department of Medicine Prize Studentship in conjunction with Clarendon and Somerville College Scholarships. The Wellcome Trust Centre for Human Genetics is supported by Wellcome Trust Centre grant 090532/Z/09/Z.	Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Alberts L. J, 2008, MOL BIOL CELL; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Baena-Lopez LA, 2012, CURR OPIN CELL BIOL, V24, P166, DOI 10.1016/j.ceb.2011.12.010; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Chang MV, 2008, CURR BIOL, V18, P1877, DOI 10.1016/j.cub.2008.10.047; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Orfila C, 2012, PLANTA, V236, P185, DOI 10.1007/s00425-012-1596-z; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Resh MD, 2013, CURR BIOL, V23, pR431, DOI 10.1016/j.cub.2013.04.024; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Torisu Y, 2008, CANCER SCI, V99, P1139, DOI 10.1111/j.1349-7006.2008.00814.x; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Vincent JP, 2011, DEV CELL, V21, P366, DOI 10.1016/j.devcel.2011.06.021; Whalen DM, 2013, P NATL ACAD SCI USA, V110, P16420, DOI 10.1073/pnas.1310097110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu D, 2009, FASEB J, V23, P1441, DOI 10.1096/fj.08-125286; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; You J, 2011, DEV DYNAM, V240, P640, DOI 10.1002/dvdy.22562; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	53	250	255	4	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					187	+		10.1038/nature14259	http://dx.doi.org/10.1038/nature14259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25731175	Green Submitted, Green Accepted			2022-12-28	WOS:000350770500029
J	Ngo, TTM; Zhang, QC; Zhou, RB; Yodh, JG; Ha, T				Ngo, Thuy T. M.; Zhang, Qiucen; Zhou, Ruobo; Yodh, Jaya G.; Ha, Taekjip			Asymmetric Unwrapping of Nucleosomes under Tension Directed by DNA Local Flexibility	CELL			English	Article							SINGLE-MOLECULE FRET; RNA-POLYMERASE-II; CORE PARTICLE; PAIR FRET; TRANSCRIPTION; CHROMATIN; DYNAMICS; FORCE; SEQUENCE; STABILITY	Dynamics of the nucleosome and exposure of nucleosomal DNA play key roles in many nuclear processes, but local dynamics of the nucleosome and its modulation by DNA sequence are poorly understood. Using single-molecule assays, we observed that the nucleosome can unwrap asymmetrically and directionally under force. The relative DNA flexibility of the inner quarters of nucleosomal DNA controls the unwrapping direction such that the nucleosome unwraps from the stiffer side. If the DNA flexibility is similar on two sides, it stochastically unwraps from either side. The two ends of the nucleosome are orchestrated such that the opening of one end helps to stabilize the other end, providing a mechanism to amplify even small differences in flexibility to a large asymmetry in nucleosome stability. Our discovery of DNA flexibility as a critical factor for nucleosome dynamics and mechanical stability suggests a novel mechanism of gene regulation by DNA sequence and modifications.	[Ngo, Thuy T. M.; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Zhang, Qiucen; Zhou, Ruobo; Yodh, Jaya G.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Yodh, JG (corresponding author), Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA.	jyodh@illinois.edu; tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Zhou, Ruobo/0000-0001-8628-0282	NIH [GM065367]; National Science Foundation Physics Frontiers Center program [PHY 0822613, PHY 1430124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1430124] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Physics Frontiers Center program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NIH (GM065367) and by the National Science Foundation Physics Frontiers Center program (PHY 0822613 and PHY 1430124). We thank A.J. Spakowitz for providing the energy function used for Monte Carlo simulations. T.H. is an investigator with the Howard Hughes Medical Institute.	Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Bintu L, 2011, NAT STRUCT MOL BIOL, V18, P1394, DOI 10.1038/nsmb.2164; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Koopmans WJA, 2007, J FLUORESC, V17, P785, DOI 10.1007/s10895-007-0218-9; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kruithof M, 2009, BIOPHYS J, V96, P3708, DOI [10.1016/j.bpj.2009.01.048, 10.1016/j.bpj.2009.01.04X]; Kulaeva OI, 2013, MOL BIOL+, V47, P655, DOI 10.1134/S0026893313050099; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mack AH, 2012, J MOL BIOL, V423, P687, DOI 10.1016/j.jmb.2012.08.021; Maffeo C, 2014, J CHEM THEORY COMPUT, V10, P2891, DOI 10.1021/ct500193u; Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Mirsaidov U, 2009, BIOPHYS J, V96, pL32, DOI 10.1016/j.bpj.2008.12.3760; Mollazadeh-Beidokhti L, 2012, BIOPHYS J, V102, P2235, DOI 10.1016/j.bpj.2012.04.012; Nag R, 2009, MUTAT RES-REV MUTAT, V682, P13, DOI 10.1016/j.mrrev.2009.01.002; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Richard P, 2013, NAT STRUCT MOL BIOL, V20, P1022, DOI 10.1038/nsmb.2657; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Severin PMD, 2011, NUCLEIC ACIDS RES, V39, P8740, DOI 10.1093/nar/gkr578; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Sudhanshu B, 2011, P NATL ACAD SCI USA, V108, P1885, DOI 10.1073/pnas.1010047108; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Toth K, 2013, CYTOM PART A, V83, P839, DOI 10.1002/cyto.a.22320; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Yen KY, 2013, CELL, V154, P1246, DOI 10.1016/j.cell.2013.08.043; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036; Zhou RB, 2010, METHOD ENZYMOL, V475, P405, DOI 10.1016/S0076-6879(10)75016-3	54	173	179	3	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1135	1144		10.1016/j.cell.2015.02.001	http://dx.doi.org/10.1016/j.cell.2015.02.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768909	Green Accepted, Bronze			2022-12-28	WOS:000351951800013
J	Tobie, G				Tobie, Gabriel			PLANETARY SCIENCE Enceladus' hot springs	NATURE			English	Editorial Material							PARTICLES; PLUME		Univ Nantes, CNRS, Lab Planetol & Geodynam, UMR 6112, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite	Tobie, G (corresponding author), Univ Nantes, CNRS, Lab Planetol & Geodynam, UMR 6112, Nantes, France.	gabriel.tobie@univ-nantes.fr						Hsu HW, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016488; Hsu HW, 2015, NATURE, V519, P207, DOI 10.1038/nature14262; Kelley D.S., 2005, OCEANOGRAPHY, V18, P32; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Kempf S, 2008, ICARUS, V193, P420, DOI 10.1016/j.icarus.2007.06.027; Kempf S, 2005, SCIENCE, V307, P1274, DOI 10.1126/science.1106218; Malamud U, 2013, ICARUS, V225, P763, DOI 10.1016/j.icarus.2013.04.024; McKay CP, 2014, ASTROBIOLOGY, V14, P352, DOI 10.1089/ast.2014.1158; Postberg F, 2011, NATURE, V474, P620, DOI 10.1038/nature10175; Tobie G, 2014, PLANET SPACE SCI, V104, P59, DOI 10.1016/j.pss.2014.10.002; Travis BJ, 2015, ICARUS, V250, P32, DOI 10.1016/j.icarus.2014.11.017	11	7	7	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					162	163		10.1038/519162a	http://dx.doi.org/10.1038/519162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25762276				2022-12-28	WOS:000350770500021
J	Shi, FZ; Zhang, Q; Wang, PF; Sun, HB; Wang, JR; Rong, X; Chen, M; Ju, CY; Reinhard, F; Chen, HW; Wrachtrup, J; Wang, JF; Du, JF				Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Sun, Hongbin; Wang, Jiarong; Rong, Xing; Chen, Ming; Ju, Chenyong; Reinhard, Friedemann; Chen, Hongwei; Wrachtrup, Joerg; Wang, Junfeng; Du, Jiangfeng			Single-protein spin resonance spectroscopy under ambient conditions	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SITE-DIRECTED SPIN; ELECTRON-SPIN; COHERENCE TIME; DIAMOND; RESOLUTION; SENSITIVITY	Magnetic resonance is essential in revealing the structure and dynamics of biomolecules. However, measuring the magnetic resonance spectrum of single biomolecules has remained an elusive goal. We demonstrate the detection of the electron spin resonance signal from a single spin-labeled protein under ambient conditions. As a sensor, we use a single nitrogen vacancy center in bulk diamond in close proximity to the protein. We measure the orientation of the spin label at the protein and detect the impact of protein motion on the spin label dynamics. In addition, we coherently drive the spin at the protein, which is a prerequisite for studies involving polarization of nuclear spins of the protein or detailed structure analysis of the protein itself.	[Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Rong, Xing; Chen, Ming; Ju, Chenyong; Du, Jiangfeng] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Rong, Xing; Chen, Ming; Ju, Chenyong; Du, Jiangfeng] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Rong, Xing; Chen, Ming; Ju, Chenyong; Du, Jiangfeng] Univ Sci & Technol China, Inst Biophys, Joint Lab Quantum Biophys, Hefei 230026, Peoples R China; [Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Rong, Xing; Chen, Ming; Ju, Chenyong; Du, Jiangfeng] Chinese Acad Sci, Hefei 230000, Peoples R China; [Shi, Fazhan; Wang, Pengfei; Rong, Xing; Ju, Chenyong; Du, Jiangfeng] Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Hefei 230026, Peoples R China; [Sun, Hongbin; Wang, Jiarong; Chen, Hongwei; Wang, Junfeng] Chinese Acad Sci, High Magnet Field Lab, Hefei 230000, Peoples R China; [Reinhard, Friedemann; Wrachtrup, Joerg] Univ Stuttgart, Phys & Integrated Quantum Sci & Technol IQST 3, D-70569 Stuttgart, Germany	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; University of Stuttgart	Du, JF (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	djf@ustc.edu.cn	rong, xing/N-3145-2015; Sun, Hongbin/C-9721-2015; rong, xing/T-2896-2019	rong, xing/0000-0001-8788-0896; Sun, Hongbin/0000-0002-7712-0655; rong, xing/0000-0001-8788-0896; Wang, Pengfei/0000-0001-5112-0502; Zhang, Qi/0000-0001-8889-2039; Reinhard, Friedemann/0000-0001-6273-7399	973 Program [2013CB921800, 2012CB917202]; National Natural Science Foundation of China [11227901, 91021005, 31470835, 11275183, 21103199]; Chinese Academy of Sciences; Max Planck Society; European Union (via the ERC grant SQUTEC); European Union (via the ERC grant DIADEMS); Baden-Wurttemberg Stiftung	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union (via the ERC grant SQUTEC); European Union (via the ERC grant DIADEMS); Baden-Wurttemberg Stiftung	We thank F. Jelezko for helpful discussions. Supported by 973 Program grants 2013CB921800 and 2012CB917202, National Natural Science Foundation of China grants 11227901, 91021005, 31470835, 11275183, and 21103199, and the Chinese Academy of Sciences. J.W. was supported by the Max Planck Society and the European Union (via the ERC grants SQUTEC and DIADEMS) and by the Baden-Wurttemberg Stiftung.	Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Bar-Gill N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2771; Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773; Borbat PP, 2001, SCIENCE, V291, P266, DOI 10.1126/science.291.5502.266; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; Doherty MW, 2013, PHYS REP, V528, P1, DOI 10.1016/j.physrep.2013.02.001; Gaponenko V, 2000, PROTEIN SCI, V9, P302; Grinolds MS, 2014, NAT NANOTECHNOL, V9, P279, DOI [10.1038/NNANO.2014.30, 10.1038/nnano.2014.30]; Grinolds MS, 2013, NAT PHYS, V9, P215, DOI [10.1038/NPHYS2543, 10.1038/nphys2543]; Grotz B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/055004; Hemminga M. A., 2007, ESR SPECTROSCOPY MEM, P133; Jacobsen K, 2005, BIOPHYS J, V88, P4351, DOI 10.1529/biophysj.105.059725; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; MANASSEN Y, 1989, PHYS REV LETT, V62, P2531, DOI 10.1103/PhysRevLett.62.2531; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Muller C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5703; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Schaffry M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.207210; Shi FZ, 2014, NAT PHYS, V10, P21, DOI [10.1038/NPHYS2814, 10.1038/nphys2814]; Shi FZ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195414; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Sushkov AO, 2014, NANO LETT, V14, P6443, DOI 10.1021/nl502988n; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Weil J. A., 2007, ELECT PARAMAGNETIC R, P316; Xiao M, 2004, NATURE, V430, P435, DOI 10.1038/nature02727	31	223	237	17	387	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1135	1138		10.1126/science.aaa2253	http://dx.doi.org/10.1126/science.aaa2253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745170				2022-12-28	WOS:000350354200052
J	Wu, XB; Wang, FG; Fan, XH; Yi, WM; Zuo, WW; Bian, FY; Jiang, LH; McGreer, ID; Wang, R; Yang, JY; Yang, Q; Thompson, D; Beletsky, Y				Wu, Xue-Bing; Wang, Feige; Fan, Xiaohui; Yi, Weimin; Zuo, Wenwen; Bian, Fuyan; Jiang, Linhua; McGreer, Ian D.; Wang, Ran; Yang, Jinyi; Yang, Qian; Thompson, David; Beletsky, Yuri			An ultraluminous quasar with a twelve-billion-solar-mass black hole at redshift 6.30	NATURE			English	Article							DIGITAL SKY SURVEY; Z-SIMILAR-TO-6 QUASARS; LUMINOSITY FUNCTION; DATA RELEASE; EVOLUTION; DISCOVERY; EMISSION; MASSES; SAMPLE	So far, roughly 40 quasars with redshifts greater than z = 6 have been discovered(1-8). Each quasar contains a black hole with a mass of about one billion solar masses (10(9) M-circle dot)(2,6,7,9-13). The existence of such black holes when the Universe was less than one billion years old presents substantial challenges to theories of the formation and growth of black holes and the coevolution of black holes and galaxies(14). Here we report the discovery of an ultraluminous quasar, SDSS J010013.02+280225.8, at redshift z = 6.30. It has an optical and near-infrared luminosity a few times greater than those of previously known z > 6 quasars. On the basis of the deep absorption trough(15) on the blue side of the Lyman-alpha emission line in the spectrum, we estimate the proper size of the ionized proximity zone associated with the quasar to be about 26 million light years, larger than found with other z > 6.1 quasars with lower luminosities(16). We estimate (on the basis of a near-infrared spectrum) that the black hole has a mass of similar to 1.2 x 10(10) M-circle dot, which is consistent with the 1.3 x 10(10) M-circle dot derived by assuming an Eddington-limited accretion rate.	[Wu, Xue-Bing; Wang, Feige; Yang, Jinyi; Yang, Qian] Peking Univ, Sch Phys, Dept Astron, Beijing 100871, Peoples R China; [Wu, Xue-Bing; Wang, Feige; Fan, Xiaohui; Jiang, Linhua; Wang, Ran; Yang, Jinyi; Yang, Qian] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Fan, Xiaohui; McGreer, Ian D.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Yi, Weimin] Chinese Acad Sci, Yunnan Observ, Kunming 650011, Peoples R China; [Yi, Weimin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yi, Weimin] Chinese Acad Sci, Key Lab Struct & Evolut Celestial Objects, Kunming 650011, Peoples R China; [Zuo, Wenwen] Chinese Acad Sci, Shanghai Astron Observ, Shanghai 200030, Peoples R China; [Bian, Fuyan] Australian Natl Univ, Res Sch Astron & Astrophys, Mt Stromlo Observ, Weston, ACT 2611, Australia; [Thompson, David] Univ Arizona, Large Binocular Telescope Observ, Tucson, AZ 85721 USA; [Beletsky, Yuri] Carnegie Inst Sci, Las Campanas Observ, La Serena, Chile	Peking University; Peking University; University of Arizona; Chinese Academy of Sciences; Yunnan Astronomical Observatory, NAOC, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS; Australian National University; University of Arizona; Carnegie Institution for Science	Wu, XB (corresponding author), Peking Univ, Sch Phys, Dept Astron, Beijing 100871, Peoples R China.	wuxb@pku.edu.cn	Yang, Jinyi/AAG-1344-2022; Yang, Jinyi/AFK-2958-2022; Jiang, Linhua/H-5485-2016	Jiang, Linhua/0000-0003-4176-6486; Wang, Feige/0000-0002-7633-431X; Bian, Fuyan/0000-0002-1620-0897	NSFC [11033001, 11373008, 11443002]; Strategic Priority Research Program 'The Emergence of Cosmological Structures' of the Chinese Academy of Sciences [XDB09000000]; National Key Basic Research Program of China [2014CB845700]; US NSF [AST 08-06861, AST 11-07682]; Chinese Academy of Sciences; People's Government of Yunnan Province; Strategic Priority Research Program 'The Emergence of Cosmological Structures' [XDB09000000]; National Astronomical Observatories, Chinese Academy of Sciences; Special Fund for Astronomy from the Ministry of Finance of China; Division Of Astronomical Sciences [1107682] Funding Source: National Science Foundation	NSFC(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program 'The Emergence of Cosmological Structures' of the Chinese Academy of Sciences; National Key Basic Research Program of China(National Basic Research Program of China); US NSF(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences); People's Government of Yunnan Province; Strategic Priority Research Program 'The Emergence of Cosmological Structures'; National Astronomical Observatories, Chinese Academy of Sciences(Chinese Academy of Sciences); Special Fund for Astronomy from the Ministry of Finance of China; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	X.-B.W. thanks the NSFC (grant nos 11033001 and 11373008), the Strategic Priority Research Program 'The Emergence of Cosmological Structures' of the Chinese Academy of Sciences (grant no. XDB09000000), and the National Key Basic Research Program of China (grant no. 2014CB845700) for support. X.F., R.W. and I.D.M. thank the US NSF (grant nos AST 08-06861 and AST 11-07682)for support R.W. thanks the NSFC (grant no. 11443002) for support. We acknowledge the support of the staff of the Lijiang 2.4-m telescope. Funding for the telescope was provided by the Chinese Academy of Sciences and the People's Government of Yunnan Province. This research uses data obtained through the Telescope Access Program (TAP), which has been funded by the Strategic Priority Research Program 'The Emergence of Cosmological Structures' (grant no. XDB09000000), National Astronomical Observatories, Chinese Academy of Sciences, and the Special Fund for Astronomy from the Ministry of Finance of China. We thank D. Osip for help with Magellan/FIRE spectroscopy, and Y.-L. Ai, L. C. Ho, Y. Shen and J.-G. Wang for suggestions about data analyses. We acknowledge the use of SDSS, 2MASS and WISE data, and of the MMT, LBT, Gemini and Magellan telescopes; detailed acknowledgments of these facilities can be found in Supplementary Information.	Banados E, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/1/14; Carilli CL, 2010, ASTROPHYS J, V714, P834, DOI 10.1088/0004-637X/714/1/834; De Rosa G, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/56; De Rosa G, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/145; Fan XH, 1999, ASTROPHYS J, V526, pL57, DOI 10.1086/312382; Fan XH, 2003, ASTRON J, V125, P1649, DOI 10.1086/368246; Fan XH, 2006, ANNU REV ASTRON ASTR, V44, P415, DOI 10.1146/annurev.astro.44.051905.092514; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Haiman Z, 2005, ASTROPHYS J, V623, P627, DOI 10.1086/428645; Jiang LH, 2008, ASTRON J, V135, P1057, DOI 10.1088/0004-6256/135/3/1057; Jiang LH, 2007, ASTRON J, V134, P1150, DOI 10.1086/520811; Kurk JD, 2007, ASTROPHYS J, V669, P32, DOI 10.1086/521596; McConnell NJ, 2011, NATURE, V480, P215, DOI 10.1038/nature10636; McLure RJ, 2004, MON NOT R ASTRON SOC, V352, P1390, DOI 10.1111/j.1365-2966.2004.08034.x; Mortlock DJ, 2011, NATURE, V474, P616, DOI 10.1038/nature10159; Peterson BM, 2004, ASTROPHYS J, V613, P682, DOI 10.1086/423269; Shen Y, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/45; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Venemans BP, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/24; Volonteri M, 2012, SCIENCE, V337, P544, DOI 10.1126/science.1220843; Wang R, 2008, ASTROPHYS J, V687, P848, DOI 10.1086/591076; Wang R, 2010, ASTROPHYS J, V714, P699, DOI 10.1088/0004-637X/714/1/699; Willott CJ, 2007, ASTRON J, V134, P2435, DOI 10.1086/522962; Willott CJ, 2010, ASTRON J, V140, P546, DOI 10.1088/0004-6256/140/2/546; Willott CJ, 2010, ASTRON J, V139, P906, DOI 10.1088/0004-6256/139/3/906; Willott CJ, 2003, ASTROPHYS J, V587, pL15, DOI 10.1086/375126; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Wu XB, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/2/49; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513	30	480	492	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					512	515		10.1038/nature14241	http://dx.doi.org/10.1038/nature14241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719667	Green Submitted			2022-12-28	WOS:000350097300041
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Politicians: if you love the NHS then set it free from your non-evidence based meddling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2015	350								h860	10.1136/bmj.h860	http://dx.doi.org/10.1136/bmj.h860			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3YG	25713019	Bronze			2022-12-28	WOS:000350286700015
J	Rose, S				Rose, Steven			The art of medicine 50 years of neuroscience	LANCET			English	Editorial Material									[Rose, Steven] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Rose, S (corresponding author), Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England.	S.P.R.Rose@open.ac.uk							0	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					598	599		10.1016/S0140-6736(15)60224-0	http://dx.doi.org/10.1016/S0140-6736(15)60224-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25713856				2022-12-28	WOS:000349214000017
J	Webb, JLA				Webb, James L. A., Jr.			The historical epidemiology of global disease challenges	LANCET			English	Editorial Material									Colby Coll, Dept Hist, Waterville, ME 04901 USA	Colby College	Webb, JLA (corresponding author), Colby Coll, Dept Hist, Waterville, ME 04901 USA.	jlwebb@colby.edu	Webb, James L.A./C-2789-2009					Echenberg M.J., 2011, AFRICA TIME CHOLERA; Giles-Vernick Tamara, 2013, GLOBAL HLTH AFRICA H; Webb JLA, 2013, J AFR HIST, V54, P3, DOI 10.1017/S0021853713000042	3	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					322	323		10.1016/S0140-6736(15)60108-8	http://dx.doi.org/10.1016/S0140-6736(15)60108-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ9CN	25713833	Bronze			2022-12-28	WOS:000348509000013
J	Wu, AHB				Wu, Alan H. B.			Pharmacogenomic testing and response to warfarin	LANCET			English	Editorial Material									Univ Calif San Francisco, San Francisco Gen Hosp, Lab Med, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Wu, AHB (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Lab Med, San Francisco, CA 94110 USA.	wualan@labmed2.ucsf.edu						Bristol-Myers Squibb, 2011, COUMADIN WARFARIN SO; Burnett HF, 2014, PHARMACOGENOMICS J, V14, P493, DOI 10.1038/tpj.2014.47; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Gonsalves WI, 2013, MAYO CLIN PROC, V88, P495, DOI 10.1016/j.mayocp.2013.03.006; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mega JL, 2014, LANCET; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Zineh I, 2013, NEW ENGL J MED, V369, P2273, DOI 10.1056/NEJMp1314529	10	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2231	2232		10.1016/S0140-6736(14)62219-4	http://dx.doi.org/10.1016/S0140-6736(14)62219-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25769360				2022-12-28	WOS:000355943500007
J	Wong, WF; LaVeist, TA; Sharfstein, JM				Wong, Winston F.; LaVeist, Thomas A.; Sharfstein, Joshua M.			Achieving Health Equity by Design	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Wong, Winston F.] Kaiser Permanente, Oakland, CA USA; [LaVeist, Thomas A.; Sharfstein, Joshua M.] Johns Hopkins Univ Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Kaiser Permanente; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wong, WF (corresponding author), 1 Kaiser Plaza, Oakland, CA 94612 USA.	winston.f.wong@kp.org						Andrulis DP, 2007, AM J HEALTH BEHAV, V31, pS122; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Centers for Disease Control and Prevention, 2013, CDC HLTH DISP IN REP; Cuffee YL, 2013, AM J PUBLIC HEALTH, V103, pE55, DOI 10.2105/AJPH.2013.301554; LaVeist TA, 2000, MED CARE RES REV, V57, P146, DOI 10.1177/107755800773743637; LaVeist TA, 2011, INT J HEALTH SERV, V41, P231, DOI 10.2190/HS.41.2.c; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Sharfstein JM, 2014, MILBANK Q, V92, P640, DOI 10.1111/1468-0009.12082; Victor RG, 2011, ARCH INTERN MED, V171, P342, DOI 10.1001/archinternmed.2010.390	9	34	35	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1417	1418		10.1001/jama.2015.2434	http://dx.doi.org/10.1001/jama.2015.2434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF8OK	25751310				2022-12-28	WOS:000352821200012
J	Gosvami, NN; Bares, JA; Mangolini, F; Konicek, AR; Yablon, DG; Carpick, RW				Gosvami, N. N.; Bares, J. A.; Mangolini, F.; Konicek, A. R.; Yablon, D. G.; Carpick, R. W.			Mechanisms of antiwear tribofilm growth revealed in situ by single-asperity sliding contacts	SCIENCE			English	Article							FILM FORMATION; ZINC DITHIOPHOSPHATE; REMOVAL PROCESSES; ALUMINUM-SILICON; ZDDP; ADDITIVES; WEAR; DECOMPOSITION; PERFORMANCE; HARDNESS	Zinc dialkyldithiophosphates (ZDDPs) form antiwear tribofilms at sliding interfaces and are widely used as additives in automotive lubricants. The mechanisms governing the tribofilm growth are not well understood, which limits the development of replacements that offer better performance and are less likely to degrade automobile catalytic converters over time. Using atomic force microscopy in ZDDP-containing lubricant base stock at elevated temperatures, we monitored the growth and properties of the tribofilms in situ in well-defined single-asperity sliding nanocontacts. Surface-based nucleation, growth, and thickness saturation of patchy tribofilms were observed. The growth rate increased exponentially with either applied compressive stress or temperature, consistent with a thermally activated, stress-assisted reaction rate model. Although some models rely on the presence of iron to catalyze tribofilm growth, the films grew regardless of the presence of iron on either the tip or substrate, highlighting the critical role of stress and thermal activation.	[Gosvami, N. N.; Bares, J. A.; Carpick, R. W.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Mangolini, F.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Konicek, A. R.; Yablon, D. G.] ExxonMobil Res & Engn Co, Corp Strateg Res, Annandale, NJ 08801 USA	University of Pennsylvania; University of Pennsylvania; Exxon Mobil Corporation	Carpick, RW (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.	carpick@seas.upenn.edu	Mangolini, Filippo/B-3976-2009; Gosvami, Nitya Nand/E-3199-2010; Gosvami, Nitya Nand/AAD-6202-2019; Gosvami, Nitya Nand/AAI-1984-2020	Mangolini, Filippo/0000-0003-3360-9122; Gosvami, Nitya Nand/0000-0003-4082-9887; 	Marie Curie International Outgoing Fellowship for Career Development within the 7th European Community Framework Programme [PIOF-GA-2012-328776]; Nanotechnology Institute through the Ben Franklin Technology Development Authority; University of Pennsylvania School of Engineering and Applied Sciences; NSF [CMMI-1200019]; ExxonMobil's Corporate Strategic Research laboratory	Marie Curie International Outgoing Fellowship for Career Development within the 7th European Community Framework Programme; Nanotechnology Institute through the Ben Franklin Technology Development Authority; University of Pennsylvania School of Engineering and Applied Sciences; NSF(National Science Foundation (NSF)); ExxonMobil's Corporate Strategic Research laboratory	Supported by the Marie Curie International Outgoing Fellowship for Career Development within the 7th European Community Framework Programme under contract PIOF-GA-2012-328776 (F.M.), the Nanotechnology Institute through the Ben Franklin Technology Development Authority, the University of Pennsylvania School of Engineering and Applied Sciences, and NSF grant CMMI-1200019. We thank the University of Pennsylvania Nano/Bio Interface Center Facilities and the Nanoscale Characterization Facility in the Singh Center for Nanotechnology for use of facilities, Evans Analytical Group (East Windsor, NJ) for AES measurements, ExxonMobil's Corporate Strategic Research laboratory for materials and financial support, Q. Tam for Matlab analysis, T. D. B. Jacobs for transmission electron microscopy analysis of AFM probes, and A. Jackson for helpful discussions.	Aktary M, 2002, TRIBOL LETT, V12, P155, DOI 10.1023/A:1014755123184; Aktary M, 2001, WEAR, V247, P172, DOI 10.1016/S0043-1648(00)00525-1; Barnes AM, 2001, TRIBOL INT, V34, P389, DOI 10.1016/S0301-679X(01)00028-7; Barnette AL, 2010, LANGMUIR, V26, P16299, DOI 10.1021/la101481c; Bec S, 1999, P ROY SOC A-MATH PHY, V455, P4181, DOI 10.1098/rspa.1999.0497; Berkani S, 2013, TRIBOL LETT, V51, P489, DOI 10.1007/s11249-013-0188-9; Burkinshaw M, 2012, TRIBOL INT, V46, P41, DOI 10.1016/j.triboint.2011.06.014; Equey S, 2008, TRIBOL INT, V41, P1090, DOI 10.1016/j.triboint.2008.03.004; Ferrari ES, 1999, WEAR, V236, P259, DOI 10.1016/S0043-1648(99)00286-0; Fujita H, 2005, TRIBOL T, V48, P567, DOI 10.1080/05698190500385187; Fujita H, 2005, TRIBOL T, V48, P558, DOI 10.1080/05698190500385211; Fuller MLS, 1998, TRIBOL INT, V31, P627, DOI 10.1016/S0301-679X(98)00084-X; Habeeb J, 1986, ASLE T, V30, P419, DOI 10.1080/05698198708981775; Jacobs TDB, 2013, NAT NANOTECHNOL, V8, P108, DOI [10.1038/NNANO.2012.255, 10.1038/nnano.2012.255]; Kim B, 2010, WEAR, V268, P579, DOI 10.1016/j.wear.2009.10.004; Li YR, 2008, TRIBOL LETT, V29, P201, DOI 10.1007/s11249-008-9297-2; Martin JM, 2012, FARADAY DISCUSS, V156, P311, DOI 10.1039/c2fd00126h; Martin JM, 1999, TRIBOL LETT, V6, P1, DOI 10.1023/A:1019191019134; Miklozic KT, 2007, TRIBOL T, V50, P328, DOI 10.1080/10402000701413505; Miklozic KT, 2001, TRIBOL LETT, V11, P71; Morina A, 2007, J PHYS D APPL PHYS, V40, P5476, DOI 10.1088/0022-3727/40/18/S08; Mosey NJ, 2005, SCIENCE, V307, P1612, DOI 10.1126/science.1107895; Nicholls MA, 2005, TRIBOL LETT, V18, P261, DOI 10.1007/s11249-004-2752-9; Nicholls MA, 2005, TRIBOL INT, V38, P15, DOI 10.1016/j.triboint.2004.05.009; ROUNDS F, 1993, TRIBOL T, V36, P297, DOI 10.1080/10402009308983162; Shakhvorostov D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2837809; Smith GC, 2000, J PHYS D APPL PHYS, V33, pR187, DOI 10.1088/0022-3727/33/20/201; Spikes H, 2004, TRIBOL LETT, V17, P469, DOI 10.1023/B:TRIL.0000044495.26882.b5; Spikes H, 2008, LUBR SCI, V20, P103, DOI 10.1002/ls.57; Taylor RI, 2012, FARADAY DISCUSS, V156, P361, DOI 10.1039/c2fd00122e; Vengudusamy B, 2013, TRIBOL LETT, V51, P469, DOI 10.1007/s11249-013-0185-z; Vengudusamy B, 2011, TRIBOL INT, V44, P165, DOI 10.1016/j.triboint.2010.10.023	32	313	318	18	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					102	106		10.1126/science.1258788	http://dx.doi.org/10.1126/science.1258788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25765069	Green Accepted			2022-12-28	WOS:000352079500035
J	Sadeghi, O; Zakharov, LN; Nyman, M				Sadeghi, Omid; Zakharov, Lev N.; Nyman, May			Aqueous formation and manipulation of the iron-oxo Keggin ion	SCIENCE			English	Article							NANOCRYSTALLINE MATERIAL; FERRIHYDRITE; ISOMERIZATION; SCATTERING; GROWTH; METAL; MODEL	There is emerging evidence that growth of synthetic and natural phases occurs by the aggregation of prenucleation clusters, rather than classical atom-by-atom growth. Ferrihydrite, an iron oxyhydroxide mineral, is the common form of Fe3+ in soils and is also in the ferritin protein. We isolated a 10 angstrom discrete iron-oxo cluster (known as the Keggin ion, Fe-13) that has the same structural features as ferrihydrite. The stabilization and manipulation of this highly reactive polyanion in water is controlled exclusively by its counterions. Upon dissolution of Fe-13 in water with precipitation of its protecting Bi3+-counterions, it rapidly aggregates to similar to 22 angstrom spherical ferrihydrite nanoparticles. Fe-13 may therefore also be a prenucleation cluster for ferrihydrite formation in natural systems, including by microbial and cellular processes.	[Sadeghi, Omid; Zakharov, Lev N.; Nyman, May] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Oregon State University	Nyman, M (corresponding author), Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA.	may.nyman@oregonstate.edu		Nyman, May/0000-0002-1787-0518	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0010802TDD]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award DE-SC0010802TDD. We thank B. Gilbert for valuable technical discussions and P. Eschbach and T. Sawyer for help with sample preparation and TEM imaging. All data are available in the supplementary materials.	Allouche L, 2001, J PHYS CHEM SOLIDS, V62, P1525, DOI 10.1016/S0022-3697(01)00069-5; Anderson TM, 2002, INORG CHEM, V41, P4252, DOI 10.1021/ic020224d; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Baumgartner J, 2013, NAT MATER, V12, P310, DOI [10.1038/NMAT3558, 10.1038/nmat3558]; BAUR WH, 1982, ACTA CRYSTALLOGR B, V38, P390, DOI 10.1107/S0567740882003057; Bino A, 2002, J AM CHEM SOC, V124, P4578, DOI 10.1021/ja025590a; Borch T, 2010, ENVIRON SCI TECHNOL, V44, P15, DOI 10.1021/es9026248; Dixit S, 2003, ENVIRON SCI TECHNOL, V37, P4182, DOI 10.1021/es030309t; Hansel CM, 2003, GEOCHIM COSMOCHIM AC, V67, P2977, DOI 10.1016/S0016-7037(03)00276-X; Hiemstra T, 2009, GEOCHIM COSMOCHIM AC, V73, P4423, DOI 10.1016/j.gca.2009.04.032; Janney DE, 2000, CLAY CLAY MINER, V48, P111, DOI 10.1346/CCMN.2000.0480114; JOHANSSON G, 1960, ACTA CHEM SCAND, V14, P771, DOI 10.3891/acta.chem.scand.14-0771; Keggin JF, 1934, P R SOC LOND A-CONTA, V144, P0075, DOI 10.1098/rspa.1934.0035; Legg BA, 2014, LANGMUIR, V30, P9931, DOI 10.1021/la502128d; Maillot F, 2011, GEOCHIM COSMOCHIM AC, V75, P2708, DOI 10.1016/j.gca.2011.03.011; Manceau A, 2014, AM MINERAL, V99, P102, DOI 10.2138/am.2014.4576; Michel FM, 2007, SCIENCE, V316, P1726, DOI 10.1126/science.1142525; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Nyman M, 2004, ANGEW CHEM INT EDIT, V43, P2787, DOI 10.1002/anie.200353410; Nyman M, 2012, CHEM SOC REV, V41, P7354, DOI 10.1039/c2cs35136f; Nyman M, 2011, DALTON T, V40, P8049, DOI 10.1039/c1dt10435g; Paktunc D, 2013, AM MINERAL, V98, P848, DOI 10.2138/am.2013.4312; Rancourt DG, 2008, AM MINERAL, V93, P1412, DOI 10.2138/am.2008.2782; Smart SE, 2013, CHEM COMMUN, V49, P11352, DOI 10.1039/c3cc44844d; Sudha JD, 2011, J MATER CHEM, V21, P16642, DOI 10.1039/c1jm13494a; Yuwono VM, 2010, J AM CHEM SOC, V132, P2163, DOI 10.1021/ja909769a; Zhang RT, 2000, J APPL CRYSTALLOGR, V33, P565, DOI 10.1107/S0021889800001345	27	139	140	0	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1359	1362		10.1126/science.aaa4620	http://dx.doi.org/10.1126/science.aaa4620			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25721507				2022-12-28	WOS:000351219600041
J	Bressler, B				Bressler, Brian			In ulcerative colitis, current use of thiopurines was associated with nonmelanoma skin cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE		Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Bressler, B (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.		Abbas, Ali/AAL-5189-2021	Abbas, Ali/0000-0001-6532-5015				Ariyaratnam J, 2014, AM J GASTROENTEROL, V109, P163, DOI 10.1038/ajg.2013.451; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Smith MA, 2010, ALIMENT PHARM THER, V32, P119, DOI 10.1111/j.1365-2036.2010.04330.x	3	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC12	10.7326/ACPJC-2015-162-6-012	http://dx.doi.org/10.7326/ACPJC-2015-162-6-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775343				2022-12-28	WOS:000351279600011
J	Dong, YY; Pike, ACW; Mackenzie, A; McClenaghan, C; Aryal, P; Dong, L; Quigley, A; Grieben, M; Goubin, S; Mukhopadhyay, S; Ruda, GF; Clausen, MV; Cao, LS; Brennan, PE; Burgess-Brown, NA; Sansom, MSP; Tucker, SJ; Carpenter, EP				Dong, Yin Yao; Pike, Ashley C. W.; Mackenzie, Alexandra; McClenaghan, Conor; Aryal, Prafulla; Dong, Liang; Quigley, Andrew; Grieben, Mariana; Goubin, Solenne; Mukhopadhyay, Shubhashish; Ruda, Gian Filippo; Clausen, Michael V.; Cao, Lishuang; Brennan, Paul E.; Burgess-Brown, Nicola A.; Sansom, Mark S. P.; Tucker, Stephen J.; Carpenter, Elisabeth P.			K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac	SCIENCE			English	Article							DOMAIN POTASSIUM CHANNEL; HYDROPHOBIC BARRIER; CRYSTAL-STRUCTURE; TRAAK; MEMBRANE; PORE; ACTIVATION; FLUOXETINE; GATE	TREK-2 (KCNK10/K2P10), a two-pore domain potassium (K2P) channel, is gated by multiple stimuli such as stretch, fatty acids, and pH and by several drugs. However, the mechanisms that control channel gating are unclear. Here we present crystal structures of the human TREK-2 channel (up to 3.4 angstrom resolution) in two conformations and in complex with norfluoxetine, the active metabolite of fluoxetine (Prozac) and a state-dependent blocker of TREK channels. Norfluoxetine binds within intramembrane fenestrations found in only one of these two conformations. Channel activation by arachidonic acid and mechanical stretch involves conversion between these states through movement of the pore-lining helices. These results provide an explanation for TREK channel mechanosensitivity, regulation by diverse stimuli, and possible off-target effects of the serotonin reuptake inhibitor Prozac.	[Dong, Yin Yao; Pike, Ashley C. W.; Mackenzie, Alexandra; Dong, Liang; Quigley, Andrew; Grieben, Mariana; Goubin, Solenne; Mukhopadhyay, Shubhashish; Ruda, Gian Filippo; Brennan, Paul E.; Burgess-Brown, Nicola A.; Carpenter, Elisabeth P.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Mackenzie, Alexandra; McClenaghan, Conor; Aryal, Prafulla; Clausen, Michael V.; Tucker, Stephen J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [McClenaghan, Conor; Aryal, Prafulla; Sansom, Mark S. P.; Tucker, Stephen J.; Carpenter, Elisabeth P.] Univ Oxford, OXION Initiat Ian Channels & Dis, Oxford OX1 3PN, England; [Aryal, Prafulla; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Ruda, Gian Filippo; Brennan, Paul E.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford OX3 7FZ, England; [Cao, Lishuang] Pfizer Neusentis, Cambridge CB21 6GS, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Pfizer	Tucker, SJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	stephen.tucker@physics.ox.ac.uk; liz.carpenter@sge.ox.ac.uk	Tucker, Stephen J./ABE-6741-2020; Tucker, Stephen J./ABE-7468-2020	Tucker, Stephen J./0000-0001-8996-2000; Tucker, Stephen J./0000-0001-8996-2000; Mukhopadhyay, Shubhashish M M/0000-0003-1430-5529; Pike, Ashley/0000-0001-9661-2607; Ruda, Gian Filippo/0000-0001-6150-2715; Dong, Yin/0000-0001-8600-6988; Carpenter, Liz/0000-0001-9138-2937; Quigley, Andrew/0000-0002-5022-9845; Voldsgaard Clausen, Michael/0000-0002-7176-5524; McClenaghan, Conor/0000-0002-0859-3854; Brennan, Paul/0000-0002-8950-7646	AbbVie [1097737]; Bayer; Boehringer Ingelheim; Genome Canada through Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; UK Biotechnology and Biological Sciences Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/J00037X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1104933] Funding Source: researchfish; BBSRC [BB/J00037X/1] Funding Source: UKRI	AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, Genome Canada through Ontario Genomics Institute grant OGI-055, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and Wellcome Trust grant 092809/Z/10/Z. M.S.P.S. and S.J.T. are supported by the UK Biotechnology and Biological Sciences Research Council and the Wellcome Trust. Atomic coordinates and structure factors have been deposited with the Protein Data Bank under accession codes 4XDJ (down state), 4BW5 (up state), 4XDL (Br-fluoxetine complex), and 4XDK (norfluoxetine complex). We declare no competing financial interests.	Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Aryal P, 2015, CHANNELS, V9, P44, DOI 10.4161/19336950.2014.981987; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Chemin J, 2007, PFLUG ARCH EUR J PHY, V455, P97, DOI 10.1007/s00424-007-0250-2; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Es-Salah-Lamoureux Z, 2010, TRENDS PHARMACOL SCI, V31, P587, DOI 10.1016/j.tips.2010.09.001; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Henry ME, 2005, NEUROPSYCHOPHARMACOL, V30, P1576, DOI 10.1038/sj.npp.1300749; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Teng JF, 2015, PFLUG ARCH EUR J PHY, V467, P27, DOI 10.1007/s00424-014-1530-2; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	28	188	188	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1256	1259		10.1126/science.1261512	http://dx.doi.org/10.1126/science.1261512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766236	Green Submitted, Green Accepted			2022-12-28	WOS:000350824300040
J	Gill, S; Le, HD; Melkani, GC; Panda, S				Gill, Shubhroz; Le, Hiep D.; Melkani, Girish C.; Panda, Satchidananda			Time-restricted feeding attenuates age-related cardiac decline in Drosophila	SCIENCE			English	Article							HEART FUNCTION; DYSFUNCTION; PATHWAY; SLEEP	Circadian clocks orchestrate periods of rest or activity and feeding or fasting over the course of a 24-hour day and maintain homeostasis. To assess whether a consolidated 24-hour cycle of feeding and fasting can sustain health, we explored the effect of time-restricted feeding (TRF; food access limited to daytime 12 hours every day) on neural, peripheral, and cardiovascular physiology in Drosophila melanogaster. We detected improved sleep, prevention of body weight gain, and deceleration of cardiac aging under TRF, even when caloric intake and activity were unchanged. We used temporal gene expression profiling and validation through classical genetics to identify the TCP-1 ring complex (TRiC) chaperonin, the mitochondrial electron transport chain complexes, and the circadian clock as pathways mediating the benefits of TRF.	[Gill, Shubhroz; Le, Hiep D.; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Gill, Shubhroz] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA; [Melkani, Girish C.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Melkani, Girish C.] San Diego State Univ, Dept Mol Biol, San Diego, CA 92182 USA; [Melkani, Girish C.] San Diego State Univ, Inst Heart, San Diego, CA 92182 USA	Salk Institute; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Melkani, GC (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	gmelkani@mail.sdsu.edu; satchin@salk.edu		Melkani, Girish/0000-0003-0353-4633	NIH [DK091618, EY016807, NS066457, RR032100, P30 CA014195, P30 EY019005]; American Federation for Aging Research [M14322]; American Heart Association [13BGIA17260057]; H.A. and Mary K. Chapman Trust; Aginsky Research Scholar Award; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Glenn Center for Aging; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR032100] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016807, P30EY019005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066457] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; American Heart Association(American Heart Association); H.A. and Mary K. Chapman Trust; Aginsky Research Scholar Award; Leona M. and Harry B. Helmsley Charitable Trust; Glenn Center for Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Vienna Drosophila RNAi Center, Bloomington Stock Center, and P. Hardin for fly strains; R. Bodmer and K. Ocorr for use of Drosophila heart analysis setup; S. Bernstein for use of the lab facility; and M. Ku and C. Benner for RNA sequencing and bioinformatics. This work was partially supported by NIH grants DK091618, EY016807, and NS066457 and American Federation for Aging Research grant M14322 to S. P. and by NIH grant RR032100 and American Heart Association grant 13BGIA17260057 to G.C.M. S.G. was supported by the H.A. and Mary K. Chapman Trust, an Aginsky Research Scholar Award, and Leona M. and Harry B. Helmsley Charitable Trust grant 2012-PG-MED002. Additional support came from NIH P30 CA014195, P30 EY019005, and the Glenn Center for Aging. We declare no conflicting interests.	Antosh M, 2011, CELL CYCLE, V10, P904, DOI 10.4161/cc.10.6.14912; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Birse RT, 2011, CRIT REV BIOCHEM MOL, V46, P376, DOI 10.3109/10409238.2011.599830; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; Farhadian SF, 2012, PHYSIOL BEHAV, V105, P544, DOI 10.1016/j.physbeh.2011.09.007; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476	13	161	162	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1265	1269		10.1126/science.1256682	http://dx.doi.org/10.1126/science.1256682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766238	Green Accepted			2022-12-28	WOS:000350824300042
J	Chen, SD; Sanjana, NE; Zheng, KJ; Shalem, O; Lee, K; Shi, X; Scott, DA; Song, J; Pan, JQ; Weissleder, R; Lee, H; Zhang, F; Sharp, PA				Chen, Sidi; Sanjana, Neville E.; Zheng, Kaijie; Shalem, Ophir; Lee, Kyungheon; Shi, Xi; Scott, David A.; Song, Jun; Pan, Jen Q.; Weissleder, Ralph; Lee, Hakho; Zhang, Feng; Sharp, Phillip A.			Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis	CELL			English	Article							CANCER; CELLS; RNA; IMMUNITY; PROVIDES; PROLIFERATION; METHYLATION; PROGRESSION; SUPPRESSES; MICRORNA	Genetic screens are powerful tools for identifying genes responsible for diverse phenotypes. Here we describe a genome-wide CRISPR/Cas9-mediated loss-of-function screen in tumor growth and metastasis. We mutagenized a non-metastatic mouse cancer cell line using a genome-scale library with 67,405 single-guide RNAs (sgRNAs). The mutant cell pool rapidly generates metastases when transplanted into immunocompromised mice. Enriched sgRNAs in lung metastases and late-stage primary tumors were found to target a small set of genes, suggesting that specific loss-of-function mutations drive tumor growth and metastasis. Individual sgRNAs and a small pool of 624 sgRNAs targeting the top-scoring genes from the primary screen dramatically accelerate metastasis. In all of these experiments, the effect of mutations on primary tumor growth positively correlates with the development of metastases. Our study demonstrates Cas9-based screening as a robust method to systematically assay gene phenotypes in cancer evolution in vivo.	[Chen, Sidi; Sharp, Phillip A.] David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Sidi; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Chen, Sidi; Sanjana, Neville E.; Zheng, Kaijie; Shalem, Ophir; Shi, Xi; Scott, David A.; Pan, Jen Q.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sanjana, Neville E.; Zheng, Kaijie; Shalem, Ophir; Shi, Xi; Scott, David A.; Pan, Jen Q.; Zhang, Feng] Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Sanjana, Neville E.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Sanjana, Neville E.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Sanjana, Neville E.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lee, Kyungheon; Song, Jun; Weissleder, Ralph; Lee, Hakho] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org; sharppa@mit.edu	Lee, Kyungheon/E-3863-2013; Macrae, Rhiannon/AAX-1536-2020; CHEN, SIDI/D-8284-2016	CHEN, SIDI/0000-0002-3819-5005; Sanjana, Neville/0000-0002-1504-0027; Shalem, Ophir/0000-0002-2267-0801; /0000-0003-0828-4143	United States Public Health Service from the NIH [R01-CA133404]; MIT-Harvard Center for Cancer Nanotechnology Excellence from the National Cancer Institute [U54 CA151884]; Skolkovo Foundation; Koch Institute from the National Cancer Institute [P30-CA14051]; NIH through NIMH [5DP1-MH100706]; NIDDK [5R01-DK097768]; National Science Foundation; Keck foundation; New York Stem Cell foundation; Damon Runyon foundation; Searle Scholars foundation; Merkin foundation; Vallee foundation; Bob Metcalfe; Dale Frey Award for Breakthrough Scientists; Simons Center for the Social Brain Postdoctoral Fellowship; NIH NHGRI [K99-HG008171]; NIH [U54 CA151884]; NSF; Department of Defense [OCRP W81XWH-14-1-0279]; NATIONAL CANCER INSTITUTE [U54CA151884, P01CA042063, P30CA014051, R01CA133404] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	United States Public Health Service from the NIH; MIT-Harvard Center for Cancer Nanotechnology Excellence from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skolkovo Foundation; Koch Institute from the National Cancer Institute; NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); Keck foundation(W.M. Keck Foundation); New York Stem Cell foundation; Damon Runyon foundation; Searle Scholars foundation; Merkin foundation; Vallee foundation; Bob Metcalfe; Dale Frey Award for Breakthrough Scientists; Simons Center for the Social Brain Postdoctoral Fellowship; NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Weinberg and R. Kerbel for critically reading the manuscript; the entire P.A.S. lab and F.Z. lab, L. Cong, T. Kelly, X. Ni, M. Nobel, J. Boehm, A. Tsherniak, S. Levine, M. Cornwall-Brady, S. Malstrom, M. Jennings, E. Vasile, C. Whittaker, K. Cormier, R. Bronson, and colleagues at the Koch Institute, Broad Institute, McGovern Institute, and Department of Biology for technical assistance and/or discussion; the Swanson Biotechnology Center for technical support (Genomics, Animal Imaging and Preclinical Testing, Bioinformatics and Computing, Microscopy, Flow Cytometry, Microscopy, and Histology, in particular). This work is supported by grants to P.A.S., including a United States Public Health Service grant R01-CA133404 from the NIH, an MIT-Harvard Center for Cancer Nanotechnology Excellence Grant U54 CA151884 from the National Cancer Institute, a generous gift from the Marie D. and Pierre Casimir-Lambert Fund, an SkTech/MIT Initiative Grant from the Skolkovo Foundation, and the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. F.Z. is supported by the NIH through NIMH grant 5DP1-MH100706) and NIDDK grant 5R01-DK097768; a Waterman Award from the National Science Foundation; the Keck, New York Stem Cell, Damon Runyon, Searle Scholars, Merkin, and Vallee foundations; and Bob Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. S. C. is a Damon Runyon Cancer Research Fellow (DRG-2117-12) and also supported by the Dale Frey Award for Breakthrough Scientists. N.E.S. is supported by a Simons Center for the Social Brain Postdoctoral Fellowship and NIH NHGRI award K99-HG008171. O.S. is a fellow of the Klarman Cell Observatory. R.W. is supported by NIH grant U54 CA151884. D. A. S. is supported by a NSF Graduate Research Fellowship. H.L. is supported by Department of Defense grant OCRP W81XWH-14-1-0279. CRISPR reagents (plasmids and libraries) are available to the academic community through Addgene. F.Z. is a co-founder of Editas Medicine and a scientific advisor for Editas Medicine and Horizon Discovery.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen SD, 2014, GENE DEV, V28, P1054, DOI 10.1101/gad.239681.114; Cheng ZS, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.51; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heimann R, 1998, J CLIN ONCOL, V16, P2686, DOI 10.1200/JCO.1998.16.8.2686; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jesien-Lewandowicz E, 2009, CANCER GENET CYTOGEN, V188, P77, DOI 10.1016/j.cancergencyto.2008.09.015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaczmarczyk G, 2012, WSPOLCZESNA ONKOL, V16, P322, DOI 10.5114/wo.2012.30061; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; KORCZAK B, 1988, MOL CELL BIOL, V8, P3143, DOI 10.1128/MCB.8.8.3143; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schiano C, 2014, BBA-REV CANCER, V1845, P66, DOI 10.1016/j.bbcan.2013.12.001; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Tang JT, 2011, CARCINOGENESIS, V32, P1207, DOI 10.1093/carcin/bgr114; TANO K, 1990, P NATL ACAD SCI USA, V87, P686, DOI 10.1073/pnas.87.2.686; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; WAGHORNE C, 1988, CANCER RES, V48, P6109; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weinberg R, 2007, BIOL CANC GARLAND SC; Yokota J, 2003, CLIN EXP METASTAS, V20, P189, DOI 10.1023/A:1022978932215; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	51	514	624	21	327	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1246	1260		10.1016/j.cell.2015.02.038	http://dx.doi.org/10.1016/j.cell.2015.02.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25748654	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000351951800022
J	Wang, YM; Cella, M; Mallinson, K; Ulrich, JD; Young, KL; Robinette, ML; Gilfillan, S; Krishnan, GM; Sudhakar, S; Zinselmeyer, BH; Holtzman, DM; Cirrito, JR; Colonna, M				Wang, Yaming; Cella, Marina; Mallinson, Kaitlin; Ulrich, Jason D.; Young, Katherine L.; Robinette, Michelle L.; Gilfillan, Susan; Krishnan, Gokul M.; Sudhakar, Shwetha; Zinselmeyer, Bernd H.; Holtzman, David M.; Cirrito, John R.; Colonna, Marco			TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model	CELL			English	Article							AMYLOID PLAQUES; NEURON LOSS; BETA; CELLS; DAP12; MUTATIONS; NEURODEGENERATION; ACCUMULATION; PHAGOCYTOSIS; INFLAMMATION	Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial surface receptor that triggers intracellular protein tyrosine phosphorylation. Recent genome-wide association studies have shown that a rare R47H mutation of TREM2 correlates with a substantial increase in the risk of developing Alzheimer's disease (AD). To address the basis for this genetic association, we studied TREM2 deficiency in the 5XFAD mouse model of AD. We found that TREM2 deficiency and haploinsufficiency augment beta-amyloid (A beta) accumulation due to a dysfunctional response of microglia, which fail to cluster around Ab plaques and become apoptotic. We further demonstrate that TREM2 senses a broad array of anionic and zwitterionic lipids known to associate with fibrillar Ab in lipid membranes and to be exposed on the surface of damaged neurons. Remarkably, the R47H mutation impairs TREM2 detection of lipid ligands. Thus, TREM2 detects damage-associated lipid patterns associated with neurodegeneration, sustaining the microglial response to Ab accumulation.	[Wang, Yaming; Cella, Marina; Robinette, Michelle L.; Gilfillan, Susan; Krishnan, Gokul M.; Zinselmeyer, Bernd H.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Mallinson, Kaitlin; Ulrich, Jason D.; Young, Katherine L.; Sudhakar, Shwetha; Holtzman, David M.; Cirrito, John R.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Mallinson, Kaitlin; Ulrich, Jason D.; Young, Katherine L.; Sudhakar, Shwetha; Holtzman, David M.; Cirrito, John R.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Mallinson, Kaitlin; Ulrich, Jason D.; Young, Katherine L.; Sudhakar, Shwetha; Holtzman, David M.; Cirrito, John R.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Wang, Yaming] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Eli Lilly	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Wang, Yaming/GNW-3745-2022; Cella, Marina/ABA-8564-2020; Zinselmeyer, Bernd/X-4802-2018	Colonna, Marco/0000-0001-5222-4987; Zinselmeyer, Bernd/0000-0003-4172-6767; Cella, Marina/0000-0003-1230-1313	Lilly Innovation Fellowship; DDRCC [P30 DK52574]; National Multiple Sclerosis Society [RG4687A1/1]; Knight Alzheimer's Disease Research Center pilot grant [P50 AG005681-30]; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	Lilly Innovation Fellowship; DDRCC; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Knight Alzheimer's Disease Research Center pilot grant; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Genome Technology Access Center (Washington University School of Medicine) for assistance with microarray analysis. We thank S. Raju (Washington University School of Medicine) for assistance with live imaging. We thank R.B. DeMattos, J.D. Sedgewick, and A.P. Martin (Eli Lilly and Company) for helpful suggestions and critical comments. Y.W. is supported by the Lilly Innovation Fellowship Award. B.H.Z. is supported by DDRCC grant P30 DK52574. M. Cella is supported by grant RG4687A1/1 from National Multiple Sclerosis Society. M. Colonna is supported by the Knight Alzheimer's Disease Research Center pilot grant P50 AG005681-30 and the Cure Alzheimer's Fund. Y.W. is an employee of Eli Lilly and Company (Indianapolis, IN).	Ahyayauch H, 2012, BIOPHYS J, V103, P453, DOI 10.1016/j.bpj.2012.06.043; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Dickson DW, 1999, AM J PATHOL, V154, P1627, DOI 10.1016/S0002-9440(10)65416-8; Eckert GP, 2005, SUB CELL BIOCHEM, V38, P319; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Frautschy SA, 1998, AM J PATHOL, V152, P307; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Guerreiro R, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.06.005; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jiang T, 2014, NEUROPSYCHOPHARMACOL; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kaku M, 2003, BRAIN RES PROTOC, V12, P104, DOI 10.1016/j.brainresprot.2003.09.001; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Martinez-Senac MD, 1999, EUR J BIOCHEM, V265, P744, DOI 10.1046/j.1432-1327.1999.00775.x; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mitrasinovic OM, 2003, NEUROSCI LETT, V344, P185, DOI 10.1016/S0304-3940(03)00474-9; Nagarathinam A, 2013, J NEUROSCI, V33, P19284, DOI 10.1523/JNEUROSCI.2542-13.2013; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Stanley ER, 2014, COLD SPRING HARB PER, V6; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tanzi RE, 2013, J ALZHEIMERS DIS, V33, pS5, DOI 10.3233/JAD-2012-129044; Thrash JC, 2009, NEUROCHEM RES, V34, P38, DOI 10.1007/s11064-008-9657-1; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023	54	862	891	7	205	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1061	1071		10.1016/j.cell.2015.01.049	http://dx.doi.org/10.1016/j.cell.2015.01.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25728668	Green Accepted, Bronze			2022-12-28	WOS:000351951800007
J	Foppa, M; Rao, SN; Manning, WJ				Foppa, Murilo; Rao, Satya N.; Manning, Warren J.			Doppler Echocardiography in the Evaluation of a Heart Murmur	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AORTIC-VALVE AREA; STENOSIS; PLANIMETRY		[Foppa, Murilo; Rao, Satya N.; Manning, Warren J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Cardiovasc Div, Dept Med,Med Sch, Boston, MA 02215 USA; [Foppa, Murilo] Univ Fed Rio Grande do Sul, Div Cardiol, Hosp Clin Porto Alegre, BR-90046900 Porto Alegre, RS, Brazil; [Manning, Warren J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Radiol, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade Federal do Rio Grande do Sul; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Manning, WJ (corresponding author), Beth Israel Deaconess Med Ctr, Cardiovasc Div, 330 Brookline Ave, Boston, MA 02215 USA.	wmanning@bidmc.harvard.edu	Foppa, Murilo/V-4845-2019	Foppa, Murilo/0000-0003-2914-4406				Clavel MA, 2008, CIRCULATION, V118, pS234, DOI 10.1161/CIRCULATIONAHA.107.757427; Debl K, 2005, INVEST RADIOL, V40, P631, DOI 10.1097/01.rli.0000178362.67085.fd; Feuchtner GM, 2007, AM J ROENTGENOL, V189, P197, DOI 10.2214/AJR.07.2069; Goland S, 2007, HEART, V93, P801, DOI 10.1136/hrt.2006.110726; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Manning WJ, 2013, JAMA-J AM MED ASSOC, V310, P1490, DOI 10.1001/jama.2013.279194; Omran H, 2003, LANCET, V361, P1241, DOI 10.1016/S0140-6736(03)12978-9; STODDARD MF, 1991, AM HEART J, V122, P1415, DOI 10.1016/0002-8703(91)90585-6	8	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1050	1051		10.1001/jama.2015.1278	http://dx.doi.org/10.1001/jama.2015.1278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756442				2022-12-28	WOS:000350643100021
J	Baker, S				Baker, Stephen			A return to the pre-antimicrobial era?	SCIENCE			English	Editorial Material							ENTERICA SEROVAR TYPHI; FLUOROQUINOLONES		[Baker, Stephen] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen] Univ Oxford, Ctr Trop Med, Oxford, England; [Baker, Stephen] London Sch Hyg & Trop Med, London WC1, England	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Baker, S (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	sbaker@oucru.org		Baker, Stephen/0000-0003-1308-5755	Wellcome Trust [100087/Z/12/Z, 100087, 089276] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CDC, 2013, ANTIBIOTIC RESISTANC; Chang H., 2015, EMBO MOL MED, DOI 10.15252/emmm.201404767; Department of Health and Department of Environment Food and Rural Affairs, 2013, UK 5 YEAR ANT RES ST; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; Ingram-Sieber K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002610; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Koirala KD, 2012, ANTIMICROB AGENTS CH, V56, P2761, DOI 10.1128/AAC.06414-11; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Parry CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001163; Perros M, 2015, SCIENCE, V347, P1062, DOI 10.1126/science.aaa3048; Robertson MN, 2014, PARASITOLOGY, V141, P148, DOI 10.1017/S0031182013001121; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; World Health Organization, 2016, ANTIMICROBIAL RESIST	15	62	65	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1064	1066		10.1126/science.aaa2868	http://dx.doi.org/10.1126/science.aaa2868			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745145				2022-12-28	WOS:000350354200017
J	Bush, A; Fleming, L				Bush, Andrew; Fleming, Louise			Diagnosis and management of asthma in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESPIRATORY SYMPTOMS; EOSINOPHIL COUNTS; ALLERGIC RHINITIS; CHILDHOOD ASTHMA; EXACERBATIONS; INTERVENTION; PREVALENCE; EXPOSURE; PARENTS; RISK		[Bush, Andrew] Univ London Imperial Coll Sci Technol & Med, Sect Paediat, London W2 1PG, England; [Fleming, Louise] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W2 1PG, England; [Fleming, Louise] Royal Brompton Harefield NHS Fdn Trust London, Dept Paediat Resp Med, London, England	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust	Bush, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Paediat, London W2 1PG, England.	a.bush@imperial.ac.uk	Fleming, Louise/ABD-7452-2020	Fleming, Louise/0000-0002-7268-7433	NERC [NE/G001944/1] Funding Source: UKRI; National Institute for Health Research [NF-SI-0510-10192] Funding Source: researchfish; Natural Environment Research Council [NE/G001944/1] Funding Source: researchfish; Asthma UK [10/058, AUK-IG-2014-287, AUK-AC-2012-01] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Asthma UK		Bracken M, 2009, ARCH DIS CHILD, V94, P780, DOI 10.1136/adc.2008.152140; Britto MT, 2014, PEDIATRICS, V133, pE418, DOI 10.1542/peds.2013-0684; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Bush A, 2011, THORAX, V66, P367, DOI 10.1136/thx.2011.160861; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Cane RS, 2001, ARCH DIS CHILD, V84, P31, DOI 10.1136/adc.84.1.31; Cates CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007313.pub2; Cook DG, 1997, THORAX, V52, P1081, DOI 10.1136/thx.52.12.1081; FitzGerald JM, 2011, THORAX, V66, P365, DOI 10.1136/thx.2010.156760; Fleming L, 2013, AM J RESP CRIT CARE, V188, P400, DOI 10.1164/rccm.201212-2156LE; Fleming L, 2012, THORAX, V67, P193, DOI 10.1136/thx.2010.156836; Gent JF, 2012, ENVIRON RES, V118, P86, DOI 10.1016/j.envres.2012.07.005; Gibson PG, 2000, COCHRANE DB SYST REV, V2; Global Initiative for Asthma, 2014, WORLD ASTHM DAY; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Nurmatov U, 2012, ALLERGY, V67, P158, DOI 10.1111/j.1398-9995.2011.02752.x; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; Pool J, 2012, THORAX, V67, P926, DOI 10.1136/thoraxjnl-2012-201607; Roberts G, 2003, J ALLERGY CLIN IMMUN, V112, P168, DOI 10.1067/mai.2003.1569; Royal College of Physicians, 2014, WHY ASTHM STILL KILL; SHAW RA, 1992, CLIN EXP ALLERGY, V22, P561, DOI 10.1111/j.1365-2222.1992.tb00166.x; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Turpeinen M, 2008, ARCH DIS CHILD, V93, P654, DOI 10.1136/adc.2007.116632; Ullmann N, 2013, ALLERGY, V68, P402, DOI 10.1111/all.12101; Wright AL, 1996, AM J RESP CRIT CARE, V153, P1259, DOI 10.1164/ajrccm.153.4.8616551	29	40	41	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2015	350								h996	10.1136/bmj.h996	http://dx.doi.org/10.1136/bmj.h996			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DP	25742964				2022-12-28	WOS:000351180000012
J	Fuchs, VR				Fuchs, Victor R.			Major Concepts of Health Care Economics	ANNALS OF INTERNAL MEDICINE			English	Article							COUNTRIES; COSTS		Stanford Inst Econ Policy Res, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Inst Econ Policy Res, 366 Galvez St, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Cohen J, 2013, HEALTH AFFAIR, V32, P762, DOI 10.1377/hlthaff.2012.0707; Culyer AJ., 2005, DICT HLTH EC; Cutler DM, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.2.3; Cutler DM, 2000, RAND J ECON, V31, P526, DOI 10.2307/2600999; Fuchs VR, 2013, JAMA-J AM MED ASSOC, V309, P33, DOI 10.1001/jama.2012.125458; FUCHS VR, 1978, J HUM RESOUR, V13, P35, DOI 10.2307/145247; Garson A, 2012, HEALTH AFFAIR, V31, P1016, DOI 10.1377/hlthaff.2011.0859; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Laugesen MJ, 2011, HEALTH AFFAIR, V30, P1647, DOI 10.1377/hlthaff.2010.0204; NEWHOUSE JP, 1982, ANN NY ACAD SCI, V387, P111, DOI 10.1111/j.1749-6632.1982.tb17166.x; Stigler G. J., 1987, NEW PALGRAVE DICT EC, VIII, P55; White C, 2014, HEALTH AFFAIR, V33, P324, DOI 10.1377/hlthaff.2013.0747	12	7	7	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2015	162	5					380	U96		10.7326/M14-1183	http://dx.doi.org/10.7326/M14-1183			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC3HT	25732280				2022-12-28	WOS:000350238300007
J	Watts, G				Watts, Geoff			Mary Frances Lyon Obituary	LANCET			English	Biographical-Item																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					768	768		10.1016/S0140-6736(15)60427-5	http://dx.doi.org/10.1016/S0140-6736(15)60427-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25752167	Bronze			2022-12-28	WOS:000350051700018
J	Falzarano, D; Feldmann, H				Falzarano, Darryl; Feldmann, Heinz			Delineating Ebola entry	SCIENCE			English	Editorial Material							NIEMANN-PICK C1; VIRUS INFECTION		[Falzarano, Darryl] Univ Saskatchewan, Int Vaccine Ctr, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Feldmann, Heinz] NIAID, Lab Virol, Div Intramural Res, NIH, Hamilton, MT USA	University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Falzarano, D (corresponding author), Univ Saskatchewan, Int Vaccine Ctr, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	feldmannh@niaid.nih.gov			Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Division Of Integrative Organismal Systems [1522491] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Hunt CL, 2012, VIRUSES-BASEL, V4, P258, DOI 10.3390/v4020258; Kolokoltsov AA, 2009, DRUG DEVELOP RES, V70, P255, DOI 10.1002/ddr.20303; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Picazo E, 2015, DRUG DISCOV TODAY, V20, P277, DOI 10.1016/j.drudis.2014.12.010; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758	10	8	9	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					947	948		10.1126/science.aaa8121	http://dx.doi.org/10.1126/science.aaa8121			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB9NQ	25722396				2022-12-28	WOS:000349958900017
J	Grogan, D				Grogan, David			The Microbes Within	NATURE			English	Editorial Material																			0	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					S2	S2		10.1038/518S2a	http://dx.doi.org/10.1038/518S2a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25715277	Bronze			2022-12-28	WOS:000350097300024
J	Liu, N; Dai, Q; Zheng, GQ; He, C; Parisien, M; Pan, T				Liu, Nian; Dai, Qing; Zheng, Guanqun; He, Chuan; Parisien, Marc; Pan, Tao			N-6-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions	NATURE			English	Article							MESSENGER-RNA; HNRNP C; SECONDARY STRUCTURE; NUCLEAR-RNA; REVEALS; TRANSCRIPTOME; RESOLUTION	RNA-binding proteins control many aspects of cellular biology through binding single-stranded RNA binding motifs (RBMs)(1-3). However, RBMs can be buried within their local RNA structures'', thus inhibiting RNA-protein interactions. N-6-methyladenosine (m(6)A), the most abundant and dynamic internal modification in eulcaryotic messenger RNA(8-19), can be selectively recognized by the YTHDF2 protein to affect the stability of cytoplasmic mRNAs(15), but how m(6)A achieves its wide-ranging physiological role needs further exploration. Here we show in human cells that m(6)A controls the RNA-structuredependent accessibility of RBMs to affect RNA-protein interactions for biological regulation; we term this mechanism 'the m6A-switch'. We found that m(6)A alters the local structure in mRNA and long non-coding RNA (IncRNA) to facilitate binding of heterogeneous nuclear ribonudeoprotein C (HNRNPC), an abundant nuclear RNAbinding protein responsible for pre-mRNA processing'. Combining photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) and anti-m(6)A immunoprecipitation (MeRIP) approaches enabled us to identify 39,060 m(6)A-switches among HNRNPC-binding sites; and global m(6)A reduction decreased HNRNPC binding at 2,798 high-confidence m(6)A-switches. We determined that these m(6)A-switch-regulated HNRNPC-binding activities affect the abundance as well as alternative splicing of target mRNAs, demonstrating the regulatory role of m(6)A-switches on gene expression and RNA maturation. Our results illustrate how RNA-binding proteins gain regulated access to their RBMs through m6A-dependent RNA structural remodelling, and provide a new direction for investigating RNA-modification-coded cellular biology.	[Liu, Nian; Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zheng, Guanqun; He, Chuan; Parisien, Marc; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [He, Chuan; Pan, Tao] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Parisien, M (corresponding author), McGill Univ, Fac Dent, Montreal, PQ H3A 0G1, Canada.	marc.parisien@mcgill.ca; taopan@uchicago.edu	Dai, Qing/ABD-8444-2021	Parisien, Marc/0000-0003-2924-5960; Liu, Nian/0000-0001-7246-7732	National Institutes of Health EUREKA [GM088599];  [K01HG006699]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088599] Funding Source: NIH RePORTER	National Institutes of Health EUREKA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health EUREKA GM088599 (C.H. and T.P.), and by K01HG006699 (Q.D.). We thank all members of the Pan and He laboratories for comments and discussions. We also thank Y. C. Leung, G. Perdrizet, Y. Pigli, J. Yue, J. Liu, Y. Yue, K. Chen and M. Yu for technical assistance. C.H. is an Investigator of the Howard Hughes Medical Institute. M.P. was a Natural Sciences and Engineering Research Council of Canada postdoctoral fellow.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; Cienikova Z, 2014, J AM CHEM SOC, V136, P14536, DOI 10.1021/ja507690d; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4472, DOI 10.1093/nar/gkg633; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Rajagopalan LE, 1998, NUCLEIC ACIDS RES, V26, P3418, DOI 10.1093/nar/26.14.3418; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	30	1038	1091	21	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					560	564		10.1038/nature14234	http://dx.doi.org/10.1038/nature14234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25719671	Green Accepted			2022-12-28	WOS:000350097300052
J	Velasquez-Manoff, M				Velasquez-Manoff, Moises			The Peacekeepers	NATURE			English	Editorial Material																			0	81	84	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					S3	+		10.1038/518S3a	http://dx.doi.org/10.1038/518S3a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25715278	Bronze			2022-12-28	WOS:000350097300025
J	Hookway, C; Buckner, S; Crosland, P; Longson, D				Hookway, Cheryl; Buckner, Sara; Crosland, Paul; Longson, Damien			Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hookway, Cheryl] Natl Inst Hlth & Care Excellence, Clin Guideline Updates Team, Manchester M1 4BT, Lancs, England; [Buckner, Sara; Crosland, Paul] Natl Inst Hlth & Care Excellence, Clin Guideline Updates Team, London, England; [Longson, Damien] Manchester Mental Hlth & Social Care Trust, Dept Psychiat, Manchester, Lancs, England	National Institute for Health & Care Excellence; National Institute for Health & Care Excellence; Open University - UK	Hookway, C (corresponding author), Natl Inst Hlth & Care Excellence, Clin Guideline Updates Team, Manchester M1 4BT, Lancs, England.	cheryl.hookway@NICE.org.uk	Crosland, Paul/N-6718-2017	Crosland, Paul/0000-0002-6445-7486				National Institute for Health and Care Excellence, 2013, INT PROC METH GUID C; National Institute for Health and Care Excellence, 2012, GUID MAN APP J K; National Institute for Health and Care Excellence, 2008, IRR BOW SYNDR AD DIA; National Institute for Health and Care Excellence, 2015, IRR BOW SYNDR DIAGN; National Institute for Health and Care Excellence (NICE), 2011, OV CANC REC IN MAN O; NHS Choices, 2015, NHS CHOIC; NICE, 2012, GUID MAN	7	73	74	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2015	350								h701	10.1136/bmj.h701	http://dx.doi.org/10.1136/bmj.h701			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AM	25716701				2022-12-28	WOS:000350292900009
J	Gordus, A; Pokala, N; Levy, S; Flavell, SW; Bargmann, CI				Gordus, Andrew; Pokala, Navin; Levy, Sagi; Flavell, Steven W.; Bargmann, Cornelia I.			Feedback from Network States Generates Variability in a Probabilistic Olfactory Circuit	CELL			English	Article							CAENORHABDITIS-ELEGANS; NEURONAL-ACTIVITY; C-ELEGANS; NEURAL CIRCUITS; IN-VIVO; SENSITIVITY; PERFORMANCE; PATTERNS; BEHAVIOR; SYSTEMS	Variability is a prominent feature of behavior and is an active element of certain behavioral strategies. To understand how neuronal circuits control variability, we examined the propagation of sensory information in a chemotaxis circuit of C. elegans where discrete sensory inputs can drive a probabilistic behavioral response. Olfactory neurons respond to odor stimuli with rapid and reliable changes in activity, but downstream AIB interneurons respond with a probabilistic delay. The interneuron response to odor depends on the collective activity of multiple neurons-AIB, RIM, and AVA-when the odor stimulus arrives. Certain activity states of the network correlate with reliable responses to odor stimuli. Artificially generating these activity states by modifying neuronal activity increases the reliability of odor responses in interneurons and the reliability of the behavioral response to odor. The integration of sensory information with network states may represent a general mechanism for generating variability in behavior.	[Gordus, Andrew; Pokala, Navin; Levy, Sagi; Flavell, Steven W.; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Gordus, Andrew; Pokala, Navin; Levy, Sagi; Flavell, Steven W.; Bargmann, Cornelia I.] Rockefeller Univ, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	cori@rockefeller.edu	Pokala, Navin/AAH-5719-2019; Levy, Sagi/AAG-1593-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618; Flavell, Steven/0000-0001-9464-1877	Marie-Josee and Henry Kravis Postdoctoral Fellowship; Human Frontiers Science Program Fellowship; G. Harold and Leila Y. Mathers Charitable Foundation; Howard Hughes Medical Institute	Marie-Josee and Henry Kravis Postdoctoral Fellowship; Human Frontiers Science Program Fellowship(Human Frontier Science Program); G. Harold and Leila Y. Mathers Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank L. Looger for GCaMP constructs, D. Albrecht and J. Larsch for advice with arena imaging, and S. Kato, M. Lockard, D. Ventimiglia, and other members of our laboratory for helpful discussions. This work was supported by a Marie-Josee and Henry Kravis Postdoctoral Fellowship to A.G., a Human Frontiers Science Program Fellowship to S. L., the G. Harold and Leila Y. Mathers Charitable Foundation, and the Howard Hughes Medical Institute. C.I.B. is a Howard Hughes Medical Institute investigator.	Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; Barlow H B, 1971, Vision Res, VSuppl 3, P87; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BRENNER S, 1974, GENETICS, V77, P71; Chaisanguanthum KS, 2014, J NEUROSCI, V34, P12071, DOI 10.1523/JNEUROSCI.3001-13.2014; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Faumont S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024666; Frederick DE, 2011, BEHAV NEUROSCI, V125, P588, DOI 10.1037/a0024371; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; Harsanyi J. C., 1973, International Journal of Game Theory, V2, P1, DOI 10.1007/BF01737554; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Larsch J, 2013, P NATL ACAD SCI USA, V110, pE4266, DOI 10.1073/pnas.1318325110; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LILLYWHITE PG, 1979, NATURE, V277, P569, DOI 10.1038/277569a0; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; Mitsutake Ayori, 2013, Methods Mol Biol, V924, P153, DOI 10.1007/978-1-62703-017-5_7; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; Press WH., 2002, NUMERICAL RECIPES C, V2; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schrodel T, 2013, NAT METHODS, V10, P1013, DOI [10.1038/NMETH.2637, 10.1038/nmeth.2637]; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Thrun S.B., 1992, EFFICIENT EXPLORATIO; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	53	111	113	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					215	227		10.1016/j.cell.2015.02.018	http://dx.doi.org/10.1016/j.cell.2015.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25772698	Bronze, Green Accepted			2022-12-28	WOS:000352708300016
J	Douglas, PS; Hoffmann, U; Patel, MR; Mark, DB; Al-Khalidi, HR; Cavanaugh, B; Cole, J; Dolor, RJ; Fordyce, CB; Huang, MG; Khan, MA; Kosinski, AS; Krucoff, MW; Malhotra, V; Picard, MH; Udelson, JE; Velazquez, EJ; Yow, E; Cooper, LS; Lee, KL				Douglas, Pamela S.; Hoffmann, Udo; Patel, Manesh R.; Mark, Daniel B.; Al-Khalidi, Hussein R.; Cavanaugh, Brendan; Cole, Jason; Dolor, Rowena J.; Fordyce, Christopher B.; Huang, Megan; Khan, Muhammad Akram; Kosinski, Andrzej S.; Krucoff, Mitchell W.; Malhotra, Vinay; Picard, Michael H.; Udelson, James E.; Velazquez, Eric J.; Yow, Eric; Cooper, Lawton S.; Lee, Kerry L.		PROMISE Investigators	Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAGNOSTIC PERFORMANCE; IONIZING-RADIATION; CT ANGIOGRAPHY; CHEST-PAIN; HEART; MANAGEMENT; RADIOLOGY; MORTALITY; TRENDS; LUNG	BACKGROUND Many patients have symptoms suggestive of coronary artery disease (CAD) and are often evaluated with the use of diagnostic testing, although there are limited data from randomized trials to guide care. METHODS We randomly assigned 10,003 symptomatic patients to a strategy of initial anatomical testing with the use of coronary computed tomographic angiography (CTA) or to functional testing (exercise electrocardiography, nuclear stress testing, or stress echocardiography). The composite primary end point was death, myocardial infarction, hospitalization for unstable angina, or major procedural complication. Secondary end points included invasive cardiac catheterization that did not show obstructive CAD and radiation exposure. RESULTS The mean age of the patients was 60.8 +/- 8.3 years, 52.7% were women, and 87.7% had chest pain or dyspnea on exertion. The mean pretest likelihood of obstructive CAD was 53.3 +/- 21.4%. Over a median follow-up period of 25 months, a primary end-point event occurred in 164 of 4996 patients in the CTA group (3.3%) and in 151 of 5007 (3.0%) in the functional-testing group (adjusted hazard ratio, 1.04; 95% confidence interval, 0.83 to 1.29; P = 0.75). CTA was associated with fewer catheterizations showing no obstructive CAD than was functional testing (3.4% vs. 4.3%, P = 0.02), although more patients in the CTA group underwent catheterization within 90 days after randomization (12.2% vs. 8.1%). The median cumulative radiation exposure per patient was lower in the CTA group than in the functional-testing group (10.0 mSv vs. 11.3 mSv), but 32.6% of the patients in the functional-testing group had no exposure, so the overall exposure was higher in the CTA group (mean, 12.0 mSv vs. 10.1 mSv; P<0.001). CONCLUSIONS In symptomatic patients with suspected CAD who required noninvasive testing, a strategy of initial CTA, as compared with functional testing, did not improve clinical outcomes over a median follow-up of 2 years. (Funded by the National Heart, Lung, and Blood Institute; PROMISE ClinicalTrials.gov number, NCT01174550.)	[Douglas, Pamela S.; Patel, Manesh R.; Mark, Daniel B.; Al-Khalidi, Hussein R.; Dolor, Rowena J.; Fordyce, Christopher B.; Huang, Megan; Kosinski, Andrzej S.; Krucoff, Mitchell W.; Velazquez, Eric J.; Yow, Eric; Lee, Kerry L.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hoffmann, Udo; Picard, Michael H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Udelson, James E.] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA; [Cavanaugh, Brendan] New Mexico Heart Inst, Albuquerque, NM USA; [Cole, Jason] Cardiol Associates, Mobile, AL USA; [Khan, Muhammad Akram] North Dallas Res Associates, Dallas, TX USA; [Malhotra, Vinay] Cardiac Study Grp, Puyallup, WA USA; [Cooper, Lawton S.] NHLBI, Bethesda, MD 20892 USA	Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Tufts Medical Center; Tufts University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Douglas, PS (corresponding author), Duke Univ, Sch Med, Med Ctr, 7022 North Pavil,POB 17969, Durham, NC 27715 USA.	pamela.douglas@duke.edu	Patel, Manesh/AAC-5385-2019; Picard, Michael/F-1567-2013	Picard, Michael/0000-0002-9264-3243; Dolor, Rowena/0000-0001-7317-9468; Douglas, Pamela/0000-0001-9876-4049	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098237, K24HL113128, R01HL098305, R01HL098236, R01HL098235] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute; PROMISE ClinicalTrials.gov number, NCT01174550.	Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Chen J, 2010, J AM COLL CARDIOL, V56, P702, DOI 10.1016/j.jacc.2010.05.014; Cheng VY, 2011, CIRCULATION, V124, P2424, DOI 10.1161/CIRCULATIONAHA.111.039255; COX DR, 1972, J R STAT SOC B, V34, P187; Daly CA, 2006, BMJ-BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE; Douglas PS, 2014, AM HEART J, V167, P796, DOI 10.1016/j.ahj.2014.03.003; Douglas PS, 2011, J AM COLL CARDIOL, V58, P801, DOI 10.1016/j.jacc.2011.05.019; Douglas PS, 2009, JACC-CARDIOVASC IMAG, V2, P897, DOI 10.1016/j.jcmg.2009.01.018; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hicks KA, 2014, J AM COLL CARDIOL; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Ladapo JA, 2014, ANN INTERN MED, V161, P482, DOI 10.7326/M14-0296; Mark DB, 2010, J AM COLL CARDIOL, V55, P1029, DOI [10.1016/j.jacc.2009.11.048, 10.1016/j.jacc.2009.11.013]; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mudrick DW, 2012, AM HEART J, V163, P454, DOI 10.1016/j.ahj.2011.11.022; Muhlestein JB, 2014, JAMA-J AM MED ASSOC, V312, P2234, DOI 10.1001/jama.2014.15825; Patel MR, 2014, AM HEART J, V167, P846, DOI 10.1016/j.ahj.2014.03.001; Rozanski A, 2013, J AM COLL CARDIOL, V61, P1054, DOI 10.1016/j.jacc.2012.11.056; Shaw L, 2012, JACC-CARDIOVASC IMAG, V5, P1292, DOI 10.1016/j.jcmg.2012.10.007; Shaw LJ, 2010, JACC-CARDIOVASC IMAG, V3, P316, DOI 10.1016/j.jcmg.2009.11.010; Thomas GS, 2013, CIRC-CARDIOVASC GENE, V6, P154, DOI 10.1161/CIRCGENETICS.112.964015	29	889	925	6	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1291	1300		10.1056/NEJMoa1415516	http://dx.doi.org/10.1056/NEJMoa1415516			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25773919	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000352028500004
J	Sandler, O; Mizrahi, SP; Weiss, N; Agam, O; Simon, I; Balaban, NQ				Sandler, Oded; Mizrahi, Sivan Pearl; Weiss, Noga; Agam, Oded; Simon, Itamar; Balaban, Nathalie Q.			Lineage correlations of single cell division time as a probe of cell-cycle dynamics	NATURE			English	Article							GENE-EXPRESSION; GENERATION TIMES; MODEL; NOISE; VARIABILITY; BACTERIA; SERIES	Stochastic processes in cells are associated with fluctuations in mRNA(1), protein production and degradation(2,3), noisy partition of cellular components at division(4), and other cell processes. Variability within a clonal population of cells originates from such stochastic processes, which may be amplified or reduced by deterministic factors(5). Cell-to-cell variability, such as that seen in the heterogeneous response of bacteria to antibiotics, or of cancer cells to treatment, is understood as the inevitable consequence of stochasticity. Variability in cell-cycle duration was observed long ago; however, its sources are still unknown. A central question is whether the variance of the observed distribution originates from stochastic processes, or whether it arises mostly from a deterministic process that only appears to be random. A surprising feature of cell-cycle-duration inheritance is that it seems to be lost within one generation but to be still present in the next generation, generating poor correlation between mother and daughter cells but high correlation between cousin cells(6). This observation suggests the existence of underlying deterministic factors that determine the main part of cell-to-cell variability. We developed an experimental system that precisely measures the cell-cycle duration of thousands of mammalian cells along several generations and a mathematical framework that allows discrimination between stochastic and deterministic processes in lineages of cells. We show that the inter-and intra-generation correlations reveal complex inheritance of the cell-cycle duration. Finally, we build a deterministic nonlinear toy model for cell-cycle inheritance that reproduces the main features of our data. Our approach constitutes a general method to identify deterministic variability in lineages of cells or organisms, which may help to predict and, eventually, reduce cell-to-cell heterogeneity in various systems, such as cancer cells under treatment.	[Sandler, Oded; Mizrahi, Sivan Pearl; Simon, Itamar] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Sandler, Oded; Mizrahi, Sivan Pearl; Weiss, Noga; Agam, Oded; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Balaban, NQ (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	agam@phys.huji.ac.il; itamarsi@ekmd.huji.ac.il; nathalieqb@phys.huji.ac.il	Pearl, Sivan/GQG-8887-2022; Balaban, Nathalie/AGI-1487-2022; Balaban, Nathalie/AAH-1004-2019	Pearl, Sivan/0000-0001-5093-8361; Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766; Agam, Oded/0000-0002-4118-8586; Simon, Itamar/0000-0002-8517-1903	ISF [592/10, 567/10, 9/09, 302/14]; ERC [281306, 260871]; Chief Scientist Office of the Israel Ministry of Health; Weinkselbaum family medical research fund; Clore Foundation	ISF(Israel Science Foundation); ERC(European Research Council (ERC)European Commission); Chief Scientist Office of the Israel Ministry of Health; Weinkselbaum family medical research fund; Clore Foundation	We thank H. Miyoshi at the Riken Tsukuba for the Fucci markers, N. Barkai, N. Shoresh, J. Theiler, S. Kadener, L. Glass, G. Asher, A. W. Murray and J. Paulsson for discussions, and M. Gorfine and R. Heller for advice on statistical analysis. We thank Q. Yang and A. van Oudenaarden for the Cyanobacteria data sets, and the authors of ref. 24 for making their published data available online. This work was supported by the ISF (grants no. 592/10 (N.Q.B.); no. 567/10(I.S.); and no. 9/09, 302/14 (O.A.)) and the ERC Starting Grant no. 281306 (I.S.), no. 260871 (N.Q.B.), the Chief Scientist Office of the Israel Ministry of Health and the Weinkselbaum family medical research fund(I.S.). I.S. thanks the USAID's ASHA Program for the upgrading of the FACS laboratory. S.P.M. is supported by the Clore Foundation.	Altinok A, 2011, INTERFACE FOCUS, V1, P36, DOI 10.1098/rsfs.2010.0009; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; COWAN R, 1986, BIOMETRICS, V42, P769, DOI 10.2307/2530692; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; FROESE G, 1964, EXP CELL RES, V35, P415, DOI 10.1016/0014-4827(64)90108-9; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; GLASS L, 1993, MED PROG TECHNOL, V19, P115; GRASMAN J, 1990, B MATH BIOL, V52, P535, DOI 10.1016/S0092-8240(05)80361-1; HEJBLUM G, 1988, J THEOR BIOL, V131, P255, DOI 10.1016/S0022-5193(88)80242-X; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; KUCZEK T, 1986, MATH BIOSCI, V79, P87, DOI 10.1016/0025-5564(86)90018-0; LLOYD D, 1992, BIOSYSTEMS, V27, P17, DOI 10.1016/0303-2647(92)90043-X; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; NURSE P, 1980, NATURE, V286, P9, DOI 10.1038/286009a0; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; POWELL EO, 1955, BIOMETRIKA, V42, P16, DOI 10.1093/biomet/42.1-2.16; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; SHIELDS R, 1977, NATURE, V267, P704, DOI 10.1038/267704a0; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Skinner J., 1994, NAT BIOTECHNOL, V12, P596; STAUDTE RG, 1984, J THEOR BIOL, V109, P127, DOI 10.1016/S0022-5193(84)80115-0; THEILER J, 1995, PHYS LETT A, V196, P335, DOI 10.1016/0375-9601(94)00856-K; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759	31	86	86	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					468	+		10.1038/nature14318	http://dx.doi.org/10.1038/nature14318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8BH	25762143				2022-12-28	WOS:000371581400002
J	Bleichert, F; Botchan, MR; Berger, JM				Bleichert, Franziska; Botchan, Michael R.; Berger, James M.			Crystal structure of the eukaryotic origin recognition complex	NATURE			English	Article							DNA-REPLICATION; CONFORMATIONAL-CHANGES; ORC6 PROTEIN; ATP-HYDROLYSIS; BINDING; SEQUENCE; DOMAIN; CLAMP; INITIATORS; HOMOLOGY	Initiation of cellular DNA replication is tightly controlled to sustain genomic integrity. In eukaryotes, the heterohexameric origin recognition complex (ORC) is essential for coordinating replication onset. Here we describe the crystal structure of Drosophila ORC at 3.5 angstrom resolution, showing that the 270 kiloclalton initiator core complex comprises a two-layered notched ring in which a collar of winged-helix domains from the Orcl-5 subunits sits atop a layer of AAA+ (ATPases associated with a variety of cellular activities) folds. Although canonical inter-AAA+ domain interactions exist between four of the six ORC subunits, unanticipated features are also evident. These include highly interdigitated domain-swapping interactions between the winged-helix folds and AAA+ modules of neighbouring protomers, and a quasi-spiral arrange. ment of DNA binding elements that circumnavigate an approximately 20 A wide channel in the centre of the complex. Comparative analyses indicate that ORC encircles DNA, using its winged-helix domain face to engage the mini-chromosome maintenance 2-7 (MCM2-7) complex during replicative helicase loading; however, an observed out-of-plane rotation of more than 900 for the Orc1 AAA+ domain disrupts interactions with catalytic amino acids in Orc4, narrowing and sealing off entry into the central channel. Prima facie, our data indicate that Drosophila ORC can switch between active and autoinhibited conformations, suggesting a novel means for cell cycle and/or developmental control of ORC functions.	[Bleichert, Franziska; Berger, James M.] Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Botchan, Michael R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Berkeley	Berger, JM (corresponding author), Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	mbotchan@berkeley.edu; jberge29@jhmi.edu			National Institutes of Health [GM071747, CA R37-30490]; UC Berkeley Miller Institute for Basic Research in Science; NATIONAL CANCER INSTITUTE [R37CA030490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Berkeley Miller Institute for Basic Research in Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline scientists at beamlines 8.3.1 of the Advanced Light Source (Berkeley Lawrence National Laboratory), 23-ID-B of the Advanced Photon Source (Argonne National Laboratory) and X25 of the National Synchrotron Light Source (Brookhaven National Laboratory) for technical support with X-ray diffraction data collection, and the Nogales laboratory (University of California, Berkeley) for EM support. We also thank A. Fisher and Y. Li for assistance with insect cell cultures. This work was supported by the National Institutes of Health (GM071747 to J.M.B. and CA R37-30490 to M.R.B.) and by a fellowship from the UC Berkeley Miller Institute for Basic Research in Science (to F.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; Bleichert F, 2013, ELIFE, V2, DOI 10.7554/eLife.00882; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Dueber EC, 2011, NUCLEIC ACIDS RES, V39, P3621, DOI 10.1093/nar/gkq1308; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Gaczynska M, 2004, P NATL ACAD SCI USA, V101, P17952, DOI 10.1073/pnas.0408369102; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Houchens CR, 2008, J BIOL CHEM, V283, P30216, DOI 10.1074/jbc.M802649200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Liu SX, 2011, P NATL ACAD SCI USA, V108, P7373, DOI 10.1073/pnas.1013676108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller P, 2010, GENE DEV, V24, P1418, DOI 10.1101/gad.1906410; Neuwald AF, 1999, GENOME RES, V9, P27; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Singleton MR, 2004, J MOL BIOL, V343, P547, DOI 10.1016/j.jmb.2004.08.044; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Sun JC, 2012, STRUCTURE, V20, P534, DOI 10.1016/j.str.2012.01.011; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738	68	84	86	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					321	+		10.1038/nature14239	http://dx.doi.org/10.1038/nature14239			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762138	Green Accepted			2022-12-28	WOS:000351171900034
J	Kramer, DB; Kesselheim, AS				Kramer, Daniel B.; Kesselheim, Aaron S.			The Watchman Saga - Closure at Last?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LEFT ATRIAL APPENDAGE; WARFARIN THERAPY; FIBRILLATION; PREVENTION; STROKE		[Kramer, Daniel B.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02163 USA; [Kramer, Daniel B.] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Kramer, Daniel B.] Hebrew SeniorLife Inst Aging Res, Boston, MA USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Hebrew SeniorLife; Harvard University; Brigham & Women's Hospital	Kramer, DB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02163 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	NATIONAL INSTITUTE ON AGING [K23AG045963] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG045963] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Kramer DB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001519; Maisel WH, 2009, NEW ENGL J MED, V360, P2601, DOI 10.1056/NEJMp0903763; Sick PB, 2007, J AM COLL CARDIOL, V49, P1490, DOI 10.1016/j.jacc.2007.02.035	5	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					994	995		10.1056/NEJMp1415738	http://dx.doi.org/10.1056/NEJMp1415738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760353	Green Accepted			2022-12-28	WOS:000350797300003
J	Cuthbertson, JD; MacMillan, DWC				Cuthbertson, James D.; MacMillan, David W. C.			The direct arylation of allylic sp(3) C-H bonds via organic and photoredox catalysis	NATURE			English	Article							ALDEHYDES; ACTIVATION; ORGANOCATALYSIS; PHOTOCHEMISTRY; OXIDATION; OLEFINS; ACIDS; ALKYL	The direct functionalization of unactivated sp(3) C-H bonds is still one of the most challenging problems facing synthetic organic chemists. The appeal of such transformations derives from their capacity to facilitate the construction of complex organic molecules via the coupling of simple and otherwise inert building blocks, without introducing extraneous functional groups. Despite notable recent efforts', the establishment of general and mild strategies for the engagement of sp(3) C-H bonds in C-C bond forming reactions has proved difficult. Within this context, the discovery of chemical transformations that are able to directly functionalize allylic methyl, methylene and methine carbons in a catalytic manner is a priority. Although protocols for direct oxidation and amination of allylic C-H bonds (that is, C-H bonds where an adjacent carbon is involved in a C=C bond) have become widely established(2,3), the engagement of allylic substrates in C-C bond forming reactions has thus far required the use of pre-functionalized coupling partners'. In particular, the direct arylation of non-functionalized allylic systems would enable access to a series of known pharmacophores (molecular features responsible for a drug's action), though a general solution to this long-standing challenge remains elusive. Here we report the use of both photoredox and organic catalysis to accomplish a mild, broadly effective direct allylic C-H arylation. This C-C bond forming reaction readily accommodates abroad range of alkene and electron-deficient arene reactants, and has been used in the direct arylation of benzylic C-H bonds.	[Cuthbertson, James D.; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Cuthbertson, James/0000-0003-3820-6816	NIHGMS [R01 GM103558-03]; Merck; Amgen; Marie Curie Actions; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103558] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Merck(Merck & Company); Amgen(Amgen); Marie Curie Actions(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by NIHGMS (R01 GM103558-03), and we also thank Merck and Amgen for funding. J.D.C. thanks Marie Curie Actions for an International Outgoing Fellowship.	BORG RM, 1984, CAN J CHEM, V62, P1785, DOI 10.1139/v84-306; Denisov E, 2009, INT J CHEM KINET, V41, P284, DOI 10.1002/kin.20404; Eames J, 2001, ANGEW CHEM INT EDIT, V40, P3567, DOI 10.1002/1521-3773(20011001)40:19<3567::AID-ANIE3567>3.0.CO;2-C; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; He J, 2014, SCIENCE, V343, P1216, DOI 10.1126/science.1249198; Hoshikawa T, 2013, CHEM SCI, V4, P3118, DOI 10.1039/c3sc51080h; JENCKS WP, 1971, J AM CHEM SOC, V93, P4433, DOI 10.1021/ja00747a016; Johannsen M, 1998, CHEM REV, V98, P1689, DOI 10.1021/cr970343o; Khursan SL, 1997, REACT KINET CATAL L, V61, P91, DOI 10.1007/BF02477518; MCMILLEN DF, 1982, ANNU REV PHYS CHEM, V33, P493, DOI 10.1146/annurev.pc.33.100182.002425; Mori Y, 2000, J PHYS CHEM A, V104, P4896, DOI 10.1021/jp0007437; Nagib DA, 2009, J AM CHEM SOC, V131, P10875, DOI 10.1021/ja9053338; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Ogawa KA, 2014, ORG LETT, V16, P1928, DOI 10.1021/ol500459x; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qvortrup K, 2014, J AM CHEM SOC, V136, P626, DOI 10.1021/ja411596q; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Sekine M, 2013, ORG LETT, V15, P714, DOI 10.1021/ol400056z; Trost BM, 1996, CHEM REV, V96, P395, DOI 10.1021/cr9409804	21	321	320	13	407	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					74	77		10.1038/nature14255	http://dx.doi.org/10.1038/nature14255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739630	Green Accepted, Green Submitted			2022-12-28	WOS:000350304000038
J	Fabian, N				Fabian, Nathan			Support low-carbon investment	NATURE			English	Editorial Material									Investor Grp Climate Change Australia & New Zeala, Sydney, NSW, Australia		Fabian, N (corresponding author), Investor Grp Climate Change Australia & New Zeala, Sydney, NSW, Australia.	nathan.fabian@igcc.org.au						International Energy Agency, 2014, SPECIAL REPORT WORLD; Mills L, 2015, GLOBAL TRENDS IN CLE; Organisation for Economic Co-operation and Development, 2015, MAPPING CHANNELS TO; Paulson H. M., 2014, NEW YORK TIMES; The Global Commission on the Economy and Climate, 2014, THE NEW CLIMATE ECON; UK Law Commission, 2014, FIDUCIARY DUTIES OF; United Nations Environment Programme, 2015, ALIGNING THE FINANCI	7	23	23	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					27	29		10.1038/519027a	http://dx.doi.org/10.1038/519027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4EQ	25739615	Bronze			2022-12-28	WOS:000350304000016
J	Spoor, F; Gunz, P; Neubauer, S; Stelzer, S; Scott, N; Kwekason, A; Dean, MC				Spoor, Fred; Gunz, Philipp; Neubauer, Simon; Stelzer, Stefanie; Scott, Nadia; Kwekason, Amandus; Dean, M. Christopher			Reconstructed Homo habilis type OH 7 suggests deep-rooted species diversity in early Homo	NATURE			English	Article							OLDUVAI-GORGE; KOOBI FORA; ENDOCRANIAL VOLUMES; CRANIAL CAPACITY; LIFE-HISTORY; FOSSILS; EVOLUTION; PRIMATE; GROWTH; SAMPLE	Besides Homo erectus (sensu lato), the eastern African fossil record of early Homo has been interpreted as representing either a single variable species, Homo habilis(1), or two species(2-6). In the latter case, however, there is no consensus over the respective groupings, and which of the two includes OH 7, the 1.8-million-year-old H. habilis holotype(7). This partial skull and hand from Olduvai Gorge remains pivotal to evaluating the early evolution of the Homo lineage, and by priority names one or other of the two taxa. However, the distorted preservation of the diagnostically important OH 7 mandible has hindered attempts to compare this specimen with other fossils(8,9). Here we present a virtual reconstruction of the OH 7 mandible, and compare it to other early Homo fossils. The reconstructed mandible is remarkably primitive, with a long and narrow dental arcade more similar to Australopithecus afarensis than to the derived parabolic arcades of Homo sapiens or H. erectus. We find that this shape variability is not consistent with a single species of early Homo. Importantly, the jaw morphology of OH 7 is incompatible with fossils assigned to Homo rudolfensiss(8) and with the A.L. 666-1 Homo maxilla. The latter is morphologically more derived than OH 7 but 500,000 years older(10), suggesting that the H. habilis lineage originated before 2.3 million years ago, thus marking deep-rooted species diversity in the genus Homo. We also reconstructed the parietal bones of OH 7 and estimated its endocranial volume. At between 729 and 824 ml it is larger than any previously published value, and emphasizes the near-complete overlap in brain size among species of early Homo. Our results clarify the H. habilis hypodigm, but raise questions about its phylogenetic relationships. Differences between species of early Homo appear to be characterized more by gnathic diversity than by differences in brain size, which was highly variable within all taxa.	[Spoor, Fred; Gunz, Philipp; Neubauer, Simon; Stelzer, Stefanie; Scott, Nadia] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Spoor, Fred; Dean, M. Christopher] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Kwekason, Amandus] Natl Museum Tanzania, Museum & House Culture, Dar Es Salaam, Tanzania	Max Planck Society; University of London; University College London	Spoor, F (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany.	f.spoor@ucl.ac.uk; gunz@eva.mpg.de	Gunz, Philipp/C-7748-2009; Neubauer, Simon/D-1317-2010	Gunz, Philipp/0000-0002-2350-4450; Neubauer, Simon/0000-0001-9113-5063; Stelzer, Stefanie/0000-0003-2408-7211	Max Planck Society	Max Planck Society(Max Planck Society)	We thank the National Museum of Tanzania, the Tanzania Commission for Science and Technology and the National Museums of Kenya for giving access to fossils in their care, and the Imaging Plus Medical Centre, Dar es Salaam, for CT scanning facilities. We are grateful to M. Leakey, L. Leakey, J.-J. Hublin and S. Anton for support and encouragement, and to R. Blumenschine, P. Corujo, R. David, P. Gokarn, W. Kimbel, K. Kupczik, R. Leakey, J. Lewis, E. Mbua, R. McCarthy, M. Meyer, P. Mitteroecker, P. Msemwa, J. Njau, D. Reinhardt, L. Schroeder, M. Skinner, A. Stoessel, A. Strauss, H. Temming and B. Wood for help with aspects of this study. Research was supported by the Max Planck Society.	Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Brown P., 2014, AUSTR ASIAN PALAEOAN; Clarke R. J., 2012, J HUM EVOL; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; HOLLOWAY RL, 1973, NATURE, V243, P97, DOI 10.1038/243097a0; HOLLOWAY RL, 1980, AM J PHYS ANTHROPOL, V53, P267, DOI 10.1002/ajpa.1330530211; HOLLOWAY RL, 1983, AM J PHYS ANTHROPOL, V60, P505, DOI 10.1002/ajpa.1330600413; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jimenez-Arenas JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406507; Joordens JCA, 2013, J HUM EVOL, V65, P731, DOI 10.1016/j.jhevol.2013.09.002; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 2010, PHILOS T R SOC B, V365, P3365, DOI 10.1098/rstb.2010.0070; LEAKEY LSB, 1961, NATURE, V189, P649, DOI 10.1038/189649a0; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; Leigh SR, 2012, EVOL BIOL, V39, P587, DOI 10.1007/s11692-012-9168-5; Leonard WR, 2007, ANNU REV NUTR, V27, P311, DOI 10.1146/annurev.nutr.27.061406.093659; Lewis JE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001071; LIEBERMAN DE, 1988, J HUM EVOL, V17, P503, DOI 10.1016/0047-2484(88)90039-5; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Marchand F., 1902, HIRNGEWICHT MENSCHEN; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Neubauer S, 2012, J HUM EVOL, V62, P498, DOI 10.1016/j.jhevol.2012.01.005; Neubauer S, 2012, AM J PHYS ANTHROPOL, V147, P319, DOI 10.1002/ajpa.21641; Neubauer S, 2010, J HUM EVOL, V59, P555, DOI 10.1016/j.jhevol.2010.06.011; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Schwartz J. H., 2003, HUMAN FOSSIL RECORD, V2; Scott N, 2014, EVOL BIOL, V41, P572, DOI 10.1007/s11692-014-9290-7; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Stringer C.B., 1986, P266; TOBIAS P. V., 1968, S AFR J SCI, V64, P81; Tobias P.V., 1991, OLDUVAI GORGE, V4; VAISNYS JR, 1984, AM J PHYS ANTHROPOL, V65, P71, DOI 10.1002/ajpa.1330650110; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; WOLPOFF MH, 1981, AM J PHYS ANTHROPOL, V56, P297, DOI 10.1002/ajpa.1330560310; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Zuckerman S, 1928, P ZOOL SOC LOND, V1928, P1	50	101	104	0	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					83	U157		10.1038/nature14224	http://dx.doi.org/10.1038/nature14224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739632				2022-12-28	WOS:000350304000040
J	Borah, S; Xi, LH; Zaug, AJ; Powell, NM; Dancik, GM; Cohen, SB; Costello, JC; Theodorescu, D; Cech, TR				Borah, Sumit; Xi, Linghe; Zaug, Arthur J.; Powell, Natasha M.; Dancik, Garrett M.; Cohen, Scott B.; Costello, James C.; Theodorescu, Dan; Cech, Thomas R.			TERT promoter mutations and telomerase reactivation in urothelial cancer	SCIENCE			English	Article							INVASIVE BLADDER-CANCER; CATALYTIC SUBUNIT GENE; REVERSE-TRANSCRIPTASE; HIGH-FREQUENCY; CELLS; MELANOMA; ASSOCIATION; MECHANISM; CARCINOMA; CHROMATIN	Reactivation of telomerase, the chromosome end-replicating enzyme, drives human cell immortality and cancer. Point mutations in the telomerase reverse transcriptase (TERT) gene promoter occur at high frequency in multiple cancers, including urothelial cancer (UC), but their effect on telomerase function has been unclear. In a study of 23 human UC cell lines, we show that these promoter mutations correlate with higher levels of TERT messenger RNA (mRNA), TERT protein, telomerase enzymatic activity, and telomere length. Although previous studies found no relation between TERT promoter mutations and UC patient outcome, we find that elevated TERT mRNA expression strongly correlates with reduced disease-specific survival in two independent UC patient cohorts (n=35; n=87). These results suggest that high telomerase activity may be a better marker of aggressive UC tumors than TERT promoter mutations alone.	[Borah, Sumit; Xi, Linghe; Zaug, Arthur J.; Powell, Natasha M.; Cech, Thomas R.] Univ Colorado, Howard Hughes Med Inst, BioFrontiers Inst, Boulder, CO 80309 USA; [Borah, Sumit; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Xi, Linghe; Powell, Natasha M.; Cech, Thomas R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Dancik, Garrett M.] Eastern Connecticut State Univ, Dept Math & Comp Sci, Willimantic, CT 06226 USA; [Cohen, Scott B.] Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Cohen, Scott B.] Univ Sydney, Westmead, NSW 2145, Australia; [Costello, James C.; Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Aurora, CO 80045 USA; [Costello, James C.; Theodorescu, Dan] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Theodorescu, Dan] Univ Colorado, Dept Surg, Aurora, CO 80045 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Connecticut State University System; Eastern Connecticut State University; Children's Medical Research Institute - Australia; University of Sydney; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Cech, TR (corresponding author), Univ Colorado, Howard Hughes Med Inst, BioFrontiers Inst, Boulder, CO 80309 USA.	thomas.cech@colorado.edu		Dancik, Garrett/0000-0002-1391-8641; Costello, James/0000-0003-3158-9682; BORAH, SUMIT/0000-0002-1842-7024	NIH [CA075115, CA104106, R01 GM099705, T32 GM08759]; Cancer Council NSW (Australia); NATIONAL CANCER INSTITUTE [P01CA104106, R01CA075115, R29CA075115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099705, T32GM008759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Council NSW (Australia)(Cancer Council New South Wales); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Owens for providing the UC23, as well as detailed information on their origins and growth conditions. This work was supported by NIH grants CA075115 and CA104106 to D.T., R01 GM099705 to T.R.C., and T32 GM08759 to L.X. S.B.C. is supported by Cancer Council NSW (Australia). T.R.C. is an investigator of the Howard Hughes Medical Institute and is on the board of directors of Merck.	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Allory Y, 2014, EUR UROL, V65, P360, DOI 10.1016/j.eururo.2013.08.052; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Cohen SB, 2008, NAT METHODS, V5, P355, DOI 10.1038/NMETH.F.209; Gildea JJ, 2002, CANCER RES, V62, P6418; Gildea JJ, 2000, GENE CHROMOSOME CANC, V27, P252, DOI 10.1002/(SICI)1098-2264(200003)27:3<252::AID-GCC5>3.0.CO;2-9; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Gunes C, 2000, CANCER RES, V60, P2116; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Heidenreich B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4401; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hurst CD, 2014, EUR UROL, V65, P367, DOI 10.1016/j.eururo.2013.08.057; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Kjeldsen E, 2010, ANTICANCER RES, V30, P3257; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Lin Y, 1996, CLIN CANCER RES, V2, P929; Listerman I, 2014, MOL CELL BIOL, V34, P280, DOI 10.1128/MCB.00844-13; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Rachakonda PS, 2013, P NATL ACAD SCI USA, V110, P17426, DOI 10.1073/pnas.1310522110; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Tallet A, 2014, ONCOGENE, V33, P3748, DOI 10.1038/onc.2013.351; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560	33	219	224	9	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					1006	1010		10.1126/science.1260200	http://dx.doi.org/10.1126/science.1260200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722414	Green Accepted			2022-12-28	WOS:000349958900042
J	Mitchell, SN; Kakani, EG; South, A; Howell, PI; Waterhouse, RM; Catteruccia, F				Mitchell, Sara N.; Kakani, Evdoxia G.; South, Adam; Howell, Paul I.; Waterhouse, Robert M.; Catteruccia, Flaminia			Evolution of sexual traits influencing vectorial capacity in anopheline mosquitoes	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; GAMBIAE; FEMALES; REPRODUCTION; COOPERATION; MALES	The availability of genome sequences from 16 anopheline species provides unprecedented opportunities to study the evolution of reproductive traits relevant for malaria transmission. In Anopheles gambiae, a likely candidate for sexual selection is male 20-hydroxyecdysone (20E). Sexual transfer of this steroid hormone as part of a mating plug dramatically changes female physiological processes intimately tied to vectorial capacity. By combining phenotypic studies with ancestral state reconstructions and phylogenetic analyses, we show that mating plug transfer and male 20E synthesis are both derived characters that have coevolved in anophelines, driving the adaptation of a female 20E-interacting protein that promotes oogenesis via mechanisms also favoring Plasmodium survival. Our data reveal coevolutionary dynamics of reproductive traits between the sexes likely to have shaped the ability of anophelines to transmit malaria.	[Mitchell, Sara N.; Kakani, Evdoxia G.; South, Adam; Catteruccia, Flaminia] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kakani, Evdoxia G.; Catteruccia, Flaminia] Univ Perugia, Dipartimento Med Sperimentale, I-06100 Perugia, Italy; [Howell, Paul I.] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Waterhouse, Robert M.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Waterhouse, Robert M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia; Centers for Disease Control & Prevention - USA; University of Geneva; Swiss Institute of Bioinformatics; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Catteruccia, F (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	fcatter@hsph.harvard.edu	Mitchell, Sara/AAB-5536-2020; Waterhouse, Robert M/A-1858-2010; Mitchell, Sara/I-3104-2014	Waterhouse, Robert M/0000-0003-4199-9052; Mitchell, Sara/0000-0002-7926-1881; Catteruccia, Flaminia/0000-0003-3295-6683	European Research Council [260897]; William F. Milton Fund (Harvard Medical School); NIH [NIH 1R01AI104956-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104956] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); William F. Milton Fund (Harvard Medical School); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Lund and D. Clarke for help with mosquito rearing and insectary procedures and M. Bernardi for assistance with artwork. We are grateful to D. Neafsey and N. Besansky for numerous helpful discussions and to S. Lewis, D. Neafsey, M. Mota, and members of the Catteruccia laboratory for careful reading of the manuscript. This work was sponsored in part by the following grants awarded to F.C.: a European Research Council FP7 ERC Starting Grant (grant Anorep, ID: 260897), a William F. Milton Fund grant (Harvard Medical School 2013), and an NIH grant (grant ID: NIH 1R01AI104956-01A1). S. N. M., E.G.K., A. S., and F.C. designed the experiments. P.I.H. provided experimental material, and S. N. M., E.G.K, and P.I.H. performed the experiments. S. N. M., E.G.K, A. S., and R.M.W. analyzed the data. S.N.M., E.G.K., A.S., and F.C. wrote the manuscript. S.N.M., E.G.K., and A.S. contributed equally to this study. All gene sequences are freely available via given gene identifiers from VectorBase (www.vectorbase.org). The single-copy ortholog sequences used to produce the species phylogeny are available via OrthoDB (http://cegg.unige.ch/orthodbmoz2). Protein sequence alignments employed for the species and MISO-AGAP002621 phylogenies are available via DRYAD: doi:10.5061/dryad.6f576.	Alonzo SH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0044; Alonzo SH, 2010, AM NAT, V175, P174, DOI 10.1086/649596; Baldini F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001695; BOWNES M, 1984, J INSECT PHYSIOL, V30, P823, DOI 10.1016/0022-1910(84)90019-2; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Cortez MR, 2012, EXP PARASITOL, V131, P363, DOI 10.1016/j.exppara.2012.05.005; Dao A, 2010, J MED ENTOMOL, V47, P769, DOI 10.1603/ME10052; Gabrieli P, 2014, P NATL ACAD SCI USA, V111, P16353, DOI 10.1073/pnas.1410488111; Lawniczak MKN, 2007, TRENDS ECOL EVOL, V22, P48, DOI 10.1016/j.tree.2006.09.012; LAWRENCE PO, 1991, IN VITRO CELL DEV B, V27, P487, DOI 10.1007/BF02631150; Lewis S, 2012, ADV STUD BEHAV, V44, P53, DOI 10.1016/B978-0-12-394288-3.00002-2; LU YH, 1986, INT J INVER REP DEV, V9, P79, DOI 10.1080/01688170.1986.10510182; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; Pondeville E, 2008, P NATL ACAD SCI USA, V105, P19631, DOI 10.1073/pnas.0809264105; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Walsh B, 2003, GENETICA, V118, P279, DOI 10.1023/A:1024194802441; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Yuval B, 2006, ANNU REV ENTOMOL, V51, P413, DOI 10.1146/annurev.ento.51.110104.151058	23	51	52	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					985	988		10.1126/science.1259435	http://dx.doi.org/10.1126/science.1259435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722409	Green Accepted			2022-12-28	WOS:000349958900036
J	Montero, J; Sarosiek, KA; DeAngelo, JD; Maertens, O; Ryan, J; Ercan, D; Piao, HY; Horowitz, NS; Berkowitz, RS; Matulonis, U; Janne, PA; Amrein, PC; Cichowski, K; Drapkin, R; Letai, A				Montero, Joan; Sarosiek, Kristopher A.; DeAngelo, Joseph D.; Maertens, Ophelia; Ryan, Jeremy; Ercan, Dalia; Piao, Huiying; Horowitz, Neil S.; Berkowitz, Ross S.; Matulonis, Ursula; Jaenne, Pasi A.; Amrein, Philip C.; Cichowski, Karen; Drapkin, Ronny; Letai, Anthony			Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy	CELL			English	Article							CAUSES RESISTANCE; PATIENT; PI3K; MITOCHONDRIA; INHIBITION; APOPTOSIS; MODELS; BAX	There is a lack of effective predictive biomarkers to precisely assign optimal therapy to cancer patients. While most efforts are directed at inferring drug response phenotype based on genotype, there is very focused and useful phenotypic information to be gained from directly perturbing the patient's living cancer cell with the drug(s) in question. To satisfy this unmet need, we developed the Dynamic BH3 Profiling technique to measure early changes in net pro-apoptotic signaling at the mitochondrion ("priming") induced by chemotherapeutic agents in cancer cells, not requiring prolonged ex vivo culture. We find in cell line and clinical experiments that early druginduced death signaling measured by Dynamic BH3 Profiling predicts chemotherapy response across many cancer types and many agents, including combinations of chemotherapies. We propose that Dynamic BH3 Profiling can be used as a broadly applicable predictive biomarker to predict cytotoxic response of cancers to chennotherapeutics in vivo.	[Montero, Joan; Sarosiek, Kristopher A.; DeAngelo, Joseph D.; Ryan, Jeremy; Ercan, Dalia; Piao, Huiying; Horowitz, Neil S.; Berkowitz, Ross S.; Matulonis, Ursula; Jaenne, Pasi A.; Drapkin, Ronny; Letai, Anthony] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Amrein, Philip C.] Massachusetts Gen Hosp, Dept Med Hematol Oncol, Boston, MA 02114 USA; [Maertens, Ophelia; Horowitz, Neil S.; Berkowitz, Ross S.; Jaenne, Pasi A.; Cichowski, Karen; Drapkin, Ronny] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Letai, A (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA.	anthony_letai@dfci.harvard.edu	Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977; DeAngelo, Joseph/0000-0001-5008-0414; Montero, Joan/0000-0002-9192-4836; Sarosiek, Kristopher/0000-0002-4618-5085; Ryan, Jeremy/0000-0002-3327-1283	Beatriu de Pinos programme from la Generalitat de Catalunya in Spain; NIH [RO1CA129974, R01CA135257, P01CA068484, P01CA139980, U01CA152990]; NATIONAL CANCER INSTITUTE [R01CA129974, P01CA139980, P01CA068484, U01CA152990, K99CA188679, R01CA135257, R21CA188858] Funding Source: NIH RePORTER	Beatriu de Pinos programme from la Generalitat de Catalunya in Spain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge funding from the Beatriu de Pinos programme from la Generalitat de Catalunya in Spain (J.M.), and NIH grants RO1CA129974, R01CA135257, P01CA068484, and P01CA139980. A.L. is a Leukemia and Lymphoma Society Scholar. R.D. would like to thank the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) and NIH grant U01CA152990. We thank the Pasquarello Tissue Bank and the DFCI Flow Cytometry. We also thank Richard P. Oakley Jr. and http://www.servier.com/Powerpoint-image-bank (licensed under Creative Commons Attribution 3.0 Unported License) for allowing usto use some images to elaborate Figure 1 and the Graphical Abstract.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ryan J, 2013, METHODS, V61, P156, DOI 10.1016/j.ymeth.2013.04.006; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yaffe MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003684; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	34	234	250	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					977	989		10.1016/j.cell.2015.01.042	http://dx.doi.org/10.1016/j.cell.2015.01.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723171	Green Accepted, Bronze			2022-12-28	WOS:000351116100019
J	Rouzine, IM; Weinberger, AD; Weinberger, LS				Rouzine, Igor M.; Weinberger, Ariel D.; Weinberger, Leor S.			An Evolutionary Role for HIV Latency in Enhancing Viral Transmission	CELL			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; T-CELL DEPLETION; GENE-EXPRESSION; SEXUAL TRANSMISSION; DENDRITIC CELLS; COITAL ACT; REPLICATION; PERSISTENCE; RESERVOIR; SIV	HIV latency is the chief obstacle to eradicating HIV but is widely believed to be an evolutionary accident providing no lentiviral fitness advantage. However, findings of latency being "hardwired" into HIV's gene-regulatory circuitry appear inconsistent with latency being an evolutionary accident, given HIV's rapid mutation rate. Here, we propose that latency is an evolutionary "bet-hedging" strategy whose frequency has been optimized to maximize lentiviral transmission by reducing viral extinction during mucosal infections. The model quantitatively fits the available patient data, matches observations of high-frequency latency establishment in cell culture and primates, and generates two counterintuitive but testable predictions. The first prediction is that conventional CD8-depletion experiments in SIV-infected macaques increase latent cells more than viremia. The second prediction is that strains engineered to have higher replicative fitness-via reduced latency-will exhibit lower infectivity in animal-model mucosal inoculations. Therapeutically, the theory predicts treatment approaches that may substantially enhance "activate-and-kill" HIV-cure strategies.	[Rouzine, Igor M.; Weinberger, Leor S.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Weinberger, Ariel D.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, QB3, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberger, AD (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	ariel.weinberger@wyss.harvard.edu; leor.weinberger@gladstone.ucsf.edu	Rouzine, Igor M/AFO-3706-2022	Rouzine, Igor M/0000-0002-0744-6705	Alfred P. Sloan Foundation; Wyss Institute Technology Development Fellowship; NIH Director's Pioneer Award Program [DP1 OD017181]; NIH as part of the Delaney Collaboratory for AIDS Research and Eradication (CARE) [R21AI109611, F32AI102520, U19AI096113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI102520, R21AI109611, U19AI096113, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [DP1DE024408] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Wyss Institute Technology Development Fellowship; NIH Director's Pioneer Award Program; NIH as part of the Delaney Collaboratory for AIDS Research and Eradication (CARE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to Lani Wu and Stephen Altschuler for input and discussions; to Alan Perelson, Warner Greene, Eric Verdin, Anand Pai, Brandon Razooky, and John Coffin for helpful comments; and to Abhyudai Singh for generating preliminary data. We are also grateful to the graphics department at the Gladstone Institutes for artistic expertise and help with figure schematics. This work was supported by the Alfred P. Sloan Foundation, the Wyss Institute Technology Development Fellowship, the NIH Director's Pioneer Award Program (DP1 OD017181), as well as NIH awards R21AI109611, F32AI102520, and U19AI096113 as part of the Delaney Collaboratory for AIDS Research and Eradication (CARE).	[Anonymous], 2011, CSH PERSPECT MED, DOI DOI 10.1101/cshperspect.a007096; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Arkin A, 1998, GENETICS, V149, P1633; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Calvanese V, 2013, VIROLOGY, V446, P283, DOI 10.1016/j.virol.2013.07.037; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Coffin J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012526; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Dahabieh MS, 2013, J VIROL, V87, P4716, DOI 10.1128/JVI.03478-12; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; De Boer RJ, 1998, J THEOR BIOL, V190, P201, DOI 10.1006/jtbi.1997.0548; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Grimmett G., 1992, PROBABILITY RANDOM P; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jeeninga RE, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-37; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nowak MA., 2000, VIRUS DYNAMICS MATH; Pearson JE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001058; Peressin M, 2014, AIDS, V28, P667, DOI 10.1097/QAD.0000000000000193; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Razooky BS, 2015, CELL, V160, P990, DOI 10.1016/j.cell.2015.02.009; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Santiago ML, 2005, J VIROL, V79, P12515, DOI 10.1128/JVI.79.19.12515-12527.2005; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sedaghat AR, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-2; Sedaghat AR, 2007, PLOS PATHOG, V3, P1165, DOI 10.1371/journal.ppat.0030122; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Su B, 2012, BLOOD, V120, P3708, DOI 10.1182/blood-2012-03-418913; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; van der Sluis RM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-73; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weinberger AD, 2013, CELL, V155, P497, DOI 10.1016/j.cell.2013.09.039; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	64	68	70	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					1002	1012		10.1016/j.cell.2015.02.017	http://dx.doi.org/10.1016/j.cell.2015.02.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723173	Green Accepted, Bronze			2022-12-28	WOS:000351116100021
J	Watts, G				Watts, Geoff			Maurizio Luisetti Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					224	224		10.1016/S0140-6736(15)60048-4	http://dx.doi.org/10.1016/S0140-6736(15)60048-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25713848				2022-12-28	WOS:000348044800016
J	Snyder, A				Snyder, Alison			Willy Burgdorfer Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu						BURGDORFER W, PUBLICATION LIST	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					110	110		10.1016/S0140-6736(15)60011-3	http://dx.doi.org/10.1016/S0140-6736(15)60011-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY7BI	25713838	Bronze			2022-12-28	WOS:000347715900013
J	Mega, JL; Walker, JR; Ruff, CT; Vandell, AG; Nordio, F; Deenadayalu, N; Murphy, SA; Lee, J; Mercuri, MF; Giugliano, RP; Antman, EM; Braunwald, E; Sabatine, MS				Mega, Jessica L.; Walker, Joseph R.; Ruff, Christian T.; Vandell, Alexander G.; Nordio, Francesco; Deenadayalu, Naveen; Murphy, Sabina A.; Lee, James; Mercuri, Michele F.; Giugliano, Robert P.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.			Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial	LANCET			English	Article							ANTICOAGULATION-RELATED OUTCOMES; ATRIAL-FIBRILLATION; CYP2C9; POLYMORPHISMS; VARIANTS; VKORC1; RISK; PHARMACOGENETICS; DETERMINANTS; METAANALYSIS	Background Warfarin is the most widely used oral anticoagulant worldwide, but serious bleeding complications are common. We tested whether genetic variants can identify patients who are at increased risk of bleeding with warfarin and, consequently, those who would derive a greater safety benefit with a direct oral anticoagulant rather than warfarin. Methods ENGAGE AF-TIMI 48 was a randomised, double-blind trial in which patients with atrial fibrillation were assigned to warfarin to achieve a target international normalised ratio of 2.0-3.0, or to higher-dose (60 mg) or lower-dose (30 mg) edoxaban once daily. A subgroup of patients was included in a prespecified genetic analysis and genotyped for variants in CYP2C9 and VKORC1. The results were used to create three genotype functional bins (normal, sensitive, and highly sensitive responders to warfarin). This trial is registered with ClinicalTrials.gov, number NCT00781391. Findings 14 348 patients were included in the genetic analysis. Of 4833 taking warfarin, 2982 (61.7%) were classified as normal responders, 1711 (35.4%) as sensitive responders, and 140 (2.9%) as highly sensitive responders. Compared with normal responders, sensitive and highly sensitive responders spent greater proportions of time over-anticoagulated in the first 90 days of treatment (median 2.2%, IQR 0-20.2; 8.4%, 0-25.8; and 18.3%, 0-32.6; p(trend) <0.0001) and had increased risks of bleeding with warfarin (sensitive responders hazard ratio 1.31, 95% CI 1.05-1.64, p=0.0179; highly sensitive responders 2.66, 1.69-4.19, p<0.0001). Genotype added independent information beyond clinical risk scoring. During the first 90 days, when compared with warfarin, treatment with edoxaban reduced bleeding more so in sensitive and highly sensitive responders than in normal responders (higher-dose edoxaban p(interaction) = 0.0066; lower-dose edoxaban p(interaction) = 0.0036). After 90 days, the reduction in bleeding risk with edoxaban versus warfarin was similarly beneficial across genotypes. Interpretation CYP2C9 and VKORC1 genotypes identify patients who are more likely to experience early bleeding with warfarin and who derive a greater early safety benefit from edoxaban compared with warfarin.	[Mega, Jessica L.; Ruff, Christian T.; Nordio, Francesco; Deenadayalu, Naveen; Murphy, Sabina A.; Giugliano, Robert P.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, TIMI Study Grp,Div Cardiovasc Med, Boston, MA 02115 USA; [Vandell, Alexander G.; Lee, James; Mercuri, Michele F.] Daiichi Sankyo Pharma Dev, Edison, NJ USA; [Walker, Joseph R.] Celgene Corp, Summit, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Daiichi Sankyo Company Limited; Bristol-Myers Squibb; Celgene Corporation	Mega, JL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	jmega@partners.org; msabatine@partners.org	Sabatine, Marc/AAJ-6751-2020; Giugliano, Robert/N-7233-2017	Sabatine, Marc/0000-0002-0691-3359; Giugliano, Robert/0000-0003-4110-7675	Daiichi Sankyo	Daiichi Sankyo(Daiichi Sankyo Company Limited)	Daiichi Sankyo.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Camm AJ, 2012, EUR HEART J, V33; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Crowther MA, 2000, LANCET, V356, P1551, DOI 10.1016/S0140-6736(00)03125-1; EMC, 2014, MAR 5 MG TABL; Food and Drug Administration, COUM TABL WARF SOD T; Food and Drug Administration, 2012, EUR HEATS RISK MAP P; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Jorgensen AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044064; Kim MJ, 2009, J CLIN PHARMACOL, V49, P138, DOI 10.1177/0091270008328098; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Lund K, 2012, BRIT J HAEMATOL, V158, P256, DOI 10.1111/j.1365-2141.2012.09150.x; Margaglione M, 2000, THROMB HAEMOSTASIS, V84, P775; Meckley LM, 2008, THROMB HAEMOSTASIS, V100, P229, DOI 10.1160/TH07-09-0552; Pare G, 2013, CIRCULATION, V127, P1404, DOI 10.1161/CIRCULATIONAHA.112.001233; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perera MA, 2013, LANCET, V382, P790, DOI 10.1016/S0140-6736(13)60681-9; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rose AJ, 2011, CIRC-CARDIOVASC QUAL, V4, P22, DOI 10.1161/CIRCOUTCOMES.110.957738; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Roth JA, 2014, CLIN PHARMACOL THER, V95, P636, DOI 10.1038/clpt.2014.26; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155; Verhoef TI, 2013, NEW ENGL J MED, V369, P2304, DOI 10.1056/NEJMoa1311388; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Zineh I, 2013, NEW ENGL J MED, V369, P2273, DOI 10.1056/NEJMp1314529	40	94	95	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2280	2287		10.1016/S0140-6736(14)61994-2	http://dx.doi.org/10.1016/S0140-6736(14)61994-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25769357				2022-12-28	WOS:000355943500030
J	Cooper, AI				Cooper, Andrew I.			MATERIALS CHEMISTRY Cooperative carbon capture	NATURE			English	Editorial Material							DIOXIDE CAPTURE; CO2		Univ Liverpool, Dept Chem, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Cooper, AI (corresponding author), Univ Liverpool, Dept Chem, POB 147, Liverpool L69 3BX, Merseyside, England.	aicooper@liv.ac.uk	Cooper, Andrew/ABE-7766-2020					Ben T, 2009, ANGEW CHEM INT EDIT, V48, P9457, DOI 10.1002/anie.200904637; Dawson R, 2012, J AM CHEM SOC, V134, P10741, DOI 10.1021/ja301926h; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; International Energy Agency, 2013, CO2 EM FUEL COMB HIG; McDonald TM, 2015, NATURE, V519, P303, DOI 10.1038/nature14327; Mottillo C, 2014, ANGEW CHEM INT EDIT, V53, P7471, DOI 10.1002/anie.201402082; Rochelle GT, 2009, SCIENCE, V325, P1652, DOI 10.1126/science.1176731; Sato H, 2014, SCIENCE, V343, P167, DOI 10.1126/science.1246423; Serre C, 2002, J AM CHEM SOC, V124, P13519, DOI 10.1021/ja0276974; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272	10	43	43	5	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					294	295		10.1038/nature14212	http://dx.doi.org/10.1038/nature14212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762147				2022-12-28	WOS:000351171900025
J	Watson, D; Christensen, L; Knudsen, KK; Richard, J; Gallazzi, A; Michalowski, MJ				Watson, Darach; Christensen, Lise; Knudsen, Kirsten Kraiberg; Richard, Johan; Gallazzi, Anna; Michalowski, Michal Jerzy			A dusty, normal galaxy in the epoch of reionization	NATURE			English	Article							STAR-FORMING GALAXIES; SIMILAR-TO 7; LYMAN BREAK GALAXIES; SUBMILLIMETER GALAXIES; PHYSICAL-PROPERTIES; STARBURST GALAXY; MOLECULAR GAS; SIMPLE-MODEL; REDSHIFT; ULTRAVIOLET	Candidates for the modest galaxies that formed most of the stars in the early Universe, at redshifts z> 7, have been found in large numbers with extremely deep restframe-ultraviolet imagingl. But it has proved difficult for existing spectrographs to characterize them using their ultraviolet light(2-4). The detailed properties of these galaxies could be measured from dust and cool gas emission at far-infrared wavelengths if the galaxies have become sufficiently enriched in dust and metals. So far, however, the most distant galaxy discovered via its ultraviolet emission and subsequently detected in dust emission is only at z = 3.2 (ref. 5), and recent results have cast doubt on whether dust and molecules can be found in typical galaxies at z >= 7(6-8). Here we report thermal dust emission from an archetypal early Universe star-forming galaxy, A1689-zDI. We detect its stellar continuum in spectroscopy and determine its redshift to be z = 7.5 +/- 0.2 from a spectroscopic detection of the Lyman-a break. A1689-zD1 is representative of the star-forming population during the epoch of reionization(9), with a total star-formation rate of about 12 solar masses per year. The galaxy is highly evolved: it has a large stellar mass and is heavily enriched in dust, with a dust-to-gas ratio close to that of the Milky Way. Dusty, evolved galaxies are thus present among the fainter star-forming population at z> 7.	[Watson, Darach; Christensen, Lise; Gallazzi, Anna] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark; [Knudsen, Kirsten Kraiberg] Chalmers Univ Technol, Onsala Space Observ, Dept Earth & Space Sci, SE-43992 Onsala, Sweden; [Richard, Johan] Univ Lyon 1, Ctr Rech Astrophys Lyon, F-69561 St Genis Laval, France; [Gallazzi, Anna] Osserv Astrofis Arcetri, Ist Nazl Astrofis, I-50125 Florence, Italy; [Michalowski, Michal Jerzy] Univ Edinburgh, Royal Observ, Inst Astron, Scottish Univ Phys Alliance, Edinburgh EH9 3HJ, Midlothian, Scotland	University of Copenhagen; Niels Bohr Institute; Chalmers University of Technology; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Istituto Nazionale Astrofisica (INAF); University of Edinburgh	Watson, D (corresponding author), Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, Juliane Maries Vej 32, DK-2100 Copenhagen O, Denmark.	darach@dark-cosmology.dk	Michałowski, Michał/AAQ-4789-2021; Christensen, Lise/M-5301-2014; Watson, Darach/E-4521-2015	Christensen, Lise/0000-0001-8415-7547; Watson, Darach/0000-0002-4465-8264; Gallazzi, Anna/0000-0002-9656-1800; Richard, Johan/0000-0001-5492-1049; Michalowski, Michal/0000-0001-9033-4140	Danish National Research Foundation; EU under a Marie Curie Intra-European Fellowship [PIEF-GA-2010-274117]; Swedish Research Council; Knut and Alice Wallenberg Foundation; European Research Council starting grant; CALENDS; Career Integration Grant [294074]; European Union Seventh Framework Programme (FP7) [267251]; Science and Technology Facilities Council	Danish National Research Foundation(Danmarks Grundforskningsfond); EU under a Marie Curie Intra-European Fellowship(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Research Council starting grant(European Research Council (ERC)); CALENDS; Career Integration Grant; European Union Seventh Framework Programme (FP7); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Dark Cosmology Centre is funded by the Danish National Research Foundation. L.C. is supported by the EU under a Marie Curie Intra-European Fellowship, contract number PIEF-GA-2010-274117. K.K. acknowledges support from the Swedish Research Council and the Knut and Alice Wallenberg Foundation. J.R. acknowledges support from a European Research Council starting grant, CALENDS, and the Career Integration Grant 294074. A.G. acknowledges support from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 267251 ("AstroFlt"). M.J.M. acknowledges the support of the Science and Technology Facilities Council. ALMA is a partnership of the European Southern Observatory (ESO, representing its member states), the National Science Foundation (USA) and National Institutes of Natural Sciences (Japan), together with the National Research Council (Canada) and the National Science Council and the Academia Sinica Institute for Astronomy and Astrophysics (Taiwan), in cooperation with Chile. The Joint ALMA Observatory is operated by the ESO, Associated Universities Inc./National Radio Astronomy Observatory and the National Astronomical Observatory of Japan. We thank L. Lindroos, J. Hjorth, J. Fynbo, A. C. Andersen, and R. Bouwens for discussions, M. Limousin for providing a lensing map of the cluster,and the Nordic ALMA Regional Center Node for assistance.	Andersen A. C., 2007, ASP C SER, V768, P170; Berger E., 2014, ASTROPHYS J UNPUB; Bolzonella M, 2000, ASTRON ASTROPHYS, V363, P476; Bouwens R. J., 2014, ASTROPHYS J IN PRESS; Bradley LD, 2008, ASTROPHYS J, V678, P647, DOI 10.1086/533519; Bradley LD, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/3; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Charlot S, 2000, ASTROPHYS J, V539, P718, DOI 10.1086/309250; Christensen L, 2012, MON NOT R ASTRON SOC, V427, P1973, DOI 10.1111/j.1365-2966.2012.22007.x; Christensen L, 2012, MON NOT R ASTRON SOC, V427, P1953, DOI 10.1111/j.1365-2966.2012.22006.x; Cooray A, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/40; da Cunha E, 2008, MON NOT R ASTRON SOC, V388, P1595, DOI 10.1111/j.1365-2966.2008.13535.x; da Cunha E, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/13; Diaz-Santos T, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/68; Draine BT, 2007, ASTROPHYS J, V663, P866, DOI 10.1086/518306; Finkelstein SL, 2013, NATURE, V502, P524, DOI 10.1038/nature12657; Fisher DB, 2014, NATURE, V505, P186, DOI 10.1038/nature12765; Gallazzi A, 2005, MON NOT R ASTRON SOC, V362, P41, DOI 10.1111/j.1365-2966.2005.09321.x; Hu EM, 2002, ASTROPHYS J, V568, pL75, DOI 10.1086/340424; Iglesias-Paramo J, 2007, ASTROPHYS J, V670, P279, DOI 10.1086/521867; Iye M, 2006, NATURE, V443, P186, DOI 10.1038/nature05104; Jiang LH, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/99; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Koekemoer A. M., 2003, 2002 HST CAL WORKSH, P337; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; MADAU P, 1995, ASTROPHYS J, V441, P18, DOI 10.1086/175332; Magdis GE, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L9; McMullin JP, 2007, ASTR SOC P, V376, P127; Meurer GR, 1999, ASTROPHYS J, V521, P64, DOI 10.1086/307523; Michalowski M, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913634; Michalowski MJ, 2010, ASTROPHYS J, V712, P942, DOI 10.1088/0004-637X/712/2/942; Ota K, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/34; Oteo I, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424607; Ouchi M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/102; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Salim S, 2005, ASTROPHYS J, V619, pL39, DOI 10.1086/424800; Schaerer D, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424649; Shibuya T, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/114; Silva L, 1998, ASTROPHYS J, V509, P103, DOI 10.1086/306476; Smit R, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/58; Smit R, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/14; Stark DP, 2014, MON NOT R ASTRON SOC, V445, P3200, DOI 10.1093/mnras/stu1618; Tan Q, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L24; Tanvir NR, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/46; Tanvir NR, 2009, NATURE, V461, P1254, DOI 10.1038/nature08459; Treu T, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L29; Zafar T, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201321413	50	237	237	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					327	+		10.1038/nature14164	http://dx.doi.org/10.1038/nature14164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25731171	Green Submitted			2022-12-28	WOS:000351171900035
J	Naeem, S; Ingram, JC; Varga, A; Agardy, T; Barten, P; Bennett, G; Bloomgarden, E; Bremer, LL; Burkill, P; Cattau, M; Ching, C; Colby, M; Cook, DC; Costanza, R; DeClerck, F; Freund, C; Gartner, T; Benner, RG; Gunderson, J; Jarrett, D; Kinzig, AP; Kiss, A; Koontz, A; Kumar, P; Lasky, JR; Masozera, M; Meyers, D; Milano, F; Naughton-Treves, L; Nichols, E; Olander, L; Olmsted, P; Perge, E; Perrings, C; Polasky, S; Potent, J; Prager, C; Quetier, F; Redford, K; Saterson, K; Thoumi, G; Vargas, MT; Vickerman, S; Weisser, W; Wilkie, D; Wunder, S				Naeem, S.; Ingram, J. C.; Varga, A.; Agardy, T.; Barten, P.; Bennett, G.; Bloomgarden, E.; Bremer, L. L.; Burkill, P.; Cattau, M.; Ching, C.; Colby, M.; Cook, D. C.; Costanza, R.; DeClerck, F.; Freund, C.; Gartner, T.; Benner, R. Goldman; Gunderson, J.; Jarrett, D.; Kinzig, A. P.; Kiss, A.; Koontz, A.; Kumar, P.; Lasky, J. R.; Masozera, M.; Meyers, D.; Milano, F.; Naughton-Treves, L.; Nichols, E.; Olander, L.; Olmsted, P.; Perge, E.; Perrings, C.; Polasky, S.; Potent, J.; Prager, C.; Quetier, F.; Redford, K.; Saterson, K.; Thoumi, G.; Vargas, M. T.; Vickerman, S.; Weisser, W.; Wilkie, D.; Wunder, S.			Get the science right when paying for nature's services	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIODIVERSITY CONSERVATION; ENVIRONMENTAL SERVICES; PAYMENTS; PROGRAMS; MONEY					sn2121@columbia.edu	Costanza, Robert/A-4912-2008; Wunder, Sven/ABE-7773-2020; Nichols, Elizabeth/L-7484-2013; Freund, Cathryn A./AAI-7805-2020; Weisser, Wolfgang W/B-9718-2014; Polasky, Stephen/AAC-5341-2019; Cook, David C/C-1064-2009; Costanza, Robert/AAJ-3546-2021; Quetier, Fabien/K-6872-2015	Costanza, Robert/0000-0001-6348-8734; Wunder, Sven/0000-0002-9422-0260; Nichols, Elizabeth/0000-0002-4960-6842; Freund, Cathryn A./0000-0002-1570-5519; Weisser, Wolfgang W/0000-0002-2757-8959; Cook, David C/0000-0002-2954-7697; Cattau, Megan/0000-0003-2164-3809; Quetier, Fabien/0000-0002-3767-0353; Jarrett, David/0000-0001-7600-5447; Bremer, Leah/0000-0003-3791-4482	U.S. Agency for International Development TRANSLINKS program [EPP-A-00-06-00014-00]; National Academies Keck Futures Initiative	U.S. Agency for International Development TRANSLINKS program(United States Agency for International Development (USAID)); National Academies Keck Futures Initiative	This work has been supported by the U.S. Agency for International Development TRANSLINKS program (EPP-A-00-06-00014-00) and the National Academies Keck Futures Initiative.	Clements T, 2010, ECOL ECON, V69, P1283, DOI 10.1016/j.ecolecon.2009.11.010; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Ellison K, 2009, FRONT ECOL ENVIRON, V7, P60, DOI 10.1890/1540-9295-7.1.60; Farley J, 2010, ECOL ECON, V69, P2060, DOI 10.1016/j.ecolecon.2010.06.010; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Grolleau G, 2012, ECOL ECON, V76, P87, DOI 10.1016/j.ecolecon.2012.02.006; Ina P., 2013, PAYMENTS ENV SERVICE; Ingram JC, 2014, ECOSYST SERV, V7, P10, DOI 10.1016/j.ecoser.2013.12.003; Kareiva P, 2008, SCIENCE, V321, P1638, DOI 10.1126/science.1162756; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Muradian R, 2010, ECOL ECON, V69, P1202, DOI 10.1016/j.ecolecon.2009.11.006; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Pirard R, 2014, ECOSYST SERV, V9, P106, DOI 10.1016/j.ecoser.2014.06.005; Sutherland WJ, 2014, ORYX, V48, P1, DOI 10.1017/S0030605313001543; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Wunder S, 2013, CONSERV LETT, V6, P230, DOI 10.1111/conl.12034; Yin RS, 2013, FOREST POLICY ECON, V35, P66, DOI 10.1016/j.forpol.2013.06.010	18	180	186	11	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1206	1207		10.1126/science.aaa1403	http://dx.doi.org/10.1126/science.aaa1403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD1GZ	25766222				2022-12-28	WOS:000350824300023
J	Booth, B; Bellouin, N				Booth, Ben; Bellouin, Nicolas			CLIMATE CHANGE Black carbon and atmospheric feedbacks	NATURE			English	Editorial Material									[Booth, Ben] Met Off, Hadley Ctr, Exeter EX1 3PB, Devon, England; [Bellouin, Nicolas] Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England	Met Office - UK; Hadley Centre; University of Reading	Booth, B (corresponding author), Met Off, Hadley Ctr, Exeter EX1 3PB, Devon, England.	ben.booth@metoffice.gov.uk; n.bellouin@reading.ac.uk		Bellouin, Nicolas/0000-0003-2109-9559				Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Sand M., 2015, J CLIM; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026	3	37	37	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					167	168		10.1038/519167a	http://dx.doi.org/10.1038/519167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25762278				2022-12-28	WOS:000350770500025
J	Brett, A				Brett, Alex			Not a tragedy but a tool	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2015	350								h906	10.1136/bmj.h906	http://dx.doi.org/10.1136/bmj.h906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EL	25762577	Bronze			2022-12-28	WOS:000351182200015
J	O'Gara, PT; Oetgen, WJ				O'Gara, Patrick T.; Oetgen, William J.			Innovation and Implementation in Cardiovascular Medicine Challenges in the Face of Opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[O'Gara, Patrick T.] Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA; [O'Gara, Patrick T.] Harvard Univ, Sch Med, Boston, MA USA; [Oetgen, William J.] Amer Coll Cardiol, Washington, DC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; American College of Cardiology	O'Gara, PT (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St,PBB A3, Boston, MA 02115 USA.	pogara@partners.org						Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Berwick D, 2014, GRADUATE MEDICAL EDU; Carroll JD, 2015, HEALTH AFFAIR, V34, P328, DOI 10.1377/hlthaff.2014.1010; Chin WW, 5 IMPERATIVES ADDRES; Lagerqvist B, 2014, NEW ENGL J MED, V371, P1111, DOI 10.1056/NEJMoa1405707; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Mozaffarian D, 2015, CIRCULATION, V131, P434, DOI 10.1161/CIR.0000000000000157; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717	9	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1007	1008		10.1001/jama.2015.1921	http://dx.doi.org/10.1001/jama.2015.1921			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756431				2022-12-28	WOS:000350643100010
J	Kelly, J; Barends, R; Fowler, AG; Megrant, A; Jeffrey, E; White, TC; Sank, D; Mutus, JY; Campbell, B; Chen, Y; Chen, Z; Chiaro, B; Dunsworth, A; Hoi, IC; Neill, C; O'Malley, PJJ; Quintana, C; Roushan, P; Vainsencher, A; Wenner, J; Cleland, AN; Martinis, JM				Kelly, J.; Barends, R.; Fowler, A. G.; Megrant, A.; Jeffrey, E.; White, T. C.; Sank, D.; Mutus, J. Y.; Campbell, B.; Chen, Yu; Chen, Z.; Chiaro, B.; Dunsworth, A.; Hoi, I. -C.; Neill, C.; O'Malley, P. J. J.; Quintana, C.; Roushan, P.; Vainsencher, A.; Wenner, J.; Cleland, A. N.; Martinis, John M.			State preservation by repetitive error detection in a superconducting quantum circuit	NATURE			English	Article							CORRECTING CODES; FAULT-TOLERANCE; REALIZATION	Quantum computing becomes viable when a quantum state can be protected from environment-induced error. If quantum bits (qubits) are sufficiently reliable, errors are sparse and quantum error correction (QEC)(1-6) is capable of identifying and correcting them. Adding more qubits improves the preservation of states by guaranteeing that increasingly larger clusters of errors will not cause logical failure a key requirement for large-scale systems. Using QEC to extend the qubit lifetime remains one of the outstanding experimental challenges in quantum computing. Here we report the protection of classical states from environmental bit-flip errors and demonstrate the suppression of these errors with increasing system size. We use a linear array of nine qubits, which is a natural step towards the two-dimensional surface code QEC scheme(7), and track errors as they occur by repeatedly performing projective quantum non-demolition parity measurements. Relative to a single physical qubit, we reduce the failure rate in retrieving an input state by a factor of 2.7 when using five of our nine qubits and by a factor of 8.5 when using all nine qubits after eight cycles. Additionally, we tomographically verify preservation of the non-classical Greenberger-Horne-Zeilinger state. The successful suppression of environment-induced errors will motivate further research into the many challenges associated with building a large-scale superconducting quantum computer.	[Kelly, J.; Barends, R.; Fowler, A. G.; Megrant, A.; Jeffrey, E.; White, T. C.; Sank, D.; Mutus, J. Y.; Campbell, B.; Chen, Yu; Chen, Z.; Chiaro, B.; Dunsworth, A.; Hoi, I. -C.; Neill, C.; O'Malley, P. J. J.; Quintana, C.; Roushan, P.; Vainsencher, A.; Wenner, J.; Cleland, A. N.; Martinis, John M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Fowler, A. G.] Univ Melbourne, Sch Phys, Ctr Quantum Computat & Commun Technol, Melbourne, Vic 3010, Australia; [Megrant, A.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Melbourne; University of California System; University of California Santa Barbara	Kelly, J (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	julian@physics.ucsb.edu; martinis@physics.ucsb.edu	Cleland, Andrew/AAG-7581-2019; Wenner, James/G-3777-2014	Wenner, James/0000-0001-7107-4734; Hoi, IoChun/0000-0002-4636-7110	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through Army Research Office [W911NF-09-1-0375, W911NF-10-1-0334]; US NSF	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through Army Research Office; US NSF(National Science Foundation (NSF))	We thank A. N. Korotkov and D. L. Moehring for discussions, and P. Duda for help with photomasks and photolithography. This work was supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through Army Research Office grants W911NF-09-1-0375 and W911NF-10-1-0334. All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI or the US Government. Devices were made at the UC Santa Barbara Nanofabrication Facility, a part of the US NSF-funded National Nanotechnology Infrastructure Network, and at the NanoStructures Cleanroom Facility.	Barends R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.080502; Bombin H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/9/095302; Bravyi S. B., 1998, PREPRINT; Calderbank AR, 1996, PHYS REV A, V54, P1098, DOI 10.1103/PhysRevA.54.1098; Chiaverini J, 2004, NATURE, V432, P602, DOI 10.1038/nature03074; Chow JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5015; Corcoles A., 2014, PREPRINT; Cory DG, 1998, PHYS REV LETT, V81, P2152, DOI 10.1103/PhysRevLett.81.2152; EDMONDS J, 1965, CANADIAN J MATH, V17, P449, DOI 10.4153/CJM-1965-045-4; EDMONDS J, 1965, J RES NATL BUR STAND, VB 69, P125, DOI 10.6028/jres.069B.013; Fowler A. G., 2014, PREPRINT; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Guhne O, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053002; Harty TP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220501; Jeffrey E, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.190504; Knill E, 2001, PHYS REV LETT, V86, P5811, DOI 10.1103/PhysRevLett.86.5811; Nigg D, 2014, SCIENCE, V345, P302, DOI 10.1126/science.1253742; Raussendorf R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190504; Reed MD, 2012, NATURE, V482, P382, DOI 10.1038/nature10786; Riste D., 2014, PREPRINT; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Sun L, 2014, NATURE, V511, P444, DOI 10.1038/nature13436	27	601	614	5	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					66	69		10.1038/nature14270	http://dx.doi.org/10.1038/nature14270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739628	Green Submitted			2022-12-28	WOS:000350304000036
J	Li, N; Chen, TW; Guo, ZV; Gerfen, CR; Svoboda, K				Li, Nuo; Chen, Tsai-Wen; Guo, Zengcai V.; Gerfen, Charles R.; Svoboda, Karel			A motor cortex circuit for motor planning and movement	NATURE			English	Article							FUNCTIONAL-ORGANIZATION; SENSORIMOTOR CORTEX; INTENDED MOVEMENT; CORTICAL ACTIVITY; NEURONAL-ACTIVITY; TRANSGENIC MICE; SINGLE NEURONS; MONKEY; MOUSE; DIRECTION	Activity in motor cortex predicts specific movements seconds before they occur, but how this preparatory activity relates to upcoming movements is obscure. We dissected the conversion of preparatory activity to movement within a structured motor cortex circuit. An anterior lateral region of the mouse cortex (a possible homologue of prernotor cortex in primates) contains equal proportions of intermingled neurons predicting ipsi- or contralateral movements, yet unilateral inactivation of this cortical region during movement planning disrupts contralateral movements. Using cell-type-specific electrophysiology, cellular imaging and optogenetic perturbation, we show that layer 5 neurons projecting within the cortex have unbiased laterality. Activity with a contralateral population bias arises specifically in layer 5 neurons projecting to the brairtstern, and only late during movement planning. These results reveal the transformation of distributed preparatory activity into movement commands within hierarchically organized cortical circuits.	[Li, Nuo; Chen, Tsai-Wen; Guo, Zengcai V.; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Gerfen, Charles R.] NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org		Chen, Tsai-Wen/0000-0001-6782-3819	Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002497] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Dickson, S. Druckmann, J. Dudman, D. Gutnisky, H. Inagaki, V. Jayaraman, D. O'Connor, S. Peron, T. Sato and G. Shepherd for comments on the manuscript and discussion, L. Walendy and E. Ophir for animal training, S. Michael and A. Hu for histology, T. Harris and B. Barbarits for the silicon probe recording system. This work was funded by the Howard Hughes Medical Institute. N.L. is a Helen Hay Whitney Foundation postdoctoral fellow.	Alstermark B, 2004, J NEUROPHYSIOL, V92, P1958, DOI 10.1152/jn.00092.2004; Arce FI, 2013, J NEUROPHYSIOL, V110, P1357, DOI 10.1152/jn.00144.2013; BAUSWEIN E, 1989, BRAIN RES, V493, P198, DOI 10.1016/0006-8993(89)91018-4; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; Bennett GA, 1941, ANAT REC, V79, P39, DOI 10.1002/ar.1090790105; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chen T. - W., 2008, THESIS U GOTTINGEN G; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CRUTCHER MD, 1990, J NEUROPHYSIOL, V64, P151, DOI 10.1152/jn.1990.64.1.151; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Guo ZCV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088678; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kaufman MT, 2014, NAT NEUROSCI, V17, P440, DOI 10.1038/nn.3643; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Murakami M, 2014, NAT NEUROSCI, V17, P1574, DOI 10.1038/nn.3826; MURRAY GM, 1992, J NEUROPHYSIOL, V67, P775, DOI 10.1152/jn.1992.67.3.775; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Pan WX, 2013, NAT NEUROSCI, V16, P71, DOI 10.1038/nn.3283; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; RIZZOLATTI G, 1983, BRAIN, V106, P655, DOI 10.1093/brain/106.3.655; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; SIMMONS PA, 1983, J NEUROPHYSIOL, V50, P838, DOI 10.1152/jn.1983.50.4.838; Stanek E, 2014, ELIFE, V3, DOI 10.7554/eLife.02511; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; SWADLOW HA, 1978, EXP BRAIN RES, V32, P439; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Turner RS, 2000, J NEUROSCI, V20, P7096, DOI 10.1523/JNEUROSCI.20-18-07096.2000; Yamashita T, 2013, NEURON, V80, P1477, DOI 10.1016/j.neuron.2013.10.059; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	54	278	280	5	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					51	U88		10.1038/nature14178	http://dx.doi.org/10.1038/nature14178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25731172				2022-12-28	WOS:000350304000033
J	Ostrom, H; Oberg, H; Xin, H; Larue, J; Beye, M; Dell'Angela, M; Gladh, J; Ng, ML; Sellberg, JA; Kaya, S; Mercurio, G; Nordlund, D; Hantschmann, M; Hieke, F; Kuhn, D; Schlotter, WF; Dakovski, GL; Turner, JJ; Minitti, MP; Mitra, A; Moeller, SP; Fohlisch, A; Wolf, M; Wurth, W; Persson, M; Norskov, JK; Abild-Pedersen, F; Ogasawara, H; Pettersson, LGM; Nilsson, A				Ostrom, H.; Oberg, H.; Xin, H.; Larue, J.; Beye, M.; Dell'Angela, M.; Gladh, J.; Ng, M. L.; Sellberg, J. A.; Kaya, S.; Mercurio, G.; Nordlund, D.; Hantschmann, M.; Hieke, F.; Kuehn, D.; Schlotter, W. F.; Dakovski, G. L.; Turner, J. J.; Minitti, M. P.; Mitra, A.; Moeller, S. P.; Foehlisch, A.; Wolf, M.; Wurth, W.; Persson, M.; Norskov, J. K.; Abild-Pedersen, F.; Ogasawara, H.; Pettersson, L. G. M.; Nilsson, A.			Probing the transition state region in catalytic CO oxidation on Ru	SCIENCE			English	Article							RAY-ABSORPTION SPECTROSCOPY; PHOTOELECTRON-SPECTROSCOPY; FEMTOSECOND DYNAMICS; ELECTRONIC-STRUCTURE; DESORPTION; LASER; FEMTOCHEMISTRY; ADSORBATES; SURFACES; RU(001)	Femtosecond x-ray laser pulses are used to probe the carbon monoxide (CO) oxidation reaction on ruthenium (Ru) initiated by an optical laser pulse. On a time scale of a few hundred femtoseconds, the optical laser pulse excites motions of CO and oxygen (O) on the surface, allowing the reactants to collide, and, with a transient close to a picosecond (ps), new electronic states appear in the OK-edge x-ray absorption spectrum. Density functional theory calculations indicate that these result from changes in the adsorption site and bond formation between CO and O with a distribution of OC-O bond lengths close to the transition state (TS). After 1 ps, 10% of the CO populate the TS region, which is consistent with predictions based on a quantum oscillator model.	[Ostrom, H.; Oberg, H.; Gladh, J.; Sellberg, J. A.; Pettersson, L. G. M.; Nilsson, A.] Stockholm Univ, AlbaNova Univ Ctr, Dept Phys, SE-10691 Stockholm, Sweden; [Xin, H.; Larue, J.; Beye, M.; Ng, M. L.; Sellberg, J. A.; Kaya, S.; Norskov, J. K.; Abild-Pedersen, F.; Nilsson, A.] SLAC Natl Accelerator Lab, SUNCAT Ctr Interface Sci & Catalysis, Menlo Pk, CA 94025 USA; [Larue, J.; Norskov, J. K.] Stanford Univ, Dept Chem Engn, SUNCAT Ctr Interface Sci & Catalysis, Stanford, CA 95305 USA; [Beye, M.; Hantschmann, M.; Kuehn, D.; Foehlisch, A.] Helmholtz Zentrum Berlin Mat & Energie GmbH, D-12489 Berlin, Germany; [Dell'Angela, M.; Mercurio, G.; Hieke, F.; Wurth, W.] Univ Hamburg, Dept Phys, D-22761 Hamburg, Germany; [Dell'Angela, M.; Mercurio, G.; Hieke, F.; Wurth, W.] Univ Hamburg, Ctr Free Electron Laser Sci, D-22761 Hamburg, Germany; [Nordlund, D.; Ogasawara, H.; Nilsson, A.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Schlotter, W. F.; Dakovski, G. L.; Turner, J. J.; Minitti, M. P.; Mitra, A.; Moeller, S. P.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Foehlisch, A.] Univ Potsdam, Fak Phys & Astron, D-14476 Potsdam, Germany; [Wolf, M.] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Wurth, W.] DESY, Photon Sci, D-22607 Hamburg, Germany; [Persson, M.] Univ Liverpool, Surface Sci Res Ctr, Liverpool L69 3BX, Merseyside, England; [Persson, M.] Univ Liverpool, Dept Chem, Liverpool L69 3BX, Merseyside, England	Stockholm University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Hamburg; University of Hamburg; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Potsdam; University of Wurzburg; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Liverpool; University of Liverpool	Nilsson, A (corresponding author), Stockholm Univ, AlbaNova Univ Ctr, Dept Phys, SE-10691 Stockholm, Sweden.	nilsson@slac.stanford.edu	Nilsson, Anders/E-1943-2011; Gladh, Jörgen/W-3493-2017; Wolf, Martin/Q-3548-2016; Abild-Pedersen, Frank/C-3248-2014; Kaya, Sarp/C-4001-2008; Sellberg, Jonas A/C-6506-2009; LaRue, Jerry/N-9047-2017; Ogasawara, Hirohito/AGU-4579-2022; Norskov, Jens K/D-2539-2017; Ogasawara, Hirohito/D-2105-2009; Beye, Martin/F-1165-2011; Persson, Mats O/A-7514-2011; Pettersson, Lars GM/J-4925-2013; Ogasawara, Hirohito/AAC-8754-2020; Nordlund, Dennis/A-8902-2008	Nilsson, Anders/0000-0003-1968-8696; Gladh, Jörgen/0000-0002-5389-5675; Abild-Pedersen, Frank/0000-0002-1911-074X; Kaya, Sarp/0000-0002-2591-5843; Sellberg, Jonas A/0000-0003-2793-5052; LaRue, Jerry/0000-0002-8081-5335; Ogasawara, Hirohito/0000-0001-5338-1079; Norskov, Jens K/0000-0002-4427-7728; Ogasawara, Hirohito/0000-0001-5338-1079; Beye, Martin/0000-0002-3924-2993; Persson, Mats O/0000-0002-1443-9490; Pettersson, Lars GM/0000-0003-1133-9934; Nordlund, Dennis/0000-0001-9524-6908; Xin, Hongliang/0000-0001-9344-1697; Alexander, Fohlisch/0000-0003-4126-8233; Dell'Angela, Martina/0000-0003-1228-2458	U.S. Department of Energy, Basic Energy Science through SUNCAT Center for Interface Science and Catalysis; Swedish Research Council; Knut and Alice Wallenberg foundation; U.S. Department of Energy through SLAC Laboratory Directed Research and Development program [DE-AC02-76SF00515]; Volkswagen Stiftung; Deutsche Forschungsgemeinschaft within the excellence cluster "Center for Ultrafast Imaging (CUI)"; LCLS, Stanford University through Stanford Institute for Materials Energy Sciences (SIMES); Lawrence Berkeley National Laboratory (LBNL), University of Hamburg through the Bundesministerium fur Bildung, Wissenschaft; Forschung und Technologie priority program [FSP 301]; Center for Free Electron Laser Science (CFEL)	U.S. Department of Energy, Basic Energy Science through SUNCAT Center for Interface Science and Catalysis(United States Department of Energy (DOE)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); U.S. Department of Energy through SLAC Laboratory Directed Research and Development program(United States Department of Energy (DOE)); Volkswagen Stiftung(Volkswagen); Deutsche Forschungsgemeinschaft within the excellence cluster "Center for Ultrafast Imaging (CUI)"(German Research Foundation (DFG)); LCLS, Stanford University through Stanford Institute for Materials Energy Sciences (SIMES); Lawrence Berkeley National Laboratory (LBNL), University of Hamburg through the Bundesministerium fur Bildung, Wissenschaft; Forschung und Technologie priority program; Center for Free Electron Laser Science (CFEL)	This work is supported by the U.S. Department of Energy, Basic Energy Science through the SUNCAT Center for Interface Science and Catalysis, the Swedish Research Council, the Knut and Alice Wallenberg foundation, the U.S. Department of Energy through the SLAC Laboratory Directed Research and Development program under contract DE-AC02-76SF00515, the Volkswagen Stiftung, and the Deutsche Forschungsgemeinschaft within the excellence cluster "Center for Ultrafast Imaging (CUI)." The spectrum calculations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at the HPC2N center. Portions of this research were carried out on the SXR Instrument at the Linac Coherent Light Source (LCLS), a division of SLAC National Accelerator Laboratory, and an Office of Science user facility operated by Stanford University for the U.S. Department of Energy. The SXR Instrument is funded by a consortium whose membership includes the LCLS, Stanford University through the Stanford Institute for Materials Energy Sciences (SIMES), Lawrence Berkeley National Laboratory (LBNL), University of Hamburg through the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie priority program FSP 301, and the Center for Free Electron Laser Science (CFEL). The experimental and theoretical data are available in the supplementary materials.	Beye M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.186101; Bonn M, 2000, PHYS REV LETT, V84, P4653, DOI 10.1103/PhysRevLett.84.4653; Bonn M, 1999, SCIENCE, V285, P1042, DOI 10.1126/science.285.5430.1042; Dell'Angela M, 2013, SCIENCE, V339, P1302, DOI 10.1126/science.1231711; Ertl G., 2009, REACTIONS SOLID SURF; Frischkorn C, 2006, CHEM REV, V106, P4207, DOI 10.1021/cr050161r; Her TH, 1998, J CHEM PHYS, V108, P8595, DOI 10.1063/1.476289; Hess C, 2000, APPL PHYS A-MATER, V71, P477, DOI 10.1007/s003390000703; Ionov PI, 1997, J CHEM PHYS, V107, P9457, DOI 10.1063/1.475242; KAO FJ, 1993, PHYS REV LETT, V71, P2094, DOI 10.1103/PhysRevLett.71.2094; Katayama T, 2013, J ELECTRON SPECTROSC, V187, P9, DOI 10.1016/j.elspec.2013.03.006; Keller C, 1998, PHYS REV B, V57, P11951, DOI 10.1103/PhysRevB.57.11951; Lisowski M, 2004, APPL PHYS A-MATER, V78, P165, DOI 10.1007/s00339-003-2301-7; Luntz AC, 2008, CHEMICAL BONDING AT SURFACES AND INTERFACES, P143, DOI 10.1016/B978-044452837-7.50004-6; Nilsson A, 2005, CATAL LETT, V100, P111, DOI 10.1007/s10562-004-3434-9; Norskov JK, 2014, Fundamental Concepts in Heterogeneous Catalysis, P1, DOI 10.1002/9781118892114; Orr-Ewing AJ, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4866761; Petek H, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4746801; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; PRYBYLA JA, 1990, PHYS REV LETT, V64, P1537, DOI 10.1103/PhysRevLett.64.1537; SCHERER NF, 1990, J CHEM PHYS, V92, P5239, DOI 10.1063/1.458531; Schlotter WF, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3698294; Stohr J., 1992, NEXAFS SPECTROSCOPY; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; Szymanski P, 2008, J PHYS CHEM C, V112, P15802, DOI 10.1021/jp8044737; TILLBORG H, 1993, PHYS REV B, V47, P1699, DOI 10.1103/PhysRevB.47.1699; TILLBORG H, 1992, SURF SCI, V273, P47, DOI 10.1016/0039-6028(92)90275-B; Triguero L, 1998, PHYS REV B, V58, P8097, DOI 10.1103/PhysRevB.58.8097; ZDANSKY EOF, 1993, PHYS REV B, V48, P2632, DOI 10.1103/PhysRevB.48.2632	29	154	162	5	450	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					978	982		10.1126/science.1261747	http://dx.doi.org/10.1126/science.1261747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722407	Green Submitted			2022-12-28	WOS:000349958900034
J	Steinman, BA; Mann, ME; Miller, SK				Steinman, Byron A.; Mann, Michael E.; Miller, Sonya K.			Atlantic and Pacific multidecadal oscillations and Northern Hemisphere temperatures	SCIENCE			English	Article							SURFACE-TEMPERATURE; INTERDECADAL CHANGES; CLIMATE; VARIABILITY; CIRCULATION; CMIP5; HIATUS; MODES	The recent slowdown in global warming has brought into question the reliability of climate model projections of future temperature change and has led to a vigorous debate over whether this slowdown is the result of naturally occurring, internal variability or forcing external to Earth's climate system. To address these issues, we applied a semi-empirical approach that combines climate observations and model simulations to estimate Atlantic-and Pacific-based internal multidecadal variability (termed "AMO" and "PMO," respectively). Using this method, the AMO and PMO are found to explain a large proportion of internal variability in Northern Hemisphere mean temperatures. Competition between a modest positive peak in the AMO and a substantially negative-trending PMO are seen to produce a slowdown or "false pause" in warming of the past decade.	[Steinman, Byron A.] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Steinman, Byron A.] Univ Minnesota, Dept Earth & Environm Sci, Duluth, MN 55812 USA; [Mann, Michael E.; Miller, Sonya K.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Mann, Michael E.; Miller, Sonya K.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Steinman, BA (corresponding author), Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA.	bsteinma@d.umn.edu	Kushnir, Yochanan/B-4472-2013; Mann, Michael E/B-8472-2017	Mann, Michael E/0000-0003-3067-296X	U.S. National Science Foundation Atmospheric and Geospace Sciences-Postdoctoral Research Fellowships (AGS-PRF) [AGS-1137750]	U.S. National Science Foundation Atmospheric and Geospace Sciences-Postdoctoral Research Fellowships (AGS-PRF)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	All raw data, Matlab code, and results from our analysis are available at the supplementary website: www.meteo.psu.edu/holocene/public_html/supplements/Science2015. We acknowledge the World Climate Research Programme's Working Group on Coupled Modeling, which is responsible for CMIP, and we thank the climate modeling groups for producing and making available their model output. We thank K. Emanuel and G. Schmidt for helpful comments on earlier versions of the manuscript. B.A.S. acknowledges support by the U.S. National Science Foundation Atmospheric and Geospace Sciences-Postdoctoral Research Fellowships (AGS-PRF) (AGS-1137750). Kaplan SST V2 data were provided by the NOAA/Office of Oceanic and Atmospheric Research/Earth System Research Laboratory Physical Sciences Division, Boulder, Colorado, USA: www.esrl.noaa.gov/psd. HadISST data were provided by the Met Office Hadley Centre: www.metoffice.gov.uk/hadobs. ERSST data were provided by NOAA: www.ncdc.noaa.gov/data-access/marineocean-data/extended-reconstructed-sea-surface-temperature-ersst-v3b.	Alexander MA, 2002, J CLIMATE, V15, P2205, DOI 10.1175/1520-0442(2002)015<2205:TABTIO>2.0.CO;2; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Chen W, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013596; Chylek P, 2014, GEOPHYS RES LETT, V41, P1689, DOI 10.1002/2014GL059274; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Cowtan K, 2014, Q J ROY METEOR SOC, V140, P1935, DOI 10.1002/qj.2297; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Dong BW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025766; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Guan B, 2009, J CLIMATE, V22, P4228, DOI 10.1175/2009JCLI2921.1; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Knight JR, 2009, J CLIMATE, V22, P1610, DOI 10.1175/2008JCLI2628.1; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Kravtsov S, 2014, GEOPHYS RES LETT, V41, P6881, DOI 10.1002/2014GL061416; Kushnir Y, 2010, J CLIMATE, V23, P5610, DOI 10.1175/2010JCLI3172.1; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Mann ME, 1999, ADV GEOPHYS, V41, P1, DOI 10.1016/S0065-2687(08)60026-6; Mann ME, 1996, J CLIMATE, V9, P2137, DOI 10.1175/1520-0442(1996)009<2137:JSMOST>2.0.CO;2; MANN ME, 1994, J GEOPHYS RES-ATMOS, V99, P25819, DOI 10.1029/94JD02396; Mann ME, 2014, GEOPHYS RES LETT, V41, P3211, DOI 10.1002/2014GL059233; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Marini C, 2014, CLIM DYNAM, V43, P607, DOI 10.1007/s00382-013-1852-3; Martin ER, 2014, GEOPHYS RES LETT, V41, P2169, DOI 10.1002/2014GL059338; McGregor S, 2014, NAT CLIM CHANGE, V4, P888, DOI [10.1038/nclimate2330, 10.1038/NCLIMATE2330]; Miller RL, 2014, J ADV MODEL EARTH SY, V6, P441, DOI 10.1002/2013MS000266; Minobe S, 1997, GEOPHYS RES LETT, V24, P683, DOI 10.1029/97GL00504; PARKER DE, 1994, J GEOPHYS RES-ATMOS, V99, P14373, DOI 10.1029/94JD00548; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Terray L, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053046; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; van Oldenborgh GJ, 2009, OCEAN SCI, V5, P293, DOI 10.5194/os-5-293-2009; Vimont DJ, 2005, J CLIMATE, V18, P2080, DOI 10.1175/JCLI3365.1; Wyatt MG, 2014, CLIM DYNAM, V42, P2763, DOI 10.1007/s00382-013-1950-2; Wyatt MG, 2012, CLIM DYNAM, V38, P929, DOI 10.1007/s00382-011-1071-8; Xue Y, 2003, J CLIMATE, V16, P1601, DOI 10.1175/1520-0442-16.10.1601; Zhang R., 2007, GEOPHYS RES LETT, P34	49	191	201	14	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					988	991		10.1126/science.1257856	http://dx.doi.org/10.1126/science.1257856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722410				2022-12-28	WOS:000349958900037
J	Gadre, A				Gadre, Arun			PERSONAL VIEW India's private healthcare sector treats patients as revenue generators	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gadre, Arun] Support Advocacy Hlth Initiat, Pune 411029, Maharashtra, India; [Gadre, Arun] Support Training Hlth Initiat, Pune 411029, Maharashtra, India		Gadre, A (corresponding author), Support Advocacy Hlth Initiat, Plot 140,Flats 3 & 4,Aman E Terrace, Pune 411029, Maharashtra, India.	drarun.gadre@gmail.com							0	14	14	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2015	350								h826	10.1136/bmj.h826	http://dx.doi.org/10.1136/bmj.h826			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AL	25712179				2022-12-28	WOS:000350292700020
J	Knaul, FM; Farmer, PE; Bhadelia, A; Berman, P; Horton, R				Knaul, Felicia M.; Farmer, Paul E.; Bhadelia, Afsan; Berman, Philippa; Horton, Richard			Closing the divide: the Harvard Global Equity Initiative-Lancet Commission on global access to pain control and palliative care	LANCET			English	Editorial Material									[Knaul, Felicia M.; Bhadelia, Afsan] Harvard Global Equ Initiat, Boston, MA 02115 USA; [Farmer, Paul E.] Harvard Univ, Sch Med, Boston, MA USA; [Berman, Philippa; Horton, Richard] The Lancet, London, England	Harvard University; Harvard Medical School	Knaul, FM (corresponding author), Harvard Global Equ Initiat, Boston, MA 02115 USA.	felicia_knaul@harvard.edu		Knaul, Felicia/0000-0002-0512-4788				Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Callahan D., 2002, THICAL DIMENSIONS HL, P3; Cohen J., 2012, APPLYING PUBLIC HLTH, P3, DOI [10.1093/acprof:oso/9780199599400.003.0010, DOI 10.1093/ACPROF:OSO/9780199599400.003.0010]; de Lima L., LEY NACL CUIDADOS PA; European Association of Palliative Care, 2014, ALB PASS 1 PALL CAR; Gawande A., 2014, MED WHAT MATTERS END; Harvard Global Equity Initiative, HGEI LANC COMM GLOB; Human Rights Watch, 2009, PLEAS DO NOT MAK US; International Association for Hospice and Palliative Care, VIS AND MISS; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kmietowicz Z., 2014, BMJ-BRIT MED J, V348, pg1744; Knaul FM, 2012, CLOSING CANC DIVIDE, P96; Knaul FM., 2012, CLOSING CANC DIVIDE, P29; Krakauer EL, 2007, ETHNOG STUD SUBJ, V7, P381; Krakauer EL, 2008, J PAIN SYMPTOM MANAG, V36, P505, DOI 10.1016/j.jpainsymman.2007.11.015; Liberman J, 2010, LANCET, V376, P856, DOI 10.1016/S0140-6736(10)60880-X; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Merriman Anne, 2010, Philos Ethics Humanit Med, V5, P10, DOI 10.1186/1747-5341-5-10; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ntizimira C., 2014, INTEGRATION PALLIATI; Pastrana T, 2014, PALLIATIVE MED, V28, P1; Paudel BD, 2015, J PAIN SYMPTOM MANAG, V49, P111, DOI 10.1016/j.jpainsymman.2014.02.011; Powell RA, 2015, LANCET ONCOL, V16, P131, DOI 10.1016/S1470-2045(15)70002-1; Secretaria de gobernacio: Diario Oficial De La Federacion, DIARIO OFICIAL FEDER; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Steedman MR, 2014, HEALTH AFFAIR, V33, P1612, DOI 10.1377/hlthaff.2014.0379; Worldwide Palliative Care Alliance World Health Organization, 2014, GLOB ATL PALL CAR EN	28	39	40	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					722	724		10.1016/S0140-6736(15)60289-6	http://dx.doi.org/10.1016/S0140-6736(15)60289-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	25762055	Bronze			2022-12-28	WOS:000360287900008
J	Glyn-Jones, S; Palmer, AJR; Agricola, R; Price, AJ; Vincent, TL; Weinans, H; Carr, AJ				Glyn-Jones, S.; Palmer, A. J. R.; Agricola, R.; Price, A. J.; Vincent, T. L.; Weinans, H.; Carr, A. J.			Osteoarthritis	LANCET			English	Article							RADIOGRAPHIC KNEE OSTEOARTHRITIS; GLYCATION END-PRODUCTS; HIP-JOINT CARTILAGE; BODY-MASS INDEX; DOUBLE-BLIND; ARTICULAR-CARTILAGE; BIOCHEMICAL MARKERS; WEIGHT-LOSS; EXTRACELLULAR-MATRIX; FEMOROACETABULAR IMPINGEMENT	Osteoarthritis is a major source of pain, disability, and socioeconomic cost worldwide. The epidemiology of the disorder is complex and multifactorial, with genetic, biological, and biomechanical components. Aetiological factors are also joint specific. Joint replacement is an effective treatment for symptomatic end-stage disease, although functional outcomes can be poor and the lifespan of prostheses is limited. Consequently, the focus is shifting to disease prevention and the treatment of early osteoarthritis. This task is challenging since conventional imaging techniques can detect only quite advanced disease and the relation between pain and structural degeneration is not close. Nevertheless, advances in both imaging and biochemical markers off er potential for diagnosis and as outcome measures for new treatments. Joint-preserving interventions under development include lifestyle modification and pharmaceutical and surgical modalities. Some show potential, but at present few have proven ability to arrest or delay disease progression.	[Glyn-Jones, S.; Palmer, A. J. R.; Price, A. J.; Vincent, T. L.; Carr, A. J.] Univ Oxford, Nuffi eld Dept Orthopaed Rheumatol & Musculoskele, Oxford, England; [Agricola, R.] Erasmus MC Univ, Med Ctr, Dept Orthopaed, Rotterdam, Netherlands; [Weinans, H.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands	University of Oxford; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Palmer, AJR (corresponding author), Nuffield Orthopaed Ctr, Botnar Ctr, Dept Orthopaed Rheumatol & Musculoskeletal Sci, Oxford OX3 7LD, England.	antony.palmer@ndorms.ox.ac.uk		Vincent, Tonia/0000-0002-3412-5712; Weinans, Harrie/0000-0002-2275-6170; Palmer, Antony/0000-0003-4616-7482	National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Unit; Arthritis Research UK Centre for Osteoarthritis Pathogenesis [20205]; Joint Royal College of Surgeons and Dunhill Medical Trust Fellowship; National Institute for Health Research [ACF-2015-13-017] Funding Source: researchfish	National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Unit; Arthritis Research UK Centre for Osteoarthritis Pathogenesis(Versus Arthritis); Joint Royal College of Surgeons and Dunhill Medical Trust Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR))	AJC, SG-J, AJP, and AJRP receive support from the National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Unit. AJC, SG-J, AJP, and TLV receive support from the Arthritis Research UK Centre for Osteoarthritis Pathogenesis (grant reference 20205). AJRP receives funding from a Joint Royal College of Surgeons and Dunhill Medical Trust Fellowship. We thank Michiel Siebelt and Cameron Brown for contributing figures 3 and 4, respectively.	Agricola R, 2013, OSTEOARTHR CARTILAGE, V21, P1514, DOI 10.1016/j.joca.2013.07.004; Agricola R, 2013, NAT REV RHEUMATOL, V9, P630, DOI 10.1038/nrrheum.2013.114; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Anandacoomarasamy A, 2012, ANN RHEUM DIS, V71, P26, DOI 10.1136/ard.2010.144725; Baker K, 2010, ANN RHEUM DIS, V69, P1779, DOI 10.1136/ard.2009.121426; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Baum T, 2013, OSTEOARTHR CARTILAGE, V21, P1474, DOI 10.1016/j.joca.2013.07.012; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Bingham CO, 2006, ARTHRITIS RHEUM-US, V54, P3494, DOI 10.1002/art.22160; Bittersohl B, 2012, INVEST RADIOL, V47, P392, DOI 10.1097/RLI.0b013e3182518d57; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Block JA, 2010, OSTEOARTHR CARTILAGE, V18, P5, DOI 10.1016/j.joca.2009.07.005; Blumenfeld O, 2013, OSTEOARTHR CARTILAGE, V21, P923, DOI 10.1016/j.joca.2013.04.009; Buckland-Wright Christopher, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS10; Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465; Burleigh A, 2012, ARTHRITIS RHEUM-US, V64, P2278, DOI 10.1002/art.34420; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Catterall JB, 2012, J BIOL CHEM, V287, P4640, DOI 10.1074/jbc.M111.249649; Chevalier X, 2009, ARTHRIT RHEUM-ARTHR, V61, P344, DOI 10.1002/art.24096; Chevalier X, 2013, NAT REV RHEUMATOL, V9, P400, DOI 10.1038/nrrheum.2013.44; Clohisy JC, 2010, CLIN ORTHOP RELAT R, V468, P555, DOI 10.1007/s11999-009-1138-6; Cohen SB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3430; Conaghan PG, 2011, OSTEOARTHR CARTILAGE, V19, P606, DOI 10.1016/j.joca.2011.02.018; Conaghan PG, 2013, NAT REV RHEUMATOL, V9, P68, DOI 10.1038/nrrheum.2012.225; Conde J, 2011, ARTHRITIS, DOI 10.1155/2011/203901; Cotofana S, 2012, ARTHRIT CARE RES, V64, P1681, DOI 10.1002/acr.21719; Cox LGE, 2012, BONE, V50, P1152, DOI 10.1016/j.bone.2012.01.024; Da Costa BR, 2012, COCHRANE DB SYST REV, V11; Dam EB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2774; DIEPPE P, 1993, ANN RHEUM DIS, V52, P557, DOI 10.1136/ard.52.8.557; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Eckstein F, 2012, OSTEOARTHR CARTILAGE, V20, P1250, DOI 10.1016/j.joca.2012.06.019; Eckstein F, 2009, CALCIFIED TISSUE INT, V84, P186, DOI 10.1007/s00223-008-9208-4; European Medicines Agency, 2014, PROT OSS REM AV FURT; Felson DT, 2013, ARTHRITIS RHEUM-US, V65, P355, DOI 10.1002/art.37726; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; Garnero P, 2001, ANN RHEUM DIS, V60, P619, DOI 10.1136/ard.60.6.619; Golightly YM, 2011, ARTHRITIS RHEUM-US, V63, P2276, DOI 10.1002/art.30412; Gossec L, 2008, OSTEOARTHR CARTILAGE, V16, P742, DOI 10.1016/j.joca.2008.02.021; Gossec L, 2009, OSTEOARTHR CARTILAGE, V17, P182, DOI 10.1016/j.joca.2008.06.009; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Gudbergsen H, 2012, OSTEOARTHR CARTILAGE, V20, P495, DOI 10.1016/j.joca.2012.02.639; Guermazi A, 2009, J BONE JOINT SURG AM, V91A, P54, DOI 10.2106/JBJS.H.01385; Guermazi A, 2013, ARTHRITIS RHEUM-US, V65, P2748, DOI 10.1002/art.38086; Guermazi A, 2013, NAT REV RHEUMATOL, V9, P236, DOI 10.1038/nrrheum.2012.223; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Happonen KE, 2010, ARTHRITIS RHEUM-US, V62, P3574, DOI 10.1002/art.27720; Harris JD, 2010, J BONE JOINT SURG AM, V92A, P2220, DOI 10.2106/JBJS.J.00049; Hartig-Andreasen C, 2012, CLIN ORTHOP RELAT R, V470, P2978, DOI 10.1007/s11999-012-2386-4; Harvey WF, 2010, ANN INTERN MED, V152, P287, DOI 10.7326/0003-4819-152-5-201003020-00006; Haugen IK, 2015, ANN RHEUM DIS, V74, P74, DOI 10.1136/annrheumdis-2013-203789; Henrotin Y, 2001, J BONE MINER RES, V16, P299, DOI 10.1359/jbmr.2001.16.2.299; Henrotin Y, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0361-z; Hiligsmann M, 2013, SEMIN ARTHRITIS RHEU, V43, P303, DOI 10.1016/j.semarthrit.2013.07.003; Hoch JM, 2011, OSTEOARTHR CARTILAGE, V19, P1396, DOI 10.1016/j.joca.2011.09.005; Hochberg MC, 2013, CURR OPIN RHEUMATOL, V25, P192, DOI 10.1097/BOR.0b013e32835cfb8e; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Javaid MK, 2010, OSTEOARTHR CARTILAGE, V18, P323, DOI 10.1016/j.joca.2009.11.002; Jevsevar DS, 2013, J AM ACAD ORTHOP SUR, V21, P571, DOI 10.5435/JAAOS-21-09-571; Jin XZ, 2015, ANN RHEUM DIS, V74, P703, DOI 10.1136/annrheumdis-2013-204494; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Keen HI, 2009, RADIOL CLIN N AM, V47, P581, DOI 10.1016/j.rcl.2009.04.007; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kijowski R, 2013, RADIOLOGY, V267, P503, DOI 10.1148/radiol.12121413; Kim HA, 2006, ARTHRITIS RHEUM-US, V54, P2152, DOI 10.1002/art.21951; Kinds MB, 2012, OSTEOARTHR CARTILAGE, V20, P997, DOI 10.1016/j.joca.2012.04.016; Krzeski P, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2315; Laslett LL, 2012, ANN RHEUM DIS, V71, P1322, DOI 10.1136/annrheumdis-2011-200970; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; le Graverand MPH, 2013, ANN RHEUM DIS, V72, P187, DOI 10.1136/annrheumdis-2012-202239; Lievense AM, 2003, ARTHRIT RHEUM-ARTHR, V49, P228, DOI 10.1002/art.11012; Liu-Bryan R, 2005, J IMMUNOL, V174, P5016, DOI 10.4049/jimmunol.174.8.5016; Liu-Bryan R, 2010, ARTHRITIS RHEUM-US, V62, P2004, DOI 10.1002/art.27475; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Lohmander LS, 2014, ARTHRITIS RHEUMATOL, V66, P1820, DOI 10.1002/art.38614; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Maksymowych WP, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4044; Malfait AM, 2013, NAT REV RHEUMATOL, V9, P654, DOI 10.1038/nrrheum.2013.138; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Mazzuca SA, 2010, OSTEOARTHR CARTILAGE, V18, P1008, DOI 10.1016/j.joca.2010.03.018; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024; Mork PJ, 2012, J EPIDEMIOL COMMUN H, V66, P678, DOI 10.1136/jech-2011-200834; Muthuri SG, 2011, OSTEOARTHR CARTILAGE, V19, P1286, DOI 10.1016/j.joca.2011.07.015; National Institute for Health and Care Excellence, 2014, OST CAR MAN AD; Neogi T, 2013, ARTHRITIS RHEUM-US, V65, P2048, DOI 10.1002/art.37987; Nevitt MC, 2010, ANN RHEUM DIS, V69, P163, DOI 10.1136/ard.2008.099531; Nicolaou S, 2012, AM J ROENTGENOL, V199, pS78, DOI 10.2214/AJR.12.9117; Nishida Y, 2004, OSTEOARTHR CARTILAGE, V12, P374, DOI 10.1016/j.joca.2004.01.008; Nishioka H, 2012, J MAGN RESON IMAGING, V35, P147, DOI 10.1002/jmri.22811; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Palmer AJR, 2013, BONE JOINT J, V95B, P738, DOI 10.1302/0301-620X.95B6.31414; Palmer AJR, 2013, BONE JOINT RES, V2, P33, DOI 10.1302/2046-3758.22.2000137; Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2; Prasad AP, 2013, OSTEOARTHR CARTILAGE, V21, P69, DOI 10.1016/j.joca.2012.09.011; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Raya JG, 2012, RADIOLOGY, V262, P550, DOI 10.1148/radiol.11110821; Raynauld JP, 2003, ARTHRITIS RHEUM, V48, P370, DOI 10.1002/art.10777; Reginster JY, 2013, ANN RHEUM DIS, V72, P179, DOI 10.1136/annrheumdis-2012-202231; Reichmann WM, 2011, OSTEOARTHR CARTILAGE, V19, P550, DOI 10.1016/j.joca.2011.01.023; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Richette P, 2011, ANN RHEUM DIS, V70, P139, DOI 10.1136/ard.2010.134015; Roemer FW, 2013, ANN RHEUM DIS, V72, P942, DOI 10.1136/annrheumdis-2012-201810; Roemer FW, 2011, ANN RHEUM DIS, V70, P1804, DOI 10.1136/ard.2011.150243; Rousseau JC, 2012, BONE, V51, P265, DOI 10.1016/j.bone.2012.04.001; Ruan MZC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005409; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Sanchez C, 2012, ARTHRITIS RHEUM-US, V64, P1193, DOI 10.1002/art.33445; Sandker MJ, 2013, BIOMATERIALS, V34, P8002, DOI 10.1016/j.biomaterials.2013.07.046; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Seidel MF, 2013, OSTEOARTHR CARTILAGE, V21, P1223, DOI 10.1016/j.joca.2013.06.004; Sharma L, 2013, ANN RHEUM DIS, V72, P235, DOI 10.1136/annrheumdis-2011-201070; Siebenrock KA, 2013, AM J SPORT MED, V41, P2308, DOI 10.1177/0363546513497564; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Spahn G, 2013, KNEE SURG SPORT TR A, V21, P96, DOI 10.1007/s00167-011-1751-2; Spector TD, 2005, ARTHRITIS RES THER, V7, pR625, DOI 10.1186/ar1716; Takayama Y, 2013, EUR J RADIOL, V82, pE192, DOI 10.1016/j.ejrad.2012.11.031; Taljanovic MS, 2008, SKELETAL RADIOL, V37, P423, DOI 10.1007/s00256-008-0446-3; Uthman OA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5555; Van Ginckel A, 2010, OSTEOARTHR CARTILAGE, V18, P1564, DOI 10.1016/j.joca.2010.10.007; van Spil WE, 2010, OSTEOARTHR CARTILAGE, V18, P605, DOI 10.1016/j.joca.2010.01.012; van Spil WE, 2013, ANN RHEUM DIS, V72, P29, DOI 10.1136/annrheumdis-2011-201177; Verbruggen G, 2012, ANN RHEUM DIS, V71, P891, DOI 10.1136/ard.2011.149849; Vincent TL, 2013, CURR OPIN PHARMACOL, V13, P449, DOI 10.1016/j.coph.2013.01.010; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Wang YY, 2012, ARTHRITIS RHEUM-US, V64, P3917, DOI 10.1002/art.34681; Weinans H, 2012, BONE, V51, P190, DOI 10.1016/j.bone.2012.02.002; Wenham CYJ, 2013, RHEUMATOLOGY, V52, P888, DOI 10.1093/rheumatology/kes386; Wiegant K, 2013, OSTEOARTHR CARTILAGE, V21, P1660, DOI 10.1016/j.joca.2013.08.006; Wirth W, 2011, OSTEOARTHR CARTILAGE, V19, P689, DOI 10.1016/j.joca.2011.02.011; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yusuf E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3894; Yusuf E, 2010, ANN RHEUM DIS, V69, P761, DOI 10.1136/ard.2008.106930; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhang YQ, 2010, ARTHRIT CARE RES, V62, P1527, DOI 10.1002/acr.20287; Zilkens C, 2014, J MAGN RESON IMAGING, V39, P94, DOI 10.1002/jmri.24096; Zilkens C, 2013, EUR J RADIOL, V82, pE81, DOI 10.1016/j.ejrad.2012.09.024	140	1355	1437	46	365	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					376	387		10.1016/S0140-6736(14)60802-3	http://dx.doi.org/10.1016/S0140-6736(14)60802-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN5CX	25748615				2022-12-28	WOS:000358448400027
J	Laing, C				Laing, Chris			On the alert for outcome improvement in acute kidney injury	LANCET			English	Editorial Material									[Laing, Chris] Royal Free Hosp, UCL Ctr Nephrol, London NW3 QRG, England; [Laing, Chris] UCL Partners Acad Hlth Sci Partnership, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London	Laing, C (corresponding author), Royal Free Hosp, UCL Ctr Nephrol, London NW3 QRG, England.	chris.laing@nhs.net						Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Colpaert K, 2012, CRIT CARE MED, V40, P1164, DOI 10.1097/CCM.0b013e3182387a6b; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ftouh S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4930; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; National Confi dential Enquiry into Patient Outcome and Death, 2009, ADD INS INJ REV CAR; Porter CJ, 2014, NEPHROL DIAL TRANSPL, V29, P1888, DOI 10.1093/ndt/gfu082; Selby NM, 2012, CLIN J AM SOC NEPHRO, V7, P533, DOI 10.2215/CJN.08970911; The Nhs 5 year forward View, 2014, NHS 5 YEAR FORW VIEW; Wilson FP, 2015, LANCET	12	4	4	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1924	1926		10.1016/S0140-6736(15)60181-7	http://dx.doi.org/10.1016/S0140-6736(15)60181-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1YR	25726516				2022-12-28	WOS:000354541700007
J	Walter, D; Lier, A; Geiselhart, A; Thalheimer, FB; Huntscha, S; Sobotta, MC; Moehrle, B; Brocks, D; Bayindir, I; Kaschutnig, P; Muedder, K; Klein, C; Jauch, A; Schroeder, T; Geiger, H; Dick, TP; Holland-Letz, T; Schmezer, P; Lane, SW; Rieger, MA; Essers, MAG; Williams, DA; Trumpp, A; Milsom, MD				Walter, Dagmar; Lier, Amelie; Geiselhart, Anja; Thalheimer, Frederic B.; Huntscha, Sina; Sobotta, Mirko C.; Moehrle, Bettina; Brocks, David; Bayindir, Irem; Kaschutnig, Paul; Muedder, Katja; Klein, Corinna; Jauch, Anna; Schroeder, Timm; Geiger, Hartmut; Dick, Tobias P.; Holland-Letz, Tim; Schmezer, Peter; Lane, Steven W.; Rieger, Michael A.; Essers, Marieke A. G.; Williams, David A.; Trumpp, Andreas; Milsom, Michael D.			Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells	NATURE			English	Article							TARGETED DISRUPTION; QUIESCENCE; CYTOKINES; DEFECTS; GROWTH; ALPHA; BLOOD	Haematopoietic stem cells (HSCs) are responsible for the lifelong production of blood cells. The accumulation of DNA damage in HSCs is a hallmark of ageing and is probably a major contributing factor in age-related tissue degeneration and malignant transformation'. A number of accelerated ageing syndromes are associated with defective DNA repair and genomic instability, including the most common inherited bone marrow failure syndrome, Fanconi anaemia'''. However, the physiological source of DNA damage in HSCs from both normal and diseased individuals remains unclear. Here we show in mice that DNA damage is a direct consequence of inducing HSCs to exit their homeostatic quiescent state in response to conditions that model physiological stress, such as infection or chronic blood loss. Repeated activation of HSCs out of their dormant state provoked the attrition of normal HSCs and, in the case of mice with a nonfunctional Fanconi anaemia DNA repair pathway, led to a complete collapse of the haematopoietic system, which phenocopied the highly penetrant bone marrow failure seen in Fanconi anaemia patients. Our findings establish a novel link between physiological stress and DNA damage in normal HSCs and provide a mechanistic explanation for the universal accumulation of DNA damage in HSCs during ageing and the accelerated failure of the haematopoietic system in Fanconi anaemia patients.	[Walter, Dagmar; Lier, Amelie; Huntscha, Sina; Klein, Corinna; Essers, Marieke A. G.; Trumpp, Andreas; Milsom, Michael D.] Heidelberg Inst Stem Cell Technol & Expt Med gGmb, D-69120 Heidelberg, Germany; [Geiselhart, Anja; Brocks, David; Bayindir, Irem; Kaschutnig, Paul; Milsom, Michael D.] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, Expt Hematol Grp, D-69120 Heidelberg, Germany; [Thalheimer, Frederic B.; Rieger, Michael A.] Goethe Univ Frankfurt, LOEWE Ctr Cell & Gene Therapy, D-60595 Frankfurt, Germany; [Thalheimer, Frederic B.; Rieger, Michael A.] Goethe Univ Frankfurt, Dept Hematol Oncol, D-60595 Frankfurt, Germany; [Sobotta, Mirko C.; Dick, Tobias P.] DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum DKFZ, Div Redox Regulat, D-69120 Heidelberg, Germany; [Moehrle, Bettina; Geiger, Hartmut] Univ Ulm, Inst Mol Med Stem Cells & Aging, D-89081 Ulm, Germany; [Muedder, Katja; Trumpp, Andreas] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Jauch, Anna] Heidelberg Univ, Inst Human Genet, D-69120 Heidelberg, Germany; [Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Geiger, Hartmut] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Holland-Letz, Tim] Deutsch Krebsforschungszentrum DKFZ, Div Biostat, D-69120 Heidelberg, Germany; [Schmezer, Peter] Deutsch Krebsforschungszentrum DKFZ, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany; [Lane, Steven W.] Univ Queensland, QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Essers, Marieke A. G.] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, Hematopoiet Stem Cells & Stress Grp, D-69120 Heidelberg, Germany; [Williams, David A.] Boston Childrens Hosp, Boston, MA 02115 USA; [Williams, David A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Williams, David A.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Williams, David A.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Cincinnati Children's Hospital Medical Center; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); QIMR Berghofer Medical Research Institute; University of Queensland; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School	Milsom, MD (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med gGmb, D-69120 Heidelberg, Germany.	m.milsom@hi-stem.de	Rieger, Michael A/L-8324-2017; Trumpp, Andreas/Z-2141-2019; Essers, Marieke A.G./B-7758-2017; Milsom, Michael/AAK-4600-2020	Rieger, Michael A/0000-0002-4158-5872; Trumpp, Andreas/0000-0002-6212-3466; Essers, Marieke A.G./0000-0003-3117-1809; Thalheimer, Frederic B./0000-0003-0423-099X; /0000-0002-3567-254X; Schroeder, Timm/0000-0001-9320-0252	Animal Laboratory Services Deutsches Krebsforschungszentrum (DKFZ) core facility; BioRN Leading-Edge Cluster "Cell-Based and Molecular Medicine" - German Federal Ministry of Education and Research; Dietmar Hopp Foundation; LOEWE Center for Cell and Gene Therapy Frankfurt, Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/17.004]; Deutsche Forschungsgemeinschaft [SFB873]; Helmholtz International Graduate School; Leukemia Foundation of Australia; Cure Cancer Australia Foundation; National Health and Medical Research Foundation of Australia	Animal Laboratory Services Deutsches Krebsforschungszentrum (DKFZ) core facility; BioRN Leading-Edge Cluster "Cell-Based and Molecular Medicine" - German Federal Ministry of Education and Research; Dietmar Hopp Foundation; LOEWE Center for Cell and Gene Therapy Frankfurt, Hessisches Ministerium fur Wissenschaft und Kunst; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz International Graduate School; Leukemia Foundation of Australia; Cure Cancer Australia Foundation; National Health and Medical Research Foundation of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank R. Gliniorz, S. Blaszkiewicz, V. Vogel and B. Schoell for technical assistance, B. Walter for help with figures and S. Frohling, M. Sprick and T. Oskarsson for critical proofreading of this manuscript. We also acknowledge support from the Animal Laboratory Services Deutsches Krebsforschungszentrum (DKFZ) core facility and S. Schmitt, A. Atzberger, J. Hartwig and K. Hexel from the Imaging and Cytometry DKFZ core facility. We are grateful to K. J. Patel for anti-mouse FANCD2 antibody and T. Southgate for the SF-CS-I-G retroviral vector. D.W., A.L., M.A.G.E., A.T. and M.D.M. were supported by the BioRN Leading-Edge Cluster "Cell-Based and Molecular Medicine" funded by the German Federal Ministry of Education and Research, and the Dietmar Hopp Foundation. M.A.R. was supported by the LOEWE Center for Cell and Gene Therapy Frankfurt, Hessisches Ministerium fur Wissenschaft und Kunst (III L 4-518/17.004 (2014)). A.T. and M.A.G.E. were also supported by the SFB873 funded by the Deutsche Forschungsgemeinschaft. A.G. and P.K. are funded by a fellowship from the Helmholtz International Graduate School and S.W.L. received support from the Leukemia Foundation of Australia, Cure Cancer Australia Foundation and the National Health and Medical Research Foundation of Australia.	[Anonymous], 2006, [No title captured]; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Bockamp E, 2006, BLOOD, V108, P1533, DOI 10.1182/blood-2005-12-012104; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Geiselhart A, 2012, ANEMIA, V2012, DOI 10.1155/2012/265790; Greve B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047185; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Haneline LS, 1998, BLOOD, V91, P4092; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Milsom MD, 2009, BLOOD, V113, P5111, DOI 10.1182/blood-2008-09-180224; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Schmezer P, 2001, MUTAGENESIS, V16, P25, DOI 10.1093/mutage/16.1.25; Schunck C, 2004, CYTOGENET GENOME RES, V104, P383, DOI 10.1159/000077520; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Thalheimer FB, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.010; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Whitney MA, 1996, BLOOD, V88, P49; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	32	376	380	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					549	+		10.1038/nature14131	http://dx.doi.org/10.1038/nature14131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25707806				2022-12-28	WOS:000353334500045
J	Liu, YC; Posey, DL; Cetron, MS; Painter, JA				Liu, Yecai; Posey, Drew L.; Cetron, Martin S.; Painter, John A.			Effect of a Culture-Based Screening Algorithm on Tuberculosis Incidence in Immigrants and Refugees Bound for the United States A Population-Based Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTION; IMPLEMENTATION; RIFAPENTINE	Background: Before 2007, immigrants and refugees bound for the United States were screened for tuberculosis (TB) by a smear-based algorithm that could not diagnose smear-negative/culture-positive TB. In 2007, the Centers for Disease Control and Prevention implemented a culture-based algorithm. Objective: To evaluate the effect of the culture-based algorithm on preventing the importation of TB to the United States by immigrants and refugees from foreign countries. Design: Population-based, cross-sectional study. Setting: Panel physician sites for overseas medical examination. Patients: Immigrants and refugees with TB. Measurements: Comparison of the increase of smear-negative/culture-positive TB cases diagnosed overseas among immigrants and refugees by the culture-based algorithm with the decline of reported cases among foreign-born persons within 1 year after arrival in the United States from 2007 to 2012. Results: Of the 3 212 421 arrivals of immigrants and refugees from 2007 to 2012, a total of 1 650 961 (51.4%) were screened by the smear-based algorithm and 1 561 460 (48.6%) were screened by the culture-based algorithm. Among the 4032 TB cases diagnosed by the culture-based algorithm, 2195 (54.4%) were smear-negative/culture-positive. Before implementation (2002 to 2006), the annual number of reported cases among foreign-born persons within 1 year after arrival was relatively constant (range, 1424 to 1626 cases; mean, 1504 cases) but decreased from 1511 to 940 cases during implementation (2007 to 2012). During the same period, the annual number of smearnegative/culture-positive TB cases diagnosed overseas among immigrants and refugees bound for the United States by the culture-based algorithm increased from 4 to 629. Limitation: This analysis did not control for the decline in new arrivals of nonimmigrant visitors to the United States and the decrease of incidence of TB in their countries of origin. Conclusion: Implementation of the culture-based algorithm may have substantially reduced the incidence of TB among newly arrived, foreign-born persons in the United States.	[Liu, Yecai; Posey, Drew L.; Cetron, Martin S.; Painter, John A.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Liu, YC (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, 1600 Clifton Rd,MS-E03, Atlanta, GA 30333 USA.	yliu@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Alami NN, 2014, MMWR-MORBID MORTAL W, V63, P229; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; [Anonymous], 2010, TUB SCREEN TREATM TE; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Barr M, 2008, ANN FLOW REPORT NONI; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Binkin NJ, 1996, CLIN INFECT DIS, V23, P1226, DOI 10.1093/clinids/23.6.1226; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Centers for Disease Control and Prevention, 2012, REP SURG GEN PREV TO, P1; Centers for Disease Control and Prevention, 2013, ONL TUB INF SYST; Centers for Disease Control and Prevention, 1991, TECHN INSTR PAN PHYS; Centers for Disease Control and Prevention, 2008, MMWR MORB MORTAL WKL, V57, P292; Dara M, 2013, EXPERT REV ANTI-INFE, V11, P137, DOI [10.1586/eri.12.168, 10.1586/ERI.12.168]; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Liu Y, 2012, ENCY IMMIGRANT HLTH, P1171; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Lowenthal P, 2011, INT J TUBERC LUNG D, V15, P761, DOI 10.5588/ijtld.10.0370; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Monger R, 2010, ANN FLOW REPORT NONI; Monger R, 2011, ANN FLOW REPORT NONI; Monger R, 2012, ANN FLOW REPORT NONI; Monger R, 2013, ANN FLOW REPORT NONI; Monger R, 2009, ANN FLOW REPORT NONI; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Oeltmann JE, 2008, EMERG INFECT DIS, V14, P1715, DOI 10.3201/eid1411.071629; Posey DL, 2014, MMWR-MORBID MORTAL W, V63, P234; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Sciortino S, 1999, INT J TUBERC LUNG D, V3, P778; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Emerging and Zoonotic Infectious Diseases, 2007, CDC IMM REQ TECHN IN; U.S. Department of Homeland Security, 2007, ANN FLOW REP TEMP AD; WHO, 2007, WHOHTMTB2007376	34	47	47	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					420	U150		10.7326/M14-2082	http://dx.doi.org/10.7326/M14-2082			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775314	Green Accepted			2022-12-28	WOS:000351279600015
J	Shroff, GR				Shroff, Gautam R.			Acute Myocardial Infarction: What's in a Name?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shroff, Gautam R.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Shroff, Gautam R.] Univ Minnesota, Minneapolis, MN USA	Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Shroff, GR (corresponding author), Hennepin Cty Med Ctr, Div Cardiovasc, 701 Pk Ave, Minneapolis, MN 55415 USA.	shrof010@umn.edu	Shroff, Gautam/H-7687-2019	Shroff, Gautam/0000-0002-7614-9560				Bandstein N, 2014, J AM COLL CARDIOL, V63, P2569, DOI 10.1016/j.jacc.2014.03.017; Braunwald E, 2013, CIRCULATION, V127, P2452, DOI 10.1161/CIRCULATIONAHA.113.001258; de Lemos JA, 2013, JAMA-J AM MED ASSOC, V309, P2262, DOI 10.1001/jama.2013.5809; Saaby L, 2014, AM J MED, V127, P295, DOI 10.1016/j.amjmed.2013.12.020; Saaby L, 2013, AM J MED, V126, P789, DOI 10.1016/j.amjmed.2013.02.029; Sandoval Y, 2014, J AM COLL CARDIOL, V63, P2079, DOI 10.1016/j.jacc.2014.02.541; Shroff GR, 2015, INT J CARDIOL, V182, P412, DOI 10.1016/j.ijcard.2014.12.141; Shroff GR, 2014, JAMA INTERN MED, V174, P1689, DOI 10.1001/jamainternmed.2014.3446; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	9	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					448	U95		10.7326/M14-2259	http://dx.doi.org/10.7326/M14-2259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775318				2022-12-28	WOS:000351279600018
J	Roberts, P; Perera, N; Wedage, O; Deraniyagala, S; Perera, J; Eregama, S; Gledhill, A; Petraglia, MD; Lee-Thorp, JA				Roberts, Patrick; Perera, Nimal; Wedage, Oshan; Deraniyagala, Siran; Perera, Jude; Eregama, Saman; Gledhill, Andrew; Petraglia, Michael D.; Lee-Thorp, Julia A.			Direct evidence for human reliance on rainforest resources in late Pleistocene Sri Lanka	SCIENCE			English	Article							TROPICAL FOREST; AGRICULTURE; AFRICAN; CLIMATE; PEOPLE; RATIOS; ITURI; ASIA	Human occupation of tropical rainforest habitats is thought to be a mainly Holocene phenomenon. Although archaeological and paleoenvironmental data have hinted at pre-Holocene rainforest foraging, earlier human reliance on rainforest resources has not been shown directly. We applied stable carbon and oxygen isotope analysis to human and faunal tooth enamel from four late Pleistocene-to-Holocene archaeological sites in Sri Lanka. The results show that human foragers relied primarily on rainforest resources from at least similar to 20,000 years ago, with a distinct preference for semi-open rainforest and rain forest edges. Homo sapiens' relationship with the tropical rainforests of South Asia is therefore long-standing, a conclusion that indicates the time-depth of anthropogenic reliance and influence on these habitats.	[Roberts, Patrick; Petraglia, Michael D.; Lee-Thorp, Julia A.] Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Oxford OX1 3QY, England; [Perera, Nimal] Postgrad Inst Archaeol, Colombo 00700, Sri Lanka; [Wedage, Oshan; Deraniyagala, Siran; Perera, Jude; Eregama, Saman] Sir Marcus Fernando Mawatha, Dept Archaeol, Colombo, Sri Lanka; [Gledhill, Andrew] Univ Bradford, Div Geog Archaeol & Environm Sci, Bradford BD7 1DP, W Yorkshire, England	University of Oxford; University Kelaniya; Postgraduate Institute of Archaeology (PGIA); University of Bradford	Roberts, P (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Dyson Perrins Bldg,S Parks Rd, Oxford OX1 3QY, England.	patrick.roberts@rlaha.ox.ac.uk	Petraglia, Michael/ABA-9748-2021	Petraglia, Michael/0000-0003-2522-5727; Roberts, Patrick/0000-0002-4403-7548	Natural Environmental Research Council; European Research Council [295719]; Boise Fund, University of Oxford; Natural Environment Research Council [NRCF010002, 1322282] Funding Source: researchfish; NERC [NRCF010002] Funding Source: UKRI	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Boise Fund, University of Oxford; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors declare no conflicts of interest. This project was funded by grants from the Natural Environmental Research Council; the European Research Council (grant no. 295719 to M.D.P.); and the Boise Fund, University of Oxford. We thank the members of Excavation Branch of the Department of Archeology, Government of Sri Lanka, for their assistance with faunal, stratigraphic, and chronological information. We also thank P. Mitchell for his comments on an earlier draft of this paper as well as E. Nitsch and J. Pouncett for their help with the R statistical package and GIS software, respectively. Fossil faunal and human samples are stored by the Department of Archeology, Government of Sri Lanka. Stable carbon and oxygen isotope data, site stratigraphies, and site chronologies are all available in the supplementary materials.	ASHTON PS, 1987, J BIOGEOGR, V14, P249, DOI 10.2307/2844895; BAHUCHET S, 1991, HUM ECOL, V19, P213, DOI 10.1007/BF00888746; BAILEY RC, 1989, AM ANTHROPOL, V91, P59, DOI 10.1525/aa.1989.91.1.02a00040; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Boivin N, 2013, QUATERN INT, V300, P32, DOI 10.1016/j.quaint.2013.01.008; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; COLINVAUX PA, 1991, AM ANTHROPOL, V93, P153, DOI 10.1525/aa.1991.93.1.02a00100; Deraniyagala S. U., 2007, ART ARCHAEOLOGY SRI, V1, P1; Deraniyagala S. U., 1992, PREHISTORY SRI LANKA; ERDELEN W, 1988, BIOL CONSERV, V43, P115, DOI 10.1016/0006-3207(88)90086-9; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTTERER KL, 1983, ANTHROPOS, V78, P169; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Krigbaum J, 2003, J ANTHROPOL ARCHAEOL, V22, P292, DOI 10.1016/S0278-4165(03)00041-2; Krigbaum J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0466; Lee-Thorp J, 2000, J HUM EVOL, V39, P565, DOI 10.1006/jhev.2000.0436; Levin NE, 2008, GEOL SOC AM SPEC PAP, V446, P215, DOI 10.1130/2008.2446(10); Levis S, 1999, J GEOPHYS RES-ATMOS, V104, P31191, DOI 10.1029/1999JD900837; Macho GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102794; Mercader J, 2002, EVOL ANTHROPOL, V11, P117, DOI 10.1002/evan.10022; Mercader J, 2000, QUATERNARY RES, V54, P102, DOI 10.1006/qres.2000.2150; Nigst PR, 2014, P NATL ACAD SCI USA, V111, P14394, DOI 10.1073/pnas.1412201111; Oelze VM, 2014, J HUM EVOL, V66, P95, DOI 10.1016/j.jhevol.2013.10.003; Perera N., 2010, BAR INT SERIES; Perera N, 2011, J HUM EVOL, V61, P254, DOI 10.1016/j.jhevol.2011.04.001; PUVANESWARAN KM, 1993, THEOR APPL CLIMATOL, V47, P105, DOI 10.1007/BF00866185; SERVANT M, 1993, GLOBAL PLANET CHANGE, V7, P25, DOI 10.1016/0921-8181(93)90038-P; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Thompson LG, 2000, J QUATERNARY SCI, V15, P377, DOI 10.1002/1099-1417(200005)15:4<377::AID-JQS542>3.0.CO;2-L; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x	36	72	72	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1246	1249		10.1126/science.aaa1230	http://dx.doi.org/10.1126/science.aaa1230			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766234				2022-12-28	WOS:000350824300037
J	Doncic, A; Atay, O; Valk, E; Grande, A; Bush, A; Vasen, G; Colman-Lerner, A; Loog, M; Skotheim, JM				Doncic, Andreas; Atay, Oguzhan; Valk, Ervin; Grande, Alicia; Bush, Alan; Vasen, Gustavo; Colman-Lerner, Alejandro; Loog, Mart; Skotheim, Jan M.			Compartmentalization of a Bistable Switch Enables Memory to Cross a Feedback-Driven Transition	CELL			English	Article							SCAFFOLD PROTEIN STE5; SIGNAL-TRANSDUCTION PATHWAY; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; DEPENDENT PHOSPHORYLATION; NEGATIVE FEEDBACK; POSITIVE FEEDBACK; KINASE CASCADE; MESSENGER-RNA	Cells make accurate decisions in the face of molecular noise and environmental fluctuations by relying not only on present pathway activity, but also on their memory of past signaling dynamics. Once a decision is made, cellular transitions are often rapid and switch-like due to positive feedback loops in the regulatory network. While positive feedback loops are good at promoting switch-like transitions, they are not expected to retain information to inform subsequent decisions. However, this expectation is based on our current understanding of network motifs that accounts for temporal, but not spatial, dynamics. Here, we show how spatial organization of the feedback-driven yeast G1/S switch enables the transmission of memory of past pheromone exposure across this transition. We expect this to be one of many examples where the exquisite spatial organization of the eukaryotic cell enables previously well-characterized network motifs to perform new and unexpected signal processing functions.	[Doncic, Andreas; Atay, Oguzhan; Skotheim, Jan M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Valk, Ervin; Loog, Mart] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Grande, Alicia; Bush, Alan; Vasen, Gustavo; Colman-Lerner, Alejandro] IFIBYNE UBA CONICET, Buenos Aires, DF, Argentina; [Grande, Alicia; Bush, Alan; Vasen, Gustavo; Colman-Lerner, Alejandro] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Stanford University; University of Tartu; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Skotheim, JM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	skotheim@stanford.edu	Bush, Alan/L-5098-2019; Colman-Lerner, Alejandro/ABC-3808-2020; Skotheim, Jan/C-3238-2015	Bush, Alan/0000-0002-0407-5750; Colman-Lerner, Alejandro/0000-0002-2557-8883; Skotheim, Jan/0000-0001-8420-6820; Atay, Oguzhan/0000-0002-7203-9575; Vasen, Gustavo/0000-0002-5968-2312	Burroughs Wellcome Fund (CASI); NIH [GM092925, GM097479]; Argentine Agency of Research and Technology (ANPCyT) [PICT2010-2248]; Estonian Science Agency [IUT2-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, R01GM097479, R01GM092925] Funding Source: NIH RePORTER	Burroughs Wellcome Fund (CASI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Argentine Agency of Research and Technology (ANPCyT); Estonian Science Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the Skotheim laboratory was supported by the Burroughs Wellcome Fund (CASI) and the NIH (GM092925). The Colman-Lerner laboratory was supported by grant PICT2010-2248 from the Argentine Agency of Research and Technology (ANPCyT) and the NIH (GM097479), while the Loog laboratory was supported by Estonian Science Agency Grant IUT2-21.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Behar M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000197; Blackwell E, 2003, MOL CELL BIOL, V23, P1135, DOI 10.1128/MCB.23.4.1135-1150.2003; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Blondel M, 1999, GENE DEV, V13, P2284, DOI 10.1101/gad.13.17.2284; Cai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084630; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Doncic A, 2013, MOL CELL, V50, P856, DOI 10.1016/j.molcel.2013.04.014; Doncic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057970; Doncic A, 2011, MOL CELL, V43, P528, DOI 10.1016/j.molcel.2011.06.025; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Gari E, 2001, GENE DEV, V15, P2803; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Holmes KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084060; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Laabs TL, 2003, P NATL ACAD SCI USA, V100, P10275, DOI 10.1073/pnas.1833999100; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; MCKINNEY JD, 1993, GENE DEV, V7, P833, DOI 10.1101/gad.7.5.833; MOORE SA, 1984, J BIOL CHEM, V259, P1004; Nagiec MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002437; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Oehlen LJWM, 1998, MOL GEN GENET, V258, P183, DOI 10.1007/s004380050722; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Pope P. A., 2014, CURR BIOL; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Qi MS, 2005, J CELL SCI, V118, P2837, DOI 10.1242/jcs.02418; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Santos SDM, 2012, CELL, V149, P1500, DOI 10.1016/j.cell.2012.05.028; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Torres MP, 2011, J BIOL CHEM, V286, P20208, DOI 10.1074/jbc.M111.239343; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; VALTZ N, 1995, J CELL BIOL, V131, P863, DOI 10.1083/jcb.131.4.863; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	58	29	29	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1182	1195		10.1016/j.cell.2015.02.032	http://dx.doi.org/10.1016/j.cell.2015.02.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768911	Green Accepted, Bronze			2022-12-28	WOS:000351951800017
J	Besseling, J; Kastelein, JJP; Defesche, JC; Hutten, BA; Hovingh, GK				Besseling, Joost; Kastelein, John J. P.; Defesche, Joep C.; Hutten, Barbara A.; Hovingh, G. Kees			Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; INSULIN-SECRETION; HEART-DISEASE; ABCA1; RISK; CHOLESTEROL; MUTATIONS; PATHOPHYSIOLOGY; METAANALYSIS	IMPORTANCE Familial hypercholesterolemia is characterized by impaired uptake of cholesterol in peripheral tissues, including the liver and the pancreas. In contrast, statins increase the cellular cholesterol uptake and are associated with increased risk for type 2 diabetes mellitus. We hypothesize that transmembrane cholesterol transport is linked to the development of type 2 diabetes. OBJECTIVE To assess the association between type 2 diabetes prevalence and familial hypercholesterolemia. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study in all individuals (n = 63 320) who underwent DNA testing for familial hypercholesterolemia in the national Dutch screening program between 1994 and 2014. EXPOSURES Deleteriousness and nondeleteriousness of familial hypercholesterolemia mutations were based on literature or laboratory function testing. Low-density lipoprotein (LDL) receptor mutations were considered more severe than apolipoprotein B gene (APOB) mutations, and receptor-negative LDL receptor mutations were considered more severe than receptor-deficient mutations. MAIN OUTCOMES AND MEASURES Prevalence of type 2 diabetes. RESULTS The prevalence of type 2 diabetes was 1.75% in familial hypercholesterolemia patients (n = 440/25 137) vs 2.93% in unaffected relatives (n = 1119/38 183) (P <.001; odds ratio [OR], 0.62 [95% CI, 0.55-0.69]). The adjusted prevalence of type 2 diabetes in familial hypercholesterolemia, determined using multivariable regression models, was 1.44% (difference, 1.49% [95% CI, 1.24%-1.71%]) (OR, 0.49 [95% CI, 0.41-0.58]; P <.001). The adjusted prevalence of type 2 diabetes by APOB vs LDL receptor gene was 1.91% vs 1.33% (OR, 0.65 [95% CI, 0.48-0.87] vs OR, 0.45 [95% CI, 0.38-0.54]), and the prevalence for receptor-deficient vs receptor-negative mutation carriers was 1.44% vs 1.12%(OR, 0.49 [95% CI, 0.40-0.60] vs OR, 0.38 [95% CI, 0.29-0.49]), respectively (P for trend <. 001 in both comparisons). CONCLUSIONS AND RELEVANCE In a cross-sectional analysis in the Netherlands, the prevalence of type 2 diabetes among patients with familial hypercholesterolemia was significantly lower than among unaffected relatives, with variability by mutation type. If this finding is confirmed in longitudinal analysis, it would raise the possibility of a causal relationship between LDL receptor-mediated transmembrane cholesterol transport and type 2 diabetes.	[Besseling, Joost; Kastelein, John J. P.; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Defesche, Joep C.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Hutten, Barbara A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,Room F4-280, NL-1105 AZ Amsterdam, Netherlands.	j.j.kastelein@amc.nl	Kastelein, John/AAF-7950-2020		Netherlands Organisation for Scientific Research (NWO) [91612122]; CardioVascular Research Initiative [CVON2011-19]; European Union (TransCard) [FP7-603091-2]; Amgen; Pfizer; Roche; Sanofi; AstraZeneca; Netherland Heart Foundation (NHS) [2010T082]; Aegerion; Boehringer Ingelheim; Cerenis; Eli Lilly; Genzyme; JSiS; MSD; Novartis; Regeneron	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CardioVascular Research Initiative; European Union (TransCard); Amgen(Amgen); Pfizer(Pfizer); Roche(Roche Holding); Sanofi; AstraZeneca(AstraZeneca); Netherland Heart Foundation (NHS); Aegerion; Boehringer Ingelheim(Boehringer Ingelheim); Cerenis; Eli Lilly(Eli Lilly); Genzyme(Sanofi-AventisGenzyme Corporation); JSiS; MSD; Novartis(Novartis); Regeneron(Regeneron)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kastelein reports receipt of a VENI grant from the Netherlands Organisation for Scientific Research (NWO, project number 91612122) and support by grants from the CardioVascular Research Initiative (CVON2011-19; Genius) and the European Union (TransCard, FP7-603091-2); receipt of lecture fees for Dr Hovingh from Amgen, Pfizer, Roche, and Sanofi; and a research grant from AstraZeneca. Dr Kastelein reports being a recipient of the Lifetime Achievement Award of the Netherland Heart Foundation (NHS, project number 2010T082) and receipt of lecture grants from Aegerion, AstraZeneca, Boehringer Ingelheim, Cerenis, Eli Lilly, Genzyme, JSiS, MSD, Novartis, Pfizer, Regeneron, Roche, and Sanofi. No other disclosures were reported.	Alonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024; Axsom K, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0299-z; Bertolini S, 2000, ARTERIOSCLER THROMB, V20, P41; Bertolini S, 2013, ATHEROSCLEROSIS, V227, P342, DOI 10.1016/j.atherosclerosis.2013.01.007; Besseling J, 2014, ATHEROSCLEROSIS, V233, P219, DOI 10.1016/j.atherosclerosis.2013.12.020; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cnop M, 2002, ENDOCRINOLOGY, V143, P3449, DOI 10.1210/en.2002-220273; COBBAERT C, 1994, EUR J CLIN CHEM CLIN, V32, P391; Costi M, 2010, ACTA DIABETOL, V47, pS169, DOI 10.1007/s00592-009-0158-8; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Harvey J. N., 2002, Journal of Epidemiology and Community Health, V56, P18, DOI 10.1136/jech.56.1.18; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Hovingh GK, 2013, EUR HEART J, V34, P962, DOI 10.1093/eurheartj/eht015; Humphries SE, 2006, J MOL MED, V84, P203, DOI 10.1007/s00109-005-0019-z; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Lombardi MP, 2000, CLIN GENET, V57, P116, DOI 10.1034/j.1399-0004.2000.570205.x; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Oram JF, 2001, J LIPID RES, V42, P1173; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Rutti S, 2009, ENDOCRINOLOGY, V150, P4521, DOI 10.1210/en.2009-0252; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Santos Carlos Antonio S T, 2008, BMC Med Res Methodol, V8, P80, DOI 10.1186/1471-2288-8-80; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; SIRTORI CR, 1990, PHARMACOL RES, V22, P555, DOI 10.1016/S1043-6618(05)80047-7; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Van de Lisdonk E, 2008, DIS CLIN GEN PRACTIT; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; Vohl MC, 1997, EUR J CLIN INVEST, V27, P366, DOI 10.1046/j.1365-2362.1997.1250669.x; Wijesekara N, 2012, DIABETES, V61, P653, DOI 10.2337/db11-0944	37	257	261	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1029	1036		10.1001/jama.2015.1206	http://dx.doi.org/10.1001/jama.2015.1206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756439	Bronze			2022-12-28	WOS:000350643100018
J	Mares, J				Mares, Julie			Food Antioxidants to Prevent Cataract	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AGE-RELATED CATARACT; PROSPECTIVE COHORT; RANDOMIZED-TRIAL; SUPPLEMENTS; RISK	Total Antioxidant Capacity of the Diet and Risk of Age-Related Cataract: A Population-Based Prospective Cohort of Women IMPORTANCE To our knowledge, no previous epidemiologic study has investigated the association between all antioxidants in the diet and age-related cataract. The total antioxidant capacity (TAC) concept aims to measure the capacity from all antioxidants in the diet by also taking synergistic effects into account. OBJECTIVE To investigate the association between the TAC of the diet and the incidence of age-related cataract in a population-based prospective cohort of middle-aged and elderly women. DESIGN, SETTING, AND PARTICIPANTS Questionnaire-based nutrition survey within the prospective Swedish Mammography Cohort study, which included 30 607 women (aged 49-83 years) who were observed for age-related cataract incidence for a mean of 7.7 years. EXPOSURE The TAC of the diet was estimated using a database of foods analyzed with the oxygen radical absorbance capacity assay. MAIN OUTCOMES AND MEASURES Information on incident age-related cataract diagnosis and extraction was collected through linkage to registers in the study area. RESULTS There were 4309 incident cases of age-related cataracts during the mean 7.7 years of follow-up (234 371 person-years). The multivariable rate ratio in the highest quintile of the TAC of the diet compared with the lowest was 0.87 (95% CI, 0.79-0.96; P for trend = .03). The main contributors to dietary TAC in the study population were fruit and vegetables (44.3%), whole grains (17.0%), and coffee (15.1%). CONCLUSIONS AND RELEVANCE Dietary TAC was inversely associated with the risk of age-related cataract. Future studies examining all antioxidants in the diet in relation to age-related cataract are needed to confirm or refute our findings.	Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison	Mares, J (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, 610 N Walnut St,1063 WARF Bldg, Madison, WI 53726 USA.	jmarespe@wisc.edu						Chew EY, 2013, JAMA OPHTHALMOL, V131, P843, DOI 10.1001/jamaophthalmol.2013.4412; Christen WG, 2014, OPHTHALMOLOGY, V121, P525, DOI 10.1016/j.ophtha.2013.09.038; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; KUPFER C, 1985, T OPHTHAL SOC UK, V104, P1; Mathew MC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004567.pub2; Rautiainen S, 2014, JAMA OPHTHALMOL, V132, P247, DOI 10.1001/jamaophthalmol.2013.6241; Rautiainen S, 2010, AM J CLIN NUTR, V91, P487, DOI 10.3945/ajcn.2009.28528; Selin JZ, 2014, ANTIOXID REDOX SIGN, V21, P700, DOI 10.1089/ars.2014.5853; Selin JZ, 2013, AM J EPIDEMIOL, V177, P548, DOI 10.1093/aje/kws279	9	10	10	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1048	1049		10.1001/jama.2014.15301	http://dx.doi.org/10.1001/jama.2014.15301			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756441				2022-12-28	WOS:000350643100020
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Patients and professionals: all in this together?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Lewis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g6845; McCartney M., 2013, THIS IS NOT INFORM C	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2015	350								h1331	10.1136/bmj.h1331	http://dx.doi.org/10.1136/bmj.h1331			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EA	25753126	Bronze			2022-12-28	WOS:000351181100006
J	Adalja, AA; Toner, E; Inglesby, TV				Adalja, Amesh A.; Toner, Eric; Inglesby, Thomas V.			Clinical Management of Potential Bioterrorism-Related Conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SMALLPOX VACCINE; INHALATIONAL ANTHRAX; POSTEXPOSURE PROPHYLAXIS; CUTANEOUS ANTHRAX; IMMUNE GLOBULIN; UNITED-STATES; IMMUNOGENICITY; SAFETY		[Adalja, Amesh A.] Univ Pittsburgh, Med Ctr, Ctr Hlth Secur, Baltimore, MD 21202 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Adalja, AA (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Hlth Secur, 621 E Pratt St,Suite 210, Baltimore, MD 21202 USA.	aadalja@upmc.edu						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1454; [Anonymous], 2009, MMWR-MORBID MORTAL W, V59, P872; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Bravata DM, 2007, ARCH PEDIAT ADOL MED, V161, P896, DOI 10.1001/archpedi.161.9.896; Centers for Disease Control and Prevention, ADV REACT FOLL SMALL; Centers for Disease Control and Prevention, MED MAN SMALLP VACC; Christian MD, 2013, CRIT CARE CLIN, V29, P717, DOI 10.1016/j.ccc.2013.03.015; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Food and Drug Administration, ACAM 2000 PRESCR INF; Frey SE, 2013, VACCINE, V31, P3025, DOI 10.1016/j.vaccine.2013.04.050; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921; Hendricks Katherine A, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2002.130687; Hodowanec A, 2014, MANDELL DOUGLAS BENN; Holty JEC, 2006, ANN INTERN MED, V144, P270, DOI 10.7326/0003-4819-144-4-200602210-00009; Hupert N, 2003, ANN INTERN MED, V139, P337, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00009; Ionin B, 2013, CLIN VACCINE IMMUNOL, V20, P1016, DOI 10.1128/CVI.00099-13; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Kayabas U, 2012, CHEMOTHERAPY, V58, P34, DOI 10.1159/000335593; Kennedy JS, 2011, J INFECT DIS, V204, P1395, DOI 10.1093/infdis/jir527; Kuehnert MJ, 2003, CLIN INFECT DIS, V36, P328, DOI 10.1086/346035; Lederman ER, 2012, J INFECT DIS, V206, P1372, DOI 10.1093/infdis/jis510; Leitenberg M, 2012, SOVIET BIOL WEAPONS; Marano N, 2008, JAMA-J AM MED ASSOC, V300, P1532, DOI 10.1001/jama.300.13.1532; Martin GJ, 2014, MANDELL DOUGLAS BENN; Mayor Adrienne, 2003, GREEK FIRE POISON AR; Mead PS, 2014, MANDELL DOUGLAS BENN; Meaney-Delman D, 2012, OBSTET GYNECOL, V120, P1439, DOI [10.1097/AOG.0b013e318270ec08, http://10.1097/AOG.0b013e318270ec08]; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603; Miller J, 2002, GERMS BIOL WEAPONS A; Mwengee W, 2006, CLIN INFECT DIS, V42, P614, DOI 10.1086/500137; Mytle N, 2013, ANTIMICROB AGENTS CH, V57, P5684, DOI 10.1128/AAC.00458-13; Nalca A, 2010, DRUG DES DEV THER, V4, P71; Narayan SK, 2009, J NEUROL SCI, V281, P41, DOI 10.1016/j.jns.2009.02.376; Penn RL, 2014, MANDELL DOUGLAS BENN; Petersen BW., 2014, ORTHOPOXVIRUSES VACC, V8, DOI [10.1007/978-1-4899-7448, DOI 10.1007/978-1-4899-7448]; Sejvar JJ, 2005, LANCET INFECT DIS, V5, P287, DOI 10.1016/S1473-3099(05)70113-4; Sell TK, 2013, BIOSECUR BIOTERROR, V11, P196, DOI 10.1089/bsp.2013.0047; Shepard CW, 2002, EMERG INFECT DIS, V8, P1124, DOI 10.3201/eid0810.020349; Smee DF, 2013, FUTURE VIROL, V8, P891, DOI 10.2217/fvl.13.76; Smith LA, 2009, VACCINE, V27, pD33, DOI 10.1016/j.vaccine.2009.08.059; Sobel J, 2009, ANTHRAX WEAPONIZATIO; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Taub DD, 2008, AM J MED, V121, P1058, DOI 10.1016/j.amjmed.2008.08.019; Walsh JJ, 2007, CLIN INFECT DIS, V44, P968, DOI 10.1086/512372; Wright JG, 2014, VACCINE, V32, P1019, DOI 10.1016/j.vaccine.2013.10.039	48	37	39	2	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					954	962		10.1056/NEJMra1409755	http://dx.doi.org/10.1056/NEJMra1409755			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738671				2022-12-28	WOS:000350304500011
J	Hopkins, K; Crosland, P; Elliott, N; Bewley, S				Hopkins, Kathryn; Crosland, Paul; Elliott, Nicole; Bewley, Susan		Clinical Guidelines Update Comm B	GUIDELINES Diagnosis and management of depression in children and young people: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MENTAL-HEALTH		[Hopkins, Kathryn; Crosland, Paul; Elliott, Nicole] Natl Inst Hlth & Care Excellence, Ctr Clin Practice, Manchester M1 4BT, Lancs, England; [Bewley, Susan] Kings Coll London, Womens Hlth Acad Ctr, London WC2R 2LS, England	National Institute for Health & Care Excellence; University of London; King's College London	Hopkins, K (corresponding author), Natl Inst Hlth & Care Excellence, Ctr Clin Practice, Manchester M1 4BT, Lancs, England.	kathryn.hopkins@nice.org.uk	Crosland, Paul/N-6718-2017	Crosland, Paul/0000-0002-6445-7486				Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Fergusson DM, 2007, BRIT J PSYCHIAT, V191, P335, DOI 10.1192/bjp.bp.107.036079; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Harrington R, 2001, BRIT MED BULL, V57, P47, DOI 10.1093/bmb/57.1.47; National Institute for Clinical Excellence (NICE), 2004, SELF HARM SHORT TERM; National Institute for Health and Care Excellence, 2015, DEPR CHILDR YOUNG PE	7	42	43	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2015	350								h824	10.1136/bmj.h824	http://dx.doi.org/10.1136/bmj.h824			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4DS	25739880				2022-12-28	WOS:000350301600002
J	Stergiopoulos, V; Hwang, SW; Gozdzik, A; Nisenbaum, R; Latimer, E; Rabouin, D; Adair, CE; Bourque, J; Connelly, J; Frankish, J; Katz, LY; Mason, K; Misir, V; O'Brien, K; Sareen, J; Schutz, CG; Singer, A; Streiner, DL; Vasiliadis, HM; Goering, PN				Stergiopoulos, Vicky; Hwang, Stephen W.; Gozdzik, Agnes; Nisenbaum, Rosane; Latimer, Eric; Rabouin, Daniel; Adair, Carol E.; Bourque, Jimmy; Connelly, Jo; Frankish, James; Katz, Laurence Y.; Mason, Kate; Misir, Vachan; O'Brien, Kristen; Sareen, Jitender; Schuetz, Christian G.; Singer, Arielle; Streiner, David L.; Vasiliadis, Helen-Maria; Goering, Paula N.		Home Chez Soi Investigators	Effect of Scattered-Site Housing Using Rent Supplements and Intensive Case Management on Housing Stability Among Homeless Adults With Mental Illness A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; 1ST; INDIVIDUALS; PEOPLE; HEALTH; INTERVENTION; MULTISITE; SERVICES; CHOICE; COSTS	IMPORTANCE Scattered-site housing with Intensive Case Management (ICM) may be an appropriate and less-costly option for homeless adults with mental illness who do not require the treatment intensity of Assertive Community Treatment. OBJECTIVE To examine the effect of scattered-site housing with ICM services on housing stability and generic quality of life among homeless adults with mental illness and moderate support needs for mental health services. DESIGN, SETTING, AND PARTICIPANTS The At Home/Chez Soi project was an unblinded, randomized trial. From October 2009 to July 2011, participants (N = 1198) were recruited in 4 Canadian cities (Vancouver, Winnipeg, Toronto, and Montreal), randomized to the intervention group (n = 689) or usual care group (n = 509), and followed up for 24 months. INTERVENTIONS The intervention consisted of scattered-site housing (using rent supplements) and off-site ICM services. The usual care group had access to existing housing and support services in their communities. MAIN OUTCOMES AND MEASURES The primary outcome was the percentage of days stably housed during the 24-month period following randomization. The secondary outcome was generic quality of life, assessed by a EuroQoL 5 Dimensions (EQ-5D) health questionnaire. RESULTS During the 24 months after randomization, the adjusted percentage of days stably housed was higher among the intervention group than the usual care group, although adjusted mean differences varied across sites. [GRAPHICS] The mean change in EQ-5D score from baseline to 24 months among the intervention group was not statistically different from the usual care group (60.5 [95% CI, 58.6 to 62.5] at baseline and 67.2 [95% CI, 65.2 to 69.1] at 24 months for the intervention group vs 62.1 [95% CI, 59.9 to 64.4] at baseline and 68.6 [95% CI, 66.3 to 71.0] at 24 months for the usual care group, difference in mean changes, 0.10 [95% CI, -2.92 to 3.13], P= . 95). CONCLUSIONS AND RELEVANCE Among homeless adults with mental illness in 4 Canadian cities, scattered site housing with ICM services compared with usual access to existing housing and community services resulted in increased housing stability over 24 months, but did not improve generic quality of life.	[Stergiopoulos, Vicky; Hwang, Stephen W.; Gozdzik, Agnes; Nisenbaum, Rosane; Mason, Kate; Misir, Vachan; O'Brien, Kristen; Singer, Arielle] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Stergiopoulos, Vicky; Streiner, David L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada; [Nisenbaum, Rosane] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Latimer, Eric] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Rabouin, Daniel] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Adair, Carol E.] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Adair, Carol E.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Bourque, Jimmy] Univ Moncton, Fac Educ, Moncton, NB E1A 3E9, Canada; [Connelly, Jo] Toronto North Support Serv, Toronto, ON, Canada; [Frankish, James] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Katz, Laurence Y.] Univ Manitoba, Dept Psychiat Psychol & Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Sareen, Jitender] Univ Manitoba, Dept Psychiat, Fac Med, Winnipeg, MB R3T 2N2, Canada; [Schuetz, Christian G.] Univ British Columbia, Inst Mental Hlth, Vancouver, BC V5Z 1M9, Canada; [Streiner, David L.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Vasiliadis, Helen-Maria] Univ Sherbrooke, Dept Community Hlth Sci, Quebec City, PQ, Canada; [Goering, Paula N.] Univ Toronto, Dept Psychiat, Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; McGill University; University of Calgary; University of Calgary; University of Moncton; University of British Columbia; University of Manitoba; University of Manitoba; University of British Columbia; McMaster University; University of Sherbrooke; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Hwang, SW (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	hwangs@smh.ca	Hwang, Stephen W./GVR-7773-2022; Streiner, David/E-6563-2011; Katz, Laurence/N-6698-2019	Streiner, David/0000-0003-0610-6271; Sareen, Jitender/0000-0001-8573-6495; Crocker, Anne/0000-0003-0571-8890; Latimer, Eric/0000-0002-4485-1056	Health Canada	Health Canada	This research has been made possible through a financial contribution from Health Canada.	BARKER S, 1994, COMMUNITY MENT HLT J, V30, P459, DOI 10.1007/BF02189063; Boothroyd RA, 2008, ADM POLICY MENT HLTH, V35, P370, DOI 10.1007/s10488-008-0179-6; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Collins SE, 2013, AM J PUBLIC HEALTH, V103, pS269, DOI 10.2105/AJPH.2013.301312; Corrigan PW, 2004, SCHIZOPHRENIA BULL, V30, P1035, DOI 10.1093/oxfordjournals.schbul.a007118; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Frane JW, 1998, DRUG INF J, V32, P423, DOI 10.1177/009286159803200213; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Greenwood RM, 2005, AM J COMMUN PSYCHOL, V36, P223, DOI 10.1007/s10464-005-8617-z; Gulcur L, 2003, J COMMUNITY APPL SOC, V13, P171, DOI 10.1002/casp.723; Henwood BF, 2014, PSYCHIAT RES, V220, P549, DOI 10.1016/j.psychres.2014.07.072; Human Resources and Skills Development Canada, HOMELESS SHELTERS AN; Hwang SW, 2014, LANCET, V384, P1541, DOI 10.1016/S0140-6736(14)61133-8; Hwang SW, 2011, MED CARE, V49, P350, DOI 10.1097/MLR.0b013e318206c50d; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Lamers LA, 2006, HEALTH ECON, V15, P1229, DOI 10.1002/hec.1125; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Lehman AF, 1996, SOC PSYCH PSYCH EPID, V31, P78, DOI 10.1007/BF00801903; Ministry of Health and Long-Term Care, 2005, ONTARIO PROGRAM STAN; Nelson G, 2012, IMPLEMENTATION AND F; Nelson G, 2014, EVAL PROGRAM PLANN, V43, P16, DOI 10.1016/j.evalprogplan.2013.10.004; Nelson G, 2013, AM J COMMUN PSYCHOL, V51, P347, DOI 10.1007/s10464-012-9554-2; Padgett DK, 2006, RES SOCIAL WORK PRAC, V16, P74, DOI 10.1177/1049731505282593; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; Ridgway P., 1990, PSYCHOSOC REHABIL J, V13, P11, DOI [10.1037/h0099479, DOI 10.1037/H0099479]; Rosenheck R, 2003, ARCH GEN PSYCHIAT, V60, P940, DOI 10.1001/archpsyc.60.9.940; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Stefancic A, 2013, AM J PSYCHIATR REHAB, V16, P240, DOI 10.1080/15487768.2013.847741; Stergiopoulos V, 2015, ACTA PSYCHIAT SCAND, V131, P256, DOI 10.1111/acps.12391; Stergiopoulos V, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-345; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Tsemberis S, 2010, HOUSING FIRST THE PA; Tsemberis S, 2007, J COMMUNITY PSYCHOL, V35, P29, DOI 10.1002/jcop.20132; US Department of Housing and Urban Development, 2012 ANNUAL HOMELESS; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259	40	70	70	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					905	915		10.1001/jama.2015.1163	http://dx.doi.org/10.1001/jama.2015.1163			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC3FN	25734732	Green Published, Bronze			2022-12-28	WOS:000350231800013
J	Luzzatto, L; Hollak, CEM; Cox, TM; Schieppati, A; Licht, C; Kaariainen, H; Merlini, G; Schaefer, F; Simoens, S; Pani, L; Garattini, S; Remuzzi, G				Luzzatto, Lucio; Hollak, Carla E. M.; Cox, Timothy M.; Schieppati, Arrigo; Licht, Christoph; Kaariainen, Helena; Merlini, Giampaolo; Schaefer, Franz; Simoens, Steven; Pani, Luca; Garattini, Silvio; Remuzzi, Giuseppe			Rare diseases and effective treatments: are we delivering?	LANCET			English	Editorial Material							ORPHAN DRUGS; ECULIZUMAB		[Luzzatto, Lucio] Ist Toscano Tumori, Florence, Italy; [Hollak, Carla E. M.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Cox, Timothy M.] Univ Cambridge, Univ Dept Med, Cambridge, England; [Schieppati, Arrigo; Garattini, Silvio; Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri, IRCCS, I-24126 Bergamo, Italy; [Schieppati, Arrigo] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Licht, Christoph] Hosp Sick Children, Div Nephrol, Toronto, ON M5G 1X8, Canada; [Kaariainen, Helena] European Platform Patients Org Sci & Ind, Brussels, Belgium; [Merlini, Giampaolo] Univ Pavia, Dept Mol Med, Amyloidosis Res & Treatment Ctr, I-27100 Pavia, Italy; [Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Pediat Nephrol Div, Heidelberg, Germany; [Simoens, Steven] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Pani, Luca] AIFA Italian Med Agcy, Rome, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Amsterdam; Academic Medical Center Amsterdam; University of Cambridge; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pavia; Ruprecht Karls University Heidelberg; KU Leuven	Remuzzi, G (corresponding author), Ist Ric Farmacol Mario Negri, IRCCS, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Merlini, Giampaolo/A-3817-2008; Garattini, Silvio/AAA-6390-2020; Pani, Luca/AAM-9467-2020; Remuzzi, Giuseppe/V-9766-2017	Merlini, Giampaolo/0000-0001-7680-3254; Garattini, Silvio/0000-0003-0647-9297; Pani, Luca/0000-0001-9273-2839; Simoens, Steven/0000-0002-9512-2005; Hollak, Carla/0000-0003-0464-1078; Remuzzi, Giuseppe/0000-0002-6194-3446				Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Hyry HI, 2014, QJM-INT J MED, V107, P241, DOI 10.1093/qjmed/hcu016; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; O'Sullivan BP, 2013, JAMA-J AM MED ASSOC, V310, P1343, DOI 10.1001/jama.2013.278129; Parker C, 2009, LANCET, V373, P759, DOI 10.1016/S0140-6736(09)60001-5; Picavet E, 2012, J CLIN PHARM THER, V37, P664, DOI 10.1111/j.1365-2710.2012.01364.x; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7	7	34	38	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					750	752		10.1016/S0140-6736(15)60297-5	http://dx.doi.org/10.1016/S0140-6736(15)60297-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25752159				2022-12-28	WOS:000350051700009
J	Watts, G				Watts, Geoff			Barrie Patrick Marmion Obituary	LANCET			English	Biographical-Item																		MARMION BP, PUBLICATION LIST	1	0	0	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					684	684		10.1016/S0140-6736(15)60278-1	http://dx.doi.org/10.1016/S0140-6736(15)60278-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7ED	25713861				2022-12-28	WOS:000349788300015
J	Ruff, CT; Giugliano, RP; Braunwald, E; Morrow, DA; Murphy, SA; Kuder, JF; Deenadayalu, N; Jarolim, P; Betcher, J; Shi, MG; Brown, K; Patel, I; Mercuri, M; Antman, EM				Ruff, Christian T.; Giugliano, Robert P.; Braunwald, Eugene; Morrow, David A.; Murphy, Sabina A.; Kuder, Julia F.; Deenadayalu, Naveen; Jarolim, Petr; Betcher, Joshua; Shi, Minggao; Brown, Karen; Patel, Indravadan; Mercuri, Michele; Antman, Elliott M.			Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial	LANCET			English	Article							ATRIAL-FIBRILLATION; WARFARIN; ANTICOAGULATION; MANAGEMENT; STROKE; METAANALYSIS; GUIDELINES; INTENSITY; THERAPY	Background New oral anticoagulants for stroke prevention in atrial fibrillation were developed to be given in fixed doses without the need for the routine monitoring that has hindered usage and acceptance of vitamin K antagonists. A concern has emerged, however, that measurement of drug concentration or anticoagulant activity might be needed to prevent excess drug concentrations, which significantly increase bleeding risk. In the ENGAGE AF-TIMI 48 trial, higher-dose and lower-dose edoxaban were compared with warfarin in patients with atrial fibrillation. Each regimen incorporated a 50% dose reduction in patients with clinical features known to increase edoxaban drug exposure. We aim to assess whether adjustment of edoxaban dose in this trial prevented excess drug concentration and the risk of bleeding events. Methods We analysed data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. We correlated edoxaban dose, plasma concentration, and anti-Factor Xa (FXa) activity and compared efficacy and safety outcomes with warfarin stratified by dose reduction status. Patients with atrial fibrillation and at moderate to high risk of stroke were randomly assigned in a 1: 1: 1 ratio to receive warfarin, dose adjusted to an international normalised ratio of 2.0-3.0, higher-dose edoxaban (60 mg once daily), or lower-dose edoxaban (30 mg once daily). Randomisation was done with use of a central, 24 h, interactive, computerised response system. International normalised ratio was measured using an encrypted point-of-care device. To maintain masking, sham international normalised ratio values were generated for patients assigned to edoxaban. Edoxaban (or placebo-edoxaban in warfarin group) doses were halved at randomisation or during the trial if patients had creatinine clearance 30-50 mL/min, bodyweight 60 kg or less, or concomitant medication with potent P-glycoprotein interaction. Efficacy outcomes included the primary endpoint of all-cause stroke or systemic embolism, ischaemic stroke, and all-cause mortality. Safety outcomes included the primary safety endpoint of major bleeding, fatal bleeding, intracranial haemorrhage, and gastrointestinal bleeding. This trial is registered with ClinicalTrials.gov, number NCT00781391. Findings Between Nov 19, 2008 and Nov 22, 2010, 21 105 patients were recruited. Patients who met clinical criteria for dose reduction at randomisation (n=5356) had higher rates of stroke, bleeding, and death compared with those who did not have a dose reduction (n=15 749). Edoxaban dose ranged from 15 mg to 60 mg, resulting in a two-fold to three fold gradient of mean trough drug exposure (16.0-48.5 ng/mL in 6780 patients with data available) and mean trough anti-FXa activity (0.35-0.85 IU/mL in 2865 patients). Dose reduction decreased mean exposure by 29% (from 48.5 ng/mL [SD 45.8] to 34.6 ng/mL [30.9]) and 35% (from 24.5 ng/mL [22.7] to 16.0 ng/mL [14.5]) and mean anti-FXa activity by 25% (from 0.85 IU/mL [0.76] to 0.64 IU/mL [0.54]) and 20% (from 0.44 IU/mL [0.37] to 0.35 IU/mL [0.28]) in the higher-dose and lower-dose regimens, respectively. Despite the lower anti-FXa activity, dose reduction preserved the efficacy of edoxaban compared with warfarin (stroke or systemic embolic event: higher dose p(interaction)=0.85, lower dose p(interaction)=0.99) and provided even greater safety (major bleeding: higher dose p(interaction) 0.02, lower dose p(interaction)=0.002). Interpretation These findings validate the strategy that tailoring of the dose of edoxaban on the basis of clinical factors alone achieves the dual goal of preventing excess drug concentrations and helps to optimise an individual patient's risk of ischaemic and bleeding events and show that the therapeutic window for edoxaban is narrower for major bleeding than thromboembolism.	[Ruff, Christian T.; Giugliano, Robert P.; Braunwald, Eugene; Morrow, David A.; Murphy, Sabina A.; Kuder, Julia F.; Deenadayalu, Naveen; Jarolim, Petr; Antman, Elliott M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ruff, Christian T.; Giugliano, Robert P.; Braunwald, Eugene; Morrow, David A.; Murphy, Sabina A.; Kuder, Julia F.; Deenadayalu, Naveen; Jarolim, Petr; Antman, Elliott M.] Harvard Univ, Sch Med, Boston, MA USA; [Betcher, Joshua] Quintiles Inc, Res Triangle Pk, NC USA; [Shi, Minggao; Brown, Karen; Patel, Indravadan; Mercuri, Michele] Daiichi Sankyo Pharma Dev, Edison, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; IQVIA; Daiichi Sankyo Company Limited	Ruff, CT (corresponding author), TIMI Study Grp, Boston, MA 02115 USA.	cruff@partners.org			Daiichi-Sankyo Pharma Development; Daiichi-Sankyo Development	Daiichi-Sankyo Pharma Development(Daiichi Sankyo Company Limited); Daiichi-Sankyo Development	Daiichi-Sankyo Pharma Development.; The ENGAGE AF-TIMI 48 trial was funded by Daiichi-Sankyo Development.	Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Beasley BN, 2011, NEW ENGL J MED, V364, P1788, DOI 10.1056/NEJMp1103050; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Liew A, 2013, CAN J CARDIOL, V29, pS34, DOI 10.1016/j.cjca.2013.04.013; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Salazar DE, 2012, THROMB HAEMOSTASIS, V107, P925, DOI 10.1160/TH11-08-0566; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261	20	280	282	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2288	2295		10.1016/S0140-6736(14)61943-7	http://dx.doi.org/10.1016/S0140-6736(14)61943-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25769361				2022-12-28	WOS:000355943500031
J	Halsey, NA; Salmon, DA				Halsey, Neal A.; Salmon, Daniel A.			Measles at Disneyland, a Problem for All Ages	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Halsey, Neal A.; Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Halsey, NA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St,Room w5041, Baltimore, MD 21205 USA.	nhalsey1@jhu.edu		salmon, daniel/0000-0002-1035-4422				[Anonymous], WHIT PAP US IN PRESS; [Anonymous], VACCINES AND AUTISM; Centers for Disease Control and Prevention, MEASL CAS OUTBR; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P1099, DOI 10.1001/jama.2015.1518; Institute of Medicine, 2013, CHILDH IMM SCHED SAF; Mnookin S., 2012, PANIC VIRUS TRUE STO; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Omer SB, 2013, NEW ENGL J MED, V368, P1374, DOI 10.1056/NEJMp1300765; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712	9	23	23	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					655	U253		10.7326/M15-0447	http://dx.doi.org/10.7326/M15-0447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25751746				2022-12-28	WOS:000354119100012
J	Liang, LM; Willis-Owen, SAG; Laprise, C; Wong, KCC; Davies, GA; Hudson, TJ; Binia, A; Hopkin, JM; Yang, IV; Grundberg, E; Busche, S; Hudson, M; Ronnblom, L; Pastinen, TM; Schwartz, DA; Lathrop, GM; Moffatt, MF; Cookson, WOCM				Liang, Liming; Willis-Owen, Saffron A. G.; Laprise, Catherine; Wong, Kenny C. C.; Davies, Gwyneth A.; Hudson, Thomas J.; Binia, Aristea; Hopkin, Julian M.; Yang, Ivana V.; Grundberg, Elin; Busche, Stephan; Hudson, Marie; Ronnblom, Lars; Pastinen, Tomi M.; Schwartz, David A.; Lathrop, G. Mark; Moffatt, Miriam F.; Cookson, William O. C. M.			An epigenome-wide association study of total serum immunoglobulin E concentration	NATURE			English	Article							DIFFERENTIAL DNA METHYLATION; T-HELPER LYMPHOCYTES; MENDELIAN RANDOMIZATION; GENOMEWIDE ASSOCIATION; TOTAL IGE; ASTHMA; EOSINOPHILS; EXPRESSION; METAANALYSIS; OMALIZUMAB	Immunoglobulin E (IgE) is a central mediator of allergic (atopic) inflammation. Therapies directed against IgE can alleviate hay fever' and allergic asthma'''. Genetic association studies have not yet identified novel therapeutic targets or pathways underlying IgE regulation'. We therefore surveyed epigenetic associations between serum IgE concentrations and methylation at loci concentrated in CpG islands genome wide in 95 nuclear pedigrees, using DNA from peripheral blood leukocytes. We validated positive results in additional families and in subjects from the general population. Here we show replicated associations with a meta-analysis false discovery rate less than 10-4 between IgE and low methylation at 36 loci. Genes annotated to these loci encode known eosinophil products, and also implicate phospholipid inflammatory mediators, specific transcription factors and mitochondrial proteins. We confirmed that methylation at these loci differed significantly in isolated eosinophils from subjects with and without asthma and high IgE levels. The top three loci accounted for 13% of IgE variation in the primary subject panel, explaining the tenfold higher variance found compared with that derived from large single-nucleotide polymorphism genome-wide association studies'''. This study identifies novel therapeutic targets and biomarkers for patient stratification for allergic diseases.	[Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Willis-Owen, Saffron A. G.; Wong, Kenny C. C.; Binia, Aristea; Moffatt, Miriam F.; Cookson, William O. C. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Laprise, Catherine] Univ Quebec Chicoutimi, Saguenay, PQ G7H 2B1, Canada; [Davies, Gwyneth A.; Hopkin, Julian M.] Swansea Univ, Coll Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales; [Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Yang, Ivana V.; Schwartz, David A.] Univ Colorado, Sch Med, Denver, CO 80206 USA; [Yang, Ivana V.; Schwartz, David A.] Natl Jewish Hlth, Denver, CO 80206 USA; [Grundberg, Elin; Busche, Stephan; Pastinen, Tomi M.; Lathrop, G. Mark] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Grundberg, Elin; Busche, Stephan; Pastinen, Tomi M.; Lathrop, G. Mark] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1B1, Canada; [Hudson, Marie] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Hudson, Marie] Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada; [Ronnblom, Lars] Uppsala Univ, SciLifeLab, Dept Med Sci, SE-75144 Uppsala, Sweden; [Pastinen, Tomi M.] McGill Univ, Ctr Hlth, Dept Med Genet, Montreal, PQ H3H 1P3, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; University of Quebec; University of Quebec Chicoutimi; Swansea University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; McGill University; McGill University; McGill University; SciLifeLab; Uppsala University; McGill University	Cookson, WOCM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	w.cookson@imperial.ac.uk	Davies, Gwyneth/C-3838-2017; Yang, Ivana V/P-3059-2018; Cookson, William/HHC-1790-2022	Davies, Gwyneth/0000-0003-1218-1008; Yang, Ivana V/0000-0002-1018-489X; Binia, Aristea/0000-0002-8327-049X; Willis-Owen, Saffron/0000-0003-2633-1150; Laprise, Catherine/0000-0001-5526-9945	Freemasons' Grand Charity; Wellcome Trust [WT 077959, WT096964]; UK Medical Research Council; Genome Quebec; le Ministere de l'Enseignement superieur; de la Recherche, de la Science et de la Technologie (MESRST), Quebec; McGill University; National Institutes of Health [R01s HL101251-01, P01-E518181]; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [G1000758, MR/K006525/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10126] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre, AUK-AC-2012-01] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181] Funding Source: NIH RePORTER	Freemasons' Grand Charity; Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Genome Quebec; le Ministere de l'Enseignement superieur; de la Recherche, de la Science et de la Technologie (MESRST), Quebec; McGill University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Freemasons' Grand Charity. The study was also funded by the Wellcome Trust under grants WT 077959 and WT096964, the UK Medical Research Council, a grant to G.M.L. from Genome Quebec, le Ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie (MESRST), Quebec and McGill University, and the National Institutes of Health R01s HL101251-01 and P01-E518181. M.F.M. and W.O.C.M.C. are Joint Wellcome Trust Senior Investigators, W.O.C.M.C. is a National Institute for Health Research Senior Investigator and C.L. is the Chairholder of the Canada Research Chair on Genetic Determinants in Asthma. We thank A.-M. Madore and V. T. Vaillancourt for the eosinophil isolation and M. Laviolette and N. Flamand for their advice on this technique.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ferland C, 2001, J LEUKOCYTE BIOL, V69, P772; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Holgate ST, 2005, CLIN EXP ALLERGY, V35, P408, DOI 10.1111/j.1365-2222.2005.02191.x; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Kita H, 2011, IMMUNOL REV, V242, P161, DOI 10.1111/j.1600-065X.2011.01026.x; Kruse S, 2000, AM J HUM GENET, V66, P1522, DOI 10.1086/302901; Laprise C, 2014, GENES IMMUN, V15, P247, DOI 10.1038/gene.2014.12; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Levin AM, 2013, J ALLERGY CLIN IMMUN, V131, P1176, DOI 10.1016/j.jaci.2012.10.002; Lohning M, 2002, ADV IMMUNOL, V80, P115, DOI 10.1016/S0065-2776(02)80014-1; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nouri-Aria KT, 2000, CLIN EXP ALLERGY, V30, P1709, DOI 10.1046/j.1365-2222.2000.00998.x; Palmer LJ, 2000, AM J RESP CRIT CARE, V161, P1836, DOI 10.1164/ajrccm.161.6.9805104; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Peachman KK, 2001, P NATL ACAD SCI USA, V98, P1717, DOI 10.1073/pnas.98.4.1717; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Relton CL, 2012, INT J EPIDEMIOL, V41, P161, DOI 10.1093/ije/dyr233; Roessler Jessica, 2012, BMC Res Notes, V5, P210, DOI 10.1186/1756-0500-5-210; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Ziyab AH, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-67	36	150	150	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					670	U188		10.1038/nature14125	http://dx.doi.org/10.1038/nature14125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25707804	Green Submitted, Green Accepted			2022-12-28	WOS:000353689700048
J	Florence, TJ; Reiser, MB				Florence, T. J.; Reiser, Michael B.			NEUROSCIENCE Hot on the trail of temperature processing	NATURE			English	Editorial Material							DROSOPHILA					florencet@janelia.hhmi.org; reiserm@janelia.hhmi.org		Reiser, Michael/0000-0002-4108-4517				FRAENKEL GS, 1960, ORIENTATION ANIMALS; Frank DD, 2015, NATURE, V519, P358, DOI 10.1038/nature14284; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Klein M, 2015, P NATL ACAD SCI USA, V112, pE220, DOI 10.1073/pnas.1416212112; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Liu WW, 2015, NATURE, V519, P353, DOI 10.1038/nature14170; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1	12	6	6	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					296	297		10.1038/nature14209	http://dx.doi.org/10.1038/nature14209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25739498				2022-12-28	WOS:000351171900027
J	Perry, RJ; Zhang, DY; Zhang, XM; Boyer, JL; Shulman, GI				Perry, Rachel J.; Zhang, Dongyan; Zhang, Xian-Man; Boyer, James L.; Shulman, Gerald I.			Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats	SCIENCE			English	Article							INSULIN-RESISTANCE	Nonalcoholic fatty liver disease (NAFLD) is a major factor in the pathogenesis of type 2 diabetes (T2D) and nonalcoholic steatohepatitis (NASH). The mitochondrial protonophore 2,4 dinitrophenol (DNP) has beneficial effects on NAFLD, insulin resistance, and obesity in preclinical models but is too toxic for clinical use. We developed a controlled-release oral formulation of DNP, called CRMP (controlled-release mitochondrial protonophore), that produces mild hepatic mitochondrial uncoupling. In rat models, CRMP reduced hypertriglyceridemia, insulin resistance, hepatic steatosis, and diabetes. It also normalized plasma transaminase concentrations, ameliorated liver fibrosis, and improved hepatic protein synthetic function in a methionine/choline-deficient rat model of NASH. Chronic treatment with CRMP was not associated with any systemic toxicity. These data offer proof of concept that mild hepatic mitochondrial uncoupling may be a safe and effective therapy for the related epidemics of metabolic syndrome, T2D, and NASH.	[Perry, Rachel J.; Zhang, Dongyan; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Perry, Rachel J.; Zhang, Xian-Man; Boyer, James L.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Perry, Rachel J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Boyer, James L.] Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064	United States National Institutes of Health [R01 DK-40936, R24 DK-085638, U24 DK-059635, T32 DK-101019, P30 DK-45735, P30 DK-34989, UL1 TR-000142]; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, U24DK059635, P30DK045735, R24DK085638, R01DK040936, T32DK101019] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Dong, C. Soroka, J. P. Camporez, M. Jurczak, J. Stack, M. Kahn, C. Borders, Y. Kosover, A. Nasiri, G. Butrico, M. Batsu, and W. Zhu for their invaluable technical assistance; C. Frassetto and A. Barkley for their work to formulate the CRMP; B. Ehrlich for assistance with the thermal algesia studies; M. Kashgarian for expert analysis of renal histology; and A. Ray and C. Tay for toxicology advice. Yale University has applied for a patent (provisional patent application 61/919, 003) related to the use of CRMP and similar protonophores for the treatment of metabolic diseases, including NAFLD/NASH and T2D. This research was funded by grants from the United States National Institutes of Health (R01 DK-40936, R24 DK-085638, U24 DK-059635, T32 DK-101019, P30 DK-45735, P30 DK-34989, and UL1 TR-000142) and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.	Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Petersen KF, 1999, AM J PHYSIOL-ENDOC M, V276, pE529, DOI 10.1152/ajpendo.1999.276.3.E529; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200	7	190	196	2	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1253	1256		10.1126/science.aaa0672	http://dx.doi.org/10.1126/science.aaa0672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25721504	Green Accepted			2022-12-28	WOS:000350824300039
J	Durham, J; Newton-John, TRO; Zakrzewska, JM				Durham, Justin; Newton-John, Toby R. O.; Zakrzewska, Joanna M.			Temporomandibular disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESEARCH DIAGNOSTIC-CRITERIA; BOTULINUM-TOXIN-A; HEALTH IMPACT PROFILE; GENE-RELATED PEPTIDE; CHRONIC PAIN; OROFACIAL PAIN; AXIS I; MYOFASCIAL PAIN; JOINT PAIN; VALIDATION PROJECT		[Durham, Justin] Newcastle Univ, Ctr Oral Hlth Res, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; [Durham, Justin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; [Newton-John, Toby R. O.] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW 2007, Australia; [Zakrzewska, Joanna M.] UCLH NHS Fdn Trust, Eastman Dent Hosp, Facial Pain Unit, London, England	Newcastle University - UK; Newcastle University - UK; University of Technology Sydney; University College London Hospitals NHS Foundation Trust; University of London; University College London	Durham, J (corresponding author), Newcastle Univ, Sch Dent Sci, Level 5, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England.	justin.durham@ncl.ac.uk	Zakrzewska, Joanna M./AAC-7378-2020; Newton-John, Toby RO/Z-5348-2019; Penzien, Donald B/H-9693-2017; Vivan, Carolina Lapaz/J-4430-2017	Zakrzewska, Joanna M./0000-0001-7805-5851; Penzien, Donald B/0000-0003-4913-7158; Vivan, Carolina Lapaz/0000-0002-3789-1965	UCL/UCLHT; Department of Health's NIHR Biomedical Research Centre; NIHR [NIHR-CS-011-003]; National Institute for Health Research [NIHR-CS-011-003, 617, CL-2008-01-007] Funding Source: researchfish	UCL/UCLHT; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We have read and understood the BMJ policy on declaration of interests and declare the following: JMZ is part funded by UCL/UCLHT, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre funding scheme; JD is funded by a NIHR clinician scientist award (NIHR-CS-011-003). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health in the United Kingdom.	Aggarwal V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008456.pub2; Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265; Ahmad M, 2009, ORAL SURG ORAL MED O, V107, P844, DOI 10.1016/j.tripleo.2009.02.023; Albino JEN, 1996, J AM DENT ASSOC, V127, P1595; Anderson GC, 2010, J OROFAC PAIN, V24, P79; Aneiros-Guerrero A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-75; Appelgren Anna, 1995, Journal of Orofacial Pain, V9, P215; Ballegaard V, 2008, CEPHALALGIA, V28, P832, DOI 10.1111/j.1468-2982.2008.01597.x; Beddis HP, 2014, BRIT DENT J, V217, P351, DOI 10.1038/sj.bdj.2014.862; Beecroft EV, 2013, BRIT DENT J, V214, DOI 10.1038/sj.bdj.2013.221; Bell WE, 1982, CLIN MANAGEMENT TEMP; Cady RJ, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-94; Cairns B, 2010, J ORAL REHABIL, V37, P481, DOI 10.1111/j.1365-2842.2010.02082.x; Cohen M, 2011, PAIN MED, V12, P1637, DOI 10.1111/j.1526-4637.2011.01264.x; Costen JB, 1934, ANN OTO RHINOL LARYN, V43, P1, DOI DOI 10.1177/000348943404300101; Dahlstrom L, 2010, ACTA ODONTOL SCAND, V68, P80, DOI 10.3109/00016350903431118; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Diatchenko L, 2006, PAIN, V123, P226, DOI 10.1016/j.pain.2006.04.015; Dorflinger L, 2013, TRANSL BEHAV MED, V3, P39, DOI 10.1007/s13142-012-0158-z; Drake RL, 2005, GRAYS ANATOMY STUDEN, P874; Durham J, 2011, J ORAL REHABIL, V38, P871, DOI 10.1111/j.1365-2842.2011.02233.x; Durham J, 2010, J DENT RES, V89, P827, DOI 10.1177/0022034510368648; Durham J., 2012, DENT EMERGENCIES; Durham J, 2013, TEMPOROMANDIBULAR DI; Durham J, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-6; Durham J, 2011, COMMUNITY DENT ORAL, V39, P532, DOI 10.1111/j.1600-0528.2011.00608.x; Dworkin SF, 2010, J ORAL REHABIL, V37, P734, DOI 10.1111/j.1365-2842.2010.02090.x; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Dworkin SF, 2011, J PAIN, V12, pT1, DOI 10.1016/j.jpain.2011.08.004; DWORKIN SF, 1994, J PROSTHET DENT, V72, P29, DOI 10.1016/0022-3913(94)90213-5; Ehde DM, 2014, AM PSYCHOL, V69, P153, DOI 10.1037/a0035747; Epker J, 1999, J AM DENT ASSOC, V130, P1470, DOI 10.14219/jada.archive.1999.0058; EPSTEIN JB, 1993, ORAL SURG ORAL MED O, V75, P32, DOI 10.1016/0030-4220(93)90402-P; Ernberg M, 2011, PAIN, V152, P1988, DOI 10.1016/j.pain.2011.03.036; Fernandes G, 2015, J ORAL REHABIL, V42, P113, DOI 10.1111/joor.12238; Fernandes G, 2013, J OROFAC PAIN, V27, P14, DOI 10.11607/jop.921; Fillingim RB, 2013, J PAIN, V14, pT75, DOI 10.1016/j.jpain.2013.06.009; Garofalo JP, 1998, J AM DENT ASSOC, V129, P438, DOI 10.14219/jada.archive.1998.0242; Gatchel RJ, 2006, J AM DENT ASSOC, V137, P339, DOI 10.14219/jada.archive.2006.0183; Goncalves DAG, 2010, HEADACHE, V50, P231, DOI 10.1111/j.1526-4610.2009.01511.x; Gonzalez YM, 2011, J AM DENT ASSOC, V142, P1183, DOI 10.14219/jada.archive.2011.0088; GRAY RJM, 1994, BRIT DENT J, V176, P429, DOI 10.1038/sj.bdj.4808473; Greene CS, 2010, J AM DENT ASSOC, V141, P1086, DOI 10.14219/jada.archive.2010.0337; Greene CS, 2001, J OROFAC PAIN, V15, P93; Guarda-Nardini L, 2008, CRANIO, V26, P126, DOI 10.1179/crn.2008.017; Hoffmann RG, 2011, CLIN J PAIN, V27, P268, DOI 10.1097/AJP.0b013e31820215f5; Isong U, 2008, J OROFAC PAIN, V22, P317; Kimos P, 2007, PAIN, V127, P151, DOI 10.1016/j.pain.2006.08.028; Koh H, 2003, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/146751858.CD003812; Kopp S, 2001, J OROFAC PAIN, V15, P9; Kurtoglu C, 2008, J ORAL MAXIL SURG, V66, P1644, DOI 10.1016/j.joms.2008.03.008; Laskin DM, 2008, J AM DENT ASSOC, V139, P124, DOI 10.14219/jada.archive.2008.0115; Laskin DM, 2012, J ORAL MAXIL SURG, V70, P1240, DOI 10.1016/j.joms.2011.05.030; LeResche L, 2007, PAIN, V129, P269, DOI 10.1016/j.pain.2006.10.012; Light KC, 2009, J PAIN, V10, P542, DOI 10.1016/j.jpain.2008.12.006; LIPTON JA, 1993, J AM DENT ASSOC, V124, P115, DOI 10.14219/jada.archive.1993.0200; List T, 1999, J OROFAC PAIN, V13, P9; List T, 2010, J ORAL REHABIL, V37, P430, DOI 10.1111/j.1365-2842.2010.02089.x; Litt MD, 2013, J PAIN, V14, P1502, DOI 10.1016/j.jpain.2013.07.017; Lobbezoo F, 2010, J ORAL REHABIL, V37, P779, DOI 10.1111/j.1365-2842.2010.02091.x; Look JO, 2010, J ORAL REHABIL, V37, P744, DOI 10.1111/j.1365-2842.2010.02121.x; Look JO, 2010, J OROFAC PAIN, V24, P25; Luther F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006541.pub2; Madland G, 2000, PAIN, V84, P225, DOI 10.1016/S0304-3959(99)00210-9; McNeill C, 1997, J PROSTHET DENT, V77, P510, DOI 10.1016/S0022-3913(97)70145-8; McNeill C., 1990, TEMPOROMANDIBULAR DI; Meloto CB, 2011, ARCH ORAL BIOL, V56, P1181, DOI 10.1016/j.archoralbio.2011.03.012; Milam SB, 1998, J ORAL MAXIL SURG, V56, P214, DOI 10.1016/S0278-2391(98)90872-2; Milam Stephen B, 2005, Odontology, V93, P7, DOI 10.1007/s10266-005-0056-7; Moufti MA, 2011, EUR J ORAL SCI, V119, P169, DOI 10.1111/j.1600-0722.2011.00809.x; Nilsson Ing-Marie, 2007, Swed Dent J Suppl, P7; Nixdorf DR, 2002, PAIN, V99, P465, DOI 10.1016/S0304-3959(02)00240-3; Ohrbach R, 2010, J ORAL REHABIL, V37, P784, DOI 10.1111/j.1365-2842.2010.02144.x; Ohrbach R, 2010, J OROFAC PAIN, V24, P48; Palla S, 2011, J OROFAC PAIN, V25, P289; Peck CC, 2014, J ORAL REHABIL, V41, P2, DOI 10.1111/joor.12132; Phillips K, 2011, BEST PRACT RES CL RH, V25, P141, DOI 10.1016/j.berh.2011.02.005; Planello AC, 2011, EUR J ORAL SCI, V119, P1, DOI 10.1111/j.1600-0722.2010.00803.x; Plesh O, 2011, J OROFAC PAIN, V25, P190; Raphael KG, 2014, J ORAL REHABIL, V41, P555, DOI 10.1111/joor.12180; Reibmann DR, 2007, J DENT, V35, P643, DOI 10.1016/j.jdent.2007.04.010; Reissmann DR, 2008, EUR J ORAL SCI, V116, P237, DOI 10.1111/j.1600-0722.2008.00528.x; Ribeiro-Dasilva MC, 2009, J PAIN, V10, P527, DOI 10.1016/j.jpain.2008.11.012; Rizzatti-Barbosa CM, 2003, CRANIO, V21, P221, DOI 10.1080/08869634.2003.11746254; Sanders AE, 2013, J PAIN, V14, pT51, DOI 10.1016/j.jpain.2013.06.001; Sato J, 2004, ORAL SURG ORAL MED O, V98, P533, DOI 10.1016/j.tripleo.2004.02.057; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Schiffman E, 2012, CEPHALALGIA, V32, P683, DOI 10.1177/0333102412446312; Schiffman EL, 2010, J OROFAC PAIN, V24, P63; Schiffman EL, 2010, J OROFAC PAIN, V24, P7; Schmitter M, 2005, J ORAL REHABIL, V32, P467, DOI 10.1111/j.1365-2842.2005.01449.x; SHARAV Y, 1987, PAIN, V31, P199, DOI 10.1016/0304-3959(87)90036-4; Shore NA, 1959, OCCLUSAL EQUILIBRATI; Siccoli MM, 2006, LANCET NEUROL, V5, P257, DOI 10.1016/S1474-4422(06)70375-1; Slade GD, 2013, PAIN, V154, P750, DOI 10.1016/j.pain.2013.01.014; Slade GD, 2011, J PAIN, V12, pT12, DOI 10.1016/j.jpain.2011.08.001; Slade GD, 2013, J PAIN, V14, p[T20, e1]; Standring S., 2008, GRAYS ANATOMY, P538; Suvinen TI, 2005, EUR J PAIN, V9, P613, DOI 10.1016/j.ejpain.2005.01.012; Svensson P, 2011, SCAND J PAIN, V2, P70, DOI 10.1016/j.sjpain.2011.01.004; Truelove E, 2010, J OROFAC PAIN, V24, P35; Turp JC, 2007, CLIN ORAL IMPLAN RES, V18, P138, DOI 10.1111/j.1600-0501.2007.01480.x; Velly AM, 2011, PAIN, V152, P2377, DOI 10.1016/j.pain.2011.07.004; Velly AM, 2010, J PAIN, V11, P1155, DOI 10.1016/j.jpain.2010.02.009; Visscher C, 2010, J OROFAC PAIN, V24, P234; Von Korff M, 2008, PAIN, V138, P267, DOI 10.1016/j.pain.2007.12.010; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vowles KE, 2012, CURR PAIN HEADACHE R, V16, P133, DOI 10.1007/s11916-012-0244-4; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046; White BA, 2001, J OROFAC PAIN, V15, P158; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wright AR, 2004, J AM DENT ASSOC, V135, P474, DOI 10.14219/jada.archive.2004.0213; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006	113	74	79	3	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2015	350								h1154	10.1136/bmj.h1154	http://dx.doi.org/10.1136/bmj.h1154			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EQ	25767130	Green Submitted			2022-12-28	WOS:000351182700002
J	Kay, RF				Kay, Richard F.			New World monkey origins	SCIENCE			English	Editorial Material							BIOGEOGRAPHY		[Kay, Richard F.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Kay, Richard F.] Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA	Duke University; Duke University	Kay, RF (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	richard.kay@duke.edu						Antoine PO, 2012, P ROY SOC B-BIOL SCI, V279, P1319, DOI 10.1098/rspb.2011.1732; Bertrand OC, 2012, AM MUS NOVIT, P1; Bond M, 2015, NATURE, V520, P538, DOI 10.1038/nature14120; Frailey Carl David, 2004, Natural History Museum of Los Angeles County Science Series, V40, P71; Kay RF, 2001, ADV PRIMATO, P339; Kay RF, 1998, J VERTEBR PALEONTOL, V18, P189, DOI 10.1080/02724634.1998.10011043; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; Kay RF, 2012, EARLY MIOCENE PALEOBIOLOGY IN PATAGONIA: HIGH-LATITUDE PALEOCOMMUNITIES OF THE SANTA CRUZ FORMATION, P306; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Seiffert ER, 2005, SCIENCE, V310, P300, DOI 10.1126/science.1116569; Seiffert ER, 2012, EVOL ANTHROPOL, V21, P239, DOI 10.1002/evan.21335; Takai M, 2000, AM J PHYS ANTHROPOL, V111, P263, DOI 10.1002/(SICI)1096-8644(200002)111:2<263::AID-AJPA10>3.3.CO;2-Y; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; Wildman DE, 2009, MOL PHYLOGENET EVOL, V53, P694, DOI 10.1016/j.ympev.2009.07.019	14	21	22	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1068	1069		10.1126/science.aaa9217	http://dx.doi.org/10.1126/science.aaa9217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745147				2022-12-28	WOS:000350354200019
J	Robak, T; Huang, HQ; Jin, J; Zhu, J; Liu, T; Samoilova, O; Pylypenko, H; Verhoef, G; Siritanaratkul, N; Osmanov, E; Alexeeva, J; Pereira, J; Drach, J; Mayer, J; Hong, XN; Okamoto, R; Pei, LX; Rooney, B; van de Velde, H; Cavalli, F				Robak, Tadeusz; Huang, Huiqiang; Jin, Jie; Zhu, Jun; Liu, Ting; Samoilova, Olga; Pylypenko, Halyna; Verhoef, Gregor; Siritanaratkul, Noppadol; Osmanov, Evgenii; Alexeeva, Julia; Pereira, Juliana; Drach, Johannes; Mayer, Jiri; Hong, Xiaonan; Okamoto, Rumiko; Pei, Lixia; Rooney, Brendan; van de Velde, Helgi; Cavalli, Franco		LYM-3002 Investigators	Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELAPSED MULTIPLE-MYELOMA; EUROPEAN-MCL-NETWORK; PERIPHERAL NEUROPATHY; RANDOMIZED-TRIALS; PHASE-2 PINNACLE; PROGNOSTIC INDEX; FREE SURVIVAL; RITUXIMAB; VINCRISTINE; CYCLOPHOSPHAMIDE	BACKGROUND The proteasome inhibitor bortezomib was initially approved for the treatment of relapsed mantle-cell lymphoma. We investigated whether substituting bortezomib for vincristine in frontline therapy with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) could improve outcomes in patients with newly diagnosed mantle-cell lymphoma. METHODS In this phase 3 trial, we randomly assigned 487 adults with newly diagnosed mantle-cell lymphoma who were ineligible or not considered for stem-cell transplantation to receive six to eight 21-day cycles of R-CHOP intravenously on day 1 (with prednisone administered orally on days 1 to 5) or VR-CAP (R-CHOP regimen, but replacing vincristine with bortezomib at a dose of 1.3 mg per square meter of body-surface area on days 1, 4, 8, and 11). The primary end point was progression-free survival. RESULTS After a median follow-up of 40 months, median progression-free survival (according to independent radiologic review) was 14.4 months in the R-CHOP group versus 24.7 months in the VR-CAP group (hazard ratio favoring the VR-CAP group, 0.63; P<0.001), a relative improvement of 59%. On the basis of investigator assessment, the median durations of progression-free survival were 16.1 months and 30.7 months, respectively (hazard ratio, 0.51; P<0.001), a relative improvement of 96%. Secondary end points were consistently improved in the VR-CAP group, including the complete response rate (42% vs. 53%), the median duration of complete response (18.0 months vs. 42.1 months), the median treatment-free interval (20.5 months vs. 40.6 months), and the 4-year overall survival rate (54% vs. 64%). Rates of neutropenia and thrombocytopenia were higher in the VR-CAP group. CONCLUSIONS VR-CAP was more effective than R-CHOP in patients with newly diagnosed mantle-cell lymphoma but at the cost of increased hematologic toxicity. (Funded by Janssen Research and Development and Millennium Pharmaceuticals; LYM-3002 ClinicalTrials.gov number, NCT00722137.)	[Robak, Tadeusz] Med Univ Lodz, Dept Hematol, Copernicus Mem Hosp, Lodz, Poland; [Huang, Huiqiang] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Jin, Jie] Zhejiang Univ, Coll Med, Dept Hematol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Jun] Beijing Canc Hosp, Dept Lymphat Oncol, Beijing, Peoples R China; [Liu, Ting] Sichuan Univ, Dept Hematol, West China Hosp, Chengdu 610064, Peoples R China; [Hong, Xiaonan] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Samoilova, Olga] Nizhny Novgorod Region Clin Hosp, Nizhnii Novgorod, Russia; [Osmanov, Evgenii] Russian Acad Med Sci, Canc Res Ctr, NN Blokhin Acad Med Sci, Moscow, Russia; [Alexeeva, Julia] Fed Ctr Heart Blood & Endocrinol, St Petersburg, Russia; [Pylypenko, Halyna] Cherkassy Reg Oncol Ctr, Dept Hematol, Cherkassy, Ukraine; [Verhoef, Gregor] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium; [van de Velde, Helgi] Janssen Res & Dev, Beerse, Belgium; [Siritanaratkul, Noppadol] Mahidol Univ, Fac Sci, Siriraj Hosp, Dept Med, Bangkok 10400, Thailand; [Pereira, Juliana] Univ Sao Paulo, Fac Med, Hosp Clin, BR-09500900 Sao Paulo, Brazil; [Drach, Johannes] Med Univ Vienna, Vienna Gen Hosp, Div Oncol, Dept Internal Med 1, Vienna, Austria; [Mayer, Jiri] Fac Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic; [Okamoto, Rumiko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Chemotherapy, Tokyo, Japan; [Pei, Lixia] Janssen Res & Dev, Raritan, NJ USA; [Rooney, Brendan] Janssen Cilag, Janssen Res & Dev, High Wycombe, Bucks, England; [Cavalli, Franco] Osped San Giovanni Bellinzona, Oncol Inst Southern Switzerland, CH-6500 Bellinzona, Switzerland	Medical University Lodz; Sun Yat Sen University; Zhejiang University; Peking University; Sichuan University; Fudan University; Russian Academy of Medical Sciences; KU Leuven; University Hospital Leuven; Johnson & Johnson; Janssen Pharmaceuticals; Mahidol University; Universidade de Sao Paulo; Medical University of Vienna; University Hospital Brno; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Institute of Oncology Research (IOR); Regional Hospital of Bellinzona & Valleys, San Giovanni	Cavalli, F (corresponding author), Osped San Giovanni Bellinzona, Oncol Inst Southern Switzerland, CH-6500 Bellinzona, Switzerland.	franco.cavalli@eoc.ch	Greil, Richard F/C-7673-2017; le gouill, steven/L-1650-2015; PEREIRA, JULIANA/C-2742-2014; Remy, GRESSIN/G-7303-2014; Belada, David/P-9728-2017; Robak, Tadeusz/AAW-7365-2021; Zachee, Pierre/B-5391-2018	Greil, Richard F/0000-0002-4462-3694; PEREIRA, JULIANA/0000-0002-0655-2821; Remy, GRESSIN/0000-0002-9188-3501; Belada, David/0000-0002-4981-6188; Robak, Tadeusz/0000-0002-3411-6357; Zachee, Pierre/0000-0002-2275-5143; Ojeda-Uribe, Mario/0000-0001-6881-6055; Alekseeva, Julia/0000-0003-4453-5616; Osmanov, Evgenii/0000-0002-3067-1601; le gouill, steven/0000-0001-9840-2128; GONZALEZ BARCA, EVA/0000-0002-1323-1508	Research and Development and Millennium Pharmaceuticals	Research and Development and Millennium Pharmaceuticals	Funded by Janssen Research and Development and Millennium Pharmaceuticals; LYM-3002 ClinicalTrials.gov number, NCT00722137.	[Anonymous], 2014, VELC BORT INJ SUB IN; Barbee MS, 2013, ANN PHARMACOTHER, V47, P1136, DOI 10.1177/1060028013503122; Broyl A, 2010, LANCET ONCOL, V11, P1057, DOI 10.1016/S1470-2045(10)70206-0; Cavaletti G, 2010, LEUKEMIA LYMPHOMA, V51, P1178, DOI 10.3109/10428194.2010.483303; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Determann O, 2008, BLOOD, V111, P2385, DOI 10.1182/blood-2007-10-117010; Dreyling M, 2014, ANN ONCOL, V25, P83, DOI 10.1093/annonc/mdu264; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Flinn IW, 2014, BLOOD, V123, P2944, DOI 10.1182/blood-2013-11-531327; Furman RR, 2010, CANCER-AM CANCER SOC, V116, P5432, DOI 10.1002/cncr.25509; Garcia M, 2009, CANCER-AM CANCER SOC, V115, P1041, DOI 10.1002/cncr.24141; Goy A, 2009, ANN ONCOL, V20, P520, DOI 10.1093/annonc/mdn656; Goy A, 2010, LEUKEMIA LYMPHOMA, V51, P1269, DOI 10.3109/10428194.2010.483302; Herrmann A, 2009, J CLIN ONCOL, V27, P511, DOI 10.1200/JCO.2008.16.8435; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Hoster E, 2014, J CLIN ONCOL, V32, P1338, DOI 10.1200/JCO.2013.52.2466; Howard OM, 2002, J CLIN ONCOL, V20, P1288, DOI 10.1200/JCO.20.5.1288; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Kluin-Nelemans HC, 2012, NEW ENGL J MED, V367, P520, DOI 10.1056/NEJMoa1200920; Lenz G, 2005, J CLIN ONCOL, V23, P1984, DOI 10.1200/JCO.2005.08.133; Lonial S, 2005, BLOOD, V106, P3777, DOI 10.1182/blood-2005-03-1173; Lonial S, 2008, BRIT J HAEMATOL, V143, P222, DOI 10.1111/j.1365-2141.2008.07321.x; McKay P, 2012, BRIT J HAEMATOL, V159, P405, DOI 10.1111/bjh.12046; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Mounier N, 2008, ANN ONCOL S4, V19; Murai K, 2014, EUR J HAEMATOL, V93, P290, DOI 10.1111/ejh.12342; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; O'Connor OA, 2009, BRIT J HAEMATOL, V145, P34, DOI 10.1111/j.1365-2141.2008.07466.x; Ribrag V, 2009, CANCER-AM CANCER SOC, V115, P4540, DOI 10.1002/cncr.24518; Ruan J, 2011, J CLIN ONCOL, V29, P690, DOI 10.1200/JCO.2010.31.1142; Rummel MJ, 2013, LANCET, V381, P1184; Shi DS, 2014, J CLIN INVEST, V124, P3757, DOI 10.1172/JCI75247; Tiemann M, 2005, BRIT J HAEMATOL, V131, P29, DOI 10.1111/j.1365-2141.2005.05716.x; Vose Julie M, 2013, Am J Hematol, V88, P1082, DOI 10.1002/ajh.23615; Williams ME, 2013, HEMATOL-AM SOC HEMAT, P568, DOI 10.1182/asheducation-2013.1.568	36	268	281	0	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					944	953		10.1056/NEJMoa1412096	http://dx.doi.org/10.1056/NEJMoa1412096			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738670	Green Published, Green Submitted			2022-12-28	WOS:000350304500010
J	Roberts, E; Ludman, AJ; Dworzynski, K; Al-Mohammad, A; Cowie, MR; McMurray, JJV; Mant, J				Roberts, Emmert; Ludman, Andrew J.; Dworzynski, Katharina; Al-Mohammad, Abdallah; Cowie, Martin R.; McMurray, John J. V.; Mant, Jonathan		NICE Guideline Dev Grp Acute Heart	The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TISSUE DOPPLER-ECHOCARDIOGRAPHY; ACUTE DYSPNEA; NT-PROBNP; EMERGENCY DIAGNOSIS; DIFFERENTIAL-DIAGNOSIS; ETIOLOGIC DIAGNOSIS; ATRIAL-FIBRILLATION; PULMONARY-DISEASE; ELDERLY-PATIENTS; RENAL-FUNCTION	Objectives To determine and compare the diagnostic accuracy of serum natriuretic peptide levels (B type natriuretic peptide, N terminal probrain natriuretic peptide (NTproBNP), and mid-regional proatrial natriuretic peptide (MRproANP)) in people presenting with acute heart failure to acute care settings using thresholds recommended in the 2012 European Society of Cardiology guidelines for heart failure. Design Systematic review and diagnostic meta-analysis. Data sources Medline, Embase, Cochrane central register of controlled trials, Cochrane database of systematic reviews, database of abstracts of reviews of effects, NHS economic evaluation database, and Health Technology Assessment up to 28 January 2014, using combinations of subject headings and terms relating to heart failure and natriuretic peptides. Eligibility criteria for selecting studies Eligible studies evaluated one or more natriuretic peptides (B type natriuretic peptide, NTproBNP, or MRproANP) in the diagnosis of acute heart failure against an acceptable reference standard in consecutive or randomly selected adults in an acute care setting. Studies were excluded if they did not present sufficient data to extract or calculate true positives, false positives, false negatives, and true negatives, or report age independent natriuretic peptide thresholds. Studies not available in English were also excluded. Results 37 unique study cohorts described in 42 study reports were included, with a total of 48 test evaluations reporting 15 263 test results. At the lower recommended thresholds of 100 ng/L for B type natriuretic peptide and 300 ng/L for NTproBNP, the natriuretic peptides have sensitivities of 0.95 (95% confidence interval 0.93 to 0.96) and 0.99 (0.97 to 1.00) and negative predictive values of 0.94 (0.90 to 0.96) and 0.98 (0.89 to 1.0), respectively, for a diagnosis of acute heart failure. At the lower recommended threshold of 120 pmol/L, MRproANP has a sensitivity ranging from 0.95 (range 0.90-0.98) to 0.97 (0.95-0.98) and a negative predictive value ranging from 0.90 (0.80-0.96) to 0.97 (0.96-0.98). At higher thresholds the sensitivity declined progressively and specificity remained variable across the range of values. There was no statistically significant difference in diagnostic accuracy between plasma B type natriuretic peptide and NTproBNP. Conclusions At the rule-out thresholds recommended in the 2012 European Society of Cardiology guidelines for heart failure, plasma B type natriuretic peptide, NTproBNP, and MRproANP have excellent ability to exclude acute heart failure. Specificity is variable, and so imaging to confirm a diagnosis of heart failure is required. There is no statistical difference between the diagnostic accuracy of plasma B type natriuretic peptide and NTproBNP. Introduction of natriuretic peptide measurement in the investigation of patients with suspected acute heart failure has the potential to allow rapid and accurate exclusion of the diagnosis.	[Roberts, Emmert] South London & Maudsley Mental Hlth Trust, Maudsley Hosp, London, England; [Ludman, Andrew J.] Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5DW, Devon, England; [Dworzynski, Katharina] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Al-Mohammad, Abdallah] Sheffield Teaching Hosp NHS Fdn Trust, South Yorkshire Cardiothorac Ctr, Sheffield, S Yorkshire, England; [Cowie, Martin R.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England; [McMurray, John J. V.] Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, Glasgow, Lanark, Scotland; [Mant, Jonathan] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	South London & Maudsley NHS Trust; University of Exeter; Royal College of Physicians; University of Sheffield; Imperial College London; Royal Brompton Hospital; University of Glasgow; University of Cambridge	Ludman, AJ (corresponding author), Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5DW, Devon, England.	a.ludman@nhs.net	Cowie, Martin R/AAQ-2818-2020; Ludman, Andrew/ABG-6513-2020; mcmurray, John/B-2467-2013; Al-Mohammad, Abdallah/I-5663-2019	Cowie, Martin R/0000-0001-7457-2552; Ludman, Andrew/0000-0001-8000-4295; mcmurray, John/0000-0002-6317-3975; Al-Mohammad, Abdallah/0000-0001-6517-8692; Roberts, Emmert/0000-0002-4152-5570	National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital, London	National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital, London	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MRC's salary was supported by the National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital, London but no authors have support from any company for the submitted work; MRC has received honorariums within the past three years from Roche Diagnostics for lecturing on the use of natriuretic peptides in the diagnosis of heart failure, no other author has a relationship with a company that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Alibay Y, 2005, BIOMED PHARMACOTHER, V59, P20, DOI 10.1016/j.biopha.2004.06.002; Arques S, 2005, AM J CARDIOL, V96, P1456, DOI 10.1016/j.amjcard.2005.07.051; Arques S, 2007, ECHOCARDIOGR-J CARD, V24, P499, DOI 10.1111/j.1540-8175.2007.00418.x; Barcarse Erin, 2004, Congest Heart Fail, V10, P171, DOI 10.1111/j.1527-5299.2004.03308.x; Bayes-Genis A, 2004, EUR J HEART FAIL, V6, P301, DOI 10.1016/j.ejheart.2003.12.013; Behnes M, 2009, INT J CARDIOL, V135, P165, DOI 10.1016/j.ijcard.2008.03.045; Berdague P, 2006, AM HEART J, V151, P690, DOI 10.1016/j.ahj.2005.04.004; Blonde-Cynober F, 2011, ARCH GERONTOL GERIAT, V52, P106, DOI 10.1016/j.archger.2010.02.010; Chenevier-Gobeaux C, 2005, CLIN CHIM ACTA, V361, P167, DOI 10.1016/j.cccn.2005.05.021; Chenevier-Gobeaux C, 2010, CLIN CHEM, V56, P1708, DOI 10.1373/clinchem.2010.145417; Chung T, 2006, AM HEART J, V152, P949, DOI 10.1016/j.ahj.2006.05.020; Clerico A, 2007, CLIN CHEM, V53, P813, DOI 10.1373/clinchem.2006.075713; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; Dokainish H, 2004, AM J CARDIOL, V93, P1130, DOI 10.1016/j.amjcard.2004.01.042; Eckstein J, 2012, HEART, V98, P1518, DOI 10.1136/heartjnl-2012-302260; Fleischer D, 1997, NEW ZEAL MED J, V110, P71; Gargani L, 2008, EUR J HEART FAIL, V10, P70, DOI 10.1016/j.ejheart.2007.10.009; Gegenhuber A, 2006, CLIN CHEM, V52, P827, DOI 10.1373/clinchem.2005.065441; Gorissen C, 2007, CLIN CHEM LAB MED, V45, P678, DOI 10.1515/CCLM.2007.119; Gruson D, 2008, SCAND J CLIN LAB INV, V68, P410, DOI 10.1080/00365510701810605; Hu ZD, 2012, CLIN BIOCHEM, V45, P1634, DOI 10.1016/j.clinbiochem.2012.08.028; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Karmpaliotis D, 2007, CHEST, V131, P964, DOI 10.1378/chest.06-1247; Klemen P, 2009, CROAT MED J, V50, P133, DOI 10.3325/cmj.2009.50.133; Lainchbury JG, 2003, J AM COLL CARDIOL, V42, P728, DOI 10.1016/S0735-1097(03)00787-3; Logeart D, 2002, J AM COLL CARDIOL, V40, P1794, DOI 10.1016/S0735-1097(02)02482-8; Lokuge A, 2010, CIRC-HEART FAIL, V3, P104, DOI 10.1161/CIRCHEARTFAILURE.109.869438; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mueller T, 2005, HEART, V91, P606, DOI 10.1136/hrt.2004.037762; National Institute for Cardiovascular Outcomes Research, 2012, NAT HEART FAIL AUD A; Nazerian P, 2010, ACAD EMERG MED, V17, P18, DOI 10.1111/j.1553-2712.2009.00630.x; Novielli N, 2010, VALUE HEALTH, V13, P952, DOI 10.1111/j.1524-4733.2010.00762.x; Parab Reshma, 2005, Crit Pathw Cardiol, V4, P140, DOI 10.1097/01.hpc.0000174912.89563.ba; Peacock WF, 2007, CARDIOLOGY, V107, P44, DOI 10.1159/000093612; Potocki M, 2010, J INTERN MED, V267, P119, DOI 10.1111/j.1365-2796.2009.02135.x; Prosen G, 2011, CRIT CARE, V15, DOI 10.1186/cc10140; Ray P, 2005, J AM GERIATR SOC, V53, P643, DOI 10.1111/j.1532-5415.2005.53213.x; Ray P, 2004, INTENS CARE MED, V30, P2230, DOI 10.1007/s00134-004-2469-0; Rogers RK, 2009, EUR J HEART FAIL, V11, P1043, DOI 10.1093/eurjhf/hfp127; Sanz MP, 2006, J CLIN LAB ANAL, V20, P227, DOI 10.1002/jcla.20146; Shaikh K, 2011, JCPSP-J COLL PHYSICI, V21, P584, DOI 10.2011/JCPSP.584588; Thygesen K, 2012, EUR HEART J, V33, P2001, DOI 10.1093/eurheartj/ehq509; Villacorta H, 2002, ARQ BRAS CARDIOL, V79, P569, DOI [10.1590/S0066-782X2002001500002, DOI 10.1590/S0066-782X2002001500002]; Wang HK, 2010, AM J EMERG MED, V28, P987, DOI 10.1016/j.ajem.2009.05.019; Worster A, 2008, CLIN BIOCHEM, V41, P250, DOI 10.1016/j.clinbiochem.2007.08.008; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Zaninotto M, 2005, CLIN BIOCHEM, V38, P1041, DOI 10.1016/j.clinbiochem.2005.07.010	51	208	223	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2015	350								h910	10.1136/bmj.h910	http://dx.doi.org/10.1136/bmj.h910			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4DS	25740799	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000350301600006
J	Kontopantelis, E; Springate, DA; Ashworth, M; Webb, RT; Buchan, IE; Doran, T				Kontopantelis, Evangelos; Springate, David A.; Ashworth, Mark; Webb, Roger T.; Buchan, Iain E.; Doran, Tim			Investigating the relationship between quality of primary care and premature mortality in England: a spatial whole-population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; FINANCIAL INCENTIVES; BLOOD-PRESSURE; UK QUALITY; OF-CARE; OUTCOMES; HEALTH; PERFORMANCE; GLUCOSE	Objectives To quantify the relationship between a national primary care pay-for-performance programme, the UK's Quality and Outcomes Framework (QOF), and all-cause and cause-specific premature mortality linked closely with conditions included in the framework. Design Longitudinal spatial study, at the level of the "lower layer super output area" (LSOA). Setting 32482 LSOAs (neighbourhoods of 1500 people on average), covering the whole population of England (approximately 53.5 million), from 2007 to 2012. Participants 8647 English general practices participating in the QOF for at least one year of the study period, including over 99% of patients registered with primary care. Intervention National pay-for-performance programme incentivising performance on over 100 quality-of-care indicators. Main outcome measures All-cause and cause-specific mortality rates for six chronic conditions: diabetes, heart failure, hypertension, ischaemic heart disease, stroke, and chronic kidney disease. We used multiple linear regressions to investigate the relationship between spatially estimated recorded quality of care and mortality. Results All-cause and cause-specific mortality rates declined over the study period. Higher mortality was associated with greater area deprivation, urban location, and higher proportion of a non-white population. In general, there was no significant relationship between practice performance on quality indicators included in the QOF and all-cause or cause-specific mortality rates in the practice locality. Conclusions Higher reported achievement of activities incentivised under a major, nationwide pay-for-performance programme did not seem to result in reduced incidence of premature death in the population.	[Kontopantelis, Evangelos; Buchan, Iain E.] Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester, Lancs, England; [Kontopantelis, Evangelos; Springate, David A.] Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Inst Populat Hlth, Manchester, Lancs, England; [Springate, David A.] Univ Manchester, Ctr Biostat, Inst Populat Hlth, Manchester, Lancs, England; [Ashworth, Mark] Kings Coll London, London WC2R 2LS, England; [Webb, Roger T.] Univ Manchester, Ctr Mental Hlth & Risk, Manchester, Lancs, England; [Doran, Tim] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Manchester; University of Manchester; University of Manchester; University of London; King's College London; University of Manchester; University of York - UK	Kontopantelis, E (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester, Lancs, England.	e.kontopantelis@manchester.ac.uk	Buchan, Iain E/H-5767-2013; Kontopantelis, Evangelos/H-2966-2019	Buchan, Iain E/0000-0003-3392-1650; Kontopantelis, Evangelos/0000-0001-6450-5815; Ashworth, Mark/0000-0001-6514-9904; Webb, Roger/0000-0001-8532-2647	NIHR School for Primary Care Research fellowship in primary healthcare; NIHR Career Development Fellowship; Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	NIHR School for Primary Care Research fellowship in primary healthcare; NIHR Career Development Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: EK was partly supported by a NIHR School for Primary Care Research fellowship in primary healthcare; TD was supported by a NIHR Career Development Fellowship. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. No other relationships or activities could appear to have influenced the submitted work.	Andersson C, 2012, DIABETOLOGIA, V55, P2348, DOI 10.1007/s00125-012-2584-3; [Anonymous], 2006, SHP2DTA STAT MOD CON; Bellamy D, 2007, INT J CLIN PRACT, V61, P1380, DOI 10.1111/j.1742-1241.2007.01447.x; Bibby P., 2004, DEV NEW CLASSIFICATI; Boseley S., 2011, GUARDIAN; Bottle A, 2008, J GEN INTERN MED, V23, P135, DOI 10.1007/s11606-007-0390-2; Campbell S, 2003, BRIT J GEN PRACT, V53, P298; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Communities and Local Government, 2013, IND DEPR 2010; Communities and Local Government, 2011, ENGL IND DEPR 2010 T; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Drukker DM, 2013, STATA J, V13, P242, DOI 10.1177/1536867X1301300202; Drukker DM, 2013, STATA J, V13, P221, DOI 10.1177/1536867X1301300201; Dusheiko M, 2011, HEALTH SERV RES, V46, P27, DOI 10.1111/j.1475-6773.2010.01184.x; Edina, 2013, UKBORDERS BOUND DAT; Engstrom S, 2001, SCAND J PRIM HEALTH, V19, P131; Fleetcroft Robert, 2010, Br J Gen Pract, V60, pe345, DOI 10.3399/bjgp10X515359; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goodacre S, 2015, EMERG MED J, V32, P244, DOI 10.1136/emermed-2013-203022; Health and Social Care Information Centre, 2013, QUAL OUTC FRAM ACH P, P20; Health and Social Care Information Centre, 2014, NUMB PAT REG GP PRAC; Health and Social Care Information Centre, 2014, PRIM CAR MORT DAT; Health and Social Care Information Centre, 2013, QUAL OUTC FRAM; Hung DY, 2007, MILBANK Q, V85, P69, DOI 10.1111/j.1468-0009.2007.00477.x; Kontopantelis E, 2013, BMJ OPEN, P3; Kontopantelis E, 2015, DIABETOLOGIA, V58, P505, DOI 10.1007/s00125-014-3473-8; Kontopantelis E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g330; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Kontopantelis E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-61; Le Grand J., 2006, MOTIVATION AGENCY PU; Li X, 2012, INVEST OPHTH VIS SCI, V53, P3082, DOI 10.1167/iovs.12-9967; LIDDELL FDK, 1984, J EPIDEMIOL COMMUN H, V38, P85, DOI 10.1136/jech.38.1.85; Lin MF, 2013, INFORM SYST RES, V24, P906, DOI 10.1287/isre.2013.0480; May C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-148; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Miller ME, 2014, DIABETES CARE, V37, P634, DOI 10.2337/dc13-1545; Office for National Statistics, 2013, NOM OFF LAB MARK STA; Office for National Statistics, 2013, SUP OUTP AR MID POP; Office for National Statistics, 2013, OP GEOGR PORT; Office for National Statistics, 2013, MORT STAT MET, P55; Office for National Statistics, 2013, NEIGHB STAT; Office for National Statistics, 2012, CHANG OUTP AR SUP OU; Office for National Statistics, 2013, SUP OUTP AR MID POP; Ordance Survey, 2013, GUID COORD SYST GREA, P43; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Purdy S, 2011, J HEALTH SERV RES PO, V16, P133, DOI 10.1258/jhsrp.2010.010013; R Development Core Team, 2009, R LANG ENV STAT COMP; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; SPMAP, 2007, SPMAP STAT MOD VIS S; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stata Statistical Software for Windows, 2013, STAT STAT SOFTW WIND; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vamos EP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5567	58	68	68	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2015	350								h904	10.1136/bmj.h904	http://dx.doi.org/10.1136/bmj.h904			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC4BV	25733592	hybrid, Green Published			2022-12-28	WOS:000350296600008
J	Jayakrishnan, B; Dildar, B; Rizavi, DM; Al Mubaihsi, SM; Al Kindi, A				Jayakrishnan, B.; Dildar, Babar; Rizavi, Dawar M.; Al Mubaihsi, Saif M.; Al Kindi, Adil			Black pleural effusion	LANCET			English	Editorial Material									[Jayakrishnan, B.; Dildar, Babar; Rizavi, Dawar M.; Al Mubaihsi, Saif M.] Sultan Qaboos Univ Hosp, Dept Med, Muscat, Oman; [Al Kindi, Adil] Sultan Qaboos Univ Hosp, Dept Surg, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University	Jayakrishnan, B (corresponding author), Sultan Qaboos Univ Hosp, Dept Med, POB 35,PC 123, Muscat, Oman.	drjayakrish@hotmail.com		Nair, Jayakrishnan/0000-0003-1130-5689; AL KINDI, ADIL H./0000-0002-8864-2627					0	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					E7	E7		10.1016/S0140-6736(14)62003-1	http://dx.doi.org/10.1016/S0140-6736(14)62003-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LR	25749643	Bronze			2022-12-28	WOS:000360287900001
J	Martin, SA; Harris, K; Jack, BW				Martin, Stephen A.; Harris, Kenn; Jack, Brian W.			The Health of Young African American Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY		[Martin, Stephen A.; Jack, Brian W.] Boston Med Ctr, Dept Family Med, Boston, MA 02118 USA; [Martin, Stephen A.; Jack, Brian W.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Harris, Kenn] Community Fdn Greater New Haven, New Haven Hlth Start, New Haven, CT USA	Boston Medical Center; Boston University	Martin, SA (corresponding author), Boston Med Ctr, Dept Family Med, 1 Boston Med Ctr Pl,Dowling 5, Boston, MA 02118 USA.	stmartin@gmail.com	Martin, Stephen A/L-9381-2013	Martin, Stephen A/0000-0002-0356-5440	PHS HHS [R40 MC21510] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alexander M., 2012, NEW JIM CROW MASS IN; Geronimus AT, 2011, AM J PUBLIC HEALTH, V101, P720, DOI 10.2105/AJPH.2010.195537; Johnson A., BOSTON GLOBE; Kochanek KD, DID CAUSE DEATH CONT; Logan JE, 2013, MMWR-MORBID MORTAL W, V62, P164; Rosen DL, 2011, ANN EPIDEMIOL, V21, P719, DOI 10.1016/j.annepidem.2011.04.007; Smith GA, 2009, PEDIATRICS, V124, P393, DOI 10.1542/peds.2009-0943; US Preventive Services Task Force, 1996, YOUTH VIOL COUNS REL	8	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1415	1416		10.1001/jama.2015.2258	http://dx.doi.org/10.1001/jama.2015.2258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF8OK	25751164				2022-12-28	WOS:000352821200011
J	Lai, LL; Davey, R; Beck, A; Xu, YX; Suffredini, AF; Palmore, T; Kabbani, S; Rogers, S; Kobinger, G; Alimonti, J; Link, CJ; Rubinson, L; Stroher, U; Wolcott, M; Dorman, W; Uyeki, TM; Feldmann, H; Lane, HC; Mulligan, MJ				Lai, Lilin; Davey, Richard; Beck, Allison; Xu, Yongxian; Suffredini, Anthony F.; Palmore, Tara; Kabbani, Sarah; Rogers, Susan; Kobinger, Gary; Alimonti, Judie; Link, Charles J., Jr.; Rubinson, Lewis; Stroeher, Ute; Wolcott, Mark; Dorman, William; Uyeki, Timothy M.; Feldmann, Heinz; Lane, H. Clifford; Mulligan, Mark J.			Emergency Postexposure Vaccination With Vesicular Stomatitis Virus-Vectored Ebola Vaccine After Needlestick	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONHUMAN-PRIMATES; MONOCLONAL-ANTIBODIES; PROTECTION; INFECTION; FEVER	IMPORTANCE Safe and effective vaccines and drugs are needed for the prevention and treatment of Ebola virus disease, including following a potentially high-risk exposure such as a needlestick. OBJECTIVE To assess response to postexposure vaccination in a health care worker who was exposed to the Ebola virus. DESIGN AND SETTING Case report of a physician who experienced a needlestick while working in an Ebola treatment unit in Sierra Leone on September 26, 2014. Medical evacuation to the United States was rapidly initiated. Given the concern about potentially lethal Ebola virus disease, the patient was offered, and provided his consent for, postexposure vaccination with an experimental vaccine available through an emergency Investigational New Drug application. He was vaccinated on September 28, 2014. INTERVENTIONS The vaccine used was VSV Delta G-ZEBOV, a replicating, attenuated, recombinant vesicular stomatitis virus (serotype Indiana) whose surface glycoprotein gene was replaced by the Zaire Ebola virus glycoprotein gene. This vaccine has entered a clinical trial for the prevention of Ebola in West Africa. RESULTS The vaccine was administered 43 hours after the needlestick occurred. Fever and moderate to severe symptoms developed 12 hours after vaccination and diminished over 3 to 4 days. The real-time reverse transcription polymerase chain reaction results were transiently positive for vesicular stomatitis virus nucleoprotein gene and Ebola virus glycoprotein gene (both included in the vaccine) but consistently negative for Ebola virus nucleoprotein gene (not in the vaccine). Early postvaccination cytokine secretion and T lymphocyte and plasmablast activation were detected. Subsequently, Ebola virus glycoprotein-specific antibodies and T cells became detectable, but antibodies against Ebola viral matrix protein 40 (not in the vaccine) were not detected. CONCLUSIONS AND RELEVANCE It is unknown if VSV Delta G-ZEBOV is safe or effective for postexposure vaccination in humans who have experienced a high-risk occupational exposure to the Ebola virus, such as a needlestick. In this patient, postexposure vaccination with VSV Delta G-ZEBOV induced a self-limited febrile syndrome that was associated with transient detection of the recombinant vesicular stomatitis vaccine virus in blood. Strong innate and Ebola-specific adaptive immune responses were detected after vaccination. The clinical syndrome and laboratory evidence were consistent with vaccination response, and no evidence of Ebola virus infection was detected.	[Lai, Lilin; Beck, Allison; Xu, Yongxian; Kabbani, Sarah; Rogers, Susan; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Emory Vaccine Ctr,Div Infect Dis,Hope Clin, Atlanta, GA USA; [Davey, Richard; Suffredini, Anthony F.; Palmore, Tara; Lane, H. Clifford] NIAID, Div Clin Res, Ctr Clin, NIH, Bethesda, MD 20892 USA; [Kobinger, Gary; Alimonti, Judie] Publ Hlth Agcy Canada, Natl Lab Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada; [Link, Charles J., Jr.] NewLink Genet Corp, Ames, IA USA; [Rubinson, Lewis] Univ Maryland, Sch Med, Div Trauma Crit Care, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Stroeher, Ute; Uyeki, Timothy M.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Wolcott, Mark; Dorman, William] US Army, Diagnost Syst Div, Med Res Inst Infect Dis, Frederick, MD USA; [Feldmann, Heinz] NIAID, Div Intramural Res, Virol Lab, NIH, Hamilton, MT USA	Emory University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID); Public Health Agency of Canada; University System of Maryland; University of Maryland Baltimore; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mulligan, MJ (corresponding author), Emory Univ, Hope Clin, Emory Vaccine Ctr, 500 Irvin Ct,Ste 200, Decatur, GA 30030 USA.	mark.mulligan@emory.edu	Mulligan, Mark/V-9275-2019	Lai, Lilin/0000-0002-9528-6990	Georgia Research Alliance and Emory University; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; Emory Vaccinology Training Program under the National Institute of Allergy and Infectious Diseases, National Institutes of Health [T32AI074492]; National Institute of Allergy and Infectious Diseases Intramural Research Program at the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074492, ZIAAI001163, ZIAAI000936, ZIAAI000984, ZIAAI001089] Funding Source: NIH RePORTER	Georgia Research Alliance and Emory University; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Emory Vaccinology Training Program under the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institute of Allergy and Infectious Diseases Intramural Research Program at the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Georgia Research Alliance and Emory University (Dr Mulligan); the National Center for Advancing Translational Sciences of the National Institutes of Health (award UL1TR000454); the Emory Vaccinology Training Program under the National Institute of Allergy and Infectious Diseases, National Institutes of Health (T32AI074492 awarded to Drs Kabbani and Mulligan); and the National Institute of Allergy and Infectious Diseases Intramural Research Program at the National Institutes of Health.	Athearn K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046516; Breman JG, 2014, NEW ENGL J MED, V371, P1663, DOI 10.1056/NEJMp1410540; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Edupuganti S, 2013, AM J TROP MED HYG, V88, P172, DOI 10.4269/ajtmh.2012.12-0179; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225; Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298; Hastie E, 2012, J GEN VIROL, V93, P2529, DOI 10.1099/vir.0.046672-0; Marzi Andrea, 2011, J Bioterror Biodef, VS1; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Rubinson L, 2015, AM J TROP MED HYG, V92, P225, DOI 10.4269/ajtmh.14-0769; Swenson DL, 2008, CLIN VACCINE IMMUNOL, V15, P460, DOI 10.1128/CVI.00431-07; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; US Food and Drug Administration, 2014, FED REG, V79; Williams KJN, 2015, VIRAL IMMUNOL, V28, P51, DOI 10.1089/vim.2014.0069; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	20	66	67	0	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1249	1255		10.1001/jama.2015.1995	http://dx.doi.org/10.1001/jama.2015.1995			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25742465	Green Accepted, Bronze			2022-12-28	WOS:000351435500024
J	Preiss, PM; Ma, RC; Tai, ME; Lukin, A; Rispoli, M; Zupancic, P; Lahini, Y; Islam, R; Greiner, M				Preiss, Philipp M.; Ma, Ruichao; Tai, M. Eric; Lukin, Alexander; Rispoli, Matthew; Zupancic, Philip; Lahini, Yoav; Islam, Rajibul; Greiner, Markus			Strongly correlated quantum walks in optical lattices	SCIENCE			English	Article							BLOCH OSCILLATIONS; ATOMS; COMPUTATION; DYNAMICS; BOSONS; GAS	Full control over the dynamics of interacting, indistinguishable quantum particles is an important prerequisite for the experimental study of strongly correlated quantum matter and the implementation of high-fidelity quantum information processing. We demonstrate such control over the quantum walk-the quantum mechanical analog of the classical random walk-in the regime where dynamics are dominated by interparticle interactions. Using interacting bosonic atoms in an optical lattice, we directly observed fundamental effects such as the emergence of correlations in two-particle quantum walks, as well as strongly correlated Bloch oscillations in tilted optical lattices. Our approach can be scaled to larger systems, greatly extending the class of problems accessible via quantum walks.	[Preiss, Philipp M.; Ma, Ruichao; Tai, M. Eric; Lukin, Alexander; Rispoli, Matthew; Zupancic, Philip; Islam, Rajibul; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Lahini, Yoav] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Greiner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu	Lahini, Yoav/Q-9223-2017; Ma, Ruichao/P-3604-2014	Ma, Ruichao/0000-0003-4516-874X; /0000-0002-1266-4678; Lahini, Yoav/0000-0002-5952-7144; Zupancic, Philip/0000-0002-4698-2818	NSF through the Center for Ultracold Atoms; Army Research Office; DARPA OLE program; MURI program; Air Force Office of Scientific Research MURI program; Gordon and Betty Moore Foundation's EPiQS Initiative; U.S. Department of Defense through the NDSEG program; NSF Graduate Research Fellowship; Pappalardo Fellowship in Physics; Division Of Physics [1125846] Funding Source: National Science Foundation	NSF through the Center for Ultracold Atoms; Army Research Office; DARPA OLE program; MURI program(MURI); Air Force Office of Scientific Research MURI program(MURI); Gordon and Betty Moore Foundation's EPiQS Initiative; U.S. Department of Defense through the NDSEG program(United States Department of Defense); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Pappalardo Fellowship in Physics; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. Aaronson, M. Endres, and M. Knap for helpful discussions. Supported by grants from NSF through the Center for Ultracold Atoms, the Army Research Office with funding from the DARPA OLE program and a MURI program, an Air Force Office of Scientific Research MURI program, the Gordon and Betty Moore Foundation's EPiQS Initiative, the U.S. Department of Defense through the NDSEG program (M.E.T.), a NSF Graduate Research Fellowship (M.R.), and the Pappalardo Fellowship in Physics (Y.L.).	Aaronson S, 2011, ACM S THEORY COMPUT, P333; AHARONOV Y, 1993, PHYS REV A, V48, P1687, DOI 10.1103/PhysRevA.48.1687; Ahlbrecht A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073050; Alberti A, 2009, NAT PHYS, V5, P547, DOI 10.1038/NPHYS1310; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; BenDahan M, 1996, PHYS REV LETT, V76, P4508, DOI 10.1103/PhysRevLett.76.4508; Bromberg Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.253904; Broome MA, 2013, SCIENCE, V339, P794, DOI 10.1126/science.1231440; Cazalilla MA, 2011, REV MOD PHYS, V83, P1405, DOI 10.1103/RevModPhys.83.1405; Childs AM, 2013, SCIENCE, V339, P791, DOI 10.1126/science.1229957; Corrielli G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2578; Crespi A, 2013, NAT PHOTONICS, V7, P545, DOI [10.1038/nphoton.2013.112, 10.1038/NPHOTON.2013.112]; Dias WS, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.155124; Venegas-Andraca SE, 2012, QUANTUM INF PROCESS, V11, P1015, DOI 10.1007/s11128-012-0432-5; Farhi E, 1998, PHYS REV A, V58, P915, DOI 10.1103/PhysRevA.58.915; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; Fukuhara T, 2013, NATURE, V502, P76, DOI 10.1038/nature12541; Genske M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.190601; Haller E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.200403; Hartmann T, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/002; Jeltes T, 2007, NATURE, V445, P402, DOI 10.1038/nature05513; Karski M, 2009, SCIENCE, V325, P174, DOI 10.1126/science.1174436; Kaufman AM, 2014, SCIENCE, V345, P306, DOI 10.1126/science.1250057; Khomeriki R, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.065601; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Lahini Y, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.011603; Manouchehri K, 2014, PHYS IMPLEMENTATION; Meinert F, 2014, SCIENCE, V344, P1259, DOI 10.1126/science.1248402; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Peruzzo A, 2010, SCIENCE, V329, P1500, DOI 10.1126/science.1193515; Ronzheimer JP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.205301; Sansoni L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.010502; Schmitz H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.090504; SHEPELYANSKY DL, 1994, PHYS REV LETT, V73, P2607, DOI 10.1103/PhysRevLett.73.2607; Spring JB, 2013, SCIENCE, V339, P798, DOI 10.1126/science.1231692; Tillmann M, 2013, NAT PHOTONICS, V7, P540, DOI [10.1038/nphoton.2013.102, 10.1038/NPHOTON.2013.102]; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Winkler K, 2006, NATURE, V441, P853, DOI 10.1038/nature04918; Zahringer F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.100503	42	274	276	12	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1229	1233		10.1126/science.1260364	http://dx.doi.org/10.1126/science.1260364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766229	Green Submitted			2022-12-28	WOS:000350824300032
J	Gennarino, VA; Singh, RK; White, JJ; De Maio, A; Han, K; Kim, JY; Jafar-Nejad, P; di Ronza, A; Kang, H; Sayegh, LS; Cooper, TA; Orr, HT; Sillitoe, RV; Zoghbi, HY				Gennarino, Vincenzo A.; Singh, Ravi K.; White, Joshua J.; De Maio, Antonia; Han, Kihoon; Kim, Ji-Yoen; Jafar-Nejad, Paymaan; di Ronza, Alberto; Kang, Hyojin; Sayegh, Layal S.; Cooper, Thomas A.; Orr, Harry T.; Sillitoe, Roy V.; Zoghbi, Huda Y.			Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels	CELL			English	Article							FAMILIAL PARKINSONS-DISEASE; RNA-BINDING PROTEINS; SPINOCEREBELLAR ATAXIA; EXPRESSION ANALYSIS; MESSENGER-RNAS; PUF FAMILY; LOCUS DUPLICATION; SCA1; IDENTIFICATION; AGGREGATION	Spinocerebellar ataxia type 1 (SCA1) is a paradigmatic neurodegenerative proteinopathy, in which a mutant protein (in this case, ATAXIN1) accumulates in neurons and exerts toxicity; in SCA1, this process causes progressive deterioration of motor coordination. Seeking to understand how post-translational modification of ATAXIN1 levels influences disease, we discovered that the RNA-binding protein PUMILIO1 (PUM1) not only directly regulates ATAXIN1 but also plays an unexpectedly important role in neuronal function. Loss of Pum1 caused progressive motor dysfunction and SCA1-like neurodegeneration with motor impairment, primarily by increasing Ataxin1 levels. Breeding Pum1(+/-) mice to SCA1 mice (Atxn(1154Q/+)) exacerbated disease progression, whereas breeding them to Atxn1(+/-) mice normalized Ataxin1 levels and largely rescued the Pum1(+/-) phenotype. Thus, both increased wildtype ATAXIN1 levels and PUM1 haploinsufficiency could contribute to human neurodegeneration. These results demonstrate the importance of studying post-transcriptional regulation of disease-driving proteins to reveal factors underlying neurodegenerative disease.	[Gennarino, Vincenzo A.; Han, Kihoon; Kim, Ji-Yoen; Jafar-Nejad, Paymaan; di Ronza, Alberto; Kang, Hyojin; Sayegh, Layal S.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Singh, Ravi K.; White, Joshua J.; Cooper, Thomas A.; Sillitoe, Roy V.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [White, Joshua J.; Sillitoe, Roy V.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [De Maio, Antonia; Cooper, Thomas A.; Sillitoe, Roy V.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Han, Kihoon; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Gennarino, Vincenzo A.; White, Joshua J.; De Maio, Antonia; Han, Kihoon; Kim, Ji-Yoen; Jafar-Nejad, Paymaan; di Ronza, Alberto; Kang, Hyojin; Sayegh, Layal S.; Sillitoe, Roy V.; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu	Gennarino, Vincenzo A./H-3306-2019; White, Joshua/AAU-7461-2020; Han, Kihoon/AAE-8919-2019; White, Joshua/AAP-9445-2021	Gennarino, Vincenzo A./0000-0002-3312-6991; White, Joshua/0000-0002-6218-623X; Han, Kihoon/0000-0002-5925-2152; White, Joshua/0000-0002-6218-623X; Zoghbi, Huda/0000-0002-0700-3349; De Maio, Antonia/0000-0002-5667-5141; Singh, Ravi/0000-0002-2524-6109; Orr, Harry/0000-0001-6118-741X	RNA In Situ Hybridization, Confocal and Mouse Behavioral Cores at the BCM Intellectual and Developmental Disabilities Research Center (IDDRC) [NIH/NICHHDP30-HD024064, 1R01NS089664-01];  [R01NS02769926]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD083092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R01NS089664, R01NS027600] Funding Source: NIH RePORTER	RNA In Situ Hybridization, Confocal and Mouse Behavioral Cores at the BCM Intellectual and Developmental Disabilities Research Center (IDDRC); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Haifan Lin (Yale Stem Cell Center and Department of Cell Biology, Yale University School of Medicine) for sharing the Pum1 mutant mice; A. McCall for helpful suggestions on analysis; X. Liu for genotyping; C. Spencer for behavioral training; C. Ljungberg for ISH analysis; D. Yu for confocal microscopy training; and members of the H.Y.Z. laboratory for helpful discussions. We also thank A. Ballabio, T. Klisch, S. Yamamoto, M. Rousseaux, M. Sardiello, C. Schaaf, C. Alcott, and V. Brandt for helpful suggestions and critical reading of the manuscript. This research was supported by R01NS02769926 (to H.Y.Z.) and the RNA In Situ Hybridization, Confocal and Mouse Behavioral Cores at the BCM Intellectual and Developmental Disabilities Research Center (IDDRC; NIH/NICHHDP30-HD024064) and 1R01NS089664-01 (to R.V.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Banfi S, 1996, HUM MOL GENET, V5, P33, DOI 10.1093/hmg/5.1.33; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen D, 2012, CURR BIOL, V22, P420, DOI 10.1016/j.cub.2012.01.039; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Gennarino VA, 2011, GENE, V480, P51, DOI 10.1016/j.gene.2011.03.005; Glorian V, 2011, CELL DEATH DIFFER, V18, P1692, DOI 10.1038/cdd.2011.35; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kundu P, 2012, NUCLEIC ACIDS RES, V40, P5088, DOI 10.1093/nar/gks148; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	49	97	100	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1087	1098		10.1016/j.cell.2015.02.012	http://dx.doi.org/10.1016/j.cell.2015.02.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768905	Bronze, Green Accepted			2022-12-28	WOS:000351951800009
J	Murphy, GJ; Pike, K; Rogers, CA; Wordsworth, S; Stokes, EA; Angelini, GD; Reeves, BC				Murphy, Gavin J.; Pike, Katie; Rogers, Chris A.; Wordsworth, Sarah; Stokes, Elizabeth A.; Angelini, Gianni D.; Reeves, Barnaby C.		TITRe2 Investigators	Liberal or Restrictive Transfusion after Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RED-BLOOD-CELL; CLINICAL-PRACTICE GUIDELINE; SCORING METHOD ASEPSIS; ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; INCREASED MORTALITY; MORBIDITY; THRESHOLDS; STRATEGIES; OUTCOMES	BACKGROUND Whether a restrictive threshold for hemoglobin level in red-cell transfusions, as compared with a liberal threshold, reduces postoperative morbidity and health care costs after cardiac surgery is uncertain. METHODS We conducted a multicenter, parallel-group trial in which patients older than 16 years of age who were undergoing nonemergency cardiac surgery were recruited from 17 centers in the United Kingdom. Patients with a postoperative hemoglobin level of less than 9 g per deciliter were randomly assigned to a restrictive transfusion threshold (hemoglobin level <7.5 g per deciliter) or a liberal transfusion threshold (hemoglobin level <9 g per deciliter). The primary outcome was a serious infection (sepsis or wound infection) or an ischemic event (permanent stroke [confirmation on brain imaging and deficit in motor, sensory, or coordination functions], myocardial infarction, infarction of the gut, or acute kidney injury) within 3 months after randomization. Health care costs, excluding the index surgery, were estimated from the day of surgery to 3 months after surgery. RESULTS A total of 2007 patients underwent randomization; 4 participants withdrew, leaving 1000 in the restrictive-threshold group and 1003 in the liberal-threshold group. Transfusion rates after randomization were 53.4% and 92.2% in the two groups, respectively. The primary outcome occurred in 35.1% of the patients in the restrictive-threshold group and 33.0% of the patients in the liberal-threshold group (odds ratio, 1.11; 95% confidence interval [CI], 0.91 to 1.34; P = 0.30); there was no indication of heterogeneity according to subgroup. There were more deaths in the restrictive-threshold group than in the liberal-threshold group (4.2% vs. 2.6%; hazard ratio, 1.64; 95% CI, 1.00 to 2.67; P = 0.045). Serious postoperative complications, excluding primary-outcome events, occurred in 35.7% of participants in the restrictive-threshold group and 34.2% of participants in the liberal-threshold group. Total costs did not differ significantly between the groups. CONCLUSIONS A restrictive transfusion threshold after cardiac surgery was not superior to a liberal threshold with respect to morbidity or health care costs.	[Murphy, Gavin J.] Univ Leicester, British Heart Fdn, Dept Cardiovasc Sci, Leicester, Leics, England; [Murphy, Gavin J.] Glenfield Gen Hosp, Leicester LE3 9QP, Leics, England; [Pike, Katie; Rogers, Chris A.; Angelini, Gianni D.; Reeves, Barnaby C.] Univ Bristol, Sch Clin Sci, Bristol Heart Inst, Bristol Royal Infirm, Bristol, Avon, England; [Wordsworth, Sarah; Stokes, Elizabeth A.] Univ Oxford, Hlth Econ Res Ctr, Nuffield Dept Populat Hlth, Oxford, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Bristol Royal Infirmary; University of Bristol; University of Oxford	Reeves, BC (corresponding author), Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Sch Clin Sci, Bristol BS2 8HW, Avon, England.	barney.reeves@bristol.ac.uk	Van den Berghe, Greet/J-6788-2018; Grocott, Michael/C-4394-2008; Zamvar, Vipin/J-3430-2013; Marik, Paul E/U-9733-2019; Casaer, Michael/Y-7131-2019; Young, John D/M-9756-2016	Van den Berghe, Greet/0000-0002-5320-1362; Grocott, Michael/0000-0002-9484-7581; Zamvar, Vipin/0000-0003-2447-828X; Casaer, Michael/0000-0002-7087-0795; Kunst, Gudrun/0000-0002-9789-1334; Wordsworth, Sarah/0000-0002-2361-3040; Reeves, Barnaby/0000-0002-5101-9487; angelini, gianni/0000-0002-1753-3730; Murphy, Gavin/0000-0003-0976-1482	National Institute for Health Research Health Technology Assessment program; National Institute for Health Research [06/402/94, NF-SI-0611-10022] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment program; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Institute for Health Research Health Technology Assessment program; Current Controlled Trials number, ISRCTN70923932.	[Anonymous], EL MARK INF TOOL EMI; [Anonymous], 2013, 201213 NHS DEP HLTH; Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P1568, DOI 10.1001/jama.2010.1406; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; Brierley RCM, 2014, TRANSFUS APHER SCI, V50, P451, DOI 10.1016/j.transci.2014.02.020; Carson Jeffrey L, 2012, Cochrane Database Syst Rev, pCD002042, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2013, JAMA-J AM MED ASSOC, V309, P83, DOI 10.1001/jama.2012.50429; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Casutt M, 1999, CRIT CARE MED, V27, P2194, DOI 10.1097/00003246-199910000-00021; Curtis L, 2013, UNIT COSTS HLTH SOCI; Englberger L, 2011, CRIT CARE, V15, DOI 10.1186/cc9960; Farmer SL, 2013, BEST PRACT RES-CLIN, V27, P43, DOI 10.1016/j.bpa.2012.12.007; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Gibbons C, 2011, Health Technol Assess, V15, P1, DOI 10.3310/hta15300; Greinacher A, 2011, TRANSFUSION, V51, P702, DOI 10.1111/j.1537-2995.2010.02882.x; Habib RH, 2005, CRIT CARE MED, V33, P1749, DOI 10.1097/01.CCM.0000171531.06133.B0; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; Joint Formulary Committee, 2013, 66 JOINT FORM COMM B; Karkouti K, 2008, CIRCULATION, V117, P478, DOI 10.1161/CIRCULATIONAHA.107.718353; Karkouti K, 2011, ANESTHESIOLOGY, V115, P523, DOI 10.1097/ALN.0b013e318229a7e8; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Murphy GJ, 2007, TRANSFUS ALTERN T S1, V9, P41; Murphy MF, 2013, NATL COMP AUDIT BLOO; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Pike K, 2015, TRIALS, P16; Reeves BC, 2008, CURR OPIN CARDIOL, V23, P607, DOI 10.1097/HCO.0b013e328310fc95; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Shehata N, 2012, TRANSFUSION, V52, P91, DOI 10.1111/j.1537-2995.2011.03236.x; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tooze JA, 2002, STAT METHODS MED RES, V11, P341, DOI 10.1191/0962280202sm291ra; Utoh J, 1999, SURG TODAY, V29, P28, DOI 10.1007/BF02482966; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Wells AW, 2009, TRANSFUSION MED, V19, P315, DOI 10.1111/j.1365-3148.2009.00933.x; WHO, 2011, PATIENT BLOOD MANAGE; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILSON APR, 1986, LANCET, V1, P311; WILSON APR, 1990, J HOSP INFECT, V16, P297, DOI 10.1016/0195-6701(90)90002-6	45	500	517	1	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					997	1008		10.1056/NEJMoa1403612	http://dx.doi.org/10.1056/NEJMoa1403612			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760354	Green Published			2022-12-28	WOS:000350797300004
J	Presnyak, V; Alhusaini, N; Chen, YH; Martin, S; Morris, N; Kline, N; Olson, S; Weinberg, D; Baker, KE; Graveley, BR; Coller, J				Presnyak, Vladimir; Alhusaini, Najwa; Chen, Ying-Hsin; Martin, Sophie; Morris, Nathan; Kline, Nicholas; Olson, Sara; Weinberg, David; Baker, Kristian E.; Graveley, Brenton R.; Coller, Jeff			Codon Optimality Is a Major Determinant of mRNA Stability	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST; TRANSLATION; PROTEIN; USAGE; DECAY; TRANSCRIPT; DIFFERENTIATION; DEADENYLATION	mRNA degradation represents a critical regulated step in gene expression. Although the major pathways in turnover have been identified, accounting for disparate half-lives has been elusive. We show that codon optimality is one feature that contributes greatly to mRNA stability. Genome-wide RNA decay analysis revealed that stable mRNAs are enriched in codons designated optimal, whereas unstable mRNAs contain predominately non-optimal codons. Substitution of optimal codons with synonymous, non-optimal codons results in dramatic mRNA destabilization, whereas the converse substitution significantly increases stability. Further, we demonstrate that codon optimality impacts ribosome translocation, connecting the processes of translation elongation and decay through codon optimality. Finally, we show that optimal codon content accounts for the similar stabilities observed in mRNAs encoding proteins with coordinated physiological function. This work demonstrates that codon optimization exists as a mechanism to finely tune levels of mRNAs and, ultimately, proteins.	[Presnyak, Vladimir; Alhusaini, Najwa; Chen, Ying-Hsin; Martin, Sophie; Kline, Nicholas; Baker, Kristian E.; Coller, Jeff] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Morris, Nathan] Case Western Reserve Univ, Ctr Clin Invest, Stat Sci Core, Cleveland, OH 44106 USA; [Weinberg, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA USA; [Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, Farmington, CT 06030 USA	Case Western Reserve University; Case Western Reserve University; University of California System; University of California San Francisco; University of Connecticut	Coller, J (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	jmc71@case.edu	Graveley, Brenton R/C-3108-2013	Kline, Nicholas/0000-0002-7616-834X; Graveley, Brenton/0000-0001-5777-5892; Martin, Sophie/0000-0002-4458-7582; Morris, Nathan/0000-0001-7989-5764; Coller, Jeff/0000-0001-5662-8110; Presnyak, Vladimir/0000-0001-6695-7102	NIH [GM095621, GM080465]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095296, R01GM080465, R01GM095621, T32GM008056] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors express their appreciation to Dr. Tim Nilsen for his suggestions and critical evaluation of the manuscript and Dr. Beth Grayhack (University of Rochester) for helpful discussion. We thank the members of the Coller and Baker labs for their input into this work. This work was funded by NIH grant GM095621 to K.E.B. and GM080465 to J.C.K.E.B. and J.C. are inventors on a patent that has been filed related to this work.	AKASHI H, 1994, GENETICS, V136, P927; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Geisberg JV, 2014, CELL, V156, P812, DOI 10.1016/j.cell.2013.12.026; Ghosh S, 2010, WIRES RNA, V1, P351, DOI 10.1002/wrna.25; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HOEKEMA A, 1987, MOL CELL BIOL, V7, P2914, DOI 10.1128/MCB.7.8.2914; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Krisko A, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r44; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Lee SR, 2013, TRENDS CELL BIOL, V23, P504, DOI 10.1016/j.tcb.2013.05.001; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Sweet T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001342; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	29	462	480	10	117	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1111	1124		10.1016/j.cell.2015.02.029	http://dx.doi.org/10.1016/j.cell.2015.02.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768907	Green Accepted, Bronze			2022-12-28	WOS:000351951800011
J	Kamerow, D				Kamerow, Douglas			US Supreme Court v Obamacare: round 2	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University	Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Lichtblau E, 2015, NY TIMES, pA15; Liptak A., 2015, NY TIMES, pA1; Mathews AW, 2015, WALL STREET J, pB1; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1162; Shear MD, 2015, NY TIMES, pA1	5	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2015	350								h1368	10.1136/bmj.h1368	http://dx.doi.org/10.1136/bmj.h1368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EL	25762529				2022-12-28	WOS:000351182200012
J	Geier, S; Furst, F; Ziegerer, E; Kupfer, T; Heber, U; Irrgang, A; Wang, B; Liu, Z; Han, Z; Sesar, B; Levitan, D; Kotak, R; Magnier, E; Smith, K; Burgett, WS; Chambers, K; Flewelling, H; Kaiser, N; Wainscoat, R; Waters, C				Geier, S.; Fuerst, F.; Ziegerer, E.; Kupfer, T.; Heber, U.; Irrgang, A.; Wang, B.; Liu, Z.; Han, Z.; Sesar, B.; Levitan, D.; Kotak, R.; Magnier, E.; Smith, K.; Burgett, W. S.; Chambers, K.; Flewelling, H.; Kaiser, N.; Wainscoat, R.; Waters, C.			The fastest unbound star in our Galaxy ejected by a thermonuclear supernova	SCIENCE			English	Article							SUBDWARF-B-STARS; SINGLE-DEGENERATE SCENARIO; HYPERVELOCITY STARS; IA SUPERNOVAE; ROTATIONAL PROPERTIES; GALACTIC HALO; WHITE-DWARFS; BLACK-HOLES; BINARY; PROGENITORS	Hypervelocity stars (HVSs) travel with velocities so high that they exceed the escape velocity of the Galaxy. Several acceleration mechanisms have been discussed. Only one HVS (US 708, HVS 2) is a compact helium star. Here we present a spectroscopic and kinematic analysis of US 708. Traveling with a velocity of similar to 1200 kilometers per second, it is the fastest unbound star in our Galaxy. In reconstructing its trajectory, the Galactic center becomes very unlikely as an origin, which is hardly consistent with the most favored ejection mechanism for the other HVSs. Furthermore, we detected that US 708 is a fast rotator. According to our binary evolution model, it was spun-up by tidal interaction in a close binary and is likely to be the ejected donor remnant of a thermonuclear supernova.	[Geier, S.] European So Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Geier, S.; Ziegerer, E.; Heber, U.; Irrgang, A.] Univ Erlangen Nurnberg, Dr Karl Remeis Observ, D-96049 Bamberg, Germany; [Geier, S.; Ziegerer, E.; Heber, U.; Irrgang, A.] Univ Erlangen Nurnberg, Erlangen Ctr Astroparticle Phys, Astron Inst, D-96049 Bamberg, Germany; [Fuerst, F.] CALTECH, Space Radiat Lab, Pasadena, CA 91125 USA; [Kupfer, T.] Radboud Univ Nijmegen, Dept Astrophys, Inst Math Astrophys & Particle Phys, NL-6500 GL Nijmegen, Netherlands; [Wang, B.; Liu, Z.; Han, Z.] Chinese Acad Sci, Yunnan Observ, Key Lab Struct & Evolut Celestial Objects, Kunming 650011, Peoples R China; [Liu, Z.] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Sesar, B.; Levitan, D.] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Sesar, B.; Chambers, K.; Flewelling, H.; Kaiser, N.; Wainscoat, R.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Kotak, R.; Smith, K.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Magnier, E.; Burgett, W. S.; Waters, C.] Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA	European Southern Observatory; University of Erlangen Nuremberg; University of Erlangen Nuremberg; California Institute of Technology; Radboud University Nijmegen; Chinese Academy of Sciences; Yunnan Astronomical Observatory, NAOC, CAS; University of Bonn; California Institute of Technology; Max Planck Society; Queens University Belfast; University of Hawaii System; University of Hawaii Manoa	Geier, S (corresponding author), European So Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany.	sgeier@eso.org	Kupfer, Thomas/J-4401-2017; Han, Zhanwen/AAH-7752-2021; Heber, Ulrich/W-3956-2019; Kotak, Rubina/F-3325-2011	Kupfer, Thomas/0000-0002-6540-1484; Heber, Ulrich/0000-0001-7798-6769; Han, Zhanwen/0000-0001-9204-7778; Magnier, Eugene/0000-0002-7965-2815; Liu, Zhengwei/0000-0002-7909-4171; Kotak, Rubina/0000-0001-5455-3653; Irrgang, Andreas/0000-0002-0465-3725; Chambers, Kenneth/0000-0001-6965-7789; Wang, Bo/0000-0002-3231-1167	W. M. Keck Foundation; NASA through the Planetary Science Division of the NASA Science Mission Directorate [NNX08AR22G]; NSF [AST-1238877]; Natural Science Foundation of China [11390374, 11033008]; Deutsche Forschungsgemeinschaft [HE1356/45-2]; Netherlands Research School for Astronomy (NOVA); Elite Network of Bavaria; Science and Technologies Council UK [ST/L000709/1]; Queen's University Belfast's contribution to the PanSTARRS1 science consortium; European Union FP7 Programme ERC [291222]; NASA [NNG08FD60C]; Science and Technology Facilities Council [ST/M003515/1, ST/L000709/1, ST/M001970/1] Funding Source: researchfish; STFC [ST/M001970/1, ST/M003515/1, ST/L000709/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [1238877] Funding Source: National Science Foundation	W. M. Keck Foundation(W.M. Keck Foundation); NASA through the Planetary Science Division of the NASA Science Mission Directorate; NSF(National Science Foundation (NSF)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Research School for Astronomy (NOVA); Elite Network of Bavaria; Science and Technologies Council UK; Queen's University Belfast's contribution to the PanSTARRS1 science consortium; European Union FP7 Programme ERC; NASA(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank H. Hirsch for providing us with the Low Resolution Imaging Spectrometer spectra. This work is based on observations obtained at the W.M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA. The W. M. Keck Observatory was made possible by the generous financial support of the W. M. Keck Foundation. We wish to recognize the important cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. This work is also based on observations at the Palomar Observatory. The Pan-STARRS1 Surveys (PS1) have been made possible through contributions from the Institute for Astronomy, the University of Hawaii, the Pan-STARRS Project Office, the Max-Planck Society and its participating institutes (the Max Planck Institute for Astronomy, Heidelberg, and the Max Planck Institute for Extraterrestrial Physics, Garching), The Johns Hopkins University, Durham University, the University of Edinburgh, Queen's University Belfast, the Harvard-Smithsonian Center for Astrophysics, the Las Cumbres Observatory Global Telescope Network, the National Central University of Taiwan, the Space Telescope Science Institute, the NASA under grant no. NNX08AR22G issued through the Planetary Science Division of the NASA Science Mission Directorate, the NSF under grant no. AST-1238877, the University of Maryland, and Eotvos Lorand University (ELTE). Z.H. is supported by the Natural Science Foundation of China (grant nos. 11390374 and 11033008). El. and A.I. are supported by the Deutsche Forschungsgemeinschaft through grant HE1356/45-2. T.K. acknowledges support from the Netherlands Research School for Astronomy (NOVA). A.I. acknowledges support from a research scholarship by the Elite Network of Bavaria. R.K. acknowledges support from Science and Technologies Council UK grant no. ST/L000709/1, Queen's University Belfast's contribution to the PanSTARRS1 science consortium. K.S. acknowledges support from European Union FP7 Programme ERC grant no 291222. F.F. acknowledges NASA contract no NNG08FD60C for the NuSTAR mission. The data observed with the SDSS and Keck telescope are published via the SDSS and Keck data archive; the PS1 data and catalog are available upon request.	Bromley BC, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L42; Brown WR, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/1/L2; Brown WR, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/1/L23; Brown WR, 2005, ASTROPHYS J, V622, pL33, DOI 10.1086/429378; Edelmann H, 2005, ASTROPHYS J, V634, pL181, DOI 10.1086/498940; Fink M, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913892; Foley RJ, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/57; Geier S, 2007, ASTRON ASTROPHYS, V464, P299, DOI 10.1051/0004-6361:20066098; Geier S, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321395; Geier S, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219463; Geier S, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/201014465; Gillessen S, 2009, ASTROPHYS J, V692, P1075, DOI 10.1088/0004-637X/692/2/1075; Han Z, 2002, MON NOT R ASTRON SOC, V336, P449, DOI 10.1046/j.1365-8711.2002.05752.x; Han Z, 2003, MON NOT R ASTRON SOC, V341, P669, DOI 10.1046/j.1365-8711.2003.06451.x; Heber U, 2008, ASTRON ASTROPHYS, V483, pL21, DOI 10.1051/0004-6361:200809767; HILLS JG, 1988, NATURE, V331, P687, DOI 10.1038/331687a0; Hirsch HA, 2005, ASTRON ASTROPHYS, V444, pL61, DOI 10.1051/0004-6361:200500212; Hirsch H, 2009, J PHYS CONF SER, V172, DOI 10.1088/1742-6596/172/1/012015; Justham S, 2009, ASTRON ASTROPHYS, V493, P1081, DOI 10.1051/0004-6361:200810106; Liu ZW, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201220903; Liu ZW, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/37; Lu YJ, 2007, ASTROPHYS J, V666, pL89, DOI 10.1086/521708; Maxted PFL, 2001, MON NOT R ASTRON SOC, V326, P1391, DOI 10.1111/j.1365-2966.2001.04714.x; Napiwotzki R, 2004, ASTROPHYS SPACE SCI, V291, P321, DOI 10.1023/B:ASTR.0000044362.07416.6c; Palladino LE, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/7; Pan KC, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/49; Pan KC, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/151; Perets HB, 2009, ASTROPHYS J, V698, P1330, DOI 10.1088/0004-637X/698/2/1330; Vennes S, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/1/L25; Wang B, 2009, MON NOT R ASTRON SOC, V395, P847, DOI 10.1111/j.1365-2966.2009.14545.x; WEBBINK RF, 1984, ASTROPHYS J, V277, P355, DOI 10.1086/161701	31	83	83	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1126	1128		10.1126/science.1259063	http://dx.doi.org/10.1126/science.1259063			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745168	Green Submitted			2022-12-28	WOS:000350354200049
J	Kales, HC; Gitlin, LN; Lyketsos, CG				Kales, Helen C.; Gitlin, Laura N.; Lyketsos, Constantine G.			Assessment and management of behavioral and psychological symptoms of dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEROTONIN REUPTAKE INHIBITORS; ATYPICAL ANTIPSYCHOTIC-DRUGS; ALZHEIMERS-DISEASE PATIENTS; HOME-BASED INTERVENTION; NEUROPSYCHIATRIC-SYMPTOMS; DOUBLE-BLIND; CAREGIVER BURDEN; RANDOMIZED-TRIAL; CHOLINESTERASE-INHIBITORS; PHARMACOLOGICAL-TREATMENT	Behavioral and psychological symptoms of dementia include agitation, depression, apathy, repetitive questioning, psychosis, aggression, sleep problems, wandering, and a variety of inappropriate behaviors. One or more of these symptoms will affect nearly all people with dementia over the course of their illness. These symptoms are among the most complex, stressful, and costly aspects of care, and they lead to a myriad of poor patient health outcomes, healthcare problems, and income loss for family care givers. The causes include neurobiologically related disease factors; unmet needs; care giver factors; environmental triggers; and interactions of individual, care giver, and environmental factors. The complexity of these symptoms means that there is no "one size fits all solution," and approaches tailored to the patient and the care giver are needed. Non-pharmacologic approaches should be used first line, although several exceptions are discussed. Non-pharmacologic approaches with the strongest evidence base involve family care giver interventions. Regarding pharmacologic treatments, antipsychotics have the strongest evidence base, although the risk to benefit ratio is a concern. An approach to integrating non-pharmacologic and pharmacologic treatments is described. Finally, the paradigm shift needed to fully institute tailored treatments for people and families dealing with these symptoms in the community is discussed.	[Kales, Helen C.] Univ Michigan, Dept Psychiat, Sect Geriatr Psychiat, Ann Arbor, MI 48109 USA; [Kales, Helen C.] US Dept Vet Affairs, Ctr Clin Management Res, Ann Arbor, MI USA; [Kales, Helen C.] VA Ann Arbor Healthcare Syst, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA; [Gitlin, Laura N.] Johns Hopkins Univ, Sch Nursing, Dept Community Publ Hlth, Baltimore, MD USA; [Gitlin, Laura N.] Johns Hopkins Univ, Sch Med, Div Geriatr & Gerontol, Baltimore, MD USA; [Gitlin, Laura N.] Johns Hopkins Univ, Ctr Innovat Care Aging, Baltimore, MD USA; [Lyketsos, Constantine G.] Johns Hopkins Bayview, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Lyketsos, Constantine G.] Johns Hopkins Univ, Baltimore, MD USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kales, HC (corresponding author), Univ Michigan, Dept Psychiat, Sect Geriatr Psychiat, Ann Arbor, MI 48109 USA.	kales@umich.edu			Johns Hopkins Alzheimer's Disease Research Center [P50AG005146];  [R01NR014200]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	Johns Hopkins Alzheimer's Disease Research Center; ; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	HCK and LNG were supported in part by R01NR014200. CGL was supported in part by the Johns Hopkins Alzheimer's Disease Research Center (P50AG005146).	Aalten P, 2005, INT J GERIATR PSYCH, V20, P531, DOI 10.1002/gps.1317; Aalten P, 2005, INT J GERIATR PSYCH, V20, P523, DOI 10.1002/gps.1316; Adkins VK, 1999, AM J ALZHEIMERS DIS, V14, P289; Al Jurdi RK, 2012, J GERIATR PSYCH NEUR, V25, P62, DOI 10.1177/0891988712436684; Algase DL., 1996, AM J ALZHEIMERS DIS, V11, P10, DOI [DOI 10.1177/153331759601100603, 10.1177/153331759601100603]; Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; American Geriatrics Society, 2013, CHOOS WIS; American Psychiatric Association, 2013, CHOOS WIS; APA Council on Geriatric Psychiatry, 2014, RES DOC US ANT MED T; Bains J, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003944; Ballard C, 2006, NAT REV NEUROSCI, V7, P492, DOI 10.1038/nrn1926; Ballard C, 2010, CNS DRUGS, V24, P729, DOI 10.2165/11319240-000000000-00000; Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Barrett E, 2004, OBES RES, V12, P362; Barris R, 1985, MODEL HUMAN OCCUPATI, P42; Beeri MS, 2002, INT J GERIATR PSYCH, V17, P403, DOI 10.1002/gps.490; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Borson S, 1997, NEUROLOGY, V48, pS17, DOI 10.1212/WNL.48.5_Suppl_6.17S; Brodaty H, 2012, AM J PSYCHIAT, V169, P946, DOI 10.1176/appi.ajp.2012.11101529; Burns A, 2011, DEMENT GERIATR COGN, V31, P158, DOI 10.1159/000324438; Caspi E, 2009, ALZHEIMERS DEMENT, V5, P30, DOI 10.1016/j.jalz.2008.05.2493; Chung J, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858; Clare L, 2002, INT J GERIATR PSYCH, V17, P962, DOI 10.1002/gps.735; Clare L., 2003, COCHRANE DB SYST REV, V4, P1, DOI [https://doi.org/10.1002/14651858.CD003260, DOI 10.1002/14651858.CD003260]; Clyburn LD, 2000, J GERONTOL B-PSYCHOL, V55, pS2, DOI 10.1093/geronb/55.1.s2; Cohen-Mansfield J, 2005, ALZHEIMERS CARE Q, V6, P129; Cohen-Mansfield J, 2013, INT PSYCHOGERIATR, V25, P236, DOI 10.1017/S104161021200172X; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; Colling Kathleen Byrne, 2002, J Gerontol Nurs, V28, P16; Conde-Sala JL, 2014, J ALZHEIMERS DIS, V42, P623, DOI 10.3233/JAD-140360; Cooke ML, 2010, AGING MENT HEALTH, V14, P905, DOI 10.1080/13607861003713190; Cooper C, 2006, J AFFECT DISORDERS, V90, P15, DOI 10.1016/j.jad.2005.08.017; Cooper C, 2007, INT J GERIATR PSYCH, V22, P181, DOI 10.1002/gps.1656; CORCORAN MA, 1992, AM J OCCUP THER, V46, P801, DOI 10.5014/ajot.46.9.801; Courtney C, 2004, LANCET, V363, P2105; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; de Vugt ME, 2005, J NEUROPSYCH CLIN N, V17, P201, DOI 10.1176/appi.neuropsych.17.2.201; de Vugt ME, 2004, INT J GERIATR PSYCH, V19, P85, DOI 10.1002/gps.1044; Declercq T, 2013, COCHRANE DB SYST REV, V3; Devanand DP, 1996, ARCH GEN PSYCHIAT, V53, P175; Dols A, 2013, INT CLIN PSYCHOPHARM, V28, P287, DOI 10.1097/YIC.0b013e32836435e2; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Drye LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098426; Dubois B, 2012, MOVEMENT DISORD, V27, P1230, DOI 10.1002/mds.25098; Finkel S I, 1996, Int Psychogeriatr, V8 Suppl 3, P497; Finkel SI, 2000, INT PSYCHOGERIATR, V12, P9, DOI 10.1017/S1041610200006694; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Forbes D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub2; Forbes D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003946.pub3; Fox C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035185; Gauthier S, 2008, INT J GERIATR PSYCH, V23, P537, DOI 10.1002/gps.1949; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Gitlin LN, 2008, AM J GERIAT PSYCHIAT, V16, P229, DOI 10.1097/JGP.0b013e318160da72; Gitlin LN, 2014, INT PSYCHOGERIATR, V26, P1805, DOI 10.1017/S1041610214001537; Gitlin LN, 2014, INT J GERIATR PSYCH, V29, P93, DOI 10.1002/gps.3979; Gitlin LN, 2012, JAMA-J AM MED ASSOC, V308, P2020, DOI 10.1001/jama.2012.36918; Gitlin LN, 2012, AM J PSYCHIAT, V169, P894, DOI 10.1176/appi.ajp.2012.12060774; Gitlin LN, 2010, JAMA-J AM MED ASSOC, V304, P983, DOI 10.1001/jama.2010.1253; Gitlin LN, 2010, J AM GERIATR SOC, V58, P1465, DOI 10.1111/j.1532-5415.2010.02971.x; Gitlin LN, 2010, AM J GERIAT PSYCHIAT, V18, P510, DOI 10.1097/JGP.0b013e3181c37d13; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Gitlin LN, 2003, ALZHEIMERS CARE Q, V4, P85; Hall G R, 1987, Arch Psychiatr Nurs, V1, P399; Hansen NV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004989.pub2; Hodgson N, CLIN J PAIN IN PRESS; Hodgson NA, 2011, ALZ DIS ASSOC DIS, V25, P109, DOI 10.1097/WAD.0b013e3181f8520a; Hogan DB, 2008, CAN MED ASSOC J, V179, P1019, DOI 10.1503/cmaj.081103; Hogan DB, 2008, CAN MED ASSOC J, V179, P787, DOI 10.1503/cmaj.070803; Howard RJ, 2007, NEW ENGL J MED, V357, P1382, DOI 10.1056/NEJMoa066583; Husebo BS, 2014, AM J GERIAT PSYCHIAT, V22, P708, DOI 10.1016/j.jagp.2012.12.006; Husebo BS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4065; Joller P, 2013, CAN FAM PHYSICIAN, V59, P255; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; Kaduszkiewicz H, 2005, BMJ-BRIT MED J, V331, P321, DOI 10.1136/bmj.331.7512.321; Kales HC, 2005, AM J GERIAT PSYCHIAT, V13, P441, DOI 10.1176/appi.ajgp.13.6.441; Kales HC, 2007, AM J PSYCHIAT, V164, P1568, DOI 10.1176/appi.ajp.2007.06101710; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Kales HC, 2012, AM J PSYCHIAT, V169, P71, DOI 10.1176/appi.ajp.2011.11030347; Katz I, 2007, INT J GERIATR PSYCH, V22, P475, DOI 10.1002/gps.1792; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kirby D, 2002, INT J GERIATR PSYCH, V17, P231, DOI 10.1002/gps.591; Kong EH, 2009, AGING MENT HEALTH, V13, P512, DOI 10.1080/13607860902774394; Konovalov S, 2008, INT PSYCHOGERIATR, V20, P293, DOI 10.1017/S1041610207006540; Kunik ME, 2010, J CLIN PSYCHIAT, V71, P1145, DOI 10.4088/JCP.08m04703oli; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Livingston G, 2005, AGE AGEING, V34, P287, DOI 10.1093/ageing/afi103; Lonergan E., 2002, COCHRANE DB SYST REV, V(2), pCD002852; Lopez OL, 2013, AM J PSYCHIAT, V170, P1051, DOI 10.1176/appi.ajp.2013.12081046; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P704, DOI 10.1176/appi.ajp.157.5.704; Lyketsos CG, 2003, ARCH GEN PSYCHIAT, V60, P737, DOI 10.1001/archpsyc.60.7.737; Lyketsos CG, 2007, INT PSYCHOGERIATR, V19, P409, DOI 10.1017/S104161020700484X; Lyketsos Constantine G, 2011, Alzheimers Dement, V7, P532, DOI 10.1016/j.jalz.2011.05.2410; Magai C, 2000, AM J GERIAT PSYCHIAT, V8, P66, DOI 10.1097/00019442-200002000-00009; Marra C, 2007, DEMENT GERIATR COGN, V24, P317, DOI 10.1159/000108115; Maslow K, 2004, NURS CLIN N AM, V39, P561, DOI 10.1016/j.cnur.2004.02.011; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Mesulam M. M., 2000, PRINCIPLES BEHAV COG; Mesulam M-M, 1985, PRINCIPLES BEHAV NEU; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Molinari V, 2010, J GERONTOL B-PSYCHOL, V65, P57, DOI 10.1093/geronb/gbp080; Murman DL, 2002, NEUROLOGY, V59, P1721, DOI 10.1212/01.WNL.0000036904.73393.E4; National Institute for Health and Care Excellence, 2012, DEM SUPP PEOPL DEM T; Nguyen VT, 2008, GERIATRICS-US, V63, P21; Nichols LO, 2011, ARCH INTERN MED, V171, P353, DOI 10.1001/archinternmed.2010.548; Norton MC, 2009, J GERONTOL B-PSYCHOL, V64, P560, DOI 10.1093/geronb/gbp052; Nowrangi MA, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0096-3; Nyatsanza S, 2003, J NEUROL NEUROSUR PS, V74, P1398, DOI 10.1136/jnnp.74.10.1398; O'Connor DW, 2009, INT PSYCHOGERIATR, V21, P225, DOI 10.1017/S1041610208007588; Olin JT, 2001, AM J GERIAT PSYCHIAT, V9, P400, DOI 10.1176/appi.ajgp.9.4.400; ONeil M.E., 2011, SYSTEMATIC EVIDENCE; Ouslander JG, 2003, J AM GERIATR SOC, V51, P1287; Peisah C, 2011, INTERN MED J, V41, P651, DOI 10.1111/j.1445-5994.2011.02560.x; Petracca GM, 2001, INT PSYCHOGERIATR, V13, P233, DOI 10.1017/S104161020100761X; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pollock BG, 2002, AM J PSYCHIAT, V159, P460, DOI 10.1176/appi.ajp.159.3.460; Pollock BG, 2007, AM J GERIAT PSYCHIAT, V15, P942, DOI 10.1097/JGP.0b013e3180cc1ff5; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Prince M, 2013, POLICY BRIEF HEADS G; Rabins P, 2011, ALZHEIMERS DEMENT, V7, pS356, DOI [10.1016/j.jalz.2011.05.1031, DOI 10.1016/J.JALZ.2011.05.1031]; Raivio MM, 2007, AM J GERIAT PSYCHIAT, V15, P416, DOI 10.1097/JGP.0b013e31802d0b00; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Reisberg B, 1996, Int Psychogeriatr, V8 Suppl 3, P301; Rockwood K, 2014, INT J GERIATR PSYCHI; Rolinski M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006504.pub2; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Rozzini L, 2010, INT PSYCHOGERIATR, V22, P114, DOI 10.1017/S1041610209990184; Ryu SH, 2005, AM J GERIAT PSYCHIAT, V13, P976, DOI 10.1176/appi.ajgp.13.11.976; Savva GM, 2009, BRIT J PSYCHIAT, V194, P212, DOI 10.1192/bjp.bp.108.049619; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; SCHNEIDER LS, 1990, J AM GERIATR SOC, V38, P553, DOI 10.1111/j.1532-5415.1990.tb02407.x; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Schoedel KA, 2012, CLIN DRUG INVEST, V32, P157, DOI [10.2165/11599870-000000000-00000, 10.2165/11633850-000000000-00000]; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P234, DOI 10.1176/appi.ajgp.12.3.234; Seitz DP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008191.pub2; Sepehry AA, 2012, DRUG AGING, V29, P793, DOI 10.1007/s40266-012-0012-5; Simoni-Wastila L, 2009, AM J GERIAT PSYCHIAT, V17, P417, DOI 10.1097/JGP.0b013e31819b8936; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Sloane PD, 2004, J AM GERIATR SOC, V52, P1795, DOI 10.1111/j.1532-5415.2004.52501.x; Smith M, 2006, NURS CLIN N AM, V41, P57, DOI 10.1016/j.cnur.2005.09.006; Spalletta G, 2010, AM J GERIAT PSYCHIAT, V18, P1026, DOI 10.1097/JGP.0b013e3181d6b68d; Staekenborg SS, 2010, J NEUROL NEUROSUR PS, V81, P547, DOI 10.1136/jnnp.2009.187500; Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858; STOTSKY B, 1984, CLIN THER, V6, P546; Sultzer DL, 2008, AM J PSYCHIAT, V165, P844, DOI 10.1176/appi.ajp.2008.07111779; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; TERI L, 1991, GERONTOLOGIST, V31, P124, DOI 10.1093/geront/31.1.124; Thorgrimsen L, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003150; Thune-Boyle ICV, 2012, INT PSYCHOGERIATR, V24, P1046, DOI 10.1017/S1041610211002365; Trinh NH, 2003, JAMA-J AM MED ASSOC, V289, P210, DOI 10.1001/jama.289.2.210; Tucker I, 2010, INT PSYCHOGERIATR, V22, P683, DOI 10.1017/S1041610210000189; TUNE LE, 1991, PSYCHIAT CLIN N AM, V14, P353; US Food and Drug Administration, 2005, DEATHS ANT ELD PAT B; Van Den Wijngaart MAG, 2007, AGING MENT HEALTH, V11, P626, DOI 10.1080/13607860701368463; Vink A, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003477.PUB2; von Gunten A, 2009, BRAIN RES BULL, V80, P179, DOI 10.1016/j.brainresbull.2009.07.004; Wancata J, 2003, INT J PSYCHIAT MED, V33, P257, DOI 10.2190/ABXK-FMWG-98YP-D1CU; Wang LY, 2009, AM J GERIAT PSYCHIAT, V17, P744, DOI 10.1097/JGP.0b013e3181ab8c61; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wilcock GK, 2008, J CLIN PSYCHIAT, V69, P341, DOI 10.4088/JCP.v69n0302; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yury CA, 2007, PSYCHOTHER PSYCHOSOM, V76, P213, DOI 10.1159/000101499; Zivin K, 2013, AM J PSYCHIAT, V170, P642, DOI 10.1176/appi.ajp.2013.12030408	171	570	588	7	181	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2015	350								h369	10.1136/bmj.h369	http://dx.doi.org/10.1136/bmj.h369			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4BV	25731881	Green Published			2022-12-28	WOS:000350296600007
J	Watts, G				Watts, Geoff			Carl Djerassi Chemist, entrepreneur, and writer whose work led to the development of the oral contraceptive. Born in Vienna, Austria, on Oct 29, 1923, he died from complications of cancer in San Francisco, CA, USA, on Jan 30, 2015, aged 91 years Obituary	LANCET			English	Biographical-Item																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					600	600		10.1016/S0140-6736(15)60225-2	http://dx.doi.org/10.1016/S0140-6736(15)60225-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25713857	Bronze			2022-12-28	WOS:000349214000018
J	Boynton, P				Boynton, Petra			The art of medicine	LANCET			English	Editorial Material												info@drpetra.co.uk		Boynton, Petra/0000-0001-6699-2266					0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					222	223		10.1016/S0140-6736(15)60047-2	http://dx.doi.org/10.1016/S0140-6736(15)60047-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ2DL	25713847				2022-12-28	WOS:000348044800015
J	Shet, A; De Costa, A; Kumarasamy, N; Rodrigues, R; Rewari, BB; Ashorn, P; Eriksson, B; Diwan, V				Shet, Anita; De Costa, Ayesha; Kumarasamy, N.; Rodrigues, Rashmi; Rewari, Bharat Bhusan; Ashorn, Per; Eriksson, Bo; Diwan, Vinod		HIVIND Study Team	Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THERAPY ADHERENCE INTERVENTIONS; ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; VIROLOGICAL FAILURE; INFECTED PATIENTS; PLANNED BEHAVIOR; HIGH-RATES; HIV/AIDS; RISK; SUPPRESSION	Objective To assess whether customised mobile phone reminders would improve adherence to therapy and thus decrease virological failure among HIV infected patients starting antiretroviral treatment (ART). Design Randomised controlled trial among HIV infected patients initiating antiretroviral treatment. Setting Three diverse healthcare delivery settings in south India: two ambulatory clinics within the Indian national programme and one private HIV healthcare clinic. Participants 631 HIV infected, ART naive, adult patients eligible to initiate first line ART were randomly assigned to mobile phone intervention (n=315) or standard care (n=316) and followed for 96 weeks.. Intervention The intervention consisted of customised, interactive, automated voice reminders, and a pictorial message that were sent weekly to the patients' mobile phones for the duration of the study. Main outcome measures The primary outcome was time to virological failure (viral load >400 copies/mL on two consecutive measurements). Secondary outcomes included ART adherence measured by pill count, death rate, and attrition rate. Suboptimal adherence was defined as mean adherence <95%. Results Using an intention-to-treat approach we found no observed difference in time to virological failure between the allocation groups: failures in the intervention and standard care arms were 49/315 (15.6%) and 49/316 (15.5%) respectively (unadjusted hazard ratio 0.98, 95% confidence interval 0.67 to 1.47, P=0.95). The rate of virological failure in the intervention and standard care groups were 10.52 and 10.73 per 100 person years respectively. Comparison of suboptimal adherence was similar between both groups (unadjusted incidence rate ratio 1.24, 95% CI 0.93 to 1.65, P=0.14). Incidence proportion of patients with suboptimal adherence was 81/300 (27.0%) in the intervention arm and 65/299 (21.7%) in the standard care arm. The results of analyses adjusted for potential confounders were similar, indicating no significant difference between the allocation groups. Other secondary outcomes such as death and attrition rates, and subgroup analysis also showed comparable results across allocation groups. Conclusions In this multicentre randomised controlled trial among ART naive patients initiating first line ART within the Indian national programme, we found no significant effect of the mobile phone intervention on either time to virological failure or ART adherence at the end of two years of therapy.	[Shet, Anita] St Johns Med Coll Hosp, Dept Pediat, Bangalore 560034, Karnataka, India; [Shet, Anita; De Costa, Ayesha; Rodrigues, Rashmi; Eriksson, Bo; Diwan, Vinod] Karolinska Inst, Dept Publ Hlth Sci, S-17177 Stockholm, Sweden; [Kumarasamy, N.] YRG Ctr AIDS Res & Educ, Madras 600113, Tamil Nadu, India; [Rodrigues, Rashmi] St Johns Med Coll Hosp, Dept Community Med, Bangalore 560034, Karnataka, India; [Rewari, Bharat Bhusan] Govt India, Minist Hlth & Family Welf, Dept AIDS Control, Natl AIDS Control Org, New Delhi 110001, India; [Ashorn, Per] Univ Tampere, Sch Med, Dept Int Hlth, FIN-33101 Tampere, Finland	St. John's National Academy of Health Sciences; St. John's Medical College; Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's Medical College; Tampere University	De Costa, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, S-17177 Stockholm, Sweden.	Ayesha.de.costa@ki.se	Neogi, Ujjwal/E-4274-2012; Rodrigues, Rashmi J/H-1901-2012; Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Rodrigues, Rashmi J/0000-0002-0656-0178; Gupta, Soham/0000-0003-1136-3010; Shet, Anita/0000-0002-7204-8164; Ashorn, Per/0000-0003-2311-2593	European Union, Framework Program 7 [222946]	European Union, Framework Program 7	This study was funded by the European Union, Framework Program 7 (project No 222946). The study sponsor had no role in the study design; collection, analysis, and interpretation of data; writing the report; or in the decision to submit the article for publication.	Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Alvarez-Uria G, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21682; Amico KR, 2006, JAIDS-J ACQ IMM DEF, V41, P285; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2007, ANT THER GUID HIV IN; Bachani D, 2010, NATL MED J INDIA, V23, P7; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; BLACKWELL B, 1992, PSYCHOTHER PSYCHOSOM, V58, P161, DOI 10.1159/000288624; Catalani Caricia, 2013, Open AIDS J, V7, P17, DOI 10.2174/1874613620130812003; da Costa TM, 2012, INT J MED INFORM, V81, P257, DOI 10.1016/j.ijmedinf.2011.10.002; De Beaudrap P, 2013, JAIDS-J ACQ IMM DEF, V62, P381, DOI 10.1097/QAI.0b013e31827a2a7a; de Bruin M, 2010, ARCH INTERN MED, V170, P240, DOI 10.1001/archinternmed.2009.536; De Costa A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-25; Ekstrand ML, 2011, INT HEALTH, V3, P27, DOI 10.1016/j.inhe.2010.11.003; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V43, pS10, DOI 10.1097/01.qai.0000248335.90190.f9; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gokarn Anant, 2012, J Assoc Physicians India, V60, P16; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; HIVIND, 2013, ANT ROLL OUT HIV IND; Horvath T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009756; Hou MY, 2010, OBSTET GYNECOL, V116, P633, DOI 10.1097/AOG.0b013e3181eb6b0f; Kobin AB, 2011, ANN PHARMACOTHER, V45, P372, DOI 10.1345/aph.1P587; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lester RT, 2013, NEW ENGL J MED, V369, P1867, DOI 10.1056/NEJMc1310509; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lio MMS, 2008, CLIN INFECT DIS, V46, P1609, DOI 10.1086/587659; Maduka O, 2013, NIGER J CLIN PRACT, V16, P302, DOI 10.4103/1119-3077.113451; Mbuagbaw L, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2013-003950, 10.1136/bmjopen-2013-002954]; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; McCambridge J, 2013, J CLIN EPIDEMIOL; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P247, DOI 10.1016/j.jclinepi.2013.09.004; Mhaskar Rahul, 2013, Indian J Community Med, V38, P74, DOI 10.4103/0970-0218.112435; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Mykhalovskiy E, 2008, MED ANTHROPOL, V27, P136, DOI 10.1080/01459740802017363; National AIDS Control Organization of India, 2013, ANN REP 2012 2013; Ollivier L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-236; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Reynolds NR, 2003, AIDS CARE, V15, P117, DOI 10.1080/0954012021000039815; Rodrigues R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040723; Rosenblum M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007196; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Saal W, 2012, J HEALTH PSYCHOL, V17, P362, DOI 10.1177/1359105311416875; Shet A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-277; Shet A, 2010, AIDS BEHAV, V14, P716, DOI 10.1007/s10461-009-9658-3; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382	50	41	42	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2014	349								g5978	10.1136/bmj.g5978	http://dx.doi.org/10.1136/bmj.g5978			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OI	25742320	hybrid, Green Published			2022-12-28	WOS:000343768700002
J	Mayer, KH				Mayer, Kenneth H.			Antiretroviral chemoprophylaxis: new successes and questions	LANCET			English	Editorial Material							PHARMACOKINETICS; INFECTION		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Fenway Hlth, Boston, MA 02215 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mayer, KH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Fenway Hlth, Boston, MA 02215 USA.	khmayer@gmail.com			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069412, UM1AI069412] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AVAC, 2015, GLOB ADV HIV PREV DA; Baeten J, 2015, C RETR OPP INF CROI; Bekker L-G, 2015, C RETR OPP INF CROI; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Graham BS, 2014, HIV RES PREVENTION 2; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S., 2015, TOPICS ANTIVIRAL MED, V23, P9, DOI 10.1016/S0140-6736(15)00056-2; Molina J.-M., 2015, C RETR OPP INF; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Rees H, 2015, C RETR OPP INF CROI; Spreen W, 2014, JAIDS-J ACQ IMM DEF, V67, P487, DOI 10.1097/QAI.0000000000000365; Trezza CR, 2014, CLIN PHARMACOKINET, V53, P611, DOI 10.1007/s40262-014-0148-z; UNAIDS, 2014, THE GAP REPP	16	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2236	2237		10.1016/S0140-6736(15)60494-9	http://dx.doi.org/10.1016/S0140-6736(15)60494-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25769358				2022-12-28	WOS:000355943500010
J	Mfinanga, S; Chanda, D; Kivuyo, SL; Guinness, L; Bottomley, C; Simms, V; Chijoka, C; Masasi, A; Kimaro, G; Ngowi, B; Kahwa, A; Mwaba, P; Harrison, TS; Egwaga, S; Jaffar, S				Mfinanga, Sayoki; Chanda, Duncan; Kivuyo, Sokoine L.; Guinness, Lorna; Bottomley, Christian; Simms, Victoria; Chijoka, Carol; Masasi, Ayubu; Kimaro, Godfather; Ngowi, Bernard; Kahwa, Amos; Mwaba, Peter; Harrison, Thomas S.; Egwaga, Saidi; Jaffar, Shabbar		REMSTART Trial Team	Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial	LANCET			English	Article							SUB-SAHARAN AFRICA; RESOURCE-LIMITED SETTINGS; HIGH-INCOME COUNTRIES; EARLY MORTALITY; TREATMENT PROGRAMS; 1ST YEAR; TUBERCULOSIS; DEATHS; UGANDA; CARE	Background Mortality in people in Africa with HIV infection starting antiretroviral therapy (ART) is high, particularly in those with advanced disease. We assessed the effect of a short period of community support to supplement clinic-based services combined with serum cryptococcal antigen screening. Methods We did an open-label, randomised controlled trial in six urban clinics in Dar es Salaam, Tanzania, and Lusaka, Zambia. From February, 2012, we enrolled eligible individuals with HIV infection (age >= 18 years, CD4 count of <200 cells per mu L, ART naive) and randomly assigned them to either the standard clinic-based care supplemented with community support or standard clinic-based care alone, stratified by country and clinic, in permuted block sizes of ten. Clinic plus community support consisted of screening for serum cryptococcal antigen combined with antifungal therapy for patients testing antigen positive, weekly home visits for the first 4 weeks on ART by lay workers to provide support, and in Tanzania alone, re-screening for tuberculosis at 6-8 weeks after ART initiation. The primary endpoint was all-cause mortality at 12 months, analysed by intention to treat. This trial is registered with the International Standard Randomised Controlled Trial Number registry, number ISCRTN 20410413. Findings Between Feb 9, 2012, and Sept 30, 2013, 1001 patients were randomly assigned to clinic plus community support and 998 to standard care. 89 (9%) of 1001 participants in the clinic plus community support group did not receive their assigned intervention, and 11 (1%) of 998 participants in the standard care group received a home visit or a cryptococcal antigen screen rather than only standard care. At 12 months, 25 (2%) of 1001 participants in the clinic plus community support group and 24 (2%) of 998 participants in the standard care group had been lost to follow-up, and were censored at their last visit for the primary analysis. At 12 months, 134 (13%) of 1001 participants in the clinic plus community support group had died compared with 180 (18%) of 998 in the standard care group. Mortality was 28% (95% CI 10-43) lower in the clinic plus community support group than in standard care group (p=0.004). Interpretation Screening and pre-emptive treatment for cryptococcal infection combined with a short initial period of adherence support after initiation of ART could substantially reduce mortality in HIV programmes in Africa.	[Mfinanga, Sayoki; Kivuyo, Sokoine L.; Masasi, Ayubu; Kimaro, Godfather; Ngowi, Bernard; Kahwa, Amos] Muhimbili Med Res Ctr, Natl Inst Med Res, Dar Es Salaam, Tanzania; [Chanda, Duncan; Chijoka, Carol; Mwaba, Peter] Univ Teaching Hosp, Inst Med Res & Training, Lusaka, Zambia; [Guinness, Lorna] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth Policy, London WC1E 7HT, England; [Bottomley, Christian; Simms, Victoria; Jaffar, Shabbar] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Harrison, Thomas S.] St Georges Univ London, Inst Infect & Immun, London, England; [Egwaga, Saidi] Minist Hlth & Sociowelf, Natl TB & Leprosy Control Program, Dar Es Salaam, Tanzania	National Institute of Medical Research; University of Zambia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; St Georges University London	Jaffar, S (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	shabbar.jaffar@lshtm.ac.uk	Mwaba, Peter/V-6017-2019; Simms, Victoria/C-3278-2009; Simms, Victoria/AAU-4134-2021; Guinness, Lorna/AAN-3875-2020; Chanda, Duncan/N-1045-2019	Simms, Victoria/0000-0002-4897-458X; Kivuyo, Sokoine Lesikari/0000-0003-2257-5254; Bottomley, Christian/0000-0002-5241-8412; Harrison, Thomas/0000-0003-3619-4348; Jaffar, Shabbar/0000-0002-9615-1588; Guinness, Lorna/0000-0002-1013-4200	European and Developing Countries Clinical Trials Partnership; Medical Research Council [MR/K012126/1] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	European and Developing Countries Clinical Trials Partnership.	Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Campbell, 2013, UNIVERSAL TRUTH NO H; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Gupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028691; Holmes CB, 2003, CLIN INFECT DIS, V36, P652, DOI 10.1086/367655; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2012, AIDS, V26, P2121, DOI 10.1097/QAD.0b013e3283565dd1; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Loyse A, 2014, LANCET INFECT DIS, V14, P371, DOI 10.1016/S1473-3099(14)70068-4; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Marseille E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051993; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Scott CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067910; Simms V, 2014, TROP MED INT HEALTH, V19, P123, DOI 10.1111/tmi.12230; Sloan DJ, 2014, CLIN EPIDEMIOL, V6, P169, DOI 10.2147/CLEP.S38850; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15	33	153	155	2	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2173	2182		10.1016/S0140-6736(15)60164-7	http://dx.doi.org/10.1016/S0140-6736(15)60164-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25765698	Green Accepted			2022-12-28	WOS:000355583000027
J	Bangalore, S; Guo, Y; Samadashvili, Z; Blecker, S; Xu, JF; Hannan, EL				Bangalore, Sripal; Guo, Yu; Samadashvili, Zaza; Blecker, Saul; Xu, Jinfeng; Hannan, Edward L.			Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BARE-METAL STENT; MYOCARDIAL-INFARCTION; PROPENSITY SCORE; ARTERY-DISEASE; GRAFT-SURGERY; INTERVENTION; RESTENOSIS; REVASCULARIZATION; ANGIOGRAPHY; MORTALITY	BACKGROUND Results of trials and registry studies have shown lower long-term mortality after coronary-artery bypass grafting (CABG) than after percutaneous coronary intervention (PCI) among patients with multivessel disease. These previous analyses did not evaluate PCI with second-generation drug-eluting stents. METHODS In an observational registry study, we compared the outcomes in patients with multivessel disease who underwent CABG with the outcomes in those who underwent PCI with the use of everolimus-eluting stents. The primary outcome was all-cause mortality. Secondary outcomes were the rates of myocardial infarction, stroke, and repeat revascularization. Propensity-score matching was used to assemble a cohort of patients with similar baseline characteristics. RESULTS Among 34,819 eligible patients, 9223 patients who underwent PCI with everolimus-eluting stents and 9223 who underwent CABG had similar propensity scores and were included in the analyses. At a mean follow-up of 2.9 years, PCI with everolimus-eluting stents, as compared with CABG, was associated with a similar risk of death (3.1% per year and 2.9% per year, respectively; hazard ratio, 1.04; 95% confidence interval [CI], 0.93 to 1.17; P = 0.50), higher risks of myocardial infarction (1.9% per year vs. 1.1% per year; hazard ratio, 1.51; 95% CI, 1.29 to 1.77; P<0.001) and repeat revascularization (7.2% per year vs. 3.1% per year; hazard ratio, 2.35; 95% CI, 2.14 to 2.58; P<0.001), and a lower risk of stroke (0.7% per year vs. 1.0% per year; hazard ratio, 0.62; 95% CI, 0.50 to 0.76; P<0.001). The higher risk of myocardial infarction with PCI than with CABG was not significant among patients with complete revascularization but was significant among those with incomplete revascularization (P = 0.02 for interaction). CONCLUSIONS In a contemporary clinical-practice registry study, the risk of death associated with PCI with everolimus-eluting stents was similar to that associated with CABG. PCI was associated with a higher risk of myocardial infarction (among patients with incomplete revascularization) and repeat revascularization but a lower risk of stroke.	[Bangalore, Sripal; Guo, Yu; Blecker, Saul; Xu, Jinfeng] NYU, Sch Med, New York, NY 10016 USA; [Samadashvili, Zaza; Hannan, Edward L.] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA	New York University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Bangalore, S (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY 10016 USA.	sripalbangalore@gmail.com	Xu, Jinfeng/AAC-5368-2020	Bangalore, Sripal/0000-0001-9485-0652; Xu, Jinfeng/0000-0002-3165-2015	Abbott Vascular; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023683] Funding Source: NIH RePORTER	Abbott Vascular(Abbott Laboratories); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by Abbott Vascular.	Ahmed A, 2006, EUR HEART J, V27, P1431, DOI 10.1093/eurheartj/ehi890; Bainey KR, 2008, INT J CARDIOL, V128, P378, DOI 10.1016/j.ijcard.2007.06.024; Bangalore S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6625; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Genereux P, 2012, J AM COLL CARDIOL, V59, P2165, DOI 10.1016/j.jacc.2012.03.010; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Hannan EL, 2009, JACC-CARDIOVASC INTE, V2, P17, DOI 10.1016/j.jcin.2008.08.021; Hannan EL, 1999, J AM COLL CARDIOL, V33, P63, DOI 10.1016/S0735-1097(98)00540-3; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB., 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sarno G, 2012, EUR HEART J, V33, P606, DOI 10.1093/eurheartj/ehr479; Sipahi I, 2014, JAMA INTERN MED, V174, P223, DOI 10.1001/jamainternmed.2013.12844; Valgimigli M, 2014, JACC-CARDIOVASC INTE, V7, P20, DOI 10.1016/j.jcin.2013.09.008; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	20	185	192	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1213	1222		10.1056/NEJMoa1412168	http://dx.doi.org/10.1056/NEJMoa1412168			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25775087				2022-12-28	WOS:000351585900007
J	DiMaggio, EN; Campisano, CJ; Rowan, J; Dupont-Nivet, G; Deino, AL; Bibi, F; Lewis, ME; Souron, A; Garello, D; Werdelin, L; Reed, KE; Arrowsmith, JR				DiMaggio, Erin N.; Campisano, Christopher J.; Rowan, John; Dupont-Nivet, Guillaume; Deino, Alan L.; Bibi, Faysal; Lewis, Margaret E.; Souron, Antoine; Garello, Dominique; Werdelin, Lars; Reed, Kaye E.; Arrowsmith, J. Ramon			Late Pliocene fossiliferous sedimentary record and the environmental context of early Homo from Afar, Ethiopia	SCIENCE			English	Article							HADAR FORMATION; EVOLUTION; PLIOPLEISTOCENE; AFRICA; RIFT; DEPRESSION; GONA; SITE; MA	Sedimentary basins in eastern Africa preserve a record of continental rifting and contain important fossil assemblages for interpreting hominin evolution. However, the record of hominin evolution between 3 and 2.5 million years ago (Ma) is poorly documented in surface outcrops, particularly in Afar, Ethiopia. Here we present the discovery of a 2.84- to 2.58-million-year-old fossil and hominin-bearing sediments in the Ledi-Geraru research area of Afar, Ethiopia, that have produced the earliest record of the genus Homo. Vertebrate fossils record a faunal turnover indicative of more open and probably arid habitats than those reconstructed earlier in this region, which is in broad agreement with hypotheses addressing the role of environmental forcing in hominin evolution at this time. Geological analyses constrain depositional and structural models of Afar and date the LD 350-1 Homo mandible to 2.80 to 2.75 Ma.	[DiMaggio, Erin N.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Campisano, Christopher J.; Rowan, John; Reed, Kaye E.] Arizona State Univ, Inst Human Origins, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Dupont-Nivet, Guillaume] CNRS Geosci Rennes, F-35042 Rennes, France; [Deino, Alan L.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Bibi, Faysal] Museum Nat Kunde, Leibniz Inst Evolut & Biodivers Sci, D-10115 Berlin, Germany; [Lewis, Margaret E.] Stockton Univ, Biol Program, Galloway, NJ 08205 USA; [Souron, Antoine] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [Garello, Dominique; Arrowsmith, J. Ramon] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Werdelin, Lars] Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); Berkeley Geochronolgy Center; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of California System; University of California Berkeley; Arizona State University; Arizona State University-Tempe; Swedish Museum of Natural History	DiMaggio, EN (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	dimaggio@psu.edu; kreed@asu.edu	Bibi, Faysal/AAZ-9917-2021; DUPONT-NIVET, Guillaume/HII-9066-2022; Lewis, Margaret E/P-8243-2016	Bibi, Faysal/0000-0002-9414-5547; Lewis, Margaret E/0000-0002-2661-1489; Campisano, Christopher/0000-0001-9530-6130; Dupont-Nivet, Guillaume/0000-0001-9905-9739; DiMaggio, Erin/0000-0002-3157-5160	NSF [BCS-1157351, BCS-1322017]; Institute of Human Origins and School of Human Evolution and Social Change at ASU; American Association of Petroleum Geologists, Society for Sedimentary Geology; Geological Society of America; Philanthropic Education Organization; Marie Curie Actions; Alexander von Humbolt Foundation; Fyssen Foundation; Human Evolution Research Center/University of California Berkeley; Direct For Social, Behav & Economic Scie [1157351] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Institute of Human Origins and School of Human Evolution and Social Change at ASU; American Association of Petroleum Geologists, Society for Sedimentary Geology; Geological Society of America; Philanthropic Education Organization; Marie Curie Actions(European Commission); Alexander von Humbolt Foundation(Alexander von Humboldt Foundation); Fyssen Foundation; Human Evolution Research Center/University of California Berkeley; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the Ethiopian Authority for Research and Conservation of Cultural Heritage, especially Y. Desta, D. Abebaw, G. Senishaw, T. Getachew, T. Assefa, and Y. Assefa. We also thank our Afar representative, M. Ahamedin, and our field crew and Afar friends, especially M. Mekonnen Bekele, and M. Jungers for field assistance. The Arizona State University (ASU) LeRoy Eyring Center for Solid State Studies and NG<SUP>3</SUP>L laboratory personnel provided laboratory support. J. Kalb and E. B. Oswald generously shared their geological and paleontological data. Discussions with C. Ebinger, W. Kimbel, and D. Feary, and comments from two anonymous reviewers, have greatly improved this manuscript. This research was funded by NSF (grants BCS-1157351 and BCS-1322017); the Institute of Human Origins and School of Human Evolution and Social Change at ASU; grants to E.N.D. from American Association of Petroleum Geologists, Society for Sedimentary Geology, Geological Society of America, and the Philanthropic Education Organization; to G.D.-N. from the Marie Curie Actions and Alexander von Humbolt Foundation; and to A.S. from the Fyssen Foundation and Human Evolution Research Center/University of California Berkeley. Supporting data for this paper are presented in the supplementary materials.	ARONSON JL, 1981, HOMINID SITES THEIR, P165; Bibi F, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0890; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Campisano CJ, 2012, J HUM EVOL, V62, P338, DOI 10.1016/j.jhevol.2011.05.002; Campisano CJ, 2008, GEOL SOC AM SPEC PAP, V446, P179, DOI 10.1130/2008.2446(08); Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; DiMaggio E., 2013, THESIS ARIZONE STATE; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hayward NJ, 1996, TECTONICS, V15, P244, DOI 10.1029/95TC02292; KALB JE, 1995, PALAEOGEOGR PALAEOCL, V114, P357, DOI 10.1016/0031-0182(94)00088-P; Kidane T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000645; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Kingston John D., 1999, P69; Lahitte P, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001689; Levin NE, 2011, PALAEOGEOGR PALAEOCL, V307, P75, DOI 10.1016/j.palaeo.2011.04.026; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; Quade J, 2008, GEOL SOC AM SPEC PAP, V446, P1, DOI 10.1130/2008.2446(01); Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Reed KE, 2008, J HUM EVOL, V54, P743, DOI 10.1016/j.jhevol.2007.08.013; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Wolfenden E, 2004, EARTH PLANET SC LETT, V224, P213, DOI 10.1016/j.epsl.2004.04.022; Wynn J. G., 2008, SPEC PAP GEOL SOC AM, V446, P87; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317	27	48	48	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1355	1359		10.1126/science.aaa1415	http://dx.doi.org/10.1126/science.aaa1415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25739409				2022-12-28	WOS:000351219600040
J	Villmoare, B; Kimbel, WH; Seyoum, C; Campisano, CJ; DiMaggio, EN; Rowan, J; Braun, DR; Arrowsmith, JR; Reed, KE				Villmoare, Brian; Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; DiMaggio, Erin N.; Rowan, John; Braun, David R.; Arrowsmith, J. Ramon; Reed, Kaye E.			Early Homo at 2.8 Ma from Ledi-Geraru, Afar, Ethiopia	SCIENCE			English	Article							EARLY HOMINID; KOOBI FORA; GENUS HOMO; OMO GROUP; EVOLUTION; KENYA; PLEISTOCENE; DIVERSITY; POSITION; CLIMATE	Our understanding of the origin of the genus Homo has been hampered by a limited fossil record in eastern Africa between 2.0 and 3.0 million years ago (Ma). Here we report the discovery of a partial hominin mandible with teeth from the Ledi-Geraru research area, Afar Regional State, Ethiopia, that establishes the presence of Homo at 2.80 to 2.75 Ma. This specimen combines primitive traits seen in early Australopithecus with derived morphology observed in later Homo, confirming that dentognathic departures from the australopith pattern occurred early in the Homo lineage. The Ledi-Geraru discovery has implications for hypotheses about the timing and place of origin of the genus Homo.	[Villmoare, Brian] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; Rowan, John; Reed, Kaye E.] Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA; [Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; Rowan, John; Reed, Kaye E.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [DiMaggio, Erin N.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Villmoare, Brian; Braun, David R.] George Washington Univ, Ctr Adv Study Hominin Paleobiol, Washington, DC 20052 USA; [Arrowsmith, J. Ramon] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA; [Villmoare, Brian] UCL, Dept Anthropol, London WC1H 0BW, England; [Seyoum, Chalachew] Author Res & Conservat Cultural Heritage, Addis Ababa, Ethiopia	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Washington University; Arizona State University; Arizona State University-Tempe; University of London; University College London	Villmoare, B (corresponding author), Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA.	brian.villmoare@unlv.edu; wkimbel.iho@asu.edu	Villmoare, Brian/W-4391-2019	Campisano, Christopher/0000-0001-9530-6130; DiMaggio, Erin/0000-0002-3157-5160	National Science Foundation (NSF) [BCS-1157351]; Institute of Human Origins at Arizona State University; NSF [BCS-0725122 HOMINID]; George Washington University Selective Excellence Program; Direct For Social, Behav & Economic Scie [1302067] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1157351] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Institute of Human Origins at Arizona State University; NSF(National Science Foundation (NSF)); George Washington University Selective Excellence Program; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the Authority for Research and Conservation of Cultural Heritage, Ethiopian Ministry of Culture and Tourism, for permission to conduct field work at Ledi-Geraru and laboratory research in the National Museum of Ethiopia, Addis Ababa, in which the LD 350-1 mandible is housed. Research funding provided by the National Science Foundation (NSF) (grant no. BCS-1157351), and the Institute of Human Origins at Arizona State University is gratefully acknowledged. B.A.V. also thanks NSF (BCS-0725122 HOMINID grant) and the George Washington University Selective Excellence Program for support during this research project. We thank Z. Alemseged, B. Asfaw, L. Berger, F. Brown, C. Feibel, D. Johanson, F. Spoor, G. Suwa, C. Ward, T. White, and B. Wood for discussion, assistance, and/or permission to examine fossils. Constructive comments by F. Spoor, B. Wood, and three anonymous referees substantially improved the manuscript. Supporting data for this paper are presented in the supplementary materials.	Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Boisserie JR, 2008, CR PALEVOL, V7, P429, DOI 10.1016/j.crpv.2008.07.010; Campisano CJ, 2007, J HUM EVOL, V53, P515, DOI 10.1016/j.jhevol.2007.05.015; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; DiMaggio EN, 2015, SCIENCE, V347, P1355, DOI 10.1126/science.aaa1415; Guatelli-Steinberg D, 2005, AM J PHYS ANTHROPOL, V128, P477, DOI 10.1002/ajpa.20194; Herries Andy I.R., 2013, P21; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; LEAKEY REF, 1985, AM J PHYS ANTHROPOL, V67, P135, DOI 10.1002/ajpa.1330670209; McDougall I, 2012, J GEOL SOC LONDON, V169, P213, DOI 10.1144/0016-76492010-188; Montagu MFA, 1954, AM J PHYS ANTHROP-NE, V12, P503, DOI 10.1002/ajpa.1330120404; Potts R, 2013, QUATERNARY SCI REV, V73, P1, DOI 10.1016/j.quascirev.2013.04.003; Spoor F, 2015, NATURE, V519, P83, DOI 10.1038/nature14224; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; SUWA G, 1994, AM J PHYS ANTHROPOL, V93, P407, DOI 10.1002/ajpa.1330930402; Suwa G., 1990, THESIS U CALIFORNIA; Tobias P.V., 1991, OLDUVAI GORGE, V4; Vrba E.S., 1988, P405; Weidenreich F., 1936, Palaeontologia Sinica, VD7, P1; WHITE TD, 1981, S AFR J SCI, V77, P445; WHITE TD, 1977, THESIS U MICHIGAN AN; White Tim D., 2005, Transactions of the Royal Society of South Africa, V60, P79; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1986, AM J PHYS ANTHROPOL, V69, P117, DOI 10.1002/ajpa.1330690113; Wood B, 2011, ANNU REV ECOL EVOL S, V42, P47, DOI 10.1146/annurev-ecolsys-102209-144653	33	213	221	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1352	1355		10.1126/science.aaa1343	http://dx.doi.org/10.1126/science.aaa1343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25739410				2022-12-28	WOS:000351219600039
J	Badhiwala, JH; Lai, CK; Alhazzani, W; Farrokhyar, F; Nassiri, F; Meade, M; Mansouri, A; Sne, N; Aref, M; Murty, N; Witiw, C; Singh, S; Yarascavitch, B; Reddy, K; Almenawer, SA				Badhiwala, Jetan H.; Lai, Chung K.; Alhazzani, Waleed; Farrokhyar, Forough; Nassiri, Farshad; Meade, Maureen; Mansouri, Alireza; Sne, Niv; Aref, Mohammed; Murty, Naresh; Witiw, Christopher; Singh, Sheila; Yarascavitch, Blake; Reddy, Kesava; Almenawer, Saleh A.			Cervical Spine Clearance in Obtunded Patients After Blunt Traumatic Injury A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							COMPUTED-TOMOGRAPHY; CORD-INJURY; EASTERN ASSOCIATION; MULTIDETECTOR CT; MRI; EPIDEMIOLOGY; SAFE; IDENTIFICATION; METAANALYSIS; PREDICTORS	Background: Cervical spine clearance protocols are controversial for unconscious patients after blunt traumatic injury and negative findings on computed tomography (CT). Purpose: To review evidence about the utility of different cervical spine clearance protocols in excluding significant cervical spine injury after negative CT results in obtunded adults with blunt traumatic injury. Data Sources: MEDLINE, EMBASE, CINAHL, Google Scholar, and the Cochrane Library were searched from January 2000 through November 2014. Study Selection: English-language studies that examined patients with negative CT results having confirmatory routine testing with magnetic resonance imaging (MRI), dynamic radiography, or clinical examination and that reported outcome measures of missed cervical spine injury, need for operative stabilization, or prolonged use of cervical collars. Data Extraction: Independent reviewers evaluated the quality of studies and abstracted the data according to a predefined protocol. Data Synthesis: Of 28 observational studies (3627 patients) that met eligibility criteria, 7 were prospective studies (1686 patients) with low risk of bias and well-interpreted, high-quality CT scans. These 7 studies showed that 0% of significant injuries were missed after negative CT results. The overall studies using confirmatory routine testing with MRI showed incidence rates of 0% to 1.5% for cervical spine instability (16 studies; 1799 patients), 0% to 7.3% for need for operative fixation (17 studies; 1555 patients), and 0% to 29.5% for prolonged collar use (16 studies; 1453 patients). Limitations: Most studies were retrospective. Approaches to management of soft tissue changes with collars varied markedly. Conclusion: Cervical spine clearance in obtunded adults after blunt traumatic injury with negative results from a well-interpreted, high-quality CT scan is probably a safe and efficient practice.	[Badhiwala, Jetan H.; Nassiri, Farshad; Mansouri, Alireza; Witiw, Christopher] Univ Toronto, Div Neurosurg, Toronto, ON M5S 2J7, Canada; [Lai, Chung K.; Aref, Mohammed; Murty, Naresh; Singh, Sheila; Reddy, Kesava; Almenawer, Saleh A.] McMaster Univ, Div Neurosurg, Hamilton, ON L8S 4L8, Canada; [Alhazzani, Waleed; Meade, Maureen] McMaster Univ, Div Crit Care, Hamilton, ON L8S 4L8, Canada; [Farrokhyar, Forough] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Sne, Niv] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Yarascavitch, Blake] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA	University of Toronto; McMaster University; McMaster University; McMaster University; McMaster University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Almenawer, SA (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Div Neurosurg, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.	Dr_menawer@hotmail.com	Singh, Sheila K/W-2799-2018; Farrokhyar, Forough/AAQ-6005-2021; Reddy, Kesava/AAR-8866-2021; Yarascavitch, Blake/AAR-8800-2021	Singh, Sheila K/0000-0003-1272-5300; Farrokhyar, Forough/0000-0001-9928-9016; Yarascavitch, Blake/0000-0003-1810-1267; Mansouri, Alireza/0000-0002-7442-7539				Adams JM, 2006, AM SURGEON, V72, P101; Anekstein Y, 2008, INJURY, V39, P339, DOI 10.1016/j.injury.2007.09.018; Brohi K, 2005, J TRAUMA, V58, P897, DOI 10.1097/01.ta.0000171984.25699.35; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Chew BG, 2013, J NEUROSURG-SPINE, V19, P576, DOI 10.3171/2013.8.SPINE12925; Claxton AR, 1998, CAN J ANAESTH, V45, P144, DOI 10.1007/BF03013253; Como JJ, 2007, J TRAUMA, V63, P544, DOI 10.1097/TA.0b013e31812e51ae; Como JJ, 2011, J TRAUMA, V70, P345, DOI 10.1097/TA.0b013e3182095b3c; Como JJ, 2009, J TRAUMA, V67, P651, DOI 10.1097/TA.0b013e3181ae583b; Damadi AA, 2008, J TRAUMA, V64, P745, DOI 10.1097/TA.0b013e3180341fc6; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; DENIS F, 1983, SPINE, V8, P817, DOI 10.1097/00007632-198311000-00003; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; Dunham CM, 2008, CRIT CARE, V12, DOI 10.1186/cc6957; Fisher BM, 2013, AM J SURG, V206, P987, DOI 10.1016/j.amjsurg.2013.08.021; FUJIMURA Y, 1995, PARAPLEGIA, V33, P195, DOI 10.1038/sc.1995.44; Gebauer G, 2012, CLIN ORTHOP RELAT R, V470, P1652, DOI 10.1007/s11999-012-2286-7; Ghanta MK, 2002, AM SURGEON, V68, P563; Goldberg W, 2001, ANN EMERG MED, V38, P17, DOI 10.1067/mem.2001.116150; Grossman MD, 1999, J TRAUMA, V47, P684, DOI 10.1097/00005373-199910000-00012; HARRIS P, 1980, PARAPLEGIA, V18, P324, DOI 10.1038/sc.1980.59; Harris TJ, 2008, SPINE, V33, P1547, DOI 10.1097/BRS.0b013e31817926c1; Hasler RM, 2012, J TRAUMA ACUTE CARE, V72, P975, DOI 10.1097/TA.0b013e31823f5e8e; Hennessy D, 2010, J TRAUMA, V68, P576, DOI 10.1097/TA.0b013e3181cf7e55; Hogan GJ, 2005, RADIOLOGY, V237, P106, DOI 10.1148/radiol.2371040697; Ide-Okochi A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-69; Kaiser ML, 2012, AM SURGEON, V78, P1156; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kanji HD, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.10.022; Khanna P, 2012, J TRAUMA ACUTE CARE, V72, P699, DOI 10.1097/TA.0b013e31822b77f9; Kihiczak D, 2001, EMERG RADIOL, V8, P276, DOI DOI 10.1007/PL00011920; Long A E, 1985, Emerg Med Clin North Am, V3, P437; Lowery DW, 2001, ANN EMERG MED, V38, P12, DOI 10.1067/mem.2001.116149; Menaker J, 2008, J TRAUMA, V64, P898, DOI 10.1097/TA.0b013e3181674675; Menaker J, 2010, AM SURGEON, V76, P157; MIRVIS SE, 1989, RADIOLOGY, V170, P831, DOI 10.1148/radiology.170.3.2492671; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Muchow RD, 2008, J TRAUMA, V64, P179, DOI 10.1097/01.ta.0000238664.74117.ac; National Spinal Cord Injury Statistical Center, 2011, 2011 ANN STAT REP SP; Neumann CR, 2009, J TRAUMA, V67, P67, DOI 10.1097/TA.0b013e3181aa63f3; Panczykowski DM, 2011, J NEUROSURG, V115, P541, DOI 10.3171/2011.4.JNS101672; Raza M, 2013, INJURY, V44, P1589, DOI 10.1016/j.injury.2013.06.005; REID DC, 1987, J TRAUMA, V27, P980, DOI 10.1097/00005373-198709000-00005; Resnick DK, 2013, NEUROSURGERY, V72, P1, DOI 10.1227/NEU.0b013e318276ee7e; Rethnam Ulfin, 2008, BMC Med Imaging, V8, P12, DOI 10.1186/1471-2342-8-12; RIGGINS RS, 1977, J TRAUMA, V17, P126, DOI 10.1097/00005373-197702000-00007; ROYE WP, 1988, J TRAUMA, V28, P1260, DOI 10.1097/00005373-198808000-00021; Russin JJ, 2013, WORLD NEUROSURG, V80, P405, DOI 10.1016/j.wneu.2013.01.036; Sarani B, 2007, J TRAUMA, V63, P637, DOI 10.1097/TA.0b013e31812eedb1; Satahoo SS, 2014, J SURG RES, V187, P225, DOI 10.1016/j.jss.2013.09.022; Schoenfeld AJ, 2010, J TRAUMA, V68, P109, DOI 10.1097/TA.0b013e3181c0b67a; Schoenwaelder M, 2009, EMERG RADIOL, V16, P129, DOI 10.1007/s10140-008-0749-7; Schuster R, 2005, ARCH SURG-CHICAGO, V140, P762, DOI 10.1001/archsurg.140.8.762; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Soult MC, 2012, AM SURGEON, V78, P741; Stassen NA, 2006, J TRAUMA, V60, P171, DOI 10.1097/01.ta.0000197647.44202.de; Steigelman M, 2008, AM J SURG, V196, P857, DOI 10.1016/j.amjsurg.2008.07.040; Stelfox HT, 2007, J TRAUMA, V63, P630, DOI 10.1097/TA.0b013e318076b537; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tan LA, 2014, CLIN NEUROL NEUROSUR, V120, P23, DOI 10.1016/j.clineuro.2014.02.006; Tomycz ND, 2008, J TRAUMA, V64, P1258, DOI 10.1097/TA.0b013e318166d2bd; van Middendorp JJ, 2010, SPINE, V35, P1079, DOI 10.1097/BRS.0b013e3181bc9fd2; White A.A., 1990, CLIN BIOMECH; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Widder S, 2004, J TRAUMA, V56, P1179, DOI 10.1097/01.TA.0000130758.71098.78	65	20	20	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					429	437		10.7326/M14-2351	http://dx.doi.org/10.7326/M14-2351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775316				2022-12-28	WOS:000351279600016
J	Conrad, CP				Conrad, Clinton P.			How climate influences sea-floor topography	SCIENCE			English	Editorial Material									Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Geol & Geophys, Honolulu, HI 96822 USA	University of Hawaii System	Conrad, CP (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Geol & Geophys, Honolulu, HI 96822 USA.	clintc@hawaii.edu	Conrad, Clinton/ABG-4901-2020	Conrad, Clinton/0000-0003-4314-2351	NSF [EAR-1151241]; Directorate For Geosciences [1151241] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	I thank P. Wessel for helpful comments. Supported by NSF grant EAR-1151241.	Buck WR, 1998, NATURE, V392, P272, DOI 10.1038/32636; Crowley JW, 2015, SCIENCE, V347, P1237, DOI 10.1126/science.1261508; GOFF JA, 2004, OCEANOGRAPHY, V17, P24, DOI DOI 10.5670/OCEANOG.2004.64; Hay CC, 2015, NATURE, V517, P481, DOI 10.1038/nature14093; Huybers P, 2009, EARTH PLANET SC LETT, V286, P479, DOI 10.1016/j.epsl.2009.07.014; Lund DC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003693; Macdonald KC, 1996, NATURE, V380, P125, DOI 10.1038/380125a0; Maclennan J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000282; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Tolstoy M, 2015, GEOPHYS RES LETT, V42, P1346, DOI 10.1002/2014GL063015	10	6	6	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1204	1205		10.1126/science.aaa6813	http://dx.doi.org/10.1126/science.aaa6813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD1GZ	25766221				2022-12-28	WOS:000350824300022
J	Wojcik, SP; Hovasapian, A; Graham, J; Motyl, M; Ditto, PH				Wojcik, Sean P.; Hovasapian, Arpine; Graham, Jesse; Motyl, Matt; Ditto, Peter H.			Conservatives report, but liberals display, greater happiness	SCIENCE			English	Article							SELF-ENHANCEMENT; POSITIVE EMOTION; PERSONALITY; HAPPIER	Research suggesting that political conservatives are happier than political liberals has relied exclusively on self-report measures of subjective well-being. We show that this finding is fully mediated by conservatives' self-enhancing style of self-report (study 1; N = 1433) and then describe three studies drawing from "big data" sources to assess liberal-conservative differences in happiness-related behavior (studies 2 to 4; N = 4936). Relative to conservatives, liberals more frequently used positive emotional language in their speech and smiled more intensely and genuinely in photographs. Our results were consistent across large samples of online survey takers, U.S. politicians, Twitter users, and LinkedIn users. Our findings illustrate the nuanced relationship between political ideology, self-enhancement, and happiness and illuminate the contradictory ways that happiness differences can manifest across behavior and self-reports.	[Wojcik, Sean P.; Hovasapian, Arpine; Ditto, Peter H.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA; [Graham, Jesse] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Motyl, Matt] Univ Illinois, Chicago, IL 60607 USA	University of California System; University of California Irvine; University of Southern California; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wojcik, SP (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA.	swojcik@uci.edu; phditto@uci.edu	Motyl, Matt/G-6480-2016	Motyl, Matt/0000-0002-7190-0802; Graham, Jesse/0000-0001-8863-7978				[Anonymous], LEG SCOR; Brooks Arthur., 2008, GROSS NATL HAPPINESS; Brown JD, 2012, PERS SOC PSYCHOL B, V38, P209, DOI 10.1177/0146167211432763; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Deci EL, 2008, J HAPPINESS STUD, V9, P1, DOI 10.1007/s10902-006-9018-1; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Ekman P., 2002, FACIAL ACTION CODING; Eriksson K, 2014, SOC PSYCHOL PERS SCI, V5, P76, DOI 10.1177/1948550613484179; Gawronski B., 2010, HDB IMPLICIT SOCIAL; Harker LA, 2001, J PERS SOC PSYCHOL, V80, P112, DOI 10.1037//0022-3514.80.1.112; Heine SJ, 2007, ASIAN J SOC PSYCHOL, V10, P198, DOI 10.1111/j.1467-839X.2007.00226.x; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Jost J. T., 2010, ONTARIO S, P173; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kernis MH, 2003, PSYCHOL INQ, V14, P1, DOI 10.1207/S15327965PLI1401_01; Krueger AB, 2014, SCIENCE, V346, P42, DOI 10.1126/science.1256392; Loughnan S, 2011, PSYCHOL SCI, V22, P1254, DOI 10.1177/0956797611417003; Napier JL, 2008, PSYCHOL SCI, V19, P565, DOI 10.1111/j.1467-9280.2008.02124.x; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Onraet E, 2013, PERS SOC PSYCHOL B, V39, P509, DOI 10.1177/0146167213478199; Paulhus D. L., 1994, BALANCED INVENTORY D; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W; Pressman SD, 2012, HEALTH PSYCHOL, V31, P297, DOI 10.1037/a0025339; Schlenker BR, 2012, J RES PERS, V46, P127, DOI 10.1016/j.jrp.2011.12.009; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; United States Congress Joint Committee on Printing, 2013, C PICT DIR 113 C; Watson D., 1994, PANAS X MANUAL POSIT, DOI [10.17077/48vtm4t2, DOI 10.17077/48VTM4T2, DOI 10.13072/MIDSS.438]; Wilson G.D., 1973, PSYCHOL CONSERVATISM; Wojcik SP, 2014, SOC PSYCHOL PERS SCI, V5, P825, DOI 10.1177/1948550614534699; Zou C, 2013, PSYCHOL ASSESSMENT, V25, P1247, DOI 10.1037/a0033902	32	81	83	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1243	1246		10.1126/science.1260817	http://dx.doi.org/10.1126/science.1260817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD1GZ	25766233				2022-12-28	WOS:000350824300036
J	Conn, SJ; Pillman, KA; Toubia, J; Conn, VM; Salmanidis, M; Phillips, CA; Roslan, S; Schreiber, AW; Gregory, PA; Goodall, GJ				Conn, Simon J.; Pillman, Katherine A.; Toubia, John; Conn, Vanessa M.; Salmanidis, Marika; Phillips, Caroline A.; Roslan, Suraya; Schreiber, Andreas W.; Gregory, Philip A.; Goodall, Gregory J.			The RNA Binding Protein Quaking Regulates Formation of circRNAs	CELL			English	Article							CIRCULAR RNAS; MESSENGER-RNA; MESENCHYMAL TRANSITION; FAMILY; IDENTIFICATION; TRANSCRIPTS; MECHANISMS; GENE	Circular RNAs (circRNAs), formed by non-sequential back-splicing of pre-mRNA transcripts, are a widespread form of non-coding RNA in animal cells. However, it is unclear whether the majority of circRNAs represent splicing by-products without function or are produced in a regulated manner to carry out specific cellular functions. We show that hundreds of circRNAs are regulated during human epithelial-mesenchymal transition (EMT) and find that the production of over one-third of abundant circRNAs is dynamically regulated by the alternative splicing factor, Quaking (QKI), which itself is regulated during EMT. Furthermore, by modulating QKI levels, we show the effect on circRNA abundance is dependent on intronic QKI binding motifs. Critically, the addition of QKI motifs is sufficient to induce de novo circRNA formation from transcripts that are normally linearly spliced. These findings demonstrate circRNAs are both purposefully synthesized and regulated by cell-type specific mechanisms, suggesting they play specific biological roles in EMT.	[Conn, Simon J.; Pillman, Katherine A.; Toubia, John; Conn, Vanessa M.; Salmanidis, Marika; Phillips, Caroline A.; Roslan, Suraya; Schreiber, Andreas W.; Gregory, Philip A.; Goodall, Gregory J.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Conn, Simon J.; Pillman, Katherine A.; Toubia, John; Conn, Vanessa M.; Salmanidis, Marika; Phillips, Caroline A.; Roslan, Suraya; Schreiber, Andreas W.; Gregory, Philip A.; Goodall, Gregory J.] Univ S Australia, Adelaide, SA 5000, Australia; [Pillman, Katherine A.; Toubia, John; Schreiber, Andreas W.] SA Pathol, ACRF Canc Genom Facil, Adelaide, SA 5000, Australia; [Phillips, Caroline A.; Schreiber, Andreas W.; Goodall, Gregory J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Gregory, Philip A.; Goodall, Gregory J.] Univ Adelaide, Dept Med, Adelaide, SA 5005, Australia	Centre for Cancer Biology; SA Pathology; University of South Australia; SA Pathology; University of Adelaide; University of Adelaide	Goodall, GJ (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia.	greg.goodall@health.sa.gov.au	Pillman, Katherine A/M-5723-2019; Gregory, Philip/F-4089-2013; SAUB, ROSLAN/B-9608-2010	Pillman, Katherine A/0000-0002-5869-889X; Gregory, Philip/0000-0002-0999-0632; Goodall, Gregory/0000-0003-1294-0692; Toubia, John/0000-0002-5135-6504; Conn, Simon/0000-0002-1376-4515; Conn, Vanessa/0000-0002-8850-8209; Schreiber, Andreas/0000-0002-9081-3405; Phillips, Caroline/0000-0002-4471-9768	Royal Adelaide Hospital Research Fund; National Health and Medical Research Council [GNT1089167, GNT1068773]; EMPathy Breast Cancer Network, a National Breast Cancer Foundation (Australia); Cancer Council SA Beat Cancer Fellowship; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	Royal Adelaide Hospital Research Fund; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); EMPathy Breast Cancer Network, a National Breast Cancer Foundation (Australia); Cancer Council SA Beat Cancer Fellowship(Cancer Council South Australia); National Breast Cancer Foundation	We thank all members of the Goodall Laboratory for valuable discussion. We thank David Lawrence of the CCB ACRF Cancer Genomics Facility for valuable discussion and for establishing sequencing analysis pipelines. Funding for this research was obtained from the Royal Adelaide Hospital Research Fund in the form of a Florey Postdoctoral Fellowship to S.J.C.; from the National Health and Medical Research Council project grants GNT1089167 to G.J.G. and S.J.C.; GNT1068773 to G.J.G. and P.A.G.; and from the EMPathy Breast Cancer Network, a National Breast Cancer Foundation (Australia)-funded National Collaborative Research Program. P.A.G. is supported by a Cancer Council SA Beat Cancer Fellowship.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Gadea G, 2014, EUR J CELL BIOL, V93, P466, DOI 10.1016/j.ejcb.2014.06.003; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Gualandi F, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e100; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Teplova M, 2013, GENE DEV, V27, P928, DOI 10.1101/gad.216531.113; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001	41	1276	1363	11	241	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1125	1134		10.1016/j.cell.2015.02.014	http://dx.doi.org/10.1016/j.cell.2015.02.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768908	Bronze			2022-12-28	WOS:000351951800012
J	Levy, SF; Blundell, JR; Venkataram, S; Petrov, DA; Fisher, DS; Sherlock, G				Levy, Sasha F.; Blundell, Jamie R.; Venkataram, Sandeep; Petrov, Dmitri A.; Fisher, Daniel S.; Sherlock, Gavin			Quantitative evolutionary dynamics using high-resolution lineage tracking	NATURE			English	Article							RAPIDLY ADAPTING POPULATIONS; SITE-SPECIFIC RECOMBINATION; BENEFICIAL MUTATIONS; ASEXUAL POPULATIONS; SACCHAROMYCES-CEREVISIAE; STAPHYLOCOCCUS-AUREUS; CLONAL INTERFERENCE; CANCER GENOME; YEAST; GENEALOGIES	Evolution of large asexual cell populations underlies similar to 30% of deaths worldwide, including those caused by bacteria, fungi, parasites, and cancer. However, the dynamics underlying these evolutionary processes remain poorly understood because they involve many competing beneficial lineages, most of which never rise above extremely low frequencies in the population. To observe these normally hidden evolutionary dynamics, we constructed a sequencing-based ultra high-resolution lineage tracking system in Saccharomyces cerevisiae that allowed us to monitor the relative frequencies of similar to 500,000 lineages simultaneously. In contrast to some expectations, we found that the spectrum of fitness effects of beneficial mutations is neither exponential nor monotonic. Early adaptation is a predictable consequence of this spectrum and is strikingly reproducible, but the initial small-effect mutations are soon outcompeted by rarer large-effect mutations that result in variability between replicates. These results suggest that early evolutionary dynamics may be deterministic for a period of time before stochastic effects become important.	[Levy, Sasha F.; Sherlock, Gavin] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Levy, Sasha F.] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY 11794 USA; [Levy, Sasha F.] SUNY Stony Brook, Dept Biochem & Cellular Biol, Stony Brook, NY 11794 USA; [Blundell, Jamie R.; Fisher, Daniel S.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Blundell, Jamie R.; Venkataram, Sandeep; Petrov, Dmitri A.; Fisher, Daniel S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University; Stanford University	Fisher, DS (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	dsfisher@stanford.edu; gsherloc@stanford.edu	Sherlock, Gavin J/E-9110-2012	Fisher, Daniel/0000-0002-5559-2491; Levy, Sasha/0000-0002-0923-1636; Blundell, Jamie Rees/0000-0001-9747-7363; Petrov, Dmitri/0000-0002-3664-9130; Sherlock, Gavin/0000-0002-1692-4983; Venkataram, Sandeep/0000-0002-2012-2633	NIH [R01 HG003328, 5-T32-HG-44-17, R25 GM067110]; NSF [DMS-1120699, PHY-1305433]; Stanford University [Bio-X IIP6-63]; Betty Moore Foundation [2919]; Louis and Beatrice Laufer Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG003328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM067110] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Stanford University(Stanford University); Betty Moore Foundation(Gordon and Betty Moore Foundation); Louis and Beatrice Laufer Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Siegal, K. Schwartz, B. Dunn, M. Jaffe, D. Kvitek, J. Thompson, D. Sellis, and Y. Zhu for discussions. FACS was performed at the Stanford Shared FACS Facility. We would like to acknowledge funding support from NIH grants R01 HG003328, 5-T32-HG-44-17 and R25 GM067110, NSF grants DMS-1120699 and PHY-1305433, Bio-X IIP6-63 grant from Stanford University, Gordon and Betty Moore Foundation grant no. 2919, and The Louis and Beatrice Laufer Center.	AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blundell JR, 2014, GENOMICS, V104, P417, DOI 10.1016/j.ygeno.2014.09.005; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Charlesworth B, 1996, CURR BIOL, V6, P220, DOI 10.1016/S0960-9822(02)00457-8; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Desai MM, 2013, GENETICS, V193, P565, DOI 10.1534/genetics.112.147157; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; Good BH, 2012, P NATL ACAD SCI USA, V109, P4950, DOI 10.1073/pnas.1119910109; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; Joseph SB, 2004, GENETICS, V168, P1817, DOI 10.1534/genetics.104.033761; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Konig C, 1998, J ANTIMICROB CHEMOTH, V42, P227, DOI 10.1093/jac/42.2.227; Kvitek DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003972; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Luria SE, 1943, GENETICS, V28, P491; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Michaelson JS, 2002, CANCER, V95, P713, DOI 10.1002/cncr.10742; Neher RA, 2013, P NATL ACAD SCI USA, V110, P437, DOI 10.1073/pnas.1213113110; Orr HA, 2003, GENETICS, V163, P1519; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rokyta DR, 2008, J MOL EVOL, V67, P368, DOI 10.1007/s00239-008-9153-x; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; SALMON SE, 1970, J CLIN INVEST, V49, P1114, DOI 10.1172/JCI106327; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Zhu YO, 2014, P NATL ACAD SCI USA, V111, pE2310, DOI 10.1073/pnas.1323011111	50	209	210	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					181	+		10.1038/nature14279	http://dx.doi.org/10.1038/nature14279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25731169	Green Accepted			2022-12-28	WOS:000350770500028
J	Zakrzewska, JM; Linskey, ME				Zakrzewska, Joanna M.; Linskey, Mark E.			SUMMARIES OF BMJ CLINICAL EVIDENCE Trigeminal neuralgia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zakrzewska, Joanna M.] Eastman Dent Hosp, Div Diagnost Surg & Med Sci, London, England; [Linskey, Mark E.] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of California System; University of California Irvine	Zakrzewska, JM (corresponding author), Eastman Dent Hosp, Div Diagnost Surg & Med Sci, London, England.	j.zakrzewska@ucl.ac.uk	Zakrzewska, Joanna M./AAC-7378-2020	Zakrzewska, Joanna M./0000-0001-7805-5851				Cruccu G, 2008, EUR J NEUROL, V15, P1013, DOI 10.1111/j.1468-1331.2008.02185.x; Medicines and Healthcare Products Regulatory Agency, 2008, DRUG SAFETY UPDATE, V1; National Institute for Health and Care Excellence, 2014, CLIN KNOWL SUMM TRIG; National Institute for Health and Care Excellence. Neuropathic pain-pharmacological management, 2013, NEUR PAIN PHARM MAN, V173; Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202; Zakrzewska JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g474	6	32	34	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2015	350								h1238	10.1136/bmj.h1238	http://dx.doi.org/10.1136/bmj.h1238			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EQ	25767102				2022-12-28	WOS:000351182700004
J	Cole, TB				Cole, Thomas B.			Couple David Park	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					992	993		10.1001/jama.2014.11625	http://dx.doi.org/10.1001/jama.2014.11625			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756423				2022-12-28	WOS:000350643100001
J	Gulland, A				Gulland, Anne			Can GPs do more to help patients with facial disfigurement?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk						Hodson H., 2012, TELEGRAPH; Julian D, 2007, FACE EQUALITY CAMPAI; Palacio RJ, 2013, WONDER	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2015	350								h1160	10.1136/bmj.h1160	http://dx.doi.org/10.1136/bmj.h1160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EH	25758246				2022-12-28	WOS:000351181800003
J	Blandford, RD				Blandford, R. D.			A century of general relativity: Astrophysics and cosmology	SCIENCE			English	Review							SUPERMASSIVE BLACK-HOLE; INFLATIONARY UNIVERSE; GRAVITATIONAL-FIELD; ACCRETION; PULSAR; ENERGY; MASS; DISCOVERY; EXTRACTION; EVOLUTION	One hundred years after its birth, general relativity has become a highly successful physical theory in the sense that it has passed a large number of experimental and observational tests and finds extensive application to a wide variety of cosmic phenomena. It remains an active area of research as new tests are on the way, epitomized by the exciting prospect of detecting gravitational waves from merging black holes. General relativity is the essential foundation of the standard model of cosmology and underlies our description of the black holes and neutron stars that are ultimately responsible for the most powerful and dramatic cosmic sources. Its interface with physics on the smallest and largest scales will continue to provide fertile areas of investigation in its next century.	Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA	Stanford University	Blandford, RD (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA.							Aartsen MG, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.022001; Abdo AA, 2009, NATURE, V462, P331, DOI 10.1038/nature08574; Adam R., 2015, ARXIV150201582; Ade PAR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.241101; Baker T., 2014, ARXIV14123455; Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; BARDEEN JM, 1970, NATURE, V226, P64, DOI 10.1038/226064a0; BEKENSTEIN JD, 1973, PHYS REV D, V7, P2333, DOI 10.1103/PhysRevD.7.2333; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; BUCHDAHL HA, 1970, MON NOT R ASTRON SOC, V150, P1; Carroll S. M., 2003, SPACETIME GEOMETRY I; Danzmann K, 1996, CLASSICAL QUANT GRAV, V13, pA247, DOI 10.1088/0264-9381/13/11A/033; Dickerson SM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.083001; Dodelson S, 2003, MODERN COSMOLOGY; Doeleman SS, 2012, SCIENCE, V338, P355, DOI 10.1126/science.1224768; Dominik M., 2014, ARXIV14057016; Eddington A, 1927, NATURE PHYS WORLD GI; Eddington A.S., 1919, OBSERVATORY, V42, P119; Einstein A, 1911, ANN PHYS-BERLIN, V35, P898; Einstein A, 1915, SITZBER K PREUSS AKA, P831; Einstein A, 1915, SITZBER K PREUSS AKA, P844; Einstein A, 1915, SITZBER K PREUSS AKA, P778; Einstein A, 1939, ANN MATH, V40, P922, DOI 10.2307/1968902; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Einstein A, 1918, SITZBER K PREUSS AKA, P154; Einstein A., 1917, AKAD WISS BERLIN MAT, V142; Everitt CWF, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.221101; Ewing A.E, 1964, SCI NEWS LETT, V85, P39, DOI DOI 10.2307/3947428; FINKELSTEIN D, 1958, PHYS REV, V110, P965, DOI 10.1103/PhysRev.110.965; Friedman A, 1922, Z PHYS, V10, P377, DOI 10.1007/BF01332580; Gamov G., 1970, MY WORLD LINE; Gaudi BS, 2008, SCIENCE, V319, P927, DOI 10.1126/science.1151947; Gebhardt K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/119; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Gezari S, 2014, PHYS TODAY, V67, P37, DOI 10.1063/PT.3.2382; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; Harry GM, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084006; Hartle J.B, 2003, GRAVITY; HAWKING SW, 1974, NATURE, V248, P30, DOI 10.1038/248030a0; HAWKING SW, 1975, COMMUN MATH PHYS, V43, P199, DOI 10.1007/BF02345020; Heckman TM, 2014, ANNU REV ASTRON ASTR, V52, P589, DOI 10.1146/annurev-astro-081913-035722; HELLINGS RW, 1983, ASTROPHYS J, V265, pL39, DOI 10.1086/183954; Hogan C. J., 2014, ARXIV13072283; HULSE RA, 1975, ASTROPHYS J, V195, pL51, DOI 10.1086/181708; Kant I., 2007, CRITIQUE JUDGEMENT; Kara E, 2013, MON NOT R ASTRON SOC, V434, P1129, DOI 10.1093/mnras/stt1055; Kaspi VM, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/84; KERR RP, 1963, PHYS REV LETT, V11, P237, DOI 10.1103/PhysRevLett.11.237; Kouveliotou C., 2013, GAMMA RAY BURSTS; Kramer M, 2008, ANNU REV ASTRON ASTR, V46, P541, DOI 10.1146/annurev.astro.46.060407.145247; Kramer M, 2014, INT J MOD PHYS D, V23, DOI 10.1142/S0218271814300043; KRAUSS LM, 1988, PHYS REV LETT, V60, P176, DOI 10.1103/PhysRevLett.60.176; Lattimer JM, 2012, ANNU REV NUCL PART S, V62, P485, DOI 10.1146/annurev-nucl-102711-095018; Laughlin R.A., 2005, DIFFERENT UNIVERSE R; Lehner L, 2014, ANNU REV ASTRON ASTR, V52, P661, DOI 10.1146/annurev-astro-081913-040031; Lemaitre G, 1934, P NATL ACAD SCI USA, V20, P12, DOI 10.1073/pnas.20.1.12; LINDE AD, 1982, PHYS LETT B, V108, P389, DOI 10.1016/0370-2693(82)91219-9; Manchester R. N., 2012, 12 MARC GROSSM M GEN, P226; McConnell NJ, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/179; McKinney JC, 2012, MON NOT R ASTRON SOC, V423, P3083, DOI 10.1111/j.1365-2966.2012.21074.x; Meier D. L., 2012, BLACK HOLE ASTROPHYS; Merritt D., 2013, DYNAMICS EVOLUTION G; Misner C.W., 1973, GRAVITATION; Narayan R, 2008, NEW ASTRON REV, V51, P733, DOI 10.1016/j.newar.2008.03.002; Newton I., 1704, OPTICKS; Nitz AH, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.124039; Novikov I., 1973, LES ASTRES OCCLUS, V343; Novikov I., 1964, USP FIZ NAUK, V84, P377; Oppenheimer JR, 1939, PHYS REV, V56, P455, DOI 10.1103/PhysRev.56.455; PACZYNSKI B, 1986, ASTROPHYS J, V304, P1, DOI 10.1086/164140; Pais Abraham, 1982, SUBTLE IS THE LORD; Peacock J. A., 1999, COSMOLOGICAL PHYS; PENROSE R, 1971, NATURE-PHYS SCI, V229, P177, DOI 10.1038/physci229177a0; Perlmutter S, 1999, PHYS REV LETT, V83, P670, DOI 10.1103/PhysRevLett.83.670; POUND RV, 1960, PHYS REV LETT, V4, P274, DOI 10.1103/PhysRevLett.4.274; Pretorius F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.121101; Randall L, 1999, PHYS REV LETT, V83, P3370, DOI 10.1103/PhysRevLett.83.3370; Ransom SM, 2014, NATURE, V505, P520, DOI 10.1038/nature12917; REES MJ, 1977, NATURE, V266, P333, DOI 10.1038/266333a0; Reynolds C S, 2013, ARXIV13023260; SALPETER EE, 1964, ASTROPHYS J, V140, P796, DOI 10.1086/147973; SCHMIDT M, 1963, NATURE, V197, P1040, DOI 10.1038/1971040a0; Schneider P., 2015, EXTRAGALACTIC ASTRON; Schwarkschid K, 1916, SITZBER K PREUSS AKA, P189; Sharon K, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/161; Spergel DN, 2015, SCIENCE, V347, P1100, DOI 10.1126/science.aaa0980; Susskind L., 2009, BLACK HOLE WAR MY BA; Suyu SH, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L35; Thorne K. S., 2015, MODERN CLASSICAL PHY; Turyshev SG, 2008, ANNU REV NUCL PART S, V58, P207, DOI 10.1146/annurev.nucl.58.020807.111839; VESSOT RFC, 1980, PHYS REV LETT, V45, P2081, DOI 10.1103/PhysRevLett.45.2081; Wagoner RV, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/2/L18; Walsh JL, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/86; Weinberg S., 2008, COSMOLOGY; Weinberg S., 1972, GRAVITATION COSMOLOG; Weisberg JM, 2010, ASTROPHYS J, V722, P1030, DOI 10.1088/0004-637X/722/2/1030; Weld DM, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.062006; WHEELER JA, 1968, AM SCHOLAR, V37, P248; Will CM, 2014, LIVING REV RELATIV, V17, DOI 10.12942/lrr-2014-4	102	3	3	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1103	1108		10.1126/science.aaa4033	http://dx.doi.org/10.1126/science.aaa4033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745165				2022-12-28	WOS:000350354200044
J	Perros, M				Perros, Manos			A sustainable model for antibiotics	SCIENCE			English	Editorial Material							GRAM-NEGATIVE BACILLI; RESISTANCE; PATHOGENS; DRUGS		AstraZeneca Innovat Med & Early Dev, Waltham, MA 02451 USA		Perros, M (corresponding author), AstraZeneca Innovat Med & Early Dev, Gatehouse Dr, Waltham, MA 02451 USA.	manos.perros@astrazeneca.com						Baker S, 2015, SCIENCE, V347, P1064, DOI 10.1126/science.aaa2868; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Karaiskos I, 2014, EXPERT OPIN PHARMACO, V15, P1351, DOI 10.1517/14656566.2014.914172; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012; Mylonakis E, 2015, CLIN INFECT DIS, V60, P892, DOI 10.1093/cid/ciu959; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Spellberg B, 2013, NAT REV DRUG DISCOV, V12, P963, DOI 10.1038/nrd3957-c1; Tenover FC, 2013, J CLIN MICROBIOL, V51, P3780, DOI 10.1128/JCM.01092-13	15	36	39	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1062	1064		10.1126/science.aaa3048	http://dx.doi.org/10.1126/science.aaa3048			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745144				2022-12-28	WOS:000350354200016
J	Hou, X; Hu, YH; Grinthal, A; Khan, M; Aizenberg, J				Hou, Xu; Hu, Yuhang; Grinthal, Alison; Khan, Mughees; Aizenberg, Joanna			Liquid-based gating mechanism with tunable multiphase selectivity and antifouling behaviour	NATURE			English	Article							MEMBRANES; WATER; PERMEATION; NANOPORES	Living organisms make extensive use of micro- and nanometre-sized pores as gatekeepers for controlling the movement of fluids, vapours and solids between complex environments. The ability of such pores to coordinate multiphase transport, in a highly selective and subtly triggered fashion and without clogging, has inspired interest in synthetic gated pores for applications ranging from fluid processing to 3D printing and lab-on-chip systems(1-10). But although specific gating and transport behaviours have been realized by precisely tailoring pore surface chemistries and pore geometries(6,11-17), a single system capable of controlling complex, selective multiphase transport has remained a distant prospect, and fouling is nearly inevitable(11,12). Here we introduce a gating mechanism that uses a capillary-stabilized liquid as a reversible, reconfigurable gate that fills and seals pores in the closed state, and creates a non-fouling, liquid-lined pore in the open state. Theoretical modelling and experiments demonstrate that for each transport substance, the gating threshold-the pressure needed to open the pores-can be rationally tuned over a wide pressure range. This enables us to realize in one system differential response profiles for a variety of liquids and gases, even letting liquids flow through the pore while preventing gas from escaping. These capabilities allow us to dynamically modulate gas-liquid sorting in a microfluidic flow and to separate a three-phase air-water-oil mixture, with the liquid lining ensuring sustained antifouling behaviour. Because the liquid gating strategy enables efficient long-term operation and can be applied to a variety of pore structures and membrane materials, and to micro- as well as macroscale fluid systems, we expect it to prove useful in a wide range of applications.	[Hou, Xu; Hu, Yuhang; Grinthal, Alison; Aizenberg, Joanna] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Hou, Xu; Khan, Mughees; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Aizenberg, J (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	jaiz@seas.harvard.edu	Hu, Yuhang/E-5378-2010	Hu, Yuhang/0000-0002-2274-4903; Hou, Xu/0000-0002-9615-9547	Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy [DE-AR0000326]	Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy(United States Department of Energy (DOE))	This work was supported in part by the Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy, under award number DE-AR0000326. We thank M. Aizenberg, R. T. Blough and X. Y. Chen for discussions; A. B. Tesler for assistance with the scanning electron microscopy; and T. S. Wong, B. D. Hatton and R. A. Belisle for assistance with antifouling experiments.	Adrus N, 2012, J MATER CHEM, V22, P3088, DOI 10.1039/c2jm15022k; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Chen PC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02776; Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868; Faulkner-Jones A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015013; Germic L, 1997, J MEMBRANE SCI, V132, P131, DOI 10.1016/S0376-7388(97)00058-6; Holt JK, 2004, 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY, P110; Kargov A, 2005, INT C REHAB ROBOT, P182; Karlsson JM, 2013, LAB CHIP, V13, P4366, DOI 10.1039/c3lc50778e; Kralj JG, 2007, LAB CHIP, V7, P256, DOI 10.1039/b610888a; Lin NH, 2010, J MATER CHEM, V20, P4642, DOI 10.1039/b926918e; Liu CC, 2011, LAB CHIP, V11, P1688, DOI 10.1039/c1lc20089e; MiettonPeuchot M, 1997, J MEMBRANE SCI, V133, P73, DOI 10.1016/S0376-7388(97)00091-4; MOHNS J, 1995, ANAL CHIM ACTA, V305, P241, DOI 10.1016/0003-2670(94)00608-O; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Namati E, 2008, AM J RESP CELL MOL, V38, P572, DOI 10.1165/rcmb.2007-0120OC; Oh KW, 2006, J MICROMECH MICROENG, V16, pR13, DOI 10.1088/0960-1317/16/5/R01; Paven M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3512; Peleg O, 2010, BIOL CHEM, V391, P719, DOI 10.1515/BC.2010.092; Peng XS, 2009, NAT NANOTECHNOL, V4, P353, DOI [10.1038/NNANO.2009.90, 10.1038/nnano.2009.90]; Powell MR, 2011, NAT NANOTECHNOL, V6, P798, DOI [10.1038/nnano.2011.189, 10.1038/NNANO.2011.189]; PURCELL WR, 1949, T AM I MIN MET ENG, V186, P39; Stroock AD, 2014, ANNU REV FLUID MECH, V46, P615, DOI 10.1146/annurev-fluid-010313-141411; Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084; Wen YQ, 2012, CHEM COMMUN, V48, P8410, DOI 10.1039/c2cc34501c; Winther-Jensen B, 2008, SCIENCE, V321, P671, DOI 10.1126/science.1159267; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Yameen B, 2009, SMALL, V5, P1287, DOI 10.1002/smll.200801318; Yusko EC, 2011, NAT NANOTECHNOL, V6, P253, DOI 10.1038/nnano.2011.12; Zhang CY, 2011, ENERG FUEL, V25, P3493, DOI 10.1021/ef101732k	30	317	323	45	942	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					70	73		10.1038/nature14253	http://dx.doi.org/10.1038/nature14253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739629	Green Submitted			2022-12-28	WOS:000350304000037
J	Kahn, MW				Kahn, Michael W.			On Taking Notice - Learning Mindfulness from (Boston) Brahmins	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kahn, Michael W.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kahn, Michael W.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kahn, MW (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Kabat-Zinn J., 1994, WHEREVER YOU GO THER	1	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					901	903		10.1056/NEJMp1410397	http://dx.doi.org/10.1056/NEJMp1410397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC4EU	25738665				2022-12-28	WOS:000350304500005
J	Dhurandhar, NV; Thomas, D				Dhurandhar, Nikhil V.; Thomas, Diana			The Link Between Dietary Sugar Intake and Cardiovascular Disease Mortality An Unresolved Question	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US ADULTS	IMPORTANCE Epidemiologic studies have suggested that higher intake of added sugar is associated with cardiovascular disease (CVD) risk factors. Few prospective studies have examined the association of added sugar intake with CVD mortality. OBJECTIVE To examine time trends of added sugar consumption as percentage of daily calories in the United States and investigate the association of this consumption with CVD mortality. DESIGN, SETTING, AND PARTICIPANTS National Health and Nutrition Examination Survey (NHANES, 1988-1994 [III], 1999-2004, and 2005-2010 [n = 31 147]) for the time trend analysis and NHANES III Linked Mortality cohort (1988-2006 [n = 11 733]), a prospective cohort of a nationally representative sample of US adults for the association study. MAIN OUTCOMES AND MEASURES Cardiovascular disease mortality. RESULTS Among US adults, the adjusted mean percentage of daily calories from added sugar increased from 15.7%(95% CI, 15.0%-16.4%) in 1988-1994 to 16.8%(16.0%-17.7%; P = .02) in 1999-2004 and decreased to 14.9%(14.2%-15.5%; P < .001) in 2005-2010. Most adults consumed 10% or more of calories from added sugar (71.4%) and approximately 10% consumed 25% or more in 2005-2010. During a median follow-up period of 14.6 years, we documented 831 CVD deaths during 163 039 person-years. Age-, sex-, and race/ethnicity-adjusted hazard ratios (HRs) of CVD mortality across quintiles of the percentage of daily calories consumed from added sugar were 1.00 (reference), 1.09 (95% CI, 1.05-1.13), 1.23 (1.12-1.34), 1.49 (1.24-1.78), and 2.43 (1.63-3.62; P < .001), respectively. After additional adjustment for sociodemographic, behavioral, and clinical characteristics, HRs were 1.00 (reference), 1.07 (1.02-1.12), 1.18 (1.06-1.31), 1.38 (1.11-1.70), and 2.03 (1.26-3.27; P = .004), respectively. Adjusted HRs were 1.30 (95% CI, 1.09-1.55) and 2.75 (1.40-5.42; P = .004), respectively, comparing participants who consumed 10.0% to 24.9% or 25.0% or more calories from added sugar with those who consumed less than 10.0% of calories from added sugar. These findings were largely consistent across age group, sex, race/ethnicity (except among non-Hispanic blacks), educational attainment, physical activity, health eating index, and body mass index. CONCLUSIONS AND RELEVANCE Most US adults consume more added sugar than is recommended for a healthy diet. We observed a significant relationship between added sugar consumption and increased risk for CVD mortality.	[Dhurandhar, Nikhil V.] Texas Tech Univ, Dept Nutr Sci, 1301 Akron Ave,Ste 402, Lubbock, TX 79409 USA; [Thomas, Diana] Montclair State Univ, Dept Math Sci, Ctr Quantitat Obes Res, Montclair, NJ USA	Texas Tech University System; Texas Tech University; Montclair State University	Dhurandhar, NV (corresponding author), Texas Tech Univ, Dept Nutr Sci, 1301 Akron Ave,Ste 402, Lubbock, TX 79409 USA.	nikhil.dhurandhar@ttu.edu			Vital Health Interventions; American Egg Board; Mathile Institute for the Advancement of Human Nutrition; Novartis Nutrition; Kellogg Company; Genentech; Ortho McNeil; Roche; Vivus; International Journal of Obesity; Lancet Infectious Diseases	Vital Health Interventions; American Egg Board; Mathile Institute for the Advancement of Human Nutrition; Novartis Nutrition; Kellogg Company; Genentech(Roche HoldingGenentech); Ortho McNeil; Roche(Roche Holding); Vivus; International Journal of Obesity; Lancet Infectious Diseases	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Dhurandhar reported having received grants from Vital Health Interventions, American Egg Board, Mathile Institute for the Advancement of Human Nutrition, Novartis Nutrition, Kellogg Company, Genentech, Ortho McNeil, and Roche and fees from the American Egg Board, Vivus, International Journal of Obesity, Roche, and Lancet Infectious Diseases and having been granted or having applied for patents related to obesity and metabolic disorders. Dr Thomas reported having been a consultant for Jenny Craig from 2011 to 2013.	Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1511, DOI 10.1001/jama.2014.12498; Institute of Medicine Panel on Macronutrients Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2005, DIET REF INT EN CARB; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563	7	16	17	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					959	+		10.1001/jama.2014.18267	http://dx.doi.org/10.1001/jama.2014.18267			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734737				2022-12-28	WOS:000350231800018
J	Jain, A				Jain, Anita			OVERDIAGNOSIS Too much medicine is not just a problem of rich countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MALARIA					ajain@bmj.com						Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; Ansah EK, 2010, BMJ-BRIT MED J, V5, P340; Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; India Brand Equity Foundation, 2014, SECT REP HEALTHC IND; Jain A, 2014, BMJ; Jishnu L, 2012, TIGER TAKES BISCUIT; KPMG Confederation of Indian Industry, EXC DIAGN CAR CREAT; Leslie T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4389; Nandraj S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h675; Panagariya A, 2013, EC POLITICAL WEEKLY; Ramalingaswami V, COMMENTARY ASIAN ENI; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Travasso C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4740	13	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2015	350								h1095	10.1136/bmj.h1095	http://dx.doi.org/10.1136/bmj.h1095			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4CX	25736534				2022-12-28	WOS:000350299500002
J	Schmid, I; Burcu, M; Zito, JM				Schmid, Ian; Burcu, Mehmet; Zito, Julie M.			Medicaid Prior Authorization Policies for Pediatric Use of Antipsychotic Medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ADOLESCENTS; CHILDREN		[Schmid, Ian] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Burcu, Mehmet; Zito, Julie M.] Univ Maryland, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore	Zito, JM (corresponding author), Univ Maryland, Dept Pharmaceut Hlth Serv Res, 220 Arch St, Baltimore, MD 21201 USA.	jzito@rx.umaryland.edu						ABIM Foundation's Choosing Wisely, AM PSYCH ASS 5 THING; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; Crystal S, 2009, HEALTH AFFAIR, V28, pW770, DOI 10.1377/hlthaff.28.5.w770; Government Accountability Office, CHILDR MENT HLTH REM; Olfson M, 2012, ARCH GEN PSYCHIAT, V69, P1247, DOI 10.1001/archgenpsychiatry.2012.647; Stein BD, 2014, J CHILD ADOL PSYCHOP, V24, P374, DOI 10.1089/cap.2014.0008	6	30	30	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					966	968		10.1001/jama.2015.0763	http://dx.doi.org/10.1001/jama.2015.0763			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734740	Bronze			2022-12-28	WOS:000350231800021
J	[Anonymous]				[Anonymous]			Jumping Frenchmen of Maine (Reprinted from JAMA, vol 191, pg 755, 1965)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Beard GM, 1880, POPULAR SCI MONTHLY, V18, P170; Hammond W. A.:, 1884, BRIT MED J, V1, P758; STEVENS H, 1965, ARCH NEUROL-CHICAGO, V12, P311, DOI 10.1001/archneur.1965.00460270087011; STEVENS HAROLD, 1964, MED ANN DIST COLUMBIA, V33-304, P277; Tourette GG, 1884, ARCH NEUROL-PARIS, V8, P68; 1965, JAMA, V191, P755	6	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					974	974		10.1001/jama.2014.11618	http://dx.doi.org/10.1001/jama.2014.11618			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25734750				2022-12-28	WOS:000350231800030
J	Singh, JP; Holzmeister, J				Singh, Jagmeet P.; Holzmeister, Johannes			SIMPLEr not to test implantable cardioverter defibrillators?	LANCET			English	Editorial Material							EXPERIENCE		[Singh, Jagmeet P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiac Arrhythmia Serv, Boston, MA USA; [Holzmeister, Johannes] Univ Zurich, Univ Heart Ctr Zurich, CH-8091 Zurich, Switzerland	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Zurich	Holzmeister, J (corresponding author), Univ Zurich, Univ Heart Ctr Zurich, CH-8091 Zurich, Switzerland.	johannes.holzmeister@gmail.com						Bardy GH, 1996, J AM COLL CARDIOL, V28, P400, DOI 10.1016/0735-1097(96)00157-X; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Blendea D, 2009, HEART, V95, P1153, DOI 10.1136/hrt.2008.162677; Dopp AL, 2008, DRUGS, V68, P607, DOI 10.2165/00003495-200868050-00004; FRAME R, 1993, PACE, V16, P149, DOI 10.1111/j.1540-8159.1993.tb01552.x; Healey JS, 2015, LANCET; Keyser A, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-77; Moss AJ, 2013, NEW ENGL J MED, V368, P965, DOI 10.1056/NEJMc1300614; Olsovsky MR, 1997, AM J CARDIOL, V80, P1098, DOI 10.1016/S0002-9149(97)00615-2; Russo AM, 2013, PACE, V36, P1522, DOI 10.1111/pace.12248; Viskin S, 2008, HEART RHYTHM, V5, P391, DOI 10.1016/j.hrthm.2008.01.006	11	1	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					753	755		10.1016/S0140-6736(15)60242-2	http://dx.doi.org/10.1016/S0140-6736(15)60242-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25715990				2022-12-28	WOS:000350051700011
J	Liu, J; Liu, Y; Liu, NY; Han, YZ; Zhang, X; Huang, H; Lifshitz, Y; Lee, ST; Zhong, J; Kang, ZH				Liu, Juan; Liu, Yang; Liu, Naiyun; Han, Yuzhi; Zhang, Xing; Huang, Hui; Lifshitz, Yeshayahu; Lee, Shuit-Tong; Zhong, Jun; Kang, Zhenhui			Metal-free efficient photocatalyst for stable visible water splitting via a two-electron pathway	SCIENCE			English	Article							GRAPHITIC CARBON NITRIDE; HYDROGEN-PRODUCTION; H-2 EVOLUTION; LIGHT-DRIVEN; PHOTOSYSTEM-II; SOLAR-ENERGY; PERFORMANCE; COMPOSITES; NANOCOMPOSITE; NANOPARTICLES	The use of solar energy to produce molecular hydrogen and oxygen (H-2 and O-2) from overall water splitting is a promising means of renewable energy storage. In the past 40 years, various inorganic and organic systems have been developed as photocatalysts for water splitting driven by visible light. These photocatalysts, however, still suffer from low quantum efficiency and/or poor stability. We report the design and fabrication of a metal-free carbon nanodot-carbon nitride (C3N4) nanocomposite and demonstrate its impressive performance for photocatalytic solar water splitting. We measured quantum efficiencies of 16% for wavelength lambda = 420 +/- 20 nanometers, 6.29% for lambda = 580 +/- 15 nanometers, and 4.42% for lambda = 600 +/- 10 nanometers, and determined an overall solar energy conversion efficiency of 2.0%. The catalyst comprises low-cost, Earth-abundant, environmentally friendly materials and shows excellent stability.	[Liu, Juan; Liu, Yang; Liu, Naiyun; Han, Yuzhi; Zhang, Xing; Huang, Hui; Lifshitz, Yeshayahu; Lee, Shuit-Tong; Zhong, Jun; Kang, Zhenhui] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China; [Lifshitz, Yeshayahu] Technion Israel Inst Technol, Dept Mat Sci & Engn, IL-3200003 Haifa, Israel	Soochow University - China; Technion Israel Institute of Technology	Lifshitz, Y (corresponding author), Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China.	shayli@tx.technion.ac.il; apannale@suda.edu.cn; zhkang@suda.edu.cn	Liu, Yang/F-3123-2014; Kang, Zhenhui/CAE-9105-2022; Li, Yang/GWM-7879-2022; Zhong, Jun/D-9296-2018; Zhang, Xing/E-8192-2015; Lee, Shuit-Tong/Q-7552-2018	Zhang, Xing/0000-0002-2925-224X; 	Collaborative Innovation Center of Suzhou Nano Science and Technology; National Basic Research Program of China (973 Program) [2012CB825803, 2013CB932702]; National Natural Science Foundation of China [51422207, 51132006, 21471106]; Specialized Research Fund for the Doctoral Program of Higher Education [20123201110018]; Suzhou Planning Project of Science and Technology [ZXG2012028]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Collaborative Innovation Center of Suzhou Nano Science and Technology; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Suzhou Planning Project of Science and Technology; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	We thank A. Rothschild for helpful discussions. We thank Beijing and Shanghai synchrotron radiation facility for XANES and EXAFS data collection. Supported by Collaborative Innovation Center of Suzhou Nano Science and Technology, the National Basic Research Program of China (973 Program) (2012CB825803, 2013CB932702), the National Natural Science Foundation of China (51422207, 51132006, 21471106), the Specialized Research Fund for the Doctoral Program of Higher Education (20123201110018), a Suzhou Planning Project of Science and Technology (ZXG2012028), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Ananyev G, 2005, PHOTOSYNTH RES, V84, P355, DOI 10.1007/s11120-004-7081-1; Baker RW, 2002, IND ENG CHEM RES, V41, P1393, DOI 10.1021/ie0108088; Balzani V, 2008, CHEMSUSCHEM, V1, P26, DOI 10.1002/cssc.200700087; Chai B, 2012, PHYS CHEM CHEM PHYS, V14, P16745, DOI 10.1039/c2cp42484c; Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645; DOMEN K, 1980, J CHEM SOC CHEM COMM, P543, DOI 10.1039/c39800000543; Gray HB, 2009, NAT CHEM, V1, P7, DOI 10.1038/nchem.141; He F, 2014, ACS APPL MATER INTER, V6, P7171, DOI 10.1021/am500198y; Hong JD, 2013, CHEMSUSCHEM, V6, P2263, DOI 10.1002/cssc.201300647; Iwase A, 2011, J AM CHEM SOC, V133, P11054, DOI 10.1021/ja203296z; Jacobsson TJ, 2013, ENERG ENVIRON SCI, V6, P3676, DOI 10.1039/c3ee42519c; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Li HT, 2012, J MATER CHEM, V22, P24230, DOI 10.1039/c2jm34690g; Liao LB, 2014, NAT NANOTECHNOL, V9, P69, DOI [10.1038/nnano.2013.272, 10.1038/NNANO.2013.272]; Licht S, 2001, J PHYS CHEM B, V105, P6281, DOI 10.1021/jp010552j; Liebig J., 1834, ANN PHARM, V10, P1, DOI [10.1002/jlac.18340100102, DOI 10.1002/JLAC.18340100102, DOI 10.1002/ADMA.201502057]; Liu JH, 2012, CHEM COMMUN, V48, P8826, DOI 10.1039/c2cc33644h; Luo JS, 2014, SCIENCE, V345, P1593, DOI 10.1126/science.1258307; Maeda K, 2006, NATURE, V440, P295, DOI 10.1038/440295a; Maeda K, 2006, J PHYS CHEM B, V110, P13753, DOI 10.1021/jp061829o; Maeda K, 2013, ACS CATAL, V3, P1486, DOI 10.1021/cs4002089; Maeda K, 2010, J PHYS CHEM LETT, V1, P2655, DOI 10.1021/jz1007966; Marschall R, 2014, ADV FUNCT MATER, V24, P2421, DOI 10.1002/adfm.201303214; Martin DJ, 2014, J AM CHEM SOC, V136, P12568, DOI 10.1021/ja506386e; Ming H, 2012, DALTON T, V41, P9526, DOI 10.1039/c2dt30985h; Mubeen S, 2013, NAT NANOTECHNOL, V8, P247, DOI 10.1038/nnano.2013.18; Pinaud BA, 2013, ENERG ENVIRON SCI, V6, P1983, DOI 10.1039/c3ee40831k; Prevot MS, 2013, J PHYS CHEM C, V117, P17879, DOI 10.1021/jp405291g; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Schwinghammer K, 2014, J AM CHEM SOC, V136, P1730, DOI 10.1021/ja411321s; Suryawanshi A, 2012, INT J HYDROGEN ENERG, V37, P9584, DOI 10.1016/j.ijhydene.2012.03.123; Tsuji I, 2005, ANGEW CHEM INT EDIT, V44, P3565, DOI 10.1002/anie.200500314; Wang XC, 2009, J AM CHEM SOC, V131, P1680, DOI 10.1021/ja809307s; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Xiang QJ, 2011, J PHYS CHEM C, V115, P7355, DOI 10.1021/jp200953k; Yang M, 2012, MATER SCI ENG B-ADV, V177, P600, DOI 10.1016/j.mseb.2012.03.004; Yang SB, 2013, ADV MATER, V25, P2452, DOI 10.1002/adma.201204453; Yin S, 2006, J EUR CERAM SOC, V26, P2735, DOI 10.1016/j.jeurceramsoc.2005.05.012; Youngblood WJ, 2009, ACCOUNTS CHEM RES, V42, P1966, DOI 10.1021/ar9002398; Yu LJ, 2014, PHYS CHEM CHEM PHYS, V16, P4106, DOI 10.1039/c3cp54316a; Zhang XH, 2014, ACS CATAL, V4, P162, DOI 10.1021/cs400863c	41	3340	3396	246	6037	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					970	974		10.1126/science.aaa3145	http://dx.doi.org/10.1126/science.aaa3145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722405				2022-12-28	WOS:000349958900032
J	Schindler, DE; Hilborn, R				Schindler, Daniel E.; Hilborn, Ray			Prediction, precaution, and policy under global change	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; MANAGEMENT; CONSERVATION; FISHERIES; COMANAGEMENT; UNCERTAINTY; COMPLEXITY; SCALE; WORLD; TOOL		[Schindler, Daniel E.; Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schindler, DE (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	deschind@uw.edu			U.S. National Science Foundation-Dynamics of Coupled Natural and Human Systems Program; Harriet Bullitt Professorship	U.S. National Science Foundation-Dynamics of Coupled Natural and Human Systems Program; Harriet Bullitt Professorship	We thank the U.S. National Science Foundation-Dynamics of Coupled Natural and Human Systems Program, and the Harriet Bullitt Professorship for funding.	Ando AW, 2012, P NATL ACAD SCI USA, V109, P6484, DOI 10.1073/pnas.1114653109; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Hilborn R, 2004, B MAR SCI, V74, P493; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Lawler JJ, 2010, FRONT ECOL ENVIRON, V8, P35, DOI 10.1890/070146; Lempert RJ, 2000, CLIMATIC CHANGE, V45, P387, DOI 10.1023/A:1005698407365; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lorenz C, 2012, J HYDROMETEOROL, V13, P1397, DOI 10.1175/JHM-D-11-088.1; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Makino M, 2005, MAR POLICY, V29, P441, DOI 10.1016/j.marpol.2004.07.005; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641; Perretti CT, 2013, P NATL ACAD SCI USA, V110, P5253, DOI 10.1073/pnas.1216076110; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SCHOEMAKER PJH, 1995, SLOAN MANAGE REV, V36, P25; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Walters C., 1986, ADAPTIVE MANAGEMENT; Ward EJ, 2014, OIKOS, V123, P652, DOI 10.1111/j.1600-0706.2014.00916.x	24	187	194	8	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					953	954		10.1126/science.1261824	http://dx.doi.org/10.1126/science.1261824			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB9NQ	25722401				2022-12-28	WOS:000349958900022
J	Smith, O; Momber, G; Bates, R; Garwood, P; Fitch, S; Pallen, M; Gaffney, V; Allaby, RG				Smith, Oliver; Momber, Garry; Bates, Richard; Garwood, Paul; Fitch, Simon; Pallen, Mark; Gaffney, Vincent; Allaby, Robin G.			Sedimentary DNA from a submerged site reveals wheat in the British Isles 8000 years ago	SCIENCE			English	Article							ANCIENT DNA	The Mesolithic-to-Neolithic transition marked the time when a hunter-gatherer economy gave way to agriculture, coinciding with rising sea levels. Bouldnor Cliff, is a submarine archaeological site off the Isle of Wight in the United Kingdom that has a well-preserved Mesolithic paleosol dated to 8000 years before the present. We analyzed a core obtained from sealed sediments, combining evidence from microgeomorphology and microfossils with sedimentary ancient DNA (sedaDNA) analyses to reconstruct floral and faunal changes during the occupation of this site, before it was submerged. In agreement with palynological analyses, the sedaDNA sequences suggest a mixed habitat of oak forest and herbaceous plants. However, they also provide evidence of wheat 2000 years earlier than mainland Britain and 400 years earlier than proximate European sites. These results suggest that sophisticated social networks linked the Neolithic front in southern Europe to the Mesolithic peoples of northern Europe.	[Smith, Oliver; Allaby, Robin G.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Momber, Garry] Natl Oceanog Ctr, Maritime Archaeol Trust, Southampton SO14 3ZH, Hants, England; [Bates, Richard] Univ St Andrews, Dept Earth Sci, St Andrews KY16 9AL, Fife, Scotland; [Garwood, Paul] Univ Birmingham, Dept Class Ancient Hist & Archaeol, Birmingham B15 2TT, W Midlands, England; [Fitch, Simon] Univ Birmingham, Sch Hist & Cultures, Birmingham B15 2TT, W Midlands, England; [Pallen, Mark] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Gaffney, Vincent] Univ Bradford, Div Archaeol Geog & Environm Sci, Bradford BD7 1DP, W Yorkshire, England	University of Warwick; NERC National Oceanography Centre; University of St Andrews; University of Birmingham; University of Birmingham; University of Warwick; University of Bradford	Allaby, RG (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.g.allaby@warwick.ac.uk		Smith, Oliver/0000-0002-0146-9244; Gaffney, Vincent/0000-0001-7918-0494; Bates, Charles Richard/0000-0001-9147-7151; Pallen, Mark/0000-0003-1807-3657; Fitch, Simon/0000-0002-0133-2678	SplashCOS network; Deucalion network; Warwick Medical School	SplashCOS network; Deucalion network; Warwick Medical School	The authors thank A. Clapham for identification of Alnus glutinosa fragments, J. Z. M. Chan and G. L. Kay for assistance with operating the MiSeq platform, and the SplashCOS and Deucalion networks for continued support. O.S. was funded by Warwick Medical School. Sequence data were deposited at the European Molecular Biology Laboratory European Bioinformatics Institute, accession number PRJEB6766 (ERP006391). We acknowledge previous supporting work by J. Gillespie (Foram analysis), D. Tomalin (lithic analysis), J. Heathcote (micromorphology and depositional evidence), and in particular R. Scaife for his pollen analysis The cores are stored in the British Ocean Sediment Core Research Facility at the National Oceanography Centre, Southampton, UK. Access to the Bouldnor Cliff cores for further analysis is provided by the Maritime Archeology Trust.	Bell T., 2006, ARCHAEOLOGY IRELAND, V20, P12; Benjamin J., 2011, SUBMERGED PREHISTORY, P85; Coles B.J., 1998, P PREHIST SOC, V64, P45, DOI [10.1017/S0079497X00002176, DOI 10.1017/S0079497X00002176]; Collard M, 2010, J ARCHAEOL SCI, V37, P866, DOI 10.1016/j.jas.2009.11.016; Crombe P., 2007, P BRIT ACAD, V144, P263, DOI [10.5871/bacad/9780197264140.003.0014, DOI 10.5871/BACAD/9780197264140.003.0014]; Gaffney V., 2009, 160 CBA, P30; Gaffney V., 2007, MAPPING DOGGERLAND, P1; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Guilaine J., 2007, PONT ROQUE HAUTE NOU, P21; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jeunesse C., 2003, REV ALSACE, V129, P97; Joly C, 2009, REV PALAEOBOT PALYNO, V154, P124, DOI 10.1016/j.revpalbo.2008.12.011; KOOIJMANS LPL, 2007, P BR ACAD, V144, P287; Lejzerowicz F, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0283; Marchand G, 2007, P BRIT ACAD, V144, P225; Momber G., 2011, MESOLITHIC OCCUPATIO, P105; Momber G., 2014, PREHISTORIC ARCHAEOL, P194; Momber G., 2011, MESOLITHIC OCCUPATIO, P19; Peeters J. H. M., 2014, J GEOSCI-CZECH, V93, P55; Robb J, 2013, CURR ANTHROPOL, V54, P657, DOI 10.1086/673859; Rowley-Conwy P, 2011, CURR ANTHROPOL, V52, pS431, DOI 10.1086/658368; Stevens CJ, 2012, ANTIQUITY, V86, P707, DOI 10.1017/S0003598X00047864; Tappin D. R., 2011, OR1054 BRIT GEOL SUR, P194; Thomas J., 2008, PREHISTORIC BRITAIN, ppp. 58; Tomalin D., 2011, MESOLITHIC OCCUPATIO, P3; Tomalin D., 2011, MESOLITHIC OCCUPATIO, P155; Tresset A., 2007, GOING MESOLITHIC NEO, P189, DOI DOI 10.5871/BACAD/9780197264140.003.0010; Whittle A., 2011, GATHERING TIME DATIN, p[348, 207]; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758	30	56	59	5	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					998	1001		10.1126/science.1261278	http://dx.doi.org/10.1126/science.1261278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25722413	Green Submitted, Green Accepted			2022-12-28	WOS:000349958900040
J	[Anonymous]				[Anonymous]			Your Microbes at Work: Fiber Fermenters Keep Us Healthy	NATURE			English	Editorial Material																			0	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					S9	S9		10.1038/518S9a	http://dx.doi.org/10.1038/518S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0SH	25715281	Bronze			2022-12-28	WOS:000427188300001
J	Varughese, RS; Ridgeon, E; Mathew, A; Sola-Del Valle, D				Varughese, Rachel S.; Ridgeon, Elliott; Mathew, Anna; Sola-Del Valle, David			A rapidly enlarging swelling of the left orbit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RHABDOMYOSARCOMA; CHILDHOOD; SURVIVAL; ONCOLOGY		[Varughese, Rachel S.; Ridgeon, Elliott] Univ Oxford, Sch Med, Oxford OX1 2JD, England; [Mathew, Anna] Worthing Dist Hosp, Dept Paediat, Worthing, W Sussex, England; [Sola-Del Valle, David] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA	University of Oxford; Harvard University; Massachusetts Eye & Ear Infirmary	Varughese, RS (corresponding author), Univ Oxford, Sch Med, S Parks Rd, Oxford OX1 2JD, England.	rachel.varughese@btinternet.com		Sola-Del Valle, David A./0000-0001-5636-6720				Boutroux H, 2015, CLIN EXP OPHTHALMOL, V43, P12, DOI 10.1111/ceo.12370; Conneely MF, 2005, NEUROIMAG CLIN N AM, V15, P121, DOI 10.1016/j.nic.2005.02.006; Eftekhari K, 2014, OPHTHAL PLAST RECONS; Jurdy L, 2013, SAUDI J OPHTHALMOL, V27, P167, DOI 10.1016/j.sjopt.2013.06.004; Karcioglu Zeynel A, 2004, Cancer Control, V11, P328; LeBedis CA, 2008, RADIOGRAPHICS, V28, P1741, DOI 10.1148/rg.286085515; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; McDowell HP, 2003, ARCH DIS CHILD, V88, P354, DOI 10.1136/adc.88.4.354; Oberlin O, 2001, J CLIN ONCOL, V19, P197, DOI 10.1200/JCO.2001.19.1.197; Passmore LM, 2006, FETAL PEDIATR PATHOL, V25, P51, DOI 10.1080/15227950600701602; Shields JA, 2003, SURV OPHTHALMOL, V48, P39, DOI 10.1016/S0039-6257(02)00415-0; Sohaib SA, 1998, CLIN RADIOL, V53, P357, DOI 10.1016/S0009-9260(98)80009-3; Stevens MCG, 2005, J CLIN ONCOL, V23, P2618, DOI 10.1200/JCO.2005.08.130; Terezakis SA, 2013, CLIN ONCOL-UK, V25, P27, DOI 10.1016/j.clon.2012.07.009; Turner JH, 2011, OTOLARYNG HEAD NECK, V145, P967, DOI 10.1177/0194599811417063; Zhu JQ, 2014, ONCOL LETT, V8, P155, DOI 10.3892/ol.2014.2094	16	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2015	350								h799	10.1136/bmj.h799	http://dx.doi.org/10.1136/bmj.h799			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4AM	25716818				2022-12-28	WOS:000350292900010
J	Olsen, AMS; Gislason, GH; McGettigan, P; Fosbol, E; Sorensen, R; Hansen, ML; Kober, L; Torp-Pedersen, C; Lamberts, M				Olsen, Anne-Marie Schjerning; Gislason, Gunnar H.; McGettigan, Patricia; Fosbol, Emil; Sorensen, Rikke; Hansen, Morten Lock; Kober, Lars; Torp-Pedersen, Christian; Lamberts, Morten			Association of NSAID Use With Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy After Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ATRIAL-FIBRILLATION; CORONARY INTERVENTION; MORTALITY; NATIONWIDE; METAANALYSIS; DENMARK; TERM; CLOPIDOGREL; INHIBITORS	IMPORTANCE Antithrombotic treatment is indicated for use in patients after myocardial infarction (MI); however, concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) could pose safety concerns. OBJECTIVE To examine the risk of bleeding and cardiovascular events among patients with prior MI taking antithrombotic drugs and for whom NSAID therapy was then prescribed. DESIGN, SETTING, AND PARTICIPANTS Using nationwide administrative registries in Denmark (2002-2011), we studied patients 30 years or older admitted with first-time MI and alive 30 days after discharge. Subsequent treatment with aspirin, clopidogrel, or oral anticoagulants and their combinations, as well as ongoing concomitant NSAID use, was determined. EXPOSURES Use of NSAIDs with ongoing antithrombotic treatment after first-time MI. MAIN OUTCOMES AND MEASURES Risk of bleeding (requiring hospitalization) or a composite cardiovascular outcome (cardiovascular death, nonfatal recurrent MI, and stroke) according to ongoing NSAID and antithrombotic therapy, calculated using adjusted time-dependent Cox regression models. RESULTS We included 61 971 patients (mean age, 67.7 [SD, 13.6] years; 63% men); of these, 34% filled at least 1 NSAID prescription. The number of deaths during a median follow-up of 3.5 years was 18 105 (29.2%). A total of 5288 bleeding events (8.5%) and 18 568 cardiovascular events (30.0%) occurred. The crude incidence rates of bleeding (events per 100 person-years) were 4.2 (95% CI, 3.8-4.6) with concomitant NSAID treatment and 2.2 (95% CI, 2.1-2.3) without NSAID treatment, whereas the rates of cardiovascular events were 11.2 (95% CI, 10.5-11.9) and 8.3 (95% CI, 8.2-8.4). The multivariate-adjusted Cox regression analysis found increased risk of bleeding with NSAID treatment compared with no NSAID treatment (hazard ratio, 2.02 [95% CI, 1.81-2.26]), and the cardiovascular risk was also increased (hazard ratio, 1.40 [95% CI, 1.30-1.49]). An increased risk of bleeding and cardiovascular events was evident with concomitant use of NSAIDs, regardless of antithrombotic treatment, types of NSAIDs, or duration of use. CONCLUSIONS AND RELEVANCE Among patients receiving antithrombotic therapy after MI, the use of NSAIDs was associated with increased risk of bleeding and excess thrombotic events, even after short-term treatment. More research is needed to confirm these findings; however, physicians should exercise appropriate caution when prescribing NSAIDs for patients who have recently experienced MI.	[Olsen, Anne-Marie Schjerning; Gislason, Gunnar H.; Sorensen, Rikke; Hansen, Morten Lock; Lamberts, Morten] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [McGettigan, Patricia] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England; [Fosbol, Emil; Kober, Lars] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Ctr Heart, Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; University of London; Queen Mary University London; Rigshospitalet; University of Copenhagen; Aalborg University	Olsen, AMS (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Post 635,Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	aols0073@geh.regionh.dk	Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Sorensen, Rikke/0000-0001-9238-6681; Fosbol, Emil/0000-0002-2048-4167; Lamberts, Morten/0000-0002-9827-440X; Kober, Lars/0000-0002-6635-1466	Danish Council for Independent Research; William Harvey Research Institute (WHRI) at Barts and the London School of Medicine and Dentistry, United Kingdom; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); William Harvey Research Institute (WHRI) at Barts and the London School of Medicine and Dentistry, United Kingdom; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded by the Danish Council for Independent Research. The authors appreciate the support from the William Harvey Research Institute (WHRI) at Barts and the London School of Medicine and Dentistry, United Kingdom.	Andersen TF, 1999, DAN MED BULL, V46, P263; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Brophy JM, 2007, HEART, V93, P189, DOI 10.1136/hrt.2006.089367; Castellsague J, 2012, DRUG SAFETY, V35, P1127, DOI 10.2165/11633470-000000000-00000; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; European Medicines Agency, 2013, PRAC REC SAM CARD PR; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Gaist D, 1997, DAN MED BULL, V44, P445; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Krishnan E, 2004, CIRCULATION, V110, P1774, DOI 10.1161/01.CIR.0000142864.83780.81; Kushner, 2010, CIRCULATION, V121, pE257, DOI 10.1161/CIR.0b013e3181d7a65e; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Levesque LE, 2006, CAN MED ASSOC J, V174, P1563, DOI 10.1503/cmaj.051679; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Olsen AMS, 2012, CIRCULATION, V126, P1955, DOI 10.1161/CIRCULATIONAHA.112.112607; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Rasmussen S, 2005, MED CARE, V43, P970, DOI 10.1097/01.mlr.0000178195.07110.d3; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Schmidt M, 2014, CLIN EPIDEMIOL, V6, P155, DOI 10.2147/CLEP.S59156; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Sorensen R, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-6; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3	36	88	95	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					805	814		10.1001/jama.2015.0809	http://dx.doi.org/10.1001/jama.2015.0809			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25710657	Bronze			2022-12-28	WOS:000349826400014
J	Aszmann, OC; Roche, AD; Salminger, S; Paternostro-Sluga, T; Herceg, M; Sturma, A; Hofer, C; Farina, D				Aszmann, Oskar C.; Roche, Aidan D.; Salminger, Stefan; Paternostro-Sluga, Tatjana; Herceg, Malvina; Sturma, Agnes; Hofer, Christian; Farina, Dario			Bionic reconstruction to restore hand function after brachial plexus injury: a case series of three patients	LANCET			English	Article							CONTRALATERAL C7 TRANSFER; PHANTOM LIMB PAIN; MUSCLE TRANSFER; ELBOW FUNCTION; SHOULDER; ARM; REINNERVATION; REHABILITATION; METAANALYSIS; PROSTHESES	Background Brachial plexus injuries can permanently impair hand function, yet present surgical reconstruction provides only poor results. Here, we present for the first time bionic reconstruction; a combined technique of selective nerve and muscle transfers, elective amputation, and prosthetic rehabilitation to regain hand function. Methods Between April 2011, and May 2014, three patients with global brachial plexus injury including lower root avulsions underwent bionic reconstruction. Treatment occurred in two stages; first, to identify and create useful electromyographic signals for prosthetic control, and second, to amputate the hand and replace it with a mechatronic prosthesis. Before amputation, the patients had a specifically tailored rehabilitation programme to enhance electromyographic signals and cognitive control of the prosthesis. Final prosthetic fitting was applied as early as 6 weeks after amputation. Findings Bionic reconstruction successfully enabled prosthetic hand use in all three patients. After 3 months, mean Action Research Arm Test score increased from 5.3 (SD 4.73) to 30.7 (14.0). Mean Southampton Hand Assessment Procedure score improved from 9.3 (SD 1.5) to 65.3 (SD 19.4). Mean Disabilities of Arm, Shoulder and Hand score improved from 46.5 (SD 18.7) to 11.7 (SD 8.42). Interpretation For patients with global brachial plexus injury with lower root avulsions, who have no alternative treatment, bionic reconstruction offers a means to restore hand function.	[Aszmann, Oskar C.; Roche, Aidan D.; Salminger, Stefan; Sturma, Agnes; Hofer, Christian] Med Univ Vienna, Christian Doppler Lab Restorat Extrem Funct, Div Plast & Reconstruct Surg, Dept Surg, A-1090 Vienna, Austria; [Paternostro-Sluga, Tatjana; Herceg, Malvina] Med Univ Vienna, Dept Phys Med & Rehabil, A-1090 Vienna, Austria; [Hofer, Christian] Otto Bock Healthcare Prod GmbH, Clin Res, Res & Dev, Vienna, Austria; [Farina, Dario] Univ Gottingen, Univ Med Ctr Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, D-37073 Gottingen, Germany	Medical University of Vienna; Medical University of Vienna; University of Gottingen	Aszmann, OC (corresponding author), Med Univ Vienna, Christian Doppler Lab Restorat Extrem Funct, Div Plast & Reconstruct Surg, Dept Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	oskar.aszmann@meduniwien.ac.at	Sturma, Agnes/AAO-1489-2021; Roche, Aidan/AAC-5695-2019; Farina, Dario/AAB-2648-2019	Sturma, Agnes/0000-0003-2066-1394; Salminger, Stefan/0000-0002-1992-7354	Austrian Council for Research and Technology Development; Austrian Federal Ministry of Science, Research Economy; European Research Council Advanced Grant DEMOVE [267888]; Christian Doppler Research Foundation of the Austrian Council for Research and Technology Development	Austrian Council for Research and Technology Development; Austrian Federal Ministry of Science, Research Economy; European Research Council Advanced Grant DEMOVE; Christian Doppler Research Foundation of the Austrian Council for Research and Technology Development	Austrian Council for Research and Technology Development, Austrian Federal Ministry of Science, Research & Economy, and European Research Council Advanced Grant DEMOVE.; This study was funded by the Christian Doppler Research Foundation of the Austrian Council for Research and Technology Development, Austrian Federal Ministry of Science, Research & Economy, and European Research Council Advanced Grant DEMOVE (contract #267888). We acknowledge the time and effort provided by the patients in this study. We thank Dr Bernhard Gesslbauer for his assistance with the analyses of histochemistry samples and Laura Hruby for analysis of the SF-36 data.	Aszmann OC, 2008, HANDCHIR MIKROCHIR P, V40, P60, DOI 10.1055/s-2007-989415; Barrie Kimberly A, 2004, Neurosurg Focus, V16, pE8; Bertelli JA, 2006, J HAND SURG-AM, V31A, P190, DOI 10.1016/j.jhsa.2005.09.020; Bertelli JA, 2011, J BRACHIAL PLEX PERI, V6, DOI 10.1186/1749-7221-6-2; Brenner P, 2001, J TRAUMA, V50, P562, DOI 10.1097/00005373-200103000-00027; BUCHTHAL F, 1980, PHYSIOL REV, V60, P90, DOI 10.1152/physrev.1980.60.1.90; Bueno RA, 2011, J HAND SURG-AM, V36A, P890, DOI 10.1016/j.jhsa.2011.02.020; DOI K, 1991, J HAND SURG-AM, V16A, P796, DOI 10.1016/S0363-5023(10)80138-8; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; GRUBER H, 1976, BRIT J PLAST SURG, V29, P70, DOI 10.1016/0007-1226(76)90096-5; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Korak KJ, 2004, BRAIN, V127, P1488, DOI 10.1093/brain/awh155; KUIKEN TA, 1995, BRAIN RES, V676, P113, DOI 10.1016/0006-8993(95)00102-V; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MALONE JM, 1982, ARCH PHYS MED REHAB, V63, P89; Merrell GA, 2001, J HAND SURG-AM, V26A, P303, DOI 10.1053/jhsu.2001.21518; Midha Rajiv, 2004, Neurosurg Focus, V16, pE5; Muthny F. A., 1996, REHABILITATION, V35, P9; Roche AD, 2014, CURR SURG REP, V2, DOI 10.1007/s40137-013-0044-8; Ruchelsman DE, 2009, BULL HOSP JT DIS, V67, P83; Sammer DM, 2012, J BONE JOINT SURG AM, V94A, P131, DOI [10.2106/JBJS.J.01075, 10.2106/JBJSJ.01075]; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Terzis JK, 1999, PLAST RECONSTR SURG, V104, P1221, DOI 10.1097/00006534-199910000-00001; Terzis JK, 2009, PLAST RECONSTR SURG, V124, P1225, DOI 10.1097/PRS.0b013e3181b5a322; Terzis JK, 2009, PLAST RECONSTR SURG, V123, P927, DOI 10.1097/PRS.0b013e31819ba48a; Wang H, 2011, YOUMANS NEUROLOGICAL; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X	30	78	78	5	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2183	2189		10.1016/S0140-6736(14)61776-1	http://dx.doi.org/10.1016/S0140-6736(14)61776-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25724529				2022-12-28	WOS:000355583000028
J	Heim, B; Ronnow, TF; Isakov, SV; Troyer, M				Heim, Bettina; Ronnow, Troels F.; Isakov, Sergei V.; Troyer, Matthias			Quantum versus classical annealing of Ising spin glasses	SCIENCE			English	Article							OPTIMIZATION; ALGORITHM; MODEL	Quantum annealers use quantum fluctuations to escape local minima and find low-energy configurations of a physical system. Strong evidence for superiority of quantum annealing (QA) has come from comparing QA implemented through quantum Monte Carlo (QMC) simulations to classical annealing. Motivated by recent experiments, we revisit the question of when quantum speedup may be expected. Although a better scaling is seen for QA in two-dimensional Ising spin glasses, this advantage is due to time discretization artifacts and measurements that are not possible on a physical quantum annealer. Simulations in the physically relevant continuous time limit, on the other hand, do not show superiority. Our results imply that care must be taken when using QMC simulations to assess the potential for quantum speedup.	[Heim, Bettina; Ronnow, Troels F.; Troyer, Matthias] ETH, Theoret Phys, CH-8093 Zurich, Switzerland; [Isakov, Sergei V.] Google, CH-8002 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Google Incorporated	Troyer, M (corresponding author), ETH, Theoret Phys, CH-8093 Zurich, Switzerland.	troyer@phys.ethz.ch	Troyer, Matthias/B-7826-2008	Troyer, Matthias/0000-0002-1469-9444	Swiss National Science Foundation through the National Competence Center in Research QSIT; European Research Council (ERC) through ERC Advanced Grant SIMCOFE; NSF [1066293]	Swiss National Science Foundation through the National Competence Center in Research QSIT; European Research Council (ERC) through ERC Advanced Grant SIMCOFE; NSF(National Science Foundation (NSF))	We thank H. G. Katzgraber, G. Santoro, and I. Zintchenko for useful discussions and G. Santoro for providing the spin glass instance used in (19). This work was supported by the Swiss National Science Foundation through the National Competence Center in Research QSIT and by the European Research Council (ERC) through ERC Advanced Grant SIMCOFE. M.T. acknowledges the hospitality of the Aspen Center for Physics, supported by NSF grant 1066293. The spin glass server (25) was used to obtain the ground states for our problem instances. The original data used to create the figures can be obtained from the corresponding author.	BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; BERTSIMAS D, 1993, STAT SCI, V8, P10, DOI 10.1214/ss/1177011077; Boixo S, 2014, NAT PHYS, V10, P218, DOI [10.1038/nphys2900, 10.1038/NPHYS2900]; Brooke J, 1999, SCIENCE, V284, P779, DOI 10.1126/science.284.5415.779; Cook SA, 1971, P 3 ANN ACM S THEOR, P151, DOI DOI 10.1145/800157.805047; Das A, 2008, REV MOD PHYS, V80, P1061, DOI 10.1103/RevModPhys.80.1061; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; FINNILA AB, 1994, CHEM PHYS LETT, V219, P343, DOI 10.1016/0009-2614(94)00117-0; GRAHAM RL, 1966, AT&T TECH J, V45, P1563, DOI 10.1002/j.1538-7305.1966.tb01709.x; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; Katzgraber HG, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021008; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Knuth D. E, 2009, ART COMPUTER PROGRAM, V4; Landau L., 1932, PHYZ SOWJETUNION, V2, P46, DOI DOI 10.1098/RSPA.1932.0165; Martonak R, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.094203; Matsuda Y, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/073021; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Radivojevic M, 2013, ANTIQUITY, V87, P1030, DOI 10.1017/S0003598X0004984X; RAY P, 1989, PHYS REV B, V39, P11828, DOI 10.1103/PhysRevB.39.11828; Rieger H, 1999, EUR PHYS J B, V9, P233, DOI 10.1007/s100510050761; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Santoro GE, 2002, SCIENCE, V295, P2427, DOI 10.1126/science.1068774; SUZUKI M, 1976, PROG THEOR PHYS, V56, P1454, DOI 10.1143/PTP.56.1454; Wong LP, 2010, INT J ARTIF INTELL T, V19, P305, DOI 10.1142/S0218213010000200; Zener C, 1932, P R SOC LOND A-CONTA, V137, P696, DOI 10.1098/rspa.1932.0165	26	122	123	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					215	217		10.1126/science.aaa4170	http://dx.doi.org/10.1126/science.aaa4170			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25765071	Green Submitted			2022-12-28	WOS:000352613700040
J	Conway, R; Low, C; Coughlan, RJ; O'Donnell, MJ; Carey, JJ				Conway, Richard; Low, Candice; Coughlan, Robert J.; O'Donnell, Martin J.; Carey, John J.			Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; MORTALITY; PLACEBO; RECOMMENDATIONS; PNEUMONITIS; MANAGEMENT; INFECTION	OBJECTIVE To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate. DATA SOURCES PubMed, Cochrane central register of controlled trials, and Embase to 9 January 2014. Study selection Double blind randomised controlled trials of methotrexate versus placebo or active comparator agents in adults with psoriatic arthritis, psoriasis, or inflammatory bowel disease. Studies with fewer than 50 participants or of less than 12 weeks' duration were excluded. DATA SYNTHESIS Two investigators independently searched both databases. All authors reviewed selected studies. We compared relative risk differences using the Mantel-Haenszel random effects method to assess total respiratory adverse events, infectious respiratory adverse events, non-infectious respiratory adverse events, interstitial lung disease, and death. RESULTS Seven studies met our inclusion criteria, six with placebo as the comparator. Heterogeneity across the studies was not significant (I-2=0%), allowing combination of trial results. 504 respiratory adverse events were documented in 1630 participants. Methotrexate was not associated with an increased risk of adverse respiratory events (relative risk 1.03, 95% confidence interval 0.90 to 1.17), respiratory infections (1.02, 0.88 to 1.19), or non-infectious respiratory events (1.07, 0.58 to 1.96). No pulmonary deaths occurred. CONCLUSIONS Findings suggested that there was no increased risk of lung disease in methotrexate treated patients with non-malignant inflammatory diseases. Given the limitations of the study, however, we cannot exclude a small but clinically important risk.	[Conway, Richard; Coughlan, Robert J.; Carey, John J.] Galway Univ Hosp, Dept Rheumatol, Galway, Ireland; [Conway, Richard; O'Donnell, Martin J.; Carey, John J.] Natl Univ Ireland Galway, Galway, Ireland; [Low, Candice] Connolly Hosp, Dept Rheumatol, Dublin, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Conway, R (corresponding author), Galway Univ Hosp, Dept Rheumatol, Merlin Pk, Galway, Ireland.	drrichardconway@gmail.com	Conway, Richard/F-2328-2013; O'Donnell, Martin/ABE-7459-2020; Carey, John/AAF-5461-2019	Conway, Richard/0000-0003-2538-3362; O'Donnell, Martin/0000-0002-7347-7761; Carey, John/0000-0001-7292-2328				Ameen M, 2001, J EUR ACAD DERMATOL, V15, P247, DOI 10.1046/j.1468-3083.2001.t01-1-00223.x; Ananthakrishnan AN, 2013, J CROHNS COLITIS, V7, P107, DOI 10.1016/j.crohns.2012.02.015; [Anonymous], 2011, REV MAN REVMAN VERS; BALESTRA DJ, 1988, JAMA-J AM MED ASSOC, V260, P62, DOI 10.1001/jama.260.1.62; BARRERA P, 1994, ANN RHEUM DIS, V53, P434, DOI 10.1136/ard.53.7.434; Bongartz T, 2010, ARTHRITIS RHEUM-US, V62, P1583, DOI 10.1002/art.27405; Chikura B, 2008, RHEUMATOLOGY, V47, P1647, DOI 10.1093/rheumatology/ken356; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Conway R, 2014, ARTHRITIS RHEUMATOL, V66, P2642, DOI [10.1002/art.38732, 10.1002/art.38322]; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; Feagan BG, 2014, GASTROENTEROLOGY, V146, P681, DOI 10.1053/j.gastro.2013.11.024; Food and Drug Administration, 2014, METH PRESCR INF; Gabbay E, 1997, AM J RESP CRIT CARE, V156, P528, DOI 10.1164/ajrccm.156.2.9609016; Gossec L, 2012, ANN RHEUM DIS, V71, P4, DOI 10.1136/annrheumdis-2011-200350; Gottlieb AB, 2012, BRIT J DERMATOL, V167, P649, DOI 10.1111/j.1365-2133.2012.11015.x; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Hotermans G, 1996, EUR RESPIR J, V9, P380, DOI 10.1183/09031936.96.09020380; Kingsley GH, 2012, RHEUMATOLOGY, V51, P1368, DOI 10.1093/rheumatology/kes001; Kluger N, 2011, J AM ACAD DERMATOL, V64, P1154, DOI 10.1016/j.jaad.2009.11.022; Kremer JM, 1997, ARTHRITIS RHEUM, V40, P1829, DOI 10.1002/art.1780401016; Lee MA, 2010, RHEUMATOLOGY, V49, P1206, DOI 10.1093/rheumatology/keq002; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Margagnoni G, 2010, J CROHNS COLITIS, V4, P211, DOI 10.1016/j.crohns.2009.11.007; McKee M, 1999, BMJ-BRIT MED J, V319, P312, DOI 10.1136/bmj.319.7205.312; Menter A, 2009, J AM ACAD DERMATOL, V61, P451, DOI 10.1016/j.jaad.2009.03.027; Reich K, 2011, NEW ENGL J MED, V365, P1586, DOI 10.1056/NEJMoa1010858; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Salaffi F, 1997, CLIN RHEUMATOL, V16, P296, DOI 10.1007/BF02238967; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Wakkee M, 2011, J AM ACAD DERMATOL, V65, P1135, DOI 10.1016/j.jaad.2010.08.036; Wasko MCM, 2013, ARTHRITIS RHEUM-US, V65, P334, DOI 10.1002/art.37723	37	74	80	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2015	350								h1269	10.1136/bmj.h1269	http://dx.doi.org/10.1136/bmj.h1269			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EV	25770113	Green Published, hybrid			2022-12-28	WOS:000351183200003
J	Riordan, CG				Riordan, Charles G.			Catalysis by nickel in its high oxidation state	SCIENCE			English	Editorial Material									Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware	Riordan, CG (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	riordan@udel.edu			Direct For Mathematical & Physical Scien [1112035] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Boudreault PLT, 2007, J AM CHEM SOC, V129, P9125, DOI 10.1021/ja071923y; Bowers J, 2009, NAT METHODS, V6, P593, DOI 10.1038/nmeth.1354; Camasso NM, 2015, SCIENCE, V347, P1218, DOI 10.1126/science.aaa4526; Garrett CE, 2004, ADV SYNTH CATAL, V346, P889, DOI 10.1002/adsc.200404071; Kieber-Emmons MT, 2007, ACCOUNTS CHEM RES, V40, P618, DOI 10.1021/ar700043n; KLEIN HF, 1994, ORGANOMETALLICS, V13, P2557, DOI 10.1021/om00019a007; Lindahl PA, 2004, J BIOL INORG CHEM, V9, P516, DOI 10.1007/s00775-004-0564-x; Phapale VB, 2009, CHEM SOC REV, V38, P1598, DOI 10.1039/b805648j; Sehnal P, 2010, CHEM REV, V110, P824, DOI 10.1021/cr9003242; SERVICE RF, 2010, SCIENCE, V330, P308; Zhou YZ, 2012, HANDB PORPHYR SCI, V19, P1	12	8	8	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1203	1204		10.1126/science.aaa7553	http://dx.doi.org/10.1126/science.aaa7553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766220				2022-12-28	WOS:000350824300021
J	Hunter, DJ				Hunter, David J.			Role of politics in understanding complex, messy health systems: an essay by David J Hunter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POLICY		Univ Durham, Sch Med Pharm & Hlth, Ctr Publ Policy & Hlth, Durham, England	Durham University	Hunter, DJ (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Ctr Publ Policy & Hlth, Durham, England.	d.j.hunter@durham.ac.uk			Medical Research Council [MR/K02325X/1, MR/K02325X/1B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alford RR, 1975, HLTH CARE POLITICS; Chapman J., 2004, SYSTEM FAILURE WHY G; Chinitz D, 2014, J HEALTH POLIT POLIC, V39, P1113, DOI 10.1215/03616878-2813719; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Crick B., 1962, DEFENCE POLITICS; de Leeuw E, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-55; Draca M., 2014, SMF CAGE GLOBAL PERS, V1; Durham Health Summit Commentary, 2014, GOV HLTH CHANG WORLD; Francis R., 2013, REP MIDST NHS FDN TR; Gray J., 2003, QAEDA WHAT IT MEANS; Greener I, 2014, REFORMING HEALTHCARE: WHAT'S THE EVIDENCE?, P1; Griffiths Roy, 1983, NHS MANAGEMENT INQUI; Harrison S, 1992, JUST MANAGING POWER; Kickbusch I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h81; Kingdon JW, 1986, AGENDAS ALTERNATIVES; Klein R, 2006, OXFORD HDB PUBLIC PO, P905; Lasswell HD, 1936, POLITICS WHO GETS WH; London Health Commission, 2014, BETT HLTH LOND; Marmor TR, 2012, POLITICS HLTH HLTH C; Marmor TR, 2007, FADS FALLACIES FOOLI; Pawson R., 2013, SCI EVALUATION REALI; Pfeffer J., 1992, MANAGING POWER POLIT; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; POLLITT C, 1990, J SOC POLICY, V19, P169, DOI 10.1017/S0047279400001987; Virchow R., 1973, MED SOC; Wanless D., 2004, SECURING GOOD HLTH W	26	21	21	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2015	350								h1214	10.1136/bmj.h1214	http://dx.doi.org/10.1136/bmj.h1214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EA	25753054				2022-12-28	WOS:000351181100002
J	Black, N				Black, Nick			Next UK Government must trust in NHS staff and local solutions	LANCET			English	Editorial Material							HEALTH		London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	nick.black@lshtm.ac.uk						Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Black N, 2014, HLTH SERV J; Black N, 2015, J HEALTH SERV RES PO, V20, P65, DOI 10.1177/1355819615570922; Francis R, 2015, FREEDOM SPEAK INDEPE; Ham C, 2015, IMPLEMENTING NHS 5 Y; Ham C., 2014, REFORMING NHS HIERAR; Mayhew S, 2014, J HEALTH SERV RES PO, V19, P124, DOI 10.1177/1355819613516943; NHS England Care Quality Commission Public Health England Health Education England Monitor Trust Development Authority, 2014, NHS 5 YEAR FORW VIEW; Public Health England, 2014, SUST RES HLTH PEOPL; Stevens S., 2014, HLTH SERV J     1222; The National Advisory Group on the Safety of Patients in England, 2013, PROMISE LEARN COMMIT	12	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					831	832		10.1016/S0140-6736(15)60458-5	http://dx.doi.org/10.1016/S0140-6736(15)60458-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC6CB	25773074				2022-12-28	WOS:000350451100008
J	Carter, SM; Rogers, W; Heath, I; Degeling, C; Doust, J; Barratt, A				Carter, S. M.; Rogers, W.; Heath, I.; Degeling, C.; Doust, J.; Barratt, A.			The challenge of overdiagnosis begins with its definition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER		[Carter, S. M.; Degeling, C.] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Rogers, W.] Macquarie Univ, Philosophy Dept, N Ryde, NSW 2109, Australia; [Rogers, W.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW 2109, Australia; [Doust, J.] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia; [Barratt, A.] Sydney Sch Publ Hlth, Sydney, NSW, Australia	University of Sydney; Macquarie University; Macquarie University; Bond University; University of Sydney	Carter, SM (corresponding author), Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia.	stacy.carter@sydney.edu.au	Carter, Stacy/A-6544-2011; Barratt, Alexandra/A-7349-2011; Doust, Jenny/AGI-8773-2022; Degeling, Chris/ABE-2049-2020	Carter, Stacy/0000-0003-2617-8694; Barratt, Alexandra/0000-0002-2561-3319; Doust, Jenny/0000-0002-4024-9308; Degeling, Chris/0000-0003-4279-3443; Rogers, Wendy/0000-0001-9186-870X				[Anonymous], PREV OV WIND BACK HA; Brito JP, 2013, BMJ-BRIT MED J, V347, pf4706; Brodersen J, 2014, APMIS, V122, P683, DOI 10.1111/apm.12278; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Carter S, 2014, PREV OV C OXF 15 17; Consumer Health Choices, 2014, PREV OV CAMP; Entwistle V, 2012, J HEALTH SERV RES PO, V17, P70, DOI 10.1258/jhsrp.2011.011029; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; FEINLEIB M, 1969, ARCH ENVIRON HEALTH, V19, P412, DOI 10.1080/00039896.1969.10666863; FOX MS, 1979, JAMA-J AM MED ASSOC, V241, P489, DOI 10.1001/jama.241.5.489; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Heath I, 2013, BMJ-BRIT MED J, V347, pf6361; Heath I, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6123; Hoffman JR, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5702; Hofmann B, 2014, EUR J EPIDEMIOL, V29, P599, DOI 10.1007/s10654-014-9920-5; Kerlikowske Karla, 2014, Evid Based Med, V19, P183, DOI 10.1136/eb-2014-101798; Maughan D, 2014, PROTECTING RESOURCES; McCartney M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4454; Mintzes B, 2006, PLOS MED, V3, P461, DOI 10.1371/journal.pmed.0030198; Morden NE, 2014, NEW ENGL J MED, V370, P589, DOI 10.1056/NEJMp1314965; Morgan DJ, 2015, JAMA INTERN MED, V175, P120, DOI 10.1001/jamainternmed.2014.5444; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; NICE, CUT NHS WAST NICES D; Otte JA, 2015, LESS IS MORE MED; Pearson Steven, 2007, J Health Serv Res Policy, V12, P160; Pickles K, BMJ OPEN IN PRESS; Rogers W, 2014, PREV OV C OXF 15 17; Thomas R, 2013, BMJ-BRIT MED J, V347, pf6172; Welch H, 2011, OVERDIAGNOSED MAKING; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	33	142	143	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2015	350								h869	10.1136/bmj.h869	http://dx.doi.org/10.1136/bmj.h869			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4DS	25740625	Green Published			2022-12-28	WOS:000350301600005
J	Jaffe, S				Jaffe, Susan			Robert Califf : leading cardiologist is new FDA Deputy Commissioner	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					765	765		10.1016/S0140-6736(15)60425-1	http://dx.doi.org/10.1016/S0140-6736(15)60425-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25752165				2022-12-28	WOS:000350051700016
J	Burkewitz, K; Morantte, I; Weir, HJM; Yeo, R; Zhang, Y; Huynh, FK; Ilkayeva, OR; Hirschey, MD; Grant, AR; Mair, WB				Burkewitz, Kristopher; Morantte, Ianessa; Weir, Heather J. M.; Yeo, Robin; Zhang, Yue; Huynh, Frank K.; Ilkayeva, Olga R.; Hirschey, Matthew D.; Grant, Ana R.; Mair, William B.			Neuronal CRTC-1 Governs Systemic Mitochondrial Metabolism and Lifespan via a Catecholamine Signal	CELL			English	Article							DIETARY RESTRICTION; OXIDATIVE STRESS; PPAR-GAMMA; AMPK; NUTRIENT; CREB; LONGEVITY; CALCINEURIN; HEALTHSPAN; OCTOPAMINE	Low energy states delay aging in multiple species, yet mechanisms coordinating energetics and longevity across tissues remain poorly defined. The conserved energy sensor AMP-activated protein kinase (AMPK) and its corresponding phosphatase calcineurin modulate longevity via the CREB regulated transcriptional coactivator (CRTC)-1 in C. elegans. We show that CRTC-1 specifically uncouples AMPK/calcineurin-mediated effects on lifespan from pleiotropic side effects by reprogramming mitochondrial and metabolic function. This pro-longevity metabolic state is regulated cell nonautonomously by CRTC-1 in the nervous system. Neuronal CRTC-1/CREB regulates peripheral metabolism antagonistically with the functional PPAR alpha ortholog, NHR-49, drives mitochondrial fragmentation in distal tissues, and suppresses the effects of AMPK on systemic mitochondrial metabolism and longevity via a cell-nonautonomous catecholamine signal. These results demonstrate that while both local and distal mechanisms combine to modulate aging, distal regulation overrides local contribution. Targeting central perception of energetic state is therefore a potential strategy to promote healthy aging.	[Burkewitz, Kristopher; Morantte, Ianessa; Weir, Heather J. M.; Yeo, Robin; Zhang, Yue; Mair, William B.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Huynh, Frank K.; Ilkayeva, Olga R.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Grant, Ana R.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Harvard University; Harvard T.H. Chan School of Public Health; Duke University; University of Michigan System; University of Michigan	Mair, WB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wmair@hsph.harvard.edu	Huynh, Frank/AAK-9575-2020	Huynh, Frank/0000-0002-4764-9558; Grant, Ana/0000-0002-5439-9331; Hirschey, Matthew/0000-0003-4541-5376; , Kristopher/0000-0001-8531-0566; Mair, William/0000-0002-0661-1342	Ellison Medical Foundation; NIH [1R01AG044346, U54CA155626, 1R01AG045351, 1F32AG044944]; American Diabetes Association/Canadian Diabetes Association [PF-3-13-4342]; NATIONAL CANCER INSTITUTE [U54CA155626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351, R01AG044346, F32AG044944] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association/Canadian Diabetes Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding support was provided by the Ellison Medical Foundation (WBM and MDH) the NIH [1R01AG044346 (WBM), U54CA155626 (WBM), 1R01AG045351 (MDH), 1F32AG044944 (KB)], and the American Diabetes Association/Canadian Diabetes Association PF-3-13-4342 (FH). We thank the Caenorhabditis Genetic Center for providing several strains, Mark Alkema for the crh-1(n3315) mutant, and Sean Curran/Paul Sternberg for the mitochondrial marker strain. We also thank Tinatini Tavhelidse and Ana Paula Morales Allende for preliminary contributions to the project.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi Kaveh, 2007, WormBook, P1; Bantubungi K, 2012, J STEROID BIOCHEM, V130, P126, DOI 10.1016/j.jsbmb.2011.10.002; Breuillaud L, 2009, NAT MED, V15, P989, DOI 10.1038/nm0909-989; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Cunningham KA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004394; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dwivedi M, 2009, AUTOPHAGY, V5, P604, DOI 10.4161/auto.5.5.8157; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Knauf C, 2006, ENDOCRINOLOGY, V147, P4067, DOI 10.1210/en.2005-1536; Kocalis HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042981; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006; Tao L, 2013, ELIFE, V2, DOI 10.7554/eLife.00518; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001	36	116	122	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					842	855		10.1016/j.cell.2015.02.004	http://dx.doi.org/10.1016/j.cell.2015.02.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723162	Bronze, Green Accepted			2022-12-28	WOS:000351116100008
J	Oshimori, N; Oristian, D; Fuchs, E				Oshimori, Naoki; Oristian, Daniel; Fuchs, Elaine			TGF-beta Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma	CELL			English	Article							GROWTH-FACTOR-BETA; STEM-CELLS; CANCER; SMAD; DIFFERENTIATION; PROGRESSION; INITIATION; EVOLUTION; HIERARCHY; SOX2	Subsets of long-lived, tumor-initiating stem cells often escape cancer therapies. However, sources and mechanisms that generate tumor heterogeneity and drug-resistant cell population are still unfolding. Here, we devise a functional reporter system to lineage trace and/or genetic ablate signaling in TGF-beta-activated squannous cell carcinoma stem cells (SCC-SCs). Dissecting TGF-beta's impact on malignant progression, we demonstrate that TGF-beta concentrating near tumor-vasculature generates heterogeneity in TGF-beta signaling at tumor-stroma interface and bestows slower-cycling properties to neighboring SCC-SCs. While non-responding progenies proliferate faster and accelerate tumor growth, TGF-beta-responding progenies invade, aberrantly differentiate, and affect gene expression. Intriguingly, TGF-beta-responding SCC-SCs show increased protection against anti-cancer drugs, but slowercycling alone does not confer survival. Rather, TGF-beta transcriptionally activates p21, which stabilizes NRF2, thereby markedly enhancing glutathione metabolism and diminishing effectiveness of anticancer therapeutics. Together, these findings establish a surprising non-genetic paradigm for TGF-beta signaling in fueling heterogeneity in SCC-SCs, tumor characteristics, and drug resistance.	[Oshimori, Naoki; Oristian, Daniel; Fuchs, Elaine] Rockefeller Univ, Robin Neustein Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Robin Neustein Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		Human Frontier Science Program; Japan Society for the Promotion of Science; NIH [K99-R00]; New York State Department of Health [NYSTEM-C029559]; National Cancer Institute [K99-CA178197]; NATIONAL CANCER INSTITUTE [K99CA178197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B. Reva for helpful consultation regarding TCGA data analyses; S. Karlsson for floxed-Tgfbr2 mice; F. Costantini for Rosa-YFP mice; L. Chin for TetO-Hras mice; and L. Polak, J. Levorse, and others for assistance in the mouse facility. We are grateful to extensive interactions and helpful discussions with former and present Fuchs lab members. We appreciate the assistance of RU's Comparative Bioscience Center (an AAALAC facility) for expert care and housing of our mice, the RU Flow Cytometry Resource Center (S. Mazel, Director) and Weill Cornell Medical College Genomics Resources Core Facility for Illumina sequencing (J. Xiang, Director). N.O was supported by Human Frontier Science Program and the Japan Society for the Promotion of Science and is now supported by NIH K99-R00 pathway to independence award. E.F. is an investigator of the Howard Hughes Medical Institute. This work was supported by grants from the NIH and from the New York State Department of Health (NYSTEM-C029559) to E.F. and from the National Cancer Institute (K99-CA178197) to N.O.	Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Berns A, 2005, CELL, V121, P811, DOI 10.1016/j.cell.2005.06.004; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Derynck R., 2008, TGF BETA FAMILY; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; GROTENDORST GR, 1989, J CELL PHYSIOL, V140, P396, DOI 10.1002/jcp.1041400226; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; NISCHT R, 1988, MOL CARCINOGEN, V1, P96, DOI 10.1002/mc.2940010205; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Siegle JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5511; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114	40	305	314	6	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					963	976		10.1016/j.cell.2015.01.043	http://dx.doi.org/10.1016/j.cell.2015.01.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	25723170	Bronze, Green Accepted			2022-12-28	WOS:000351116100018
J	Rochmyaningsih, D				Rochmyaningsih, Dyna			Focus on political Islamic groups to boost science	NATURE			English	Editorial Material												drochmya87@gmail.com							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					457	457		10.1038/518457a	http://dx.doi.org/10.1038/518457a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC1JP	25719629	Bronze			2022-12-28	WOS:000350097300004
J	Lessa, FC; Winston, LG; McDonald, LC				Lessa, Fernanda C.; Winston, Lisa G.; McDonald, L. Clifford		Emerging Infect Program C Difficil	Burden of Clostridium difficile Infection in the United States REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Lessa, Fernanda C.; McDonald, L. Clifford] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Winston, Lisa G.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Lessa, FC (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.	flessa@cdc.gov	; Kuijper, Ed/AAB-7853-2022	McDonald, L. Clifford/0000-0003-3044-5572; Kuijper, Ed/0000-0001-5726-2405				Deshpande A, 2011, CLIN INFECT DIS, V53, pE81, DOI 10.1093/cid/cir505; Dubberke ER, 2011, J CLIN MICROBIOL, V49, P2887, DOI 10.1128/JCM.00891-11; Hensgens MPM, 2014, CLIN MICROBIOL INFEC, V20, pO1067, DOI 10.1111/1469-0691.12758	3	1769	1820	2	101	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2369	2370						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	25714160				2022-12-28	WOS:000356019200027
J	Lessa, FC; Mu, Y; Bamberg, WM; Beldavs, ZG; Dumyati, GK; Dunn, JR; Farley, MM; Holzbauer, SM; Meek, JI; Phipps, EC; Wilson, LE; Winston, LG; Cohen, JA; Limbago, BM; Fridkin, SK; Gerding, DN; McDonald, LC				Lessa, Fernanda C.; Mu, Yi; Bamberg, Wendy M.; Beldavs, Zintars G.; Dumyati, Ghinwa K.; Dunn, John R.; Farley, Monica M.; Holzbauer, Stacy M.; Meek, James I.; Phipps, Erin C.; Wilson, Lucy E.; Winston, Lisa G.; Cohen, Jessica A.; Limbago, Brandi M.; Fridkin, Scott K.; Gerding, Dale N.; McDonald, L. Clifford			Burden of Clostridium difficile Infection in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CHANGING EPIDEMIOLOGY; HOSPITAL-ONSET; RATES; DISEASE; PREVALENCE; VALIDATION; PREDICTORS; MORTALITY; PROGRAM	BACKGROUND The magnitude and scope of Clostridium difficile infection in the United States continue to evolve. METHODS In 2011, we performed active population-and laboratory-based surveillance across 10 geographic areas in the United States to identify cases of C. difficile infection (stool specimens positive for C. difficile on either toxin or molecular assay in residents >= 1 year of age). Cases were classified as community-associated or health care-associated. In a sample of cases of C. difficile infection, specimens were cultured and isolates underwent molecular typing. We used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection. RESULTS A total of 15,461 cases of C. difficile infection were identified in the 10 geographic areas; 65.8% were health care-associated, but only 24.2% had onset during hospitalization. After adjustment for predictors of disease incidence, the estimated number of incident C. difficile infections in the United States was 453,000 (95% confidence interval [CI], 397,100 to 508,500). The incidence was estimated to be higher among females (rate ratio, 1.26; 95% CI, 1.25 to 1.27), whites (rate ratio, 1.72; 95% CI, 1.56 to 2.0), and persons 65 years of age or older (rate ratio, 8.65; 95% CI, 8.16 to 9.31). The estimated number of first recurrences of C. difficile infection was 83,000 (95% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100). The North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care-associated infections than among community-associated infections (30.7% vs. 18.8%, P< 0.001) CONCLUSIONS C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011.	[Lessa, Fernanda C.; Mu, Yi; Cohen, Jessica A.; Limbago, Brandi M.; Fridkin, Scott K.; McDonald, L. Clifford] Ctr Dis Control & Prevent CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div Healthcare Qual Promot, Atlanta, GA USA; [Farley, Monica M.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Farley, Monica M.] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; [Holzbauer, Stacy M.] CDC Off Publ Hlth Preparedness & Response, Div State & Local Readiness, Atlanta, GA USA; [Cohen, Jessica A.] Atlanta Res & Educ Fdn, Atlanta, GA USA; [Bamberg, Wendy M.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Beldavs, Zintars G.] Oregon Hlth Author, Publ Hlth Div, Portland, OR USA; [Dumyati, Ghinwa K.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Dunn, John R.] Tennessee Dept Hlth, Nashville, TN USA; [Holzbauer, Stacy M.] Minnesota Dept Hlth, St Paul, MN USA; [Meek, James I.] Yale Univ, Sch Publ Hlth, Connecticut Emerging Infect Program, New Haven, CT USA; [Phipps, Erin C.] Univ New Mexico, New Mexico Emerging Infect Program, Albuquerque, NM 87131 USA; [Wilson, Lucy E.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Winston, Lisa G.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA; [Gerding, Dale N.] Loyola Univ, Chicago Stritch Sch Med, Dept Med, Maywood, IL 60153 USA; [Gerding, Dale N.] Edward Hines Jr Vet Affairs Hosp, Hines, IL USA	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Colorado Department of Public Health & Environment; University of Rochester; Tennessee Department Health; Minnesota Department of Health (MHD); Yale University; University of New Mexico; Maryland Department of Health & Mental Hygiene; University of California System; University of California San Francisco; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Lessa, FC (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS C-25, Atlanta, GA 30333 USA.	flessa@cdc.gov	; Kuijper, Ed/AAB-7853-2022	McDonald, L. Clifford/0000-0003-3044-5572; Kuijper, Ed/0000-0001-5726-2405	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the Centers for Disease Control and Prevention.	[Anonymous], 2009, SAMPLING DESIGN ANAL; [Anonymous], 2014, FED REG, V79, P10524; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P1201; ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; Ashiru-Oredope D, 2012, J ANTIMICROB CHEMOTH, V67, pI51, DOI 10.1093/jac/dks202; Aslam S, 2005, LANCET INFECT DIS, V5, P549, DOI 10.1016/S1473-3099(05)70215-2; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bloomfield MG, 2013, EUR J GASTROEN HEPAT, V25, P700, DOI 10.1097/MEG.0b013e32835ed64d; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P51476; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Cohen J, 2014, J CLIN MICROBIOL, V52, P632, DOI 10.1128/JCM.02177-13; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Costa MC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-38; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI DOI 10.1007/s00134-012-2769-8; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gould CV, 2013, CLIN INFECT DIS, V57, P1304, DOI 10.1093/cid/cit492; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Healthcare Cost and Utilization Project, 201201 HEALTHC COST; HEITJAN DF, 1991, J R STAT SOC C-APPL, V40, P13; Hensgens MPM, 2013, CLIN INFECT DIS, V56, P1108, DOI 10.1093/cid/cis1209; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Koo HL, 2014, INFECT CONT HOSP EP, V35, P667, DOI 10.1086/676433; Kuntz JL, 2012, EMERG INFECT DIS, V18, P960, DOI 10.3201/eid1806.111528; Lessa FC, 2014, OPEN FORUM INFE 0630; Longtin Y, 2013, CLIN INFECT DIS, V56, P67, DOI 10.1093/cid/cis840; Loo VG, 2006, NEW ENGL J MED, V354, P2200; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; Pawar D, 2012, INFECT CONT HOSP EP, V33, P1107, DOI 10.1086/668031; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Ratnayake L, 2011, J HOSP INFECT, V79, P242, DOI 10.1016/j.jhin.2011.06.013; See I, 2014, CLIN INFECT DIS, V58, P1394, DOI 10.1093/cid/ciu125; Sharp S, 2010, PRACTICAL GUIDANCE D; Tabak YP, 2013, INFECT CONT HOSP EP, V34, P588, DOI 10.1086/670621; VISCIDI R, 1981, GASTROENTEROLOGY, V81, P5; Wayne E, 2014, 2013 IDWEEK SAN FRAN; Weese JS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-41; Wendt JM, 2014, PEDIATRICS, V133, P651, DOI 10.1542/peds.2013-3049; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Zilberberg MD, 2014, J HOSP MED, V9, P418, DOI 10.1002/jhm.2189	49	1769	1820	2	101	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					825	834		10.1056/NEJMoa1408913	http://dx.doi.org/10.1056/NEJMoa1408913			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB8SQ	25714160				2022-12-28	WOS:000349901700007
J	Gewin, V				Gewin, Virginia			OUTREACH Speak up for science	NATURE			English	Article																		Jamieson KH, 2014, P NATL ACAD SCI USA, V111, P13598, DOI 10.1073/pnas.1320868111; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Scott-Phillips TC, 2014, EVOLUTION, V68, P1231, DOI 10.1111/evo.12332; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	5	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					231	233		10.1038/nj7533-231a	http://dx.doi.org/10.1038/nj7533-231a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25767845	Bronze			2022-12-28	WOS:000347477600043
